Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	...25	Residue	Gene
NM_007294.4(BRCA1):c.5588A>G (p.Tyr1863Cys)	BRCA1	Y1863C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631316	17	41197699	17	43045682	631316	618547	rs1567756242	NC_000017.11:43045681:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 26, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1863	BRCA1
NM_007294.4(BRCA1):c.5587T>G (p.Tyr1863Asp)	BRCA1	Y1863D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000231744	17	41197700	17	43045683	231744	235922	rs763740623	NC_000017.11:43045682:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1863	BRCA1
NM_007294.4(BRCA1):c.5586C>A (p.His1862Gln)	BRCA1	H1862Q	Hereditary cancer-predisposing syndrome	VCV002774824	17	41197701	17	43045684	2774824	2935551	NA	NC_000017.11:43045683:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1862	BRCA1
NM_007294.4(BRCA1):c.5586C>G (p.His1862Gln)	BRCA1	H1862Q	Hereditary breast ovarian cancer syndrome	VCV001522936	17	41197701	17	43045684	1522936	1460129	rs774127304	NC_000017.11:43045683:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1862	BRCA1
NM_007294.4(BRCA1):c.5585A>G (p.His1862Arg)	BRCA1	H1862R	Hereditary breast ovarian cancer syndrome	VCV000462678	17	41197702	17	43045685	462678	467871	rs80357183	NC_000017.11:43045684:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 30, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1862	BRCA1
NM_007294.4(BRCA1):c.5585A>T (p.His1862Leu)	BRCA1	H1862L	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast	VCV000055637	17	41197702	17	43045685	55637	70304	rs80357183	NC_000017.11:43045684:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Feb 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1862	BRCA1
NM_007294.4(BRCA1):c.5584C>T (p.His1862Tyr)	BRCA1	H1862Y	Hereditary cancer-predisposing syndrome	VCV001748439	17	41197703	17	43045686	1748439	1806687	NA	NC_000017.11:43045685:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 19, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1862	BRCA1
NM_007294.4(BRCA1):c.5583C>A (p.Ser1861Arg)	BRCA1	S1861R	Hereditary breast ovarian cancer syndrome	VCV002011282	17	41197704	17	43045687	2011282	2074356	NA	NC_000017.11:43045686:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1861	BRCA1
NM_007294.4(BRCA1):c.5582G>A (p.Ser1861Asn)	BRCA1	S1861N	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001381587	17	41197705	17	43045688	1381587	1496549	rs2152483837	NC_000017.11:43045687:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1861	BRCA1
NM_007294.4(BRCA1):c.5580C>A (p.His1860Gln)	BRCA1	H1860Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001748423	17	41197707	17	43045690	1748423	1806671	NA	NC_000017.11:43045689:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1860	BRCA1
NM_007294.4(BRCA1):c.5580C>G (p.His1860Gln)	BRCA1	H1860Q	not specified|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803401	17	41197707	17	43045690	803401	791755	rs1597796507	NC_000017.11:43045689:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1860	BRCA1
NM_007294.4(BRCA1):c.5579A>C (p.His1860Pro)	BRCA1	H1860P	not provided	VCV000041833	17	41197708	17	43045691	41833	50272	rs201196020	NC_000017.11:43045690:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Jul 13, 2012	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1860	BRCA1
NM_007294.4(BRCA1):c.5578C>A (p.His1860Asn)	BRCA1	H1860N	Hereditary breast ovarian cancer syndrome	VCV001714923	17	41197709	17	43045692	1714923	1777924	NA	NC_000017.11:43045691:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1860	BRCA1
NM_007294.4(BRCA1):c.5576C>T (p.Pro1859Leu)	BRCA1	P1859L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002090625	17	41197711	17	43045694	2090625	2148429	NA	NC_000017.11:43045693:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1859	BRCA1
NM_007294.4(BRCA1):c.5576C>G (p.Pro1859Arg)	BRCA1	P1859R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055634	17	41197711	17	43045694	55634	70301	rs80357322	NC_000017.11:43045693:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1859	BRCA1
NM_007294.4(BRCA1):c.5575C>T (p.Pro1859Ser)	BRCA1	P1859S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified	VCV000462677	17	41197712	17	43045695	462677	468103	rs1555574342	NC_000017.11:43045694:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1859	BRCA1
NM_007294.4(BRCA1):c.5575C>A (p.Pro1859Thr)	BRCA1	P1859T	Hereditary breast ovarian cancer syndrome	VCV000462676	17	41197712	17	43045695	462676	468106	rs1555574342	NC_000017.11:43045694:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	May 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1859	BRCA1
NM_007294.4(BRCA1):c.5574C>G (p.Ile1858Met)	BRCA1	I1858M	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000438943	17	41197713	17	43045696	438943	432890	rs876659941	NC_000017.11:43045695:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1858	BRCA1
NM_007294.4(BRCA1):c.5573T>A (p.Ile1858Asn)	BRCA1	I1858N	Hereditary breast ovarian cancer syndrome	VCV000851795	17	41197714	17	43045697	851795	845357	rs755427809	NC_000017.11:43045696:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 13, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1858	BRCA1
NM_007294.4(BRCA1):c.5573T>C (p.Ile1858Thr)	BRCA1	I1858T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000186496	17	41197714	17	43045697	186496	184863	rs755427809	NC_000017.11:43045696:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1858	BRCA1
NM_007294.4(BRCA1):c.5572A>G (p.Ile1858Val)	BRCA1	I1858V	Hereditary breast ovarian cancer syndrome	VCV002693360	17	41197715	17	43045698	2693360	2857344	NA	NC_000017.11:43045697:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1858	BRCA1
NM_007294.4(BRCA1):c.5572A>T (p.Ile1858Phe)	BRCA1	I1858F	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409352	17	41197715	17	43045698	409352	402454	rs765656957	NC_000017.11:43045697:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1858	BRCA1
NM_007294.4(BRCA1):c.5572A>C (p.Ile1858Leu)	BRCA1	I1858L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183951	17	41197715	17	43045698	183951	184864	rs765656957	NC_000017.11:43045697:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1858	BRCA1
NM_007294.4(BRCA1):c.5571G>T (p.Gln1857His)	BRCA1	Q1857H	Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000246518	17	41197716	17	43045699	246518	245017	rs28897699	NC_000017.11:43045698:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1857	BRCA1
NM_007294.4(BRCA1):c.5571G>C (p.Gln1857His)	BRCA1	Q1857H	Hereditary cancer-predisposing syndrome	VCV000185265	17	41197716	17	43045699	185265	184865	rs28897699	NC_000017.11:43045698:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1857	BRCA1
NM_007294.4(BRCA1):c.5567C>T (p.Pro1856Leu)	BRCA1	P1856L	Hereditary cancer-predisposing syndrome	VCV000921369	17	41197720	17	43045703	921369	913858	rs2050857212	NC_000017.11:43045702:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 27, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1856	BRCA1
NM_007294.4(BRCA1):c.5566C>G (p.Pro1856Ala)	BRCA1	P1856A	Hereditary breast ovarian cancer syndrome	VCV002954773	17	41197721	17	43045704	2954773	3115127	NA	NC_000017.11:43045703:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1856	BRCA1
NM_007294.4(BRCA1):c.5566C>A (p.Pro1856Thr)	BRCA1	P1856T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409334	17	41197721	17	43045704	409334	401936	rs80357274	NC_000017.11:43045703:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1856	BRCA1
NM_007294.4(BRCA1):c.5566C>T (p.Pro1856Ser)	BRCA1	P1856S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000055632	17	41197721	17	43045704	55632	70299	rs80357274	NC_000017.11:43045703:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1856	BRCA1
NM_007294.4(BRCA1):c.5565A>G (p.Ile1855Met)	BRCA1	I1855M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869059	17	41197722	17	43045705	869059	853071	rs758449088	NC_000017.11:43045704:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1855	BRCA1
NM_007294.4(BRCA1):c.5564T>G (p.Ile1855Arg)	BRCA1	I1855R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869058	17	41197723	17	43045706	869058	853072	rs900082291	NC_000017.11:43045705:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1855	BRCA1
NM_007294.4(BRCA1):c.5564T>A (p.Ile1855Lys)	BRCA1	I1855K	Hereditary cancer-predisposing syndrome	VCV000868679	17	41197723	17	43045706	868679	853073	rs900082291	NC_000017.11:43045705:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1855	BRCA1
NM_007294.4(BRCA1):c.5564T>C (p.Ile1855Thr)	BRCA1	I1855T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482917	17	41197723	17	43045706	482917	478640	rs900082291	NC_000017.11:43045705:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1855	BRCA1
NM_007294.4(BRCA1):c.5563A>T (p.Ile1855Leu)	BRCA1	I1855L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868678	17	41197724	17	43045707	868678	853074	rs2050858402	NC_000017.11:43045706:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1855	BRCA1
NM_007294.4(BRCA1):c.5563A>G (p.Ile1855Val)	BRCA1	I1855V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000868677	17	41197724	17	43045707	868677	853075	rs2050858402	NC_000017.11:43045706:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1855	BRCA1
NM_007294.4(BRCA1):c.5563A>C (p.Ile1855Leu)	BRCA1	I1855L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868676	17	41197724	17	43045707	868676	853076	rs2050858402	NC_000017.11:43045706:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1855	BRCA1
NM_007294.4(BRCA1):c.5561T>G (p.Leu1854Arg)	BRCA1	L1854R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867670	17	41197726	17	43045709	867670	853079	rs80356996	NC_000017.11:43045708:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1854	BRCA1
NM_007294.4(BRCA1):c.5561T>A (p.Leu1854Gln)	BRCA1	L1854Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867669	17	41197726	17	43045709	867669	853080	rs80356996	NC_000017.11:43045708:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1854	BRCA1
NM_007294.4(BRCA1):c.5561T>C (p.Leu1854Pro)	BRCA1	L1854P	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000055631	17	41197726	17	43045709	55631	70298	rs80356996	NC_000017.11:43045708:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1854	BRCA1
NM_007294.4(BRCA1):c.5560C>G (p.Leu1854Val)	BRCA1	L1854V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867667	17	41197727	17	43045710	867667	853082	rs2050859600	NC_000017.11:43045709:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1854	BRCA1
NM_007294.4(BRCA1):c.5560C>A (p.Leu1854Met)	BRCA1	L1854M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867666	17	41197727	17	43045710	867666	853083	rs2050859600	NC_000017.11:43045709:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1854	BRCA1
NM_007294.4(BRCA1):c.5558A>T (p.Tyr1853Phe)	BRCA1	Y1853F	Hereditary cancer-predisposing syndrome	VCV000865017	17	41197729	17	43045712	865017	853085	rs80357258	NC_000017.11:43045711:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 4, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1853	BRCA1
NM_007294.4(BRCA1):c.5558A>C (p.Tyr1853Ser)	BRCA1	Y1853S	Hereditary cancer-predisposing syndrome	VCV000865016	17	41197729	17	43045712	865016	853086	rs80357258	NC_000017.11:43045711:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Sep 10, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1853	BRCA1
NM_007294.4(BRCA1):c.5558A>G (p.Tyr1853Cys)	BRCA1	Y1853C	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055627	17	41197729	17	43045712	55627	70294	rs80357258	NC_000017.11:43045711:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1853	BRCA1
NM_007294.4(BRCA1):c.5557T>G (p.Tyr1853Asp)	BRCA1	Y1853D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865015	17	41197730	17	43045713	865015	853087	rs2050860958	NC_000017.11:43045712:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1853	BRCA1
NM_007294.4(BRCA1):c.5557T>C (p.Tyr1853His)	BRCA1	Y1853H	Hereditary breast ovarian cancer syndrome	VCV000865014	17	41197730	17	43045713	865014	853088	rs2050860958	NC_000017.11:43045712:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1853	BRCA1
NM_007294.4(BRCA1):c.5557T>A (p.Tyr1853Asn)	BRCA1	Y1853N	Hereditary breast ovarian cancer syndrome	VCV000433738	17	41197730	17	43045713	433738	427518	rs2050860958	NC_000017.11:43045712:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Oct 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1853	BRCA1
NM_007294.4(BRCA1):c.5555C>G (p.Thr1852Ser)	BRCA1	T1852S	Hereditary breast ovarian cancer syndrome	VCV000869042	17	41197732	17	43045715	869042	853091	rs730881502	NC_000017.11:43045714:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1852	BRCA1
NM_007294.4(BRCA1):c.5555C>A (p.Thr1852Asn)	BRCA1	T1852N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869041	17	41197732	17	43045715	869041	853092	rs730881502	NC_000017.11:43045714:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1852	BRCA1
NM_007294.4(BRCA1):c.5555C>T (p.Thr1852Ile)	BRCA1	T1852I	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000182174	17	41197732	17	43045715	182174	180811	rs730881502	NC_000017.11:43045714:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1852	BRCA1
NM_007294.4(BRCA1):c.5554A>T (p.Thr1852Ser)	BRCA1	T1852S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869040	17	41197733	17	43045716	869040	853093	rs1555574370	NC_000017.11:43045715:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1852	BRCA1
NM_007294.4(BRCA1):c.5554A>C (p.Thr1852Pro)	BRCA1	T1852P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869039	17	41197733	17	43045716	869039	853094	rs1555574370	NC_000017.11:43045715:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1852	BRCA1
NM_007294.4(BRCA1):c.5554A>G (p.Thr1852Ala)	BRCA1	T1852A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000441287	17	41197733	17	43045716	441287	435102	rs1555574370	NC_000017.11:43045715:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1852	BRCA1
NM_007294.4(BRCA1):c.5553C>G (p.Asp1851Glu)	BRCA1	D1851E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868661	17	41197734	17	43045717	868661	853095	rs80357326	NC_000017.11:43045716:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5553C>A (p.Asp1851Glu)	BRCA1	D1851E	Hereditary cancer-predisposing syndrome	VCV000055624	17	41197734	17	43045717	55624	70291	rs80357326	NC_000017.11:43045716:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5552A>T (p.Asp1851Val)	BRCA1	D1851V	Hereditary breast ovarian cancer syndrome	VCV000868660	17	41197735	17	43045718	868660	853096	rs2050862656	NC_000017.11:43045717:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 19, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5552A>G (p.Asp1851Gly)	BRCA1	D1851G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868659	17	41197735	17	43045718	868659	853097	rs2050862656	NC_000017.11:43045717:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5552A>C (p.Asp1851Ala)	BRCA1	D1851A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868658	17	41197735	17	43045718	868658	853098	rs2050862656	NC_000017.11:43045717:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5551G>T (p.Asp1851Tyr)	BRCA1	D1851Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868657	17	41197736	17	43045719	868657	853099	rs2050862880	NC_000017.11:43045718:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5551G>C (p.Asp1851His)	BRCA1	D1851H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868656	17	41197736	17	43045719	868656	853100	rs2050862880	NC_000017.11:43045718:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5551G>A (p.Asp1851Asn)	BRCA1	D1851N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000853644	17	41197736	17	43045719	853644	845359	rs2050862880	NC_000017.11:43045718:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1851	BRCA1
NM_007294.4(BRCA1):c.5549T>G (p.Leu1850Arg)	BRCA1	L1850R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867654	17	41197738	17	43045721	867654	853102	rs2050863562	NC_000017.11:43045720:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1850	BRCA1
NM_007294.4(BRCA1):c.5549T>C (p.Leu1850Pro)	BRCA1	L1850P	Hereditary breast ovarian cancer syndrome	VCV000867653	17	41197738	17	43045721	867653	853103	rs2050863562	NC_000017.11:43045720:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1850	BRCA1
NM_007294.4(BRCA1):c.5549T>A (p.Leu1850Gln)	BRCA1	L1850Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867652	17	41197738	17	43045721	867652	853104	rs2050863562	NC_000017.11:43045720:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1850	BRCA1
NM_007294.4(BRCA1):c.5548C>G (p.Leu1850Val)	BRCA1	L1850V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865005	17	41197739	17	43045722	865005	853106	rs2050863835	NC_000017.11:43045721:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1850	BRCA1
NM_007294.4(BRCA1):c.5548C>A (p.Leu1850Met)	BRCA1	L1850M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865004	17	41197739	17	43045722	865004	853107	rs2050863835	NC_000017.11:43045721:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1850	BRCA1
NM_007294.4(BRCA1):c.5547G>T (p.Glu1849Asp)	BRCA1	E1849D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865003	17	41197740	17	43045723	865003	853108	rs1426388214	NC_000017.11:43045722:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1849	BRCA1
NM_007294.4(BRCA1):c.5547G>C (p.Glu1849Asp)	BRCA1	E1849D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865002	17	41197740	17	43045723	865002	853109	rs1426388214	NC_000017.11:43045722:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1849	BRCA1
NM_007294.4(BRCA1):c.5546A>T (p.Glu1849Val)	BRCA1	E1849V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865001	17	41197741	17	43045724	865001	853110	rs2050864495	NC_000017.11:43045723:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1849	BRCA1
NM_007294.4(BRCA1):c.5546A>G (p.Glu1849Gly)	BRCA1	E1849G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865000	17	41197741	17	43045724	865000	853111	rs2050864495	NC_000017.11:43045723:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1849	BRCA1
NM_007294.4(BRCA1):c.5546A>C (p.Glu1849Ala)	BRCA1	E1849A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864999	17	41197741	17	43045724	864999	853112	rs2050864495	NC_000017.11:43045723:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1849	BRCA1
NM_007294.4(BRCA1):c.5545G>C (p.Glu1849Gln)	BRCA1	E1849Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869029	17	41197742	17	43045725	869029	853114	rs2050864747	NC_000017.11:43045724:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1849	BRCA1
NM_007294.4(BRCA1):c.5545G>A (p.Glu1849Lys)	BRCA1	E1849K	Hereditary cancer-predisposing syndrome	VCV000869028	17	41197742	17	43045725	869028	853115	rs2050864747	NC_000017.11:43045724:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jan 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1849	BRCA1
NM_007294.4(BRCA1):c.5544G>T (p.Gln1848His)	BRCA1	Q1848H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869027	17	41197743	17	43045726	869027	853116	rs2050865178	NC_000017.11:43045725:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1848	BRCA1
NM_007294.4(BRCA1):c.5544G>C (p.Gln1848His)	BRCA1	Q1848H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869026	17	41197743	17	43045726	869026	853117	rs2050865178	NC_000017.11:43045725:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1848	BRCA1
NM_007294.4(BRCA1):c.5543A>T (p.Gln1848Leu)	BRCA1	Q1848L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869024	17	41197744	17	43045727	869024	853119	rs2050865445	NC_000017.11:43045726:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1848	BRCA1
NM_007294.4(BRCA1):c.5543A>G (p.Gln1848Arg)	BRCA1	Q1848R	Hereditary cancer-predisposing syndrome	VCV000869023	17	41197744	17	43045727	869023	853120	rs2050865445	NC_000017.11:43045726:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jan 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1848	BRCA1
NM_007294.4(BRCA1):c.5543A>C (p.Gln1848Pro)	BRCA1	Q1848P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868640	17	41197744	17	43045727	868640	853121	rs2050865445	NC_000017.11:43045726:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1848	BRCA1
NM_007294.4(BRCA1):c.5542C>G (p.Gln1848Glu)	BRCA1	Q1848E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868639	17	41197745	17	43045728	868639	853122	rs886040303	NC_000017.11:43045727:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1848	BRCA1
NM_007294.4(BRCA1):c.5542C>A (p.Gln1848Lys)	BRCA1	Q1848K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868638	17	41197745	17	43045728	868638	853123	rs886040303	NC_000017.11:43045727:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1848	BRCA1
NM_007294.4(BRCA1):c.5541C>G (p.Cys1847Trp)	BRCA1	C1847W	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000868637	17	41197746	17	43045729	868637	853124	rs397509295	NC_000017.11:43045728:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1847	BRCA1
NM_007294.4(BRCA1):c.5540G>C (p.Cys1847Ser)	BRCA1	C1847S	Hereditary cancer-predisposing syndrome	VCV000867639	17	41197747	17	43045730	867639	853125	rs1182000313	NC_000017.11:43045729:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Nov 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1847	BRCA1
NM_007294.4(BRCA1):c.5540G>A (p.Cys1847Tyr)	BRCA1	C1847Y	Hereditary cancer-predisposing syndrome|not provided	VCV000867638	17	41197747	17	43045730	867638	853126	rs1182000313	NC_000017.11:43045729:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 22, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1847	BRCA1
NM_007294.4(BRCA1):c.5540G>T (p.Cys1847Phe)	BRCA1	C1847F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000582037	17	41197747	17	43045730	582037	569065	rs1182000313	NC_000017.11:43045729:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1847	BRCA1
NM_007294.4(BRCA1):c.5539T>G (p.Cys1847Gly)	BRCA1	C1847G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867637	17	41197748	17	43045731	867637	853127	rs2050866725	NC_000017.11:43045730:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1847	BRCA1
NM_007294.4(BRCA1):c.5539T>C (p.Cys1847Arg)	BRCA1	C1847R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867636	17	41197748	17	43045731	867636	853128	rs2050866725	NC_000017.11:43045730:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1847	BRCA1
NM_007294.4(BRCA1):c.5539T>A (p.Cys1847Ser)	BRCA1	C1847S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867635	17	41197748	17	43045731	867635	853129	rs2050866725	NC_000017.11:43045730:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1847	BRCA1
NM_007294.4(BRCA1):c.5538G>T (p.Gln1846His)	BRCA1	Q1846H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867634	17	41197749	17	43045732	867634	853130	rs80356849	NC_000017.11:43045731:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1846	BRCA1
NM_007294.4(BRCA1):c.5538G>C (p.Gln1846His)	BRCA1	Q1846H	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000482930	17	41197749	17	43045732	482930	478549	rs80356849	NC_000017.11:43045731:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1846	BRCA1
NM_007294.4(BRCA1):c.5537A>T (p.Gln1846Leu)	BRCA1	Q1846L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864987	17	41197750	17	43045733	864987	853131	rs2050867530	NC_000017.11:43045732:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1846	BRCA1
NM_007294.4(BRCA1):c.5537A>G (p.Gln1846Arg)	BRCA1	Q1846R	Hereditary cancer-predisposing syndrome	VCV000864986	17	41197750	17	43045733	864986	853132	rs2050867530	NC_000017.11:43045732:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Apr 16, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1846	BRCA1
NM_007294.4(BRCA1):c.5537A>C (p.Gln1846Pro)	BRCA1	Q1846P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864985	17	41197750	17	43045733	864985	853133	rs2050867530	NC_000017.11:43045732:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1846	BRCA1
NM_007294.4(BRCA1):c.5536C>G (p.Gln1846Glu)	BRCA1	Q1846E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864984	17	41197751	17	43045734	864984	853134	rs80356873	NC_000017.11:43045733:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1846	BRCA1
NM_007294.4(BRCA1):c.5536C>A (p.Gln1846Lys)	BRCA1	Q1846K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000825811	17	41197751	17	43045734	825811	813639	rs80356873	NC_000017.11:43045733:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1846	BRCA1
NM_007294.4(BRCA1):c.5534A>T (p.Tyr1845Phe)	BRCA1	Y1845F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869019	17	41197753	17	43045736	869019	853136	rs876660280	NC_000017.11:43045735:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1845	BRCA1
NM_007294.4(BRCA1):c.5534A>C (p.Tyr1845Ser)	BRCA1	Y1845S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869018	17	41197753	17	43045736	869018	853137	rs876660280	NC_000017.11:43045735:T:G	single nucleotide variant	3 prime UTR variant|missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1845	BRCA1
NM_007294.4(BRCA1):c.5534A>G (p.Tyr1845Cys)	BRCA1	Y1845C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233238	17	41197753	17	43045736	233238	235925	rs876660280	NC_000017.11:43045735:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1845	BRCA1
NM_007294.4(BRCA1):c.5533T>G (p.Tyr1845Asp)	BRCA1	Y1845D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869017	17	41197754	17	43045737	869017	853138	rs2050869285	NC_000017.11:43045736:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1845	BRCA1
NM_007294.4(BRCA1):c.5533T>C (p.Tyr1845His)	BRCA1	Y1845H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869016	17	41197754	17	43045737	869016	853139	rs2050869285	NC_000017.11:43045736:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1845	BRCA1
NM_007294.4(BRCA1):c.5533T>A (p.Tyr1845Asn)	BRCA1	Y1845N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869015	17	41197754	17	43045737	869015	853140	rs2050869285	NC_000017.11:43045736:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1845	BRCA1
NM_007294.4(BRCA1):c.5531T>A (p.Leu1844His)	BRCA1	L1844H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868627	17	41197756	17	43045739	868627	853143	rs80357323	NC_000017.11:43045738:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1844	BRCA1
NM_007294.4(BRCA1):c.5531T>C (p.Leu1844Pro)	BRCA1	L1844P	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000419732	17	41197756	17	43045739	419732	409940	rs80357323	NC_000017.11:43045738:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1844	BRCA1
NM_007294.4(BRCA1):c.5531T>G (p.Leu1844Arg)	BRCA1	L1844R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055615	17	41197756	17	43045739	55615	70282	rs80357323	NC_000017.11:43045738:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1844	BRCA1
NM_007294.4(BRCA1):c.5530C>T (p.Leu1844Phe)	BRCA1	L1844F	Hereditary breast ovarian cancer syndrome	VCV000868626	17	41197757	17	43045740	868626	853144	rs1471435242	NC_000017.11:43045739:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1844	BRCA1
NM_007294.4(BRCA1):c.5530C>G (p.Leu1844Val)	BRCA1	L1844V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868625	17	41197757	17	43045740	868625	853145	rs1471435242	NC_000017.11:43045739:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1844	BRCA1
NM_007294.4(BRCA1):c.5530C>A (p.Leu1844Ile)	BRCA1	L1844I	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000482889	17	41197757	17	43045740	482889	478642	rs1471435242	NC_000017.11:43045739:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1844	BRCA1
NM_007294.4(BRCA1):c.5529_5530delinsCA (p.Leu1844Ile)	BRCA1	L1844I	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000438942	17	41197757 - 41197758	17	43045740 - 43045741	438942	432891	rs1555574389	NC_000017.11:43045739:GT:TG	Indel	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1844	BRCA1
NM_007294.4(BRCA1):c.5528C>G (p.Ala1843Gly)	BRCA1	A1843G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867627	17	41197759	17	43045742	867627	853147	rs730881447	NC_000017.11:43045741:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1843	BRCA1
NM_007294.4(BRCA1):c.5528C>T (p.Ala1843Val)	BRCA1	A1843V	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000496396	17	41197759	17	43045742	496396	487931	rs730881447	NC_000017.11:43045741:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1843	BRCA1
NM_007294.4(BRCA1):c.5528C>A (p.Ala1843Glu)	BRCA1	A1843E	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000182082	17	41197759	17	43045742	182082	180812	rs730881447	NC_000017.11:43045741:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 7, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1843	BRCA1
NM_007294.4(BRCA1):c.5527G>T (p.Ala1843Ser)	BRCA1	A1843S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867626	17	41197760	17	43045743	867626	853148	rs80357019	NC_000017.11:43045742:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1843	BRCA1
NM_007294.4(BRCA1):c.5527G>A (p.Ala1843Thr)	BRCA1	A1843T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864974	17	41197760	17	43045743	864974	853149	rs80357019	NC_000017.11:43045742:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1843	BRCA1
NM_007294.4(BRCA1):c.5527G>C (p.Ala1843Pro)	BRCA1	A1843P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055614	17	41197760	17	43045743	55614	70281	rs80357019	NC_000017.11:43045742:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Aug 13, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1843	BRCA1
NM_007294.4(BRCA1):c.5525T>G (p.Val1842Gly)	BRCA1	V1842G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864971	17	41197762	17	43045745	864971	853152	rs1555574400	NC_000017.11:43045744:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1842	BRCA1
NM_007294.4(BRCA1):c.5525T>C (p.Val1842Ala)	BRCA1	V1842A	Hereditary cancer-predisposing syndrome	VCV000864970	17	41197762	17	43045745	864970	853153	rs1555574400	NC_000017.11:43045744:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 17, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1842	BRCA1
NM_007294.4(BRCA1):c.5525T>A (p.Val1842Glu)	BRCA1	V1842E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000481475	17	41197762	17	43045745	481475	478643	rs1555574400	NC_000017.11:43045744:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1842	BRCA1
NM_007294.4(BRCA1):c.5524G>C (p.Val1842Leu)	BRCA1	V1842L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869008	17	41197763	17	43045746	869008	853155	rs1296005499	NC_000017.11:43045745:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1842	BRCA1
NM_007294.4(BRCA1):c.5524G>A (p.Val1842Ile)	BRCA1	V1842I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000869007	17	41197763	17	43045746	869007	853156	rs1296005499	NC_000017.11:43045745:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1842	BRCA1
NM_007294.4(BRCA1):c.5524G>T (p.Val1842Leu)	BRCA1	V1842L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864969	17	41197763	17	43045746	864969	853154	rs1296005499	NC_000017.11:43045745:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1842	BRCA1
NM_007294.4(BRCA1):c.5523T>G (p.Ser1841Arg)	BRCA1	S1841R	Hereditary breast ovarian cancer syndrome	VCV000869006	17	41197764	17	43045747	869006	853157	rs878854960	NC_000017.11:43045746:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5523T>A (p.Ser1841Arg)	BRCA1	S1841R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869005	17	41197764	17	43045747	869005	853158	rs878854960	NC_000017.11:43045746:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5522G>T (p.Ser1841Ile)	BRCA1	S1841I	Hereditary breast ovarian cancer syndrome	VCV000869004	17	41197765	17	43045748	869004	853159	rs80357368	NC_000017.11:43045747:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Apr 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5522G>C (p.Ser1841Thr)	BRCA1	S1841T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000423044	17	41197765	17	43045748	423044	409941	rs80357368	NC_000017.11:43045747:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5522G>A (p.Ser1841Asn)	BRCA1	S1841N	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055613	17	41197765	17	43045748	55613	70280	rs80357368	NC_000017.11:43045747:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5521A>T (p.Ser1841Cys)	BRCA1	S1841C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868617	17	41197766	17	43045749	868617	853160	rs80357299	NC_000017.11:43045748:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5521A>G (p.Ser1841Gly)	BRCA1	S1841G	Hereditary cancer-predisposing syndrome	VCV000825803	17	41197766	17	43045749	825803	813640	rs80357299	NC_000017.11:43045748:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 20, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5521A>C (p.Ser1841Arg)	BRCA1	S1841R	Hereditary breast ovarian cancer syndrome|not provided	VCV000037681	17	41197766	17	43045749	37681	46237	rs80357299	NC_000017.11:43045748:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Jun 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1841	BRCA1
NM_007294.4(BRCA1):c.5520C>G (p.Asp1840Glu)	BRCA1	D1840E	Hereditary cancer-predisposing syndrome	VCV000868615	17	41197767	17	43045750	868615	853162	rs2050873874	NC_000017.11:43045749:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5520C>A (p.Asp1840Glu)	BRCA1	D1840E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868614	17	41197767	17	43045750	868614	853163	rs2050873874	NC_000017.11:43045749:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5519A>T (p.Asp1840Val)	BRCA1	D1840V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868613	17	41197768	17	43045751	868613	853164	rs2050874260	NC_000017.11:43045750:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5519A>G (p.Asp1840Gly)	BRCA1	D1840G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868612	17	41197768	17	43045751	868612	853165	rs2050874260	NC_000017.11:43045750:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5519A>C (p.Asp1840Ala)	BRCA1	D1840A	Hereditary breast ovarian cancer syndrome	VCV000861117	17	41197768	17	43045751	861117	845360	rs2050874260	NC_000017.11:43045750:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5518G>C (p.Asp1840His)	BRCA1	D1840H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867620	17	41197769	17	43045752	867620	853166	rs1567756588	NC_000017.11:43045751:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5518G>T (p.Asp1840Tyr)	BRCA1	D1840Y	not specified|Hereditary breast ovarian cancer syndrome	VCV000648216	17	41197769	17	43045752	648216	645917	rs1567756588	NC_000017.11:43045751:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5518G>A (p.Asp1840Asn)	BRCA1	D1840N	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000580534	17	41197769	17	43045752	580534	574463	rs1567756588	NC_000017.11:43045751:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1840	BRCA1
NM_007294.4(BRCA1):c.5517G>T (p.Leu1839Phe)	BRCA1	L1839F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867619	17	41197770	17	43045753	867619	853167	rs2050875063	NC_000017.11:43045752:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1839	BRCA1
NM_007294.4(BRCA1):c.5517G>C (p.Leu1839Phe)	BRCA1	L1839F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867618	17	41197770	17	43045753	867618	853168	rs2050875063	NC_000017.11:43045752:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1839	BRCA1
NM_007294.4(BRCA1):c.5516T>C (p.Leu1839Ser)	BRCA1	L1839S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091656	17	41197771	17	43045754	91656	97133	rs398122702	NC_000017.11:43045753:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1839	BRCA1
NM_007294.4(BRCA1):c.5515T>G (p.Leu1839Val)	BRCA1	L1839V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867616	17	41197772	17	43045755	867616	853170	rs2050875474	NC_000017.11:43045754:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1839	BRCA1
NM_007294.4(BRCA1):c.5513T>C (p.Val1838Ala)	BRCA1	V1838A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864953	17	41197774	17	43045757	864953	853174	rs80357107	NC_000017.11:43045756:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1838	BRCA1
NM_007294.4(BRCA1):c.5513T>G (p.Val1838Gly)	BRCA1	V1838G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254643	17	41197774	17	43045757	254643	249180	rs80357107	NC_000017.11:43045756:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Jul 1, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1838	BRCA1
NM_007294.4(BRCA1):c.5513T>A (p.Val1838Glu)	BRCA1	V1838E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055611	17	41197774	17	43045757	55611	70278	rs80357107	NC_000017.11:43045756:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1838	BRCA1
NM_007294.4(BRCA1):c.5512G>C (p.Val1838Leu)	BRCA1	V1838L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869002	17	41197775	17	43045758	869002	853175	rs730881501	NC_000017.11:43045757:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1838	BRCA1
NM_007294.4(BRCA1):c.5512G>T (p.Val1838Leu)	BRCA1	V1838L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000184981	17	41197775	17	43045758	184981	184869	rs730881501	NC_000017.11:43045757:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1838	BRCA1
NM_007294.4(BRCA1):c.5512G>A (p.Val1838Met)	BRCA1	V1838M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000182173	17	41197775	17	43045758	182173	180813	rs730881501	NC_000017.11:43045757:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1838	BRCA1
NM_007294.4(BRCA1):c.5510_5511delinsCT (p.Trp1837Ser)	BRCA1	W1837S	Hereditary breast ovarian cancer syndrome|not provided	VCV001065962	17	41197776 - 41197777	17	43045759 - 43045760	1065962	1056433	rs2152547868	NC_000017.11:43045758:CC:AG	Indel	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5511G>C (p.Trp1837Cys)	BRCA1	W1837C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000421244	17	41197776	17	43045759	421244	409942	rs80356914	NC_000017.11:43045758:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	May 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5511G>T (p.Trp1837Cys)	BRCA1	W1837C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037680	17	41197776	17	43045759	37680	46236	rs80356914	NC_000017.11:43045758:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5510G>T (p.Trp1837Leu)	BRCA1	W1837L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869001	17	41197777	17	43045760	869001	853176	rs80357307	NC_000017.11:43045759:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5510G>C (p.Trp1837Ser)	BRCA1	W1837S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869000	17	41197777	17	43045760	869000	853177	rs80357307	NC_000017.11:43045759:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5509T>A (p.Trp1837Arg)	BRCA1	W1837R	not provided|Hereditary breast ovarian cancer syndrome	VCV000853483	17	41197778	17	43045761	853483	845361	rs80356959	NC_000017.11:43045760:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5509T>G (p.Trp1837Gly)	BRCA1	W1837G	BRCA1-related cancer predisposition	VCV000055607	17	41197778	17	43045761	55607	70274	rs80356959	NC_000017.11:43045760:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5509T>C (p.Trp1837Arg)	BRCA1	W1837R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037679	17	41197778	17	43045761	37679	46235	rs80356959	NC_000017.11:43045760:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1837	BRCA1
NM_007294.4(BRCA1):c.5508G>T (p.Glu1836Asp)	BRCA1	E1836D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868607	17	41197779	17	43045762	868607	853178	rs2050877902	NC_000017.11:43045761:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1836	BRCA1
NM_007294.4(BRCA1):c.5508G>C (p.Glu1836Asp)	BRCA1	E1836D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868606	17	41197779	17	43045762	868606	853179	rs2050877902	NC_000017.11:43045761:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1836	BRCA1
NM_007294.4(BRCA1):c.5507A>T (p.Glu1836Val)	BRCA1	E1836V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868604	17	41197780	17	43045763	868604	853181	rs2050878133	NC_000017.11:43045762:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1836	BRCA1
NM_007294.4(BRCA1):c.5507A>G (p.Glu1836Gly)	BRCA1	E1836G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868603	17	41197780	17	43045763	868603	853182	rs2050878133	NC_000017.11:43045762:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1836	BRCA1
NM_007294.4(BRCA1):c.5507A>C (p.Glu1836Ala)	BRCA1	E1836A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867611	17	41197780	17	43045763	867611	853183	rs2050878133	NC_000017.11:43045762:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1836	BRCA1
NM_007294.4(BRCA1):c.5506G>C (p.Glu1836Gln)	BRCA1	E1836Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867610	17	41197781	17	43045764	867610	853184	rs80356942	NC_000017.11:43045763:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1836	BRCA1
NM_007294.4(BRCA1):c.5506G>A (p.Glu1836Lys)	BRCA1	E1836K	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055605	17	41197781	17	43045764	55605	70272	rs80356942	NC_000017.11:43045763:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1836	BRCA1
NM_007294.4(BRCA1):c.5504G>T (p.Arg1835Leu)	BRCA1	R1835L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867606	17	41197783	17	43045766	867606	853188	rs273902776	NC_000017.11:43045765:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1835	BRCA1
NM_007294.4(BRCA1):c.5504G>C (p.Arg1835Pro)	BRCA1	R1835P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000182172	17	41197783	17	43045766	182172	180814	rs273902776	NC_000017.11:43045765:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1835	BRCA1
NM_007294.4(BRCA1):c.5504G>A (p.Arg1835Gln)	BRCA1	R1835Q	not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm	VCV000055604	17	41197783	17	43045766	55604	70271	rs273902776	NC_000017.11:43045765:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1835	BRCA1
NM_007294.4(BRCA1):c.5503C>G (p.Arg1835Gly)	BRCA1	R1835G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000864945	17	41197784	17	43045767	864945	853189	rs41293465	NC_000017.11:43045766:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1835	BRCA1
NM_007294.4(BRCA1):c.5501C>G (p.Thr1834Ser)	BRCA1	T1834S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868991	17	41197786	17	43045769	868991	853193	rs730881500	NC_000017.11:43045768:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1834	BRCA1
NM_007294.4(BRCA1):c.5501C>A (p.Thr1834Asn)	BRCA1	T1834N	Hereditary breast ovarian cancer syndrome	VCV000840931	17	41197786	17	43045769	840931	845362	rs730881500	NC_000017.11:43045768:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1834	BRCA1
NM_007294.4(BRCA1):c.5501C>T (p.Thr1834Ile)	BRCA1	T1834I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000182171	17	41197786	17	43045769	182171	180815	rs730881500	NC_000017.11:43045768:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1834	BRCA1
NM_007294.4(BRCA1):c.5500A>T (p.Thr1834Ser)	BRCA1	T1834S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868990	17	41197787	17	43045770	868990	853194	rs2050880456	NC_000017.11:43045769:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1834	BRCA1
NM_007294.4(BRCA1):c.5500A>G (p.Thr1834Ala)	BRCA1	T1834A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868989	17	41197787	17	43045770	868989	853195	rs2050880456	NC_000017.11:43045769:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1834	BRCA1
NM_007294.4(BRCA1):c.5500A>C (p.Thr1834Pro)	BRCA1	T1834P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868988	17	41197787	17	43045770	868988	853196	rs2050880456	NC_000017.11:43045769:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1834	BRCA1
NM_007294.4(BRCA1):c.5498T>G (p.Val1833Gly)	BRCA1	V1833G	Hereditary breast ovarian cancer syndrome	VCV002135737	17	41197789	17	43045772	2135737	2188992	NA	NC_000017.11:43045771:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	May 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1833	BRCA1
NM_007294.4(BRCA1):c.5498T>A (p.Val1833Glu)	BRCA1	V1833E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868596	17	41197789	17	43045772	868596	853200	rs587782340	NC_000017.11:43045771:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1833	BRCA1
NM_007294.4(BRCA1):c.5498T>C (p.Val1833Ala)	BRCA1	V1833A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142256	17	41197789	17	43045772	142256	151970	rs587782340	NC_000017.11:43045771:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 21, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1833	BRCA1
NM_007294.4(BRCA1):c.5497G>T (p.Val1833Leu)	BRCA1	V1833L	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV002565337	17	41197790	17	43045773	2565337	2732311	NA	NC_000017.11:43045772:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Sep 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1833	BRCA1
NM_007294.4(BRCA1):c.5497G>C (p.Val1833Leu)	BRCA1	V1833L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868595	17	41197790	17	43045773	868595	853201	rs80357268	NC_000017.11:43045772:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1833	BRCA1
NM_007294.4(BRCA1):c.5497G>A (p.Val1833Met)	BRCA1	V1833M	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000055598	17	41197790	17	43045773	55598	70265	rs80357268	NC_000017.11:43045772:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1833	BRCA1
NM_007294.4(BRCA1):c.5495T>G (p.Val1832Gly)	BRCA1	V1832G	Hereditary breast ovarian cancer syndrome	VCV000868594	17	41197792	17	43045775	868594	853202	rs749290001	NC_000017.11:43045774:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1832	BRCA1
NM_007294.4(BRCA1):c.5495T>C (p.Val1832Ala)	BRCA1	V1832A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868593	17	41197792	17	43045775	868593	853203	rs749290001	NC_000017.11:43045774:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1832	BRCA1
NM_007294.4(BRCA1):c.5494G>A (p.Val1832Met)	BRCA1	V1832M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001171791	17	41197793	17	43045776	1171791	1161351	rs2050882095	NC_000017.11:43045775:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 31, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1832	BRCA1
NM_007294.4(BRCA1):c.5494G>C (p.Val1832Leu)	BRCA1	V1832L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868592	17	41197793	17	43045776	868592	853204	rs2050882095	NC_000017.11:43045775:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1832	BRCA1
NM_007294.4(BRCA1):c.5492C>T (p.Pro1831Leu)	BRCA1	P1831L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867597	17	41197795	17	43045778	867597	853208	rs587782778	NC_000017.11:43045777:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1831	BRCA1
NM_007294.4(BRCA1):c.5492C>A (p.Pro1831His)	BRCA1	P1831H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867596	17	41197795	17	43045778	867596	853209	rs587782778	NC_000017.11:43045777:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1831	BRCA1
NM_007294.4(BRCA1):c.5492C>G (p.Pro1831Arg)	BRCA1	P1831R	not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142865	17	41197795	17	43045778	142865	152579	rs587782778	NC_000017.11:43045777:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1831	BRCA1
NM_007294.4(BRCA1):c.5491C>T (p.Pro1831Ser)	BRCA1	P1831S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867595	17	41197796	17	43045779	867595	853210	rs768239314	NC_000017.11:43045778:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1831	BRCA1
NM_007294.4(BRCA1):c.5491C>G (p.Pro1831Ala)	BRCA1	P1831A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867594	17	41197796	17	43045779	867594	853211	rs768239314	NC_000017.11:43045778:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1831	BRCA1
NM_007294.4(BRCA1):c.5491C>A (p.Pro1831Thr)	BRCA1	P1831T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864938	17	41197796	17	43045779	864938	853212	rs768239314	NC_000017.11:43045778:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1831	BRCA1
NM_007294.4(BRCA1):c.5488_5489delinsAG (p.Ala1830Arg)	BRCA1	A1830R	Hereditary breast ovarian cancer syndrome	VCV000969085	17	41197798 - 41197799	17	43045781 - 43045782	969085	958115	rs2050883999	NC_000017.11:43045780:GC:CT	Indel	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1830	BRCA1
NM_007294.4(BRCA1):c.5489C>T (p.Ala1830Val)	BRCA1	A1830V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864934	17	41197798	17	43045781	864934	853216	rs2050883748	NC_000017.11:43045780:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1830	BRCA1
NM_007294.4(BRCA1):c.5489C>G (p.Ala1830Gly)	BRCA1	A1830G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864933	17	41197798	17	43045781	864933	853217	rs2050883748	NC_000017.11:43045780:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1830	BRCA1
NM_007294.4(BRCA1):c.5489C>A (p.Ala1830Glu)	BRCA1	A1830E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864932	17	41197798	17	43045781	864932	853218	rs2050883748	NC_000017.11:43045780:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1830	BRCA1
NM_007294.4(BRCA1):c.5488G>C (p.Ala1830Pro)	BRCA1	A1830P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868984	17	41197799	17	43045782	868984	853220	rs80357393	NC_000017.11:43045781:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1830	BRCA1
NM_007294.4(BRCA1):c.5488G>T (p.Ala1830Ser)	BRCA1	A1830S	Ovarian cancer	VCV000864931	17	41197799	17	43045782	864931	853219	rs80357393	NC_000017.11:43045781:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Jan 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1830	BRCA1
NM_007294.4(BRCA1):c.5488G>A (p.Ala1830Thr)	BRCA1	A1830T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055594	17	41197799	17	43045782	55594	70261	rs80357393	NC_000017.11:43045781:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 20, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1830	BRCA1
NM_007294.4(BRCA1):c.5487G>T (p.Glu1829Asp)	BRCA1	E1829D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868983	17	41197800	17	43045783	868983	853221	rs2050884436	NC_000017.11:43045782:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1829	BRCA1
NM_007294.4(BRCA1):c.5487G>C (p.Glu1829Asp)	BRCA1	E1829D	Hereditary breast ovarian cancer syndrome	VCV000868982	17	41197800	17	43045783	868982	853222	rs2050884436	NC_000017.11:43045782:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1829	BRCA1
NM_007294.4(BRCA1):c.5486A>T (p.Glu1829Val)	BRCA1	E1829V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868980	17	41197801	17	43045784	868980	853224	rs2050884691	NC_000017.11:43045783:T:A	single nucleotide variant	missense variant|stop lost|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1829	BRCA1
NM_007294.4(BRCA1):c.5486A>G (p.Glu1829Gly)	BRCA1	E1829G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868979	17	41197801	17	43045784	868979	853225	rs2050884691	NC_000017.11:43045783:T:C	single nucleotide variant	missense variant|stop lost|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1829	BRCA1
NM_007294.4(BRCA1):c.5486A>C (p.Glu1829Ala)	BRCA1	E1829A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868978	17	41197801	17	43045784	868978	853226	rs2050884691	NC_000017.11:43045783:T:G	single nucleotide variant	missense variant|stop lost|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1829	BRCA1
NM_007294.4(BRCA1):c.5485G>C (p.Glu1829Gln)	BRCA1	E1829Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868583	17	41197802	17	43045785	868583	853228	rs869320789	NC_000017.11:43045784:C:G	single nucleotide variant	missense variant|stop lost|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1829	BRCA1
NM_007294.4(BRCA1):c.5485G>A (p.Glu1829Lys)	BRCA1	E1829K	BRCA1-related disorder|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000225731	17	41197802	17	43045785	225731	227557	rs869320789	NC_000017.11:43045784:C:T	single nucleotide variant	missense variant|synonymous variant|non-coding transcript variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1829	BRCA1
NM_007294.4(BRCA1):c.5484T>G (p.Cys1828Trp)	BRCA1	C1828W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868582	17	41197803	17	43045786	868582	853229	rs2050885130	NC_000017.11:43045785:A:C	single nucleotide variant	missense variant|stop lost|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1828	BRCA1
NM_007294.4(BRCA1):c.5483G>T (p.Cys1828Phe)	BRCA1	C1828F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868579	17	41197804	17	43045787	868579	853232	rs2050885374	NC_000017.11:43045786:C:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1828	BRCA1
NM_007294.4(BRCA1):c.5483G>C (p.Cys1828Ser)	BRCA1	C1828S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868578	17	41197804	17	43045787	868578	853233	rs2050885374	NC_000017.11:43045786:C:G	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1828	BRCA1
NM_007294.4(BRCA1):c.5483G>A (p.Cys1828Tyr)	BRCA1	C1828Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867590	17	41197804	17	43045787	867590	853234	rs2050885374	NC_000017.11:43045786:C:T	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1828	BRCA1
NM_007294.4(BRCA1):c.5482T>C (p.Cys1828Arg)	BRCA1	C1828R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867589	17	41197805	17	43045788	867589	853235	rs1060502342	NC_000017.11:43045787:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1828	BRCA1
NM_007294.4(BRCA1):c.5482T>A (p.Cys1828Ser)	BRCA1	C1828S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867588	17	41197805	17	43045788	867588	853236	rs1060502342	NC_000017.11:43045787:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1828	BRCA1
NM_007294.4(BRCA1):c.5482T>G (p.Cys1828Gly)	BRCA1	C1828G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409329	17	41197805	17	43045788	409329	402459	rs1060502342	NC_000017.11:43045787:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1828	BRCA1
NM_007294.4(BRCA1):c.5481G>T (p.Met1827Ile)	BRCA1	M1827I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867587	17	41197806	17	43045789	867587	853237	rs587782432	NC_000017.11:43045788:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5481G>C (p.Met1827Ile)	BRCA1	M1827I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867586	17	41197806	17	43045789	867586	853238	rs587782432	NC_000017.11:43045788:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5481G>A (p.Met1827Ile)	BRCA1	M1827I	Breast-ovarian cancer, familial, susceptibility to, 1|See cases|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000142395	17	41197806	17	43045789	142395	152109	rs587782432	NC_000017.11:43045788:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5480T>G (p.Met1827Arg)	BRCA1	M1827R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867585	17	41197807	17	43045790	867585	853239	rs2050886535	NC_000017.11:43045789:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5480T>C (p.Met1827Thr)	BRCA1	M1827T	Hereditary breast ovarian cancer syndrome	VCV000864923	17	41197807	17	43045790	864923	853240	rs2050886535	NC_000017.11:43045789:A:G	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5480T>A (p.Met1827Lys)	BRCA1	M1827K	Hereditary cancer-predisposing syndrome	VCV000864922	17	41197807	17	43045790	864922	853241	rs2050886535	NC_000017.11:43045789:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5479A>T (p.Met1827Leu)	BRCA1	M1827L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864921	17	41197808	17	43045791	864921	853242	rs771606902	NC_000017.11:43045790:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5479A>C (p.Met1827Leu)	BRCA1	M1827L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864920	17	41197808	17	43045791	864920	853243	rs771606902	NC_000017.11:43045790:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5479A>G (p.Met1827Val)	BRCA1	M1827V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000844324	17	41197808	17	43045791	844324	845363	rs771606902	NC_000017.11:43045790:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1827	BRCA1
NM_007294.4(BRCA1):c.5478G>C (p.Gln1826His)	BRCA1	Q1826H	Hereditary cancer-predisposing syndrome	VCV000864919	17	41197809	17	43045792	864919	853244	rs80357332	NC_000017.11:43045791:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 19, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5478G>T (p.Gln1826His)	BRCA1	Q1826H	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055592	17	41197809	17	43045792	55592	70259	rs80357332	NC_000017.11:43045791:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5477A>G (p.Gln1826Arg)	BRCA1	Q1826R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868971	17	41197810	17	43045793	868971	853245	rs730881499	NC_000017.11:43045792:T:C	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5477A>C (p.Gln1826Pro)	BRCA1	Q1826P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868970	17	41197810	17	43045793	868970	853246	rs730881499	NC_000017.11:43045792:T:G	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5477A>T (p.Gln1826Leu)	BRCA1	Q1826L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000182170	17	41197810	17	43045793	182170	180817	rs730881499	NC_000017.11:43045792:T:A	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5476C>T (p.Gln1826Ter)	BRCA1	Q1826*	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000868969	17	41197811	17	43045794	868969	853247	rs587782887	NC_000017.11:43045793:G:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5476C>G (p.Gln1826Glu)	BRCA1	Q1826E	Hereditary cancer-predisposing syndrome	VCV000868968	17	41197811	17	43045794	868968	853248	rs587782887	NC_000017.11:43045793:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5476C>A (p.Gln1826Lys)	BRCA1	Q1826K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000143005	17	41197811	17	43045794	143005	152719	rs587782887	NC_000017.11:43045793:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 22, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1826	BRCA1
NM_007294.4(BRCA1):c.5474G>T (p.Gly1825Val)	BRCA1	G1825V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868571	17	41197813	17	43045796	868571	853250	rs2050888423	NC_000017.11:43045795:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1825	BRCA1
NM_007294.4(BRCA1):c.5474G>C (p.Gly1825Ala)	BRCA1	G1825A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868570	17	41197813	17	43045796	868570	853251	rs2050888423	NC_000017.11:43045795:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1825	BRCA1
NM_007294.4(BRCA1):c.5474G>A (p.Gly1825Glu)	BRCA1	G1825E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868569	17	41197813	17	43045796	868569	853252	rs2050888423	NC_000017.11:43045795:C:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1825	BRCA1
NM_007294.4(BRCA1):c.5473G>T (p.Gly1825Trp)	BRCA1	G1825W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868568	17	41197814	17	43045797	868568	853253	rs398122700	NC_000017.11:43045796:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1825	BRCA1
NM_007294.4(BRCA1):c.5473G>C (p.Gly1825Arg)	BRCA1	G1825R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868567	17	41197814	17	43045797	868567	853254	rs398122700	NC_000017.11:43045796:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1825	BRCA1
NM_007294.4(BRCA1):c.5473G>A (p.Gly1825Arg)	BRCA1	G1825R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000091654	17	41197814	17	43045797	91654	97131	rs398122700	NC_000017.11:43045796:C:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1825	BRCA1
NM_007294.4(BRCA1):c.5472T>G (p.Ile1824Met)	BRCA1	I1824M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868566	17	41197815	17	43045798	868566	853255	rs2050888912	NC_000017.11:43045797:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1824	BRCA1
NM_007294.4(BRCA1):c.5471T>G (p.Ile1824Ser)	BRCA1	I1824S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867579	17	41197816	17	43045799	867579	853258	rs1301025671	NC_000017.11:43045798:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1824	BRCA1
NM_007294.4(BRCA1):c.5471T>C (p.Ile1824Thr)	BRCA1	I1824T	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000867578	17	41197816	17	43045799	867578	853259	rs1301025671	NC_000017.11:43045798:A:G	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Jun 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1824	BRCA1
NM_007294.4(BRCA1):c.5471T>A (p.Ile1824Asn)	BRCA1	I1824N	Hereditary cancer-predisposing syndrome	VCV000867577	17	41197816	17	43045799	867577	853260	rs1301025671	NC_000017.11:43045798:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jun 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1824	BRCA1
NM_007294.4(BRCA1):c.5470A>T (p.Ile1824Phe)	BRCA1	I1824F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867576	17	41197817	17	43045800	867576	853261	rs587782026	NC_000017.11:43045799:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1824	BRCA1
NM_007294.4(BRCA1):c.5470A>C (p.Ile1824Leu)	BRCA1	I1824L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867575	17	41197817	17	43045800	867575	853262	rs587782026	NC_000017.11:43045799:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1824	BRCA1
NM_007294.4(BRCA1):c.5470A>G (p.Ile1824Val)	BRCA1	I1824V	Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000141804	17	41197817	17	43045800	141804	151518	rs587782026	NC_000017.11:43045799:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1824	BRCA1
NM_007294.4(BRCA1):c.5468C>T (p.Ala1823Val)	BRCA1	A1823V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864911	17	41197819	17	43045802	864911	853265	rs765681061	NC_000017.11:43045801:G:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1823	BRCA1
NM_007294.4(BRCA1):c.5468C>G (p.Ala1823Gly)	BRCA1	A1823G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864910	17	41197819	17	43045802	864910	853266	rs765681061	NC_000017.11:43045801:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1823	BRCA1
NM_007294.4(BRCA1):c.5468C>A (p.Ala1823Glu)	BRCA1	A1823E	Hereditary breast ovarian cancer syndrome	VCV000864909	17	41197819	17	43045802	864909	853267	rs765681061	NC_000017.11:43045801:G:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Uncertain significance	Nov 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1823	BRCA1
NM_007294.4(BRCA1):c.5467G>T (p.Ala1823Ser)	BRCA1	A1823S	Hereditary cancer-predisposing syndrome	VCV000868922	17	41199660	17	43047643	868922	853268	rs80357212	NC_000017.11:43047642:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1823	BRCA1
NM_007294.4(BRCA1):c.5467G>C (p.Ala1823Pro)	BRCA1	A1823P	Hereditary cancer-predisposing syndrome	VCV000868921	17	41199660	17	43047643	868921	853269	rs80357212	NC_000017.11:43047642:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Mar 1, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1823	BRCA1
NM_007294.4(BRCA1):c.5467G>A (p.Ala1823Thr)	BRCA1	A1823T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055588	17	41199660	17	43047643	55588	70255	rs80357212	NC_000017.11:43047642:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1823	BRCA1
NM_007294.4(BRCA1):c.5466T>G (p.His1822Gln)	BRCA1	H1822Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868920	17	41199661	17	43047644	868920	853270	rs886052975	NC_000017.11:43047643:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5466T>A (p.His1822Gln)	BRCA1	H1822Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868523	17	41199661	17	43047644	868523	853271	rs886052975	NC_000017.11:43047643:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5465A>T (p.His1822Leu)	BRCA1	H1822L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868522	17	41199662	17	43047645	868522	853272	rs2050976068	NC_000017.11:43047644:T:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5465A>G (p.His1822Arg)	BRCA1	H1822R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868521	17	41199662	17	43047645	868521	853273	rs2050976068	NC_000017.11:43047644:T:C	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	May 1, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5465A>C (p.His1822Pro)	BRCA1	H1822P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868520	17	41199662	17	43047645	868520	853274	rs2050976068	NC_000017.11:43047644:T:G	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5464C>T (p.His1822Tyr)	BRCA1	H1822Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868519	17	41199663	17	43047646	868519	853275	rs2050976551	NC_000017.11:43047645:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5464C>G (p.His1822Asp)	BRCA1	H1822D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868518	17	41199663	17	43047646	868518	853276	rs2050976551	NC_000017.11:43047645:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5464C>A (p.His1822Asn)	BRCA1	H1822N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868517	17	41199663	17	43047646	868517	853277	rs2050976551	NC_000017.11:43047645:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1822	BRCA1
NM_007294.4(BRCA1):c.5463C>G (p.Phe1821Leu)	BRCA1	F1821L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868110	17	41199664	17	43047647	868110	853279	rs2050977262	NC_000017.11:43047646:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5463C>A (p.Phe1821Leu)	BRCA1	F1821L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868109	17	41199664	17	43047647	868109	853280	rs2050977262	NC_000017.11:43047646:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5462T>G (p.Phe1821Cys)	BRCA1	F1821C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868108	17	41199665	17	43047648	868108	853281	rs2050977559	NC_000017.11:43047647:A:C	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5462T>C (p.Phe1821Ser)	BRCA1	F1821S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868107	17	41199665	17	43047648	868107	853282	rs2050977559	NC_000017.11:43047647:A:G	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5462T>A (p.Phe1821Tyr)	BRCA1	F1821Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868106	17	41199665	17	43047648	868106	853283	rs2050977559	NC_000017.11:43047647:A:T	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5461T>G (p.Phe1821Val)	BRCA1	F1821V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868105	17	41199666	17	43047649	868105	853284	rs2050978032	NC_000017.11:43047648:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5461T>C (p.Phe1821Leu)	BRCA1	F1821L	Hereditary breast ovarian cancer syndrome	VCV000868104	17	41199666	17	43047649	868104	853285	rs2050978032	NC_000017.11:43047648:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5461T>A (p.Phe1821Ile)	BRCA1	F1821I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865550	17	41199666	17	43047649	865550	853286	rs2050978032	NC_000017.11:43047648:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1821	BRCA1
NM_007294.4(BRCA1):c.5459G>T (p.Gly1820Val)	BRCA1	G1820V	Hereditary breast ovarian cancer syndrome	VCV000865546	17	41199668	17	43047651	865546	853290	rs2050978714	NC_000017.11:43047650:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1820	BRCA1
NM_007294.4(BRCA1):c.5459G>C (p.Gly1820Ala)	BRCA1	G1820A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865545	17	41199668	17	43047651	865545	853291	rs2050978714	NC_000017.11:43047650:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1820	BRCA1
NM_007294.4(BRCA1):c.5459G>A (p.Gly1820Asp)	BRCA1	G1820D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865544	17	41199668	17	43047651	865544	853292	rs2050978714	NC_000017.11:43047650:C:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1820	BRCA1
NM_007294.4(BRCA1):c.5458G>C (p.Gly1820Arg)	BRCA1	G1820R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868913	17	41199669	17	43047652	868913	853294	rs398122698	NC_000017.11:43047651:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1820	BRCA1
NM_007294.4(BRCA1):c.5458G>T (p.Gly1820Cys)	BRCA1	G1820C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865543	17	41199669	17	43047652	865543	853293	rs398122698	NC_000017.11:43047651:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1820	BRCA1
NM_007294.4(BRCA1):c.5458G>A (p.Gly1820Ser)	BRCA1	G1820S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000091650	17	41199669	17	43047652	91650	97127	rs398122698	NC_000017.11:43047651:C:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1820	BRCA1
NM_007294.4(BRCA1):c.5457T>G (p.Asn1819Lys)	BRCA1	N1819K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868912	17	41199670	17	43047653	868912	853295	rs1597799334	NC_000017.11:43047652:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5457T>A (p.Asn1819Lys)	BRCA1	N1819K	Hereditary breast ovarian cancer syndrome	VCV000868911	17	41199670	17	43047653	868911	853296	rs1597799334	NC_000017.11:43047652:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5456A>T (p.Asn1819Ile)	BRCA1	N1819I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868910	17	41199671	17	43047654	868910	853297	rs80357286	NC_000017.11:43047653:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5456A>C (p.Asn1819Thr)	BRCA1	N1819T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868909	17	41199671	17	43047654	868909	853298	rs80357286	NC_000017.11:43047653:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5456A>G (p.Asn1819Ser)	BRCA1	N1819S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000055585	17	41199671	17	43047654	55585	70252	rs80357286	NC_000017.11:43047653:T:C	single nucleotide variant	missense variant|synonymous variant	Benign/Likely benign	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5455A>T (p.Asn1819Tyr)	BRCA1	N1819Y	Hereditary breast ovarian cancer syndrome	VCV000868511	17	41199672	17	43047655	868511	853299	rs2050979993	NC_000017.11:43047654:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 10, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5455A>G (p.Asn1819Asp)	BRCA1	N1819D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868510	17	41199672	17	43047655	868510	853300	rs2050979993	NC_000017.11:43047654:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5455A>C (p.Asn1819His)	BRCA1	N1819H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868509	17	41199672	17	43047655	868509	853301	rs2050979993	NC_000017.11:43047654:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1819	BRCA1
NM_007294.4(BRCA1):c.5454C>G (p.Asp1818Glu)	BRCA1	D1818E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868508	17	41199673	17	43047656	868508	853302	rs1555574705	NC_000017.11:43047655:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5454C>A (p.Asp1818Glu)	BRCA1	D1818E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868507	17	41199673	17	43047656	868507	853303	rs1555574705	NC_000017.11:43047655:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5453A>T (p.Asp1818Val)	BRCA1	D1818V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868506	17	41199674	17	43047657	868506	853304	rs80357477	NC_000017.11:43047656:T:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5453A>C (p.Asp1818Ala)	BRCA1	D1818A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865535	17	41199674	17	43047657	865535	853305	rs80357477	NC_000017.11:43047656:T:G	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5453A>G (p.Asp1818Gly)	BRCA1	D1818G	Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037672	17	41199674	17	43047657	37672	46228	rs80357477	NC_000017.11:43047656:T:C	single nucleotide variant	missense variant|synonymous variant	Pathogenic/Likely pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5452G>T (p.Asp1818Tyr)	BRCA1	D1818Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865534	17	41199675	17	43047658	865534	853306	rs2050981068	NC_000017.11:43047657:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5452G>C (p.Asp1818His)	BRCA1	D1818H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865533	17	41199675	17	43047658	865533	853307	rs2050981068	NC_000017.11:43047657:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5452G>A (p.Asp1818Asn)	BRCA1	D1818N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865532	17	41199675	17	43047658	865532	853308	rs2050981068	NC_000017.11:43047657:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1818	BRCA1
NM_007294.4(BRCA1):c.5451G>T (p.Glu1817Asp)	BRCA1	E1817D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865531	17	41199676	17	43047659	865531	853309	rs1057523707	NC_000017.11:43047658:C:A	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5451G>C (p.Glu1817Asp)	BRCA1	E1817D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865530	17	41199676	17	43047659	865530	853310	rs1057523707	NC_000017.11:43047658:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5450A>G (p.Glu1817Gly)	BRCA1	E1817G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867399	17	41199677	17	43047660	867399	853312	rs2050981907	NC_000017.11:43047659:T:C	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5450A>C (p.Glu1817Ala)	BRCA1	E1817A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867398	17	41199677	17	43047660	867398	853313	rs2050981907	NC_000017.11:43047659:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5450A>T (p.Glu1817Val)	BRCA1	E1817V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865529	17	41199677	17	43047660	865529	853311	rs2050981907	NC_000017.11:43047659:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5449G>C (p.Glu1817Gln)	BRCA1	E1817Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867397	17	41199678	17	43047661	867397	853314	rs80356868	NC_000017.11:43047660:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5449G>A (p.Glu1817Lys)	BRCA1	E1817K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867396	17	41199678	17	43047661	867396	853315	rs80356868	NC_000017.11:43047660:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5449G>T (p.Glu1817Ter)	BRCA1	E1817*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055583	17	41199678	17	43047661	55583	70250	rs80356868	NC_000017.11:43047660:C:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1817	BRCA1
NM_007294.4(BRCA1):c.5447C>T (p.Thr1816Ile)	BRCA1	T1816I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868904	17	41199680	17	43047663	868904	853318	rs1567757864	NC_000017.11:43047662:G:A	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1816	BRCA1
NM_007294.4(BRCA1):c.5447C>G (p.Thr1816Arg)	BRCA1	T1816R	Hereditary cancer-predisposing syndrome	VCV000825739	17	41199680	17	43047663	825739	813642	rs1567757864	NC_000017.11:43047662:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Sep 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1816	BRCA1
NM_007294.4(BRCA1):c.5447C>A (p.Thr1816Lys)	BRCA1	T1816K	Hereditary cancer-predisposing syndrome	VCV000631079	17	41199680	17	43047663	631079	618551	rs1567757864	NC_000017.11:43047662:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1816	BRCA1
NM_007294.4(BRCA1):c.5446A>T (p.Thr1816Ser)	BRCA1	T1816S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868903	17	41199681	17	43047664	868903	853319	rs2050983010	NC_000017.11:43047663:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1816	BRCA1
NM_007294.4(BRCA1):c.5446A>G (p.Thr1816Ala)	BRCA1	T1816A	Hereditary cancer-predisposing syndrome	VCV000868902	17	41199681	17	43047664	868902	853320	rs2050983010	NC_000017.11:43047663:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Sep 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1816	BRCA1
NM_007294.4(BRCA1):c.5446A>C (p.Thr1816Pro)	BRCA1	T1816P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868901	17	41199681	17	43047664	868901	853321	rs2050983010	NC_000017.11:43047663:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1816	BRCA1
NM_007294.4(BRCA1):c.5445G>T (p.Trp1815Cys)	BRCA1	W1815C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868900	17	41199682	17	43047665	868900	853322	rs397509284	NC_000017.11:43047664:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5445G>C (p.Trp1815Cys)	BRCA1	W1815C	Hereditary breast ovarian cancer syndrome	VCV000868899	17	41199682	17	43047665	868899	853323	rs397509284	NC_000017.11:43047664:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5445G>A (p.Trp1815Ter)	BRCA1	W1815*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055581	17	41199682	17	43047665	55581	70248	rs397509284	NC_000017.11:43047664:C:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5444G>T (p.Trp1815Leu)	BRCA1	W1815L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868499	17	41199683	17	43047666	868499	853324	rs80356962	NC_000017.11:43047665:C:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5444G>C (p.Trp1815Ser)	BRCA1	W1815S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000566786	17	41199683	17	43047666	566786	571375	rs80356962	NC_000017.11:43047665:C:G	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5443T>G (p.Trp1815Gly)	BRCA1	W1815G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868498	17	41199684	17	43047667	868498	853325	rs2050983659	NC_000017.11:43047666:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5443T>C (p.Trp1815Arg)	BRCA1	W1815R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868497	17	41199684	17	43047667	868497	853326	rs2050983659	NC_000017.11:43047666:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5443T>A (p.Trp1815Arg)	BRCA1	W1815R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868496	17	41199684	17	43047667	868496	853327	rs2050983659	NC_000017.11:43047666:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1815	BRCA1
NM_007294.4(BRCA1):c.5441C>T (p.Ala1814Val)	BRCA1	A1814V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865520	17	41199686	17	43047669	865520	853331	rs1398117278	NC_000017.11:43047668:G:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1814	BRCA1
NM_007294.4(BRCA1):c.5441C>G (p.Ala1814Gly)	BRCA1	A1814G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865519	17	41199686	17	43047669	865519	853332	rs1398117278	NC_000017.11:43047668:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1814	BRCA1
NM_007294.4(BRCA1):c.5441C>A (p.Ala1814Asp)	BRCA1	A1814D	not provided|Hereditary cancer-predisposing syndrome	VCV000825736	17	41199686	17	43047669	825736	813643	rs1398117278	NC_000017.11:43047668:G:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Uncertain significance	Feb 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1814	BRCA1
NM_007294.4(BRCA1):c.5440G>T (p.Ala1814Ser)	BRCA1	A1814S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865518	17	41199687	17	43047670	865518	853333	rs2050984571	NC_000017.11:43047669:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1814	BRCA1
NM_007294.4(BRCA1):c.5440G>C (p.Ala1814Pro)	BRCA1	A1814P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865517	17	41199687	17	43047670	865517	853334	rs2050984571	NC_000017.11:43047669:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1814	BRCA1
NM_007294.4(BRCA1):c.5440G>A (p.Ala1814Thr)	BRCA1	A1814T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865516	17	41199687	17	43047670	865516	853335	rs2050984571	NC_000017.11:43047669:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1814	BRCA1
NM_007294.4(BRCA1):c.5439T>G (p.Asp1813Glu)	BRCA1	D1813E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867393	17	41199688	17	43047671	867393	853336	rs760396669	NC_000017.11:43047670:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5439T>A (p.Asp1813Glu)	BRCA1	D1813E	Hereditary cancer-predisposing syndrome	VCV000867392	17	41199688	17	43047671	867392	853337	rs760396669	NC_000017.11:43047670:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 17, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5438A>G (p.Asp1813Gly)	BRCA1	D1813G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867391	17	41199689	17	43047672	867391	853338	rs1555574715	NC_000017.11:43047671:T:C	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5438A>C (p.Asp1813Ala)	BRCA1	D1813A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867390	17	41199689	17	43047672	867390	853339	rs1555574715	NC_000017.11:43047671:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5438A>T (p.Asp1813Val)	BRCA1	D1813V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489733	17	41199689	17	43047672	489733	482925	rs1555574715	NC_000017.11:43047671:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 1, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5437G>C (p.Asp1813His)	BRCA1	D1813H	not provided	VCV000867389	17	41199690	17	43047673	867389	853340	rs1303996018	NC_000017.11:43047672:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5437G>A (p.Asp1813Asn)	BRCA1	D1813N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000865508	17	41199690	17	43047673	865508	853341	rs1303996018	NC_000017.11:43047672:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5437G>T (p.Asp1813Tyr)	BRCA1	D1813Y	Hereditary cancer-predisposing syndrome	VCV000479266	17	41199690	17	43047673	479266	478553	rs1303996018	NC_000017.11:43047672:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 5, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1813	BRCA1
NM_007294.4(BRCA1):c.5435C>T (p.Pro1812Leu)	BRCA1	P1812L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865504	17	41199692	17	43047675	865504	853345	rs2050986502	NC_000017.11:43047674:G:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1812	BRCA1
NM_007294.4(BRCA1):c.5435C>G (p.Pro1812Arg)	BRCA1	P1812R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865503	17	41199692	17	43047675	865503	853346	rs2050986502	NC_000017.11:43047674:G:C	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1812	BRCA1
NM_007294.4(BRCA1):c.5435C>A (p.Pro1812Gln)	BRCA1	P1812Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865502	17	41199692	17	43047675	865502	853347	rs2050986502	NC_000017.11:43047674:G:T	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1812	BRCA1
NM_007294.4(BRCA1):c.5434C>A (p.Pro1812Thr)	BRCA1	P1812T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868487	17	41199693	17	43047676	868487	853349	rs1800751	NC_000017.11:43047675:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1812	BRCA1
NM_007294.4(BRCA1):c.5434C>T (p.Pro1812Ser)	BRCA1	P1812S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865501	17	41199693	17	43047676	865501	853348	rs1800751	NC_000017.11:43047675:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1812	BRCA1
NM_007294.4(BRCA1):c.5434C>G (p.Pro1812Ala)	BRCA1	P1812A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000037670	17	41199693	17	43047676	37670	46226	rs1800751	NC_000017.11:43047675:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 5, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1812	BRCA1
NM_007294.4(BRCA1):c.5433G>T (p.Gln1811His)	BRCA1	Q1811H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868486	17	41199694	17	43047677	868486	853350	rs4438367	NC_000017.11:43047676:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5433G>C (p.Gln1811His)	BRCA1	Q1811H	Hereditary cancer-predisposing syndrome	VCV000479210	17	41199694	17	43047677	479210	478556	rs4438367	NC_000017.11:43047676:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 30, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5432A>T (p.Gln1811Leu)	BRCA1	Q1811L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868484	17	41199695	17	43047678	868484	853352	rs80357040	NC_000017.11:43047677:T:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5432A>C (p.Gln1811Pro)	BRCA1	Q1811P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868483	17	41199695	17	43047678	868483	853353	rs80357040	NC_000017.11:43047677:T:G	single nucleotide variant	missense variant|synonymous variant	Likely pathogenic	Mar 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5432A>G (p.Gln1811Arg)	BRCA1	Q1811R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055578	17	41199695	17	43047678	55578	70245	rs80357040	NC_000017.11:43047677:T:C	single nucleotide variant	missense variant|synonymous variant	Likely pathogenic	Oct 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5431C>G (p.Gln1811Glu)	BRCA1	Q1811E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865493	17	41199696	17	43047679	865493	853354	rs397509283	NC_000017.11:43047678:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5431C>A (p.Gln1811Lys)	BRCA1	Q1811K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865492	17	41199696	17	43047679	865492	853355	rs397509283	NC_000017.11:43047678:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5431C>T (p.Gln1811Ter)	BRCA1	Q1811*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055577	17	41199696	17	43047679	55577	70244	rs397509283	NC_000017.11:43047678:G:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1811	BRCA1
NM_007294.4(BRCA1):c.5429T>A (p.Val1810Glu)	BRCA1	V1810E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867388	17	41199698	17	43047681	867388	853358	rs80357451	NC_000017.11:43047680:A:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1810	BRCA1
NM_007294.4(BRCA1):c.5429T>C (p.Val1810Ala)	BRCA1	V1810A	Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000185996	17	41199698	17	43047681	185996	184871	rs80357451	NC_000017.11:43047680:A:G	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Jun 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1810	BRCA1
NM_007294.4(BRCA1):c.5429T>G (p.Val1810Gly)	BRCA1	V1810G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055576	17	41199698	17	43047681	55576	70243	rs80357451	NC_000017.11:43047680:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 28, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1810	BRCA1
NM_007294.4(BRCA1):c.5428G>T (p.Val1810Leu)	BRCA1	V1810L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867387	17	41199699	17	43047682	867387	853359	rs2050988927	NC_000017.11:43047681:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1810	BRCA1
NM_007294.4(BRCA1):c.5428G>C (p.Val1810Leu)	BRCA1	V1810L	Hereditary cancer-predisposing syndrome	VCV000867386	17	41199699	17	43047682	867386	853360	rs2050988927	NC_000017.11:43047681:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1810	BRCA1
NM_007294.4(BRCA1):c.5428G>A (p.Val1810Met)	BRCA1	V1810M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000867385	17	41199699	17	43047682	867385	853361	rs2050988927	NC_000017.11:43047681:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1810	BRCA1
NM_007294.4(BRCA1):c.5426T>A (p.Val1809Asp)	BRCA1	V1809D	Hereditary cancer-predisposing syndrome	VCV000825725	17	41199701	17	43047684	825725	813644	rs80357216	NC_000017.11:43047683:A:T	single nucleotide variant	missense variant|synonymous variant	Likely pathogenic	Sep 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1809	BRCA1
NM_007294.4(BRCA1):c.5426T>C (p.Val1809Ala)	BRCA1	V1809A	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055575	17	41199701	17	43047684	55575	70242	rs80357216	NC_000017.11:43047683:A:G	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1809	BRCA1
NM_007294.4(BRCA1):c.5425G>A (p.Val1809Ile)	BRCA1	V1809I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000240822	17	41199702	17	43047685	240822	242756	rs28897698	NC_000017.11:43047684:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1809	BRCA1
NM_007294.4(BRCA1):c.5425G>T (p.Val1809Phe)	BRCA1	V1809F	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055573	17	41199702	17	43047685	55573	70240	rs28897698	NC_000017.11:43047684:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1809	BRCA1
NM_007294.4(BRCA1):c.5423T>G (p.Val1808Gly)	BRCA1	V1808G	Hereditary cancer-predisposing syndrome	VCV000489732	17	41199704	17	43047687	489732	482983	rs80357358	NC_000017.11:43047686:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1808	BRCA1
NM_007294.4(BRCA1):c.5423T>A (p.Val1808Glu)	BRCA1	V1808E	not provided|Hereditary breast ovarian cancer syndrome	VCV000409308	17	41199704	17	43047687	409308	401949	rs80357358	NC_000017.11:43047686:A:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1808	BRCA1
NM_007294.4(BRCA1):c.5423T>C (p.Val1808Ala)	BRCA1	V1808A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055572	17	41199704	17	43047687	55572	70239	rs80357358	NC_000017.11:43047686:A:G	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1808	BRCA1
NM_007294.4(BRCA1):c.5422G>A (p.Val1808Met)	BRCA1	V1808M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002450691	17	41199705	17	43047688	2450691	2423177	NA	NC_000017.11:43047687:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1808	BRCA1
NM_007294.4(BRCA1):c.5422G>C (p.Val1808Leu)	BRCA1	V1808L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865482	17	41199705	17	43047688	865482	853365	rs1555574756	NC_000017.11:43047687:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1808	BRCA1
NM_007294.4(BRCA1):c.5422G>T (p.Val1808Leu)	BRCA1	V1808L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Familial cancer of breast	VCV000489731	17	41199705	17	43047688	489731	482929	rs1555574756	NC_000017.11:43047687:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1808	BRCA1
NM_007294.4(BRCA1):c.5421T>G (p.Ile1807Met)	BRCA1	I1807M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865481	17	41199706	17	43047689	865481	853366	rs2050990955	NC_000017.11:43047688:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1807	BRCA1
NM_007294.4(BRCA1):c.5420T>G (p.Ile1807Ser)	BRCA1	I1807S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868479	17	41199707	17	43047690	868479	853369	rs2050991229	NC_000017.11:43047689:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1807	BRCA1
NM_007294.4(BRCA1):c.5420T>C (p.Ile1807Thr)	BRCA1	I1807T	Ovarian cancer|Hereditary breast ovarian cancer syndrome	VCV000868478	17	41199707	17	43047690	868478	853370	rs2050991229	NC_000017.11:43047689:A:G	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Dec 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1807	BRCA1
NM_007294.4(BRCA1):c.5420T>A (p.Ile1807Asn)	BRCA1	I1807N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868477	17	41199707	17	43047690	868477	853371	rs2050991229	NC_000017.11:43047689:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1807	BRCA1
NM_007294.4(BRCA1):c.5419A>C (p.Ile1807Leu)	BRCA1	I1807L	Hereditary breast ovarian cancer syndrome	VCV000868476	17	41199708	17	43047691	868476	853372	rs786202721	NC_000017.11:43047690:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1807	BRCA1
NM_007294.4(BRCA1):c.5419A>T (p.Ile1807Phe)	BRCA1	I1807F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825717	17	41199708	17	43047691	825717	813645	rs786202721	NC_000017.11:43047690:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1807	BRCA1
NM_007294.4(BRCA1):c.5419A>G (p.Ile1807Val)	BRCA1	I1807V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000186137	17	41199708	17	43047691	186137	184872	rs786202721	NC_000017.11:43047690:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1807	BRCA1
NM_007294.4(BRCA1):c.5417C>T (p.Pro1806Leu)	BRCA1	P1806L	Hereditary breast ovarian cancer syndrome	VCV000868080	17	41199710	17	43047693	868080	853375	rs2050992362	NC_000017.11:43047692:G:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1806	BRCA1
NM_007294.4(BRCA1):c.5417C>G (p.Pro1806Arg)	BRCA1	P1806R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868079	17	41199710	17	43047693	868079	853376	rs2050992362	NC_000017.11:43047692:G:C	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1806	BRCA1
NM_007294.4(BRCA1):c.5417C>A (p.Pro1806Gln)	BRCA1	P1806Q	Hereditary breast ovarian cancer syndrome	VCV000868078	17	41199710	17	43047693	868078	853377	rs2050992362	NC_000017.11:43047692:G:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1806	BRCA1
NM_007294.4(BRCA1):c.5416C>A (p.Pro1806Thr)	BRCA1	P1806T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868077	17	41199711	17	43047694	868077	853378	rs80357241	NC_000017.11:43047693:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1806	BRCA1
NM_007294.4(BRCA1):c.5416C>T (p.Pro1806Ser)	BRCA1	P1806S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000834190	17	41199711	17	43047694	834190	845364	rs80357241	NC_000017.11:43047693:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 16, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1806	BRCA1
NM_007294.4(BRCA1):c.5416C>G (p.Pro1806Ala)	BRCA1	P1806A	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055570	17	41199711	17	43047694	55570	70237	rs80357241	NC_000017.11:43047693:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1806	BRCA1
NM_007294.4(BRCA1):c.5415C>G (p.His1805Gln)	BRCA1	H1805Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867381	17	41199712	17	43047695	867381	853379	rs1060504559	NC_000017.11:43047694:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5415C>A (p.His1805Gln)	BRCA1	H1805Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867380	17	41199712	17	43047695	867380	853380	rs1060504559	NC_000017.11:43047694:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5414A>T (p.His1805Leu)	BRCA1	H1805L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867379	17	41199713	17	43047696	867379	853381	rs397509281	NC_000017.11:43047695:T:A	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5414A>G (p.His1805Arg)	BRCA1	H1805R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867378	17	41199713	17	43047696	867378	853382	rs397509281	NC_000017.11:43047695:T:C	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5414A>C (p.His1805Pro)	BRCA1	H1805P	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000055569	17	41199713	17	43047696	55569	70236	rs397509281	NC_000017.11:43047695:T:G	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5413C>G (p.His1805Asp)	BRCA1	H1805D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867377	17	41199714	17	43047697	867377	853383	rs587782873	NC_000017.11:43047696:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5413C>A (p.His1805Asn)	BRCA1	H1805N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867376	17	41199714	17	43047697	867376	853384	rs587782873	NC_000017.11:43047696:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5413C>T (p.His1805Tyr)	BRCA1	H1805Y	Hereditary cancer-predisposing syndrome	VCV000142988	17	41199714	17	43047697	142988	152702	rs587782873	NC_000017.11:43047696:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 14, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1805	BRCA1
NM_007294.4(BRCA1):c.5411T>G (p.Val1804Gly)	BRCA1	V1804G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865471	17	41199716	17	43047699	865471	853387	rs80356920	NC_000017.11:43047698:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1804	BRCA1
NM_007294.4(BRCA1):c.5411T>C (p.Val1804Ala)	BRCA1	V1804A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865470	17	41199716	17	43047699	865470	853388	rs80356920	NC_000017.11:43047698:A:G	single nucleotide variant	missense variant|synonymous variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1804	BRCA1
NM_007294.4(BRCA1):c.5411T>A (p.Val1804Asp)	BRCA1	V1804D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055568	17	41199716	17	43047699	55568	70235	rs80356920	NC_000017.11:43047698:A:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1804	BRCA1
NM_007294.4(BRCA1):c.5410G>A (p.Val1804Ile)	BRCA1	V1804I	Hereditary breast ovarian cancer syndrome	VCV000868465	17	41199717	17	43047700	868465	853391	rs2050994882	NC_000017.11:43047699:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1804	BRCA1
NM_007294.4(BRCA1):c.5410G>T (p.Val1804Phe)	BRCA1	V1804F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865469	17	41199717	17	43047700	865469	853389	rs2050994882	NC_000017.11:43047699:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1804	BRCA1
NM_007294.4(BRCA1):c.5410G>C (p.Val1804Leu)	BRCA1	V1804L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865468	17	41199717	17	43047700	865468	853390	rs2050994882	NC_000017.11:43047699:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1804	BRCA1
NM_007294.4(BRCA1):c.5408G>A (p.Gly1803Asp)	BRCA1	G1803D	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868461	17	41199719	17	43047702	868461	853395	rs80357149	NC_000017.11:43047701:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1803	BRCA1
NM_007294.4(BRCA1):c.5408G>T (p.Gly1803Val)	BRCA1	G1803V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000628196	17	41199719	17	43047702	628196	618552	rs80357149	NC_000017.11:43047701:C:A	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1803	BRCA1
NM_007294.4(BRCA1):c.5408G>C (p.Gly1803Ala)	BRCA1	G1803A	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037668	17	41199719	17	43047702	37668	46224	rs80357149	NC_000017.11:43047701:C:G	single nucleotide variant	missense variant|synonymous variant	Pathogenic/Likely pathogenic	Dec 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1803	BRCA1
NM_007294.4(BRCA1):c.5407G>C (p.Gly1803Arg)	BRCA1	G1803R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868074	17	41199720	17	43047703	868074	853396	rs876659510	NC_000017.11:43047702:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1803	BRCA1
NM_007294.4(BRCA1):c.5407G>T (p.Gly1803Cys)	BRCA1	G1803C	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000651964	17	41199720	17	43047703	651964	645919	rs876659510	NC_000017.11:43047702:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1803	BRCA1
NM_007294.4(BRCA1):c.5407G>A (p.Gly1803Ser)	BRCA1	G1803S	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000232037	17	41199720	17	43047703	232037	235927	rs876659510	NC_000017.11:43047702:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 3, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1803	BRCA1
NM_007294.4(BRCA1):c.5405C>T (p.Thr1802Ile)	BRCA1	T1802I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868055	17	41201139	17	43049122	868055	853399	rs2051072173	NC_000017.11:43049121:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Oct 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1802	BRCA1
NM_007294.4(BRCA1):c.5405C>G (p.Thr1802Arg)	BRCA1	T1802R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868054	17	41201139	17	43049122	868054	853400	rs2051072173	NC_000017.11:43049121:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1802	BRCA1
NM_007294.4(BRCA1):c.5405C>A (p.Thr1802Lys)	BRCA1	T1802K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868053	17	41201139	17	43049122	868053	853401	rs2051072173	NC_000017.11:43049121:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1802	BRCA1
NM_007294.4(BRCA1):c.5404A>T (p.Thr1802Ser)	BRCA1	T1802S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868052	17	41201140	17	43049123	868052	853402	rs1555575080	NC_000017.11:43049122:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1802	BRCA1
NM_007294.4(BRCA1):c.5404A>G (p.Thr1802Ala)	BRCA1	T1802A	Hereditary cancer-predisposing syndrome	VCV000868051	17	41201140	17	43049123	868051	853403	rs1555575080	NC_000017.11:43049122:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	Feb 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1802	BRCA1
NM_007294.4(BRCA1):c.5404A>C (p.Thr1802Pro)	BRCA1	T1802P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000485379	17	41201140	17	43049123	485379	478561	rs1555575080	NC_000017.11:43049122:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Dec 17, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1802	BRCA1
NM_007294.4(BRCA1):c.5402G>T (p.Gly1801Val)	BRCA1	G1801V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865704	17	41201142	17	43049125	865704	853407	rs531210457	NC_000017.11:43049124:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1801	BRCA1
NM_007294.4(BRCA1):c.5402G>C (p.Gly1801Ala)	BRCA1	G1801A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865703	17	41201142	17	43049125	865703	853408	rs531210457	NC_000017.11:43049124:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1801	BRCA1
NM_007294.4(BRCA1):c.5402G>A (p.Gly1801Asp)	BRCA1	G1801D	not specified|Inherited ovarian cancer (without breast cancer)|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000142834	17	41201142	17	43049125	142834	152548	rs531210457	NC_000017.11:43049124:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1801	BRCA1
NM_007294.4(BRCA1):c.5401G>T (p.Gly1801Cys)	BRCA1	G1801C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865702	17	41201143	17	43049126	865702	853409	rs587776492	NC_000017.11:43049125:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1801	BRCA1
NM_007294.4(BRCA1):c.5401G>C (p.Gly1801Arg)	BRCA1	G1801R	not specified	VCV000865701	17	41201143	17	43049126	865701	853410	rs587776492	NC_000017.11:43049125:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1801	BRCA1
NM_007294.4(BRCA1):c.5401G>A (p.Gly1801Ser)	BRCA1	G1801S	Hereditary breast ovarian cancer syndrome	VCV000156196	17	41201143	17	43049126	156196	165995	rs587776492	NC_000017.11:43049125:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1801	BRCA1
NM_007294.4(BRCA1):c.5399T>C (p.Leu1800Pro)	BRCA1	L1800P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865420	17	41201145	17	43049128	865420	853414	rs2051074040	NC_000017.11:43049127:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1800	BRCA1
NM_007294.4(BRCA1):c.5399T>A (p.Leu1800His)	BRCA1	L1800H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865419	17	41201145	17	43049128	865419	853415	rs2051074040	NC_000017.11:43049127:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1800	BRCA1
NM_007294.4(BRCA1):c.5399T>G (p.Leu1800Arg)	BRCA1	L1800R	Hereditary breast ovarian cancer syndrome	VCV000844181	17	41201145	17	43049128	844181	845365	rs2051074040	NC_000017.11:43049127:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 31, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1800	BRCA1
NM_007294.4(BRCA1):c.5398C>G (p.Leu1800Val)	BRCA1	L1800V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868420	17	41201146	17	43049129	868420	853417	rs2051074344	NC_000017.11:43049128:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1800	BRCA1
NM_007294.4(BRCA1):c.5398C>A (p.Leu1800Ile)	BRCA1	L1800I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868419	17	41201146	17	43049129	868419	853418	rs2051074344	NC_000017.11:43049128:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1800	BRCA1
NM_007294.4(BRCA1):c.5398C>T (p.Leu1800Phe)	BRCA1	L1800F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000865418	17	41201146	17	43049129	865418	853416	rs2051074344	NC_000017.11:43049128:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Aug 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1800	BRCA1
NM_007294.4(BRCA1):c.5396C>G (p.Thr1799Ser)	BRCA1	T1799S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868416	17	41201148	17	43049131	868416	853421	rs786201945	NC_000017.11:43049130:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1799	BRCA1
NM_007294.4(BRCA1):c.5396C>A (p.Thr1799Asn)	BRCA1	T1799N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868415	17	41201148	17	43049131	868415	853422	rs786201945	NC_000017.11:43049130:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1799	BRCA1
NM_007294.4(BRCA1):c.5396C>T (p.Thr1799Ile)	BRCA1	T1799I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000185124	17	41201148	17	43049131	185124	184873	rs786201945	NC_000017.11:43049130:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1799	BRCA1
NM_007294.4(BRCA1):c.5395A>T (p.Thr1799Ser)	BRCA1	T1799S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868050	17	41201149	17	43049132	868050	853423	rs2051075653	NC_000017.11:43049131:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1799	BRCA1
NM_007294.4(BRCA1):c.5395A>G (p.Thr1799Ala)	BRCA1	T1799A	Hereditary breast ovarian cancer syndrome	VCV000868049	17	41201149	17	43049132	868049	853424	rs2051075653	NC_000017.11:43049131:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1799	BRCA1
NM_007294.4(BRCA1):c.5395A>C (p.Thr1799Pro)	BRCA1	T1799P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868048	17	41201149	17	43049132	868048	853425	rs2051075653	NC_000017.11:43049131:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1799	BRCA1
NM_007294.4(BRCA1):c.5394C>G (p.Phe1798Leu)	BRCA1	F1798L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868047	17	41201150	17	43049133	868047	853426	rs777371808	NC_000017.11:43049132:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5394C>A (p.Phe1798Leu)	BRCA1	F1798L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868046	17	41201150	17	43049133	868046	853427	rs777371808	NC_000017.11:43049132:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5393T>G (p.Phe1798Cys)	BRCA1	F1798C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868045	17	41201151	17	43049134	868045	853428	rs2051076234	NC_000017.11:43049133:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5393T>C (p.Phe1798Ser)	BRCA1	F1798S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868044	17	41201151	17	43049134	868044	853429	rs2051076234	NC_000017.11:43049133:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5393T>A (p.Phe1798Tyr)	BRCA1	F1798Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865695	17	41201151	17	43049134	865695	853430	rs2051076234	NC_000017.11:43049133:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5392T>G (p.Phe1798Val)	BRCA1	F1798V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865694	17	41201152	17	43049135	865694	853431	rs2051076501	NC_000017.11:43049134:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5392T>C (p.Phe1798Leu)	BRCA1	F1798L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865693	17	41201152	17	43049135	865693	853432	rs2051076501	NC_000017.11:43049134:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5392T>A (p.Phe1798Ile)	BRCA1	F1798I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865692	17	41201152	17	43049135	865692	853433	rs2051076501	NC_000017.11:43049134:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1798	BRCA1
NM_007294.4(BRCA1):c.5390C>T (p.Ser1797Leu)	BRCA1	S1797L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000252886	17	41201154	17	43049137	252886	247287	rs879255492	NC_000017.11:43049136:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1797	BRCA1
NM_007294.4(BRCA1):c.5389T>G (p.Ser1797Ala)	BRCA1	S1797A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865412	17	41201155	17	43049138	865412	853437	rs2051077510	NC_000017.11:43049137:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1797	BRCA1
NM_007294.4(BRCA1):c.5389T>C (p.Ser1797Pro)	BRCA1	S1797P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865411	17	41201155	17	43049138	865411	853438	rs2051077510	NC_000017.11:43049137:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1797	BRCA1
NM_007294.4(BRCA1):c.5389T>A (p.Ser1797Thr)	BRCA1	S1797T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865410	17	41201155	17	43049138	865410	853439	rs2051077510	NC_000017.11:43049137:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1797	BRCA1
NM_007294.4(BRCA1):c.5387C>T (p.Ser1796Leu)	BRCA1	S1796L	not specified	VCV000496395	17	41201157	17	43049140	496395	487709	rs80357055	NC_000017.11:43049139:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1796	BRCA1
NM_007294.4(BRCA1):c.5386T>G (p.Ser1796Ala)	BRCA1	S1796A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868407	17	41201158	17	43049141	868407	853443	rs2051078701	NC_000017.11:43049140:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1796	BRCA1
NM_007294.4(BRCA1):c.5386T>C (p.Ser1796Pro)	BRCA1	S1796P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868406	17	41201158	17	43049141	868406	853444	rs2051078701	NC_000017.11:43049140:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1796	BRCA1
NM_007294.4(BRCA1):c.5386T>A (p.Ser1796Thr)	BRCA1	S1796T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868405	17	41201158	17	43049141	868405	853445	rs2051078701	NC_000017.11:43049140:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1796	BRCA1
NM_007294.4(BRCA1):c.5384T>G (p.Leu1795Arg)	BRCA1	L1795R	Hereditary cancer-predisposing syndrome	VCV000868042	17	41201160	17	43049143	868042	853449	rs2051079713	NC_000017.11:43049142:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	Sep 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1795	BRCA1
NM_007294.4(BRCA1):c.5384T>C (p.Leu1795Pro)	BRCA1	L1795P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868041	17	41201160	17	43049143	868041	853450	rs2051079713	NC_000017.11:43049142:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1795	BRCA1
NM_007294.4(BRCA1):c.5384T>A (p.Leu1795His)	BRCA1	L1795H	Hereditary breast ovarian cancer syndrome	VCV000868040	17	41201160	17	43049143	868040	853451	rs2051079713	NC_000017.11:43049142:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1795	BRCA1
NM_007294.4(BRCA1):c.5383C>G (p.Leu1795Val)	BRCA1	L1795V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868039	17	41201161	17	43049144	868039	853452	rs878854958	NC_000017.11:43049143:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1795	BRCA1
NM_007294.4(BRCA1):c.5383C>A (p.Leu1795Ile)	BRCA1	L1795I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000628641	17	41201161	17	43049144	628641	618553	rs878854958	NC_000017.11:43049143:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1795	BRCA1
NM_007294.4(BRCA1):c.5383C>T (p.Leu1795Phe)	BRCA1	L1795F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000240821	17	41201161	17	43049144	240821	242757	rs878854958	NC_000017.11:43049143:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1795	BRCA1
NM_007294.4(BRCA1):c.5382G>C (p.Glu1794Asp)	BRCA1	E1794D	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000439444	17	41201162	17	43049145	439444	433270	rs397509275	NC_000017.11:43049144:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	Jun 10, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1794	BRCA1
NM_007294.4(BRCA1):c.5382G>T (p.Glu1794Asp)	BRCA1	E1794D	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055557	17	41201162	17	43049145	55557	70224	rs397509275	NC_000017.11:43049144:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1794	BRCA1
NM_007294.4(BRCA1):c.5381A>T (p.Glu1794Val)	BRCA1	E1794V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865681	17	41201163	17	43049146	865681	853453	rs2051080642	NC_000017.11:43049145:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1794	BRCA1
NM_007294.4(BRCA1):c.5381A>G (p.Glu1794Gly)	BRCA1	E1794G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865680	17	41201163	17	43049146	865680	853454	rs2051080642	NC_000017.11:43049145:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1794	BRCA1
NM_007294.4(BRCA1):c.5381A>C (p.Glu1794Ala)	BRCA1	E1794A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865679	17	41201163	17	43049146	865679	853455	rs2051080642	NC_000017.11:43049145:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1794	BRCA1
NM_007294.4(BRCA1):c.5380G>C (p.Glu1794Gln)	BRCA1	E1794Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865678	17	41201164	17	43049147	865678	853456	rs776323117	NC_000017.11:43049146:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1794	BRCA1
NM_007294.4(BRCA1):c.5380G>A (p.Glu1794Lys)	BRCA1	E1794K	Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related disorder|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000865677	17	41201164	17	43049147	865677	853457	rs776323117	NC_000017.11:43049146:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1794	BRCA1
NM_007294.4(BRCA1):c.5379G>T (p.Lys1793Asn)	BRCA1	K1793N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865400	17	41201165	17	43049148	865400	853458	rs1367255905	NC_000017.11:43049147:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1793	BRCA1
NM_007294.4(BRCA1):c.5379G>C (p.Lys1793Asn)	BRCA1	K1793N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865399	17	41201165	17	43049148	865399	853459	rs1367255905	NC_000017.11:43049147:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1793	BRCA1
NM_007294.4(BRCA1):c.5378A>T (p.Lys1793Met)	BRCA1	K1793M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865397	17	41201166	17	43049149	865397	853461	rs730881446	NC_000017.11:43049148:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1793	BRCA1
NM_007294.4(BRCA1):c.5378A>G (p.Lys1793Arg)	BRCA1	K1793R	Hereditary breast ovarian cancer syndrome	VCV000865396	17	41201166	17	43049149	865396	853462	rs730881446	NC_000017.11:43049148:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1793	BRCA1
NM_007294.4(BRCA1):c.5378A>C (p.Lys1793Thr)	BRCA1	K1793T	not specified|not provided	VCV000182081	17	41201166	17	43049149	182081	180820	rs730881446	NC_000017.11:43049148:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 23, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1793	BRCA1
NM_007294.4(BRCA1):c.5377A>C (p.Lys1793Gln)	BRCA1	K1793Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868394	17	41201167	17	43049150	868394	853464	rs397509274	NC_000017.11:43049149:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1793	BRCA1
NM_007294.4(BRCA1):c.5377A>G (p.Lys1793Glu)	BRCA1	K1793E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865395	17	41201167	17	43049150	865395	853463	rs397509274	NC_000017.11:43049149:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1793	BRCA1
NM_007294.4(BRCA1):c.5375T>G (p.Val1792Gly)	BRCA1	V1792G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868391	17	41201169	17	43049152	868391	853467	rs2051082443	NC_000017.11:43049151:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1792	BRCA1
NM_007294.4(BRCA1):c.5375T>C (p.Val1792Ala)	BRCA1	V1792A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868390	17	41201169	17	43049152	868390	853468	rs2051082443	NC_000017.11:43049151:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1792	BRCA1
NM_007294.4(BRCA1):c.5375T>A (p.Val1792Glu)	BRCA1	V1792E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868389	17	41201169	17	43049152	868389	853469	rs2051082443	NC_000017.11:43049151:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1792	BRCA1
NM_007294.4(BRCA1):c.5374G>T (p.Val1792Leu)	BRCA1	V1792L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868388	17	41201170	17	43049153	868388	853470	rs1555575131	NC_000017.11:43049152:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1792	BRCA1
NM_007294.4(BRCA1):c.5374G>A (p.Val1792Met)	BRCA1	V1792M	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000581900	17	41201170	17	43049153	581900	574464	rs1555575131	NC_000017.11:43049152:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1792	BRCA1
NM_007294.4(BRCA1):c.5374G>C (p.Val1792Leu)	BRCA1	V1792L	Hereditary cancer-predisposing syndrome	VCV000485397	17	41201170	17	43049153	485397	478648	rs1555575131	NC_000017.11:43049152:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 8, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1792	BRCA1
NM_007294.4(BRCA1):c.5372T>G (p.Val1791Gly)	BRCA1	V1791G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868035	17	41201172	17	43049155	868035	853474	rs864622244	NC_000017.11:43049154:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1791	BRCA1
NM_007294.4(BRCA1):c.5372T>A (p.Val1791Glu)	BRCA1	V1791E	Malignant tumor of breast	VCV000433732	17	41201172	17	43049155	433732	427524	rs864622244	NC_000017.11:43049154:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1791	BRCA1
NM_007294.4(BRCA1):c.5372T>C (p.Val1791Ala)	BRCA1	V1791A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000219775	17	41201172	17	43049155	219775	222646	rs864622244	NC_000017.11:43049154:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1791	BRCA1
NM_007294.4(BRCA1):c.5371G>C (p.Val1791Leu)	BRCA1	V1791L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865671	17	41201173	17	43049156	865671	853475	rs145758886	NC_000017.11:43049155:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1791	BRCA1
NM_007294.4(BRCA1):c.5371G>A (p.Val1791Met)	BRCA1	V1791M	Hereditary cancer-predisposing syndrome	VCV000234129	17	41201173	17	43049156	234129	235929	rs145758886	NC_000017.11:43049155:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 2, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1791	BRCA1
NM_007294.4(BRCA1):c.5371G>T (p.Val1791Leu)	BRCA1	V1791L	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142002	17	41201173	17	43049156	142002	151716	rs145758886	NC_000017.11:43049155:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1791	BRCA1
NM_007294.4(BRCA1):c.5369C>T (p.Ser1790Phe)	BRCA1	S1790F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865667	17	41201175	17	43049158	865667	853479	rs2051084243	NC_000017.11:43049157:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1790	BRCA1
NM_007294.4(BRCA1):c.5369C>G (p.Ser1790Cys)	BRCA1	S1790C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865666	17	41201175	17	43049158	865666	853480	rs2051084243	NC_000017.11:43049157:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1790	BRCA1
NM_007294.4(BRCA1):c.5369C>A (p.Ser1790Tyr)	BRCA1	S1790Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865390	17	41201175	17	43049158	865390	853481	rs2051084243	NC_000017.11:43049157:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1790	BRCA1
NM_007294.4(BRCA1):c.5368T>G (p.Ser1790Ala)	BRCA1	S1790A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865389	17	41201176	17	43049159	865389	853482	rs1567758993	NC_000017.11:43049158:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1790	BRCA1
NM_007294.4(BRCA1):c.5368T>A (p.Ser1790Thr)	BRCA1	S1790T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865388	17	41201176	17	43049159	865388	853483	rs1567758993	NC_000017.11:43049158:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1790	BRCA1
NM_007294.4(BRCA1):c.5368T>C (p.Ser1790Pro)	BRCA1	S1790P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630815	17	41201176	17	43049159	630815	618554	rs1567758993	NC_000017.11:43049158:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 21, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1790	BRCA1
NM_007294.4(BRCA1):c.5366C>G (p.Ala1789Gly)	BRCA1	A1789G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868381	17	41201178	17	43049161	868381	853487	rs2051085308	NC_000017.11:43049160:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1789	BRCA1
NM_007294.4(BRCA1):c.5366C>A (p.Ala1789Asp)	BRCA1	A1789D	Hereditary breast ovarian cancer syndrome	VCV000868380	17	41201178	17	43049161	868380	853488	rs2051085308	NC_000017.11:43049160:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Feb 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1789	BRCA1
NM_007294.4(BRCA1):c.5366C>T (p.Ala1789Val)	BRCA1	A1789V	Hereditary cancer-predisposing syndrome	VCV000865385	17	41201178	17	43049161	865385	853486	rs2051085308	NC_000017.11:43049160:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jul 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1789	BRCA1
NM_007294.4(BRCA1):c.5365G>C (p.Ala1789Pro)	BRCA1	A1789P	Hereditary cancer-predisposing syndrome	VCV000628780	17	41201179	17	43049162	628780	618555	rs80357078	NC_000017.11:43049161:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 8, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1789	BRCA1
NM_007294.4(BRCA1):c.5365G>T (p.Ala1789Ser)	BRCA1	A1789S	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000055553	17	41201179	17	43049162	55553	70220	rs80357078	NC_000017.11:43049161:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1789	BRCA1
NM_007294.4(BRCA1):c.5365G>A (p.Ala1789Thr)	BRCA1	A1789T	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055552	17	41201179	17	43049162	55552	70219	rs80357078	NC_000017.11:43049161:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1789	BRCA1
NM_007294.4(BRCA1):c.5363G>C (p.Gly1788Ala)	BRCA1	G1788A	Hereditary breast ovarian cancer syndrome	VCV000531438	17	41201181	17	43049164	531438	531276	rs80357069	NC_000017.11:43049163:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Aug 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1788	BRCA1
NM_007294.4(BRCA1):c.5363G>A (p.Gly1788Asp)	BRCA1	G1788D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055551	17	41201181	17	43049164	55551	70218	rs80357069	NC_000017.11:43049163:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 25, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1788	BRCA1
NM_007294.4(BRCA1):c.5363G>T (p.Gly1788Val)	BRCA1	G1788V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037660	17	41201181	17	43049164	37660	46216	rs80357069	NC_000017.11:43049163:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1788	BRCA1
NM_007294.4(BRCA1):c.5362G>C (p.Gly1788Arg)	BRCA1	G1788R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868034	17	41201182	17	43049165	868034	853492	rs397509271	NC_000017.11:43049164:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1788	BRCA1
NM_007294.4(BRCA1):c.5362G>A (p.Gly1788Ser)	BRCA1	G1788S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868033	17	41201182	17	43049165	868033	853493	rs397509271	NC_000017.11:43049164:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1788	BRCA1
NM_007294.4(BRCA1):c.5362G>T (p.Gly1788Cys)	BRCA1	G1788C	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055550	17	41201182	17	43049165	55550	70217	rs397509271	NC_000017.11:43049164:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Nov 29, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1788	BRCA1
NM_007294.4(BRCA1):c.5361T>G (p.Cys1787Trp)	BRCA1	C1787W	Hereditary breast ovarian cancer syndrome	VCV000868032	17	41201183	17	43049166	868032	853494	rs2051087788	NC_000017.11:43049165:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1787	BRCA1
NM_007294.4(BRCA1):c.5360G>T (p.Cys1787Phe)	BRCA1	C1787F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865658	17	41201184	17	43049167	865658	853497	rs1597801649	NC_000017.11:43049166:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1787	BRCA1
NM_007294.4(BRCA1):c.5360G>C (p.Cys1787Ser)	BRCA1	C1787S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865657	17	41201184	17	43049167	865657	853498	rs1597801649	NC_000017.11:43049166:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1787	BRCA1
NM_007294.4(BRCA1):c.5360G>A (p.Cys1787Tyr)	BRCA1	C1787Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000662455	17	41201184	17	43049167	662455	645920	rs1597801649	NC_000017.11:43049166:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jul 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1787	BRCA1
NM_007294.4(BRCA1):c.5359T>G (p.Cys1787Gly)	BRCA1	C1787G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865656	17	41201185	17	43049168	865656	853499	rs80357065	NC_000017.11:43049167:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1787	BRCA1
NM_007294.4(BRCA1):c.5359T>C (p.Cys1787Arg)	BRCA1	C1787R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865655	17	41201185	17	43049168	865655	853500	rs80357065	NC_000017.11:43049167:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1787	BRCA1
NM_007294.4(BRCA1):c.5359T>A (p.Cys1787Ser)	BRCA1	C1787S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055548	17	41201185	17	43049168	55548	70215	rs80357065	NC_000017.11:43049167:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	Mar 25, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1787	BRCA1
NM_007294.4(BRCA1):c.5357T>G (p.Leu1786Arg)	BRCA1	L1786R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865378	17	41201187	17	43049170	865378	853503	rs398122697	NC_000017.11:43049169:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1786	BRCA1
NM_007294.4(BRCA1):c.5357T>A (p.Leu1786Gln)	BRCA1	L1786Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865377	17	41201187	17	43049170	865377	853504	rs398122697	NC_000017.11:43049169:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1786	BRCA1
NM_007294.4(BRCA1):c.5357T>C (p.Leu1786Pro)	BRCA1	L1786P	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091649	17	41201187	17	43049170	91649	97126	rs398122697	NC_000017.11:43049169:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	May 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1786	BRCA1
NM_007294.4(BRCA1):c.5356C>G (p.Leu1786Val)	BRCA1	L1786V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865376	17	41201188	17	43049171	865376	853505	rs1555575167	NC_000017.11:43049170:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1786	BRCA1
NM_007294.4(BRCA1):c.5356C>A (p.Leu1786Met)	BRCA1	L1786M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865375	17	41201188	17	43049171	865375	853506	rs1555575167	NC_000017.11:43049170:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1786	BRCA1
NM_007294.4(BRCA1):c.5354_5355delinsCC (p.Gln1785Pro)	BRCA1	Q1785P	Hereditary cancer-predisposing syndrome	VCV001747022	17	41201189 - 41201190	17	43049172 - 43049173	1747022	1802773	NA	NC_000017.11:43049171:CT:GG	Indel	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5355G>C (p.Gln1785His)	BRCA1	Q1785H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868371	17	41201189	17	43049172	868371	853507	rs397509269	NC_000017.11:43049171:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5355G>T (p.Gln1785His)	BRCA1	Q1785H	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055547	17	41201189	17	43049172	55547	70214	rs397509269	NC_000017.11:43049171:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5354A>T (p.Gln1785Leu)	BRCA1	Q1785L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868369	17	41201190	17	43049173	868369	853509	rs876660057	NC_000017.11:43049172:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5354A>G (p.Gln1785Arg)	BRCA1	Q1785R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868368	17	41201190	17	43049173	868368	853510	rs876660057	NC_000017.11:43049172:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5354A>C (p.Gln1785Pro)	BRCA1	Q1785P	Hereditary cancer-predisposing syndrome	VCV000232897	17	41201190	17	43049173	232897	235930	rs876660057	NC_000017.11:43049172:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 9, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5353C>G (p.Gln1785Glu)	BRCA1	Q1785E	Hereditary breast ovarian cancer syndrome	VCV000868367	17	41201191	17	43049174	868367	853511	rs80356969	NC_000017.11:43049173:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 2, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5353C>A (p.Gln1785Lys)	BRCA1	Q1785K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868030	17	41201191	17	43049174	868030	853512	rs80356969	NC_000017.11:43049173:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1785	BRCA1
NM_007294.4(BRCA1):c.5351T>G (p.Val1784Gly)	BRCA1	V1784G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868028	17	41201193	17	43049176	868028	853514	rs1367077331	NC_000017.11:43049175:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1784	BRCA1
NM_007294.4(BRCA1):c.5351T>C (p.Val1784Ala)	BRCA1	V1784A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868027	17	41201193	17	43049176	868027	853515	rs1367077331	NC_000017.11:43049175:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1784	BRCA1
NM_007294.4(BRCA1):c.5351T>A (p.Val1784Glu)	BRCA1	V1784E	Hereditary cancer-predisposing syndrome	VCV000868026	17	41201193	17	43049176	868026	853516	rs1367077331	NC_000017.11:43049175:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Mar 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1784	BRCA1
NM_007294.4(BRCA1):c.5350G>T (p.Val1784Leu)	BRCA1	V1784L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868025	17	41201194	17	43049177	868025	853517	rs1060502328	NC_000017.11:43049176:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1784	BRCA1
NM_007294.4(BRCA1):c.5350G>C (p.Val1784Leu)	BRCA1	V1784L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865647	17	41201194	17	43049177	865647	853518	rs1060502328	NC_000017.11:43049176:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1784	BRCA1
NM_007294.4(BRCA1):c.5350G>A (p.Val1784Ile)	BRCA1	V1784I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409303	17	41201194	17	43049177	409303	401958	rs1060502328	NC_000017.11:43049176:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 21, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1784	BRCA1
NM_007294.4(BRCA1):c.5349G>T (p.Met1783Ile)	BRCA1	M1783I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865646	17	41201195	17	43049178	865646	853519	rs587782019	NC_000017.11:43049177:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5349G>C (p.Met1783Ile)	BRCA1	M1783I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865645	17	41201195	17	43049178	865645	853520	rs587782019	NC_000017.11:43049177:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5349G>A (p.Met1783Ile)	BRCA1	M1783I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000141796	17	41201195	17	43049178	141796	151510	rs587782019	NC_000017.11:43049177:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5348T>G (p.Met1783Arg)	BRCA1	M1783R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865644	17	41201196	17	43049179	865644	853521	rs55808233	NC_000017.11:43049178:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5348T>A (p.Met1783Lys)	BRCA1	M1783K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865643	17	41201196	17	43049179	865643	853522	rs55808233	NC_000017.11:43049178:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5348T>C (p.Met1783Thr)	BRCA1	M1783T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast neoplasm|Hereditary cancer|Hereditary breast ovarian cancer syndrome	VCV000037659	17	41201196	17	43049179	37659	46215	rs55808233	NC_000017.11:43049178:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5347A>T (p.Met1783Leu)	BRCA1	M1783L	Hereditary breast ovarian cancer syndrome	VCV000865370	17	41201197	17	43049180	865370	853523	rs80357012	NC_000017.11:43049179:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Benign	Jul 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5347A>G (p.Met1783Val)	BRCA1	M1783V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000531270	17	41201197	17	43049180	531270	531541	rs80357012	NC_000017.11:43049179:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5347A>C (p.Met1783Leu)	BRCA1	M1783L	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000055545	17	41201197	17	43049180	55545	70212	rs80357012	NC_000017.11:43049179:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1783	BRCA1
NM_007294.4(BRCA1):c.5346G>T (p.Trp1782Cys)	BRCA1	W1782C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865369	17	41201198	17	43049181	865369	853524	rs80357284	NC_000017.11:43049180:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1782	BRCA1
NM_007294.4(BRCA1):c.5346G>C (p.Trp1782Cys)	BRCA1	W1782C	Hereditary breast ovarian cancer syndrome	VCV000865368	17	41201198	17	43049181	865368	853525	rs80357284	NC_000017.11:43049180:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1782	BRCA1
NM_007294.4(BRCA1):c.5345G>T (p.Trp1782Leu)	BRCA1	W1782L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865367	17	41201199	17	43049182	865367	853526	rs80357219	NC_000017.11:43049181:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1782	BRCA1
NM_007294.4(BRCA1):c.5345G>C (p.Trp1782Ser)	BRCA1	W1782S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865366	17	41201199	17	43049182	865366	853527	rs80357219	NC_000017.11:43049181:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1782	BRCA1
NM_007294.4(BRCA1):c.5344T>G (p.Trp1782Gly)	BRCA1	W1782G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868359	17	41201200	17	43049183	868359	853528	rs2051093708	NC_000017.11:43049182:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1782	BRCA1
NM_007294.4(BRCA1):c.5344T>C (p.Trp1782Arg)	BRCA1	W1782R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868358	17	41201200	17	43049183	868358	853529	rs2051093708	NC_000017.11:43049182:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1782	BRCA1
NM_007294.4(BRCA1):c.5344T>A (p.Trp1782Arg)	BRCA1	W1782R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868357	17	41201200	17	43049183	868357	853530	rs2051093708	NC_000017.11:43049182:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1782	BRCA1
NM_007294.4(BRCA1):c.5343A>T (p.Glu1781Asp)	BRCA1	E1781D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868356	17	41201201	17	43049184	868356	853531	rs1555575182	NC_000017.11:43049183:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1781	BRCA1
NM_007294.4(BRCA1):c.5343A>C (p.Glu1781Asp)	BRCA1	E1781D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000489730	17	41201201	17	43049184	489730	482930	rs1555575182	NC_000017.11:43049183:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1781	BRCA1
NM_007294.4(BRCA1):c.5342A>T (p.Glu1781Val)	BRCA1	E1781V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868354	17	41201202	17	43049185	868354	853533	rs2051094692	NC_000017.11:43049184:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1781	BRCA1
NM_007294.4(BRCA1):c.5342A>C (p.Glu1781Ala)	BRCA1	E1781A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868024	17	41201202	17	43049185	868024	853534	rs2051094692	NC_000017.11:43049184:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1781	BRCA1
NM_007294.4(BRCA1):c.5341G>C (p.Glu1781Gln)	BRCA1	E1781Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868023	17	41201203	17	43049186	868023	853535	rs397509268	NC_000017.11:43049185:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1781	BRCA1
NM_007294.4(BRCA1):c.5341G>A (p.Glu1781Lys)	BRCA1	E1781K	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825665	17	41201203	17	43049186	825665	813647	rs397509268	NC_000017.11:43049185:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1781	BRCA1
NM_007294.4(BRCA1):c.5339T>A (p.Leu1780Gln)	BRCA1	L1780Q	Hereditary breast ovarian cancer syndrome	VCV000462670	17	41201205	17	43049188	462670	467669	rs80357474	NC_000017.11:43049187:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jan 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1780	BRCA1
NM_007294.4(BRCA1):c.5339T>G (p.Leu1780Arg)	BRCA1	L1780R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000096949	17	41201205	17	43049188	96949	102852	rs80357474	NC_000017.11:43049187:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jun 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1780	BRCA1
NM_007294.4(BRCA1):c.5339T>C (p.Leu1780Pro)	BRCA1	L1780P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000055541	17	41201205	17	43049188	55541	70208	rs80357474	NC_000017.11:43049187:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1780	BRCA1
NM_007294.4(BRCA1):c.5338C>G (p.Leu1780Val)	BRCA1	L1780V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868022	17	41201206	17	43049189	868022	853536	rs1309977577	NC_000017.11:43049188:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1780	BRCA1
NM_007294.4(BRCA1):c.5337A>T (p.Gln1779His)	BRCA1	Q1779H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868021	17	41201207	17	43049190	868021	853537	rs876659718	NC_000017.11:43049189:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1779	BRCA1
NM_007294.4(BRCA1):c.5337A>C (p.Gln1779His)	BRCA1	Q1779H	Hereditary cancer-predisposing syndrome	VCV000865637	17	41201207	17	43049190	865637	853538	rs876659718	NC_000017.11:43049189:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	Aug 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1779	BRCA1
NM_007294.4(BRCA1):c.5336A>T (p.Gln1779Leu)	BRCA1	Q1779L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865636	17	41201208	17	43049191	865636	853539	rs2051096772	NC_000017.11:43049190:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1779	BRCA1
NM_007294.4(BRCA1):c.5336A>G (p.Gln1779Arg)	BRCA1	Q1779R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865635	17	41201208	17	43049191	865635	853540	rs2051096772	NC_000017.11:43049190:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1779	BRCA1
NM_007294.4(BRCA1):c.5336A>C (p.Gln1779Pro)	BRCA1	Q1779P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865634	17	41201208	17	43049191	865634	853541	rs2051096772	NC_000017.11:43049190:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1779	BRCA1
NM_007294.4(BRCA1):c.5335C>A (p.Gln1779Lys)	BRCA1	Q1779K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865633	17	41201209	17	43049192	865633	853542	rs397509267	NC_000017.11:43049191:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1779	BRCA1
NM_007294.4(BRCA1):c.5335C>G (p.Gln1779Glu)	BRCA1	Q1779E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825658	17	41201209	17	43049192	825658	813649	rs397509267	NC_000017.11:43049191:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1779	BRCA1
NM_007294.4(BRCA1):c.5334T>G (p.Asp1778Glu)	BRCA1	D1778E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865357	17	41201210	17	43049193	865357	853543	rs754152768	NC_000017.11:43049192:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5334T>A (p.Asp1778Glu)	BRCA1	D1778E	Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000865356	17	41201210	17	43049193	865356	853544	rs754152768	NC_000017.11:43049192:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5333A>T (p.Asp1778Val)	BRCA1	D1778V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865355	17	41201211	17	43049194	865355	853545	rs80357041	NC_000017.11:43049193:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5333A>C (p.Asp1778Ala)	BRCA1	D1778A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865354	17	41201211	17	43049194	865354	853546	rs80357041	NC_000017.11:43049193:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5333A>G (p.Asp1778Gly)	BRCA1	D1778G	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000055539	17	41201211	17	43049194	55539	70206	rs80357041	NC_000017.11:43049193:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5332G>T (p.Asp1778Tyr)	BRCA1	D1778Y	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055532	17	41203080	17	43051063	55532	70199	rs80357112	NC_000017.11:43051062:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5332G>C (p.Asp1778His)	BRCA1	D1778H	not provided|Hereditary breast ovarian cancer syndrome	VCV000055531	17	41203080	17	43051063	55531	70198	rs80357112	NC_000017.11:43051062:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5332G>A (p.Asp1778Asn)	BRCA1	D1778N	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055530	17	41203080	17	43051063	55530	70197	rs80357112	NC_000017.11:43051062:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1778	BRCA1
NM_007294.4(BRCA1):c.5330C>G (p.Thr1777Arg)	BRCA1	T1777R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867996	17	41203082	17	43051065	867996	853550	rs398122696	NC_000017.11:43051064:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1777	BRCA1
NM_007294.4(BRCA1):c.5330C>A (p.Thr1777Lys)	BRCA1	T1777K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867995	17	41203082	17	43051065	867995	853551	rs398122696	NC_000017.11:43051064:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1777	BRCA1
NM_007294.4(BRCA1):c.5330C>T (p.Thr1777Ile)	BRCA1	T1777I	Hereditary breast ovarian cancer syndrome	VCV000091648	17	41203082	17	43051065	91648	97125	rs398122696	NC_000017.11:43051064:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1777	BRCA1
NM_007294.4(BRCA1):c.5329A>G (p.Thr1777Ala)	BRCA1	T1777A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865603	17	41203083	17	43051066	865603	853552	rs879255296	NC_000017.11:43051065:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1777	BRCA1
NM_007294.4(BRCA1):c.5329A>C (p.Thr1777Pro)	BRCA1	T1777P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865602	17	41203083	17	43051066	865602	853553	rs879255296	NC_000017.11:43051065:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1777	BRCA1
NM_007294.4(BRCA1):c.5329A>T (p.Thr1777Ser)	BRCA1	T1777S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252402	17	41203083	17	43051066	252402	246809	rs879255296	NC_000017.11:43051065:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 10, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1777	BRCA1
NM_007294.4(BRCA1):c.5327C>G (p.Pro1776Arg)	BRCA1	P1776R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865600	17	41203085	17	43051068	865600	853555	rs398122695	NC_000017.11:43051067:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1776	BRCA1
NM_007294.4(BRCA1):c.5327C>A (p.Pro1776His)	BRCA1	P1776H	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000246175	17	41203085	17	43051068	246175	245019	rs398122695	NC_000017.11:43051067:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1776	BRCA1
NM_007294.4(BRCA1):c.5327C>T (p.Pro1776Leu)	BRCA1	P1776L	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000091647	17	41203085	17	43051068	91647	97124	rs398122695	NC_000017.11:43051067:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1776	BRCA1
NM_007294.4(BRCA1):c.5326C>G (p.Pro1776Ala)	BRCA1	P1776A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865308	17	41203086	17	43051069	865308	853556	rs1800757	NC_000017.11:43051068:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1776	BRCA1
NM_007294.4(BRCA1):c.5326C>A (p.Pro1776Thr)	BRCA1	P1776T	Hereditary breast ovarian cancer syndrome	VCV000865307	17	41203086	17	43051069	865307	853557	rs1800757	NC_000017.11:43051068:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1776	BRCA1
NM_007294.4(BRCA1):c.5326C>T (p.Pro1776Ser)	BRCA1	P1776S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000409312	17	41203086	17	43051069	409312	402467	rs1800757	NC_000017.11:43051068:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1776	BRCA1
NM_007294.4(BRCA1):c.5325G>T (p.Met1775Ile)	BRCA1	M1775I	Hereditary cancer-predisposing syndrome	VCV000865306	17	41203087	17	43051070	865306	853558	rs1135401885	NC_000017.11:43051069:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5325G>C (p.Met1775Ile)	BRCA1	M1775I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865305	17	41203087	17	43051070	865305	853559	rs1135401885	NC_000017.11:43051069:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5325G>A (p.Met1775Ile)	BRCA1	M1775I	not specified	VCV000431278	17	41203087	17	43051070	431278	424786	rs1135401885	NC_000017.11:43051069:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2014	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5324T>C (p.Met1775Thr)	BRCA1	M1775T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825652	17	41203088	17	43051071	825652	813651	rs41293463	NC_000017.11:43051070:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	BRCA1	M1775K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017695	17	41203088	17	43051071	17695	32734	rs41293463	NC_000017.11:43051070:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5324T>G (p.Met1775Arg)	BRCA1	M1775R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017694	17	41203088	17	43051071	17694	32733	rs41293463	NC_000017.11:43051070:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5323A>T (p.Met1775Leu)	BRCA1	M1775L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868307	17	41203089	17	43051072	868307	853560	rs2051198464	NC_000017.11:43051071:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5323A>G (p.Met1775Val)	BRCA1	M1775V	Hereditary cancer-predisposing syndrome	VCV000868306	17	41203089	17	43051072	868306	853561	rs2051198464	NC_000017.11:43051071:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Aug 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5323A>C (p.Met1775Leu)	BRCA1	M1775L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868305	17	41203089	17	43051072	868305	853562	rs2051198464	NC_000017.11:43051071:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1775	BRCA1
NM_007294.4(BRCA1):c.5322C>G (p.Asn1774Lys)	BRCA1	N1774K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868303	17	41203090	17	43051073	868303	853564	rs2051198731	NC_000017.11:43051072:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5322C>A (p.Asn1774Lys)	BRCA1	N1774K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868302	17	41203090	17	43051073	868302	853565	rs2051198731	NC_000017.11:43051072:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5321A>T (p.Asn1774Ile)	BRCA1	N1774I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867994	17	41203091	17	43051074	867994	853566	rs587781770	NC_000017.11:43051073:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5321A>C (p.Asn1774Thr)	BRCA1	N1774T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867993	17	41203091	17	43051074	867993	853567	rs587781770	NC_000017.11:43051073:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5321A>G (p.Asn1774Ser)	BRCA1	N1774S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000141467	17	41203091	17	43051074	141467	151181	rs587781770	NC_000017.11:43051073:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5320A>T (p.Asn1774Tyr)	BRCA1	N1774Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867992	17	41203092	17	43051075	867992	853568	rs1597804254	NC_000017.11:43051074:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5320A>G (p.Asn1774Asp)	BRCA1	N1774D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867991	17	41203092	17	43051075	867991	853569	rs1597804254	NC_000017.11:43051074:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5320A>C (p.Asn1774His)	BRCA1	N1774H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825649	17	41203092	17	43051075	825649	813652	rs1597804254	NC_000017.11:43051074:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1774	BRCA1
NM_007294.4(BRCA1):c.5318C>G (p.Thr1773Ser)	BRCA1	T1773S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865592	17	41203094	17	43051077	865592	853572	rs80357428	NC_000017.11:43051076:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1773	BRCA1
NM_007294.4(BRCA1):c.5318C>A (p.Thr1773Asn)	BRCA1	T1773N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865591	17	41203094	17	43051077	865591	853573	rs80357428	NC_000017.11:43051076:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1773	BRCA1
NM_007294.4(BRCA1):c.5318C>T (p.Thr1773Ile)	BRCA1	T1773I	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000055522	17	41203094	17	43051077	55522	70189	rs80357428	NC_000017.11:43051076:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1773	BRCA1
NM_007294.4(BRCA1):c.5317A>G (p.Thr1773Ala)	BRCA1	T1773A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865590	17	41203095	17	43051078	865590	853574	rs80357324	NC_000017.11:43051077:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1773	BRCA1
NM_007294.4(BRCA1):c.5317A>C (p.Thr1773Pro)	BRCA1	T1773P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865589	17	41203095	17	43051078	865589	853575	rs80357324	NC_000017.11:43051077:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1773	BRCA1
NM_007294.4(BRCA1):c.5317A>T (p.Thr1773Ser)	BRCA1	T1773S	not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000055521	17	41203095	17	43051078	55521	70188	rs80357324	NC_000017.11:43051077:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1773	BRCA1
NM_007294.4(BRCA1):c.5316C>A (p.Phe1772Leu)	BRCA1	F1772L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865298	17	41203096	17	43051079	865298	853577	rs2051200680	NC_000017.11:43051078:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1772	BRCA1
NM_007294.4(BRCA1):c.5315T>C (p.Phe1772Ser)	BRCA1	F1772S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865297	17	41203097	17	43051080	865297	853578	rs1555575700	NC_000017.11:43051079:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1772	BRCA1
NM_007294.4(BRCA1):c.5315T>A (p.Phe1772Tyr)	BRCA1	F1772Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865296	17	41203097	17	43051080	865296	853579	rs1555575700	NC_000017.11:43051079:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1772	BRCA1
NM_007294.4(BRCA1):c.5315T>G (p.Phe1772Cys)	BRCA1	F1772C	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000462669	17	41203097	17	43051080	462669	467674	rs1555575700	NC_000017.11:43051079:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1772	BRCA1
NM_007294.4(BRCA1):c.5314T>G (p.Phe1772Val)	BRCA1	F1772V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865295	17	41203098	17	43051081	865295	853580	rs2051201351	NC_000017.11:43051080:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1772	BRCA1
NM_007294.4(BRCA1):c.5314T>C (p.Phe1772Leu)	BRCA1	F1772L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865294	17	41203098	17	43051081	865294	853581	rs2051201351	NC_000017.11:43051080:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1772	BRCA1
NM_007294.4(BRCA1):c.5314T>A (p.Phe1772Ile)	BRCA1	F1772I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865293	17	41203098	17	43051081	865293	853582	rs2051201351	NC_000017.11:43051080:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1772	BRCA1
NM_007294.4(BRCA1):c.5312C>A (p.Pro1771His)	BRCA1	P1771H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868299	17	41203100	17	43051083	868299	853585	rs80357025	NC_000017.11:43051082:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1771	BRCA1
NM_007294.4(BRCA1):c.5312C>T (p.Pro1771Leu)	BRCA1	P1771L	Hereditary cancer-predisposing syndrome	VCV000055519	17	41203100	17	43051083	55519	70186	rs80357025	NC_000017.11:43051082:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 23, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1771	BRCA1
NM_007294.4(BRCA1):c.5312C>G (p.Pro1771Arg)	BRCA1	P1771R	Hereditary breast ovarian cancer syndrome	VCV000055518	17	41203100	17	43051083	55518	70185	rs80357025	NC_000017.11:43051082:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jan 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1771	BRCA1
NM_007294.4(BRCA1):c.5311C>G (p.Pro1771Ala)	BRCA1	P1771A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868298	17	41203101	17	43051084	868298	853586	rs576727185	NC_000017.11:43051083:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1771	BRCA1
NM_007294.4(BRCA1):c.5311C>A (p.Pro1771Thr)	BRCA1	P1771T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868297	17	41203101	17	43051084	868297	853587	rs576727185	NC_000017.11:43051083:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1771	BRCA1
NM_007294.4(BRCA1):c.5311C>T (p.Pro1771Ser)	BRCA1	P1771S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000860125	17	41203101	17	43051084	860125	845366	rs576727185	NC_000017.11:43051083:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 21, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1771	BRCA1
NM_007294.4(BRCA1):c.5309G>A (p.Gly1770Glu)	BRCA1	G1770E	Hereditary cancer-predisposing syndrome	VCV000867980	17	41203103	17	43051086	867980	853589	rs863224765	NC_000017.11:43051085:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1770	BRCA1
NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	BRCA1	G1770V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417832	17	41203103	17	43051086	417832	404710	rs863224765	NC_000017.11:43051085:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jul 18, 2018	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1770	BRCA1
NM_007294.4(BRCA1):c.5309G>C (p.Gly1770Ala)	BRCA1	G1770A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000216675	17	41203103	17	43051086	216675	213303	rs863224765	NC_000017.11:43051085:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1770	BRCA1
NM_007294.4(BRCA1):c.5308G>T (p.Gly1770Trp)	BRCA1	G1770W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867979	17	41203104	17	43051087	867979	853590	rs2051203696	NC_000017.11:43051086:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1770	BRCA1
NM_007294.4(BRCA1):c.5308G>C (p.Gly1770Arg)	BRCA1	G1770R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867978	17	41203104	17	43051087	867978	853591	rs2051203696	NC_000017.11:43051086:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1770	BRCA1
NM_007294.4(BRCA1):c.5308G>A (p.Gly1770Arg)	BRCA1	G1770R	Hereditary breast ovarian cancer syndrome	VCV000865581	17	41203104	17	43051087	865581	853592	rs2051203696	NC_000017.11:43051086:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1770	BRCA1
NM_007294.4(BRCA1):c.5306A>T (p.Tyr1769Phe)	BRCA1	Y1769F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865579	17	41203106	17	43051089	865579	853594	rs397509257	NC_000017.11:43051088:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1769	BRCA1
NM_007294.4(BRCA1):c.5306A>C (p.Tyr1769Ser)	BRCA1	Y1769S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865578	17	41203106	17	43051089	865578	853595	rs397509257	NC_000017.11:43051088:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1769	BRCA1
NM_007294.4(BRCA1):c.5306A>G (p.Tyr1769Cys)	BRCA1	Y1769C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|not provided	VCV000055513	17	41203106	17	43051089	55513	70180	rs397509257	NC_000017.11:43051088:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1769	BRCA1
NM_007294.4(BRCA1):c.5305T>G (p.Tyr1769Asp)	BRCA1	Y1769D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865577	17	41203107	17	43051090	865577	853596	rs2051204673	NC_000017.11:43051089:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1769	BRCA1
NM_007294.4(BRCA1):c.5305T>A (p.Tyr1769Asn)	BRCA1	Y1769N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865287	17	41203107	17	43051090	865287	853597	rs2051204673	NC_000017.11:43051089:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1769	BRCA1
NM_007294.4(BRCA1):c.5304C>G (p.Cys1768Trp)	BRCA1	C1768W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865286	17	41203108	17	43051091	865286	853598	rs138493864	NC_000017.11:43051090:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1768	BRCA1
NM_007294.4(BRCA1):c.5303G>T (p.Cys1768Phe)	BRCA1	C1768F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865284	17	41203109	17	43051092	865284	853600	rs730881497	NC_000017.11:43051091:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1768	BRCA1
NM_007294.4(BRCA1):c.5303G>C (p.Cys1768Ser)	BRCA1	C1768S	Hereditary breast ovarian cancer syndrome	VCV000865283	17	41203109	17	43051092	865283	853601	rs730881497	NC_000017.11:43051091:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1768	BRCA1
NM_007294.4(BRCA1):c.5303G>A (p.Cys1768Tyr)	BRCA1	C1768Y	not provided|Hereditary breast ovarian cancer syndrome	VCV000182167	17	41203109	17	43051092	182167	180823	rs730881497	NC_000017.11:43051091:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1768	BRCA1
NM_007294.4(BRCA1):c.5302T>C (p.Cys1768Arg)	BRCA1	C1768R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868296	17	41203110	17	43051093	868296	853602	rs431825416	NC_000017.11:43051092:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1768	BRCA1
NM_007294.4(BRCA1):c.5302T>A (p.Cys1768Ser)	BRCA1	C1768S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868295	17	41203110	17	43051093	868295	853603	rs431825416	NC_000017.11:43051092:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1768	BRCA1
NM_007294.4(BRCA1):c.5302T>G (p.Cys1768Gly)	BRCA1	C1768G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096948	17	41203110	17	43051093	96948	102851	rs431825416	NC_000017.11:43051092:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 25, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1768	BRCA1
NM_007294.4(BRCA1):c.5301T>G (p.Cys1767Trp)	BRCA1	C1767W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868294	17	41203111	17	43051094	868294	853604	rs886040288	NC_000017.11:43051093:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1767	BRCA1
NM_007294.4(BRCA1):c.5300G>T (p.Cys1767Phe)	BRCA1	C1767F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868292	17	41203112	17	43051095	868292	853606	rs1597804426	NC_000017.11:43051094:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 20, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1767	BRCA1
NM_007294.4(BRCA1):c.5300G>A (p.Cys1767Tyr)	BRCA1	C1767Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868291	17	41203112	17	43051095	868291	853607	rs1597804426	NC_000017.11:43051094:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1767	BRCA1
NM_007294.4(BRCA1):c.5300G>C (p.Cys1767Ser)	BRCA1	C1767S	Hereditary breast ovarian cancer syndrome|not provided	VCV000801087	17	41203112	17	43051095	801087	789610	rs1597804426	NC_000017.11:43051094:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1767	BRCA1
NM_007294.4(BRCA1):c.5299T>G (p.Cys1767Gly)	BRCA1	C1767G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867970	17	41203113	17	43051096	867970	853608	rs1567760645	NC_000017.11:43051095:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1767	BRCA1
NM_007294.4(BRCA1):c.5299T>A (p.Cys1767Ser)	BRCA1	C1767S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867969	17	41203113	17	43051096	867969	853609	rs1567760645	NC_000017.11:43051095:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1767	BRCA1
NM_007294.4(BRCA1):c.5299T>C (p.Cys1767Arg)	BRCA1	C1767R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630918	17	41203113	17	43051096	630918	618556	rs1567760645	NC_000017.11:43051095:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1767	BRCA1
NM_007294.4(BRCA1):c.5298C>G (p.Ile1766Met)	BRCA1	I1766M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867967	17	41203114	17	43051097	867967	853611	rs2051207482	NC_000017.11:43051096:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1766	BRCA1
NM_007294.4(BRCA1):c.5297T>C (p.Ile1766Thr)	BRCA1	I1766T	Hereditary breast ovarian cancer syndrome	VCV000867965	17	41203115	17	43051098	867965	853613	rs80357463	NC_000017.11:43051097:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jul 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1766	BRCA1
NM_007294.4(BRCA1):c.5297T>A (p.Ile1766Asn)	BRCA1	I1766N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267594	17	41203115	17	43051098	267594	262926	rs80357463	NC_000017.11:43051097:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1766	BRCA1
NM_007294.4(BRCA1):c.5297T>G (p.Ile1766Ser)	BRCA1	I1766S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037656	17	41203115	17	43051098	37656	46212	rs80357463	NC_000017.11:43051097:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1766	BRCA1
NM_007294.4(BRCA1):c.5296A>T (p.Ile1766Phe)	BRCA1	I1766F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865571	17	41203116	17	43051099	865571	853614	rs886039314	NC_000017.11:43051098:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1766	BRCA1
NM_007294.4(BRCA1):c.5296A>C (p.Ile1766Leu)	BRCA1	I1766L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865570	17	41203116	17	43051099	865570	853615	rs886039314	NC_000017.11:43051098:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1766	BRCA1
NM_007294.4(BRCA1):c.5296A>G (p.Ile1766Val)	BRCA1	I1766V	not specified|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000265052	17	41203116	17	43051099	265052	260170	rs886039314	NC_000017.11:43051098:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1766	BRCA1
NM_007294.4(BRCA1):c.5295A>T (p.Glu1765Asp)	BRCA1	E1765D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865569	17	41203117	17	43051100	865569	853616	rs2051208709	NC_000017.11:43051099:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1765	BRCA1
NM_007294.4(BRCA1):c.5295A>C (p.Glu1765Asp)	BRCA1	E1765D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865567	17	41203117	17	43051100	865567	853618	rs2051208709	NC_000017.11:43051099:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1765	BRCA1
NM_007294.4(BRCA1):c.5294A>T (p.Glu1765Val)	BRCA1	E1765V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865566	17	41203118	17	43051101	865566	853619	rs2051209003	NC_000017.11:43051100:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1765	BRCA1
NM_007294.4(BRCA1):c.5294A>G (p.Glu1765Gly)	BRCA1	E1765G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865275	17	41203118	17	43051101	865275	853620	rs2051209003	NC_000017.11:43051100:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1765	BRCA1
NM_007294.4(BRCA1):c.5294A>C (p.Glu1765Ala)	BRCA1	E1765A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865274	17	41203118	17	43051101	865274	853621	rs2051209003	NC_000017.11:43051100:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1765	BRCA1
NM_007294.4(BRCA1):c.5293G>C (p.Glu1765Gln)	BRCA1	E1765Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865273	17	41203119	17	43051102	865273	853622	rs397509256	NC_000017.11:43051101:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1765	BRCA1
NM_007294.4(BRCA1):c.5293G>A (p.Glu1765Lys)	BRCA1	E1765K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865272	17	41203119	17	43051102	865272	853623	rs397509256	NC_000017.11:43051101:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1765	BRCA1
NM_007294.4(BRCA1):c.5291T>A (p.Leu1764Gln)	BRCA1	L1764Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868290	17	41203121	17	43051104	868290	853627	rs80357281	NC_000017.11:43051103:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1764	BRCA1
NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	BRCA1	L1764P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055510	17	41203121	17	43051104	55510	70177	rs80357281	NC_000017.11:43051103:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1764	BRCA1
NM_007294.4(BRCA1):c.5290C>G (p.Leu1764Val)	BRCA1	L1764V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868289	17	41203122	17	43051105	868289	853628	rs1295469179	NC_000017.11:43051104:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1764	BRCA1
NM_007294.4(BRCA1):c.5290C>A (p.Leu1764Ile)	BRCA1	L1764I	Hereditary breast ovarian cancer syndrome	VCV000868288	17	41203122	17	43051105	868288	853629	rs1295469179	NC_000017.11:43051104:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 2, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1764	BRCA1
NM_007294.4(BRCA1):c.5288G>A (p.Gly1763Glu)	BRCA1	G1763E	Hereditary breast ovarian cancer syndrome	VCV000955912	17	41203124	17	43051107	955912	949925	rs80357007	NC_000017.11:43051106:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1763	BRCA1
NM_007294.4(BRCA1):c.5288G>C (p.Gly1763Ala)	BRCA1	G1763A	not specified	VCV000868287	17	41203124	17	43051107	868287	853630	rs80357007	NC_000017.11:43051106:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1763	BRCA1
NM_007294.4(BRCA1):c.5288G>T (p.Gly1763Val)	BRCA1	G1763V	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000055507	17	41203124	17	43051107	55507	70174	rs80357007	NC_000017.11:43051106:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1763	BRCA1
NM_007294.4(BRCA1):c.5287G>C (p.Gly1763Arg)	BRCA1	G1763R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000234183	17	41203125	17	43051108	234183	235933	rs876660907	NC_000017.11:43051107:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1763	BRCA1
NM_007294.4(BRCA1):c.5286G>T (p.Arg1762Ser)	BRCA1	R1762S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868286	17	41203126	17	43051109	868286	853631	rs1567760695	NC_000017.11:43051108:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1762	BRCA1
NM_007294.4(BRCA1):c.5286G>C (p.Arg1762Ser)	BRCA1	R1762S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867957	17	41203126	17	43051109	867957	853632	rs1567760695	NC_000017.11:43051108:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1762	BRCA1
NM_007294.4(BRCA1):c.5285G>C (p.Arg1762Thr)	BRCA1	R1762T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000648860	17	41203127	17	43051110	648860	645921	rs398122694	NC_000017.11:43051109:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1762	BRCA1
NM_007294.4(BRCA1):c.5285G>A (p.Arg1762Lys)	BRCA1	R1762K	Hereditary cancer-predisposing syndrome|not provided	VCV000422395	17	41203127	17	43051110	422395	409946	rs398122694	NC_000017.11:43051109:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 5, 2019	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1762	BRCA1
NM_007294.4(BRCA1):c.5285G>T (p.Arg1762Met)	BRCA1	R1762M	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000091646	17	41203127	17	43051110	91646	97123	rs398122694	NC_000017.11:43051109:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1762	BRCA1
NM_007294.4(BRCA1):c.5284A>T (p.Arg1762Trp)	BRCA1	R1762W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867955	17	41203128	17	43051111	867955	853634	rs2051212335	NC_000017.11:43051110:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1762	BRCA1
NM_007294.4(BRCA1):c.5284A>G (p.Arg1762Gly)	BRCA1	R1762G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867954	17	41203128	17	43051111	867954	853635	rs2051212335	NC_000017.11:43051110:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1762	BRCA1
NM_007294.4(BRCA1):c.5283C>G (p.Phe1761Leu)	BRCA1	F1761L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867344	17	41203129	17	43051112	867344	853638	rs2051212831	NC_000017.11:43051111:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5283C>A (p.Phe1761Leu)	BRCA1	F1761L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867343	17	41203129	17	43051112	867343	853639	rs2051212831	NC_000017.11:43051111:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5282T>A (p.Phe1761Tyr)	BRCA1	F1761Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867342	17	41203130	17	43051113	867342	853640	rs80356905	NC_000017.11:43051112:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5282T>G (p.Phe1761Cys)	BRCA1	F1761C	not specified|Hereditary breast ovarian cancer syndrome	VCV000440481	17	41203130	17	43051113	440481	432894	rs80356905	NC_000017.11:43051112:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 1, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5282T>C (p.Phe1761Ser)	BRCA1	F1761S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055505	17	41203130	17	43051113	55505	70172	rs80356905	NC_000017.11:43051112:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5281T>G (p.Phe1761Val)	BRCA1	F1761V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867341	17	41203131	17	43051114	867341	853641	rs1567760717	NC_000017.11:43051113:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5281T>A (p.Phe1761Ile)	BRCA1	F1761I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865265	17	41203131	17	43051114	865265	853642	rs1567760717	NC_000017.11:43051113:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5281T>C (p.Phe1761Leu)	BRCA1	F1761L	Hereditary cancer-predisposing syndrome	VCV000630802	17	41203131	17	43051114	630802	618557	rs1567760717	NC_000017.11:43051113:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1761	BRCA1
NM_007294.4(BRCA1):c.5280C>G (p.Ile1760Met)	BRCA1	I1760M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865264	17	41203132	17	43051115	865264	853643	rs750040616	NC_000017.11:43051114:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1760	BRCA1
NM_007294.4(BRCA1):c.5279T>G (p.Ile1760Ser)	BRCA1	I1760S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865263	17	41203133	17	43051116	865263	853644	rs2051214306	NC_000017.11:43051115:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1760	BRCA1
NM_007294.4(BRCA1):c.5279T>C (p.Ile1760Thr)	BRCA1	I1760T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865262	17	41203133	17	43051116	865262	853645	rs2051214306	NC_000017.11:43051115:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1760	BRCA1
NM_007294.4(BRCA1):c.5279T>A (p.Ile1760Asn)	BRCA1	I1760N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865261	17	41203133	17	43051116	865261	853646	rs2051214306	NC_000017.11:43051115:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1760	BRCA1
NM_007294.4(BRCA1):c.5278A>G (p.Ile1760Val)	BRCA1	I1760V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868285	17	41203134	17	43051117	868285	853648	rs2051214609	NC_000017.11:43051116:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1760	BRCA1
NM_007294.4(BRCA1):c.5278A>C (p.Ile1760Leu)	BRCA1	I1760L	not provided	VCV000868284	17	41203134	17	43051117	868284	853649	rs2051214609	NC_000017.11:43051116:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1760	BRCA1
NM_007294.4(BRCA1):c.5278A>T (p.Ile1760Phe)	BRCA1	I1760F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865260	17	41203134	17	43051117	865260	853647	rs2051214609	NC_000017.11:43051116:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1760	BRCA1
NM_007294.4(BRCA1):c.5277G>C (p.Lys1759Asn)	BRCA1	K1759N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868251	17	41209069	17	43057052	868251	853650	rs80356854	NC_000017.11:43057051:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5277G>T (p.Lys1759Asn)	BRCA1	K1759N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232061	17	41209069	17	43057052	232061	235934	rs80356854	NC_000017.11:43057051:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5276A>T (p.Lys1759Met)	BRCA1	K1759M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868250	17	41209070	17	43057053	868250	853651	rs431825415	NC_000017.11:43057052:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5276A>C (p.Lys1759Thr)	BRCA1	K1759T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868249	17	41209070	17	43057053	868249	853652	rs431825415	NC_000017.11:43057052:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5275_5276delinsTG (p.Lys1759Trp)	BRCA1	K1759W	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188165	17	41209070 - 41209071	17	43057053 - 43057054	188165	186255	rs786204116	NC_000017.11:43057052:TT:CA	Indel	missense variant|non-coding transcript variant	Uncertain significance	Jul 19, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5276A>G (p.Lys1759Arg)	BRCA1	K1759R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096947	17	41209070	17	43057053	96947	102850	rs431825415	NC_000017.11:43057052:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5275A>G (p.Lys1759Glu)	BRCA1	K1759E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867919	17	41209071	17	43057054	867919	853654	rs2051496536	NC_000017.11:43057053:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5275A>C (p.Lys1759Gln)	BRCA1	K1759Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867918	17	41209071	17	43057054	867918	853655	rs2051496536	NC_000017.11:43057053:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1759	BRCA1
NM_007294.4(BRCA1):c.5274A>T (p.Arg1758Ser)	BRCA1	R1758S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867917	17	41209072	17	43057055	867917	853656	rs758739620	NC_000017.11:43057054:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1758	BRCA1
NM_007294.4(BRCA1):c.5274A>C (p.Arg1758Ser)	BRCA1	R1758S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867916	17	41209072	17	43057055	867916	853657	rs758739620	NC_000017.11:43057054:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1758	BRCA1
NM_007294.4(BRCA1):c.5273G>T (p.Arg1758Ile)	BRCA1	R1758I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867915	17	41209073	17	43057056	867915	853658	rs2051497373	NC_000017.11:43057055:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1758	BRCA1
NM_007294.4(BRCA1):c.5273G>C (p.Arg1758Thr)	BRCA1	R1758T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867914	17	41209073	17	43057056	867914	853659	rs2051497373	NC_000017.11:43057055:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1758	BRCA1
NM_007294.4(BRCA1):c.5273G>A (p.Arg1758Lys)	BRCA1	R1758K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867913	17	41209073	17	43057056	867913	853660	rs2051497373	NC_000017.11:43057055:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1758	BRCA1
NM_007294.4(BRCA1):c.5272A>G (p.Arg1758Gly)	BRCA1	R1758G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000656220	17	41209074	17	43057057	656220	645922	rs1597810455	NC_000017.11:43057056:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1758	BRCA1
NM_007294.4(BRCA1):c.5271C>G (p.Asp1757Glu)	BRCA1	D1757E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867299	17	41209075	17	43057058	867299	853664	rs1597810460	NC_000017.11:43057057:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5271C>A (p.Asp1757Glu)	BRCA1	D1757E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825607	17	41209075	17	43057058	825607	813653	rs1597810460	NC_000017.11:43057057:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5270A>T (p.Asp1757Val)	BRCA1	D1757V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867298	17	41209076	17	43057059	867298	853665	rs2051498474	NC_000017.11:43057058:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5270A>G (p.Asp1757Gly)	BRCA1	D1757G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867297	17	41209076	17	43057059	867297	853666	rs2051498474	NC_000017.11:43057058:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5270A>C (p.Asp1757Ala)	BRCA1	D1757A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865222	17	41209076	17	43057059	865222	853667	rs2051498474	NC_000017.11:43057058:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5269G>A (p.Asp1757Asn)	BRCA1	D1757N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000531222	17	41209077	17	43057060	531222	531284	rs863224764	NC_000017.11:43057059:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 7, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5269G>T (p.Asp1757Tyr)	BRCA1	D1757Y	Hereditary cancer-predisposing syndrome	VCV000441431	17	41209077	17	43057060	441431	435104	rs863224764	NC_000017.11:43057059:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5269G>C (p.Asp1757His)	BRCA1	D1757H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000216674	17	41209077	17	43057060	216674	213304	rs863224764	NC_000017.11:43057059:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 15, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1757	BRCA1
NM_007294.4(BRCA1):c.5268G>T (p.Gln1756His)	BRCA1	Q1756H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865221	17	41209078	17	43057061	865221	853668	rs571834423	NC_000017.11:43057060:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1756	BRCA1
NM_007294.4(BRCA1):c.5268G>C (p.Gln1756His)	BRCA1	Q1756H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865220	17	41209078	17	43057061	865220	853669	rs571834423	NC_000017.11:43057060:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1756	BRCA1
NM_007294.4(BRCA1):c.5267A>C (p.Gln1756Pro)	BRCA1	Q1756P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868241	17	41209079	17	43057062	868241	853671	rs1567764257	NC_000017.11:43057061:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1756	BRCA1
NM_007294.4(BRCA1):c.5267A>T (p.Gln1756Leu)	BRCA1	Q1756L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865219	17	41209079	17	43057062	865219	853670	rs1567764257	NC_000017.11:43057061:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1756	BRCA1
NM_007294.4(BRCA1):c.5267A>G (p.Gln1756Arg)	BRCA1	Q1756R	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000580844	17	41209079	17	43057062	580844	569074	rs1567764257	NC_000017.11:43057061:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1756	BRCA1
NM_007294.4(BRCA1):c.5266C>G (p.Gln1756Glu)	BRCA1	Q1756E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868240	17	41209080	17	43057063	868240	853672	rs397509247	NC_000017.11:43057062:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1756	BRCA1
NM_007294.4(BRCA1):c.5266C>A (p.Gln1756Lys)	BRCA1	Q1756K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868239	17	41209080	17	43057063	868239	853673	rs397509247	NC_000017.11:43057062:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1756	BRCA1
NM_007294.4(BRCA1):c.5264C>G (p.Ser1755Cys)	BRCA1	S1755C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867908	17	41209082	17	43057065	867908	853676	rs1555576858	NC_000017.11:43057064:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1755	BRCA1
NM_007294.4(BRCA1):c.5264C>A (p.Ser1755Tyr)	BRCA1	S1755Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867907	17	41209082	17	43057065	867907	853677	rs1555576858	NC_000017.11:43057064:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1755	BRCA1
NM_007294.4(BRCA1):c.5264C>T (p.Ser1755Phe)	BRCA1	S1755F	Hereditary breast ovarian cancer syndrome	VCV000531431	17	41209082	17	43057065	531431	531542	rs1555576858	NC_000017.11:43057064:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1755	BRCA1
NM_007294.4(BRCA1):c.5263T>G (p.Ser1755Ala)	BRCA1	S1755A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867906	17	41209083	17	43057066	867906	853678	rs2051501553	NC_000017.11:43057065:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1755	BRCA1
NM_007294.4(BRCA1):c.5263T>C (p.Ser1755Pro)	BRCA1	S1755P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867905	17	41209083	17	43057066	867905	853679	rs2051501553	NC_000017.11:43057065:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1755	BRCA1
NM_007294.4(BRCA1):c.5263T>A (p.Ser1755Thr)	BRCA1	S1755T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867904	17	41209083	17	43057066	867904	853680	rs2051501553	NC_000017.11:43057065:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1755	BRCA1
NM_007294.4(BRCA1):c.5262A>T (p.Glu1754Asp)	BRCA1	E1754D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867903	17	41209084	17	43057067	867903	853681	rs2051501825	NC_000017.11:43057066:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1754	BRCA1
NM_007294.4(BRCA1):c.5262A>C (p.Glu1754Asp)	BRCA1	E1754D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867289	17	41209084	17	43057067	867289	853683	rs2051501825	NC_000017.11:43057066:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1754	BRCA1
NM_007294.4(BRCA1):c.5261A>T (p.Glu1754Val)	BRCA1	E1754V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867288	17	41209085	17	43057068	867288	853684	rs2051502100	NC_000017.11:43057067:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1754	BRCA1
NM_007294.4(BRCA1):c.5261A>G (p.Glu1754Gly)	BRCA1	E1754G	Hereditary breast ovarian cancer syndrome	VCV000867287	17	41209085	17	43057068	867287	853685	rs2051502100	NC_000017.11:43057067:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1754	BRCA1
NM_007294.4(BRCA1):c.5261A>C (p.Glu1754Ala)	BRCA1	E1754A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867286	17	41209085	17	43057068	867286	853686	rs2051502100	NC_000017.11:43057067:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1754	BRCA1
NM_007294.4(BRCA1):c.5260G>C (p.Glu1754Gln)	BRCA1	E1754Q	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462666	17	41209086	17	43057069	462666	467675	rs80357432	NC_000017.11:43057068:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1754	BRCA1
NM_007294.4(BRCA1):c.5260G>A (p.Glu1754Lys)	BRCA1	E1754K	Hereditary breast ovarian cancer syndrome	VCV000188419	17	41209086	17	43057069	188419	186536	rs80357432	NC_000017.11:43057068:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1754	BRCA1
NM_007294.4(BRCA1):c.5259A>C (p.Arg1753Ser)	BRCA1	R1753S	Hereditary breast ovarian cancer syndrome	VCV000865211	17	41209087	17	43057070	865211	853687	rs771577266	NC_000017.11:43057069:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1753	BRCA1
NM_007294.4(BRCA1):c.5259A>T (p.Arg1753Ser)	BRCA1	R1753S	Hereditary breast ovarian cancer syndrome	VCV000409370	17	41209087	17	43057070	409370	402621	rs771577266	NC_000017.11:43057069:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1753	BRCA1
NM_007294.4(BRCA1):c.5258G>T (p.Arg1753Ile)	BRCA1	R1753I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865210	17	41209088	17	43057071	865210	853688	rs397509246	NC_000017.11:43057070:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1753	BRCA1
NM_007294.4(BRCA1):c.5258G>C (p.Arg1753Thr)	BRCA1	R1753T	not provided|Hereditary breast ovarian cancer syndrome	VCV000055488	17	41209088	17	43057071	55488	70155	rs397509246	NC_000017.11:43057070:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 17, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1753	BRCA1
NM_007294.4(BRCA1):c.5258G>A (p.Arg1753Lys)	BRCA1	R1753K	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055487	17	41209088	17	43057071	55487	70154	rs397509246	NC_000017.11:43057070:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1753	BRCA1
NM_007294.4(BRCA1):c.5257A>G (p.Arg1753Gly)	BRCA1	R1753G	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000801086	17	41209089	17	43057072	801086	789611	rs1597810544	NC_000017.11:43057071:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1753	BRCA1
NM_007294.4(BRCA1):c.5255C>A (p.Ala1752Glu)	BRCA1	A1752E	Hereditary cancer-predisposing syndrome	VCV000868230	17	41209091	17	43057074	868230	853693	rs80357028	NC_000017.11:43057073:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1752	BRCA1
NM_007294.4(BRCA1):c.5255C>G (p.Ala1752Gly)	BRCA1	A1752G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482908	17	41209091	17	43057074	482908	479253	rs80357028	NC_000017.11:43057073:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1752	BRCA1
NM_007294.4(BRCA1):c.5255C>T (p.Ala1752Val)	BRCA1	A1752V	Hereditary breast ovarian cancer syndrome	VCV000055484	17	41209091	17	43057074	55484	70151	rs80357028	NC_000017.11:43057073:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 31, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1752	BRCA1
NM_007294.4(BRCA1):c.5254G>T (p.Ala1752Ser)	BRCA1	A1752S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868229	17	41209092	17	43057075	868229	853694	rs80357074	NC_000017.11:43057074:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1752	BRCA1
NM_007294.4(BRCA1):c.5254G>A (p.Ala1752Thr)	BRCA1	A1752T	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000096944	17	41209092	17	43057075	96944	102847	rs80357074	NC_000017.11:43057074:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1752	BRCA1
NM_007294.4(BRCA1):c.5254G>C (p.Ala1752Pro)	BRCA1	A1752P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055483	17	41209092	17	43057075	55483	70150	rs80357074	NC_000017.11:43057074:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1752	BRCA1
NM_007294.4(BRCA1):c.5252G>T (p.Arg1751Leu)	BRCA1	R1751L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531284	17	41209094	17	43057077	531284	531048	rs80357442	NC_000017.11:43057076:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1751	BRCA1
NM_007294.4(BRCA1):c.5252G>C (p.Arg1751Pro)	BRCA1	R1751P	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055482	17	41209094	17	43057077	55482	70149	rs80357442	NC_000017.11:43057076:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	May 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1751	BRCA1
NM_007294.4(BRCA1):c.5252G>A (p.Arg1751Gln)	BRCA1	R1751Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055481	17	41209094	17	43057077	55481	70148	rs80357442	NC_000017.11:43057076:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1751	BRCA1
NM_007294.4(BRCA1):c.5251C>G (p.Arg1751Gly)	BRCA1	R1751G	Hereditary breast ovarian cancer syndrome	VCV000433728	17	41209095	17	43057078	433728	427528	rs80357123	NC_000017.11:43057077:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jan 6, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1751	BRCA1
NM_007294.4(BRCA1):c.5250G>T (p.Lys1750Asn)	BRCA1	K1750N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867280	17	41209096	17	43057079	867280	853698	rs1597810591	NC_000017.11:43057078:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1750	BRCA1
NM_007294.4(BRCA1):c.5250G>C (p.Lys1750Asn)	BRCA1	K1750N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867279	17	41209096	17	43057079	867279	853699	rs1597810591	NC_000017.11:43057078:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1750	BRCA1
NM_007294.4(BRCA1):c.5249A>T (p.Lys1750Met)	BRCA1	K1750M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867278	17	41209097	17	43057080	867278	853700	rs2051506626	NC_000017.11:43057079:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1750	BRCA1
NM_007294.4(BRCA1):c.5249A>G (p.Lys1750Arg)	BRCA1	K1750R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000867277	17	41209097	17	43057080	867277	853701	rs2051506626	NC_000017.11:43057079:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 21, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1750	BRCA1
NM_007294.4(BRCA1):c.5249A>C (p.Lys1750Thr)	BRCA1	K1750T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867276	17	41209097	17	43057080	867276	853702	rs2051506626	NC_000017.11:43057079:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1750	BRCA1
NM_007294.4(BRCA1):c.5248A>G (p.Lys1750Glu)	BRCA1	K1750E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865200	17	41209098	17	43057081	865200	853704	rs2051507325	NC_000017.11:43057080:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1750	BRCA1
NM_007294.4(BRCA1):c.5248A>C (p.Lys1750Gln)	BRCA1	K1750Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865199	17	41209098	17	43057081	865199	853705	rs2051507325	NC_000017.11:43057080:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1750	BRCA1
NM_007294.4(BRCA1):c.5246C>A (p.Pro1749Gln)	BRCA1	P1749Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868222	17	41209100	17	43057083	868222	853709	rs80357462	NC_000017.11:43057082:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1749	BRCA1
NM_007294.4(BRCA1):c.5246C>T (p.Pro1749Leu)	BRCA1	P1749L	Hereditary breast ovarian cancer syndrome	VCV000531311	17	41209100	17	43057083	531311	531543	rs80357462	NC_000017.11:43057082:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1749	BRCA1
NM_007294.4(BRCA1):c.5246C>G (p.Pro1749Arg)	BRCA1	P1749R	not provided	VCV000055479	17	41209100	17	43057083	55479	70146	rs80357462	NC_000017.11:43057082:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 2, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1749	BRCA1
NM_007294.4(BRCA1):c.5245C>T (p.Pro1749Ser)	BRCA1	P1749S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868221	17	41209101	17	43057084	868221	853710	rs397509244	NC_000017.11:43057083:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1749	BRCA1
NM_007294.4(BRCA1):c.5245C>A (p.Pro1749Thr)	BRCA1	P1749T	Hereditary cancer-predisposing syndrome	VCV000232831	17	41209101	17	43057084	232831	235936	rs397509244	NC_000017.11:43057083:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1749	BRCA1
NM_007294.4(BRCA1):c.5245C>G (p.Pro1749Ala)	BRCA1	P1749A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055478	17	41209101	17	43057084	55478	70145	rs397509244	NC_000017.11:43057083:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1749	BRCA1
NM_007294.4(BRCA1):c.5243G>C (p.Gly1748Ala)	BRCA1	G1748A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867884	17	41209103	17	43057086	867884	853714	rs397509243	NC_000017.11:43057085:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1748	BRCA1
NM_007294.4(BRCA1):c.5243G>T (p.Gly1748Val)	BRCA1	G1748V	not provided|Hereditary cancer-predisposing syndrome	VCV000496392	17	41209103	17	43057086	496392	487943	rs397509243	NC_000017.11:43057085:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 25, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1748	BRCA1
NM_007294.4(BRCA1):c.5243G>A (p.Gly1748Asp)	BRCA1	G1748D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055476	17	41209103	17	43057086	55476	70143	rs397509243	NC_000017.11:43057085:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 28, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1748	BRCA1
NM_007294.4(BRCA1):c.5242G>C (p.Gly1748Arg)	BRCA1	G1748R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240819	17	41209104	17	43057087	240819	242759	rs397507245	NC_000017.11:43057086:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 3, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1748	BRCA1
NM_007294.4(BRCA1):c.5242G>A (p.Gly1748Ser)	BRCA1	G1748S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055475	17	41209104	17	43057087	55475	70142	rs397507245	NC_000017.11:43057086:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1748	BRCA1
NM_007294.4(BRCA1):c.5242G>T (p.Gly1748Cys)	BRCA1	G1748C	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000037650	17	41209104	17	43057087	37650	46206	rs397507245	NC_000017.11:43057086:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jul 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1748	BRCA1
NM_007294.4(BRCA1):c.5241A>T (p.Gln1747His)	BRCA1	Q1747H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867883	17	41209105	17	43057088	867883	853715	rs397509242	NC_000017.11:43057087:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1747	BRCA1
NM_007294.4(BRCA1):c.5241A>C (p.Gln1747His)	BRCA1	Q1747H	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055474	17	41209105	17	43057088	55474	70141	rs397509242	NC_000017.11:43057087:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1747	BRCA1
NM_007294.4(BRCA1):c.5240A>T (p.Gln1747Leu)	BRCA1	Q1747L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867268	17	41209106	17	43057089	867268	853717	rs2051510661	NC_000017.11:43057088:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1747	BRCA1
NM_007294.4(BRCA1):c.5240A>G (p.Gln1747Arg)	BRCA1	Q1747R	Hereditary breast ovarian cancer syndrome	VCV000867267	17	41209106	17	43057089	867267	853718	rs2051510661	NC_000017.11:43057088:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1747	BRCA1
NM_007294.4(BRCA1):c.5240A>C (p.Gln1747Pro)	BRCA1	Q1747P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867266	17	41209106	17	43057089	867266	853719	rs2051510661	NC_000017.11:43057088:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1747	BRCA1
NM_007294.4(BRCA1):c.5239C>G (p.Gln1747Glu)	BRCA1	Q1747E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000867265	17	41209107	17	43057090	867265	853720	rs80357367	NC_000017.11:43057089:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1747	BRCA1
NM_007294.4(BRCA1):c.5239C>A (p.Gln1747Lys)	BRCA1	Q1747K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867264	17	41209107	17	43057090	867264	853721	rs80357367	NC_000017.11:43057089:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1747	BRCA1
NM_007294.4(BRCA1):c.5238C>A (p.His1746Gln)	BRCA1	H1746Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865191	17	41209108	17	43057091	865191	853723	rs786202389	NC_000017.11:43057090:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5238C>G (p.His1746Gln)	BRCA1	H1746Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185702	17	41209108	17	43057091	185702	184882	rs786202389	NC_000017.11:43057090:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5237A>T (p.His1746Leu)	BRCA1	H1746L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865190	17	41209109	17	43057092	865190	853724	rs876659991	NC_000017.11:43057091:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5237A>G (p.His1746Arg)	BRCA1	H1746R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865189	17	41209109	17	43057092	865189	853725	rs876659991	NC_000017.11:43057091:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5237A>C (p.His1746Pro)	BRCA1	H1746P	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000232790	17	41209109	17	43057092	232790	235937	rs876659991	NC_000017.11:43057091:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5236C>G (p.His1746Asp)	BRCA1	H1746D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000531399	17	41209110	17	43057093	531399	531162	rs80357146	NC_000017.11:43057092:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5236C>T (p.His1746Tyr)	BRCA1	H1746Y	Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer	VCV000433726	17	41209110	17	43057093	433726	427530	rs80357146	NC_000017.11:43057092:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2013	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5236C>A (p.His1746Asn)	BRCA1	H1746N	Hereditary cancer-predisposing syndrome	VCV000055472	17	41209110	17	43057093	55472	70139	rs80357146	NC_000017.11:43057092:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1746	BRCA1
NM_007294.4(BRCA1):c.5235C>G (p.Asn1745Lys)	BRCA1	N1745K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868213	17	41209111	17	43057094	868213	853727	rs2051513534	NC_000017.11:43057093:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5235C>A (p.Asn1745Lys)	BRCA1	N1745K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868212	17	41209111	17	43057094	868212	853728	rs2051513534	NC_000017.11:43057093:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5234A>T (p.Asn1745Ile)	BRCA1	N1745I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868211	17	41209112	17	43057095	868211	853729	rs1567764456	NC_000017.11:43057094:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5234A>C (p.Asn1745Thr)	BRCA1	N1745T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868210	17	41209112	17	43057095	868210	853730	rs1567764456	NC_000017.11:43057094:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5234A>G (p.Asn1745Ser)	BRCA1	N1745S	not provided	VCV000560856	17	41209112	17	43057095	560856	551932	rs1567764456	NC_000017.11:43057094:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5233A>T (p.Asn1745Tyr)	BRCA1	N1745Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868209	17	41209113	17	43057096	868209	853731	rs2051514369	NC_000017.11:43057095:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5233A>G (p.Asn1745Asp)	BRCA1	N1745D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868208	17	41209113	17	43057096	868208	853732	rs2051514369	NC_000017.11:43057095:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5233A>C (p.Asn1745His)	BRCA1	N1745H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868207	17	41209113	17	43057096	868207	853733	rs2051514369	NC_000017.11:43057095:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1745	BRCA1
NM_007294.4(BRCA1):c.5232A>T (p.Arg1744Ser)	BRCA1	R1744S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867874	17	41209114	17	43057097	867874	853734	rs2051514714	NC_000017.11:43057096:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1744	BRCA1
NM_007294.4(BRCA1):c.5232A>C (p.Arg1744Ser)	BRCA1	R1744S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867872	17	41209114	17	43057097	867872	853736	rs2051514714	NC_000017.11:43057096:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1744	BRCA1
NM_007294.4(BRCA1):c.5231G>T (p.Arg1744Ile)	BRCA1	R1744I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867871	17	41209115	17	43057098	867871	853737	rs1567764460	NC_000017.11:43057097:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1744	BRCA1
NM_007294.4(BRCA1):c.5231G>C (p.Arg1744Thr)	BRCA1	R1744T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867870	17	41209115	17	43057098	867870	853738	rs1567764460	NC_000017.11:43057097:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1744	BRCA1
NM_007294.4(BRCA1):c.5231G>A (p.Arg1744Lys)	BRCA1	R1744K	Hereditary breast ovarian cancer syndrome	VCV000571901	17	41209115	17	43057098	571901	571378	rs1567764460	NC_000017.11:43057097:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1744	BRCA1
NM_007294.4(BRCA1):c.5230A>G (p.Arg1744Gly)	BRCA1	R1744G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867868	17	41209116	17	43057099	867868	853740	rs2051515528	NC_000017.11:43057098:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1744	BRCA1
NM_007294.4(BRCA1):c.5228G>T (p.Gly1743Val)	BRCA1	G1743V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867254	17	41209118	17	43057101	867254	853745	rs1346819781	NC_000017.11:43057100:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1743	BRCA1
NM_007294.4(BRCA1):c.5228G>A (p.Gly1743Glu)	BRCA1	G1743E	Hereditary breast ovarian cancer syndrome	VCV000867253	17	41209118	17	43057101	867253	853746	rs1346819781	NC_000017.11:43057100:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jan 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1743	BRCA1
NM_007294.4(BRCA1):c.5228G>C (p.Gly1743Ala)	BRCA1	G1743A	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000496391	17	41209118	17	43057101	496391	487843	rs1346819781	NC_000017.11:43057100:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1743	BRCA1
NM_007294.4(BRCA1):c.5227G>C (p.Gly1743Arg)	BRCA1	G1743R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865182	17	41209119	17	43057102	865182	853747	rs2051517323	NC_000017.11:43057101:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1743	BRCA1
NM_007294.4(BRCA1):c.5227G>A (p.Gly1743Arg)	BRCA1	G1743R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000865181	17	41209119	17	43057102	865181	853748	rs2051517323	NC_000017.11:43057101:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1743	BRCA1
NM_007294.4(BRCA1):c.5226T>G (p.Asn1742Lys)	BRCA1	N1742K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865180	17	41209120	17	43057103	865180	853749	rs2051517669	NC_000017.11:43057102:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5226T>A (p.Asn1742Lys)	BRCA1	N1742K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865178	17	41209120	17	43057103	865178	853751	rs2051517669	NC_000017.11:43057102:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5225A>T (p.Asn1742Ile)	BRCA1	N1742I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865177	17	41209121	17	43057104	865177	853752	rs864622104	NC_000017.11:43057103:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5225A>C (p.Asn1742Thr)	BRCA1	N1742T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865176	17	41209121	17	43057104	865176	853753	rs864622104	NC_000017.11:43057103:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5225A>G (p.Asn1742Ser)	BRCA1	N1742S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000219464	17	41209121	17	43057104	219464	222650	rs864622104	NC_000017.11:43057103:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5224A>T (p.Asn1742Tyr)	BRCA1	N1742Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868200	17	41209122	17	43057105	868200	853754	rs1597810828	NC_000017.11:43057104:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5224A>C (p.Asn1742His)	BRCA1	N1742H	Hereditary breast ovarian cancer syndrome	VCV000868199	17	41209122	17	43057105	868199	853755	rs1597810828	NC_000017.11:43057104:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5224A>G (p.Asn1742Asp)	BRCA1	N1742D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825568	17	41209122	17	43057105	825568	813656	rs1597810828	NC_000017.11:43057104:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 26, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1742	BRCA1
NM_007294.4(BRCA1):c.5222T>C (p.Val1741Ala)	BRCA1	V1741A	Hereditary breast ovarian cancer syndrome	VCV000868195	17	41209124	17	43057107	868195	853759	rs80357023	NC_000017.11:43057106:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1741	BRCA1
NM_007294.4(BRCA1):c.5222T>A (p.Val1741Asp)	BRCA1	V1741D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868194	17	41209124	17	43057107	868194	853760	rs80357023	NC_000017.11:43057106:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1741	BRCA1
NM_007294.4(BRCA1):c.5222T>G (p.Val1741Gly)	BRCA1	V1741G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055468	17	41209124	17	43057107	55468	70135	rs80357023	NC_000017.11:43057106:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 29, 2002	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1741	BRCA1
NM_007294.4(BRCA1):c.5221G>C (p.Val1741Leu)	BRCA1	V1741L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867859	17	41209125	17	43057108	867859	853761	rs876659122	NC_000017.11:43057107:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1741	BRCA1
NM_007294.4(BRCA1):c.5221G>A (p.Val1741Ile)	BRCA1	V1741I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000231376	17	41209125	17	43057108	231376	235939	rs876659122	NC_000017.11:43057107:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1741	BRCA1
NM_007294.4(BRCA1):c.5219T>G (p.Val1740Gly)	BRCA1	V1740G	Hereditary breast ovarian cancer syndrome	VCV000867858	17	41209127	17	43057110	867858	853762	rs1555576951	NC_000017.11:43057109:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1740	BRCA1
NM_007294.4(BRCA1):c.5219T>C (p.Val1740Ala)	BRCA1	V1740A	Hereditary cancer-predisposing syndrome	VCV000491102	17	41209127	17	43057110	491102	485085	rs1555576951	NC_000017.11:43057109:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1740	BRCA1
NM_007294.4(BRCA1):c.5218G>C (p.Val1740Leu)	BRCA1	V1740L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867857	17	41209128	17	43057111	867857	853763	rs2051520551	NC_000017.11:43057110:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1740	BRCA1
NM_007294.4(BRCA1):c.5217T>A (p.Asp1739Glu)	BRCA1	D1739E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867855	17	41209129	17	43057112	867855	853765	rs80357340	NC_000017.11:43057111:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5217T>G (p.Asp1739Glu)	BRCA1	D1739E	Hereditary cancer-predisposing syndrome	VCV000055467	17	41209129	17	43057112	55467	70134	rs80357340	NC_000017.11:43057111:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Mar 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5216A>C (p.Asp1739Ala)	BRCA1	D1739A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867522	17	41209130	17	43057113	867522	853766	rs80357227	NC_000017.11:43057112:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5216A>T (p.Asp1739Val)	BRCA1	D1739V	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055466	17	41209130	17	43057113	55466	70133	rs80357227	NC_000017.11:43057112:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5216A>G (p.Asp1739Gly)	BRCA1	D1739G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055465	17	41209130	17	43057113	55465	70132	rs80357227	NC_000017.11:43057112:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5215G>C (p.Asp1739His)	BRCA1	D1739H	Hereditary cancer-predisposing syndrome	VCV000481487	17	41209131	17	43057114	481487	478519	rs80357283	NC_000017.11:43057113:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5215G>A (p.Asp1739Asn)	BRCA1	D1739N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479223	17	41209131	17	43057114	479223	479256	rs80357283	NC_000017.11:43057113:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5215G>T (p.Asp1739Tyr)	BRCA1	D1739Y	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055464	17	41209131	17	43057114	55464	70131	rs80357283	NC_000017.11:43057113:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Mar 22, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1739	BRCA1
NM_007294.4(BRCA1):c.5213G>C (p.Gly1738Ala)	BRCA1	G1738A	Hereditary cancer-predisposing syndrome	VCV000865166	17	41209133	17	43057116	865166	853770	rs80357450	NC_000017.11:43057115:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1738	BRCA1
NM_007294.4(BRCA1):c.5213G>T (p.Gly1738Val)	BRCA1	G1738V	Hereditary breast ovarian cancer syndrome	VCV000845528	17	41209133	17	43057116	845528	845369	rs80357450	NC_000017.11:43057115:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 30, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1738	BRCA1
NM_007294.4(BRCA1):c.5213G>A (p.Gly1738Glu)	BRCA1	G1738E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000055462	17	41209133	17	43057116	55462	70129	rs80357450	NC_000017.11:43057115:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1738	BRCA1
NM_007294.4(BRCA1):c.5212G>C (p.Gly1738Arg)	BRCA1	G1738R	Hereditary cancer-predisposing syndrome	VCV000865165	17	41209134	17	43057117	865165	853771	rs80356937	NC_000017.11:43057116:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1738	BRCA1
NM_007294.4(BRCA1):c.5212G>A (p.Gly1738Arg)	BRCA1	G1738R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055461	17	41209134	17	43057117	55461	70128	rs80356937	NC_000017.11:43057116:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1738	BRCA1
NM_007294.4(BRCA1):c.5211A>C (p.Arg1737Ser)	BRCA1	R1737S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868188	17	41209135	17	43057118	868188	853773	rs1555576963	NC_000017.11:43057117:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1737	BRCA1
NM_007294.4(BRCA1):c.5211A>T (p.Arg1737Ser)	BRCA1	R1737S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865164	17	41209135	17	43057118	865164	853772	rs1555576963	NC_000017.11:43057117:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1737	BRCA1
NM_007294.4(BRCA1):c.5210G>T (p.Arg1737Ile)	BRCA1	R1737I	Hereditary breast ovarian cancer syndrome	VCV000868187	17	41209136	17	43057119	868187	853774	rs2051524645	NC_000017.11:43057118:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1737	BRCA1
NM_007294.4(BRCA1):c.5210G>C (p.Arg1737Thr)	BRCA1	R1737T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868186	17	41209136	17	43057119	868186	853775	rs2051524645	NC_000017.11:43057118:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1737	BRCA1
NM_007294.4(BRCA1):c.5210G>A (p.Arg1737Lys)	BRCA1	R1737K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868185	17	41209136	17	43057119	868185	853776	rs2051524645	NC_000017.11:43057118:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1737	BRCA1
NM_007294.4(BRCA1):c.5209A>G (p.Arg1737Gly)	BRCA1	R1737G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868184	17	41209137	17	43057120	868184	853777	rs80357496	NC_000017.11:43057119:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1737	BRCA1
NM_007294.4(BRCA1):c.5207T>A (p.Val1736Asp)	BRCA1	V1736D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867844	17	41209139	17	43057122	867844	853782	rs45553935	NC_000017.11:43057121:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1736	BRCA1
NM_007294.4(BRCA1):c.5207T>G (p.Val1736Gly)	BRCA1	V1736G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055456	17	41209139	17	43057122	55456	70123	rs45553935	NC_000017.11:43057121:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 16, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1736	BRCA1
NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	BRCA1	V1736A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037648	17	41209139	17	43057122	37648	46204	rs45553935	NC_000017.11:43057121:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 25, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1736	BRCA1
NM_007294.4(BRCA1):c.5206G>T (p.Val1736Phe)	BRCA1	V1736F	Hereditary breast ovarian cancer syndrome	VCV000867843	17	41209140	17	43057123	867843	853783	rs377595653	NC_000017.11:43057122:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1736	BRCA1
NM_007294.4(BRCA1):c.5206G>C (p.Val1736Leu)	BRCA1	V1736L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867842	17	41209140	17	43057123	867842	853784	rs377595653	NC_000017.11:43057122:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1736	BRCA1
NM_007294.4(BRCA1):c.5206G>A (p.Val1736Ile)	BRCA1	V1736I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867518	17	41209140	17	43057123	867518	853785	rs377595653	NC_000017.11:43057122:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1736	BRCA1
NM_007294.4(BRCA1):c.5205A>C (p.Glu1735Asp)	BRCA1	E1735D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867516	17	41209141	17	43057124	867516	853787	rs431825412	NC_000017.11:43057123:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1735	BRCA1
NM_007294.4(BRCA1):c.5205A>T (p.Glu1735Asp)	BRCA1	E1735D	Hereditary breast ovarian cancer syndrome	VCV000096943	17	41209141	17	43057124	96943	102846	rs431825412	NC_000017.11:43057123:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1735	BRCA1
NM_007294.4(BRCA1):c.5204A>T (p.Glu1735Val)	BRCA1	E1735V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867515	17	41209142	17	43057125	867515	853788	rs2051527499	NC_000017.11:43057124:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1735	BRCA1
NM_007294.4(BRCA1):c.5204A>G (p.Glu1735Gly)	BRCA1	E1735G	Hereditary breast ovarian cancer syndrome	VCV000867514	17	41209142	17	43057125	867514	853789	rs2051527499	NC_000017.11:43057124:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1735	BRCA1
NM_007294.4(BRCA1):c.5204A>C (p.Glu1735Ala)	BRCA1	E1735A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867513	17	41209142	17	43057125	867513	853790	rs2051527499	NC_000017.11:43057124:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1735	BRCA1
NM_007294.4(BRCA1):c.5203G>C (p.Glu1735Gln)	BRCA1	E1735Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865156	17	41209143	17	43057126	865156	853792	rs397509238	NC_000017.11:43057125:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1735	BRCA1
NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	BRCA1	E1735K	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055455	17	41209143	17	43057126	55455	70122	rs397509238	NC_000017.11:43057125:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1735	BRCA1
NM_007294.4(BRCA1):c.5202T>A (p.Phe1734Leu)	BRCA1	F1734L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865155	17	41209144	17	43057127	865155	853793	rs869320780	NC_000017.11:43057126:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5202T>G (p.Phe1734Leu)	BRCA1	F1734L	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000225711	17	41209144	17	43057127	225711	227558	rs869320780	NC_000017.11:43057126:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5201T>A (p.Phe1734Tyr)	BRCA1	F1734Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865154	17	41209145	17	43057128	865154	853794	rs397509237	NC_000017.11:43057127:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5201T>G (p.Phe1734Cys)	BRCA1	F1734C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000646505	17	41209145	17	43057128	646505	645923	rs397509237	NC_000017.11:43057127:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5201T>C (p.Phe1734Ser)	BRCA1	F1734S	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000055454	17	41209145	17	43057128	55454	70121	rs397509237	NC_000017.11:43057127:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5200T>G (p.Phe1734Val)	BRCA1	F1734V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868175	17	41209146	17	43057129	868175	853795	rs80356957	NC_000017.11:43057128:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5200T>A (p.Phe1734Ile)	BRCA1	F1734I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000232047	17	41209146	17	43057129	232047	235941	rs80356957	NC_000017.11:43057128:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5200T>C (p.Phe1734Leu)	BRCA1	F1734L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125806	17	41209146	17	43057129	125806	131344	rs80356957	NC_000017.11:43057128:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 29, 2002	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1734	BRCA1
NM_007294.4(BRCA1):c.5199T>G (p.Asp1733Glu)	BRCA1	D1733E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868174	17	41209147	17	43057130	868174	853796	rs2051529721	NC_000017.11:43057129:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5199T>A (p.Asp1733Glu)	BRCA1	D1733E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868172	17	41209147	17	43057130	868172	853798	rs2051529721	NC_000017.11:43057129:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5198A>C (p.Asp1733Ala)	BRCA1	D1733A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867837	17	41209148	17	43057131	867837	853799	rs80357270	NC_000017.11:43057130:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5198A>T (p.Asp1733Val)	BRCA1	D1733V	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491101	17	41209148	17	43057131	491101	484893	rs80357270	NC_000017.11:43057130:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5198A>G (p.Asp1733Gly)	BRCA1	D1733G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055453	17	41209148	17	43057131	55453	70120	rs80357270	NC_000017.11:43057130:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5197G>T (p.Asp1733Tyr)	BRCA1	D1733Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867836	17	41209149	17	43057132	867836	853800	rs398122693	NC_000017.11:43057131:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5197G>C (p.Asp1733His)	BRCA1	D1733H	Hereditary cancer-predisposing syndrome	VCV000628107	17	41209149	17	43057132	628107	618558	rs398122693	NC_000017.11:43057131:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5197G>A (p.Asp1733Asn)	BRCA1	D1733N	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000091643	17	41209149	17	43057132	91643	97120	rs398122693	NC_000017.11:43057131:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1733	BRCA1
NM_007294.4(BRCA1):c.5196T>G (p.His1732Gln)	BRCA1	H1732Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867835	17	41209150	17	43057133	867835	853801	rs1567764670	NC_000017.11:43057132:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5196T>A (p.His1732Gln)	BRCA1	H1732Q	Hereditary cancer-predisposing syndrome	VCV000825529	17	41209150	17	43057133	825529	813660	rs1567764670	NC_000017.11:43057132:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5195A>T (p.His1732Leu)	BRCA1	H1732L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867834	17	41209151	17	43057134	867834	853802	rs1597811076	NC_000017.11:43057133:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5195A>C (p.His1732Pro)	BRCA1	H1732P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867503	17	41209151	17	43057134	867503	853803	rs1597811076	NC_000017.11:43057133:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5195A>G (p.His1732Arg)	BRCA1	H1732R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000653572	17	41209151	17	43057134	653572	645924	rs1597811076	NC_000017.11:43057133:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 13, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5194C>T (p.His1732Tyr)	BRCA1	H1732Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867502	17	41209152	17	43057135	867502	853804	rs2051531560	NC_000017.11:43057134:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5194C>G (p.His1732Asp)	BRCA1	H1732D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867501	17	41209152	17	43057135	867501	853805	rs2051531560	NC_000017.11:43057134:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5194C>A (p.His1732Asn)	BRCA1	H1732N	Hereditary breast ovarian cancer syndrome	VCV000867500	17	41209152	17	43057135	867500	853806	rs2051531560	NC_000017.11:43057134:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1732	BRCA1
NM_007294.4(BRCA1):c.5193G>T (p.Glu1731Asp)	BRCA1	E1731D	Hereditary breast ovarian cancer syndrome	VCV000867789	17	41215350	17	43063333	867789	853807	rs876660702	NC_000017.11:43063332:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1731	BRCA1
NM_007294.4(BRCA1):c.5193G>C (p.Glu1731Asp)	BRCA1	E1731D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867788	17	41215350	17	43063333	867788	853808	rs876660702	NC_000017.11:43063332:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1731	BRCA1
NM_007294.4(BRCA1):c.5192A>T (p.Glu1731Val)	BRCA1	E1731V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867787	17	41215351	17	43063334	867787	853809	rs2051854642	NC_000017.11:43063333:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1731	BRCA1
NM_007294.4(BRCA1):c.5192A>G (p.Glu1731Gly)	BRCA1	E1731G	Hereditary breast ovarian cancer syndrome	VCV000867786	17	41215351	17	43063334	867786	853810	rs2051854642	NC_000017.11:43063333:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1731	BRCA1
NM_007294.4(BRCA1):c.5192A>C (p.Glu1731Ala)	BRCA1	E1731A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867459	17	41215351	17	43063334	867459	853811	rs2051854642	NC_000017.11:43063333:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1731	BRCA1
NM_007294.4(BRCA1):c.5191G>C (p.Glu1731Gln)	BRCA1	E1731Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867458	17	41215352	17	43063335	867458	853812	rs397507244	NC_000017.11:43063334:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1731	BRCA1
NM_007294.4(BRCA1):c.5191G>A (p.Glu1731Lys)	BRCA1	E1731K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000091641	17	41215352	17	43063335	91641	97118	rs397507244	NC_000017.11:43063334:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1731	BRCA1
NM_007294.4(BRCA1):c.5190T>G (p.Asn1730Lys)	BRCA1	N1730K	Hereditary cancer-predisposing syndrome	VCV000867457	17	41215353	17	43063336	867457	853813	rs2051855598	NC_000017.11:43063335:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Sep 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5190T>A (p.Asn1730Lys)	BRCA1	N1730K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867455	17	41215353	17	43063336	867455	853815	rs2051855598	NC_000017.11:43063335:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5189A>C (p.Asn1730Thr)	BRCA1	N1730T	Hereditary cancer-predisposing syndrome	VCV000865097	17	41215354	17	43063337	865097	853816	rs80357171	NC_000017.11:43063336:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5189A>T (p.Asn1730Ile)	BRCA1	N1730I	Hereditary cancer-predisposing syndrome	VCV000485403	17	41215354	17	43063337	485403	478562	rs80357171	NC_000017.11:43063336:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 20, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5189A>G (p.Asn1730Ser)	BRCA1	N1730S	not specified|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055447	17	41215354	17	43063337	55447	70114	rs80357171	NC_000017.11:43063336:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5188A>T (p.Asn1730Tyr)	BRCA1	N1730Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865096	17	41215355	17	43063338	865096	853817	rs2051856271	NC_000017.11:43063337:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5188A>G (p.Asn1730Asp)	BRCA1	N1730D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865095	17	41215355	17	43063338	865095	853818	rs2051856271	NC_000017.11:43063337:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5188A>C (p.Asn1730His)	BRCA1	N1730H	Hereditary breast ovarian cancer syndrome	VCV000865094	17	41215355	17	43063338	865094	853819	rs2051856271	NC_000017.11:43063337:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1730	BRCA1
NM_007294.4(BRCA1):c.5186T>G (p.Leu1729Arg)	BRCA1	L1729R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868121	17	41215357	17	43063340	868121	853823	rs730881496	NC_000017.11:43063339:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1729	BRCA1
NM_007294.4(BRCA1):c.5186T>C (p.Leu1729Pro)	BRCA1	L1729P	Hereditary cancer-predisposing syndrome	VCV000825518	17	41215357	17	43063340	825518	813661	rs730881496	NC_000017.11:43063339:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1729	BRCA1
NM_007294.4(BRCA1):c.5186T>A (p.Leu1729Gln)	BRCA1	L1729Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000182166	17	41215357	17	43063340	182166	180824	rs730881496	NC_000017.11:43063339:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1729	BRCA1
NM_007294.4(BRCA1):c.5185C>G (p.Leu1729Val)	BRCA1	L1729V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868120	17	41215358	17	43063341	868120	853824	rs1207677103	NC_000017.11:43063340:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1729	BRCA1
NM_007294.4(BRCA1):c.5185C>A (p.Leu1729Met)	BRCA1	L1729M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868119	17	41215358	17	43063341	868119	853825	rs1207677103	NC_000017.11:43063340:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1729	BRCA1
NM_007294.4(BRCA1):c.5184G>T (p.Met1728Ile)	BRCA1	M1728I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868118	17	41215359	17	43063342	868118	853826	rs2051857855	NC_000017.11:43063341:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5184G>C (p.Met1728Ile)	BRCA1	M1728I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868117	17	41215359	17	43063342	868117	853827	rs2051857855	NC_000017.11:43063341:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5184G>A (p.Met1728Ile)	BRCA1	M1728I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867781	17	41215359	17	43063342	867781	853828	rs2051857855	NC_000017.11:43063341:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5183T>G (p.Met1728Arg)	BRCA1	M1728R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867780	17	41215360	17	43063343	867780	853829	rs2051858178	NC_000017.11:43063342:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5183T>C (p.Met1728Thr)	BRCA1	M1728T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000867779	17	41215360	17	43063343	867779	853830	rs2051858178	NC_000017.11:43063342:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5183T>A (p.Met1728Lys)	BRCA1	M1728K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867778	17	41215360	17	43063343	867778	853831	rs2051858178	NC_000017.11:43063342:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5182A>T (p.Met1728Leu)	BRCA1	M1728L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867777	17	41215361	17	43063344	867777	853832	rs2051858497	NC_000017.11:43063343:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5182A>G (p.Met1728Val)	BRCA1	M1728V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867776	17	41215361	17	43063344	867776	853833	rs2051858497	NC_000017.11:43063343:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5182A>C (p.Met1728Leu)	BRCA1	M1728L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867775	17	41215361	17	43063344	867775	853834	rs2051858497	NC_000017.11:43063343:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1728	BRCA1
NM_007294.4(BRCA1):c.5181A>T (p.Lys1727Asn)	BRCA1	K1727N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867774	17	41215362	17	43063345	867774	853835	rs2051859200	NC_000017.11:43063344:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1727	BRCA1
NM_007294.4(BRCA1):c.5181A>C (p.Lys1727Asn)	BRCA1	K1727N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867448	17	41215362	17	43063345	867448	853837	rs2051859200	NC_000017.11:43063344:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1727	BRCA1
NM_007294.4(BRCA1):c.5180A>T (p.Lys1727Ile)	BRCA1	K1727I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867447	17	41215363	17	43063346	867447	853838	rs2051859511	NC_000017.11:43063345:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1727	BRCA1
NM_007294.4(BRCA1):c.5180A>G (p.Lys1727Arg)	BRCA1	K1727R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867446	17	41215363	17	43063346	867446	853839	rs2051859511	NC_000017.11:43063345:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1727	BRCA1
NM_007294.4(BRCA1):c.5180A>C (p.Lys1727Thr)	BRCA1	K1727T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867445	17	41215363	17	43063346	867445	853840	rs2051859511	NC_000017.11:43063345:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1727	BRCA1
NM_007294.4(BRCA1):c.5179A>G (p.Lys1727Glu)	BRCA1	K1727E	BRCA1-related disorder	VCV000867444	17	41215364	17	43063347	867444	853841	rs80357347	NC_000017.11:43063346:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 18, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1727	BRCA1
NM_007294.4(BRCA1):c.5179A>C (p.Lys1727Gln)	BRCA1	K1727Q	not provided	VCV000418072	17	41215364	17	43063347	418072	409948	rs80357347	NC_000017.11:43063346:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 27, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1727	BRCA1
NM_007294.4(BRCA1):c.5178A>T (p.Arg1726Ser)	BRCA1	R1726S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865085	17	41215365	17	43063348	865085	853842	rs2051860476	NC_000017.11:43063347:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1726	BRCA1
NM_007294.4(BRCA1):c.5178A>C (p.Arg1726Ser)	BRCA1	R1726S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865083	17	41215365	17	43063348	865083	853844	rs2051860476	NC_000017.11:43063347:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1726	BRCA1
NM_007294.4(BRCA1):c.5177G>A (p.Arg1726Lys)	BRCA1	R1726K	Hereditary breast ovarian cancer syndrome	VCV000865082	17	41215366	17	43063349	865082	853845	rs786203547	NC_000017.11:43063348:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 17, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1726	BRCA1
NM_007294.4(BRCA1):c.5177G>C (p.Arg1726Thr)	BRCA1	R1726T	Hereditary breast ovarian cancer syndrome	VCV000531408	17	41215366	17	43063349	531408	531552	rs786203547	NC_000017.11:43063348:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1726	BRCA1
NM_007294.4(BRCA1):c.5177G>T (p.Arg1726Ile)	BRCA1	R1726I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000187201	17	41215366	17	43063349	187201	184883	rs786203547	NC_000017.11:43063348:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1726	BRCA1
NM_007294.4(BRCA1):c.5176A>G (p.Arg1726Gly)	BRCA1	R1726G	not provided|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified	VCV000055443	17	41215367	17	43063350	55443	70110	rs80357501	NC_000017.11:43063349:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1726	BRCA1
NM_007294.4(BRCA1):c.5175A>T (p.Glu1725Asp)	BRCA1	E1725D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868773	17	41215368	17	43063351	868773	853847	rs191373374	NC_000017.11:43063350:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1725	BRCA1
NM_007294.4(BRCA1):c.5175A>C (p.Glu1725Asp)	BRCA1	E1725D	Hereditary breast ovarian cancer syndrome|not provided|not specified	VCV000419703	17	41215368	17	43063351	419703	409949	rs191373374	NC_000017.11:43063350:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 12, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1725	BRCA1
NM_007294.4(BRCA1):c.5174A>T (p.Glu1725Val)	BRCA1	E1725V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868772	17	41215369	17	43063352	868772	853848	rs2051862353	NC_000017.11:43063351:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1725	BRCA1
NM_007294.4(BRCA1):c.5174A>G (p.Glu1725Gly)	BRCA1	E1725G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868771	17	41215369	17	43063352	868771	853849	rs2051862353	NC_000017.11:43063351:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1725	BRCA1
NM_007294.4(BRCA1):c.5174A>C (p.Glu1725Ala)	BRCA1	E1725A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868770	17	41215369	17	43063352	868770	853850	rs2051862353	NC_000017.11:43063351:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1725	BRCA1
NM_007294.4(BRCA1):c.5173G>C (p.Glu1725Gln)	BRCA1	E1725Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867767	17	41215370	17	43063353	867767	853851	rs80357291	NC_000017.11:43063352:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1725	BRCA1
NM_007294.4(BRCA1):c.5173G>A (p.Glu1725Lys)	BRCA1	E1725K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867766	17	41215370	17	43063353	867766	853852	rs80357291	NC_000017.11:43063352:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1725	BRCA1
NM_007294.4(BRCA1):c.5172A>T (p.Lys1724Asn)	BRCA1	K1724N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867765	17	41215371	17	43063354	867765	853853	rs879254150	NC_000017.11:43063353:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1724	BRCA1
NM_007294.4(BRCA1):c.5172A>C (p.Lys1724Asn)	BRCA1	K1724N	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000246200	17	41215371	17	43063354	246200	245021	rs879254150	NC_000017.11:43063353:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1724	BRCA1
NM_007294.4(BRCA1):c.5171A>T (p.Lys1724Ile)	BRCA1	K1724I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867763	17	41215372	17	43063355	867763	853855	rs2051863566	NC_000017.11:43063354:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1724	BRCA1
NM_007294.4(BRCA1):c.5171A>G (p.Lys1724Arg)	BRCA1	K1724R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867762	17	41215372	17	43063355	867762	853856	rs2051863566	NC_000017.11:43063354:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1724	BRCA1
NM_007294.4(BRCA1):c.5171A>C (p.Lys1724Thr)	BRCA1	K1724T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867761	17	41215372	17	43063355	867761	853857	rs2051863566	NC_000017.11:43063354:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1724	BRCA1
NM_007294.4(BRCA1):c.5170A>G (p.Lys1724Glu)	BRCA1	K1724E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867434	17	41215373	17	43063356	867434	853859	rs2051863875	NC_000017.11:43063355:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1724	BRCA1
NM_007294.4(BRCA1):c.5170A>C (p.Lys1724Gln)	BRCA1	K1724Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867433	17	41215373	17	43063356	867433	853860	rs2051863875	NC_000017.11:43063355:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1724	BRCA1
NM_007294.4(BRCA1):c.5169T>G (p.Ile1723Met)	BRCA1	I1723M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867432	17	41215374	17	43063357	867432	853861	rs2051864221	NC_000017.11:43063356:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1723	BRCA1
NM_007294.4(BRCA1):c.5168T>G (p.Ile1723Ser)	BRCA1	I1723S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867429	17	41215375	17	43063358	867429	853864	rs1064793533	NC_000017.11:43063357:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1723	BRCA1
NM_007294.4(BRCA1):c.5168T>C (p.Ile1723Thr)	BRCA1	I1723T	Hereditary breast ovarian cancer syndrome	VCV000531248	17	41215375	17	43063358	531248	531292	rs1064793533	NC_000017.11:43063357:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Oct 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1723	BRCA1
NM_007294.4(BRCA1):c.5168T>A (p.Ile1723Asn)	BRCA1	I1723N	not provided|Hereditary cancer-predisposing syndrome	VCV000418930	17	41215375	17	43063358	418930	409950	rs1064793533	NC_000017.11:43063357:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 27, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1723	BRCA1
NM_007294.4(BRCA1):c.5167A>T (p.Ile1723Phe)	BRCA1	I1723F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865079	17	41215376	17	43063359	865079	853865	rs1426821558	NC_000017.11:43063358:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1723	BRCA1
NM_007294.4(BRCA1):c.5167A>C (p.Ile1723Leu)	BRCA1	I1723L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865078	17	41215376	17	43063359	865078	853866	rs1426821558	NC_000017.11:43063358:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1723	BRCA1
NM_007294.4(BRCA1):c.5167A>G (p.Ile1723Val)	BRCA1	I1723V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462662	17	41215376	17	43063359	462662	468113	rs1426821558	NC_000017.11:43063358:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1723	BRCA1
NM_007294.4(BRCA1):c.5165C>G (p.Ser1722Cys)	BRCA1	S1722C	not provided|Hereditary breast ovarian cancer syndrome	VCV000868766	17	41215378	17	43063361	868766	853870	rs80357104	NC_000017.11:43063360:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1722	BRCA1
NM_007294.4(BRCA1):c.5165C>A (p.Ser1722Tyr)	BRCA1	S1722Y	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491098	17	41215378	17	43063361	491098	484900	rs80357104	NC_000017.11:43063360:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1722	BRCA1
NM_007294.4(BRCA1):c.5165C>T (p.Ser1722Phe)	BRCA1	S1722F	not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055441	17	41215378	17	43063361	55441	70108	rs80357104	NC_000017.11:43063360:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1722	BRCA1
NM_007294.4(BRCA1):c.5164T>G (p.Ser1722Ala)	BRCA1	S1722A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868765	17	41215379	17	43063362	868765	853871	rs483353100	NC_000017.11:43063361:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1722	BRCA1
NM_007294.4(BRCA1):c.5164T>A (p.Ser1722Thr)	BRCA1	S1722T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868764	17	41215379	17	43063362	868764	853872	rs483353100	NC_000017.11:43063361:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1722	BRCA1
NM_007294.4(BRCA1):c.5164T>C (p.Ser1722Pro)	BRCA1	S1722P	Hereditary cancer-predisposing syndrome	VCV000125791	17	41215379	17	43063362	125791	131329	rs483353100	NC_000017.11:43063361:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Apr 9, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1722	BRCA1
NM_007294.4(BRCA1):c.5163G>T (p.Gln1721His)	BRCA1	Q1721H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868763	17	41215380	17	43063363	868763	853873	rs1403122031	NC_000017.11:43063362:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1721	BRCA1
NM_007294.4(BRCA1):c.5163G>C (p.Gln1721His)	BRCA1	Q1721H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868762	17	41215380	17	43063363	868762	853874	rs1403122031	NC_000017.11:43063362:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1721	BRCA1
NM_007294.4(BRCA1):c.5162A>T (p.Gln1721Leu)	BRCA1	Q1721L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867756	17	41215381	17	43063364	867756	853875	rs2051867806	NC_000017.11:43063363:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1721	BRCA1
NM_007294.4(BRCA1):c.5162A>G (p.Gln1721Arg)	BRCA1	Q1721R	Hereditary breast ovarian cancer syndrome	VCV000867755	17	41215381	17	43063364	867755	853876	rs2051867806	NC_000017.11:43063363:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1721	BRCA1
NM_007294.4(BRCA1):c.5162A>C (p.Gln1721Pro)	BRCA1	Q1721P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867754	17	41215381	17	43063364	867754	853877	rs2051867806	NC_000017.11:43063363:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 22, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1721	BRCA1
NM_007294.4(BRCA1):c.5161C>A (p.Gln1721Lys)	BRCA1	Q1721K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867753	17	41215382	17	43063365	867753	853878	rs878854957	NC_000017.11:43063364:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1721	BRCA1
NM_007294.4(BRCA1):c.5161C>G (p.Gln1721Glu)	BRCA1	Q1721E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000240818	17	41215382	17	43063365	240818	242760	rs878854957	NC_000017.11:43063364:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1721	BRCA1
NM_007294.4(BRCA1):c.5158A>T (p.Thr1720Ser)	BRCA1	T1720S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867752	17	41215385	17	43063368	867752	853879	rs56195342	NC_000017.11:43063367:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1720	BRCA1
NM_007294.4(BRCA1):c.5158A>G (p.Thr1720Ala)	BRCA1	T1720A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055438	17	41215385	17	43063368	55438	70105	rs56195342	NC_000017.11:43063367:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1720	BRCA1
NM_007294.4(BRCA1):c.5156T>A (p.Val1719Glu)	BRCA1	V1719E	not specified|Hereditary cancer-predisposing syndrome	VCV000867427	17	41215387	17	43063370	867427	853881	rs1247437511	NC_000017.11:43063369:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1719	BRCA1
NM_007294.4(BRCA1):c.5156T>C (p.Val1719Ala)	BRCA1	V1719A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000652310	17	41215387	17	43063370	652310	645925	rs1247437511	NC_000017.11:43063369:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1719	BRCA1
NM_007294.4(BRCA1):c.5156T>G (p.Val1719Gly)	BRCA1	V1719G	Hereditary cancer-predisposing syndrome	VCV000482950	17	41215387	17	43063370	482950	478563	rs1247437511	NC_000017.11:43063369:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 12, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1719	BRCA1
NM_007294.4(BRCA1):c.5155G>C (p.Val1719Leu)	BRCA1	V1719L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867426	17	41215388	17	43063371	867426	853882	rs749465132	NC_000017.11:43063370:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1719	BRCA1
NM_007294.4(BRCA1):c.5155G>A (p.Val1719Met)	BRCA1	V1719M	not specified|Hereditary cancer-predisposing syndrome	VCV000825488	17	41215388	17	43063371	825488	813662	rs749465132	NC_000017.11:43063370:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1719	BRCA1
NM_007294.4(BRCA1):c.5155G>T (p.Val1719Leu)	BRCA1	V1719L	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000245993	17	41215388	17	43063371	245993	245022	rs749465132	NC_000017.11:43063370:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1719	BRCA1
NM_007294.4(BRCA1):c.5154G>C (p.Trp1718Cys)	BRCA1	W1718C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865068	17	41215389	17	43063372	865068	853883	rs80357239	NC_000017.11:43063371:C:G	single nucleotide variant	missense variant|non-coding transcript variant|synonymous variant	Pathogenic	NA	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5154G>T (p.Trp1718Cys)	BRCA1	W1718C	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000055435	17	41215389	17	43063372	55435	70102	rs80357239	NC_000017.11:43063371:C:A	single nucleotide variant	missense variant|synonymous variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5153G>T (p.Trp1718Leu)	BRCA1	W1718L	Hereditary breast ovarian cancer syndrome	VCV000632609	17	41215390	17	43063373	632609	621043	rs41293461	NC_000017.11:43063372:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2019	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5153G>C (p.Trp1718Ser)	BRCA1	W1718S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055433	17	41215390	17	43063373	55433	70100	rs41293461	NC_000017.11:43063372:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 16, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5153G>A (p.Trp1718Ter)	BRCA1	W1718*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055432	17	41215390	17	43063373	55432	70099	rs41293461	NC_000017.11:43063372:C:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5152T>C (p.Trp1718Arg)	BRCA1	W1718R	Hereditary cancer-predisposing syndrome	VCV000865030	17	41215891	17	43063874	865030	853884	rs1567769155	NC_000017.11:43063873:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5152T>A (p.Trp1718Arg)	BRCA1	W1718R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865029	17	41215891	17	43063874	865029	853885	rs1567769155	NC_000017.11:43063873:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5152T>G (p.Trp1718Gly)	BRCA1	W1718G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000627968	17	41215891	17	43063874	627968	618559	rs1567769155	NC_000017.11:43063873:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1718	BRCA1
NM_007294.4(BRCA1):c.5151C>G (p.Phe1717Leu)	BRCA1	F1717L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865027	17	41215892	17	43063875	865027	853887	rs2051906420	NC_000017.11:43063874:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5151C>A (p.Phe1717Leu)	BRCA1	F1717L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865026	17	41215892	17	43063875	865026	853888	rs2051906420	NC_000017.11:43063874:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5150T>G (p.Phe1717Cys)	BRCA1	F1717C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865025	17	41215893	17	43063876	865025	853889	rs2051906738	NC_000017.11:43063875:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5150T>C (p.Phe1717Ser)	BRCA1	F1717S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865024	17	41215893	17	43063876	865024	853890	rs2051906738	NC_000017.11:43063875:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5150T>A (p.Phe1717Tyr)	BRCA1	F1717Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865023	17	41215893	17	43063876	865023	853891	rs2051906738	NC_000017.11:43063875:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5149T>G (p.Phe1717Val)	BRCA1	F1717V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868715	17	41215894	17	43063877	868715	853892	rs2051907296	NC_000017.11:43063876:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5149T>C (p.Phe1717Leu)	BRCA1	F1717L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868714	17	41215894	17	43063877	868714	853893	rs2051907296	NC_000017.11:43063876:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5149T>A (p.Phe1717Ile)	BRCA1	F1717I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868713	17	41215894	17	43063877	868713	853894	rs2051907296	NC_000017.11:43063876:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1717	BRCA1
NM_007294.4(BRCA1):c.5146_5148delinsAAA (p.Tyr1716Lys)	BRCA1	Y1716K	Hereditary cancer-predisposing syndrome	VCV000489729	17	41215895 - 41215897	17	43063878 - 43063880	489729	482989	rs1555578543	NC_000017.11:43063877:ATA:TTT	Indel	missense variant|non-coding transcript variant	Uncertain significance	Jul 2, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1716	BRCA1
NM_007294.4(BRCA1):c.5147A>T (p.Tyr1716Phe)	BRCA1	Y1716F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868711	17	41215896	17	43063879	868711	853896	rs587782456	NC_000017.11:43063878:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1716	BRCA1
NM_007294.4(BRCA1):c.5147A>C (p.Tyr1716Ser)	BRCA1	Y1716S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000187156	17	41215896	17	43063879	187156	184886	rs587782456	NC_000017.11:43063878:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1716	BRCA1
NM_007294.4(BRCA1):c.5147A>G (p.Tyr1716Cys)	BRCA1	Y1716C	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000142424	17	41215896	17	43063879	142424	152138	rs587782456	NC_000017.11:43063878:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1716	BRCA1
NM_007294.4(BRCA1):c.5146T>G (p.Tyr1716Asp)	BRCA1	Y1716D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867699	17	41215897	17	43063880	867699	853897	rs1597819932	NC_000017.11:43063879:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1716	BRCA1
NM_007294.4(BRCA1):c.5146T>C (p.Tyr1716His)	BRCA1	Y1716H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825476	17	41215897	17	43063880	825476	813663	rs1597819932	NC_000017.11:43063879:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1716	BRCA1
NM_007294.4(BRCA1):c.5146T>A (p.Tyr1716Asn)	BRCA1	Y1716N	Hereditary cancer-predisposing syndrome	VCV000825475	17	41215897	17	43063880	825475	813664	rs1597819932	NC_000017.11:43063879:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 25, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1716	BRCA1
NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	BRCA1	S1715R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055418	17	41215898	17	43063881	55418	70085	rs80357094	NC_000017.11:43063880:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5145C>A (p.Ser1715Arg)	BRCA1	S1715R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055417	17	41215898	17	43063881	55417	70084	rs80357094	NC_000017.11:43063880:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Apr 12, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5144G>C (p.Ser1715Thr)	BRCA1	S1715T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867403	17	41215899	17	43063882	867403	853899	rs45444999	NC_000017.11:43063881:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5144G>T (p.Ser1715Ile)	BRCA1	S1715I	not provided	VCV000422674	17	41215899	17	43063882	422674	409951	rs45444999	NC_000017.11:43063881:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5144G>A (p.Ser1715Asn)	BRCA1	S1715N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055416	17	41215899	17	43063882	55416	70083	rs45444999	NC_000017.11:43063881:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5143A>G (p.Ser1715Gly)	BRCA1	S1715G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867402	17	41215900	17	43063883	867402	853900	rs80357222	NC_000017.11:43063882:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5143A>T (p.Ser1715Cys)	BRCA1	S1715C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000055415	17	41215900	17	43063883	55415	70082	rs80357222	NC_000017.11:43063882:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	May 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5143A>C (p.Ser1715Arg)	BRCA1	S1715R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055414	17	41215900	17	43063883	55414	70081	rs80357222	NC_000017.11:43063882:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1715	BRCA1
NM_007294.4(BRCA1):c.5141T>A (p.Val1714Asp)	BRCA1	V1714D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865012	17	41215902	17	43063885	865012	853903	rs80357243	NC_000017.11:43063884:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1714	BRCA1
NM_007294.4(BRCA1):c.5141T>C (p.Val1714Ala)	BRCA1	V1714A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629871	17	41215902	17	43063885	629871	618560	rs80357243	NC_000017.11:43063884:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1714	BRCA1
NM_007294.4(BRCA1):c.5141T>G (p.Val1714Gly)	BRCA1	V1714G	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Breast neoplasm	VCV000055413	17	41215902	17	43063885	55413	70080	rs80357243	NC_000017.11:43063884:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1714	BRCA1
NM_007294.4(BRCA1):c.5140G>C (p.Val1714Leu)	BRCA1	V1714L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865011	17	41215903	17	43063886	865011	853904	rs1567769244	NC_000017.11:43063885:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1714	BRCA1
NM_007294.4(BRCA1):c.5140G>A (p.Val1714Ile)	BRCA1	V1714I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000865010	17	41215903	17	43063886	865010	853905	rs1567769244	NC_000017.11:43063885:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1714	BRCA1
NM_007294.4(BRCA1):c.5140G>T (p.Val1714Phe)	BRCA1	V1714F	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000631061	17	41215903	17	43063886	631061	618561	rs1567769244	NC_000017.11:43063885:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 24, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1714	BRCA1
NM_007294.4(BRCA1):c.5138_5139delinsGG (p.Val1713Gly)	BRCA1	V1713G	Hereditary cancer-predisposing syndrome	VCV001745580	17	41215904 - 41215905	17	43063887 - 43063888	1745580	1802632	NA	NC_000017.11:43063886:TA:CC	Indel	missense variant|non-coding transcript variant	Pathogenic	Oct 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1713	BRCA1
NM_007294.4(BRCA1):c.5138T>G (p.Val1713Gly)	BRCA1	V1713G	Hereditary cancer-predisposing syndrome	VCV000868702	17	41215905	17	43063888	868702	853908	rs80357132	NC_000017.11:43063887:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1713	BRCA1
NM_007294.4(BRCA1):c.5138T>A (p.Val1713Glu)	BRCA1	V1713E	not provided	VCV000868701	17	41215905	17	43063888	868701	853909	rs80357132	NC_000017.11:43063887:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1713	BRCA1
NM_007294.4(BRCA1):c.5138T>C (p.Val1713Ala)	BRCA1	V1713A	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000055412	17	41215905	17	43063888	55412	70079	rs80357132	NC_000017.11:43063887:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1713	BRCA1
NM_007294.4(BRCA1):c.5137G>T (p.Val1713Leu)	BRCA1	V1713L	Hereditary cancer-predisposing syndrome	VCV000868700	17	41215906	17	43063889	868700	853910	rs1064793309	NC_000017.11:43063888:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 28, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1713	BRCA1
NM_007294.4(BRCA1):c.5137G>C (p.Val1713Leu)	BRCA1	V1713L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868699	17	41215906	17	43063889	868699	853911	rs1064793309	NC_000017.11:43063888:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1713	BRCA1
NM_007294.4(BRCA1):c.5137G>A (p.Val1713Ile)	BRCA1	V1713I	Ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000418578	17	41215906	17	43063889	418578	409952	rs1064793309	NC_000017.11:43063888:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1713	BRCA1
NM_007294.4(BRCA1):c.5136G>T (p.Trp1712Cys)	BRCA1	W1712C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868698	17	41215907	17	43063890	868698	853912	rs80357418	NC_000017.11:43063889:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1712	BRCA1
NM_007294.4(BRCA1):c.5136G>C (p.Trp1712Cys)	BRCA1	W1712C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867689	17	41215907	17	43063890	867689	853913	rs80357418	NC_000017.11:43063889:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1712	BRCA1
NM_007294.4(BRCA1):c.5135G>T (p.Trp1712Leu)	BRCA1	W1712L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867688	17	41215908	17	43063891	867688	853914	rs876658672	NC_000017.11:43063890:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1712	BRCA1
NM_007294.4(BRCA1):c.5135G>C (p.Trp1712Ser)	BRCA1	W1712S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867687	17	41215908	17	43063891	867687	853915	rs876658672	NC_000017.11:43063890:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1712	BRCA1
NM_007294.4(BRCA1):c.5134T>G (p.Trp1712Gly)	BRCA1	W1712G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867686	17	41215909	17	43063892	867686	853916	rs2051913334	NC_000017.11:43063891:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1712	BRCA1
NM_007294.4(BRCA1):c.5134T>C (p.Trp1712Arg)	BRCA1	W1712R	Hereditary breast ovarian cancer syndrome	VCV000867685	17	41215909	17	43063892	867685	853917	rs2051913334	NC_000017.11:43063891:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1712	BRCA1
NM_007294.4(BRCA1):c.5134T>A (p.Trp1712Arg)	BRCA1	W1712R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867684	17	41215909	17	43063892	867684	853918	rs2051913334	NC_000017.11:43063891:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1712	BRCA1
NM_007294.4(BRCA1):c.5133A>T (p.Lys1711Asn)	BRCA1	K1711N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864998	17	41215910	17	43063893	864998	853919	rs1597820025	NC_000017.11:43063892:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1711	BRCA1
NM_007294.4(BRCA1):c.5133A>C (p.Lys1711Asn)	BRCA1	K1711N	Hereditary cancer-predisposing syndrome	VCV000864997	17	41215910	17	43063893	864997	853920	rs1597820025	NC_000017.11:43063892:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jul 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1711	BRCA1
NM_007294.4(BRCA1):c.5132A>T (p.Lys1711Ile)	BRCA1	K1711I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864996	17	41215911	17	43063894	864996	853921	rs2051914244	NC_000017.11:43063893:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1711	BRCA1
NM_007294.4(BRCA1):c.5132A>G (p.Lys1711Arg)	BRCA1	K1711R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864995	17	41215911	17	43063894	864995	853922	rs2051914244	NC_000017.11:43063893:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1711	BRCA1
NM_007294.4(BRCA1):c.5132A>C (p.Lys1711Thr)	BRCA1	K1711T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864994	17	41215911	17	43063894	864994	853923	rs2051914244	NC_000017.11:43063893:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1711	BRCA1
NM_007294.4(BRCA1):c.5131A>G (p.Lys1711Glu)	BRCA1	K1711E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864993	17	41215912	17	43063895	864993	853924	rs886040272	NC_000017.11:43063894:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1711	BRCA1
NM_007294.4(BRCA1):c.5131A>C (p.Lys1711Gln)	BRCA1	K1711Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409313	17	41215912	17	43063895	409313	401972	rs886040272	NC_000017.11:43063894:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 4, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1711	BRCA1
NM_007294.4(BRCA1):c.5129G>T (p.Gly1710Val)	BRCA1	G1710V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869068	17	41215914	17	43063897	869068	853928	rs398122691	NC_000017.11:43063896:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1710	BRCA1
NM_007294.4(BRCA1):c.5129G>C (p.Gly1710Ala)	BRCA1	G1710A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869067	17	41215914	17	43063897	869067	853929	rs398122691	NC_000017.11:43063896:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1710	BRCA1
NM_007294.4(BRCA1):c.5129G>A (p.Gly1710Glu)	BRCA1	G1710E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000091638	17	41215914	17	43063897	91638	97115	rs398122691	NC_000017.11:43063896:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1710	BRCA1
NM_007294.4(BRCA1):c.5128G>C (p.Gly1710Arg)	BRCA1	G1710R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868692	17	41215915	17	43063898	868692	853930	rs397509229	NC_000017.11:43063897:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1710	BRCA1
NM_007294.4(BRCA1):c.5128G>A (p.Gly1710Arg)	BRCA1	G1710R	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000801083	17	41215915	17	43063898	801083	789613	rs397509229	NC_000017.11:43063897:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1710	BRCA1
NM_007294.4(BRCA1):c.5126G>T (p.Gly1709Val)	BRCA1	G1709V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868688	17	41215917	17	43063900	868688	853934	rs786204269	NC_000017.11:43063899:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1709	BRCA1
NM_007294.4(BRCA1):c.5126G>C (p.Gly1709Ala)	BRCA1	G1709A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868687	17	41215917	17	43063900	868687	853935	rs786204269	NC_000017.11:43063899:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1709	BRCA1
NM_007294.4(BRCA1):c.5126G>A (p.Gly1709Glu)	BRCA1	G1709E	not provided	VCV000188417	17	41215917	17	43063900	188417	186538	rs786204269	NC_000017.11:43063899:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 19, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1709	BRCA1
NM_007294.4(BRCA1):c.5125G>C (p.Gly1709Arg)	BRCA1	G1709R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867676	17	41215918	17	43063901	867676	853937	rs886038197	NC_000017.11:43063900:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1709	BRCA1
NM_007294.4(BRCA1):c.5125G>A (p.Gly1709Arg)	BRCA1	G1709R	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254642	17	41215918	17	43063901	254642	249181	rs886038197	NC_000017.11:43063900:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1709	BRCA1
NM_007294.4(BRCA1):c.5123C>G (p.Ala1708Gly)	BRCA1	A1708G	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867673	17	41215920	17	43063903	867673	853940	rs28897696	NC_000017.11:43063902:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1708	BRCA1
NM_007294.4(BRCA1):c.5123C>A (p.Ala1708Glu)	BRCA1	A1708E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055407	17	41215920	17	43063903	55407	70074	rs28897696	NC_000017.11:43063902:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1708	BRCA1
NM_007294.4(BRCA1):c.5123C>T (p.Ala1708Val)	BRCA1	A1708V	not specified|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000037640	17	41215920	17	43063903	37640	46196	rs28897696	NC_000017.11:43063902:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1708	BRCA1
NM_007294.4(BRCA1):c.5122G>T (p.Ala1708Ser)	BRCA1	A1708S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864982	17	41215921	17	43063904	864982	853941	rs397507243	NC_000017.11:43063903:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1708	BRCA1
NM_007294.4(BRCA1):c.5122G>C (p.Ala1708Pro)	BRCA1	A1708P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864981	17	41215921	17	43063904	864981	853942	rs397507243	NC_000017.11:43063903:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1708	BRCA1
NM_007294.4(BRCA1):c.5122G>A (p.Ala1708Thr)	BRCA1	A1708T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037639	17	41215921	17	43063904	37639	46195	rs397507243	NC_000017.11:43063903:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1708	BRCA1
NM_007294.4(BRCA1):c.5121T>G (p.Ile1707Met)	BRCA1	I1707M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864980	17	41215922	17	43063905	864980	853943	rs2051918751	NC_000017.11:43063904:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1707	BRCA1
NM_007294.4(BRCA1):c.5120T>A (p.Ile1707Asn)	BRCA1	I1707N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869057	17	41215923	17	43063906	869057	853946	rs1064796143	NC_000017.11:43063905:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1707	BRCA1
NM_007294.4(BRCA1):c.5120T>C (p.Ile1707Thr)	BRCA1	I1707T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000481464	17	41215923	17	43063906	481464	479263	rs1064796143	NC_000017.11:43063905:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1707	BRCA1
NM_007294.4(BRCA1):c.5120T>G (p.Ile1707Ser)	BRCA1	I1707S	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000422989	17	41215923	17	43063906	422989	409953	rs1064796143	NC_000017.11:43063905:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1707	BRCA1
NM_007294.4(BRCA1):c.5119A>T (p.Ile1707Phe)	BRCA1	I1707F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869056	17	41215924	17	43063907	869056	853947	rs1597820147	NC_000017.11:43063906:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1707	BRCA1
NM_007294.4(BRCA1):c.5119A>G (p.Ile1707Val)	BRCA1	I1707V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869055	17	41215924	17	43063907	869055	853948	rs1597820147	NC_000017.11:43063906:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1707	BRCA1
NM_007294.4(BRCA1):c.5119A>C (p.Ile1707Leu)	BRCA1	I1707L	Hereditary cancer-predisposing syndrome	VCV000825461	17	41215924	17	43063907	825461	813665	rs1597820147	NC_000017.11:43063906:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1707	BRCA1
NM_007294.4(BRCA1):c.5117G>T (p.Gly1706Val)	BRCA1	G1706V	Hereditary breast ovarian cancer syndrome	VCV000868673	17	41215926	17	43063909	868673	853952	rs80356860	NC_000017.11:43063908:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1706	BRCA1
NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	BRCA1	G1706A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055406	17	41215926	17	43063909	55406	70073	rs80356860	NC_000017.11:43063908:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1706	BRCA1
NM_007294.4(BRCA1):c.5117G>A (p.Gly1706Glu)	BRCA1	G1706E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037638	17	41215926	17	43063909	37638	46194	rs80356860	NC_000017.11:43063908:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1706	BRCA1
NM_007294.4(BRCA1):c.5116G>A (p.Gly1706Arg)	BRCA1	G1706R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267221	17	41215927	17	43063910	267221	262101	rs886040864	NC_000017.11:43063909:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 26, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1706	BRCA1
NM_007294.4(BRCA1):c.5116G>C (p.Gly1706Arg)	BRCA1	G1706R	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267219	17	41215927	17	43063910	267219	262100	rs886040864	NC_000017.11:43063909:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 13, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1706	BRCA1
NM_007294.4(BRCA1):c.5114T>A (p.Leu1705Gln)	BRCA1	L1705Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867664	17	41215929	17	43063912	867664	853956	rs397507242	NC_000017.11:43063911:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1705	BRCA1
NM_007294.4(BRCA1):c.5114T>G (p.Leu1705Arg)	BRCA1	L1705R	Hereditary breast ovarian cancer syndrome	VCV000240816	17	41215929	17	43063912	240816	242762	rs397507242	NC_000017.11:43063911:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1705	BRCA1
NM_007294.4(BRCA1):c.5114T>C (p.Leu1705Pro)	BRCA1	L1705P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037637	17	41215929	17	43063912	37637	46193	rs397507242	NC_000017.11:43063911:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1705	BRCA1
NM_007294.4(BRCA1):c.5113C>A (p.Leu1705Ile)	BRCA1	L1705I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867663	17	41215930	17	43063913	867663	853957	rs80356858	NC_000017.11:43063912:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1705	BRCA1
NM_007294.4(BRCA1):c.5113C>G (p.Leu1705Val)	BRCA1	L1705V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000041832	17	41215930	17	43063913	41832	50271	rs80356858	NC_000017.11:43063912:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1705	BRCA1
NM_007294.4(BRCA1):c.5112T>G (p.Phe1704Leu)	BRCA1	F1704L	Hereditary breast ovarian cancer syndrome|not provided	VCV000867662	17	41215931	17	43063914	867662	853958	rs2051921852	NC_000017.11:43063913:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 3, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5112T>A (p.Phe1704Leu)	BRCA1	F1704L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864967	17	41215931	17	43063914	864967	853960	rs2051921852	NC_000017.11:43063913:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5111T>G (p.Phe1704Cys)	BRCA1	F1704C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864966	17	41215932	17	43063915	864966	853961	rs1555578598	NC_000017.11:43063914:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5111T>C (p.Phe1704Ser)	BRCA1	F1704S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864965	17	41215932	17	43063915	864965	853962	rs1555578598	NC_000017.11:43063914:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5111T>A (p.Phe1704Tyr)	BRCA1	F1704Y	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479267	17	41215932	17	43063915	479267	478566	rs1555578598	NC_000017.11:43063914:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5110T>G (p.Phe1704Val)	BRCA1	F1704V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864964	17	41215933	17	43063916	864964	853963	rs1555578599	NC_000017.11:43063915:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5110T>A (p.Phe1704Ile)	BRCA1	F1704I	not provided|Hereditary breast ovarian cancer syndrome	VCV000864963	17	41215933	17	43063916	864963	853964	rs1555578599	NC_000017.11:43063915:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5110T>C (p.Phe1704Leu)	BRCA1	F1704L	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440479	17	41215933	17	43063916	440479	432896	rs1555578599	NC_000017.11:43063915:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1704	BRCA1
NM_007294.4(BRCA1):c.5108A>T (p.Tyr1703Phe)	BRCA1	Y1703F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869037	17	41215935	17	43063918	869037	853966	rs876660071	NC_000017.11:43063917:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1703	BRCA1
NM_007294.4(BRCA1):c.5108A>C (p.Tyr1703Ser)	BRCA1	Y1703S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869036	17	41215935	17	43063918	869036	853967	rs876660071	NC_000017.11:43063917:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1703	BRCA1
NM_007294.4(BRCA1):c.5108A>G (p.Tyr1703Cys)	BRCA1	Y1703C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S	VCV000232915	17	41215935	17	43063918	232915	235945	rs876660071	NC_000017.11:43063917:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1703	BRCA1
NM_007294.4(BRCA1):c.5107T>A (p.Tyr1703Asn)	BRCA1	Y1703N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868655	17	41215936	17	43063919	868655	853968	rs863224763	NC_000017.11:43063918:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1703	BRCA1
NM_007294.4(BRCA1):c.5107T>G (p.Tyr1703Asp)	BRCA1	Y1703D	not specified|Hereditary breast ovarian cancer syndrome	VCV000252884	17	41215936	17	43063919	252884	247285	rs863224763	NC_000017.11:43063918:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1703	BRCA1
NM_007294.4(BRCA1):c.5107T>C (p.Tyr1703His)	BRCA1	Y1703H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000216673	17	41215936	17	43063919	216673	213305	rs863224763	NC_000017.11:43063918:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 20, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1703	BRCA1
NM_007294.4(BRCA1):c.5106A>T (p.Lys1702Asn)	BRCA1	K1702N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868654	17	41215937	17	43063920	868654	853969	rs1060504574	NC_000017.11:43063919:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1702	BRCA1
NM_007294.4(BRCA1):c.5106A>C (p.Lys1702Asn)	BRCA1	K1702N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868653	17	41215937	17	43063920	868653	853970	rs1060504574	NC_000017.11:43063919:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1702	BRCA1
NM_007294.4(BRCA1):c.5105A>T (p.Lys1702Ile)	BRCA1	K1702I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868652	17	41215938	17	43063921	868652	853971	rs2051924695	NC_000017.11:43063920:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1702	BRCA1
NM_007294.4(BRCA1):c.5105A>G (p.Lys1702Arg)	BRCA1	K1702R	Hereditary breast ovarian cancer syndrome	VCV000868651	17	41215938	17	43063921	868651	853972	rs2051924695	NC_000017.11:43063920:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1702	BRCA1
NM_007294.4(BRCA1):c.5105A>C (p.Lys1702Thr)	BRCA1	K1702T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868650	17	41215938	17	43063921	868650	853973	rs2051924695	NC_000017.11:43063920:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1702	BRCA1
NM_007294.4(BRCA1):c.5104A>G (p.Lys1702Glu)	BRCA1	K1702E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867650	17	41215939	17	43063922	867650	853975	rs2051925024	NC_000017.11:43063921:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1702	BRCA1
NM_007294.4(BRCA1):c.5104A>C (p.Lys1702Gln)	BRCA1	K1702Q	Hereditary cancer-predisposing syndrome	VCV000867649	17	41215939	17	43063922	867649	853976	rs2051925024	NC_000017.11:43063921:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1702	BRCA1
NM_007294.4(BRCA1):c.5102T>G (p.Leu1701Arg)	BRCA1	L1701R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867646	17	41215941	17	43063924	867646	853979	rs1597820325	NC_000017.11:43063923:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1701	BRCA1
NM_007294.4(BRCA1):c.5102T>A (p.Leu1701Gln)	BRCA1	L1701Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867645	17	41215941	17	43063924	867645	853980	rs1597820325	NC_000017.11:43063923:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1701	BRCA1
NM_007294.4(BRCA1):c.5102T>C (p.Leu1701Pro)	BRCA1	L1701P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000664982	17	41215941	17	43063924	664982	645926	rs1597820325	NC_000017.11:43063923:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1701	BRCA1
NM_007294.4(BRCA1):c.5101C>G (p.Leu1701Val)	BRCA1	L1701V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864951	17	41215942	17	43063925	864951	853982	rs910555398	NC_000017.11:43063924:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1701	BRCA1
NM_007294.4(BRCA1):c.5101C>A (p.Leu1701Met)	BRCA1	L1701M	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409300	17	41215942	17	43063925	409300	401980	rs910555398	NC_000017.11:43063924:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1701	BRCA1
NM_007294.4(BRCA1):c.5099C>A (p.Thr1700Lys)	BRCA1	T1700K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869022	17	41215944	17	43063927	869022	853987	rs2051927197	NC_000017.11:43063926:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1700	BRCA1
NM_007294.4(BRCA1):c.5099C>T (p.Thr1700Ile)	BRCA1	T1700I	Hereditary cancer-predisposing syndrome	VCV000864948	17	41215944	17	43063927	864948	853985	rs2051927197	NC_000017.11:43063926:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 5, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1700	BRCA1
NM_007294.4(BRCA1):c.5099C>G (p.Thr1700Arg)	BRCA1	T1700R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864947	17	41215944	17	43063927	864947	853986	rs2051927197	NC_000017.11:43063926:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1700	BRCA1
NM_007294.4(BRCA1):c.5098A>C (p.Thr1700Pro)	BRCA1	T1700P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531317	17	41215945	17	43063928	531317	531056	rs397509227	NC_000017.11:43063927:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1700	BRCA1
NM_007294.4(BRCA1):c.5098A>G (p.Thr1700Ala)	BRCA1	T1700A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055399	17	41215945	17	43063928	55399	70066	rs397509227	NC_000017.11:43063927:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1700	BRCA1
NM_007294.4(BRCA1):c.5096G>T (p.Arg1699Leu)	BRCA1	R1699L	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055398	17	41215947	17	43063930	55398	70065	rs41293459	NC_000017.11:43063929:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1699	BRCA1
NM_007294.4(BRCA1):c.5096G>C (p.Arg1699Pro)	BRCA1	R1699P	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055397	17	41215947	17	43063930	55397	70064	rs41293459	NC_000017.11:43063929:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1699	BRCA1
NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	BRCA1	R1699Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037636	17	41215947	17	43063930	37636	46192	rs41293459	NC_000017.11:43063929:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 10, 2017	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1699	BRCA1
NM_007294.4(BRCA1):c.5095C>G (p.Arg1699Gly)	BRCA1	R1699G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869021	17	41215948	17	43063931	869021	853988	rs55770810	NC_000017.11:43063930:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1699	BRCA1
NM_007294.4(BRCA1):c.5095C>T (p.Arg1699Trp)	BRCA1	R1699W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055396	17	41215948	17	43063931	55396	70063	rs55770810	NC_000017.11:43063930:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1699	BRCA1
NM_007294.4(BRCA1):c.5094A>T (p.Glu1698Asp)	BRCA1	E1698D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869020	17	41215949	17	43063932	869020	853989	rs764891781	NC_000017.11:43063931:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1698	BRCA1
NM_007294.4(BRCA1):c.5094A>C (p.Glu1698Asp)	BRCA1	E1698D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868636	17	41215949	17	43063932	868636	853990	rs764891781	NC_000017.11:43063931:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1698	BRCA1
NM_007294.4(BRCA1):c.5093A>T (p.Glu1698Val)	BRCA1	E1698V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868635	17	41215950	17	43063933	868635	853991	rs2051929401	NC_000017.11:43063932:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1698	BRCA1
NM_007294.4(BRCA1):c.5093A>G (p.Glu1698Gly)	BRCA1	E1698G	Hereditary breast ovarian cancer syndrome	VCV000868634	17	41215950	17	43063933	868634	853992	rs2051929401	NC_000017.11:43063932:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1698	BRCA1
NM_007294.4(BRCA1):c.5093A>C (p.Glu1698Ala)	BRCA1	E1698A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868633	17	41215950	17	43063933	868633	853993	rs2051929401	NC_000017.11:43063932:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1698	BRCA1
NM_007294.4(BRCA1):c.5092G>C (p.Glu1698Gln)	BRCA1	E1698Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868631	17	41215951	17	43063934	868631	853995	rs2051929740	NC_000017.11:43063933:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1698	BRCA1
NM_007294.4(BRCA1):c.5092G>A (p.Glu1698Lys)	BRCA1	E1698K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868630	17	41215951	17	43063934	868630	853996	rs2051929740	NC_000017.11:43063933:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1698	BRCA1
NM_007294.4(BRCA1):c.5091T>G (p.Cys1697Trp)	BRCA1	C1697W	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000801082	17	41215952	17	43063935	801082	789614	rs1597820426	NC_000017.11:43063934:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1697	BRCA1
NM_007294.4(BRCA1):c.5090G>T (p.Cys1697Phe)	BRCA1	C1697F	Hereditary breast ovarian cancer syndrome	VCV000867631	17	41215953	17	43063936	867631	853999	rs397507241	NC_000017.11:43063935:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 12, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1697	BRCA1
NM_007294.4(BRCA1):c.5090G>C (p.Cys1697Ser)	BRCA1	C1697S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000867630	17	41215953	17	43063936	867630	854000	rs397507241	NC_000017.11:43063935:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1697	BRCA1
NM_007294.4(BRCA1):c.5090G>A (p.Cys1697Tyr)	BRCA1	C1697Y	BRCA1-related cancer predisposition	VCV000037635	17	41215953	17	43063936	37635	46191	rs397507241	NC_000017.11:43063935:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1697	BRCA1
NM_007294.4(BRCA1):c.5089T>G (p.Cys1697Gly)	BRCA1	C1697G	Hereditary cancer-predisposing syndrome	VCV000867629	17	41215954	17	43063937	867629	854001	rs80356993	NC_000017.11:43063936:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1697	BRCA1
NM_007294.4(BRCA1):c.5089T>A (p.Cys1697Ser)	BRCA1	C1697S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000141077	17	41215954	17	43063937	141077	150791	rs80356993	NC_000017.11:43063936:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 13, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1697	BRCA1
NM_007294.4(BRCA1):c.5089T>C (p.Cys1697Arg)	BRCA1	C1697R	BRCA1-related cancer predisposition	VCV000055392	17	41215954	17	43063937	55392	70059	rs80356993	NC_000017.11:43063936:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1697	BRCA1
NM_007294.4(BRCA1):c.5087T>G (p.Val1696Gly)	BRCA1	V1696G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864939	17	41215956	17	43063939	864939	854004	rs397509226	NC_000017.11:43063938:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1696	BRCA1
NM_007294.4(BRCA1):c.5087T>C (p.Val1696Ala)	BRCA1	V1696A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631419	17	41215956	17	43063939	631419	618562	rs397509226	NC_000017.11:43063938:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1696	BRCA1
NM_007294.4(BRCA1):c.5087T>A (p.Val1696Glu)	BRCA1	V1696E	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055391	17	41215956	17	43063939	55391	70058	rs397509226	NC_000017.11:43063938:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1696	BRCA1
NM_007294.4(BRCA1):c.5086G>A (p.Val1696Met)	BRCA1	V1696M	Hereditary breast ovarian cancer syndrome	VCV000409346	17	41215957	17	43063940	409346	401983	rs80357125	NC_000017.11:43063939:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1696	BRCA1
NM_007294.4(BRCA1):c.5086G>T (p.Val1696Leu)	BRCA1	V1696L	Hereditary breast ovarian cancer syndrome	VCV000240813	17	41215957	17	43063940	240813	242765	rs80357125	NC_000017.11:43063939:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1696	BRCA1
NM_007294.4(BRCA1):c.5086G>C (p.Val1696Leu)	BRCA1	V1696L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055390	17	41215957	17	43063940	55390	70057	rs80357125	NC_000017.11:43063939:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1696	BRCA1
NM_007294.4(BRCA1):c.5085T>G (p.Phe1695Leu)	BRCA1	F1695L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869014	17	41215958	17	43063941	869014	854005	rs80357387	NC_000017.11:43063940:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	BRCA1	F1695L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055389	17	41215958	17	43063941	55389	70056	rs80357387	NC_000017.11:43063940:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5084T>G (p.Phe1695Cys)	BRCA1	F1695C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869012	17	41215959	17	43063942	869012	854007	rs2051933725	NC_000017.11:43063941:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5084T>C (p.Phe1695Ser)	BRCA1	F1695S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869011	17	41215959	17	43063942	869011	854008	rs2051933725	NC_000017.11:43063941:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5084T>A (p.Phe1695Tyr)	BRCA1	F1695Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869010	17	41215959	17	43063942	869010	854009	rs2051933725	NC_000017.11:43063941:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5083T>G (p.Phe1695Val)	BRCA1	F1695V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869009	17	41215960	17	43063943	869009	854010	rs2051934276	NC_000017.11:43063942:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5083T>C (p.Phe1695Leu)	BRCA1	F1695L	Hereditary breast ovarian cancer syndrome	VCV000868624	17	41215960	17	43063943	868624	854011	rs2051934276	NC_000017.11:43063942:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5083T>A (p.Phe1695Ile)	BRCA1	F1695I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868623	17	41215960	17	43063943	868623	854012	rs2051934276	NC_000017.11:43063942:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1695	BRCA1
NM_007294.4(BRCA1):c.5082G>T (p.Glu1694Asp)	BRCA1	E1694D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868622	17	41215961	17	43063944	868622	854013	rs2051934604	NC_000017.11:43063943:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1694	BRCA1
NM_007294.4(BRCA1):c.5082G>C (p.Glu1694Asp)	BRCA1	E1694D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868621	17	41215961	17	43063944	868621	854014	rs2051934604	NC_000017.11:43063943:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1694	BRCA1
NM_007294.4(BRCA1):c.5081A>T (p.Glu1694Val)	BRCA1	E1694V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868619	17	41215962	17	43063945	868619	854016	rs1567769562	NC_000017.11:43063944:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1694	BRCA1
NM_007294.4(BRCA1):c.5081A>C (p.Glu1694Ala)	BRCA1	E1694A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868618	17	41215962	17	43063945	868618	854017	rs1567769562	NC_000017.11:43063944:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1694	BRCA1
NM_007294.4(BRCA1):c.5081A>G (p.Glu1694Gly)	BRCA1	E1694G	Hereditary breast ovarian cancer syndrome	VCV000567879	17	41215962	17	43063945	567879	571137	rs1567769562	NC_000017.11:43063944:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1694	BRCA1
NM_007294.4(BRCA1):c.5080G>C (p.Glu1694Gln)	BRCA1	E1694Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867625	17	41215963	17	43063946	867625	854018	rs80356896	NC_000017.11:43063945:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1694	BRCA1
NM_007294.4(BRCA1):c.5080G>A (p.Glu1694Lys)	BRCA1	E1694K	Hereditary breast ovarian cancer syndrome	VCV000566134	17	41215963	17	43063946	566134	569080	rs80356896	NC_000017.11:43063945:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1694	BRCA1
NM_007294.4(BRCA1):c.5078C>G (p.Ala1693Gly)	BRCA1	A1693G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867621	17	41215965	17	43063948	867621	854022	rs1567769586	NC_000017.11:43063947:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1693	BRCA1
NM_007294.4(BRCA1):c.5078C>A (p.Ala1693Asp)	BRCA1	A1693D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864930	17	41215965	17	43063948	864930	854023	rs1567769586	NC_000017.11:43063947:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1693	BRCA1
NM_007294.4(BRCA1):c.5078C>T (p.Ala1693Val)	BRCA1	A1693V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000631209	17	41215965	17	43063948	631209	618563	rs1567769586	NC_000017.11:43063947:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1693	BRCA1
NM_007294.4(BRCA1):c.5077G>T (p.Ala1693Ser)	BRCA1	A1693S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864929	17	41215966	17	43063949	864929	854024	rs1040027065	NC_000017.11:43063948:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1693	BRCA1
NM_007294.4(BRCA1):c.5077G>C (p.Ala1693Pro)	BRCA1	A1693P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864928	17	41215966	17	43063949	864928	854025	rs1040027065	NC_000017.11:43063948:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1693	BRCA1
NM_007294.4(BRCA1):c.5077G>A (p.Ala1693Thr)	BRCA1	A1693T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864927	17	41215966	17	43063949	864927	854026	rs1040027065	NC_000017.11:43063948:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1693	BRCA1
NM_007294.4(BRCA1):c.5076T>G (p.Asp1692Glu)	BRCA1	D1692E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864926	17	41215967	17	43063950	864926	854027	rs2051937547	NC_000017.11:43063949:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5076T>A (p.Asp1692Glu)	BRCA1	D1692E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864924	17	41215967	17	43063950	864924	854029	rs2051937547	NC_000017.11:43063949:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5075A>G (p.Asp1692Gly)	BRCA1	D1692G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869003	17	41215968	17	43063951	869003	854030	rs397509222	NC_000017.11:43063950:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5075A>C (p.Asp1692Ala)	BRCA1	D1692A	not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254641	17	41215968	17	43063951	254641	249182	rs397509222	NC_000017.11:43063950:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5075A>T (p.Asp1692Val)	BRCA1	D1692V	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055383	17	41215968	17	43063951	55383	70050	rs397509222	NC_000017.11:43063950:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5074G>T (p.Asp1692Tyr)	BRCA1	D1692Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055376	17	41219625	17	43067608	55376	70043	rs80187739	NC_000017.11:43067607:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5074G>C (p.Asp1692His)	BRCA1	D1692H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037633	17	41219625	17	43067608	37633	46189	rs80187739	NC_000017.11:43067607:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5074G>A (p.Asp1692Asn)	BRCA1	D1692N	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037632	17	41219625	17	43067608	37632	46188	rs80187739	NC_000017.11:43067607:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1692	BRCA1
NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	BRCA1	T1691R	Hereditary cancer-predisposing syndrome	VCV000055373	17	41219627	17	43067610	55373	70040	rs80357034	NC_000017.11:43067609:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 4, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1691	BRCA1
NM_007294.4(BRCA1):c.5072C>T (p.Thr1691Ile)	BRCA1	T1691I	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000037628	17	41219627	17	43067610	37628	46184	rs80357034	NC_000017.11:43067609:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1691	BRCA1
NM_007294.4(BRCA1):c.5072C>A (p.Thr1691Lys)	BRCA1	T1691K	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000037627	17	41219627	17	43067610	37627	46183	rs80357034	NC_000017.11:43067609:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1691	BRCA1
NM_007294.4(BRCA1):c.5071A>T (p.Thr1691Ser)	BRCA1	T1691S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868985	17	41219628	17	43067611	868985	854031	rs397509219	NC_000017.11:43067610:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1691	BRCA1
NM_007294.4(BRCA1):c.5071A>C (p.Thr1691Pro)	BRCA1	T1691P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868591	17	41219628	17	43067611	868591	854032	rs397509219	NC_000017.11:43067610:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1691	BRCA1
NM_007294.4(BRCA1):c.5071A>G (p.Thr1691Ala)	BRCA1	T1691A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Familial cancer of breast	VCV000055371	17	41219628	17	43067611	55371	70038	rs397509219	NC_000017.11:43067610:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1691	BRCA1
NM_007294.4(BRCA1):c.5070A>T (p.Lys1690Asn)	BRCA1	K1690N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868590	17	41219629	17	43067612	868590	854033	rs2052157151	NC_000017.11:43067611:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1690	BRCA1
NM_007294.4(BRCA1):c.5070A>C (p.Lys1690Asn)	BRCA1	K1690N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868588	17	41219629	17	43067612	868588	854035	rs2052157151	NC_000017.11:43067611:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1690	BRCA1
NM_007294.4(BRCA1):c.5069A>T (p.Lys1690Ile)	BRCA1	K1690I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868587	17	41219630	17	43067613	868587	854036	rs2052157455	NC_000017.11:43067612:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1690	BRCA1
NM_007294.4(BRCA1):c.5069A>G (p.Lys1690Arg)	BRCA1	K1690R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868586	17	41219630	17	43067613	868586	854037	rs2052157455	NC_000017.11:43067612:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1690	BRCA1
NM_007294.4(BRCA1):c.5069A>C (p.Lys1690Thr)	BRCA1	K1690T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868585	17	41219630	17	43067613	868585	854038	rs2052157455	NC_000017.11:43067612:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1690	BRCA1
NM_007294.4(BRCA1):c.5068A>G (p.Lys1690Glu)	BRCA1	K1690E	Hereditary breast ovarian cancer syndrome	VCV000867593	17	41219631	17	43067614	867593	854039	rs397507239	NC_000017.11:43067613:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1690	BRCA1
NM_007294.4(BRCA1):c.5068A>C (p.Lys1690Gln)	BRCA1	K1690Q	not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|not specified|Familial cancer of breast|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055370	17	41219631	17	43067614	55370	70037	rs397507239	NC_000017.11:43067613:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1690	BRCA1
NM_007294.4(BRCA1):c.5067G>T (p.Met1689Ile)	BRCA1	M1689I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867592	17	41219632	17	43067615	867592	854040	rs1597825629	NC_000017.11:43067614:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5067G>C (p.Met1689Ile)	BRCA1	M1689I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000867591	17	41219632	17	43067615	867591	854041	rs1597825629	NC_000017.11:43067614:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5067G>A (p.Met1689Ile)	BRCA1	M1689I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000644391	17	41219632	17	43067615	644391	645927	rs1597825629	NC_000017.11:43067614:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 27, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5066T>A (p.Met1689Lys)	BRCA1	M1689K	Hereditary cancer-predisposing syndrome	VCV000864899	17	41219633	17	43067616	864899	854042	rs80357061	NC_000017.11:43067615:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Aug 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5066T>C (p.Met1689Thr)	BRCA1	M1689T	not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000055369	17	41219633	17	43067616	55369	70036	rs80357061	NC_000017.11:43067615:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5066T>G (p.Met1689Arg)	BRCA1	M1689R	Hereditary cancer-predisposing syndrome|not provided|BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037625	17	41219633	17	43067616	37625	46181	rs80357061	NC_000017.11:43067615:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5065A>T (p.Met1689Leu)	BRCA1	M1689L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864898	17	41219634	17	43067617	864898	854043	rs1555579619	NC_000017.11:43067616:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5065A>C (p.Met1689Leu)	BRCA1	M1689L	not provided	VCV000496390	17	41219634	17	43067617	496390	487851	rs1555579619	NC_000017.11:43067616:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5065A>G (p.Met1689Val)	BRCA1	M1689V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481444	17	41219634	17	43067617	481444	479275	rs1555579619	NC_000017.11:43067616:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 16, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1689	BRCA1
NM_007294.4(BRCA1):c.5063T>A (p.Val1688Asp)	BRCA1	V1688D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868977	17	41219636	17	43067619	868977	854047	rs1597825664	NC_000017.11:43067618:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1688	BRCA1
NM_007294.4(BRCA1):c.5063T>G (p.Val1688Gly)	BRCA1	V1688G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864895	17	41219636	17	43067619	864895	854046	rs1597825664	NC_000017.11:43067618:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1688	BRCA1
NM_007294.4(BRCA1):c.5063T>C (p.Val1688Ala)	BRCA1	V1688A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000655629	17	41219636	17	43067619	655629	645928	rs1597825664	NC_000017.11:43067618:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1688	BRCA1
NM_007294.4(BRCA1):c.5062G>T (p.Val1688Phe)	BRCA1	V1688F	Hereditary breast ovarian cancer syndrome	VCV000868976	17	41219637	17	43067620	868976	854048	rs2052159968	NC_000017.11:43067619:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	May 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1688	BRCA1
NM_007294.4(BRCA1):c.5062G>C (p.Val1688Leu)	BRCA1	V1688L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868975	17	41219637	17	43067620	868975	854049	rs2052159968	NC_000017.11:43067619:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1688	BRCA1
NM_007294.4(BRCA1):c.5062G>A (p.Val1688Ile)	BRCA1	V1688I	Hereditary breast ovarian cancer syndrome	VCV000868974	17	41219637	17	43067620	868974	854050	rs2052159968	NC_000017.11:43067619:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1688	BRCA1
NM_007294.4(BRCA1):c.5060T>C (p.Val1687Ala)	BRCA1	V1687A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868577	17	41219639	17	43067622	868577	854053	rs1555579627	NC_000017.11:43067621:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1687	BRCA1
NM_007294.4(BRCA1):c.5060T>A (p.Val1687Asp)	BRCA1	V1687D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868576	17	41219639	17	43067622	868576	854054	rs1555579627	NC_000017.11:43067621:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1687	BRCA1
NM_007294.4(BRCA1):c.5060T>G (p.Val1687Gly)	BRCA1	V1687G	Hereditary breast ovarian cancer syndrome	VCV000433721	17	41219639	17	43067622	433721	427536	rs1555579627	NC_000017.11:43067621:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1687	BRCA1
NM_007294.4(BRCA1):c.5059G>T (p.Val1687Phe)	BRCA1	V1687F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868575	17	41219640	17	43067623	868575	854055	rs2052161154	NC_000017.11:43067622:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1687	BRCA1
NM_007294.4(BRCA1):c.5059G>C (p.Val1687Leu)	BRCA1	V1687L	Hereditary cancer-predisposing syndrome	VCV000868574	17	41219640	17	43067623	868574	854056	rs2052161154	NC_000017.11:43067622:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 14, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1687	BRCA1
NM_007294.4(BRCA1):c.5059G>A (p.Val1687Ile)	BRCA1	V1687I	Hereditary cancer-predisposing syndrome	VCV000868573	17	41219640	17	43067623	868573	854057	rs2052161154	NC_000017.11:43067622:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Sep 2, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1687	BRCA1
NM_007294.4(BRCA1):c.5058T>G (p.His1686Gln)	BRCA1	H1686Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868572	17	41219641	17	43067624	868572	854058	rs397509218	NC_000017.11:43067623:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5058T>A (p.His1686Gln)	BRCA1	H1686Q	Hereditary breast ovarian cancer syndrome	VCV000055366	17	41219641	17	43067624	55366	70033	rs397509218	NC_000017.11:43067623:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5057A>T (p.His1686Leu)	BRCA1	H1686L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867584	17	41219642	17	43067625	867584	854059	rs730882166	NC_000017.11:43067624:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5057A>C (p.His1686Pro)	BRCA1	H1686P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000584509	17	41219642	17	43067625	584509	575609	rs730882166	NC_000017.11:43067624:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 1, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5057A>G (p.His1686Arg)	BRCA1	H1686R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000183179	17	41219642	17	43067625	183179	181314	rs730882166	NC_000017.11:43067624:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Sep 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5056C>G (p.His1686Asp)	BRCA1	H1686D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867583	17	41219643	17	43067626	867583	854060	rs1555579648	NC_000017.11:43067625:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Feb 2, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5056C>A (p.His1686Asn)	BRCA1	H1686N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867582	17	41219643	17	43067626	867582	854061	rs1555579648	NC_000017.11:43067625:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5056C>T (p.His1686Tyr)	BRCA1	H1686Y	Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000531444	17	41219643	17	43067626	531444	531064	rs1555579648	NC_000017.11:43067625:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1686	BRCA1
NM_007294.4(BRCA1):c.5054C>G (p.Thr1685Ser)	BRCA1	T1685S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864886	17	41219645	17	43067628	864886	854064	rs80357043	NC_000017.11:43067627:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1685	BRCA1
NM_007294.4(BRCA1):c.5054C>A (p.Thr1685Asn)	BRCA1	T1685N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864885	17	41219645	17	43067628	864885	854065	rs80357043	NC_000017.11:43067627:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1685	BRCA1
NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	BRCA1	T1685I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055365	17	41219645	17	43067628	55365	70032	rs80357043	NC_000017.11:43067627:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1685	BRCA1
NM_007294.4(BRCA1):c.5053A>T (p.Thr1685Ser)	BRCA1	T1685S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864884	17	41219646	17	43067629	864884	854066	rs80356890	NC_000017.11:43067628:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1685	BRCA1
NM_007294.4(BRCA1):c.5053A>C (p.Thr1685Pro)	BRCA1	T1685P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864883	17	41219646	17	43067629	864883	854067	rs80356890	NC_000017.11:43067628:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1685	BRCA1
NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	BRCA1	T1685A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055364	17	41219646	17	43067629	55364	70031	rs80356890	NC_000017.11:43067628:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1685	BRCA1
NM_007294.4(BRCA1):c.5051C>T (p.Thr1684Ile)	BRCA1	T1684I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868966	17	41219648	17	43067631	868966	854068	rs2052164896	NC_000017.11:43067630:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1684	BRCA1
NM_007294.4(BRCA1):c.5051C>G (p.Thr1684Ser)	BRCA1	T1684S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868965	17	41219648	17	43067631	868965	854069	rs2052164896	NC_000017.11:43067630:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1684	BRCA1
NM_007294.4(BRCA1):c.5051C>A (p.Thr1684Asn)	BRCA1	T1684N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868964	17	41219648	17	43067631	868964	854070	rs2052164896	NC_000017.11:43067630:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1684	BRCA1
NM_007294.4(BRCA1):c.5050A>T (p.Thr1684Ser)	BRCA1	T1684S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000653644	17	41219649	17	43067632	653644	645929	rs879255491	NC_000017.11:43067631:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1684	BRCA1
NM_007294.4(BRCA1):c.5050A>G (p.Thr1684Ala)	BRCA1	T1684A	Hereditary cancer-predisposing syndrome	VCV000485376	17	41219649	17	43067632	485376	478569	rs879255491	NC_000017.11:43067631:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1684	BRCA1
NM_007294.4(BRCA1):c.5050A>C (p.Thr1684Pro)	BRCA1	T1684P	Hereditary breast ovarian cancer syndrome	VCV000252883	17	41219649	17	43067632	252883	247284	rs879255491	NC_000017.11:43067631:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1684	BRCA1
NM_007294.4(BRCA1):c.5049G>T (p.Glu1683Asp)	BRCA1	E1683D	Hereditary cancer-predisposing syndrome	VCV000868565	17	41219650	17	43067633	868565	854071	rs2052165956	NC_000017.11:43067632:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1683	BRCA1
NM_007294.4(BRCA1):c.5049G>C (p.Glu1683Asp)	BRCA1	E1683D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868564	17	41219650	17	43067633	868564	854072	rs2052165956	NC_000017.11:43067632:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1683	BRCA1
NM_007294.4(BRCA1):c.5048A>T (p.Glu1683Val)	BRCA1	E1683V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868562	17	41219651	17	43067634	868562	854074	rs1597825787	NC_000017.11:43067633:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1683	BRCA1
NM_007294.4(BRCA1):c.5048A>C (p.Glu1683Ala)	BRCA1	E1683A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868561	17	41219651	17	43067634	868561	854075	rs1597825787	NC_000017.11:43067633:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1683	BRCA1
NM_007294.4(BRCA1):c.5048A>G (p.Glu1683Gly)	BRCA1	E1683G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825397	17	41219651	17	43067634	825397	813667	rs1597825787	NC_000017.11:43067633:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1683	BRCA1
NM_007294.4(BRCA1):c.5047G>C (p.Glu1683Gln)	BRCA1	E1683Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867574	17	41219652	17	43067635	867574	854076	rs80356879	NC_000017.11:43067634:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1683	BRCA1
NM_007294.4(BRCA1):c.5047G>A (p.Glu1683Lys)	BRCA1	E1683K	Hereditary cancer-predisposing syndrome	VCV000867573	17	41219652	17	43067635	867573	854077	rs80356879	NC_000017.11:43067634:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 7, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1683	BRCA1
NM_007294.4(BRCA1):c.5046A>T (p.Glu1682Asp)	BRCA1	E1682D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867572	17	41219653	17	43067636	867572	854078	rs2052167113	NC_000017.11:43067635:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1682	BRCA1
NM_007294.4(BRCA1):c.5046A>C (p.Glu1682Asp)	BRCA1	E1682D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867570	17	41219653	17	43067636	867570	854080	rs2052167113	NC_000017.11:43067635:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1682	BRCA1
NM_007294.4(BRCA1):c.5045A>G (p.Glu1682Gly)	BRCA1	E1682G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867569	17	41219654	17	43067637	867569	854081	rs80357265	NC_000017.11:43067636:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1682	BRCA1
NM_007294.4(BRCA1):c.5045A>C (p.Glu1682Ala)	BRCA1	E1682A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867568	17	41219654	17	43067637	867568	854082	rs80357265	NC_000017.11:43067636:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1682	BRCA1
NM_007294.4(BRCA1):c.5045A>T (p.Glu1682Val)	BRCA1	E1682V	Hereditary cancer-predisposing syndrome	VCV000055362	17	41219654	17	43067637	55362	70029	rs80357265	NC_000017.11:43067636:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 29, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1682	BRCA1
NM_007294.4(BRCA1):c.5044G>C (p.Glu1682Gln)	BRCA1	E1682Q	not provided	VCV000801081	17	41219655	17	43067638	801081	789615	rs80356958	NC_000017.11:43067637:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1682	BRCA1
NM_007294.4(BRCA1):c.5044G>A (p.Glu1682Lys)	BRCA1	E1682K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055361	17	41219655	17	43067638	55361	70028	rs80356958	NC_000017.11:43067637:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1682	BRCA1
NM_007294.4(BRCA1):c.5042C>A (p.Thr1681Asn)	BRCA1	T1681N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868958	17	41219657	17	43067640	868958	854088	rs766784305	NC_000017.11:43067639:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1681	BRCA1
NM_007294.4(BRCA1):c.5042C>G (p.Thr1681Ser)	BRCA1	T1681S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864873	17	41219657	17	43067640	864873	854087	rs766784305	NC_000017.11:43067639:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1681	BRCA1
NM_007294.4(BRCA1):c.5042C>T (p.Thr1681Ile)	BRCA1	T1681I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000188416	17	41219657	17	43067640	188416	186539	rs766784305	NC_000017.11:43067639:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1681	BRCA1
NM_007294.4(BRCA1):c.5041A>T (p.Thr1681Ser)	BRCA1	T1681S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868957	17	41219658	17	43067641	868957	854089	rs876659314	NC_000017.11:43067640:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1681	BRCA1
NM_007294.4(BRCA1):c.5041A>G (p.Thr1681Ala)	BRCA1	T1681A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868956	17	41219658	17	43067641	868956	854090	rs876659314	NC_000017.11:43067640:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1681	BRCA1
NM_007294.4(BRCA1):c.5041A>C (p.Thr1681Pro)	BRCA1	T1681P	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231712	17	41219658	17	43067641	231712	235946	rs876659314	NC_000017.11:43067640:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1681	BRCA1
NM_007294.4(BRCA1):c.5040T>G (p.Ile1680Met)	BRCA1	I1680M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868955	17	41219659	17	43067642	868955	854091	rs2052169752	NC_000017.11:43067641:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1680	BRCA1
NM_007294.4(BRCA1):c.5039T>G (p.Ile1680Ser)	BRCA1	I1680S	Hereditary breast ovarian cancer syndrome	VCV000868952	17	41219660	17	43067643	868952	854094	rs1489545368	NC_000017.11:43067642:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 21, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1680	BRCA1
NM_007294.4(BRCA1):c.5039T>C (p.Ile1680Thr)	BRCA1	I1680T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868554	17	41219660	17	43067643	868554	854095	rs1489545368	NC_000017.11:43067642:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1680	BRCA1
NM_007294.4(BRCA1):c.5039T>A (p.Ile1680Asn)	BRCA1	I1680N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868553	17	41219660	17	43067643	868553	854096	rs1489545368	NC_000017.11:43067642:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1680	BRCA1
NM_007294.4(BRCA1):c.5038A>T (p.Ile1680Phe)	BRCA1	I1680F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868552	17	41219661	17	43067644	868552	854097	rs2052170937	NC_000017.11:43067643:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1680	BRCA1
NM_007294.4(BRCA1):c.5038A>G (p.Ile1680Val)	BRCA1	I1680V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868551	17	41219661	17	43067644	868551	854098	rs2052170937	NC_000017.11:43067643:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1680	BRCA1
NM_007294.4(BRCA1):c.5038A>C (p.Ile1680Leu)	BRCA1	I1680L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868550	17	41219661	17	43067644	868550	854099	rs2052170937	NC_000017.11:43067643:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1680	BRCA1
NM_007294.4(BRCA1):c.5036T>G (p.Leu1679Arg)	BRCA1	L1679R	Hereditary breast ovarian cancer syndrome	VCV000867560	17	41219663	17	43067646	867560	854102	rs760038328	NC_000017.11:43067645:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 1, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1679	BRCA1
NM_007294.4(BRCA1):c.5036T>A (p.Leu1679Gln)	BRCA1	L1679Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867559	17	41219663	17	43067646	867559	854103	rs760038328	NC_000017.11:43067645:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1679	BRCA1
NM_007294.4(BRCA1):c.5036T>C (p.Leu1679Pro)	BRCA1	L1679P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000216672	17	41219663	17	43067646	216672	213306	rs760038328	NC_000017.11:43067645:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1679	BRCA1
NM_007294.4(BRCA1):c.5035C>A (p.Leu1679Ile)	BRCA1	L1679I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867557	17	41219664	17	43067647	867557	854105	rs934248073	NC_000017.11:43067646:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1679	BRCA1
NM_007294.4(BRCA1):c.5035C>G (p.Leu1679Val)	BRCA1	L1679V	Hereditary breast ovarian cancer syndrome	VCV000665905	17	41219664	17	43067647	665905	645930	rs934248073	NC_000017.11:43067646:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1679	BRCA1
NM_007294.4(BRCA1):c.5034T>G (p.Asn1678Lys)	BRCA1	N1678K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867556	17	41219665	17	43067648	867556	854106	rs898511378	NC_000017.11:43067647:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5034T>A (p.Asn1678Lys)	BRCA1	N1678K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865558	17	41219665	17	43067648	865558	854107	rs898511378	NC_000017.11:43067647:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5033A>T (p.Asn1678Ile)	BRCA1	N1678I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865557	17	41219666	17	43067649	865557	854108	rs2052173415	NC_000017.11:43067648:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5033A>G (p.Asn1678Ser)	BRCA1	N1678S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865556	17	41219666	17	43067649	865556	854109	rs2052173415	NC_000017.11:43067648:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5033A>C (p.Asn1678Thr)	BRCA1	N1678T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865555	17	41219666	17	43067649	865555	854110	rs2052173415	NC_000017.11:43067648:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5032A>T (p.Asn1678Tyr)	BRCA1	N1678Y	Hereditary breast ovarian cancer syndrome	VCV000865554	17	41219667	17	43067650	865554	854111	rs2052174148	NC_000017.11:43067649:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5032A>G (p.Asn1678Asp)	BRCA1	N1678D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865553	17	41219667	17	43067650	865553	854112	rs2052174148	NC_000017.11:43067649:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5032A>C (p.Asn1678His)	BRCA1	N1678H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865552	17	41219667	17	43067650	865552	854113	rs2052174148	NC_000017.11:43067649:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1678	BRCA1
NM_007294.4(BRCA1):c.5030C>G (p.Thr1677Ser)	BRCA1	T1677S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868943	17	41219669	17	43067652	868943	854116	rs876660263	NC_000017.11:43067651:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1677	BRCA1
NM_007294.4(BRCA1):c.5030C>A (p.Thr1677Asn)	BRCA1	T1677N	Hereditary cancer-predisposing syndrome	VCV000868942	17	41219669	17	43067652	868942	854117	rs876660263	NC_000017.11:43067651:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1677	BRCA1
NM_007294.4(BRCA1):c.5030C>T (p.Thr1677Ile)	BRCA1	T1677I	Hereditary cancer-predisposing syndrome	VCV000233207	17	41219669	17	43067652	233207	235947	rs876660263	NC_000017.11:43067651:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 3, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1677	BRCA1
NM_007294.4(BRCA1):c.5029A>T (p.Thr1677Ser)	BRCA1	T1677S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868941	17	41219670	17	43067653	868941	854118	rs2052175330	NC_000017.11:43067652:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1677	BRCA1
NM_007294.4(BRCA1):c.5029A>G (p.Thr1677Ala)	BRCA1	T1677A	Hereditary breast ovarian cancer syndrome	VCV000868940	17	41219670	17	43067653	868940	854119	rs2052175330	NC_000017.11:43067652:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1677	BRCA1
NM_007294.4(BRCA1):c.5029A>C (p.Thr1677Pro)	BRCA1	T1677P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868939	17	41219670	17	43067653	868939	854120	rs2052175330	NC_000017.11:43067652:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1677	BRCA1
NM_007294.4(BRCA1):c.5028A>C (p.Leu1676Phe)	BRCA1	L1676F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868539	17	41219671	17	43067654	868539	854121	rs1064793596	NC_000017.11:43067653:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1676	BRCA1
NM_007294.4(BRCA1):c.5028A>T (p.Leu1676Phe)	BRCA1	L1676F	Hereditary breast ovarian cancer syndrome|not provided	VCV000419031	17	41219671	17	43067654	419031	409954	rs1064793596	NC_000017.11:43067653:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 23, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1676	BRCA1
NM_007294.4(BRCA1):c.5027T>C (p.Leu1676Ser)	BRCA1	L1676S	Hereditary breast ovarian cancer syndrome	VCV002046266	17	41219672	17	43067655	2046266	2096400	NA	NC_000017.11:43067654:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1676	BRCA1
NM_007294.4(BRCA1):c.5026T>G (p.Leu1676Val)	BRCA1	L1676V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868538	17	41219673	17	43067656	868538	854122	rs1567772244	NC_000017.11:43067655:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1676	BRCA1
NM_007294.4(BRCA1):c.5026T>A (p.Leu1676Ile)	BRCA1	L1676I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868537	17	41219673	17	43067656	868537	854123	rs1567772244	NC_000017.11:43067655:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1676	BRCA1
NM_007294.4(BRCA1):c.5024C>G (p.Thr1675Ser)	BRCA1	T1675S	Hereditary cancer-predisposing syndrome	VCV001744853	17	41219675	17	43067658	1744853	1805699	NA	NC_000017.11:43067657:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 2, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1675	BRCA1
NM_007294.4(BRCA1):c.5024C>A (p.Thr1675Asn)	BRCA1	T1675N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867547	17	41219675	17	43067658	867547	854124	rs150729791	NC_000017.11:43067657:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1675	BRCA1
NM_007294.4(BRCA1):c.5024C>T (p.Thr1675Ile)	BRCA1	T1675I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240811	17	41219675	17	43067658	240811	242767	rs150729791	NC_000017.11:43067657:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1675	BRCA1
NM_007294.4(BRCA1):c.5023A>C (p.Thr1675Pro)	BRCA1	T1675P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867546	17	41219676	17	43067659	867546	854125	rs774452090	NC_000017.11:43067658:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1675	BRCA1
NM_007294.4(BRCA1):c.5023A>T (p.Thr1675Ser)	BRCA1	T1675S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000825381	17	41219676	17	43067659	825381	813668	rs774452090	NC_000017.11:43067658:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1675	BRCA1
NM_007294.4(BRCA1):c.5023A>G (p.Thr1675Ala)	BRCA1	T1675A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482928	17	41219676	17	43067659	482928	478661	rs774452090	NC_000017.11:43067658:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1675	BRCA1
NM_007294.4(BRCA1):c.5021T>C (p.Ile1674Thr)	BRCA1	I1674T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867545	17	41219678	17	43067661	867545	854126	rs2052178079	NC_000017.11:43067660:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1674	BRCA1
NM_007294.4(BRCA1):c.5020A>G (p.Ile1674Val)	BRCA1	I1674V	Hereditary cancer-predisposing syndrome	VCV000867544	17	41219679	17	43067662	867544	854127	rs1050371477	NC_000017.11:43067661:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 10, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1674	BRCA1
NM_007294.4(BRCA1):c.5020A>C (p.Ile1674Leu)	BRCA1	I1674L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867543	17	41219679	17	43067662	867543	854128	rs1050371477	NC_000017.11:43067661:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1674	BRCA1
NM_007294.4(BRCA1):c.5019C>G (p.His1673Gln)	BRCA1	H1673Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865541	17	41219680	17	43067663	865541	854130	rs2052178742	NC_000017.11:43067662:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5019C>A (p.His1673Gln)	BRCA1	H1673Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865540	17	41219680	17	43067663	865540	854131	rs2052178742	NC_000017.11:43067662:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5018A>T (p.His1673Leu)	BRCA1	H1673L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865539	17	41219681	17	43067664	865539	854132	rs1064793913	NC_000017.11:43067663:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5018A>C (p.His1673Pro)	BRCA1	H1673P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865538	17	41219681	17	43067664	865538	854133	rs1064793913	NC_000017.11:43067663:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5018A>G (p.His1673Arg)	BRCA1	H1673R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000419497	17	41219681	17	43067664	419497	409955	rs1064793913	NC_000017.11:43067663:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5017C>A (p.His1673Asn)	BRCA1	H1673N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868931	17	41219682	17	43067665	868931	854136	rs758539222	NC_000017.11:43067664:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5017C>T (p.His1673Tyr)	BRCA1	H1673Y	Hereditary cancer-predisposing syndrome	VCV000865537	17	41219682	17	43067665	865537	854134	rs758539222	NC_000017.11:43067664:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5017C>G (p.His1673Asp)	BRCA1	H1673D	Hereditary cancer-predisposing syndrome	VCV000865536	17	41219682	17	43067665	865536	854135	rs758539222	NC_000017.11:43067664:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Nov 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1673	BRCA1
NM_007294.4(BRCA1):c.5016C>G (p.His1672Gln)	BRCA1	H1672Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868929	17	41219683	17	43067666	868929	854138	rs2052180111	NC_000017.11:43067665:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5016C>A (p.His1672Gln)	BRCA1	H1672Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868928	17	41219683	17	43067666	868928	854139	rs2052180111	NC_000017.11:43067665:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5015A>G (p.His1672Arg)	BRCA1	H1672R	Hereditary cancer-predisposing syndrome	VCV000868927	17	41219684	17	43067667	868927	854140	rs1567772328	NC_000017.11:43067666:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 26, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5015A>C (p.His1672Pro)	BRCA1	H1672P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868926	17	41219684	17	43067667	868926	854141	rs1567772328	NC_000017.11:43067666:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5015A>T (p.His1672Leu)	BRCA1	H1672L	Hereditary cancer-predisposing syndrome	VCV000631148	17	41219684	17	43067667	631148	618566	rs1567772328	NC_000017.11:43067666:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5014C>G (p.His1672Asp)	BRCA1	H1672D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868531	17	41219685	17	43067668	868531	854142	rs587781477	NC_000017.11:43067667:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5014C>A (p.His1672Asn)	BRCA1	H1672N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868530	17	41219685	17	43067668	868530	854143	rs587781477	NC_000017.11:43067667:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5014C>T (p.His1672Tyr)	BRCA1	H1672Y	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000141076	17	41219685	17	43067668	141076	150790	rs587781477	NC_000017.11:43067667:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1672	BRCA1
NM_007294.4(BRCA1):c.5013A>T (p.Lys1671Asn)	BRCA1	K1671N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868529	17	41219686	17	43067669	868529	854144	rs2052181061	NC_000017.11:43067668:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1671	BRCA1
NM_007294.4(BRCA1):c.5013A>C (p.Lys1671Asn)	BRCA1	K1671N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868527	17	41219686	17	43067669	868527	854146	rs2052181061	NC_000017.11:43067668:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1671	BRCA1
NM_007294.4(BRCA1):c.5012A>T (p.Lys1671Ile)	BRCA1	K1671I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868526	17	41219687	17	43067670	868526	854147	rs2052181606	NC_000017.11:43067669:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1671	BRCA1
NM_007294.4(BRCA1):c.5012A>G (p.Lys1671Arg)	BRCA1	K1671R	Hereditary breast ovarian cancer syndrome	VCV000868525	17	41219687	17	43067670	868525	854148	rs2052181606	NC_000017.11:43067669:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 11, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1671	BRCA1
NM_007294.4(BRCA1):c.5012A>C (p.Lys1671Thr)	BRCA1	K1671T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868524	17	41219687	17	43067670	868524	854149	rs2052181606	NC_000017.11:43067669:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1671	BRCA1
NM_007294.4(BRCA1):c.5011A>G (p.Lys1671Glu)	BRCA1	K1671E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867535	17	41219688	17	43067671	867535	854151	rs2052181996	NC_000017.11:43067670:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1671	BRCA1
NM_007294.4(BRCA1):c.5011A>C (p.Lys1671Gln)	BRCA1	K1671Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867534	17	41219688	17	43067671	867534	854152	rs2052181996	NC_000017.11:43067670:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1671	BRCA1
NM_007294.4(BRCA1):c.5010A>T (p.Arg1670Ser)	BRCA1	R1670S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867533	17	41219689	17	43067672	867533	854153	rs777828258	NC_000017.11:43067671:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1670	BRCA1
NM_007294.4(BRCA1):c.5010A>C (p.Arg1670Ser)	BRCA1	R1670S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867532	17	41219689	17	43067672	867532	854154	rs777828258	NC_000017.11:43067671:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1670	BRCA1
NM_007294.4(BRCA1):c.5009G>T (p.Arg1670Ile)	BRCA1	R1670I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867531	17	41219690	17	43067673	867531	854155	rs2052182633	NC_000017.11:43067672:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1670	BRCA1
NM_007294.4(BRCA1):c.5009G>C (p.Arg1670Thr)	BRCA1	R1670T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867530	17	41219690	17	43067673	867530	854156	rs2052182633	NC_000017.11:43067672:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1670	BRCA1
NM_007294.4(BRCA1):c.5009G>A (p.Arg1670Lys)	BRCA1	R1670K	not provided	VCV000865528	17	41219690	17	43067673	865528	854157	rs2052182633	NC_000017.11:43067672:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1670	BRCA1
NM_007294.4(BRCA1):c.5008A>G (p.Arg1670Gly)	BRCA1	R1670G	Hereditary cancer-predisposing syndrome	VCV000865526	17	41219691	17	43067674	865526	854159	rs1057523976	NC_000017.11:43067673:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1670	BRCA1
NM_007294.4(BRCA1):c.5006C>A (p.Ala1669Asp)	BRCA1	A1669D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868919	17	41219693	17	43067676	868919	854163	rs1057518640	NC_000017.11:43067675:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1669	BRCA1
NM_007294.4(BRCA1):c.5006C>G (p.Ala1669Gly)	BRCA1	A1669G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865523	17	41219693	17	43067676	865523	854162	rs1057518640	NC_000017.11:43067675:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1669	BRCA1
NM_007294.4(BRCA1):c.5006C>T (p.Ala1669Val)	BRCA1	A1669V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm	VCV000373827	17	41219693	17	43067676	373827	360717	rs1057518640	NC_000017.11:43067675:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1669	BRCA1
NM_007294.4(BRCA1):c.5005G>C (p.Ala1669Pro)	BRCA1	A1669P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868918	17	41219694	17	43067677	868918	854164	rs80357087	NC_000017.11:43067676:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1669	BRCA1
NM_007294.4(BRCA1):c.5005G>A (p.Ala1669Thr)	BRCA1	A1669T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000868917	17	41219694	17	43067677	868917	854165	rs80357087	NC_000017.11:43067676:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1669	BRCA1
NM_007294.4(BRCA1):c.5005G>T (p.Ala1669Ser)	BRCA1	A1669S	Breast carcinoma|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome	VCV000041831	17	41219694	17	43067677	41831	50270	rs80357087	NC_000017.11:43067676:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1669	BRCA1
NM_007294.4(BRCA1):c.5004T>G (p.Phe1668Leu)	BRCA1	F1668L	Hereditary breast ovarian cancer syndrome	VCV000868916	17	41219695	17	43067678	868916	854166	rs2052185251	NC_000017.11:43067677:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5004T>A (p.Phe1668Leu)	BRCA1	F1668L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868914	17	41219695	17	43067678	868914	854168	rs2052185251	NC_000017.11:43067677:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5003T>A (p.Phe1668Tyr)	BRCA1	F1668Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868516	17	41219696	17	43067679	868516	854169	rs1567772408	NC_000017.11:43067678:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5003T>G (p.Phe1668Cys)	BRCA1	F1668C	Hereditary cancer-predisposing syndrome	VCV000631339	17	41219696	17	43067679	631339	618567	rs1567772408	NC_000017.11:43067678:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5003T>C (p.Phe1668Ser)	BRCA1	F1668S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629251	17	41219696	17	43067679	629251	618568	rs1567772408	NC_000017.11:43067678:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5002T>G (p.Phe1668Val)	BRCA1	F1668V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868515	17	41219697	17	43067680	868515	854170	rs587781472	NC_000017.11:43067679:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 2, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5002T>C (p.Phe1668Leu)	BRCA1	F1668L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868514	17	41219697	17	43067680	868514	854171	rs587781472	NC_000017.11:43067679:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5002T>A (p.Phe1668Ile)	BRCA1	F1668I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141071	17	41219697	17	43067680	141071	150785	rs587781472	NC_000017.11:43067679:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 8, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1668	BRCA1
NM_007294.4(BRCA1):c.5001G>T (p.Lys1667Asn)	BRCA1	K1667N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868513	17	41219698	17	43067681	868513	854172	rs889937720	NC_000017.11:43067680:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1667	BRCA1
NM_007294.4(BRCA1):c.5001G>C (p.Lys1667Asn)	BRCA1	K1667N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868512	17	41219698	17	43067681	868512	854173	rs889937720	NC_000017.11:43067680:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1667	BRCA1
NM_007294.4(BRCA1):c.5000A>T (p.Lys1667Met)	BRCA1	K1667M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868103	17	41219699	17	43067682	868103	854174	rs1057519495	NC_000017.11:43067681:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1667	BRCA1
NM_007294.4(BRCA1):c.5000A>C (p.Lys1667Thr)	BRCA1	K1667T	Hereditary cancer-predisposing syndrome	VCV000868102	17	41219699	17	43067682	868102	854175	rs1057519495	NC_000017.11:43067681:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1667	BRCA1
NM_007294.4(BRCA1):c.5000A>G (p.Lys1667Arg)	BRCA1	K1667R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000375448	17	41219699	17	43067682	375448	362215	rs1057519495	NC_000017.11:43067681:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 12, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1667	BRCA1
NM_007294.4(BRCA1):c.4999A>C (p.Lys1667Gln)	BRCA1	K1667Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868101	17	41219700	17	43067683	868101	854176	rs80357204	NC_000017.11:43067682:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1667	BRCA1
NM_007294.4(BRCA1):c.4999A>G (p.Lys1667Glu)	BRCA1	K1667E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000489727	17	41219700	17	43067683	489727	482932	rs80357204	NC_000017.11:43067682:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1667	BRCA1
NM_007294.4(BRCA1):c.4997A>T (p.Tyr1666Phe)	BRCA1	Y1666F	Hereditary breast ovarian cancer syndrome	VCV000865515	17	41219702	17	43067685	865515	854178	rs397509216	NC_000017.11:43067684:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1666	BRCA1
NM_007294.4(BRCA1):c.4997A>C (p.Tyr1666Ser)	BRCA1	Y1666S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865514	17	41219702	17	43067685	865514	854179	rs397509216	NC_000017.11:43067684:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1666	BRCA1
NM_007294.4(BRCA1):c.4997A>G (p.Tyr1666Cys)	BRCA1	Y1666C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055352	17	41219702	17	43067685	55352	70019	rs397509216	NC_000017.11:43067684:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1666	BRCA1
NM_007294.4(BRCA1):c.4996T>G (p.Tyr1666Asp)	BRCA1	Y1666D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865513	17	41219703	17	43067686	865513	854180	rs397509215	NC_000017.11:43067685:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1666	BRCA1
NM_007294.4(BRCA1):c.4996T>A (p.Tyr1666Asn)	BRCA1	Y1666N	Hereditary cancer-predisposing syndrome	VCV000865512	17	41219703	17	43067686	865512	854181	rs397509215	NC_000017.11:43067685:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Sep 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1666	BRCA1
NM_007294.4(BRCA1):c.4996T>C (p.Tyr1666His)	BRCA1	Y1666H	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000055351	17	41219703	17	43067686	55351	70018	rs397509215	NC_000017.11:43067685:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1666	BRCA1
NM_007294.4(BRCA1):c.4994T>C (p.Val1665Ala)	BRCA1	V1665A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868906	17	41219705	17	43067688	868906	854185	rs1476854015	NC_000017.11:43067687:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1665	BRCA1
NM_007294.4(BRCA1):c.4994T>A (p.Val1665Glu)	BRCA1	V1665E	Familial cancer of breast	VCV000868905	17	41219705	17	43067688	868905	854186	rs1476854015	NC_000017.11:43067687:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1665	BRCA1
NM_007294.4(BRCA1):c.4994T>G (p.Val1665Gly)	BRCA1	V1665G	Hereditary cancer-predisposing syndrome	VCV000825350	17	41219705	17	43067688	825350	813669	rs1476854015	NC_000017.11:43067687:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jul 30, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1665	BRCA1
NM_007294.4(BRCA1):c.4993G>T (p.Val1665Leu)	BRCA1	V1665L	Hereditary cancer-predisposing syndrome	VCV000825349	17	41219706	17	43067689	825349	813670	rs80357169	NC_000017.11:43067688:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 21, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1665	BRCA1
NM_007294.4(BRCA1):c.4993G>C (p.Val1665Leu)	BRCA1	V1665L	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479204	17	41219706	17	43067689	479204	478664	rs80357169	NC_000017.11:43067688:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1665	BRCA1
NM_007294.4(BRCA1):c.4993G>A (p.Val1665Met)	BRCA1	V1665M	not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055350	17	41219706	17	43067689	55350	70017	rs80357169	NC_000017.11:43067688:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1665	BRCA1
NM_007294.4(BRCA1):c.4991T>G (p.Leu1664Arg)	BRCA1	L1664R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868504	17	41219708	17	43067691	868504	854188	rs80357314	NC_000017.11:43067690:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1664	BRCA1
NM_007294.4(BRCA1):c.4991T>A (p.Leu1664His)	BRCA1	L1664H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868503	17	41219708	17	43067691	868503	854189	rs80357314	NC_000017.11:43067690:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1664	BRCA1
NM_007294.4(BRCA1):c.4991T>C (p.Leu1664Pro)	BRCA1	L1664P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037621	17	41219708	17	43067691	37621	46177	rs80357314	NC_000017.11:43067690:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1664	BRCA1
NM_007294.4(BRCA1):c.4990C>T (p.Leu1664Phe)	BRCA1	L1664F	Hereditary cancer-predisposing syndrome	VCV000868502	17	41219709	17	43067692	868502	854190	rs1467535423	NC_000017.11:43067691:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 28, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1664	BRCA1
NM_007294.4(BRCA1):c.4990C>G (p.Leu1664Val)	BRCA1	L1664V	Hereditary cancer-predisposing syndrome	VCV000868501	17	41219709	17	43067692	868501	854191	rs1467535423	NC_000017.11:43067691:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 25, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1664	BRCA1
NM_007294.4(BRCA1):c.4990C>A (p.Leu1664Ile)	BRCA1	L1664I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868500	17	41219709	17	43067692	868500	854192	rs1467535423	NC_000017.11:43067691:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1664	BRCA1
NM_007294.4(BRCA1):c.4989G>T (p.Met1663Ile)	BRCA1	M1663I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868099	17	41219710	17	43067693	868099	854193	rs748807039	NC_000017.11:43067692:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2020	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4989G>C (p.Met1663Ile)	BRCA1	M1663I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868098	17	41219710	17	43067693	868098	854194	rs748807039	NC_000017.11:43067692:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4989G>A (p.Met1663Ile)	BRCA1	M1663I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868097	17	41219710	17	43067693	868097	854195	rs748807039	NC_000017.11:43067692:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4988T>G (p.Met1663Arg)	BRCA1	M1663R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868096	17	41219711	17	43067694	868096	854196	rs80357205	NC_000017.11:43067693:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4988T>C (p.Met1663Thr)	BRCA1	M1663T	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000868095	17	41219711	17	43067694	868095	854197	rs80357205	NC_000017.11:43067693:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4988T>A (p.Met1663Lys)	BRCA1	M1663K	BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000055349	17	41219711	17	43067694	55349	70016	rs80357205	NC_000017.11:43067693:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4987A>G (p.Met1663Val)	BRCA1	M1663V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868094	17	41219712	17	43067695	868094	854198	rs80357117	NC_000017.11:43067694:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4987A>C (p.Met1663Leu)	BRCA1	M1663L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865510	17	41219712	17	43067695	865510	854199	rs80357117	NC_000017.11:43067694:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4987A>T (p.Met1663Leu)	BRCA1	M1663L	Hereditary breast ovarian cancer syndrome	VCV000055348	17	41219712	17	43067695	55348	70015	rs80357117	NC_000017.11:43067694:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 20, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1663	BRCA1
NM_007294.4(BRCA1):c.4986T>G (p.Phe1662Leu)	BRCA1	F1662L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868084	17	41222945	17	43070928	868084	854200	rs2052353460	NC_000017.11:43070927:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4986T>A (p.Phe1662Leu)	BRCA1	F1662L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868082	17	41222945	17	43070928	868082	854202	rs2052353460	NC_000017.11:43070927:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4985T>G (p.Phe1662Cys)	BRCA1	F1662C	Hereditary breast ovarian cancer syndrome	VCV000868081	17	41222946	17	43070929	868081	854203	rs28897695	NC_000017.11:43070928:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4985T>A (p.Phe1662Tyr)	BRCA1	F1662Y	Hereditary breast ovarian cancer syndrome	VCV000865489	17	41222946	17	43070929	865489	854204	rs28897695	NC_000017.11:43070928:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	BRCA1	F1662S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055339	17	41222946	17	43070929	55339	70006	rs28897695	NC_000017.11:43070928:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4984T>G (p.Phe1662Val)	BRCA1	F1662V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865488	17	41222947	17	43070930	865488	854205	rs2052354206	NC_000017.11:43070929:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4984T>C (p.Phe1662Leu)	BRCA1	F1662L	Hereditary breast ovarian cancer syndrome	VCV000865487	17	41222947	17	43070930	865487	854206	rs2052354206	NC_000017.11:43070929:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4984T>A (p.Phe1662Ile)	BRCA1	F1662I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865486	17	41222947	17	43070930	865486	854207	rs2052354206	NC_000017.11:43070929:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1662	BRCA1
NM_007294.4(BRCA1):c.4983A>T (p.Glu1661Asp)	BRCA1	E1661D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865485	17	41222948	17	43070931	865485	854208	rs2052354666	NC_000017.11:43070930:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1661	BRCA1
NM_007294.4(BRCA1):c.4983A>C (p.Glu1661Asp)	BRCA1	E1661D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865483	17	41222948	17	43070931	865483	854210	rs2052354666	NC_000017.11:43070930:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1661	BRCA1
NM_007294.4(BRCA1):c.4982A>T (p.Glu1661Val)	BRCA1	E1661V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868891	17	41222949	17	43070932	868891	854211	rs2052355093	NC_000017.11:43070931:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1661	BRCA1
NM_007294.4(BRCA1):c.4982A>G (p.Glu1661Gly)	BRCA1	E1661G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868890	17	41222949	17	43070932	868890	854212	rs2052355093	NC_000017.11:43070931:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1661	BRCA1
NM_007294.4(BRCA1):c.4982A>C (p.Glu1661Ala)	BRCA1	E1661A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868889	17	41222949	17	43070932	868889	854213	rs2052355093	NC_000017.11:43070931:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1661	BRCA1
NM_007294.4(BRCA1):c.4981G>C (p.Glu1661Gln)	BRCA1	E1661Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868888	17	41222950	17	43070933	868888	854214	rs80357401	NC_000017.11:43070932:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1661	BRCA1
NM_007294.4(BRCA1):c.4981G>A (p.Glu1661Lys)	BRCA1	E1661K	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000375447	17	41222950	17	43070933	375447	362216	rs80357401	NC_000017.11:43070932:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1661	BRCA1
NM_007294.4(BRCA1):c.4980A>T (p.Glu1660Asp)	BRCA1	E1660D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868887	17	41222951	17	43070934	868887	854215	rs2052355896	NC_000017.11:43070933:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1660	BRCA1
NM_007294.4(BRCA1):c.4980A>C (p.Glu1660Asp)	BRCA1	E1660D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868473	17	41222951	17	43070934	868473	854217	rs2052355896	NC_000017.11:43070933:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1660	BRCA1
NM_007294.4(BRCA1):c.4979A>T (p.Glu1660Val)	BRCA1	E1660V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868472	17	41222952	17	43070935	868472	854218	rs2052356167	NC_000017.11:43070934:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1660	BRCA1
NM_007294.4(BRCA1):c.4979A>G (p.Glu1660Gly)	BRCA1	E1660G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868471	17	41222952	17	43070935	868471	854219	rs2052356167	NC_000017.11:43070934:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1660	BRCA1
NM_007294.4(BRCA1):c.4979A>C (p.Glu1660Ala)	BRCA1	E1660A	not provided	VCV000868470	17	41222952	17	43070935	868470	854220	rs2052356167	NC_000017.11:43070934:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1660	BRCA1
NM_007294.4(BRCA1):c.4978G>C (p.Glu1660Gln)	BRCA1	E1660Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868468	17	41222953	17	43070936	868468	854222	rs2052356742	NC_000017.11:43070935:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1660	BRCA1
NM_007294.4(BRCA1):c.4978G>A (p.Glu1660Lys)	BRCA1	E1660K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868467	17	41222953	17	43070936	868467	854223	rs2052356742	NC_000017.11:43070935:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1660	BRCA1
NM_007294.4(BRCA1):c.4976C>T (p.Pro1659Leu)	BRCA1	P1659L	Hereditary breast ovarian cancer syndrome	VCV000868075	17	41222955	17	43070938	868075	854226	rs2052357390	NC_000017.11:43070937:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1659	BRCA1
NM_007294.4(BRCA1):c.4976C>G (p.Pro1659Arg)	BRCA1	P1659R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865748	17	41222955	17	43070938	865748	854227	rs2052357390	NC_000017.11:43070937:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1659	BRCA1
NM_007294.4(BRCA1):c.4976C>A (p.Pro1659Gln)	BRCA1	P1659Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865747	17	41222955	17	43070938	865747	854228	rs2052357390	NC_000017.11:43070937:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1659	BRCA1
NM_007294.4(BRCA1):c.4975C>T (p.Pro1659Ser)	BRCA1	P1659S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865746	17	41222956	17	43070939	865746	854229	rs2052357870	NC_000017.11:43070938:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1659	BRCA1
NM_007294.4(BRCA1):c.4975C>G (p.Pro1659Ala)	BRCA1	P1659A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865745	17	41222956	17	43070939	865745	854230	rs2052357870	NC_000017.11:43070938:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1659	BRCA1
NM_007294.4(BRCA1):c.4975C>A (p.Pro1659Thr)	BRCA1	P1659T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865744	17	41222956	17	43070939	865744	854231	rs2052357870	NC_000017.11:43070938:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1659	BRCA1
NM_007294.4(BRCA1):c.4973C>G (p.Thr1658Ser)	BRCA1	T1658S	Hereditary breast ovarian cancer syndrome	VCV002865766	17	41222958	17	43070941	2865766	3026839	NA	NC_000017.11:43070940:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1658	BRCA1
NM_007294.4(BRCA1):c.4973C>T (p.Thr1658Ile)	BRCA1	T1658I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001365368	17	41222958	17	43070941	1365368	1402238	rs1015073230	NC_000017.11:43070940:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1658	BRCA1
NM_007294.4(BRCA1):c.4973C>A (p.Thr1658Asn)	BRCA1	T1658N	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630092	17	41222958	17	43070941	630092	618569	rs1015073230	NC_000017.11:43070940:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1658	BRCA1
NM_007294.4(BRCA1):c.4972A>T (p.Thr1658Ser)	BRCA1	T1658S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865478	17	41222959	17	43070942	865478	854232	rs2052358713	NC_000017.11:43070941:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1658	BRCA1
NM_007294.4(BRCA1):c.4972A>G (p.Thr1658Ala)	BRCA1	T1658A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865477	17	41222959	17	43070942	865477	854233	rs2052358713	NC_000017.11:43070941:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1658	BRCA1
NM_007294.4(BRCA1):c.4970T>G (p.Leu1657Arg)	BRCA1	L1657R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865475	17	41222961	17	43070944	865475	854235	rs1597830263	NC_000017.11:43070943:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1657	BRCA1
NM_007294.4(BRCA1):c.4970T>A (p.Leu1657Gln)	BRCA1	L1657Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865474	17	41222961	17	43070944	865474	854236	rs1597830263	NC_000017.11:43070943:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1657	BRCA1
NM_007294.4(BRCA1):c.4970T>C (p.Leu1657Pro)	BRCA1	L1657P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000661520	17	41222961	17	43070944	661520	645931	rs1597830263	NC_000017.11:43070943:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 15, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1657	BRCA1
NM_007294.4(BRCA1):c.4969C>G (p.Leu1657Val)	BRCA1	L1657V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868884	17	41222962	17	43070945	868884	854238	rs2052359756	NC_000017.11:43070944:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1657	BRCA1
NM_007294.4(BRCA1):c.4969C>A (p.Leu1657Met)	BRCA1	L1657M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868883	17	41222962	17	43070945	868883	854239	rs2052359756	NC_000017.11:43070944:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1657	BRCA1
NM_007294.4(BRCA1):c.4967G>T (p.Gly1656Val)	BRCA1	G1656V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868879	17	41222964	17	43070947	868879	854243	rs80357414	NC_000017.11:43070946:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1656	BRCA1
NM_007294.4(BRCA1):c.4967G>C (p.Gly1656Ala)	BRCA1	G1656A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868878	17	41222964	17	43070947	868878	854244	rs80357414	NC_000017.11:43070946:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1656	BRCA1
NM_007294.4(BRCA1):c.4967G>A (p.Gly1656Asp)	BRCA1	G1656D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055337	17	41222964	17	43070947	55337	70004	rs80357414	NC_000017.11:43070946:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2004	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1656	BRCA1
NM_007294.4(BRCA1):c.4966G>T (p.Gly1656Cys)	BRCA1	G1656C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868460	17	41222965	17	43070948	868460	854245	rs2052361087	NC_000017.11:43070947:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1656	BRCA1
NM_007294.4(BRCA1):c.4966G>C (p.Gly1656Arg)	BRCA1	G1656R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868459	17	41222965	17	43070948	868459	854246	rs2052361087	NC_000017.11:43070947:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1656	BRCA1
NM_007294.4(BRCA1):c.4966G>A (p.Gly1656Ser)	BRCA1	G1656S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868458	17	41222965	17	43070948	868458	854247	rs2052361087	NC_000017.11:43070947:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1656	BRCA1
NM_007294.4(BRCA1):c.4964C>G (p.Ser1655Cys)	BRCA1	S1655C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865736	17	41222967	17	43070950	865736	854251	rs80357390	NC_000017.11:43070949:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1655	BRCA1
NM_007294.4(BRCA1):c.4964C>A (p.Ser1655Tyr)	BRCA1	S1655Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865735	17	41222967	17	43070950	865735	854252	rs80357390	NC_000017.11:43070949:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1655	BRCA1
NM_007294.4(BRCA1):c.4964C>T (p.Ser1655Phe)	BRCA1	S1655F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055333	17	41222967	17	43070950	55333	70000	rs80357390	NC_000017.11:43070949:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1655	BRCA1
NM_007294.4(BRCA1):c.4963T>G (p.Ser1655Ala)	BRCA1	S1655A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865734	17	41222968	17	43070951	865734	854253	rs1057518639	NC_000017.11:43070950:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1655	BRCA1
NM_007294.4(BRCA1):c.4963T>A (p.Ser1655Thr)	BRCA1	S1655T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865733	17	41222968	17	43070951	865733	854254	rs1057518639	NC_000017.11:43070950:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1655	BRCA1
NM_007294.4(BRCA1):c.4963T>C (p.Ser1655Pro)	BRCA1	S1655P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Breast neoplasm|not provided	VCV000373826	17	41222968	17	43070951	373826	360718	rs1057518639	NC_000017.11:43070950:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 3, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1655	BRCA1
NM_007294.4(BRCA1):c.4961T>G (p.Val1654Gly)	BRCA1	V1654G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865467	17	41222970	17	43070953	865467	854257	rs1408104448	NC_000017.11:43070952:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1654	BRCA1
NM_007294.4(BRCA1):c.4961T>C (p.Val1654Ala)	BRCA1	V1654A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865466	17	41222970	17	43070953	865466	854258	rs1408104448	NC_000017.11:43070952:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1654	BRCA1
NM_007294.4(BRCA1):c.4961T>A (p.Val1654Glu)	BRCA1	V1654E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865465	17	41222970	17	43070953	865465	854259	rs1408104448	NC_000017.11:43070952:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1654	BRCA1
NM_007294.4(BRCA1):c.4960G>T (p.Val1654Leu)	BRCA1	V1654L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865464	17	41222971	17	43070954	865464	854260	rs2052362962	NC_000017.11:43070953:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1654	BRCA1
NM_007294.4(BRCA1):c.4960G>C (p.Val1654Leu)	BRCA1	V1654L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865463	17	41222971	17	43070954	865463	854261	rs2052362962	NC_000017.11:43070953:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1654	BRCA1
NM_007294.4(BRCA1):c.4960G>A (p.Val1654Met)	BRCA1	V1654M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865462	17	41222971	17	43070954	865462	854262	rs2052362962	NC_000017.11:43070953:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1654	BRCA1
NM_007294.4(BRCA1):c.4958T>G (p.Val1653Gly)	BRCA1	V1653G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868877	17	41222973	17	43070956	868877	854265	rs2052363535	NC_000017.11:43070955:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1653	BRCA1
NM_007294.4(BRCA1):c.4958T>C (p.Val1653Ala)	BRCA1	V1653A	Hereditary cancer-predisposing syndrome	VCV000868876	17	41222973	17	43070956	868876	854266	rs2052363535	NC_000017.11:43070955:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1653	BRCA1
NM_007294.4(BRCA1):c.4958T>A (p.Val1653Glu)	BRCA1	V1653E	Hereditary cancer-predisposing syndrome	VCV000868875	17	41222973	17	43070956	868875	854267	rs2052363535	NC_000017.11:43070955:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Feb 27, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1653	BRCA1
NM_007294.4(BRCA1):c.4957G>T (p.Val1653Leu)	BRCA1	V1653L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868874	17	41222974	17	43070957	868874	854268	rs80357261	NC_000017.11:43070956:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1653	BRCA1
NM_007294.4(BRCA1):c.4957G>C (p.Val1653Leu)	BRCA1	V1653L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868873	17	41222974	17	43070957	868873	854269	rs80357261	NC_000017.11:43070956:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1653	BRCA1
NM_007294.4(BRCA1):c.4957G>A (p.Val1653Met)	BRCA1	V1653M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055331	17	41222974	17	43070957	55331	69998	rs80357261	NC_000017.11:43070956:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 18, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1653	BRCA1
NM_007294.4(BRCA1):c.4956G>T (p.Met1652Ile)	BRCA1	M1652I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868872	17	41222975	17	43070958	868872	854270	rs1799967	NC_000017.11:43070957:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4956G>C (p.Met1652Ile)	BRCA1	M1652I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868871	17	41222975	17	43070958	868871	854271	rs1799967	NC_000017.11:43070957:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4955_4956delinsAA (p.Met1652Lys)	BRCA1	M1652K	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000665843	17	41222975 - 41222976	17	43070958 - 43070959	665843	645932	rs1597830347	NC_000017.11:43070957:CA:TT	Indel	missense variant|non-coding transcript variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	BRCA1	M1652I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041830	17	41222975	17	43070958	41830	50269	rs1799967	NC_000017.11:43070957:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4955T>G (p.Met1652Arg)	BRCA1	M1652R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868449	17	41222976	17	43070959	868449	854272	rs80356968	NC_000017.11:43070958:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4955T>A (p.Met1652Lys)	BRCA1	M1652K	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer	VCV000188415	17	41222976	17	43070959	188415	186540	rs80356968	NC_000017.11:43070958:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4955T>C (p.Met1652Thr)	BRCA1	M1652T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037615	17	41222976	17	43070959	37615	46171	rs80356968	NC_000017.11:43070958:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4954A>C (p.Met1652Leu)	BRCA1	M1652L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868448	17	41222977	17	43070960	868448	854273	rs1348949389	NC_000017.11:43070959:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4954A>T (p.Met1652Leu)	BRCA1	M1652L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000573569	17	41222977	17	43070960	573569	574468	rs1348949389	NC_000017.11:43070959:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 26, 2019	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4954A>G (p.Met1652Val)	BRCA1	M1652V	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479222	17	41222977	17	43070960	479222	479282	rs1348949389	NC_000017.11:43070959:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1652	BRCA1
NM_007294.4(BRCA1):c.4952C>G (p.Ser1651Cys)	BRCA1	S1651C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865721	17	41222979	17	43070962	865721	854277	rs80356938	NC_000017.11:43070961:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1651	BRCA1
NM_007294.4(BRCA1):c.4952C>A (p.Ser1651Tyr)	BRCA1	S1651Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865720	17	41222979	17	43070962	865720	854278	rs80356938	NC_000017.11:43070961:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1651	BRCA1
NM_007294.4(BRCA1):c.4952C>T (p.Ser1651Phe)	BRCA1	S1651F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055330	17	41222979	17	43070962	55330	69997	rs80356938	NC_000017.11:43070961:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1651	BRCA1
NM_007294.4(BRCA1):c.4951T>G (p.Ser1651Ala)	BRCA1	S1651A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865719	17	41222980	17	43070963	865719	854279	rs879254042	NC_000017.11:43070962:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1651	BRCA1
NM_007294.4(BRCA1):c.4951T>A (p.Ser1651Thr)	BRCA1	S1651T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865718	17	41222980	17	43070963	865718	854280	rs879254042	NC_000017.11:43070962:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1651	BRCA1
NM_007294.4(BRCA1):c.4951T>C (p.Ser1651Pro)	BRCA1	S1651P	not provided|Hereditary cancer-predisposing syndrome	VCV000246002	17	41222980	17	43070963	246002	245025	rs879254042	NC_000017.11:43070962:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1651	BRCA1
NM_007294.4(BRCA1):c.4950G>T (p.Met1650Ile)	BRCA1	M1650I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865453	17	41222981	17	43070964	865453	854281	rs2052366574	NC_000017.11:43070963:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4950G>C (p.Met1650Ile)	BRCA1	M1650I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865452	17	41222981	17	43070964	865452	854282	rs2052366574	NC_000017.11:43070963:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4950G>A (p.Met1650Ile)	BRCA1	M1650I	Hereditary breast ovarian cancer syndrome	VCV000850101	17	41222981	17	43070964	850101	845370	rs2052366574	NC_000017.11:43070963:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 28, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4949T>G (p.Met1650Arg)	BRCA1	M1650R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865451	17	41222982	17	43070965	865451	854283	rs778487856	NC_000017.11:43070964:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4949T>A (p.Met1650Lys)	BRCA1	M1650K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865450	17	41222982	17	43070965	865450	854284	rs778487856	NC_000017.11:43070964:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4949T>C (p.Met1650Thr)	BRCA1	M1650T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441375	17	41222982	17	43070965	441375	435106	rs778487856	NC_000017.11:43070964:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4948A>C (p.Met1650Leu)	BRCA1	M1650L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868870	17	41222983	17	43070966	868870	854287	rs1567774493	NC_000017.11:43070965:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4948A>T (p.Met1650Leu)	BRCA1	M1650L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865449	17	41222983	17	43070966	865449	854285	rs1567774493	NC_000017.11:43070965:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4948A>G (p.Met1650Val)	BRCA1	M1650V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000865448	17	41222983	17	43070966	865448	854286	rs1567774493	NC_000017.11:43070965:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1650	BRCA1
NM_007294.4(BRCA1):c.4947A>T (p.Arg1649Ser)	BRCA1	R1649S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868869	17	41222984	17	43070967	868869	854288	rs2052367562	NC_000017.11:43070966:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1649	BRCA1
NM_007294.4(BRCA1):c.4947A>C (p.Arg1649Ser)	BRCA1	R1649S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868867	17	41222984	17	43070967	868867	854290	rs2052367562	NC_000017.11:43070966:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1649	BRCA1
NM_007294.4(BRCA1):c.4946G>T (p.Arg1649Ile)	BRCA1	R1649I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868866	17	41222985	17	43070968	868866	854291	rs876660509	NC_000017.11:43070967:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1649	BRCA1
NM_007294.4(BRCA1):c.4946G>A (p.Arg1649Lys)	BRCA1	R1649K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868865	17	41222985	17	43070968	868865	854292	rs876660509	NC_000017.11:43070967:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1649	BRCA1
NM_007294.4(BRCA1):c.4946G>C (p.Arg1649Thr)	BRCA1	R1649T	Hereditary cancer-predisposing syndrome	VCV000233593	17	41222985	17	43070968	233593	235950	rs876660509	NC_000017.11:43070967:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 26, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1649	BRCA1
NM_007294.4(BRCA1):c.4945A>G (p.Arg1649Gly)	BRCA1	R1649G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868440	17	41222986	17	43070969	868440	854294	rs1312537519	NC_000017.11:43070968:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1649	BRCA1
NM_007294.4(BRCA1):c.4944A>T (p.Lys1648Asn)	BRCA1	K1648N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868438	17	41222987	17	43070970	868438	854296	rs2052368958	NC_000017.11:43070969:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1648	BRCA1
NM_007294.4(BRCA1):c.4944A>C (p.Lys1648Asn)	BRCA1	K1648N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868436	17	41222987	17	43070970	868436	854298	rs2052368958	NC_000017.11:43070969:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1648	BRCA1
NM_007294.4(BRCA1):c.4943A>T (p.Lys1648Ile)	BRCA1	K1648I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868435	17	41222988	17	43070971	868435	854299	rs201810810	NC_000017.11:43070970:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1648	BRCA1
NM_007294.4(BRCA1):c.4943A>G (p.Lys1648Arg)	BRCA1	K1648R	Hereditary cancer-predisposing syndrome	VCV000868434	17	41222988	17	43070971	868434	854300	rs201810810	NC_000017.11:43070970:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jun 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1648	BRCA1
NM_007294.4(BRCA1):c.4943A>C (p.Lys1648Thr)	BRCA1	K1648T	Hereditary cancer-predisposing syndrome	VCV000868433	17	41222988	17	43070971	868433	854301	rs201810810	NC_000017.11:43070970:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1648	BRCA1
NM_007294.4(BRCA1):c.4942A>C (p.Lys1648Gln)	BRCA1	K1648Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865712	17	41222989	17	43070972	865712	854302	rs747694453	NC_000017.11:43070971:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1648	BRCA1
NM_007294.4(BRCA1):c.4942A>G (p.Lys1648Glu)	BRCA1	K1648E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000662443	17	41222989	17	43070972	662443	645934	rs747694453	NC_000017.11:43070971:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1648	BRCA1
NM_007294.4(BRCA1):c.4941C>G (p.Asn1647Lys)	BRCA1	N1647K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865710	17	41222990	17	43070973	865710	854304	rs80357302	NC_000017.11:43070972:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4941C>A (p.Asn1647Lys)	BRCA1	N1647K	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055325	17	41222990	17	43070973	55325	69992	rs80357302	NC_000017.11:43070972:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4940A>T (p.Asn1647Ile)	BRCA1	N1647I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865709	17	41222991	17	43070974	865709	854305	rs2052370581	NC_000017.11:43070973:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4940A>G (p.Asn1647Ser)	BRCA1	N1647S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000865708	17	41222991	17	43070974	865708	854306	rs2052370581	NC_000017.11:43070973:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4940A>C (p.Asn1647Thr)	BRCA1	N1647T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865441	17	41222991	17	43070974	865441	854307	rs2052370581	NC_000017.11:43070973:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4939A>T (p.Asn1647Tyr)	BRCA1	N1647Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865440	17	41222992	17	43070975	865440	854308	rs2052370892	NC_000017.11:43070974:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4939A>G (p.Asn1647Asp)	BRCA1	N1647D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865439	17	41222992	17	43070975	865439	854309	rs2052370892	NC_000017.11:43070974:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4939A>C (p.Asn1647His)	BRCA1	N1647H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865438	17	41222992	17	43070975	865438	854310	rs2052370892	NC_000017.11:43070974:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1647	BRCA1
NM_007294.4(BRCA1):c.4937T>C (p.Val1646Ala)	BRCA1	V1646A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868863	17	41222994	17	43070977	868863	854315	rs28897694	NC_000017.11:43070976:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1646	BRCA1
NM_007294.4(BRCA1):c.4937T>A (p.Val1646Asp)	BRCA1	V1646D	Hereditary cancer-predisposing syndrome	VCV000868862	17	41222994	17	43070977	868862	854316	rs28897694	NC_000017.11:43070976:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1646	BRCA1
NM_007294.4(BRCA1):c.4937T>G (p.Val1646Gly)	BRCA1	V1646G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865434	17	41222994	17	43070977	865434	854314	rs28897694	NC_000017.11:43070976:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1646	BRCA1
NM_007294.4(BRCA1):c.4936G>T (p.Val1646Phe)	BRCA1	V1646F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868861	17	41222995	17	43070978	868861	854317	rs2052371775	NC_000017.11:43070977:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1646	BRCA1
NM_007294.4(BRCA1):c.4936G>C (p.Val1646Leu)	BRCA1	V1646L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868860	17	41222995	17	43070978	868860	854318	rs2052371775	NC_000017.11:43070977:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1646	BRCA1
NM_007294.4(BRCA1):c.4936G>A (p.Val1646Ile)	BRCA1	V1646I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868859	17	41222995	17	43070978	868859	854319	rs2052371775	NC_000017.11:43070977:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1646	BRCA1
NM_007294.4(BRCA1):c.4935G>T (p.Arg1645Ser)	BRCA1	R1645S	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome	VCV000868858	17	41222996	17	43070979	868858	854320	rs80357373	NC_000017.11:43070978:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1645	BRCA1
NM_007294.4(BRCA1):c.4935G>C (p.Arg1645Ser)	BRCA1	R1645S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055321	17	41222996	17	43070979	55321	69988	rs80357373	NC_000017.11:43070978:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1645	BRCA1
NM_007294.4(BRCA1):c.4934G>A (p.Arg1645Lys)	BRCA1	R1645K	Hereditary cancer-predisposing syndrome	VCV000868425	17	41222997	17	43070980	868425	854322	rs70953661	NC_000017.11:43070979:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 7, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1645	BRCA1
NM_007294.4(BRCA1):c.4934G>C (p.Arg1645Thr)	BRCA1	R1645T	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000142312	17	41222997	17	43070980	142312	152026	rs70953661	NC_000017.11:43070979:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1645	BRCA1
NM_007294.4(BRCA1):c.4934G>T (p.Arg1645Met)	BRCA1	R1645M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055320	17	41222997	17	43070980	55320	69987	rs70953661	NC_000017.11:43070979:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1645	BRCA1
NM_007294.4(BRCA1):c.4933A>T (p.Arg1645Trp)	BRCA1	R1645W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868424	17	41222998	17	43070981	868424	854323	rs80356926	NC_000017.11:43070980:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1645	BRCA1
NM_007294.4(BRCA1):c.4933A>G (p.Arg1645Gly)	BRCA1	R1645G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055319	17	41222998	17	43070981	55319	69986	rs80356926	NC_000017.11:43070980:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1645	BRCA1
NM_007294.4(BRCA1):c.4932A>T (p.Glu1644Asp)	BRCA1	E1644D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868422	17	41222999	17	43070982	868422	854325	rs2052374025	NC_000017.11:43070981:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1644	BRCA1
NM_007294.4(BRCA1):c.4932A>C (p.Glu1644Asp)	BRCA1	E1644D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865700	17	41222999	17	43070982	865700	854327	rs2052374025	NC_000017.11:43070981:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1644	BRCA1
NM_007294.4(BRCA1):c.4931A>T (p.Glu1644Val)	BRCA1	E1644V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865699	17	41223000	17	43070983	865699	854328	rs80357016	NC_000017.11:43070982:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1644	BRCA1
NM_007294.4(BRCA1):c.4931A>C (p.Glu1644Ala)	BRCA1	E1644A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865698	17	41223000	17	43070983	865698	854329	rs80357016	NC_000017.11:43070982:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1644	BRCA1
NM_007294.4(BRCA1):c.4931A>G (p.Glu1644Gly)	BRCA1	E1644G	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055318	17	41223000	17	43070983	55318	69985	rs80357016	NC_000017.11:43070982:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1644	BRCA1
NM_007294.4(BRCA1):c.4930G>A (p.Glu1644Lys)	BRCA1	E1644K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865697	17	41223001	17	43070984	865697	854330	rs397509205	NC_000017.11:43070983:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1644	BRCA1
NM_007294.4(BRCA1):c.4930G>C (p.Glu1644Gln)	BRCA1	E1644Q	Hereditary cancer-predisposing syndrome	VCV000825302	17	41223001	17	43070984	825302	813672	rs397509205	NC_000017.11:43070983:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jul 3, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1644	BRCA1
NM_007294.4(BRCA1):c.4928C>T (p.Thr1643Ile)	BRCA1	T1643I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865429	17	41223003	17	43070986	865429	854333	rs2052375394	NC_000017.11:43070985:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1643	BRCA1
NM_007294.4(BRCA1):c.4928C>G (p.Thr1643Arg)	BRCA1	T1643R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865428	17	41223003	17	43070986	865428	854334	rs2052375394	NC_000017.11:43070985:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1643	BRCA1
NM_007294.4(BRCA1):c.4928C>A (p.Thr1643Lys)	BRCA1	T1643K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865427	17	41223003	17	43070986	865427	854335	rs2052375394	NC_000017.11:43070985:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1643	BRCA1
NM_007294.4(BRCA1):c.4927A>T (p.Thr1643Ser)	BRCA1	T1643S	Hereditary cancer-predisposing syndrome	VCV000865426	17	41223004	17	43070987	865426	854336	rs2052375713	NC_000017.11:43070986:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1643	BRCA1
NM_007294.4(BRCA1):c.4927A>G (p.Thr1643Ala)	BRCA1	T1643A	Hereditary breast ovarian cancer syndrome	VCV000865425	17	41223004	17	43070987	865425	854337	rs2052375713	NC_000017.11:43070986:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1643	BRCA1
NM_007294.4(BRCA1):c.4927A>C (p.Thr1643Pro)	BRCA1	T1643P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865424	17	41223004	17	43070987	865424	854338	rs2052375713	NC_000017.11:43070986:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1643	BRCA1
NM_007294.4(BRCA1):c.4925C>T (p.Ser1642Leu)	BRCA1	S1642L	Hereditary cancer-predisposing syndrome	VCV000868853	17	41223006	17	43070989	868853	854342	rs2052376303	NC_000017.11:43070988:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1642	BRCA1
NM_007294.4(BRCA1):c.4924T>G (p.Ser1642Ala)	BRCA1	S1642A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868850	17	41223007	17	43070990	868850	854345	rs2052376601	NC_000017.11:43070989:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1642	BRCA1
NM_007294.4(BRCA1):c.4924T>C (p.Ser1642Pro)	BRCA1	S1642P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868849	17	41223007	17	43070990	868849	854346	rs2052376601	NC_000017.11:43070989:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1642	BRCA1
NM_007294.4(BRCA1):c.4924T>A (p.Ser1642Thr)	BRCA1	S1642T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868414	17	41223007	17	43070990	868414	854347	rs2052376601	NC_000017.11:43070989:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1642	BRCA1
NM_007294.4(BRCA1):c.4922C>G (p.Ala1641Gly)	BRCA1	A1641G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868411	17	41223009	17	43070992	868411	854350	rs1597830578	NC_000017.11:43070991:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1641	BRCA1
NM_007294.4(BRCA1):c.4922C>A (p.Ala1641Asp)	BRCA1	A1641D	Hereditary cancer-predisposing syndrome	VCV000868410	17	41223009	17	43070992	868410	854351	rs1597830578	NC_000017.11:43070991:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1641	BRCA1
NM_007294.4(BRCA1):c.4922C>T (p.Ala1641Val)	BRCA1	A1641V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825294	17	41223009	17	43070992	825294	813673	rs1597830578	NC_000017.11:43070991:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1641	BRCA1
NM_007294.4(BRCA1):c.4921G>T (p.Ala1641Ser)	BRCA1	A1641S	Familial cancer of breast	VCV000868409	17	41223010	17	43070993	868409	854352	rs1800726	NC_000017.11:43070992:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1641	BRCA1
NM_007294.4(BRCA1):c.4921G>C (p.Ala1641Pro)	BRCA1	A1641P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865688	17	41223010	17	43070993	865688	854353	rs1800726	NC_000017.11:43070992:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1641	BRCA1
NM_007294.4(BRCA1):c.4921G>A (p.Ala1641Thr)	BRCA1	A1641T	Hereditary cancer-predisposing syndrome	VCV000055316	17	41223010	17	43070993	55316	69983	rs1800726	NC_000017.11:43070992:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 28, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1641	BRCA1
NM_007294.4(BRCA1):c.4919C>T (p.Thr1640Ile)	BRCA1	T1640I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865684	17	41223012	17	43070995	865684	854357	rs1036328075	NC_000017.11:43070994:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1640	BRCA1
NM_007294.4(BRCA1):c.4919C>G (p.Thr1640Arg)	BRCA1	T1640R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865683	17	41223012	17	43070995	865683	854358	rs1036328075	NC_000017.11:43070994:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1640	BRCA1
NM_007294.4(BRCA1):c.4919C>A (p.Thr1640Lys)	BRCA1	T1640K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865682	17	41223012	17	43070995	865682	854359	rs1036328075	NC_000017.11:43070994:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1640	BRCA1
NM_007294.4(BRCA1):c.4918A>T (p.Thr1640Ser)	BRCA1	T1640S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865417	17	41223013	17	43070996	865417	854360	rs1555580683	NC_000017.11:43070995:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1640	BRCA1
NM_007294.4(BRCA1):c.4918A>C (p.Thr1640Pro)	BRCA1	T1640P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865416	17	41223013	17	43070996	865416	854361	rs1555580683	NC_000017.11:43070995:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1640	BRCA1
NM_007294.4(BRCA1):c.4918A>G (p.Thr1640Ala)	BRCA1	T1640A	Hereditary cancer-predisposing syndrome	VCV000481432	17	41223013	17	43070996	481432	479293	rs1555580683	NC_000017.11:43070995:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1640	BRCA1
NM_007294.4(BRCA1):c.4917G>T (p.Leu1639Phe)	BRCA1	L1639F	Hereditary breast ovarian cancer syndrome	VCV000865415	17	41223014	17	43070997	865415	854362	rs1060504558	NC_000017.11:43070996:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1639	BRCA1
NM_007294.4(BRCA1):c.4917G>C (p.Leu1639Phe)	BRCA1	L1639F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865414	17	41223014	17	43070997	865414	854363	rs1060504558	NC_000017.11:43070996:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1639	BRCA1
NM_007294.4(BRCA1):c.4916T>G (p.Leu1639Trp)	BRCA1	L1639W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865413	17	41223015	17	43070998	865413	854364	rs1567774676	NC_000017.11:43070997:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1639	BRCA1
NM_007294.4(BRCA1):c.4916T>C (p.Leu1639Ser)	BRCA1	L1639S	Hereditary cancer-predisposing syndrome	VCV000628290	17	41223015	17	43070998	628290	618570	rs1567774676	NC_000017.11:43070997:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1639	BRCA1
NM_007294.4(BRCA1):c.4915T>G (p.Leu1639Val)	BRCA1	L1639V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868847	17	41223016	17	43070999	868847	854366	rs1213264226	NC_000017.11:43070998:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1639	BRCA1
NM_007294.4(BRCA1):c.4915T>A (p.Leu1639Met)	BRCA1	L1639M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868846	17	41223016	17	43070999	868846	854367	rs1213264226	NC_000017.11:43070998:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1639	BRCA1
NM_007294.4(BRCA1):c.4914A>T (p.Glu1638Asp)	BRCA1	E1638D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868845	17	41223017	17	43071000	868845	854368	rs786201216	NC_000017.11:43070999:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1638	BRCA1
NM_007294.4(BRCA1):c.4914A>C (p.Glu1638Asp)	BRCA1	E1638D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868844	17	41223017	17	43071000	868844	854369	rs786201216	NC_000017.11:43070999:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1638	BRCA1
NM_007294.4(BRCA1):c.4913A>T (p.Glu1638Val)	BRCA1	E1638V	not specified	VCV000868843	17	41223018	17	43071001	868843	854370	rs2052380495	NC_000017.11:43071000:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1638	BRCA1
NM_007294.4(BRCA1):c.4913A>G (p.Glu1638Gly)	BRCA1	E1638G	Hereditary breast ovarian cancer syndrome	VCV000868402	17	41223018	17	43071001	868402	854371	rs2052380495	NC_000017.11:43071000:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1638	BRCA1
NM_007294.4(BRCA1):c.4913A>C (p.Glu1638Ala)	BRCA1	E1638A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868401	17	41223018	17	43071001	868401	854372	rs2052380495	NC_000017.11:43071000:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1638	BRCA1
NM_007294.4(BRCA1):c.4912G>C (p.Glu1638Gln)	BRCA1	E1638Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868399	17	41223019	17	43071002	868399	854374	rs2052380758	NC_000017.11:43071001:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1638	BRCA1
NM_007294.4(BRCA1):c.4912G>A (p.Glu1638Lys)	BRCA1	E1638K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868398	17	41223019	17	43071002	868398	854375	rs2052380758	NC_000017.11:43071001:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 5, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1638	BRCA1
NM_007294.4(BRCA1):c.4910C>G (p.Pro1637Arg)	BRCA1	P1637R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865676	17	41223021	17	43071004	865676	854379	rs80357048	NC_000017.11:43071003:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1637	BRCA1
NM_007294.4(BRCA1):c.4910C>A (p.Pro1637Gln)	BRCA1	P1637Q	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000422707	17	41223021	17	43071004	422707	409956	rs80357048	NC_000017.11:43071003:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 6, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1637	BRCA1
NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	BRCA1	P1637L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055314	17	41223021	17	43071004	55314	69981	rs80357048	NC_000017.11:43071003:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1637	BRCA1
NM_007294.4(BRCA1):c.4909C>G (p.Pro1637Ala)	BRCA1	P1637A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865675	17	41223022	17	43071005	865675	854380	rs876659989	NC_000017.11:43071004:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1637	BRCA1
NM_007294.4(BRCA1):c.4909C>A (p.Pro1637Thr)	BRCA1	P1637T	Hereditary cancer-predisposing syndrome	VCV000865674	17	41223022	17	43071005	865674	854381	rs876659989	NC_000017.11:43071004:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1637	BRCA1
NM_007294.4(BRCA1):c.4909C>T (p.Pro1637Ser)	BRCA1	P1637S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232788	17	41223022	17	43071005	232788	235952	rs876659989	NC_000017.11:43071004:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 30, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1637	BRCA1
NM_007294.4(BRCA1):c.4908G>T (p.Lys1636Asn)	BRCA1	K1636N	Hereditary cancer-predisposing syndrome	VCV000865673	17	41223023	17	43071006	865673	854382	rs1567774705	NC_000017.11:43071005:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jun 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1636	BRCA1
NM_007294.4(BRCA1):c.4908G>C (p.Lys1636Asn)	BRCA1	K1636N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865672	17	41223023	17	43071006	865672	854383	rs1567774705	NC_000017.11:43071005:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1636	BRCA1
NM_007294.4(BRCA1):c.4907A>T (p.Lys1636Met)	BRCA1	K1636M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865407	17	41223024	17	43071007	865407	854384	rs2052382212	NC_000017.11:43071006:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1636	BRCA1
NM_007294.4(BRCA1):c.4907A>G (p.Lys1636Arg)	BRCA1	K1636R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865406	17	41223024	17	43071007	865406	854385	rs2052382212	NC_000017.11:43071006:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1636	BRCA1
NM_007294.4(BRCA1):c.4907A>C (p.Lys1636Thr)	BRCA1	K1636T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865405	17	41223024	17	43071007	865405	854386	rs2052382212	NC_000017.11:43071006:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1636	BRCA1
NM_007294.4(BRCA1):c.4906A>G (p.Lys1636Glu)	BRCA1	K1636E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865403	17	41223025	17	43071008	865403	854388	rs2052382533	NC_000017.11:43071007:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1636	BRCA1
NM_007294.4(BRCA1):c.4906A>C (p.Lys1636Gln)	BRCA1	K1636Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865402	17	41223025	17	43071008	865402	854389	rs2052382533	NC_000017.11:43071007:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1636	BRCA1
NM_007294.4(BRCA1):c.4905G>C (p.Glu1635Asp)	BRCA1	E1635D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868842	17	41223026	17	43071009	868842	854391	rs2052383010	NC_000017.11:43071008:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1635	BRCA1
NM_007294.4(BRCA1):c.4905G>T (p.Glu1635Asp)	BRCA1	E1635D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865401	17	41223026	17	43071009	865401	854390	rs2052383010	NC_000017.11:43071008:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1635	BRCA1
NM_007294.4(BRCA1):c.4904A>T (p.Glu1635Val)	BRCA1	E1635V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868840	17	41223027	17	43071010	868840	854393	rs2052383280	NC_000017.11:43071009:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1635	BRCA1
NM_007294.4(BRCA1):c.4904A>G (p.Glu1635Gly)	BRCA1	E1635G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868839	17	41223027	17	43071010	868839	854394	rs2052383280	NC_000017.11:43071009:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1635	BRCA1
NM_007294.4(BRCA1):c.4904A>C (p.Glu1635Ala)	BRCA1	E1635A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868838	17	41223027	17	43071010	868838	854395	rs2052383280	NC_000017.11:43071009:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1635	BRCA1
NM_007294.4(BRCA1):c.4903G>C (p.Glu1635Gln)	BRCA1	E1635Q	Hereditary breast ovarian cancer syndrome	VCV000570792	17	41223028	17	43071011	570792	571399	rs200432771	NC_000017.11:43071010:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1635	BRCA1
NM_007294.4(BRCA1):c.4903G>A (p.Glu1635Lys)	BRCA1	E1635K	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000041829	17	41223028	17	43071011	41829	50268	rs200432771	NC_000017.11:43071010:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1635	BRCA1
NM_007294.4(BRCA1):c.4902G>T (p.Arg1634Ser)	BRCA1	R1634S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868387	17	41223029	17	43071012	868387	854396	rs746199881	NC_000017.11:43071011:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1634	BRCA1
NM_007294.4(BRCA1):c.4902G>C (p.Arg1634Ser)	BRCA1	R1634S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868386	17	41223029	17	43071012	868386	854397	rs746199881	NC_000017.11:43071011:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1634	BRCA1
NM_007294.4(BRCA1):c.4901G>C (p.Arg1634Thr)	BRCA1	R1634T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868385	17	41223030	17	43071013	868385	854398	rs1489040931	NC_000017.11:43071012:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1634	BRCA1
NM_007294.4(BRCA1):c.4901G>A (p.Arg1634Lys)	BRCA1	R1634K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000868384	17	41223030	17	43071013	868384	854399	rs1489040931	NC_000017.11:43071012:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1634	BRCA1
NM_007294.4(BRCA1):c.4900A>G (p.Arg1634Gly)	BRCA1	R1634G	Hereditary breast ovarian cancer syndrome	VCV000650798	17	41223031	17	43071014	650798	645935	rs1597830733	NC_000017.11:43071013:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 31, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1634	BRCA1
NM_007294.4(BRCA1):c.4899C>G (p.Ser1633Arg)	BRCA1	S1633R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868382	17	41223032	17	43071015	868382	854401	rs1567774741	NC_000017.11:43071014:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4899C>A (p.Ser1633Arg)	BRCA1	S1633R	Hereditary cancer-predisposing syndrome	VCV000631413	17	41223032	17	43071015	631413	618572	rs1567774741	NC_000017.11:43071014:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4898G>T (p.Ser1633Ile)	BRCA1	S1633I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865665	17	41223033	17	43071016	865665	854402	rs2052385316	NC_000017.11:43071015:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4898G>C (p.Ser1633Thr)	BRCA1	S1633T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865664	17	41223033	17	43071016	865664	854403	rs2052385316	NC_000017.11:43071015:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4898G>A (p.Ser1633Asn)	BRCA1	S1633N	not provided	VCV000865663	17	41223033	17	43071016	865663	854404	rs2052385316	NC_000017.11:43071015:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4897A>T (p.Ser1633Cys)	BRCA1	S1633C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865662	17	41223034	17	43071017	865662	854405	rs1555580711	NC_000017.11:43071016:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4897A>G (p.Ser1633Gly)	BRCA1	S1633G	not specified	VCV000865661	17	41223034	17	43071017	865661	854406	rs1555580711	NC_000017.11:43071016:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Nov 14, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4897A>C (p.Ser1633Arg)	BRCA1	S1633R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531355	17	41223034	17	43071017	531355	531181	rs1555580711	NC_000017.11:43071016:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1633	BRCA1
NM_007294.4(BRCA1):c.4895T>C (p.Val1632Ala)	BRCA1	V1632A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865392	17	41223036	17	43071019	865392	854410	rs1397965282	NC_000017.11:43071018:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1632	BRCA1
NM_007294.4(BRCA1):c.4895T>A (p.Val1632Glu)	BRCA1	V1632E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865391	17	41223036	17	43071019	865391	854411	rs1397965282	NC_000017.11:43071018:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1632	BRCA1
NM_007294.4(BRCA1):c.4895T>G (p.Val1632Gly)	BRCA1	V1632G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630951	17	41223036	17	43071019	630951	618573	rs1397965282	NC_000017.11:43071018:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1632	BRCA1
NM_007294.4(BRCA1):c.4894G>C (p.Val1632Leu)	BRCA1	V1632L	Hereditary cancer-predisposing syndrome	VCV000631407	17	41223037	17	43071020	631407	618574	rs770193975	NC_000017.11:43071019:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1632	BRCA1
NM_007294.4(BRCA1):c.4894G>A (p.Val1632Met)	BRCA1	V1632M	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000409339	17	41223037	17	43071020	409339	401986	rs770193975	NC_000017.11:43071019:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1632	BRCA1
NM_007294.4(BRCA1):c.4894G>T (p.Val1632Leu)	BRCA1	V1632L	Hereditary cancer-predisposing syndrome	VCV000186979	17	41223037	17	43071020	186979	184895	rs770193975	NC_000017.11:43071019:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 23, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1632	BRCA1
NM_007294.4(BRCA1):c.4893T>G (p.Ser1631Arg)	BRCA1	S1631R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868837	17	41223038	17	43071021	868837	854412	rs80356850	NC_000017.11:43071020:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4893T>A (p.Ser1631Arg)	BRCA1	S1631R	Hereditary cancer-predisposing syndrome	VCV000628576	17	41223038	17	43071021	628576	618575	rs80356850	NC_000017.11:43071020:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4892G>T (p.Ser1631Ile)	BRCA1	S1631I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868836	17	41223039	17	43071022	868836	854413	rs273901742	NC_000017.11:43071021:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4892G>C (p.Ser1631Thr)	BRCA1	S1631T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868835	17	41223039	17	43071022	868835	854414	rs273901742	NC_000017.11:43071021:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4892G>A (p.Ser1631Asn)	BRCA1	S1631N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055309	17	41223039	17	43071022	55309	69976	rs273901742	NC_000017.11:43071021:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 2, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4891A>G (p.Ser1631Gly)	BRCA1	S1631G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868834	17	41223040	17	43071023	868834	854415	rs786202734	NC_000017.11:43071022:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4891A>C (p.Ser1631Arg)	BRCA1	S1631R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868376	17	41223040	17	43071023	868376	854416	rs786202734	NC_000017.11:43071022:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4891A>T (p.Ser1631Cys)	BRCA1	S1631C	Hereditary cancer-predisposing syndrome	VCV000186154	17	41223040	17	43071023	186154	184896	rs786202734	NC_000017.11:43071022:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Nov 29, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1631	BRCA1
NM_007294.4(BRCA1):c.4889A>G (p.Glu1630Gly)	BRCA1	E1630G	not provided	VCV001050408	17	41223042	17	43071025	1050408	1038552	rs2153824237	NC_000017.11:43071024:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1630	BRCA1
NM_007294.4(BRCA1):c.4888G>A (p.Glu1630Lys)	BRCA1	E1630K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000967028	17	41223043	17	43071026	967028	958116	rs1173155015	NC_000017.11:43071025:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1630	BRCA1
NM_007294.4(BRCA1):c.4886A>G (p.Glu1629Gly)	BRCA1	E1629G	Hereditary breast ovarian cancer syndrome|not provided	VCV001520029	17	41223045	17	43071028	1520029	1516025	rs2153824923	NC_000017.11:43071027:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 18, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1629	BRCA1
NM_007294.4(BRCA1):c.4884G>A (p.Met1628Ile)	BRCA1	M1628I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001043747	17	41223047	17	43071030	1043747	1033303	rs80357158	NC_000017.11:43071029:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1628	BRCA1
NM_007294.4(BRCA1):c.4884G>T (p.Met1628Ile)	BRCA1	M1628I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055307	17	41223047	17	43071030	55307	69974	rs80357158	NC_000017.11:43071029:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1628	BRCA1
NM_007294.4(BRCA1):c.4883T>A (p.Met1628Lys)	BRCA1	M1628K	Hereditary cancer-predisposing syndrome	VCV000926247	17	41223048	17	43071031	926247	913860	rs4986854	NC_000017.11:43071030:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1628	BRCA1
NM_007294.4(BRCA1):c.4883T>C (p.Met1628Thr)	BRCA1	M1628T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041828	17	41223048	17	43071031	41828	50267	rs4986854	NC_000017.11:43071030:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1628	BRCA1
NM_007294.4(BRCA1):c.4882A>G (p.Met1628Val)	BRCA1	M1628V	Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000055306	17	41223049	17	43071032	55306	69973	rs80357465	NC_000017.11:43071031:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1628	BRCA1
NM_007294.4(BRCA1):c.4880C>G (p.Ala1627Gly)	BRCA1	A1627G	Hereditary cancer-predisposing syndrome	VCV003226168	17	41223051	17	43071034	3226168	3387232	NA	NC_000017.11:43071033:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1627	BRCA1
NM_007294.4(BRCA1):c.4880C>T (p.Ala1627Val)	BRCA1	A1627V	Hereditary cancer-predisposing syndrome	VCV000927806	17	41223051	17	43071034	927806	913861	rs764015648	NC_000017.11:43071033:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1627	BRCA1
NM_007294.4(BRCA1):c.4879G>T (p.Ala1627Ser)	BRCA1	A1627S	not provided|Hereditary breast ovarian cancer syndrome	VCV000851676	17	41223052	17	43071035	851676	845371	rs774505084	NC_000017.11:43071034:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1627	BRCA1
NM_007294.4(BRCA1):c.4879G>A (p.Ala1627Thr)	BRCA1	A1627T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441357	17	41223052	17	43071035	441357	435107	rs774505084	NC_000017.11:43071034:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1627	BRCA1
NM_007294.4(BRCA1):c.4878T>G (p.Asn1626Lys)	BRCA1	N1626K	Hereditary cancer-predisposing syndrome	VCV003261469	17	41223053	17	43071036	3261469	3424238	NA	NC_000017.11:43071035:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 17, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1626	BRCA1
NM_007294.4(BRCA1):c.4876A>G (p.Asn1626Asp)	BRCA1	N1626D	Hereditary breast ovarian cancer syndrome	VCV002821947	17	41223055	17	43071038	2821947	2981750	NA	NC_000017.11:43071037:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1626	BRCA1
NM_007294.4(BRCA1):c.4874A>T (p.Tyr1625Phe)	BRCA1	Y1625F	Hereditary breast ovarian cancer syndrome	VCV001063194	17	41223057	17	43071040	1063194	1050280	rs730881494	NC_000017.11:43071039:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1625	BRCA1
NM_007294.4(BRCA1):c.4874A>G (p.Tyr1625Cys)	BRCA1	Y1625C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182164	17	41223057	17	43071040	182164	180826	rs730881494	NC_000017.11:43071039:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1625	BRCA1
NM_007294.4(BRCA1):c.4873T>C (p.Tyr1625His)	BRCA1	Y1625H	Hereditary breast ovarian cancer syndrome	VCV002746610	17	41223058	17	43071041	2746610	2897485	NA	NC_000017.11:43071040:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1625	BRCA1
NM_007294.4(BRCA1):c.4873T>A (p.Tyr1625Asn)	BRCA1	Y1625N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000838907	17	41223058	17	43071041	838907	845372	rs2052392087	NC_000017.11:43071040:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1625	BRCA1
NM_007294.4(BRCA1):c.4871G>C (p.Gly1624Ala)	BRCA1	G1624A	Hereditary cancer-predisposing syndrome	VCV001743725	17	41223060	17	43071043	1743725	1802071	NA	NC_000017.11:43071042:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1624	BRCA1
NM_007294.4(BRCA1):c.4871G>A (p.Gly1624Glu)	BRCA1	G1624E	Hereditary breast ovarian cancer syndrome	VCV000462656	17	41223060	17	43071043	462656	467679	rs1555580767	NC_000017.11:43071042:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 13, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1624	BRCA1
NM_007294.4(BRCA1):c.4868C>T (p.Ala1623Val)	BRCA1	A1623V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001325655	17	41223063	17	43071046	1325655	1315920	rs80356862	NC_000017.11:43071045:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1623	BRCA1
NM_007294.4(BRCA1):c.4868C>G (p.Ala1623Gly)	BRCA1	A1623G	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000037614	17	41223063	17	43071046	37614	46170	rs80356862	NC_000017.11:43071045:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1623	BRCA1
NM_007294.4(BRCA1):c.4867G>A (p.Ala1623Thr)	BRCA1	A1623T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002729036	17	41223064	17	43071047	2729036	2883062	NA	NC_000017.11:43071046:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1623	BRCA1
NM_007294.4(BRCA1):c.4867G>T (p.Ala1623Ser)	BRCA1	A1623S	Hereditary cancer-predisposing syndrome	VCV001743673	17	41223064	17	43071047	1743673	1802019	NA	NC_000017.11:43071046:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 17, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1623	BRCA1
NM_007294.4(BRCA1):c.4865C>T (p.Thr1622Ile)	BRCA1	T1622I	not provided	VCV001712224	17	41223066	17	43071049	1712224	1710646	NA	NC_000017.11:43071048:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1622	BRCA1
NM_007294.4(BRCA1):c.4865C>G (p.Thr1622Ser)	BRCA1	T1622S	Hereditary cancer-predisposing syndrome	VCV000185934	17	41223066	17	43071049	185934	184897	rs786202573	NC_000017.11:43071048:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 8, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1622	BRCA1
NM_007294.4(BRCA1):c.4864A>G (p.Thr1622Ala)	BRCA1	T1622A	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185243	17	41223067	17	43071050	185243	184898	rs786202026	NC_000017.11:43071049:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1622	BRCA1
NM_007294.4(BRCA1):c.4862A>T (p.Asp1621Val)	BRCA1	D1621V	Hereditary breast ovarian cancer syndrome	VCV002131913	17	41223069	17	43071052	2131913	2187754	NA	NC_000017.11:43071051:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1621	BRCA1
NM_007294.4(BRCA1):c.4862A>G (p.Asp1621Gly)	BRCA1	D1621G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001509910	17	41223069	17	43071052	1509910	1445829	rs1555580777	NC_000017.11:43071051:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1621	BRCA1
NM_007294.4(BRCA1):c.4862A>C (p.Asp1621Ala)	BRCA1	D1621A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491088	17	41223069	17	43071052	491088	485099	rs1555580777	NC_000017.11:43071051:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 20, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1621	BRCA1
NM_007294.4(BRCA1):c.4859C>T (p.Thr1620Ile)	BRCA1	T1620I	Hereditary breast ovarian cancer syndrome	VCV003014818	17	41223072	17	43071055	3014818	3181607	NA	NC_000017.11:43071054:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1620	BRCA1
NM_007294.4(BRCA1):c.4858A>G (p.Thr1620Ala)	BRCA1	T1620A	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000141333	17	41223073	17	43071056	141333	151047	rs8176219	NC_000017.11:43071055:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1620	BRCA1
NM_007294.4(BRCA1):c.4856C>T (p.Thr1619Ile)	BRCA1	T1619I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231443	17	41223075	17	43071058	231443	235953	rs876659163	NC_000017.11:43071057:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1619	BRCA1
NM_007294.4(BRCA1):c.4855A>G (p.Thr1619Ala)	BRCA1	T1619A	Hereditary breast ovarian cancer syndrome	VCV001064261	17	41223076	17	43071059	1064261	1050281	rs2153830785	NC_000017.11:43071058:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1619	BRCA1
NM_007294.4(BRCA1):c.4853A>G (p.His1618Arg)	BRCA1	H1618R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482919	17	41223078	17	43071061	482919	478576	rs1277159752	NC_000017.11:43071060:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1618	BRCA1
NM_007294.4(BRCA1):c.4852C>T (p.His1618Tyr)	BRCA1	H1618Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000418981	17	41223079	17	43071062	418981	409957	rs755920262	NC_000017.11:43071061:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1618	BRCA1
NM_007294.4(BRCA1):c.4852C>A (p.His1618Asn)	BRCA1	H1618N	not provided|Hereditary breast ovarian cancer syndrome	VCV000245717	17	41223079	17	43071062	245717	245026	rs755920262	NC_000017.11:43071061:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1618	BRCA1
NM_007294.4(BRCA1):c.4850C>T (p.Ala1617Val)	BRCA1	A1617V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000919232	17	41223081	17	43071064	919232	913862	rs2052395309	NC_000017.11:43071063:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1617	BRCA1
NM_007294.4(BRCA1):c.4849G>A (p.Ala1617Thr)	BRCA1	A1617T	not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV002680207	17	41223082	17	43071065	2680207	2833934	NA	NC_000017.11:43071064:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1617	BRCA1
NM_007294.4(BRCA1):c.4849G>T (p.Ala1617Ser)	BRCA1	A1617S	Hereditary breast ovarian cancer syndrome	VCV001721423	17	41223082	17	43071065	1721423	1772757	NA	NC_000017.11:43071064:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1617	BRCA1
NM_007294.4(BRCA1):c.4847C>T (p.Ala1616Val)	BRCA1	A1616V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000923712	17	41223084	17	43071067	923712	913863	rs2052395711	NC_000017.11:43071066:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1616	BRCA1
NM_007294.4(BRCA1):c.4846G>C (p.Ala1616Pro)	BRCA1	A1616P	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001810756	17	41223085	17	43071068	1810756	1867769	NA	NC_000017.11:43071067:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1616	BRCA1
NM_007294.4(BRCA1):c.4846G>A (p.Ala1616Thr)	BRCA1	A1616T	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|BRCA1-related disorder	VCV000971555	17	41223085	17	43071068	971555	958117	rs890599236	NC_000017.11:43071067:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1616	BRCA1
NM_007294.4(BRCA1):c.4844C>G (p.Ala1615Gly)	BRCA1	A1615G	Hereditary breast ovarian cancer syndrome	VCV000953690	17	41223087	17	43071070	953690	949926	rs1555580805	NC_000017.11:43071069:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 14, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1615	BRCA1
NM_007294.4(BRCA1):c.4844C>T (p.Ala1615Val)	BRCA1	A1615V	Hereditary cancer-predisposing syndrome	VCV000489725	17	41223087	17	43071070	489725	482935	rs1555580805	NC_000017.11:43071069:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1615	BRCA1
NM_007294.4(BRCA1):c.4843G>C (p.Ala1615Pro)	BRCA1	A1615P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825223	17	41223088	17	43071071	825223	813677	rs80356987	NC_000017.11:43071070:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1615	BRCA1
NM_007294.4(BRCA1):c.4843G>A (p.Ala1615Thr)	BRCA1	A1615T	Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000055302	17	41223088	17	43071071	55302	69969	rs80356987	NC_000017.11:43071070:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1615	BRCA1
NM_007294.4(BRCA1):c.4841C>G (p.Pro1614Arg)	BRCA1	P1614R	Hereditary breast ovarian cancer syndrome	VCV002765383	17	41223090	17	43071073	2765383	2926130	NA	NC_000017.11:43071072:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1614	BRCA1
NM_007294.4(BRCA1):c.4841C>T (p.Pro1614Leu)	BRCA1	P1614L	Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000216671	17	41223090	17	43071073	216671	213308	rs766305255	NC_000017.11:43071072:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1614	BRCA1
NM_007294.4(BRCA1):c.4840C>G (p.Pro1614Ala)	BRCA1	P1614A	Hereditary breast ovarian cancer syndrome	VCV001010734	17	41223091	17	43071074	1010734	997559	rs70953660	NC_000017.11:43071073:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 18, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1614	BRCA1
NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	BRCA1	P1614S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055301	17	41223091	17	43071074	55301	69968	rs70953660	NC_000017.11:43071073:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1614	BRCA1
NM_007294.4(BRCA1):c.4837_4838delinsGA (p.Ser1613Asp)	BRCA1	S1613D	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000919925	17	41223093 - 41223094	17	43071076 - 43071077	919925	913864	rs2052398037	NC_000017.11:43071075:CT:TC	Indel	missense variant|non-coding transcript variant	Uncertain significance	Sep 6, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1613	BRCA1
NM_007294.4(BRCA1):c.4838G>A (p.Ser1613Asn)	BRCA1	S1613N	Hereditary cancer-predisposing syndrome	VCV000481463	17	41223093	17	43071076	481463	478526	rs1555580821	NC_000017.11:43071075:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 24, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1613	BRCA1
NM_007294.4(BRCA1):c.4837A>C (p.Ser1613Arg)	BRCA1	S1613R	Hereditary cancer-predisposing syndrome	VCV001743457	17	41223094	17	43071077	1743457	1805603	NA	NC_000017.11:43071076:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1613	BRCA1
NM_007294.4(BRCA1):c.4837A>G (p.Ser1613Gly)	BRCA1	S1613G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041827	17	41223094	17	43071077	41827	50266	rs1799966	NC_000017.11:43071076:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1613	BRCA1
NM_007294.4(BRCA1):c.4837A>T (p.Ser1613Cys)	BRCA1	S1613C	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000037613	17	41223094	17	43071077	37613	46169	rs1799966	NC_000017.11:43071076:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Mar 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1613	BRCA1
NM_007294.4(BRCA1):c.4836G>T (p.Gln1612His)	BRCA1	Q1612H	Hereditary breast ovarian cancer syndrome	VCV002099260	17	41223095	17	43071078	2099260	2150581	NA	NC_000017.11:43071077:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1612	BRCA1
NM_007294.4(BRCA1):c.4836G>C (p.Gln1612His)	BRCA1	Q1612H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000185283	17	41223095	17	43071078	185283	184901	rs747688901	NC_000017.11:43071077:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 24, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1612	BRCA1
NM_007294.4(BRCA1):c.4835A>G (p.Gln1612Arg)	BRCA1	Q1612R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002774827	17	41223096	17	43071079	2774827	2935554	NA	NC_000017.11:43071078:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1612	BRCA1
NM_007294.4(BRCA1):c.4835A>T (p.Gln1612Leu)	BRCA1	Q1612L	not provided	VCV000993137	17	41223096	17	43071079	993137	981159	rs2052399471	NC_000017.11:43071078:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1612	BRCA1
NM_007294.4(BRCA1):c.4832C>T (p.Ala1611Val)	BRCA1	A1611V	Hereditary cancer-predisposing syndrome	VCV001743443	17	41223099	17	43071082	1743443	1805589	NA	NC_000017.11:43071081:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1611	BRCA1
NM_007294.4(BRCA1):c.4831G>T (p.Ala1611Ser)	BRCA1	A1611S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001500242	17	41223100	17	43071083	1500242	1408604	rs2052400387	NC_000017.11:43071082:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1611	BRCA1
NM_007294.4(BRCA1):c.4829C>T (p.Ser1610Phe)	BRCA1	S1610F	not provided|Hereditary breast ovarian cancer syndrome	VCV002866332	17	41223102	17	43071085	2866332	3023804	NA	NC_000017.11:43071084:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1610	BRCA1
NM_007294.4(BRCA1):c.4826A>G (p.Glu1609Gly)	BRCA1	E1609G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125731	17	41223105	17	43071088	125731	131269	rs483353096	NC_000017.11:43071087:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2013	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1609	BRCA1
NM_007294.4(BRCA1):c.4823C>T (p.Ala1608Val)	BRCA1	A1608V	Hereditary breast ovarian cancer syndrome	VCV000055296	17	41223108	17	43071091	55296	69963	rs80357072	NC_000017.11:43071090:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1608	BRCA1
NM_007294.4(BRCA1):c.4822G>A (p.Ala1608Thr)	BRCA1	A1608T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631142	17	41223109	17	43071092	631142	618576	rs1567775064	NC_000017.11:43071091:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1608	BRCA1
NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	BRCA1	K1606E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037612	17	41223115	17	43071098	37612	46168	rs80356943	NC_000017.11:43071097:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1606	BRCA1
NM_007294.4(BRCA1):c.4814T>C (p.Leu1605Ser)	BRCA1	L1605S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000864486	17	41223117	17	43071100	864486	845373	rs2052403153	NC_000017.11:43071099:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1605	BRCA1
NM_007294.4(BRCA1):c.4813T>A (p.Leu1605Met)	BRCA1	L1605M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000185823	17	41223118	17	43071101	185823	184903	rs80356833	NC_000017.11:43071100:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1605	BRCA1
NM_007294.4(BRCA1):c.4813T>G (p.Leu1605Val)	BRCA1	L1605V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055295	17	41223118	17	43071101	55295	69962	rs80356833	NC_000017.11:43071100:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 17, 2010	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1605	BRCA1
NM_007294.4(BRCA1):c.4811A>G (p.Gln1604Arg)	BRCA1	Q1604R	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055292	17	41223120	17	43071103	55292	69959	rs80357439	NC_000017.11:43071102:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1604	BRCA1
NM_007294.4(BRCA1):c.4810C>A (p.Gln1604Lys)	BRCA1	Q1604K	Hereditary cancer-predisposing syndrome	VCV001743283	17	41223121	17	43071104	1743283	1805429	NA	NC_000017.11:43071103:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1604	BRCA1
NM_007294.4(BRCA1):c.4810C>G (p.Gln1604Glu)	BRCA1	Q1604E	Hereditary breast ovarian cancer syndrome	VCV000662076	17	41223121	17	43071104	662076	645936	rs80357352	NC_000017.11:43071103:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1604	BRCA1
NM_007294.4(BRCA1):c.4808C>T (p.Pro1603Leu)	BRCA1	P1603L	Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000419702	17	41223123	17	43071106	419702	409958	rs1064794054	NC_000017.11:43071105:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1603	BRCA1
NM_007294.4(BRCA1):c.4804G>T (p.Val1602Phe)	BRCA1	V1602F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825189	17	41223127	17	43071110	825189	813678	rs1597831323	NC_000017.11:43071109:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1602	BRCA1
NM_007294.4(BRCA1):c.4802A>G (p.Lys1601Arg)	BRCA1	K1601R	Hereditary breast ovarian cancer syndrome	VCV001720991	17	41223129	17	43071112	1720991	1774973	NA	NC_000017.11:43071111:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1601	BRCA1
NM_007294.4(BRCA1):c.4801A>C (p.Lys1601Gln)	BRCA1	K1601Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481187	17	41223130	17	43071113	481187	478668	rs80357303	NC_000017.11:43071112:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 3, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1601	BRCA1
NM_007294.4(BRCA1):c.4796C>T (p.Ala1599Val)	BRCA1	A1599V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825179	17	41223135	17	43071118	825179	813679	rs749702730	NC_000017.11:43071117:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1599	BRCA1
NM_007294.4(BRCA1):c.4795G>A (p.Ala1599Thr)	BRCA1	A1599T	Hereditary breast ovarian cancer syndrome	VCV000663314	17	41223136	17	43071119	663314	645937	rs1597831380	NC_000017.11:43071118:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1599	BRCA1
NM_007294.4(BRCA1):c.4793C>T (p.Ser1598Phe)	BRCA1	S1598F	Hereditary breast ovarian cancer syndrome	VCV001446083	17	41223138	17	43071121	1446083	1390913	rs2153837843	NC_000017.11:43071120:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1598	BRCA1
NM_007294.4(BRCA1):c.4790C>T (p.Thr1597Ile)	BRCA1	T1597I	not provided|Hereditary cancer-predisposing syndrome	VCV002585854	17	41223141	17	43071124	2585854	2753414	NA	NC_000017.11:43071123:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1597	BRCA1
NM_007294.4(BRCA1):c.4790C>G (p.Thr1597Ser)	BRCA1	T1597S	Hereditary cancer-predisposing syndrome	VCV001743105	17	41223141	17	43071124	1743105	1805253	NA	NC_000017.11:43071123:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1597	BRCA1
NM_007294.4(BRCA1):c.4790C>A (p.Thr1597Asn)	BRCA1	T1597N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided	VCV000141272	17	41223141	17	43071124	141272	150986	rs587781623	NC_000017.11:43071123:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1597	BRCA1
NM_007294.4(BRCA1):c.4789A>G (p.Thr1597Ala)	BRCA1	T1597A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055288	17	41223142	17	43071125	55288	69955	rs80357187	NC_000017.11:43071124:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1597	BRCA1
NM_007294.4(BRCA1):c.4787C>T (p.Ser1596Leu)	BRCA1	S1596L	Breast neoplasm	VCV000055287	17	41223144	17	43071127	55287	69954	rs80357429	NC_000017.11:43071126:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1596	BRCA1
NM_007294.4(BRCA1):c.4786T>G (p.Ser1596Ala)	BRCA1	S1596A	not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000851302	17	41223145	17	43071128	851302	845375	rs2052408436	NC_000017.11:43071127:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1596	BRCA1
NM_007294.4(BRCA1):c.4784C>T (p.Ser1595Phe)	BRCA1	S1595F	Hereditary breast ovarian cancer syndrome	VCV002720433	17	41223147	17	43071130	2720433	2880944	NA	NC_000017.11:43071129:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1595	BRCA1
NM_007294.4(BRCA1):c.4783T>G (p.Ser1595Ala)	BRCA1	S1595A	Hereditary breast ovarian cancer syndrome	VCV002834642	17	41223148	17	43071131	2834642	2991909	NA	NC_000017.11:43071130:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1595	BRCA1
NM_007294.4(BRCA1):c.4783T>A (p.Ser1595Thr)	BRCA1	S1595T	Hereditary breast ovarian cancer syndrome	VCV000851990	17	41223148	17	43071131	851990	845376	rs1325644035	NC_000017.11:43071130:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 27, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1595	BRCA1
NM_007294.4(BRCA1):c.4783T>C (p.Ser1595Pro)	BRCA1	S1595P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441500	17	41223148	17	43071131	441500	435109	rs1325644035	NC_000017.11:43071130:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1595	BRCA1
NM_007294.4(BRCA1):c.4781C>T (p.Pro1594Leu)	BRCA1	P1594L	Hereditary cancer-predisposing syndrome	VCV001743052	17	41223150	17	43071133	1743052	1809133	NA	NC_000017.11:43071132:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 13, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1594	BRCA1
NM_007294.4(BRCA1):c.4781C>A (p.Pro1594Gln)	BRCA1	P1594Q	Hereditary cancer-predisposing syndrome	VCV000489724	17	41223150	17	43071133	489724	483017	rs1301724072	NC_000017.11:43071132:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1594	BRCA1
NM_007294.4(BRCA1):c.4780C>A (p.Pro1594Thr)	BRCA1	P1594T	Hereditary cancer-predisposing syndrome	VCV002774830	17	41223151	17	43071134	2774830	2935557	NA	NC_000017.11:43071133:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 12, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1594	BRCA1
NM_007294.4(BRCA1):c.4780C>T (p.Pro1594Ser)	BRCA1	P1594S	not specified|Hereditary cancer-predisposing syndrome	VCV000633087	17	41223151	17	43071134	633087	621570	rs587782012	NC_000017.11:43071133:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1594	BRCA1
NM_007294.4(BRCA1):c.4780C>G (p.Pro1594Ala)	BRCA1	P1594A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141789	17	41223151	17	43071134	141789	151503	rs587782012	NC_000017.11:43071133:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1594	BRCA1
NM_007294.4(BRCA1):c.4778T>C (p.Ile1593Thr)	BRCA1	I1593T	Hereditary breast ovarian cancer syndrome	VCV002768919	17	41223153	17	43071136	2768919	2927069	NA	NC_000017.11:43071135:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1593	BRCA1
NM_007294.4(BRCA1):c.4777A>T (p.Ile1593Leu)	BRCA1	I1593L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055286	17	41223154	17	43071137	55286	69953	rs397509197	NC_000017.11:43071136:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Sep 1, 2023	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1593	BRCA1
NM_007294.4(BRCA1):c.4777A>G (p.Ile1593Val)	BRCA1	I1593V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055285	17	41223154	17	43071137	55285	69952	rs397509197	NC_000017.11:43071136:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1593	BRCA1
NM_007294.4(BRCA1):c.4776C>G (p.Asn1592Lys)	BRCA1	N1592K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183931	17	41223155	17	43071138	183931	184904	rs761925468	NC_000017.11:43071137:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1592	BRCA1
NM_007294.4(BRCA1):c.4775A>G (p.Asn1592Ser)	BRCA1	N1592S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187395	17	41223156	17	43071139	187395	184905	rs786203699	NC_000017.11:43071138:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1592	BRCA1
NM_007294.4(BRCA1):c.4774A>C (p.Asn1592His)	BRCA1	N1592H	Hereditary cancer-predisposing syndrome	VCV000584508	17	41223157	17	43071140	584508	575610	rs1567775261	NC_000017.11:43071139:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 1, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1592	BRCA1
NM_007294.4(BRCA1):c.4771_4772delinsAA (p.Gly1591Asn)	BRCA1	G1591N	Hereditary cancer-predisposing syndrome	VCV000825160	17	41223159 - 41223160	17	43071142 - 43071143	825160	813680	rs1597831484	NC_000017.11:43071141:CC:TT	Indel	missense variant|non-coding transcript variant	Uncertain significance	Oct 22, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1591	BRCA1
NM_007294.4(BRCA1):c.4772G>A (p.Gly1591Asp)	BRCA1	G1591D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462655	17	41223159	17	43071142	462655	467682	rs1555580956	NC_000017.11:43071141:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 14, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1591	BRCA1
NM_007294.4(BRCA1):c.4771G>A (p.Gly1591Ser)	BRCA1	G1591S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000142926	17	41223160	17	43071143	142926	152640	rs587782825	NC_000017.11:43071142:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1591	BRCA1
NM_007294.4(BRCA1):c.4769T>G (p.Val1590Gly)	BRCA1	V1590G	not specified	VCV001697602	17	41223162	17	43071145	1697602	1689986	rs773524529	NC_000017.11:43071144:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1590	BRCA1
NM_007294.4(BRCA1):c.4769T>C (p.Val1590Ala)	BRCA1	V1590A	Hereditary cancer-predisposing syndrome	VCV000479272	17	41223162	17	43071145	479272	479299	rs773524529	NC_000017.11:43071144:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 29, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1590	BRCA1
NM_007294.4(BRCA1):c.4768G>A (p.Val1590Ile)	BRCA1	V1590I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001742935	17	41223163	17	43071146	1742935	1809016	NA	NC_000017.11:43071145:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1590	BRCA1
NM_007294.4(BRCA1):c.4766G>C (p.Arg1589Pro)	BRCA1	R1589P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000888623	17	41223165	17	43071148	888623	877639	rs80357341	NC_000017.11:43071147:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1589	BRCA1
NM_007294.4(BRCA1):c.4766G>A (p.Arg1589His)	BRCA1	R1589H	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055284	17	41223165	17	43071148	55284	69951	rs80357341	NC_000017.11:43071147:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jan 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1589	BRCA1
NM_007294.4(BRCA1):c.4765C>G (p.Arg1589Gly)	BRCA1	R1589G	not provided	VCV000496389	17	41223166	17	43071149	496389	487946	rs80357002	NC_000017.11:43071148:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 7, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1589	BRCA1
NM_007294.4(BRCA1):c.4765C>T (p.Arg1589Cys)	BRCA1	R1589C	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055283	17	41223166	17	43071149	55283	69950	rs80357002	NC_000017.11:43071148:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1589	BRCA1
NM_007294.4(BRCA1):c.4763C>T (p.Ala1588Val)	BRCA1	A1588V	Hereditary breast ovarian cancer syndrome	VCV002957934	17	41223168	17	43071151	2957934	3119146	NA	NC_000017.11:43071150:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1588	BRCA1
NM_007294.4(BRCA1):c.4760C>T (p.Ser1587Leu)	BRCA1	S1587L	Hereditary breast ovarian cancer syndrome	VCV002915509	17	41223171	17	43071154	2915509	3074059	NA	NC_000017.11:43071153:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1587	BRCA1
NM_007294.4(BRCA1):c.4757A>T (p.Glu1586Val)	BRCA1	E1586V	Hereditary cancer-predisposing syndrome	VCV002565351	17	41223174	17	43071157	2565351	2732324	NA	NC_000017.11:43071156:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1586	BRCA1
NM_007294.4(BRCA1):c.4754C>T (p.Pro1585Leu)	BRCA1	P1585L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003073181	17	41223177	17	43071160	3073181	3234137	NA	NC_000017.11:43071159:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1585	BRCA1
NM_007294.4(BRCA1):c.4753C>G (p.Pro1585Ala)	BRCA1	P1585A	Hereditary breast ovarian cancer syndrome	VCV002099626	17	41223178	17	43071161	2099626	2147184	NA	NC_000017.11:43071160:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1585	BRCA1
NM_007294.4(BRCA1):c.4753C>T (p.Pro1585Ser)	BRCA1	P1585S	Hereditary cancer-predisposing syndrome	VCV001742857	17	41223178	17	43071161	1742857	91399	rs267604892	NC_000017.11:43071160:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1585	BRCA1
NM_007294.4(BRCA1):c.4751C>G (p.Ala1584Gly)	BRCA1	A1584G	Hereditary breast ovarian cancer syndrome	VCV002057967	17	41223180	17	43071163	2057967	2113254	NA	NC_000017.11:43071162:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1584	BRCA1
NM_007294.4(BRCA1):c.4751C>T (p.Ala1584Val)	BRCA1	A1584V	Hereditary breast ovarian cancer syndrome	VCV000409295	17	41223180	17	43071163	409295	402645	rs1060502323	NC_000017.11:43071162:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1584	BRCA1
NM_007294.4(BRCA1):c.4750G>T (p.Ala1584Ser)	BRCA1	A1584S	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055279	17	41223181	17	43071164	55279	69946	rs80357070	NC_000017.11:43071163:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1584	BRCA1
NM_007294.4(BRCA1):c.4749A>T (p.Arg1583Ser)	BRCA1	R1583S	Hereditary breast ovarian cancer syndrome	VCV001496674	17	41223182	17	43071165	1496674	1382076	rs1597831609	NC_000017.11:43071164:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1583	BRCA1
NM_007294.4(BRCA1):c.4748G>C (p.Arg1583Thr)	BRCA1	R1583T	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000928766	17	41223183	17	43071166	928766	917247	rs752624544	NC_000017.11:43071165:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1583	BRCA1
NM_007294.4(BRCA1):c.4748G>A (p.Arg1583Lys)	BRCA1	R1583K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230482	17	41223183	17	43071166	230482	235956	rs752624544	NC_000017.11:43071165:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1583	BRCA1
NM_007294.4(BRCA1):c.4747A>G (p.Arg1583Gly)	BRCA1	R1583G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000928447	17	41223184	17	43071167	928447	913867	rs2052417045	NC_000017.11:43071166:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1583	BRCA1
NM_007294.4(BRCA1):c.4746C>G (p.Asp1582Glu)	BRCA1	D1582E	Hereditary breast ovarian cancer syndrome	VCV001054980	17	41223185	17	43071168	1054980	1050282	rs2153877481	NC_000017.11:43071167:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 28, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1582	BRCA1
NM_007294.4(BRCA1):c.4745A>G (p.Asp1582Gly)	BRCA1	D1582G	Hereditary breast ovarian cancer syndrome	VCV002098260	17	41223186	17	43071169	2098260	2157456	NA	NC_000017.11:43071168:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1582	BRCA1
NM_007294.4(BRCA1):c.4744G>A (p.Asp1582Asn)	BRCA1	D1582N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001742791	17	41223187	17	43071170	1742791	1808874	NA	NC_000017.11:43071169:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1582	BRCA1
NM_007294.4(BRCA1):c.4743A>C (p.Glu1581Asp)	BRCA1	E1581D	Familial cancer of breast	VCV000055277	17	41223188	17	43071171	55277	69944	rs397509194	NC_000017.11:43071170:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1581	BRCA1
NM_007294.4(BRCA1):c.4741G>A (p.Glu1581Lys)	BRCA1	E1581K	Hereditary breast ovarian cancer syndrome	VCV002699149	17	41223190	17	43071173	2699149	2865272	NA	NC_000017.11:43071172:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1581	BRCA1
NM_007294.4(BRCA1):c.4741G>C (p.Glu1581Gln)	BRCA1	E1581Q	Hereditary cancer-predisposing syndrome	VCV002450674	17	41223190	17	43071173	2450674	2423160	NA	NC_000017.11:43071172:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1581	BRCA1
NM_007294.4(BRCA1):c.4739C>A (p.Ser1580Tyr)	BRCA1	S1580Y	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431267	17	41223192	17	43071175	431267	424796	rs80357411	NC_000017.11:43071174:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1580	BRCA1
NM_007294.4(BRCA1):c.4739C>T (p.Ser1580Phe)	BRCA1	S1580F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055275	17	41223192	17	43071175	55275	69942	rs80357411	NC_000017.11:43071174:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1580	BRCA1
NM_007294.4(BRCA1):c.4736C>T (p.Pro1579Leu)	BRCA1	P1579L	Hereditary cancer-predisposing syndrome	VCV000922319	17	41223195	17	43071178	922319	913868	rs2052418833	NC_000017.11:43071177:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1579	BRCA1
NM_007294.4(BRCA1):c.4735C>T (p.Pro1579Ser)	BRCA1	P1579S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001055766	17	41223196	17	43071179	1055766	1050283	rs145466894	NC_000017.11:43071178:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1579	BRCA1
NM_007294.4(BRCA1):c.4735C>G (p.Pro1579Ala)	BRCA1	P1579A	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000142301	17	41223196	17	43071179	142301	152015	rs145466894	NC_000017.11:43071178:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1579	BRCA1
NM_007294.4(BRCA1):c.4733A>G (p.Asp1578Gly)	BRCA1	D1578G	not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055274	17	41223198	17	43071181	55274	69941	rs80356930	NC_000017.11:43071180:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1578	BRCA1
NM_007294.4(BRCA1):c.4730C>T (p.Ser1577Phe)	BRCA1	S1577F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491086	17	41223201	17	43071184	491086	485065	rs273901741	NC_000017.11:43071183:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 8, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1577	BRCA1
NM_007294.4(BRCA1):c.4730C>A (p.Ser1577Tyr)	BRCA1	S1577Y	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000125729	17	41223201	17	43071184	125729	131267	rs273901741	NC_000017.11:43071183:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1577	BRCA1
NM_007294.4(BRCA1):c.4729T>G (p.Ser1577Ala)	BRCA1	S1577A	Ovarian cancer	VCV000981650	17	41223202	17	43071185	981650	969735	rs80356909	NC_000017.11:43071184:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 19, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1577	BRCA1
NM_007294.4(BRCA1):c.4729T>C (p.Ser1577Pro)	BRCA1	S1577P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000055272	17	41223202	17	43071185	55272	69939	rs80356909	NC_000017.11:43071184:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Jan 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1577	BRCA1
NM_007294.4(BRCA1):c.4727A>G (p.Glu1576Gly)	BRCA1	E1576G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000231185	17	41223204	17	43071187	231185	235957	rs876659007	NC_000017.11:43071186:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1576	BRCA1
NM_007294.4(BRCA1):c.4726G>C (p.Glu1576Gln)	BRCA1	E1576Q	Hereditary breast ovarian cancer syndrome|not specified	VCV000418071	17	41223205	17	43071188	418071	409960	rs1060502355	NC_000017.11:43071187:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 14, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1576	BRCA1
NM_007294.4(BRCA1):c.4726G>A (p.Glu1576Lys)	BRCA1	E1576K	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409355	17	41223205	17	43071188	409355	402046	rs1060502355	NC_000017.11:43071187:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1576	BRCA1
NM_007294.4(BRCA1):c.4724C>T (p.Pro1575Leu)	BRCA1	P1575L	Hereditary breast ovarian cancer syndrome	VCV002816372	17	41223207	17	43071190	2816372	2977042	NA	NC_000017.11:43071189:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1575	BRCA1
NM_007294.4(BRCA1):c.4724C>A (p.Pro1575His)	BRCA1	P1575H	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055270	17	41223207	17	43071190	55270	69937	rs80357052	NC_000017.11:43071189:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1575	BRCA1
NM_007294.4(BRCA1):c.4723C>A (p.Pro1575Thr)	BRCA1	P1575T	Hereditary breast ovarian cancer syndrome	VCV001488496	17	41223208	17	43071191	1488496	1419967	rs755370895	NC_000017.11:43071190:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1575	BRCA1
NM_007294.4(BRCA1):c.4720G>T (p.Asp1574Tyr)	BRCA1	D1574Y	Hereditary breast ovarian cancer syndrome	VCV000936973	17	41223211	17	43071194	936973	937942	rs2052421567	NC_000017.11:43071193:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 14, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1574	BRCA1
NM_007294.4(BRCA1):c.4717G>C (p.Asp1573His)	BRCA1	D1573H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000569880	17	41223214	17	43071197	569880	569086	rs1188628175	NC_000017.11:43071196:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1573	BRCA1
NM_007294.4(BRCA1):c.4715C>T (p.Ser1572Phe)	BRCA1	S1572F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003073447	17	41223216	17	43071199	3073447	3234403	NA	NC_000017.11:43071198:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1572	BRCA1
NM_007294.4(BRCA1):c.4715C>G (p.Ser1572Cys)	BRCA1	S1572C	Hereditary breast ovarian cancer syndrome	VCV002764794	17	41223216	17	43071199	2764794	2928560	NA	NC_000017.11:43071198:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1572	BRCA1
NM_007294.4(BRCA1):c.4713C>G (p.Phe1571Leu)	BRCA1	F1571L	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000481193	17	41223218	17	43071201	481193	479300	rs768945711	NC_000017.11:43071200:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1571	BRCA1
NM_007294.4(BRCA1):c.4712T>C (p.Phe1571Ser)	BRCA1	F1571S	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055268	17	41223219	17	43071202	55268	69935	rs273901740	NC_000017.11:43071201:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1571	BRCA1
NM_007294.4(BRCA1):c.4711T>C (p.Phe1571Leu)	BRCA1	F1571L	Hereditary breast ovarian cancer syndrome	VCV002734229	17	41223220	17	43071203	2734229	2898559	NA	NC_000017.11:43071202:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1571	BRCA1
NM_007294.4(BRCA1):c.4711T>A (p.Phe1571Ile)	BRCA1	F1571I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001952868	17	41223220	17	43071203	1952868	2018176	NA	NC_000017.11:43071202:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 31, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1571	BRCA1
NM_007294.4(BRCA1):c.4709T>C (p.Leu1570Pro)	BRCA1	L1570P	Hereditary breast ovarian cancer syndrome	VCV001000183	17	41223222	17	43071205	1000183	997560	rs2052423979	NC_000017.11:43071204:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1570	BRCA1
NM_007294.4(BRCA1):c.4706G>C (p.Ser1569Thr)	BRCA1	S1569T	Hereditary breast ovarian cancer syndrome	VCV002733523	17	41223225	17	43071208	2733523	2897858	NA	NC_000017.11:43071207:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1569	BRCA1
NM_007294.4(BRCA1):c.4702A>G (p.Ile1568Val)	BRCA1	I1568V	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055265	17	41223229	17	43071212	55265	69932	rs80357119	NC_000017.11:43071211:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1568	BRCA1
NM_007294.4(BRCA1):c.4700G>C (p.Gly1567Ala)	BRCA1	G1567A	Hereditary breast ovarian cancer syndrome	VCV002771885	17	41223231	17	43071214	2771885	2927871	NA	NC_000017.11:43071213:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1567	BRCA1
NM_007294.4(BRCA1):c.4700G>A (p.Gly1567Glu)	BRCA1	G1567E	Hereditary cancer-predisposing syndrome	VCV001742554	17	41223231	17	43071214	1742554	1798755	NA	NC_000017.11:43071213:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 18, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1567	BRCA1
NM_007294.4(BRCA1):c.4700G>T (p.Gly1567Val)	BRCA1	G1567V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441380	17	41223231	17	43071214	441380	435110	rs1555581074	NC_000017.11:43071213:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1567	BRCA1
NM_007294.4(BRCA1):c.4699G>A (p.Gly1567Arg)	BRCA1	G1567R	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000489723	17	41223232	17	43071215	489723	482938	rs568753972	NC_000017.11:43071214:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1567	BRCA1
NM_007294.4(BRCA1):c.4697C>G (p.Ser1566Cys)	BRCA1	S1566C	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000565578	17	41223234	17	43071217	565578	569089	rs1060502325	NC_000017.11:43071216:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1566	BRCA1
NM_007294.4(BRCA1):c.4697C>A (p.Ser1566Tyr)	BRCA1	S1566Y	BRCA1-related disorder|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409298	17	41223234	17	43071217	409298	402648	rs1060502325	NC_000017.11:43071216:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1566	BRCA1
NM_007294.4(BRCA1):c.4696T>G (p.Ser1566Ala)	BRCA1	S1566A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000182163	17	41223235	17	43071218	182163	180827	rs730881493	NC_000017.11:43071217:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 10, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1566	BRCA1
NM_007294.4(BRCA1):c.4693G>C (p.Glu1565Gln)	BRCA1	E1565Q	Hereditary cancer-predisposing syndrome	VCV001742492	17	41223238	17	43071221	1742492	1798693	NA	NC_000017.11:43071220:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 6, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1565	BRCA1
NM_007294.4(BRCA1):c.4693G>A (p.Glu1565Lys)	BRCA1	E1565K	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000216670	17	41223238	17	43071221	216670	213309	rs863224762	NC_000017.11:43071220:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 22, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1565	BRCA1
NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	BRCA1	L1564P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055262	17	41223240	17	43071223	55262	69929	rs56119278	NC_000017.11:43071222:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1564	BRCA1
NM_007294.4(BRCA1):c.4690C>G (p.Leu1564Val)	BRCA1	L1564V	not provided	VCV002681813	17	41223241	17	43071224	2681813	2842852	NA	NC_000017.11:43071223:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1564	BRCA1
NM_007294.4(BRCA1):c.4685C>G (p.Pro1562Arg)	BRCA1	P1562R	Hereditary breast ovarian cancer syndrome	VCV001005528	17	41223246	17	43071229	1005528	997561	rs80357096	NC_000017.11:43071228:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1562	BRCA1
NM_007294.4(BRCA1):c.4685C>T (p.Pro1562Leu)	BRCA1	P1562L	Hereditary cancer-predisposing syndrome	VCV000055261	17	41223246	17	43071229	55261	69928	rs80357096	NC_000017.11:43071228:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1562	BRCA1
NM_007294.4(BRCA1):c.4684C>T (p.Pro1562Ser)	BRCA1	P1562S	Hereditary cancer-predisposing syndrome	VCV001742408	17	41223247	17	43071230	1742408	1798609	NA	NC_000017.11:43071229:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1562	BRCA1
NM_007294.4(BRCA1):c.4682C>A (p.Thr1561Asn)	BRCA1	T1561N	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000246219	17	41223249	17	43071232	246219	245027	rs56158747	NC_000017.11:43071231:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1561	BRCA1
NM_007294.4(BRCA1):c.4682C>T (p.Thr1561Ile)	BRCA1	T1561I	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|not specified	VCV000055259	17	41223249	17	43071232	55259	69926	rs56158747	NC_000017.11:43071231:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1561	BRCA1
NM_007294.4(BRCA1):c.4679G>A (p.Gly1560Glu)	BRCA1	G1560E	Hereditary breast ovarian cancer syndrome	VCV001518880	17	41223252	17	43071235	1518880	1343073	rs564757581	NC_000017.11:43071234:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1560	BRCA1
NM_007294.4(BRCA1):c.4679G>T (p.Gly1560Val)	BRCA1	G1560V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related disorder|Hereditary cancer-predisposing syndrome|not provided	VCV000142627	17	41223252	17	43071235	142627	152341	rs564757581	NC_000017.11:43071234:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1560	BRCA1
NM_007294.4(BRCA1):c.4677G>C (p.Glu1559Asp)	BRCA1	E1559D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000141610	17	41223254	17	43071237	141610	151324	rs587781876	NC_000017.11:43071236:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1559	BRCA1
NM_007294.4(BRCA1):c.4676A>T (p.Glu1559Val)	BRCA1	E1559V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001354612	17	41223255	17	43071238	1354612	1434197	rs2153902423	NC_000017.11:43071237:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1559	BRCA1
NM_007294.4(BRCA1):c.4675G>C (p.Glu1559Gln)	BRCA1	E1559Q	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037605	17	41226348	17	43074331	37605	46161	rs80356988	NC_000017.11:43074330:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 2, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1559	BRCA1
NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	BRCA1	E1559K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037604	17	41226348	17	43074331	37604	46160	rs80356988	NC_000017.11:43074330:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1559	BRCA1
NM_007294.4(BRCA1):c.4673T>G (p.Leu1558Arg)	BRCA1	L1558R	Hereditary breast ovarian cancer syndrome	VCV000659074	17	41226350	17	43074333	659074	645941	rs1597835669	NC_000017.11:43074332:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 15, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1558	BRCA1
NM_007294.4(BRCA1):c.4672C>G (p.Leu1558Val)	BRCA1	L1558V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479263	17	41226351	17	43074334	479263	478672	rs1555581794	NC_000017.11:43074333:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1558	BRCA1
NM_007294.4(BRCA1):c.4671T>G (p.Asp1557Glu)	BRCA1	D1557E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000658642	17	41226352	17	43074335	658642	645943	rs1597835696	NC_000017.11:43074334:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1557	BRCA1
NM_007294.4(BRCA1):c.4670A>G (p.Asp1557Gly)	BRCA1	D1557G	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000225710	17	41226353	17	43074336	225710	227559	rs869320779	NC_000017.11:43074335:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1557	BRCA1
NM_007294.4(BRCA1):c.4669G>A (p.Asp1557Asn)	BRCA1	D1557N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441446	17	41226354	17	43074337	441446	435112	rs80356906	NC_000017.11:43074336:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1557	BRCA1
NM_007294.4(BRCA1):c.4669G>T (p.Asp1557Tyr)	BRCA1	D1557Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000409325	17	41226354	17	43074337	409325	402048	rs80356906	NC_000017.11:43074336:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1557	BRCA1
NM_007294.4(BRCA1):c.4669G>C (p.Asp1557His)	BRCA1	D1557H	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000055255	17	41226354	17	43074337	55255	69922	rs80356906	NC_000017.11:43074336:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1557	BRCA1
NM_007294.4(BRCA1):c.4668A>C (p.Gln1556His)	BRCA1	Q1556H	not specified|Hereditary breast ovarian cancer syndrome	VCV001683332	17	41226355	17	43074338	1683332	1675230	rs1485442602	NC_000017.11:43074337:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1556	BRCA1
NM_007294.4(BRCA1):c.4667A>G (p.Gln1556Arg)	BRCA1	Q1556R	Hereditary cancer-predisposing syndrome	VCV000441427	17	41226356	17	43074339	441427	435113	rs1555581811	NC_000017.11:43074338:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1556	BRCA1
NM_007294.4(BRCA1):c.4664G>C (p.Arg1555Thr)	BRCA1	R1555T	not specified	VCV001686510	17	41226359	17	43074342	1686510	1678516	rs786202165	NC_000017.11:43074341:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1555	BRCA1
NM_007294.4(BRCA1):c.4664G>A (p.Arg1555Lys)	BRCA1	R1555K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S	VCV000185428	17	41226359	17	43074342	185428	184912	rs786202165	NC_000017.11:43074341:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 29, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1555	BRCA1
NM_007294.4(BRCA1):c.4663A>T (p.Arg1555Trp)	BRCA1	R1555W	Hereditary cancer-predisposing syndrome	VCV001742268	17	41226360	17	43074343	1742268	1798469	NA	NC_000017.11:43074342:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1555	BRCA1
NM_007294.4(BRCA1):c.4660C>A (p.Pro1554Thr)	BRCA1	P1554T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001484791	17	41226363	17	43074346	1484791	1478329	rs2153989518	NC_000017.11:43074345:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1554	BRCA1
NM_007294.4(BRCA1):c.4659G>C (p.Leu1553Phe)	BRCA1	L1553F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001742220	17	41226364	17	43074347	1742220	1801862	NA	NC_000017.11:43074346:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1553	BRCA1
NM_007294.4(BRCA1):c.4657T>A (p.Leu1553Met)	BRCA1	L1553M	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055254	17	41226366	17	43074349	55254	69921	rs80357431	NC_000017.11:43074348:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1553	BRCA1
NM_007294.4(BRCA1):c.4655A>G (p.Tyr1552Cys)	BRCA1	Y1552C	not specified	VCV000996241	17	41226368	17	43074351	996241	983996	rs2052589802	NC_000017.11:43074350:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1552	BRCA1
NM_007294.4(BRCA1):c.4654T>C (p.Tyr1552His)	BRCA1	Y1552H	Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000433716	17	41226369	17	43074352	433716	427542	rs1265352633	NC_000017.11:43074351:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1552	BRCA1
NM_007294.4(BRCA1):c.4652C>T (p.Ser1551Phe)	BRCA1	S1551F	Hereditary breast ovarian cancer syndrome	VCV001005841	17	41226371	17	43074354	1005841	997562	rs2052590804	NC_000017.11:43074353:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 30, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1551	BRCA1
NM_007294.4(BRCA1):c.4649C>T (p.Thr1550Ile)	BRCA1	T1550I	not provided|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055251	17	41226374	17	43074357	55251	69918	rs80357076	NC_000017.11:43074356:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1550	BRCA1
NM_007294.4(BRCA1):c.4648A>T (p.Thr1550Ser)	BRCA1	T1550S	Hereditary breast ovarian cancer syndrome	VCV002045176	17	41226375	17	43074358	2045176	2092748	NA	NC_000017.11:43074357:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1550	BRCA1
NM_007294.4(BRCA1):c.4648A>G (p.Thr1550Ala)	BRCA1	T1550A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000954020	17	41226375	17	43074358	954020	949927	rs1193177255	NC_000017.11:43074357:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1550	BRCA1
NM_007294.4(BRCA1):c.4647A>C (p.Glu1549Asp)	BRCA1	E1549D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482929	17	41226376	17	43074359	482929	479303	rs1371814796	NC_000017.11:43074358:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1549	BRCA1
NM_007294.4(BRCA1):c.4646A>T (p.Glu1549Val)	BRCA1	E1549V	Hereditary cancer-predisposing syndrome	VCV000231176	17	41226377	17	43074360	231176	235961	rs876659001	NC_000017.11:43074359:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 14, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1549	BRCA1
NM_007294.4(BRCA1):c.4643C>T (p.Thr1548Met)	BRCA1	T1548M	not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055249	17	41226380	17	43074363	55249	69916	rs273900737	NC_000017.11:43074362:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1548	BRCA1
NM_007294.4(BRCA1):c.4641G>C (p.Leu1547Phe)	BRCA1	L1547F	Hereditary breast ovarian cancer syndrome	VCV000646290	17	41226382	17	43074365	646290	645944	rs864622265	NC_000017.11:43074364:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1547	BRCA1
NM_007294.4(BRCA1):c.4641G>T (p.Leu1547Phe)	BRCA1	L1547F	Hereditary breast ovarian cancer syndrome	VCV000219819	17	41226382	17	43074365	219819	222654	rs864622265	NC_000017.11:43074364:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1547	BRCA1
NM_007294.4(BRCA1):c.4639T>G (p.Leu1547Val)	BRCA1	L1547V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000496386	17	41226384	17	43074367	496386	487711	rs730881492	NC_000017.11:43074366:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1547	BRCA1
NM_007294.4(BRCA1):c.4639T>A (p.Leu1547Met)	BRCA1	L1547M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182162	17	41226384	17	43074367	182162	180828	rs730881492	NC_000017.11:43074366:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 16, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1547	BRCA1
NM_007294.4(BRCA1):c.4638T>G (p.Asp1546Glu)	BRCA1	D1546E	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000037601	17	41226385	17	43074368	37601	46157	rs397507235	NC_000017.11:43074367:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 2, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1546	BRCA1
NM_007294.4(BRCA1):c.4636G>C (p.Asp1546His)	BRCA1	D1546H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479201	17	41226387	17	43074370	479201	479304	rs28897691	NC_000017.11:43074369:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1546	BRCA1
NM_007294.4(BRCA1):c.4636G>T (p.Asp1546Tyr)	BRCA1	D1546Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055246	17	41226387	17	43074370	55246	69913	rs28897691	NC_000017.11:43074369:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1546	BRCA1
NM_007294.4(BRCA1):c.4636G>A (p.Asp1546Asn)	BRCA1	D1546N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055245	17	41226387	17	43074370	55245	69912	rs28897691	NC_000017.11:43074369:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1546	BRCA1
NM_007294.4(BRCA1):c.4635C>G (p.His1545Gln)	BRCA1	H1545Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409336	17	41226388	17	43074371	409336	402649	rs373686790	NC_000017.11:43074370:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1545	BRCA1
NM_007294.4(BRCA1):c.4634A>G (p.His1545Arg)	BRCA1	H1545R	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825056	17	41226389	17	43074372	825056	813684	rs1597835935	NC_000017.11:43074371:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1545	BRCA1
NM_007294.4(BRCA1):c.4633C>T (p.His1545Tyr)	BRCA1	H1545Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001466706	17	41226390	17	43074373	1466706	1348064	rs2153996148	NC_000017.11:43074372:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1545	BRCA1
NM_007294.4(BRCA1):c.4631C>T (p.Pro1544Leu)	BRCA1	P1544L	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055244	17	41226392	17	43074375	55244	69911	rs80356917	NC_000017.11:43074374:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1544	BRCA1
NM_007294.4(BRCA1):c.4630C>A (p.Pro1544Thr)	BRCA1	P1544T	Hereditary cancer-predisposing syndrome	VCV001742043	17	41226393	17	43074376	1742043	1801686	NA	NC_000017.11:43074375:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1544	BRCA1
NM_007294.4(BRCA1):c.4625C>G (p.Ser1542Cys)	BRCA1	S1542C	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000055242	17	41226398	17	43074381	55242	69909	rs41293457	NC_000017.11:43074380:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1542	BRCA1
NM_007294.4(BRCA1):c.4624T>C (p.Ser1542Pro)	BRCA1	S1542P	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000920744	17	41226399	17	43074382	920744	913871	rs2052595821	NC_000017.11:43074381:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1542	BRCA1
NM_007294.4(BRCA1):c.4623G>C (p.Glu1541Asp)	BRCA1	E1541D	Hereditary cancer-predisposing syndrome	VCV001741973	17	41226400	17	43074383	1741973	1801616	NA	NC_000017.11:43074382:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1541	BRCA1
NM_007294.4(BRCA1):c.4621G>C (p.Glu1541Gln)	BRCA1	E1541Q	Hereditary cancer-predisposing syndrome	VCV002774832	17	41226402	17	43074385	2774832	2935559	NA	NC_000017.11:43074384:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1541	BRCA1
NM_007294.4(BRCA1):c.4619A>G (p.Glu1540Gly)	BRCA1	E1540G	Hereditary breast ovarian cancer syndrome	VCV002765073	17	41226404	17	43074387	2765073	2925820	NA	NC_000017.11:43074386:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1540	BRCA1
NM_007294.4(BRCA1):c.4618G>A (p.Glu1540Lys)	BRCA1	E1540K	Hereditary breast ovarian cancer syndrome	VCV002048892	17	41226405	17	43074388	2048892	2114535	NA	NC_000017.11:43074387:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1540	BRCA1
NM_007294.4(BRCA1):c.4618G>C (p.Glu1540Gln)	BRCA1	E1540Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825047	17	41226405	17	43074388	825047	813685	rs80357277	NC_000017.11:43074387:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1540	BRCA1
NM_007294.4(BRCA1):c.4616T>C (p.Leu1539Pro)	BRCA1	L1539P	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409342	17	41226407	17	43074390	409342	402650	rs377629427	NC_000017.11:43074389:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1539	BRCA1
NM_007294.4(BRCA1):c.4614_4615delinsTT (p.Gln1538His)	BRCA1	Q1538H	not specified	VCV000182117	17	41226408 - 41226409	17	43074391 - 43074392	182117	180829	rs730881464	NC_000017.11:43074390:GC:AA	Indel	missense variant|non-coding transcript variant	Uncertain significance	Jan 15, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1538	BRCA1
NM_007294.4(BRCA1):c.4612C>G (p.Gln1538Glu)	BRCA1	Q1538E	Hereditary breast ovarian cancer syndrome	VCV002133413	17	41226411	17	43074394	2133413	2190102	NA	NC_000017.11:43074393:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1538	BRCA1
NM_007294.4(BRCA1):c.4611A>T (p.Gln1537His)	BRCA1	Q1537H	Hereditary cancer-predisposing syndrome	VCV001741895	17	41226412	17	43074395	1741895	1801538	NA	NC_000017.11:43074394:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1537	BRCA1
NM_007294.4(BRCA1):c.4610A>G (p.Gln1537Arg)	BRCA1	Q1537R	Hereditary breast ovarian cancer syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000419383	17	41226413	17	43074396	419383	409962	rs70953659	NC_000017.11:43074395:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1537	BRCA1
NM_007294.4(BRCA1):c.4608G>T (p.Glu1536Asp)	BRCA1	E1536D	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001022166	17	41226415	17	43074398	1022166	1012762	rs2052599261	NC_000017.11:43074397:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1536	BRCA1
NM_007294.4(BRCA1):c.4606G>A (p.Glu1536Lys)	BRCA1	E1536K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001741846	17	41226417	17	43074400	1741846	1801490	NA	NC_000017.11:43074399:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1536	BRCA1
NM_007294.4(BRCA1):c.4606G>C (p.Glu1536Gln)	BRCA1	E1536Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233522	17	41226417	17	43074400	233522	235962	rs876660460	NC_000017.11:43074399:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1536	BRCA1
NM_007294.4(BRCA1):c.4603G>A (p.Glu1535Lys)	BRCA1	E1535K	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000231268	17	41226420	17	43074403	231268	235963	rs80357366	NC_000017.11:43074402:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1535	BRCA1
NM_007294.4(BRCA1):c.4600G>A (p.Val1534Met)	BRCA1	V1534M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055235	17	41226423	17	43074406	55235	69902	rs55815649	NC_000017.11:43074405:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1534	BRCA1
NM_007294.4(BRCA1):c.4598A>T (p.Asp1533Val)	BRCA1	D1533V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002584874	17	41226425	17	43074408	2584874	2752436	NA	NC_000017.11:43074407:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	NA	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1533	BRCA1
NM_007294.4(BRCA1):c.4598A>G (p.Asp1533Gly)	BRCA1	D1533G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001899333	17	41226425	17	43074408	1899333	1963462	NA	NC_000017.11:43074407:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 15, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1533	BRCA1
NM_007294.4(BRCA1):c.4597G>A (p.Asp1533Asn)	BRCA1	D1533N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441499	17	41226426	17	43074409	441499	435115	rs899108857	NC_000017.11:43074408:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1533	BRCA1
NM_007294.4(BRCA1):c.4597G>T (p.Asp1533Tyr)	BRCA1	D1533Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441437	17	41226426	17	43074409	441437	435114	rs899108857	NC_000017.11:43074408:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1533	BRCA1
NM_007294.4(BRCA1):c.4595T>C (p.Val1532Ala)	BRCA1	V1532A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001013802	17	41226428	17	43074411	1013802	1012763	rs2052601019	NC_000017.11:43074410:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1532	BRCA1
NM_007294.4(BRCA1):c.4594G>A (p.Val1532Ile)	BRCA1	V1532I	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000184744	17	41226429	17	43074412	184744	184915	rs786201658	NC_000017.11:43074411:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1532	BRCA1
NM_007294.4(BRCA1):c.4592T>C (p.Val1531Ala)	BRCA1	V1531A	Hereditary breast ovarian cancer syndrome	VCV001715651	17	41226431	17	43074414	1715651	1773596	NA	NC_000017.11:43074413:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1531	BRCA1
NM_007294.4(BRCA1):c.4591G>T (p.Val1531Phe)	BRCA1	V1531F	not provided	VCV000801079	17	41226432	17	43074415	801079	789616	rs1555581897	NC_000017.11:43074414:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1531	BRCA1
NM_007294.4(BRCA1):c.4591G>A (p.Val1531Ile)	BRCA1	V1531I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000485392	17	41226432	17	43074415	485392	478529	rs1555581897	NC_000017.11:43074414:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1531	BRCA1
NM_007294.4(BRCA1):c.4590G>T (p.Lys1530Asn)	BRCA1	K1530N	Hereditary breast ovarian cancer syndrome	VCV001352454	17	41226433	17	43074416	1352454	1505664	rs2154005761	NC_000017.11:43074415:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1530	BRCA1
NM_007294.4(BRCA1):c.4589A>C (p.Lys1530Thr)	BRCA1	K1530T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091633	17	41226434	17	43074417	91633	97110	rs398122689	NC_000017.11:43074416:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1530	BRCA1
NM_007294.4(BRCA1):c.4588A>C (p.Lys1530Gln)	BRCA1	K1530Q	Hereditary cancer-predisposing syndrome	VCV000825018	17	41226435	17	43074418	825018	813687	rs764016240	NC_000017.11:43074417:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1530	BRCA1
NM_007294.4(BRCA1):c.4586T>C (p.Ile1529Thr)	BRCA1	I1529T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001741675	17	41226437	17	43074420	1741675	1805118	NA	NC_000017.11:43074419:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1529	BRCA1
NM_007294.4(BRCA1):c.4586T>G (p.Ile1529Ser)	BRCA1	I1529S	Hereditary breast ovarian cancer syndrome	VCV001009406	17	41226437	17	43074420	1009406	997563	rs1597836187	NC_000017.11:43074419:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1529	BRCA1
NM_007294.4(BRCA1):c.4585A>G (p.Ile1529Val)	BRCA1	I1529V	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055233	17	41226438	17	43074421	55233	69900	rs80357095	NC_000017.11:43074420:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1529	BRCA1
NM_007294.4(BRCA1):c.4583T>C (p.Leu1528Pro)	BRCA1	L1528P	Hereditary cancer-predisposing syndrome	VCV000481486	17	41226440	17	43074423	481486	478599	rs1555581911	NC_000017.11:43074422:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1528	BRCA1
NM_007294.4(BRCA1):c.4582C>G (p.Leu1528Val)	BRCA1	L1528V	Hereditary breast ovarian cancer syndrome	VCV000963819	17	41226441	17	43074424	963819	949928	rs2052603566	NC_000017.11:43074423:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1528	BRCA1
NM_007294.4(BRCA1):c.4581G>T (p.Glu1527Asp)	BRCA1	E1527D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001015826	17	41226442	17	43074425	1015826	1012764	rs1060504560	NC_000017.11:43074424:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1527	BRCA1
NM_007294.4(BRCA1):c.4580A>C (p.Glu1527Ala)	BRCA1	E1527A	Hereditary breast ovarian cancer syndrome	VCV003008299	17	41226443	17	43074426	3008299	3165950	NA	NC_000017.11:43074425:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1527	BRCA1
NM_007294.4(BRCA1):c.4580A>T (p.Glu1527Val)	BRCA1	E1527V	Hereditary breast ovarian cancer syndrome	VCV001461372	17	41226443	17	43074426	1461372	1498203	rs1473461169	NC_000017.11:43074425:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1527	BRCA1
NM_007294.4(BRCA1):c.4580A>G (p.Glu1527Gly)	BRCA1	E1527G	Hereditary breast ovarian cancer syndrome	VCV000835355	17	41226443	17	43074426	835355	845381	rs1473461169	NC_000017.11:43074425:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 13, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1527	BRCA1
NM_007294.4(BRCA1):c.4579_4580delinsAT (p.Glu1527Met)	BRCA1	E1527M	Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome	VCV000545481	17	41226443 - 41226444	17	43074426 - 43074427	545481	535747	rs1555581922	NC_000017.11:43074425:TC:AT	Indel	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1527	BRCA1
NM_007294.4(BRCA1):c.4579G>A (p.Glu1527Lys)	BRCA1	E1527K	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055231	17	41226444	17	43074427	55231	69898	rs80357237	NC_000017.11:43074426:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1527	BRCA1
NM_007294.4(BRCA1):c.4576G>C (p.Glu1526Gln)	BRCA1	E1526Q	Hereditary breast ovarian cancer syndrome	VCV002905316	17	41226447	17	43074430	2905316	3065421	NA	NC_000017.11:43074429:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1526	BRCA1
NM_007294.4(BRCA1):c.4576G>A (p.Glu1526Lys)	BRCA1	E1526K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531282	17	41226447	17	43074430	531282	531563	rs878853294	NC_000017.11:43074429:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 16, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1526	BRCA1
NM_007294.4(BRCA1):c.4574A>G (p.Gln1525Arg)	BRCA1	Q1525R	Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000186994	17	41226449	17	43074432	186994	184916	rs786203386	NC_000017.11:43074431:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1525	BRCA1
NM_007294.4(BRCA1):c.4571C>G (p.Ser1524Cys)	BRCA1	S1524C	Hereditary cancer-predisposing syndrome	VCV000441520	17	41226452	17	43074435	441520	435116	rs1555581944	NC_000017.11:43074434:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1524	BRCA1
NM_007294.4(BRCA1):c.4568C>T (p.Pro1523Leu)	BRCA1	P1523L	not provided|Hereditary cancer-predisposing syndrome	VCV000482903	17	41226455	17	43074438	482903	478601	rs1555581955	NC_000017.11:43074437:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1523	BRCA1
NM_007294.4(BRCA1):c.4567C>A (p.Pro1523Thr)	BRCA1	P1523T	Hereditary breast ovarian cancer syndrome	VCV001993943	17	41226456	17	43074439	1993943	2059605	NA	NC_000017.11:43074438:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1523	BRCA1
NM_007294.4(BRCA1):c.4567C>T (p.Pro1523Ser)	BRCA1	P1523S	Hereditary breast ovarian cancer syndrome	VCV001063272	17	41226456	17	43074439	1063272	1050285	rs1390166929	NC_000017.11:43074438:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1523	BRCA1
NM_007294.4(BRCA1):c.4567C>G (p.Pro1523Ala)	BRCA1	P1523A	Hereditary breast ovarian cancer syndrome	VCV000646371	17	41226456	17	43074439	646371	645945	rs1390166929	NC_000017.11:43074438:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1523	BRCA1
NM_007294.4(BRCA1):c.4565A>G (p.Tyr1522Cys)	BRCA1	Y1522C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000055228	17	41226458	17	43074441	55228	69895	rs80357379	NC_000017.11:43074440:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1522	BRCA1
NM_007294.4(BRCA1):c.4564T>C (p.Tyr1522His)	BRCA1	Y1522H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000627833	17	41226459	17	43074442	627833	618579	rs1567778091	NC_000017.11:43074441:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1522	BRCA1
NM_007294.4(BRCA1):c.4562A>G (p.Asn1521Ser)	BRCA1	N1521S	Hereditary cancer-predisposing syndrome	VCV002774834	17	41226461	17	43074444	2774834	2935561	NA	NC_000017.11:43074443:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1521	BRCA1
NM_007294.4(BRCA1):c.4559G>C (p.Arg1520Thr)	BRCA1	R1520T	Hereditary cancer-predisposing syndrome	VCV000482932	17	41226464	17	43074447	482932	479310	rs1555581971	NC_000017.11:43074446:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 24, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1520	BRCA1
NM_007294.4(BRCA1):c.4555A>G (p.Asn1519Asp)	BRCA1	N1519D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000571121	17	41226468	17	43074451	571121	574469	rs1567778111	NC_000017.11:43074450:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1519	BRCA1
NM_007294.4(BRCA1):c.4554G>C (p.Gln1518His)	BRCA1	Q1518H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000936650	17	41226469	17	43074452	936650	937944	rs786202635	NC_000017.11:43074451:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 4, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1518	BRCA1
NM_007294.4(BRCA1):c.4553A>G (p.Gln1518Arg)	BRCA1	Q1518R	not specified|Hereditary breast ovarian cancer syndrome	VCV001802916	17	41226470	17	43074453	1802916	1859947	NA	NC_000017.11:43074452:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1518	BRCA1
NM_007294.4(BRCA1):c.4552C>A (p.Gln1518Lys)	BRCA1	Q1518K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000232176	17	41226471	17	43074454	232176	235965	rs80356881	NC_000017.11:43074453:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1518	BRCA1
NM_007294.4(BRCA1):c.4552C>G (p.Gln1518Glu)	BRCA1	Q1518E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000219563	17	41226471	17	43074454	219563	222655	rs80356881	NC_000017.11:43074453:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1518	BRCA1
NM_007294.4(BRCA1):c.4550T>C (p.Leu1517Pro)	BRCA1	L1517P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441429	17	41226473	17	43074456	441429	435117	rs1555581980	NC_000017.11:43074455:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1517	BRCA1
NM_007294.4(BRCA1):c.4549C>A (p.Leu1517Ile)	BRCA1	L1517I	Hereditary cancer-predisposing syndrome	VCV001741398	17	41226474	17	43074457	1741398	1794544	NA	NC_000017.11:43074456:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1517	BRCA1
NM_007294.4(BRCA1):c.4549C>T (p.Leu1517Phe)	BRCA1	L1517F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000661280	17	41226474	17	43074457	661280	645946	rs137894496	NC_000017.11:43074456:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1517	BRCA1
NM_007294.4(BRCA1):c.4549C>G (p.Leu1517Val)	BRCA1	L1517V	Hereditary cancer-predisposing syndrome	VCV000491082	17	41226474	17	43074457	491082	485070	rs137894496	NC_000017.11:43074456:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1517	BRCA1
NM_007294.4(BRCA1):c.4547G>A (p.Ser1516Asn)	BRCA1	S1516N	Hereditary cancer-predisposing syndrome	VCV001741390	17	41226476	17	43074459	1741390	1794536	NA	NC_000017.11:43074458:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1516	BRCA1
NM_007294.4(BRCA1):c.4544G>A (p.Gly1515Glu)	BRCA1	G1515E	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000091632	17	41226479	17	43074462	91632	97109	rs398122688	NC_000017.11:43074461:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1515	BRCA1
NM_007294.4(BRCA1):c.4541C>T (p.Ser1514Phe)	BRCA1	S1514F	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000216669	17	41226482	17	43074465	216669	213310	rs863224761	NC_000017.11:43074464:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1514	BRCA1
NM_007294.4(BRCA1):c.4537T>C (p.Cys1513Arg)	BRCA1	C1513R	Hereditary cancer-predisposing syndrome	VCV001741305	17	41226486	17	43074469	1741305	1808682	NA	NC_000017.11:43074468:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1513	BRCA1
NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	BRCA1	S1512I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041826	17	41226488	17	43074471	41826	50265	rs1800744	NC_000017.11:43074470:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1512	BRCA1
NM_007294.4(BRCA1):c.4534A>G (p.Ser1512Gly)	BRCA1	S1512G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000824982	17	41226489	17	43074472	824982	813688	rs80357137	NC_000017.11:43074471:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1512	BRCA1
NM_007294.4(BRCA1):c.4534A>T (p.Ser1512Cys)	BRCA1	S1512C	Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055224	17	41226489	17	43074472	55224	69891	rs80357137	NC_000017.11:43074471:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1512	BRCA1
NM_007294.4(BRCA1):c.4533C>A (p.His1511Gln)	BRCA1	H1511Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000570598	17	41226490	17	43074473	570598	571413	rs1567778195	NC_000017.11:43074472:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 31, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1511	BRCA1
NM_007294.4(BRCA1):c.4532A>G (p.His1511Arg)	BRCA1	H1511R	not provided	VCV001049065	17	41226491	17	43074474	1049065	1038556	rs1555582004	NC_000017.11:43074473:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1511	BRCA1
NM_007294.4(BRCA1):c.4532A>C (p.His1511Pro)	BRCA1	H1511P	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479208	17	41226491	17	43074474	479208	478603	rs1555582004	NC_000017.11:43074473:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1511	BRCA1
NM_007294.4(BRCA1):c.4531C>G (p.His1511Asp)	BRCA1	H1511D	Hereditary cancer-predisposing syndrome	VCV002450663	17	41226492	17	43074475	2450663	2423149	NA	NC_000017.11:43074474:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1511	BRCA1
NM_007294.4(BRCA1):c.4531C>T (p.His1511Tyr)	BRCA1	H1511Y	Hereditary breast ovarian cancer syndrome	VCV001461672	17	41226492	17	43074475	1461672	1494615	rs2154019243	NC_000017.11:43074474:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1511	BRCA1
NM_007294.4(BRCA1):c.4530G>T (p.Met1510Ile)	BRCA1	M1510I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000957112	17	41226493	17	43074476	957112	949929	rs1555582010	NC_000017.11:43074475:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1510	BRCA1
NM_007294.4(BRCA1):c.4530G>A (p.Met1510Ile)	BRCA1	M1510I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482904	17	41226493	17	43074476	482904	478614	rs1555582010	NC_000017.11:43074475:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1510	BRCA1
NM_007294.4(BRCA1):c.4529T>C (p.Met1510Thr)	BRCA1	M1510T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000420259	17	41226494	17	43074477	420259	409963	rs1064794378	NC_000017.11:43074476:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1510	BRCA1
NM_007294.4(BRCA1):c.4528A>C (p.Met1510Leu)	BRCA1	M1510L	Hereditary breast ovarian cancer syndrome	VCV002771704	17	41226495	17	43074478	2771704	2927690	NA	NC_000017.11:43074477:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1510	BRCA1
NM_007294.4(BRCA1):c.4528A>G (p.Met1510Val)	BRCA1	M1510V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001741241	17	41226495	17	43074478	1741241	1808618	NA	NC_000017.11:43074477:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 28, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1510	BRCA1
NM_007294.4(BRCA1):c.4526A>G (p.Tyr1509Cys)	BRCA1	Y1509C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441381	17	41226497	17	43074480	441381	435118	rs1555582023	NC_000017.11:43074479:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1509	BRCA1
NM_007294.4(BRCA1):c.4521G>T (p.Arg1507Ser)	BRCA1	R1507S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000951707	17	41226502	17	43074485	951707	928273	rs1435385135	NC_000017.11:43074484:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 20, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1507	BRCA1
NM_007294.4(BRCA1):c.4520G>C (p.Arg1507Thr)	BRCA1	R1507T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041825	17	41226503	17	43074486	41825	50264	rs80357470	NC_000017.11:43074485:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1507	BRCA1
NM_007294.4(BRCA1):c.4519A>G (p.Arg1507Gly)	BRCA1	R1507G	Hereditary cancer-predisposing syndrome	VCV000627910	17	41226504	17	43074487	627910	618580	rs1567778299	NC_000017.11:43074486:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1507	BRCA1
NM_007294.4(BRCA1):c.4516G>T (p.Asp1506Tyr)	BRCA1	D1506Y	Hereditary cancer-predisposing syndrome	VCV001741166	17	41226507	17	43074490	1741166	1808543	NA	NC_000017.11:43074489:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1506	BRCA1
NM_007294.4(BRCA1):c.4516G>A (p.Asp1506Asn)	BRCA1	D1506N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000954694	17	41226507	17	43074490	954694	949930	rs2052614346	NC_000017.11:43074489:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1506	BRCA1
NM_007294.4(BRCA1):c.4515T>A (p.Asp1505Glu)	BRCA1	D1505E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001376444	17	41226508	17	43074491	1376444	1466976	rs1057522167	NC_000017.11:43074490:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 1, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1505	BRCA1
NM_007294.4(BRCA1):c.4514A>G (p.Asp1505Gly)	BRCA1	D1505G	Hereditary breast ovarian cancer syndrome	VCV000650220	17	41226509	17	43074492	650220	645947	rs1567778319	NC_000017.11:43074491:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1505	BRCA1
NM_007294.4(BRCA1):c.4514A>T (p.Asp1505Val)	BRCA1	D1505V	Hereditary breast ovarian cancer syndrome	VCV000570514	17	41226509	17	43074492	570514	569094	rs1567778319	NC_000017.11:43074491:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1505	BRCA1
NM_007294.4(BRCA1):c.4513G>A (p.Asp1505Asn)	BRCA1	D1505N	Hereditary breast ovarian cancer syndrome	VCV000965452	17	41226510	17	43074493	965452	958119	rs1555582052	NC_000017.11:43074492:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1505	BRCA1
NM_007294.4(BRCA1):c.4513G>C (p.Asp1505His)	BRCA1	D1505H	Hereditary cancer-predisposing syndrome	VCV000479215	17	41226510	17	43074493	479215	478532	rs1555582052	NC_000017.11:43074492:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 3, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1505	BRCA1
NM_007294.4(BRCA1):c.4512A>T (p.Leu1504Phe)	BRCA1	L1504F	Hereditary cancer-predisposing syndrome	VCV003226158	17	41226511	17	43074494	3226158	3387222	NA	NC_000017.11:43074493:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1504	BRCA1
NM_007294.4(BRCA1):c.4512A>C (p.Leu1504Phe)	BRCA1	L1504F	Hereditary breast ovarian cancer syndrome	VCV002753975	17	41226511	17	43074494	2753975	2916445	NA	NC_000017.11:43074493:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1504	BRCA1
NM_007294.4(BRCA1):c.4510T>G (p.Leu1504Val)	BRCA1	L1504V	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000619629	17	41226513	17	43074496	619629	611229	rs1567778337	NC_000017.11:43074495:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1504	BRCA1
NM_007294.4(BRCA1):c.4507T>A (p.Ser1503Thr)	BRCA1	S1503T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069229	17	41226516	17	43074499	3069229	3229856	NA	NC_000017.11:43074498:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1503	BRCA1
NM_007294.4(BRCA1):c.4505C>T (p.Pro1502Leu)	BRCA1	P1502L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000644764	17	41226518	17	43074501	644764	645948	rs56335406	NC_000017.11:43074500:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1502	BRCA1
NM_007294.4(BRCA1):c.4505C>A (p.Pro1502Gln)	BRCA1	P1502Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000185183	17	41226518	17	43074501	185183	184920	rs56335406	NC_000017.11:43074500:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1502	BRCA1
NM_007294.4(BRCA1):c.4504C>T (p.Pro1502Ser)	BRCA1	P1502S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055218	17	41226519	17	43074502	55218	69885	rs80357383	NC_000017.11:43074501:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 21, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1502	BRCA1
NM_007294.4(BRCA1):c.4502G>A (p.Cys1501Tyr)	BRCA1	C1501Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001044675	17	41226521	17	43074504	1044675	1033304	rs1567778370	NC_000017.11:43074503:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 14, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1501	BRCA1
NM_007294.4(BRCA1):c.4501T>C (p.Cys1501Arg)	BRCA1	C1501R	Hereditary cancer-predisposing syndrome	VCV001741056	17	41226522	17	43074505	1741056	1808433	NA	NC_000017.11:43074504:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1501	BRCA1
NM_007294.4(BRCA1):c.4496C>T (p.Ser1499Phe)	BRCA1	S1499F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002879621	17	41226527	17	43074510	2879621	3039485	NA	NC_000017.11:43074509:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1499	BRCA1
NM_007294.4(BRCA1):c.4493C>G (p.Pro1498Arg)	BRCA1	P1498R	Hereditary cancer-predisposing syndrome	VCV000485378	17	41226530	17	43074513	485378	478622	rs1555582079	NC_000017.11:43074512:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1498	BRCA1
NM_007294.4(BRCA1):c.4492C>T (p.Pro1498Ser)	BRCA1	P1498S	BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824937	17	41226531	17	43074514	824937	813689	rs1597836625	NC_000017.11:43074513:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1498	BRCA1
NM_007294.4(BRCA1):c.4489T>G (p.Ser1497Ala)	BRCA1	S1497A	Hereditary breast ovarian cancer syndrome	VCV002020069	17	41226534	17	43074517	2020069	2083109	NA	NC_000017.11:43074516:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1497	BRCA1
NM_007294.4(BRCA1):c.4487C>T (p.Ser1496Leu)	BRCA1	S1496L	Hereditary cancer-predisposing syndrome	VCV001740931	17	41226536	17	43074519	1740931	1808308	NA	NC_000017.11:43074518:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1496	BRCA1
NM_007294.4(BRCA1):c.4486T>A (p.Ser1496Thr)	BRCA1	S1496T	Hereditary breast ovarian cancer syndrome	VCV002693375	17	41226537	17	43074520	2693375	2857359	NA	NC_000017.11:43074519:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1496	BRCA1
NM_007294.4(BRCA1):c.4485G>C (p.Arg1495Ser)	BRCA1	R1495S	not provided	VCV000419384	17	41226538	17	43074521	419384	409965	rs1064793833	NC_000017.11:43074520:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 1, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1495	BRCA1
NM_007294.4(BRCA1):c.4484G>C (p.Arg1495Thr)	BRCA1	R1495T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000245697	17	41228505	17	43076488	245697	245029	rs80357389	NC_000017.11:43076487:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1495	BRCA1
NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	BRCA1	R1495M	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer	VCV000037598	17	41228505	17	43076488	37598	46154	rs80357389	NC_000017.11:43076487:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Mar 26, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1495	BRCA1
NM_007294.4(BRCA1):c.4484G>A (p.Arg1495Lys)	BRCA1	R1495K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000037597	17	41228505	17	43076488	37597	46153	rs80357389	NC_000017.11:43076487:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1495	BRCA1
NM_007294.4(BRCA1):c.4483A>T (p.Arg1495Trp)	BRCA1	R1495W	Hereditary breast ovarian cancer syndrome	VCV002836927	17	41228506	17	43076489	2836927	2999306	NA	NC_000017.11:43076488:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1495	BRCA1
NM_007294.4(BRCA1):c.4481A>C (p.Glu1494Ala)	BRCA1	E1494A	not specified	VCV001705078	17	41228508	17	43076491	1705078	1699610	NA	NC_000017.11:43076490:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1494	BRCA1
NM_007294.4(BRCA1):c.4481A>G (p.Glu1494Gly)	BRCA1	E1494G	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481436	17	41228508	17	43076491	481436	478633	rs758779691	NC_000017.11:43076490:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1494	BRCA1
NM_007294.4(BRCA1):c.4480G>A (p.Glu1494Lys)	BRCA1	E1494K	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055208	17	41228509	17	43076492	55208	69875	rs80357148	NC_000017.11:43076491:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1494	BRCA1
NM_007294.4(BRCA1):c.4478T>C (p.Val1493Ala)	BRCA1	V1493A	Hereditary breast ovarian cancer syndrome	VCV002698834	17	41228511	17	43076494	2698834	2855125	NA	NC_000017.11:43076493:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1493	BRCA1
NM_007294.4(BRCA1):c.4477G>C (p.Val1493Leu)	BRCA1	V1493L	Hereditary cancer-predisposing syndrome	VCV001740863	17	41228512	17	43076495	1740863	1798363	NA	NC_000017.11:43076494:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1493	BRCA1
NM_007294.4(BRCA1):c.4477G>T (p.Val1493Leu)	BRCA1	V1493L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001024428	17	41228512	17	43076495	1024428	1012765	rs949577051	NC_000017.11:43076494:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1493	BRCA1
NM_007294.4(BRCA1):c.4477G>A (p.Val1493Met)	BRCA1	V1493M	Hereditary breast ovarian cancer syndrome	VCV000531259	17	41228512	17	43076495	531259	531210	rs949577051	NC_000017.11:43076494:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 17, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1493	BRCA1
NM_007294.4(BRCA1):c.4475G>T (p.Gly1492Val)	BRCA1	G1492V	Hereditary cancer-predisposing syndrome	VCV001172378	17	41228514	17	43076497	1172378	1161354	rs2052719059	NC_000017.11:43076496:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 15, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1492	BRCA1
NM_007294.4(BRCA1):c.4475G>A (p.Gly1492Glu)	BRCA1	G1492E	Hereditary breast ovarian cancer syndrome	VCV000839626	17	41228514	17	43076497	839626	845382	rs2052719059	NC_000017.11:43076496:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1492	BRCA1
NM_007294.4(BRCA1):c.4474G>A (p.Gly1492Arg)	BRCA1	G1492R	Hereditary breast ovarian cancer syndrome	VCV000645683	17	41228515	17	43076498	645683	645949	rs863224511	NC_000017.11:43076497:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 16, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1492	BRCA1
NM_007294.4(BRCA1):c.4472C>T (p.Pro1491Leu)	BRCA1	P1491L	Hereditary breast ovarian cancer syndrome	VCV001999192	17	41228517	17	43076500	1999192	2060985	NA	NC_000017.11:43076499:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1491	BRCA1
NM_007294.4(BRCA1):c.4472C>G (p.Pro1491Arg)	BRCA1	P1491R	Hereditary breast ovarian cancer syndrome	VCV000953812	17	41228517	17	43076500	953812	949931	rs2052719695	NC_000017.11:43076499:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 9, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1491	BRCA1
NM_007294.4(BRCA1):c.4471C>T (p.Pro1491Ser)	BRCA1	P1491S	not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000801076	17	41228518	17	43076501	801076	789617	rs111034213	NC_000017.11:43076500:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1491	BRCA1
NM_007294.4(BRCA1):c.4471C>A (p.Pro1491Thr)	BRCA1	P1491T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441439	17	41228518	17	43076501	441439	435119	rs111034213	NC_000017.11:43076500:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1491	BRCA1
NM_007294.4(BRCA1):c.4471C>G (p.Pro1491Ala)	BRCA1	P1491A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055207	17	41228518	17	43076501	55207	69874	rs111034213	NC_000017.11:43076500:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1491	BRCA1
NM_007294.4(BRCA1):c.4470A>T (p.Glu1490Asp)	BRCA1	E1490D	Hereditary cancer-predisposing syndrome	VCV000482951	17	41228519	17	43076502	482951	478676	rs1555582549	NC_000017.11:43076501:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1490	BRCA1
NM_007294.4(BRCA1):c.4468G>A (p.Glu1490Lys)	BRCA1	E1490K	Hereditary cancer-predisposing syndrome	VCV003226156	17	41228521	17	43076504	3226156	3387220	NA	NC_000017.11:43076503:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1490	BRCA1
NM_007294.4(BRCA1):c.4466A>T (p.Lys1489Ile)	BRCA1	K1489I	Hereditary breast ovarian cancer syndrome|not provided	VCV000951768	17	41228523	17	43076506	951768	928274	rs587781880	NC_000017.11:43076505:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1489	BRCA1
NM_007294.4(BRCA1):c.4466A>G (p.Lys1489Arg)	BRCA1	K1489R	Hereditary cancer-predisposing syndrome	VCV000141615	17	41228523	17	43076506	141615	151329	rs587781880	NC_000017.11:43076505:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1489	BRCA1
NM_007294.4(BRCA1):c.4465A>G (p.Lys1489Glu)	BRCA1	K1489E	Hereditary breast ovarian cancer syndrome|not provided	VCV000951096	17	41228524	17	43076507	951096	928275	rs2052721149	NC_000017.11:43076506:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1489	BRCA1
NM_007294.4(BRCA1):c.4463A>C (p.Asn1488Thr)	BRCA1	N1488T	not provided	VCV000619628	17	41228526	17	43076509	619628	611230	rs1567779520	NC_000017.11:43076508:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 13, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1488	BRCA1
NM_007294.4(BRCA1):c.4460A>G (p.Lys1487Arg)	BRCA1	K1487R	Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000055206	17	41228529	17	43076512	55206	69873	rs80357126	NC_000017.11:43076511:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 10, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1487	BRCA1
NM_007294.4(BRCA1):c.4459A>G (p.Lys1487Glu)	BRCA1	K1487E	Hereditary cancer-predisposing syndrome	VCV001740750	17	41228530	17	43076513	1740750	1798250	NA	NC_000017.11:43076512:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1487	BRCA1
NM_007294.4(BRCA1):c.4458T>G (p.Ser1486Arg)	BRCA1	S1486R	not provided	VCV000252387	17	41228531	17	43076514	252387	246816	rs879255285	NC_000017.11:43076513:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1486	BRCA1
NM_007294.4(BRCA1):c.4457G>A (p.Ser1486Asn)	BRCA1	S1486N	not provided	VCV001275856	17	41228532	17	43076515	1275856	1265734	rs577465138	NC_000017.11:43076514:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1486	BRCA1
NM_007294.4(BRCA1):c.4456A>G (p.Ser1486Gly)	BRCA1	S1486G	Hereditary cancer-predisposing syndrome|not specified	VCV003256349	17	41228533	17	43076516	3256349	3415111	NA	NC_000017.11:43076515:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1486	BRCA1
NM_007294.4(BRCA1):c.4456A>T (p.Ser1486Cys)	BRCA1	S1486C	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037593	17	41228533	17	43076516	37593	46149	rs397507232	NC_000017.11:43076515:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1486	BRCA1
NM_007294.4(BRCA1):c.4454C>G (p.Thr1485Ser)	BRCA1	T1485S	Hereditary breast ovarian cancer syndrome	VCV000856839	17	41228535	17	43076518	856839	845383	rs80356870	NC_000017.11:43076517:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 18, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1485	BRCA1
NM_007294.4(BRCA1):c.4454C>T (p.Thr1485Ile)	BRCA1	T1485I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000055203	17	41228535	17	43076518	55203	69870	rs80356870	NC_000017.11:43076517:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1485	BRCA1
NM_007294.4(BRCA1):c.4453A>G (p.Thr1485Ala)	BRCA1	T1485A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001740719	17	41228536	17	43076519	1740719	1798219	NA	NC_000017.11:43076518:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1485	BRCA1
NM_007294.4(BRCA1):c.4450T>G (p.Ser1484Ala)	BRCA1	S1484A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630099	17	41228539	17	43076522	630099	618581	rs80357404	NC_000017.11:43076521:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1484	BRCA1
NM_007294.4(BRCA1):c.4450T>A (p.Ser1484Thr)	BRCA1	S1484T	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055201	17	41228539	17	43076522	55201	69868	rs80357404	NC_000017.11:43076521:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1484	BRCA1
NM_007294.4(BRCA1):c.4449T>A (p.Ser1483Arg)	BRCA1	S1483R	Hereditary cancer-predisposing syndrome	VCV000441497	17	41228540	17	43076523	441497	435120	rs1555582581	NC_000017.11:43076522:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1483	BRCA1
NM_007294.4(BRCA1):c.4447A>C (p.Ser1483Arg)	BRCA1	S1483R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441440	17	41228542	17	43076525	441440	435121	rs1555582583	NC_000017.11:43076524:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1483	BRCA1
NM_007294.4(BRCA1):c.4446T>A (p.Asp1482Glu)	BRCA1	D1482E	Hereditary breast ovarian cancer syndrome	VCV002992774	17	41228543	17	43076526	2992774	3151734	NA	NC_000017.11:43076525:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1482	BRCA1
NM_007294.4(BRCA1):c.4446T>G (p.Asp1482Glu)	BRCA1	D1482E	Hereditary cancer-predisposing syndrome	VCV000481168	17	41228543	17	43076526	481168	479312	rs1555582586	NC_000017.11:43076525:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 28, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1482	BRCA1
NM_007294.4(BRCA1):c.4445A>C (p.Asp1482Ala)	BRCA1	D1482A	Hereditary breast ovarian cancer syndrome	VCV001009272	17	41228544	17	43076527	1009272	997564	rs757726297	NC_000017.11:43076526:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1482	BRCA1
NM_007294.4(BRCA1):c.4445A>G (p.Asp1482Gly)	BRCA1	D1482G	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000808278	17	41228544	17	43076527	808278	797545	rs757726297	NC_000017.11:43076526:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1482	BRCA1
NM_007294.4(BRCA1):c.4445A>T (p.Asp1482Val)	BRCA1	D1482V	Hereditary breast ovarian cancer syndrome	VCV000531232	17	41228544	17	43076527	531232	531564	rs757726297	NC_000017.11:43076526:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 18, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1482	BRCA1
NM_007294.4(BRCA1):c.4444G>A (p.Asp1482Asn)	BRCA1	D1482N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001500055	17	41228545	17	43076528	1500055	1385875	rs2052725872	NC_000017.11:43076527:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 15, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1482	BRCA1
NM_007294.4(BRCA1):c.4442C>T (p.Ala1481Val)	BRCA1	A1481V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000946648	17	41228547	17	43076530	946648	928276	rs2052726464	NC_000017.11:43076529:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1481	BRCA1
NM_007294.4(BRCA1):c.4441_4442delinsCT (p.Ala1481Leu)	BRCA1	A1481L	Hereditary breast ovarian cancer syndrome	VCV000848658	17	41228547 - 41228548	17	43076530 - 43076531	848658	845384	rs2052726634	NC_000017.11:43076529:GC:AG	Indel	missense variant|non-coding transcript variant	Uncertain significance	May 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1481	BRCA1
NM_007294.4(BRCA1):c.4441G>A (p.Ala1481Thr)	BRCA1	A1481T	BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000431186	17	41228548	17	43076531	431186	424712	rs1135401828	NC_000017.11:43076530:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1481	BRCA1
NM_007294.4(BRCA1):c.4439C>G (p.Ser1480Cys)	BRCA1	S1480C	Hereditary cancer-predisposing syndrome	VCV001740602	17	41228550	17	43076533	1740602	1798103	NA	NC_000017.11:43076532:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 6, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1480	BRCA1
NM_007294.4(BRCA1):c.4438T>C (p.Ser1480Pro)	BRCA1	S1480P	Hereditary breast ovarian cancer syndrome	VCV000945255	17	41228551	17	43076534	945255	928277	rs2052727249	NC_000017.11:43076533:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 24, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1480	BRCA1
NM_007294.4(BRCA1):c.4435G>A (p.Val1479Met)	BRCA1	V1479M	Hereditary breast ovarian cancer syndrome	VCV002129609	17	41228554	17	43076537	2129609	2191033	NA	NC_000017.11:43076536:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1479	BRCA1
NM_007294.4(BRCA1):c.4435G>C (p.Val1479Leu)	BRCA1	V1479L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187167	17	41228554	17	43076537	187167	184921	rs786203524	NC_000017.11:43076536:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1479	BRCA1
NM_007294.4(BRCA1):c.4434G>T (p.Glu1478Asp)	BRCA1	E1478D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001035284	17	41228555	17	43076538	1035284	1033305	rs1555582594	NC_000017.11:43076537:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1478	BRCA1
NM_007294.4(BRCA1):c.4434G>C (p.Glu1478Asp)	BRCA1	E1478D	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000440475	17	41228555	17	43076538	440475	432899	rs1555582594	NC_000017.11:43076537:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1478	BRCA1
NM_007294.4(BRCA1):c.4430T>G (p.Phe1477Cys)	BRCA1	F1477C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003240942	17	41228559	17	43076542	3240942	3399925	NA	NC_000017.11:43076541:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1477	BRCA1
NM_007294.4(BRCA1):c.4430T>C (p.Phe1477Ser)	BRCA1	F1477S	Hereditary cancer-predisposing syndrome	VCV000233654	17	41228559	17	43076542	233654	235967	rs876660550	NC_000017.11:43076541:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1477	BRCA1
NM_007294.4(BRCA1):c.4429T>G (p.Phe1477Val)	BRCA1	F1477V	Hereditary breast ovarian cancer syndrome	VCV000850560	17	41228560	17	43076543	850560	845385	rs2052729085	NC_000017.11:43076542:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 11, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1477	BRCA1
NM_007294.4(BRCA1):c.4427A>G (p.Lys1476Arg)	BRCA1	K1476R	Hereditary breast ovarian cancer syndrome	VCV002771147	17	41228562	17	43076545	2771147	2933163	NA	NC_000017.11:43076544:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1476	BRCA1
NM_007294.4(BRCA1):c.4427A>C (p.Lys1476Thr)	BRCA1	K1476T	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000496384	17	41228562	17	43076545	496384	487863	rs750437234	NC_000017.11:43076544:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1476	BRCA1
NM_007294.4(BRCA1):c.4426A>G (p.Lys1476Glu)	BRCA1	K1476E	Hereditary cancer-predisposing syndrome	VCV000921098	17	41228563	17	43076546	921098	913874	rs2052729907	NC_000017.11:43076545:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 27, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1476	BRCA1
NM_007294.4(BRCA1):c.4425C>G (p.Asp1475Glu)	BRCA1	D1475E	Hereditary cancer-predisposing syndrome	VCV001740509	17	41228564	17	43076547	1740509	1798011	NA	NC_000017.11:43076546:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1475	BRCA1
NM_007294.4(BRCA1):c.4423G>T (p.Asp1475Tyr)	BRCA1	D1475Y	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000234224	17	41228566	17	43076549	234224	235968	rs876660940	NC_000017.11:43076548:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1475	BRCA1
NM_007294.4(BRCA1):c.4421C>A (p.Ala1474Asp)	BRCA1	A1474D	Hereditary cancer-predisposing syndrome	VCV001740486	17	41228568	17	43076551	1740486	1791516	NA	NC_000017.11:43076550:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1474	BRCA1
NM_007294.4(BRCA1):c.4420G>A (p.Ala1474Thr)	BRCA1	A1474T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481446	17	41228569	17	43076552	481446	478538	rs1555582616	NC_000017.11:43076551:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 4, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1474	BRCA1
NM_007294.4(BRCA1):c.4417T>C (p.Ser1473Pro)	BRCA1	S1473P	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000091630	17	41228572	17	43076555	91630	97107	rs398122686	NC_000017.11:43076554:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1473	BRCA1
NM_007294.4(BRCA1):c.4414C>T (p.Leu1472Phe)	BRCA1	L1472F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000041824	17	41228575	17	43076558	41824	50263	rs200582930	NC_000017.11:43076557:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1472	BRCA1
NM_007294.4(BRCA1):c.4412G>A (p.Gly1471Asp)	BRCA1	G1471D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000631018	17	41228577	17	43076560	631018	618583	rs587782708	NC_000017.11:43076559:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1471	BRCA1
NM_007294.4(BRCA1):c.4412G>T (p.Gly1471Val)	BRCA1	G1471V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000485391	17	41228577	17	43076560	485391	478680	rs587782708	NC_000017.11:43076559:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1471	BRCA1
NM_007294.4(BRCA1):c.4412G>C (p.Gly1471Ala)	BRCA1	G1471A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142774	17	41228577	17	43076560	142774	152488	rs587782708	NC_000017.11:43076559:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1471	BRCA1
NM_007294.4(BRCA1):c.4411G>A (p.Gly1471Ser)	BRCA1	G1471S	Hereditary cancer-predisposing syndrome	VCV000630636	17	41228578	17	43076561	630636	618584	rs1567779701	NC_000017.11:43076560:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1471	BRCA1
NM_007294.4(BRCA1):c.4410A>T (p.Glu1470Asp)	BRCA1	E1470D	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000089064	17	41228579	17	43076562	89064	94607	rs80357075	NC_000017.11:43076561:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1470	BRCA1
NM_007294.4(BRCA1):c.4406C>G (p.Pro1469Arg)	BRCA1	P1469R	Hereditary breast ovarian cancer syndrome	VCV002746294	17	41228583	17	43076566	2746294	2911804	NA	NC_000017.11:43076565:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1469	BRCA1
NM_007294.4(BRCA1):c.4406C>T (p.Pro1469Leu)	BRCA1	P1469L	Hereditary cancer-predisposing syndrome	VCV001692971	17	41228583	17	43076566	1692971	1685411	rs2052734184	NC_000017.11:43076565:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1469	BRCA1
NM_007294.4(BRCA1):c.4405C>A (p.Pro1469Thr)	BRCA1	P1469T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 2	VCV000664253	17	41228584	17	43076567	664253	645950	rs80356960	NC_000017.11:43076566:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1469	BRCA1
NM_007294.4(BRCA1):c.4405C>T (p.Pro1469Ser)	BRCA1	P1469S	Hereditary cancer-predisposing syndrome	VCV000055194	17	41228584	17	43076567	55194	69861	rs80356960	NC_000017.11:43076566:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 8, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1469	BRCA1
NM_007294.4(BRCA1):c.4403A>C (p.Asn1468Thr)	BRCA1	N1468T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001014065	17	41228586	17	43076569	1014065	1012766	rs778707598	NC_000017.11:43076568:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1468	BRCA1
NM_007294.4(BRCA1):c.4402A>C (p.Asn1468His)	BRCA1	N1468H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055193	17	41228587	17	43076570	55193	69860	rs80357022	NC_000017.11:43076569:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1468	BRCA1
NM_007294.4(BRCA1):c.4402A>G (p.Asn1468Asp)	BRCA1	N1468D	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037591	17	41228587	17	43076570	37591	46147	rs80357022	NC_000017.11:43076569:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1468	BRCA1
NM_007294.4(BRCA1):c.4400A>G (p.Gln1467Arg)	BRCA1	Q1467R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069230	17	41228589	17	43076572	3069230	3229857	NA	NC_000017.11:43076571:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1467	BRCA1
NM_007294.4(BRCA1):c.4399C>G (p.Gln1467Glu)	BRCA1	Q1467E	not specified	VCV002576274	17	41228590	17	43076573	2576274	2741170	NA	NC_000017.11:43076572:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1467	BRCA1
NM_007294.4(BRCA1):c.4397G>T (p.Ser1466Ile)	BRCA1	S1466I	Hereditary breast ovarian cancer syndrome	VCV001375849	17	41228592	17	43076575	1375849	1470235	rs2154069294	NC_000017.11:43076574:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 18, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1466	BRCA1
NM_007294.4(BRCA1):c.4396A>T (p.Ser1466Cys)	BRCA1	S1466C	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000420981	17	41228593	17	43076576	420981	409967	rs1064794830	NC_000017.11:43076575:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 6, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1466	BRCA1
NM_007294.4(BRCA1):c.4394T>A (p.Ile1465Lys)	BRCA1	I1465K	Hereditary cancer-predisposing syndrome	VCV001740251	17	41228595	17	43076578	1740251	1791284	NA	NC_000017.11:43076577:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 17, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1465	BRCA1
NM_007294.4(BRCA1):c.4393A>G (p.Ile1465Val)	BRCA1	I1465V	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000801075	17	41228596	17	43076579	801075	789618	rs1567779778	NC_000017.11:43076578:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1465	BRCA1
NM_007294.4(BRCA1):c.4393A>C (p.Ile1465Leu)	BRCA1	I1465L	Malignant tumor of breast	VCV000433714	17	41228596	17	43076579	433714	427544	rs1567779778	NC_000017.11:43076578:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1465	BRCA1
NM_007294.4(BRCA1):c.4391C>T (p.Pro1464Leu)	BRCA1	P1464L	Hereditary breast ovarian cancer syndrome	VCV001481377	17	41228598	17	43076581	1481377	1451815	rs2052738000	NC_000017.11:43076580:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1464	BRCA1
NM_007294.4(BRCA1):c.4391C>G (p.Pro1464Arg)	BRCA1	P1464R	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000944868	17	41228598	17	43076581	944868	928278	rs2052738000	NC_000017.11:43076580:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1464	BRCA1
NM_007294.4(BRCA1):c.4390C>G (p.Pro1464Ala)	BRCA1	P1464A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000639775	17	41228599	17	43076582	639775	645951	rs1259139517	NC_000017.11:43076581:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1464	BRCA1
NM_007294.4(BRCA1):c.4390C>T (p.Pro1464Ser)	BRCA1	P1464S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628044	17	41228599	17	43076582	628044	618585	rs1259139517	NC_000017.11:43076581:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 17, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1464	BRCA1
NM_007294.4(BRCA1):c.4390C>A (p.Pro1464Thr)	BRCA1	P1464T	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531324	17	41228599	17	43076582	531324	531211	rs1259139517	NC_000017.11:43076581:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1464	BRCA1
NM_007294.4(BRCA1):c.4388A>T (p.Tyr1463Phe)	BRCA1	Y1463F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000920532	17	41228601	17	43076584	920532	913876	rs2052739409	NC_000017.11:43076583:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1463	BRCA1
NM_007294.4(BRCA1):c.4387T>C (p.Tyr1463His)	BRCA1	Y1463H	Hereditary breast ovarian cancer syndrome	VCV001416615	17	41228602	17	43076585	1416615	1487355	rs1163509151	NC_000017.11:43076584:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 4, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1463	BRCA1
NM_007294.4(BRCA1):c.4387T>A (p.Tyr1463Asn)	BRCA1	Y1463N	Hereditary breast ovarian cancer syndrome	VCV000938286	17	41228602	17	43076585	938286	937945	rs1163509151	NC_000017.11:43076584:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1463	BRCA1
NM_007294.4(BRCA1):c.4385A>T (p.Glu1462Val)	BRCA1	E1462V	Hereditary cancer-predisposing syndrome	VCV000824847	17	41228604	17	43076587	824847	813692	rs1567779859	NC_000017.11:43076586:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 5, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1462	BRCA1
NM_007294.4(BRCA1):c.4385A>G (p.Glu1462Gly)	BRCA1	E1462G	not provided	VCV000433713	17	41228604	17	43076587	433713	427545	rs1567779859	NC_000017.11:43076586:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1462	BRCA1
NM_007294.4(BRCA1):c.4384G>A (p.Glu1462Lys)	BRCA1	E1462K	Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000194244	17	41228605	17	43076588	194244	191407	rs141255461	NC_000017.11:43076587:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1462	BRCA1
NM_007294.4(BRCA1):c.4383T>A (p.Ser1461Arg)	BRCA1	S1461R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096932	17	41228606	17	43076589	96932	102835	rs431825408	NC_000017.11:43076588:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1461	BRCA1
NM_007294.4(BRCA1):c.4382G>A (p.Ser1461Asn)	BRCA1	S1461N	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV002124828	17	41228607	17	43076590	2124828	2181422	NA	NC_000017.11:43076589:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1461	BRCA1
NM_007294.4(BRCA1):c.4382G>C (p.Ser1461Thr)	BRCA1	S1461T	Hereditary breast ovarian cancer syndrome	VCV000531434	17	41228607	17	43076590	531434	531066	rs1555582692	NC_000017.11:43076589:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1461	BRCA1
NM_007294.4(BRCA1):c.4381A>G (p.Ser1461Gly)	BRCA1	S1461G	Hereditary breast ovarian cancer syndrome	VCV002009627	17	41228608	17	43076591	2009627	2070149	NA	NC_000017.11:43076590:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1461	BRCA1
NM_007294.4(BRCA1):c.4379G>C (p.Ser1460Thr)	BRCA1	S1460T	Hereditary cancer-predisposing syndrome	VCV002774835	17	41228610	17	43076593	2774835	2935562	NA	NC_000017.11:43076592:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1460	BRCA1
NM_007294.4(BRCA1):c.4379G>A (p.Ser1460Asn)	BRCA1	S1460N	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000055185	17	41228610	17	43076593	55185	69852	rs397509167	NC_000017.11:43076592:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1460	BRCA1
NM_007294.4(BRCA1):c.4377A>T (p.Lys1459Asn)	BRCA1	K1459N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952219	17	41228612	17	43076595	952219	928279	rs2052743174	NC_000017.11:43076594:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1459	BRCA1
NM_007294.4(BRCA1):c.4376A>T (p.Lys1459Ile)	BRCA1	K1459I	Hereditary breast ovarian cancer syndrome|not provided	VCV001331217	17	41228613	17	43076596	1331217	1321892	rs1555582697	NC_000017.11:43076595:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 2, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1459	BRCA1
NM_007294.4(BRCA1):c.4376A>G (p.Lys1459Arg)	BRCA1	K1459R	Hereditary cancer-predisposing syndrome	VCV000479194	17	41228613	17	43076596	479194	478539	rs1555582697	NC_000017.11:43076595:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1459	BRCA1
NM_007294.4(BRCA1):c.4375A>G (p.Lys1459Glu)	BRCA1	K1459E	Hereditary breast ovarian cancer syndrome	VCV002111745	17	41228614	17	43076597	2111745	2160566	NA	NC_000017.11:43076596:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1459	BRCA1
NM_007294.4(BRCA1):c.4373A>T (p.Gln1458Leu)	BRCA1	Q1458L	Hereditary breast ovarian cancer syndrome|not specified	VCV000934818	17	41228616	17	43076599	934818	937946	rs1377750822	NC_000017.11:43076598:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1458	BRCA1
NM_007294.4(BRCA1):c.4372C>G (p.Gln1458Glu)	BRCA1	Q1458E	Hereditary breast ovarian cancer syndrome	VCV000950696	17	41228617	17	43076600	950696	928280	rs80356932	NC_000017.11:43076599:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 22, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1458	BRCA1
NM_007294.4(BRCA1):c.4370C>T (p.Ser1457Leu)	BRCA1	S1457L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824837	17	41228619	17	43076602	824837	813693	rs80357130	NC_000017.11:43076601:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1457	BRCA1
NM_007294.4(BRCA1):c.4369T>C (p.Ser1457Pro)	BRCA1	S1457P	Hereditary cancer-predisposing syndrome	VCV001740065	17	41228620	17	43076603	1740065	1791098	NA	NC_000017.11:43076602:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1457	BRCA1
NM_007294.4(BRCA1):c.4367C>T (p.Thr1456Ile)	BRCA1	T1456I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000863784	17	41228622	17	43076605	863784	845387	rs2052745199	NC_000017.11:43076604:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1456	BRCA1
NM_007294.4(BRCA1):c.4366A>G (p.Thr1456Ala)	BRCA1	T1456A	Hereditary cancer-predisposing syndrome	VCV000184974	17	41228623	17	43076606	184974	184925	rs786201835	NC_000017.11:43076605:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1456	BRCA1
NM_007294.4(BRCA1):c.4365A>C (p.Leu1455Phe)	BRCA1	L1455F	Hereditary cancer-predisposing syndrome	VCV003226154	17	41228624	17	43076607	3226154	3387218	NA	NC_000017.11:43076606:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1455	BRCA1
NM_007294.4(BRCA1):c.4364T>C (p.Leu1455Ser)	BRCA1	L1455S	Hereditary cancer-predisposing syndrome	VCV002585837	17	41228625	17	43076608	2585837	2753397	NA	NC_000017.11:43076607:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1455	BRCA1
NM_007294.4(BRCA1):c.4361T>C (p.Val1454Ala)	BRCA1	V1454A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000142639	17	41228628	17	43076611	142639	152353	rs587782606	NC_000017.11:43076610:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1454	BRCA1
NM_007294.4(BRCA1):c.4360G>A (p.Val1454Ile)	BRCA1	V1454I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000433712	17	41228629	17	43076612	433712	427546	rs1555582714	NC_000017.11:43076611:C:T	single nucleotide variant	missense variant|splice acceptor variant|intron variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1454	BRCA1
NM_007294.4(BRCA1):c.4358C>G (p.Ala1453Gly)	BRCA1	A1453G	Hereditary cancer-predisposing syndrome	VCV001739973	17	41228631	17	43076614	1739973	1794419	NA	NC_000017.11:43076613:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1453	BRCA1
NM_007294.4(BRCA1):c.4358C>A (p.Ala1453Glu)	BRCA1	A1453E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001479797	17	41228631	17	43076614	1479797	1364467	rs1171055085	NC_000017.11:43076613:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 14, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1453	BRCA1
NM_007294.4(BRCA1):c.4358C>T (p.Ala1453Val)	BRCA1	A1453V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481452	17	41228631	17	43076614	481452	478540	rs1171055085	NC_000017.11:43076613:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1453	BRCA1
NM_007294.4(BRCA1):c.4358-2720G>A	BRCA1	V1475I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000371872	17	41231351	17	43079334	371872	358936	rs183331660	NC_000017.11:43079333:C:T	single nucleotide variant	intron variant|missense variant	Likely benign	Jun 23, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2725T>C	BRCA1	I1473T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000523689	17	41231356	17	43079339	523689	514340	rs374519494	NC_000017.11:43079338:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 2, 2018	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2726A>T	BRCA1	I1402L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002503102	17	41231357	17	43079340	2503102	2668284	NA	NC_000017.11:43079339:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2023	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2726A>G	BRCA1	I1473V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000371813	17	41231357	17	43079340	371813	358937	rs775348455	NC_000017.11:43079339:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 19, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2735A>G	BRCA1	R1470G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000371865	17	41231366	17	43079349	371865	358938	rs1057517571	NC_000017.11:43079348:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Jun 3, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2738C>T	BRCA1	P1469S	Hereditary cancer-predisposing syndrome	VCV000491078	17	41231369	17	43079352	491078	485073	rs1555583238	NC_000017.11:43079351:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 9, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2740G>C	BRCA1	R1397T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002574679	17	41231371	17	43079354	2574679	2739615	NA	NC_000017.11:43079353:C:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Aug 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2755C>G	BRCA1	S1392C	BRCA1-related disorder	VCV002635525	17	41231386	17	43079369	2635525	2799530	NA	NC_000017.11:43079368:G:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4358-2773A>G	BRCA1	H1457R	Carcinoma of head of pancreas	VCV000559971	17	41231404	17	43079387	559971	550690	rs750825948	NC_000017.11:43079386:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	May 22, 2017	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.4357G>A (p.Ala1453Thr)	BRCA1	A1453T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001491600	17	41234421	17	43082404	1491600	1342637	rs1555583984	NC_000017.11:43082403:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1453	BRCA1
NM_007294.4(BRCA1):c.4357G>T (p.Ala1453Ser)	BRCA1	A1453S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000496668	17	41234421	17	43082404	496668	488139	rs1555583984	NC_000017.11:43082403:C:A	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Uncertain significance	Mar 1, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1453	BRCA1
NM_007294.4(BRCA1):c.4355A>C (p.Lys1452Thr)	BRCA1	K1452T	Hereditary breast ovarian cancer syndrome	VCV001346271	17	41234423	17	43082406	1346271	1378560	rs2154144450	NC_000017.11:43082405:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1452	BRCA1
NM_007294.4(BRCA1):c.4354A>G (p.Lys1452Glu)	BRCA1	K1452E	not specified	VCV001686511	17	41234424	17	43082407	1686511	1678517	rs398122685	NC_000017.11:43082406:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1452	BRCA1
NM_007294.4(BRCA1):c.4353A>T (p.Glu1451Asp)	BRCA1	E1451D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002680222	17	41234425	17	43082408	2680222	2833950	NA	NC_000017.11:43082407:T:A	single nucleotide variant	missense variant	Uncertain significance	May 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1451	BRCA1
NM_007294.4(BRCA1):c.4352A>G (p.Glu1451Gly)	BRCA1	E1451G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000480987	17	41234426	17	43082409	480987	478636	rs949793708	NC_000017.11:43082408:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 3, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1451	BRCA1
NM_007294.4(BRCA1):c.4351G>A (p.Glu1451Lys)	BRCA1	E1451K	Hereditary cancer-predisposing syndrome	VCV000482942	17	41234427	17	43082410	482942	478544	rs1555583989	NC_000017.11:43082409:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1451	BRCA1
NM_007294.4(BRCA1):c.4349C>T (p.Ser1450Leu)	BRCA1	S1450L	Hereditary cancer-predisposing syndrome	VCV000630572	17	41234429	17	43082412	630572	618586	rs886040226	NC_000017.11:43082411:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1450	BRCA1
NM_007294.4(BRCA1):c.4346C>T (p.Thr1449Ile)	BRCA1	T1449I	Hereditary breast ovarian cancer syndrome	VCV001374575	17	41234432	17	43082415	1374575	1453544	rs2154145216	NC_000017.11:43082414:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1449	BRCA1
NM_007294.4(BRCA1):c.4345A>C (p.Thr1449Pro)	BRCA1	T1449P	Hereditary cancer-predisposing syndrome	VCV001739880	17	41234433	17	43082416	1739880	1794326	NA	NC_000017.11:43082415:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1449	BRCA1
NM_007294.4(BRCA1):c.4344C>G (p.Ser1448Arg)	BRCA1	S1448R	Hereditary cancer-predisposing syndrome	VCV000824811	17	41234434	17	43082417	824811	813694	rs1250691798	NC_000017.11:43082416:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1448	BRCA1
NM_007294.4(BRCA1):c.4343G>A (p.Ser1448Asn)	BRCA1	S1448N	not provided|Hereditary cancer-predisposing syndrome	VCV000125707	17	41234435	17	43082418	125707	131245	rs80357354	NC_000017.11:43082417:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 14, 2016	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1448	BRCA1
NM_007294.4(BRCA1):c.4343G>C (p.Ser1448Thr)	BRCA1	S1448T	Familial cancer of breast	VCV000055175	17	41234435	17	43082418	55175	69842	rs80357354	NC_000017.11:43082417:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1448	BRCA1
NM_007294.4(BRCA1):c.4342A>G (p.Ser1448Gly)	BRCA1	S1448G	Hereditary breast ovarian cancer syndrome|Breast neoplasm|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055174	17	41234436	17	43082419	55174	69841	rs80357486	NC_000017.11:43082418:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1448	BRCA1
NM_007294.4(BRCA1):c.4339C>A (p.Gln1447Lys)	BRCA1	Q1447K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000182161	17	41234439	17	43082422	182161	180831	rs80357067	NC_000017.11:43082421:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1447	BRCA1
NM_007294.4(BRCA1):c.4338A>T (p.Glu1446Asp)	BRCA1	E1446D	Hereditary breast ovarian cancer syndrome	VCV000531260	17	41234440	17	43082423	531260	531310	rs1555584018	NC_000017.11:43082422:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1446	BRCA1
NM_007294.4(BRCA1):c.4337A>G (p.Glu1446Gly)	BRCA1	E1446G	Hereditary cancer-predisposing syndrome	VCV000491074	17	41234441	17	43082424	491074	485123	rs1273755215	NC_000017.11:43082423:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1446	BRCA1
NM_007294.4(BRCA1):c.4337A>C (p.Glu1446Ala)	BRCA1	E1446A	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440473	17	41234441	17	43082424	440473	432901	rs1273755215	NC_000017.11:43082423:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1446	BRCA1
NM_007294.4(BRCA1):c.4334C>G (p.Pro1445Arg)	BRCA1	P1445R	Hereditary breast ovarian cancer syndrome	VCV002748372	17	41234444	17	43082427	2748372	2918625	NA	NC_000017.11:43082426:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1445	BRCA1
NM_007294.4(BRCA1):c.4333C>G (p.Pro1445Ala)	BRCA1	P1445A	Hereditary breast ovarian cancer syndrome	VCV001325657	17	41234445	17	43082428	1325657	1315922	rs876660684	NC_000017.11:43082427:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1445	BRCA1
NM_007294.4(BRCA1):c.4333C>T (p.Pro1445Ser)	BRCA1	P1445S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001005598	17	41234445	17	43082428	1005598	997565	rs876660684	NC_000017.11:43082427:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1445	BRCA1
NM_007294.4(BRCA1):c.4333C>A (p.Pro1445Thr)	BRCA1	P1445T	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome	VCV000233854	17	41234445	17	43082428	233854	235971	rs876660684	NC_000017.11:43082427:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1445	BRCA1
NM_007294.4(BRCA1):c.4331A>T (p.Asn1444Ile)	BRCA1	N1444I	Hereditary breast ovarian cancer syndrome	VCV000662999	17	41234447	17	43082430	662999	645952	rs1597847702	NC_000017.11:43082429:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1444	BRCA1
NM_007294.4(BRCA1):c.4330A>C (p.Asn1444His)	BRCA1	N1444H	Hereditary cancer-predisposing syndrome	VCV002565340	17	41234448	17	43082431	2565340	2732314	NA	NC_000017.11:43082430:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1444	BRCA1
NM_007294.4(BRCA1):c.4328G>T (p.Arg1443Leu)	BRCA1	R1443L	Hereditary breast ovarian cancer syndrome	VCV001003150	17	41234450	17	43082433	1003150	997566	rs4986849	NC_000017.11:43082432:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 17, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1443	BRCA1
NM_007294.4(BRCA1):c.4328G>A (p.Arg1443Gln)	BRCA1	R1443Q	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000055169	17	41234450	17	43082433	55169	69836	rs4986849	NC_000017.11:43082432:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1443	BRCA1
NM_007294.4(BRCA1):c.4327C>G (p.Arg1443Gly)	BRCA1	R1443G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017676	17	41234451	17	43082434	17676	32715	rs41293455	NC_000017.11:43082433:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1443	BRCA1
NM_007294.4(BRCA1):c.4325T>A (p.Leu1442Gln)	BRCA1	L1442Q	Hereditary breast ovarian cancer syndrome	VCV002748373	17	41234453	17	43082436	2748373	2918626	NA	NC_000017.11:43082435:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1442	BRCA1
NM_007294.4(BRCA1):c.4323C>A (p.Asp1441Glu)	BRCA1	D1441E	Hereditary breast ovarian cancer syndrome	VCV000951122	17	41234455	17	43082438	951122	928281	rs1057523168	NC_000017.11:43082437:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1441	BRCA1
NM_007294.4(BRCA1):c.4321G>A (p.Asp1441Asn)	BRCA1	D1441N	not specified	VCV002687847	17	41234457	17	43082440	2687847	2848884	NA	NC_000017.11:43082439:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1441	BRCA1
NM_007294.4(BRCA1):c.4319A>G (p.Glu1440Gly)	BRCA1	E1440G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000185580	17	41234459	17	43082442	185580	184927	rs786202288	NC_000017.11:43082441:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1440	BRCA1
NM_007294.4(BRCA1):c.4318G>A (p.Glu1440Lys)	BRCA1	E1440K	Hereditary cancer-predisposing syndrome	VCV000824788	17	41234460	17	43082443	824788	813696	rs1555584070	NC_000017.11:43082442:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 30, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1440	BRCA1
NM_007294.4(BRCA1):c.4318G>C (p.Glu1440Gln)	BRCA1	E1440Q	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433710	17	41234460	17	43082443	433710	427548	rs1555584070	NC_000017.11:43082442:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1440	BRCA1
NM_007294.4(BRCA1):c.4316T>C (p.Leu1439Pro)	BRCA1	L1439P	Hereditary breast ovarian cancer syndrome	VCV002769335	17	41234462	17	43082445	2769335	2923610	NA	NC_000017.11:43082444:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1439	BRCA1
NM_007294.4(BRCA1):c.4315C>G (p.Leu1439Val)	BRCA1	L1439V	Hereditary breast ovarian cancer syndrome	VCV002747718	17	41234463	17	43082446	2747718	2904611	NA	NC_000017.11:43082445:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1439	BRCA1
NM_007294.4(BRCA1):c.4315C>T (p.Leu1439Phe)	BRCA1	L1439F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216668	17	41234463	17	43082446	216668	213313	rs781260818	NC_000017.11:43082445:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1439	BRCA1
NM_007294.4(BRCA1):c.4313C>T (p.Ala1438Val)	BRCA1	A1438V	Hereditary breast ovarian cancer syndrome	VCV002915510	17	41234465	17	43082448	2915510	3074060	NA	NC_000017.11:43082447:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1438	BRCA1
NM_007294.4(BRCA1):c.4312G>A (p.Ala1438Thr)	BRCA1	A1438T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824782	17	41234466	17	43082449	824782	813697	rs1597847811	NC_000017.11:43082448:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1438	BRCA1
NM_007294.4(BRCA1):c.4310C>T (p.Ser1437Phe)	BRCA1	S1437F	Hereditary breast ovarian cancer syndrome	VCV000531421	17	41234468	17	43082451	531421	531215	rs1555584083	NC_000017.11:43082450:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1437	BRCA1
NM_007294.4(BRCA1):c.4307C>T (p.Ser1436Phe)	BRCA1	S1436F	Hereditary breast ovarian cancer syndrome	VCV001059740	17	41234471	17	43082454	1059740	1050288	rs755614810	NC_000017.11:43082453:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 8, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1436	BRCA1
NM_007294.4(BRCA1):c.4305C>G (p.Asp1435Glu)	BRCA1	D1435E	not provided	VCV000182080	17	41234473	17	43082456	182080	180832	rs730881445	NC_000017.11:43082455:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 3, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1435	BRCA1
NM_007294.4(BRCA1):c.4304A>T (p.Asp1435Val)	BRCA1	D1435V	Hereditary breast ovarian cancer syndrome	VCV000658688	17	41234474	17	43082457	658688	645953	rs876660809	NC_000017.11:43082456:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 15, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1435	BRCA1
NM_007294.4(BRCA1):c.4304A>G (p.Asp1435Gly)	BRCA1	D1435G	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000234039	17	41234474	17	43082457	234039	235972	rs876660809	NC_000017.11:43082456:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1435	BRCA1
NM_007294.4(BRCA1):c.4302T>A (p.Ser1434Arg)	BRCA1	S1434R	Hereditary cancer-predisposing syndrome	VCV003226152	17	41234476	17	43082459	3226152	3387216	NA	NC_000017.11:43082458:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1434	BRCA1
NM_007294.4(BRCA1):c.4300A>G (p.Ser1434Gly)	BRCA1	S1434G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824773	17	41234478	17	43082461	824773	813698	rs1597847911	NC_000017.11:43082460:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1434	BRCA1
NM_007294.4(BRCA1):c.4298T>C (p.Ile1433Thr)	BRCA1	I1433T	Hereditary cancer-predisposing syndrome	VCV000924219	17	41234480	17	43082463	924219	913877	rs1317431294	NC_000017.11:43082462:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 6, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1433	BRCA1
NM_007294.4(BRCA1):c.4297A>G (p.Ile1433Val)	BRCA1	I1433V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186786	17	41234481	17	43082464	186786	184929	rs541512953	NC_000017.11:43082463:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1433	BRCA1
NM_007294.4(BRCA1):c.4294A>G (p.Ile1432Val)	BRCA1	I1432V	Hereditary breast ovarian cancer syndrome	VCV001049902	17	41234484	17	43082467	1049902	1038560	rs80357157	NC_000017.11:43082466:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1432	BRCA1
NM_007294.4(BRCA1):c.4294A>C (p.Ile1432Leu)	BRCA1	I1432L	Hereditary cancer-predisposing syndrome	VCV000055163	17	41234484	17	43082467	55163	69830	rs80357157	NC_000017.11:43082466:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Aug 30, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1432	BRCA1
NM_007294.4(BRCA1):c.4292C>T (p.Ser1431Phe)	BRCA1	S1431F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462643	17	41234486	17	43082469	462643	467687	rs748839289	NC_000017.11:43082468:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1431	BRCA1
NM_007294.4(BRCA1):c.4289C>G (p.Pro1430Arg)	BRCA1	P1430R	Hereditary cancer-predisposing syndrome	VCV001739401	17	41234489	17	43082472	1739401	1797770	NA	NC_000017.11:43082471:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1430	BRCA1
NM_007294.4(BRCA1):c.4289C>T (p.Pro1430Leu)	BRCA1	P1430L	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000950626	17	41234489	17	43082472	950626	928282	rs1597847973	NC_000017.11:43082471:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1430	BRCA1
NM_007294.4(BRCA1):c.4288C>G (p.Pro1430Ala)	BRCA1	P1430A	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531218	17	41234490	17	43082473	531218	531068	rs80357466	NC_000017.11:43082472:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1430	BRCA1
NM_007294.4(BRCA1):c.4288C>T (p.Pro1430Ser)	BRCA1	P1430S	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055162	17	41234490	17	43082473	55162	69829	rs80357466	NC_000017.11:43082472:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1430	BRCA1
NM_007294.4(BRCA1):c.4286A>G (p.Tyr1429Cys)	BRCA1	Y1429C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000231566	17	41234492	17	43082475	231566	235973	rs876659228	NC_000017.11:43082474:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 25, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1429	BRCA1
NM_007294.4(BRCA1):c.4285T>C (p.Tyr1429His)	BRCA1	Y1429H	Hereditary cancer-predisposing syndrome	VCV001739379	17	41234493	17	43082476	1739379	1797749	NA	NC_000017.11:43082475:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 30, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1429	BRCA1
NM_007294.4(BRCA1):c.4281C>G (p.Asn1427Lys)	BRCA1	N1427K	Hereditary cancer-predisposing syndrome	VCV001739351	17	41234497	17	43082480	1739351	1797721	NA	NC_000017.11:43082479:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1427	BRCA1
NM_007294.4(BRCA1):c.4276T>A (p.Ser1426Thr)	BRCA1	S1426T	not provided	VCV003372696	17	41234502	17	43082485	3372696	3531886	NA	NC_000017.11:43082484:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1426	BRCA1
NM_007294.4(BRCA1):c.4274C>T (p.Pro1425Leu)	BRCA1	P1425L	Hereditary cancer-predisposing syndrome	VCV001739278	17	41234504	17	43082487	1739278	1797648	NA	NC_000017.11:43082486:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1425	BRCA1
NM_007294.4(BRCA1):c.4273C>T (p.Pro1425Ser)	BRCA1	P1425S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000252880	17	41234505	17	43082488	252880	247281	rs768327850	NC_000017.11:43082487:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1425	BRCA1
NM_007294.4(BRCA1):c.4273C>G (p.Pro1425Ala)	BRCA1	P1425A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252398	17	41234505	17	43082488	252398	246818	rs768327850	NC_000017.11:43082487:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 17, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1425	BRCA1
NM_007294.4(BRCA1):c.4272G>C (p.Gln1424His)	BRCA1	Q1424H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091627	17	41234506	17	43082489	91627	97104	rs398122684	NC_000017.11:43082488:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1424	BRCA1
NM_007294.4(BRCA1):c.4271A>G (p.Gln1424Arg)	BRCA1	Q1424R	Malignant tumor of pancreas	VCV000559982	17	41234507	17	43082490	559982	550701	rs1555584133	NC_000017.11:43082489:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 30, 2017	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1424	BRCA1
NM_007294.4(BRCA1):c.4268G>A (p.Ser1423Asn)	BRCA1	S1423N	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000946942	17	41234510	17	43082493	946942	928283	rs876660129	NC_000017.11:43082492:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1423	BRCA1
NM_007294.4(BRCA1):c.4268G>T (p.Ser1423Ile)	BRCA1	S1423I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000233009	17	41234510	17	43082493	233009	235974	rs876660129	NC_000017.11:43082492:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1423	BRCA1
NM_007294.4(BRCA1):c.4265G>A (p.Gly1422Glu)	BRCA1	G1422E	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462642	17	41234513	17	43082496	462642	468128	rs747364414	NC_000017.11:43082495:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1422	BRCA1
NM_007294.4(BRCA1):c.4264G>A (p.Gly1422Arg)	BRCA1	G1422R	Hereditary breast ovarian cancer syndrome	VCV002820578	17	41234514	17	43082497	2820578	2981664	NA	NC_000017.11:43082496:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1422	BRCA1
NM_007294.4(BRCA1):c.4262A>C (p.His1421Pro)	BRCA1	H1421P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000924853	17	41234516	17	43082499	924853	913878	rs80357079	NC_000017.11:43082498:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1421	BRCA1
NM_007294.4(BRCA1):c.4262A>T (p.His1421Leu)	BRCA1	H1421L	not specified	VCV000055158	17	41234516	17	43082499	55158	69825	rs80357079	NC_000017.11:43082498:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2014	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1421	BRCA1
NM_007294.4(BRCA1):c.4262A>G (p.His1421Arg)	BRCA1	H1421R	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055157	17	41234516	17	43082499	55157	69824	rs80357079	NC_000017.11:43082498:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1421	BRCA1
NM_007294.4(BRCA1):c.4261C>T (p.His1421Tyr)	BRCA1	H1421Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055156	17	41234517	17	43082500	55156	69823	rs80357013	NC_000017.11:43082499:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1421	BRCA1
NM_007294.4(BRCA1):c.4260G>T (p.Gln1420His)	BRCA1	Q1420H	Hereditary cancer-predisposing syndrome	VCV000631225	17	41234518	17	43082501	631225	618587	rs1567783343	NC_000017.11:43082500:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1420	BRCA1
NM_007294.4(BRCA1):c.4258C>G (p.Gln1420Glu)	BRCA1	Q1420E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230483	17	41234520	17	43082503	230483	235975	rs80357305	NC_000017.11:43082502:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 29, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1420	BRCA1
NM_007294.4(BRCA1):c.4255G>C (p.Glu1419Gln)	BRCA1	E1419Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055154	17	41234523	17	43082506	55154	69821	rs80357309	NC_000017.11:43082505:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1419	BRCA1
NM_007294.4(BRCA1):c.4254A>T (p.Leu1418Phe)	BRCA1	L1418F	Hereditary cancer-predisposing syndrome	VCV000441391	17	41234524	17	43082507	441391	435122	rs1555584157	NC_000017.11:43082506:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1418	BRCA1
NM_007294.4(BRCA1):c.4253T>C (p.Leu1418Ser)	BRCA1	L1418S	not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000246517	17	41234525	17	43082508	246517	245030	rs397509157	NC_000017.11:43082507:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1418	BRCA1
NM_007294.4(BRCA1):c.4250T>C (p.Val1417Ala)	BRCA1	V1417A	Colorectal cancer, susceptibility to, 1	VCV003367142	17	41234528	17	43082511	3367142	3526343	NA	NC_000017.11:43082510:A:G	single nucleotide variant	missense variant	Uncertain significance	May 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1417	BRCA1
NM_007294.4(BRCA1):c.4249G>T (p.Val1417Leu)	BRCA1	V1417L	Hereditary cancer-predisposing syndrome	VCV001739051	17	41234529	17	43082512	1739051	1788048	NA	NC_000017.11:43082511:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1417	BRCA1
NM_007294.4(BRCA1):c.4249G>A (p.Val1417Met)	BRCA1	V1417M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462641	17	41234529	17	43082512	462641	468129	rs1029805420	NC_000017.11:43082511:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1417	BRCA1
NM_007294.4(BRCA1):c.4247C>G (p.Ala1416Gly)	BRCA1	A1416G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000824716	17	41234531	17	43082514	824716	813699	rs1597848252	NC_000017.11:43082513:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1416	BRCA1
NM_007294.4(BRCA1):c.4246G>A (p.Ala1416Thr)	BRCA1	A1416T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000491073	17	41234532	17	43082515	491073	485077	rs370999077	NC_000017.11:43082514:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1416	BRCA1
NM_007294.4(BRCA1):c.4243G>C (p.Glu1415Gln)	BRCA1	E1415Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462640	17	41234535	17	43082518	462640	468136	rs1057519558	NC_000017.11:43082517:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 15, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1415	BRCA1
NM_007294.4(BRCA1):c.4243G>A (p.Glu1415Lys)	BRCA1	E1415K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462639	17	41234535	17	43082518	462639	466847	rs1057519558	NC_000017.11:43082517:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1415	BRCA1
NM_007294.4(BRCA1):c.4241T>G (p.Leu1414Arg)	BRCA1	L1414R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000245779	17	41234537	17	43082520	245779	245031	rs878854951	NC_000017.11:43082519:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1414	BRCA1
NM_007294.4(BRCA1):c.4241T>C (p.Leu1414Pro)	BRCA1	L1414P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000240801	17	41234537	17	43082520	240801	242777	rs878854951	NC_000017.11:43082519:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1414	BRCA1
NM_007294.4(BRCA1):c.4240C>G (p.Leu1414Val)	BRCA1	L1414V	Hereditary breast ovarian cancer syndrome	VCV002819115	17	41234538	17	43082521	2819115	2977641	NA	NC_000017.11:43082520:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1414	BRCA1
NM_007294.4(BRCA1):c.4237G>C (p.Glu1413Gln)	BRCA1	E1413Q	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001738950	17	41234541	17	43082524	1738950	1787949	NA	NC_000017.11:43082523:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1413	BRCA1
NM_007294.4(BRCA1):c.4237G>A (p.Glu1413Lys)	BRCA1	E1413K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000824708	17	41234541	17	43082524	824708	813700	rs397509153	NC_000017.11:43082523:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1413	BRCA1
NM_007294.4(BRCA1):c.4234G>C (p.Ala1412Pro)	BRCA1	A1412P	Hereditary breast ovarian cancer syndrome	VCV000650035	17	41234544	17	43082527	650035	645955	rs765183110	NC_000017.11:43082526:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1412	BRCA1
NM_007294.4(BRCA1):c.4234G>A (p.Ala1412Thr)	BRCA1	A1412T	Hereditary cancer-predisposing syndrome	VCV000491072	17	41234544	17	43082527	491072	485336	rs765183110	NC_000017.11:43082526:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1412	BRCA1
NM_007294.4(BRCA1):c.4234G>T (p.Ala1412Ser)	BRCA1	A1412S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489722	17	41234544	17	43082527	489722	482945	rs765183110	NC_000017.11:43082526:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1412	BRCA1
NM_007294.4(BRCA1):c.4233G>A (p.Met1411Ile)	BRCA1	M1411I	Hereditary cancer-predisposing syndrome	VCV000628271	17	41234545	17	43082528	628271	618588	rs1567783458	NC_000017.11:43082527:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1411	BRCA1
NM_007294.4(BRCA1):c.4232T>C (p.Met1411Thr)	BRCA1	M1411T	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055147	17	41234546	17	43082529	55147	69814	rs273900729	NC_000017.11:43082528:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Mar 28, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1411	BRCA1
NM_007294.4(BRCA1):c.4231A>G (p.Met1411Val)	BRCA1	M1411V	Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000141465	17	41234547	17	43082530	141465	151179	rs587781768	NC_000017.11:43082529:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1411	BRCA1
NM_007294.4(BRCA1):c.4229A>T (p.Glu1410Val)	BRCA1	E1410V	Hereditary cancer-predisposing syndrome	VCV000918553	17	41234549	17	43082532	918553	913879	rs2053062712	NC_000017.11:43082531:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1410	BRCA1
NM_007294.4(BRCA1):c.4227G>C (p.Gln1409His)	BRCA1	Q1409H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002774838	17	41234551	17	43082534	2774838	2935565	NA	NC_000017.11:43082533:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1409	BRCA1
NM_007294.4(BRCA1):c.4226A>C (p.Gln1409Pro)	BRCA1	Q1409P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV001992376	17	41234552	17	43082535	1992376	2049024	NA	NC_000017.11:43082534:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1409	BRCA1
NM_007294.4(BRCA1):c.4226A>T (p.Gln1409Leu)	BRCA1	Q1409L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000921480	17	41234552	17	43082535	921480	913880	rs1018305119	NC_000017.11:43082534:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 26, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1409	BRCA1
NM_007294.4(BRCA1):c.4224G>C (p.Gln1408His)	BRCA1	Q1408H	Hereditary breast ovarian cancer syndrome	VCV000694279	17	41234554	17	43082537	694279	682124	rs1597848407	NC_000017.11:43082536:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Aug 30, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1408	BRCA1
NM_007294.4(BRCA1):c.4223A>C (p.Gln1408Pro)	BRCA1	Q1408P	Hereditary breast ovarian cancer syndrome	VCV000531425	17	41234555	17	43082538	531425	531314	rs1555584227	NC_000017.11:43082537:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1408	BRCA1
NM_007294.4(BRCA1):c.4223A>G (p.Gln1408Arg)	BRCA1	Q1408R	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481440	17	41234555	17	43082538	481440	478683	rs1555584227	NC_000017.11:43082537:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1408	BRCA1
NM_007294.4(BRCA1):c.4220T>G (p.Leu1407Arg)	BRCA1	L1407R	Hereditary cancer-predisposing syndrome	VCV000481429	17	41234558	17	43082541	481429	478688	rs80357492	NC_000017.11:43082540:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 22, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1407	BRCA1
NM_007294.4(BRCA1):c.4220T>C (p.Leu1407Pro)	BRCA1	L1407P	Hereditary breast ovarian cancer syndrome	VCV000055144	17	41234558	17	43082541	55144	69811	rs80357492	NC_000017.11:43082540:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1407	BRCA1
NM_007294.4(BRCA1):c.4219C>G (p.Leu1407Val)	BRCA1	L1407V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037576	17	41234559	17	43082542	37576	46132	rs397507227	NC_000017.11:43082541:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1407	BRCA1
NM_007294.4(BRCA1):c.4218G>C (p.Lys1406Asn)	BRCA1	K1406N	Hereditary breast ovarian cancer syndrome	VCV002731680	17	41234560	17	43082543	2731680	2890435	NA	NC_000017.11:43082542:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1406	BRCA1
NM_007294.4(BRCA1):c.4218G>T (p.Lys1406Asn)	BRCA1	K1406N	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000999083	17	41234560	17	43082543	999083	997567	rs1800707	NC_000017.11:43082542:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1406	BRCA1
NM_007294.4(BRCA1):c.4217A>C (p.Lys1406Thr)	BRCA1	K1406T	Hereditary breast ovarian cancer syndrome	VCV001363350	17	41234561	17	43082544	1363350	1489210	rs2154159589	NC_000017.11:43082543:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 23, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1406	BRCA1
NM_007294.4(BRCA1):c.4216A>C (p.Lys1406Gln)	BRCA1	K1406Q	Hereditary breast ovarian cancer syndrome	VCV002842713	17	41234562	17	43082545	2842713	2997419	NA	NC_000017.11:43082544:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1406	BRCA1
NM_007294.4(BRCA1):c.4213A>G (p.Ile1405Val)	BRCA1	I1405V	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037575	17	41234565	17	43082548	37575	46131	rs80357353	NC_000017.11:43082547:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1405	BRCA1
NM_007294.4(BRCA1):c.4211T>G (p.Leu1404Arg)	BRCA1	L1404R	not provided|Hereditary breast ovarian cancer syndrome|Ovarian cancer|Hereditary cancer-predisposing syndrome|not specified	VCV000491071	17	41234567	17	43082550	491071	485125	rs80356916	NC_000017.11:43082549:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1404	BRCA1
NM_007294.4(BRCA1):c.4211T>C (p.Leu1404Pro)	BRCA1	L1404P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055143	17	41234567	17	43082550	55143	69810	rs80356916	NC_000017.11:43082549:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 12, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1404	BRCA1
NM_007294.4(BRCA1):c.4205A>C (p.His1402Pro)	BRCA1	H1402P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000240800	17	41234573	17	43082556	240800	242778	rs80356882	NC_000017.11:43082555:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1402	BRCA1
NM_007294.4(BRCA1):c.4205A>G (p.His1402Arg)	BRCA1	H1402R	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055141	17	41234573	17	43082556	55141	69808	rs80356882	NC_000017.11:43082555:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1402	BRCA1
NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	BRCA1	H1402Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055140	17	41234574	17	43082557	55140	69807	rs80357365	NC_000017.11:43082556:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1402	BRCA1
NM_007294.4(BRCA1):c.4203A>T (p.Gln1401His)	BRCA1	Q1401H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000941274	17	41234575	17	43082558	941274	937947	rs2053067871	NC_000017.11:43082557:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1401	BRCA1
NM_007294.4(BRCA1):c.4201C>A (p.Gln1401Lys)	BRCA1	Q1401K	Hereditary cancer-predisposing syndrome	VCV002774839	17	41234577	17	43082560	2774839	2935566	NA	NC_000017.11:43082559:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1401	BRCA1
NM_007294.4(BRCA1):c.4200G>C (p.Met1400Ile)	BRCA1	M1400I	not provided	VCV000801074	17	41234578	17	43082561	801074	789619	rs374416358	NC_000017.11:43082560:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 2, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1400	BRCA1
NM_007294.4(BRCA1):c.4199T>A (p.Met1400Lys)	BRCA1	M1400K	Hereditary breast ovarian cancer syndrome	VCV000653845	17	41234579	17	43082562	653845	645957	rs80357473	NC_000017.11:43082561:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 9, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1400	BRCA1
NM_007294.4(BRCA1):c.4199T>C (p.Met1400Thr)	BRCA1	M1400T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000055138	17	41234579	17	43082562	55138	69805	rs80357473	NC_000017.11:43082561:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1400	BRCA1
NM_007294.4(BRCA1):c.4198A>G (p.Met1400Val)	BRCA1	M1400V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055137	17	41234580	17	43082563	55137	69804	rs80357306	NC_000017.11:43082562:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1400	BRCA1
NM_007294.4(BRCA1):c.4196C>G (p.Thr1399Ser)	BRCA1	T1399S	Hereditary cancer-predisposing syndrome	VCV000230250	17	41234582	17	43082565	230250	235977	rs876658465	NC_000017.11:43082564:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1399	BRCA1
NM_007294.4(BRCA1):c.4195A>G (p.Thr1399Ala)	BRCA1	T1399A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001424745	17	41234583	17	43082566	1424745	1353255	rs2154162286	NC_000017.11:43082565:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1399	BRCA1
NM_007294.4(BRCA1):c.4193A>T (p.Asp1398Val)	BRCA1	D1398V	Hereditary breast ovarian cancer syndrome	VCV001064293	17	41234585	17	43082568	1064293	1050289	rs761640584	NC_000017.11:43082567:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1398	BRCA1
NM_007294.4(BRCA1):c.4193A>G (p.Asp1398Gly)	BRCA1	D1398G	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216667	17	41234585	17	43082568	216667	213314	rs761640584	NC_000017.11:43082567:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1398	BRCA1
NM_007294.4(BRCA1):c.4192G>A (p.Asp1398Asn)	BRCA1	D1398N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000650198	17	41234586	17	43082569	650198	645958	rs876660331	NC_000017.11:43082568:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 19, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1398	BRCA1
NM_007294.4(BRCA1):c.4192G>T (p.Asp1398Tyr)	BRCA1	D1398Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233320	17	41234586	17	43082569	233320	235978	rs876660331	NC_000017.11:43082568:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 18, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1398	BRCA1
NM_007294.4(BRCA1):c.4191G>T (p.Arg1397Ser)	BRCA1	R1397S	Hereditary cancer-predisposing syndrome	VCV001738577	17	41234587	17	43082570	1738577	1790910	NA	NC_000017.11:43082569:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1397	BRCA1
NM_007294.4(BRCA1):c.4190G>A (p.Arg1397Lys)	BRCA1	R1397K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630120	17	41234588	17	43082571	630120	618589	rs767421571	NC_000017.11:43082570:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1397	BRCA1
NM_007294.4(BRCA1):c.4189A>G (p.Arg1397Gly)	BRCA1	R1397G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001508878	17	41234589	17	43082572	1508878	1451995	rs886037792	NC_000017.11:43082571:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1397	BRCA1
NM_007294.4(BRCA1):c.4186C>G (p.Gln1396Glu)	BRCA1	Q1396E	Hereditary cancer-predisposing syndrome	VCV002450696	17	41234592	17	43082575	2450696	2423182	NA	NC_000017.11:43082574:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1396	BRCA1
NM_007294.4(BRCA1):c.4186C>A (p.Gln1396Lys)	BRCA1	Q1396K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000182160	17	41234592	17	43082575	182160	180834	rs80357011	NC_000017.11:43082574:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1396	BRCA1
NM_007294.4(BRCA1):c.4185G>T (p.Gln1395His)	BRCA1	Q1395H	Hereditary breast ovarian cancer syndrome	VCV001410374	17	41242961	17	43090944	1410374	1513681	rs80356857	NC_000017.11:43090943:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1395	BRCA1
NM_007294.4(BRCA1):c.4185G>C (p.Gln1395His)	BRCA1	Q1395H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232793	17	41242961	17	43090944	232793	235979	rs80356857	NC_000017.11:43090943:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1395	BRCA1
NM_007294.4(BRCA1):c.4184A>G (p.Gln1395Arg)	BRCA1	Q1395R	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055127	17	41242962	17	43090945	55127	69794	rs80356972	NC_000017.11:43090944:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1395	BRCA1
NM_007294.4(BRCA1):c.4183C>G (p.Gln1395Glu)	BRCA1	Q1395E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001513251	17	41242963	17	43090946	1513251	1472306	rs80357260	NC_000017.11:43090945:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1395	BRCA1
NM_007294.4(BRCA1):c.4181C>T (p.Thr1394Ile)	BRCA1	T1394I	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000037573	17	41242965	17	43090948	37573	46129	rs397507226	NC_000017.11:43090947:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1394	BRCA1
NM_007294.4(BRCA1):c.4180A>C (p.Thr1394Pro)	BRCA1	T1394P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000462637	17	41242966	17	43090949	462637	466853	rs1555586062	NC_000017.11:43090948:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1394	BRCA1
NM_007294.4(BRCA1):c.4178C>G (p.Thr1393Ser)	BRCA1	T1393S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000531373	17	41242968	17	43090951	531373	531317	rs1555586071	NC_000017.11:43090950:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1393	BRCA1
NM_007294.4(BRCA1):c.4177A>G (p.Thr1393Ala)	BRCA1	T1393A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142985	17	41242969	17	43090952	142985	152699	rs587782870	NC_000017.11:43090951:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1393	BRCA1
NM_007294.4(BRCA1):c.4175T>C (p.Leu1392Ser)	BRCA1	L1392S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000578485	17	41242971	17	43090954	578485	569111	rs778319854	NC_000017.11:43090953:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1392	BRCA1
NM_007294.4(BRCA1):c.4172T>G (p.Ile1391Ser)	BRCA1	I1391S	Hereditary breast ovarian cancer syndrome	VCV000462636	17	41242974	17	43090957	462636	467688	rs397509146	NC_000017.11:43090956:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 5, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1391	BRCA1
NM_007294.4(BRCA1):c.4172T>C (p.Ile1391Thr)	BRCA1	I1391T	not specified	VCV000055123	17	41242974	17	43090957	55123	69790	rs397509146	NC_000017.11:43090956:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1391	BRCA1
NM_007294.4(BRCA1):c.4171A>G (p.Ile1391Val)	BRCA1	I1391V	Hereditary breast ovarian cancer syndrome	VCV000648881	17	41242975	17	43090958	648881	645959	rs1597858078	NC_000017.11:43090957:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1391	BRCA1
NM_007294.4(BRCA1):c.4169A>G (p.Asp1390Gly)	BRCA1	D1390G	not provided|Hereditary breast ovarian cancer syndrome	VCV000496377	17	41242977	17	43090960	496377	487713	rs1165149350	NC_000017.11:43090959:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1390	BRCA1
NM_007294.4(BRCA1):c.4168G>A (p.Asp1390Asn)	BRCA1	D1390N	Hereditary breast ovarian cancer syndrome|not provided	VCV000462635	17	41242978	17	43090961	462635	467689	rs752300203	NC_000017.11:43090960:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1390	BRCA1
NM_007294.4(BRCA1):c.4166G>A (p.Ser1389Asn)	BRCA1	S1389N	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055119	17	41242980	17	43090963	55119	69786	rs78951648	NC_000017.11:43090962:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1389	BRCA1
NM_007294.4(BRCA1):c.4165A>C (p.Ser1389Arg)	BRCA1	S1389R	Hereditary breast ovarian cancer syndrome	VCV000945108	17	41242981	17	43090964	945108	928284	rs2053435043	NC_000017.11:43090963:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1389	BRCA1
NM_007294.4(BRCA1):c.4164G>T (p.Gln1388His)	BRCA1	Q1388H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001738365	17	41242982	17	43090965	1738365	1790698	NA	NC_000017.11:43090964:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1388	BRCA1
NM_007294.4(BRCA1):c.4163A>G (p.Gln1388Arg)	BRCA1	Q1388R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001020675	17	41242983	17	43090966	1020675	1012768	rs1246721860	NC_000017.11:43090965:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1388	BRCA1
NM_007294.4(BRCA1):c.4162C>A (p.Gln1388Lys)	BRCA1	Q1388K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001005980	17	41242984	17	43090967	1005980	997568	rs876660601	NC_000017.11:43090966:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1388	BRCA1
NM_007294.4(BRCA1):c.4160C>G (p.Ser1387Cys)	BRCA1	S1387C	Hereditary cancer-predisposing syndrome	VCV002585845	17	41242986	17	43090969	2585845	2753405	NA	NC_000017.11:43090968:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1387	BRCA1
NM_007294.4(BRCA1):c.4159T>C (p.Ser1387Pro)	BRCA1	S1387P	Breast-ovarian cancer, familial, susceptibility to, 1|Ovarian cancer|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm	VCV000224433	17	41242987	17	43090970	224433	226198	rs876658221	NC_000017.11:43090969:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1387	BRCA1
NM_007294.4(BRCA1):c.4154T>A (p.Leu1385Gln)	BRCA1	L1385Q	Hereditary cancer-predisposing syndrome	VCV001738287	17	41242992	17	43090975	1738287	1797521	NA	NC_000017.11:43090974:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1385	BRCA1
NM_007294.4(BRCA1):c.4154T>C (p.Leu1385Pro)	BRCA1	L1385P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000808279	17	41242992	17	43090975	808279	797546	rs1597858317	NC_000017.11:43090974:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1385	BRCA1
NM_007294.4(BRCA1):c.4153C>G (p.Leu1385Val)	BRCA1	L1385V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001497111	17	41242993	17	43090976	1497111	1475732	rs2154253619	NC_000017.11:43090975:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1385	BRCA1
NM_007294.4(BRCA1):c.4151G>A (p.Gly1384Glu)	BRCA1	G1384E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187199	17	41242995	17	43090978	187199	184934	rs786203545	NC_000017.11:43090977:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 25, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1384	BRCA1
NM_007294.4(BRCA1):c.4150G>T (p.Gly1384Trp)	BRCA1	G1384W	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000964444	17	41242996	17	43090979	964444	949933	rs1555586146	NC_000017.11:43090978:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1384	BRCA1
NM_007294.4(BRCA1):c.4150G>A (p.Gly1384Arg)	BRCA1	G1384R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462634	17	41242996	17	43090979	462634	467923	rs1555586146	NC_000017.11:43090978:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1384	BRCA1
NM_007294.4(BRCA1):c.4148C>T (p.Ser1383Leu)	BRCA1	S1383L	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000418953	17	41242998	17	43090981	418953	409969	rs80357071	NC_000017.11:43090980:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1383	BRCA1
NM_007294.4(BRCA1):c.4147T>C (p.Ser1383Pro)	BRCA1	S1383P	Hereditary cancer-predisposing syndrome	VCV000926722	17	41242999	17	43090982	926722	913881	rs2053438954	NC_000017.11:43090981:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1383	BRCA1
NM_007294.4(BRCA1):c.4144T>A (p.Cys1382Ser)	BRCA1	C1382S	not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000185348	17	41243002	17	43090985	185348	184935	rs786202106	NC_000017.11:43090984:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1382	BRCA1
NM_007294.4(BRCA1):c.4143C>A (p.Asp1381Glu)	BRCA1	D1381E	Hereditary cancer-predisposing syndrome	VCV001738179	17	41243003	17	43090986	1738179	1797415	NA	NC_000017.11:43090985:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1381	BRCA1
NM_007294.4(BRCA1):c.4143C>G (p.Asp1381Glu)	BRCA1	D1381E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000628110	17	41243003	17	43090986	628110	618591	rs1567788391	NC_000017.11:43090985:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1381	BRCA1
NM_007294.4(BRCA1):c.4138G>A (p.Glu1380Lys)	BRCA1	E1380K	Hereditary breast ovarian cancer syndrome	VCV002752886	17	41243008	17	43090991	2752886	2913627	NA	NC_000017.11:43090990:C:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1380	BRCA1
NM_007294.4(BRCA1):c.4133T>C (p.Val1378Ala)	BRCA1	V1378A	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000632684	17	41243013	17	43090996	632684	621574	rs1567788422	NC_000017.11:43090995:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1378	BRCA1
NM_007294.4(BRCA1):c.4132G>T (p.Val1378Phe)	BRCA1	V1378F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482891	17	41243014	17	43090997	482891	478638	rs28897690	NC_000017.11:43090996:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1378	BRCA1
NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	BRCA1	V1378I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055111	17	41243014	17	43090997	55111	69778	rs28897690	NC_000017.11:43090996:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1378	BRCA1
NM_007294.4(BRCA1):c.4131C>A (p.Ser1377Arg)	BRCA1	S1377R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055110	17	41243015	17	43090998	55110	69777	rs80356871	NC_000017.11:43090997:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1377	BRCA1
NM_007294.4(BRCA1):c.4130G>A (p.Ser1377Asn)	BRCA1	S1377N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000627743	17	41243016	17	43090999	627743	618592	rs1567788442	NC_000017.11:43090998:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1377	BRCA1
NM_007294.4(BRCA1):c.4129A>G (p.Ser1377Gly)	BRCA1	S1377G	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000182159	17	41243017	17	43091000	182159	180835	rs730881491	NC_000017.11:43090999:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1377	BRCA1
NM_007294.4(BRCA1):c.4127C>G (p.Thr1376Arg)	BRCA1	T1376R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000037571	17	41243019	17	43091002	37571	46127	rs80356986	NC_000017.11:43091001:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1376	BRCA1
NM_007294.4(BRCA1):c.4126A>G (p.Thr1376Ala)	BRCA1	T1376A	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000824612	17	41243020	17	43091003	824612	813703	rs576828558	NC_000017.11:43091002:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1376	BRCA1
NM_007294.4(BRCA1):c.4124A>G (p.Glu1375Gly)	BRCA1	E1375G	Hereditary breast ovarian cancer syndrome	VCV001432384	17	41243022	17	43091005	1432384	1484495	rs2154256106	NC_000017.11:43091004:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1375	BRCA1
NM_007294.4(BRCA1):c.4123G>A (p.Glu1375Lys)	BRCA1	E1375K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491067	17	41243023	17	43091006	491067	485341	rs80357397	NC_000017.11:43091005:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1375	BRCA1
NM_007294.4(BRCA1):c.4122T>A (p.Ser1374Arg)	BRCA1	S1374R	Hereditary breast ovarian cancer syndrome|not specified	VCV000440472	17	41243024	17	43091007	440472	432902	rs1555586200	NC_000017.11:43091006:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 24, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1374	BRCA1
NM_007294.4(BRCA1):c.4121G>A (p.Ser1374Asn)	BRCA1	S1374N	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000583140	17	41243025	17	43091008	583140	569117	rs1382449149	NC_000017.11:43091007:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1374	BRCA1
NM_007294.4(BRCA1):c.4120A>T (p.Ser1374Cys)	BRCA1	S1374C	Hereditary cancer-predisposing syndrome	VCV002565358	17	41243026	17	43091009	2565358	2732331	NA	NC_000017.11:43091008:T:A	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1374	BRCA1
NM_007294.4(BRCA1):c.4120A>G (p.Ser1374Gly)	BRCA1	S1374G	Hereditary cancer-predisposing syndrome	VCV001738022	17	41243026	17	43091009	1738022	1797258	NA	NC_000017.11:43091008:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1374	BRCA1
NM_007294.4(BRCA1):c.4117G>A (p.Glu1373Lys)	BRCA1	E1373K	Hereditary breast ovarian cancer syndrome	VCV002836573	17	41243029	17	43091012	2836573	3002345	NA	NC_000017.11:43091011:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1373	BRCA1
NM_007294.4(BRCA1):c.4115G>T (p.Cys1372Phe)	BRCA1	C1372F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001737955	17	41243031	17	43091014	1737955	1797191	NA	NC_000017.11:43091013:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1372	BRCA1
NM_007294.4(BRCA1):c.4115G>A (p.Cys1372Tyr)	BRCA1	C1372Y	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055105	17	41243031	17	43091014	55105	69772	rs55848034	NC_000017.11:43091013:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1372	BRCA1
NM_007294.4(BRCA1):c.4112G>C (p.Gly1371Ala)	BRCA1	G1371A	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000993166	17	41243034	17	43091017	993166	981163	rs1441376381	NC_000017.11:43091016:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1371	BRCA1
NM_007294.4(BRCA1):c.4111G>A (p.Gly1371Arg)	BRCA1	G1371R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630121	17	41243035	17	43091018	630121	618593	rs774593602	NC_000017.11:43091017:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1371	BRCA1
NM_007294.4(BRCA1):c.4111G>C (p.Gly1371Arg)	BRCA1	G1371R	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000185744	17	41243035	17	43091018	185744	184937	rs774593602	NC_000017.11:43091017:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1371	BRCA1
NM_007294.4(BRCA1):c.4108T>C (p.Ser1370Pro)	BRCA1	S1370P	Hereditary breast ovarian cancer syndrome	VCV002125868	17	41243038	17	43091021	2125868	2185037	NA	NC_000017.11:43091020:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1370	BRCA1
NM_007294.4(BRCA1):c.4105G>T (p.Ala1369Ser)	BRCA1	A1369S	Hereditary cancer-predisposing syndrome	VCV001737880	17	41243041	17	43091024	1737880	1787743	NA	NC_000017.11:43091023:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 17, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1369	BRCA1
NM_007294.4(BRCA1):c.4105G>A (p.Ala1369Thr)	BRCA1	A1369T	Hereditary breast ovarian cancer syndrome	VCV001024990	17	41243041	17	43091024	1024990	1012769	rs1597858676	NC_000017.11:43091023:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1369	BRCA1
NM_007294.4(BRCA1):c.4105G>C (p.Ala1369Pro)	BRCA1	A1369P	Hereditary breast ovarian cancer syndrome	VCV000663808	17	41243041	17	43091024	663808	645961	rs1597858676	NC_000017.11:43091023:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 18, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1369	BRCA1
NM_007294.4(BRCA1):c.4103C>T (p.Ala1368Val)	BRCA1	A1368V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000824595	17	41243043	17	43091026	824595	813704	rs1385360559	NC_000017.11:43091025:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1368	BRCA1
NM_007294.4(BRCA1):c.4102G>A (p.Ala1368Thr)	BRCA1	A1368T	not provided|Hereditary breast ovarian cancer syndrome	VCV000423494	17	41243044	17	43091027	423494	409971	rs1064796463	NC_000017.11:43091026:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 30, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1368	BRCA1
NM_007294.4(BRCA1):c.4099G>A (p.Glu1367Lys)	BRCA1	E1367K	Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000245679	17	41243047	17	43091030	245679	245032	rs786202998	NC_000017.11:43091029:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 21, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1367	BRCA1
NM_007294.4(BRCA1):c.4097G>A (p.Gly1366Asp)	BRCA1	G1366D	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000234236	17	41243049	17	43091032	234236	235982	rs876660948	NC_000017.11:43091031:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1366	BRCA1
NM_007294.4(BRCA1):c.4096G>C (p.Gly1366Arg)	BRCA1|LOC126862571	G1366R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441362	17	41243452	17	43091435	441362	435123	rs431825405	NC_000017.11:43091434:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 7, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1366	BRCA1
NM_007294.4(BRCA1):c.4096G>A (p.Gly1366Ser)	BRCA1|LOC126862571	G1366S	not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096925	17	41243452	17	43091435	96925	102828	rs431825405	NC_000017.11:43091434:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1366	BRCA1
NM_007294.4(BRCA1):c.4093T>G (p.Leu1365Val)	BRCA1|LOC126862571	L1365V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000634740	17	41243455	17	43091438	634740	622561	rs1567788936	NC_000017.11:43091437:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1365	BRCA1
NM_007294.4(BRCA1):c.4092C>G (p.Asn1364Lys)	BRCA1|LOC126862571	N1364K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001992957	17	41243456	17	43091439	1992957	2052610	NA	NC_000017.11:43091438:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1364	BRCA1
NM_007294.4(BRCA1):c.4091A>C (p.Asn1364Thr)	BRCA1|LOC126862571	N1364T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000950528	17	41243457	17	43091440	950528	928285	rs765156052	NC_000017.11:43091439:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1364	BRCA1
NM_007294.4(BRCA1):c.4088C>T (p.Ser1363Leu)	BRCA1|LOC126862571	S1363L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000091622	17	41243460	17	43091443	91622	97099	rs398122680	NC_000017.11:43091442:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1363	BRCA1
NM_007294.4(BRCA1):c.4086T>A (p.Asp1362Glu)	BRCA1|LOC126862571	D1362E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001379235	17	41243462	17	43091445	1379235	1486464	rs2154264837	NC_000017.11:43091444:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1362	BRCA1
NM_007294.4(BRCA1):c.4085A>T (p.Asp1362Val)	LOC126862571|BRCA1	D1362V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000824578	17	41243463	17	43091446	824578	813705	rs1597859423	NC_000017.11:43091445:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1362	BRCA1
NM_007294.4(BRCA1):c.4084G>T (p.Asp1362Tyr)	BRCA1|LOC126862571	D1362Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001737655	17	41243464	17	43091447	1737655	1787519	NA	NC_000017.11:43091446:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1362	BRCA1
NM_007294.4(BRCA1):c.4084G>C (p.Asp1362His)	BRCA1|LOC126862571	D1362H	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001463398	17	41243464	17	43091447	1463398	1507961	rs775463394	NC_000017.11:43091446:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1362	BRCA1
NM_007294.4(BRCA1):c.4084G>A (p.Asp1362Asn)	BRCA1|LOC126862571	D1362N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000575669	17	41243464	17	43091447	575669	569119	rs775463394	NC_000017.11:43091446:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1362	BRCA1
NM_007294.4(BRCA1):c.4083G>A (p.Met1361Ile)	BRCA1|LOC126862571	M1361I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000037564	17	41243465	17	43091448	37564	46120	rs374192364	NC_000017.11:43091447:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1361	BRCA1
NM_007294.4(BRCA1):c.4082T>C (p.Met1361Thr)	BRCA1|LOC126862571	M1361T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000648735	17	41243466	17	43091449	648735	645962	rs763596987	NC_000017.11:43091448:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1361	BRCA1
NM_007294.4(BRCA1):c.4081A>T (p.Met1361Leu)	BRCA1|LOC126862571	M1361L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000812551	17	41243467	17	43091450	812551	800791	rs80357218	NC_000017.11:43091449:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1361	BRCA1
NM_007294.4(BRCA1):c.4081A>G (p.Met1361Val)	BRCA1|LOC126862571	M1361V	not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000185881	17	41243467	17	43091450	185881	184940	rs80357218	NC_000017.11:43091449:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1361	BRCA1
NM_007294.4(BRCA1):c.4081A>C (p.Met1361Leu)	BRCA1|LOC126862571	M1361L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055099	17	41243467	17	43091450	55099	69766	rs80357218	NC_000017.11:43091449:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1361	BRCA1
NM_007294.4(BRCA1):c.4080C>G (p.Ser1360Arg)	BRCA1|LOC126862571	S1360R	Hereditary cancer-predisposing syndrome|not specified	VCV000928523	17	41243468	17	43091451	928523	917249	rs2053471401	NC_000017.11:43091450:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1360	BRCA1
NM_007294.4(BRCA1):c.4079G>A (p.Ser1360Asn)	BRCA1|LOC126862571	S1360N	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV001060654	17	41243469	17	43091452	1060654	1050290	rs2154265376	NC_000017.11:43091451:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1360	BRCA1
NM_007294.4(BRCA1):c.4076A>G (p.Gln1359Arg)	BRCA1|LOC126862571	Q1359R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001345247	17	41243472	17	43091455	1345247	1443213	rs1567789002	NC_000017.11:43091454:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1359	BRCA1
NM_007294.4(BRCA1):c.4075C>A (p.Gln1359Lys)	BRCA1|LOC126862571	Q1359K	not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000801073	17	41243473	17	43091456	801073	789620	rs80357456	NC_000017.11:43091455:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1359	BRCA1
NM_007294.4(BRCA1):c.4075C>G (p.Gln1359Glu)	BRCA1|LOC126862571	Q1359E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037563	17	41243473	17	43091456	37563	46119	rs80357456	NC_000017.11:43091455:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1359	BRCA1
NM_007294.4(BRCA1):c.4073A>T (p.Glu1358Val)	BRCA1|LOC126862571	E1358V	Hereditary breast ovarian cancer syndrome	VCV002814991	17	41243475	17	43091458	2814991	2973521	NA	NC_000017.11:43091457:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1358	BRCA1
NM_007294.4(BRCA1):c.4073A>G (p.Glu1358Gly)	BRCA1|LOC126862571	E1358G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided	VCV000037562	17	41243475	17	43091458	37562	46118	rs397507225	NC_000017.11:43091457:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1358	BRCA1
NM_007294.4(BRCA1):c.4072G>A (p.Glu1358Lys)	LOC126862571|BRCA1	E1358K	Hereditary cancer-predisposing syndrome	VCV000055096	17	41243476	17	43091459	55096	69763	rs397509136	NC_000017.11:43091458:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1358	BRCA1
NM_007294.4(BRCA1):c.4071A>T (p.Glu1357Asp)	LOC126862571|BRCA1	E1357D	not specified|Hereditary cancer-predisposing syndrome	VCV000489720	17	41243477	17	43091460	489720	482958	rs786201475	NC_000017.11:43091459:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1357	BRCA1
NM_007294.4(BRCA1):c.4069G>C (p.Glu1357Gln)	BRCA1|LOC126862571	E1357Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000838493	17	41243479	17	43091462	838493	845390	rs886040195	NC_000017.11:43091461:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1357	BRCA1
NM_007294.4(BRCA1):c.4067A>T (p.Gln1356Leu)	BRCA1|LOC126862571	Q1356L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001394899	17	41243481	17	43091464	1394899	1415788	rs2154266330	NC_000017.11:43091463:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1356	BRCA1
NM_007294.4(BRCA1):c.4066C>A (p.Gln1356Lys)	BRCA1|LOC126862571	Q1356K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001345033	17	41243482	17	43091465	1345033	1336853	rs886040193	NC_000017.11:43091464:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1356	BRCA1
NM_007294.4(BRCA1):c.4064A>G (p.Asn1355Ser)	BRCA1|LOC126862571	N1355S	Hereditary cancer-predisposing syndrome	VCV000629008	17	41243484	17	43091467	629008	618594	rs1567789081	NC_000017.11:43091466:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1355	BRCA1
NM_007294.4(BRCA1):c.4063A>G (p.Asn1355Asp)	BRCA1|LOC126862571	N1355D	not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233624	17	41243485	17	43091468	233624	235983	rs876660530	NC_000017.11:43091467:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1355	BRCA1
NM_007294.4(BRCA1):c.4061A>G (p.Asn1354Ser)	BRCA1|LOC126862571	N1354S	not provided|Hereditary cancer-predisposing syndrome	VCV000496375	17	41243487	17	43091470	496375	487958	rs767246037	NC_000017.11:43091469:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1354	BRCA1
NM_007294.4(BRCA1):c.4060A>G (p.Asn1354Asp)	BRCA1|LOC126862571	N1354D	Hereditary breast ovarian cancer syndrome	VCV002861842	17	41243488	17	43091471	2861842	3029204	NA	NC_000017.11:43091470:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1354	BRCA1
NM_007294.4(BRCA1):c.4057G>A (p.Glu1353Lys)	BRCA1|LOC126862571	E1353K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000655565	17	41243491	17	43091474	655565	645963	rs80357178	NC_000017.11:43091473:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1353	BRCA1
NM_007294.4(BRCA1):c.4055A>G (p.Glu1352Gly)	BRCA1|LOC126862571	E1352G	Hereditary cancer-predisposing syndrome|not provided	VCV002442604	17	41243493	17	43091476	2442604	2416315	NA	NC_000017.11:43091475:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1352	BRCA1
NM_007294.4(BRCA1):c.4055A>T (p.Glu1352Val)	BRCA1|LOC126862571	E1352V	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000246375	17	41243493	17	43091476	246375	245033	rs879254228	NC_000017.11:43091475:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1352	BRCA1
NM_007294.4(BRCA1):c.4054G>C (p.Glu1352Gln)	BRCA1|LOC126862571	E1352Q	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000481150	17	41243494	17	43091477	481150	478694	rs80357202	NC_000017.11:43091476:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1352	BRCA1
NM_007294.4(BRCA1):c.4054G>A (p.Glu1352Lys)	BRCA1|LOC126862571	E1352K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055089	17	41243494	17	43091477	55089	69756	rs80357202	NC_000017.11:43091476:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1352	BRCA1
NM_007294.4(BRCA1):c.4049G>T (p.Gly1350Val)	BRCA1|LOC126862571	G1350V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462631	17	41243499	17	43091482	462631	467924	rs1433564897	NC_000017.11:43091481:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1350	BRCA1
NM_007294.4(BRCA1):c.4048G>A (p.Gly1350Ser)	BRCA1|LOC126862571	G1350S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001376445	17	41243500	17	43091483	1376445	1466977	rs748674194	NC_000017.11:43091482:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1350	BRCA1
NM_007294.4(BRCA1):c.4048G>C (p.Gly1350Arg)	BRCA1|LOC126862571	G1350R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462630	17	41243500	17	43091483	462630	467699	rs748674194	NC_000017.11:43091482:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1350	BRCA1
NM_007294.4(BRCA1):c.4048G>T (p.Gly1350Cys)	BRCA1|LOC126862571	G1350C	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000231563	17	41243500	17	43091483	231563	235984	rs748674194	NC_000017.11:43091482:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1350	BRCA1
NM_007294.4(BRCA1):c.4046C>G (p.Thr1349Arg)	BRCA1|LOC126862571	T1349R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000462629	17	41243502	17	43091485	462629	468143	rs80357345	NC_000017.11:43091484:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1349	BRCA1
NM_007294.4(BRCA1):c.4046C>T (p.Thr1349Met)	BRCA1|LOC126862571	T1349M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055085	17	41243502	17	43091485	55085	69752	rs80357345	NC_000017.11:43091484:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1349	BRCA1
NM_007294.4(BRCA1):c.4045A>G (p.Thr1349Ala)	BRCA1|LOC126862571	T1349A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462628	17	41243503	17	43091486	462628	467927	rs80357231	NC_000017.11:43091485:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1349	BRCA1
NM_007294.4(BRCA1):c.4045A>C (p.Thr1349Pro)	BRCA1|LOC126862571	T1349P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055084	17	41243503	17	43091486	55084	69751	rs80357231	NC_000017.11:43091485:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1349	BRCA1
NM_007294.4(BRCA1):c.4043G>A (p.Gly1348Glu)	BRCA1|LOC126862571	G1348E	not specified	VCV003339194	17	41243505	17	43091488	3339194	3498461	NA	NC_000017.11:43091487:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1348	BRCA1
NM_007294.4(BRCA1):c.4043G>T (p.Gly1348Val)	BRCA1|LOC126862571	G1348V	Hereditary cancer-predisposing syndrome	VCV001737302	17	41243505	17	43091488	1737302	1790501	NA	NC_000017.11:43091487:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1348	BRCA1
NM_007294.4(BRCA1):c.4040G>T (p.Arg1347Ile)	BRCA1|LOC126862571	R1347I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002113170	17	41243508	17	43091491	2113170	2164458	NA	NC_000017.11:43091490:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1347	BRCA1
NM_007294.4(BRCA1):c.4040G>A (p.Arg1347Lys)	BRCA1|LOC126862571	R1347K	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000055081	17	41243508	17	43091491	55081	69748	rs80357210	NC_000017.11:43091490:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1347	BRCA1
NM_007294.4(BRCA1):c.4039A>G (p.Arg1347Gly)	BRCA1|LOC126862571	R1347G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041821	17	41243509	17	43091492	41821	50260	rs28897689	NC_000017.11:43091491:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1347	BRCA1
NM_007294.4(BRCA1):c.4038A>C (p.Glu1346Asp)	BRCA1|LOC126862571	E1346D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000936376	17	41243510	17	43091493	936376	937948	rs2053480824	NC_000017.11:43091492:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1346	BRCA1
NM_007294.4(BRCA1):c.4037A>G (p.Glu1346Gly)	BRCA1|LOC126862571	E1346G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001022374	17	41243511	17	43091494	1022374	1012770	rs2053481117	NC_000017.11:43091493:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1346	BRCA1
NM_007294.4(BRCA1):c.4036G>A (p.Glu1346Lys)	BRCA1|LOC126862571	E1346K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000037561	17	41243512	17	43091495	37561	46117	rs80357407	NC_000017.11:43091494:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1346	BRCA1
NM_007294.4(BRCA1):c.4035A>T (p.Glu1345Asp)	BRCA1|LOC126862571	E1345D	Hereditary breast ovarian cancer syndrome	VCV003009099	17	41243513	17	43091496	3009099	3159105	NA	NC_000017.11:43091495:T:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Mar 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1345	BRCA1
NM_007294.4(BRCA1):c.4034A>T (p.Glu1345Val)	BRCA1|LOC126862571	E1345V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824526	17	41243514	17	43091497	824526	813708	rs745638837	NC_000017.11:43091496:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1345	BRCA1
NM_007294.4(BRCA1):c.4032T>A (p.Asp1344Glu)	BRCA1|LOC126862571	D1344E	not specified|Hereditary cancer-predisposing syndrome	VCV000917791	17	41243516	17	43091499	917791	906103	rs769589630	NC_000017.11:43091498:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1344	BRCA1
NM_007294.4(BRCA1):c.4031A>G (p.Asp1344Gly)	BRCA1|LOC126862571	D1344G	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055077	17	41243517	17	43091500	55077	69744	rs55639854	NC_000017.11:43091499:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1344	BRCA1
NM_007294.4(BRCA1):c.4028A>G (p.Asp1343Gly)	BRCA1|LOC126862571	D1343G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001421304	17	41243520	17	43091503	1421304	1422720	rs775339017	NC_000017.11:43091502:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1343	BRCA1
NM_007294.4(BRCA1):c.4028A>T (p.Asp1343Val)	BRCA1|LOC126862571	D1343V	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000409318	17	41243520	17	43091503	409318	402661	rs775339017	NC_000017.11:43091502:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1343	BRCA1
NM_007294.4(BRCA1):c.4027G>C (p.Asp1343His)	BRCA1|LOC126862571	D1343H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000951602	17	41243521	17	43091504	951602	928286	rs1160287128	NC_000017.11:43091503:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1343	BRCA1
NM_007294.4(BRCA1):c.4027G>T (p.Asp1343Tyr)	BRCA1|LOC126862571	D1343Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479227	17	41243521	17	43091504	479227	478570	rs1160287128	NC_000017.11:43091503:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1343	BRCA1
NM_007294.4(BRCA1):c.4024T>A (p.Ser1342Thr)	LOC126862571|BRCA1	S1342T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001466282	17	41243524	17	43091507	1466282	1449107	rs2154268924	NC_000017.11:43091506:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1342	BRCA1
NM_007294.4(BRCA1):c.4022T>C (p.Val1341Ala)	BRCA1|LOC126862571	V1341A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001720861	17	41243526	17	43091509	1720861	1774843	NA	NC_000017.11:43091508:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1341	BRCA1
NM_007294.4(BRCA1):c.4021G>A (p.Val1341Ile)	BRCA1|LOC126862571	V1341I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479257	17	41243527	17	43091510	479257	479332	rs762908108	NC_000017.11:43091509:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1341	BRCA1
NM_007294.4(BRCA1):c.4020G>T (p.Leu1340Phe)	BRCA1|LOC126862571	L1340F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441310	17	41243528	17	43091511	441310	435125	rs1555586637	NC_000017.11:43091510:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1340	BRCA1
NM_007294.4(BRCA1):c.4016A>T (p.Glu1339Val)	BRCA1|LOC126862571	E1339V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001717903	17	41243532	17	43091515	1717903	1771879	NA	NC_000017.11:43091514:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1339	BRCA1
NM_007294.4(BRCA1):c.4016A>G (p.Glu1339Gly)	BRCA1|LOC126862571	E1339G	not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000265050	17	41243532	17	43091515	265050	260172	rs886039313	NC_000017.11:43091514:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1339	BRCA1
NM_007294.4(BRCA1):c.4015G>A (p.Glu1339Lys)	BRCA1|LOC126862571	E1339K	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000182157	17	41243533	17	43091516	182157	180837	rs80357021	NC_000017.11:43091515:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1339	BRCA1
NM_007294.4(BRCA1):c.4013A>G (p.Lys1338Arg)	BRCA1|LOC126862571	K1338R	Hereditary cancer-predisposing syndrome|not provided	VCV000496374	17	41243535	17	43091518	496374	487959	rs1555586661	NC_000017.11:43091517:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1338	BRCA1
NM_007294.4(BRCA1):c.4011C>G (p.Asp1337Glu)	BRCA1|LOC126862571	D1337E	Hereditary cancer-predisposing syndrome	VCV000055075	17	41243537	17	43091520	55075	69742	rs80356886	NC_000017.11:43091519:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1337	BRCA1
NM_007294.4(BRCA1):c.4009G>T (p.Asp1337Tyr)	BRCA1|LOC126862571	D1337Y	not provided	VCV002580697	17	41243539	17	43091522	2580697	2748283	NA	NC_000017.11:43091521:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1337	BRCA1
NM_007294.4(BRCA1):c.4009G>C (p.Asp1337His)	BRCA1|LOC126862571	D1337H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000279705	17	41243539	17	43091522	279705	264675	rs886041144	NC_000017.11:43091521:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1337	BRCA1
NM_007294.4(BRCA1):c.4007G>T (p.Ser1336Ile)	BRCA1|LOC126862571	S1336I	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001330088	17	41243541	17	43091524	1330088	1320771	rs2053486331	NC_000017.11:43091523:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1336	BRCA1
NM_007294.4(BRCA1):c.4006A>T (p.Ser1336Cys)	BRCA1|LOC126862571	S1336C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000489719	17	41243542	17	43091525	489719	482991	rs976725810	NC_000017.11:43091524:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Sep 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1336	BRCA1
NM_007294.4(BRCA1):c.4004T>A (p.Leu1335Gln)	BRCA1|LOC126862571	L1335Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002110986	17	41243544	17	43091527	2110986	2167555	NA	NC_000017.11:43091526:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1335	BRCA1
NM_007294.4(BRCA1):c.4003C>G (p.Leu1335Val)	BRCA1|LOC126862571	L1335V	Hereditary cancer-predisposing syndrome	VCV001736954	17	41243545	17	43091528	1736954	1793996	NA	NC_000017.11:43091527:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1335	BRCA1
NM_007294.4(BRCA1):c.4001G>A (p.Gly1334Asp)	BRCA1|LOC126862571	G1334D	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001053289	17	41243547	17	43091530	1053289	1050291	rs2053486938	NC_000017.11:43091529:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1334	BRCA1
NM_007294.4(BRCA1):c.4001G>T (p.Gly1334Val)	BRCA1|LOC126862571	G1334V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001009551	17	41243547	17	43091530	1009551	997569	rs2053486938	NC_000017.11:43091529:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1334	BRCA1
NM_007294.4(BRCA1):c.3998T>C (p.Val1333Ala)	BRCA1|LOC126862571	V1333A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000431258	17	41243550	17	43091533	431258	424805	rs1135401872	NC_000017.11:43091532:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1333	BRCA1
NM_007294.4(BRCA1):c.3997G>A (p.Val1333Ile)	BRCA1|LOC126862571	V1333I	Hereditary breast ovarian cancer syndrome|not specified	VCV002576276	17	41243551	17	43091534	2576276	2741172	NA	NC_000017.11:43091533:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1333	BRCA1
NM_007294.4(BRCA1):c.3997G>T (p.Val1333Phe)	BRCA1|LOC126862571	V1333F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000962956	17	41243551	17	43091534	962956	949934	rs2053487730	NC_000017.11:43091533:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1333	BRCA1
NM_007294.4(BRCA1):c.3995G>A (p.Gly1332Glu)	LOC126862571|BRCA1	G1332E	Hereditary cancer-predisposing syndrome	VCV000824466	17	41243553	17	43091536	824466	813710	rs730881490	NC_000017.11:43091535:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1332	BRCA1
NM_007294.4(BRCA1):c.3995G>T (p.Gly1332Val)	BRCA1|LOC126862571	G1332V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182156	17	41243553	17	43091536	182156	180838	rs730881490	NC_000017.11:43091535:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1332	BRCA1
NM_007294.4(BRCA1):c.3994G>A (p.Gly1332Arg)	BRCA1|LOC126862571	G1332R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002015902	17	41243554	17	43091537	2015902	2064830	NA	NC_000017.11:43091536:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1332	BRCA1
NM_007294.4(BRCA1):c.3994G>C (p.Gly1332Arg)	BRCA1|LOC126862571	G1332R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000950471	17	41243554	17	43091537	950471	928287	rs2053488210	NC_000017.11:43091536:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1332	BRCA1
NM_007294.4(BRCA1):c.3993G>C (p.Gln1331His)	BRCA1|LOC126862571	Q1331H	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV001736786	17	41243555	17	43091538	1736786	1793828	NA	NC_000017.11:43091537:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1331	BRCA1
NM_007294.4(BRCA1):c.3992A>G (p.Gln1331Arg)	BRCA1|LOC126862571	Q1331R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409366	17	41243556	17	43091539	409366	402676	rs1060502363	NC_000017.11:43091538:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1331	BRCA1
NM_007294.4(BRCA1):c.3990C>G (p.Ser1330Arg)	BRCA1|LOC126862571	S1330R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001464112	17	41243558	17	43091541	1464112	1342468	rs876660808	NC_000017.11:43091540:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1330	BRCA1
NM_007294.4(BRCA1):c.3988A>T (p.Ser1330Cys)	BRCA1|LOC126862571	S1330C	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000462627	17	41243560	17	43091543	462627	466854	rs1555586688	NC_000017.11:43091542:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1330	BRCA1
NM_007294.4(BRCA1):c.3985G>A (p.Glu1329Lys)	BRCA1|LOC126862571	E1329K	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000231968	17	41243563	17	43091546	231968	235986	rs876659467	NC_000017.11:43091545:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1329	BRCA1
NM_007294.4(BRCA1):c.3982T>C (p.Ser1328Pro)	BRCA1|LOC126862571	S1328P	Hereditary cancer-predisposing syndrome|not specified	VCV002429231	17	41243566	17	43091549	2429231	2402664	NA	NC_000017.11:43091548:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1328	BRCA1
NM_007294.4(BRCA1):c.3980A>G (p.Gln1327Arg)	BRCA1|LOC126862571	Q1327R	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182079	17	41243568	17	43091551	182079	180839	rs730881444	NC_000017.11:43091550:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1327	BRCA1
NM_007294.4(BRCA1):c.3979C>A (p.Gln1327Lys)	BRCA1|LOC126862571	Q1327K	Hereditary breast ovarian cancer syndrome	VCV002851139	17	41243569	17	43091552	2851139	3009641	NA	NC_000017.11:43091551:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1327	BRCA1
NM_007294.4(BRCA1):c.3979C>G (p.Gln1327Glu)	LOC126862571|BRCA1	Q1327E	Hereditary cancer-predisposing syndrome	VCV000824454	17	41243569	17	43091552	824454	813711	rs876659720	NC_000017.11:43091551:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1327	BRCA1
NM_007294.4(BRCA1):c.3977A>G (p.His1326Arg)	BRCA1|LOC126862571	H1326R	Hereditary cancer-predisposing syndrome	VCV001736654	17	41243571	17	43091554	1736654	1793697	NA	NC_000017.11:43091553:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1326	BRCA1
NM_007294.4(BRCA1):c.3976C>T (p.His1326Tyr)	BRCA1|LOC126862571	H1326Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000572521	17	41243572	17	43091555	572521	571153	rs1567789376	NC_000017.11:43091554:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1326	BRCA1
NM_007294.4(BRCA1):c.3974G>A (p.Arg1325Lys)	BRCA1|LOC126862571	R1325K	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000419316	17	41243574	17	43091557	419316	409973	rs921253348	NC_000017.11:43091556:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Sep 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1325	BRCA1
NM_007294.4(BRCA1):c.3972G>A (p.Met1324Ile)	BRCA1|LOC126862571	M1324I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001053267	17	41243576	17	43091559	1053267	1050292	rs2053491671	NC_000017.11:43091558:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1324	BRCA1
NM_007294.4(BRCA1):c.3971T>C (p.Met1324Thr)	BRCA1|LOC126862571	M1324T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824447	17	41243577	17	43091560	824447	813712	rs1597860147	NC_000017.11:43091559:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1324	BRCA1
NM_007294.4(BRCA1):c.3970A>G (p.Met1324Val)	BRCA1|LOC126862571	M1324V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001404686	17	41243578	17	43091561	1404686	1405447	rs587782241	NC_000017.11:43091560:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1324	BRCA1
NM_007294.4(BRCA1):c.3970A>T (p.Met1324Leu)	BRCA1|LOC126862571	M1324L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided	VCV000142109	17	41243578	17	43091561	142109	151823	rs587782241	NC_000017.11:43091560:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1324	BRCA1
NM_007294.4(BRCA1):c.3969A>T (p.Gln1323His)	LOC126862571|BRCA1	Q1323H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233442	17	41243579	17	43091562	233442	235988	rs876660410	NC_000017.11:43091561:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1323	BRCA1
NM_007294.4(BRCA1):c.3968A>G (p.Gln1323Arg)	BRCA1|LOC126862571	Q1323R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002004721	17	41243580	17	43091563	2004721	2058787	NA	NC_000017.11:43091562:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1323	BRCA1
NM_007294.4(BRCA1):c.3965A>G (p.Lys1322Arg)	BRCA1|LOC126862571	K1322R	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000481448	17	41243583	17	43091566	481448	479335	rs80357042	NC_000017.11:43091565:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1322	BRCA1
NM_007294.4(BRCA1):c.3965A>C (p.Lys1322Thr)	BRCA1|LOC126862571	K1322T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000185202	17	41243583	17	43091566	185202	184944	rs80357042	NC_000017.11:43091565:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1322	BRCA1
NM_007294.4(BRCA1):c.3965A>T (p.Lys1322Ile)	BRCA1|LOC126862571	K1322I	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055060	17	41243583	17	43091566	55060	69727	rs80357042	NC_000017.11:43091565:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1322	BRCA1
NM_007294.4(BRCA1):c.3964A>G (p.Lys1322Glu)	BRCA1|LOC126862571	K1322E	Hereditary cancer-predisposing syndrome	VCV000232294	17	41243584	17	43091567	232294	235989	rs80357343	NC_000017.11:43091566:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1322	BRCA1
NM_007294.4(BRCA1):c.3964A>C (p.Lys1322Gln)	BRCA1|LOC126862571	K1322Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000231080	17	41243584	17	43091567	231080	235990	rs80357343	NC_000017.11:43091566:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1322	BRCA1
NM_007294.4(BRCA1):c.3962C>T (p.Ser1321Phe)	BRCA1|LOC126862571	S1321F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001310290	17	41243586	17	43091569	1310290	1302140	rs386833394	NC_000017.11:43091568:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1321	BRCA1
NM_007294.4(BRCA1):c.3962C>A (p.Ser1321Tyr)	BRCA1|LOC126862571	S1321Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142790	17	41243586	17	43091569	142790	152504	rs386833394	NC_000017.11:43091568:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1321	BRCA1
NM_007294.4(BRCA1):c.3962C>G (p.Ser1321Cys)	BRCA1|LOC126862571	S1321C	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000041820	17	41243586	17	43091569	41820	50259	rs386833394	NC_000017.11:43091568:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1321	BRCA1
NM_007294.4(BRCA1):c.3961T>A (p.Ser1321Thr)	BRCA1|LOC126862571	S1321T	Hereditary cancer-predisposing syndrome	VCV002565333	17	41243587	17	43091570	2565333	2732307	NA	NC_000017.11:43091569:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1321	BRCA1
NM_007294.4(BRCA1):c.3959C>A (p.Ser1320Tyr)	BRCA1|LOC126862571	S1320Y	Hereditary cancer-predisposing syndrome	VCV001736489	17	41243589	17	43091572	1736489	1797022	NA	NC_000017.11:43091571:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1320	BRCA1
NM_007294.4(BRCA1):c.3959C>G (p.Ser1320Cys)	BRCA1|LOC126862571	S1320C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001042860	17	41243589	17	43091572	1042860	1033307	rs2053494663	NC_000017.11:43091571:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1320	BRCA1
NM_007294.4(BRCA1):c.3959C>T (p.Ser1320Phe)	BRCA1|LOC126862571	S1320F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001008789	17	41243589	17	43091572	1008789	997570	rs2053494663	NC_000017.11:43091571:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1320	BRCA1
NM_007294.4(BRCA1):c.3958T>C (p.Ser1320Pro)	BRCA1|LOC126862571	S1320P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125659	17	41243590	17	43091573	125659	131197	rs80356855	NC_000017.11:43091572:A:G	single nucleotide variant	intron variant|missense variant	Benign	Jan 1, 2000	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1320	BRCA1
NM_007294.4(BRCA1):c.3956G>C (p.Gly1319Ala)	BRCA1|LOC126862571	G1319A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001943286	17	41243592	17	43091575	1943286	1998273	NA	NC_000017.11:43091574:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1319	BRCA1
NM_007294.4(BRCA1):c.3956G>A (p.Gly1319Asp)	BRCA1|LOC126862571	G1319D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000142673	17	41243592	17	43091575	142673	152387	rs587782634	NC_000017.11:43091574:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1319	BRCA1
NM_007294.4(BRCA1):c.3955G>T (p.Gly1319Cys)	BRCA1|LOC126862571	G1319C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003072980	17	41243593	17	43091576	3072980	3229251	NA	NC_000017.11:43091575:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1319	BRCA1
NM_007294.4(BRCA1):c.3955G>A (p.Gly1319Ser)	BRCA1|LOC126862571	G1319S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000096922	17	41243593	17	43091576	96922	102825	rs431825403	NC_000017.11:43091575:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1319	BRCA1
NM_007294.4(BRCA1):c.3953T>C (p.Ile1318Thr)	BRCA1|LOC126862571	I1318T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481166	17	41243595	17	43091578	481166	478696	rs1388475291	NC_000017.11:43091577:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1318	BRCA1
NM_007294.4(BRCA1):c.3952A>G (p.Ile1318Val)	BRCA1|LOC126862571	I1318V	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055058	17	41243596	17	43091579	55058	69725	rs397509121	NC_000017.11:43091578:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1318	BRCA1
NM_007294.4(BRCA1):c.3944C>G (p.Pro1315Arg)	LOC126862571|BRCA1	P1315R	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096921	17	41243604	17	43091587	96921	102824	rs80357500	NC_000017.11:43091586:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1315	BRCA1
NM_007294.4(BRCA1):c.3944C>A (p.Pro1315His)	BRCA1|LOC126862571	P1315H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055057	17	41243604	17	43091587	55057	69724	rs80357500	NC_000017.11:43091586:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1315	BRCA1
NM_007294.4(BRCA1):c.3943C>G (p.Pro1315Ala)	BRCA1|LOC126862571	P1315A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002450687	17	41243605	17	43091588	2450687	2423173	NA	NC_000017.11:43091587:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1315	BRCA1
NM_007294.4(BRCA1):c.3943C>A (p.Pro1315Thr)	BRCA1|LOC126862571	P1315T	Hereditary cancer-predisposing syndrome	VCV001736369	17	41243605	17	43091588	1736369	1796902	NA	NC_000017.11:43091587:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1315	BRCA1
NM_007294.4(BRCA1):c.3941A>G (p.Asp1314Gly)	LOC126862571|BRCA1	D1314G	Hereditary breast ovarian cancer syndrome	VCV002757680	17	41243607	17	43091590	2757680	2917552	NA	NC_000017.11:43091589:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1314	BRCA1
NM_007294.4(BRCA1):c.3941A>T (p.Asp1314Val)	BRCA1|LOC126862571	D1314V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479232	17	41243607	17	43091590	479232	478701	rs759916956	NC_000017.11:43091589:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1314	BRCA1
NM_007294.4(BRCA1):c.3940G>A (p.Asp1314Asn)	BRCA1|LOC126862571	D1314N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055056	17	41243608	17	43091591	55056	69723	rs80356954	NC_000017.11:43091590:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1314	BRCA1
NM_007294.4(BRCA1):c.3938A>C (p.Gln1313Pro)	BRCA1|LOC126862571	Q1313P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002756472	17	41243610	17	43091593	2756472	2909873	NA	NC_000017.11:43091592:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1313	BRCA1
NM_007294.4(BRCA1):c.3938A>G (p.Gln1313Arg)	BRCA1|LOC126862571	Q1313R	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000440470	17	41243610	17	43091593	440470	432903	rs765729710	NC_000017.11:43091592:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1313	BRCA1
NM_007294.4(BRCA1):c.3935C>G (p.Thr1312Ser)	LOC126862571|BRCA1	T1312S	Hereditary cancer-predisposing syndrome	VCV000479229	17	41243613	17	43091596	479229	478651	rs1555586769	NC_000017.11:43091595:G:C	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1312	BRCA1
NM_007294.4(BRCA1):c.3933C>A (p.Asn1311Lys)	BRCA1|LOC126862571	N1311K	Hereditary cancer-predisposing syndrome	VCV000824398	17	41243615	17	43091598	824398	813713	rs1597860407	NC_000017.11:43091597:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1311	BRCA1
NM_007294.4(BRCA1):c.3932A>G (p.Asn1311Ser)	LOC126862571|BRCA1	N1311S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001325661	17	41243616	17	43091599	1325661	1315926	rs2154276206	NC_000017.11:43091598:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1311	BRCA1
NM_007294.4(BRCA1):c.3931A>G (p.Asn1311Asp)	LOC126862571|BRCA1	N1311D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000219751	17	41243617	17	43091600	219751	222659	rs864622233	NC_000017.11:43091599:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1311	BRCA1
NM_007294.4(BRCA1):c.3929C>T (p.Thr1310Ile)	BRCA1|LOC126862571	T1310I	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409324	17	41243619	17	43091602	409324	402495	rs80357257	NC_000017.11:43091601:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1310	BRCA1
NM_007294.4(BRCA1):c.3929C>G (p.Thr1310Arg)	BRCA1|LOC126862571	T1310R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000220135	17	41243619	17	43091602	220135	222660	rs80357257	NC_000017.11:43091601:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1310	BRCA1
NM_007294.4(BRCA1):c.3929C>A (p.Thr1310Lys)	BRCA1|LOC126862571	T1310K	Hereditary cancer-predisposing syndrome|Hereditary cancer|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000055053	17	41243619	17	43091602	55053	69720	rs80357257	NC_000017.11:43091601:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1310	BRCA1
NM_007294.4(BRCA1):c.3928A>G (p.Thr1310Ala)	BRCA1|LOC126862571	T1310A	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000923335	17	41243620	17	43091603	923335	913884	rs2053499046	NC_000017.11:43091602:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1310	BRCA1
NM_007294.4(BRCA1):c.3926A>G (p.Asn1309Ser)	BRCA1|LOC126862571	N1309S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000942423	17	41243622	17	43091605	942423	937949	rs2053499342	NC_000017.11:43091604:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1309	BRCA1
NM_007294.4(BRCA1):c.3925A>G (p.Asn1309Asp)	BRCA1|LOC126862571	N1309D	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000928511	17	41243623	17	43091606	928511	917251	rs2053499636	NC_000017.11:43091605:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1309	BRCA1
NM_007294.4(BRCA1):c.3925A>C (p.Asn1309His)	LOC126862571|BRCA1	N1309H	Hereditary cancer-predisposing syndrome	VCV000919379	17	41243623	17	43091606	919379	913885	rs2053499636	NC_000017.11:43091605:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1309	BRCA1
NM_007294.4(BRCA1):c.3923C>T (p.Ala1308Val)	BRCA1|LOC126862571	A1308V	Hereditary breast ovarian cancer syndrome	VCV002754777	17	41243625	17	43091608	2754777	2909476	NA	NC_000017.11:43091607:G:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1308	BRCA1
NM_007294.4(BRCA1):c.3920C>T (p.Thr1307Ile)	LOC126862571|BRCA1	T1307I	Hereditary cancer-predisposing syndrome	VCV003226147	17	41243628	17	43091611	3226147	3387211	NA	NC_000017.11:43091610:G:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1307	BRCA1
NM_007294.4(BRCA1):c.3918G>T (p.Leu1306Phe)	BRCA1|LOC126862571	L1306F	Hereditary cancer-predisposing syndrome	VCV001285144	17	41243630	17	43091613	1285144	1274991	rs786202068	NC_000017.11:43091612:C:A	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1306	BRCA1
NM_007294.4(BRCA1):c.3918G>C (p.Leu1306Phe)	BRCA1|LOC126862571	L1306F	Hereditary cancer-predisposing syndrome	VCV000185302	17	41243630	17	43091613	185302	184945	rs786202068	NC_000017.11:43091612:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1306	BRCA1
NM_007294.4(BRCA1):c.3914A>T (p.Asp1305Val)	BRCA1|LOC126862571	D1305V	not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000096920	17	41243634	17	43091617	96920	102823	rs431825402	NC_000017.11:43091616:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1305	BRCA1
NM_007294.4(BRCA1):c.3913G>A (p.Asp1305Asn)	BRCA1|LOC126862571	D1305N	Hereditary cancer-predisposing syndrome	VCV001736130	17	41243635	17	43091618	1736130	1787289	NA	NC_000017.11:43091617:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1305	BRCA1
NM_007294.4(BRCA1):c.3913G>C (p.Asp1305His)	BRCA1|LOC126862571	D1305H	Hereditary cancer-predisposing syndrome	VCV000489718	17	41243635	17	43091618	489718	482970	rs1555586799	NC_000017.11:43091617:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1305	BRCA1
NM_007294.4(BRCA1):c.3910G>C (p.Glu1304Gln)	BRCA1|LOC126862571	E1304Q	not specified|Hereditary cancer-predisposing syndrome	VCV002774844	17	41243638	17	43091621	2774844	2935571	NA	NC_000017.11:43091620:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1304	BRCA1
NM_007294.4(BRCA1):c.3909G>T (p.Leu1303Phe)	BRCA1|LOC126862571	L1303F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001714988	17	41243639	17	43091622	1714988	1777989	NA	NC_000017.11:43091621:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1303	BRCA1
NM_007294.4(BRCA1):c.3908T>G (p.Leu1303Trp)	BRCA1|LOC126862571	L1303W	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001348340	17	41243640	17	43091623	1348340	1459570	rs2154277653	NC_000017.11:43091622:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1303	BRCA1
NM_007294.4(BRCA1):c.3906A>T (p.Glu1302Asp)	BRCA1|LOC126862571	E1302D	Hereditary cancer-predisposing syndrome	VCV000630705	17	41243642	17	43091625	630705	618595	rs1567789643	NC_000017.11:43091624:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1302	BRCA1
NM_007294.4(BRCA1):c.3905A>G (p.Glu1302Gly)	LOC126862571|BRCA1	E1302G	Hereditary cancer-predisposing syndrome	VCV002774845	17	41243643	17	43091626	2774845	2935572	NA	NC_000017.11:43091625:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1302	BRCA1
NM_007294.4(BRCA1):c.3904G>A (p.Glu1302Lys)	LOC126862571|BRCA1	E1302K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000229767	17	41243644	17	43091627	229767	235992	rs80357461	NC_000017.11:43091626:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1302	BRCA1
NM_007294.4(BRCA1):c.3903T>A (p.Ser1301Arg)	BRCA1|LOC126862571	S1301R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055044	17	41243645	17	43091628	55044	69711	rs273900719	NC_000017.11:43091627:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1301	BRCA1
NM_007294.4(BRCA1):c.3902G>T (p.Ser1301Ile)	BRCA1|LOC126862571	S1301I	Hereditary breast ovarian cancer syndrome	VCV002771887	17	41243646	17	43091629	2771887	2927873	NA	NC_000017.11:43091628:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1301	BRCA1
NM_007294.4(BRCA1):c.3902G>A (p.Ser1301Asn)	BRCA1|LOC126862571	S1301N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000375449	17	41243646	17	43091629	375449	362217	rs1057519496	NC_000017.11:43091628:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1301	BRCA1
NM_007294.4(BRCA1):c.3901A>T (p.Ser1301Cys)	BRCA1|LOC126862571	S1301C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441430	17	41243647	17	43091630	441430	435126	rs786203580	NC_000017.11:43091629:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1301	BRCA1
NM_007294.4(BRCA1):c.3901A>G (p.Ser1301Gly)	LOC126862571|BRCA1	S1301G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187243	17	41243647	17	43091630	187243	184946	rs786203580	NC_000017.11:43091629:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1301	BRCA1
NM_007294.4(BRCA1):c.3897G>T (p.Gln1299His)	BRCA1|LOC126862571	Q1299H	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000091618	17	41243651	17	43091634	91618	97095	rs398122678	NC_000017.11:43091633:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1299	BRCA1
NM_007294.4(BRCA1):c.3896A>G (p.Gln1299Arg)	BRCA1|LOC126862571	Q1299R	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000234126	17	41243652	17	43091635	234126	235993	rs876660866	NC_000017.11:43091634:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1299	BRCA1
NM_007294.4(BRCA1):c.3895C>G (p.Gln1299Glu)	BRCA1|LOC126862571	Q1299E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000957851	17	41243653	17	43091636	957851	949935	rs80357038	NC_000017.11:43091635:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1299	BRCA1
NM_007294.4(BRCA1):c.3893C>T (p.Ser1298Leu)	BRCA1|LOC126862571	S1298L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000245990	17	41243655	17	43091638	245990	245034	rs80357440	NC_000017.11:43091637:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1298	BRCA1
NM_007294.4(BRCA1):c.3892T>A (p.Ser1298Thr)	BRCA1|LOC126862571	S1298T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824347	17	41243656	17	43091639	824347	813714	rs1597860615	NC_000017.11:43091638:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1298	BRCA1
NM_007294.4(BRCA1):c.3890C>A (p.Ser1297Tyr)	BRCA1|LOC126862571	S1297Y	Hereditary cancer-predisposing syndrome|not provided	VCV002439558	17	41243658	17	43091641	2439558	2409537	NA	NC_000017.11:43091640:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1297	BRCA1
NM_007294.4(BRCA1):c.3889T>A (p.Ser1297Thr)	BRCA1|LOC126862571	S1297T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000481466	17	41243659	17	43091642	481466	478581	rs1450793674	NC_000017.11:43091641:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1297	BRCA1
NM_007294.4(BRCA1):c.3889T>C (p.Ser1297Pro)	BRCA1|LOC126862571	S1297P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000479231	17	41243659	17	43091642	479231	478653	rs1450793674	NC_000017.11:43091641:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1297	BRCA1
NM_007294.4(BRCA1):c.3887T>G (p.Phe1296Cys)	BRCA1|LOC126862571	F1296C	Hereditary cancer-predisposing syndrome	VCV000482964	17	41243661	17	43091644	482964	478654	rs1555586855	NC_000017.11:43091643:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1296	BRCA1
NM_007294.4(BRCA1):c.3886T>C (p.Phe1296Leu)	BRCA1|LOC126862571	F1296L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000658764	17	41243662	17	43091645	658764	645967	rs1597860658	NC_000017.11:43091644:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1296	BRCA1
NM_007294.4(BRCA1):c.3881G>T (p.Ser1294Ile)	BRCA1|LOC126862571	S1294I	Hereditary cancer-predisposing syndrome	VCV000824333	17	41243667	17	43091650	824333	813715	rs776996813	NC_000017.11:43091649:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1294	BRCA1
NM_007294.4(BRCA1):c.3880A>G (p.Ser1294Gly)	BRCA1|LOC126862571	S1294G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001371774	17	41243668	17	43091651	1371774	1365283	rs2154279207	NC_000017.11:43091650:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1294	BRCA1
NM_007294.4(BRCA1):c.3877_3878delinsTT (p.Ala1293Phe)	BRCA1|LOC126862571	A1293F	Hereditary cancer-predisposing syndrome|not provided	VCV001735756	17	41243670 - 41243671	17	43091653 - 43091654	1735756	1786917	NA	NC_000017.11:43091652:GC:AA	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1293	BRCA1
NM_007294.4(BRCA1):c.3878C>T (p.Ala1293Val)	BRCA1|LOC126862571	A1293V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055036	17	41243670	17	43091653	55036	69703	rs80357213	NC_000017.11:43091652:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1293	BRCA1
NM_007294.4(BRCA1):c.3878C>A (p.Ala1293Asp)	BRCA1|LOC126862571	A1293D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055035	17	41243670	17	43091653	55035	69702	rs80357213	NC_000017.11:43091652:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1293	BRCA1
NM_007294.4(BRCA1):c.3877G>A (p.Ala1293Thr)	BRCA1|LOC126862571	A1293T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001036207	17	41243671	17	43091654	1036207	1033308	rs397507223	NC_000017.11:43091653:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1293	BRCA1
NM_007294.4(BRCA1):c.3877G>C (p.Ala1293Pro)	BRCA1|LOC126862571	A1293P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037555	17	41243671	17	43091654	37555	46111	rs397507223	NC_000017.11:43091653:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1293	BRCA1
NM_007294.4(BRCA1):c.3875C>G (p.Ser1292Cys)	BRCA1|LOC126862571	S1292C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000576678	17	41243673	17	43091656	576678	571427	rs876658340	NC_000017.11:43091655:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1292	BRCA1
NM_007294.4(BRCA1):c.3875C>A (p.Ser1292Tyr)	BRCA1|LOC126862571	S1292Y	Hereditary cancer-predisposing syndrome	VCV000230029	17	41243673	17	43091656	230029	235994	rs876658340	NC_000017.11:43091655:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1292	BRCA1
NM_007294.4(BRCA1):c.3874T>C (p.Ser1292Pro)	BRCA1|LOC126862571	S1292P	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187559	17	41243674	17	43091657	187559	184947	rs786203823	NC_000017.11:43091656:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1292	BRCA1
NM_007294.4(BRCA1):c.3872G>A (p.Cys1291Tyr)	BRCA1|LOC126862571	C1291Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001462472	17	41243676	17	43091659	1462472	1432875	rs781212379	NC_000017.11:43091658:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1291	BRCA1
NM_007294.4(BRCA1):c.3869A>C (p.Lys1290Thr)	BRCA1|LOC126862571	K1290T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000096918	17	41243679	17	43091662	96918	102821	rs431825401	NC_000017.11:43091661:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1290	BRCA1
NM_007294.4(BRCA1):c.3868A>G (p.Lys1290Glu)	BRCA1|LOC126862571	K1290E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000091617	17	41243680	17	43091663	91617	97094	rs80357254	NC_000017.11:43091662:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1290	BRCA1
NM_007294.4(BRCA1):c.3866C>G (p.Thr1289Arg)	BRCA1|LOC126862571	T1289R	Hereditary cancer-predisposing syndrome	VCV001735642	17	41243682	17	43091665	1735642	1790136	NA	NC_000017.11:43091664:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1289	BRCA1
NM_007294.4(BRCA1):c.3866C>T (p.Thr1289Ile)	BRCA1|LOC126862571	T1289I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001424409	17	41243682	17	43091665	1424409	1438285	rs2154280244	NC_000017.11:43091664:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1289	BRCA1
NM_007294.4(BRCA1):c.3865A>C (p.Thr1289Pro)	BRCA1|LOC126862571	T1289P	not provided|Hereditary cancer-predisposing syndrome	VCV000421921	17	41243683	17	43091666	421921	409974	rs1064795449	NC_000017.11:43091665:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1289	BRCA1
NM_007294.4(BRCA1):c.3862G>C (p.Glu1288Gln)	BRCA1|LOC126862571	E1288Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232341	17	41243686	17	43091669	232341	235995	rs876659708	NC_000017.11:43091668:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1288	BRCA1
NM_007294.4(BRCA1):c.3860A>C (p.Glu1287Ala)	BRCA1|LOC126862571	E1287A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001735605	17	41243688	17	43091671	1735605	1790099	NA	NC_000017.11:43091670:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1287	BRCA1
NM_007294.4(BRCA1):c.3860A>G (p.Glu1287Gly)	BRCA1|LOC126862571	E1287G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001477696	17	41243688	17	43091671	1477696	1436575	rs2053510326	NC_000017.11:43091670:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1287	BRCA1
NM_007294.4(BRCA1):c.3859G>A (p.Glu1287Lys)	BRCA1|LOC126862571	E1287K	Hereditary cancer-predisposing syndrome|not specified	VCV000440469	17	41243689	17	43091672	440469	432904	rs1555586934	NC_000017.11:43091671:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1287	BRCA1
NM_007294.4(BRCA1):c.3857G>A (p.Ser1286Asn)	BRCA1|LOC126862571	S1286N	Hereditary breast ovarian cancer syndrome	VCV002900152	17	41243691	17	43091674	2900152	3064150	NA	NC_000017.11:43091673:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1286	BRCA1
NM_007294.4(BRCA1):c.3857G>T (p.Ser1286Ile)	BRCA1|LOC126862571	S1286I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000925337	17	41243691	17	43091674	925337	913886	rs142383077	NC_000017.11:43091673:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1286	BRCA1
NM_007294.4(BRCA1):c.3857G>C (p.Ser1286Thr)	BRCA1|LOC126862571	S1286T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000187761	17	41243691	17	43091674	187761	184948	rs142383077	NC_000017.11:43091673:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1286	BRCA1
NM_007294.4(BRCA1):c.3856A>G (p.Ser1286Gly)	BRCA1|LOC126862571	S1286G	Hereditary cancer-predisposing syndrome	VCV001735553	17	41243692	17	43091675	1735553	1790047	NA	NC_000017.11:43091674:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1286	BRCA1
NM_007294.4(BRCA1):c.3853C>T (p.Leu1285Phe)	BRCA1|LOC126862571	L1285F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001056581	17	41243695	17	43091678	1056581	1050294	rs2154281078	NC_000017.11:43091677:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1285	BRCA1
NM_007294.4(BRCA1):c.3852C>A (p.His1284Gln)	BRCA1|LOC126862571	H1284Q	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000864100	17	41243696	17	43091679	864100	845391	rs776070899	NC_000017.11:43091678:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1284	BRCA1
NM_007294.4(BRCA1):c.3851A>T (p.His1284Leu)	BRCA1|LOC126862571	H1284L	Hereditary cancer-predisposing syndrome	VCV000824302	17	41243697	17	43091680	824302	813716	rs80357499	NC_000017.11:43091679:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1284	BRCA1
NM_007294.4(BRCA1):c.3851A>G (p.His1284Arg)	BRCA1|LOC126862571	H1284R	Hereditary cancer-predisposing syndrome	VCV000055029	17	41243697	17	43091680	55029	69696	rs80357499	NC_000017.11:43091679:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1284	BRCA1
NM_007294.4(BRCA1):c.3848A>G (p.His1283Arg)	BRCA1|LOC126862571	H1283R	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified	VCV000055028	17	41243700	17	43091683	55028	69695	rs80357047	NC_000017.11:43091682:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Feb 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1283	BRCA1
NM_007294.4(BRCA1):c.3847C>T (p.His1283Tyr)	BRCA1|LOC126862571	H1283Y	Hereditary cancer-predisposing syndrome	VCV000441432	17	41243701	17	43091684	441432	435127	rs1555586946	NC_000017.11:43091683:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1283	BRCA1
NM_007294.4(BRCA1):c.3845A>G (p.Glu1282Gly)	BRCA1|LOC126862571	E1282G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV001380496	17	41243703	17	43091686	1380496	1421318	rs80357217	NC_000017.11:43091685:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1282	BRCA1
NM_007294.4(BRCA1):c.3845A>T (p.Glu1282Val)	BRCA1|LOC126862571	E1282V	Hereditary cancer-predisposing syndrome|BRCA1-related disorder|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055027	17	41243703	17	43091686	55027	69694	rs80357217	NC_000017.11:43091685:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1282	BRCA1
NM_007294.4(BRCA1):c.3844G>C (p.Glu1282Gln)	BRCA1|LOC126862571	E1282Q	Hereditary cancer-predisposing syndrome	VCV001735456	17	41243704	17	43091687	1735456	1789951	NA	NC_000017.11:43091686:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1282	BRCA1
NM_007294.4(BRCA1):c.3844G>A (p.Glu1282Lys)	BRCA1|LOC126862571	E1282K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001506012	17	41243704	17	43091687	1506012	1339742	rs2154281717	NC_000017.11:43091686:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1282	BRCA1
NM_007294.4(BRCA1):c.3843G>T (p.Gln1281His)	BRCA1|LOC126862571	Q1281H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000640718	17	41243705	17	43091688	640718	645969	rs1597860926	NC_000017.11:43091687:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1281	BRCA1
NM_007294.4(BRCA1):c.3842A>G (p.Gln1281Arg)	BRCA1|LOC126862571	Q1281R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000852100	17	41243706	17	43091689	852100	845392	rs80357483	NC_000017.11:43091688:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1281	BRCA1
NM_007294.4(BRCA1):c.3842A>C (p.Gln1281Pro)	BRCA1|LOC126862571	Q1281P	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000055025	17	41243706	17	43091689	55025	69692	rs80357483	NC_000017.11:43091688:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1281	BRCA1
NM_007294.4(BRCA1):c.3841C>G (p.Gln1281Glu)	BRCA1|LOC126862571	Q1281E	not provided|Hereditary cancer-predisposing syndrome	VCV000421031	17	41243707	17	43091690	421031	409975	rs80356866	NC_000017.11:43091689:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1281	BRCA1
NM_007294.4(BRCA1):c.3839C>A (p.Ser1280Tyr)	BRCA1|LOC126862571	S1280Y	Hereditary cancer-predisposing syndrome	VCV000824280	17	41243709	17	43091692	824280	813717	rs1597860978	NC_000017.11:43091691:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1280	BRCA1
NM_007294.4(BRCA1):c.3838T>C (p.Ser1280Pro)	BRCA1|LOC126862571	S1280P	Hereditary cancer-predisposing syndrome	VCV000631163	17	41243710	17	43091693	631163	618597	rs1567789887	NC_000017.11:43091692:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1280	BRCA1
NM_007294.4(BRCA1):c.3836C>T (p.Ala1279Val)	BRCA1|LOC126862571	A1279V	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462623	17	41243712	17	43091695	462623	466859	rs1555586967	NC_000017.11:43091694:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1279	BRCA1
NM_007294.4(BRCA1):c.3835G>C (p.Ala1279Pro)	BRCA1|LOC126862571	A1279P	Hereditary cancer-predisposing syndrome	VCV000629161	17	41243713	17	43091696	629161	618598	rs80357036	NC_000017.11:43091695:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1279	BRCA1
NM_007294.4(BRCA1):c.3835G>T (p.Ala1279Ser)	BRCA1|LOC126862571	A1279S	not provided|Hereditary cancer-predisposing syndrome	VCV000421098	17	41243713	17	43091696	421098	409976	rs80357036	NC_000017.11:43091695:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1279	BRCA1
NM_007294.4(BRCA1):c.3835G>A (p.Ala1279Thr)	BRCA1|LOC126862571	A1279T	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified	VCV000055020	17	41243713	17	43091696	55020	69687	rs80357036	NC_000017.11:43091695:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1279	BRCA1
NM_007294.4(BRCA1):c.3834G>C (p.Lys1278Asn)	BRCA1|LOC126862571	K1278N	not provided	VCV002672697	17	41243714	17	43091697	2672697	2840217	NA	NC_000017.11:43091696:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1278	BRCA1
NM_007294.4(BRCA1):c.3830C>T (p.Ala1277Val)	BRCA1|LOC126862571	A1277V	not provided|Hereditary cancer-predisposing syndrome	VCV000182155	17	41243718	17	43091701	182155	180841	rs730881489	NC_000017.11:43091700:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1277	BRCA1
NM_007294.4(BRCA1):c.3829G>C (p.Ala1277Pro)	BRCA1|LOC126862571	A1277P	Hereditary cancer-predisposing syndrome	VCV000055019	17	41243719	17	43091702	55019	69686	rs397509112	NC_000017.11:43091701:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1277	BRCA1
NM_007294.4(BRCA1):c.3826T>G (p.Leu1276Val)	BRCA1|LOC126862571	L1276V	not specified|Hereditary cancer-predisposing syndrome	VCV000506525	17	41243722	17	43091705	506525	506086	rs876659178	NC_000017.11:43091704:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1276	BRCA1
NM_007294.4(BRCA1):c.3824T>G (p.Ile1275Arg)	BRCA1|LOC126862571	I1275R	Hereditary cancer-predisposing syndrome	VCV001735290	17	41243724	17	43091707	1735290	1793629	NA	NC_000017.11:43091706:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1275	BRCA1
NM_007294.4(BRCA1):c.3824T>A (p.Ile1275Lys)	BRCA1|LOC126862571	I1275K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000857696	17	41243724	17	43091707	857696	845393	rs2053516476	NC_000017.11:43091706:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1275	BRCA1
NM_007294.4(BRCA1):c.3823A>G (p.Ile1275Val)	BRCA1|LOC126862571	I1275V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037549	17	41243725	17	43091708	37549	46105	rs80357280	NC_000017.11:43091707:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1275	BRCA1
NM_007294.4(BRCA1):c.3820G>C (p.Val1274Leu)	BRCA1|LOC126862571	V1274L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000861349	17	41243728	17	43091711	861349	845394	rs2053517601	NC_000017.11:43091710:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1274	BRCA1
NM_007294.4(BRCA1):c.3819G>C (p.Gln1273His)	BRCA1|LOC126862571	Q1273H	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000853265	17	41243729	17	43091712	853265	845395	rs1293826790	NC_000017.11:43091711:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1273	BRCA1
NM_007294.4(BRCA1):c.3818A>T (p.Gln1273Leu)	BRCA1|LOC126862571	Q1273L	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000842937	17	41243730	17	43091713	842937	845396	rs431825400	NC_000017.11:43091712:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Feb 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1273	BRCA1
NM_007294.4(BRCA1):c.3818A>G (p.Gln1273Arg)	BRCA1|LOC126862571	Q1273R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000096917	17	41243730	17	43091713	96917	102820	rs431825400	NC_000017.11:43091712:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Dec 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1273	BRCA1
NM_007294.4(BRCA1):c.3816C>A (p.Asn1272Lys)	BRCA1|LOC126862571	N1272K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000185053	17	41243732	17	43091715	185053	184949	rs786201893	NC_000017.11:43091714:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1272	BRCA1
NM_007294.4(BRCA1):c.3815A>G (p.Asn1272Ser)	BRCA1|LOC126862571	N1272S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000232792	17	41243733	17	43091716	232792	235998	rs772703445	NC_000017.11:43091715:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1272	BRCA1
NM_007294.4(BRCA1):c.3814A>G (p.Asn1272Asp)	BRCA1|LOC126862571	N1272D	Hereditary cancer-predisposing syndrome	VCV001735186	17	41243734	17	43091717	1735186	1793525	NA	NC_000017.11:43091716:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1272	BRCA1
NM_007294.4(BRCA1):c.3812G>A (p.Ser1271Asn)	BRCA1|LOC126862571	S1271N	Hereditary cancer-predisposing syndrome	VCV001735170	17	41243736	17	43091719	1735170	1793509	NA	NC_000017.11:43091718:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1271	BRCA1
NM_007294.4(BRCA1):c.3812G>C (p.Ser1271Thr)	BRCA1|LOC126862571	S1271T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000570753	17	41243736	17	43091719	570753	571431	rs1567789989	NC_000017.11:43091718:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1271	BRCA1
NM_007294.4(BRCA1):c.3811A>G (p.Ser1271Gly)	BRCA1|LOC126862571	S1271G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001007721	17	41243737	17	43091720	1007721	997571	rs2053519524	NC_000017.11:43091719:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1271	BRCA1
NM_007294.4(BRCA1):c.3809G>T (p.Cys1270Phe)	BRCA1|LOC126862571	C1270F	Hereditary breast ovarian cancer syndrome	VCV002698570	17	41243739	17	43091722	2698570	2858710	NA	NC_000017.11:43091721:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1270	BRCA1
NM_007294.4(BRCA1):c.3809G>A (p.Cys1270Tyr)	BRCA1|LOC126862571	C1270Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000433708	17	41243739	17	43091722	433708	427550	rs1207787135	NC_000017.11:43091721:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1270	BRCA1
NM_007294.4(BRCA1):c.3808T>G (p.Cys1270Gly)	BRCA1|LOC126862571	C1270G	Hereditary cancer-predisposing syndrome	VCV003226145	17	41243740	17	43091723	3226145	3387209	NA	NC_000017.11:43091722:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1270	BRCA1
NM_007294.4(BRCA1):c.3808T>C (p.Cys1270Arg)	BRCA1|LOC126862571	C1270R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001171706	17	41243740	17	43091723	1171706	1161357	rs2154285914	NC_000017.11:43091722:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1270	BRCA1
NM_007294.4(BRCA1):c.3807C>G (p.Asp1269Glu)	BRCA1|LOC126862571	D1269E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000186925	17	41243741	17	43091724	186925	184951	rs786202569	NC_000017.11:43091723:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1269	BRCA1
NM_007294.4(BRCA1):c.3806A>G (p.Asp1269Gly)	BRCA1|LOC126862571	D1269G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000947706	17	41243742	17	43091725	947706	928289	rs2053520234	NC_000017.11:43091724:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1269	BRCA1
NM_007294.4(BRCA1):c.3805G>T (p.Asp1269Tyr)	BRCA1|LOC126862571	D1269Y	Hereditary cancer-predisposing syndrome	VCV002450697	17	41243743	17	43091726	2450697	2423183	NA	NC_000017.11:43091725:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1269	BRCA1
NM_007294.4(BRCA1):c.3804T>G (p.Asn1268Lys)	LOC126862571|BRCA1	N1268K	Hereditary cancer-predisposing syndrome	VCV000186549	17	41243744	17	43091727	186549	184952	rs140588714	NC_000017.11:43091726:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1268	BRCA1
NM_007294.4(BRCA1):c.3803A>G (p.Asn1268Ser)	LOC126862571|BRCA1	N1268S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055011	17	41243745	17	43091728	55011	69678	rs273900716	NC_000017.11:43091727:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1268	BRCA1
NM_007294.4(BRCA1):c.3800T>C (p.Leu1267Ser)	BRCA1|LOC126862571	L1267S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000142031	17	41243748	17	43091731	142031	151745	rs587782190	NC_000017.11:43091730:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1267	BRCA1
NM_007294.4(BRCA1):c.3798C>A (p.Ser1266Arg)	BRCA1|LOC126862571	S1266R	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230616	17	41243750	17	43091733	230616	235999	rs200648498	NC_000017.11:43091732:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1266	BRCA1
NM_007294.4(BRCA1):c.3798C>G (p.Ser1266Arg)	BRCA1|LOC126862571	S1266R	Hereditary cancer-predisposing syndrome	VCV000091615	17	41243750	17	43091733	91615	97092	rs200648498	NC_000017.11:43091732:G:C	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1266	BRCA1
NM_007294.4(BRCA1):c.3797G>A (p.Ser1266Asn)	BRCA1|LOC126862571	S1266N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000999201	17	41243751	17	43091734	999201	997572	rs80357160	NC_000017.11:43091733:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1266	BRCA1
NM_007294.4(BRCA1):c.3797G>T (p.Ser1266Ile)	BRCA1|LOC126862571	S1266I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000141540	17	41243751	17	43091734	141540	151254	rs80357160	NC_000017.11:43091733:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1266	BRCA1
NM_007294.4(BRCA1):c.3797G>C (p.Ser1266Thr)	BRCA1|LOC126862571	S1266T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055009	17	41243751	17	43091734	55009	69676	rs80357160	NC_000017.11:43091733:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1266	BRCA1
NM_007294.4(BRCA1):c.3794A>G (p.Asn1265Ser)	BRCA1|LOC126862571	N1265S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001510278	17	41243754	17	43091737	1510278	1442333	rs2154286843	NC_000017.11:43091736:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1265	BRCA1
NM_007294.4(BRCA1):c.3793A>C (p.Asn1265His)	BRCA1|LOC126862571	N1265H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409368	17	41243755	17	43091738	409368	402499	rs1060502364	NC_000017.11:43091737:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1265	BRCA1
NM_007294.4(BRCA1):c.3792G>C (p.Lys1264Asn)	BRCA1|LOC126862571	K1264N	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000824216	17	41243756	17	43091739	824216	813719	rs894781955	NC_000017.11:43091738:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1264	BRCA1
NM_007294.4(BRCA1):c.3791A>G (p.Lys1264Arg)	BRCA1|LOC126862571	K1264R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531245	17	41243757	17	43091740	531245	531260	rs1555587039	NC_000017.11:43091739:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1264	BRCA1
NM_007294.4(BRCA1):c.3787T>G (p.Leu1263Val)	BRCA1|LOC126862571	L1263V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002585828	17	41243761	17	43091744	2585828	2753388	NA	NC_000017.11:43091743:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1263	BRCA1
NM_007294.4(BRCA1):c.3785C>T (p.Ser1262Leu)	BRCA1|LOC126862571	S1262L	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000055007	17	41243763	17	43091746	55007	69674	rs80357269	NC_000017.11:43091745:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1262	BRCA1
NM_007294.4(BRCA1):c.3784T>C (p.Ser1262Pro)	BRCA1|LOC126862571	S1262P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000481459	17	41243764	17	43091747	481459	478704	rs1011096937	NC_000017.11:43091746:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1262	BRCA1
NM_007294.4(BRCA1):c.3783A>T (p.Leu1261Phe)	BRCA1|LOC126862571	L1261F	Hereditary cancer-predisposing syndrome	VCV000041819	17	41243765	17	43091748	41819	50258	rs80356831	NC_000017.11:43091747:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1261	BRCA1
NM_007294.4(BRCA1):c.3782T>C (p.Leu1261Ser)	BRCA1|LOC126862571	L1261S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037548	17	41243766	17	43091749	37548	46104	rs397507219	NC_000017.11:43091748:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1261	BRCA1
NM_007294.4(BRCA1):c.3778T>G (p.Leu1260Val)	BRCA1|LOC126862571	L1260V	Hereditary cancer-predisposing syndrome	VCV000481470	17	41243770	17	43091753	481470	478665	rs1555587079	NC_000017.11:43091752:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1260	BRCA1
NM_007294.4(BRCA1):c.3776A>C (p.Asn1259Thr)	BRCA1|LOC126862571	N1259T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided	VCV000125651	17	41243772	17	43091755	125651	131189	rs483353090	NC_000017.11:43091754:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1259	BRCA1
NM_007294.4(BRCA1):c.3775A>G (p.Asn1259Asp)	BRCA1|LOC126862571	N1259D	Hereditary cancer-predisposing syndrome	VCV000824193	17	41243773	17	43091756	824193	813722	rs1597861381	NC_000017.11:43091755:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1259	BRCA1
NM_007294.4(BRCA1):c.3774G>C (p.Glu1258Asp)	BRCA1|LOC126862571	E1258D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000968349	17	41243774	17	43091757	968349	958122	rs431825399	NC_000017.11:43091756:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1258	BRCA1
NM_007294.4(BRCA1):c.3774G>T (p.Glu1258Asp)	LOC126862571|BRCA1	E1258D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096916	17	41243774	17	43091757	96916	102819	rs431825399	NC_000017.11:43091756:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1258	BRCA1
NM_007294.4(BRCA1):c.3772G>A (p.Glu1258Lys)	BRCA1|LOC126862571	E1258K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000572647	17	41243776	17	43091759	572647	571155	rs397509105	NC_000017.11:43091758:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1258	BRCA1
NM_007294.4(BRCA1):c.3771G>C (p.Glu1257Asp)	BRCA1|LOC126862571	E1257D	Hereditary cancer-predisposing syndrome	VCV002591721	17	41243777	17	43091760	2591721	2761901	NA	NC_000017.11:43091759:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1257	BRCA1
NM_007294.4(BRCA1):c.3770A>G (p.Glu1257Gly)	BRCA1|LOC126862571	E1257G	Hereditary cancer-predisposing syndrome	VCV000824187	17	41243778	17	43091761	824187	813723	rs1597861451	NC_000017.11:43091760:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1257	BRCA1
NM_007294.4(BRCA1):c.3769G>A (p.Glu1257Lys)	BRCA1|LOC126862571	E1257K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000580205	17	41243779	17	43091762	580205	571436	rs1567790183	NC_000017.11:43091761:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1257	BRCA1
NM_007294.4(BRCA1):c.3767C>T (p.Thr1256Ile)	BRCA1|LOC126862571	T1256I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001519305	17	41243781	17	43091764	1519305	1433802	rs2154289053	NC_000017.11:43091763:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1256	BRCA1
NM_007294.4(BRCA1):c.3763A>G (p.Asn1255Asp)	BRCA1|LOC126862571	N1255D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002121231	17	41243785	17	43091768	2121231	2180413	NA	NC_000017.11:43091767:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1255	BRCA1
NM_007294.4(BRCA1):c.3762G>T (p.Lys1254Asn)	BRCA1|LOC126862571	K1254N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001519354	17	41243786	17	43091769	1519354	1433851	rs2053529032	NC_000017.11:43091768:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1254	BRCA1
NM_007294.4(BRCA1):c.3760A>G (p.Lys1254Glu)	BRCA1|LOC126862571	K1254E	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054994	17	41243788	17	43091771	54994	69661	rs80357362	NC_000017.11:43091770:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1254	BRCA1
NM_007294.4(BRCA1):c.3758C>T (p.Ser1253Phe)	BRCA1|LOC126862571	S1253F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001718296	17	41243790	17	43091773	1718296	1778656	NA	NC_000017.11:43091772:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1253	BRCA1
NM_007294.4(BRCA1):c.3758C>G (p.Ser1253Cys)	BRCA1|LOC126862571	S1253C	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Fanconi anemia, complementation group S|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000186252	17	41243790	17	43091773	186252	184954	rs397509100	NC_000017.11:43091772:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1253	BRCA1
NM_007294.4(BRCA1):c.3758C>A (p.Ser1253Tyr)	BRCA1|LOC126862571	S1253Y	Hereditary cancer-predisposing syndrome	VCV000054990	17	41243790	17	43091773	54990	69657	rs397509100	NC_000017.11:43091772:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1253	BRCA1
NM_007294.4(BRCA1):c.3755T>G (p.Leu1252Arg)	BRCA1|LOC126862571	L1252R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001421638	17	41243793	17	43091776	1421638	1423054	rs1555587147	NC_000017.11:43091775:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1252	BRCA1
NM_007294.4(BRCA1):c.3755T>C (p.Leu1252Pro)	BRCA1|LOC126862571	L1252P	Hereditary cancer-predisposing syndrome	VCV000479202	17	41243793	17	43091776	479202	479341	rs1555587147	NC_000017.11:43091775:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1252	BRCA1
NM_007294.4(BRCA1):c.3754C>G (p.Leu1252Val)	BRCA1|LOC126862571	L1252V	Hereditary cancer-predisposing syndrome	VCV001734589	17	41243794	17	43091777	1734589	1796381	NA	NC_000017.11:43091776:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1252	BRCA1
NM_007294.4(BRCA1):c.3753T>G (p.Cys1251Trp)	BRCA1|LOC126862571	C1251W	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631326	17	41243795	17	43091778	631326	618599	rs397509098	NC_000017.11:43091777:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1251	BRCA1
NM_007294.4(BRCA1):c.3752G>A (p.Cys1251Tyr)	BRCA1|LOC126862571	C1251Y	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000246072	17	41243796	17	43091779	246072	245035	rs879254079	NC_000017.11:43091778:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1251	BRCA1
NM_007294.4(BRCA1):c.3751T>A (p.Cys1251Ser)	BRCA1|LOC126862571	C1251S	not provided	VCV003340195	17	41243797	17	43091780	3340195	3499453	NA	NC_000017.11:43091779:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1251	BRCA1
NM_007294.4(BRCA1):c.3750G>T (p.Glu1250Asp)	BRCA1|LOC126862571	E1250D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531374	17	41243798	17	43091781	531374	531074	rs145903082	NC_000017.11:43091780:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1250	BRCA1
NM_007294.4(BRCA1):c.3750G>C (p.Glu1250Asp)	BRCA1|LOC126862571	E1250D	not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000141786	17	41243798	17	43091781	141786	151500	rs145903082	NC_000017.11:43091780:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1250	BRCA1
NM_007294.4(BRCA1):c.3749A>G (p.Glu1250Gly)	BRCA1|LOC126862571	E1250G	Hereditary breast ovarian cancer syndrome	VCV002748795	17	41243799	17	43091782	2748795	2915155	NA	NC_000017.11:43091781:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1250	BRCA1
NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys)	BRCA1|LOC126862571	E1250K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054987	17	41243800	17	43091783	54987	69654	rs28897686	NC_000017.11:43091782:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1250	BRCA1
NM_007294.4(BRCA1):c.3746C>G (p.Thr1249Ser)	BRCA1|LOC126862571	T1249S	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000054986	17	41243802	17	43091785	54986	69653	rs80357099	NC_000017.11:43091784:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1249	BRCA1
NM_007294.4(BRCA1):c.3745A>G (p.Thr1249Ala)	BRCA1|LOC126862571	T1249A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000434526	17	41243803	17	43091786	434526	429968	rs1555587189	NC_000017.11:43091785:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1249	BRCA1
NM_007294.4(BRCA1):c.3743C>G (p.Ala1248Gly)	BRCA1|LOC126862571	A1248G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002450668	17	41243805	17	43091788	2450668	2423154	NA	NC_000017.11:43091787:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1248	BRCA1
NM_007294.4(BRCA1):c.3743C>T (p.Ala1248Val)	BRCA1|LOC126862571	A1248V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001364646	17	41243805	17	43091788	1364646	1409127	rs1339736533	NC_000017.11:43091787:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1248	BRCA1
NM_007294.4(BRCA1):c.3742G>A (p.Ala1248Thr)	LOC126862571|BRCA1	A1248T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001063293	17	41243806	17	43091789	1063293	1050295	rs2053534351	NC_000017.11:43091788:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1248	BRCA1
NM_007294.4(BRCA1):c.3740T>C (p.Val1247Ala)	BRCA1|LOC126862571	V1247A	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000835429	17	41243808	17	43091791	835429	845397	rs2053534509	NC_000017.11:43091790:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1247	BRCA1
NM_007294.4(BRCA1):c.3739G>A (p.Val1247Ile)	BRCA1|LOC126862571	V1247I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054985	17	41243809	17	43091792	54985	69652	rs80357191	NC_000017.11:43091791:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1247	BRCA1
NM_007294.4(BRCA1):c.3737C>T (p.Thr1246Ile)	BRCA1|LOC126862571	T1246I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000650348	17	41243811	17	43091794	650348	645970	rs878854949	NC_000017.11:43091793:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1246	BRCA1
NM_007294.4(BRCA1):c.3737C>A (p.Thr1246Asn)	BRCA1|LOC126862571	T1246N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000240797	17	41243811	17	43091794	240797	242781	rs878854949	NC_000017.11:43091793:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1246	BRCA1
NM_007294.4(BRCA1):c.3736A>G (p.Thr1246Ala)	BRCA1|LOC126862571	T1246A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000156192	17	41243812	17	43091795	156192	165991	rs587776488	NC_000017.11:43091794:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1246	BRCA1
NM_007294.4(BRCA1):c.3734G>A (p.Ser1245Asn)	BRCA1|LOC126862571	S1245N	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409344	17	41243814	17	43091797	409344	402061	rs1060502348	NC_000017.11:43091796:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1245	BRCA1
NM_007294.4(BRCA1):c.3733A>G (p.Ser1245Gly)	BRCA1|LOC126862571	S1245G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000969347	17	41243815	17	43091798	969347	958123	rs2053536157	NC_000017.11:43091797:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1245	BRCA1
NM_007294.4(BRCA1):c.3731A>T (p.His1244Leu)	BRCA1|LOC126862571	H1244L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002128271	17	41243817	17	43091800	2128271	2182274	NA	NC_000017.11:43091799:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1244	BRCA1
NM_007294.4(BRCA1):c.3729G>T (p.Arg1243Ser)	BRCA1|LOC126862571	R1243S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001508867	17	41243819	17	43091802	1508867	1451984	rs2154292175	NC_000017.11:43091801:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1243	BRCA1
NM_007294.4(BRCA1):c.3728G>C (p.Arg1243Thr)	BRCA1|LOC126862571	R1243T	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001708959	17	41243820	17	43091803	1708959	1707313	NA	NC_000017.11:43091802:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1243	BRCA1
NM_007294.4(BRCA1):c.3728G>A (p.Arg1243Lys)	BRCA1|LOC126862571	R1243K	Hereditary cancer-predisposing syndrome	VCV000824131	17	41243820	17	43091803	824131	813725	rs1597861763	NC_000017.11:43091802:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1243	BRCA1
NM_007294.4(BRCA1):c.3724A>T (p.Thr1242Ser)	BRCA1|LOC126862571	T1242S	Hereditary cancer-predisposing syndrome	VCV001734321	17	41243824	17	43091807	1734321	1786740	NA	NC_000017.11:43091806:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1242	BRCA1
NM_007294.4(BRCA1):c.3724A>G (p.Thr1242Ala)	BRCA1|LOC126862571	T1242A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054982	17	41243824	17	43091807	54982	69649	rs80357037	NC_000017.11:43091806:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1242	BRCA1
NM_007294.4(BRCA1):c.3722C>G (p.Ser1241Cys)	BRCA1|LOC126862571	S1241C	Hereditary cancer-predisposing syndrome	VCV000054980	17	41243826	17	43091809	54980	69647	rs80357143	NC_000017.11:43091808:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1241	BRCA1
NM_007294.4(BRCA1):c.3722C>A (p.Ser1241Tyr)	BRCA1|LOC126862571	S1241Y	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054979	17	41243826	17	43091809	54979	69646	rs80357143	NC_000017.11:43091808:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1241	BRCA1
NM_007294.4(BRCA1):c.3721T>C (p.Ser1241Pro)	BRCA1|LOC126862571	S1241P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002816063	17	41243827	17	43091810	2816063	2976733	NA	NC_000017.11:43091809:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1241	BRCA1
NM_007294.4(BRCA1):c.3720G>C (p.Gln1240His)	BRCA1|LOC126862571	Q1240H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000252875	17	41243828	17	43091811	252875	247276	rs876658341	NC_000017.11:43091810:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1240	BRCA1
NM_007294.4(BRCA1):c.3716C>T (p.Ser1239Phe)	BRCA1|LOC126862571	S1239F	not provided|Hereditary cancer-predisposing syndrome	VCV001809546	17	41243832	17	43091815	1809546	1866550	NA	NC_000017.11:43091814:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1239	BRCA1
NM_007294.4(BRCA1):c.3713C>G (p.Pro1238Arg)	BRCA1|LOC126862571	P1238R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054974	17	41243835	17	43091818	54974	69641	rs28897688	NC_000017.11:43091817:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1238	BRCA1
NM_007294.4(BRCA1):c.3713C>T (p.Pro1238Leu)	BRCA1|LOC126862571	P1238L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037543	17	41243835	17	43091818	37543	46099	rs28897688	NC_000017.11:43091817:G:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1238	BRCA1
NM_007294.4(BRCA1):c.3712C>T (p.Pro1238Ser)	BRCA1|LOC126862571	P1238S	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000232448	17	41243836	17	43091819	232448	236002	rs876659772	NC_000017.11:43091818:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1238	BRCA1
NM_007294.4(BRCA1):c.3711A>G (p.Ile1237Met)	LOC126862571|BRCA1	I1237M	Hereditary breast ovarian cancer syndrome|Breast neoplasm|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054973	17	41243837	17	43091820	54973	69640	rs80357388	NC_000017.11:43091819:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1237	BRCA1
NM_007294.4(BRCA1):c.3710T>C (p.Ile1237Thr)	LOC126862571|BRCA1	I1237T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000234148	17	41243838	17	43091821	234148	236003	rs876660883	NC_000017.11:43091820:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1237	BRCA1
NM_007294.4(BRCA1):c.3708T>A (p.Asn1236Lys)	BRCA1|LOC126862571	N1236K	Hereditary cancer-predisposing syndrome	VCV000922840	17	41243840	17	43091823	922840	913887	rs28897687	NC_000017.11:43091822:A:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1236	BRCA1
NM_007294.4(BRCA1):c.3708T>G (p.Asn1236Lys)	BRCA1|LOC126862571	N1236K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054970	17	41243840	17	43091823	54970	69637	rs28897687	NC_000017.11:43091822:A:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1236	BRCA1
NM_007294.4(BRCA1):c.3707A>G (p.Asn1236Ser)	BRCA1|LOC126862571	N1236S	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000216665	17	41243841	17	43091824	216665	213315	rs863224760	NC_000017.11:43091823:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Sep 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1236	BRCA1
NM_007294.4(BRCA1):c.3706A>G (p.Asn1236Asp)	BRCA1|LOC126862571	N1236D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630051	17	41243842	17	43091825	630051	618600	rs1567790509	NC_000017.11:43091824:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1236	BRCA1
NM_007294.4(BRCA1):c.3701T>G (p.Val1234Gly)	LOC126862571|BRCA1	V1234G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002131382	17	41243847	17	43091830	2131382	2191517	NA	NC_000017.11:43091829:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1234	BRCA1
NM_007294.4(BRCA1):c.3700G>C (p.Val1234Leu)	BRCA1|LOC126862571	V1234L	not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216664	17	41243848	17	43091831	216664	213316	rs763354142	NC_000017.11:43091830:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1234	BRCA1
NM_007294.4(BRCA1):c.3698A>C (p.Lys1233Thr)	BRCA1|LOC126862571	K1233T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001447898	17	41243850	17	43091833	1447898	1403784	rs80357141	NC_000017.11:43091832:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1233	BRCA1
NM_007294.4(BRCA1):c.3698A>G (p.Lys1233Arg)	BRCA1|LOC126862571	K1233R	Hereditary cancer-predisposing syndrome	VCV000054964	17	41243850	17	43091833	54964	69631	rs80357141	NC_000017.11:43091832:T:C	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1233	BRCA1
NM_007294.4(BRCA1):c.3697A>G (p.Lys1233Glu)	BRCA1|LOC126862571	K1233E	Hereditary cancer-predisposing syndrome	VCV001734003	17	41243851	17	43091834	1734003	1789753	NA	NC_000017.11:43091833:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1233	BRCA1
NM_007294.4(BRCA1):c.3692T>C (p.Phe1231Ser)	BRCA1|LOC126862571	F1231S	Hereditary breast ovarian cancer syndrome	VCV002760060	17	41243856	17	43091839	2760060	2910872	NA	NC_000017.11:43091838:A:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1231	BRCA1
NM_007294.4(BRCA1):c.3692T>G (p.Phe1231Cys)	BRCA1|LOC126862571	F1231C	Hereditary cancer-predisposing syndrome	VCV001733978	17	41243856	17	43091839	1733978	1789728	NA	NC_000017.11:43091838:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1231	BRCA1
NM_007294.4(BRCA1):c.3691T>C (p.Phe1231Leu)	BRCA1|LOC126862571	F1231L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|not specified	VCV000037541	17	41243857	17	43091840	37541	46097	rs41293451	NC_000017.11:43091839:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1231	BRCA1
NM_007294.4(BRCA1):c.3688T>G (p.Leu1230Val)	BRCA1|LOC126862571	L1230V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000890889	17	41243860	17	43091843	890889	877641	rs786201581	NC_000017.11:43091842:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1230	BRCA1
NM_007294.4(BRCA1):c.3688T>A (p.Leu1230Ile)	BRCA1|LOC126862571	L1230I	Hereditary cancer-predisposing syndrome	VCV000824070	17	41243860	17	43091843	824070	813729	rs786201581	NC_000017.11:43091842:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1230	BRCA1
NM_007294.4(BRCA1):c.3687G>T (p.Leu1229Phe)	BRCA1|LOC126862571	L1229F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001499398	17	41243861	17	43091844	1499398	1389101	rs2154294699	NC_000017.11:43091843:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1229	BRCA1
NM_007294.4(BRCA1):c.3686T>C (p.Leu1229Ser)	BRCA1|LOC126862571	L1229S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069954	17	41243862	17	43091845	3069954	3233529	NA	NC_000017.11:43091844:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1229	BRCA1
NM_007294.4(BRCA1):c.3683A>G (p.His1228Arg)	BRCA1|LOC126862571	H1228R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001733899	17	41243865	17	43091848	1733899	1789649	NA	NC_000017.11:43091847:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1228	BRCA1
NM_007294.4(BRCA1):c.3682C>A (p.His1228Asn)	BRCA1|LOC126862571	H1228N	Hereditary cancer-predisposing syndrome	VCV003226141	17	41243866	17	43091849	3226141	3387205	NA	NC_000017.11:43091848:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1228	BRCA1
NM_007294.4(BRCA1):c.3682C>T (p.His1228Tyr)	BRCA1|LOC126862571	H1228Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000584948	17	41243866	17	43091849	584948	575997	rs1567790599	NC_000017.11:43091848:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1228	BRCA1
NM_007294.4(BRCA1):c.3681A>T (p.Gln1227His)	BRCA1|LOC126862571	Q1227H	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182154	17	41243867	17	43091850	182154	180844	rs730881488	NC_000017.11:43091849:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1227	BRCA1
NM_007294.4(BRCA1):c.3680A>T (p.Gln1227Leu)	BRCA1|LOC126862571	Q1227L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003074391	17	41243868	17	43091851	3074391	3231525	NA	NC_000017.11:43091850:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1227	BRCA1
NM_007294.4(BRCA1):c.3677T>C (p.Phe1226Ser)	BRCA1|LOC126862571	F1226S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000950939	17	41243871	17	43091854	950939	928290	rs1396926041	NC_000017.11:43091853:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1226	BRCA1
NM_007294.4(BRCA1):c.3676T>G (p.Phe1226Val)	BRCA1|LOC126862571	F1226V	Hereditary cancer-predisposing syndrome	VCV003226140	17	41243872	17	43091855	3226140	3387204	NA	NC_000017.11:43091854:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1226	BRCA1
NM_007294.4(BRCA1):c.3674G>A (p.Cys1225Tyr)	BRCA1|LOC126862571	C1225Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000939559	17	41243874	17	43091857	939559	937951	rs1567790638	NC_000017.11:43091856:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1225	BRCA1
NM_007294.4(BRCA1):c.3674G>C (p.Cys1225Ser)	BRCA1|LOC126862571	C1225S	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000632681	17	41243874	17	43091857	632681	621577	rs1567790638	NC_000017.11:43091856:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1225	BRCA1
NM_007294.4(BRCA1):c.3673T>A (p.Cys1225Ser)	BRCA1|LOC126862571	C1225S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001009310	17	41243875	17	43091858	1009310	997573	rs1382025345	NC_000017.11:43091857:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1225	BRCA1
NM_007294.4(BRCA1):c.3673T>G (p.Cys1225Gly)	BRCA1|LOC126862571	C1225G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462621	17	41243875	17	43091858	462621	467930	rs1382025345	NC_000017.11:43091857:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1225	BRCA1
NM_007294.4(BRCA1):c.3671C>T (p.Pro1224Leu)	BRCA1|LOC126862571	P1224L	Hereditary cancer-predisposing syndrome	VCV001733795	17	41243877	17	43091860	1733795	1789545	NA	NC_000017.11:43091859:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1224	BRCA1
NM_007294.4(BRCA1):c.3670C>T (p.Pro1224Ser)	BRCA1|LOC126862571	P1224S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001733790	17	41243878	17	43091861	1733790	1789540	NA	NC_000017.11:43091860:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1224	BRCA1
NM_007294.4(BRCA1):c.3668T>C (p.Leu1223Pro)	BRCA1|LOC126862571	L1223P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001365085	17	41243880	17	43091863	1365085	1502129	rs2154295855	NC_000017.11:43091862:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1223	BRCA1
NM_007294.4(BRCA1):c.3667C>G (p.Leu1223Val)	BRCA1|LOC126862571	L1223V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952987	17	41243881	17	43091864	952987	928291	rs1555587309	NC_000017.11:43091863:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1223	BRCA1
NM_007294.4(BRCA1):c.3667C>T (p.Leu1223Phe)	BRCA1|LOC126862571	L1223F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462619	17	41243881	17	43091864	462619	467716	rs1555587309	NC_000017.11:43091863:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1223	BRCA1
NM_007294.4(BRCA1):c.3666G>C (p.Glu1222Asp)	LOC126862571|BRCA1	E1222D	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000462618	17	41243882	17	43091865	462618	468145	rs1555587312	NC_000017.11:43091864:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1222	BRCA1
NM_007294.4(BRCA1):c.3664G>A (p.Glu1222Lys)	BRCA1|LOC126862571	E1222K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV001000551	17	41243884	17	43091867	1000551	997574	rs80357356	NC_000017.11:43091866:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1222	BRCA1
NM_007294.4(BRCA1):c.3662A>C (p.Glu1221Ala)	BRCA1|LOC126862571	E1221A	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054958	17	41243886	17	43091869	54958	69625	rs273900713	NC_000017.11:43091868:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1221	BRCA1
NM_007294.4(BRCA1):c.3660T>G (p.Asp1220Glu)	BRCA1|LOC126862571	D1220E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001005942	17	41243888	17	43091871	1005942	997575	rs1365746397	NC_000017.11:43091870:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1220	BRCA1
NM_007294.4(BRCA1):c.3659A>T (p.Asp1220Val)	BRCA1|LOC126862571	D1220V	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000232408	17	41243889	17	43091872	232408	236004	rs766572561	NC_000017.11:43091871:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1220	BRCA1
NM_007294.4(BRCA1):c.3657G>T (p.Glu1219Asp)	BRCA1|LOC126862571	E1219D	Hereditary breast ovarian cancer syndrome	VCV002035518	17	41243891	17	43091874	2035518	2097302	NA	NC_000017.11:43091873:C:A	single nucleotide variant	missense variant|intron variant	Benign	Oct 14, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1219	BRCA1
NM_007294.4(BRCA1):c.3657G>C (p.Glu1219Asp)	BRCA1|LOC126862571	E1219D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037537	17	41243891	17	43091874	37537	46093	rs80356876	NC_000017.11:43091873:C:G	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1219	BRCA1
NM_007294.4(BRCA1):c.3656A>G (p.Glu1219Gly)	BRCA1|LOC126862571	E1219G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001472400	17	41243892	17	43091875	1472400	1397782	rs2154296539	NC_000017.11:43091874:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1219	BRCA1
NM_007294.4(BRCA1):c.3655G>C (p.Glu1219Gln)	BRCA1|LOC126862571	E1219Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000961282	17	41243893	17	43091876	961282	949936	rs80356921	NC_000017.11:43091875:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1219	BRCA1
NM_007294.4(BRCA1):c.3655G>A (p.Glu1219Lys)	BRCA1|LOC126862571	E1219K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054956	17	41243893	17	43091876	54956	69623	rs80356921	NC_000017.11:43091875:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1219	BRCA1
NM_007294.4(BRCA1):c.3653G>A (p.Ser1218Asn)	LOC126862571|BRCA1	S1218N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001046087	17	41243895	17	43091878	1046087	1033310	rs2053549058	NC_000017.11:43091877:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1218	BRCA1
NM_007294.4(BRCA1):c.3652A>T (p.Ser1218Cys)	BRCA1|LOC126862571	S1218C	Hereditary cancer-predisposing syndrome	VCV000054955	17	41243896	17	43091879	54955	69622	rs80356894	NC_000017.11:43091878:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1218	BRCA1
NM_007294.4(BRCA1):c.3652A>G (p.Ser1218Gly)	BRCA1|LOC126862571	S1218G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|not provided	VCV000037536	17	41243896	17	43091879	37536	46092	rs80356894	NC_000017.11:43091878:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1218	BRCA1
NM_007294.4(BRCA1):c.3650C>G (p.Ser1217Cys)	BRCA1|LOC126862571	S1217C	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000091611	17	41243898	17	43091881	91611	97088	rs398122676	NC_000017.11:43091880:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1217	BRCA1
NM_007294.4(BRCA1):c.3649T>C (p.Ser1217Pro)	BRCA1|LOC126862571	S1217P	not specified|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054953	17	41243899	17	43091882	54953	69620	rs273900712	NC_000017.11:43091881:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1217	BRCA1
NM_007294.4(BRCA1):c.3645C>G (p.Asn1215Lys)	BRCA1|LOC126862571	N1215K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001026607	17	41243903	17	43091886	1026607	1012771	rs758329415	NC_000017.11:43091885:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1215	BRCA1
NM_007294.4(BRCA1):c.3644A>G (p.Asn1215Ser)	BRCA1|LOC126862571	N1215S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000186902	17	41243904	17	43091887	186902	184959	rs786203310	NC_000017.11:43091886:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1215	BRCA1
NM_007294.4(BRCA1):c.3643A>T (p.Asn1215Tyr)	LOC126862571|BRCA1	N1215Y	Hereditary breast ovarian cancer syndrome	VCV002751150	17	41243905	17	43091888	2751150	2913188	NA	NC_000017.11:43091887:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1215	BRCA1
NM_007294.4(BRCA1):c.3642G>C (p.Glu1214Asp)	BRCA1|LOC126862571	E1214D	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000496369	17	41243906	17	43091889	496369	487961	rs398122675	NC_000017.11:43091888:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1214	BRCA1
NM_007294.4(BRCA1):c.3642G>T (p.Glu1214Asp)	BRCA1|LOC126862571	E1214D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000091610	17	41243906	17	43091889	91610	97087	rs398122675	NC_000017.11:43091888:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1214	BRCA1
NM_007294.4(BRCA1):c.3640G>C (p.Glu1214Gln)	BRCA1|LOC126862571	E1214Q	Hereditary cancer-predisposing syndrome|not specified	VCV000917778	17	41243908	17	43091891	917778	906104	rs80356923	NC_000017.11:43091890:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1214	BRCA1
NM_007294.4(BRCA1):c.3640G>A (p.Glu1214Lys)	BRCA1|LOC126862571	E1214K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054948	17	41243908	17	43091891	54948	69615	rs80356923	NC_000017.11:43091890:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1214	BRCA1
NM_007294.4(BRCA1):c.3637G>A (p.Glu1213Lys)	BRCA1|LOC126862571	E1213K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001684258	17	41243911	17	43091894	1684258	1676188	NA	NC_000017.11:43091893:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1213	BRCA1
NM_007294.4(BRCA1):c.3635C>T (p.Ser1212Leu)	BRCA1|LOC126862571	S1212L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001049577	17	41243913	17	43091896	1049577	1038564	rs886038021	NC_000017.11:43091895:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1212	BRCA1
NM_007294.4(BRCA1):c.3634T>G (p.Ser1212Ala)	BRCA1|LOC126862571	S1212A	Hereditary breast ovarian cancer syndrome	VCV002871064	17	41243914	17	43091897	2871064	3037446	NA	NC_000017.11:43091896:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1212	BRCA1
NM_007294.4(BRCA1):c.3634T>C (p.Ser1212Pro)	BRCA1|LOC126862571	S1212P	not provided|Hereditary cancer-predisposing syndrome	VCV000801071	17	41243914	17	43091897	801071	789622	rs1597862383	NC_000017.11:43091896:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1212	BRCA1
NM_007294.4(BRCA1):c.3632C>T (p.Ser1211Phe)	BRCA1|LOC126862571	S1211F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001353153	17	41243916	17	43091899	1353153	1421135	rs1555587377	NC_000017.11:43091898:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1211	BRCA1
NM_007294.4(BRCA1):c.3632C>G (p.Ser1211Cys)	BRCA1|LOC126862571	S1211C	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479240	17	41243916	17	43091899	479240	478595	rs1555587377	NC_000017.11:43091898:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1211	BRCA1
NM_007294.4(BRCA1):c.3631T>G (p.Ser1211Ala)	LOC126862571|BRCA1	S1211A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000971812	17	41243917	17	43091900	971812	958124	rs2053553313	NC_000017.11:43091899:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1211	BRCA1
NM_007294.4(BRCA1):c.3629A>T (p.Glu1210Val)	BRCA1|LOC126862571	E1210V	Hereditary breast ovarian cancer syndrome	VCV002702784	17	41243919	17	43091902	2702784	2866335	NA	NC_000017.11:43091901:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1210	BRCA1
NM_007294.4(BRCA1):c.3629A>G (p.Glu1210Gly)	BRCA1|LOC126862571	E1210G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409341	17	41243919	17	43091902	409341	402069	rs1060502347	NC_000017.11:43091901:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1210	BRCA1
NM_007294.4(BRCA1):c.3626T>C (p.Leu1209Ser)	BRCA1|LOC126862571	L1209S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001061482	17	41243922	17	43091905	1061482	1050296	rs786203884	NC_000017.11:43091904:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1209	BRCA1
NM_007294.4(BRCA1):c.3625T>G (p.Leu1209Val)	BRCA1|LOC126862571	L1209V	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054942	17	41243923	17	43091906	54942	69609	rs273900711	NC_000017.11:43091905:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1209	BRCA1
NM_007294.4(BRCA1):c.3621_3622delinsAG (p.Lys1208Glu)	LOC126862571|BRCA1	K1208E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630631	17	41243926 - 41243927	17	43091909 - 43091910	630631	618602	rs1567790889	NC_000017.11:43091908:TC:CT	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1208	BRCA1
NM_007294.4(BRCA1):c.3622A>G (p.Lys1208Glu)	BRCA1|LOC126862571	K1208E	Hereditary cancer-predisposing syndrome	VCV000054940	17	41243926	17	43091909	54940	69607	rs80357152	NC_000017.11:43091908:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1208	BRCA1
NM_007294.4(BRCA1):c.3620A>T (p.Lys1207Met)	BRCA1|LOC126862571	K1207M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462616	17	41243928	17	43091911	462616	466862	rs1555587402	NC_000017.11:43091910:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1207	BRCA1
NM_007294.4(BRCA1):c.3619A>G (p.Lys1207Glu)	BRCA1|LOC126862571	K1207E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000089060	17	41243929	17	43091912	89060	94603	rs80357455	NC_000017.11:43091911:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1207	BRCA1
NM_007294.4(BRCA1):c.3616G>A (p.Ala1206Thr)	BRCA1|LOC126862571	A1206T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002072382	17	41243932	17	43091915	2072382	2120322	NA	NC_000017.11:43091914:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1206	BRCA1
NM_007294.4(BRCA1):c.3616G>T (p.Ala1206Ser)	BRCA1|LOC126862571	A1206S	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441433	17	41243932	17	43091915	441433	435130	rs1555587407	NC_000017.11:43091914:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1206	BRCA1
NM_007294.4(BRCA1):c.3614G>T (p.Gly1205Val)	BRCA1|LOC126862571	G1205V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000651402	17	41243934	17	43091917	651402	645971	rs1597862536	NC_000017.11:43091916:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1205	BRCA1
NM_007294.4(BRCA1):c.3613G>C (p.Gly1205Arg)	BRCA1|LOC126862571	G1205R	Hereditary cancer-predisposing syndrome	VCV000054937	17	41243935	17	43091918	54937	69604	rs80357294	NC_000017.11:43091917:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1205	BRCA1
NM_007294.4(BRCA1):c.3613G>A (p.Gly1205Arg)	BRCA1|LOC126862571	G1205R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054936	17	41243935	17	43091918	54936	69603	rs80357294	NC_000017.11:43091917:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1205	BRCA1
NM_007294.4(BRCA1):c.3611G>C (p.Arg1204Thr)	BRCA1|LOC126862571	R1204T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000485393	17	41243937	17	43091920	485393	478713	rs1456509049	NC_000017.11:43091919:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1204	BRCA1
NM_007294.4(BRCA1):c.3610A>G (p.Arg1204Gly)	BRCA1|LOC126862571	R1204G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001011036	17	41243938	17	43091921	1011036	997576	rs2053557648	NC_000017.11:43091920:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1204	BRCA1
NM_007294.4(BRCA1):c.3608G>A (p.Arg1203Gln)	BRCA1|LOC126862571	R1203Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054935	17	41243940	17	43091923	54935	69602	rs55930959	NC_000017.11:43091922:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1203	BRCA1
NM_007294.4(BRCA1):c.3607C>G (p.Arg1203Gly)	BRCA1|LOC126862571	R1203G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054934	17	41243941	17	43091924	54934	69601	rs62625308	NC_000017.11:43091923:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1203	BRCA1
NM_007294.4(BRCA1):c.3604T>C (p.Tyr1202His)	BRCA1|LOC126862571	Y1202H	Hereditary cancer-predisposing syndrome	VCV001733143	17	41243944	17	43091927	1733143	1796217	NA	NC_000017.11:43091926:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1202	BRCA1
NM_007294.4(BRCA1):c.3602G>A (p.Gly1201Asp)	BRCA1|LOC126862571	G1201D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630054	17	41243946	17	43091929	630054	618603	rs1567790971	NC_000017.11:43091928:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1201	BRCA1
NM_007294.4(BRCA1):c.3601G>C (p.Gly1201Arg)	BRCA1|LOC126862571	G1201R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000489717	17	41243947	17	43091930	489717	483018	rs55725337	NC_000017.11:43091929:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1201	BRCA1
NM_007294.4(BRCA1):c.3601G>A (p.Gly1201Ser)	BRCA1|LOC126862571	G1201S	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000054932	17	41243947	17	43091930	54932	69599	rs55725337	NC_000017.11:43091929:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1201	BRCA1
NM_007294.4(BRCA1):c.3600G>T (p.Gln1200His)	BRCA1|LOC126862571	Q1200H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054931	17	41243948	17	43091931	54931	69598	rs56214134	NC_000017.11:43091930:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1200	BRCA1
NM_007294.4(BRCA1):c.3600G>C (p.Gln1200His)	BRCA1|LOC126862571	Q1200H	not specified|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054930	17	41243948	17	43091931	54930	69597	rs56214134	NC_000017.11:43091930:C:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1200	BRCA1
NM_007294.4(BRCA1):c.3599A>C (p.Gln1200Pro)	BRCA1|LOC126862571	Q1200P	Hereditary breast ovarian cancer syndrome	VCV002839251	17	41243949	17	43091932	2839251	2996522	NA	NC_000017.11:43091931:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1200	BRCA1
NM_007294.4(BRCA1):c.3596C>T (p.Ala1199Val)	BRCA1|LOC126862571	A1199V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000142428	17	41243952	17	43091935	142428	152142	rs587782458	NC_000017.11:43091934:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1199	BRCA1
NM_007294.4(BRCA1):c.3595G>C (p.Ala1199Pro)	BRCA1|LOC126862571	A1199P	Hereditary cancer-predisposing syndrome	VCV001733016	17	41243953	17	43091936	1733016	1796090	NA	NC_000017.11:43091935:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1199	BRCA1
NM_007294.4(BRCA1):c.3595G>T (p.Ala1199Ser)	BRCA1|LOC126862571	A1199S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462614	17	41243953	17	43091936	462614	467933	rs1555587437	NC_000017.11:43091935:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1199	BRCA1
NM_007294.4(BRCA1):c.3590A>G (p.His1197Arg)	LOC126862571|BRCA1	H1197R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000956510	17	41243958	17	43091941	956510	949937	rs2053559788	NC_000017.11:43091940:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1197	BRCA1
NM_007294.4(BRCA1):c.3590A>T (p.His1197Leu)	BRCA1|LOC126862571	H1197L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000949639	17	41243958	17	43091941	949639	928292	rs2053559788	NC_000017.11:43091940:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1197	BRCA1
NM_007294.4(BRCA1):c.3587C>T (p.Thr1196Ile)	BRCA1|LOC126862571	T1196I	not specified|BRCA1-related disorder|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054926	17	41243961	17	43091944	54926	69593	rs80356944	NC_000017.11:43091943:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1196	BRCA1
NM_007294.4(BRCA1):c.3587C>A (p.Thr1196Lys)	BRCA1|LOC126862571	T1196K	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054925	17	41243961	17	43091944	54925	69592	rs80356944	NC_000017.11:43091943:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1196	BRCA1
NM_007294.4(BRCA1):c.3586A>G (p.Thr1196Ala)	BRCA1|LOC126862571	T1196A	not provided	VCV002663340	17	41243962	17	43091945	2663340	2830790	NA	NC_000017.11:43091944:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1196	BRCA1
NM_007294.4(BRCA1):c.3586A>T (p.Thr1196Ser)	BRCA1|LOC126862571	T1196S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441435	17	41243962	17	43091945	441435	435131	rs1340335862	NC_000017.11:43091944:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1196	BRCA1
NM_007294.4(BRCA1):c.3585T>A (p.His1195Gln)	BRCA1|LOC126862571	H1195Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000946048	17	41243963	17	43091946	946048	928293	rs2053561125	NC_000017.11:43091945:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1195	BRCA1
NM_007294.4(BRCA1):c.3584A>G (p.His1195Arg)	BRCA1|LOC126862571	H1195R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000142258	17	41243964	17	43091947	142258	151972	rs28897685	NC_000017.11:43091946:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1195	BRCA1
NM_007294.4(BRCA1):c.3583C>G (p.His1195Asp)	BRCA1|LOC126862571	H1195D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409296	17	41243965	17	43091948	409296	402501	rs876659903	NC_000017.11:43091947:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1195	BRCA1
NM_007294.4(BRCA1):c.3583C>T (p.His1195Tyr)	BRCA1|LOC126862571	H1195Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232653	17	41243965	17	43091948	232653	236008	rs876659903	NC_000017.11:43091947:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1195	BRCA1
NM_007294.4(BRCA1):c.3581C>G (p.Thr1194Ser)	BRCA1|LOC126862571	T1194S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000965434	17	41243967	17	43091950	965434	958125	rs80357290	NC_000017.11:43091949:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1194	BRCA1
NM_007294.4(BRCA1):c.3581C>T (p.Thr1194Ile)	BRCA1|LOC126862571	T1194I	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054922	17	41243967	17	43091950	54922	69589	rs80357290	NC_000017.11:43091949:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1194	BRCA1
NM_007294.4(BRCA1):c.3580A>G (p.Thr1194Ala)	BRCA1|LOC126862571	T1194A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000409316	17	41243968	17	43091951	409316	402683	rs369982706	NC_000017.11:43091950:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1194	BRCA1
NM_007294.4(BRCA1):c.3579C>G (p.Phe1193Leu)	BRCA1|LOC126862571	F1193L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000938265	17	41243969	17	43091952	938265	937952	rs2053562704	NC_000017.11:43091951:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1193	BRCA1
NM_007294.4(BRCA1):c.3577T>G (p.Phe1193Val)	BRCA1|LOC126862571	F1193V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721271	17	41243971	17	43091954	1721271	1772605	NA	NC_000017.11:43091953:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1193	BRCA1
NM_007294.4(BRCA1):c.3574C>T (p.Pro1192Ser)	BRCA1|LOC126862571	P1192S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000918749	17	41243974	17	43091957	918749	913890	rs754014157	NC_000017.11:43091956:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1192	BRCA1
NM_007294.4(BRCA1):c.3572G>A (p.Ser1191Asn)	BRCA1|LOC126862571	S1191N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240794	17	41243976	17	43091959	240794	242783	rs878854948	NC_000017.11:43091958:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1191	BRCA1
NM_007294.4(BRCA1):c.3571A>G (p.Ser1191Gly)	BRCA1|LOC126862571	S1191G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000924367	17	41243977	17	43091960	924367	913891	rs2053563998	NC_000017.11:43091959:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1191	BRCA1
NM_007294.4(BRCA1):c.3569C>G (p.Pro1190Arg)	BRCA1|LOC126862571	P1190R	Hereditary cancer-predisposing syndrome	VCV003261475	17	41243979	17	43091962	3261475	3424244	NA	NC_000017.11:43091961:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 2, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1190	BRCA1
NM_007294.4(BRCA1):c.3569C>T (p.Pro1190Leu)	BRCA1|LOC126862571	P1190L	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000233875	17	41243979	17	43091962	233875	236009	rs755209182	NC_000017.11:43091961:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1190	BRCA1
NM_007294.4(BRCA1):c.3568C>T (p.Pro1190Ser)	BRCA1|LOC126862571	P1190S	Hereditary cancer-predisposing syndrome	VCV001732756	17	41243980	17	43091963	1732756	1786443	NA	NC_000017.11:43091962:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1190	BRCA1
NM_007294.4(BRCA1):c.3566G>T (p.Ser1189Ile)	BRCA1|LOC126862571	S1189I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001052861	17	41243982	17	43091965	1052861	1050297	rs2154302764	NC_000017.11:43091964:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1189	BRCA1
NM_007294.4(BRCA1):c.3565A>C (p.Ser1189Arg)	BRCA1|LOC126862571	S1189R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001046490	17	41243983	17	43091966	1046490	1033311	rs1567791142	NC_000017.11:43091965:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1189	BRCA1
NM_007294.4(BRCA1):c.3565A>T (p.Ser1189Cys)	BRCA1|LOC126862571	S1189C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000582398	17	41243983	17	43091966	582398	574471	rs1567791142	NC_000017.11:43091965:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1189	BRCA1
NM_007294.4(BRCA1):c.3564G>C (p.Arg1188Ser)	BRCA1|LOC126862571	R1188S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000252874	17	41243984	17	43091967	252874	247275	rs879255484	NC_000017.11:43091966:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1188	BRCA1
NM_007294.4(BRCA1):c.3563G>T (p.Arg1188Met)	BRCA1|LOC126862571	R1188M	Hereditary cancer-predisposing syndrome	VCV001050301	17	41243985	17	43091968	1050301	1038565	rs2154303009	NC_000017.11:43091967:C:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1188	BRCA1
NM_007294.4(BRCA1):c.3560G>T (p.Ser1187Ile)	BRCA1|LOC126862571	S1187I	Hereditary breast ovarian cancer syndrome	VCV002837646	17	41243988	17	43091971	2837646	2996203	NA	NC_000017.11:43091970:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1187	BRCA1
NM_007294.4(BRCA1):c.3560G>C (p.Ser1187Thr)	BRCA1|LOC126862571	S1187T	Hereditary cancer-predisposing syndrome|not provided	VCV000619626	17	41243988	17	43091971	619626	611234	rs80356975	NC_000017.11:43091970:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1187	BRCA1
NM_007294.4(BRCA1):c.3560G>A (p.Ser1187Asn)	BRCA1|LOC126862571	S1187N	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054917	17	41243988	17	43091971	54917	69584	rs80356975	NC_000017.11:43091970:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1187	BRCA1
NM_007294.4(BRCA1):c.3557T>A (p.Leu1186His)	BRCA1|LOC126862571	L1186H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000572392	17	41243991	17	43091974	572392	571438	rs1567791164	NC_000017.11:43091973:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1186	BRCA1
NM_007294.4(BRCA1):c.3556C>A (p.Leu1186Ile)	BRCA1|LOC126862571	L1186I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001390651	17	41243992	17	43091975	1390651	1396824	rs1555587505	NC_000017.11:43091974:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1186	BRCA1
NM_007294.4(BRCA1):c.3556C>G (p.Leu1186Val)	BRCA1|LOC126862571	L1186V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001004786	17	41243992	17	43091975	1004786	997577	rs1555587505	NC_000017.11:43091974:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1186	BRCA1
NM_007294.4(BRCA1):c.3556C>T (p.Leu1186Phe)	BRCA1|LOC126862571	L1186F	not provided|BRCA1-related disorder|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531251	17	41243992	17	43091975	531251	531571	rs1555587505	NC_000017.11:43091974:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1186	BRCA1
NM_007294.4(BRCA1):c.3555G>T (p.Glu1185Asp)	BRCA1|LOC126862571	E1185D	Hereditary cancer-predisposing syndrome|not specified|not provided|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome	VCV000089059	17	41243993	17	43091976	89059	94602	rs587779368	NC_000017.11:43091975:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1185	BRCA1
NM_007294.4(BRCA1):c.3554A>G (p.Glu1185Gly)	BRCA1|LOC126862571	E1185G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000937484	17	41243994	17	43091977	937484	937953	rs2053566295	NC_000017.11:43091976:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1185	BRCA1
NM_007294.4(BRCA1):c.3551G>A (p.Gly1184Glu)	BRCA1|LOC126862571	G1184E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630188	17	41243997	17	43091980	630188	618604	rs1567791181	NC_000017.11:43091979:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1184	BRCA1
NM_007294.4(BRCA1):c.3550G>A (p.Gly1184Arg)	BRCA1|LOC126862571	G1184R	Hereditary cancer-predisposing syndrome	VCV001732593	17	41243998	17	43091981	1732593	1786280	NA	NC_000017.11:43091980:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1184	BRCA1
NM_007294.4(BRCA1):c.3548_3549delinsGG (p.Lys1183Arg)	BRCA1|LOC126862571	K1183R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000920987	17	41243999 - 41244000	17	43091982 - 43091983	920987	913893	rs2053567538	NC_000017.11:43091981:TT:CC	Indel	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1183	BRCA1
NM_007294.4(BRCA1):c.3548A>T (p.Lys1183Ile)	BRCA1|LOC126862571	K1183I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531339	17	41244000	17	43091983	531339	531263	rs16942	NC_000017.11:43091982:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1183	BRCA1
NM_007294.4(BRCA1):c.3548A>G (p.Lys1183Arg)	BRCA1|LOC126862571	K1183R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041818	17	41244000	17	43091983	41818	50257	rs16942	NC_000017.11:43091982:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1183	BRCA1
NM_007294.4(BRCA1):c.3547A>G (p.Lys1183Glu)	BRCA1|LOC126862571	K1183E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002015377	17	41244001	17	43091984	2015377	2068175	NA	NC_000017.11:43091983:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1183	BRCA1
NM_007294.4(BRCA1):c.3545A>T (p.Gln1182Leu)	BRCA1|LOC126862571	Q1182L	Hereditary cancer-predisposing syndrome	VCV000441338	17	41244003	17	43091986	441338	435132	rs1555587532	NC_000017.11:43091985:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1182	BRCA1
NM_007294.4(BRCA1):c.3542T>G (p.Val1181Gly)	BRCA1|LOC126862571	V1181G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000847346	17	41244006	17	43091989	847346	845400	rs80357032	NC_000017.11:43091988:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1181	BRCA1
NM_007294.4(BRCA1):c.3542T>C (p.Val1181Ala)	BRCA1|LOC126862571	V1181A	Hereditary cancer-predisposing syndrome	VCV000054912	17	41244006	17	43091989	54912	69579	rs80357032	NC_000017.11:43091988:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1181	BRCA1
NM_007294.4(BRCA1):c.3541G>C (p.Val1181Leu)	BRCA1|LOC126862571	V1181L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001346072	17	41244007	17	43091990	1346072	1378361	rs56336919	NC_000017.11:43091989:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1181	BRCA1
NM_007294.4(BRCA1):c.3541G>T (p.Val1181Phe)	BRCA1|LOC126862571	V1181F	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000823906	17	41244007	17	43091990	823906	813733	rs56336919	NC_000017.11:43091989:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1181	BRCA1
NM_007294.4(BRCA1):c.3541G>A (p.Val1181Ile)	BRCA1|LOC126862571	V1181I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054911	17	41244007	17	43091990	54911	69578	rs56336919	NC_000017.11:43091989:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1181	BRCA1
NM_007294.4(BRCA1):c.3540C>A (p.Ser1180Arg)	BRCA1|LOC126862571	S1180R	Hereditary breast ovarian cancer syndrome	VCV002811475	17	41244008	17	43091991	2811475	2972556	NA	NC_000017.11:43091990:G:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1180	BRCA1
NM_007294.4(BRCA1):c.3540C>G (p.Ser1180Arg)	BRCA1|LOC126862571	S1180R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000846030	17	41244008	17	43091991	846030	845401	rs928545955	NC_000017.11:43091990:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1180	BRCA1
NM_007294.4(BRCA1):c.3539G>C (p.Ser1180Thr)	BRCA1|LOC126862571	S1180T	Hereditary cancer-predisposing syndrome	VCV000925307	17	41244009	17	43091992	925307	913894	rs1064793057	NC_000017.11:43091991:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1180	BRCA1
NM_007294.4(BRCA1):c.3539G>A (p.Ser1180Asn)	BRCA1|LOC126862571	S1180N	not provided|Hereditary cancer-predisposing syndrome	VCV000418069	17	41244009	17	43091992	418069	409978	rs1064793057	NC_000017.11:43091991:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1180	BRCA1
NM_007294.4(BRCA1):c.3538A>C (p.Ser1180Arg)	BRCA1|LOC126862571	S1180R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002692275	17	41244010	17	43091993	2692275	2853278	NA	NC_000017.11:43091992:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 2, 2020	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1180	BRCA1
NM_007294.4(BRCA1):c.3535A>G (p.Lys1179Glu)	BRCA1|LOC126862571	K1179E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002450669	17	41244013	17	43091996	2450669	2423155	NA	NC_000017.11:43091995:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1179	BRCA1
NM_007294.4(BRCA1):c.3535A>C (p.Lys1179Gln)	BRCA1|LOC126862571	K1179Q	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000142028	17	41244013	17	43091996	142028	151742	rs587782188	NC_000017.11:43091995:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1179	BRCA1
NM_007294.4(BRCA1):c.3533G>T (p.Ser1178Ile)	BRCA1|LOC126862571	S1178I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001054658	17	41244015	17	43091998	1054658	1050298	rs1294360179	NC_000017.11:43091997:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1178	BRCA1
NM_007294.4(BRCA1):c.3533G>C (p.Ser1178Thr)	BRCA1|LOC126862571	S1178T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489716	17	41244015	17	43091998	489716	482972	rs1294360179	NC_000017.11:43091997:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1178	BRCA1
NM_007294.4(BRCA1):c.3533G>A (p.Ser1178Asn)	BRCA1|LOC126862571	S1178N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000441297	17	41244015	17	43091998	441297	435133	rs1294360179	NC_000017.11:43091997:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1178	BRCA1
NM_007294.4(BRCA1):c.3532A>G (p.Ser1178Gly)	BRCA1|LOC126862571	S1178G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000582877	17	41244016	17	43091999	582877	569124	rs1567791298	NC_000017.11:43091998:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1178	BRCA1
NM_007294.4(BRCA1):c.3527T>A (p.Val1176Asp)	BRCA1|LOC126862571	V1176D	Hereditary cancer-predisposing syndrome	VCV000054908	17	41244021	17	43092004	54908	69575	rs80357027	NC_000017.11:43092003:A:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1176	BRCA1
NM_007294.4(BRCA1):c.3526G>A (p.Val1176Ile)	BRCA1|LOC126862571	V1176I	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000565640	17	41244022	17	43092005	565640	574472	rs777796838	NC_000017.11:43092004:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1176	BRCA1
NM_007294.4(BRCA1):c.3524C>T (p.Ala1175Val)	BRCA1|LOC126862571	A1175V	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000632683	17	41244024	17	43092007	632683	621578	rs1567791322	NC_000017.11:43092006:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1175	BRCA1
NM_007294.4(BRCA1):c.3523G>A (p.Ala1175Thr)	BRCA1|LOC126862571	A1175T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000823882	17	41244025	17	43092008	823882	813735	rs1597863144	NC_000017.11:43092007:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1175	BRCA1
NM_007294.4(BRCA1):c.3521C>T (p.Ser1174Phe)	BRCA1|LOC126862571	S1174F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001051872	17	41244027	17	43092010	1051872	1050299	rs1055368753	NC_000017.11:43092009:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1174	BRCA1
NM_007294.4(BRCA1):c.3521C>G (p.Ser1174Cys)	BRCA1|LOC126862571	S1174C	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000651521	17	41244027	17	43092010	651521	645972	rs1055368753	NC_000017.11:43092009:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1174	BRCA1
NM_007294.4(BRCA1):c.3518G>T (p.Ser1173Ile)	BRCA1|LOC126862571	S1173I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000863842	17	41244030	17	43092013	863842	845402	rs746949187	NC_000017.11:43092012:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1173	BRCA1
NM_007294.4(BRCA1):c.3518G>A (p.Ser1173Asn)	BRCA1|LOC126862571	S1173N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000240793	17	41244030	17	43092013	240793	242784	rs746949187	NC_000017.11:43092012:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1173	BRCA1
NM_007294.4(BRCA1):c.3517A>G (p.Ser1173Gly)	BRCA1|LOC126862571	S1173G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000925711	17	41244031	17	43092014	925711	913895	rs2053573116	NC_000017.11:43092013:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1173	BRCA1
NM_007294.4(BRCA1):c.3515A>C (p.Glu1172Ala)	BRCA1|LOC126862571	E1172A	Hereditary breast ovarian cancer syndrome|not provided	VCV002811183	17	41244033	17	43092016	2811183	2975696	NA	NC_000017.11:43092015:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1172	BRCA1
NM_007294.4(BRCA1):c.3515A>T (p.Glu1172Val)	BRCA1|LOC126862571	E1172V	not provided|Hereditary cancer-predisposing syndrome	VCV000993047	17	41244033	17	43092016	993047	981165	rs80357206	NC_000017.11:43092015:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1172	BRCA1
NM_007294.4(BRCA1):c.3515A>G (p.Glu1172Gly)	BRCA1|LOC126862571	E1172G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054907	17	41244033	17	43092016	54907	69574	rs80357206	NC_000017.11:43092015:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1172	BRCA1
NM_007294.4(BRCA1):c.3511A>G (p.Lys1171Glu)	BRCA1|LOC126862571	K1171E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441353	17	41244037	17	43092020	441353	435135	rs730882164	NC_000017.11:43092019:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1171	BRCA1
NM_007294.4(BRCA1):c.3510T>G (p.Ile1170Met)	BRCA1|LOC126862571	I1170M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000650534	17	41244038	17	43092021	650534	645973	rs183119644	NC_000017.11:43092020:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1170	BRCA1
NM_007294.4(BRCA1):c.3509T>C (p.Ile1170Thr)	BRCA1|LOC126862571	I1170T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001468069	17	41244039	17	43092022	1468069	1362314	rs780869838	NC_000017.11:43092021:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1170	BRCA1
NM_007294.4(BRCA1):c.3508A>G (p.Ile1170Val)	BRCA1|LOC126862571	I1170V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479203	17	41244040	17	43092023	479203	478598	rs273899708	NC_000017.11:43092022:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1170	BRCA1
NM_007294.4(BRCA1):c.3508A>T (p.Ile1170Phe)	BRCA1|LOC126862571	I1170F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054905	17	41244040	17	43092023	54905	69572	rs273899708	NC_000017.11:43092022:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1170	BRCA1
NM_007294.4(BRCA1):c.3506A>G (p.Asp1169Gly)	BRCA1|LOC126862571	D1169G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000571624	17	41244042	17	43092025	571624	574473	rs1323940169	NC_000017.11:43092024:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1169	BRCA1
NM_007294.4(BRCA1):c.3505G>A (p.Asp1169Asn)	BRCA1|LOC126862571	D1169N	Hereditary cancer-predisposing syndrome	VCV000823862	17	41244043	17	43092026	823862	813736	rs876659269	NC_000017.11:43092025:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1169	BRCA1
NM_007294.4(BRCA1):c.3505G>T (p.Asp1169Tyr)	BRCA1|LOC126862571	D1169Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231627	17	41244043	17	43092026	231627	236010	rs876659269	NC_000017.11:43092025:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1169	BRCA1
NM_007294.4(BRCA1):c.3504T>G (p.Asn1168Lys)	BRCA1|LOC126862571	N1168K	Hereditary cancer-predisposing syndrome	VCV000628230	17	41244044	17	43092027	628230	618605	rs1458197554	NC_000017.11:43092026:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1168	BRCA1
NM_007294.4(BRCA1):c.3502A>T (p.Asn1168Tyr)	BRCA1|LOC126862571	N1168Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001382976	17	41244046	17	43092029	1382976	1509572	rs2154307903	NC_000017.11:43092028:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1168	BRCA1
NM_007294.4(BRCA1):c.3500A>C (p.Glu1167Ala)	BRCA1|LOC126862571	E1167A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001501760	17	41244048	17	43092031	1501760	1398628	rs2154308012	NC_000017.11:43092030:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1167	BRCA1
NM_007294.4(BRCA1):c.3500A>G (p.Glu1167Gly)	BRCA1|LOC126862571	E1167G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001472998	17	41244048	17	43092031	1472998	1501243	rs2154308012	NC_000017.11:43092030:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1167	BRCA1
NM_007294.4(BRCA1):c.3499G>A (p.Glu1167Lys)	BRCA1|LOC126862571	E1167K	Hereditary cancer-predisposing syndrome	VCV001732008	17	41244049	17	43092032	1732008	1789040	NA	NC_000017.11:43092031:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1167	BRCA1
NM_007294.4(BRCA1):c.3497C>A (p.Ala1166Asp)	BRCA1|LOC126862571	A1166D	Hereditary breast ovarian cancer syndrome	VCV002832858	17	41244051	17	43092034	2832858	2991402	NA	NC_000017.11:43092033:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1166	BRCA1
NM_007294.4(BRCA1):c.3496G>C (p.Ala1166Pro)	BRCA1|LOC126862571	A1166P	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000216663	17	41244052	17	43092035	216663	213317	rs745418679	NC_000017.11:43092034:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1166	BRCA1
NM_007294.4(BRCA1):c.3494T>C (p.Phe1165Ser)	BRCA1|LOC126862571	F1165S	Hereditary breast ovarian cancer syndrome	VCV002846188	17	41244054	17	43092037	2846188	3008548	NA	NC_000017.11:43092036:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1165	BRCA1
NM_007294.4(BRCA1):c.3494T>G (p.Phe1165Cys)	BRCA1|LOC126862571	F1165C	Hereditary cancer-predisposing syndrome	VCV001731973	17	41244054	17	43092037	1731973	1789005	NA	NC_000017.11:43092036:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1165	BRCA1
NM_007294.4(BRCA1):c.3491G>C (p.Ser1164Thr)	BRCA1|LOC126862571	S1164T	Hereditary cancer-predisposing syndrome	VCV001731941	17	41244057	17	43092040	1731941	1788973	NA	NC_000017.11:43092039:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1164	BRCA1
NM_007294.4(BRCA1):c.3491G>T (p.Ser1164Ile)	BRCA1|LOC126862571	S1164I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054900	17	41244057	17	43092040	54900	69567	rs397509075	NC_000017.11:43092039:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1164	BRCA1
NM_007294.4(BRCA1):c.3488C>G (p.Thr1163Ser)	BRCA1|LOC126862571	T1163S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001419542	17	41244060	17	43092043	1419542	1387220	rs80356918	NC_000017.11:43092042:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1163	BRCA1
NM_007294.4(BRCA1):c.3488C>T (p.Thr1163Ile)	BRCA1|LOC126862571	T1163I	Hereditary cancer-predisposing syndrome	VCV000054899	17	41244060	17	43092043	54899	69566	rs80356918	NC_000017.11:43092042:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1163	BRCA1
NM_007294.4(BRCA1):c.3487A>G (p.Thr1163Ala)	BRCA1|LOC126862571	T1163A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479235	17	41244061	17	43092044	479235	478677	rs769456095	NC_000017.11:43092043:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1163	BRCA1
NM_007294.4(BRCA1):c.3484G>A (p.Asp1162Asn)	BRCA1|LOC126862571	D1162N	Hereditary cancer-predisposing syndrome	VCV003226138	17	41244064	17	43092047	3226138	3387202	NA	NC_000017.11:43092046:C:T	single nucleotide variant	intron variant|missense variant	Likely benign	Nov 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1162	BRCA1
NM_007294.4(BRCA1):c.3484G>T (p.Asp1162Tyr)	BRCA1|LOC126862571	D1162Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479213	17	41244064	17	43092047	479213	478679	rs1555587619	NC_000017.11:43092046:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1162	BRCA1
NM_007294.4(BRCA1):c.3482A>C (p.Glu1161Ala)	BRCA1|LOC126862571	E1161A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001509039	17	41244066	17	43092049	1509039	1452156	rs2053579677	NC_000017.11:43092048:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1161	BRCA1
NM_007294.4(BRCA1):c.3481G>A (p.Glu1161Lys)	BRCA1|LOC126862571	E1161K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000823822	17	41244067	17	43092050	823822	813737	rs786203438	NC_000017.11:43092049:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1161	BRCA1
NM_007294.4(BRCA1):c.3479A>C (p.Lys1160Thr)	LOC126862571|BRCA1	K1160T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000665681	17	41244069	17	43092052	665681	645974	rs1597863410	NC_000017.11:43092051:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1160	BRCA1
NM_007294.4(BRCA1):c.3478A>G (p.Lys1160Glu)	BRCA1|LOC126862571	K1160E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001063657	17	41244070	17	43092053	1063657	1050300	rs2154311006	NC_000017.11:43092052:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1160	BRCA1
NM_007294.4(BRCA1):c.3476T>A (p.Ile1159Lys)	BRCA1|LOC126862571	I1159K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000578385	17	41244072	17	43092055	578385	569126	rs1567791496	NC_000017.11:43092054:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1159	BRCA1
NM_007294.4(BRCA1):c.3475A>G (p.Ile1159Val)	BRCA1|LOC126862571	I1159V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000229985	17	41244073	17	43092056	229985	236011	rs876658318	NC_000017.11:43092055:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1159	BRCA1
NM_007294.4(BRCA1):c.3472G>A (p.Glu1158Lys)	BRCA1|LOC126862571	E1158K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000650751	17	41244076	17	43092059	650751	645975	rs397509072	NC_000017.11:43092058:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1158	BRCA1
NM_007294.4(BRCA1):c.3470G>C (p.Gly1157Ala)	BRCA1|LOC126862571	G1157A	Hereditary cancer-predisposing syndrome	VCV000231397	17	41244078	17	43092061	231397	236012	rs876659133	NC_000017.11:43092060:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1157	BRCA1
NM_007294.4(BRCA1):c.3469G>C (p.Gly1157Arg)	BRCA1|LOC126862571	G1157R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001958921	17	41244079	17	43092062	1958921	2012598	NA	NC_000017.11:43092061:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1157	BRCA1
NM_007294.4(BRCA1):c.3467A>G (p.Asp1156Gly)	LOC126862571|BRCA1	D1156G	Hereditary cancer-predisposing syndrome	VCV003226137	17	41244081	17	43092064	3226137	3387201	NA	NC_000017.11:43092063:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1156	BRCA1
NM_007294.4(BRCA1):c.3467A>T (p.Asp1156Val)	BRCA1|LOC126862571	D1156V	Hereditary cancer-predisposing syndrome	VCV001731692	17	41244081	17	43092064	1731692	1792596	NA	NC_000017.11:43092063:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1156	BRCA1
NM_007294.4(BRCA1):c.3467A>C (p.Asp1156Ala)	BRCA1|LOC126862571	D1156A	Hereditary cancer-predisposing syndrome	VCV001174984	17	41244081	17	43092064	1174984	1164506	rs2154312065	NC_000017.11:43092063:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1156	BRCA1
NM_007294.4(BRCA1):c.3466G>A (p.Asp1156Asn)	BRCA1|LOC126862571	D1156N	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000418557	17	41244082	17	43092065	418557	409980	rs1064793302	NC_000017.11:43092064:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1156	BRCA1
NM_007294.4(BRCA1):c.3465T>A (p.Asp1155Glu)	BRCA1|LOC126862571	D1155E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000922213	17	41244083	17	43092066	922213	913896	rs1567791539	NC_000017.11:43092065:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1155	BRCA1
NM_007294.4(BRCA1):c.3463G>C (p.Asp1155His)	BRCA1|LOC126862571	D1155H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054891	17	41244085	17	43092068	54891	69558	rs80357484	NC_000017.11:43092067:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1155	BRCA1
NM_007294.4(BRCA1):c.3461T>C (p.Leu1154Ser)	BRCA1|LOC126862571	L1154S	Hereditary cancer-predisposing syndrome	VCV003261464	17	41244087	17	43092070	3261464	3424233	NA	NC_000017.11:43092069:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1154	BRCA1
NM_007294.4(BRCA1):c.3460T>A (p.Leu1154Ile)	BRCA1|LOC126862571	L1154I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000582774	17	41244088	17	43092071	582774	571440	rs1567791553	NC_000017.11:43092070:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1154	BRCA1
NM_007294.4(BRCA1):c.3458T>C (p.Leu1153Pro)	BRCA1|LOC126862571	L1153P	Hereditary cancer-predisposing syndrome|not specified	VCV000823795	17	41244090	17	43092073	823795	813739	rs1597863549	NC_000017.11:43092072:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1153	BRCA1
NM_007294.4(BRCA1):c.3457C>G (p.Leu1153Val)	BRCA1|LOC126862571	L1153V	Hereditary cancer-predisposing syndrome	VCV000482918	17	41244091	17	43092074	482918	479360	rs1555587658	NC_000017.11:43092073:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1153	BRCA1
NM_007294.4(BRCA1):c.3456C>A (p.Asp1152Glu)	BRCA1|LOC126862571	D1152E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001370870	17	41244092	17	43092075	1370870	1430937	rs2154314157	NC_000017.11:43092074:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1152	BRCA1
NM_007294.4(BRCA1):c.3454G>C (p.Asp1152His)	BRCA1|LOC126862571	D1152H	Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000496367	17	41244094	17	43092077	496367	487934	rs80357175	NC_000017.11:43092076:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1152	BRCA1
NM_007294.4(BRCA1):c.3454G>A (p.Asp1152Asn)	BRCA1|LOC126862571	D1152N	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054890	17	41244094	17	43092077	54890	69557	rs80357175	NC_000017.11:43092076:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1152	BRCA1
NM_007294.4(BRCA1):c.3452A>T (p.Asp1151Val)	LOC126862571|BRCA1	D1151V	Hereditary breast ovarian cancer syndrome	VCV002915512	17	41244096	17	43092079	2915512	3074062	NA	NC_000017.11:43092078:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1151	BRCA1
NM_007294.4(BRCA1):c.3451G>A (p.Asp1151Asn)	BRCA1|LOC126862571	D1151N	Hereditary cancer-predisposing syndrome	VCV001731571	17	41244097	17	43092080	1731571	1792475	NA	NC_000017.11:43092079:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1151	BRCA1
NM_007294.4(BRCA1):c.3449C>T (p.Pro1150Leu)	BRCA1|LOC126862571	P1150L	Hereditary cancer-predisposing syndrome|not provided	VCV000142830	17	41244099	17	43092082	142830	152544	rs587782752	NC_000017.11:43092081:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1150	BRCA1
NM_007294.4(BRCA1):c.3448C>A (p.Pro1150Thr)	BRCA1|LOC126862571	P1150T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000953678	17	41244100	17	43092083	953678	949938	rs80357272	NC_000017.11:43092082:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1150	BRCA1
NM_007294.4(BRCA1):c.3448C>T (p.Pro1150Ser)	BRCA1|LOC126862571	P1150S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054887	17	41244100	17	43092083	54887	69554	rs80357272	NC_000017.11:43092082:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1150	BRCA1
NM_007294.4(BRCA1):c.3445A>T (p.Thr1149Ser)	BRCA1|LOC126862571	T1149S	Hereditary cancer-predisposing syndrome	VCV001731502	17	41244103	17	43092086	1731502	1792407	NA	NC_000017.11:43092085:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1149	BRCA1
NM_007294.4(BRCA1):c.3444G>T (p.Glu1148Asp)	LOC126862571|BRCA1	E1148D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001468825	17	41244104	17	43092087	1468825	1359184	rs2154315177	NC_000017.11:43092086:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1148	BRCA1
NM_007294.4(BRCA1):c.3444G>C (p.Glu1148Asp)	BRCA1|LOC126862571	E1148D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001403802	17	41244104	17	43092087	1403802	1467168	rs2154315177	NC_000017.11:43092086:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1148	BRCA1
NM_007294.4(BRCA1):c.3442G>A (p.Glu1148Lys)	BRCA1|LOC126862571	E1148K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000956650	17	41244106	17	43092089	956650	949939	rs886038012	NC_000017.11:43092088:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1148	BRCA1
NM_007294.4(BRCA1):c.3440C>A (p.Ser1147Tyr)	BRCA1|LOC126862571	S1147Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233955	17	41244108	17	43092091	233955	236014	rs876660757	NC_000017.11:43092090:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1147	BRCA1
NM_007294.4(BRCA1):c.3438T>G (p.Cys1146Trp)	BRCA1|LOC126862571	C1146W	Hereditary cancer-predisposing syndrome	VCV000924303	17	41244110	17	43092093	924303	913897	rs1555587693	NC_000017.11:43092092:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1146	BRCA1
NM_007294.4(BRCA1):c.3437G>A (p.Cys1146Tyr)	BRCA1|LOC126862571	C1146Y	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000096913	17	41244111	17	43092094	96913	102816	rs80357247	NC_000017.11:43092093:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1146	BRCA1
NM_007294.4(BRCA1):c.3437G>C (p.Cys1146Ser)	BRCA1|LOC126862571	C1146S	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054886	17	41244111	17	43092094	54886	69553	rs80357247	NC_000017.11:43092093:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1146	BRCA1
NM_007294.4(BRCA1):c.3436T>G (p.Cys1146Gly)	LOC126862571|BRCA1	C1146G	Hereditary cancer-predisposing syndrome	VCV000628831	17	41244112	17	43092095	628831	618607	rs1567791612	NC_000017.11:43092094:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1146	BRCA1
NM_007294.4(BRCA1):c.3433G>A (p.Val1145Ile)	BRCA1|LOC126862571	V1145I	Hereditary cancer-predisposing syndrome	VCV000491062	17	41244115	17	43092098	491062	485144	rs431825396	NC_000017.11:43092097:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1145	BRCA1
NM_007294.4(BRCA1):c.3433G>T (p.Val1145Phe)	BRCA1|LOC126862571	V1145F	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000096912	17	41244115	17	43092098	96912	102815	rs431825396	NC_000017.11:43092097:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1145	BRCA1
NM_007294.4(BRCA1):c.3432G>T (p.Gln1144His)	LOC126862571|BRCA1	Q1144H	Hereditary cancer-predisposing syndrome	VCV000054884	17	41244116	17	43092099	54884	69551	rs80356922	NC_000017.11:43092098:C:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1144	BRCA1
NM_007294.4(BRCA1):c.3428C>G (p.Ser1143Cys)	BRCA1|LOC126862571	S1143C	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000187054	17	41244120	17	43092103	187054	184968	rs80357434	NC_000017.11:43092102:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1143	BRCA1
NM_007294.4(BRCA1):c.3428C>T (p.Ser1143Phe)	BRCA1|LOC126862571	S1143F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054880	17	41244120	17	43092103	54880	69547	rs80357434	NC_000017.11:43092102:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1143	BRCA1
NM_007294.4(BRCA1):c.3427T>C (p.Ser1143Pro)	BRCA1|LOC126862571	S1143P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001434447	17	41244121	17	43092104	1434447	1494263	rs2154316944	NC_000017.11:43092103:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1143	BRCA1
NM_007294.4(BRCA1):c.3425C>T (p.Ala1142Val)	BRCA1|LOC126862571	A1142V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479241	17	41244123	17	43092106	479241	478681	rs1555587711	NC_000017.11:43092105:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1142	BRCA1
NM_007294.4(BRCA1):c.3424G>A (p.Ala1142Thr)	BRCA1|LOC126862571	A1142T	Hereditary breast ovarian cancer syndrome	VCV002839250	17	41244124	17	43092107	2839250	2996521	NA	NC_000017.11:43092106:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1142	BRCA1
NM_007294.4(BRCA1):c.3424G>T (p.Ala1142Ser)	BRCA1|LOC126862571	A1142S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000571397	17	41244124	17	43092107	571397	571443	rs80357101	NC_000017.11:43092106:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1142	BRCA1
NM_007294.4(BRCA1):c.3424G>C (p.Ala1142Pro)	BRCA1|LOC126862571	A1142P	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054878	17	41244124	17	43092107	54878	69545	rs80357101	NC_000017.11:43092106:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1142	BRCA1
NM_007294.4(BRCA1):c.3423T>A (p.His1141Gln)	BRCA1|LOC126862571	H1141Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001444399	17	41244125	17	43092108	1444399	1388364	rs863224419	NC_000017.11:43092107:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1141	BRCA1
NM_007294.4(BRCA1):c.3422A>C (p.His1141Pro)	BRCA1|LOC126862571	H1141P	Hereditary cancer-predisposing syndrome	VCV001731281	17	41244126	17	43092109	1731281	1795654	NA	NC_000017.11:43092108:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1141	BRCA1
NM_007294.4(BRCA1):c.3421C>G (p.His1141Asp)	LOC126862571|BRCA1	H1141D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003074857	17	41244127	17	43092110	3074857	3229823	NA	NC_000017.11:43092109:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1141	BRCA1
NM_007294.4(BRCA1):c.3421C>T (p.His1141Tyr)	BRCA1|LOC126862571	H1141Y	Hereditary cancer-predisposing syndrome	VCV000441495	17	41244127	17	43092110	441495	435136	rs1555587727	NC_000017.11:43092109:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1141	BRCA1
NM_007294.4(BRCA1):c.3419G>A (p.Ser1140Asn)	BRCA1|LOC126862571	S1140N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000852463	17	41244129	17	43092112	852463	845403	rs2053590016	NC_000017.11:43092111:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1140	BRCA1
NM_007294.4(BRCA1):c.3418A>C (p.Ser1140Arg)	BRCA1|LOC126862571	S1140R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481449	17	41244130	17	43092113	481449	478720	rs2227945	NC_000017.11:43092112:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1140	BRCA1
NM_007294.4(BRCA1):c.3418A>G (p.Ser1140Gly)	BRCA1|LOC126862571	S1140G	BRCA1-related cancer predisposition	VCV000041817	17	41244130	17	43092113	41817	50256	rs2227945	NC_000017.11:43092112:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1140	BRCA1
NM_007294.4(BRCA1):c.3417T>G (p.Ser1139Arg)	BRCA1|LOC126862571	S1139R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000956204	17	41244131	17	43092114	956204	949940	rs2053590409	NC_000017.11:43092113:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1139	BRCA1
NM_007294.4(BRCA1):c.3416G>T (p.Ser1139Ile)	BRCA1|LOC126862571	S1139I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054873	17	41244132	17	43092115	54873	69540	rs80357228	NC_000017.11:43092114:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1139	BRCA1
NM_007294.4(BRCA1):c.3415A>C (p.Ser1139Arg)	BRCA1|LOC126862571	S1139R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141462	17	41244133	17	43092116	141462	151176	rs587781765	NC_000017.11:43092115:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1139	BRCA1
NM_007294.4(BRCA1):c.3413G>A (p.Gly1138Glu)	BRCA1|LOC126862571	G1138E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001719021	17	41244135	17	43092118	1719021	1776525	NA	NC_000017.11:43092117:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1138	BRCA1
NM_007294.4(BRCA1):c.3411G>A (p.Met1137Ile)	BRCA1|LOC126862571	M1137I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186375	17	41244137	17	43092120	186375	184969	rs786202900	NC_000017.11:43092119:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1137	BRCA1
NM_007294.4(BRCA1):c.3410T>C (p.Met1137Thr)	BRCA1|LOC126862571	M1137T	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054871	17	41244138	17	43092121	54871	69538	rs80357297	NC_000017.11:43092120:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1137	BRCA1
NM_007294.4(BRCA1):c.3409A>T (p.Met1137Leu)	BRCA1|LOC126862571	M1137L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003074567	17	41244139	17	43092122	3074567	3229534	NA	NC_000017.11:43092121:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1137	BRCA1
NM_007294.4(BRCA1):c.3409A>G (p.Met1137Val)	LOC126862571|BRCA1	M1137V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000462610	17	41244139	17	43092122	462610	467939	rs771479616	NC_000017.11:43092121:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1137	BRCA1
NM_007294.4(BRCA1):c.3407C>G (p.Pro1136Arg)	BRCA1|LOC126862571	P1136R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000054869	17	41244141	17	43092124	54869	69536	rs80357329	NC_000017.11:43092123:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1136	BRCA1
NM_007294.4(BRCA1):c.3406C>T (p.Pro1136Ser)	BRCA1|LOC126862571	P1136S	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000823737	17	41244142	17	43092125	823737	813742	rs431825395	NC_000017.11:43092124:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1136	BRCA1
NM_007294.4(BRCA1):c.3406C>A (p.Pro1136Thr)	BRCA1|LOC126862571	P1136T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096911	17	41244142	17	43092125	96911	102814	rs431825395	NC_000017.11:43092124:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1136	BRCA1
NM_007294.4(BRCA1):c.3403C>G (p.Gln1135Glu)	BRCA1|LOC126862571	Q1135E	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4	VCV000240792	17	41244145	17	43092128	240792	242785	rs80357136	NC_000017.11:43092127:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1135	BRCA1
NM_007294.4(BRCA1):c.3401A>T (p.Glu1134Val)	BRCA1|LOC126862571	E1134V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000233080	17	41244147	17	43092130	233080	236015	rs762744684	NC_000017.11:43092129:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1134	BRCA1
NM_007294.4(BRCA1):c.3400G>A (p.Glu1134Lys)	BRCA1|LOC126862571	E1134K	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000491061	17	41244148	17	43092131	491061	484912	rs80357018	NC_000017.11:43092130:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1134	BRCA1
NM_007294.4(BRCA1):c.3398T>C (p.Leu1133Ser)	BRCA1|LOC126862571	L1133S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230481	17	41244150	17	43092133	230481	236016	rs80356971	NC_000017.11:43092132:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1133	BRCA1
NM_007294.4(BRCA1):c.3394A>G (p.Asn1132Asp)	BRCA1|LOC126862571	N1132D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000183852	17	41244154	17	43092137	183852	184970	rs530464947	NC_000017.11:43092136:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1132	BRCA1
NM_007294.4(BRCA1):c.3392_3393delinsTA (p.Asp1131Val)	BRCA1|LOC126862571	D1131V	Hereditary cancer-predisposing syndrome	VCV000187044	17	41244155 - 41244156	17	43092138 - 43092139	187044	184971	rs786203428	NC_000017.11:43092137:AT:TA	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1131	BRCA1
NM_007294.4(BRCA1):c.3392A>T (p.Asp1131Val)	BRCA1|LOC126862571	D1131V	Hereditary cancer-predisposing syndrome	VCV000481480	17	41244156	17	43092139	481480	479366	rs1555587813	NC_000017.11:43092138:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1131	BRCA1
NM_007294.4(BRCA1):c.3392A>G (p.Asp1131Gly)	BRCA1|LOC126862571	D1131G	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462608	17	41244156	17	43092139	462608	468154	rs1555587813	NC_000017.11:43092138:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1131	BRCA1
NM_007294.4(BRCA1):c.3391G>T (p.Asp1131Tyr)	BRCA1|LOC126862571	D1131Y	Hereditary cancer-predisposing syndrome	VCV002585841	17	41244157	17	43092140	2585841	2753401	NA	NC_000017.11:43092139:C:A	single nucleotide variant	missense variant|intron variant|splice acceptor variant	Uncertain significance	Aug 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1131	BRCA1
NM_007294.4(BRCA1):c.3391G>C (p.Asp1131His)	BRCA1|LOC126862571	D1131H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001938167	17	41244157	17	43092140	1938167	1997041	NA	NC_000017.11:43092139:C:G	single nucleotide variant	intron variant|splice acceptor variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1131	BRCA1
NM_007294.4(BRCA1):c.3391G>A (p.Asp1131Asn)	BRCA1|LOC126862571	D1131N	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000496366	17	41244157	17	43092140	496366	487935	rs1555587816	NC_000017.11:43092139:C:T	single nucleotide variant	missense variant|intron variant|splice acceptor variant	Conflicting classifications of pathogenicity	Oct 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1131	BRCA1
NM_007294.4(BRCA1):c.3388T>C (p.Ser1130Pro)	BRCA1|LOC126862571	S1130P	Hereditary cancer-predisposing syndrome|not provided	VCV001309096	17	41244160	17	43092143	1309096	1301124	rs2154320882	NC_000017.11:43092142:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1130	BRCA1
NM_007294.4(BRCA1):c.3386T>C (p.Ile1129Thr)	BRCA1|LOC126862571	I1129T	not provided|Hereditary cancer-predisposing syndrome	VCV000619792	17	41244162	17	43092145	619792	611235	rs1567791871	NC_000017.11:43092144:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1129	BRCA1
NM_007294.4(BRCA1):c.3385A>G (p.Ile1129Val)	BRCA1|LOC126862571	I1129V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000649690	17	41244163	17	43092146	649690	645977	rs1597863986	NC_000017.11:43092145:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1129	BRCA1
NM_007294.4(BRCA1):c.3383T>C (p.Leu1128Pro)	BRCA1|LOC126862571	L1128P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481427	17	41244165	17	43092148	481427	478602	rs1555587827	NC_000017.11:43092147:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1128	BRCA1
NM_007294.4(BRCA1):c.3382C>G (p.Leu1128Val)	BRCA1|LOC126862571	L1128V	Hereditary cancer-predisposing syndrome	VCV003261497	17	41244166	17	43092149	3261497	3424265	NA	NC_000017.11:43092148:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1128	BRCA1
NM_007294.4(BRCA1):c.3379T>C (p.Tyr1127His)	BRCA1|LOC126862571	Y1127H	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479249	17	41244169	17	43092152	479249	478726	rs1451089848	NC_000017.11:43092151:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1127	BRCA1
NM_007294.4(BRCA1):c.3377C>T (p.Pro1126Leu)	BRCA1|LOC126862571	P1126L	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054862	17	41244171	17	43092154	54862	69529	rs80356887	NC_000017.11:43092153:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1126	BRCA1
NM_007294.4(BRCA1):c.3374C>G (p.Ser1125Cys)	BRCA1|LOC126862571	S1125C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001360771	17	41244174	17	43092157	1360771	1360337	rs1555587835	NC_000017.11:43092156:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1125	BRCA1
NM_007294.4(BRCA1):c.3374C>A (p.Ser1125Tyr)	BRCA1|LOC126862571	S1125Y	Hereditary cancer-predisposing syndrome	VCV000433706	17	41244174	17	43092157	433706	427552	rs1555587835	NC_000017.11:43092156:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1125	BRCA1
NM_007294.4(BRCA1):c.3373T>C (p.Ser1125Pro)	BRCA1|LOC126862571	S1125P	Hereditary cancer-predisposing syndrome	VCV000482911	17	41244175	17	43092158	482911	478736	rs1555587839	NC_000017.11:43092157:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1125	BRCA1
NM_007294.4(BRCA1):c.3372C>A (p.Phe1124Leu)	BRCA1|LOC126862571	F1124L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001034479	17	41244176	17	43092159	1034479	1033313	rs786203431	NC_000017.11:43092158:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1124	BRCA1
NM_007294.4(BRCA1):c.3368A>T (p.Asp1123Val)	BRCA1|LOC126862571	D1123V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000531304	17	41244180	17	43092163	531304	531338	rs1555587851	NC_000017.11:43092162:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1123	BRCA1
NM_007294.4(BRCA1):c.3367G>T (p.Asp1123Tyr)	BRCA1|LOC126862571	D1123Y	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054860	17	41244181	17	43092164	54860	69527	rs80356867	NC_000017.11:43092163:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1123	BRCA1
NM_007294.4(BRCA1):c.3365C>T (p.Thr1122Ile)	BRCA1|LOC126862571	T1122I	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001044703	17	41244183	17	43092166	1044703	1033314	rs2053599251	NC_000017.11:43092165:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1122	BRCA1
NM_007294.4(BRCA1):c.3362A>T (p.Asn1121Ile)	BRCA1|LOC126862571	N1121I	Hereditary cancer-predisposing syndrome	VCV001730625	17	41244186	17	43092169	1730625	1785614	NA	NC_000017.11:43092168:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1121	BRCA1
NM_007294.4(BRCA1):c.3362A>G (p.Asn1121Ser)	BRCA1|LOC126862571	N1121S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000037527	17	41244186	17	43092169	37527	46083	rs80356919	NC_000017.11:43092168:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1121	BRCA1
NM_007294.4(BRCA1):c.3361A>G (p.Asn1121Asp)	BRCA1|LOC126862571	N1121D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531290	17	41244187	17	43092170	531290	531342	rs876660526	NC_000017.11:43092169:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1121	BRCA1
NM_007294.4(BRCA1):c.3361A>C (p.Asn1121His)	BRCA1|LOC126862571	N1121H	Hereditary cancer-predisposing syndrome	VCV000233620	17	41244187	17	43092170	233620	236017	rs876660526	NC_000017.11:43092169:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1121	BRCA1
NM_007294.4(BRCA1):c.3359T>A (p.Val1120Asp)	BRCA1|LOC126862571	V1120D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000489715	17	41244189	17	43092172	489715	482987	rs1361427704	NC_000017.11:43092171:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1120	BRCA1
NM_007294.4(BRCA1):c.3358G>C (p.Val1120Leu)	BRCA1|LOC126862571	V1120L	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000811966	17	41244190	17	43092173	811966	800038	rs748894760	NC_000017.11:43092172:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1120	BRCA1
NM_007294.4(BRCA1):c.3358G>A (p.Val1120Ile)	LOC126862571|BRCA1	V1120I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000184039	17	41244190	17	43092173	184039	184973	rs748894760	NC_000017.11:43092172:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1120	BRCA1
NM_007294.4(BRCA1):c.3356C>T (p.Thr1119Ile)	BRCA1|LOC126862571	T1119I	Hereditary breast ovarian cancer syndrome	VCV002743875	17	41244192	17	43092175	2743875	2907228	NA	NC_000017.11:43092174:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1119	BRCA1
NM_007294.4(BRCA1):c.3356C>G (p.Thr1119Ser)	BRCA1|LOC126862571	T1119S	Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000216662	17	41244192	17	43092175	216662	213319	rs863224759	NC_000017.11:43092174:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1119	BRCA1
NM_007294.4(BRCA1):c.3355A>G (p.Thr1119Ala)	BRCA1|LOC126862571	T1119A	Hereditary cancer-predisposing syndrome	VCV000918360	17	41244193	17	43092176	918360	913898	rs80356949	NC_000017.11:43092175:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1119	BRCA1
NM_007294.4(BRCA1):c.3355A>T (p.Thr1119Ser)	BRCA1|LOC126862571	T1119S	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000054855	17	41244193	17	43092176	54855	69522	rs80356949	NC_000017.11:43092175:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1119	BRCA1
NM_007294.4(BRCA1):c.3354G>T (p.Gln1118His)	BRCA1|LOC126862571	Q1118H	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000037525	17	41244194	17	43092177	37525	46081	rs80357334	NC_000017.11:43092176:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1118	BRCA1
NM_007294.4(BRCA1):c.3352C>G (p.Gln1118Glu)	BRCA1|LOC126862571	Q1118E	Hereditary cancer-predisposing syndrome	VCV003226136	17	41244196	17	43092179	3226136	3387200	NA	NC_000017.11:43092178:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1118	BRCA1
NM_007294.4(BRCA1):c.3350T>C (p.Val1117Ala)	BRCA1|LOC126862571	V1117A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000924285	17	41244198	17	43092181	924285	913899	rs2053602865	NC_000017.11:43092180:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1117	BRCA1
NM_007294.4(BRCA1):c.3349G>C (p.Val1117Leu)	BRCA1|LOC126862571	V1117L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001475929	17	41244199	17	43092182	1475929	1423648	rs2154326025	NC_000017.11:43092181:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1117	BRCA1
NM_007294.4(BRCA1):c.3347T>G (p.Val1116Gly)	LOC126862571|BRCA1	V1116G	Hereditary cancer-predisposing syndrome	VCV000186699	17	41244201	17	43092184	186699	184974	rs786203153	NC_000017.11:43092183:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1116	BRCA1
NM_007294.4(BRCA1):c.3346G>A (p.Val1116Ile)	LOC126862571|BRCA1	V1116I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001730463	17	41244202	17	43092185	1730463	1788797	NA	NC_000017.11:43092184:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1116	BRCA1
NM_007294.4(BRCA1):c.3346G>C (p.Val1116Leu)	BRCA1|LOC126862571	V1116L	not specified|not provided|BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054853	17	41244202	17	43092185	54853	69520	rs55909400	NC_000017.11:43092184:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1116	BRCA1
NM_007294.4(BRCA1):c.3345A>C (p.Glu1115Asp)	BRCA1|LOC126862571	E1115D	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000229872	17	41244203	17	43092186	229872	236018	rs876658243	NC_000017.11:43092185:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1115	BRCA1
NM_007294.4(BRCA1):c.3344A>T (p.Glu1115Val)	BRCA1|LOC126862571	E1115V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531234	17	41244204	17	43092187	531234	531264	rs1555587933	NC_000017.11:43092186:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1115	BRCA1
NM_007294.4(BRCA1):c.3341A>G (p.Glu1114Gly)	BRCA1|LOC126862571	E1114G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001352647	17	41244207	17	43092190	1352647	1505856	rs2154327006	NC_000017.11:43092189:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1114	BRCA1
NM_007294.4(BRCA1):c.3340G>A (p.Glu1114Lys)	BRCA1|LOC126862571	E1114K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000949517	17	41244208	17	43092191	949517	928296	rs80357278	NC_000017.11:43092190:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1114	BRCA1
NM_007294.4(BRCA1):c.3338A>G (p.Tyr1113Cys)	BRCA1|LOC126862571	Y1113C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000644849	17	41244210	17	43092193	644849	645978	rs1225577943	NC_000017.11:43092192:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1113	BRCA1
NM_007294.4(BRCA1):c.3337T>C (p.Tyr1113His)	BRCA1|LOC126862571	Y1113H	Hereditary cancer-predisposing syndrome	VCV002585842	17	41244211	17	43092194	2585842	2753402	NA	NC_000017.11:43092193:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Aug 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1113	BRCA1
NM_007294.4(BRCA1):c.3337T>G (p.Tyr1113Asp)	BRCA1|LOC126862571	Y1113D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000951166	17	41244211	17	43092194	951166	928297	rs2053606087	NC_000017.11:43092193:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1113	BRCA1
NM_007294.4(BRCA1):c.3334G>C (p.Glu1112Gln)	BRCA1|LOC126862571	E1112Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001353259	17	41244214	17	43092197	1353259	1499258	rs2154327700	NC_000017.11:43092196:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1112	BRCA1
NM_007294.4(BRCA1):c.3331C>G (p.Gln1111Glu)	BRCA1|LOC126862571	Q1111E	Hereditary cancer-predisposing syndrome	VCV000823615	17	41244217	17	43092200	823615	813743	rs80357089	NC_000017.11:43092199:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1111	BRCA1
NM_007294.4(BRCA1):c.3327A>C (p.Lys1109Asn)	BRCA1|LOC126862571	K1109N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037522	17	41244221	17	43092204	37522	46078	rs41293449	NC_000017.11:43092203:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1109	BRCA1
NM_007294.4(BRCA1):c.3326A>G (p.Lys1109Arg)	BRCA1|LOC126862571	K1109R	not provided|Hereditary cancer-predisposing syndrome	VCV002429538	17	41244222	17	43092205	2429538	2403036	NA	NC_000017.11:43092204:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1109	BRCA1
NM_007294.4(BRCA1):c.3324A>G (p.Ile1108Met)	BRCA1|LOC126862571	I1108M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001730229	17	41244224	17	43092207	1730229	1788564	NA	NC_000017.11:43092206:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Sep 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1108	BRCA1
NM_007294.4(BRCA1):c.3323T>C (p.Ile1108Thr)	LOC126862571|BRCA1	I1108T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003072354	17	41244225	17	43092208	3072354	3230795	NA	NC_000017.11:43092207:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1108	BRCA1
NM_007294.4(BRCA1):c.3322A>G (p.Ile1108Val)	BRCA1|LOC126862571	I1108V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001379372	17	41244226	17	43092209	1379372	1486600	rs2154329049	NC_000017.11:43092208:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1108	BRCA1
NM_007294.4(BRCA1):c.3321A>T (p.Glu1107Asp)	BRCA1|LOC126862571	E1107D	Hereditary cancer-predisposing syndrome	VCV002450677	17	41244227	17	43092210	2450677	2423163	NA	NC_000017.11:43092209:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1107	BRCA1
NM_007294.4(BRCA1):c.3320A>G (p.Glu1107Gly)	BRCA1|LOC126862571	E1107G	Hereditary cancer-predisposing syndrome	VCV000823606	17	41244228	17	43092211	823606	813744	rs1597864403	NC_000017.11:43092210:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1107	BRCA1
NM_007294.4(BRCA1):c.3319G>A (p.Glu1107Lys)	BRCA1|LOC126862571	E1107K	not specified	VCV002501191	17	41244229	17	43092212	2501191	2524083	NA	NC_000017.11:43092211:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1107	BRCA1
NM_007294.4(BRCA1):c.3317C>T (p.Pro1106Leu)	BRCA1|LOC126862571	P1106L	Hereditary breast ovarian cancer syndrome	VCV002839096	17	41244231	17	43092214	2839096	2996367	NA	NC_000017.11:43092213:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1106	BRCA1
NM_007294.4(BRCA1):c.3316C>G (p.Pro1106Ala)	BRCA1|LOC126862571	P1106A	Hereditary cancer-predisposing syndrome|not provided	VCV001703930	17	41244232	17	43092215	1703930	1696407	NA	NC_000017.11:43092214:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1106	BRCA1
NM_007294.4(BRCA1):c.3316C>T (p.Pro1106Ser)	BRCA1|LOC126862571	P1106S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630122	17	41244232	17	43092215	630122	618609	rs45599040	NC_000017.11:43092214:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1106	BRCA1
NM_007294.4(BRCA1):c.3315T>A (p.His1105Gln)	BRCA1|LOC126862571	H1105Q	Hereditary cancer-predisposing syndrome	VCV000823569	17	41244233	17	43092216	823569	813746	rs1597864422	NC_000017.11:43092215:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1105	BRCA1
NM_007294.4(BRCA1):c.3313C>A (p.His1105Asn)	BRCA1|LOC126862571	H1105N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054834	17	41244235	17	43092218	54834	69501	rs80357288	NC_000017.11:43092217:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1105	BRCA1
NM_007294.4(BRCA1):c.3312G>C (p.Lys1104Asn)	BRCA1|LOC126862571	K1104N	Hereditary cancer-predisposing syndrome	VCV000823561	17	41244236	17	43092219	823561	813747	rs876659024	NC_000017.11:43092218:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1104	BRCA1
NM_007294.4(BRCA1):c.3311A>G (p.Lys1104Arg)	BRCA1|LOC126862571	K1104R	Hereditary breast ovarian cancer syndrome	VCV002833962	17	41244237	17	43092220	2833962	2995071	NA	NC_000017.11:43092219:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1104	BRCA1
NM_007294.4(BRCA1):c.3310A>G (p.Lys1104Glu)	BRCA1|LOC126862571	K1104E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001502042	17	41244238	17	43092221	1502042	1411260	rs2154329912	NC_000017.11:43092220:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1104	BRCA1
NM_007294.4(BRCA1):c.3308G>C (p.Cys1103Ser)	BRCA1|LOC126862571	C1103S	Hereditary cancer-predisposing syndrome	VCV001730038	17	41244240	17	43092223	1730038	1792244	NA	NC_000017.11:43092222:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1103	BRCA1
NM_007294.4(BRCA1):c.3308G>A (p.Cys1103Tyr)	BRCA1|LOC126862571	C1103Y	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided	VCV000419152	17	41244240	17	43092223	419152	409981	rs80357135	NC_000017.11:43092222:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1103	BRCA1
NM_007294.4(BRCA1):c.3308G>T (p.Cys1103Phe)	BRCA1|LOC126862571	C1103F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054832	17	41244240	17	43092223	54832	69499	rs80357135	NC_000017.11:43092222:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1103	BRCA1
NM_007294.4(BRCA1):c.3306T>G (p.Asn1102Lys)	LOC126862571|BRCA1	N1102K	Hereditary cancer-predisposing syndrome	VCV002565352	17	41244242	17	43092225	2565352	2732325	NA	NC_000017.11:43092224:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1102	BRCA1
NM_007294.4(BRCA1):c.3305A>T (p.Asn1102Ile)	BRCA1|LOC126862571	N1102I	Hereditary breast ovarian cancer syndrome	VCV002996243	17	41244243	17	43092226	2996243	3162951	NA	NC_000017.11:43092225:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1102	BRCA1
NM_007294.4(BRCA1):c.3305A>G (p.Asn1102Ser)	LOC126862571|BRCA1	N1102S	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054831	17	41244243	17	43092226	54831	69498	rs80356900	NC_000017.11:43092225:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1102	BRCA1
NM_007294.4(BRCA1):c.3302G>A (p.Ser1101Asn)	BRCA1|LOC126862571	S1101N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054830	17	41244246	17	43092229	54830	69497	rs41293447	NC_000017.11:43092228:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1101	BRCA1
NM_007294.4(BRCA1):c.3301A>G (p.Ser1101Gly)	BRCA1|LOC126862571	S1101G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000656160	17	41244247	17	43092230	656160	645979	rs1597864528	NC_000017.11:43092229:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1101	BRCA1
NM_007294.4(BRCA1):c.3299G>A (p.Gly1100Glu)	BRCA1|LOC126862571	G1100E	Hereditary breast ovarian cancer syndrome	VCV002765028	17	41244249	17	43092232	2765028	2928794	NA	NC_000017.11:43092231:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1100	BRCA1
NM_007294.4(BRCA1):c.3299G>C (p.Gly1100Ala)	BRCA1|LOC126862571	G1100A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002098067	17	41244249	17	43092232	2098067	2146923	NA	NC_000017.11:43092231:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1100	BRCA1
NM_007294.4(BRCA1):c.3298G>A (p.Gly1100Arg)	BRCA1|LOC126862571	G1100R	Hereditary cancer-predisposing syndrome	VCV000485388	17	41244250	17	43092233	485388	478605	rs1555587999	NC_000017.11:43092232:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1100	BRCA1
NM_007294.4(BRCA1):c.3296C>G (p.Pro1099Arg)	BRCA1|LOC126862571	P1099R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002087916	17	41244252	17	43092235	2087916	2154875	NA	NC_000017.11:43092234:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1099	BRCA1
NM_007294.4(BRCA1):c.3296C>T (p.Pro1099Leu)	BRCA1|LOC126862571	P1099L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041816	17	41244252	17	43092235	41816	50255	rs80357201	NC_000017.11:43092234:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1099	BRCA1
NM_007294.4(BRCA1):c.3295C>G (p.Pro1099Ala)	BRCA1|LOC126862571	P1099A	Hereditary breast ovarian cancer syndrome	VCV002886229	17	41244253	17	43092236	2886229	3053943	NA	NC_000017.11:43092235:G:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1099	BRCA1
NM_007294.4(BRCA1):c.3292C>T (p.Leu1098Phe)	BRCA1|LOC126862571	L1098F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252394	17	41244256	17	43092239	252394	246819	rs879255291	NC_000017.11:43092238:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1098	BRCA1
NM_007294.4(BRCA1):c.3289A>G (p.Ser1097Gly)	BRCA1|LOC126862571	S1097G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001394257	17	41244259	17	43092242	1394257	1338280	rs587782864	NC_000017.11:43092241:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1097	BRCA1
NM_007294.4(BRCA1):c.3289A>C (p.Ser1097Arg)	BRCA1|LOC126862571	S1097R	Hereditary cancer-predisposing syndrome	VCV000823433	17	41244259	17	43092242	823433	813749	rs587782864	NC_000017.11:43092241:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1097	BRCA1
NM_007294.4(BRCA1):c.3289A>T (p.Ser1097Cys)	BRCA1|LOC126862571	S1097C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142978	17	41244259	17	43092242	142978	152692	rs587782864	NC_000017.11:43092241:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1097	BRCA1
NM_007294.4(BRCA1):c.3287A>G (p.Gln1096Arg)	BRCA1|LOC126862571	Q1096R	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054820	17	41244261	17	43092244	54820	69487	rs273899704	NC_000017.11:43092243:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1096	BRCA1
NM_007294.4(BRCA1):c.3286C>A (p.Gln1096Lys)	BRCA1|LOC126862571	Q1096K	Hereditary cancer-predisposing syndrome	VCV000482959	17	41244262	17	43092245	482959	478684	rs80357485	NC_000017.11:43092244:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1096	BRCA1
NM_007294.4(BRCA1):c.3283A>G (p.Lys1095Glu)	BRCA1|LOC126862571	K1095E	Hereditary cancer-predisposing syndrome	VCV001729764	17	41244265	17	43092248	1729764	1791971	NA	NC_000017.11:43092247:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1095	BRCA1
NM_007294.4(BRCA1):c.3281A>C (p.Tyr1094Ser)	BRCA1|LOC126862571	Y1094S	Hereditary cancer-predisposing syndrome	VCV001729736	17	41244267	17	43092250	1729736	1795411	NA	NC_000017.11:43092249:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1094	BRCA1
NM_007294.4(BRCA1):c.3281A>G (p.Tyr1094Cys)	LOC126862571|BRCA1	Y1094C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000639392	17	41244267	17	43092250	639392	645981	rs1597864637	NC_000017.11:43092249:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1094	BRCA1
NM_007294.4(BRCA1):c.3280T>G (p.Tyr1094Asp)	BRCA1|LOC126862571	Y1094D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000855149	17	41244268	17	43092251	855149	845404	rs1555588026	NC_000017.11:43092250:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1094	BRCA1
NM_007294.4(BRCA1):c.3280T>C (p.Tyr1094His)	BRCA1|LOC126862571	Y1094H	not specified|Hereditary cancer-predisposing syndrome	VCV000438923	17	41244268	17	43092251	438923	432907	rs1555588026	NC_000017.11:43092250:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1094	BRCA1
NM_007294.4(BRCA1):c.3278T>C (p.Val1093Ala)	BRCA1|LOC126862571	V1093A	Hereditary cancer-predisposing syndrome	VCV001729684	17	41244270	17	43092253	1729684	1795359	NA	NC_000017.11:43092252:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1093	BRCA1
NM_007294.4(BRCA1):c.3277G>A (p.Val1093Ile)	BRCA1|LOC126862571	V1093I	not provided|Hereditary cancer-predisposing syndrome	VCV000993046	17	41244271	17	43092254	993046	981166	rs587778117	NC_000017.11:43092253:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1093	BRCA1
NM_007294.4(BRCA1):c.3277G>T (p.Val1093Phe)	LOC126862571|BRCA1	V1093F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000133724	17	41244271	17	43092254	133724	137463	rs587778117	NC_000017.11:43092253:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1093	BRCA1
NM_007294.4(BRCA1):c.3276G>T (p.Glu1092Asp)	BRCA1|LOC126862571	E1092D	Hereditary cancer-predisposing syndrome	VCV000489714	17	41244272	17	43092255	489714	482992	rs764458412	NC_000017.11:43092254:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1092	BRCA1
NM_007294.4(BRCA1):c.3275A>G (p.Glu1092Gly)	BRCA1|LOC126862571	E1092G	Hereditary cancer-predisposing syndrome	VCV000922736	17	41244273	17	43092256	922736	913900	rs751368643	NC_000017.11:43092255:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1092	BRCA1
NM_007294.4(BRCA1):c.3274G>A (p.Glu1092Lys)	BRCA1|LOC126862571	E1092K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230059	17	41244274	17	43092257	230059	236023	rs876658360	NC_000017.11:43092256:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1092	BRCA1
NM_007294.4(BRCA1):c.3272C>T (p.Pro1091Leu)	BRCA1|LOC126862571	P1091L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000835769	17	41244276	17	43092259	835769	845405	rs2053616216	NC_000017.11:43092258:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1091	BRCA1
NM_007294.4(BRCA1):c.3271C>T (p.Pro1091Ser)	BRCA1|LOC126862571	P1091S	Hereditary breast ovarian cancer syndrome	VCV002757403	17	41244277	17	43092260	2757403	2917275	NA	NC_000017.11:43092259:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1091	BRCA1
NM_007294.4(BRCA1):c.3270A>T (p.Gln1090His)	BRCA1|LOC126862571	Q1090H	not specified|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000182153	17	41244278	17	43092261	182153	180845	rs369925993	NC_000017.11:43092260:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1090	BRCA1
NM_007294.4(BRCA1):c.3269A>G (p.Gln1090Arg)	BRCA1|LOC126862571	Q1090R	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000462606	17	41244279	17	43092262	462606	467719	rs1555588045	NC_000017.11:43092261:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1090	BRCA1
NM_007294.4(BRCA1):c.3267G>T (p.Leu1089Phe)	BRCA1|LOC126862571	L1089F	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000485399	17	41244281	17	43092264	485399	478685	rs767544239	NC_000017.11:43092263:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1089	BRCA1
NM_007294.4(BRCA1):c.3263T>G (p.Val1088Gly)	BRCA1|LOC126862571	V1088G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001729563	17	41244285	17	43092268	1729563	1795239	NA	NC_000017.11:43092267:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1088	BRCA1
NM_007294.4(BRCA1):c.3263T>A (p.Val1088Asp)	BRCA1|LOC126862571	V1088D	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054814	17	41244285	17	43092268	54814	69481	rs80356901	NC_000017.11:43092267:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1088	BRCA1
NM_007294.4(BRCA1):c.3262G>T (p.Val1088Phe)	BRCA1|LOC126862571	V1088F	Hereditary cancer-predisposing syndrome	VCV002565334	17	41244286	17	43092269	2565334	2732308	NA	NC_000017.11:43092268:C:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1088	BRCA1
NM_007294.4(BRCA1):c.3260G>C (p.Gly1087Ala)	BRCA1|LOC126862571	G1087A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054812	17	41244288	17	43092271	54812	69479	rs80357172	NC_000017.11:43092270:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1087	BRCA1
NM_007294.4(BRCA1):c.3259G>A (p.Gly1087Arg)	BRCA1|LOC126862571	G1087R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001325662	17	41244289	17	43092272	1325662	1315927	rs2154334028	NC_000017.11:43092271:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1087	BRCA1
NM_007294.4(BRCA1):c.3257T>C (p.Leu1086Ser)	BRCA1|LOC126862571	L1086S	Hereditary cancer-predisposing syndrome	VCV000054809	17	41244291	17	43092274	54809	69476	rs80357006	NC_000017.11:43092273:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1086	BRCA1
NM_007294.4(BRCA1):c.3255A>T (p.Arg1085Ser)	BRCA1|LOC126862571	R1085S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001034478	17	41244293	17	43092276	1034478	1033315	rs2053619110	NC_000017.11:43092275:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1085	BRCA1
NM_007294.4(BRCA1):c.3251T>C (p.Leu1084Pro)	BRCA1|LOC126862571	L1084P	Hereditary cancer-predisposing syndrome	VCV002397566	17	41244297	17	43092280	2397566	2378858	NA	NC_000017.11:43092279:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1084	BRCA1
NM_007294.4(BRCA1):c.3250C>T (p.Leu1084Phe)	BRCA1|LOC126862571	L1084F	Hereditary cancer-predisposing syndrome	VCV002450693	17	41244298	17	43092281	2450693	2423179	NA	NC_000017.11:43092280:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1084	BRCA1
NM_007294.4(BRCA1):c.3250C>G (p.Leu1084Val)	BRCA1|LOC126862571	L1084V	Hereditary cancer-predisposing syndrome	VCV001729418	17	41244298	17	43092281	1729418	1795094	NA	NC_000017.11:43092280:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1084	BRCA1
NM_007294.4(BRCA1):c.3250C>A (p.Leu1084Ile)	BRCA1|LOC126862571	L1084I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000245941	17	41244298	17	43092281	245941	245037	rs879254009	NC_000017.11:43092280:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1084	BRCA1
NM_007294.4(BRCA1):c.3249G>A (p.Met1083Ile)	BRCA1|LOC126862571	M1083I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001407672	17	41244299	17	43092282	1407672	1506553	rs1367761716	NC_000017.11:43092281:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1083	BRCA1
NM_007294.4(BRCA1):c.3248T>C (p.Met1083Thr)	BRCA1|LOC126862571	M1083T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000187732	17	41244300	17	43092283	187732	184977	rs786203958	NC_000017.11:43092282:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1083	BRCA1
NM_007294.4(BRCA1):c.3247A>G (p.Met1083Val)	BRCA1|LOC126862571	M1083V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000185061	17	41244301	17	43092284	185061	184978	rs397507213	NC_000017.11:43092283:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1083	BRCA1
NM_007294.4(BRCA1):c.3247A>C (p.Met1083Leu)	BRCA1|LOC126862571	M1083L	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000037517	17	41244301	17	43092284	37517	46073	rs397507213	NC_000017.11:43092283:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1083	BRCA1
NM_007294.4(BRCA1):c.3245C>A (p.Ala1082Asp)	BRCA1|LOC126862571	A1082D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001396375	17	41244303	17	43092286	1396375	1418126	rs1555588115	NC_000017.11:43092285:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1082	BRCA1
NM_007294.4(BRCA1):c.3245C>T (p.Ala1082Val)	BRCA1|LOC126862571	A1082V	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000441288	17	41244303	17	43092286	441288	435137	rs1555588115	NC_000017.11:43092285:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1082	BRCA1
NM_007294.4(BRCA1):c.3244G>T (p.Ala1082Ser)	BRCA1|LOC126862571	A1082S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000801070	17	41244304	17	43092287	801070	789623	rs779459487	NC_000017.11:43092286:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1082	BRCA1
NM_007294.4(BRCA1):c.3244G>A (p.Ala1082Thr)	BRCA1|LOC126862571	A1082T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000565971	17	41244304	17	43092287	565971	571445	rs779459487	NC_000017.11:43092286:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1082	BRCA1
NM_007294.4(BRCA1):c.3242A>C (p.Asn1081Thr)	BRCA1|LOC126862571	N1081T	Hereditary cancer-predisposing syndrome	VCV001729311	17	41244306	17	43092289	1729311	1785599	NA	NC_000017.11:43092288:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1081	BRCA1
NM_007294.4(BRCA1):c.3242A>G (p.Asn1081Ser)	BRCA1|LOC126862571	N1081S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000662436	17	41244306	17	43092289	662436	645982	rs753440254	NC_000017.11:43092288:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1081	BRCA1
NM_007294.4(BRCA1):c.3241A>G (p.Asn1081Asp)	BRCA1|LOC126862571	N1081D	Hereditary cancer-predisposing syndrome	VCV000232694	17	41244307	17	43092290	232694	236025	rs876659928	NC_000017.11:43092289:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jul 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1081	BRCA1
NM_007294.4(BRCA1):c.3240G>T (p.Leu1080Phe)	BRCA1|LOC126862571	L1080F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001492698	17	41244308	17	43092291	1492698	1516836	rs2154335204	NC_000017.11:43092290:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1080	BRCA1
NM_007294.4(BRCA1):c.3238T>G (p.Leu1080Val)	BRCA1|LOC126862571	L1080V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531225	17	41244310	17	43092293	531225	531266	rs754597283	NC_000017.11:43092292:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1080	BRCA1
NM_007294.4(BRCA1):c.3230G>A (p.Gly1077Glu)	BRCA1|LOC126862571	G1077E	Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000579547	17	41244318	17	43092301	579547	569127	rs1567792424	NC_000017.11:43092300:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1077	BRCA1
NM_007294.4(BRCA1):c.3228A>T (p.Arg1076Ser)	LOC126862571|BRCA1	R1076S	Hereditary cancer-predisposing syndrome	VCV000054803	17	41244320	17	43092303	54803	69470	rs397509048	NC_000017.11:43092302:T:A	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1076	BRCA1
NM_007294.4(BRCA1):c.3227G>A (p.Arg1076Lys)	BRCA1|LOC126862571	R1076K	Hereditary cancer-predisposing syndrome	VCV001729137	17	41244321	17	43092304	1729137	1785426	NA	NC_000017.11:43092303:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1076	BRCA1
NM_007294.4(BRCA1):c.3227G>T (p.Arg1076Ile)	BRCA1|LOC126862571	R1076I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230930	17	41244321	17	43092304	230930	236027	rs80357313	NC_000017.11:43092303:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1076	BRCA1
NM_007294.4(BRCA1):c.3227G>C (p.Arg1076Thr)	BRCA1|LOC126862571	R1076T	Hereditary cancer-predisposing syndrome	VCV000054802	17	41244321	17	43092304	54802	69469	rs80357313	NC_000017.11:43092303:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1076	BRCA1
NM_007294.4(BRCA1):c.3225C>G (p.Asn1075Lys)	BRCA1|LOC126862571	N1075K	Hereditary cancer-predisposing syndrome	VCV000441344	17	41244323	17	43092306	441344	435138	rs778607600	NC_000017.11:43092305:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1075	BRCA1
NM_007294.4(BRCA1):c.3224A>G (p.Asn1075Ser)	BRCA1|LOC126862571	N1075S	Hereditary breast ovarian cancer syndrome	VCV002818206	17	41244324	17	43092307	2818206	2984421	NA	NC_000017.11:43092306:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1075	BRCA1
NM_007294.4(BRCA1):c.3223A>G (p.Asn1075Asp)	BRCA1|LOC126862571	N1075D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000573320	17	41244325	17	43092308	573320	569145	rs1567792459	NC_000017.11:43092307:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1075	BRCA1
NM_007294.4(BRCA1):c.3221G>C (p.Arg1074Thr)	LOC126862571|BRCA1	R1074T	not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185414	17	41244327	17	43092310	185414	184980	rs786202155	NC_000017.11:43092309:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1074	BRCA1
NM_007294.4(BRCA1):c.3220A>G (p.Arg1074Gly)	BRCA1|LOC126862571	R1074G	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054800	17	41244328	17	43092311	54800	69467	rs80357263	NC_000017.11:43092310:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1074	BRCA1
NM_007294.4(BRCA1):c.3218G>T (p.Gly1073Val)	BRCA1|LOC126862571	G1073V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001720465	17	41244330	17	43092313	1720465	1776647	NA	NC_000017.11:43092312:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1073	BRCA1
NM_007294.4(BRCA1):c.3218G>A (p.Gly1073Asp)	BRCA1|LOC126862571	G1073D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630123	17	41244330	17	43092313	630123	618613	rs757632961	NC_000017.11:43092312:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1073	BRCA1
NM_007294.4(BRCA1):c.3217G>C (p.Gly1073Arg)	BRCA1|LOC126862571	G1073R	not provided|Hereditary cancer-predisposing syndrome	VCV002429561	17	41244331	17	43092314	2429561	2403059	NA	NC_000017.11:43092313:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1073	BRCA1
NM_007294.4(BRCA1):c.3217G>A (p.Gly1073Ser)	BRCA1|LOC126862571	G1073S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240789	17	41244331	17	43092314	240789	242786	rs878854945	NC_000017.11:43092313:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1073	BRCA1
NM_007294.4(BRCA1):c.3214C>A (p.Leu1072Ile)	BRCA1|LOC126862571	L1072I	Hereditary breast ovarian cancer syndrome	VCV002860134	17	41244334	17	43092317	2860134	3028771	NA	NC_000017.11:43092316:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1072	BRCA1
NM_007294.4(BRCA1):c.3212A>G (p.Glu1071Gly)	BRCA1	E1071G	Hereditary cancer-predisposing syndrome	VCV001728951	17	41244336	17	43092319	1728951	1785241	NA	NC_000017.11:43092318:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1071	BRCA1
NM_007294.4(BRCA1):c.3211G>A (p.Glu1071Lys)	BRCA1	E1071K	Hereditary cancer-predisposing syndrome|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000184828	17	41244337	17	43092320	184828	184981	rs41293445	NC_000017.11:43092319:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1071	BRCA1
NM_007294.4(BRCA1):c.3209C>A (p.Ala1070Glu)	BRCA1	A1070E	Hereditary breast ovarian cancer syndrome	VCV002915513	17	41244339	17	43092322	2915513	3074063	NA	NC_000017.11:43092321:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1070	BRCA1
NM_007294.4(BRCA1):c.3209C>G (p.Ala1070Gly)	BRCA1	A1070G	Hereditary cancer-predisposing syndrome|not specified	VCV000037515	17	41244339	17	43092322	37515	46071	rs397507212	NC_000017.11:43092321:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1070	BRCA1
NM_007294.4(BRCA1):c.3207A>T (p.Gln1069His)	BRCA1	Q1069H	Hereditary cancer-predisposing syndrome	VCV000631034	17	41244341	17	43092324	631034	618614	rs1567792523	NC_000017.11:43092323:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1069	BRCA1
NM_007294.4(BRCA1):c.3206A>T (p.Gln1069Leu)	BRCA1	Q1069L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409374	17	41244342	17	43092325	409374	402692	rs879254151	NC_000017.11:43092324:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1069	BRCA1
NM_007294.4(BRCA1):c.3206A>C (p.Gln1069Pro)	BRCA1	Q1069P	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000246204	17	41244342	17	43092325	246204	245038	rs879254151	NC_000017.11:43092324:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1069	BRCA1
NM_007294.4(BRCA1):c.3200A>G (p.Asn1067Ser)	BRCA1	N1067S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531349	17	41244348	17	43092331	531349	531268	rs1555588214	NC_000017.11:43092330:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1067	BRCA1
NM_007294.4(BRCA1):c.3199A>T (p.Asn1067Tyr)	BRCA1	N1067Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000660719	17	41244349	17	43092332	660719	645984	rs1597865137	NC_000017.11:43092331:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1067	BRCA1
NM_007294.4(BRCA1):c.3196G>A (p.Glu1066Lys)	BRCA1	E1066K	Hereditary cancer-predisposing syndrome	VCV000823145	17	41244352	17	43092335	823145	813753	rs1555588220	NC_000017.11:43092334:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1066	BRCA1
NM_007294.4(BRCA1):c.3195T>G (p.Asp1065Glu)	BRCA1	D1065E	Hereditary cancer-predisposing syndrome	VCV000629201	17	41244353	17	43092336	629201	618615	rs1567792553	NC_000017.11:43092335:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1065	BRCA1
NM_007294.4(BRCA1):c.3194A>G (p.Asp1065Gly)	BRCA1	D1065G	not provided	VCV003373180	17	41244354	17	43092337	3373180	3532370	NA	NC_000017.11:43092336:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1065	BRCA1
NM_007294.4(BRCA1):c.3194A>T (p.Asp1065Val)	BRCA1	D1065V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531367	17	41244354	17	43092337	531367	531271	rs1555588228	NC_000017.11:43092336:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1065	BRCA1
NM_007294.4(BRCA1):c.3193G>A (p.Asp1065Asn)	BRCA1	D1065N	Hereditary breast ovarian cancer syndrome	VCV002828954	17	41244355	17	43092338	2828954	2983620	NA	NC_000017.11:43092337:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1065	BRCA1
NM_007294.4(BRCA1):c.3193G>T (p.Asp1065Tyr)	BRCA1	D1065Y	Hereditary breast ovarian cancer syndrome	VCV002761260	17	41244355	17	43092338	2761260	2925026	NA	NC_000017.11:43092337:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1065	BRCA1
NM_007294.4(BRCA1):c.3192T>G (p.Ser1064Arg)	BRCA1	S1064R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001485049	17	41244356	17	43092339	1485049	1393775	rs2154337710	NC_000017.11:43092338:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1064	BRCA1
NM_007294.4(BRCA1):c.3191G>C (p.Ser1064Thr)	BRCA1	S1064T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001058334	17	41244357	17	43092340	1058334	1050301	rs2154337756	NC_000017.11:43092339:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1064	BRCA1
NM_007294.4(BRCA1):c.3190A>C (p.Ser1064Arg)	BRCA1	S1064R	Hereditary breast ovarian cancer syndrome	VCV003338012	17	41244358	17	43092341	3338012	3496672	NA	NC_000017.11:43092340:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	1064	BRCA1
NM_007294.4(BRCA1):c.3190A>G (p.Ser1064Gly)	BRCA1	S1064G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001055401	17	41244358	17	43092341	1055401	1050302	rs273899702	NC_000017.11:43092340:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1064	BRCA1
NM_007294.4(BRCA1):c.3190A>T (p.Ser1064Cys)	BRCA1	S1064C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000054795	17	41244358	17	43092341	54795	69462	rs273899702	NC_000017.11:43092340:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1064	BRCA1
NM_007294.4(BRCA1):c.3188C>T (p.Ser1063Phe)	BRCA1	S1063F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001728607	17	41244360	17	43092343	1728607	1788242	NA	NC_000017.11:43092342:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1063	BRCA1
NM_007294.4(BRCA1):c.3187T>G (p.Ser1063Ala)	BRCA1	S1063A	Hereditary cancer-predisposing syndrome|not provided	VCV001330094	17	41244361	17	43092344	1330094	1320777	rs2154337925	NC_000017.11:43092343:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1063	BRCA1
NM_007294.4(BRCA1):c.3185G>A (p.Gly1062Asp)	BRCA1	G1062D	Hereditary cancer-predisposing syndrome	VCV001728580	17	41244363	17	43092346	1728580	1788215	NA	NC_000017.11:43092345:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1062	BRCA1
NM_007294.4(BRCA1):c.3185G>C (p.Gly1062Ala)	BRCA1	G1062A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000950588	17	41244363	17	43092346	950588	928298	rs397507211	NC_000017.11:43092345:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1062	BRCA1
NM_007294.4(BRCA1):c.3185G>T (p.Gly1062Val)	BRCA1	G1062V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000037513	17	41244363	17	43092346	37513	46069	rs397507211	NC_000017.11:43092345:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1062	BRCA1
NM_007294.4(BRCA1):c.3184G>T (p.Gly1062Cys)	BRCA1	G1062C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002129572	17	41244364	17	43092347	2129572	2190996	NA	NC_000017.11:43092346:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1062	BRCA1
NM_007294.4(BRCA1):c.3184G>A (p.Gly1062Ser)	BRCA1	G1062S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628537	17	41244364	17	43092347	628537	618616	rs1567792594	NC_000017.11:43092346:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1062	BRCA1
NM_007294.4(BRCA1):c.3183A>G (p.Ile1061Met)	BRCA1	I1061M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001494999	17	41244365	17	43092348	1494999	1368785	rs2154338105	NC_000017.11:43092347:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1061	BRCA1
NM_007294.4(BRCA1):c.3182T>C (p.Ile1061Thr)	BRCA1	I1061T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000823111	17	41244366	17	43092349	823111	813754	rs1567792602	NC_000017.11:43092348:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1061	BRCA1
NM_007294.4(BRCA1):c.3181A>C (p.Ile1061Leu)	BRCA1	I1061L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482961	17	41244367	17	43092350	482961	478609	rs876658975	NC_000017.11:43092349:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1061	BRCA1
NM_007294.4(BRCA1):c.3181A>G (p.Ile1061Val)	BRCA1	I1061V	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000231131	17	41244367	17	43092350	231131	236028	rs876658975	NC_000017.11:43092349:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1061	BRCA1
NM_007294.4(BRCA1):c.3179A>C (p.Glu1060Ala)	BRCA1	E1060A	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054790	17	41244369	17	43092352	54790	69457	rs80357184	NC_000017.11:43092351:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Sep 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1060	BRCA1
NM_007294.4(BRCA1):c.3178G>A (p.Glu1060Lys)	BRCA1	E1060K	Hereditary breast ovarian cancer syndrome	VCV002845678	17	41244370	17	43092353	2845678	3011877	NA	NC_000017.11:43092352:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1060	BRCA1
NM_007294.4(BRCA1):c.3178G>C (p.Glu1060Gln)	BRCA1	E1060Q	Hereditary cancer-predisposing syndrome	VCV000252872	17	41244370	17	43092353	252872	247273	rs80357424	NC_000017.11:43092352:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1060	BRCA1
NM_007294.4(BRCA1):c.3176A>G (p.Asn1059Ser)	BRCA1	N1059S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002037533	17	41244372	17	43092355	2037533	2094155	NA	NC_000017.11:43092354:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1059	BRCA1
NM_007294.4(BRCA1):c.3173T>G (p.Ile1058Ser)	BRCA1	I1058S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462605	17	41244375	17	43092358	462605	467720	rs1555588264	NC_000017.11:43092357:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1058	BRCA1
NM_007294.4(BRCA1):c.3172A>T (p.Ile1058Phe)	BRCA1	I1058F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001512423	17	41244376	17	43092359	1512423	1478673	rs1064795478	NC_000017.11:43092358:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1058	BRCA1
NM_007294.4(BRCA1):c.3172A>G (p.Ile1058Val)	BRCA1	I1058V	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000421966	17	41244376	17	43092359	421966	409982	rs1064795478	NC_000017.11:43092358:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1058	BRCA1
NM_007294.4(BRCA1):c.3170G>C (p.Ser1057Thr)	BRCA1	S1057T	Hereditary cancer-predisposing syndrome	VCV000823064	17	41244378	17	43092361	823064	813755	rs587776487	NC_000017.11:43092360:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1057	BRCA1
NM_007294.4(BRCA1):c.3170G>A (p.Ser1057Asn)	BRCA1	S1057N	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000156191	17	41244378	17	43092361	156191	165990	rs587776487	NC_000017.11:43092360:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1057	BRCA1
NM_007294.4(BRCA1):c.3169A>C (p.Ser1057Arg)	BRCA1	S1057R	Hereditary cancer-predisposing syndrome	VCV000230222	17	41244379	17	43092362	230222	236031	rs80357479	NC_000017.11:43092361:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1057	BRCA1
NM_007294.4(BRCA1):c.3169A>G (p.Ser1057Gly)	BRCA1	S1057G	not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000054787	17	41244379	17	43092362	54787	69454	rs80357479	NC_000017.11:43092361:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1057	BRCA1
NM_007294.4(BRCA1):c.3167C>A (p.Ser1056Tyr)	BRCA1	S1056Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001728378	17	41244381	17	43092364	1728378	1791778	NA	NC_000017.11:43092363:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1056	BRCA1
NM_007294.4(BRCA1):c.3167C>T (p.Ser1056Phe)	BRCA1	S1056F	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000231051	17	41244381	17	43092364	231051	236032	rs587781588	NC_000017.11:43092363:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1056	BRCA1
NM_007294.4(BRCA1):c.3167C>G (p.Ser1056Cys)	BRCA1	S1056C	Hereditary cancer-predisposing syndrome	VCV000141223	17	41244381	17	43092364	141223	150937	rs587781588	NC_000017.11:43092363:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1056	BRCA1
NM_007294.4(BRCA1):c.3166T>G (p.Ser1056Ala)	BRCA1	S1056A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000940260	17	41244382	17	43092365	940260	937956	rs876659601	NC_000017.11:43092364:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1056	BRCA1
NM_007294.4(BRCA1):c.3166T>C (p.Ser1056Pro)	BRCA1	S1056P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000232179	17	41244382	17	43092365	232179	236033	rs876659601	NC_000017.11:43092364:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1056	BRCA1
NM_007294.4(BRCA1):c.3164G>T (p.Gly1055Val)	BRCA1	G1055V	Hereditary cancer-predisposing syndrome	VCV003226135	17	41244384	17	43092367	3226135	3387199	NA	NC_000017.11:43092366:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1055	BRCA1
NM_007294.4(BRCA1):c.3163G>T (p.Gly1055Cys)	BRCA1	G1055C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001064208	17	41244385	17	43092368	1064208	1050303	rs749417532	NC_000017.11:43092367:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1055	BRCA1
NM_007294.4(BRCA1):c.3163G>A (p.Gly1055Ser)	BRCA1	G1055S	not provided|Hereditary cancer-predisposing syndrome	VCV000630124	17	41244385	17	43092368	630124	618617	rs749417532	NC_000017.11:43092367:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1055	BRCA1
NM_007294.4(BRCA1):c.3160G>T (p.Val1054Leu)	BRCA1	V1054L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001522881	17	41244388	17	43092371	1522881	1460074	rs876658479	NC_000017.11:43092370:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1054	BRCA1
NM_007294.4(BRCA1):c.3160G>A (p.Val1054Met)	BRCA1	V1054M	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000230277	17	41244388	17	43092371	230277	236034	rs876658479	NC_000017.11:43092370:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1054	BRCA1
NM_007294.4(BRCA1):c.3159A>C (p.Glu1053Asp)	BRCA1	E1053D	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000630988	17	41244389	17	43092372	630988	618618	rs1567792698	NC_000017.11:43092371:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1053	BRCA1
NM_007294.4(BRCA1):c.3155A>G (p.Asn1052Ser)	BRCA1	N1052S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000091606	17	41244393	17	43092376	91606	97083	rs398122672	NC_000017.11:43092375:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1052	BRCA1
NM_007294.4(BRCA1):c.3154A>G (p.Asn1052Asp)	BRCA1	N1052D	Hereditary cancer-predisposing syndrome	VCV000232778	17	41244394	17	43092377	232778	236035	rs768995134	NC_000017.11:43092376:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1052	BRCA1
NM_007294.4(BRCA1):c.3152C>T (p.Thr1051Ile)	BRCA1	T1051I	Hereditary cancer-predisposing syndrome	VCV000441444	17	41244396	17	43092379	441444	435140	rs397509039	NC_000017.11:43092378:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1051	BRCA1
NM_007294.4(BRCA1):c.3152C>G (p.Thr1051Ser)	BRCA1	T1051S	Hereditary cancer-predisposing syndrome	VCV000054781	17	41244396	17	43092379	54781	69448	rs397509039	NC_000017.11:43092378:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1051	BRCA1
NM_007294.4(BRCA1):c.3151A>C (p.Thr1051Pro)	BRCA1	T1051P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002111609	17	41244397	17	43092380	2111609	2164184	NA	NC_000017.11:43092379:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1051	BRCA1
NM_007294.4(BRCA1):c.3151A>G (p.Thr1051Ala)	BRCA1	T1051A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome	VCV000091605	17	41244397	17	43092380	91605	97082	rs398122671	NC_000017.11:43092379:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1051	BRCA1
NM_007294.4(BRCA1):c.3150T>G (p.Ser1050Arg)	BRCA1	S1050R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481491	17	41244398	17	43092381	481491	478738	rs1555588305	NC_000017.11:43092380:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1050	BRCA1
NM_007294.4(BRCA1):c.3149G>A (p.Ser1050Asn)	BRCA1	S1050N	Hereditary breast ovarian cancer syndrome	VCV002762917	17	41244399	17	43092382	2762917	2927978	NA	NC_000017.11:43092381:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1050	BRCA1
NM_007294.4(BRCA1):c.3149G>C (p.Ser1050Thr)	BRCA1	S1050T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000822994	17	41244399	17	43092382	822994	813756	rs1597865440	NC_000017.11:43092381:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1050	BRCA1
NM_007294.4(BRCA1):c.3148A>G (p.Ser1050Gly)	BRCA1	S1050G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000862098	17	41244400	17	43092383	862098	845407	rs2053635674	NC_000017.11:43092382:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1050	BRCA1
NM_007294.4(BRCA1):c.3146C>G (p.Ser1049Cys)	BRCA1	S1049C	Hereditary cancer-predisposing syndrome	VCV001728128	17	41244402	17	43092385	1728128	1791528	NA	NC_000017.11:43092384:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1049	BRCA1
NM_007294.4(BRCA1):c.3143G>T (p.Gly1048Val)	BRCA1	G1048V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054777	17	41244405	17	43092388	54777	69444	rs80356899	NC_000017.11:43092387:C:A	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1048	BRCA1
NM_007294.4(BRCA1):c.3143G>A (p.Gly1048Asp)	BRCA1	G1048D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054776	17	41244405	17	43092388	54776	69443	rs80356899	NC_000017.11:43092387:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1048	BRCA1
NM_007294.4(BRCA1):c.3142G>T (p.Gly1048Cys)	BRCA1	G1048C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002050082	17	41244406	17	43092389	2050082	2104086	NA	NC_000017.11:43092388:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1048	BRCA1
NM_007294.4(BRCA1):c.3140T>C (p.Val1047Ala)	BRCA1	V1047A	Hereditary cancer-predisposing syndrome	VCV000054775	17	41244408	17	43092391	54775	69442	rs397509037	NC_000017.11:43092390:A:G	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1047	BRCA1
NM_007294.4(BRCA1):c.3139G>A (p.Val1047Ile)	BRCA1	V1047I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000659737	17	41244409	17	43092392	659737	645986	rs1597865476	NC_000017.11:43092391:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1047	BRCA1
NM_007294.4(BRCA1):c.3137A>C (p.Glu1046Ala)	BRCA1	E1046A	Hereditary breast ovarian cancer syndrome	VCV002846744	17	41244411	17	43092394	2846744	3014919	NA	NC_000017.11:43092393:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1046	BRCA1
NM_007294.4(BRCA1):c.3136G>C (p.Glu1046Gln)	BRCA1	E1046Q	Hereditary cancer-predisposing syndrome	VCV000480995	17	41244412	17	43092395	480995	479371	rs1555588329	NC_000017.11:43092394:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1046	BRCA1
NM_007294.4(BRCA1):c.3135T>A (p.Asn1045Lys)	BRCA1	N1045K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721824	17	41244413	17	43092396	1721824	1779542	NA	NC_000017.11:43092395:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1045	BRCA1
NM_007294.4(BRCA1):c.3135T>G (p.Asn1045Lys)	BRCA1	N1045K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000954381	17	41244413	17	43092396	954381	949941	rs2053637366	NC_000017.11:43092395:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1045	BRCA1
NM_007294.4(BRCA1):c.3134A>G (p.Asn1045Ser)	BRCA1	N1045S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479197	17	41244414	17	43092397	479197	478739	rs1555588330	NC_000017.11:43092396:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1045	BRCA1
NM_007294.4(BRCA1):c.3133A>G (p.Asn1045Asp)	BRCA1	N1045D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002055058	17	41244415	17	43092398	2055058	2109058	NA	NC_000017.11:43092397:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1045	BRCA1
NM_007294.4(BRCA1):c.3132T>G (p.Ile1044Met)	BRCA1	I1044M	Hereditary cancer-predisposing syndrome	VCV000441445	17	41244416	17	43092399	441445	435141	rs1555588333	NC_000017.11:43092398:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1044	BRCA1
NM_007294.4(BRCA1):c.3131T>C (p.Ile1044Thr)	BRCA1	I1044T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001024907	17	41244417	17	43092400	1024907	1012772	rs2053637993	NC_000017.11:43092399:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1044	BRCA1
NM_007294.4(BRCA1):c.3131T>G (p.Ile1044Ser)	BRCA1	I1044S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000858473	17	41244417	17	43092400	858473	845408	rs2053637993	NC_000017.11:43092399:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1044	BRCA1
NM_007294.4(BRCA1):c.3130A>G (p.Ile1044Val)	BRCA1	I1044V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037510	17	41244418	17	43092401	37510	46066	rs80357271	NC_000017.11:43092400:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1044	BRCA1
NM_007294.4(BRCA1):c.3129T>A (p.Asn1043Lys)	BRCA1	N1043K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001514451	17	41244419	17	43092402	1514451	1485494	rs1555588339	NC_000017.11:43092401:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1043	BRCA1
NM_007294.4(BRCA1):c.3128A>G (p.Asn1043Ser)	BRCA1	N1043S	Hereditary cancer-predisposing syndrome	VCV003226132	17	41244420	17	43092403	3226132	3387196	NA	NC_000017.11:43092402:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Sep 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1043	BRCA1
NM_007294.4(BRCA1):c.3128A>C (p.Asn1043Thr)	BRCA1	N1043T	Hereditary cancer-predisposing syndrome	VCV000628251	17	41244420	17	43092403	628251	618619	rs1228972723	NC_000017.11:43092402:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1043	BRCA1
NM_007294.4(BRCA1):c.3127A>C (p.Asn1043His)	BRCA1	N1043H	Hereditary cancer-predisposing syndrome	VCV000491058	17	41244421	17	43092404	491058	484915	rs587782630	NC_000017.11:43092403:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1043	BRCA1
NM_007294.4(BRCA1):c.3127A>G (p.Asn1043Asp)	BRCA1	N1043D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142668	17	41244421	17	43092404	142668	152382	rs587782630	NC_000017.11:43092403:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1043	BRCA1
NM_007294.4(BRCA1):c.3126C>A (p.Ser1042Arg)	BRCA1	S1042R	Hereditary cancer-predisposing syndrome	VCV001727896	17	41244422	17	43092405	1727896	1794764	NA	NC_000017.11:43092404:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1042	BRCA1
NM_007294.4(BRCA1):c.3126C>G (p.Ser1042Arg)	BRCA1	S1042R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240787	17	41244422	17	43092405	240787	242787	rs878854943	NC_000017.11:43092404:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1042	BRCA1
NM_007294.4(BRCA1):c.3125G>A (p.Ser1042Asn)	BRCA1	S1042N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952782	17	41244423	17	43092406	952782	928300	rs767217821	NC_000017.11:43092405:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1042	BRCA1
NM_007294.4(BRCA1):c.3124A>C (p.Ser1042Arg)	BRCA1	S1042R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000652188	17	41244424	17	43092407	652188	645987	rs1597865563	NC_000017.11:43092406:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1042	BRCA1
NM_007294.4(BRCA1):c.3122C>T (p.Ser1041Leu)	BRCA1	S1041L	Hereditary cancer-predisposing syndrome	VCV000560366	17	41244426	17	43092409	560366	551419	rs397509035	NC_000017.11:43092408:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1041	BRCA1
NM_007294.4(BRCA1):c.3119G>T (p.Ser1040Ile)	BRCA1	S1040I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001692963	17	41244429	17	43092412	1692963	1685403	rs4986852	NC_000017.11:43092411:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1040	BRCA1
NM_007294.4(BRCA1):c.3119G>C (p.Ser1040Thr)	BRCA1	S1040T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462603	17	41244429	17	43092412	462603	467946	rs4986852	NC_000017.11:43092411:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1040	BRCA1
NM_007294.4(BRCA1):c.3119G>A (p.Ser1040Asn)	BRCA1	S1040N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017670	17	41244429	17	43092412	17670	32709	rs4986852	NC_000017.11:43092411:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1040	BRCA1
NM_007294.4(BRCA1):c.3118A>G (p.Ser1040Gly)	BRCA1	S1040G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002153465	17	41244430	17	43092413	2153465	1882327	NA	NC_000017.11:43092412:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1040	BRCA1
NM_007294.4(BRCA1):c.3116C>T (p.Ala1039Val)	BRCA1	A1039V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000628386	17	41244432	17	43092415	628386	618620	rs1173254670	NC_000017.11:43092414:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1039	BRCA1
NM_007294.4(BRCA1):c.3114A>C (p.Glu1038Asp)	BRCA1	E1038D	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000927721	17	41244434	17	43092417	927721	913904	rs1479034426	NC_000017.11:43092416:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1038	BRCA1
NM_007294.4(BRCA1):c.3113A>C (p.Glu1038Ala)	BRCA1	E1038A	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000240786	17	41244435	17	43092418	240786	242788	rs16941	NC_000017.11:43092417:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1038	BRCA1
NM_007294.4(BRCA1):c.3113A>G (p.Glu1038Gly)	BRCA1	E1038G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041815	17	41244435	17	43092418	41815	50254	rs16941	NC_000017.11:43092417:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1038	BRCA1
NM_007294.4(BRCA1):c.3106T>C (p.Phe1036Leu)	BRCA1	F1036L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000265049	17	41244442	17	43092425	265049	260173	rs766381694	NC_000017.11:43092424:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1036	BRCA1
NM_007294.4(BRCA1):c.3104T>C (p.Val1035Ala)	BRCA1	V1035A	Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000531214	17	41244444	17	43092427	531214	531347	rs1555588389	NC_000017.11:43092426:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1035	BRCA1
NM_007294.4(BRCA1):c.3101A>C (p.Asn1034Thr)	BRCA1	N1034T	Hereditary cancer-predisposing syndrome	VCV001727646	17	41244447	17	43092430	1727646	1785126	NA	NC_000017.11:43092429:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1034	BRCA1
NM_007294.4(BRCA1):c.3100A>C (p.Asn1034His)	BRCA1	N1034H	Hereditary cancer-predisposing syndrome	VCV002450684	17	41244448	17	43092431	2450684	2423170	NA	NC_000017.11:43092430:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1034	BRCA1
NM_007294.4(BRCA1):c.3100A>G (p.Asn1034Asp)	BRCA1	N1034D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001398452	17	41244448	17	43092431	1398452	1431381	rs2154342594	NC_000017.11:43092430:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1034	BRCA1
NM_007294.4(BRCA1):c.3098A>G (p.Glu1033Gly)	BRCA1	E1033G	not provided	VCV002574388	17	41244450	17	43092433	2574388	2739322	NA	NC_000017.11:43092432:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1033	BRCA1
NM_007294.4(BRCA1):c.3097G>A (p.Glu1033Lys)	BRCA1	E1033K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000182152	17	41244451	17	43092434	182152	180847	rs273899698	NC_000017.11:43092433:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1033	BRCA1
NM_007294.4(BRCA1):c.3095G>C (p.Arg1032Thr)	BRCA1	R1032T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003070012	17	41244453	17	43092436	3070012	3233587	NA	NC_000017.11:43092435:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1032	BRCA1
NM_007294.4(BRCA1):c.3092T>G (p.Ile1031Ser)	BRCA1	I1031S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216661	17	41244456	17	43092439	216661	213320	rs863224758	NC_000017.11:43092438:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1031	BRCA1
NM_007294.4(BRCA1):c.3091A>G (p.Ile1031Val)	BRCA1	I1031V	Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Hereditary breast ovarian cancer syndrome	VCV000188293	17	41244457	17	43092440	188293	186256	rs786203979	NC_000017.11:43092439:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1031	BRCA1
NM_007294.4(BRCA1):c.3091A>T (p.Ile1031Phe)	BRCA1	I1031F	Hereditary cancer-predisposing syndrome	VCV000187759	17	41244457	17	43092440	187759	184983	rs786203979	NC_000017.11:43092439:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1031	BRCA1
NM_007294.4(BRCA1):c.3089A>G (p.Asn1030Ser)	BRCA1	N1030S	not specified	VCV003339864	17	41244459	17	43092442	3339864	3499127	NA	NC_000017.11:43092441:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1030	BRCA1
NM_007294.4(BRCA1):c.3088A>C (p.Asn1030His)	BRCA1	N1030H	Hereditary breast ovarian cancer syndrome	VCV002765872	17	41244460	17	43092443	2765872	2922746	NA	NC_000017.11:43092442:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1030	BRCA1
NM_007294.4(BRCA1):c.3088A>G (p.Asn1030Asp)	BRCA1	N1030D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001055956	17	41244460	17	43092443	1055956	1050304	rs2154343150	NC_000017.11:43092442:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1030	BRCA1
NM_007294.4(BRCA1):c.3086A>G (p.Asn1029Ser)	BRCA1	N1029S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630125	17	41244462	17	43092445	630125	618621	rs753286589	NC_000017.11:43092444:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1029	BRCA1
NM_007294.4(BRCA1):c.3085A>G (p.Asn1029Asp)	BRCA1	N1029D	Hereditary breast ovarian cancer syndrome	VCV002865390	17	41244463	17	43092446	2865390	3030171	NA	NC_000017.11:43092445:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1029	BRCA1
NM_007294.4(BRCA1):c.3083G>T (p.Arg1028Leu)	BRCA1	R1028L	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185826	17	41244465	17	43092448	185826	184984	rs80357459	NC_000017.11:43092447:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1028	BRCA1
NM_007294.4(BRCA1):c.3083G>A (p.Arg1028His)	BRCA1	R1028H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037507	17	41244465	17	43092448	37507	46063	rs80357459	NC_000017.11:43092447:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1028	BRCA1
NM_007294.4(BRCA1):c.3082C>T (p.Arg1028Cys)	BRCA1	R1028C	BRCA1-related cancer predisposition	VCV000037506	17	41244466	17	43092449	37506	46062	rs80357049	NC_000017.11:43092448:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1028	BRCA1
NM_007294.4(BRCA1):c.3079_3080delinsGA (p.Ser1027Asp)	BRCA1	S1027D	Hereditary cancer-predisposing syndrome|not specified	VCV000632677	17	41244468 - 41244469	17	43092451 - 43092452	632677	621580	rs1567793005	NC_000017.11:43092450:CT:TC	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1027	BRCA1
NM_007294.4(BRCA1):c.3080G>C (p.Ser1027Thr)	BRCA1	S1027T	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S	VCV000496362	17	41244468	17	43092451	496362	487936	rs80357386	NC_000017.11:43092450:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1027	BRCA1
NM_007294.4(BRCA1):c.3080G>A (p.Ser1027Asn)	BRCA1	S1027N	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054767	17	41244468	17	43092451	54767	69434	rs80357386	NC_000017.11:43092450:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1027	BRCA1
NM_007294.4(BRCA1):c.3078T>G (p.Ile1026Met)	BRCA1	I1026M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000433704	17	41244470	17	43092453	433704	427554	rs1555588422	NC_000017.11:43092452:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1026	BRCA1
NM_007294.4(BRCA1):c.3077T>C (p.Ile1026Thr)	BRCA1	I1026T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001504250	17	41244471	17	43092454	1504250	1337125	rs2154343607	NC_000017.11:43092453:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1026	BRCA1
NM_007294.4(BRCA1):c.3076A>G (p.Ile1026Val)	BRCA1	I1026V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001049110	17	41244472	17	43092455	1049110	1038568	rs1468925322	NC_000017.11:43092454:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1026	BRCA1
NM_007294.4(BRCA1):c.3074C>T (p.Thr1025Ile)	BRCA1	T1025I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054766	17	41244474	17	43092457	54766	69433	rs397509034	NC_000017.11:43092456:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1025	BRCA1
NM_007294.4(BRCA1):c.3072C>A (p.Ser1024Arg)	BRCA1	S1024R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001727270	17	41244476	17	43092459	1727270	1784750	NA	NC_000017.11:43092458:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1024	BRCA1
NM_007294.4(BRCA1):c.3072C>G (p.Ser1024Arg)	BRCA1	S1024R	Hereditary cancer-predisposing syndrome	VCV000054765	17	41244476	17	43092459	54765	69432	rs397509033	NC_000017.11:43092458:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1024	BRCA1
NM_007294.4(BRCA1):c.3071G>C (p.Ser1024Thr)	BRCA1	S1024T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast neoplasm	VCV000224431	17	41244477	17	43092460	224431	226201	rs757579891	NC_000017.11:43092459:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1024	BRCA1
NM_007294.4(BRCA1):c.3071G>A (p.Ser1024Asn)	BRCA1	S1024N	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187719	17	41244477	17	43092460	187719	184986	rs757579891	NC_000017.11:43092459:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1024	BRCA1
NM_007294.4(BRCA1):c.3068T>A (p.Val1023Glu)	BRCA1	V1023E	Hereditary breast ovarian cancer syndrome	VCV002841232	17	41244480	17	43092463	2841232	2993385	NA	NC_000017.11:43092462:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1023	BRCA1
NM_007294.4(BRCA1):c.3068T>G (p.Val1023Gly)	BRCA1	V1023G	Hereditary cancer-predisposing syndrome	VCV002475141	17	41244480	17	43092463	2475141	2456923	NA	NC_000017.11:43092462:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1023	BRCA1
NM_007294.4(BRCA1):c.3065C>T (p.Thr1022Ile)	BRCA1	T1022I	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185304	17	41244483	17	43092466	185304	184988	rs786202070	NC_000017.11:43092465:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1022	BRCA1
NM_007294.4(BRCA1):c.3062G>C (p.Ser1021Thr)	BRCA1	S1021T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001799388	17	41244486	17	43092469	1799388	1854996	NA	NC_000017.11:43092468:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1021	BRCA1
NM_007294.4(BRCA1):c.3061A>G (p.Ser1021Gly)	BRCA1	S1021G	not provided|Hereditary cancer-predisposing syndrome	VCV000993203	17	41244487	17	43092470	993203	981167	rs2053648539	NC_000017.11:43092469:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1021	BRCA1
NM_007294.4(BRCA1):c.3059C>G (p.Pro1020Arg)	BRCA1	P1020R	Hereditary cancer-predisposing syndrome	VCV003226130	17	41244489	17	43092472	3226130	3387194	NA	NC_000017.11:43092471:G:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Mar 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1020	BRCA1
NM_007294.4(BRCA1):c.3058C>G (p.Pro1020Ala)	BRCA1	P1020A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002006887	17	41244490	17	43092473	2006887	2066122	NA	NC_000017.11:43092472:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1020	BRCA1
NM_007294.4(BRCA1):c.3058C>T (p.Pro1020Ser)	BRCA1	P1020S	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001709805	17	41244490	17	43092473	1709805	1708159	NA	NC_000017.11:43092472:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1020	BRCA1
NM_007294.4(BRCA1):c.3056T>G (p.Ile1019Ser)	BRCA1	I1019S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001505013	17	41244492	17	43092475	1505013	1413883	rs2154344910	NC_000017.11:43092474:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1019	BRCA1
NM_007294.4(BRCA1):c.3055A>G (p.Ile1019Val)	BRCA1	I1019V	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037504	17	41244493	17	43092476	37504	46060	rs80357311	NC_000017.11:43092475:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1019	BRCA1
NM_007294.4(BRCA1):c.3053A>G (p.Asn1018Ser)	BRCA1	N1018S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000629195	17	41244495	17	43092478	629195	618622	rs1567793093	NC_000017.11:43092477:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1018	BRCA1
NM_007294.4(BRCA1):c.3050A>C (p.Glu1017Ala)	BRCA1	E1017A	Hereditary cancer-predisposing syndrome	VCV002450690	17	41244498	17	43092481	2450690	2423176	NA	NC_000017.11:43092480:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1017	BRCA1
NM_007294.4(BRCA1):c.3049G>C (p.Glu1017Gln)	BRCA1	E1017Q	Hereditary cancer-predisposing syndrome	VCV001799227	17	41244499	17	43092482	1799227	1854836	NA	NC_000017.11:43092481:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1017	BRCA1
NM_007294.4(BRCA1):c.3049G>A (p.Glu1017Lys)	BRCA1	E1017K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000970579	17	41244499	17	43092482	970579	958128	rs80357004	NC_000017.11:43092481:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1017	BRCA1
NM_007294.4(BRCA1):c.3048T>G (p.Asn1016Lys)	BRCA1	N1016K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252871	17	41244500	17	43092483	252871	247272	rs879255482	NC_000017.11:43092482:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1016	BRCA1
NM_007294.4(BRCA1):c.3047A>G (p.Asn1016Ser)	BRCA1	N1016S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000584950	17	41244501	17	43092484	584950	575999	rs1567793123	NC_000017.11:43092483:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1016	BRCA1
NM_007294.4(BRCA1):c.3046A>G (p.Asn1016Asp)	BRCA1	N1016D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054762	17	41244502	17	43092485	54762	69429	rs80357154	NC_000017.11:43092484:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1016	BRCA1
NM_007294.4(BRCA1):c.3044G>A (p.Gly1015Glu)	BRCA1	G1015E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002756710	17	41244504	17	43092487	2756710	2910111	NA	NC_000017.11:43092486:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1015	BRCA1
NM_007294.4(BRCA1):c.3043G>A (p.Gly1015Arg)	BRCA1	G1015R	Hereditary cancer-predisposing syndrome	VCV003226128	17	41244505	17	43092488	3226128	3387192	NA	NC_000017.11:43092487:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 2, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1015	BRCA1
NM_007294.4(BRCA1):c.3042G>A (p.Met1014Ile)	BRCA1	M1014I	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000496363	17	41244506	17	43092489	496363	487970	rs1555588493	NC_000017.11:43092488:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1014	BRCA1
NM_007294.4(BRCA1):c.3041T>C (p.Met1014Thr)	BRCA1	M1014T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091604	17	41244507	17	43092490	91604	97081	rs80357020	NC_000017.11:43092489:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1014	BRCA1
NM_007294.4(BRCA1):c.3041T>A (p.Met1014Lys)	BRCA1	M1014K	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000054761	17	41244507	17	43092490	54761	69428	rs80357020	NC_000017.11:43092489:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1014	BRCA1
NM_007294.4(BRCA1):c.3040A>T (p.Met1014Leu)	BRCA1	M1014L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000054760	17	41244508	17	43092491	54760	69427	rs80356933	NC_000017.11:43092490:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1014	BRCA1
NM_007294.4(BRCA1):c.3040A>G (p.Met1014Val)	BRCA1	M1014V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054759	17	41244508	17	43092491	54759	69426	rs80356933	NC_000017.11:43092490:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1014	BRCA1
NM_007294.4(BRCA1):c.3037G>C (p.Glu1013Gln)	BRCA1	E1013Q	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	VCV002442964	17	41244511	17	43092494	2442964	2416685	NA	NC_000017.11:43092493:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1013	BRCA1
NM_007294.4(BRCA1):c.3037G>A (p.Glu1013Lys)	BRCA1	E1013K	Hereditary cancer-predisposing syndrome	VCV000433703	17	41244511	17	43092494	433703	427555	rs1555588500	NC_000017.11:43092493:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1013	BRCA1
NM_007294.4(BRCA1):c.3036A>C (p.Arg1012Ser)	BRCA1	R1012S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000570066	17	41244512	17	43092495	570066	571159	rs1567793150	NC_000017.11:43092494:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1012	BRCA1
NM_007294.4(BRCA1):c.3035G>C (p.Arg1012Thr)	BRCA1	R1012T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000844302	17	41244513	17	43092496	844302	845409	rs876658464	NC_000017.11:43092495:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1012	BRCA1
NM_007294.4(BRCA1):c.3035G>A (p.Arg1012Lys)	BRCA1	R1012K	Hereditary cancer-predisposing syndrome	VCV000230249	17	41244513	17	43092496	230249	236036	rs876658464	NC_000017.11:43092495:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1012	BRCA1
NM_007294.4(BRCA1):c.3034A>G (p.Arg1012Gly)	BRCA1	R1012G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441441	17	41244514	17	43092497	441441	435142	rs1555588503	NC_000017.11:43092496:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1012	BRCA1
NM_007294.4(BRCA1):c.3032A>G (p.Glu1011Gly)	BRCA1	E1011G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000835664	17	41244516	17	43092499	835664	845410	rs2053652997	NC_000017.11:43092498:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1011	BRCA1
NM_007294.4(BRCA1):c.3031G>A (p.Glu1011Lys)	BRCA1	E1011K	Hereditary cancer-predisposing syndrome	VCV000232759	17	41244517	17	43092500	232759	236037	rs876659974	NC_000017.11:43092499:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1011	BRCA1
NM_007294.4(BRCA1):c.3029C>T (p.Pro1010Leu)	BRCA1	P1010L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000664325	17	41244519	17	43092502	664325	645990	rs1597866094	NC_000017.11:43092501:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1010	BRCA1
NM_007294.4(BRCA1):c.3028C>A (p.Pro1010Thr)	BRCA1	P1010T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000934392	17	41244520	17	43092503	934392	937957	rs1057519249	NC_000017.11:43092502:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1010	BRCA1
NM_007294.4(BRCA1):c.3028C>T (p.Pro1010Ser)	BRCA1	P1010S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000374941	17	41244520	17	43092503	374941	361882	rs1057519249	NC_000017.11:43092502:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1010	BRCA1
NM_007294.4(BRCA1):c.3025T>A (p.Ser1009Thr)	BRCA1	S1009T	Hereditary cancer-predisposing syndrome|not provided	VCV001302498	17	41244523	17	43092506	1302498	1292779	rs2053654131	NC_000017.11:43092505:A:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1009	BRCA1
NM_007294.4(BRCA1):c.3025T>C (p.Ser1009Pro)	BRCA1	S1009P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001026712	17	41244523	17	43092506	1026712	1012773	rs2053654131	NC_000017.11:43092505:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1009	BRCA1
NM_007294.4(BRCA1):c.3024G>T (p.Met1008Ile)	BRCA1	M1008I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000822631	17	41244524	17	43092507	822631	813761	rs1800704	NC_000017.11:43092506:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1008	BRCA1
NM_007294.4(BRCA1):c.3024G>A (p.Met1008Ile)	BRCA1	M1008I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041814	17	41244524	17	43092507	41814	50253	rs1800704	NC_000017.11:43092506:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1008	BRCA1
NM_007294.4(BRCA1):c.3022A>C (p.Met1008Leu)	BRCA1	M1008L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142775	17	41244526	17	43092509	142775	152489	rs56321129	NC_000017.11:43092508:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1008	BRCA1
NM_007294.4(BRCA1):c.3022A>G (p.Met1008Val)	BRCA1	M1008V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054755	17	41244526	17	43092509	54755	69422	rs56321129	NC_000017.11:43092508:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1008	BRCA1
NM_007294.4(BRCA1):c.3020C>T (p.Ser1007Leu)	BRCA1	S1007L	Hereditary breast ovarian cancer syndrome	VCV002760192	17	41244528	17	43092511	2760192	2911004	NA	NC_000017.11:43092510:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1007	BRCA1
NM_007294.4(BRCA1):c.3018T>G (p.His1006Gln)	BRCA1	H1006Q	Hereditary cancer-predisposing syndrome	VCV003261448	17	41244530	17	43092513	3261448	3424217	NA	NC_000017.11:43092512:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 24, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1006	BRCA1
NM_007294.4(BRCA1):c.3017A>C (p.His1006Pro)	BRCA1	H1006P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001003072	17	41244531	17	43092514	1003072	997578	rs2053655843	NC_000017.11:43092513:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1006	BRCA1
NM_007294.4(BRCA1):c.3016C>A (p.His1006Asn)	BRCA1	H1006N	Hereditary cancer-predisposing syndrome	VCV001798857	17	41244532	17	43092515	1798857	1856126	NA	NC_000017.11:43092514:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1006	BRCA1
NM_007294.4(BRCA1):c.3010G>A (p.Glu1004Lys)	BRCA1	E1004K	Hereditary cancer-predisposing syndrome	VCV000926126	17	41244538	17	43092521	926126	913905	rs786202534	NC_000017.11:43092520:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1004	BRCA1
NM_007294.4(BRCA1):c.3010G>C (p.Glu1004Gln)	BRCA1	E1004Q	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000185883	17	41244538	17	43092521	185883	184991	rs786202534	NC_000017.11:43092520:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1004	BRCA1
NM_007294.4(BRCA1):c.3009T>G (p.Phe1003Leu)	BRCA1	F1003L	Hereditary breast ovarian cancer syndrome	VCV002811089	17	41244539	17	43092522	2811089	2975602	NA	NC_000017.11:43092521:A:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1003	BRCA1
NM_007294.4(BRCA1):c.3008T>C (p.Phe1003Ser)	BRCA1	F1003S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000822568	17	41244540	17	43092523	822568	813762	rs1344422504	NC_000017.11:43092522:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1003	BRCA1
NM_007294.4(BRCA1):c.3005A>G (p.Asn1002Ser)	BRCA1	N1002S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069955	17	41244543	17	43092526	3069955	3233530	NA	NC_000017.11:43092525:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1002	BRCA1
NM_007294.4(BRCA1):c.3005A>T (p.Asn1002Ile)	BRCA1	N1002I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462597	17	41244543	17	43092526	462597	468157	rs1555588553	NC_000017.11:43092525:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1002	BRCA1
NM_007294.4(BRCA1):c.3004A>G (p.Asn1002Asp)	BRCA1	N1002D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000186062	17	41244544	17	43092527	186062	184993	rs786202665	NC_000017.11:43092526:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1002	BRCA1
NM_007294.4(BRCA1):c.3001G>A (p.Glu1001Lys)	BRCA1	E1001K	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000822554	17	41244547	17	43092530	822554	813763	rs886038007	NC_000017.11:43092529:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1001	BRCA1
NM_007294.4(BRCA1):c.3000G>C (p.Glu1000Asp)	BRCA1	E1000D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000628971	17	41244548	17	43092531	628971	618623	rs748410422	NC_000017.11:43092530:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1000	BRCA1
NM_007294.4(BRCA1):c.2999A>T (p.Glu1000Val)	BRCA1	E1000V	Hereditary cancer-predisposing syndrome	VCV003226127	17	41244549	17	43092532	3226127	3387191	NA	NC_000017.11:43092531:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1000	BRCA1
NM_007294.4(BRCA1):c.2999A>G (p.Glu1000Gly)	BRCA1	E1000G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409306	17	41244549	17	43092532	409306	402694	rs1060502330	NC_000017.11:43092531:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1000	BRCA1
NM_007294.4(BRCA1):c.2998G>C (p.Glu1000Gln)	BRCA1	E1000Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001369424	17	41244550	17	43092533	1369424	1414437	rs80357124	NC_000017.11:43092532:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1000	BRCA1
NM_007294.4(BRCA1):c.2998G>A (p.Glu1000Lys)	BRCA1	E1000K	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000054742	17	41244550	17	43092533	54742	69409	rs80357124	NC_000017.11:43092532:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	1000	BRCA1
NM_007294.4(BRCA1):c.2996T>C (p.Leu999Pro)	BRCA1	L999P	Hereditary cancer-predisposing syndrome	VCV003261462	17	41244552	17	43092535	3261462	3424231	NA	NC_000017.11:43092534:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	999	BRCA1
NM_007294.4(BRCA1):c.2996T>A (p.Leu999Gln)	BRCA1	L999Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003072366	17	41244552	17	43092535	3072366	3230807	NA	NC_000017.11:43092534:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	999	BRCA1
NM_007294.4(BRCA1):c.2996T>G (p.Leu999Arg)	BRCA1	L999R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232042	17	41244552	17	43092535	232042	236039	rs876659514	NC_000017.11:43092534:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	999	BRCA1
NM_007294.4(BRCA1):c.2993T>G (p.Leu998Arg)	BRCA1	L998R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000648468	17	41244555	17	43092538	648468	645991	rs1567793330	NC_000017.11:43092537:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	998	BRCA1
NM_007294.4(BRCA1):c.2993T>A (p.Leu998Gln)	BRCA1	L998Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000628929	17	41244555	17	43092538	628929	618624	rs1567793330	NC_000017.11:43092537:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	998	BRCA1
NM_007294.4(BRCA1):c.2992C>G (p.Leu998Val)	BRCA1	L998V	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000231296	17	41244556	17	43092539	231296	236040	rs876659077	NC_000017.11:43092538:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	998	BRCA1
NM_007294.4(BRCA1):c.2990A>G (p.Asn997Ser)	BRCA1	N997S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000822444	17	41244558	17	43092541	822444	813764	rs1597866298	NC_000017.11:43092540:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	997	BRCA1
NM_007294.4(BRCA1):c.2988A>T (p.Lys996Asn)	BRCA1	K996N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002061699	17	41244560	17	43092543	2061699	2120847	NA	NC_000017.11:43092542:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	996	BRCA1
NM_007294.4(BRCA1):c.2987A>G (p.Lys996Arg)	BRCA1	K996R	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000186373	17	41244561	17	43092544	186373	184994	rs786202898	NC_000017.11:43092543:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	996	BRCA1
NM_007294.4(BRCA1):c.2985G>T (p.Lys995Asn)	BRCA1	K995N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531400	17	41244563	17	43092546	531400	531274	rs1555588591	NC_000017.11:43092545:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	995	BRCA1
NM_007294.4(BRCA1):c.2984A>C (p.Lys995Thr)	BRCA1	K995T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001464395	17	41244564	17	43092547	1464395	1436065	rs1567793358	NC_000017.11:43092546:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	995	BRCA1
NM_007294.4(BRCA1):c.2983A>G (p.Lys995Glu)	BRCA1	K995E	Hereditary cancer-predisposing syndrome	VCV001798417	17	41244565	17	43092548	1798417	1856557	NA	NC_000017.11:43092547:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	995	BRCA1
NM_007294.4(BRCA1):c.2983A>C (p.Lys995Gln)	BRCA1	K995Q	Hereditary cancer-predisposing syndrome	VCV000822428	17	41244565	17	43092548	822428	813765	rs879255315	NC_000017.11:43092547:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	995	BRCA1
NM_007294.4(BRCA1):c.2981G>T (p.Cys994Phe)	BRCA1	C994F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000655973	17	41244567	17	43092550	655973	645993	rs1238452758	NC_000017.11:43092549:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	994	BRCA1
NM_007294.4(BRCA1):c.2981G>A (p.Cys994Tyr)	BRCA1	C994Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000482925	17	41244567	17	43092550	482925	478693	rs1238452758	NC_000017.11:43092549:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	994	BRCA1
NM_007294.4(BRCA1):c.2980T>G (p.Cys994Gly)	BRCA1	C994G	Hereditary breast ovarian cancer syndrome	VCV002729595	17	41244568	17	43092551	2729595	2889637	NA	NC_000017.11:43092550:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	994	BRCA1
NM_007294.4(BRCA1):c.2980T>C (p.Cys994Arg)	BRCA1	C994R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000193694	17	41244568	17	43092551	193694	190857	rs144853230	NC_000017.11:43092550:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	994	BRCA1
NM_007294.4(BRCA1):c.2980T>A (p.Cys994Ser)	BRCA1	C994S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000156190	17	41244568	17	43092551	156190	165989	rs144853230	NC_000017.11:43092550:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	994	BRCA1
NM_007294.4(BRCA1):c.2975C>T (p.Thr992Ile)	BRCA1	T992I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002105545	17	41244573	17	43092556	2105545	2169897	NA	NC_000017.11:43092555:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	992	BRCA1
NM_007294.4(BRCA1):c.2973A>C (p.Lys991Asn)	BRCA1	K991N	Hereditary cancer-predisposing syndrome	VCV000233853	17	41244575	17	43092558	233853	236041	rs876660683	NC_000017.11:43092557:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	991	BRCA1
NM_007294.4(BRCA1):c.2969T>C (p.Val990Ala)	BRCA1	V990A	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000233926	17	41244579	17	43092562	233926	236042	rs760588785	NC_000017.11:43092561:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	990	BRCA1
NM_007294.4(BRCA1):c.2968G>A (p.Val990Ile)	BRCA1	V990I	Hereditary cancer-predisposing syndrome	VCV000054734	17	41244580	17	43092563	54734	69401	rs397509029	NC_000017.11:43092562:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	990	BRCA1
NM_007294.4(BRCA1):c.2967T>G (p.Phe989Leu)	BRCA1	F989L	Hereditary cancer-predisposing syndrome	VCV000822379	17	41244581	17	43092564	822379	813766	rs876659270	NC_000017.11:43092563:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	989	BRCA1
NM_007294.4(BRCA1):c.2967T>A (p.Phe989Leu)	BRCA1	F989L	Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000231629	17	41244581	17	43092564	231629	236043	rs876659270	NC_000017.11:43092563:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	989	BRCA1
NM_007294.4(BRCA1):c.2963C>T (p.Ser988Leu)	BRCA1	S988L	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037494	17	41244585	17	43092568	37494	46050	rs397507206	NC_000017.11:43092567:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	988	BRCA1
NM_007294.4(BRCA1):c.2960A>G (p.Lys987Arg)	BRCA1	K987R	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000232789	17	41244588	17	43092571	232789	236044	rs876659990	NC_000017.11:43092570:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	987	BRCA1
NM_007294.4(BRCA1):c.2959A>G (p.Lys987Glu)	BRCA1	K987E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000240784	17	41244589	17	43092572	240784	242789	rs878854941	NC_000017.11:43092571:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	987	BRCA1
NM_007294.4(BRCA1):c.2957T>C (p.Ile986Thr)	BRCA1	I986T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069231	17	41244591	17	43092574	3069231	3229858	NA	NC_000017.11:43092573:A:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	986	BRCA1
NM_007294.4(BRCA1):c.2956A>C (p.Ile986Leu)	BRCA1	I986L	Hereditary breast ovarian cancer syndrome	VCV002749184	17	41244592	17	43092575	2749184	2912525	NA	NC_000017.11:43092574:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	986	BRCA1
NM_007294.4(BRCA1):c.2954C>T (p.Pro985Leu)	BRCA1	P985L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002813102	17	41244594	17	43092577	2813102	2972904	NA	NC_000017.11:43092576:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	985	BRCA1
NM_007294.4(BRCA1):c.2953C>T (p.Pro985Ser)	BRCA1	P985S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000496360	17	41244595	17	43092578	496360	487722	rs1555588649	NC_000017.11:43092577:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	985	BRCA1
NM_007294.4(BRCA1):c.2951T>C (p.Phe984Ser)	BRCA1	F984S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002697490	17	41244597	17	43092580	2697490	2864887	NA	NC_000017.11:43092579:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Feb 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	984	BRCA1
NM_007294.4(BRCA1):c.2950T>C (p.Phe984Leu)	BRCA1	F984L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000822349	17	41244598	17	43092581	822349	813767	rs1597866542	NC_000017.11:43092580:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	984	BRCA1
NM_007294.4(BRCA1):c.2948T>G (p.Leu983Arg)	BRCA1	L983R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001367257	17	41244600	17	43092583	1367257	1404978	rs2154350949	NC_000017.11:43092582:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	983	BRCA1
NM_007294.4(BRCA1):c.2944C>G (p.Pro982Ala)	BRCA1	P982A	Hereditary cancer-predisposing syndrome	VCV001692962	17	41244604	17	43092587	1692962	1685402	rs776568544	NC_000017.11:43092586:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	982	BRCA1
NM_007294.4(BRCA1):c.2942C>A (p.Pro981Gln)	BRCA1	P981Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000231209	17	41244606	17	43092589	231209	236046	rs876659025	NC_000017.11:43092588:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	981	BRCA1
NM_007294.4(BRCA1):c.2941C>G (p.Pro981Ala)	BRCA1	P981A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002683815	17	41244607	17	43092590	2683815	2844853	NA	NC_000017.11:43092589:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Sep 1, 2023	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	981	BRCA1
NM_007294.4(BRCA1):c.2941C>A (p.Pro981Thr)	BRCA1	P981T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531238	17	41244607	17	43092590	531238	531587	rs1555588677	NC_000017.11:43092589:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	981	BRCA1
NM_007294.4(BRCA1):c.2939T>C (p.Ile980Thr)	BRCA1	I980T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002131880	17	41244609	17	43092592	2131880	2189868	NA	NC_000017.11:43092591:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	980	BRCA1
NM_007294.4(BRCA1):c.2936G>T (p.Arg979Leu)	BRCA1	R979L	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000801068	17	41244612	17	43092595	801068	789624	rs80356985	NC_000017.11:43092594:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	979	BRCA1
NM_007294.4(BRCA1):c.2936G>A (p.Arg979His)	BRCA1	R979H	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054728	17	41244612	17	43092595	54728	69395	rs80356985	NC_000017.11:43092594:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	979	BRCA1
NM_007294.4(BRCA1):c.2935C>G (p.Arg979Gly)	BRCA1	R979G	Hereditary breast ovarian cancer syndrome	VCV002859985	17	41244613	17	43092596	2859985	3028622	NA	NC_000017.11:43092595:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	979	BRCA1
NM_007294.4(BRCA1):c.2935C>A (p.Arg979Ser)	BRCA1	R979S	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182078	17	41244613	17	43092596	182078	180850	rs80356970	NC_000017.11:43092595:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	979	BRCA1
NM_007294.4(BRCA1):c.2935C>T (p.Arg979Cys)	BRCA1	R979C	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054727	17	41244613	17	43092596	54727	69394	rs80356970	NC_000017.11:43092595:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	979	BRCA1
NM_007294.4(BRCA1):c.2933A>G (p.Tyr978Cys)	BRCA1	Y978C	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216659	17	41244615	17	43092598	216659	213321	rs863224756	NC_000017.11:43092597:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	978	BRCA1
NM_007294.4(BRCA1):c.2932T>C (p.Tyr978His)	BRCA1	Y978H	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232085	17	41244616	17	43092599	232085	236047	rs876659545	NC_000017.11:43092598:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	978	BRCA1
NM_007294.4(BRCA1):c.2930C>T (p.Pro977Leu)	BRCA1	P977L	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	VCV000409337	17	41244618	17	43092601	409337	401997	rs141465583	NC_000017.11:43092600:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	977	BRCA1
NM_007294.4(BRCA1):c.2929C>G (p.Pro977Ala)	BRCA1	P977A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000927296	17	41244619	17	43092602	927296	913907	rs1064794043	NC_000017.11:43092601:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	977	BRCA1
NM_007294.4(BRCA1):c.2929C>T (p.Pro977Ser)	BRCA1	P977S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000419688	17	41244619	17	43092602	419688	409987	rs1064794043	NC_000017.11:43092601:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	977	BRCA1
NM_007294.4(BRCA1):c.2924A>G (p.Gln975Arg)	BRCA1	Q975R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002113266	17	41244624	17	43092607	2113266	2164554	NA	NC_000017.11:43092606:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	975	BRCA1
NM_007294.4(BRCA1):c.2923C>A (p.Gln975Lys)	BRCA1	Q975K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001478400	17	41244625	17	43092608	1478400	1351907	rs80357497	NC_000017.11:43092607:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	975	BRCA1
NM_007294.4(BRCA1):c.2922A>C (p.Leu974Phe)	BRCA1	L974F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000182151	17	41244626	17	43092609	182151	180851	rs730881487	NC_000017.11:43092608:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	974	BRCA1
NM_007294.4(BRCA1):c.2921T>C (p.Leu974Ser)	BRCA1	L974S	Hereditary cancer-predisposing syndrome	VCV000054720	17	41244627	17	43092610	54720	69387	rs80356872	NC_000017.11:43092609:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	974	BRCA1
NM_007294.4(BRCA1):c.2918T>G (p.Leu973Arg)	BRCA1	L973R	not provided	VCV002681806	17	41244630	17	43092613	2681806	2842845	NA	NC_000017.11:43092612:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	973	BRCA1
NM_007294.4(BRCA1):c.2917C>A (p.Leu973Ile)	BRCA1	L973I	not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000577416	17	41244631	17	43092614	577416	574476	rs80357080	NC_000017.11:43092613:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	973	BRCA1
NM_007294.4(BRCA1):c.2917C>G (p.Leu973Val)	BRCA1	L973V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054717	17	41244631	17	43092614	54717	69384	rs80357080	NC_000017.11:43092613:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	973	BRCA1
NM_007294.4(BRCA1):c.2915G>A (p.Gly972Glu)	BRCA1	G972E	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000142793	17	41244633	17	43092616	142793	152507	rs587782721	NC_000017.11:43092615:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	972	BRCA1
NM_007294.4(BRCA1):c.2913T>A (p.His971Gln)	BRCA1	H971Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001384181	17	41244635	17	43092618	1384181	1447777	rs786203804	NC_000017.11:43092617:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	971	BRCA1
NM_007294.4(BRCA1):c.2913T>G (p.His971Gln)	BRCA1	H971Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000638983	17	41244635	17	43092618	638983	645994	rs786203804	NC_000017.11:43092617:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	971	BRCA1
NM_007294.4(BRCA1):c.2912A>G (p.His971Arg)	BRCA1	H971R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000628452	17	41244636	17	43092619	628452	618626	rs1567793641	NC_000017.11:43092618:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	971	BRCA1
NM_007294.4(BRCA1):c.2911C>T (p.His971Tyr)	BRCA1	H971Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000919499	17	41244637	17	43092620	919499	913909	rs80357478	NC_000017.11:43092619:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	971	BRCA1
NM_007294.4(BRCA1):c.2911C>G (p.His971Asp)	BRCA1	H971D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431233	17	41244637	17	43092620	431233	424829	rs80357478	NC_000017.11:43092619:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	971	BRCA1
NM_007294.4(BRCA1):c.2911C>A (p.His971Asn)	BRCA1	H971N	Hereditary cancer-predisposing syndrome	VCV000054714	17	41244637	17	43092620	54714	69381	rs80357478	NC_000017.11:43092619:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	971	BRCA1
NM_007294.4(BRCA1):c.2910A>C (p.Lys970Asn)	BRCA1	K970N	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000096910	17	41244638	17	43092621	96910	102813	rs431825394	NC_000017.11:43092620:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	970	BRCA1
NM_007294.4(BRCA1):c.2909A>G (p.Lys970Arg)	BRCA1	K970R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000647254	17	41244639	17	43092622	647254	645995	rs756559408	NC_000017.11:43092621:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	970	BRCA1
NM_007294.4(BRCA1):c.2909A>T (p.Lys970Ile)	BRCA1	K970I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000409365	17	41244639	17	43092622	409365	402071	rs756559408	NC_000017.11:43092621:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	970	BRCA1
NM_007294.4(BRCA1):c.2908A>G (p.Lys970Glu)	BRCA1	K970E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630058	17	41244640	17	43092623	630058	618627	rs1567793674	NC_000017.11:43092622:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	970	BRCA1
NM_007294.4(BRCA1):c.2907T>A (p.Asn969Lys)	BRCA1	N969K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001015821	17	41244641	17	43092624	1015821	1012774	rs2053674031	NC_000017.11:43092623:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	969	BRCA1
NM_007294.4(BRCA1):c.2906A>G (p.Asn969Ser)	BRCA1	N969S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000567051	17	41244642	17	43092625	567051	571449	rs1567793695	NC_000017.11:43092624:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	969	BRCA1
NM_007294.4(BRCA1):c.2905A>T (p.Asn969Tyr)	BRCA1	N969Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001510721	17	41244643	17	43092626	1510721	1465398	rs587781641	NC_000017.11:43092625:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	969	BRCA1
NM_007294.4(BRCA1):c.2905A>G (p.Asn969Asp)	BRCA1	N969D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000141301	17	41244643	17	43092626	141301	151015	rs587781641	NC_000017.11:43092625:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	969	BRCA1
NM_007294.4(BRCA1):c.2903C>A (p.Pro968Gln)	BRCA1	P968Q	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV002692278	17	41244645	17	43092628	2692278	2853281	NA	NC_000017.11:43092627:G:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Dec 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	968	BRCA1
NM_007294.4(BRCA1):c.2902C>G (p.Pro968Ala)	BRCA1	P968A	Hereditary cancer-predisposing syndrome	VCV001797469	17	41244646	17	43092629	1797469	1854387	NA	NC_000017.11:43092628:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	968	BRCA1
NM_007294.4(BRCA1):c.2902C>T (p.Pro968Ser)	BRCA1	P968S	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000856943	17	41244646	17	43092629	856943	845412	rs1182090591	NC_000017.11:43092628:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	968	BRCA1
NM_007294.4(BRCA1):c.2900C>T (p.Thr967Ile)	BRCA1	T967I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821968	17	41244648	17	43092631	821968	813769	rs1249532992	NC_000017.11:43092630:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	967	BRCA1
NM_007294.4(BRCA1):c.2899A>T (p.Thr967Ser)	BRCA1	T967S	Hereditary cancer-predisposing syndrome	VCV000054711	17	41244649	17	43092632	54711	69378	rs273899690	NC_000017.11:43092631:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	967	BRCA1
NM_007294.4(BRCA1):c.2897T>C (p.Ile966Thr)	BRCA1	I966T	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000246006	17	41244651	17	43092634	246006	245039	rs879254045	NC_000017.11:43092633:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	966	BRCA1
NM_007294.4(BRCA1):c.2896A>G (p.Ile966Val)	BRCA1	I966V	Hereditary cancer-predisposing syndrome	VCV000921416	17	41244652	17	43092635	921416	913910	rs1274520145	NC_000017.11:43092634:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	966	BRCA1
NM_007294.4(BRCA1):c.2894T>G (p.Leu965Arg)	BRCA1	L965R	Hereditary cancer-predisposing syndrome	VCV000233849	17	41244654	17	43092637	233849	236049	rs876660682	NC_000017.11:43092636:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	965	BRCA1
NM_007294.4(BRCA1):c.2893C>T (p.Leu965Phe)	BRCA1	L965F	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000857839	17	41244655	17	43092638	857839	845413	rs1060502344	NC_000017.11:43092637:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	965	BRCA1
NM_007294.4(BRCA1):c.2893C>G (p.Leu965Val)	BRCA1	L965V	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000409335	17	41244655	17	43092638	409335	402696	rs1060502344	NC_000017.11:43092637:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	965	BRCA1
NM_007294.4(BRCA1):c.2891G>A (p.Gly964Glu)	BRCA1	G964E	Hereditary cancer-predisposing syndrome	VCV000821951	17	41244657	17	43092640	821951	813770	rs1597866960	NC_000017.11:43092639:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	964	BRCA1
NM_007294.4(BRCA1):c.2890G>A (p.Gly964Arg)	BRCA1	G964R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000245974	17	41244658	17	43092641	245974	245040	rs879254027	NC_000017.11:43092640:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	964	BRCA1
NM_007294.4(BRCA1):c.2888C>T (p.Thr963Ile)	BRCA1	T963I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000182077	17	41244660	17	43092643	182077	180852	rs730881443	NC_000017.11:43092642:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	963	BRCA1
NM_007294.4(BRCA1):c.2887A>T (p.Thr963Ser)	BRCA1	T963S	Hereditary breast ovarian cancer syndrome	VCV002841675	17	41244661	17	43092644	2841675	3003612	NA	NC_000017.11:43092643:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	963	BRCA1
NM_007294.4(BRCA1):c.2885A>G (p.Glu962Gly)	BRCA1	E962G	not specified|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000574001	17	41244663	17	43092646	574001	574477	rs780367532	NC_000017.11:43092645:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	962	BRCA1
NM_007294.4(BRCA1):c.2884G>A (p.Glu962Lys)	BRCA1	E962K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054709	17	41244664	17	43092647	54709	69376	rs80356955	NC_000017.11:43092646:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	962	BRCA1
NM_007294.4(BRCA1):c.2883C>A (p.Asn961Lys)	BRCA1	N961K	Hereditary cancer-predisposing syndrome	VCV002585819	17	41244665	17	43092648	2585819	2753379	NA	NC_000017.11:43092647:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	961	BRCA1
NM_007294.4(BRCA1):c.2882A>G (p.Asn961Ser)	BRCA1	N961S	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000246160	17	41244666	17	43092649	246160	245041	rs879254130	NC_000017.11:43092648:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	961	BRCA1
NM_007294.4(BRCA1):c.2881A>G (p.Asn961Asp)	BRCA1	N961D	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV002915514	17	41244667	17	43092650	2915514	3074064	NA	NC_000017.11:43092649:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	961	BRCA1
NM_007294.4(BRCA1):c.2881A>T (p.Asn961Tyr)	BRCA1	N961Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000655201	17	41244667	17	43092650	655201	645996	rs786203786	NC_000017.11:43092649:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	961	BRCA1
NM_007294.4(BRCA1):c.2881A>C (p.Asn961His)	BRCA1	N961H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187504	17	41244667	17	43092650	187504	185000	rs786203786	NC_000017.11:43092649:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	961	BRCA1
NM_007294.4(BRCA1):c.2879G>C (p.Gly960Ala)	BRCA1	G960A	Hereditary cancer-predisposing syndrome	VCV001797141	17	41244669	17	43092652	1797141	1855715	NA	NC_000017.11:43092651:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	960	BRCA1
NM_007294.4(BRCA1):c.2879G>A (p.Gly960Asp)	BRCA1	G960D	Hereditary cancer-predisposing syndrome	VCV000054708	17	41244669	17	43092652	54708	69375	rs397509022	NC_000017.11:43092651:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	960	BRCA1
NM_007294.4(BRCA1):c.2878G>A (p.Gly960Ser)	BRCA1	G960S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481478	17	41244670	17	43092653	481478	478759	rs1555588796	NC_000017.11:43092652:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	960	BRCA1
NM_007294.4(BRCA1):c.2877A>C (p.Arg959Ser)	BRCA1	R959S	Hereditary cancer-predisposing syndrome	VCV000142819	17	41244671	17	43092654	142819	152533	rs587782743	NC_000017.11:43092653:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	959	BRCA1
NM_007294.4(BRCA1):c.2876G>A (p.Arg959Lys)	BRCA1	R959K	Hereditary breast ovarian cancer syndrome	VCV002907521	17	41244672	17	43092655	2907521	3062668	NA	NC_000017.11:43092654:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	959	BRCA1
NM_007294.4(BRCA1):c.2875A>G (p.Arg959Gly)	BRCA1	R959G	Hereditary cancer-predisposing syndrome	VCV000821939	17	41244673	17	43092656	821939	813771	rs1401324575	NC_000017.11:43092655:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	959	BRCA1
NM_007294.4(BRCA1):c.2874C>A (p.Phe958Leu)	BRCA1	F958L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000919191	17	41244674	17	43092657	919191	913911	rs1029207537	NC_000017.11:43092656:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	958	BRCA1
NM_007294.4(BRCA1):c.2873T>C (p.Phe958Ser)	BRCA1	F958S	Hereditary cancer-predisposing syndrome	VCV001797075	17	41244675	17	43092658	1797075	1855649	NA	NC_000017.11:43092657:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	958	BRCA1
NM_007294.4(BRCA1):c.2872T>C (p.Phe958Leu)	BRCA1	F958L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186606	17	41244676	17	43092659	186606	185001	rs80356878	NC_000017.11:43092658:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	958	BRCA1
NM_007294.4(BRCA1):c.2872T>A (p.Phe958Ile)	BRCA1	F958I	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054706	17	41244676	17	43092659	54706	69373	rs80356878	NC_000017.11:43092658:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	958	BRCA1
NM_007294.4(BRCA1):c.2870A>C (p.Gln957Pro)	BRCA1	Q957P	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	VCV000626902	17	41244678	17	43092661	626902	615143	rs1567793946	NC_000017.11:43092660:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	957	BRCA1
NM_007294.4(BRCA1):c.2867C>G (p.Ser956Cys)	BRCA1	S956C	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409320	17	41244681	17	43092664	409320	402085	rs1060502336	NC_000017.11:43092663:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	956	BRCA1
NM_007294.4(BRCA1):c.2866T>C (p.Ser956Pro)	BRCA1	S956P	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002130530	17	41244682	17	43092665	2130530	2187658	NA	NC_000017.11:43092664:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	956	BRCA1
NM_007294.4(BRCA1):c.2863T>C (p.Ser955Pro)	BRCA1	S955P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001332354	17	41244685	17	43092668	1332354	1323072	rs2154355696	NC_000017.11:43092667:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	955	BRCA1
NM_007294.4(BRCA1):c.2861T>C (p.Leu954Pro)	BRCA1	L954P	Hereditary cancer-predisposing syndrome	VCV002585820	17	41244687	17	43092670	2585820	2753380	NA	NC_000017.11:43092669:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	954	BRCA1
NM_007294.4(BRCA1):c.2861T>A (p.Leu954Gln)	BRCA1	L954Q	Hereditary cancer-predisposing syndrome	VCV001796968	17	41244687	17	43092670	1796968	1855543	NA	NC_000017.11:43092669:A:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	954	BRCA1
NM_007294.4(BRCA1):c.2860C>G (p.Leu954Val)	BRCA1	L954V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002736386	17	41244688	17	43092671	2736386	2895077	NA	NC_000017.11:43092670:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	954	BRCA1
NM_007294.4(BRCA1):c.2857T>G (p.Cys953Gly)	BRCA1	C953G	Hereditary cancer-predisposing syndrome	VCV003261498	17	41244691	17	43092674	3261498	3424266	NA	NC_000017.11:43092673:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	953	BRCA1
NM_007294.4(BRCA1):c.2857T>C (p.Cys953Arg)	BRCA1	C953R	Hereditary cancer-predisposing syndrome	VCV000481447	17	41244691	17	43092674	481447	479380	rs1555588840	NC_000017.11:43092673:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	953	BRCA1
NM_007294.4(BRCA1):c.2851A>G (p.Arg951Gly)	BRCA1	R951G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000649341	17	41244697	17	43092680	649341	645998	rs1347533994	NC_000017.11:43092679:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	951	BRCA1
NM_007294.4(BRCA1):c.2849C>A (p.Ser950Tyr)	BRCA1	S950Y	Hereditary cancer-predisposing syndrome	VCV001796799	17	41244699	17	43092682	1796799	1855374	NA	NC_000017.11:43092681:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	950	BRCA1
NM_007294.4(BRCA1):c.2849C>T (p.Ser950Phe)	BRCA1	S950F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000462595	17	41244699	17	43092682	462595	467722	rs1555588847	NC_000017.11:43092681:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	950	BRCA1
NM_007294.4(BRCA1):c.2846G>A (p.Gly949Asp)	BRCA1	G949D	Hereditary cancer-predisposing syndrome|not provided	VCV000182150	17	41244702	17	43092685	182150	180854	rs730881486	NC_000017.11:43092684:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	949	BRCA1
NM_007294.4(BRCA1):c.2845G>A (p.Gly949Ser)	BRCA1	G949S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000579135	17	41244703	17	43092686	579135	569147	rs1324818767	NC_000017.11:43092685:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	949	BRCA1
NM_007294.4(BRCA1):c.2842G>A (p.Gly948Arg)	BRCA1	G948R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001412685	17	41244706	17	43092689	1412685	1356283	rs2154356683	NC_000017.11:43092688:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	948	BRCA1
NM_007294.4(BRCA1):c.2841A>C (p.Lys947Asn)	BRCA1	K947N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001378482	17	41244707	17	43092690	1378482	1492912	rs864622618	NC_000017.11:43092689:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	947	BRCA1
NM_007294.4(BRCA1):c.2841A>T (p.Lys947Asn)	BRCA1	K947N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000220648	17	41244707	17	43092690	220648	222663	rs864622618	NC_000017.11:43092689:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	947	BRCA1
NM_007294.4(BRCA1):c.2840A>G (p.Lys947Arg)	BRCA1	K947R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481455	17	41244708	17	43092691	481455	479381	rs778118145	NC_000017.11:43092690:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	947	BRCA1
NM_007294.4(BRCA1):c.2836A>G (p.Ile946Val)	BRCA1	I946V	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821790	17	41244712	17	43092695	821790	813775	rs876660901	NC_000017.11:43092694:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	946	BRCA1
NM_007294.4(BRCA1):c.2836A>T (p.Ile946Phe)	BRCA1	I946F	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000234176	17	41244712	17	43092695	234176	236051	rs876660901	NC_000017.11:43092694:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	946	BRCA1
NM_007294.4(BRCA1):c.2834G>C (p.Ser945Thr)	BRCA1	S945T	not specified	VCV002445711	17	41244714	17	43092697	2445711	915055	rs746727823	NC_000017.11:43092696:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	945	BRCA1
NM_007294.4(BRCA1):c.2833A>G (p.Ser945Gly)	BRCA1	S945G	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000619789	17	41244715	17	43092698	619789	611239	rs1567794085	NC_000017.11:43092697:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	945	BRCA1
NM_007294.4(BRCA1):c.2831G>A (p.Cys944Tyr)	BRCA1	C944Y	not specified|Hereditary cancer-predisposing syndrome	VCV000230809	17	41244717	17	43092700	230809	236052	rs770769275	NC_000017.11:43092699:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	944	BRCA1
NM_007294.4(BRCA1):c.2830T>G (p.Cys944Gly)	BRCA1	C944G	not provided|Hereditary cancer-predisposing syndrome	VCV001183948	17	41244718	17	43092701	1183948	1173007	rs1064795603	NC_000017.11:43092700:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	944	BRCA1
NM_007294.4(BRCA1):c.2830T>A (p.Cys944Ser)	BRCA1	C944S	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000422172	17	41244718	17	43092701	422172	409988	rs1064795603	NC_000017.11:43092700:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	944	BRCA1
NM_007294.4(BRCA1):c.2828A>G (p.Lys943Arg)	BRCA1	K943R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001040298	17	41244720	17	43092703	1040298	1033316	rs2053689894	NC_000017.11:43092702:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	943	BRCA1
NM_007294.4(BRCA1):c.2824_2825delinsAA (p.Ala942Asn)	BRCA1	A942N	Hereditary cancer-predisposing syndrome	VCV003226123	17	41244723 - 41244724	17	43092706 - 43092707	3226123	3387187	NA	NC_000017.11:43092705:GC:TT	Indel	missense variant|intron variant	Uncertain significance	Aug 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	942	BRCA1
NM_007294.4(BRCA1):c.2825C>A (p.Ala942Asp)	BRCA1	A942D	Hereditary cancer-predisposing syndrome	VCV001796495	17	41244723	17	43092706	1796495	1849398	NA	NC_000017.11:43092705:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	942	BRCA1
NM_007294.4(BRCA1):c.2824G>A (p.Ala942Thr)	BRCA1	A942T	Hereditary cancer-predisposing syndrome	VCV001796491	17	41244724	17	43092707	1796491	1849395	NA	NC_000017.11:43092706:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	942	BRCA1
NM_007294.4(BRCA1):c.2824G>C (p.Ala942Pro)	BRCA1	A942P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001386762	17	41244724	17	43092707	1386762	1357889	rs2154357673	NC_000017.11:43092706:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	942	BRCA1
NM_007294.4(BRCA1):c.2823T>G (p.Asn941Lys)	BRCA1	N941K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000661501	17	41244725	17	43092708	661501	646000	rs1465630651	NC_000017.11:43092707:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	941	BRCA1
NM_007294.4(BRCA1):c.2822A>C (p.Asn941Thr)	BRCA1	N941T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952178	17	41244726	17	43092709	952178	928301	rs776512377	NC_000017.11:43092708:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	941	BRCA1
NM_007294.4(BRCA1):c.2822A>G (p.Asn941Ser)	BRCA1	N941S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000485402	17	41244726	17	43092709	485402	479382	rs776512377	NC_000017.11:43092708:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	941	BRCA1
NM_007294.4(BRCA1):c.2820T>A (p.Asp940Glu)	BRCA1	D940E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001796448	17	41244728	17	43092711	1796448	1852883	NA	NC_000017.11:43092710:A:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	940	BRCA1
NM_007294.4(BRCA1):c.2819A>G (p.Asp940Gly)	BRCA1	D940G	Hereditary cancer-predisposing syndrome	VCV000928128	17	41244729	17	43092712	928128	913913	rs745954644	NC_000017.11:43092711:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	940	BRCA1
NM_007294.4(BRCA1):c.2818G>C (p.Asp940His)	BRCA1	D940H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630900	17	41244730	17	43092713	630900	618628	rs80357077	NC_000017.11:43092712:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	940	BRCA1
NM_007294.4(BRCA1):c.2818G>T (p.Asp940Tyr)	BRCA1	D940Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054689	17	41244730	17	43092713	54689	69356	rs80357077	NC_000017.11:43092712:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	940	BRCA1
NM_007294.4(BRCA1):c.2816T>C (p.Val939Ala)	BRCA1	V939A	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531209	17	41244732	17	43092715	531209	531277	rs1555588894	NC_000017.11:43092714:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	939	BRCA1
NM_007294.4(BRCA1):c.2815G>T (p.Val939Phe)	BRCA1	V939F	Hereditary breast ovarian cancer syndrome|not specified	VCV002501192	17	41244733	17	43092716	2501192	2524084	NA	NC_000017.11:43092715:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	939	BRCA1
NM_007294.4(BRCA1):c.2815G>A (p.Val939Ile)	BRCA1	V939I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000462594	17	41244733	17	43092716	462594	468167	rs1555588896	NC_000017.11:43092715:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	939	BRCA1
NM_007294.4(BRCA1):c.2813C>T (p.Pro938Leu)	BRCA1	P938L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000419626	17	41244735	17	43092718	419626	409989	rs1064793999	NC_000017.11:43092717:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	938	BRCA1
NM_007294.4(BRCA1):c.2812C>T (p.Pro938Ser)	BRCA1	P938S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000801066	17	41244736	17	43092719	801066	789626	rs1597867531	NC_000017.11:43092718:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	938	BRCA1
NM_007294.4(BRCA1):c.2809A>G (p.Lys937Glu)	BRCA1	K937E	Hereditary cancer-predisposing syndrome	VCV001171872	17	41244739	17	43092722	1171872	1161358	rs1555588915	NC_000017.11:43092721:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	937	BRCA1
NM_007294.4(BRCA1):c.2808T>G (p.Asp936Glu)	BRCA1	D936E	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|Familial cancer of breast	VCV000182149	17	41244740	17	43092723	182149	180855	rs730881485	NC_000017.11:43092722:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	936	BRCA1
NM_007294.4(BRCA1):c.2806G>A (p.Asp936Asn)	BRCA1	D936N	Hereditary cancer-predisposing syndrome	VCV001796271	17	41244742	17	43092725	1796271	1852706	NA	NC_000017.11:43092724:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	936	BRCA1
NM_007294.4(BRCA1):c.2804A>G (p.Lys935Arg)	BRCA1	K935R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002066045	17	41244744	17	43092727	2066045	2128730	NA	NC_000017.11:43092726:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	935	BRCA1
NM_007294.4(BRCA1):c.2803A>C (p.Lys935Gln)	BRCA1	K935Q	Hereditary cancer-predisposing syndrome	VCV002565348	17	41244745	17	43092728	2565348	2732321	NA	NC_000017.11:43092727:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	935	BRCA1
NM_007294.4(BRCA1):c.2801A>G (p.Gln934Arg)	BRCA1	Q934R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001346585	17	41244747	17	43092730	1346585	1456547	rs2154358844	NC_000017.11:43092729:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	934	BRCA1
NM_007294.4(BRCA1):c.2800C>G (p.Gln934Glu)	BRCA1	Q934E	Hereditary cancer-predisposing syndrome	VCV001796215	17	41244748	17	43092731	1796215	1852650	NA	NC_000017.11:43092730:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	934	BRCA1
NM_007294.4(BRCA1):c.2798G>C (p.Gly933Ala)	BRCA1	G933A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233288	17	41244750	17	43092733	233288	236054	rs80356941	NC_000017.11:43092732:C:G	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	933	BRCA1
NM_007294.4(BRCA1):c.2798G>A (p.Gly933Asp)	BRCA1	G933D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000037490	17	41244750	17	43092733	37490	46046	rs80356941	NC_000017.11:43092732:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	933	BRCA1
NM_007294.4(BRCA1):c.2797G>C (p.Gly933Arg)	BRCA1	G933R	Hereditary breast ovarian cancer syndrome	VCV002746250	17	41244751	17	43092734	2746250	2911760	NA	NC_000017.11:43092733:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	933	BRCA1
NM_007294.4(BRCA1):c.2797G>T (p.Gly933Cys)	BRCA1	G933C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001464104	17	41244751	17	43092734	1464104	1342460	rs2154359101	NC_000017.11:43092733:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	933	BRCA1
NM_007294.4(BRCA1):c.2795T>C (p.Val932Ala)	BRCA1	V932A	Hereditary cancer-predisposing syndrome|not specified	VCV001677157	17	41244753	17	43092736	1677157	1668789	rs2154359210	NC_000017.11:43092735:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	932	BRCA1
NM_007294.4(BRCA1):c.2794G>T (p.Val932Phe)	BRCA1	V932F	Hereditary cancer-predisposing syndrome	VCV000821817	17	41244754	17	43092737	821817	813776	rs762589415	NC_000017.11:43092736:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	932	BRCA1
NM_007294.4(BRCA1):c.2791G>A (p.Val931Met)	BRCA1	V931M	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630796	17	41244757	17	43092740	630796	618629	rs763639161	NC_000017.11:43092739:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	931	BRCA1
NM_007294.4(BRCA1):c.2791G>T (p.Val931Leu)	BRCA1	V931L	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome	VCV000219899	17	41244757	17	43092740	219899	222664	rs763639161	NC_000017.11:43092739:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	931	BRCA1
NM_007294.4(BRCA1):c.2789C>T (p.Pro930Leu)	BRCA1	P930L	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000054680	17	41244759	17	43092742	54680	69347	rs80357256	NC_000017.11:43092741:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	930	BRCA1
NM_007294.4(BRCA1):c.2788C>A (p.Pro930Thr)	BRCA1	P930T	Hereditary breast ovarian cancer syndrome	VCV002885713	17	41244760	17	43092743	2885713	3043718	NA	NC_000017.11:43092742:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	930	BRCA1
NM_007294.4(BRCA1):c.2783G>T (p.Gly928Val)	BRCA1	G928V	Hereditary cancer-predisposing syndrome	VCV001795965	17	41244765	17	43092748	1795965	1853324	NA	NC_000017.11:43092747:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	928	BRCA1
NM_007294.4(BRCA1):c.2783G>A (p.Gly928Asp)	BRCA1	G928D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000041813	17	41244765	17	43092748	41813	50252	rs202004680	NC_000017.11:43092747:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	928	BRCA1
NM_007294.4(BRCA1):c.2782G>A (p.Gly928Ser)	BRCA1	G928S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054679	17	41244766	17	43092749	54679	69346	rs80356995	NC_000017.11:43092748:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	928	BRCA1
NM_007294.4(BRCA1):c.2780C>T (p.Ala927Val)	BRCA1	A927V	Hereditary breast ovarian cancer syndrome	VCV002739324	17	41244768	17	43092751	2739324	2899677	NA	NC_000017.11:43092750:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	927	BRCA1
NM_007294.4(BRCA1):c.2779G>A (p.Ala927Thr)	BRCA1	A927T	Hereditary breast ovarian cancer syndrome	VCV002823682	17	41244769	17	43092752	2823682	2982196	NA	NC_000017.11:43092751:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	927	BRCA1
NM_007294.4(BRCA1):c.2779G>T (p.Ala927Ser)	BRCA1	A927S	Hereditary breast ovarian cancer syndrome	VCV002820919	17	41244769	17	43092752	2820919	2978164	NA	NC_000017.11:43092751:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	927	BRCA1
NM_007294.4(BRCA1):c.2776A>G (p.Thr926Ala)	BRCA1	T926A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002663975	17	41244772	17	43092755	2663975	2831445	NA	NC_000017.11:43092754:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	926	BRCA1
NM_007294.4(BRCA1):c.2774T>G (p.Ile925Ser)	BRCA1	I925S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002565342	17	41244774	17	43092757	2565342	2732316	NA	NC_000017.11:43092756:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	925	BRCA1
NM_007294.4(BRCA1):c.2774T>C (p.Ile925Thr)	BRCA1	I925T	not provided|Hereditary cancer-predisposing syndrome	VCV000560854	17	41244774	17	43092757	560854	551933	rs1567794296	NC_000017.11:43092756:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	925	BRCA1
NM_007294.4(BRCA1):c.2773A>G (p.Ile925Val)	BRCA1	I925V	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000185111	17	41244775	17	43092758	185111	185005	rs4986847	NC_000017.11:43092757:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	925	BRCA1
NM_007294.4(BRCA1):c.2773A>C (p.Ile925Leu)	BRCA1	I925L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037489	17	41244775	17	43092758	37489	46045	rs4986847	NC_000017.11:43092757:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	925	BRCA1
NM_007294.4(BRCA1):c.2771A>C (p.Asn924Thr)	BRCA1	N924T	Hereditary breast ovarian cancer syndrome	VCV002698209	17	41244777	17	43092760	2698209	2858350	NA	NC_000017.11:43092759:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	924	BRCA1
NM_007294.4(BRCA1):c.2768T>C (p.Val923Ala)	BRCA1	V923A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000861761	17	41244780	17	43092763	861761	845415	rs2053698662	NC_000017.11:43092762:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	923	BRCA1
NM_007294.4(BRCA1):c.2767G>A (p.Val923Ile)	BRCA1	V923I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001426644	17	41244781	17	43092764	1426644	1366317	rs1324340897	NC_000017.11:43092763:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	923	BRCA1
NM_007294.4(BRCA1):c.2765C>T (p.Thr922Ile)	BRCA1	T922I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000187427	17	41244783	17	43092766	187427	185006	rs80357460	NC_000017.11:43092765:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	922	BRCA1
NM_007294.4(BRCA1):c.2765C>G (p.Thr922Arg)	BRCA1	T922R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054676	17	41244783	17	43092766	54676	69343	rs80357460	NC_000017.11:43092765:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	922	BRCA1
NM_007294.4(BRCA1):c.2764A>G (p.Thr922Ala)	BRCA1	T922A	Hereditary cancer-predisposing syndrome	VCV000441359	17	41244784	17	43092767	441359	435145	rs1555588988	NC_000017.11:43092766:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	922	BRCA1
NM_007294.4(BRCA1):c.2763G>C (p.Gln921His)	BRCA1	Q921H	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000993200	17	41244785	17	43092768	993200	981170	rs1057522511	NC_000017.11:43092767:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	921	BRCA1
NM_007294.4(BRCA1):c.2762A>G (p.Gln921Arg)	BRCA1	Q921R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000433702	17	41244786	17	43092769	433702	427556	rs1555588991	NC_000017.11:43092768:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	921	BRCA1
NM_007294.4(BRCA1):c.2761C>G (p.Gln921Glu)	BRCA1	Q921E	Hereditary cancer-predisposing syndrome	VCV001795695	17	41244787	17	43092770	1795695	1853054	NA	NC_000017.11:43092769:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	921	BRCA1
NM_007294.4(BRCA1):c.2761C>A (p.Gln921Lys)	BRCA1	Q921K	Hereditary cancer-predisposing syndrome	VCV000921786	17	41244787	17	43092770	921786	913914	rs80357377	NC_000017.11:43092769:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	921	BRCA1
NM_007294.4(BRCA1):c.2759T>C (p.Val920Ala)	BRCA1	V920A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054672	17	41244789	17	43092772	54672	69339	rs80357008	NC_000017.11:43092771:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	920	BRCA1
NM_007294.4(BRCA1):c.2758G>C (p.Val920Leu)	BRCA1	V920L	Hereditary cancer-predisposing syndrome	VCV001171577	17	41244790	17	43092773	1171577	1161359	rs80357361	NC_000017.11:43092772:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	920	BRCA1
NM_007294.4(BRCA1):c.2758G>T (p.Val920Leu)	BRCA1	V920L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000567742	17	41244790	17	43092773	567742	569152	rs80357361	NC_000017.11:43092772:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	920	BRCA1
NM_007294.4(BRCA1):c.2758G>A (p.Val920Ile)	BRCA1	V920I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037488	17	41244790	17	43092773	37488	46044	rs80357361	NC_000017.11:43092772:C:T	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	920	BRCA1
NM_007294.4(BRCA1):c.2756C>T (p.Pro919Leu)	BRCA1	P919L	Hereditary breast ovarian cancer syndrome	VCV002757634	17	41244792	17	43092775	2757634	2917506	NA	NC_000017.11:43092774:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	919	BRCA1
NM_007294.4(BRCA1):c.2754G>C (p.Lys918Asn)	BRCA1	K918N	Hereditary breast ovarian cancer syndrome	VCV002901511	17	41244794	17	43092777	2901511	3068302	NA	NC_000017.11:43092776:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 21, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	918	BRCA1
NM_007294.4(BRCA1):c.2754G>T (p.Lys918Asn)	BRCA1	K918N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091600	17	41244794	17	43092777	91600	97077	rs398122668	NC_000017.11:43092776:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	918	BRCA1
NM_007294.4(BRCA1):c.2752A>C (p.Lys918Gln)	BRCA1	K918Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054671	17	41244796	17	43092779	54671	69338	rs397509010	NC_000017.11:43092778:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	918	BRCA1
NM_007294.4(BRCA1):c.2751C>G (p.Ile917Met)	BRCA1	I917M	not provided|Hereditary cancer-predisposing syndrome	VCV000821765	17	41244797	17	43092780	821765	813777	rs1597867872	NC_000017.11:43092779:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	917	BRCA1
NM_007294.4(BRCA1):c.2750T>G (p.Ile917Ser)	BRCA1	I917S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000216658	17	41244798	17	43092781	216658	213322	rs587781492	NC_000017.11:43092780:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	917	BRCA1
NM_007294.4(BRCA1):c.2750T>C (p.Ile917Thr)	BRCA1	I917T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000141097	17	41244798	17	43092781	141097	150811	rs587781492	NC_000017.11:43092780:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	917	BRCA1
NM_007294.4(BRCA1):c.2749A>G (p.Ile917Val)	BRCA1	I917V	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000927647	17	41244799	17	43092782	927647	913915	rs1334134701	NC_000017.11:43092781:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	917	BRCA1
NM_007294.4(BRCA1):c.2747A>G (p.Asn916Ser)	BRCA1	N916S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482965	17	41244801	17	43092784	482965	478618	rs864622588	NC_000017.11:43092783:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	916	BRCA1
NM_007294.4(BRCA1):c.2747A>T (p.Asn916Ile)	BRCA1	N916I	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000220573	17	41244801	17	43092784	220573	222665	rs864622588	NC_000017.11:43092783:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	916	BRCA1
NM_007294.4(BRCA1):c.2746A>C (p.Asn916His)	BRCA1	N916H	Hereditary cancer-predisposing syndrome	VCV001171820	17	41244802	17	43092785	1171820	1161360	rs398122666	NC_000017.11:43092784:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	916	BRCA1
NM_007294.4(BRCA1):c.2746A>G (p.Asn916Asp)	BRCA1	N916D	Hereditary cancer-predisposing syndrome	VCV000482936	17	41244802	17	43092785	482936	478619	rs398122666	NC_000017.11:43092784:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	916	BRCA1
NM_007294.4(BRCA1):c.2746A>T (p.Asn916Tyr)	BRCA1	N916Y	Hereditary cancer-predisposing syndrome	VCV000091598	17	41244802	17	43092785	91598	97075	rs398122666	NC_000017.11:43092784:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	916	BRCA1
NM_007294.4(BRCA1):c.2744C>G (p.Ser915Cys)	BRCA1	S915C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001503334	17	41244804	17	43092787	1503334	1401052	rs1222778457	NC_000017.11:43092786:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	915	BRCA1
NM_007294.4(BRCA1):c.2743T>A (p.Ser915Thr)	BRCA1	S915T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001351199	17	41244805	17	43092788	1351199	1407549	rs2154361863	NC_000017.11:43092787:A:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	915	BRCA1
NM_007294.4(BRCA1):c.2741A>G (p.Glu914Gly)	BRCA1	E914G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002148538	17	41244807	17	43092790	2148538	1880866	NA	NC_000017.11:43092789:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	914	BRCA1
NM_007294.4(BRCA1):c.2740G>C (p.Glu914Gln)	BRCA1	E914Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001409056	17	41244808	17	43092791	1409056	1496845	rs80357419	NC_000017.11:43092790:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	914	BRCA1
NM_007294.4(BRCA1):c.2740G>A (p.Glu914Lys)	BRCA1	E914K	Hereditary cancer-predisposing syndrome	VCV000479250	17	41244808	17	43092791	479250	478620	rs80357419	NC_000017.11:43092790:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	914	BRCA1
NM_007294.4(BRCA1):c.2739T>A (p.Asn913Lys)	BRCA1	N913K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054665	17	41244809	17	43092792	54665	69332	rs273899688	NC_000017.11:43092791:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	913	BRCA1
NM_007294.4(BRCA1):c.2738A>C (p.Asn913Thr)	BRCA1	N913T	Hereditary breast ovarian cancer syndrome	VCV002765149	17	41244810	17	43092793	2765149	2925896	NA	NC_000017.11:43092792:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	913	BRCA1
NM_007294.4(BRCA1):c.2738A>G (p.Asn913Ser)	BRCA1	N913S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided	VCV000232370	17	41244810	17	43092793	232370	236060	rs199954851	NC_000017.11:43092792:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	913	BRCA1
NM_007294.4(BRCA1):c.2737A>G (p.Asn913Asp)	BRCA1	N913D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821740	17	41244811	17	43092794	821740	813778	rs1597867982	NC_000017.11:43092793:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	913	BRCA1
NM_007294.4(BRCA1):c.2736G>T (p.Lys912Asn)	BRCA1	K912N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000627997	17	41244812	17	43092795	627997	618631	rs1555589046	NC_000017.11:43092794:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	912	BRCA1
NM_007294.4(BRCA1):c.2736G>C (p.Lys912Asn)	BRCA1	K912N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000441518	17	41244812	17	43092795	441518	435146	rs1555589046	NC_000017.11:43092794:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	912	BRCA1
NM_007294.4(BRCA1):c.2735A>G (p.Lys912Arg)	BRCA1	K912R	not specified|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000037487	17	41244813	17	43092796	37487	46043	rs397507204	NC_000017.11:43092795:T:C	single nucleotide variant	intron variant|missense variant	Likely benign	Jan 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	912	BRCA1
NM_007294.4(BRCA1):c.2734A>G (p.Lys912Glu)	BRCA1	K912E	Hereditary cancer-predisposing syndrome	VCV001795316	17	41244814	17	43092797	1795316	1853977	NA	NC_000017.11:43092796:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	912	BRCA1
NM_007294.4(BRCA1):c.2734A>C (p.Lys912Gln)	BRCA1	K912Q	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000531231	17	41244814	17	43092797	531231	531350	rs1555589048	NC_000017.11:43092796:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	912	BRCA1
NM_007294.4(BRCA1):c.2732G>A (p.Gly911Glu)	BRCA1	G911E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000096908	17	41244816	17	43092799	96908	102811	rs431825392	NC_000017.11:43092798:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	911	BRCA1
NM_007294.4(BRCA1):c.2729A>G (p.Gln910Arg)	BRCA1	Q910R	Hereditary cancer-predisposing syndrome	VCV001692961	17	41244819	17	43092802	1692961	1685401	rs2154362527	NC_000017.11:43092801:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	910	BRCA1
NM_007294.4(BRCA1):c.2728C>G (p.Gln910Glu)	BRCA1	Q910E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531365	17	41244820	17	43092803	531365	531280	rs397509004	NC_000017.11:43092802:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	910	BRCA1
NM_007294.4(BRCA1):c.2726A>G (p.Asn909Ser)	BRCA1	N909S	Hereditary breast ovarian cancer syndrome	VCV002763191	17	41244822	17	43092805	2763191	2928252	NA	NC_000017.11:43092804:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	909	BRCA1
NM_007294.4(BRCA1):c.2726A>T (p.Asn909Ile)	BRCA1	N909I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Breast neoplasm|not specified|Hereditary cancer-predisposing syndrome	VCV000037486	17	41244822	17	43092805	37486	46042	rs80357127	NC_000017.11:43092804:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	909	BRCA1
NM_007294.4(BRCA1):c.2725A>T (p.Asn909Tyr)	BRCA1	N909Y	Hereditary cancer-predisposing syndrome	VCV001795231	17	41244823	17	43092806	1795231	1853893	NA	NC_000017.11:43092805:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	909	BRCA1
NM_007294.4(BRCA1):c.2724A>C (p.Glu908Asp)	BRCA1	E908D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481453	17	41244824	17	43092807	481453	478760	rs1350643283	NC_000017.11:43092806:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	908	BRCA1
NM_007294.4(BRCA1):c.2723A>C (p.Glu908Ala)	BRCA1	E908A	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491052	17	41244825	17	43092808	491052	485086	rs1064794969	NC_000017.11:43092807:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	908	BRCA1
NM_007294.4(BRCA1):c.2723A>G (p.Glu908Gly)	BRCA1	E908G	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000421195	17	41244825	17	43092808	421195	409993	rs1064794969	NC_000017.11:43092807:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	908	BRCA1
NM_007294.4(BRCA1):c.2720A>G (p.Glu907Gly)	BRCA1	E907G	Hereditary cancer-predisposing syndrome	VCV000491051	17	41244828	17	43092811	491051	485349	rs1555589078	NC_000017.11:43092810:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	907	BRCA1
NM_007294.4(BRCA1):c.2719G>A (p.Glu907Lys)	BRCA1	E907K	Hereditary cancer-predisposing syndrome	VCV002565343	17	41244829	17	43092812	2565343	2732317	NA	NC_000017.11:43092811:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	907	BRCA1
NM_007294.4(BRCA1):c.2716A>C (p.Lys906Gln)	BRCA1	K906Q	Hereditary cancer-predisposing syndrome	VCV000628997	17	41244832	17	43092815	628997	618633	rs1567794535	NC_000017.11:43092814:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	906	BRCA1
NM_007294.4(BRCA1):c.2714A>G (p.Gln905Arg)	BRCA1	Q905R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000037485	17	41244834	17	43092817	37485	46041	rs397507203	NC_000017.11:43092816:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	905	BRCA1
NM_007294.4(BRCA1):c.2710G>C (p.Glu904Gln)	BRCA1	E904Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141808	17	41244838	17	43092821	141808	151522	rs80357035	NC_000017.11:43092820:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	904	BRCA1
NM_007294.4(BRCA1):c.2708G>A (p.Cys903Tyr)	BRCA1	C903Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000821642	17	41244840	17	43092823	821642	813779	rs1597868170	NC_000017.11:43092822:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	903	BRCA1
NM_007294.4(BRCA1):c.2707T>C (p.Cys903Arg)	BRCA1	C903R	Hereditary cancer-predisposing syndrome	VCV000482896	17	41244841	17	43092824	482896	478764	rs1555589103	NC_000017.11:43092823:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	903	BRCA1
NM_007294.4(BRCA1):c.2706A>C (p.Glu902Asp)	BRCA1	E902D	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000091597	17	41244842	17	43092825	91597	97074	rs398122665	NC_000017.11:43092824:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	902	BRCA1
NM_007294.4(BRCA1):c.2705A>G (p.Glu902Gly)	BRCA1	E902G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000928778	17	41244843	17	43092826	928778	917253	rs747287311	NC_000017.11:43092825:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	902	BRCA1
NM_007294.4(BRCA1):c.2703T>G (p.Phe901Leu)	BRCA1	F901L	Hereditary cancer-predisposing syndrome	VCV001794958	17	41244845	17	43092828	1794958	1849167	NA	NC_000017.11:43092827:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	901	BRCA1
NM_007294.4(BRCA1):c.2702T>C (p.Phe901Ser)	BRCA1	F901S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000037482	17	41244846	17	43092829	37482	46038	rs397507202	NC_000017.11:43092828:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	901	BRCA1
NM_007294.4(BRCA1):c.2699C>G (p.Thr900Ser)	BRCA1	T900S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001473180	17	41244849	17	43092832	1473180	1501425	rs2154363860	NC_000017.11:43092831:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	900	BRCA1
NM_007294.4(BRCA1):c.2698A>G (p.Thr900Ala)	BRCA1	T900A	Hereditary cancer-predisposing syndrome	VCV001794861	17	41244850	17	43092833	1794861	1849070	NA	NC_000017.11:43092832:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	900	BRCA1
NM_007294.4(BRCA1):c.2698A>T (p.Thr900Ser)	BRCA1	T900S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721850	17	41244850	17	43092833	1721850	1779568	NA	NC_000017.11:43092832:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	900	BRCA1
NM_007294.4(BRCA1):c.2696T>G (p.Val899Gly)	BRCA1	V899G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000420451	17	41244852	17	43092835	420451	409995	rs1064794483	NC_000017.11:43092834:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	899	BRCA1
NM_007294.4(BRCA1):c.2692A>G (p.Lys898Glu)	BRCA1	K898E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054649	17	41244856	17	43092839	54649	69316	rs80357420	NC_000017.11:43092838:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	898	BRCA1
NM_007294.4(BRCA1):c.2690C>T (p.Pro897Leu)	BRCA1	P897L	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000156188	17	41244858	17	43092841	156188	165987	rs587776484	NC_000017.11:43092840:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	897	BRCA1
NM_007294.4(BRCA1):c.2689C>T (p.Pro897Ser)	BRCA1	P897S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000419883	17	41244859	17	43092842	419883	409996	rs770583134	NC_000017.11:43092841:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	897	BRCA1
NM_007294.4(BRCA1):c.2688T>G (p.Ser896Arg)	BRCA1	S896R	Hereditary cancer-predisposing syndrome	VCV001794759	17	41244860	17	43092843	1794759	1848968	NA	NC_000017.11:43092842:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	896	BRCA1
NM_007294.4(BRCA1):c.2687G>A (p.Ser896Asn)	BRCA1	S896N	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001052268	17	41244861	17	43092844	1052268	1050305	rs2053714262	NC_000017.11:43092843:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	896	BRCA1
NM_007294.4(BRCA1):c.2687G>T (p.Ser896Ile)	BRCA1	S896I	Hereditary cancer-predisposing syndrome	VCV000925098	17	41244861	17	43092844	925098	913917	rs2053714262	NC_000017.11:43092843:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	896	BRCA1
NM_007294.4(BRCA1):c.2686A>T (p.Ser896Cys)	BRCA1	S896C	Hereditary cancer-predisposing syndrome	VCV000054647	17	41244862	17	43092845	54647	69314	rs80357188	NC_000017.11:43092844:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	896	BRCA1
NM_007294.4(BRCA1):c.2684A>C (p.Gln895Pro)	BRCA1	Q895P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000957939	17	41244864	17	43092847	957939	949944	rs587781914	NC_000017.11:43092846:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	895	BRCA1
NM_007294.4(BRCA1):c.2684A>G (p.Gln895Arg)	BRCA1	Q895R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141656	17	41244864	17	43092847	141656	151370	rs587781914	NC_000017.11:43092846:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	895	BRCA1
NM_007294.4(BRCA1):c.2682A>T (p.Lys894Asn)	BRCA1	K894N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489712	17	41244866	17	43092849	489712	482988	rs1131692093	NC_000017.11:43092848:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	894	BRCA1
NM_007294.4(BRCA1):c.2679G>T (p.Lys893Asn)	BRCA1	K893N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141468	17	41244869	17	43092852	141468	151182	rs587781771	NC_000017.11:43092851:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	893	BRCA1
NM_007294.4(BRCA1):c.2678A>G (p.Lys893Arg)	BRCA1	K893R	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000581219	17	41244870	17	43092853	581219	571161	rs1567794714	NC_000017.11:43092852:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	893	BRCA1
NM_007294.4(BRCA1):c.2677A>C (p.Lys893Gln)	BRCA1	K893Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000054640	17	41244871	17	43092854	54640	69307	rs80357170	NC_000017.11:43092853:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	893	BRCA1
NM_007294.4(BRCA1):c.2675T>C (p.Leu892Ser)	BRCA1	L892S	Hereditary cancer-predisposing syndrome	VCV000054638	17	41244873	17	43092856	54638	69305	rs397508994	NC_000017.11:43092855:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	892	BRCA1
NM_007294.4(BRCA1):c.2672C>A (p.Ser891Tyr)	BRCA1	S891Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000942267	17	41244876	17	43092859	942267	937959	rs2053717743	NC_000017.11:43092858:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	891	BRCA1
NM_007294.4(BRCA1):c.2671T>G (p.Ser891Ala)	BRCA1	S891A	Hereditary cancer-predisposing syndrome	VCV003261477	17	41244877	17	43092860	3261477	3424246	NA	NC_000017.11:43092859:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 2, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	891	BRCA1
NM_007294.4(BRCA1):c.2669G>T (p.Gly890Val)	BRCA1	G890V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037479	17	41244879	17	43092862	37479	46035	rs80356874	NC_000017.11:43092861:C:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	890	BRCA1
NM_007294.4(BRCA1):c.2668G>A (p.Gly890Arg)	BRCA1	G890R	not provided|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|not specified|Inherited ovarian cancer (without breast cancer)|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054634	17	41244880	17	43092863	54634	69301	rs80357200	NC_000017.11:43092862:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	890	BRCA1
NM_007294.4(BRCA1):c.2666C>A (p.Ser889Tyr)	BRCA1	S889Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000420729	17	41244882	17	43092865	420729	409997	rs769712441	NC_000017.11:43092864:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	889	BRCA1
NM_007294.4(BRCA1):c.2666C>T (p.Ser889Phe)	BRCA1	S889F	not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000186759	17	41244882	17	43092865	186759	185009	rs769712441	NC_000017.11:43092864:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	889	BRCA1
NM_007294.4(BRCA1):c.2663A>G (p.His888Arg)	BRCA1	H888R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491050	17	41244885	17	43092868	491050	485087	rs876658843	NC_000017.11:43092867:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	888	BRCA1
NM_007294.4(BRCA1):c.2663A>T (p.His888Leu)	BRCA1	H888L	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482938	17	41244885	17	43092868	482938	478765	rs876658843	NC_000017.11:43092867:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	888	BRCA1
NM_007294.4(BRCA1):c.2663A>C (p.His888Pro)	BRCA1	H888P	not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000230920	17	41244885	17	43092868	230920	236066	rs876658843	NC_000017.11:43092867:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	888	BRCA1
NM_007294.4(BRCA1):c.2662C>T (p.His888Tyr)	BRCA1	H888Y	not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided	VCV000054632	17	41244886	17	43092869	54632	69299	rs80357480	NC_000017.11:43092868:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	888	BRCA1
NM_007294.4(BRCA1):c.2657C>G (p.Ser886Cys)	BRCA1	S886C	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000141950	17	41244891	17	43092874	141950	151664	rs587782134	NC_000017.11:43092873:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jul 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	886	BRCA1
NM_007294.4(BRCA1):c.2655C>G (p.Phe885Leu)	BRCA1	F885L	Hereditary cancer-predisposing syndrome	VCV002565359	17	41244893	17	43092876	2565359	2732332	NA	NC_000017.11:43092875:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	885	BRCA1
NM_007294.4(BRCA1):c.2655C>A (p.Phe885Leu)	BRCA1	F885L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002133946	17	41244893	17	43092876	2133946	2188492	NA	NC_000017.11:43092875:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	885	BRCA1
NM_007294.4(BRCA1):c.2654T>A (p.Phe885Tyr)	BRCA1	F885Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000582375	17	41244894	17	43092877	582375	574478	rs1567794788	NC_000017.11:43092876:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	885	BRCA1
NM_007294.4(BRCA1):c.2650A>G (p.Thr884Ala)	BRCA1	T884A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054628	17	41244898	17	43092881	54628	69295	rs80357120	NC_000017.11:43092880:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	884	BRCA1
NM_007294.4(BRCA1):c.2648C>T (p.Ala883Val)	BRCA1	A883V	Hereditary cancer-predisposing syndrome	VCV000096907	17	41244900	17	43092883	96907	102810	rs431825391	NC_000017.11:43092882:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	883	BRCA1
NM_007294.4(BRCA1):c.2647G>A (p.Ala883Thr)	BRCA1	A883T	Hereditary cancer-predisposing syndrome	VCV000821626	17	41244901	17	43092884	821626	813780	rs1597868632	NC_000017.11:43092883:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	883	BRCA1
NM_007294.4(BRCA1):c.2646T>G (p.Cys882Trp)	BRCA1	C882W	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000956855	17	41244902	17	43092885	956855	949945	rs2053723557	NC_000017.11:43092884:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	882	BRCA1
NM_007294.4(BRCA1):c.2645G>A (p.Cys882Tyr)	BRCA1	C882Y	Hereditary cancer-predisposing syndrome	VCV000441383	17	41244903	17	43092886	441383	435147	rs1555589241	NC_000017.11:43092885:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	882	BRCA1
NM_007294.4(BRCA1):c.2644T>C (p.Cys882Arg)	BRCA1	C882R	Hereditary cancer-predisposing syndrome	VCV000441301	17	41244904	17	43092887	441301	435148	rs184374817	NC_000017.11:43092886:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	882	BRCA1
NM_007294.4(BRCA1):c.2644T>A (p.Cys882Ser)	BRCA1	C882S	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000245978	17	41244904	17	43092887	245978	245044	rs184374817	NC_000017.11:43092886:A:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	882	BRCA1
NM_007294.4(BRCA1):c.2643A>T (p.Glu881Asp)	BRCA1	E881D	not specified|Hereditary cancer-predisposing syndrome	VCV001804788	17	41244905	17	43092888	1804788	1861803	NA	NC_000017.11:43092887:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	881	BRCA1
NM_007294.4(BRCA1):c.2642A>G (p.Glu881Gly)	BRCA1	E881G	Hereditary breast ovarian cancer syndrome	VCV002831991	17	41244906	17	43092889	2831991	2998205	NA	NC_000017.11:43092888:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jan 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	881	BRCA1
NM_007294.4(BRCA1):c.2639A>G (p.Glu880Gly)	BRCA1	E880G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001375867	17	41244909	17	43092892	1375867	1470253	rs2154367305	NC_000017.11:43092891:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	880	BRCA1
NM_007294.4(BRCA1):c.2638_2639delinsAC (p.Glu880Thr)	BRCA1	E880T	Hereditary cancer-predisposing syndrome|not specified	VCV000182107	17	41244909 - 41244910	17	43092892 - 43092893	182107	180856	rs730881460	NC_000017.11:43092891:TC:GT	Indel	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	880	BRCA1
NM_007294.4(BRCA1):c.2638G>C (p.Glu880Gln)	BRCA1	E880Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000142303	17	41244910	17	43092893	142303	152017	rs587782370	NC_000017.11:43092892:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	880	BRCA1
NM_007294.4(BRCA1):c.2635G>A (p.Glu879Lys)	BRCA1	E879K	Hereditary cancer-predisposing syndrome	VCV000054624	17	41244913	17	43092896	54624	69291	rs80357251	NC_000017.11:43092895:C:T	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	879	BRCA1
NM_007294.4(BRCA1):c.2633C>T (p.Ala878Val)	BRCA1	A878V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479220	17	41244915	17	43092898	479220	478695	rs1555589255	NC_000017.11:43092897:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	878	BRCA1
NM_007294.4(BRCA1):c.2632G>A (p.Ala878Thr)	BRCA1	A878T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054623	17	41244916	17	43092899	54623	69290	rs80357230	NC_000017.11:43092898:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	878	BRCA1
NM_007294.4(BRCA1):c.2630A>G (p.Asn877Ser)	BRCA1	N877S	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000187381	17	41244918	17	43092901	187381	185011	rs786203689	NC_000017.11:43092900:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	877	BRCA1
NM_007294.4(BRCA1):c.2627_2628delinsTT (p.Gly876Val)	BRCA1	G876V	Hereditary cancer-predisposing syndrome	VCV001794006	17	41244920 - 41244921	17	43092903 - 43092904	1794006	1842286	NA	NC_000017.11:43092902:TC:AA	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	876	BRCA1
NM_007294.4(BRCA1):c.2626G>A (p.Gly876Arg)	BRCA1	G876R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631233	17	41244922	17	43092905	631233	618634	rs1567794885	NC_000017.11:43092904:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	876	BRCA1
NM_007294.4(BRCA1):c.2624C>T (p.Pro875Leu)	BRCA1	P875L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001522093	17	41244924	17	43092907	1522093	1344108	rs867654871	NC_000017.11:43092906:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	875	BRCA1
NM_007294.4(BRCA1):c.2624C>G (p.Pro875Arg)	BRCA1	P875R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000964381	17	41244924	17	43092907	964381	949946	rs867654871	NC_000017.11:43092906:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	875	BRCA1
NM_007294.4(BRCA1):c.2623C>G (p.Pro875Ala)	BRCA1	P875A	Hereditary cancer-predisposing syndrome	VCV001793976	17	41244925	17	43092908	1793976	1842256	NA	NC_000017.11:43092907:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	875	BRCA1
NM_007294.4(BRCA1):c.2623C>T (p.Pro875Ser)	BRCA1	P875S	Hereditary cancer-predisposing syndrome	VCV000630126	17	41244925	17	43092908	630126	618635	rs866257451	NC_000017.11:43092907:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	875	BRCA1
NM_007294.4(BRCA1):c.2620A>G (p.Asn874Asp)	BRCA1	N874D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821584	17	41244928	17	43092911	821584	813782	rs1064795862	NC_000017.11:43092910:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	874	BRCA1
NM_007294.4(BRCA1):c.2620A>C (p.Asn874His)	BRCA1	N874H	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000422565	17	41244928	17	43092911	422565	409998	rs1064795862	NC_000017.11:43092910:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	874	BRCA1
NM_007294.4(BRCA1):c.2618C>T (p.Ser873Leu)	BRCA1	S873L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630907	17	41244930	17	43092913	630907	618636	rs1567794912	NC_000017.11:43092912:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	873	BRCA1
NM_007294.4(BRCA1):c.2615T>C (p.Phe872Ser)	BRCA1	F872S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000821573	17	41244933	17	43092916	821573	813783	rs1597868786	NC_000017.11:43092915:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	872	BRCA1
NM_007294.4(BRCA1):c.2614T>G (p.Phe872Val)	BRCA1	F872V	Hereditary cancer-predisposing syndrome|not specified	VCV001686512	17	41244934	17	43092917	1686512	1678518	rs2053728394	NC_000017.11:43092916:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	872	BRCA1
NM_007294.4(BRCA1):c.2614T>C (p.Phe872Leu)	BRCA1	F872L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001002750	17	41244934	17	43092917	1002750	997579	rs2053728394	NC_000017.11:43092916:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	872	BRCA1
NM_007294.4(BRCA1):c.2611_2612delinsGT (p.Pro871Val)	BRCA1	P871V	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000418068	17	41244936 - 41244937	17	43092919 - 43092920	418068	409999	rs1064793056	NC_000017.11:43092918:GG:AC	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	871	BRCA1
NM_007294.4(BRCA1):c.2612C>G (p.Pro871Arg)	BRCA1	P871R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000091594	17	41244936	17	43092919	91594	97071	rs799917	NC_000017.11:43092918:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	871	BRCA1
NM_007294.4(BRCA1):c.2612C>A (p.Pro871Gln)	BRCA1	P871Q	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054618	17	41244936	17	43092919	54618	69285	rs799917	NC_000017.11:43092918:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	871	BRCA1
NM_007294.4(BRCA1):c.2612C>T (p.Pro871Leu)	BRCA1	P871L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041812	17	41244936	17	43092919	41812	50251	rs799917	NC_000017.11:43092918:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	871	BRCA1
NM_007294.4(BRCA1):c.2611C>T (p.Pro871Ser)	BRCA1	P871S	Hereditary cancer-predisposing syndrome|not provided	VCV001310394	17	41244937	17	43092920	1310394	1302244	rs2154368683	NC_000017.11:43092919:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	871	BRCA1
NM_007294.4(BRCA1):c.2609C>G (p.Ala870Gly)	BRCA1	A870G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482954	17	41244939	17	43092922	482954	479386	rs1060502324	NC_000017.11:43092921:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	870	BRCA1
NM_007294.4(BRCA1):c.2609C>T (p.Ala870Val)	BRCA1	A870V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000409297	17	41244939	17	43092922	409297	402086	rs1060502324	NC_000017.11:43092921:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	870	BRCA1
NM_007294.4(BRCA1):c.2608G>C (p.Ala870Pro)	BRCA1	A870P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000937580	17	41244940	17	43092923	937580	937960	rs753256448	NC_000017.11:43092922:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	870	BRCA1
NM_007294.4(BRCA1):c.2608G>A (p.Ala870Thr)	BRCA1	A870T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000567191	17	41244940	17	43092923	567191	574480	rs753256448	NC_000017.11:43092922:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	870	BRCA1
NM_007294.4(BRCA1):c.2607T>A (p.Phe869Leu)	BRCA1	F869L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000949684	17	41244941	17	43092924	949684	928302	rs2053730454	NC_000017.11:43092923:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	869	BRCA1
NM_007294.4(BRCA1):c.2603C>T (p.Ser868Leu)	BRCA1	S868L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002061314	17	41244945	17	43092928	2061314	2124006	NA	NC_000017.11:43092927:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	868	BRCA1
NM_007294.4(BRCA1):c.2602T>C (p.Ser868Pro)	BRCA1	S868P	Hereditary breast ovarian cancer syndrome	VCV002759181	17	41244946	17	43092929	2759181	2917763	NA	NC_000017.11:43092928:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	868	BRCA1
NM_007294.4(BRCA1):c.2600A>G (p.Gln867Arg)	BRCA1	Q867R	Hereditary cancer-predisposing syndrome	VCV000054615	17	41244948	17	43092931	54615	69282	rs397508985	NC_000017.11:43092930:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	867	BRCA1
NM_007294.4(BRCA1):c.2599C>G (p.Gln867Glu)	BRCA1	Q867E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000862352	17	41244949	17	43092932	862352	845416	rs886038001	NC_000017.11:43092931:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	867	BRCA1
NM_007294.4(BRCA1):c.2597G>A (p.Arg866His)	BRCA1	R866H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054613	17	41244951	17	43092934	54613	69280	rs80356911	NC_000017.11:43092933:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	866	BRCA1
NM_007294.4(BRCA1):c.2596C>T (p.Arg866Cys)	BRCA1	R866C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041811	17	41244952	17	43092935	41811	50250	rs41286300	NC_000017.11:43092934:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	866	BRCA1
NM_007294.4(BRCA1):c.2595G>C (p.Lys865Asn)	BRCA1	K865N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001044289	17	41244953	17	43092936	1044289	1033317	rs1268762258	NC_000017.11:43092935:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	865	BRCA1
NM_007294.4(BRCA1):c.2593A>G (p.Lys865Glu)	BRCA1	K865E	Hereditary cancer-predisposing syndrome	VCV002585852	17	41244955	17	43092938	2585852	2753412	NA	NC_000017.11:43092937:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	865	BRCA1
NM_007294.4(BRCA1):c.2591C>T (p.Ser864Leu)	BRCA1	S864L	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054611	17	41244957	17	43092940	54611	69278	rs80357003	NC_000017.11:43092939:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	864	BRCA1
NM_007294.4(BRCA1):c.2590T>G (p.Ser864Ala)	BRCA1	S864A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054609	17	41244958	17	43092941	54609	69276	rs80357285	NC_000017.11:43092940:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	864	BRCA1
NM_007294.4(BRCA1):c.2588T>C (p.Val863Ala)	BRCA1	V863A	Hereditary cancer-predisposing syndrome	VCV001793452	17	41244960	17	43092943	1793452	1845578	NA	NC_000017.11:43092942:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	863	BRCA1
NM_007294.4(BRCA1):c.2587G>A (p.Val863Ile)	BRCA1	V863I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000481465	17	41244961	17	43092944	481465	478626	rs1555589325	NC_000017.11:43092943:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	863	BRCA1
NM_007294.4(BRCA1):c.2586G>C (p.Lys862Asn)	BRCA1	K862N	Hereditary cancer-predisposing syndrome	VCV000441296	17	41244962	17	43092945	441296	435149	rs1555589330	NC_000017.11:43092944:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	862	BRCA1
NM_007294.4(BRCA1):c.2585A>G (p.Lys862Arg)	BRCA1	K862R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000845804	17	41244963	17	43092946	845804	845417	rs2053734181	NC_000017.11:43092945:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	862	BRCA1
NM_007294.4(BRCA1):c.2584A>G (p.Lys862Glu)	BRCA1	K862E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037476	17	41244964	17	43092947	37476	46032	rs80356927	NC_000017.11:43092946:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	862	BRCA1
NM_007294.4(BRCA1):c.2583C>G (p.Phe861Leu)	BRCA1	F861L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000569197	17	41244965	17	43092948	569197	571168	rs1555589334	NC_000017.11:43092947:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	861	BRCA1
NM_007294.4(BRCA1):c.2582T>G (p.Phe861Cys)	BRCA1	F861C	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054608	17	41244966	17	43092949	54608	69275	rs80357098	NC_000017.11:43092948:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	861	BRCA1
NM_007294.4(BRCA1):c.2579C>T (p.Thr860Ile)	BRCA1	T860I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531237	17	41244969	17	43092952	531237	531588	rs1555589337	NC_000017.11:43092951:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	860	BRCA1
NM_007294.4(BRCA1):c.2578A>G (p.Thr860Ala)	BRCA1	T860A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821512	17	41244970	17	43092953	821512	813785	rs373207084	NC_000017.11:43092952:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	860	BRCA1
NM_007294.4(BRCA1):c.2576A>G (p.Asn859Ser)	BRCA1	N859S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000821510	17	41244972	17	43092955	821510	813786	rs1597869096	NC_000017.11:43092954:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	859	BRCA1
NM_007294.4(BRCA1):c.2575A>G (p.Asn859Asp)	BRCA1	N859D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481428	17	41244973	17	43092956	481428	478770	rs1555589354	NC_000017.11:43092955:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	859	BRCA1
NM_007294.4(BRCA1):c.2573A>G (p.Gln858Arg)	BRCA1	Q858R	Hereditary cancer-predisposing syndrome	VCV001793271	17	41244975	17	43092958	1793271	1848784	NA	NC_000017.11:43092957:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	858	BRCA1
NM_007294.4(BRCA1):c.2569T>A (p.Leu857Met)	BRCA1	L857M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000857724	17	41244979	17	43092962	857724	845418	rs779895958	NC_000017.11:43092961:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	857	BRCA1
NM_007294.4(BRCA1):c.2567A>G (p.Tyr856Cys)	BRCA1	Y856C	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000219500	17	41244981	17	43092964	219500	222667	rs864622122	NC_000017.11:43092963:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	856	BRCA1
NM_007294.4(BRCA1):c.2566T>C (p.Tyr856His)	BRCA1	Y856H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054604	17	41244982	17	43092965	54604	69271	rs80356892	NC_000017.11:43092964:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	856	BRCA1
NM_007294.4(BRCA1):c.2564A>G (p.Gln855Arg)	BRCA1	Q855R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531320	17	41244984	17	43092967	531320	531281	rs768001441	NC_000017.11:43092966:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	855	BRCA1
NM_007294.4(BRCA1):c.2564A>T (p.Gln855Leu)	BRCA1	Q855L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491047	17	41244984	17	43092967	491047	485350	rs768001441	NC_000017.11:43092966:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	855	BRCA1
NM_007294.4(BRCA1):c.2564A>C (p.Gln855Pro)	BRCA1	Q855P	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000186203	17	41244984	17	43092967	186203	185013	rs768001441	NC_000017.11:43092966:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	855	BRCA1
NM_007294.4(BRCA1):c.2563C>A (p.Gln855Lys)	BRCA1	Q855K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000569114	17	41244985	17	43092968	569114	569154	rs80357131	NC_000017.11:43092967:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	855	BRCA1
NM_007294.4(BRCA1):c.2561C>T (p.Ala854Val)	BRCA1	A854V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054601	17	41244987	17	43092970	54601	69268	rs80357315	NC_000017.11:43092969:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	854	BRCA1
NM_007294.4(BRCA1):c.2560G>C (p.Ala854Pro)	BRCA1	A854P	Hereditary cancer-predisposing syndrome	VCV001793112	17	41244988	17	43092971	1793112	1848625	NA	NC_000017.11:43092970:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	854	BRCA1
NM_007294.4(BRCA1):c.2560G>A (p.Ala854Thr)	BRCA1	A854T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000642954	17	41244988	17	43092971	642954	646001	rs1597869238	NC_000017.11:43092970:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	854	BRCA1
NM_007294.4(BRCA1):c.2558A>T (p.Asp853Val)	BRCA1	D853V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001331978	17	41244990	17	43092973	1331978	1322698	rs2154371171	NC_000017.11:43092972:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	853	BRCA1
NM_007294.4(BRCA1):c.2555T>C (p.Leu852Pro)	BRCA1	L852P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462591	17	41244993	17	43092976	462591	466881	rs1555589415	NC_000017.11:43092975:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	852	BRCA1
NM_007294.4(BRCA1):c.2554C>T (p.Leu852Phe)	BRCA1	L852F	not provided|Hereditary cancer-predisposing syndrome	VCV000993164	17	41244994	17	43092977	993164	981171	rs863224754	NC_000017.11:43092976:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	852	BRCA1
NM_007294.4(BRCA1):c.2554C>G (p.Leu852Val)	BRCA1	L852V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000216656	17	41244994	17	43092977	216656	213323	rs863224754	NC_000017.11:43092976:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	852	BRCA1
NM_007294.4(BRCA1):c.2552A>G (p.Glu851Gly)	BRCA1	E851G	Hereditary cancer-predisposing syndrome	VCV000629065	17	41244996	17	43092979	629065	618637	rs1567795186	NC_000017.11:43092978:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	851	BRCA1
NM_007294.4(BRCA1):c.2551G>A (p.Glu851Lys)	BRCA1	E851K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000091593	17	41244997	17	43092980	91593	97070	rs398122662	NC_000017.11:43092979:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	851	BRCA1
NM_007294.4(BRCA1):c.2548A>C (p.Ser850Arg)	BRCA1	S850R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462589	17	41245000	17	43092983	462589	467724	rs1555589429	NC_000017.11:43092982:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	850	BRCA1
NM_007294.4(BRCA1):c.2547A>C (p.Glu849Asp)	BRCA1	E849D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001719839	17	41245001	17	43092984	1719839	1772495	NA	NC_000017.11:43092983:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	849	BRCA1
NM_007294.4(BRCA1):c.2546A>G (p.Glu849Gly)	BRCA1	E849G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000631249	17	41245002	17	43092985	631249	618638	rs1567795227	NC_000017.11:43092984:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	849	BRCA1
NM_007294.4(BRCA1):c.2545G>C (p.Glu849Gln)	BRCA1	E849Q	Hereditary cancer-predisposing syndrome	VCV002565339	17	41245003	17	43092986	2565339	2732313	NA	NC_000017.11:43092985:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	849	BRCA1
NM_007294.4(BRCA1):c.2543A>G (p.Glu848Gly)	BRCA1	E848G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000646251	17	41245005	17	43092988	646251	646002	rs1597869343	NC_000017.11:43092987:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	848	BRCA1
NM_007294.4(BRCA1):c.2541G>A (p.Met847Ile)	BRCA1	M847I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000054594	17	41245007	17	43092990	54594	69261	rs80357195	NC_000017.11:43092989:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	847	BRCA1
NM_007294.4(BRCA1):c.2540T>A (p.Met847Lys)	BRCA1	M847K	Hereditary cancer-predisposing syndrome|not provided	VCV001307126	17	41245008	17	43092991	1307126	1296075	rs2154372081	NC_000017.11:43092990:A:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	847	BRCA1
NM_007294.4(BRCA1):c.2539A>G (p.Met847Val)	BRCA1	M847V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441436	17	41245009	17	43092992	441436	435151	rs1555589446	NC_000017.11:43092991:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	847	BRCA1
NM_007294.4(BRCA1):c.2538A>C (p.Glu846Asp)	BRCA1	E846D	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000619624	17	41245010	17	43092993	619624	611240	rs1567795266	NC_000017.11:43092992:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	846	BRCA1
NM_007294.4(BRCA1):c.2536G>A (p.Glu846Lys)	BRCA1	E846K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000187166	17	41245012	17	43092995	187166	185014	rs786203523	NC_000017.11:43092994:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	846	BRCA1
NM_007294.4(BRCA1):c.2535A>G (p.Ile845Met)	BRCA1	I845M	Hereditary cancer-predisposing syndrome	VCV000821409	17	41245013	17	43092996	821409	813791	rs876660248	NC_000017.11:43092995:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	845	BRCA1
NM_007294.4(BRCA1):c.2534T>G (p.Ile845Arg)	BRCA1	I845R	Hereditary cancer-predisposing syndrome	VCV003226120	17	41245014	17	43092997	3226120	3387184	NA	NC_000017.11:43092996:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	845	BRCA1
NM_007294.4(BRCA1):c.2534T>C (p.Ile845Thr)	BRCA1	I845T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054593	17	41245014	17	43092997	54593	69260	rs397508976	NC_000017.11:43092996:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	845	BRCA1
NM_007294.4(BRCA1):c.2533A>G (p.Ile845Val)	BRCA1	I845V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001792726	17	41245015	17	43092998	1792726	1851775	NA	NC_000017.11:43092997:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	845	BRCA1
NM_007294.4(BRCA1):c.2531G>A (p.Ser844Asn)	BRCA1	S844N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000630127	17	41245017	17	43093000	630127	618639	rs56051266	NC_000017.11:43092999:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	844	BRCA1
NM_007294.4(BRCA1):c.2530A>G (p.Ser844Gly)	BRCA1	S844G	Hereditary cancer-predisposing syndrome	VCV001792691	17	41245018	17	43093001	1792691	1851741	NA	NC_000017.11:43093000:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	844	BRCA1
NM_007294.4(BRCA1):c.2528C>G (p.Thr843Arg)	BRCA1	T843R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462588	17	41245020	17	43093003	462588	467725	rs1555589466	NC_000017.11:43093002:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	843	BRCA1
NM_007294.4(BRCA1):c.2527A>G (p.Thr843Ala)	BRCA1	T843A	Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000054592	17	41245021	17	43093004	54592	69259	rs80357435	NC_000017.11:43093003:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	843	BRCA1
NM_007294.4(BRCA1):c.2525A>G (p.Glu842Gly)	BRCA1	E842G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091592	17	41245023	17	43093006	91592	97069	rs28897684	NC_000017.11:43093005:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	842	BRCA1
NM_007294.4(BRCA1):c.2524G>A (p.Glu842Lys)	BRCA1	E842K	Hereditary cancer-predisposing syndrome	VCV000230412	17	41245024	17	43093007	230412	236072	rs876658552	NC_000017.11:43093006:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	842	BRCA1
NM_007294.4(BRCA1):c.2522G>T (p.Arg841Leu)	BRCA1	R841L	Hereditary cancer-predisposing syndrome	VCV001792565	17	41245026	17	43093009	1792565	1851615	NA	NC_000017.11:43093008:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	841	BRCA1
NM_007294.4(BRCA1):c.2522G>C (p.Arg841Pro)	BRCA1	R841P	Hereditary cancer-predisposing syndrome|not provided	VCV000489711	17	41245026	17	43093009	489711	482994	rs80357337	NC_000017.11:43093008:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	841	BRCA1
NM_007294.4(BRCA1):c.2522G>A (p.Arg841Gln)	BRCA1	R841Q	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054591	17	41245026	17	43093009	54591	69258	rs80357337	NC_000017.11:43093008:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	841	BRCA1
NM_007294.4(BRCA1):c.2521C>T (p.Arg841Trp)	BRCA1	R841W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017681	17	41245027	17	43093010	17681	32720	rs1800709	NC_000017.11:43093009:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	841	BRCA1
NM_007294.4(BRCA1):c.2519G>A (p.Ser840Asn)	BRCA1	S840N	Hereditary breast ovarian cancer syndrome	VCV002894046	17	41245029	17	43093012	2894046	3045978	NA	NC_000017.11:43093011:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jan 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	840	BRCA1
NM_007294.4(BRCA1):c.2518A>C (p.Ser840Arg)	BRCA1	S840R	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232178	17	41245030	17	43093013	232178	236073	rs377475866	NC_000017.11:43093012:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	840	BRCA1
NM_007294.4(BRCA1):c.2518A>G (p.Ser840Gly)	BRCA1	S840G	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187463	17	41245030	17	43093013	187463	185016	rs377475866	NC_000017.11:43093012:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	840	BRCA1
NM_007294.4(BRCA1):c.2518A>T (p.Ser840Cys)	BRCA1	S840C	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome	VCV000089056	17	41245030	17	43093013	89056	94599	rs377475866	NC_000017.11:43093012:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	840	BRCA1
NM_007294.4(BRCA1):c.2516A>G (p.His839Arg)	BRCA1	H839R	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821422	17	41245032	17	43093015	821422	813792	rs1050289746	NC_000017.11:43093014:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	839	BRCA1
NM_007294.4(BRCA1):c.2515C>T (p.His839Tyr)	BRCA1	H839Y	Ovarian cancer	VCV002445306	17	41245033	17	43093016	2445306	2419032	NA	NC_000017.11:43093015:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jan 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	839	BRCA1
NM_007294.4(BRCA1):c.2514C>A (p.Asn838Lys)	BRCA1	N838K	Hereditary cancer-predisposing syndrome	VCV001792437	17	41245034	17	43093017	1792437	1842025	NA	NC_000017.11:43093016:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	838	BRCA1
NM_007294.4(BRCA1):c.2512A>G (p.Asn838Asp)	BRCA1	N838D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001431803	17	41245036	17	43093019	1431803	1405874	rs2154373420	NC_000017.11:43093018:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	838	BRCA1
NM_007294.4(BRCA1):c.2510T>A (p.Val837Asp)	BRCA1	V837D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002075020	17	41245038	17	43093021	2075020	2123818	NA	NC_000017.11:43093020:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	837	BRCA1
NM_007294.4(BRCA1):c.2509G>A (p.Val837Ile)	BRCA1	V837I	Hereditary cancer-predisposing syndrome	VCV003226119	17	41245039	17	43093022	3226119	3387183	NA	NC_000017.11:43093021:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	837	BRCA1
NM_007294.4(BRCA1):c.2504A>G (p.His835Arg)	BRCA1	H835R	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002001791	17	41245044	17	43093027	2001791	2054992	NA	NC_000017.11:43093026:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	835	BRCA1
NM_007294.4(BRCA1):c.2504A>C (p.His835Pro)	BRCA1	H835P	Hereditary cancer-predisposing syndrome|not specified	VCV000821402	17	41245044	17	43093027	821402	813793	rs765157365	NC_000017.11:43093026:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	835	BRCA1
NM_007294.4(BRCA1):c.2503C>T (p.His835Tyr)	BRCA1	H835Y	not specified|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441498	17	41245045	17	43093028	441498	435153	rs751656678	NC_000017.11:43093027:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	835	BRCA1
NM_007294.4(BRCA1):c.2501G>C (p.Gly834Ala)	BRCA1	G834A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001045652	17	41245047	17	43093030	1045652	1033318	rs757383244	NC_000017.11:43093029:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	834	BRCA1
NM_007294.4(BRCA1):c.2501G>T (p.Gly834Val)	BRCA1	G834V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482960	17	41245047	17	43093030	482960	478698	rs757383244	NC_000017.11:43093029:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	834	BRCA1
NM_007294.4(BRCA1):c.2501G>A (p.Gly834Glu)	BRCA1	G834E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000462587	17	41245047	17	43093030	462587	467960	rs757383244	NC_000017.11:43093029:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	834	BRCA1
NM_007294.4(BRCA1):c.2500G>C (p.Gly834Arg)	BRCA1	G834R	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000185491	17	41245048	17	43093031	185491	185017	rs786202215	NC_000017.11:43093030:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	834	BRCA1
NM_007294.4(BRCA1):c.2492A>G (p.Tyr831Cys)	BRCA1	Y831C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002692279	17	41245056	17	43093039	2692279	2853282	NA	NC_000017.11:43093038:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 2, 2020	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	831	BRCA1
NM_007294.4(BRCA1):c.2491T>C (p.Tyr831His)	BRCA1	Y831H	Hereditary cancer-predisposing syndrome	VCV000821355	17	41245057	17	43093040	821355	813794	rs1060502350	NC_000017.11:43093039:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	831	BRCA1
NM_007294.4(BRCA1):c.2491T>G (p.Tyr831Asp)	BRCA1	Y831D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000409348	17	41245057	17	43093040	409348	402087	rs1060502350	NC_000017.11:43093039:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	831	BRCA1
NM_007294.4(BRCA1):c.2490G>T (p.Lys830Asn)	BRCA1	K830N	Hereditary cancer-predisposing syndrome	VCV001792069	17	41245058	17	43093041	1792069	1012775	NA	NC_000017.11:43093040:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	830	BRCA1
NM_007294.4(BRCA1):c.2489A>G (p.Lys830Arg)	BRCA1	K830R	Hereditary cancer-predisposing syndrome	VCV000923989	17	41245059	17	43093042	923989	913919	rs1597869641	NC_000017.11:43093041:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	830	BRCA1
NM_007294.4(BRCA1):c.2489A>T (p.Lys830Met)	BRCA1	K830M	Hereditary cancer-predisposing syndrome	VCV000821351	17	41245059	17	43093042	821351	813795	rs1597869641	NC_000017.11:43093041:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	830	BRCA1
NM_007294.4(BRCA1):c.2488A>G (p.Lys830Glu)	BRCA1	K830E	Hereditary breast ovarian cancer syndrome	VCV002752887	17	41245060	17	43093043	2752887	2913628	NA	NC_000017.11:43093042:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	830	BRCA1
NM_007294.4(BRCA1):c.2486T>G (p.Phe829Cys)	BRCA1	F829C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952637	17	41245062	17	43093045	952637	928303	rs2053753019	NC_000017.11:43093044:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	829	BRCA1
NM_007294.4(BRCA1):c.2483G>C (p.Gly828Ala)	BRCA1	G828A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001962155	17	41245065	17	43093048	1962155	2013250	NA	NC_000017.11:43093047:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	828	BRCA1
NM_007294.4(BRCA1):c.2483G>T (p.Gly828Val)	BRCA1	G828V	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000496358	17	41245065	17	43093048	496358	487973	rs1555589578	NC_000017.11:43093047:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	828	BRCA1
NM_007294.4(BRCA1):c.2482G>C (p.Gly828Arg)	BRCA1	G828R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000934721	17	41245066	17	43093049	934721	937962	rs80357185	NC_000017.11:43093048:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	828	BRCA1
NM_007294.4(BRCA1):c.2482G>A (p.Gly828Ser)	BRCA1	G828S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054581	17	41245066	17	43093049	54581	69248	rs80357185	NC_000017.11:43093048:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	828	BRCA1
NM_007294.4(BRCA1):c.2481A>C (p.Glu827Asp)	BRCA1	E827D	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000054580	17	41245067	17	43093050	54580	69247	rs397508970	NC_000017.11:43093049:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	827	BRCA1
NM_007294.4(BRCA1):c.2479G>A (p.Glu827Lys)	BRCA1	E827K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721940	17	41245069	17	43093052	1721940	1779658	NA	NC_000017.11:43093051:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	827	BRCA1
NM_007294.4(BRCA1):c.2479G>C (p.Glu827Gln)	BRCA1	E827Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000645518	17	41245069	17	43093052	645518	646003	rs1597869731	NC_000017.11:43093051:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	827	BRCA1
NM_007294.4(BRCA1):c.2477C>G (p.Thr826Arg)	BRCA1	T826R	Hereditary cancer-predisposing syndrome	VCV002585835	17	41245071	17	43093054	2585835	2753395	NA	NC_000017.11:43093053:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	826	BRCA1
NM_007294.4(BRCA1):c.2477C>T (p.Thr826Ile)	BRCA1	T826I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000843829	17	41245071	17	43093054	843829	845421	rs28897683	NC_000017.11:43093053:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	826	BRCA1
NM_007294.4(BRCA1):c.2477C>A (p.Thr826Lys)	BRCA1	T826K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037473	17	41245071	17	43093054	37473	46029	rs28897683	NC_000017.11:43093053:G:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	826	BRCA1
NM_007294.4(BRCA1):c.2476A>G (p.Thr826Ala)	BRCA1	T826A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000970794	17	41245072	17	43093055	970794	958130	rs1597869768	NC_000017.11:43093054:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	826	BRCA1
NM_007294.4(BRCA1):c.2476A>C (p.Thr826Pro)	BRCA1	T826P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821335	17	41245072	17	43093055	821335	813796	rs1597869768	NC_000017.11:43093054:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	826	BRCA1
NM_007294.4(BRCA1):c.2474A>T (p.Asp825Val)	BRCA1	D825V	Hereditary cancer-predisposing syndrome	VCV000054576	17	41245074	17	43093057	54576	69243	rs80357249	NC_000017.11:43093056:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	825	BRCA1
NM_007294.4(BRCA1):c.2473G>C (p.Asp825His)	BRCA1	D825H	Hereditary cancer-predisposing syndrome	VCV003261467	17	41245075	17	43093058	3261467	3424236	NA	NC_000017.11:43093057:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	825	BRCA1
NM_007294.4(BRCA1):c.2473G>T (p.Asp825Tyr)	BRCA1	D825Y	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054575	17	41245075	17	43093058	54575	69242	rs80357328	NC_000017.11:43093057:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	825	BRCA1
NM_007294.4(BRCA1):c.2472T>G (p.Asn824Lys)	BRCA1	N824K	Hereditary cancer-predisposing syndrome	VCV003226117	17	41245076	17	43093059	3226117	3390622	NA	NC_000017.11:43093058:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	824	BRCA1
NM_007294.4(BRCA1):c.2471A>T (p.Asn824Ile)	BRCA1	N824I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000963966	17	41245077	17	43093060	963966	949947	rs1485586275	NC_000017.11:43093059:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	824	BRCA1
NM_007294.4(BRCA1):c.2471A>G (p.Asn824Ser)	BRCA1	N824S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481488	17	41245077	17	43093060	481488	478774	rs1485586275	NC_000017.11:43093059:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	824	BRCA1
NM_007294.4(BRCA1):c.2470A>C (p.Asn824His)	BRCA1	N824H	Hereditary cancer-predisposing syndrome	VCV000489710	17	41245078	17	43093061	489710	482990	rs1555589617	NC_000017.11:43093060:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	824	BRCA1
NM_007294.4(BRCA1):c.2468G>A (p.Arg823Lys)	BRCA1	R823K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001446321	17	41245080	17	43093063	1446321	1387272	rs876659731	NC_000017.11:43093062:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	823	BRCA1
NM_007294.4(BRCA1):c.2468G>C (p.Arg823Thr)	BRCA1	R823T	Hereditary cancer-predisposing syndrome	VCV000485401	17	41245080	17	43093063	485401	479405	rs876659731	NC_000017.11:43093062:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	823	BRCA1
NM_007294.4(BRCA1):c.2468G>T (p.Arg823Ile)	BRCA1	R823I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000232385	17	41245080	17	43093063	232385	236074	rs876659731	NC_000017.11:43093062:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	823	BRCA1
NM_007294.4(BRCA1):c.2466T>G (p.Asn822Lys)	BRCA1	N822K	not provided|Hereditary cancer-predisposing syndrome	VCV000420787	17	41245082	17	43093065	420787	410001	rs1064794701	NC_000017.11:43093064:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	822	BRCA1
NM_007294.4(BRCA1):c.2465A>G (p.Asn822Ser)	BRCA1	N822S	Hereditary cancer-predisposing syndrome	VCV000485385	17	41245083	17	43093066	485385	478635	rs1555589630	NC_000017.11:43093065:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	822	BRCA1
NM_007294.4(BRCA1):c.2462A>G (p.Asp821Gly)	BRCA1	D821G	Hereditary cancer-predisposing syndrome	VCV003261496	17	41245086	17	43093069	3261496	3424264	NA	NC_000017.11:43093068:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	821	BRCA1
NM_007294.4(BRCA1):c.2462A>T (p.Asp821Val)	BRCA1	D821V	Hereditary cancer-predisposing syndrome	VCV001791648	17	41245086	17	43093069	1791648	1848465	NA	NC_000017.11:43093068:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	821	BRCA1
NM_007294.4(BRCA1):c.2460A>T (p.Lys820Asn)	BRCA1	K820N	Hereditary breast ovarian cancer syndrome	VCV002755706	17	41245088	17	43093071	2755706	2916878	NA	NC_000017.11:43093070:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	820	BRCA1
NM_007294.4(BRCA1):c.2458A>G (p.Lys820Glu)	BRCA1	K820E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041810	17	41245090	17	43093073	41810	50249	rs56082113	NC_000017.11:43093072:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	820	BRCA1
NM_007294.4(BRCA1):c.2456C>T (p.Ser819Phe)	BRCA1	S819F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002131859	17	41245092	17	43093075	2131859	2189847	NA	NC_000017.11:43093074:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	819	BRCA1
NM_007294.4(BRCA1):c.2456C>A (p.Ser819Tyr)	BRCA1	S819Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002007392	17	41245092	17	43093075	2007392	2062752	NA	NC_000017.11:43093074:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	819	BRCA1
NM_007294.4(BRCA1):c.2456C>G (p.Ser819Cys)	BRCA1	S819C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000156187	17	41245092	17	43093075	156187	165986	rs192655097	NC_000017.11:43093074:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	819	BRCA1
NM_007294.4(BRCA1):c.2453G>T (p.Cys818Phe)	BRCA1	C818F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002021147	17	41245095	17	43093078	2021147	2076492	NA	NC_000017.11:43093077:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	818	BRCA1
NM_007294.4(BRCA1):c.2452T>G (p.Cys818Gly)	BRCA1	C818G	Hereditary cancer-predisposing syndrome	VCV001791515	17	41245096	17	43093079	1791515	1245720	NA	NC_000017.11:43093078:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	818	BRCA1
NM_007294.4(BRCA1):c.2450G>A (p.Gly817Asp)	BRCA1	G817D	Hereditary cancer-predisposing syndrome	VCV003226116	17	41245098	17	43093081	3226116	3390621	NA	NC_000017.11:43093080:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	817	BRCA1
NM_007294.4(BRCA1):c.2450G>T (p.Gly817Val)	BRCA1	G817V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409372	17	41245098	17	43093081	409372	402095	rs1060502365	NC_000017.11:43093080:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	817	BRCA1
NM_007294.4(BRCA1):c.2449G>A (p.Gly817Ser)	BRCA1	G817S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479245	17	41245099	17	43093082	479245	478722	rs1555589646	NC_000017.11:43093081:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	817	BRCA1
NM_007294.4(BRCA1):c.2447A>T (p.His816Leu)	BRCA1	H816L	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000496357	17	41245101	17	43093084	496357	487939	rs80357108	NC_000017.11:43093083:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	816	BRCA1
NM_007294.4(BRCA1):c.2447A>G (p.His816Arg)	BRCA1	H816R	Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|not provided	VCV000037470	17	41245101	17	43093084	37470	46026	rs80357108	NC_000017.11:43093083:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	816	BRCA1
NM_007294.4(BRCA1):c.2446C>G (p.His816Asp)	BRCA1	H816D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001791394	17	41245102	17	43093085	1791394	1848214	NA	NC_000017.11:43093084:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	816	BRCA1
NM_007294.4(BRCA1):c.2446C>A (p.His816Asn)	BRCA1	H816N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001023503	17	41245102	17	43093085	1023503	1012776	rs1597869935	NC_000017.11:43093084:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	816	BRCA1
NM_007294.4(BRCA1):c.2444T>C (p.Ile815Thr)	BRCA1	I815T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000182148	17	41245104	17	43093087	182148	180858	rs730881484	NC_000017.11:43093086:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	815	BRCA1
NM_007294.4(BRCA1):c.2437G>A (p.Gly813Arg)	BRCA1	G813R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000566372	17	41245111	17	43093094	566372	569158	rs80357186	NC_000017.11:43093093:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	813	BRCA1
NM_007294.4(BRCA1):c.2435A>G (p.Lys812Arg)	BRCA1	K812R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000845394	17	41245113	17	43093096	845394	845423	rs2053760679	NC_000017.11:43093095:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	812	BRCA1
NM_007294.4(BRCA1):c.2434A>G (p.Lys812Glu)	BRCA1	K812E	not provided|Hereditary cancer-predisposing syndrome	VCV001791205	17	41245114	17	43093097	1791205	1851566	NA	NC_000017.11:43093096:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	812	BRCA1
NM_007294.4(BRCA1):c.2432C>G (p.Pro811Arg)	BRCA1	P811R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952438	17	41245116	17	43093099	952438	928305	rs2053761478	NC_000017.11:43093098:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	811	BRCA1
NM_007294.4(BRCA1):c.2431C>T (p.Pro811Ser)	BRCA1	P811S	Hereditary cancer-predisposing syndrome	VCV003226115	17	41245117	17	43093100	3226115	3390620	NA	NC_000017.11:43093099:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	811	BRCA1
NM_007294.4(BRCA1):c.2429A>G (p.Asn810Ser)	BRCA1	N810S	Hereditary breast ovarian cancer syndrome	VCV002763194	17	41245119	17	43093102	2763194	2928255	NA	NC_000017.11:43093101:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	810	BRCA1
NM_007294.4(BRCA1):c.2428A>T (p.Asn810Tyr)	BRCA1	N810Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054567	17	41245120	17	43093103	54567	69234	rs28897682	NC_000017.11:43093102:T:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	810	BRCA1
NM_007294.4(BRCA1):c.2426A>C (p.Glu809Ala)	BRCA1	E809A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001719414	17	41245122	17	43093105	1719414	1774718	NA	NC_000017.11:43093104:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	809	BRCA1
NM_007294.4(BRCA1):c.2426A>G (p.Glu809Gly)	BRCA1	E809G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified	VCV000037468	17	41245122	17	43093105	37468	46024	rs397507201	NC_000017.11:43093104:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	809	BRCA1
NM_007294.4(BRCA1):c.2425G>C (p.Glu809Gln)	BRCA1	E809Q	Hereditary cancer-predisposing syndrome	VCV001791084	17	41245123	17	43093106	1791084	1851445	NA	NC_000017.11:43093105:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	809	BRCA1
NM_007294.4(BRCA1):c.2425G>A (p.Glu809Lys)	BRCA1	E809K	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188213	17	41245123	17	43093106	188213	186257	rs786204151	NC_000017.11:43093105:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	809	BRCA1
NM_007294.4(BRCA1):c.2423T>C (p.Phe808Ser)	BRCA1	F808S	Hereditary cancer-predisposing syndrome|not provided	VCV000091589	17	41245125	17	43093108	91589	97066	rs398122660	NC_000017.11:43093107:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	808	BRCA1
NM_007294.4(BRCA1):c.2420C>A (p.Ala807Glu)	BRCA1	A807E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054566	17	41245128	17	43093111	54566	69233	rs273899683	NC_000017.11:43093110:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	807	BRCA1
NM_007294.4(BRCA1):c.2419G>C (p.Ala807Pro)	BRCA1	A807P	Hereditary breast ovarian cancer syndrome	VCV002735349	17	41245129	17	43093112	2735349	2901374	NA	NC_000017.11:43093111:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	807	BRCA1
NM_007294.4(BRCA1):c.2419G>A (p.Ala807Thr)	BRCA1	A807T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000821253	17	41245129	17	43093112	821253	813797	rs80357240	NC_000017.11:43093111:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	807	BRCA1
NM_007294.4(BRCA1):c.2419G>T (p.Ala807Ser)	BRCA1	A807S	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054564	17	41245129	17	43093112	54564	69231	rs80357240	NC_000017.11:43093111:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	807	BRCA1
NM_007294.4(BRCA1):c.2417C>G (p.Ala806Gly)	BRCA1	A806G	Hereditary cancer-predisposing syndrome	VCV003261478	17	41245131	17	43093114	3261478	3424247	NA	NC_000017.11:43093113:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	806	BRCA1
NM_007294.4(BRCA1):c.2417C>T (p.Ala806Val)	BRCA1	A806V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000462585	17	41245131	17	43093114	462585	468178	rs1555589705	NC_000017.11:43093113:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	806	BRCA1
NM_007294.4(BRCA1):c.2416G>A (p.Ala806Thr)	BRCA1	A806T	not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054563	17	41245132	17	43093115	54563	69230	rs80357144	NC_000017.11:43093114:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	806	BRCA1
NM_007294.4(BRCA1):c.2414G>A (p.Cys805Tyr)	BRCA1	C805Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409350	17	41245134	17	43093117	409350	402016	rs1060502352	NC_000017.11:43093116:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	805	BRCA1
NM_007294.4(BRCA1):c.2413T>G (p.Cys805Gly)	BRCA1	C805G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002053712	17	41245135	17	43093118	2053712	2105127	NA	NC_000017.11:43093117:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	805	BRCA1
NM_007294.4(BRCA1):c.2413T>C (p.Cys805Arg)	BRCA1	C805R	Hereditary cancer-predisposing syndrome	VCV000054562	17	41245135	17	43093118	54562	69229	rs397508966	NC_000017.11:43093117:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	805	BRCA1
NM_007294.4(BRCA1):c.2412G>C (p.Gln804His)	BRCA1	Q804H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054561	17	41245136	17	43093119	54561	69228	rs55746541	NC_000017.11:43093118:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	804	BRCA1
NM_007294.4(BRCA1):c.2410C>G (p.Gln804Glu)	BRCA1	Q804E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000186730	17	41245138	17	43093121	186730	185022	rs80356982	NC_000017.11:43093120:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	804	BRCA1
NM_007294.4(BRCA1):c.2409T>G (p.Ser803Arg)	BRCA1	S803R	not specified	VCV002506341	17	41245139	17	43093122	2506341	2671296	NA	NC_000017.11:43093121:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	803	BRCA1
NM_007294.4(BRCA1):c.2409T>A (p.Ser803Arg)	BRCA1	S803R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002109006	17	41245139	17	43093122	2109006	2170764	NA	NC_000017.11:43093121:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	803	BRCA1
NM_007294.4(BRCA1):c.2408G>A (p.Ser803Asn)	BRCA1	S803N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002064408	17	41245140	17	43093123	2064408	2128392	NA	NC_000017.11:43093122:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	803	BRCA1
NM_007294.4(BRCA1):c.2407A>G (p.Ser803Gly)	BRCA1	S803G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000945299	17	41245141	17	43093124	945299	928306	rs2053766204	NC_000017.11:43093123:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	803	BRCA1
NM_007294.4(BRCA1):c.2405T>G (p.Val802Gly)	BRCA1	V802G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462584	17	41245143	17	43093126	462584	466884	rs1555589737	NC_000017.11:43093125:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	802	BRCA1
NM_007294.4(BRCA1):c.2404G>A (p.Val802Met)	BRCA1	V802M	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000633089	17	41245144	17	43093127	633089	621583	rs876660885	NC_000017.11:43093126:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	802	BRCA1
NM_007294.4(BRCA1):c.2404G>C (p.Val802Leu)	BRCA1	V802L	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000481483	17	41245144	17	43093127	481483	478723	rs876660885	NC_000017.11:43093126:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	802	BRCA1
NM_007294.4(BRCA1):c.2404G>T (p.Val802Leu)	BRCA1	V802L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000234150	17	41245144	17	43093127	234150	236076	rs876660885	NC_000017.11:43093126:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	802	BRCA1
NM_007294.4(BRCA1):c.2403T>G (p.Cys801Trp)	BRCA1	C801W	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000439440	17	41245145	17	43093128	439440	433272	rs80357381	NC_000017.11:43093127:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	801	BRCA1
NM_007294.4(BRCA1):c.2402G>C (p.Cys801Ser)	BRCA1	C801S	Hereditary cancer-predisposing syndrome	VCV001790754	17	41245146	17	43093129	1790754	1841655	NA	NC_000017.11:43093128:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	801	BRCA1
NM_007294.4(BRCA1):c.2402G>T (p.Cys801Phe)	BRCA1	C801F	Hereditary cancer-predisposing syndrome	VCV000923426	17	41245146	17	43093129	923426	913921	rs1567795821	NC_000017.11:43093128:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	801	BRCA1
NM_007294.4(BRCA1):c.2402G>A (p.Cys801Tyr)	BRCA1	C801Y	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000581709	17	41245146	17	43093129	581709	574481	rs1567795821	NC_000017.11:43093128:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	801	BRCA1
NM_007294.4(BRCA1):c.2401T>C (p.Cys801Arg)	BRCA1	C801R	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000419022	17	41245147	17	43093130	419022	410002	rs1064793591	NC_000017.11:43093129:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	801	BRCA1
NM_007294.4(BRCA1):c.2399A>C (p.Lys800Thr)	BRCA1	K800T	Hereditary cancer-predisposing syndrome	VCV001790656	17	41245149	17	43093132	1790656	1841557	NA	NC_000017.11:43093131:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	800	BRCA1
NM_007294.4(BRCA1):c.2397T>A (p.Asn799Lys)	BRCA1	N799K	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000054556	17	41245151	17	43093134	54556	69223	rs80357203	NC_000017.11:43093133:A:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	799	BRCA1
NM_007294.4(BRCA1):c.2396A>G (p.Asn799Ser)	BRCA1	N799S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000141806	17	41245152	17	43093135	141806	151520	rs587782027	NC_000017.11:43093134:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	799	BRCA1
NM_007294.4(BRCA1):c.2393C>G (p.Pro798Arg)	BRCA1	P798R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000570578	17	41245155	17	43093138	570578	574482	rs876660005	NC_000017.11:43093137:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	798	BRCA1
NM_007294.4(BRCA1):c.2393C>T (p.Pro798Leu)	BRCA1	P798L	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000232813	17	41245155	17	43093138	232813	236078	rs876660005	NC_000017.11:43093137:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	798	BRCA1
NM_007294.4(BRCA1):c.2392C>G (p.Pro798Ala)	BRCA1	P798A	Hereditary cancer-predisposing syndrome	VCV000599042	17	41245156	17	43093139	599042	590174	rs398122658	NC_000017.11:43093138:G:C	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	798	BRCA1
NM_007294.4(BRCA1):c.2392C>A (p.Pro798Thr)	BRCA1	P798T	Hereditary cancer-predisposing syndrome	VCV000485383	17	41245156	17	43093139	485383	478641	rs398122658	NC_000017.11:43093138:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	798	BRCA1
NM_007294.4(BRCA1):c.2392C>T (p.Pro798Ser)	BRCA1	P798S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091587	17	41245156	17	43093139	91587	97064	rs398122658	NC_000017.11:43093138:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	798	BRCA1
NM_007294.4(BRCA1):c.2389G>C (p.Glu797Gln)	BRCA1	E797Q	Hereditary cancer-predisposing syndrome	VCV000922667	17	41245159	17	43093142	922667	913922	rs62625306	NC_000017.11:43093141:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	797	BRCA1
NM_007294.4(BRCA1):c.2389G>A (p.Glu797Lys)	BRCA1	E797K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091586	17	41245159	17	43093142	91586	97063	rs62625306	NC_000017.11:43093141:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	797	BRCA1
NM_007294.4(BRCA1):c.2387C>G (p.Thr796Arg)	BRCA1	T796R	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000496355	17	41245161	17	43093144	496355	487877	rs80357364	NC_000017.11:43093143:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	796	BRCA1
NM_007294.4(BRCA1):c.2387C>T (p.Thr796Ile)	BRCA1	T796I	Hereditary breast ovarian cancer syndrome|Breast neoplasm|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000054551	17	41245161	17	43093144	54551	69218	rs80357364	NC_000017.11:43093143:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	796	BRCA1
NM_007294.4(BRCA1):c.2386A>G (p.Thr796Ala)	BRCA1	T796A	not provided	VCV002682152	17	41245162	17	43093145	2682152	2843183	NA	NC_000017.11:43093144:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	796	BRCA1
NM_007294.4(BRCA1):c.2383A>G (p.Lys795Glu)	BRCA1	K795E	Hereditary cancer-predisposing syndrome	VCV000628587	17	41245165	17	43093148	628587	618640	rs1567795889	NC_000017.11:43093147:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	795	BRCA1
NM_007294.4(BRCA1):c.2381C>T (p.Ala794Val)	BRCA1	A794V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233404	17	41245167	17	43093150	233404	236080	rs7502059	NC_000017.11:43093149:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Sep 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	794	BRCA1
NM_007294.4(BRCA1):c.2380G>T (p.Ala794Ser)	BRCA1	A794S	Hereditary cancer-predisposing syndrome	VCV001790446	17	41245168	17	43093151	1790446	1841347	NA	NC_000017.11:43093150:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	794	BRCA1
NM_007294.4(BRCA1):c.2375G>A (p.Gly792Glu)	BRCA1	G792E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000842423	17	41245173	17	43093156	842423	845424	rs2053771901	NC_000017.11:43093155:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	792	BRCA1
NM_007294.4(BRCA1):c.2374G>A (p.Gly792Arg)	BRCA1	G792R	Hereditary cancer-predisposing syndrome	VCV000482952	17	41245174	17	43093157	482952	479411	rs1555589778	NC_000017.11:43093156:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	792	BRCA1
NM_007294.4(BRCA1):c.2372T>C (p.Leu791Pro)	BRCA1	L791P	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV002691148	17	41245176	17	43093159	2691148	2852181	NA	NC_000017.11:43093158:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 5, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	791	BRCA1
NM_007294.4(BRCA1):c.2372T>G (p.Leu791Arg)	BRCA1	L791R	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821176	17	41245176	17	43093159	821176	813800	rs774730386	NC_000017.11:43093158:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	791	BRCA1
NM_007294.4(BRCA1):c.2371C>A (p.Leu791Ile)	BRCA1	L791I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001061168	17	41245177	17	43093160	1061168	1050306	rs1567795916	NC_000017.11:43093159:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	791	BRCA1
NM_007294.4(BRCA1):c.2371C>G (p.Leu791Val)	BRCA1	L791V	Hereditary cancer-predisposing syndrome	VCV000629997	17	41245177	17	43093160	629997	618641	rs1567795916	NC_000017.11:43093159:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	791	BRCA1
NM_007294.4(BRCA1):c.2368A>G (p.Thr790Ala)	BRCA1	T790A	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037465	17	41245180	17	43093163	37465	46021	rs41286298	NC_000017.11:43093162:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	790	BRCA1
NM_007294.4(BRCA1):c.2366G>A (p.Ser789Asn)	BRCA1	S789N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000659849	17	41245182	17	43093165	659849	646005	rs1597870436	NC_000017.11:43093164:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	789	BRCA1
NM_007294.4(BRCA1):c.2365A>G (p.Ser789Gly)	BRCA1	S789G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000845101	17	41245183	17	43093166	845101	845425	rs2053773104	NC_000017.11:43093165:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	789	BRCA1
NM_007294.4(BRCA1):c.2363T>A (p.Val788Asp)	BRCA1	V788D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000945383	17	41245185	17	43093168	945383	928307	rs2053773275	NC_000017.11:43093167:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	788	BRCA1
NM_007294.4(BRCA1):c.2362G>A (p.Val788Ile)	BRCA1	V788I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000054550	17	41245186	17	43093169	54550	69217	rs80357060	NC_000017.11:43093168:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	788	BRCA1
NM_007294.4(BRCA1):c.2360A>G (p.Glu787Gly)	BRCA1	E787G	not specified	VCV002581435	17	41245188	17	43093171	2581435	2749016	NA	NC_000017.11:43093170:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	787	BRCA1
NM_007294.4(BRCA1):c.2359G>A (p.Glu787Lys)	BRCA1	E787K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001790114	17	41245189	17	43093172	1790114	1844861	NA	NC_000017.11:43093171:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	787	BRCA1
NM_007294.4(BRCA1):c.2359G>C (p.Glu787Gln)	BRCA1	E787Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001432111	17	41245189	17	43093172	1432111	1484223	rs1288796003	NC_000017.11:43093171:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	787	BRCA1
NM_007294.4(BRCA1):c.2357T>A (p.Leu786Gln)	BRCA1	L786Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000924777	17	41245191	17	43093174	924777	913924	rs760864137	NC_000017.11:43093173:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	786	BRCA1
NM_007294.4(BRCA1):c.2357T>C (p.Leu786Pro)	BRCA1	L786P	Hereditary cancer-predisposing syndrome	VCV000630128	17	41245191	17	43093174	630128	618642	rs760864137	NC_000017.11:43093173:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	786	BRCA1
NM_007294.4(BRCA1):c.2355A>C (p.Leu785Phe)	BRCA1	L785F	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000629066	17	41245193	17	43093176	629066	618643	rs1567795966	NC_000017.11:43093175:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	785	BRCA1
NM_007294.4(BRCA1):c.2354T>C (p.Leu785Ser)	BRCA1	L785S	Hereditary breast ovarian cancer syndrome	VCV002706734	17	41245194	17	43093177	2706734	2870308	NA	NC_000017.11:43093176:A:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	785	BRCA1
NM_007294.4(BRCA1):c.2351C>G (p.Ser784Trp)	BRCA1	S784W	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000856874	17	41245197	17	43093180	856874	845426	rs55914168	NC_000017.11:43093179:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	784	BRCA1
NM_007294.4(BRCA1):c.2351C>T (p.Ser784Leu)	BRCA1	S784L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037464	17	41245197	17	43093180	37464	46020	rs55914168	NC_000017.11:43093179:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	784	BRCA1
NM_007294.4(BRCA1):c.2350T>G (p.Ser784Ala)	BRCA1	S784A	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054542	17	41245198	17	43093181	54542	69209	rs80357399	NC_000017.11:43093180:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	784	BRCA1
NM_007294.4(BRCA1):c.2348T>A (p.Ile783Asn)	BRCA1	I783N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001418291	17	41245200	17	43093183	1418291	1489887	rs562370358	NC_000017.11:43093182:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	783	BRCA1
NM_007294.4(BRCA1):c.2347A>G (p.Ile783Val)	BRCA1	I783V	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054541	17	41245201	17	43093184	54541	69208	rs80356948	NC_000017.11:43093183:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	783	BRCA1
NM_007294.4(BRCA1):c.2346T>A (p.Ser782Arg)	BRCA1	S782R	Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000496356	17	41245202	17	43093185	496356	487879	rs1555589837	NC_000017.11:43093184:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	782	BRCA1
NM_007294.4(BRCA1):c.2345G>T (p.Ser782Ile)	BRCA1	S782I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000569120	17	41245203	17	43093186	569120	569159	rs1567796012	NC_000017.11:43093185:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	782	BRCA1
NM_007294.4(BRCA1):c.2344A>G (p.Ser782Gly)	BRCA1	S782G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000570674	17	41245204	17	43093187	570674	571172	rs1433746078	NC_000017.11:43093186:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	782	BRCA1
NM_007294.4(BRCA1):c.2342A>C (p.Glu781Ala)	BRCA1	E781A	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000156186	17	41245206	17	43093189	156186	165985	rs587776482	NC_000017.11:43093188:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	781	BRCA1
NM_007294.4(BRCA1):c.2341G>A (p.Glu781Lys)	BRCA1	E781K	Hereditary cancer-predisposing syndrome	VCV002774852	17	41245207	17	43093190	2774852	2935579	NA	NC_000017.11:43093189:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	781	BRCA1
NM_007294.4(BRCA1):c.2341G>C (p.Glu781Gln)	BRCA1	E781Q	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000628750	17	41245207	17	43093190	628750	618644	rs757933953	NC_000017.11:43093189:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	781	BRCA1
NM_007294.4(BRCA1):c.2339A>G (p.Gln780Arg)	BRCA1	Q780R	Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000438919	17	41245209	17	43093192	438919	432910	rs1410232200	NC_000017.11:43093191:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	780	BRCA1
NM_007294.4(BRCA1):c.2338C>G (p.Gln780Glu)	BRCA1	Q780E	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer	VCV000091584	17	41245210	17	43093193	91584	97061	rs80356945	NC_000017.11:43093192:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	780	BRCA1
NM_007294.4(BRCA1):c.2338C>A (p.Gln780Lys)	BRCA1	Q780K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054539	17	41245210	17	43093193	54539	69206	rs80356945	NC_000017.11:43093192:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	780	BRCA1
NM_007294.4(BRCA1):c.2336C>T (p.Thr779Ile)	BRCA1	T779I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001516076	17	41245212	17	43093195	1516076	1407354	rs2154382857	NC_000017.11:43093194:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	779	BRCA1
NM_007294.4(BRCA1):c.2335A>C (p.Thr779Pro)	BRCA1	T779P	Hereditary cancer-predisposing syndrome|not specified	VCV001330114	17	41245213	17	43093196	1330114	1320796	rs1348270931	NC_000017.11:43093195:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	779	BRCA1
NM_007294.4(BRCA1):c.2335A>T (p.Thr779Ser)	BRCA1	T779S	Hereditary breast ovarian cancer syndrome	VCV001325663	17	41245213	17	43093196	1325663	1315928	rs1348270931	NC_000017.11:43093195:T:A	single nucleotide variant	missense variant|intron variant	Benign	Apr 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	779	BRCA1
NM_007294.4(BRCA1):c.2333G>A (p.Gly778Asp)	BRCA1	G778D	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182147	17	41245215	17	43093198	182147	180859	rs730881483	NC_000017.11:43093197:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	778	BRCA1
NM_007294.4(BRCA1):c.2330A>T (p.Tyr777Phe)	BRCA1	Y777F	Hereditary cancer-predisposing syndrome	VCV001789716	17	41245218	17	43093201	1789716	1847847	NA	NC_000017.11:43093200:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	777	BRCA1
NM_007294.4(BRCA1):c.2330A>G (p.Tyr777Cys)	BRCA1	Y777C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000133723	17	41245218	17	43093201	133723	137462	rs587778116	NC_000017.11:43093200:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	777	BRCA1
NM_007294.4(BRCA1):c.2329T>C (p.Tyr777His)	BRCA1	Y777H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000821108	17	41245219	17	43093202	821108	813803	rs397507199	NC_000017.11:43093201:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	777	BRCA1
NM_007294.4(BRCA1):c.2329T>G (p.Tyr777Asp)	BRCA1	Y777D	not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000037463	17	41245219	17	43093202	37463	46019	rs397507199	NC_000017.11:43093201:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	777	BRCA1
NM_007294.4(BRCA1):c.2324C>G (p.Thr775Ser)	BRCA1	T775S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002159540	17	41245224	17	43093207	2159540	1890546	NA	NC_000017.11:43093206:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	775	BRCA1
NM_007294.4(BRCA1):c.2324C>T (p.Thr775Ile)	BRCA1	T775I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000646088	17	41245224	17	43093207	646088	646006	rs1567796086	NC_000017.11:43093206:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	775	BRCA1
NM_007294.4(BRCA1):c.2321G>C (p.Gly774Ala)	BRCA1	G774A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001034998	17	41245227	17	43093210	1034998	1033319	rs730881482	NC_000017.11:43093209:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	774	BRCA1
NM_007294.4(BRCA1):c.2321G>A (p.Gly774Asp)	BRCA1	G774D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000182146	17	41245227	17	43093210	182146	180860	rs730881482	NC_000017.11:43093209:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	774	BRCA1
NM_007294.4(BRCA1):c.2320G>A (p.Gly774Ser)	BRCA1	G774S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001064262	17	41245228	17	43093211	1064262	1050307	rs1555589917	NC_000017.11:43093210:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	774	BRCA1
NM_007294.4(BRCA1):c.2320G>T (p.Gly774Cys)	BRCA1	G774C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462583	17	41245228	17	43093211	462583	468183	rs1555589917	NC_000017.11:43093210:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	774	BRCA1
NM_007294.4(BRCA1):c.2318C>G (p.Pro773Arg)	BRCA1	P773R	Hereditary cancer-predisposing syndrome	VCV001789512	17	41245230	17	43093213	1789512	1847643	NA	NC_000017.11:43093212:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	773	BRCA1
NM_007294.4(BRCA1):c.2318C>T (p.Pro773Leu)	BRCA1	P773L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000966441	17	41245230	17	43093213	966441	958131	rs2053781755	NC_000017.11:43093212:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	773	BRCA1
NM_007294.4(BRCA1):c.2315T>C (p.Val772Ala)	BRCA1	V772A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041809	17	41245233	17	43093216	41809	50248	rs80357467	NC_000017.11:43093215:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	772	BRCA1
NM_007294.4(BRCA1):c.2314G>T (p.Val772Leu)	BRCA1	V772L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000972567	17	41245234	17	43093217	972567	958132	rs1567796129	NC_000017.11:43093216:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	772	BRCA1
NM_007294.4(BRCA1):c.2314G>A (p.Val772Ile)	BRCA1	V772I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000576133	17	41245234	17	43093217	576133	574483	rs1567796129	NC_000017.11:43093216:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	772	BRCA1
NM_007294.4(BRCA1):c.2312T>C (p.Leu771Ser)	BRCA1	L771S	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000182145	17	41245236	17	43093219	182145	180861	rs730881481	NC_000017.11:43093218:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	771	BRCA1
NM_007294.4(BRCA1):c.2309C>T (p.Ser770Leu)	BRCA1	S770L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125553	17	41245239	17	43093222	125553	131091	rs80357063	NC_000017.11:43093221:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic	Jun 6, 2005	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	770	BRCA1
NM_007294.4(BRCA1):c.2306T>C (p.Ile769Thr)	BRCA1	I769T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001022688	17	41245242	17	43093225	1022688	1012777	rs372366481	NC_000017.11:43093224:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	769	BRCA1
NM_007294.4(BRCA1):c.2303G>A (p.Ser768Asn)	BRCA1	S768N	Hereditary cancer-predisposing syndrome	VCV000821002	17	41245245	17	43093228	821002	813804	rs1597870869	NC_000017.11:43093227:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	768	BRCA1
NM_007294.4(BRCA1):c.2302A>G (p.Ser768Gly)	BRCA1	S768G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000091583	17	41245246	17	43093229	91583	97060	rs398122656	NC_000017.11:43093228:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	768	BRCA1
NM_007294.4(BRCA1):c.2301C>A (p.Ser767Arg)	BRCA1	S767R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000955600	17	41245247	17	43093230	955600	949948	rs2053785413	NC_000017.11:43093229:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	767	BRCA1
NM_007294.4(BRCA1):c.2300G>C (p.Ser767Thr)	BRCA1	S767T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628413	17	41245248	17	43093231	628413	618645	rs1567796202	NC_000017.11:43093230:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	767	BRCA1
NM_007294.4(BRCA1):c.2299A>T (p.Ser767Cys)	BRCA1	S767C	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000091582	17	41245249	17	43093232	91582	97059	rs80357194	NC_000017.11:43093231:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	767	BRCA1
NM_007294.4(BRCA1):c.2299A>G (p.Ser767Gly)	BRCA1	S767G	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000037461	17	41245249	17	43093232	37461	46017	rs80357194	NC_000017.11:43093231:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	767	BRCA1
NM_007294.4(BRCA1):c.2298T>A (p.Ser766Arg)	BRCA1	S766R	Hereditary cancer-predisposing syndrome	VCV000821047	17	41245250	17	43093233	821047	813805	rs1597870899	NC_000017.11:43093232:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	766	BRCA1
NM_007294.4(BRCA1):c.2297G>C (p.Ser766Thr)	BRCA1	S766T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001382179	17	41245251	17	43093234	1382179	1434608	rs1567796224	NC_000017.11:43093233:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	766	BRCA1
NM_007294.4(BRCA1):c.2297G>A (p.Ser766Asn)	BRCA1	S766N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000578520	17	41245251	17	43093234	578520	571178	rs1567796224	NC_000017.11:43093233:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	766	BRCA1
NM_007294.4(BRCA1):c.2296A>C (p.Ser766Arg)	BRCA1	S766R	Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome	VCV000481438	17	41245252	17	43093235	481438	478777	rs398122655	NC_000017.11:43093234:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	766	BRCA1
NM_007294.4(BRCA1):c.2296A>G (p.Ser766Gly)	BRCA1	S766G	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000091581	17	41245252	17	43093235	91581	97058	rs398122655	NC_000017.11:43093234:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	766	BRCA1
NM_007294.4(BRCA1):c.2294A>G (p.Glu765Gly)	BRCA1	E765G	not provided|Hereditary cancer-predisposing syndrome	VCV000054525	17	41245254	17	43093237	54525	69192	rs80357085	NC_000017.11:43093236:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	765	BRCA1
NM_007294.4(BRCA1):c.2293G>A (p.Glu765Lys)	BRCA1	E765K	not provided	VCV003075765	17	41245255	17	43093238	3075765	3235056	NA	NC_000017.11:43093237:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 18, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	765	BRCA1
NM_007294.4(BRCA1):c.2293G>C (p.Glu765Gln)	BRCA1	E765Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001479206	17	41245255	17	43093238	1479206	1426577	rs80357449	NC_000017.11:43093237:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	765	BRCA1
NM_007294.4(BRCA1):c.2291T>C (p.Val764Ala)	BRCA1	V764A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001392157	17	41245257	17	43093240	1392157	1409498	rs1234701709	NC_000017.11:43093239:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	764	BRCA1
NM_007294.4(BRCA1):c.2290G>A (p.Val764Ile)	BRCA1	V764I	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000821044	17	41245258	17	43093241	821044	813807	rs768904580	NC_000017.11:43093240:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	764	BRCA1
NM_007294.4(BRCA1):c.2288C>A (p.Ser763Tyr)	BRCA1	S763Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000656279	17	41245260	17	43093243	656279	646007	rs876660112	NC_000017.11:43093242:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	763	BRCA1
NM_007294.4(BRCA1):c.2288C>G (p.Ser763Cys)	BRCA1	S763C	Hereditary cancer-predisposing syndrome	VCV000232980	17	41245260	17	43093243	232980	236084	rs876660112	NC_000017.11:43093242:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	763	BRCA1
NM_007294.4(BRCA1):c.2286A>T (p.Arg762Ser)	BRCA1	R762S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054522	17	41245262	17	43093245	54522	69189	rs273898682	NC_000017.11:43093244:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	762	BRCA1
NM_007294.4(BRCA1):c.2283A>C (p.Glu761Asp)	BRCA1	E761D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000619018	17	41245265	17	43093248	619018	610417	rs1567796302	NC_000017.11:43093247:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	761	BRCA1
NM_007294.4(BRCA1):c.2282A>G (p.Glu761Gly)	BRCA1	E761G	Hereditary cancer-predisposing syndrome	VCV001788957	17	41245266	17	43093249	1788957	1841170	NA	NC_000017.11:43093248:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	761	BRCA1
NM_007294.4(BRCA1):c.2282A>C (p.Glu761Ala)	BRCA1	E761A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000054520	17	41245266	17	43093249	54520	69187	rs80356869	NC_000017.11:43093248:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	761	BRCA1
NM_007294.4(BRCA1):c.2281G>C (p.Glu761Gln)	BRCA1	E761Q	Hereditary breast ovarian cancer syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000185726	17	41245267	17	43093250	185726	185026	rs397507198	NC_000017.11:43093249:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	761	BRCA1
NM_007294.4(BRCA1):c.2281G>A (p.Glu761Lys)	BRCA1	E761K	Hereditary cancer-predisposing syndrome	VCV000037460	17	41245267	17	43093250	37460	46016	rs397507198	NC_000017.11:43093249:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	761	BRCA1
NM_007294.4(BRCA1):c.2279C>T (p.Thr760Ile)	BRCA1	T760I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000659006	17	41245269	17	43093252	659006	646008	rs1161074446	NC_000017.11:43093251:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	760	BRCA1
NM_007294.4(BRCA1):c.2278A>G (p.Thr760Ala)	BRCA1	T760A	Hereditary cancer-predisposing syndrome	VCV001788885	17	41245270	17	43093253	1788885	1841099	NA	NC_000017.11:43093252:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	760	BRCA1
NM_007294.4(BRCA1):c.2274G>T (p.Leu758Phe)	BRCA1	L758F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000854873	17	41245274	17	43093257	854873	845428	rs876660823	NC_000017.11:43093256:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	758	BRCA1
NM_007294.4(BRCA1):c.2269G>T (p.Val757Phe)	BRCA1	V757F	not specified|Hereditary cancer-predisposing syndrome	VCV000438918	17	41245279	17	43093262	438918	432911	rs772617029	NC_000017.11:43093261:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	757	BRCA1
NM_007294.4(BRCA1):c.2268G>T (p.Arg756Ser)	BRCA1	R756S	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Breast neoplasm|Hereditary cancer-predisposing syndrome	VCV000224428	17	41245280	17	43093263	224428	226204	rs80356884	NC_000017.11:43093262:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	756	BRCA1
NM_007294.4(BRCA1):c.2268G>C (p.Arg756Ser)	BRCA1	R756S	Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054518	17	41245280	17	43093263	54518	69185	rs80356884	NC_000017.11:43093262:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	756	BRCA1
NM_007294.4(BRCA1):c.2267G>C (p.Arg756Thr)	BRCA1	R756T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000966335	17	41245281	17	43093264	966335	958134	rs975724885	NC_000017.11:43093263:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	756	BRCA1
NM_007294.4(BRCA1):c.2267G>A (p.Arg756Lys)	BRCA1	R756K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441329	17	41245281	17	43093264	441329	435155	rs975724885	NC_000017.11:43093263:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	756	BRCA1
NM_007294.4(BRCA1):c.2266A>G (p.Arg756Gly)	BRCA1	R756G	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000421371	17	41245282	17	43093265	421371	410003	rs1064795091	NC_000017.11:43093264:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	756	BRCA1
NM_007294.4(BRCA1):c.2264A>C (p.Glu755Ala)	BRCA1	E755A	Hereditary cancer-predisposing syndrome|not provided	VCV000619787	17	41245284	17	43093267	619787	611242	rs922908090	NC_000017.11:43093266:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	755	BRCA1
NM_007294.4(BRCA1):c.2264A>G (p.Glu755Gly)	BRCA1	E755G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482906	17	41245284	17	43093267	482906	479415	rs922908090	NC_000017.11:43093266:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	755	BRCA1
NM_007294.4(BRCA1):c.2263G>A (p.Glu755Lys)	BRCA1	E755K	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000230102	17	41245285	17	43093268	230102	236086	rs41286296	NC_000017.11:43093267:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	755	BRCA1
NM_007294.4(BRCA1):c.2260G>A (p.Gly754Arg)	BRCA1	G754R	Hereditary cancer-predisposing syndrome	VCV001788629	17	41245288	17	43093271	1788629	1844689	NA	NC_000017.11:43093270:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	754	BRCA1
NM_007294.4(BRCA1):c.2259T>G (p.Ser753Arg)	BRCA1	S753R	not provided|Hereditary cancer-predisposing syndrome	VCV000182144	17	41245289	17	43093272	182144	180862	rs730881480	NC_000017.11:43093271:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	753	BRCA1
NM_007294.4(BRCA1):c.2258G>C (p.Ser753Thr)	BRCA1	S753T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001788551	17	41245290	17	43093273	1788551	1844611	NA	NC_000017.11:43093272:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	753	BRCA1
NM_007294.4(BRCA1):c.2258G>A (p.Ser753Asn)	BRCA1	S753N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000240782	17	41245290	17	43093273	240782	242791	rs878854939	NC_000017.11:43093272:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	753	BRCA1
NM_007294.4(BRCA1):c.2253G>C (p.Met751Ile)	BRCA1	M751I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462581	17	41245295	17	43093278	462581	467964	rs1555590040	NC_000017.11:43093277:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	751	BRCA1
NM_007294.4(BRCA1):c.2252T>C (p.Met751Thr)	BRCA1	M751T	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000141357	17	41245296	17	43093279	141357	151071	rs587781684	NC_000017.11:43093278:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	751	BRCA1
NM_007294.4(BRCA1):c.2249T>C (p.Leu750Pro)	BRCA1	L750P	not provided|Hereditary cancer-predisposing syndrome	VCV000496354	17	41245299	17	43093282	496354	487724	rs1555590048	NC_000017.11:43093281:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	750	BRCA1
NM_007294.4(BRCA1):c.2248C>A (p.Leu750Ile)	BRCA1	L750I	not provided|Hereditary cancer-predisposing syndrome	VCV000993135	17	41245300	17	43093283	993135	981172	rs2053794986	NC_000017.11:43093282:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	750	BRCA1
NM_007294.4(BRCA1):c.2246A>G (p.Asp749Gly)	BRCA1	D749G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000947747	17	41245302	17	43093285	947747	928309	rs730881479	NC_000017.11:43093284:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	749	BRCA1
NM_007294.4(BRCA1):c.2246A>T (p.Asp749Val)	BRCA1	D749V	not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182143	17	41245302	17	43093285	182143	180863	rs730881479	NC_000017.11:43093284:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	749	BRCA1
NM_007294.4(BRCA1):c.2245G>A (p.Asp749Asn)	BRCA1	D749N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240781	17	41245303	17	43093286	240781	242792	rs80357114	NC_000017.11:43093285:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	749	BRCA1
NM_007294.4(BRCA1):c.2245G>C (p.Asp749His)	BRCA1	D749H	Hereditary cancer-predisposing syndrome	VCV000125550	17	41245303	17	43093286	125550	131088	rs80357114	NC_000017.11:43093285:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	749	BRCA1
NM_007294.4(BRCA1):c.2245G>T (p.Asp749Tyr)	BRCA1	D749Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000054512	17	41245303	17	43093286	54512	69179	rs80357114	NC_000017.11:43093285:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	749	BRCA1
NM_007294.4(BRCA1):c.2243A>G (p.Lys748Arg)	BRCA1	K748R	not provided|Hereditary cancer-predisposing syndrome	VCV000631383	17	41245305	17	43093288	631383	618647	rs1567796448	NC_000017.11:43093287:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	748	BRCA1
NM_007294.4(BRCA1):c.2242A>G (p.Lys748Glu)	BRCA1	K748E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000665745	17	41245306	17	43093289	665745	646009	rs760810832	NC_000017.11:43093288:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	748	BRCA1
NM_007294.4(BRCA1):c.2240C>T (p.Pro747Leu)	BRCA1	P747L	Hereditary cancer-predisposing syndrome	VCV001788275	17	41245308	17	43093291	1788275	1844338	NA	NC_000017.11:43093290:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	747	BRCA1
NM_007294.4(BRCA1):c.2239C>A (p.Pro747Thr)	BRCA1	P747T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002128273	17	41245309	17	43093292	2128273	2182276	NA	NC_000017.11:43093291:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	747	BRCA1
NM_007294.4(BRCA1):c.2239C>T (p.Pro747Ser)	BRCA1	P747S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000462580	17	41245309	17	43093292	462580	466886	rs1555590087	NC_000017.11:43093291:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	747	BRCA1
NM_007294.4(BRCA1):c.2238C>A (p.Asp746Glu)	BRCA1	D746E	Hereditary cancer-predisposing syndrome	VCV000186185	17	41245310	17	43093293	186185	185027	rs786202757	NC_000017.11:43093292:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	746	BRCA1
NM_007294.4(BRCA1):c.2237A>T (p.Asp746Val)	BRCA1	D746V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002683814	17	41245311	17	43093294	2683814	2844852	NA	NC_000017.11:43093293:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	Sep 1, 2023	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	746	BRCA1
NM_007294.4(BRCA1):c.2237A>C (p.Asp746Ala)	BRCA1	D746A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001373190	17	41245311	17	43093294	1373190	1463190	rs2154388675	NC_000017.11:43093293:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	746	BRCA1
NM_007294.4(BRCA1):c.2236G>A (p.Asp746Asn)	BRCA1	D746N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001019393	17	41245312	17	43093295	1019393	1012778	rs876660267	NC_000017.11:43093294:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	746	BRCA1
NM_007294.4(BRCA1):c.2236G>T (p.Asp746Tyr)	BRCA1	D746Y	Hereditary cancer-predisposing syndrome	VCV000233217	17	41245312	17	43093295	233217	236087	rs876660267	NC_000017.11:43093294:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	746	BRCA1
NM_007294.4(BRCA1):c.2235A>C (p.Glu745Asp)	BRCA1	E745D	Hereditary cancer-predisposing syndrome	VCV000233216	17	41245313	17	43093296	233216	236088	rs876660266	NC_000017.11:43093295:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	745	BRCA1
NM_007294.4(BRCA1):c.2231C>T (p.Ala744Val)	BRCA1	A744V	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001319808	17	41245317	17	43093300	1319808	1310057	rs786204220	NC_000017.11:43093299:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	744	BRCA1
NM_007294.4(BRCA1):c.2231C>A (p.Ala744Asp)	BRCA1	A744D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000188330	17	41245317	17	43093300	188330	186258	rs786204220	NC_000017.11:43093299:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	744	BRCA1
NM_007294.4(BRCA1):c.2230G>T (p.Ala744Ser)	BRCA1	A744S	Hereditary cancer-predisposing syndrome	VCV002585821	17	41245318	17	43093301	2585821	2753381	NA	NC_000017.11:43093300:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	744	BRCA1
NM_007294.4(BRCA1):c.2230G>C (p.Ala744Pro)	BRCA1	A744P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001979063	17	41245318	17	43093301	1979063	2038240	NA	NC_000017.11:43093300:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	744	BRCA1
NM_007294.4(BRCA1):c.2230G>A (p.Ala744Thr)	BRCA1	A744T	Hereditary cancer-predisposing syndrome	VCV000187051	17	41245318	17	43093301	187051	185029	rs786203435	NC_000017.11:43093300:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	744	BRCA1
NM_007294.4(BRCA1):c.2228A>G (p.Asn743Ser)	BRCA1	N743S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000628747	17	41245320	17	43093303	628747	618648	rs1567796489	NC_000017.11:43093302:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	743	BRCA1
NM_007294.4(BRCA1):c.2227A>T (p.Asn743Tyr)	BRCA1	N743Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069232	17	41245321	17	43093304	3069232	3229859	NA	NC_000017.11:43093303:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	743	BRCA1
NM_007294.4(BRCA1):c.2227A>G (p.Asn743Asp)	BRCA1	N743D	Hereditary breast ovarian cancer syndrome	VCV002696704	17	41245321	17	43093304	2696704	2858123	NA	NC_000017.11:43093303:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	743	BRCA1
NM_007294.4(BRCA1):c.2227A>C (p.Asn743His)	BRCA1	N743H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482913	17	41245321	17	43093304	482913	478658	rs1212635015	NC_000017.11:43093303:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	743	BRCA1
NM_007294.4(BRCA1):c.2225A>G (p.Asn742Ser)	BRCA1	N742S	Hereditary cancer-predisposing syndrome|not specified	VCV000403717	17	41245323	17	43093306	403717	390694	rs1060499618	NC_000017.11:43093305:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	742	BRCA1
NM_007294.4(BRCA1):c.2224A>G (p.Asn742Asp)	BRCA1	N742D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000230731	17	41245324	17	43093307	230731	236089	rs876658733	NC_000017.11:43093306:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	742	BRCA1
NM_007294.4(BRCA1):c.2222C>A (p.Ser741Tyr)	BRCA1	S741Y	Hereditary breast ovarian cancer syndrome	VCV002809079	17	41245326	17	43093309	2809079	2965030	NA	NC_000017.11:43093308:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	741	BRCA1
NM_007294.4(BRCA1):c.2222C>T (p.Ser741Phe)	BRCA1	S741F	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054507	17	41245326	17	43093309	54507	69174	rs80357051	NC_000017.11:43093308:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	741	BRCA1
NM_007294.4(BRCA1):c.2222C>G (p.Ser741Cys)	BRCA1	S741C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054506	17	41245326	17	43093309	54506	69173	rs80357051	NC_000017.11:43093308:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	741	BRCA1
NM_007294.4(BRCA1):c.2221T>C (p.Ser741Pro)	BRCA1	S741P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000945077	17	41245327	17	43093310	945077	928310	rs2053800581	NC_000017.11:43093309:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	741	BRCA1
NM_007294.4(BRCA1):c.2218G>A (p.Val740Met)	BRCA1	V740M	Hereditary cancer-predisposing syndrome	VCV000820887	17	41245330	17	43093313	820887	813808	rs80357415	NC_000017.11:43093312:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	740	BRCA1
NM_007294.4(BRCA1):c.2218G>T (p.Val740Leu)	BRCA1	V740L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000185481	17	41245330	17	43093313	185481	185030	rs80357415	NC_000017.11:43093312:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	740	BRCA1
NM_007294.4(BRCA1):c.2218G>C (p.Val740Leu)	BRCA1	V740L	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054505	17	41245330	17	43093313	54505	69172	rs80357415	NC_000017.11:43093312:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	740	BRCA1
NM_007294.4(BRCA1):c.2217A>C (p.Lys739Asn)	BRCA1	K739N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531343	17	41245331	17	43093314	531343	531283	rs200521980	NC_000017.11:43093313:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	739	BRCA1
NM_007294.4(BRCA1):c.2215A>C (p.Lys739Gln)	BRCA1	K739Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531240	17	41245333	17	43093316	531240	531352	rs56329598	NC_000017.11:43093315:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	739	BRCA1
NM_007294.4(BRCA1):c.2215A>G (p.Lys739Glu)	BRCA1	K739E	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000481479	17	41245333	17	43093316	481479	479422	rs56329598	NC_000017.11:43093315:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	739	BRCA1
NM_007294.4(BRCA1):c.2212G>C (p.Val738Leu)	BRCA1	V738L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002108545	17	41245336	17	43093319	2108545	2159959	NA	NC_000017.11:43093318:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	738	BRCA1
NM_007294.4(BRCA1):c.2210C>G (p.Thr737Arg)	BRCA1	T737R	Hereditary cancer-predisposing syndrome	VCV001687136	17	41245338	17	43093321	1687136	1679430	rs2154392997	NC_000017.11:43093320:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	737	BRCA1
NM_007294.4(BRCA1):c.2209A>G (p.Thr737Ala)	BRCA1	T737A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000584951	17	41245339	17	43093322	584951	576000	rs1567796585	NC_000017.11:43093321:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	737	BRCA1
NM_007294.4(BRCA1):c.2207A>G (p.Glu736Gly)	BRCA1	E736G	Hereditary cancer-predisposing syndrome	VCV000481433	17	41245341	17	43093324	481433	478731	rs397507196	NC_000017.11:43093323:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	736	BRCA1
NM_007294.4(BRCA1):c.2207A>C (p.Glu736Ala)	BRCA1	E736A	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037455	17	41245341	17	43093324	37455	46011	rs397507196	NC_000017.11:43093323:T:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Mar 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	736	BRCA1
NM_007294.4(BRCA1):c.2206G>A (p.Glu736Lys)	BRCA1	E736K	Hereditary cancer-predisposing syndrome	VCV001787693	17	41245342	17	43093325	1787693	1850673	NA	NC_000017.11:43093324:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	736	BRCA1
NM_007294.4(BRCA1):c.2206G>C (p.Glu736Gln)	BRCA1	E736Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001717822	17	41245342	17	43093325	1717822	1771798	NA	NC_000017.11:43093324:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	736	BRCA1
NM_007294.4(BRCA1):c.2203C>G (p.Leu735Val)	BRCA1	L735V	not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000141481	17	41245345	17	43093328	141481	151195	rs587781781	NC_000017.11:43093327:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	735	BRCA1
NM_007294.4(BRCA1):c.2200A>G (p.Lys734Glu)	BRCA1	K734E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000955992	17	41245348	17	43093331	955992	949949	rs2053806415	NC_000017.11:43093330:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	734	BRCA1
NM_007294.4(BRCA1):c.2195A>G (p.Glu732Gly)	BRCA1	E732G	Hereditary cancer-predisposing syndrome	VCV000919819	17	41245353	17	43093336	919819	913930	rs876660463	NC_000017.11:43093335:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	732	BRCA1
NM_007294.4(BRCA1):c.2195A>C (p.Glu732Ala)	BRCA1	E732A	Hereditary cancer-predisposing syndrome	VCV000233526	17	41245353	17	43093336	233526	236090	rs876660463	NC_000017.11:43093335:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	732	BRCA1
NM_007294.4(BRCA1):c.2194G>A (p.Glu732Lys)	BRCA1	E732K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001787465	17	41245354	17	43093337	1787465	1850446	NA	NC_000017.11:43093336:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	732	BRCA1
NM_007294.4(BRCA1):c.2185G>A (p.Glu729Lys)	BRCA1	E729K	Hereditary cancer-predisposing syndrome	VCV000232579	17	41245363	17	43093346	232579	236091	rs876659852	NC_000017.11:43093345:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	729	BRCA1
NM_007294.4(BRCA1):c.2183G>C (p.Arg728Thr)	BRCA1	R728T	Hereditary cancer-predisposing syndrome|not specified	VCV000633093	17	41245365	17	43093348	633093	621585	rs80357335	NC_000017.11:43093347:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	728	BRCA1
NM_007294.4(BRCA1):c.2183G>A (p.Arg728Lys)	BRCA1	R728K	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054487	17	41245365	17	43093348	54487	69154	rs80357335	NC_000017.11:43093347:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	728	BRCA1
NM_007294.4(BRCA1):c.2182A>G (p.Arg728Gly)	BRCA1	R728G	Hereditary cancer-predisposing syndrome|not provided	VCV000496353	17	41245366	17	43093349	496353	487885	rs1555590265	NC_000017.11:43093348:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	728	BRCA1
NM_007294.4(BRCA1):c.2180C>T (p.Pro727Leu)	BRCA1	P727L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054486	17	41245368	17	43093351	54486	69153	rs80356912	NC_000017.11:43093350:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	727	BRCA1
NM_007294.4(BRCA1):c.2177T>C (p.Leu726Pro)	BRCA1	L726P	Hereditary cancer-predisposing syndrome|not specified	VCV000431185	17	41245371	17	43093354	431185	424713	rs1135401827	NC_000017.11:43093353:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	726	BRCA1
NM_007294.4(BRCA1):c.2176C>T (p.Leu726Phe)	BRCA1	L726F	Hereditary cancer-predisposing syndrome	VCV003261482	17	41245372	17	43093355	3261482	3424250	NA	NC_000017.11:43093354:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	726	BRCA1
NM_007294.4(BRCA1):c.2175C>G (p.Ser725Arg)	BRCA1	S725R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001992952	17	41245373	17	43093356	1992952	2052605	NA	NC_000017.11:43093355:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	725	BRCA1
NM_007294.4(BRCA1):c.2174G>T (p.Ser725Ile)	BRCA1	S725I	Hereditary breast ovarian cancer syndrome	VCV002736836	17	41245374	17	43093357	2736836	2905406	NA	NC_000017.11:43093356:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	725	BRCA1
NM_007294.4(BRCA1):c.2174G>C (p.Ser725Thr)	BRCA1	S725T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531211	17	41245374	17	43093357	531211	531287	rs1555590284	NC_000017.11:43093356:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	725	BRCA1
NM_007294.4(BRCA1):c.2173A>G (p.Ser725Gly)	BRCA1	S725G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000438917	17	41245375	17	43093358	438917	432912	rs1555590290	NC_000017.11:43093357:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	725	BRCA1
NM_007294.4(BRCA1):c.2170_2172delinsTCC (p.Pro724Ser)	BRCA1	P724S	not provided|Hereditary cancer-predisposing syndrome	VCV001787082	17	41245376 - 41245378	17	43093359 - 43093361	1787082	1840603	NA	NC_000017.11:43093358:AGG:GGA	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	724	BRCA1
NM_007294.4(BRCA1):c.2171C>T (p.Pro724Leu)	BRCA1	P724L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000581291	17	41245377	17	43093360	581291	571453	rs751104940	NC_000017.11:43093359:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	724	BRCA1
NM_007294.4(BRCA1):c.2170C>A (p.Pro724Thr)	BRCA1	P724T	Hereditary breast ovarian cancer syndrome	VCV002705998	17	41245378	17	43093361	2705998	2877323	NA	NC_000017.11:43093360:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	724	BRCA1
NM_007294.4(BRCA1):c.2170C>T (p.Pro724Ser)	BRCA1	P724S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001364297	17	41245378	17	43093361	1364297	1386236	rs2154395681	NC_000017.11:43093360:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	724	BRCA1
NM_007294.4(BRCA1):c.2168A>G (p.Asn723Ser)	BRCA1	N723S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001787009	17	41245380	17	43093363	1787009	1840530	NA	NC_000017.11:43093362:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	723	BRCA1
NM_007294.4(BRCA1):c.2167A>G (p.Asn723Asp)	BRCA1	N723D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037454	17	41245381	17	43093364	37454	46010	rs4986845	NC_000017.11:43093363:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	723	BRCA1
NM_007294.4(BRCA1):c.2165T>C (p.Val722Ala)	BRCA1	V722A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462576	17	41245383	17	43093366	462576	467968	rs1555590311	NC_000017.11:43093365:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	722	BRCA1
NM_007294.4(BRCA1):c.2164G>T (p.Val722Phe)	BRCA1	V722F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001720088	17	41245384	17	43093367	1720088	1779127	NA	NC_000017.11:43093366:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	722	BRCA1
NM_007294.4(BRCA1):c.2162T>G (p.Phe721Cys)	BRCA1	F721C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001481945	17	41245386	17	43093369	1481945	1445181	rs2154396157	NC_000017.11:43093368:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	721	BRCA1
NM_007294.4(BRCA1):c.2161T>C (p.Phe721Leu)	BRCA1	F721L	Hereditary cancer-predisposing syndrome|not specified	VCV001330065	17	41245387	17	43093370	1330065	1320748	rs2154396226	NC_000017.11:43093369:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	721	BRCA1
NM_007294.4(BRCA1):c.2159A>G (p.Glu720Gly)	BRCA1	E720G	Hereditary cancer-predisposing syndrome|not provided	VCV001310166	17	41245389	17	43093372	1310166	1302016	rs2053814550	NC_000017.11:43093371:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	720	BRCA1
NM_007294.4(BRCA1):c.2158G>C (p.Glu720Gln)	BRCA1	E720Q	Hereditary cancer-predisposing syndrome	VCV000921272	17	41245390	17	43093373	921272	913931	rs80356875	NC_000017.11:43093372:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	720	BRCA1
NM_007294.4(BRCA1):c.2158G>A (p.Glu720Lys)	BRCA1	E720K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000054479	17	41245390	17	43093373	54479	69146	rs80356875	NC_000017.11:43093372:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	720	BRCA1
NM_007294.4(BRCA1):c.2156A>C (p.Lys719Thr)	BRCA1	K719T	Hereditary cancer-predisposing syndrome	VCV000234201	17	41245392	17	43093375	234201	236092	rs876660920	NC_000017.11:43093374:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	719	BRCA1
NM_007294.4(BRCA1):c.2155A>G (p.Lys719Glu)	BRCA1	K719E	BRCA1-related cancer predisposition	VCV000037452	17	41245393	17	43093376	37452	46008	rs80357147	NC_000017.11:43093375:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	719	BRCA1
NM_007294.4(BRCA1):c.2153T>C (p.Leu718Pro)	BRCA1	L718P	Hereditary cancer-predisposing syndrome|not specified	VCV001330123	17	41245395	17	43093378	1330123	1320805	rs748550848	NC_000017.11:43093377:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	718	BRCA1
NM_007294.4(BRCA1):c.2153T>G (p.Leu718Arg)	BRCA1	L718R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder	VCV000482963	17	41245395	17	43093378	482963	478732	rs748550848	NC_000017.11:43093377:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	718	BRCA1
NM_007294.4(BRCA1):c.2150A>G (p.Glu717Gly)	BRCA1	E717G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001515824	17	41245398	17	43093381	1515824	1407103	rs2154396821	NC_000017.11:43093380:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	717	BRCA1
NM_007294.4(BRCA1):c.2149G>A (p.Glu717Lys)	BRCA1	E717K	Hereditary breast ovarian cancer syndrome	VCV002736594	17	41245399	17	43093382	2736594	2905173	NA	NC_000017.11:43093381:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	717	BRCA1
NM_007294.4(BRCA1):c.2148T>A (p.Ser716Arg)	BRCA1	S716R	not provided|Hereditary cancer-predisposing syndrome	VCV000182142	17	41245400	17	43093383	182142	180864	rs730881478	NC_000017.11:43093382:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	716	BRCA1
NM_007294.4(BRCA1):c.2147G>C (p.Ser716Thr)	BRCA1	S716T	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000496352	17	41245401	17	43093384	496352	487977	rs1555590369	NC_000017.11:43093383:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	716	BRCA1
NM_007294.4(BRCA1):c.2146A>G (p.Ser716Gly)	BRCA1	S716G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001172246	17	41245402	17	43093385	1172246	1161362	rs2053817086	NC_000017.11:43093384:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	716	BRCA1
NM_007294.4(BRCA1):c.2144C>G (p.Thr715Ser)	BRCA1	T715S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000922509	17	41245404	17	43093387	922509	913932	rs2053817641	NC_000017.11:43093386:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	715	BRCA1
NM_007294.4(BRCA1):c.2143A>G (p.Thr715Ala)	BRCA1	T715A	Hereditary breast ovarian cancer syndrome	VCV002752906	17	41245405	17	43093388	2752906	2913647	NA	NC_000017.11:43093387:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	715	BRCA1
NM_007294.4(BRCA1):c.2143A>T (p.Thr715Ser)	BRCA1	T715S	not provided|Hereditary cancer-predisposing syndrome	VCV000182141	17	41245405	17	43093388	182141	180865	rs730881477	NC_000017.11:43093387:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	715	BRCA1
NM_007294.4(BRCA1):c.2140A>C (p.Asn714His)	BRCA1	N714H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000964322	17	41245408	17	43093391	964322	949950	rs568312345	NC_000017.11:43093390:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	714	BRCA1
NM_007294.4(BRCA1):c.2140A>G (p.Asn714Asp)	BRCA1	N714D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000922899	17	41245408	17	43093391	922899	913933	rs568312345	NC_000017.11:43093390:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	714	BRCA1
NM_007294.4(BRCA1):c.2135G>A (p.Cys712Tyr)	BRCA1	C712Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001463053	17	41245413	17	43093396	1463053	1511490	rs1555590395	NC_000017.11:43093395:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	712	BRCA1
NM_007294.4(BRCA1):c.2135G>T (p.Cys712Phe)	BRCA1	C712F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482921	17	41245413	17	43093396	482921	478662	rs1555590395	NC_000017.11:43093395:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	712	BRCA1
NM_007294.4(BRCA1):c.2134T>C (p.Cys712Arg)	BRCA1	C712R	Hereditary cancer-predisposing syndrome	VCV000185228	17	41245414	17	43093397	185228	185032	rs786202015	NC_000017.11:43093396:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	712	BRCA1
NM_007294.4(BRCA1):c.2132A>C (p.Lys711Thr)	BRCA1	K711T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002082889	17	41245416	17	43093399	2082889	2143401	NA	NC_000017.11:43093398:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	711	BRCA1
NM_007294.4(BRCA1):c.2131A>C (p.Lys711Gln)	BRCA1	K711Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000409331	17	41245417	17	43093400	409331	402025	rs747046197	NC_000017.11:43093399:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	711	BRCA1
NM_007294.4(BRCA1):c.2131A>G (p.Lys711Glu)	BRCA1	K711E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Ovarian cancer	VCV000229793	17	41245417	17	43093400	229793	236093	rs747046197	NC_000017.11:43093399:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	711	BRCA1
NM_007294.4(BRCA1):c.2129C>T (p.Thr710Ile)	BRCA1	T710I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV001308175	17	41245419	17	43093402	1308175	1296796	rs2053820830	NC_000017.11:43093401:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	710	BRCA1
NM_007294.4(BRCA1):c.2128A>G (p.Thr710Ala)	BRCA1	T710A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000232737	17	41245420	17	43093403	232737	236094	rs876659959	NC_000017.11:43093402:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	710	BRCA1
NM_007294.4(BRCA1):c.2126T>C (p.Phe709Ser)	BRCA1	F709S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001387599	17	41245422	17	43093405	1387599	1474324	rs1567796937	NC_000017.11:43093404:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	709	BRCA1
NM_007294.4(BRCA1):c.2126T>G (p.Phe709Cys)	BRCA1	F709C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000569527	17	41245422	17	43093405	569527	571465	rs1567796937	NC_000017.11:43093404:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	709	BRCA1
NM_007294.4(BRCA1):c.2125T>G (p.Phe709Val)	BRCA1	F709V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000844787	17	41245423	17	43093406	844787	845430	rs2053822369	NC_000017.11:43093405:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	709	BRCA1
NM_007294.4(BRCA1):c.2123C>G (p.Ser708Cys)	BRCA1	S708C	Hereditary cancer-predisposing syndrome	VCV000485400	17	41245425	17	43093408	485400	478783	rs80357182	NC_000017.11:43093407:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	708	BRCA1
NM_007294.4(BRCA1):c.2123C>T (p.Ser708Phe)	BRCA1	S708F	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related disorder|not specified	VCV000091576	17	41245425	17	43093408	91576	97053	rs80357182	NC_000017.11:43093407:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	708	BRCA1
NM_007294.4(BRCA1):c.2123C>A (p.Ser708Tyr)	BRCA1	S708Y	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037447	17	41245425	17	43093408	37447	46003	rs80357182	NC_000017.11:43093407:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	708	BRCA1
NM_007294.4(BRCA1):c.2120G>T (p.Gly707Val)	BRCA1	G707V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069233	17	41245428	17	43093411	3069233	3229860	NA	NC_000017.11:43093410:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	707	BRCA1
NM_007294.4(BRCA1):c.2120G>C (p.Gly707Ala)	BRCA1	G707A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002692283	17	41245428	17	43093411	2692283	2853285	NA	NC_000017.11:43093410:C:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Mar 2, 2020	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	707	BRCA1
NM_007294.4(BRCA1):c.2119_2120delinsTT (p.Gly707Phe)	BRCA1	G707F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002138042	17	41245428 - 41245429	17	43093411 - 43093412	2138042	1871651	NA	NC_000017.11:43093410:CC:AA	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	707	BRCA1
NM_007294.4(BRCA1):c.2120G>A (p.Gly707Asp)	BRCA1	G707D	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000054468	17	41245428	17	43093411	54468	69135	rs80357192	NC_000017.11:43093410:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	707	BRCA1
NM_007294.4(BRCA1):c.2119G>A (p.Gly707Ser)	BRCA1	G707S	Hereditary breast ovarian cancer syndrome	VCV002796224	17	41245429	17	43093412	2796224	2954762	NA	NC_000017.11:43093411:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	707	BRCA1
NM_007294.4(BRCA1):c.2119G>T (p.Gly707Cys)	BRCA1	G707C	Hereditary cancer-predisposing syndrome	VCV001786208	17	41245429	17	43093412	1786208	1846960	NA	NC_000017.11:43093411:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	707	BRCA1
NM_007294.4(BRCA1):c.2119G>C (p.Gly707Arg)	BRCA1	G707R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000140990	17	41245429	17	43093412	140990	150704	rs587781420	NC_000017.11:43093411:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	707	BRCA1
NM_007294.4(BRCA1):c.2117C>G (p.Pro706Arg)	BRCA1	P706R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001501635	17	41245431	17	43093414	1501635	1398503	rs759655692	NC_000017.11:43093413:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	706	BRCA1
NM_007294.4(BRCA1):c.2117C>T (p.Pro706Leu)	BRCA1	P706L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000628627	17	41245431	17	43093414	628627	618651	rs759655692	NC_000017.11:43093413:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	706	BRCA1
NM_007294.4(BRCA1):c.2116C>T (p.Pro706Ser)	BRCA1	P706S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000656956	17	41245432	17	43093415	656956	646012	rs1597872071	NC_000017.11:43093414:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	706	BRCA1
NM_007294.4(BRCA1):c.2114C>T (p.Ala705Val)	BRCA1	A705V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001380811	17	41245434	17	43093417	1380811	1499654	rs2154398643	NC_000017.11:43093416:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	705	BRCA1
NM_007294.4(BRCA1):c.2113G>T (p.Ala705Ser)	BRCA1	A705S	Hereditary breast ovarian cancer syndrome	VCV002777860	17	41245435	17	43093418	2777860	2936856	NA	NC_000017.11:43093417:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	705	BRCA1
NM_007294.4(BRCA1):c.2113G>A (p.Ala705Thr)	BRCA1	A705T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000820748	17	41245435	17	43093418	820748	813812	rs1597872085	NC_000017.11:43093417:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	705	BRCA1
NM_007294.4(BRCA1):c.2111A>G (p.Asn704Ser)	BRCA1	N704S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000972025	17	41245437	17	43093420	972025	958136	rs2053824395	NC_000017.11:43093419:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	704	BRCA1
NM_007294.4(BRCA1):c.2110A>G (p.Asn704Asp)	BRCA1	N704D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001786099	17	41245438	17	43093421	1786099	1846852	NA	NC_000017.11:43093420:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	704	BRCA1
NM_007294.4(BRCA1):c.2110A>C (p.Asn704His)	BRCA1	N704H	Hereditary cancer-predisposing syndrome	VCV000820741	17	41245438	17	43093421	820741	813813	rs1597872096	NC_000017.11:43093420:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	704	BRCA1
NM_007294.4(BRCA1):c.2108C>T (p.Thr703Ile)	BRCA1	T703I	Hereditary cancer-predisposing syndrome	VCV000441434	17	41245440	17	43093423	441434	435156	rs1302055573	NC_000017.11:43093422:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	703	BRCA1
NM_007294.4(BRCA1):c.2107A>G (p.Thr703Ala)	BRCA1	T703A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000924723	17	41245441	17	43093424	924723	913934	rs2053825384	NC_000017.11:43093423:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	703	BRCA1
NM_007294.4(BRCA1):c.2102A>G (p.Lys701Arg)	BRCA1	K701R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000229967	17	41245446	17	43093429	229967	236095	rs876658307	NC_000017.11:43093428:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	701	BRCA1
NM_007294.4(BRCA1):c.2099T>A (p.Leu700Gln)	BRCA1	L700Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000820712	17	41245449	17	43093432	820712	813814	rs1567797015	NC_000017.11:43093431:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	700	BRCA1
NM_007294.4(BRCA1):c.2099T>C (p.Leu700Pro)	BRCA1	L700P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631155	17	41245449	17	43093432	631155	618652	rs1567797015	NC_000017.11:43093431:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	700	BRCA1
NM_007294.4(BRCA1):c.2098C>G (p.Leu700Val)	BRCA1	L700V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV001330120	17	41245450	17	43093433	1330120	1320802	rs775424259	NC_000017.11:43093432:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	700	BRCA1
NM_007294.4(BRCA1):c.2097G>C (p.Glu699Asp)	BRCA1	E699D	Hereditary breast ovarian cancer syndrome	VCV002794473	17	41245451	17	43093434	2794473	2954308	NA	NC_000017.11:43093433:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	699	BRCA1
NM_007294.4(BRCA1):c.2096A>T (p.Glu699Val)	BRCA1	E699V	Hereditary cancer-predisposing syndrome	VCV003226112	17	41245452	17	43093435	3226112	3390617	NA	NC_000017.11:43093434:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	699	BRCA1
NM_007294.4(BRCA1):c.2096A>G (p.Glu699Gly)	BRCA1	E699G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000820705	17	41245452	17	43093435	820705	813815	rs1597872173	NC_000017.11:43093434:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	699	BRCA1
NM_007294.4(BRCA1):c.2095G>C (p.Glu699Gln)	BRCA1	E699Q	Hereditary cancer-predisposing syndrome	VCV000229966	17	41245453	17	43093436	229966	236097	rs876658306	NC_000017.11:43093435:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	699	BRCA1
NM_007294.4(BRCA1):c.2093C>T (p.Pro698Leu)	BRCA1	P698L	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000482905	17	41245455	17	43093438	482905	478734	rs1555590478	NC_000017.11:43093437:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	698	BRCA1
NM_007294.4(BRCA1):c.2091C>G (p.Phe697Leu)	BRCA1	F697L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001785737	17	41245457	17	43093440	1785737	1849995	NA	NC_000017.11:43093439:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	697	BRCA1
NM_007294.4(BRCA1):c.2090T>G (p.Phe697Cys)	BRCA1	F697C	Hereditary cancer-predisposing syndrome	VCV001785733	17	41245458	17	43093441	1785733	1849991	NA	NC_000017.11:43093440:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	697	BRCA1
NM_007294.4(BRCA1):c.2090T>A (p.Phe697Tyr)	BRCA1	F697Y	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000633092	17	41245458	17	43093441	633092	621586	rs730881476	NC_000017.11:43093440:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	697	BRCA1
NM_007294.4(BRCA1):c.2090T>C (p.Phe697Ser)	BRCA1	F697S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000182140	17	41245458	17	43093441	182140	180866	rs730881476	NC_000017.11:43093440:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	697	BRCA1
NM_007294.4(BRCA1):c.2089T>C (p.Phe697Leu)	BRCA1	F697L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001038907	17	41245459	17	43093442	1038907	1033320	rs2053828310	NC_000017.11:43093441:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	697	BRCA1
NM_007294.4(BRCA1):c.2087C>T (p.Thr696Ile)	BRCA1	T696I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000861683	17	41245461	17	43093444	861683	845431	rs1334969117	NC_000017.11:43093443:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	696	BRCA1
NM_007294.4(BRCA1):c.2086A>G (p.Thr696Ala)	BRCA1	T696A	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054457	17	41245462	17	43093445	54457	69124	rs80357441	NC_000017.11:43093444:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	696	BRCA1
NM_007294.4(BRCA1):c.2084A>G (p.Asp695Gly)	BRCA1	D695G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001785607	17	41245464	17	43093447	1785607	1840404	NA	NC_000017.11:43093446:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	695	BRCA1
NM_007294.4(BRCA1):c.2083G>T (p.Asp695Tyr)	BRCA1	D695Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054456	17	41245465	17	43093448	54456	69123	rs28897681	NC_000017.11:43093447:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	695	BRCA1
NM_007294.4(BRCA1):c.2083G>A (p.Asp695Asn)	BRCA1	D695N	not specified|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054455	17	41245465	17	43093448	54455	69122	rs28897681	NC_000017.11:43093447:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	695	BRCA1
NM_007294.4(BRCA1):c.2078_2082delinsGCAGT (p.Asp693Gly)	BRCA1	D693G	Hereditary cancer-predisposing syndrome|not specified	VCV000928534	17	41245466 - 41245470	17	43093449 - 43093453	928534	917256	rs2053829800	NC_000017.11:43093448:GCTGT:ACTGC	Indel	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	693	BRCA1
NM_007294.4(BRCA1):c.2081G>C (p.Ser694Thr)	BRCA1	S694T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002099300	17	41245467	17	43093450	2099300	2150621	NA	NC_000017.11:43093449:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	694	BRCA1
NM_007294.4(BRCA1):c.2081G>A (p.Ser694Asn)	BRCA1	S694N	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000096904	17	41245467	17	43093450	96904	102807	rs431825388	NC_000017.11:43093449:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	694	BRCA1
NM_007294.4(BRCA1):c.2080A>G (p.Ser694Gly)	BRCA1	S694G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002193246	17	41245468	17	43093451	2193246	1932395	NA	NC_000017.11:43093450:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	694	BRCA1
NM_007294.4(BRCA1):c.2079C>G (p.Asp693Glu)	BRCA1	D693E	Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV002565368	17	41245469	17	43093452	2565368	2732341	NA	NC_000017.11:43093451:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	693	BRCA1
NM_007294.4(BRCA1):c.2078A>G (p.Asp693Gly)	BRCA1	D693G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000630129	17	41245470	17	43093453	630129	618653	rs756748588	NC_000017.11:43093452:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	693	BRCA1
NM_007294.4(BRCA1):c.2077G>T (p.Asp693Tyr)	BRCA1	D693Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125534	17	41245471	17	43093454	125534	131072	rs4986850	NC_000017.11:43093453:C:A	single nucleotide variant	missense variant|intron variant	Benign	Dec 17, 2010	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	693	BRCA1
NM_007294.4(BRCA1):c.2077G>A (p.Asp693Asn)	BRCA1	D693N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041808	17	41245471	17	43093454	41808	50247	rs4986850	NC_000017.11:43093453:C:T	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	693	BRCA1
NM_007294.4(BRCA1):c.2076T>A (p.His692Gln)	BRCA1	H692Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142622	17	41245472	17	43093455	142622	152336	rs587782595	NC_000017.11:43093454:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	692	BRCA1
NM_007294.4(BRCA1):c.2075A>G (p.His692Arg)	BRCA1	H692R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001785447	17	41245473	17	43093456	1785447	1840244	NA	NC_000017.11:43093455:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	692	BRCA1
NM_007294.4(BRCA1):c.2075A>C (p.His692Pro)	BRCA1	H692P	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000872254	17	41245473	17	43093456	872254	860391	rs2053831947	NC_000017.11:43093455:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	692	BRCA1
NM_007294.4(BRCA1):c.2074C>T (p.His692Tyr)	BRCA1	H692Y	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000433700	17	41245474	17	43093457	433700	427558	rs545736576	NC_000017.11:43093456:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	692	BRCA1
NM_007294.4(BRCA1):c.2072G>C (p.Arg691Thr)	BRCA1	R691T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000438916	17	41245476	17	43093459	438916	432913	rs1555590574	NC_000017.11:43093458:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	691	BRCA1
NM_007294.4(BRCA1):c.2071A>G (p.Arg691Gly)	BRCA1	R691G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000820636	17	41245477	17	43093460	820636	813816	rs1597872365	NC_000017.11:43093459:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	691	BRCA1
NM_007294.4(BRCA1):c.2069A>G (p.Lys690Arg)	BRCA1	K690R	Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV001395723	17	41245479	17	43093462	1395723	1425122	rs2154401162	NC_000017.11:43093461:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	690	BRCA1
NM_007294.4(BRCA1):c.2068A>G (p.Lys690Glu)	BRCA1	K690E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141034	17	41245480	17	43093463	141034	150748	rs587781448	NC_000017.11:43093462:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	690	BRCA1
NM_007294.4(BRCA1):c.2067T>G (p.Ser689Arg)	BRCA1	S689R	Hereditary breast ovarian cancer syndrome	VCV002733684	17	41245481	17	43093464	2733684	2898019	NA	NC_000017.11:43093463:A:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jun 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	689	BRCA1
NM_007294.4(BRCA1):c.2066G>A (p.Ser689Asn)	BRCA1	S689N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001720073	17	41245482	17	43093465	1720073	1779112	NA	NC_000017.11:43093464:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	689	BRCA1
NM_007294.4(BRCA1):c.2066G>C (p.Ser689Thr)	BRCA1	S689T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001492029	17	41245482	17	43093465	1492029	1446260	rs779748579	NC_000017.11:43093464:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	689	BRCA1
NM_007294.4(BRCA1):c.2065A>G (p.Ser689Gly)	BRCA1	S689G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified	VCV000233092	17	41245483	17	43093466	233092	236098	rs876660188	NC_000017.11:43093465:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	689	BRCA1
NM_007294.4(BRCA1):c.2063C>G (p.Thr688Arg)	BRCA1	T688R	Hereditary cancer-predisposing syndrome	VCV001785257	17	41245485	17	43093468	1785257	1840054	NA	NC_000017.11:43093467:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	688	BRCA1
NM_007294.4(BRCA1):c.2062A>G (p.Thr688Ala)	BRCA1	T688A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000820629	17	41245486	17	43093469	820629	813818	rs1597872432	NC_000017.11:43093468:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	688	BRCA1
NM_007294.4(BRCA1):c.2061G>C (p.Gln687His)	BRCA1	Q687H	Hereditary cancer-predisposing syndrome	VCV001785241	17	41245487	17	43093470	1785241	1840038	NA	NC_000017.11:43093469:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	687	BRCA1
NM_007294.4(BRCA1):c.2060A>G (p.Gln687Arg)	BRCA1	Q687R	Hereditary cancer-predisposing syndrome	VCV001785219	17	41245488	17	43093471	1785219	1840016	NA	NC_000017.11:43093470:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	687	BRCA1
NM_007294.4(BRCA1):c.2060A>C (p.Gln687Pro)	BRCA1	Q687P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000037443	17	41245488	17	43093471	37443	45999	rs28897680	NC_000017.11:43093470:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	687	BRCA1
NM_007294.4(BRCA1):c.2058A>T (p.Glu686Asp)	BRCA1	E686D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000619622	17	41245490	17	43093473	619622	611244	rs1262148583	NC_000017.11:43093472:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	686	BRCA1
NM_007294.4(BRCA1):c.2056G>A (p.Glu686Lys)	BRCA1	E686K	Hereditary breast ovarian cancer syndrome	VCV002757397	17	41245492	17	43093475	2757397	2917269	NA	NC_000017.11:43093474:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	686	BRCA1
NM_007294.4(BRCA1):c.2055T>A (p.Asn685Lys)	BRCA1	N685K	Hereditary cancer-predisposing syndrome	VCV003226111	17	41245493	17	43093476	3226111	3390616	NA	NC_000017.11:43093475:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 25, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	685	BRCA1
NM_007294.4(BRCA1):c.2053A>G (p.Asn685Asp)	BRCA1	N685D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002124491	17	41245495	17	43093478	2124491	2184952	NA	NC_000017.11:43093477:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	685	BRCA1
NM_007294.4(BRCA1):c.2051C>T (p.Pro684Leu)	BRCA1	P684L	Hereditary cancer-predisposing syndrome	VCV001785077	17	41245497	17	43093480	1785077	1843722	NA	NC_000017.11:43093479:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	684	BRCA1
NM_007294.4(BRCA1):c.2050C>A (p.Pro684Thr)	BRCA1	P684T	Hereditary cancer-predisposing syndrome	VCV000187671	17	41245498	17	43093481	187671	185034	rs397508934	NC_000017.11:43093480:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	684	BRCA1
NM_007294.4(BRCA1):c.2050C>T (p.Pro684Ser)	BRCA1	P684S	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054447	17	41245498	17	43093481	54447	69114	rs397508934	NC_000017.11:43093480:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	684	BRCA1
NM_007294.4(BRCA1):c.2048A>G (p.Lys683Arg)	BRCA1	K683R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000409357	17	41245500	17	43093483	409357	402039	rs1060502357	NC_000017.11:43093482:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	683	BRCA1
NM_007294.4(BRCA1):c.2047A>C (p.Lys683Gln)	BRCA1	K683Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001972548	17	41245501	17	43093484	1972548	2026107	NA	NC_000017.11:43093483:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	683	BRCA1
NM_007294.4(BRCA1):c.2047A>G (p.Lys683Glu)	BRCA1	K683E	Hereditary cancer-predisposing syndrome	VCV001784986	17	41245501	17	43093484	1784986	1843631	NA	NC_000017.11:43093483:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	683	BRCA1
NM_007294.4(BRCA1):c.2045A>G (p.Asn682Ser)	BRCA1	N682S	Hereditary breast ovarian cancer syndrome|not provided	VCV002570989	17	41245503	17	43093486	2570989	2735946	NA	NC_000017.11:43093485:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	682	BRCA1
NM_007294.4(BRCA1):c.2044A>G (p.Asn682Asp)	BRCA1	N682D	Hereditary cancer-predisposing syndrome	VCV001784943	17	41245504	17	43093487	1784943	1843588	NA	NC_000017.11:43093486:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	682	BRCA1
NM_007294.4(BRCA1):c.2043T>G (p.Ser681Arg)	BRCA1	S681R	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000230089	17	41245505	17	43093488	230089	236099	rs143920945	NC_000017.11:43093487:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	681	BRCA1
NM_007294.4(BRCA1):c.2042G>T (p.Ser681Ile)	BRCA1	S681I	Hereditary cancer-predisposing syndrome	VCV002774855	17	41245506	17	43093489	2774855	1245719	NA	NC_000017.11:43093488:C:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	681	BRCA1
NM_007294.4(BRCA1):c.2042G>A (p.Ser681Asn)	BRCA1	S681N	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000630466	17	41245506	17	43093489	630466	618654	rs1452826319	NC_000017.11:43093488:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	681	BRCA1
NM_007294.4(BRCA1):c.2039A>G (p.Lys680Arg)	BRCA1	K680R	Hereditary cancer-predisposing syndrome|not provided	VCV000182139	17	41245509	17	43093492	182139	180867	rs730881475	NC_000017.11:43093491:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	680	BRCA1
NM_007294.4(BRCA1):c.2038A>G (p.Lys680Glu)	BRCA1	K680E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629034	17	41245510	17	43093493	629034	618655	rs1135401850	NC_000017.11:43093492:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	680	BRCA1
NM_007294.4(BRCA1):c.2036A>G (p.Lys679Arg)	BRCA1	K679R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001470480	17	41245512	17	43093495	1470480	1372442	rs2053838870	NC_000017.11:43093494:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	679	BRCA1
NM_007294.4(BRCA1):c.2036A>C (p.Lys679Thr)	BRCA1	K679T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000838783	17	41245512	17	43093495	838783	845432	rs2053838870	NC_000017.11:43093494:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	679	BRCA1
NM_007294.4(BRCA1):c.2033C>T (p.Ala678Val)	BRCA1	A678V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462574	17	41245515	17	43093498	462574	468208	rs1555590634	NC_000017.11:43093497:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	678	BRCA1
NM_007294.4(BRCA1):c.2030G>T (p.Gly677Val)	BRCA1	G677V	Hereditary breast ovarian cancer syndrome	VCV002823978	17	41245518	17	43093501	2823978	2982491	NA	NC_000017.11:43093500:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	677	BRCA1
NM_007294.4(BRCA1):c.2029G>A (p.Gly677Arg)	BRCA1	G677R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000641832	17	41245519	17	43093502	641832	646013	rs1597872603	NC_000017.11:43093501:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	677	BRCA1
NM_007294.4(BRCA1):c.2027C>T (p.Thr676Ile)	BRCA1	T676I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000820542	17	41245521	17	43093504	820542	813823	rs1597872628	NC_000017.11:43093503:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	676	BRCA1
NM_007294.4(BRCA1):c.2026A>G (p.Thr676Ala)	BRCA1	T676A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000926207	17	41245522	17	43093505	926207	913936	rs1268006720	NC_000017.11:43093504:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	676	BRCA1
NM_007294.4(BRCA1):c.2024C>T (p.Ala675Val)	BRCA1	A675V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001395965	17	41245524	17	43093507	1395965	1350744	rs2154403344	NC_000017.11:43093506:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	675	BRCA1
NM_007294.4(BRCA1):c.2023G>A (p.Ala675Thr)	BRCA1	A675T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000656387	17	41245525	17	43093508	656387	646014	rs1597872640	NC_000017.11:43093507:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	675	BRCA1
NM_007294.4(BRCA1):c.2021C>G (p.Pro674Arg)	BRCA1	P674R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000233643	17	41245527	17	43093510	233643	236101	rs876660543	NC_000017.11:43093509:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	674	BRCA1
NM_007294.4(BRCA1):c.2020C>A (p.Pro674Thr)	BRCA1	P674T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001784548	17	41245528	17	43093511	1784548	1846608	NA	NC_000017.11:43093510:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	674	BRCA1
NM_007294.4(BRCA1):c.2020C>T (p.Pro674Ser)	BRCA1	P674S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001477650	17	41245528	17	43093511	1477650	1436529	rs1567797243	NC_000017.11:43093510:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	674	BRCA1
NM_007294.4(BRCA1):c.2017G>C (p.Glu673Gln)	BRCA1	E673Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000661099	17	41245531	17	43093514	661099	646016	rs80357391	NC_000017.11:43093513:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	673	BRCA1
NM_007294.4(BRCA1):c.2014A>G (p.Lys672Glu)	BRCA1	K672E	Hereditary cancer-predisposing syndrome	VCV000186344	17	41245534	17	43093517	186344	185035	rs397508929	NC_000017.11:43093516:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	672	BRCA1
NM_007294.4(BRCA1):c.2011G>A (p.Gly671Ser)	BRCA1	G671S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001961006	17	41245537	17	43093520	1961006	2009947	NA	NC_000017.11:43093519:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	671	BRCA1
NM_007294.4(BRCA1):c.2008G>A (p.Glu670Lys)	BRCA1	E670K	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054433	17	41245540	17	43093523	54433	69100	rs80357029	NC_000017.11:43093522:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	670	BRCA1
NM_007294.4(BRCA1):c.2006T>A (p.Met669Lys)	BRCA1	M669K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002108546	17	41245542	17	43093525	2108546	2159960	NA	NC_000017.11:43093524:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	669	BRCA1
NM_007294.4(BRCA1):c.2006T>C (p.Met669Thr)	BRCA1	M669T	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037442	17	41245542	17	43093525	37442	45998	rs80356895	NC_000017.11:43093524:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	669	BRCA1
NM_007294.4(BRCA1):c.2005A>T (p.Met669Leu)	BRCA1	M669L	not specified|Hereditary cancer-predisposing syndrome	VCV002581472	17	41245543	17	43093526	2581472	2749052	NA	NC_000017.11:43093525:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	669	BRCA1
NM_007294.4(BRCA1):c.2005A>C (p.Met669Leu)	BRCA1	M669L	Hereditary cancer-predisposing syndrome	VCV001784306	17	41245543	17	43093526	1784306	1849865	NA	NC_000017.11:43093525:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	669	BRCA1
NM_007294.4(BRCA1):c.2005A>G (p.Met669Val)	BRCA1	M669V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000933240	17	41245543	17	43093526	933240	937965	rs561988641	NC_000017.11:43093525:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	669	BRCA1
NM_007294.4(BRCA1):c.2002C>T (p.Leu668Phe)	BRCA1	L668F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037441	17	41245546	17	43093529	37441	45997	rs80357250	NC_000017.11:43093528:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	668	BRCA1
NM_007294.4(BRCA1):c.1997T>C (p.Leu666Pro)	BRCA1	L666P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000584952	17	41245551	17	43093534	584952	576001	rs1567797346	NC_000017.11:43093533:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	666	BRCA1
NM_007294.4(BRCA1):c.1996C>A (p.Leu666Ile)	BRCA1	L666I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001198624	17	41245552	17	43093535	1198624	1188542	rs1555590709	NC_000017.11:43093534:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	666	BRCA1
NM_007294.4(BRCA1):c.1996C>G (p.Leu666Val)	BRCA1	L666V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482892	17	41245552	17	43093535	482892	478740	rs1555590709	NC_000017.11:43093534:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	666	BRCA1
NM_007294.4(BRCA1):c.1995C>G (p.Asn665Lys)	BRCA1	N665K	Hereditary cancer-predisposing syndrome	VCV000054428	17	41245553	17	43093536	54428	69095	rs80357238	NC_000017.11:43093535:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	665	BRCA1
NM_007294.4(BRCA1):c.1988G>C (p.Ser663Thr)	BRCA1	S663T	Hereditary breast ovarian cancer syndrome	VCV002755848	17	41245560	17	43093543	2755848	2917020	NA	NC_000017.11:43093542:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	663	BRCA1
NM_007294.4(BRCA1):c.1988G>A (p.Ser663Asn)	BRCA1	S663N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001716726	17	41245560	17	43093543	1716726	1778407	NA	NC_000017.11:43093542:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	663	BRCA1
NM_007294.4(BRCA1):c.1987A>G (p.Ser663Gly)	BRCA1	S663G	Hereditary breast ovarian cancer syndrome	VCV002708709	17	41245561	17	43093544	2708709	2871000	NA	NC_000017.11:43093543:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 12, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	663	BRCA1
NM_007294.4(BRCA1):c.1985A>G (p.His662Arg)	BRCA1	H662R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054427	17	41245563	17	43093546	54427	69094	rs80357494	NC_000017.11:43093545:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	662	BRCA1
NM_007294.4(BRCA1):c.1984C>T (p.His662Tyr)	BRCA1	H662Y	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054426	17	41245564	17	43093547	54426	69093	rs397508927	NC_000017.11:43093546:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	662	BRCA1
NM_007294.4(BRCA1):c.1982G>T (p.Arg661Met)	BRCA1	R661M	Hereditary cancer-predisposing syndrome	VCV001783834	17	41245566	17	43093549	1783834	1839930	NA	NC_000017.11:43093548:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	661	BRCA1
NM_007294.4(BRCA1):c.1982G>A (p.Arg661Lys)	BRCA1	R661K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001679000	17	41245566	17	43093549	1679000	1670794	rs2053848136	NC_000017.11:43093548:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	661	BRCA1
NM_007294.4(BRCA1):c.1981A>G (p.Arg661Gly)	BRCA1	R661G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462573	17	41245567	17	43093550	462573	467735	rs1555590724	NC_000017.11:43093549:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	661	BRCA1
NM_007294.4(BRCA1):c.1979T>C (p.Val660Ala)	BRCA1	V660A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000573388	17	41245569	17	43093552	573388	574484	rs1567797385	NC_000017.11:43093551:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	660	BRCA1
NM_007294.4(BRCA1):c.1978G>T (p.Val660Phe)	BRCA1	V660F	Hereditary cancer-predisposing syndrome	VCV000820458	17	41245570	17	43093553	820458	813824	rs876660889	NC_000017.11:43093552:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	660	BRCA1
NM_007294.4(BRCA1):c.1978G>A (p.Val660Ile)	BRCA1	V660I	Inherited ovarian cancer (without breast cancer)|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000234157	17	41245570	17	43093553	234157	236102	rs876660889	NC_000017.11:43093552:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	660	BRCA1
NM_007294.4(BRCA1):c.1976C>G (p.Pro659Arg)	BRCA1	P659R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001004775	17	41245572	17	43093555	1004775	997580	rs1258526903	NC_000017.11:43093554:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	659	BRCA1
NM_007294.4(BRCA1):c.1976C>T (p.Pro659Leu)	BRCA1	P659L	Hereditary cancer-predisposing syndrome|not specified	VCV000929017	17	41245572	17	43093555	929017	917257	rs1258526903	NC_000017.11:43093554:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	659	BRCA1
NM_007294.4(BRCA1):c.1975C>T (p.Pro659Ser)	BRCA1	P659S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002177977	17	41245573	17	43093556	2177977	1915787	NA	NC_000017.11:43093555:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	659	BRCA1
NM_007294.4(BRCA1):c.1975C>G (p.Pro659Ala)	BRCA1	P659A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000156185	17	41245573	17	43093556	156185	165984	rs587776481	NC_000017.11:43093555:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	659	BRCA1
NM_007294.4(BRCA1):c.1974G>A (p.Met658Ile)	BRCA1	M658I	Hereditary breast ovarian cancer syndrome	VCV001168433	17	41245574	17	43093557	1168433	1157986	rs55678461	NC_000017.11:43093556:C:T	single nucleotide variant	intron variant|missense variant	Benign	Aug 14, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	658	BRCA1
NM_007294.4(BRCA1):c.1974G>C (p.Met658Ile)	BRCA1	M658I	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000054425	17	41245574	17	43093557	54425	69092	rs55678461	NC_000017.11:43093556:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	658	BRCA1
NM_007294.4(BRCA1):c.1972A>G (p.Met658Val)	BRCA1	M658V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001946625	17	41245576	17	43093559	1946625	1999032	NA	NC_000017.11:43093558:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	658	BRCA1
NM_007294.4(BRCA1):c.1969C>A (p.Gln657Lys)	BRCA1	Q657K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531381	17	41245579	17	43093562	531381	531592	rs397508926	NC_000017.11:43093561:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	657	BRCA1
NM_007294.4(BRCA1):c.1968C>G (p.Asn656Lys)	BRCA1	N656K	Hereditary breast ovarian cancer syndrome	VCV002760114	17	41245580	17	43093563	2760114	2910926	NA	NC_000017.11:43093562:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	656	BRCA1
NM_007294.4(BRCA1):c.1967A>G (p.Asn656Ser)	BRCA1	N656S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054422	17	41245581	17	43093564	54422	69089	rs397508925	NC_000017.11:43093563:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	656	BRCA1
NM_007294.4(BRCA1):c.1966A>T (p.Asn656Tyr)	BRCA1	N656Y	Hereditary cancer-predisposing syndrome	VCV000559977	17	41245582	17	43093565	559977	550696	rs786203455	NC_000017.11:43093564:T:A	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	656	BRCA1
NM_007294.4(BRCA1):c.1966A>G (p.Asn656Asp)	BRCA1	N656D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000187080	17	41245582	17	43093565	187080	185036	rs786203455	NC_000017.11:43093564:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	656	BRCA1
NM_007294.4(BRCA1):c.1964A>G (p.Tyr655Cys)	BRCA1	Y655C	Hereditary cancer-predisposing syndrome	VCV001783490	17	41245584	17	43093567	1783490	1839586	NA	NC_000017.11:43093566:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	655	BRCA1
NM_007294.4(BRCA1):c.1963_1964delinsAT (p.Tyr655Ile)	BRCA1	Y655I	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000633094	17	41245584 - 41245585	17	43093567 - 43093568	633094	621587	rs1567797539	NC_000017.11:43093566:TA:AT	Indel	intron variant|missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	655	BRCA1
NM_007294.4(BRCA1):c.1964A>T (p.Tyr655Phe)	BRCA1	Y655F	Hereditary cancer-predisposing syndrome	VCV000054421	17	41245584	17	43093567	54421	69088	rs80357193	NC_000017.11:43093566:T:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	655	BRCA1
NM_007294.4(BRCA1):c.1963T>G (p.Tyr655Asp)	BRCA1	Y655D	Hereditary cancer-predisposing syndrome	VCV000054418	17	41245585	17	43093568	54418	69085	rs80357166	NC_000017.11:43093567:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	655	BRCA1
NM_007294.4(BRCA1):c.1962G>C (p.Lys654Asn)	BRCA1	K654N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002005560	17	41245586	17	43093569	2005560	2052324	NA	NC_000017.11:43093568:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	654	BRCA1
NM_007294.4(BRCA1):c.1960A>C (p.Lys654Gln)	BRCA1	K654Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000572395	17	41245588	17	43093571	572395	571474	rs80357355	NC_000017.11:43093570:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	654	BRCA1
NM_007294.4(BRCA1):c.1960A>G (p.Lys654Glu)	BRCA1	K654E	Hereditary cancer-predisposing syndrome	VCV000054415	17	41245588	17	43093571	54415	69082	rs80357355	NC_000017.11:43093570:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	654	BRCA1
NM_007294.4(BRCA1):c.1954A>G (p.Lys652Glu)	BRCA1	K652E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628623	17	41245594	17	43093577	628623	618656	rs1567797589	NC_000017.11:43093576:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	652	BRCA1
NM_007294.4(BRCA1):c.1951A>G (p.Lys651Glu)	BRCA1	K651E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000641842	17	41245597	17	43093580	641842	646017	rs1555590804	NC_000017.11:43093579:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	651	BRCA1
NM_007294.4(BRCA1):c.1951A>C (p.Lys651Gln)	BRCA1	K651Q	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000491038	17	41245597	17	43093580	491038	485369	rs1555590804	NC_000017.11:43093579:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	651	BRCA1
NM_007294.4(BRCA1):c.1949T>G (p.Ile650Arg)	BRCA1	I650R	Hereditary cancer-predisposing syndrome	VCV000479216	17	41245599	17	43093582	479216	478785	rs1555590816	NC_000017.11:43093581:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	650	BRCA1
NM_007294.4(BRCA1):c.1949T>C (p.Ile650Thr)	BRCA1	I650T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462572	17	41245599	17	43093582	462572	468214	rs1555590816	NC_000017.11:43093581:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	650	BRCA1
NM_007294.4(BRCA1):c.1948A>G (p.Ile650Val)	BRCA1	I650V	Hereditary cancer-predisposing syndrome	VCV001783156	17	41245600	17	43093583	1783156	1843101	NA	NC_000017.11:43093582:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	650	BRCA1
NM_007294.4(BRCA1):c.1945G>A (p.Glu649Lys)	BRCA1	E649K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV002011023	17	41245603	17	43093586	2011023	2074097	NA	NC_000017.11:43093585:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	649	BRCA1
NM_007294.4(BRCA1):c.1945G>C (p.Glu649Gln)	BRCA1	E649Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054407	17	41245603	17	43093586	54407	69074	rs80356907	NC_000017.11:43093585:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	649	BRCA1
NM_007294.4(BRCA1):c.1943A>G (p.Glu648Gly)	BRCA1	E648G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002007395	17	41245605	17	43093588	2007395	2062755	NA	NC_000017.11:43093587:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	648	BRCA1
NM_007294.4(BRCA1):c.1942G>A (p.Glu648Lys)	BRCA1	E648K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721686	17	41245606	17	43093589	1721686	1779404	NA	NC_000017.11:43093588:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	648	BRCA1
NM_007294.4(BRCA1):c.1937G>A (p.Ser646Asn)	BRCA1	S646N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000925846	17	41245611	17	43093594	925846	913937	rs2053857094	NC_000017.11:43093593:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	646	BRCA1
NM_007294.4(BRCA1):c.1934C>G (p.Ser645Cys)	BRCA1	S645C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531244	17	41245614	17	43093597	531244	531294	rs80357129	NC_000017.11:43093596:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	645	BRCA1
NM_007294.4(BRCA1):c.1934C>A (p.Ser645Tyr)	BRCA1	S645Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000054404	17	41245614	17	43093597	54404	69071	rs80357129	NC_000017.11:43093596:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	645	BRCA1
NM_007294.4(BRCA1):c.1933T>C (p.Ser645Pro)	BRCA1	S645P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000654416	17	41245615	17	43093598	654416	646018	rs1597873252	NC_000017.11:43093597:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	645	BRCA1
NM_007294.4(BRCA1):c.1932T>G (p.Cys644Trp)	BRCA1	C644W	Hereditary cancer-predisposing syndrome	VCV000054403	17	41245616	17	43093599	54403	69070	rs397508918	NC_000017.11:43093598:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	644	BRCA1
NM_007294.4(BRCA1):c.1931G>C (p.Cys644Ser)	BRCA1	C644S	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000630428	17	41245617	17	43093600	630428	618657	rs876658606	NC_000017.11:43093599:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	644	BRCA1
NM_007294.4(BRCA1):c.1931G>T (p.Cys644Phe)	BRCA1	C644F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230514	17	41245617	17	43093600	230514	236104	rs876658606	NC_000017.11:43093599:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	644	BRCA1
NM_007294.4(BRCA1):c.1930T>G (p.Cys644Gly)	BRCA1	C644G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001005082	17	41245618	17	43093601	1005082	997581	rs753521391	NC_000017.11:43093600:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	644	BRCA1
NM_007294.4(BRCA1):c.1930T>A (p.Cys644Ser)	BRCA1	C644S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409347	17	41245618	17	43093601	409347	402042	rs753521391	NC_000017.11:43093600:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	644	BRCA1
NM_007294.4(BRCA1):c.1929T>A (p.Ser643Arg)	BRCA1	S643R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001988462	17	41245619	17	43093602	1988462	2047610	NA	NC_000017.11:43093601:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	643	BRCA1
NM_007294.4(BRCA1):c.1929T>G (p.Ser643Arg)	BRCA1	S643R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409362	17	41245619	17	43093602	409362	402103	rs1060502361	NC_000017.11:43093601:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	643	BRCA1
NM_007294.4(BRCA1):c.1928G>T (p.Ser643Ile)	BRCA1	S643I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233327	17	41245620	17	43093603	233327	236105	rs876660335	NC_000017.11:43093602:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	643	BRCA1
NM_007294.4(BRCA1):c.1927A>G (p.Ser643Gly)	BRCA1	S643G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054402	17	41245621	17	43093604	54402	69069	rs80357105	NC_000017.11:43093603:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	643	BRCA1
NM_007294.4(BRCA1):c.1925A>T (p.Asp642Val)	BRCA1	D642V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001504838	17	41245623	17	43093606	1504838	1417588	rs786204049	NC_000017.11:43093605:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	642	BRCA1
NM_007294.4(BRCA1):c.1925A>G (p.Asp642Gly)	BRCA1	D642G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000188072	17	41245623	17	43093606	188072	186259	rs786204049	NC_000017.11:43093605:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	642	BRCA1
NM_007294.4(BRCA1):c.1924G>A (p.Asp642Asn)	BRCA1	D642N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000631379	17	41245624	17	43093607	631379	618658	rs80357344	NC_000017.11:43093606:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	642	BRCA1
NM_007294.4(BRCA1):c.1924G>T (p.Asp642Tyr)	BRCA1	D642Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000448991	17	41245624	17	43093607	448991	445778	rs80357344	NC_000017.11:43093606:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	642	BRCA1
NM_007294.4(BRCA1):c.1924G>C (p.Asp642His)	BRCA1	D642H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054401	17	41245624	17	43093607	54401	69068	rs80357344	NC_000017.11:43093606:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	642	BRCA1
NM_007294.4(BRCA1):c.1922T>C (p.Ile641Thr)	BRCA1	I641T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000182138	17	41245626	17	43093609	182138	180868	rs730881474	NC_000017.11:43093608:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	641	BRCA1
NM_007294.4(BRCA1):c.1920A>C (p.Gln640His)	BRCA1	Q640H	Hereditary cancer-predisposing syndrome	VCV000820342	17	41245628	17	43093611	820342	813827	rs587782843	NC_000017.11:43093610:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	640	BRCA1
NM_007294.4(BRCA1):c.1920A>T (p.Gln640His)	BRCA1	Q640H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000142950	17	41245628	17	43093611	142950	152664	rs587782843	NC_000017.11:43093610:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	640	BRCA1
NM_007294.4(BRCA1):c.1919A>C (p.Gln640Pro)	BRCA1	Q640P	Hereditary cancer-predisposing syndrome	VCV000187742	17	41245629	17	43093612	187742	185040	rs786203965	NC_000017.11:43093611:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	640	BRCA1
NM_007294.4(BRCA1):c.1917G>T (p.Leu639Phe)	BRCA1	L639F	Hereditary cancer-predisposing syndrome	VCV000820338	17	41245631	17	43093614	820338	813828	rs786202103	NC_000017.11:43093613:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	639	BRCA1
NM_007294.4(BRCA1):c.1913A>C (p.Glu638Ala)	BRCA1	E638A	Hereditary cancer-predisposing syndrome	VCV000185123	17	41245635	17	43093618	185123	185042	rs786201944	NC_000017.11:43093617:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	638	BRCA1
NM_007294.4(BRCA1):c.1912G>A (p.Glu638Lys)	BRCA1	E638K	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000037433	17	41245636	17	43093619	37433	45989	rs80357005	NC_000017.11:43093618:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	638	BRCA1
NM_007294.4(BRCA1):c.1910C>G (p.Thr637Ser)	BRCA1	T637S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001039797	17	41245638	17	43093621	1039797	1033321	rs1555590925	NC_000017.11:43093620:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	637	BRCA1
NM_007294.4(BRCA1):c.1910C>T (p.Thr637Ile)	BRCA1	T637I	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479207	17	41245638	17	43093621	479207	479434	rs1555590925	NC_000017.11:43093620:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jul 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	637	BRCA1
NM_007294.4(BRCA1):c.1909A>T (p.Thr637Ser)	BRCA1	T637S	Hereditary breast ovarian cancer syndrome	VCV002989136	17	41245639	17	43093622	2989136	3150684	NA	NC_000017.11:43093621:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	637	BRCA1
NM_007294.4(BRCA1):c.1907G>T (p.Cys636Phe)	BRCA1	C636F	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001352429	17	41245641	17	43093624	1352429	1505639	rs398122649	NC_000017.11:43093623:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	636	BRCA1
NM_007294.4(BRCA1):c.1907G>C (p.Cys636Ser)	BRCA1	C636S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000579537	17	41245641	17	43093624	579537	571190	rs398122649	NC_000017.11:43093623:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	636	BRCA1
NM_007294.4(BRCA1):c.1907G>A (p.Cys636Tyr)	BRCA1	C636Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000091570	17	41245641	17	43093624	91570	97047	rs398122649	NC_000017.11:43093623:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	636	BRCA1
NM_007294.4(BRCA1):c.1906T>G (p.Cys636Gly)	BRCA1	C636G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000820284	17	41245642	17	43093625	820284	813829	rs1334848140	NC_000017.11:43093624:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	636	BRCA1
NM_007294.4(BRCA1):c.1905T>G (p.Asn635Lys)	BRCA1	N635K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000849828	17	41245643	17	43093626	849828	845433	rs369373293	NC_000017.11:43093625:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	635	BRCA1
NM_007294.4(BRCA1):c.1904A>C (p.Asn635Thr)	BRCA1	N635T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001996036	17	41245644	17	43093627	1996036	2056546	NA	NC_000017.11:43093626:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	635	BRCA1
NM_007294.4(BRCA1):c.1904A>G (p.Asn635Ser)	BRCA1	N635S	Hereditary cancer-predisposing syndrome	VCV000820278	17	41245644	17	43093627	820278	813830	rs1597873443	NC_000017.11:43093626:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	635	BRCA1
NM_007294.4(BRCA1):c.1903A>G (p.Asn635Asp)	BRCA1	N635D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000627654	17	41245645	17	43093628	627654	618660	rs1567797783	NC_000017.11:43093627:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	635	BRCA1
NM_007294.4(BRCA1):c.1901C>T (p.Pro634Leu)	BRCA1	P634L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182137	17	41245647	17	43093630	182137	180869	rs80357121	NC_000017.11:43093629:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	634	BRCA1
NM_007294.4(BRCA1):c.1901C>G (p.Pro634Arg)	BRCA1	P634R	Hereditary cancer-predisposing syndrome	VCV000054392	17	41245647	17	43093630	54392	69059	rs80357121	NC_000017.11:43093629:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	634	BRCA1
NM_007294.4(BRCA1):c.1900C>T (p.Pro634Ser)	BRCA1	P634S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054391	17	41245648	17	43093631	54391	69058	rs80357056	NC_000017.11:43093630:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	634	BRCA1
NM_007294.4(BRCA1):c.1898C>T (p.Pro633Leu)	BRCA1	P633L	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000091568	17	41245650	17	43093633	91568	97045	rs398122647	NC_000017.11:43093632:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	633	BRCA1
NM_007294.4(BRCA1):c.1897C>T (p.Pro633Ser)	BRCA1	P633S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|BRCA1-related disorder	VCV000054387	17	41245651	17	43093634	54387	69054	rs80356902	NC_000017.11:43093633:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	633	BRCA1
NM_007294.4(BRCA1):c.1897C>A (p.Pro633Thr)	BRCA1	P633T	Hereditary cancer-predisposing syndrome	VCV000054386	17	41245651	17	43093634	54386	69053	rs80356902	NC_000017.11:43093633:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	633	BRCA1
NM_007294.4(BRCA1):c.1895G>A (p.Ser632Asn)	BRCA1	S632N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder	VCV000054385	17	41245653	17	43093636	54385	69052	rs80356983	NC_000017.11:43093635:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	632	BRCA1
NM_007294.4(BRCA1):c.1892T>G (p.Leu631Arg)	BRCA1	L631R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001492468	17	41245656	17	43093639	1492468	1516606	rs1386991114	NC_000017.11:43093638:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	631	BRCA1
NM_007294.4(BRCA1):c.1892T>C (p.Leu631Pro)	BRCA1	L631P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000571655	17	41245656	17	43093639	571655	569162	rs1386991114	NC_000017.11:43093638:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	631	BRCA1
NM_007294.4(BRCA1):c.1891C>A (p.Leu631Ile)	BRCA1	L631I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000231463	17	41245657	17	43093640	231463	236106	rs876659175	NC_000017.11:43093639:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	631	BRCA1
NM_007294.4(BRCA1):c.1888A>T (p.Asn630Tyr)	BRCA1	N630Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000820271	17	41245660	17	43093643	820271	813831	rs1597873547	NC_000017.11:43093642:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	630	BRCA1
NM_007294.4(BRCA1):c.1887A>C (p.Arg629Ser)	BRCA1	R629S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001428761	17	41245661	17	43093644	1428761	1457725	rs2154413792	NC_000017.11:43093643:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	629	BRCA1
NM_007294.4(BRCA1):c.1886G>T (p.Arg629Ile)	BRCA1	R629I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S	VCV000233033	17	41245662	17	43093645	233033	236107	rs876660144	NC_000017.11:43093644:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	629	BRCA1
NM_007294.4(BRCA1):c.1885A>G (p.Arg629Gly)	BRCA1	R629G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000840872	17	41245663	17	43093646	840872	845434	rs1555590987	NC_000017.11:43093645:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	629	BRCA1
NM_007294.4(BRCA1):c.1884T>G (p.Ser628Arg)	BRCA1	S628R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054380	17	41245664	17	43093647	54380	69047	rs80357495	NC_000017.11:43093646:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	628	BRCA1
NM_007294.4(BRCA1):c.1882A>G (p.Ser628Gly)	BRCA1	S628G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482920	17	41245666	17	43093649	482920	478744	rs1555591000	NC_000017.11:43093648:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	628	BRCA1
NM_007294.4(BRCA1):c.1880T>C (p.Val627Ala)	BRCA1	V627A	Hereditary cancer-predisposing syndrome	VCV002585844	17	41245668	17	43093651	2585844	2753404	NA	NC_000017.11:43093650:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	627	BRCA1
NM_007294.4(BRCA1):c.1880T>A (p.Val627Asp)	BRCA1	V627D	not specified|Hereditary cancer-predisposing syndrome	VCV000633097	17	41245668	17	43093651	633097	621588	rs770002293	NC_000017.11:43093650:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	627	BRCA1
NM_007294.4(BRCA1):c.1880T>G (p.Val627Gly)	BRCA1	V627G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000193697	17	41245668	17	43093651	193697	190860	rs770002293	NC_000017.11:43093650:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	627	BRCA1
NM_007294.4(BRCA1):c.1879G>A (p.Val627Ile)	BRCA1	V627I	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054377	17	41245669	17	43093652	54377	69044	rs80357425	NC_000017.11:43093651:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	627	BRCA1
NM_007294.4(BRCA1):c.1877T>A (p.Val626Glu)	BRCA1	V626E	Hereditary cancer-predisposing syndrome	VCV001781807	17	41245671	17	43093654	1781807	1835203	NA	NC_000017.11:43093653:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	626	BRCA1
NM_007294.4(BRCA1):c.1876G>C (p.Val626Leu)	BRCA1	V626L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069234	17	41245672	17	43093655	3069234	3229861	NA	NC_000017.11:43093654:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	626	BRCA1
NM_007294.4(BRCA1):c.1876G>T (p.Val626Leu)	BRCA1	V626L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001055889	17	41245672	17	43093655	1055889	1050308	rs2053869047	NC_000017.11:43093654:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	626	BRCA1
NM_007294.4(BRCA1):c.1876G>A (p.Val626Ile)	BRCA1	V626I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000946745	17	41245672	17	43093655	946745	928312	rs2053869047	NC_000017.11:43093654:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	626	BRCA1
NM_007294.4(BRCA1):c.1874T>C (p.Leu625Pro)	BRCA1	L625P	Hereditary breast ovarian cancer syndrome	VCV002772607	17	41245674	17	43093657	2772607	2933759	NA	NC_000017.11:43093656:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	625	BRCA1
NM_007294.4(BRCA1):c.1870G>A (p.Glu624Lys)	BRCA1	E624K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054374	17	41245678	17	43093661	54374	69041	rs80356950	NC_000017.11:43093660:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	624	BRCA1
NM_007294.4(BRCA1):c.1868T>C (p.Leu623Pro)	BRCA1	L623P	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054373	17	41245680	17	43093663	54373	69040	rs397508915	NC_000017.11:43093662:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	623	BRCA1
NM_007294.4(BRCA1):c.1867C>T (p.Leu623Phe)	BRCA1	L623F	Hereditary breast ovarian cancer syndrome	VCV002823744	17	41245681	17	43093664	2823744	2982257	NA	NC_000017.11:43093663:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	623	BRCA1
NM_007294.4(BRCA1):c.1865C>G (p.Ala622Gly)	BRCA1	A622G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000661225	17	41245683	17	43093666	661225	646020	rs56039126	NC_000017.11:43093665:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	622	BRCA1
NM_007294.4(BRCA1):c.1865C>T (p.Ala622Val)	BRCA1	A622V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054371	17	41245683	17	43093666	54371	69038	rs56039126	NC_000017.11:43093665:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	622	BRCA1
NM_007294.4(BRCA1):c.1864G>A (p.Ala622Thr)	BRCA1	A622T	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000619786	17	41245684	17	43093667	619786	611245	rs1567797954	NC_000017.11:43093666:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	622	BRCA1
NM_007294.4(BRCA1):c.1862A>C (p.His621Pro)	BRCA1	H621P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001380800	17	41245686	17	43093669	1380800	1421622	rs2053871006	NC_000017.11:43093668:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	621	BRCA1
NM_007294.4(BRCA1):c.1862A>G (p.His621Arg)	BRCA1	H621R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000950868	17	41245686	17	43093669	950868	928313	rs2053871006	NC_000017.11:43093668:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	621	BRCA1
NM_007294.4(BRCA1):c.1861C>T (p.His621Tyr)	BRCA1	H621Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000820206	17	41245687	17	43093670	820206	813832	rs1597873711	NC_000017.11:43093669:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	621	BRCA1
NM_007294.4(BRCA1):c.1859T>C (p.Ile620Thr)	BRCA1	I620T	Hereditary cancer-predisposing syndrome	VCV001781463	17	41245689	17	43093672	1781463	1838810	NA	NC_000017.11:43093671:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	620	BRCA1
NM_007294.4(BRCA1):c.1859T>A (p.Ile620Asn)	BRCA1	I620N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482931	17	41245689	17	43093672	482931	478790	rs1555591085	NC_000017.11:43093671:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	620	BRCA1
NM_007294.4(BRCA1):c.1856A>G (p.His619Arg)	BRCA1	H619R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409369	17	41245692	17	43093675	409369	402047	rs771890863	NC_000017.11:43093674:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	619	BRCA1
NM_007294.4(BRCA1):c.1855C>T (p.His619Tyr)	BRCA1	H619Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV001171235	17	41245693	17	43093676	1171235	1161363	rs773212667	NC_000017.11:43093675:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	619	BRCA1
NM_007294.4(BRCA1):c.1854G>C (p.Arg618Ser)	BRCA1	R618S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001448523	17	41245694	17	43093677	1448523	1423222	rs1060504585	NC_000017.11:43093676:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	618	BRCA1
NM_007294.4(BRCA1):c.1854G>T (p.Arg618Ser)	BRCA1	R618S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000820162	17	41245694	17	43093677	820162	813833	rs1060504585	NC_000017.11:43093676:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	618	BRCA1
NM_007294.4(BRCA1):c.1853G>C (p.Arg618Thr)	BRCA1	R618T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628544	17	41245695	17	43093678	628544	618661	rs876659527	NC_000017.11:43093677:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	618	BRCA1
NM_007294.4(BRCA1):c.1853G>A (p.Arg618Lys)	BRCA1	R618K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232057	17	41245695	17	43093678	232057	236109	rs876659527	NC_000017.11:43093677:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	618	BRCA1
NM_007294.4(BRCA1):c.1852A>T (p.Arg618Trp)	BRCA1	R618W	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001038775	17	41245696	17	43093679	1038775	1033322	rs2053872916	NC_000017.11:43093678:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	618	BRCA1
NM_007294.4(BRCA1):c.1850C>T (p.Thr617Ile)	BRCA1	T617I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001466448	17	41245698	17	43093681	1466448	1347807	rs2154417111	NC_000017.11:43093680:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	617	BRCA1
NM_007294.4(BRCA1):c.1850C>A (p.Thr617Asn)	BRCA1	T617N	Hereditary cancer-predisposing syndrome	VCV001049469	17	41245698	17	43093681	1049469	1038575	rs2154417111	NC_000017.11:43093680:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	617	BRCA1
NM_007294.4(BRCA1):c.1849A>G (p.Thr617Ala)	BRCA1	T617A	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000041807	17	41245699	17	43093682	41807	50246	rs45564238	NC_000017.11:43093681:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	617	BRCA1
NM_007294.4(BRCA1):c.1846T>C (p.Ser616Pro)	BRCA1	S616P	Hereditary breast ovarian cancer syndrome	VCV002991774	17	41245702	17	43093685	2991774	3144384	NA	NC_000017.11:43093684:A:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Oct 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	616	BRCA1
NM_007294.4(BRCA1):c.1844C>A (p.Ser615Tyr)	BRCA1	S615Y	Hereditary breast ovarian cancer syndrome	VCV002811842	17	41245704	17	43093687	2811842	2969080	NA	NC_000017.11:43093686:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	615	BRCA1
NM_007294.4(BRCA1):c.1844C>T (p.Ser615Phe)	BRCA1	S615F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091566	17	41245704	17	43093687	91566	97043	rs398122645	NC_000017.11:43093686:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	615	BRCA1
NM_007294.4(BRCA1):c.1843T>G (p.Ser615Ala)	BRCA1	S615A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000939128	17	41245705	17	43093688	939128	937966	rs1384752453	NC_000017.11:43093687:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	615	BRCA1
NM_007294.4(BRCA1):c.1842G>T (p.Lys614Asn)	BRCA1	K614N	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000252401	17	41245706	17	43093689	252401	246822	rs760109939	NC_000017.11:43093688:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	614	BRCA1
NM_007294.4(BRCA1):c.1839_1841delinsAGT (p.Lys614Val)	BRCA1	K614V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002446382	17	41245707 - 41245709	17	43093690 - 43093692	2446382	646021	rs1597873873	NC_000017.11:43093689:TTC:ACT	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	614	BRCA1
NM_007294.4(BRCA1):c.1841A>C (p.Lys614Thr)	BRCA1	K614T	Hereditary cancer-predisposing syndrome	VCV001781161	17	41245707	17	43093690	1781161	1839429	NA	NC_000017.11:43093689:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	614	BRCA1
NM_007294.4(BRCA1):c.1841A>G (p.Lys614Arg)	BRCA1	K614R	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000820172	17	41245707	17	43093690	820172	813834	rs1597873869	NC_000017.11:43093689:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	614	BRCA1
NM_007294.4(BRCA1):c.1838G>T (p.Arg613Met)	BRCA1	R613M	Hereditary cancer-predisposing syndrome	VCV000820139	17	41245710	17	43093693	820139	813835	rs786203937	NC_000017.11:43093692:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	613	BRCA1
NM_007294.4(BRCA1):c.1838G>A (p.Arg613Lys)	BRCA1	R613K	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187705	17	41245710	17	43093693	187705	185048	rs786203937	NC_000017.11:43093692:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	613	BRCA1
NM_007294.4(BRCA1):c.1837A>G (p.Arg613Gly)	BRCA1	R613G	BRCA1-related disorder|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000216655	17	41245711	17	43093694	216655	213326	rs863224753	NC_000017.11:43093693:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	613	BRCA1
NM_007294.4(BRCA1):c.1834A>G (p.Arg612Gly)	BRCA1	R612G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054367	17	41245714	17	43093697	54367	69034	rs80357245	NC_000017.11:43093696:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	612	BRCA1
NM_007294.4(BRCA1):c.1830G>T (p.Arg610Ser)	BRCA1	R610S	Hereditary breast ovarian cancer syndrome	VCV002700123	17	41245718	17	43093701	2700123	2858975	NA	NC_000017.11:43093700:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	610	BRCA1
NM_007294.4(BRCA1):c.1829G>C (p.Arg610Thr)	BRCA1	R610T	not provided|Hereditary cancer-predisposing syndrome	VCV000418825	17	41245719	17	43093702	418825	410005	rs876660322	NC_000017.11:43093701:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	610	BRCA1
NM_007294.4(BRCA1):c.1829G>A (p.Arg610Lys)	BRCA1	R610K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233305	17	41245719	17	43093702	233305	236111	rs876660322	NC_000017.11:43093701:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	610	BRCA1
NM_007294.4(BRCA1):c.1828A>G (p.Arg610Gly)	BRCA1	R610G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091565	17	41245720	17	43093703	91565	97042	rs398122644	NC_000017.11:43093702:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	610	BRCA1
NM_007294.4(BRCA1):c.1826A>G (p.Asn609Ser)	BRCA1	N609S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000037429	17	41245722	17	43093705	37429	45985	rs80357236	NC_000017.11:43093704:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	609	BRCA1
NM_007294.4(BRCA1):c.1825A>T (p.Asn609Tyr)	BRCA1	N609Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000960102	17	41245723	17	43093706	960102	949952	rs2053878598	NC_000017.11:43093705:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	609	BRCA1
NM_007294.4(BRCA1):c.1823A>G (p.Lys608Arg)	BRCA1	K608R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002011476	17	41245725	17	43093708	2011476	2070705	NA	NC_000017.11:43093707:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	608	BRCA1
NM_007294.4(BRCA1):c.1819A>G (p.Lys607Glu)	BRCA1	K607E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast neoplasm	VCV000224430	17	41245729	17	43093712	224430	226205	rs80357220	NC_000017.11:43093711:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	607	BRCA1
NM_007294.4(BRCA1):c.1817C>T (p.Pro606Leu)	BRCA1	P606L	not specified|Hereditary cancer-predisposing syndrome	VCV001329037	17	41245731	17	43093714	1329037	1319723	rs2154419849	NC_000017.11:43093713:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	606	BRCA1
NM_007294.4(BRCA1):c.1814C>A (p.Ala605Glu)	BRCA1	A605E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462568	17	41245734	17	43093717	462568	466890	rs1555591195	NC_000017.11:43093716:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	605	BRCA1
NM_007294.4(BRCA1):c.1813G>C (p.Ala605Pro)	BRCA1	A605P	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000619785	17	41245735	17	43093718	619785	611246	rs587781613	NC_000017.11:43093717:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	605	BRCA1
NM_007294.4(BRCA1):c.1813G>T (p.Ala605Ser)	BRCA1	A605S	Hereditary cancer-predisposing syndrome	VCV000141262	17	41245735	17	43093718	141262	150976	rs587781613	NC_000017.11:43093717:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	605	BRCA1
NM_007294.4(BRCA1):c.1812A>C (p.Lys604Asn)	BRCA1	K604N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001325665	17	41245736	17	43093719	1325665	1315930	rs2154420505	NC_000017.11:43093718:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	604	BRCA1
NM_007294.4(BRCA1):c.1810A>G (p.Lys604Glu)	BRCA1	K604E	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV001004428	17	41245738	17	43093721	1004428	997582	rs2053879900	NC_000017.11:43093720:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	604	BRCA1
NM_007294.4(BRCA1):c.1807T>C (p.Ser603Pro)	BRCA1	S603P	Hereditary breast ovarian cancer syndrome	VCV002711967	17	41245741	17	43093724	2711967	2871694	NA	NC_000017.11:43093723:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	603	BRCA1
NM_007294.4(BRCA1):c.1807T>G (p.Ser603Ala)	BRCA1	S603A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462567	17	41245741	17	43093724	462567	468218	rs1555591208	NC_000017.11:43093723:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	603	BRCA1
NM_007294.4(BRCA1):c.1805A>G (p.Asn602Ser)	BRCA1	N602S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628485	17	41245743	17	43093726	628485	618662	rs1567798189	NC_000017.11:43093725:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	602	BRCA1
NM_007294.4(BRCA1):c.1803C>A (p.His601Gln)	BRCA1	H601Q	not specified	VCV003256351	17	41245745	17	43093728	3256351	3415113	NA	NC_000017.11:43093727:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Jul 31, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	601	BRCA1
NM_007294.4(BRCA1):c.1802A>G (p.His601Arg)	BRCA1	H601R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000188204	17	41245746	17	43093729	188204	186260	rs371631805	NC_000017.11:43093728:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	601	BRCA1
NM_007294.4(BRCA1):c.1800C>G (p.Ile600Met)	BRCA1	I600M	Hereditary cancer-predisposing syndrome	VCV000054354	17	41245748	17	43093731	54354	69021	rs80357452	NC_000017.11:43093730:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	600	BRCA1
NM_007294.4(BRCA1):c.1799T>A (p.Ile600Asn)	BRCA1	I600N	Hereditary cancer-predisposing syndrome	VCV002565355	17	41245749	17	43093732	2565355	2732328	NA	NC_000017.11:43093731:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	600	BRCA1
NM_007294.4(BRCA1):c.1799T>C (p.Ile600Thr)	BRCA1	I600T	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479261	17	41245749	17	43093732	479261	478750	rs398122643	NC_000017.11:43093731:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	600	BRCA1
NM_007294.4(BRCA1):c.1799T>G (p.Ile600Ser)	BRCA1	I600S	Hereditary cancer-predisposing syndrome	VCV000091564	17	41245749	17	43093732	91564	97041	rs398122643	NC_000017.11:43093731:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	600	BRCA1
NM_007294.4(BRCA1):c.1796A>G (p.Asn599Ser)	BRCA1	N599S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000652519	17	41245752	17	43093735	652519	646022	rs1174268388	NC_000017.11:43093734:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	599	BRCA1
NM_007294.4(BRCA1):c.1795A>G (p.Asn599Asp)	BRCA1	N599D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001999229	17	41245753	17	43093736	1999229	2061022	NA	NC_000017.11:43093735:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	599	BRCA1
NM_007294.4(BRCA1):c.1792T>G (p.Leu598Val)	BRCA1	L598V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000575985	17	41245756	17	43093739	575985	569164	rs1060504554	NC_000017.11:43093738:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	598	BRCA1
NM_007294.4(BRCA1):c.1791A>C (p.Glu597Asp)	BRCA1	E597D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001411198	17	41245757	17	43093740	1411198	1343588	rs749415463	NC_000017.11:43093739:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	597	BRCA1
NM_007294.4(BRCA1):c.1789G>C (p.Glu597Gln)	BRCA1	E597Q	Hereditary breast ovarian cancer syndrome	VCV002906972	17	41245759	17	43093742	2906972	3065778	NA	NC_000017.11:43093741:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	597	BRCA1
NM_007294.4(BRCA1):c.1789G>A (p.Glu597Lys)	BRCA1	E597K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041806	17	41245759	17	43093742	41806	50245	rs55650082	NC_000017.11:43093741:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	597	BRCA1
NM_007294.4(BRCA1):c.1787T>C (p.Leu596Pro)	BRCA1	L596P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000846451	17	41245761	17	43093744	846451	845435	rs2053883873	NC_000017.11:43093743:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	596	BRCA1
NM_007294.4(BRCA1):c.1786C>T (p.Leu596Phe)	BRCA1	L596F	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182136	17	41245762	17	43093745	182136	180872	rs80357371	NC_000017.11:43093744:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	596	BRCA1
NM_007294.4(BRCA1):c.1786C>G (p.Leu596Val)	BRCA1	L596V	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054347	17	41245762	17	43093745	54347	69014	rs80357371	NC_000017.11:43093744:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	596	BRCA1
NM_007294.4(BRCA1):c.1784A>G (p.Glu595Gly)	BRCA1	E595G	Hereditary cancer-predisposing syndrome	VCV000233515	17	41245764	17	43093747	233515	236113	rs876660455	NC_000017.11:43093746:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	595	BRCA1
NM_007294.4(BRCA1):c.1783G>C (p.Glu595Gln)	BRCA1	E595Q	Hereditary breast ovarian cancer syndrome	VCV002844348	17	41245765	17	43093748	2844348	3007989	NA	NC_000017.11:43093747:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	595	BRCA1
NM_007294.4(BRCA1):c.1782G>A (p.Met594Ile)	BRCA1	M594I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001053889	17	41245766	17	43093749	1053889	1050309	rs2154423571	NC_000017.11:43093748:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	594	BRCA1
NM_007294.4(BRCA1):c.1781T>C (p.Met594Thr)	BRCA1	M594T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000949994	17	41245767	17	43093750	949994	928314	rs2053884703	NC_000017.11:43093749:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	594	BRCA1
NM_007294.4(BRCA1):c.1780A>G (p.Met594Val)	BRCA1	M594V	Hereditary breast ovarian cancer syndrome	VCV002709517	17	41245768	17	43093751	2709517	2878263	NA	NC_000017.11:43093750:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	594	BRCA1
NM_007294.4(BRCA1):c.1777A>C (p.Asn593His)	BRCA1	N593H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001779891	17	41245771	17	43093754	1779891	1838543	NA	NC_000017.11:43093753:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	593	BRCA1
NM_007294.4(BRCA1):c.1775G>A (p.Ser592Asn)	BRCA1	S592N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186563	17	41245773	17	43093756	186563	185051	rs786203044	NC_000017.11:43093755:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	592	BRCA1
NM_007294.4(BRCA1):c.1774A>C (p.Ser592Arg)	BRCA1	S592R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000654417	17	41245774	17	43093757	654417	646023	rs1597874233	NC_000017.11:43093756:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	592	BRCA1
NM_007294.4(BRCA1):c.1773A>G (p.Ile591Met)	BRCA1	I591M	Hereditary cancer-predisposing syndrome|Hereditary cancer|Hereditary breast ovarian cancer syndrome|not provided	VCV000574474	17	41245775	17	43093758	574474	571194	rs1555591259	NC_000017.11:43093757:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	591	BRCA1
NM_007294.4(BRCA1):c.1772T>C (p.Ile591Thr)	BRCA1	I591T	not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054345	17	41245776	17	43093759	54345	69012	rs80356859	NC_000017.11:43093758:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	May 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	591	BRCA1
NM_007294.4(BRCA1):c.1771A>G (p.Ile591Val)	BRCA1	I591V	not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000421781	17	41245777	17	43093760	421781	410006	rs1064795358	NC_000017.11:43093759:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	591	BRCA1
NM_007294.4(BRCA1):c.1769G>A (p.Ser590Asn)	BRCA1	S590N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409345	17	41245779	17	43093762	409345	402532	rs1060502349	NC_000017.11:43093761:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	590	BRCA1
NM_007294.4(BRCA1):c.1768A>C (p.Ser590Arg)	BRCA1	S590R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003073236	17	41245780	17	43093763	3073236	3234192	NA	NC_000017.11:43093762:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	590	BRCA1
NM_007294.4(BRCA1):c.1768A>T (p.Ser590Cys)	BRCA1	S590C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000919950	17	41245780	17	43093763	919950	913938	rs80357454	NC_000017.11:43093762:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	590	BRCA1
NM_007294.4(BRCA1):c.1768A>G (p.Ser590Gly)	BRCA1	S590G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054344	17	41245780	17	43093763	54344	69011	rs80357454	NC_000017.11:43093762:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	590	BRCA1
NM_007294.4(BRCA1):c.1767C>G (p.Ser589Arg)	BRCA1	S589R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001714945	17	41245781	17	43093764	1714945	1777946	NA	NC_000017.11:43093763:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	589	BRCA1
NM_007294.4(BRCA1):c.1767C>A (p.Ser589Arg)	BRCA1	S589R	Hereditary cancer-predisposing syndrome	VCV000156486	17	41245781	17	43093764	156486	166251	rs587783039	NC_000017.11:43093763:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	589	BRCA1
NM_007294.4(BRCA1):c.1766G>T (p.Ser589Ile)	BRCA1	S589I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000801061	17	41245782	17	43093765	801061	789628	rs1567798335	NC_000017.11:43093764:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	589	BRCA1
NM_007294.4(BRCA1):c.1766G>A (p.Ser589Asn)	BRCA1	S589N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000619784	17	41245782	17	43093765	619784	611247	rs1567798335	NC_000017.11:43093764:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	589	BRCA1
NM_007294.4(BRCA1):c.1765A>G (p.Ser589Gly)	BRCA1	S589G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001947263	17	41245783	17	43093766	1947263	1996226	NA	NC_000017.11:43093765:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	589	BRCA1
NM_007294.4(BRCA1):c.1764C>A (p.Ser588Arg)	BRCA1	S588R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001361721	17	41245784	17	43093767	1361721	1476445	rs1597874296	NC_000017.11:43093766:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	588	BRCA1
NM_007294.4(BRCA1):c.1764C>G (p.Ser588Arg)	BRCA1	S588R	Hereditary cancer-predisposing syndrome|not provided	VCV000820039	17	41245784	17	43093767	820039	813838	rs1597874296	NC_000017.11:43093766:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	588	BRCA1
NM_007294.4(BRCA1):c.1763_1764delinsAA (p.Ser588Lys)	BRCA1	S588K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479211	17	41245784 - 41245785	17	43093767 - 43093768	479211	478666	rs1555591274	NC_000017.11:43093766:GC:TT	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	588	BRCA1
NM_007294.4(BRCA1):c.1763_1764delinsTT (p.Ser588Ile)	BRCA1	S588I	BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000438915	17	41245784 - 41245785	17	43093767 - 43093768	438915	260360	rs1555591274	NC_000017.11:43093766:GC:AA	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	588	BRCA1
NM_007294.4(BRCA1):c.1763G>T (p.Ser588Ile)	BRCA1	S588I	Hereditary breast ovarian cancer syndrome	VCV002829259	17	41245785	17	43093768	2829259	2980088	NA	NC_000017.11:43093767:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	588	BRCA1
NM_007294.4(BRCA1):c.1763G>A (p.Ser588Asn)	BRCA1	S588N	Hereditary cancer-predisposing syndrome	VCV001779625	17	41245785	17	43093768	1779625	1838278	NA	NC_000017.11:43093767:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	588	BRCA1
NM_007294.4(BRCA1):c.1762A>G (p.Ser588Gly)	BRCA1	S588G	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531235	17	41245786	17	43093769	531235	531357	rs1169162396	NC_000017.11:43093768:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	588	BRCA1
NM_007294.4(BRCA1):c.1761A>G (p.Ile587Met)	BRCA1	I587M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000853783	17	41245787	17	43093770	853783	845436	rs1057523389	NC_000017.11:43093769:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	587	BRCA1
NM_007294.4(BRCA1):c.1760T>C (p.Ile587Thr)	BRCA1	I587T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000648181	17	41245788	17	43093771	648181	646024	rs1597874348	NC_000017.11:43093770:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	587	BRCA1
NM_007294.4(BRCA1):c.1759A>G (p.Ile587Val)	BRCA1	I587V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000662219	17	41245789	17	43093772	662219	646025	rs1597874361	NC_000017.11:43093771:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	587	BRCA1
NM_007294.4(BRCA1):c.1757C>T (p.Pro586Leu)	BRCA1	P586L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV001444310	17	41245791	17	43093774	1444310	1388275	rs1064795270	NC_000017.11:43093773:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	586	BRCA1
NM_007294.4(BRCA1):c.1757C>G (p.Pro586Arg)	BRCA1	P586R	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000421644	17	41245791	17	43093774	421644	410007	rs1064795270	NC_000017.11:43093773:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	586	BRCA1
NM_007294.4(BRCA1):c.1756C>A (p.Pro586Thr)	BRCA1	P586T	Hereditary cancer-predisposing syndrome	VCV003226109	17	41245792	17	43093775	3226109	3390614	NA	NC_000017.11:43093774:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	586	BRCA1
NM_007294.4(BRCA1):c.1756C>T (p.Pro586Ser)	BRCA1	P586S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054342	17	41245792	17	43093775	54342	69009	rs80357153	NC_000017.11:43093774:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	586	BRCA1
NM_007294.4(BRCA1):c.1755A>T (p.Glu585Asp)	BRCA1	E585D	Hereditary cancer-predisposing syndrome	VCV002565356	17	41245793	17	43093776	2565356	2732329	NA	NC_000017.11:43093775:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	585	BRCA1
NM_007294.4(BRCA1):c.1753G>A (p.Glu585Lys)	BRCA1	E585K	Hereditary breast ovarian cancer syndrome	VCV002696485	17	41245795	17	43093778	2696485	2857905	NA	NC_000017.11:43093777:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	585	BRCA1
NM_007294.4(BRCA1):c.1753G>C (p.Glu585Gln)	BRCA1	E585Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001495865	17	41245795	17	43093778	1495865	1362780	rs2154426325	NC_000017.11:43093777:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	585	BRCA1
NM_007294.4(BRCA1):c.1751C>T (p.Ala584Val)	BRCA1	A584V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001047709	17	41245797	17	43093780	1047709	1033323	rs2053890440	NC_000017.11:43093779:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	584	BRCA1
NM_007294.4(BRCA1):c.1748A>C (p.Lys583Thr)	BRCA1	K583T	Hereditary breast ovarian cancer syndrome	VCV002843333	17	41245800	17	43093783	2843333	3003988	NA	NC_000017.11:43093782:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	583	BRCA1
NM_007294.4(BRCA1):c.1747A>G (p.Lys583Glu)	BRCA1	K583E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer	VCV000091562	17	41245801	17	43093784	91562	97039	rs80356928	NC_000017.11:43093783:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	583	BRCA1
NM_007294.4(BRCA1):c.1745C>A (p.Thr582Lys)	BRCA1	T582K	Hereditary cancer-predisposing syndrome	VCV000628457	17	41245803	17	43093786	628457	618664	rs786202386	NC_000017.11:43093785:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	582	BRCA1
NM_007294.4(BRCA1):c.1745C>T (p.Thr582Met)	BRCA1	T582M	Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000185698	17	41245803	17	43093786	185698	185052	rs786202386	NC_000017.11:43093785:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	582	BRCA1
NM_007294.4(BRCA1):c.1744A>G (p.Thr582Ala)	BRCA1	T582A	Hereditary cancer-predisposing syndrome	VCV000054340	17	41245804	17	43093787	54340	69007	rs397508906	NC_000017.11:43093786:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	582	BRCA1
NM_007294.4(BRCA1):c.1742A>G (p.Lys581Arg)	BRCA1	K581R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000819955	17	41245806	17	43093789	819955	813841	rs1597874458	NC_000017.11:43093788:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	581	BRCA1
NM_007294.4(BRCA1):c.1740C>G (p.Phe580Leu)	BRCA1	F580L	Hereditary breast ovarian cancer syndrome	VCV002865540	17	41245808	17	43093791	2865540	3026613	NA	NC_000017.11:43093790:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	580	BRCA1
NM_007294.4(BRCA1):c.1738T>C (p.Phe580Leu)	BRCA1	F580L	Hereditary cancer-predisposing syndrome|not provided	VCV001330049	17	41245810	17	43093793	1330049	1320732	rs2154427147	NC_000017.11:43093792:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	580	BRCA1
NM_007294.4(BRCA1):c.1735G>C (p.Ala579Pro)	BRCA1	A579P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001779064	17	41245813	17	43093796	1779064	1831648	NA	NC_000017.11:43093795:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	579	BRCA1
NM_007294.4(BRCA1):c.1733C>T (p.Ser578Phe)	BRCA1	S578F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479214	17	41245815	17	43093798	479214	479435	rs80356939	NC_000017.11:43093797:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	578	BRCA1
NM_007294.4(BRCA1):c.1733C>A (p.Ser578Tyr)	BRCA1	S578Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054338	17	41245815	17	43093798	54338	69005	rs80356939	NC_000017.11:43093797:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	578	BRCA1
NM_007294.4(BRCA1):c.1732T>C (p.Ser578Pro)	BRCA1	S578P	Hereditary cancer-predisposing syndrome	VCV001779017	17	41245816	17	43093799	1779017	1831601	NA	NC_000017.11:43093798:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	578	BRCA1
NM_007294.4(BRCA1):c.1731A>C (p.Glu577Asp)	BRCA1	E577D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069235	17	41245817	17	43093800	3069235	3229862	NA	NC_000017.11:43093799:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	577	BRCA1
NM_007294.4(BRCA1):c.1729G>C (p.Glu577Gln)	BRCA1	E577Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000860128	17	41245819	17	43093802	860128	845437	rs397508903	NC_000017.11:43093801:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	577	BRCA1
NM_007294.4(BRCA1):c.1727A>G (p.Lys576Arg)	BRCA1	K576R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000920445	17	41245821	17	43093804	920445	913939	rs2053893835	NC_000017.11:43093803:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	576	BRCA1
NM_007294.4(BRCA1):c.1726A>G (p.Lys576Glu)	BRCA1	K576E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001349608	17	41245822	17	43093805	1349608	1394371	rs2154427861	NC_000017.11:43093804:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	576	BRCA1
NM_007294.4(BRCA1):c.1724A>G (p.Glu575Gly)	BRCA1	E575G	Hereditary cancer|not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186110	17	41245824	17	43093807	186110	185055	rs111539978	NC_000017.11:43093806:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	575	BRCA1
NM_007294.4(BRCA1):c.1723G>A (p.Glu575Lys)	BRCA1	E575K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Fanconi anemia, complementation group S	VCV000054334	17	41245825	17	43093808	54334	69001	rs397508902	NC_000017.11:43093807:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	575	BRCA1
NM_007294.4(BRCA1):c.1721T>C (p.Leu574Pro)	BRCA1	L574P	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000409328	17	41245827	17	43093810	409328	402534	rs1060502341	NC_000017.11:43093809:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	574	BRCA1
NM_007294.4(BRCA1):c.1720C>T (p.Leu574Phe)	BRCA1	L574F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV001652406	17	41245828	17	43093811	1652406	1664319	rs1323998441	NC_000017.11:43093810:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	574	BRCA1
NM_007294.4(BRCA1):c.1718C>T (p.Ser573Leu)	BRCA1	S573L	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000233482	17	41245830	17	43093813	233482	236117	rs876660434	NC_000017.11:43093812:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	573	BRCA1
NM_007294.4(BRCA1):c.1717T>A (p.Ser573Thr)	BRCA1	S573T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000819915	17	41245831	17	43093814	819915	813842	rs876660448	NC_000017.11:43093813:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	573	BRCA1
NM_007294.4(BRCA1):c.1717T>C (p.Ser573Pro)	BRCA1	S573P	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233500	17	41245831	17	43093814	233500	236118	rs876660448	NC_000017.11:43093813:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	573	BRCA1
NM_007294.4(BRCA1):c.1714G>A (p.Glu572Lys)	BRCA1	E572K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481462	17	41245834	17	43093817	481462	478791	rs730881473	NC_000017.11:43093816:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	572	BRCA1
NM_007294.4(BRCA1):c.1714G>C (p.Glu572Gln)	BRCA1	E572Q	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232791	17	41245834	17	43093817	232791	236119	rs730881473	NC_000017.11:43093816:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	572	BRCA1
NM_007294.4(BRCA1):c.1713A>G (p.Ile571Met)	BRCA1	I571M	not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186051	17	41245835	17	43093818	186051	185056	rs552505690	NC_000017.11:43093817:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	571	BRCA1
NM_007294.4(BRCA1):c.1712T>G (p.Ile571Arg)	BRCA1	I571R	Hereditary cancer-predisposing syndrome	VCV000819888	17	41245836	17	43093819	819888	813843	rs80357159	NC_000017.11:43093818:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	571	BRCA1
NM_007294.4(BRCA1):c.1712T>A (p.Ile571Lys)	BRCA1	I571K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481467	17	41245836	17	43093819	481467	478667	rs80357159	NC_000017.11:43093818:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	571	BRCA1
NM_007294.4(BRCA1):c.1712T>C (p.Ile571Thr)	BRCA1	I571T	not specified|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000054330	17	41245836	17	43093819	54330	68997	rs80357159	NC_000017.11:43093818:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	571	BRCA1
NM_007294.4(BRCA1):c.1711A>G (p.Ile571Val)	BRCA1	I571V	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462566	17	41245837	17	43093820	462566	466892	rs1310719199	NC_000017.11:43093819:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	571	BRCA1
NM_007294.4(BRCA1):c.1709C>T (p.Pro570Leu)	BRCA1	P570L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001014997	17	41245839	17	43093822	1014997	1012779	rs879254020	NC_000017.11:43093821:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	570	BRCA1
NM_007294.4(BRCA1):c.1709C>A (p.Pro570Gln)	BRCA1	P570Q	Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000245965	17	41245839	17	43093822	245965	245047	rs879254020	NC_000017.11:43093821:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	570	BRCA1
NM_007294.4(BRCA1):c.1707C>A (p.Asn569Lys)	BRCA1	N569K	Hereditary cancer-predisposing syndrome	VCV003261454	17	41245841	17	43093824	3261454	3424223	NA	NC_000017.11:43093823:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 19, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	569	BRCA1
NM_007294.4(BRCA1):c.1707C>G (p.Asn569Lys)	BRCA1	N569K	Hereditary cancer-predisposing syndrome	VCV000927021	17	41245841	17	43093824	927021	913940	rs876659110	NC_000017.11:43093823:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	569	BRCA1
NM_007294.4(BRCA1):c.1706A>G (p.Asn569Ser)	BRCA1	N569S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000819849	17	41245842	17	43093825	819849	813844	rs1060502329	NC_000017.11:43093824:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	569	BRCA1
NM_007294.4(BRCA1):c.1706A>T (p.Asn569Ile)	BRCA1	N569I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000409304	17	41245842	17	43093825	409304	402540	rs1060502329	NC_000017.11:43093824:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	569	BRCA1
NM_007294.4(BRCA1):c.1705A>G (p.Asn569Asp)	BRCA1	N569D	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000140844	17	41245843	17	43093826	140844	150558	rs587781315	NC_000017.11:43093825:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	569	BRCA1
NM_007294.4(BRCA1):c.1703C>T (p.Pro568Leu)	BRCA1	P568L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054329	17	41245845	17	43093828	54329	68996	rs80356910	NC_000017.11:43093827:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	568	BRCA1
NM_007294.4(BRCA1):c.1703C>G (p.Pro568Arg)	BRCA1	P568R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000054328	17	41245845	17	43093828	54328	68995	rs80356910	NC_000017.11:43093827:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	568	BRCA1
NM_007294.4(BRCA1):c.1702C>G (p.Pro568Ala)	BRCA1	P568A	Hereditary cancer-predisposing syndrome|not provided	VCV001309729	17	41245846	17	43093829	1309729	1299104	rs755122577	NC_000017.11:43093828:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	568	BRCA1
NM_007294.4(BRCA1):c.1702C>T (p.Pro568Ser)	BRCA1	P568S	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000185060	17	41245846	17	43093829	185060	185057	rs755122577	NC_000017.11:43093828:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	568	BRCA1
NM_007294.4(BRCA1):c.1701T>G (p.Asn567Lys)	BRCA1	N567K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531411	17	41245847	17	43093830	531411	531296	rs1555591359	NC_000017.11:43093829:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	567	BRCA1
NM_007294.4(BRCA1):c.1700A>C (p.Asn567Thr)	BRCA1	N567T	Hereditary cancer-predisposing syndrome	VCV000924368	17	41245848	17	43093831	924368	913941	rs2053898401	NC_000017.11:43093830:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	567	BRCA1
NM_007294.4(BRCA1):c.1696A>C (p.Lys566Gln)	BRCA1	K566Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000843699	17	41245852	17	43093835	843699	845438	rs1597874665	NC_000017.11:43093834:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	566	BRCA1
NM_007294.4(BRCA1):c.1696A>G (p.Lys566Glu)	BRCA1	K566E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000639551	17	41245852	17	43093835	639551	646026	rs1597874665	NC_000017.11:43093834:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	566	BRCA1
NM_007294.4(BRCA1):c.1694A>T (p.Glu565Val)	BRCA1	E565V	Hereditary cancer-predisposing syndrome	VCV001778196	17	41245854	17	43093837	1778196	1838128	NA	NC_000017.11:43093836:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	565	BRCA1
NM_007294.4(BRCA1):c.1694A>C (p.Glu565Ala)	BRCA1	E565A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001778192	17	41245854	17	43093837	1778192	1838124	NA	NC_000017.11:43093836:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	565	BRCA1
NM_007294.4(BRCA1):c.1690A>C (p.Asn564His)	BRCA1	N564H	Hereditary cancer-predisposing syndrome	VCV000054326	17	41245858	17	43093841	54326	68993	rs397507191	NC_000017.11:43093840:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	564	BRCA1
NM_007294.4(BRCA1):c.1690A>T (p.Asn564Tyr)	BRCA1	N564Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037427	17	41245858	17	43093841	37427	45983	rs397507191	NC_000017.11:43093840:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	564	BRCA1
NM_007294.4(BRCA1):c.1688A>C (p.Gln563Pro)	BRCA1	Q563P	Hereditary cancer-predisposing syndrome	VCV001778048	17	41245860	17	43093843	1778048	1837980	NA	NC_000017.11:43093842:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	563	BRCA1
NM_007294.4(BRCA1):c.1687C>A (p.Gln563Lys)	BRCA1	Q563K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001407394	17	41245861	17	43093844	1407394	1483603	rs80356898	NC_000017.11:43093843:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	563	BRCA1
NM_007294.4(BRCA1):c.1686T>G (p.Ile562Met)	BRCA1	I562M	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441443	17	41245862	17	43093845	441443	435157	rs1268133978	NC_000017.11:43093844:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	562	BRCA1
NM_007294.4(BRCA1):c.1685T>C (p.Ile562Thr)	BRCA1	I562T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531291	17	41245863	17	43093846	531291	531078	rs1555591375	NC_000017.11:43093845:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	562	BRCA1
NM_007294.4(BRCA1):c.1684A>C (p.Ile562Leu)	BRCA1	I562L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002089181	17	41245864	17	43093847	2089181	2148281	NA	NC_000017.11:43093846:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	562	BRCA1
NM_007294.4(BRCA1):c.1684A>G (p.Ile562Val)	BRCA1	I562V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000580866	17	41245864	17	43093847	580866	574485	rs1567798727	NC_000017.11:43093846:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	562	BRCA1
NM_007294.4(BRCA1):c.1679A>T (p.Asp560Val)	BRCA1	D560V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628573	17	41245869	17	43093852	628573	618666	rs1567798739	NC_000017.11:43093851:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	560	BRCA1
NM_007294.4(BRCA1):c.1676G>A (p.Gly559Asp)	BRCA1	G559D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000630049	17	41245872	17	43093855	630049	618667	rs80356980	NC_000017.11:43093854:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	559	BRCA1
NM_007294.4(BRCA1):c.1676G>T (p.Gly559Val)	BRCA1	G559V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054323	17	41245872	17	43093855	54323	68990	rs80356980	NC_000017.11:43093854:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	559	BRCA1
NM_007294.4(BRCA1):c.1675G>A (p.Gly559Ser)	BRCA1	G559S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462565	17	41245873	17	43093856	462565	467736	rs1555591384	NC_000017.11:43093855:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	559	BRCA1
NM_007294.4(BRCA1):c.1673A>T (p.Lys558Ile)	BRCA1	K558I	Hereditary cancer-predisposing syndrome	VCV001777742	17	41245875	17	43093858	1777742	1828244	NA	NC_000017.11:43093857:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	558	BRCA1
NM_007294.4(BRCA1):c.1672A>C (p.Lys558Gln)	BRCA1	K558Q	Hereditary cancer-predisposing syndrome	VCV000037424	17	41245876	17	43093859	37424	45980	rs397507190	NC_000017.11:43093858:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	558	BRCA1
NM_007294.4(BRCA1):c.1670C>T (p.Thr557Ile)	BRCA1	T557I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631083	17	41245878	17	43093861	631083	618668	rs1567798771	NC_000017.11:43093860:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	557	BRCA1
NM_007294.4(BRCA1):c.1669A>G (p.Thr557Ala)	BRCA1	T557A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054321	17	41245879	17	43093862	54321	68988	rs397508895	NC_000017.11:43093861:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	557	BRCA1
NM_007294.4(BRCA1):c.1666A>G (p.Lys556Glu)	BRCA1	K556E	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000578705	17	41245882	17	43093865	578705	571477	rs587783041	NC_000017.11:43093864:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	556	BRCA1
NM_007294.4(BRCA1):c.1666A>C (p.Lys556Gln)	BRCA1	K556Q	Hereditary cancer-predisposing syndrome	VCV000156488	17	41245882	17	43093865	156488	166253	rs587783041	NC_000017.11:43093864:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	556	BRCA1
NM_007294.4(BRCA1):c.1665T>G (p.Asn555Lys)	BRCA1	N555K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002070908	17	41245883	17	43093866	2070908	2130132	NA	NC_000017.11:43093865:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	555	BRCA1
NM_007294.4(BRCA1):c.1664A>C (p.Asn555Thr)	BRCA1	N555T	Hereditary breast ovarian cancer syndrome	VCV002694476	17	41245884	17	43093867	2694476	2860615	NA	NC_000017.11:43093866:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	555	BRCA1
NM_007294.4(BRCA1):c.1664A>G (p.Asn555Ser)	BRCA1	N555S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001489883	17	41245884	17	43093867	1489883	1514876	rs2154431398	NC_000017.11:43093866:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	555	BRCA1
NM_007294.4(BRCA1):c.1663A>G (p.Asn555Asp)	BRCA1	N555D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000945062	17	41245885	17	43093868	945062	928316	rs2053904001	NC_000017.11:43093867:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	555	BRCA1
NM_007294.4(BRCA1):c.1662G>T (p.Glu554Asp)	BRCA1	E554D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001346052	17	41245886	17	43093869	1346052	1378341	rs876659028	NC_000017.11:43093868:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	554	BRCA1
NM_007294.4(BRCA1):c.1662G>C (p.Glu554Asp)	BRCA1	E554D	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4	VCV000231215	17	41245886	17	43093869	231215	236122	rs876659028	NC_000017.11:43093868:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	554	BRCA1
NM_007294.4(BRCA1):c.1661A>G (p.Glu554Gly)	BRCA1	E554G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000819777	17	41245887	17	43093870	819777	813845	rs1597874812	NC_000017.11:43093869:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	554	BRCA1
NM_007294.4(BRCA1):c.1660G>C (p.Glu554Gln)	BRCA1	E554Q	Hereditary breast ovarian cancer syndrome	VCV002697233	17	41245888	17	43093871	2697233	2854803	NA	NC_000017.11:43093870:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	554	BRCA1
NM_007294.4(BRCA1):c.1660G>A (p.Glu554Lys)	BRCA1	E554K	Hereditary cancer-predisposing syndrome	VCV001777482	17	41245888	17	43093871	1777482	1827984	NA	NC_000017.11:43093870:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	554	BRCA1
NM_007294.4(BRCA1):c.1658A>G (p.His553Arg)	BRCA1	H553R	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000943608	17	41245890	17	43093873	943608	937967	rs748431827	NC_000017.11:43093872:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	553	BRCA1
NM_007294.4(BRCA1):c.1658A>C (p.His553Pro)	BRCA1	H553P	Hereditary cancer-predisposing syndrome	VCV000185399	17	41245890	17	43093873	185399	185058	rs748431827	NC_000017.11:43093872:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	553	BRCA1
NM_007294.4(BRCA1):c.1657C>T (p.His553Tyr)	BRCA1	H553Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV001330004	17	41245891	17	43093874	1330004	1320688	rs1176222161	NC_000017.11:43093873:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	553	BRCA1
NM_007294.4(BRCA1):c.1655G>A (p.Gly552Asp)	BRCA1	G552D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631260	17	41245893	17	43093876	631260	618669	rs397508893	NC_000017.11:43093875:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	552	BRCA1
NM_007294.4(BRCA1):c.1655G>T (p.Gly552Val)	BRCA1	G552V	Hereditary cancer-predisposing syndrome	VCV000054319	17	41245893	17	43093876	54319	68986	rs397508893	NC_000017.11:43093875:C:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	552	BRCA1
NM_007294.4(BRCA1):c.1654G>A (p.Gly552Ser)	BRCA1	G552S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232405	17	41245894	17	43093877	232405	236123	rs758598971	NC_000017.11:43093876:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	552	BRCA1
NM_007294.4(BRCA1):c.1652G>A (p.Ser551Asn)	BRCA1	S551N	Hereditary cancer-predisposing syndrome|not specified|not provided	VCV001312623	17	41245896	17	43093879	1312623	1302884	rs2154431888	NC_000017.11:43093878:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	551	BRCA1
NM_007294.4(BRCA1):c.1651A>C (p.Ser551Arg)	BRCA1	S551R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000950867	17	41245897	17	43093880	950867	928317	rs730881472	NC_000017.11:43093879:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	551	BRCA1
NM_007294.4(BRCA1):c.1651A>G (p.Ser551Gly)	BRCA1	S551G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182134	17	41245897	17	43093880	182134	180874	rs730881472	NC_000017.11:43093879:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	551	BRCA1
NM_007294.4(BRCA1):c.1649A>G (p.Asn550Ser)	BRCA1	N550S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000421571	17	41245899	17	43093882	421571	410008	rs1064795217	NC_000017.11:43093881:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	550	BRCA1
NM_007294.4(BRCA1):c.1648A>G (p.Asn550Asp)	BRCA1	N550D	Hereditary cancer-predisposing syndrome	VCV002585840	17	41245900	17	43093883	2585840	2753400	NA	NC_000017.11:43093882:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	550	BRCA1
NM_007294.4(BRCA1):c.1648A>C (p.Asn550His)	BRCA1	N550H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037423	17	41245900	17	43093883	37423	45979	rs56012641	NC_000017.11:43093882:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	550	BRCA1
NM_007294.4(BRCA1):c.1645A>T (p.Thr549Ser)	BRCA1	T549S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002059411	17	41245903	17	43093886	2059411	2117270	NA	NC_000017.11:43093885:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	549	BRCA1
NM_007294.4(BRCA1):c.1643T>G (p.Ile548Ser)	BRCA1	I548S	Hereditary cancer-predisposing syndrome	VCV001209888	17	41245905	17	43093888	1209888	1200065	rs2154432348	NC_000017.11:43093887:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	548	BRCA1
NM_007294.4(BRCA1):c.1642A>G (p.Ile548Val)	BRCA1	I548V	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054316	17	41245906	17	43093889	54316	68983	rs80356981	NC_000017.11:43093888:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	548	BRCA1
NM_007294.4(BRCA1):c.1639A>T (p.Asn547Tyr)	BRCA1	N547Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628085	17	41245909	17	43093892	628085	618670	rs1060502351	NC_000017.11:43093891:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	547	BRCA1
NM_007294.4(BRCA1):c.1639A>C (p.Asn547His)	BRCA1	N547H	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000409349	17	41245909	17	43093892	409349	402701	rs1060502351	NC_000017.11:43093891:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	547	BRCA1
NM_007294.4(BRCA1):c.1638G>A (p.Met546Ile)	BRCA1	M546I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000409327	17	41245910	17	43093893	409327	402708	rs1060502340	NC_000017.11:43093892:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	546	BRCA1
NM_007294.4(BRCA1):c.1636A>G (p.Met546Val)	BRCA1	M546V	Hereditary cancer-predisposing syndrome	VCV000142331	17	41245912	17	43093895	142331	152045	rs587782390	NC_000017.11:43093894:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	546	BRCA1
NM_007294.4(BRCA1):c.1633G>T (p.Val545Leu)	BRCA1	V545L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001014279	17	41245915	17	43093898	1014279	1012781	rs1304908704	NC_000017.11:43093897:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	545	BRCA1
NM_007294.4(BRCA1):c.1631_1632delinsGG (p.Gln544Arg)	BRCA1	Q544R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462564	17	41245916 - 41245917	17	43093899 - 43093900	462564	466895	rs1555591449	NC_000017.11:43093898:TT:CC	Indel	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	544	BRCA1
NM_007294.4(BRCA1):c.1631A>T (p.Gln544Leu)	BRCA1	Q544L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000631174	17	41245917	17	43093900	631174	618671	rs397508892	NC_000017.11:43093899:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	544	BRCA1
NM_007294.4(BRCA1):c.1631A>C (p.Gln544Pro)	BRCA1	Q544P	Hereditary cancer-predisposing syndrome	VCV000054314	17	41245917	17	43093900	54314	68981	rs397508892	NC_000017.11:43093899:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	544	BRCA1
NM_007294.4(BRCA1):c.1627G>C (p.Gly543Arg)	BRCA1	G543R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001056771	17	41245921	17	43093904	1056771	1050310	rs2154433275	NC_000017.11:43093903:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	543	BRCA1
NM_007294.4(BRCA1):c.1625A>T (p.Asn542Ile)	BRCA1	N542I	Hereditary cancer-predisposing syndrome	VCV001776679	17	41245923	17	43093906	1776679	1833954	NA	NC_000017.11:43093905:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	542	BRCA1
NM_007294.4(BRCA1):c.1625A>G (p.Asn542Ser)	BRCA1	N542S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001367120	17	41245923	17	43093906	1367120	1404842	rs2154433378	NC_000017.11:43093905:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	542	BRCA1
NM_007294.4(BRCA1):c.1624A>G (p.Asn542Asp)	BRCA1	N542D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531325	17	41245924	17	43093907	531325	531084	rs1555591461	NC_000017.11:43093906:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	542	BRCA1
NM_007294.4(BRCA1):c.1622A>G (p.Gln541Arg)	BRCA1	Q541R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001497130	17	41245926	17	43093909	1497130	1475751	rs2154433518	NC_000017.11:43093908:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	541	BRCA1
NM_007294.4(BRCA1):c.1620G>C (p.Glu540Asp)	BRCA1	E540D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531310	17	41245928	17	43093911	531310	531299	rs1555591465	NC_000017.11:43093910:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	540	BRCA1
NM_007294.4(BRCA1):c.1619A>C (p.Glu540Ala)	BRCA1	E540A	Hereditary cancer-predisposing syndrome	VCV003261461	17	41245929	17	43093912	3261461	3424230	NA	NC_000017.11:43093911:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	540	BRCA1
NM_007294.4(BRCA1):c.1619A>G (p.Glu540Gly)	BRCA1	E540G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002103445	17	41245929	17	43093912	2103445	2169095	NA	NC_000017.11:43093911:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	540	BRCA1
NM_007294.4(BRCA1):c.1618G>A (p.Glu540Lys)	BRCA1	E540K	not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182133	17	41245930	17	43093913	182133	180875	rs730881471	NC_000017.11:43093912:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	540	BRCA1
NM_007294.4(BRCA1):c.1616C>G (p.Thr539Arg)	BRCA1	T539R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002132506	17	41245932	17	43093915	2132506	2186507	NA	NC_000017.11:43093914:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	539	BRCA1
NM_007294.4(BRCA1):c.1616C>A (p.Thr539Lys)	BRCA1	T539K	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000182132	17	41245932	17	43093915	182132	180876	rs80357374	NC_000017.11:43093914:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	539	BRCA1
NM_007294.4(BRCA1):c.1616C>T (p.Thr539Met)	BRCA1	T539M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054310	17	41245932	17	43093915	54310	68977	rs80357374	NC_000017.11:43093914:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	539	BRCA1
NM_007294.4(BRCA1):c.1612C>G (p.Gln538Glu)	BRCA1	Q538E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001484187	17	41245936	17	43093919	1484187	1455117	rs80356893	NC_000017.11:43093918:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	538	BRCA1
NM_007294.4(BRCA1):c.1610A>C (p.Asn537Thr)	BRCA1	N537T	Hereditary cancer-predisposing syndrome	VCV001776374	17	41245938	17	43093921	1776374	1837604	NA	NC_000017.11:43093920:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	537	BRCA1
NM_007294.4(BRCA1):c.1609A>G (p.Asn537Asp)	BRCA1	N537D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000091558	17	41245939	17	43093922	91558	97035	rs398122639	NC_000017.11:43093921:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	537	BRCA1
NM_007294.4(BRCA1):c.1607C>T (p.Thr536Ile)	BRCA1	T536I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000819657	17	41245941	17	43093924	819657	813846	rs398122638	NC_000017.11:43093923:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	536	BRCA1
NM_007294.4(BRCA1):c.1607C>A (p.Thr536Asn)	BRCA1	T536N	Hereditary cancer-predisposing syndrome	VCV000482957	17	41245941	17	43093924	482957	478670	rs398122638	NC_000017.11:43093923:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	536	BRCA1
NM_007294.4(BRCA1):c.1607C>G (p.Thr536Ser)	BRCA1	T536S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091557	17	41245941	17	43093924	91557	97034	rs398122638	NC_000017.11:43093923:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	536	BRCA1
NM_007294.4(BRCA1):c.1604G>C (p.Gly535Ala)	BRCA1	G535A	Hereditary cancer-predisposing syndrome|not provided	VCV000419039	17	41245944	17	43093927	419039	410009	rs1064793602	NC_000017.11:43093926:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	535	BRCA1
NM_007294.4(BRCA1):c.1603G>A (p.Gly535Arg)	BRCA1	G535R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000438913	17	41245945	17	43093928	438913	432915	rs1555591488	NC_000017.11:43093927:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	535	BRCA1
NM_007294.4(BRCA1):c.1601A>G (p.Gln534Arg)	BRCA1	Q534R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054304	17	41245947	17	43093930	54304	68971	rs80357173	NC_000017.11:43093929:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	534	BRCA1
NM_007294.4(BRCA1):c.1598A>G (p.Asn533Ser)	BRCA1	N533S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000188408	17	41245950	17	43093933	188408	186547	rs786204263	NC_000017.11:43093932:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	533	BRCA1
NM_007294.4(BRCA1):c.1594A>T (p.Ile532Leu)	BRCA1	I532L	Hereditary cancer-predisposing syndrome	VCV000926833	17	41245954	17	43093937	926833	913942	rs2053915860	NC_000017.11:43093936:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	532	BRCA1
NM_007294.4(BRCA1):c.1593G>A (p.Met531Ile)	BRCA1	M531I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003074124	17	41245955	17	43093938	3074124	3231260	NA	NC_000017.11:43093937:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	531	BRCA1
NM_007294.4(BRCA1):c.1593G>T (p.Met531Ile)	BRCA1	M531I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001396909	17	41245955	17	43093938	1396909	1414783	rs2154434764	NC_000017.11:43093937:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	531	BRCA1
NM_007294.4(BRCA1):c.1591A>G (p.Met531Val)	BRCA1	M531V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001063010	17	41245957	17	43093940	1063010	1050311	rs2053916000	NC_000017.11:43093939:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	531	BRCA1
NM_007294.4(BRCA1):c.1591A>T (p.Met531Leu)	BRCA1	M531L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000922305	17	41245957	17	43093940	922305	913943	rs2053916000	NC_000017.11:43093939:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	531	BRCA1
NM_007294.4(BRCA1):c.1590A>C (p.Glu530Asp)	BRCA1	E530D	Hereditary cancer-predisposing syndrome	VCV003226107	17	41245958	17	43093941	3226107	3390612	NA	NC_000017.11:43093940:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 7, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	530	BRCA1
NM_007294.4(BRCA1):c.1589A>T (p.Glu530Val)	BRCA1	E530V	Hereditary cancer-predisposing syndrome|not provided	VCV000819553	17	41245959	17	43093942	819553	813848	rs1555591512	NC_000017.11:43093941:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	530	BRCA1
NM_007294.4(BRCA1):c.1589A>G (p.Glu530Gly)	BRCA1	E530G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000496349	17	41245959	17	43093942	496349	487894	rs1555591512	NC_000017.11:43093941:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	530	BRCA1
NM_007294.4(BRCA1):c.1585C>T (p.Pro529Ser)	BRCA1	P529S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001443073	17	41245963	17	43093946	1443073	1371960	rs769380445	NC_000017.11:43093945:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	529	BRCA1
NM_007294.4(BRCA1):c.1581G>T (p.Lys527Asn)	BRCA1	K527N	Hereditary cancer-predisposing syndrome	VCV001775717	17	41245967	17	43093950	1775717	1827517	NA	NC_000017.11:43093949:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	527	BRCA1
NM_007294.4(BRCA1):c.1581G>C (p.Lys527Asn)	BRCA1	K527N	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054300	17	41245967	17	43093950	54300	68967	rs80357493	NC_000017.11:43093949:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	527	BRCA1
NM_007294.4(BRCA1):c.1580A>G (p.Lys527Arg)	BRCA1	K527R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000418567	17	41245968	17	43093951	418567	410010	rs774959350	NC_000017.11:43093950:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	527	BRCA1
NM_007294.4(BRCA1):c.1577A>C (p.Gln526Pro)	BRCA1	Q526P	Hereditary cancer-predisposing syndrome	VCV000923531	17	41245971	17	43093954	923531	913944	rs2053917320	NC_000017.11:43093953:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	526	BRCA1
NM_007294.4(BRCA1):c.1574T>C (p.Val525Ala)	BRCA1	V525A	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000245690	17	41245974	17	43093957	245690	245048	rs879253902	NC_000017.11:43093956:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	525	BRCA1
NM_007294.4(BRCA1):c.1573G>C (p.Val525Leu)	BRCA1	V525L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000954894	17	41245975	17	43093958	954894	949954	rs80357273	NC_000017.11:43093957:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	525	BRCA1
NM_007294.4(BRCA1):c.1573G>A (p.Val525Ile)	BRCA1	V525I	not provided|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054298	17	41245975	17	43093958	54298	68965	rs80357273	NC_000017.11:43093957:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	525	BRCA1
NM_007294.4(BRCA1):c.1571C>G (p.Ala524Gly)	BRCA1	A524G	Hereditary cancer-predisposing syndrome	VCV003226106	17	41245977	17	43093960	3226106	3390611	NA	NC_000017.11:43093959:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	524	BRCA1
NM_007294.4(BRCA1):c.1571C>T (p.Ala524Val)	BRCA1	A524V	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054297	17	41245977	17	43093960	54297	68964	rs80357333	NC_000017.11:43093959:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	524	BRCA1
NM_007294.4(BRCA1):c.1570G>A (p.Ala524Thr)	BRCA1	A524T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000940587	17	41245978	17	43093961	940587	937968	rs761178502	NC_000017.11:43093960:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	524	BRCA1
NM_007294.4(BRCA1):c.1568T>C (p.Leu523Ser)	BRCA1	L523S	Hereditary breast ovarian cancer syndrome	VCV002819093	17	41245980	17	43093963	2819093	2977619	NA	NC_000017.11:43093962:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	523	BRCA1
NM_007294.4(BRCA1):c.1568T>G (p.Leu523Trp)	BRCA1	L523W	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054295	17	41245980	17	43093963	54295	68962	rs397508885	NC_000017.11:43093962:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	523	BRCA1
NM_007294.4(BRCA1):c.1567T>A (p.Leu523Met)	BRCA1	L523M	Hereditary cancer-predisposing syndrome	VCV003226105	17	41245981	17	43093964	3226105	3390610	NA	NC_000017.11:43093963:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	523	BRCA1
NM_007294.4(BRCA1):c.1567T>G (p.Leu523Val)	BRCA1	L523V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000937374	17	41245981	17	43093964	937374	937969	rs754398271	NC_000017.11:43093963:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	523	BRCA1
NM_007294.4(BRCA1):c.1566T>G (p.Asp522Glu)	BRCA1	D522E	not provided|Hereditary cancer-predisposing syndrome	VCV001803468	17	41245982	17	43093965	1803468	1860496	NA	NC_000017.11:43093964:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	522	BRCA1
NM_007294.4(BRCA1):c.1564G>A (p.Asp522Asn)	BRCA1	D522N	Hereditary cancer-predisposing syndrome	VCV000054293	17	41245984	17	43093967	54293	68960	rs80357453	NC_000017.11:43093966:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	522	BRCA1
NM_007294.4(BRCA1):c.1562C>T (p.Ala521Val)	BRCA1	A521V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002068874	17	41245986	17	43093969	2068874	2122845	NA	NC_000017.11:43093968:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	521	BRCA1
NM_007294.4(BRCA1):c.1562C>G (p.Ala521Gly)	BRCA1	A521G	Hereditary cancer-predisposing syndrome	VCV001775283	17	41245986	17	43093969	1775283	1830480	NA	NC_000017.11:43093968:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	521	BRCA1
NM_007294.4(BRCA1):c.1561G>C (p.Ala521Pro)	BRCA1	A521P	Hereditary cancer-predisposing syndrome	VCV000431216	17	41245987	17	43093970	431216	424846	rs80357122	NC_000017.11:43093969:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	521	BRCA1
NM_007294.4(BRCA1):c.1561G>A (p.Ala521Thr)	BRCA1	A521T	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000054291	17	41245987	17	43093970	54291	68958	rs80357122	NC_000017.11:43093969:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	521	BRCA1
NM_007294.4(BRCA1):c.1558A>C (p.Lys520Gln)	BRCA1	K520Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462563	17	41245990	17	43093973	462563	468220	rs1555591572	NC_000017.11:43093972:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	520	BRCA1
NM_007294.4(BRCA1):c.1557G>C (p.Lys519Asn)	BRCA1	K519N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001389897	17	41245991	17	43093974	1389897	1373497	rs2154437017	NC_000017.11:43093973:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	519	BRCA1
NM_007294.4(BRCA1):c.1555A>C (p.Lys519Gln)	BRCA1	K519Q	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000054290	17	41245993	17	43093976	54290	68957	rs397508882	NC_000017.11:43093975:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	519	BRCA1
NM_007294.4(BRCA1):c.1554C>G (p.Ile518Met)	BRCA1	I518M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001363342	17	41245994	17	43093977	1363342	1489202	rs1064794487	NC_000017.11:43093976:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	518	BRCA1
NM_007294.4(BRCA1):c.1553T>C (p.Ile518Thr)	BRCA1	I518T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000582489	17	41245995	17	43093978	582489	574486	rs1567799193	NC_000017.11:43093977:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	518	BRCA1
NM_007294.4(BRCA1):c.1552A>G (p.Ile518Val)	BRCA1	I518V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000819513	17	41245996	17	43093979	819513	813851	rs1597875402	NC_000017.11:43093978:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	518	BRCA1
NM_007294.4(BRCA1):c.1549T>A (p.Phe517Ile)	BRCA1	F517I	Hereditary breast ovarian cancer syndrome	VCV002716815	17	41245999	17	43093982	2716815	2876513	NA	NC_000017.11:43093981:A:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	517	BRCA1
NM_007294.4(BRCA1):c.1548T>G (p.Asp516Glu)	BRCA1	D516E	Hereditary breast ovarian cancer syndrome	VCV002815522	17	41246000	17	43093983	2815522	2970193	NA	NC_000017.11:43093982:A:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	516	BRCA1
NM_007294.4(BRCA1):c.1546G>C (p.Asp516His)	BRCA1	D516H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002138043	17	41246002	17	43093985	2138043	1871652	NA	NC_000017.11:43093984:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	516	BRCA1
NM_007294.4(BRCA1):c.1544A>G (p.Glu515Gly)	BRCA1	E515G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054288	17	41246004	17	43093987	54288	68955	rs397508881	NC_000017.11:43093986:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	515	BRCA1
NM_007294.4(BRCA1):c.1543G>A (p.Glu515Lys)	BRCA1	E515K	Hereditary cancer-predisposing syndrome	VCV000631084	17	41246005	17	43093988	631084	618672	rs886037990	NC_000017.11:43093987:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	515	BRCA1
NM_007294.4(BRCA1):c.1541C>G (p.Pro514Arg)	BRCA1	P514R	Hereditary cancer-predisposing syndrome	VCV000630130	17	41246007	17	43093990	630130	618673	rs56100707	NC_000017.11:43093989:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	514	BRCA1
NM_007294.4(BRCA1):c.1541C>T (p.Pro514Leu)	BRCA1	P514L	not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000619620	17	41246007	17	43093990	619620	611249	rs56100707	NC_000017.11:43093989:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	514	BRCA1
NM_007294.4(BRCA1):c.1540C>T (p.Pro514Ser)	BRCA1	P514S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001774841	17	41246008	17	43093991	1774841	1833427	NA	NC_000017.11:43093990:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	514	BRCA1
NM_007294.4(BRCA1):c.1540C>A (p.Pro514Thr)	BRCA1	P514T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482935	17	41246008	17	43093991	482935	478808	rs1555591584	NC_000017.11:43093990:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	514	BRCA1
NM_007294.4(BRCA1):c.1538A>C (p.His513Pro)	BRCA1	H513P	Hereditary cancer-predisposing syndrome	VCV001774749	17	41246010	17	43093993	1774749	1837285	NA	NC_000017.11:43093992:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	513	BRCA1
NM_007294.4(BRCA1):c.1538A>G (p.His513Arg)	BRCA1	H513R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531377	17	41246010	17	43093993	531377	531306	rs1356078500	NC_000017.11:43093992:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	513	BRCA1
NM_007294.4(BRCA1):c.1537C>A (p.His513Asn)	BRCA1	H513N	Hereditary cancer-predisposing syndrome	VCV002774858	17	41246011	17	43093994	2774858	2935584	NA	NC_000017.11:43093993:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	513	BRCA1
NM_007294.4(BRCA1):c.1537C>T (p.His513Tyr)	BRCA1	H513Y	Hereditary cancer-predisposing syndrome	VCV001774740	17	41246011	17	43093994	1774740	1837276	NA	NC_000017.11:43093993:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	513	BRCA1
NM_007294.4(BRCA1):c.1534C>G (p.Leu512Val)	BRCA1	L512V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000141741	17	41246014	17	43093997	141741	151455	rs41286294	NC_000017.11:43093996:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	512	BRCA1
NM_007294.4(BRCA1):c.1534C>T (p.Leu512Phe)	BRCA1	L512F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037420	17	41246014	17	43093997	37420	45976	rs41286294	NC_000017.11:43093996:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	512	BRCA1
NM_007294.4(BRCA1):c.1532G>T (p.Gly511Val)	BRCA1	G511V	Hereditary cancer-predisposing syndrome	VCV000037419	17	41246016	17	43093999	37419	45975	rs397507188	NC_000017.11:43093998:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	511	BRCA1
NM_007294.4(BRCA1):c.1531G>A (p.Gly511Ser)	BRCA1	G511S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000581890	17	41246017	17	43094000	581890	569168	rs1567799248	NC_000017.11:43093999:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Aug 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	511	BRCA1
NM_007294.4(BRCA1):c.1528T>A (p.Ser510Thr)	BRCA1	S510T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001315521	17	41246020	17	43094003	1315521	1305781	rs777916645	NC_000017.11:43094002:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	510	BRCA1
NM_007294.4(BRCA1):c.1528T>G (p.Ser510Ala)	BRCA1	S510A	Hereditary cancer-predisposing syndrome|not provided	VCV001012905	17	41246020	17	43094003	1012905	1001014	rs777916645	NC_000017.11:43094002:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	510	BRCA1
NM_007294.4(BRCA1):c.1526C>T (p.Thr509Ile)	BRCA1	T509I	Hereditary breast ovarian cancer syndrome	VCV002979394	17	41246022	17	43094005	2979394	3137986	NA	NC_000017.11:43094004:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	509	BRCA1
NM_007294.4(BRCA1):c.1525A>T (p.Thr509Ser)	BRCA1	T509S	Hereditary breast ovarian cancer syndrome	VCV002816159	17	41246023	17	43094006	2816159	2976829	NA	NC_000017.11:43094005:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	509	BRCA1
NM_007294.4(BRCA1):c.1525A>G (p.Thr509Ala)	BRCA1	T509A	Hereditary cancer-predisposing syndrome	VCV001275855	17	41246023	17	43094006	1275855	1265733	rs1238203770	NC_000017.11:43094005:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	509	BRCA1
NM_007294.4(BRCA1):c.1523C>A (p.Pro508His)	BRCA1	P508H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000919309	17	41246025	17	43094008	919309	913946	rs398122637	NC_000017.11:43094007:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	508	BRCA1
NM_007294.4(BRCA1):c.1523C>T (p.Pro508Leu)	BRCA1	P508L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091555	17	41246025	17	43094008	91555	97032	rs398122637	NC_000017.11:43094007:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	508	BRCA1
NM_007294.4(BRCA1):c.1522C>T (p.Pro508Ser)	BRCA1	P508S	Hereditary cancer-predisposing syndrome	VCV001774458	17	41246026	17	43094009	1774458	1836997	NA	NC_000017.11:43094008:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	508	BRCA1
NM_007294.4(BRCA1):c.1522C>G (p.Pro508Ala)	BRCA1	P508A	Hereditary cancer-predisposing syndrome	VCV000482916	17	41246026	17	43094009	482916	478810	rs1555591622	NC_000017.11:43094008:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	508	BRCA1
NM_007294.4(BRCA1):c.1520G>A (p.Arg507Lys)	BRCA1	R507K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001498293	17	41246028	17	43094011	1498293	1372933	rs80357224	NC_000017.11:43094010:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	507	BRCA1
NM_007294.4(BRCA1):c.1520G>T (p.Arg507Ile)	BRCA1	R507I	Hereditary cancer-predisposing syndrome	VCV000054284	17	41246028	17	43094011	54284	68951	rs80357224	NC_000017.11:43094010:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	507	BRCA1
NM_007294.4(BRCA1):c.1517G>A (p.Arg506Lys)	BRCA1	R506K	Hereditary cancer-predisposing syndrome	VCV002450667	17	41246031	17	43094014	2450667	2423153	NA	NC_000017.11:43094013:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	506	BRCA1
NM_007294.4(BRCA1):c.1516A>G (p.Arg506Gly)	BRCA1	R506G	Hereditary breast ovarian cancer syndrome	VCV002863355	17	41246032	17	43094015	2863355	3019542	NA	NC_000017.11:43094014:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	506	BRCA1
NM_007294.4(BRCA1):c.1514A>T (p.Lys505Ile)	BRCA1	K505I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000252866	17	41246034	17	43094017	252866	247267	rs879254266	NC_000017.11:43094016:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	505	BRCA1
NM_007294.4(BRCA1):c.1514A>G (p.Lys505Arg)	BRCA1	K505R	not provided|Hereditary cancer-predisposing syndrome	VCV000246451	17	41246034	17	43094017	246451	245049	rs879254266	NC_000017.11:43094016:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	505	BRCA1
NM_007294.4(BRCA1):c.1513A>G (p.Lys505Glu)	BRCA1	K505E	Hereditary cancer-predisposing syndrome	VCV000921457	17	41246035	17	43094018	921457	913947	rs397508877	NC_000017.11:43094017:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	505	BRCA1
NM_007294.4(BRCA1):c.1511G>T (p.Arg504Leu)	BRCA1	R504L	Hereditary cancer-predisposing syndrome	VCV000921759	17	41246037	17	43094020	921759	913948	rs56272539	NC_000017.11:43094019:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	504	BRCA1
NM_007294.4(BRCA1):c.1511G>A (p.Arg504His)	BRCA1	R504H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054278	17	41246037	17	43094020	54278	68945	rs56272539	NC_000017.11:43094019:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	504	BRCA1
NM_007294.4(BRCA1):c.1510C>G (p.Arg504Gly)	BRCA1	R504G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001367693	17	41246038	17	43094021	1367693	1401543	rs80357445	NC_000017.11:43094020:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	504	BRCA1
NM_007294.4(BRCA1):c.1510C>T (p.Arg504Cys)	BRCA1	R504C	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054277	17	41246038	17	43094021	54277	68944	rs80357445	NC_000017.11:43094020:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	504	BRCA1
NM_007294.4(BRCA1):c.1509G>C (p.Lys503Asn)	BRCA1	K503N	Hereditary breast ovarian cancer syndrome	VCV002914954	17	41246039	17	43094022	2914954	3079692	NA	NC_000017.11:43094021:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	503	BRCA1
NM_007294.4(BRCA1):c.1508A>G (p.Lys503Arg)	BRCA1	K503R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|not specified	VCV000054274	17	41246040	17	43094023	54274	68941	rs62625304	NC_000017.11:43094022:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	503	BRCA1
NM_007294.4(BRCA1):c.1505T>C (p.Leu502Ser)	BRCA1	L502S	Hereditary cancer-predisposing syndrome	VCV000819410	17	41246043	17	43094026	819410	813852	rs886039957	NC_000017.11:43094025:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	502	BRCA1
NM_007294.4(BRCA1):c.1502A>C (p.Lys501Thr)	BRCA1	K501T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000438911	17	41246046	17	43094029	438911	432917	rs113656989	NC_000017.11:43094028:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	501	BRCA1
NM_007294.4(BRCA1):c.1501A>C (p.Lys501Gln)	BRCA1	K501Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000819382	17	41246047	17	43094030	819382	813853	rs1064793883	NC_000017.11:43094029:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	501	BRCA1
NM_007294.4(BRCA1):c.1501A>G (p.Lys501Glu)	BRCA1	K501E	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000419456	17	41246047	17	43094030	419456	410012	rs1064793883	NC_000017.11:43094029:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	501	BRCA1
NM_007294.4(BRCA1):c.1500T>A (p.Asn500Lys)	BRCA1	N500K	Hereditary breast ovarian cancer syndrome	VCV002884072	17	41246048	17	43094031	2884072	3043374	NA	NC_000017.11:43094030:A:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	500	BRCA1
NM_007294.4(BRCA1):c.1500T>G (p.Asn500Lys)	BRCA1	N500K	Hereditary cancer-predisposing syndrome	VCV001774022	17	41246048	17	43094031	1774022	1827128	NA	NC_000017.11:43094030:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	500	BRCA1
NM_007294.4(BRCA1):c.1499A>G (p.Asn500Ser)	BRCA1	N500S	Hereditary cancer-predisposing syndrome	VCV000489708	17	41246049	17	43094032	489708	482999	rs1555591677	NC_000017.11:43094031:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	500	BRCA1
NM_007294.4(BRCA1):c.1498A>G (p.Asn500Asp)	BRCA1	N500D	Hereditary cancer-predisposing syndrome|not provided	VCV000496348	17	41246050	17	43094033	496348	487730	rs1555591681	NC_000017.11:43094032:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	500	BRCA1
NM_007294.4(BRCA1):c.1496C>T (p.Thr499Ile)	BRCA1	T499I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000229940	17	41246052	17	43094035	229940	236127	rs876658285	NC_000017.11:43094034:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	499	BRCA1
NM_007294.4(BRCA1):c.1495A>C (p.Thr499Pro)	BRCA1	T499P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000846776	17	41246053	17	43094036	846776	845441	rs2053931342	NC_000017.11:43094035:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	499	BRCA1
NM_007294.4(BRCA1):c.1493T>C (p.Leu498Pro)	BRCA1	L498P	Hereditary cancer-predisposing syndrome	VCV003226103	17	41246055	17	43094038	3226103	3390608	NA	NC_000017.11:43094037:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 16, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	498	BRCA1
NM_007294.4(BRCA1):c.1490C>G (p.Pro497Arg)	BRCA1	P497R	Hereditary cancer-predisposing syndrome	VCV003226102	17	41246058	17	43094041	3226102	3390607	NA	NC_000017.11:43094040:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	497	BRCA1
NM_007294.4(BRCA1):c.1490C>T (p.Pro497Leu)	BRCA1	P497L	Hereditary cancer-predisposing syndrome	VCV000479224	17	41246058	17	43094041	479224	478814	rs1555591693	NC_000017.11:43094040:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	497	BRCA1
NM_007294.4(BRCA1):c.1489C>A (p.Pro497Thr)	BRCA1	P497T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000489707	17	41246059	17	43094042	489707	482975	rs1555591695	NC_000017.11:43094041:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	497	BRCA1
NM_007294.4(BRCA1):c.1487G>T (p.Arg496Leu)	BRCA1	R496L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000480977	17	41246061	17	43094044	480977	478753	rs28897677	NC_000017.11:43094043:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	496	BRCA1
NM_007294.4(BRCA1):c.1487G>A (p.Arg496His)	BRCA1	R496H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041805	17	41246061	17	43094044	41805	50244	rs28897677	NC_000017.11:43094043:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	496	BRCA1
NM_007294.4(BRCA1):c.1486C>A (p.Arg496Ser)	BRCA1	R496S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054267	17	41246062	17	43094045	54267	68934	rs28897676	NC_000017.11:43094044:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	496	BRCA1
NM_007294.4(BRCA1):c.1486C>T (p.Arg496Cys)	BRCA1	R496C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037416	17	41246062	17	43094045	37416	45972	rs28897676	NC_000017.11:43094044:G:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	496	BRCA1
NM_007294.4(BRCA1):c.1485G>T (p.Glu495Asp)	BRCA1	E495D	Hereditary cancer-predisposing syndrome	VCV001773660	17	41246063	17	43094046	1773660	1830166	NA	NC_000017.11:43094045:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	495	BRCA1
NM_007294.4(BRCA1):c.1484A>G (p.Glu495Gly)	BRCA1	E495G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003074420	17	41246064	17	43094047	3074420	3231554	NA	NC_000017.11:43094046:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	495	BRCA1
NM_007294.4(BRCA1):c.1484A>C (p.Glu495Ala)	BRCA1	E495A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000575821	17	41246064	17	43094047	575821	571198	rs1567799498	NC_000017.11:43094046:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	495	BRCA1
NM_007294.4(BRCA1):c.1480C>A (p.Gln494Lys)	BRCA1	Q494K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002585849	17	41246068	17	43094051	2585849	2753409	NA	NC_000017.11:43094050:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	494	BRCA1
NM_007294.4(BRCA1):c.1480C>G (p.Gln494Glu)	BRCA1	Q494E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000918686	17	41246068	17	43094051	918686	913949	rs80357010	NC_000017.11:43094050:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	494	BRCA1
NM_007294.4(BRCA1):c.1478T>C (p.Ile493Thr)	BRCA1	I493T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462560	17	41246070	17	43094053	462560	466904	rs1555591707	NC_000017.11:43094052:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	493	BRCA1
NM_007294.4(BRCA1):c.1477A>C (p.Ile493Leu)	BRCA1	I493L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000856541	17	41246071	17	43094054	856541	845442	rs2053933371	NC_000017.11:43094053:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	493	BRCA1
NM_007294.4(BRCA1):c.1476A>G (p.Ile492Met)	BRCA1	I492M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002905781	17	41246072	17	43094055	2905781	3062230	NA	NC_000017.11:43094054:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	492	BRCA1
NM_007294.4(BRCA1):c.1474A>G (p.Ile492Val)	BRCA1	I492V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000660456	17	41246074	17	43094057	660456	646028	rs1597875858	NC_000017.11:43094056:T:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jul 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	492	BRCA1
NM_007294.4(BRCA1):c.1473G>T (p.Gln491His)	BRCA1	Q491H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001039566	17	41246075	17	43094058	1039566	1033324	rs2053933782	NC_000017.11:43094057:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	491	BRCA1
NM_007294.4(BRCA1):c.1472A>C (p.Gln491Pro)	BRCA1	Q491P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000229818	17	41246076	17	43094059	229818	236128	rs80357376	NC_000017.11:43094058:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	491	BRCA1
NM_007294.4(BRCA1):c.1472A>G (p.Gln491Arg)	BRCA1	Q491R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054265	17	41246076	17	43094059	54265	68932	rs80357376	NC_000017.11:43094058:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	491	BRCA1
NM_007294.4(BRCA1):c.1471C>G (p.Gln491Glu)	BRCA1	Q491E	Hereditary cancer-predisposing syndrome	VCV000481431	17	41246077	17	43094060	481431	478675	rs62625303	NC_000017.11:43094059:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	491	BRCA1
NM_007294.4(BRCA1):c.1469C>T (p.Pro490Leu)	BRCA1	P490L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000229946	17	41246079	17	43094062	229946	236129	rs876658291	NC_000017.11:43094061:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	490	BRCA1
NM_007294.4(BRCA1):c.1468C>T (p.Pro490Ser)	BRCA1	P490S	Hereditary cancer-predisposing syndrome	VCV001773294	17	41246080	17	43094063	1773294	1833188	NA	NC_000017.11:43094062:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	490	BRCA1
NM_007294.4(BRCA1):c.1465G>A (p.Glu489Lys)	BRCA1	E489K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054261	17	41246083	17	43094066	54261	68928	rs80357167	NC_000017.11:43094065:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	489	BRCA1
NM_007294.4(BRCA1):c.1460T>G (p.Val487Gly)	BRCA1	V487G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482955	17	41246088	17	43094071	482955	478818	rs748812609	NC_000017.11:43094070:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	487	BRCA1
NM_007294.4(BRCA1):c.1460T>C (p.Val487Ala)	BRCA1	V487A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000252865	17	41246088	17	43094071	252865	247266	rs748812609	NC_000017.11:43094070:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	487	BRCA1
NM_007294.4(BRCA1):c.1459G>A (p.Val487Ile)	BRCA1	V487I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002064438	17	41246089	17	43094072	2064438	2128422	NA	NC_000017.11:43094071:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Feb 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	487	BRCA1
NM_007294.4(BRCA1):c.1459G>T (p.Val487Phe)	BRCA1	V487F	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000037414	17	41246089	17	43094072	37414	45970	rs369588942	NC_000017.11:43094071:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	487	BRCA1
NM_007294.4(BRCA1):c.1458T>G (p.Phe486Leu)	BRCA1	F486L	Hereditary cancer-predisposing syndrome	VCV000054260	17	41246090	17	43094073	54260	68927	rs80357400	NC_000017.11:43094072:A:C	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	486	BRCA1
NM_007294.4(BRCA1):c.1458T>A (p.Phe486Leu)	BRCA1	F486L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054259	17	41246090	17	43094073	54259	68926	rs80357400	NC_000017.11:43094072:A:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Sep 9, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	486	BRCA1
NM_007294.4(BRCA1):c.1457T>C (p.Phe486Ser)	BRCA1	F486S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000819266	17	41246091	17	43094074	819266	813854	rs774159828	NC_000017.11:43094073:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	486	BRCA1
NM_007294.4(BRCA1):c.1456T>A (p.Phe486Ile)	BRCA1	F486I	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182090	17	41246092	17	43094075	182090	180877	rs55906931	NC_000017.11:43094074:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	486	BRCA1
NM_007294.4(BRCA1):c.1456T>C (p.Phe486Leu)	BRCA1	F486L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054258	17	41246092	17	43094075	54258	68925	rs55906931	NC_000017.11:43094074:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	486	BRCA1
NM_007294.4(BRCA1):c.1454C>T (p.Ala485Val)	BRCA1	A485V	Hereditary cancer-predisposing syndrome	VCV001773016	17	41246094	17	43094077	1773016	1836859	NA	NC_000017.11:43094076:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	485	BRCA1
NM_007294.4(BRCA1):c.1454C>G (p.Ala485Gly)	BRCA1	A485G	Hereditary cancer-predisposing syndrome	VCV001773015	17	41246094	17	43094077	1773015	1836858	NA	NC_000017.11:43094076:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	485	BRCA1
NM_007294.4(BRCA1):c.1453G>A (p.Ala485Thr)	BRCA1	A485T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001974842	17	41246095	17	43094078	1974842	2033978	NA	NC_000017.11:43094077:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	485	BRCA1
NM_007294.4(BRCA1):c.1451G>A (p.Gly484Glu)	BRCA1	G484E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000923908	17	41246097	17	43094080	923908	913950	rs2053936550	NC_000017.11:43094079:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	484	BRCA1
NM_007294.4(BRCA1):c.1450G>A (p.Gly484Arg)	BRCA1	G484R	not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000568267	17	41246098	17	43094081	568267	574487	rs80357304	NC_000017.11:43094080:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	484	BRCA1
NM_007294.4(BRCA1):c.1448T>C (p.Ile483Thr)	BRCA1	I483T	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054255	17	41246100	17	43094083	54255	68922	rs80357489	NC_000017.11:43094082:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	483	BRCA1
NM_007294.4(BRCA1):c.1447A>G (p.Ile483Val)	BRCA1	I483V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001718720	17	41246101	17	43094084	1718720	1776224	NA	NC_000017.11:43094083:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	483	BRCA1
NM_007294.4(BRCA1):c.1444A>G (p.Ile482Val)	BRCA1	I482V	Hereditary breast ovarian cancer syndrome	VCV002768905	17	41246104	17	43094087	2768905	2927055	NA	NC_000017.11:43094086:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	482	BRCA1
NM_007294.4(BRCA1):c.1442T>C (p.Leu481Pro)	BRCA1	L481P	Hereditary cancer-predisposing syndrome	VCV000921100	17	41246106	17	43094089	921100	913951	rs2053937820	NC_000017.11:43094088:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	481	BRCA1
NM_007294.4(BRCA1):c.1441C>A (p.Leu481Ile)	BRCA1	L481I	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000856298	17	41246107	17	43094090	856298	845443	rs1397842308	NC_000017.11:43094089:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	481	BRCA1
NM_007294.4(BRCA1):c.1441C>G (p.Leu481Val)	BRCA1	L481V	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000433698	17	41246107	17	43094090	433698	427560	rs1397842308	NC_000017.11:43094089:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	481	BRCA1
NM_007294.4(BRCA1):c.1440T>G (p.Asn480Lys)	BRCA1	N480K	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001060799	17	41246108	17	43094091	1060799	1050312	rs2154446030	NC_000017.11:43094090:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	480	BRCA1
NM_007294.4(BRCA1):c.1438A>C (p.Asn480His)	BRCA1	N480H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001772642	17	41246110	17	43094093	1772642	1836486	NA	NC_000017.11:43094092:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	480	BRCA1
NM_007294.4(BRCA1):c.1436A>G (p.Glu479Gly)	BRCA1	E479G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000819211	17	41246112	17	43094095	819211	813857	rs1597876039	NC_000017.11:43094094:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	479	BRCA1
NM_007294.4(BRCA1):c.1435G>C (p.Glu479Gln)	BRCA1	E479Q	Hereditary cancer-predisposing syndrome	VCV000819208	17	41246113	17	43094096	819208	813858	rs1064794100	NC_000017.11:43094095:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	479	BRCA1
NM_007294.4(BRCA1):c.1435G>A (p.Glu479Lys)	BRCA1	E479K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000419779	17	41246113	17	43094096	419779	410013	rs1064794100	NC_000017.11:43094095:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	479	BRCA1
NM_007294.4(BRCA1):c.1433C>G (p.Thr478Ser)	BRCA1	T478S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001409827	17	41246115	17	43094098	1409827	1435083	rs2154446383	NC_000017.11:43094097:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	478	BRCA1
NM_007294.4(BRCA1):c.1427A>G (p.His476Arg)	BRCA1	H476R	not specified|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054251	17	41246121	17	43094104	54251	68918	rs55720177	NC_000017.11:43094103:T:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	476	BRCA1
NM_007294.4(BRCA1):c.1426C>T (p.His476Tyr)	BRCA1	H476Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001772378	17	41246122	17	43094105	1772378	1826790	NA	NC_000017.11:43094104:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	476	BRCA1
NM_007294.4(BRCA1):c.1424G>T (p.Ser475Ile)	BRCA1	S475I	Hereditary cancer-predisposing syndrome	VCV001772339	17	41246124	17	43094107	1772339	1826751	NA	NC_000017.11:43094106:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	475	BRCA1
NM_007294.4(BRCA1):c.1424G>A (p.Ser475Asn)	BRCA1	S475N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000645043	17	41246124	17	43094107	645043	646029	rs1567799668	NC_000017.11:43094106:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	475	BRCA1
NM_007294.4(BRCA1):c.1423A>G (p.Ser475Gly)	BRCA1	S475G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000661167	17	41246125	17	43094108	661167	646030	rs1064794047	NC_000017.11:43094107:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	475	BRCA1
NM_007294.4(BRCA1):c.1423A>T (p.Ser475Cys)	BRCA1	S475C	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000419692	17	41246125	17	43094108	419692	410014	rs1064794047	NC_000017.11:43094107:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	475	BRCA1
NM_007294.4(BRCA1):c.1421T>C (p.Leu474Ser)	BRCA1	L474S	Hereditary cancer-predisposing syndrome	VCV000805950	17	41246127	17	43094110	805950	794278	rs80357490	NC_000017.11:43094109:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	474	BRCA1
NM_007294.4(BRCA1):c.1418A>C (p.Asn473Thr)	BRCA1	N473T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000653618	17	41246130	17	43094113	653618	646031	rs80357057	NC_000017.11:43094112:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	473	BRCA1
NM_007294.4(BRCA1):c.1418A>T (p.Asn473Ile)	BRCA1	N473I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054249	17	41246130	17	43094113	54249	68916	rs80357057	NC_000017.11:43094112:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	473	BRCA1
NM_007294.4(BRCA1):c.1418A>G (p.Asn473Ser)	BRCA1	N473S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054248	17	41246130	17	43094113	54248	68915	rs80357057	NC_000017.11:43094112:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	473	BRCA1
NM_007294.4(BRCA1):c.1414C>A (p.Pro472Thr)	BRCA1	P472T	Hereditary cancer-predisposing syndrome	VCV001772099	17	41246134	17	43094117	1772099	1829910	NA	NC_000017.11:43094116:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	472	BRCA1
NM_007294.4(BRCA1):c.1412T>C (p.Leu471Pro)	BRCA1	L471P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000819162	17	41246136	17	43094119	819162	813859	rs1167718207	NC_000017.11:43094118:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	471	BRCA1
NM_007294.4(BRCA1):c.1411C>T (p.Leu471Phe)	BRCA1	L471F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001522766	17	41246137	17	43094120	1522766	1459960	rs1282963652	NC_000017.11:43094119:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	471	BRCA1
NM_007294.4(BRCA1):c.1409G>A (p.Ser470Asn)	BRCA1	S470N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000627698	17	41246139	17	43094122	627698	618675	rs1567799713	NC_000017.11:43094121:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	470	BRCA1
NM_007294.4(BRCA1):c.1408A>G (p.Ser470Gly)	BRCA1	S470G	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000846197	17	41246140	17	43094123	846197	845444	rs2053942184	NC_000017.11:43094122:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	470	BRCA1
NM_007294.4(BRCA1):c.1406C>G (p.Ala469Gly)	BRCA1	A469G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000054245	17	41246142	17	43094125	54245	68912	rs80357073	NC_000017.11:43094124:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	469	BRCA1
NM_007294.4(BRCA1):c.1405G>T (p.Ala469Ser)	BRCA1	A469S	Hereditary breast ovarian cancer syndrome	VCV002815548	17	41246143	17	43094126	2815548	2966384	NA	NC_000017.11:43094125:C:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	469	BRCA1
NM_007294.4(BRCA1):c.1405G>A (p.Ala469Thr)	BRCA1	A469T	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome	VCV000037411	17	41246143	17	43094126	37411	45967	rs397507187	NC_000017.11:43094125:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	469	BRCA1
NM_007294.4(BRCA1):c.1401G>C (p.Lys467Asn)	BRCA1	K467N	Hereditary cancer-predisposing syndrome	VCV001771818	17	41246147	17	43094130	1771818	1829630	NA	NC_000017.11:43094129:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	467	BRCA1
NM_007294.4(BRCA1):c.1400A>G (p.Lys467Arg)	BRCA1	K467R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000231714	17	41246148	17	43094131	231714	236131	rs876659316	NC_000017.11:43094130:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	467	BRCA1
NM_007294.4(BRCA1):c.1397G>A (p.Arg466Gln)	BRCA1	R466Q	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091552	17	41246151	17	43094134	91552	97029	rs199540030	NC_000017.11:43094133:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	466	BRCA1
NM_007294.4(BRCA1):c.1396C>G (p.Arg466Gly)	BRCA1	R466G	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054240	17	41246152	17	43094135	54240	68907	rs80356964	NC_000017.11:43094134:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	466	BRCA1
NM_007294.4(BRCA1):c.1396C>T (p.Arg466Trp)	BRCA1	R466W	Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|BRCA1-related disorder|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037410	17	41246152	17	43094135	37410	45966	rs80356964	NC_000017.11:43094134:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	466	BRCA1
NM_007294.4(BRCA1):c.1394A>G (p.Tyr465Cys)	BRCA1	Y465C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000232629	17	41246154	17	43094137	232629	236132	rs876659885	NC_000017.11:43094136:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	465	BRCA1
NM_007294.4(BRCA1):c.1393T>C (p.Tyr465His)	BRCA1	Y465H	Hereditary breast ovarian cancer syndrome	VCV002813703	17	41246155	17	43094138	2813703	2969653	NA	NC_000017.11:43094137:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	465	BRCA1
NM_007294.4(BRCA1):c.1393T>G (p.Tyr465Asp)	BRCA1	Y465D	Hereditary cancer-predisposing syndrome	VCV000054239	17	41246155	17	43094138	54239	68906	rs397508869	NC_000017.11:43094137:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	465	BRCA1
NM_007294.4(BRCA1):c.1391C>T (p.Thr464Ile)	BRCA1	T464I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054237	17	41246157	17	43094140	54237	68904	rs62625301	NC_000017.11:43094139:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	464	BRCA1
NM_007294.4(BRCA1):c.1390A>G (p.Thr464Ala)	BRCA1	T464A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer	VCV000225728	17	41246158	17	43094141	225728	227565	rs869320787	NC_000017.11:43094140:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	464	BRCA1
NM_007294.4(BRCA1):c.1387A>G (p.Lys463Glu)	BRCA1	K463E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000431211	17	41246161	17	43094144	431211	424851	rs1135401844	NC_000017.11:43094143:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	463	BRCA1
NM_007294.4(BRCA1):c.1385G>A (p.Gly462Glu)	BRCA1	G462E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001491586	17	41246163	17	43094146	1491586	1342623	rs2053947222	NC_000017.11:43094145:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	462	BRCA1
NM_007294.4(BRCA1):c.1384G>A (p.Gly462Arg)	BRCA1	G462R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000054230	17	41246164	17	43094147	54230	68897	rs80357221	NC_000017.11:43094146:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	462	BRCA1
NM_007294.4(BRCA1):c.1383T>A (p.Phe461Leu)	BRCA1	F461L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054228	17	41246165	17	43094148	54228	68895	rs56046357	NC_000017.11:43094147:A:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	461	BRCA1
NM_007294.4(BRCA1):c.1381T>G (p.Phe461Val)	BRCA1	F461V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001461860	17	41246167	17	43094150	1461860	1494803	rs62625300	NC_000017.11:43094149:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	461	BRCA1
NM_007294.4(BRCA1):c.1381T>C (p.Phe461Leu)	BRCA1	F461L	Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054227	17	41246167	17	43094150	54227	68894	rs62625300	NC_000017.11:43094149:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	461	BRCA1
NM_007294.4(BRCA1):c.1379T>C (p.Ile460Thr)	BRCA1	I460T	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000843219	17	41246169	17	43094152	843219	845446	rs398122634	NC_000017.11:43094151:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	460	BRCA1
NM_007294.4(BRCA1):c.1379T>G (p.Ile460Arg)	BRCA1	I460R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome	VCV000091551	17	41246169	17	43094152	91551	97028	rs398122634	NC_000017.11:43094151:A:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	460	BRCA1
NM_007294.4(BRCA1):c.1378A>C (p.Ile460Leu)	BRCA1	I460L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001771208	17	41246170	17	43094153	1771208	1836346	NA	NC_000017.11:43094152:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	460	BRCA1
NM_007294.4(BRCA1):c.1377A>C (p.Lys459Asn)	BRCA1	K459N	Hereditary cancer-predisposing syndrome	VCV000921448	17	41246171	17	43094154	921448	913953	rs2053948858	NC_000017.11:43094153:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	459	BRCA1
NM_007294.4(BRCA1):c.1375A>C (p.Lys459Gln)	BRCA1	K459Q	Hereditary cancer-predisposing syndrome	VCV000928010	17	41246173	17	43094156	928010	913954	rs886039947	NC_000017.11:43094155:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	459	BRCA1
NM_007294.4(BRCA1):c.1374C>G (p.Asp458Glu)	BRCA1	D458E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002683812	17	41246174	17	43094157	2683812	2844850	NA	NC_000017.11:43094156:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Sep 1, 2023	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	458	BRCA1
NM_007294.4(BRCA1):c.1374C>A (p.Asp458Glu)	BRCA1	D458E	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000245916	17	41246174	17	43094157	245916	245050	rs879253999	NC_000017.11:43094156:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	458	BRCA1
NM_007294.4(BRCA1):c.1373A>T (p.Asp458Val)	BRCA1	D458V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001514318	17	41246175	17	43094158	1514318	1492132	rs2154450396	NC_000017.11:43094157:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	458	BRCA1
NM_007294.4(BRCA1):c.1372G>A (p.Asp458Asn)	BRCA1	D458N	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV001411075	17	41246176	17	43094159	1411075	1343465	rs2154450550	NC_000017.11:43094158:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	458	BRCA1
NM_007294.4(BRCA1):c.1367T>C (p.Ile456Thr)	BRCA1	I456T	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054222	17	41246181	17	43094164	54222	68889	rs80357360	NC_000017.11:43094163:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	456	BRCA1
NM_007294.4(BRCA1):c.1366A>C (p.Ile456Leu)	BRCA1	I456L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002450662	17	41246182	17	43094165	2450662	2423148	NA	NC_000017.11:43094164:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	456	BRCA1
NM_007294.4(BRCA1):c.1364A>T (p.Asn455Ile)	BRCA1	N455I	Hereditary cancer-predisposing syndrome	VCV003226099	17	41246184	17	43094167	3226099	3390604	NA	NC_000017.11:43094166:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	455	BRCA1
NM_007294.4(BRCA1):c.1364A>G (p.Asn455Ser)	BRCA1	N455S	Hereditary cancer-predisposing syndrome	VCV002774860	17	41246184	17	43094167	2774860	2935586	NA	NC_000017.11:43094166:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	455	BRCA1
NM_007294.4(BRCA1):c.1363A>G (p.Asn455Asp)	BRCA1	N455D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000818986	17	41246185	17	43094168	818986	813860	rs1468740591	NC_000017.11:43094167:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	455	BRCA1
NM_007294.4(BRCA1):c.1361G>A (p.Ser454Asn)	BRCA1	S454N	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome	VCV000054220	17	41246187	17	43094170	54220	68887	rs80357181	NC_000017.11:43094169:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	454	BRCA1
NM_007294.4(BRCA1):c.1360A>C (p.Ser454Arg)	BRCA1	S454R	Hereditary cancer-predisposing syndrome	VCV002585838	17	41246188	17	43094171	2585838	2753398	NA	NC_000017.11:43094170:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	454	BRCA1
NM_007294.4(BRCA1):c.1358A>C (p.Glu453Ala)	BRCA1	E453A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001025124	17	41246190	17	43094173	1025124	1012782	rs1567799925	NC_000017.11:43094172:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	453	BRCA1
NM_007294.4(BRCA1):c.1357G>C (p.Glu453Gln)	BRCA1	E453Q	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000423223	17	41246191	17	43094174	423223	410015	rs768054411	NC_000017.11:43094173:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	453	BRCA1
NM_007294.4(BRCA1):c.1355T>A (p.Val452Glu)	BRCA1	V452E	Hereditary cancer-predisposing syndrome	VCV001770692	17	41246193	17	43094176	1770692	1826392	NA	NC_000017.11:43094175:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	452	BRCA1
NM_007294.4(BRCA1):c.1355T>C (p.Val452Ala)	BRCA1	V452A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240773	17	41246193	17	43094176	240773	242799	rs878854932	NC_000017.11:43094175:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	452	BRCA1
NM_007294.4(BRCA1):c.1354G>A (p.Val452Ile)	BRCA1	V452I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001410648	17	41246194	17	43094177	1410648	1510086	rs2154455068	NC_000017.11:43094176:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	452	BRCA1
NM_007294.4(BRCA1):c.1351T>G (p.Ser451Ala)	BRCA1	S451A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000961857	17	41246197	17	43094180	961857	949955	rs2053952551	NC_000017.11:43094179:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	451	BRCA1
NM_007294.4(BRCA1):c.1350A>T (p.Lys450Asn)	BRCA1	K450N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803417	17	41246198	17	43094181	803417	791771	rs1597876640	NC_000017.11:43094180:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	450	BRCA1
NM_007294.4(BRCA1):c.1349A>C (p.Lys450Thr)	BRCA1	K450T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001504294	17	41246199	17	43094182	1504294	1337169	rs778668550	NC_000017.11:43094181:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	450	BRCA1
NM_007294.4(BRCA1):c.1349A>G (p.Lys450Arg)	BRCA1	K450R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001471719	17	41246199	17	43094182	1471719	1388746	rs778668550	NC_000017.11:43094181:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	450	BRCA1
NM_007294.4(BRCA1):c.1348A>G (p.Lys450Glu)	BRCA1	K450E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001357359	17	41246200	17	43094183	1357359	1345334	rs2053952990	NC_000017.11:43094182:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	450	BRCA1
NM_007294.4(BRCA1):c.1345T>C (p.Ser449Pro)	BRCA1	S449P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000646029	17	41246203	17	43094186	646029	646032	rs1597876653	NC_000017.11:43094185:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	449	BRCA1
NM_007294.4(BRCA1):c.1344C>G (p.His448Gln)	BRCA1	H448Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001058860	17	41246204	17	43094187	1058860	1050313	rs1395644015	NC_000017.11:43094186:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	448	BRCA1
NM_007294.4(BRCA1):c.1343A>G (p.His448Arg)	BRCA1	H448R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000993198	17	41246205	17	43094188	993198	981174	rs1597876676	NC_000017.11:43094187:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	448	BRCA1
NM_007294.4(BRCA1):c.1343A>C (p.His448Pro)	BRCA1	H448P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000658241	17	41246205	17	43094188	658241	646033	rs1597876676	NC_000017.11:43094187:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	448	BRCA1
NM_007294.4(BRCA1):c.1342C>T (p.His448Tyr)	BRCA1	H448Y	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000187241	17	41246206	17	43094189	187241	185067	rs786203578	NC_000017.11:43094188:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	448	BRCA1
NM_007294.4(BRCA1):c.1340T>C (p.Val447Ala)	BRCA1	V447A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001410408	17	41246208	17	43094191	1410408	1513715	rs2154457435	NC_000017.11:43094190:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	447	BRCA1
NM_007294.4(BRCA1):c.1339G>A (p.Val447Ile)	BRCA1	V447I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142873	17	41246209	17	43094192	142873	152587	rs587782784	NC_000017.11:43094191:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	447	BRCA1
NM_007294.4(BRCA1):c.1337G>T (p.Arg446Ile)	BRCA1	R446I	Hereditary cancer-predisposing syndrome	VCV001770273	17	41246211	17	43094194	1770273	1829378	NA	NC_000017.11:43094193:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	446	BRCA1
NM_007294.4(BRCA1):c.1336A>G (p.Arg446Gly)	BRCA1	R446G	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000141392	17	41246212	17	43094195	141392	151106	rs587781715	NC_000017.11:43094194:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	446	BRCA1
NM_007294.4(BRCA1):c.1334A>G (p.Glu445Gly)	BRCA1	E445G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000818970	17	41246214	17	43094197	818970	813861	rs1597876729	NC_000017.11:43094196:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	445	BRCA1
NM_007294.4(BRCA1):c.1333G>C (p.Glu445Gln)	BRCA1	E445Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054203	17	41246215	17	43094198	54203	68870	rs80356915	NC_000017.11:43094197:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	445	BRCA1
NM_007294.4(BRCA1):c.1332T>G (p.Ser444Arg)	BRCA1	S444R	Hereditary cancer-predisposing syndrome	VCV000491031	17	41246216	17	43094199	491031	484932	rs1555591925	NC_000017.11:43094198:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	444	BRCA1
NM_007294.4(BRCA1):c.1331G>T (p.Ser444Ile)	BRCA1	S444I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001010603	17	41246217	17	43094200	1010603	997583	rs1597876749	NC_000017.11:43094199:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	444	BRCA1
NM_007294.4(BRCA1):c.1331G>A (p.Ser444Asn)	BRCA1	S444N	Hereditary cancer-predisposing syndrome	VCV000818955	17	41246217	17	43094200	818955	813862	rs1597876749	NC_000017.11:43094199:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	444	BRCA1
NM_007294.4(BRCA1):c.1328A>G (p.Lys443Arg)	BRCA1	K443R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV001010509	17	41246220	17	43094203	1010509	997584	rs2053956439	NC_000017.11:43094202:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	443	BRCA1
NM_007294.4(BRCA1):c.1325G>A (p.Cys442Tyr)	BRCA1	C442Y	Hereditary breast ovarian cancer syndrome	VCV002790182	17	41246223	17	43094206	2790182	2959946	NA	NC_000017.11:43094205:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	442	BRCA1
NM_007294.4(BRCA1):c.1324T>A (p.Cys442Ser)	BRCA1	C442S	Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome	VCV000545479	17	41246224	17	43094207	545479	535749	rs876660734	NC_000017.11:43094206:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	442	BRCA1
NM_007294.4(BRCA1):c.1324T>C (p.Cys442Arg)	BRCA1	C442R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233923	17	41246224	17	43094207	233923	236134	rs876660734	NC_000017.11:43094206:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	442	BRCA1
NM_007294.4(BRCA1):c.1323A>G (p.Ile441Met)	BRCA1	I441M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491030	17	41246225	17	43094208	491030	484944	rs1555591935	NC_000017.11:43094207:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	441	BRCA1
NM_007294.4(BRCA1):c.1322T>C (p.Ile441Thr)	BRCA1	I441T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000818924	17	41246226	17	43094209	818924	813863	rs1163497041	NC_000017.11:43094208:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	441	BRCA1
NM_007294.4(BRCA1):c.1321A>G (p.Ile441Val)	BRCA1	I441V	Hereditary cancer-predisposing syndrome	VCV000628756	17	41246227	17	43094210	628756	618676	rs1567800029	NC_000017.11:43094209:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	441	BRCA1
NM_007294.4(BRCA1):c.1319T>C (p.Leu440Ser)	BRCA1	L440S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054196	17	41246229	17	43094212	54196	68863	rs273897656	NC_000017.11:43094211:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	440	BRCA1
NM_007294.4(BRCA1):c.1316C>G (p.Ala439Gly)	BRCA1	A439G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000862887	17	41246232	17	43094215	862887	845447	rs777132211	NC_000017.11:43094214:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	439	BRCA1
NM_007294.4(BRCA1):c.1315G>C (p.Ala439Pro)	BRCA1	A439P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001057543	17	41246233	17	43094216	1057543	1050314	rs1064794098	NC_000017.11:43094215:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	439	BRCA1
NM_007294.4(BRCA1):c.1315G>A (p.Ala439Thr)	BRCA1	A439T	Hereditary cancer-predisposing syndrome	VCV000818886	17	41246233	17	43094216	818886	813864	rs1064794098	NC_000017.11:43094215:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	439	BRCA1
NM_007294.4(BRCA1):c.1315G>T (p.Ala439Ser)	BRCA1	A439S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000419772	17	41246233	17	43094216	419772	410016	rs1064794098	NC_000017.11:43094215:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	439	BRCA1
NM_007294.4(BRCA1):c.1313A>C (p.Glu438Ala)	BRCA1	E438A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182131	17	41246235	17	43094218	182131	180879	rs730881470	NC_000017.11:43094217:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	438	BRCA1
NM_007294.4(BRCA1):c.1311T>G (p.His437Gln)	BRCA1	H437Q	Hereditary cancer-predisposing syndrome	VCV002450665	17	41246237	17	43094220	2450665	2423151	NA	NC_000017.11:43094219:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	437	BRCA1
NM_007294.4(BRCA1):c.1311T>A (p.His437Gln)	BRCA1	H437Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001722233	17	41246237	17	43094220	1722233	1777095	NA	NC_000017.11:43094219:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	437	BRCA1
NM_007294.4(BRCA1):c.1310A>T (p.His437Leu)	BRCA1	H437L	Hereditary cancer-predisposing syndrome|not provided	VCV001675671	17	41246238	17	43094221	1675671	1245717	rs80357255	NC_000017.11:43094220:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	437	BRCA1
NM_007294.4(BRCA1):c.1310A>G (p.His437Arg)	BRCA1	H437R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000633088	17	41246238	17	43094221	633088	621589	rs80357255	NC_000017.11:43094220:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	437	BRCA1
NM_007294.4(BRCA1):c.1310A>C (p.His437Pro)	BRCA1	H437P	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054195	17	41246238	17	43094221	54195	68862	rs80357255	NC_000017.11:43094220:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	437	BRCA1
NM_007294.4(BRCA1):c.1309C>T (p.His437Tyr)	BRCA1	H437Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491029	17	41246239	17	43094222	491029	485104	rs759878392	NC_000017.11:43094221:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	437	BRCA1
NM_007294.4(BRCA1):c.1307C>T (p.Pro436Leu)	BRCA1	P436L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV001492634	17	41246241	17	43094224	1492634	1516772	rs2154459839	NC_000017.11:43094223:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	436	BRCA1
NM_007294.4(BRCA1):c.1307C>A (p.Pro436His)	BRCA1	P436H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001382181	17	41246241	17	43094224	1382181	1434610	rs2154459839	NC_000017.11:43094223:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	436	BRCA1
NM_007294.4(BRCA1):c.1304A>T (p.Asp435Val)	BRCA1	D435V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001026797	17	41246244	17	43094227	1026797	1012783	rs2053960174	NC_000017.11:43094226:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	435	BRCA1
NM_007294.4(BRCA1):c.1301G>A (p.Ser434Asn)	BRCA1	S434N	Hereditary cancer-predisposing syndrome	VCV000924513	17	41246247	17	43094230	924513	913957	rs1485510803	NC_000017.11:43094229:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	434	BRCA1
NM_007294.4(BRCA1):c.1300A>T (p.Ser434Cys)	BRCA1	S434C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002108999	17	41246248	17	43094231	2108999	2170757	NA	NC_000017.11:43094230:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	434	BRCA1
NM_007294.4(BRCA1):c.1300A>C (p.Ser434Arg)	BRCA1	S434R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000837806	17	41246248	17	43094231	837806	845448	rs786203753	NC_000017.11:43094230:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	434	BRCA1
NM_007294.4(BRCA1):c.1300A>G (p.Ser434Gly)	BRCA1	S434G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187465	17	41246248	17	43094231	187465	185069	rs786203753	NC_000017.11:43094230:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	434	BRCA1
NM_007294.4(BRCA1):c.1298C>T (p.Ala433Val)	BRCA1	A433V	Hereditary cancer-predisposing syndrome	VCV001769270	17	41246250	17	43094233	1769270	1835707	NA	NC_000017.11:43094232:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	433	BRCA1
NM_007294.4(BRCA1):c.1297G>A (p.Ala433Thr)	BRCA1	A433T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003074624	17	41246251	17	43094234	3074624	3229591	NA	NC_000017.11:43094233:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	433	BRCA1
NM_007294.4(BRCA1):c.1295T>C (p.Leu432Pro)	BRCA1	L432P	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000156183	17	41246253	17	43094236	156183	165982	rs369394098	NC_000017.11:43094235:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	432	BRCA1
NM_007294.4(BRCA1):c.1294C>A (p.Leu432Met)	BRCA1	L432M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000961296	17	41246254	17	43094237	961296	949956	rs864622454	NC_000017.11:43094236:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	432	BRCA1
NM_007294.4(BRCA1):c.1291T>G (p.Leu431Val)	BRCA1	L431V	Hereditary cancer-predisposing syndrome|not provided	VCV001303574	17	41246257	17	43094240	1303574	1293851	rs960381964	NC_000017.11:43094239:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	431	BRCA1
NM_007294.4(BRCA1):c.1291T>A (p.Leu431Ile)	BRCA1	L431I	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000577812	17	41246257	17	43094240	577812	571482	rs960381964	NC_000017.11:43094239:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	431	BRCA1
NM_007294.4(BRCA1):c.1289A>G (p.Asp430Gly)	BRCA1	D430G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000853871	17	41246259	17	43094242	853871	845449	rs2053963023	NC_000017.11:43094241:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	430	BRCA1
NM_007294.4(BRCA1):c.1288G>C (p.Asp430His)	BRCA1	D430H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001443709	17	41246260	17	43094243	1443709	1487710	rs2154461295	NC_000017.11:43094242:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	430	BRCA1
NM_007294.4(BRCA1):c.1287A>G (p.Ile429Met)	BRCA1	I429M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002101403	17	41246261	17	43094244	2101403	2147661	NA	NC_000017.11:43094243:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	429	BRCA1
NM_007294.4(BRCA1):c.1286T>G (p.Ile429Arg)	BRCA1	I429R	Hereditary cancer-predisposing syndrome	VCV000482937	17	41246262	17	43094245	482937	479449	rs775869160	NC_000017.11:43094244:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	429	BRCA1
NM_007294.4(BRCA1):c.1286T>C (p.Ile429Thr)	BRCA1	I429T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187435	17	41246262	17	43094245	187435	185070	rs775869160	NC_000017.11:43094244:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	429	BRCA1
NM_007294.4(BRCA1):c.1284A>C (p.Lys428Asn)	BRCA1	K428N	Hereditary cancer-predisposing syndrome	VCV002585836	17	41246264	17	43094247	2585836	2753396	NA	NC_000017.11:43094246:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	428	BRCA1
NM_007294.4(BRCA1):c.1281G>C (p.Glu427Asp)	BRCA1	E427D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000999984	17	41246267	17	43094250	999984	997585	rs1567800181	NC_000017.11:43094249:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	427	BRCA1
NM_007294.4(BRCA1):c.1277C>T (p.Ser426Leu)	BRCA1	S426L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001766861	17	41246271	17	43094254	1766861	1825104	NA	NC_000017.11:43094253:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	426	BRCA1
NM_007294.4(BRCA1):c.1276T>G (p.Ser426Ala)	BRCA1	S426A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002162354	17	41246272	17	43094255	2162354	1894651	NA	NC_000017.11:43094254:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	426	BRCA1
NM_007294.4(BRCA1):c.1274C>A (p.Ser425Tyr)	BRCA1	S425Y	Hereditary cancer-predisposing syndrome	VCV001766186	17	41246274	17	43094257	1766186	1814764	NA	NC_000017.11:43094256:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	425	BRCA1
NM_007294.4(BRCA1):c.1273T>C (p.Ser425Pro)	BRCA1	S425P	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721552	17	41246275	17	43094258	1721552	1772886	NA	NC_000017.11:43094257:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	425	BRCA1
NM_007294.4(BRCA1):c.1270G>A (p.Gly424Ser)	BRCA1	G424S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630131	17	41246278	17	43094261	630131	618677	rs763051683	NC_000017.11:43094260:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	424	BRCA1
NM_007294.4(BRCA1):c.1270G>C (p.Gly424Arg)	BRCA1	G424R	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000418958	17	41246278	17	43094261	418958	410018	rs763051683	NC_000017.11:43094260:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	424	BRCA1
NM_007294.4(BRCA1):c.1268C>T (p.Ser423Phe)	BRCA1	S423F	Hereditary cancer-predisposing syndrome	VCV001172436	17	41246280	17	43094263	1172436	1161364	rs2154463118	NC_000017.11:43094262:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	423	BRCA1
NM_007294.4(BRCA1):c.1265A>G (p.Tyr422Cys)	BRCA1	Y422C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952650	17	41246283	17	43094266	952650	928319	rs1567800230	NC_000017.11:43094265:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	422	BRCA1
NM_007294.4(BRCA1):c.1265A>T (p.Tyr422Phe)	BRCA1	Y422F	Hereditary cancer-predisposing syndrome	VCV000628112	17	41246283	17	43094266	628112	618678	rs1567800230	NC_000017.11:43094265:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	422	BRCA1
NM_007294.4(BRCA1):c.1264T>C (p.Tyr422His)	BRCA1	Y422H	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441286	17	41246284	17	43094267	441286	435159	rs764186025	NC_000017.11:43094266:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	422	BRCA1
NM_007294.4(BRCA1):c.1263A>C (p.Glu421Asp)	BRCA1	E421D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069236	17	41246285	17	43094268	3069236	3229863	NA	NC_000017.11:43094267:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	421	BRCA1
NM_007294.4(BRCA1):c.1262A>G (p.Glu421Gly)	BRCA1	E421G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054180	17	41246286	17	43094269	54180	68847	rs397508849	NC_000017.11:43094268:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	421	BRCA1
NM_007294.4(BRCA1):c.1261G>A (p.Glu421Lys)	BRCA1	E421K	Hereditary cancer-predisposing syndrome	VCV000054179	17	41246287	17	43094270	54179	68846	rs80357046	NC_000017.11:43094269:C:T	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	421	BRCA1
NM_007294.4(BRCA1):c.1259A>G (p.Asp420Gly)	BRCA1	D420G	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000182076	17	41246289	17	43094272	182076	180880	rs730881442	NC_000017.11:43094271:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	420	BRCA1
NM_007294.4(BRCA1):c.1258G>C (p.Asp420His)	BRCA1	D420H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000841465	17	41246290	17	43094273	841465	845450	rs80357488	NC_000017.11:43094272:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	420	BRCA1
NM_007294.4(BRCA1):c.1258G>A (p.Asp420Asn)	BRCA1	D420N	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000573069	17	41246290	17	43094273	573069	571484	rs80357488	NC_000017.11:43094272:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	420	BRCA1
NM_007294.4(BRCA1):c.1258G>T (p.Asp420Tyr)	BRCA1	D420Y	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000054178	17	41246290	17	43094273	54178	68845	rs80357488	NC_000017.11:43094272:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	420	BRCA1
NM_007294.4(BRCA1):c.1256T>G (p.Val419Gly)	BRCA1	V419G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000091542	17	41246292	17	43094275	91542	97019	rs398122628	NC_000017.11:43094274:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	419	BRCA1
NM_007294.4(BRCA1):c.1255G>T (p.Val419Leu)	BRCA1	V419L	Hereditary cancer-predisposing syndrome	VCV001761777	17	41246293	17	43094276	1761777	1823719	NA	NC_000017.11:43094275:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	419	BRCA1
NM_007294.4(BRCA1):c.1255G>A (p.Val419Ile)	BRCA1	V419I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482949	17	41246293	17	43094276	482949	478761	rs876658873	NC_000017.11:43094275:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	419	BRCA1
NM_007294.4(BRCA1):c.1255G>C (p.Val419Leu)	BRCA1	V419L	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230967	17	41246293	17	43094276	230967	236136	rs876658873	NC_000017.11:43094275:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	419	BRCA1
NM_007294.4(BRCA1):c.1253A>C (p.Glu418Ala)	BRCA1	E418A	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481489	17	41246295	17	43094278	481489	478687	rs1555592050	NC_000017.11:43094277:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Jun 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	418	BRCA1
NM_007294.4(BRCA1):c.1251T>G (p.Asn417Lys)	BRCA1	N417K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054175	17	41246297	17	43094280	54175	68842	rs80357197	NC_000017.11:43094279:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	417	BRCA1
NM_007294.4(BRCA1):c.1250A>C (p.Asn417Thr)	BRCA1	N417T	Hereditary cancer-predisposing syndrome	VCV001760542	17	41246298	17	43094281	1760542	1819970	NA	NC_000017.11:43094280:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	417	BRCA1
NM_007294.4(BRCA1):c.1250A>G (p.Asn417Ser)	BRCA1	N417S	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054174	17	41246298	17	43094281	54174	68841	rs80357113	NC_000017.11:43094280:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	417	BRCA1
NM_007294.4(BRCA1):c.1246C>G (p.Leu416Val)	BRCA1	L416V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001398676	17	41246302	17	43094285	1398676	1427742	rs1567800325	NC_000017.11:43094284:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	416	BRCA1
NM_007294.4(BRCA1):c.1244T>C (p.Val415Ala)	BRCA1	V415A	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000422833	17	41246304	17	43094287	422833	410019	rs1064796031	NC_000017.11:43094286:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	415	BRCA1
NM_007294.4(BRCA1):c.1243G>T (p.Val415Phe)	BRCA1	V415F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462555	17	41246305	17	43094288	462555	467988	rs587782770	NC_000017.11:43094287:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	415	BRCA1
NM_007294.4(BRCA1):c.1243G>A (p.Val415Ile)	BRCA1	V415I	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000142855	17	41246305	17	43094288	142855	152569	rs587782770	NC_000017.11:43094287:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	415	BRCA1
NM_007294.4(BRCA1):c.1242C>A (p.Asp414Glu)	BRCA1	D414E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001473792	17	41246306	17	43094289	1473792	1387788	rs372400428	NC_000017.11:43094288:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	414	BRCA1
NM_007294.4(BRCA1):c.1241A>G (p.Asp414Gly)	BRCA1	D414G	Hereditary breast ovarian cancer syndrome	VCV002730714	17	41246307	17	43094290	2730714	2883449	NA	NC_000017.11:43094289:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	414	BRCA1
NM_007294.4(BRCA1):c.1241A>C (p.Asp414Ala)	BRCA1	D414A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462554	17	41246307	17	43094290	462554	467992	rs1555592086	NC_000017.11:43094289:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	414	BRCA1
NM_007294.4(BRCA1):c.1240G>T (p.Asp414Tyr)	BRCA1	D414Y	Hereditary cancer-predisposing syndrome	VCV001050740	17	41246308	17	43094291	1050740	1038578	rs2154464961	NC_000017.11:43094290:C:A	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	414	BRCA1
NM_007294.4(BRCA1):c.1238T>G (p.Leu413Trp)	BRCA1	L413W	Hereditary breast ovarian cancer syndrome	VCV002757431	17	41246310	17	43094293	2757431	2917303	NA	NC_000017.11:43094292:A:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Dec 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	413	BRCA1
NM_007294.4(BRCA1):c.1237T>G (p.Leu413Val)	BRCA1	L413V	Hereditary cancer-predisposing syndrome	VCV000479198	17	41246311	17	43094294	479198	478690	rs574008372	NC_000017.11:43094293:A:C	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	413	BRCA1
NM_007294.4(BRCA1):c.1234G>T (p.Val412Leu)	BRCA1	V412L	Hereditary cancer-predisposing syndrome	VCV003261490	17	41246314	17	43094297	3261490	3424258	NA	NC_000017.11:43094296:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 22, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	412	BRCA1
NM_007294.4(BRCA1):c.1234G>C (p.Val412Leu)	BRCA1	V412L	Hereditary cancer-predisposing syndrome	VCV002774861	17	41246314	17	43094297	2774861	2935587	NA	NC_000017.11:43094296:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	412	BRCA1
NM_007294.4(BRCA1):c.1234G>A (p.Val412Ile)	BRCA1	V412I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000156182	17	41246314	17	43094297	156182	165981	rs587776478	NC_000017.11:43094296:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	412	BRCA1
NM_007294.4(BRCA1):c.1233T>G (p.Asp411Glu)	BRCA1	D411E	BRCA1-related cancer predisposition	VCV000041804	17	41246315	17	43094298	41804	50243	rs80357024	NC_000017.11:43094297:A:C	single nucleotide variant	intron variant|missense variant	Benign	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	411	BRCA1
NM_007294.4(BRCA1):c.1232A>T (p.Asp411Val)	BRCA1	D411V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Familial cancer of breast	VCV000182130	17	41246316	17	43094299	182130	180881	rs730881469	NC_000017.11:43094298:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	411	BRCA1
NM_007294.4(BRCA1):c.1231G>C (p.Asp411His)	BRCA1	D411H	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000929252	17	41246317	17	43094300	929252	917258	rs80357301	NC_000017.11:43094299:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	411	BRCA1
NM_007294.4(BRCA1):c.1231G>A (p.Asp411Asn)	BRCA1	D411N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054168	17	41246317	17	43094300	54168	68835	rs80357301	NC_000017.11:43094299:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	411	BRCA1
NM_007294.4(BRCA1):c.1228G>C (p.Ala410Pro)	BRCA1	A410P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001754889	17	41246320	17	43094303	1754889	1821979	NA	NC_000017.11:43094302:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	410	BRCA1
NM_007294.4(BRCA1):c.1228G>A (p.Ala410Thr)	BRCA1	A410T	not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000246448	17	41246320	17	43094303	246448	245051	rs779974365	NC_000017.11:43094302:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	410	BRCA1
NM_007294.4(BRCA1):c.1226T>G (p.Val409Gly)	BRCA1	V409G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001002154	17	41246322	17	43094305	1002154	997586	rs786202539	NC_000017.11:43094304:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	409	BRCA1
NM_007294.4(BRCA1):c.1226T>C (p.Val409Ala)	BRCA1	V409A	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000185888	17	41246322	17	43094305	185888	185077	rs786202539	NC_000017.11:43094304:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	409	BRCA1
NM_007294.4(BRCA1):c.1222A>G (p.Lys408Glu)	BRCA1	K408E	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000037399	17	41246326	17	43094309	37399	45955	rs80357253	NC_000017.11:43094308:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	408	BRCA1
NM_007294.4(BRCA1):c.1220C>G (p.Ala407Gly)	BRCA1	A407G	Hereditary cancer-predisposing syndrome	VCV002565345	17	41246328	17	43094311	2565345	2732319	NA	NC_000017.11:43094310:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	407	BRCA1
NM_007294.4(BRCA1):c.1219G>A (p.Ala407Thr)	BRCA1	A407T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001035312	17	41246329	17	43094312	1035312	1033325	rs2053973967	NC_000017.11:43094311:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	407	BRCA1
NM_007294.4(BRCA1):c.1217A>G (p.Asn406Ser)	BRCA1	N406S	Hereditary cancer-predisposing syndrome	VCV003226097	17	41246331	17	43094314	3226097	3390602	NA	NC_000017.11:43094313:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	406	BRCA1
NM_007294.4(BRCA1):c.1214C>T (p.Ser405Leu)	BRCA1	S405L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002066182	17	41246334	17	43094317	2066182	2128867	NA	NC_000017.11:43094316:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	405	BRCA1
NM_007294.4(BRCA1):c.1212A>C (p.Glu404Asp)	BRCA1	E404D	Hereditary cancer-predisposing syndrome|not specified	VCV000928533	17	41246336	17	43094319	928533	917259	rs1057521863	NC_000017.11:43094318:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	404	BRCA1
NM_007294.4(BRCA1):c.1208C>T (p.Ser403Phe)	BRCA1	S403F	Hereditary cancer-predisposing syndrome	VCV000054163	17	41246340	17	43094323	54163	68830	rs80356934	NC_000017.11:43094322:G:A	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	403	BRCA1
NM_007294.4(BRCA1):c.1207T>G (p.Ser403Ala)	BRCA1	S403A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000818573	17	41246341	17	43094324	818573	813865	rs1555592200	NC_000017.11:43094323:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	403	BRCA1
NM_007294.4(BRCA1):c.1207T>C (p.Ser403Pro)	BRCA1	S403P	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000481460	17	41246341	17	43094324	481460	479451	rs1555592200	NC_000017.11:43094323:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	403	BRCA1
NM_007294.4(BRCA1):c.1206G>T (p.Glu402Asp)	BRCA1	E402D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001172310	17	41246342	17	43094325	1172310	1161365	rs1283231905	NC_000017.11:43094324:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	402	BRCA1
NM_007294.4(BRCA1):c.1206G>C (p.Glu402Asp)	BRCA1	E402D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000845696	17	41246342	17	43094325	845696	845451	rs1283231905	NC_000017.11:43094324:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	402	BRCA1
NM_007294.4(BRCA1):c.1205A>G (p.Glu402Gly)	BRCA1	E402G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001392791	17	41246343	17	43094326	1392791	1502693	rs1555592216	NC_000017.11:43094325:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	402	BRCA1
NM_007294.4(BRCA1):c.1205A>T (p.Glu402Val)	BRCA1	E402V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462552	17	41246343	17	43094326	462552	467753	rs1555592216	NC_000017.11:43094325:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	402	BRCA1
NM_007294.4(BRCA1):c.1204G>A (p.Glu402Lys)	BRCA1	E402K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000650355	17	41246344	17	43094327	650355	646035	rs273897655	NC_000017.11:43094326:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	402	BRCA1
NM_007294.4(BRCA1):c.1202G>C (p.Gly401Ala)	BRCA1	G401A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000091541	17	41246346	17	43094329	91541	97018	rs397507184	NC_000017.11:43094328:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Oct 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	401	BRCA1
NM_007294.4(BRCA1):c.1202G>A (p.Gly401Glu)	BRCA1	G401E	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000037398	17	41246346	17	43094329	37398	45954	rs397507184	NC_000017.11:43094328:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	401	BRCA1
NM_007294.4(BRCA1):c.1201G>A (p.Gly401Arg)	BRCA1	G401R	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531230	17	41246347	17	43094330	531230	531377	rs1555592242	NC_000017.11:43094329:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	401	BRCA1
NM_007294.4(BRCA1):c.1199A>T (p.Asp400Val)	BRCA1	D400V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001007698	17	41246349	17	43094332	1007698	997587	rs1555592245	NC_000017.11:43094331:T:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	400	BRCA1
NM_007294.4(BRCA1):c.1199A>G (p.Asp400Gly)	BRCA1	D400G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441494	17	41246349	17	43094332	441494	435161	rs1555592245	NC_000017.11:43094331:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	400	BRCA1
NM_007294.4(BRCA1):c.1198G>A (p.Asp400Asn)	BRCA1	D400N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001060748	17	41246350	17	43094333	1060748	1050315	rs2053979139	NC_000017.11:43094332:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	400	BRCA1
NM_007294.4(BRCA1):c.1196A>G (p.His399Arg)	BRCA1	H399R	Hereditary cancer-predisposing syndrome	VCV000136078	17	41246352	17	43094335	136078	139790	rs587780794	NC_000017.11:43094334:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	399	BRCA1
NM_007294.4(BRCA1):c.1195C>T (p.His399Tyr)	BRCA1	H399Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000999096	17	41246353	17	43094336	999096	997588	rs2053979560	NC_000017.11:43094335:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	399	BRCA1
NM_007294.4(BRCA1):c.1193C>T (p.Ser398Leu)	BRCA1	S398L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000652057	17	41246355	17	43094338	652057	646036	rs80357068	NC_000017.11:43094337:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	398	BRCA1
NM_007294.4(BRCA1):c.1192T>G (p.Ser398Ala)	BRCA1	S398A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000954592	17	41246356	17	43094339	954592	949957	rs2053980032	NC_000017.11:43094338:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	398	BRCA1
NM_007294.4(BRCA1):c.1190A>T (p.Asp397Val)	BRCA1	D397V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000654531	17	41246358	17	43094341	654531	646037	rs747727601	NC_000017.11:43094340:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	397	BRCA1
NM_007294.4(BRCA1):c.1189G>A (p.Asp397Asn)	BRCA1	D397N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002744350	17	41246359	17	43094342	2744350	2900819	NA	NC_000017.11:43094341:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	397	BRCA1
NM_007294.4(BRCA1):c.1187A>T (p.Asp396Val)	BRCA1	D396V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629134	17	41246361	17	43094344	629134	618681	rs1555592280	NC_000017.11:43094343:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	396	BRCA1
NM_007294.4(BRCA1):c.1187A>G (p.Asp396Gly)	BRCA1	D396G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531267	17	41246361	17	43094344	531267	531108	rs1555592280	NC_000017.11:43094343:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	396	BRCA1
NM_007294.4(BRCA1):c.1186G>A (p.Asp396Asn)	BRCA1	D396N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000186688	17	41246362	17	43094345	186688	185079	rs786203145	NC_000017.11:43094344:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	396	BRCA1
NM_007294.4(BRCA1):c.1181G>A (p.Gly394Asp)	BRCA1	G394D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000818516	17	41246367	17	43094350	818516	813866	rs1555592295	NC_000017.11:43094349:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	394	BRCA1
NM_007294.4(BRCA1):c.1181G>T (p.Gly394Val)	BRCA1	G394V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000481471	17	41246367	17	43094350	481471	478692	rs1555592295	NC_000017.11:43094349:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	394	BRCA1
NM_007294.4(BRCA1):c.1180G>A (p.Gly394Ser)	BRCA1	G394S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001464620	17	41246368	17	43094351	1464620	1514332	rs771837028	NC_000017.11:43094350:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	394	BRCA1
NM_007294.4(BRCA1):c.1175T>C (p.Leu392Pro)	BRCA1	L392P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000462551	17	41246373	17	43094356	462551	467998	rs777305766	NC_000017.11:43094355:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	392	BRCA1
NM_007294.4(BRCA1):c.1169A>G (p.Asp390Gly)	BRCA1	D390G	Hereditary cancer	VCV003338486	17	41246379	17	43094362	3338486	3497147	NA	NC_000017.11:43094361:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Aug 12, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	390	BRCA1
NM_007294.4(BRCA1):c.1169A>C (p.Asp390Ala)	BRCA1	D390A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001482193	17	41246379	17	43094362	1482193	1445429	rs2154472427	NC_000017.11:43094361:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	390	BRCA1
NM_007294.4(BRCA1):c.1168G>A (p.Asp390Asn)	BRCA1	D390N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001325667	17	41246380	17	43094363	1325667	1315932	rs2154472475	NC_000017.11:43094362:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	390	BRCA1
NM_007294.4(BRCA1):c.1167T>A (p.Ser389Arg)	BRCA1	S389R	Hereditary cancer-predisposing syndrome	VCV001692956	17	41246381	17	43094364	1692956	1685396	rs2154472526	NC_000017.11:43094363:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	389	BRCA1
NM_007294.4(BRCA1):c.1163G>A (p.Arg388Lys)	BRCA1	R388K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001027319	17	41246385	17	43094368	1027319	1012784	rs786203567	NC_000017.11:43094367:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	388	BRCA1
NM_007294.4(BRCA1):c.1163G>C (p.Arg388Thr)	BRCA1	R388T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187229	17	41246385	17	43094368	187229	185080	rs786203567	NC_000017.11:43094367:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	388	BRCA1
NM_007294.4(BRCA1):c.1162A>G (p.Arg388Gly)	BRCA1	R388G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001737108	17	41246386	17	43094369	1737108	1790307	NA	NC_000017.11:43094368:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	388	BRCA1
NM_007294.4(BRCA1):c.1160C>G (p.Ser387Cys)	BRCA1	S387C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629962	17	41246388	17	43094371	629962	618682	rs1567800665	NC_000017.11:43094370:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	387	BRCA1
NM_007294.4(BRCA1):c.1159T>A (p.Ser387Thr)	BRCA1	S387T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231852	17	41246389	17	43094372	231852	236139	rs876659403	NC_000017.11:43094371:A:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	387	BRCA1
NM_007294.4(BRCA1):c.1155G>T (p.Trp385Cys)	BRCA1	W385C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided	VCV000240771	17	41246393	17	43094376	240771	242800	rs876660558	NC_000017.11:43094375:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	385	BRCA1
NM_007294.4(BRCA1):c.1148A>G (p.Asn383Ser)	BRCA1	N383S	not provided|Hereditary cancer-predisposing syndrome	VCV001319809	17	41246400	17	43094383	1319809	1310058	rs770090143	NC_000017.11:43094382:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	383	BRCA1
NM_007294.4(BRCA1):c.1147A>C (p.Asn383His)	BRCA1	N383H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000842598	17	41246401	17	43094384	842598	845452	rs2053985160	NC_000017.11:43094383:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	383	BRCA1
NM_007294.4(BRCA1):c.1145T>C (p.Val382Ala)	BRCA1	V382A	Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000929007	17	41246403	17	43094386	929007	917260	rs2053985286	NC_000017.11:43094385:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	382	BRCA1
NM_007294.4(BRCA1):c.1144G>A (p.Val382Ile)	BRCA1	V382I	Hereditary breast ovarian cancer syndrome	VCV002794607	17	41246404	17	43094387	2794607	2954442	NA	NC_000017.11:43094386:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	382	BRCA1
NM_007294.4(BRCA1):c.1144G>C (p.Val382Leu)	BRCA1	V382L	Hereditary cancer-predisposing syndrome	VCV001732175	17	41246404	17	43094387	1732175	1789206	NA	NC_000017.11:43094386:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	382	BRCA1
NM_007294.4(BRCA1):c.1144G>T (p.Val382Phe)	BRCA1	V382F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000822244	17	41246404	17	43094387	822244	813867	rs1160165083	NC_000017.11:43094386:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	382	BRCA1
NM_007294.4(BRCA1):c.1142A>G (p.Lys381Arg)	BRCA1	K381R	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000531242	17	41246406	17	43094389	531242	531313	rs1555592379	NC_000017.11:43094388:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	381	BRCA1
NM_007294.4(BRCA1):c.1141A>C (p.Lys381Gln)	BRCA1	K381Q	Hereditary breast ovarian cancer syndrome	VCV002863619	17	41246407	17	43094390	2863619	3029694	NA	NC_000017.11:43094389:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	381	BRCA1
NM_007294.4(BRCA1):c.1139A>G (p.Gln380Arg)	BRCA1	Q380R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441392	17	41246409	17	43094392	441392	435162	rs876659193	NC_000017.11:43094391:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	380	BRCA1
NM_007294.4(BRCA1):c.1139A>C (p.Gln380Pro)	BRCA1	Q380P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000231499	17	41246409	17	43094392	231499	236142	rs876659193	NC_000017.11:43094391:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	380	BRCA1
NM_007294.4(BRCA1):c.1137T>G (p.Ile379Met)	BRCA1	I379M	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Fanconi anemia, complementation group S	VCV000054143	17	41246411	17	43094394	54143	68810	rs56128296	NC_000017.11:43094393:A:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jul 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	379	BRCA1
NM_007294.4(BRCA1):c.1136T>C (p.Ile379Thr)	BRCA1	I379T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000580309	17	41246412	17	43094395	580309	574488	rs1567800757	NC_000017.11:43094394:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	379	BRCA1
NM_007294.4(BRCA1):c.1135A>T (p.Ile379Phe)	BRCA1	I379F	Hereditary cancer-predisposing syndrome|not provided	VCV001699865	17	41246413	17	43094396	1699865	1692237	rs864622723	NC_000017.11:43094395:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	379	BRCA1
NM_007294.4(BRCA1):c.1135A>G (p.Ile379Val)	BRCA1	I379V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000221036	17	41246413	17	43094396	221036	222673	rs864622723	NC_000017.11:43094395:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	379	BRCA1
NM_007294.4(BRCA1):c.1134C>A (p.Ser378Arg)	BRCA1	S378R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000216654	17	41246414	17	43094397	216654	213327	rs863224752	NC_000017.11:43094396:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	378	BRCA1
NM_007294.4(BRCA1):c.1133G>T (p.Ser378Ile)	BRCA1	S378I	Hereditary cancer-predisposing syndrome	VCV003226096	17	41246415	17	43094398	3226096	3390601	NA	NC_000017.11:43094397:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	378	BRCA1
NM_007294.4(BRCA1):c.1133G>C (p.Ser378Thr)	BRCA1	S378T	Hereditary cancer-predisposing syndrome	VCV002585853	17	41246415	17	43094398	2585853	2753413	NA	NC_000017.11:43094397:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	378	BRCA1
NM_007294.4(BRCA1):c.1132A>G (p.Ser378Gly)	BRCA1	S378G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479258	17	41246416	17	43094399	479258	478766	rs1555592404	NC_000017.11:43094398:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	378	BRCA1
NM_007294.4(BRCA1):c.1131C>G (p.Ser377Arg)	BRCA1	S377R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489706	17	41246417	17	43094400	489706	483020	rs786203434	NC_000017.11:43094399:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	377	BRCA1
NM_007294.4(BRCA1):c.1131C>A (p.Ser377Arg)	BRCA1	S377R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187050	17	41246417	17	43094400	187050	185081	rs786203434	NC_000017.11:43094399:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	377	BRCA1
NM_007294.4(BRCA1):c.1130G>A (p.Ser377Asn)	BRCA1	S377N	Hereditary cancer-predisposing syndrome	VCV000054142	17	41246418	17	43094401	54142	68809	rs80357398	NC_000017.11:43094400:C:T	single nucleotide variant	intron variant|missense variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	377	BRCA1
NM_007294.4(BRCA1):c.1129A>G (p.Ser377Gly)	BRCA1	S377G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481490	17	41246419	17	43094402	481490	478703	rs1555592415	NC_000017.11:43094401:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	377	BRCA1
NM_007294.4(BRCA1):c.1127A>G (p.Asn376Ser)	BRCA1	N376S	Hereditary cancer-predisposing syndrome	VCV000054139	17	41246421	17	43094404	54139	68806	rs80356976	NC_000017.11:43094403:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	376	BRCA1
NM_007294.4(BRCA1):c.1124T>G (p.Leu375Arg)	BRCA1	L375R	Hereditary cancer-predisposing syndrome	VCV001798746	17	41246424	17	43094407	1798746	1856015	NA	NC_000017.11:43094406:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	375	BRCA1
NM_007294.4(BRCA1):c.1121C>T (p.Thr374Ile)	BRCA1	T374I	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000054136	17	41246427	17	43094410	54136	68803	rs80357235	NC_000017.11:43094409:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	374	BRCA1
NM_007294.4(BRCA1):c.1119A>G (p.Ile373Met)	BRCA1	I373M	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV002118277	17	41246429	17	43094412	2118277	2176059	NA	NC_000017.11:43094411:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	373	BRCA1
NM_007294.4(BRCA1):c.1118T>G (p.Ile373Arg)	BRCA1	I373R	Hereditary cancer-predisposing syndrome	VCV001171931	17	41246430	17	43094413	1171931	1161366	rs2154475121	NC_000017.11:43094412:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	373	BRCA1
NM_007294.4(BRCA1):c.1117A>G (p.Ile373Val)	BRCA1	I373V	Hereditary cancer-predisposing syndrome	VCV002774862	17	41246431	17	43094414	2774862	2935588	NA	NC_000017.11:43094413:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	373	BRCA1
NM_007294.4(BRCA1):c.1117A>C (p.Ile373Leu)	BRCA1	I373L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Neoplasm	VCV002123307	17	41246431	17	43094414	2123307	2177206	NA	NC_000017.11:43094413:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	373	BRCA1
NM_007294.4(BRCA1):c.1114T>C (p.Trp372Arg)	BRCA1	W372R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000485404	17	41246434	17	43094417	485404	479458	rs1306111238	NC_000017.11:43094416:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	372	BRCA1
NM_007294.4(BRCA1):c.1114T>A (p.Trp372Arg)	BRCA1	W372R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462550	17	41246434	17	43094417	462550	467758	rs1306111238	NC_000017.11:43094416:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	372	BRCA1
NM_007294.4(BRCA1):c.1109T>C (p.Val370Ala)	BRCA1	V370A	Hereditary breast ovarian cancer syndrome	VCV002753645	17	41246439	17	43094422	2753645	2920011	NA	NC_000017.11:43094421:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	370	BRCA1
NM_007294.4(BRCA1):c.1108G>T (p.Val370Phe)	BRCA1	V370F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV001794369	17	41246440	17	43094423	1794369	1852115	NA	NC_000017.11:43094422:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	370	BRCA1
NM_007294.4(BRCA1):c.1108G>A (p.Val370Ile)	BRCA1	V370I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000644245	17	41246440	17	43094423	644245	646038	rs1567800850	NC_000017.11:43094422:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	370	BRCA1
NM_007294.4(BRCA1):c.1108G>C (p.Val370Leu)	BRCA1	V370L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000628528	17	41246440	17	43094423	628528	618683	rs1567800850	NC_000017.11:43094422:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	370	BRCA1
NM_007294.4(BRCA1):c.1106A>T (p.Asp369Val)	BRCA1	D369V	Hereditary cancer-predisposing syndrome	VCV000629064	17	41246442	17	43094425	629064	618684	rs80357416	NC_000017.11:43094424:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	369	BRCA1
NM_007294.4(BRCA1):c.1106A>G (p.Asp369Gly)	BRCA1	D369G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054129	17	41246442	17	43094425	54129	68796	rs80357416	NC_000017.11:43094424:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	369	BRCA1
NM_007294.4(BRCA1):c.1105G>A (p.Asp369Asn)	BRCA1	D369N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037390	17	41246443	17	43094426	37390	45946	rs56056711	NC_000017.11:43094425:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	369	BRCA1
NM_007294.4(BRCA1):c.1100C>G (p.Thr367Ser)	BRCA1	T367S	not specified	VCV002691999	17	41246448	17	43094431	2691999	2853002	NA	NC_000017.11:43094430:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	367	BRCA1
NM_007294.4(BRCA1):c.1100C>A (p.Thr367Asn)	BRCA1	T367N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002139078	17	41246448	17	43094431	2139078	1874873	NA	NC_000017.11:43094430:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	367	BRCA1
NM_007294.4(BRCA1):c.1099A>G (p.Thr367Ala)	BRCA1	T367A	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000240769	17	41246449	17	43094432	240769	242802	rs878854929	NC_000017.11:43094431:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	367	BRCA1
NM_007294.4(BRCA1):c.1097A>T (p.Asp366Val)	BRCA1	D366V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141466	17	41246451	17	43094434	141466	151180	rs587781769	NC_000017.11:43094433:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	366	BRCA1
NM_007294.4(BRCA1):c.1096G>A (p.Asp366Asn)	BRCA1	D366N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001352067	17	41246452	17	43094435	1352067	1482603	rs1289961661	NC_000017.11:43094434:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	366	BRCA1
NM_007294.4(BRCA1):c.1096G>C (p.Asp366His)	BRCA1	D366H	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489705	17	41246452	17	43094435	489705	482982	rs1289961661	NC_000017.11:43094434:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	366	BRCA1
NM_007294.4(BRCA1):c.1094G>C (p.Arg365Thr)	BRCA1	R365T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001479230	17	41246454	17	43094437	1479230	1426600	rs2053994698	NC_000017.11:43094436:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	365	BRCA1
NM_007294.4(BRCA1):c.1094G>A (p.Arg365Lys)	BRCA1	R365K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000948211	17	41246454	17	43094437	948211	928321	rs2053994698	NC_000017.11:43094436:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	365	BRCA1
NM_007294.4(BRCA1):c.1094G>T (p.Arg365Ile)	BRCA1	R365I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000925793	17	41246454	17	43094437	925793	913961	rs2053994698	NC_000017.11:43094436:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Apr 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	365	BRCA1
NM_007294.4(BRCA1):c.1093A>G (p.Arg365Gly)	BRCA1	R365G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001039705	17	41246455	17	43094438	1039705	1033326	rs398122627	NC_000017.11:43094437:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	365	BRCA1
NM_007294.4(BRCA1):c.1090C>G (p.Pro364Ala)	BRCA1	P364A	Hereditary breast ovarian cancer syndrome	VCV002842763	17	41246458	17	43094441	2842763	2997469	NA	NC_000017.11:43094440:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	364	BRCA1
NM_007294.4(BRCA1):c.1090C>A (p.Pro364Thr)	BRCA1	P364T	Hereditary cancer-predisposing syndrome	VCV000233289	17	41246458	17	43094441	233289	236146	rs876660309	NC_000017.11:43094440:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	364	BRCA1
NM_007294.4(BRCA1):c.1088A>C (p.Asn363Thr)	BRCA1	N363T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001718956	17	41246460	17	43094443	1718956	1776460	NA	NC_000017.11:43094442:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	363	BRCA1
NM_007294.4(BRCA1):c.1082C>T (p.Ser361Leu)	BRCA1	S361L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409299	17	41246466	17	43094449	409299	402717	rs397508833	NC_000017.11:43094448:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	361	BRCA1
NM_007294.4(BRCA1):c.1081T>G (p.Ser361Ala)	BRCA1	S361A	Hereditary cancer-predisposing syndrome	VCV001297678	17	41246467	17	43094450	1297678	1287465	rs80356946	NC_000017.11:43094449:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	361	BRCA1
NM_007294.4(BRCA1):c.1081T>C (p.Ser361Pro)	BRCA1	S361P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome	VCV000054120	17	41246467	17	43094450	54120	68787	rs80356946	NC_000017.11:43094449:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	361	BRCA1
NM_007294.4(BRCA1):c.1079G>A (p.Cys360Tyr)	BRCA1	C360Y	Hereditary cancer-predisposing syndrome	VCV003134927	17	41246469	17	43094452	3134927	3302078	NA	NC_000017.11:43094451:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	360	BRCA1
NM_007294.4(BRCA1):c.1078T>C (p.Cys360Arg)	BRCA1	C360R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000142880	17	41246470	17	43094453	142880	152594	rs587782790	NC_000017.11:43094452:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	360	BRCA1
NM_007294.4(BRCA1):c.1076C>T (p.Pro359Leu)	BRCA1	P359L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054118	17	41246472	17	43094455	54118	68785	rs397508831	NC_000017.11:43094454:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	359	BRCA1
NM_007294.4(BRCA1):c.1075C>T (p.Pro359Ser)	BRCA1	P359S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000252384	17	41246473	17	43094456	252384	246823	rs767666190	NC_000017.11:43094455:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	359	BRCA1
NM_007294.4(BRCA1):c.1073T>C (p.Leu358Pro)	BRCA1	L358P	Hereditary cancer-predisposing syndrome	VCV001784220	17	41246475	17	43094458	1784220	1849779	NA	NC_000017.11:43094457:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	358	BRCA1
NM_007294.4(BRCA1):c.1072C>G (p.Leu358Val)	BRCA1	L358V	Hereditary cancer-predisposing syndrome	VCV002585832	17	41246476	17	43094459	2585832	2753392	NA	NC_000017.11:43094458:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	358	BRCA1
NM_007294.4(BRCA1):c.1069A>G (p.Lys357Glu)	BRCA1	K357E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000855083	17	41246479	17	43094462	855083	845454	rs2053998767	NC_000017.11:43094461:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	357	BRCA1
NM_007294.4(BRCA1):c.1067A>G (p.Gln356Arg)	BRCA1	Q356R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041803	17	41246481	17	43094464	41803	50242	rs1799950	NC_000017.11:43094463:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	356	BRCA1
NM_007294.4(BRCA1):c.1064A>G (p.Lys355Arg)	BRCA1	K355R	Hereditary cancer-predisposing syndrome	VCV000054112	17	41246484	17	43094467	54112	68779	rs80357246	NC_000017.11:43094466:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	355	BRCA1
NM_007294.4(BRCA1):c.1061A>G (p.Asn354Ser)	BRCA1	N354S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000570311	17	41246487	17	43094470	570311	571200	rs1555592577	NC_000017.11:43094469:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	354	BRCA1
NM_007294.4(BRCA1):c.1061A>T (p.Asn354Ile)	BRCA1	N354I	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462547	17	41246487	17	43094470	462547	468228	rs1555592577	NC_000017.11:43094469:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	354	BRCA1
NM_007294.4(BRCA1):c.1059G>C (p.Trp353Cys)	BRCA1	W353C	Hereditary cancer-predisposing syndrome	VCV000186240	17	41246489	17	43094472	186240	185083	rs80356935	NC_000017.11:43094471:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	353	BRCA1
NM_007294.4(BRCA1):c.1054G>C (p.Glu352Gln)	BRCA1	E352Q	Hereditary cancer-predisposing syndrome	VCV001778202	17	41246494	17	43094477	1778202	1838134	NA	NC_000017.11:43094476:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	352	BRCA1
NM_007294.4(BRCA1):c.1054G>A (p.Glu352Lys)	BRCA1	E352K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409333	17	41246494	17	43094477	409333	402060	rs80357472	NC_000017.11:43094476:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	352	BRCA1
NM_007294.4(BRCA1):c.1052A>G (p.Lys351Arg)	BRCA1	K351R	not provided|Hereditary cancer-predisposing syndrome	VCV001777505	17	41246496	17	43094479	1777505	1828007	NA	NC_000017.11:43094478:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	351	BRCA1
NM_007294.4(BRCA1):c.1052A>T (p.Lys351Ile)	BRCA1	K351I	Hereditary cancer-predisposing syndrome	VCV000822080	17	41246496	17	43094479	822080	813869	rs765323349	NC_000017.11:43094478:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	351	BRCA1
NM_007294.4(BRCA1):c.1051A>C (p.Lys351Gln)	BRCA1	K351Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001062596	17	41246497	17	43094480	1062596	1050316	rs1178253962	NC_000017.11:43094479:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	351	BRCA1
NM_007294.4(BRCA1):c.1049G>C (p.Arg350Thr)	BRCA1	R350T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001519424	17	41246499	17	43094482	1519424	1433918	rs2054001685	NC_000017.11:43094481:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	350	BRCA1
NM_007294.4(BRCA1):c.1049G>T (p.Arg350Ile)	BRCA1	R350I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001351067	17	41246499	17	43094482	1351067	1407417	rs2054001685	NC_000017.11:43094481:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	350	BRCA1
NM_007294.4(BRCA1):c.1049G>A (p.Arg350Lys)	BRCA1	R350K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000921476	17	41246499	17	43094482	921476	913964	rs2054001685	NC_000017.11:43094481:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	350	BRCA1
NM_007294.4(BRCA1):c.1046A>G (p.Glu349Gly)	BRCA1	E349G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001497408	17	41246502	17	43094485	1497408	1476029	rs2154478875	NC_000017.11:43094484:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	349	BRCA1
NM_007294.4(BRCA1):c.1045G>A (p.Glu349Lys)	BRCA1	E349K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000922205	17	41246503	17	43094486	922205	913965	rs80357338	NC_000017.11:43094485:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	349	BRCA1
NM_007294.4(BRCA1):c.1043G>T (p.Cys348Phe)	BRCA1	C348F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002092620	17	41246505	17	43094488	2092620	2149130	NA	NC_000017.11:43094487:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	348	BRCA1
NM_007294.4(BRCA1):c.1043G>A (p.Cys348Tyr)	BRCA1	C348Y	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000225706	17	41246505	17	43094488	225706	227566	rs752198747	NC_000017.11:43094487:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	348	BRCA1
NM_007294.4(BRCA1):c.1042T>C (p.Cys348Arg)	BRCA1	C348R	Hereditary cancer-predisposing syndrome	VCV000185101	17	41246506	17	43094489	185101	185084	rs786201928	NC_000017.11:43094488:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	348	BRCA1
NM_007294.4(BRCA1):c.1040T>C (p.Leu347Pro)	BRCA1	L347P	Hereditary cancer-predisposing syndrome	VCV000924649	17	41246508	17	43094491	924649	913966	rs757987511	NC_000017.11:43094490:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	347	BRCA1
NM_007294.4(BRCA1):c.1040T>A (p.Leu347Gln)	BRCA1	L347Q	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441364	17	41246508	17	43094491	441364	435163	rs757987511	NC_000017.11:43094490:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	347	BRCA1
NM_007294.4(BRCA1):c.1037C>T (p.Pro346Leu)	BRCA1	P346L	Hereditary cancer-predisposing syndrome	VCV003226094	17	41246511	17	43094494	3226094	3390599	NA	NC_000017.11:43094493:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	346	BRCA1
NM_007294.4(BRCA1):c.1037C>G (p.Pro346Arg)	BRCA1	P346R	Hereditary breast ovarian cancer syndrome	VCV002768599	17	41246511	17	43094494	2768599	2926750	NA	NC_000017.11:43094493:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	346	BRCA1
NM_007294.4(BRCA1):c.1037C>A (p.Pro346His)	BRCA1	P346H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491026	17	41246511	17	43094494	491026	484946	rs1555592620	NC_000017.11:43094493:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	346	BRCA1
NM_007294.4(BRCA1):c.1036C>A (p.Pro346Thr)	BRCA1	P346T	Hereditary cancer-predisposing syndrome	VCV003226093	17	41246512	17	43094495	3226093	3390598	NA	NC_000017.11:43094494:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	346	BRCA1
NM_007294.4(BRCA1):c.1036C>G (p.Pro346Ala)	BRCA1	P346A	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000573731	17	41246512	17	43094495	573731	574489	rs80357015	NC_000017.11:43094494:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	346	BRCA1
NM_007294.4(BRCA1):c.1036C>T (p.Pro346Ser)	BRCA1	P346S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037389	17	41246512	17	43094495	37389	45945	rs80357015	NC_000017.11:43094494:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	346	BRCA1
NM_007294.4(BRCA1):c.1034A>G (p.Asp345Gly)	BRCA1	D345G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001718842	17	41246514	17	43094497	1718842	1776346	NA	NC_000017.11:43094496:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	345	BRCA1
NM_007294.4(BRCA1):c.1033G>T (p.Asp345Tyr)	BRCA1	D345Y	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	VCV000037388	17	41246515	17	43094498	37388	45944	rs80356961	NC_000017.11:43094497:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	345	BRCA1
NM_007294.4(BRCA1):c.1031C>G (p.Ala344Gly)	BRCA1	A344G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001047210	17	41246517	17	43094500	1047210	1033327	rs876658636	NC_000017.11:43094499:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	344	BRCA1
NM_007294.4(BRCA1):c.1031C>A (p.Ala344Asp)	BRCA1	A344D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000565976	17	41246517	17	43094500	565976	571495	rs876658636	NC_000017.11:43094499:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	344	BRCA1
NM_007294.4(BRCA1):c.1031C>T (p.Ala344Val)	BRCA1	A344V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230563	17	41246517	17	43094500	230563	236148	rs876658636	NC_000017.11:43094499:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	344	BRCA1
NM_007294.4(BRCA1):c.1030G>A (p.Ala344Thr)	BRCA1	A344T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054104	17	41246518	17	43094501	54104	68771	rs79727659	NC_000017.11:43094500:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	344	BRCA1
NM_007294.4(BRCA1):c.1028A>G (p.Asn343Ser)	BRCA1	N343S	Hereditary cancer-predisposing syndrome|not provided	VCV003261443	17	41246520	17	43094503	3261443	3424212	NA	NC_000017.11:43094502:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	May 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	343	BRCA1
NM_007294.4(BRCA1):c.1027_1028delinsTG (p.Asn343Cys)	BRCA1	N343C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002683811	17	41246520 - 41246521	17	43094503 - 43094504	2683811	2844849	NA	NC_000017.11:43094502:TT:CA	Indel	intron variant|missense variant	Likely benign	Sep 1, 2023	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	343	BRCA1
NM_007294.4(BRCA1):c.1027A>G (p.Asn343Asp)	BRCA1	N343D	Hereditary breast ovarian cancer syndrome	VCV002750867	17	41246521	17	43094504	2750867	2912905	NA	NC_000017.11:43094503:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Aug 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	343	BRCA1
NM_007294.4(BRCA1):c.1025T>A (p.Leu342Gln)	BRCA1	L342Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000654052	17	41246523	17	43094506	654052	646039	rs1555592634	NC_000017.11:43094505:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	342	BRCA1
NM_007294.4(BRCA1):c.1025T>C (p.Leu342Pro)	BRCA1	L342P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441393	17	41246523	17	43094506	441393	435164	rs1555592634	NC_000017.11:43094505:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	342	BRCA1
NM_007294.4(BRCA1):c.1024C>A (p.Leu342Met)	BRCA1	L342M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001426807	17	41246524	17	43094507	1426807	1366480	rs2154479720	NC_000017.11:43094506:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	342	BRCA1
NM_007294.4(BRCA1):c.1022A>C (p.Asp341Ala)	BRCA1	D341A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000574708	17	41246526	17	43094509	574708	571204	rs1567801162	NC_000017.11:43094508:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	341	BRCA1
NM_007294.4(BRCA1):c.1021G>T (p.Asp341Tyr)	BRCA1	D341Y	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000482915	17	41246527	17	43094510	482915	478706	rs756987689	NC_000017.11:43094509:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	341	BRCA1
NM_007294.4(BRCA1):c.1021G>A (p.Asp341Asn)	BRCA1	D341N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000409364	17	41246527	17	43094510	409364	402112	rs756987689	NC_000017.11:43094509:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	341	BRCA1
NM_007294.4(BRCA1):c.1019T>C (p.Val340Ala)	BRCA1	V340A	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002091299	17	41246529	17	43094512	2091299	2145338	NA	NC_000017.11:43094511:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	340	BRCA1
NM_007294.4(BRCA1):c.1017G>T (p.Lys339Asn)	BRCA1	K339N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479262	17	41246531	17	43094514	479262	479468	rs863224416	NC_000017.11:43094513:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	339	BRCA1
NM_007294.4(BRCA1):c.1016A>G (p.Lys339Arg)	BRCA1	K339R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000549761	17	41246532	17	43094515	549761	540531	rs587781737	NC_000017.11:43094514:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	339	BRCA1
NM_007294.4(BRCA1):c.1016A>C (p.Lys339Thr)	BRCA1	K339T	Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000141428	17	41246532	17	43094515	141428	151142	rs587781737	NC_000017.11:43094514:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	339	BRCA1
NM_007294.4(BRCA1):c.1015A>G (p.Lys339Glu)	BRCA1	K339E	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000096894	17	41246533	17	43094516	96894	102797	rs55842957	NC_000017.11:43094515:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	339	BRCA1
NM_007294.4(BRCA1):c.1012A>G (p.Lys338Glu)	BRCA1	K338E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000409360	17	41246536	17	43094519	409360	402116	rs397508826	NC_000017.11:43094518:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	338	BRCA1
NM_007294.4(BRCA1):c.1011A>C (p.Glu337Asp)	BRCA1	E337D	not provided	VCV002507342	17	41246537	17	43094520	2507342	2672332	NA	NC_000017.11:43094519:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 30, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	337	BRCA1
NM_007294.4(BRCA1):c.1009G>C (p.Glu337Gln)	BRCA1	E337Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000940092	17	41246539	17	43094522	940092	937972	rs2054008789	NC_000017.11:43094521:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	337	BRCA1
NM_007294.4(BRCA1):c.1007C>G (p.Thr336Arg)	BRCA1	T336R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000818253	17	41246541	17	43094524	818253	813872	rs1597878639	NC_000017.11:43094523:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	336	BRCA1
NM_007294.4(BRCA1):c.1006A>G (p.Thr336Ala)	BRCA1	T336A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000954033	17	41246542	17	43094525	954033	949959	rs2054009524	NC_000017.11:43094524:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	336	BRCA1
NM_007294.4(BRCA1):c.1005C>A (p.Ser335Arg)	BRCA1	S335R	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233381	17	41246543	17	43094526	233381	236150	rs876660367	NC_000017.11:43094525:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	335	BRCA1
NM_007294.4(BRCA1):c.1001C>G (p.Pro334Arg)	BRCA1	P334R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002825184	17	41246547	17	43094530	2825184	2986269	NA	NC_000017.11:43094529:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	334	BRCA1
NM_007294.4(BRCA1):c.1001C>A (p.Pro334His)	BRCA1	P334H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096893	17	41246547	17	43094530	96893	102796	rs41286290	NC_000017.11:43094529:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	334	BRCA1
NM_007294.4(BRCA1):c.1001C>T (p.Pro334Leu)	BRCA1	P334L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054099	17	41246547	17	43094530	54099	68766	rs41286290	NC_000017.11:43094529:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	334	BRCA1
NM_007294.4(BRCA1):c.1000C>T (p.Pro334Ser)	BRCA1	P334S	Hereditary breast ovarian cancer syndrome	VCV002846163	17	41246548	17	43094531	2846163	3008523	NA	NC_000017.11:43094530:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	334	BRCA1
NM_007294.4(BRCA1):c.1000C>G (p.Pro334Ala)	BRCA1	P334A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721386	17	41246548	17	43094531	1721386	1772720	NA	NC_000017.11:43094530:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	334	BRCA1
NM_007294.4(BRCA1):c.1000C>A (p.Pro334Thr)	BRCA1	P334T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531405	17	41246548	17	43094531	531405	531597	rs1555592700	NC_000017.11:43094530:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	334	BRCA1
NM_007294.4(BRCA1):c.998C>A (p.Thr333Asn)	BRCA1	T333N	Hereditary cancer-predisposing syndrome	VCV002565360	17	41246550	17	43094533	2565360	2732333	NA	NC_000017.11:43094532:G:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	May 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	333	BRCA1
NM_007294.4(BRCA1):c.998C>G (p.Thr333Ser)	BRCA1	T333S	Hereditary cancer-predisposing syndrome	VCV000629227	17	41246550	17	43094533	629227	618685	rs431825420	NC_000017.11:43094532:G:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	333	BRCA1
NM_007294.4(BRCA1):c.998C>T (p.Thr333Ile)	BRCA1	T333I	Hereditary cancer-predisposing syndrome	VCV000096957	17	41246550	17	43094533	96957	102860	rs431825420	NC_000017.11:43094532:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	333	BRCA1
NM_007294.4(BRCA1):c.997A>G (p.Thr333Ala)	BRCA1	T333A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000184709	17	41246551	17	43094534	184709	185085	rs786201634	NC_000017.11:43094533:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	333	BRCA1
NM_007294.4(BRCA1):c.995G>A (p.Arg332Gln)	BRCA1	R332Q	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000055776	17	41246553	17	43094536	55776	70443	rs80357464	NC_000017.11:43094535:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	332	BRCA1
NM_007294.4(BRCA1):c.994C>G (p.Arg332Gly)	BRCA1	R332G	Hereditary cancer-predisposing syndrome	VCV000823578	17	41246554	17	43094537	823578	813873	rs80357176	NC_000017.11:43094536:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	332	BRCA1
NM_007294.4(BRCA1):c.994C>T (p.Arg332Trp)	BRCA1	R332W	Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|not specified	VCV000055775	17	41246554	17	43094537	55775	70442	rs80357176	NC_000017.11:43094536:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	332	BRCA1
NM_007294.4(BRCA1):c.993G>C (p.Arg331Ser)	BRCA1	R331S	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055774	17	41246555	17	43094538	55774	70441	rs80357140	NC_000017.11:43094537:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	331	BRCA1
NM_007294.4(BRCA1):c.988G>A (p.Asp330Asn)	BRCA1	D330N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000037713	17	41246560	17	43094543	37713	46269	rs397507259	NC_000017.11:43094542:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	330	BRCA1
NM_007294.4(BRCA1):c.986A>G (p.Asn329Ser)	BRCA1	N329S	Hereditary cancer-predisposing syndrome	VCV001768440	17	41246562	17	43094545	1768440	1828849	NA	NC_000017.11:43094544:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	329	BRCA1
NM_007294.4(BRCA1):c.985A>C (p.Asn329His)	BRCA1	N329H	Hereditary breast ovarian cancer syndrome	VCV002762619	17	41246563	17	43094546	2762619	2931113	NA	NC_000017.11:43094545:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	329	BRCA1
NM_007294.4(BRCA1):c.985A>T (p.Asn329Tyr)	BRCA1	N329Y	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000187436	17	41246563	17	43094546	187436	185087	rs786203732	NC_000017.11:43094545:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	329	BRCA1
NM_007294.4(BRCA1):c.983G>A (p.Cys328Tyr)	BRCA1	C328Y	Hereditary cancer-predisposing syndrome	VCV000823503	17	41246565	17	43094548	823503	813874	rs1567801307	NC_000017.11:43094547:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	328	BRCA1
NM_007294.4(BRCA1):c.982T>G (p.Cys328Gly)	BRCA1	C328G	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000566912	17	41246566	17	43094549	566912	571496	rs748156170	NC_000017.11:43094548:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	328	BRCA1
NM_007294.4(BRCA1):c.982T>C (p.Cys328Arg)	BRCA1	C328R	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV000230150	17	41246566	17	43094549	230150	236152	rs748156170	NC_000017.11:43094548:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	328	BRCA1
NM_007294.4(BRCA1):c.976G>C (p.Glu326Gln)	BRCA1	E326Q	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000801090	17	41246572	17	43094555	801090	789629	rs773433679	NC_000017.11:43094554:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	326	BRCA1
NM_007294.4(BRCA1):c.974A>G (p.Lys325Arg)	BRCA1	K325R	Hereditary cancer-predisposing syndrome	VCV002585822	17	41246574	17	43094557	2585822	2753382	NA	NC_000017.11:43094556:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	325	BRCA1
NM_007294.4(BRCA1):c.974A>C (p.Lys325Thr)	BRCA1	K325T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000948091	17	41246574	17	43094557	948091	928322	rs2054013870	NC_000017.11:43094556:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	325	BRCA1
NM_007294.4(BRCA1):c.973A>G (p.Lys325Glu)	BRCA1	K325E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002126190	17	41246575	17	43094558	2126190	2185358	NA	NC_000017.11:43094557:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	325	BRCA1
NM_007294.4(BRCA1):c.972T>G (p.Ser324Arg)	BRCA1	S324R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001061970	17	41246576	17	43094559	1061970	1050317	rs2154481654	NC_000017.11:43094558:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	324	BRCA1
NM_007294.4(BRCA1):c.971G>T (p.Ser324Ile)	BRCA1	S324I	Hereditary breast ovarian cancer syndrome	VCV002703513	17	41246577	17	43094560	2703513	2859804	NA	NC_000017.11:43094559:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	324	BRCA1
NM_007294.4(BRCA1):c.971G>A (p.Ser324Asn)	BRCA1	S324N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000481450	17	41246577	17	43094560	481450	478781	rs1462728426	NC_000017.11:43094559:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	324	BRCA1
NM_007294.4(BRCA1):c.970A>G (p.Ser324Gly)	BRCA1	S324G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000942977	17	41246578	17	43094561	942977	937973	rs2054014425	NC_000017.11:43094560:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	324	BRCA1
NM_007294.4(BRCA1):c.968G>C (p.Gly323Ala)	BRCA1	G323A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001497834	17	41246580	17	43094563	1497834	1376354	rs2054014720	NC_000017.11:43094562:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	323	BRCA1
NM_007294.4(BRCA1):c.968G>A (p.Gly323Glu)	BRCA1	G323E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001017178	17	41246580	17	43094563	1017178	1012785	rs2054014720	NC_000017.11:43094562:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	323	BRCA1
NM_007294.4(BRCA1):c.967G>A (p.Gly323Arg)	BRCA1	G323R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000643434	17	41246581	17	43094564	643434	646040	rs1597878824	NC_000017.11:43094563:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	323	BRCA1
NM_007294.4(BRCA1):c.964G>C (p.Ala322Pro)	BRCA1	A322P	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055767	17	41246584	17	43094567	55767	70434	rs80357252	NC_000017.11:43094566:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	322	BRCA1
NM_007294.4(BRCA1):c.964G>A (p.Ala322Thr)	BRCA1	A322T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000055766	17	41246584	17	43094567	55766	70433	rs80357252	NC_000017.11:43094566:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	322	BRCA1
NM_007294.4(BRCA1):c.957C>A (p.Asn319Lys)	BRCA1	N319K	Hereditary cancer-predisposing syndrome	VCV003226181	17	41246591	17	43094574	3226181	3387244	NA	NC_000017.11:43094573:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	319	BRCA1
NM_007294.4(BRCA1):c.956A>C (p.Asn319Thr)	BRCA1	N319T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001767402	17	41246592	17	43094575	1767402	1821742	NA	NC_000017.11:43094574:T:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	319	BRCA1
NM_007294.4(BRCA1):c.956A>G (p.Asn319Ser)	BRCA1	N319S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037711	17	41246592	17	43094575	37711	46267	rs397507258	NC_000017.11:43094574:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	319	BRCA1
NM_007294.4(BRCA1):c.955A>G (p.Asn319Asp)	BRCA1	N319D	Hereditary cancer-predisposing syndrome	VCV001767376	17	41246593	17	43094576	1767376	1245715	NA	NC_000017.11:43094575:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	319	BRCA1
NM_007294.4(BRCA1):c.954T>A (p.His318Gln)	BRCA1	H318Q	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000431184	17	41246594	17	43094577	431184	424714	rs1135401826	NC_000017.11:43094576:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	318	BRCA1
NM_007294.4(BRCA1):c.953A>T (p.His318Leu)	BRCA1	H318L	Ovarian cancer	VCV002445397	17	41246595	17	43094578	2445397	2419123	NA	NC_000017.11:43094577:T:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Jan 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	318	BRCA1
NM_007294.4(BRCA1):c.953A>G (p.His318Arg)	BRCA1	H318R	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000569329	17	41246595	17	43094578	569329	571207	rs776278453	NC_000017.11:43094577:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	318	BRCA1
NM_007294.4(BRCA1):c.948C>A (p.Ser316Arg)	BRCA1	S316R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001303010	17	41246600	17	43094583	1303010	1293289	rs1555592782	NC_000017.11:43094582:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	316	BRCA1
NM_007294.4(BRCA1):c.948C>G (p.Ser316Arg)	BRCA1	S316R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000482897	17	41246600	17	43094583	482897	478842	rs1555592782	NC_000017.11:43094582:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	316	BRCA1
NM_007294.4(BRCA1):c.947G>A (p.Ser316Asn)	BRCA1	S316N	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000441333	17	41246601	17	43094584	441333	435165	rs1465372282	NC_000017.11:43094583:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	316	BRCA1
NM_007294.4(BRCA1):c.946A>G (p.Ser316Gly)	BRCA1	S316G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037709	17	41246602	17	43094585	37709	46265	rs55874646	NC_000017.11:43094584:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	316	BRCA1
NM_007294.4(BRCA1):c.945G>C (p.Arg315Ser)	BRCA1	R315S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000647790	17	41246603	17	43094586	647790	646041	rs1555592789	NC_000017.11:43094585:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	315	BRCA1
NM_007294.4(BRCA1):c.944G>A (p.Arg315Lys)	BRCA1	R315K	Hereditary cancer-predisposing syndrome	VCV000441447	17	41246604	17	43094587	441447	435166	rs1555592792	NC_000017.11:43094586:C:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	315	BRCA1
NM_007294.4(BRCA1):c.943A>G (p.Arg315Gly)	BRCA1	R315G	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055761	17	41246605	17	43094588	55761	70428	rs80357050	NC_000017.11:43094587:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	315	BRCA1
NM_007294.4(BRCA1):c.941C>T (p.Ala314Val)	BRCA1	A314V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000216676	17	41246607	17	43094590	216676	213329	rs863224766	NC_000017.11:43094589:G:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	314	BRCA1
NM_007294.4(BRCA1):c.934G>A (p.Gly312Ser)	BRCA1	G312S	not provided	VCV003340388	17	41246614	17	43094597	3340388	3499644	NA	NC_000017.11:43094596:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	BRCA1
NM_007294.4(BRCA1):c.934G>T (p.Gly312Cys)	BRCA1	G312C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003073045	17	41246614	17	43094597	3073045	3229315	NA	NC_000017.11:43094596:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	BRCA1
NM_007294.4(BRCA1):c.932C>G (p.Pro311Arg)	BRCA1	P311R	Hereditary cancer-predisposing syndrome|not specified	VCV001686513	17	41246616	17	43094599	1686513	1678519	rs1301795658	NC_000017.11:43094598:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	311	BRCA1
NM_007294.4(BRCA1):c.932C>T (p.Pro311Leu)	BRCA1	P311L	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000628645	17	41246616	17	43094599	628645	618686	rs1301795658	NC_000017.11:43094598:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	311	BRCA1
NM_007294.4(BRCA1):c.931C>T (p.Pro311Ser)	BRCA1	P311S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001766562	17	41246617	17	43094600	1766562	1825291	NA	NC_000017.11:43094599:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	311	BRCA1
NM_007294.4(BRCA1):c.929A>G (p.Gln310Arg)	BRCA1	Q310R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001345668	17	41246619	17	43094602	1345668	1452536	rs1597879098	NC_000017.11:43094601:T:C	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	310	BRCA1
NM_007294.4(BRCA1):c.929A>C (p.Gln310Pro)	BRCA1	Q310P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000655576	17	41246619	17	43094602	655576	646043	rs1597879098	NC_000017.11:43094601:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	310	BRCA1
NM_007294.4(BRCA1):c.926A>C (p.Lys309Thr)	BRCA1	K309T	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055756	17	41246622	17	43094605	55756	70423	rs80356877	NC_000017.11:43094604:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	309	BRCA1
NM_007294.4(BRCA1):c.925A>C (p.Lys309Gln)	BRCA1	K309Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003071943	17	41246623	17	43094606	3071943	3232120	NA	NC_000017.11:43094605:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	309	BRCA1
NM_007294.4(BRCA1):c.925A>G (p.Lys309Glu)	BRCA1	K309E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000252893	17	41246623	17	43094606	252893	247294	rs879255498	NC_000017.11:43094605:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	309	BRCA1
NM_007294.4(BRCA1):c.923G>A (p.Ser308Asn)	BRCA1	S308N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240832	17	41246625	17	43094608	240832	242803	rs561998108	NC_000017.11:43094607:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	308	BRCA1
NM_007294.4(BRCA1):c.923G>C (p.Ser308Thr)	BRCA1	S308T	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000182129	17	41246625	17	43094608	182129	180882	rs561998108	NC_000017.11:43094607:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	308	BRCA1
NM_007294.4(BRCA1):c.922A>G (p.Ser308Gly)	BRCA1	S308G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S	VCV000419382	17	41246626	17	43094609	419382	410020	rs55767801	NC_000017.11:43094608:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	308	BRCA1
NM_007294.4(BRCA1):c.919A>G (p.Lys307Glu)	BRCA1	K307E	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482907	17	41246629	17	43094612	482907	479483	rs1216516227	NC_000017.11:43094611:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	307	BRCA1
NM_007294.4(BRCA1):c.917A>G (p.Asn306Ser)	BRCA1	N306S	Hereditary breast ovarian cancer syndrome	VCV002866882	17	41246631	17	43094614	2866882	3030374	NA	NC_000017.11:43094613:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	306	BRCA1
NM_007294.4(BRCA1):c.916A>G (p.Asn306Asp)	BRCA1	N306D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002131600	17	41246632	17	43094615	2131600	2189588	NA	NC_000017.11:43094614:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	306	BRCA1
NM_007294.4(BRCA1):c.914G>T (p.Cys305Phe)	BRCA1	C305F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000823049	17	41246634	17	43094617	823049	813875	rs751124745	NC_000017.11:43094616:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	305	BRCA1
NM_007294.4(BRCA1):c.914G>A (p.Cys305Tyr)	BRCA1	C305Y	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000229918	17	41246634	17	43094617	229918	236153	rs751124745	NC_000017.11:43094616:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	305	BRCA1
NM_007294.4(BRCA1):c.913T>C (p.Cys305Arg)	BRCA1	C305R	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000928767	17	41246635	17	43094618	928767	917261	rs1597879229	NC_000017.11:43094617:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	305	BRCA1
NM_007294.4(BRCA1):c.910T>C (p.Phe304Leu)	BRCA1	F304L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629600	17	41246638	17	43094621	629600	618687	rs1567801570	NC_000017.11:43094620:A:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Dec 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	304	BRCA1
NM_007294.4(BRCA1):c.905C>A (p.Ala302Asp)	BRCA1	A302D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002134723	17	41246643	17	43094626	2134723	2192280	NA	NC_000017.11:43094625:G:T	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	BRCA1
NM_007294.4(BRCA1):c.905C>G (p.Ala302Gly)	BRCA1	A302G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001053745	17	41246643	17	43094626	1053745	1050318	rs1418676444	NC_000017.11:43094625:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	BRCA1
NM_007294.4(BRCA1):c.905C>T (p.Ala302Val)	BRCA1	A302V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001035776	17	41246643	17	43094626	1035776	1033328	rs1418676444	NC_000017.11:43094625:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	BRCA1
NM_007294.4(BRCA1):c.904G>A (p.Ala302Thr)	BRCA1	A302T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001405927	17	41246644	17	43094627	1405927	1493189	rs2154486087	NC_000017.11:43094626:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	BRCA1
NM_007294.4(BRCA1):c.903G>T (p.Lys301Asn)	BRCA1	K301N	Hereditary cancer-predisposing syndrome	VCV000822923	17	41246645	17	43094628	822923	813876	rs1038244014	NC_000017.11:43094627:C:A	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	301	BRCA1
NM_007294.4(BRCA1):c.902A>G (p.Lys301Arg)	BRCA1	K301R	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000240831	17	41246646	17	43094629	240831	242804	rs878854965	NC_000017.11:43094628:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	301	BRCA1
NM_007294.4(BRCA1):c.901A>G (p.Lys301Glu)	BRCA1	K301E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001394854	17	41246647	17	43094630	1394854	1415743	rs756859863	NC_000017.11:43094629:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	301	BRCA1
NM_007294.4(BRCA1):c.901A>C (p.Lys301Gln)	BRCA1	K301Q	Hereditary cancer-predisposing syndrome	VCV001049569	17	41246647	17	43094630	1049569	1038580	rs756859863	NC_000017.11:43094629:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	301	BRCA1
NM_007294.4(BRCA1):c.900A>C (p.Glu300Asp)	BRCA1	E300D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000055747	17	41246648	17	43094631	55747	70414	rs80356861	NC_000017.11:43094630:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	300	BRCA1
NM_007294.4(BRCA1):c.898G>A (p.Glu300Lys)	BRCA1	E300K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000462691	17	41246650	17	43094633	462691	468012	rs886040330	NC_000017.11:43094632:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	300	BRCA1
NM_007294.4(BRCA1):c.896T>C (p.Val299Ala)	BRCA1	V299A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000822857	17	41246652	17	43094635	822857	813877	rs1597879349	NC_000017.11:43094634:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	299	BRCA1
NM_007294.4(BRCA1):c.895G>A (p.Val299Ile)	BRCA1	V299I	Hereditary cancer-predisposing syndrome	VCV003261446	17	41246653	17	43094636	3261446	3424215	NA	NC_000017.11:43094635:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	299	BRCA1
NM_007294.4(BRCA1):c.895G>C (p.Val299Leu)	BRCA1	V299L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002006351	17	41246653	17	43094636	2006351	2069446	NA	NC_000017.11:43094635:C:G	single nucleotide variant	intron variant|missense variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	299	BRCA1
NM_007294.4(BRCA1):c.894T>G (p.Asn298Lys)	BRCA1	N298K	Hereditary cancer-predisposing syndrome	VCV002585848	17	41246654	17	43094637	2585848	2753408	NA	NC_000017.11:43094636:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	298	BRCA1
NM_007294.4(BRCA1):c.893A>G (p.Asn298Ser)	BRCA1	N298S	Hereditary breast ovarian cancer syndrome	VCV002880991	17	41246655	17	43094638	2880991	3042589	NA	NC_000017.11:43094637:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jan 7, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	298	BRCA1
NM_007294.4(BRCA1):c.891G>T (p.Met297Ile)	BRCA1	M297I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000812549	17	41246657	17	43094640	812549	800792	rs80357103	NC_000017.11:43094639:C:A	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	297	BRCA1
NM_007294.4(BRCA1):c.891G>A (p.Met297Ile)	BRCA1	M297I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055743	17	41246657	17	43094640	55743	70410	rs80357103	NC_000017.11:43094639:C:T	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	297	BRCA1
NM_007294.4(BRCA1):c.890T>A (p.Met297Lys)	BRCA1	M297K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055742	17	41246658	17	43094641	55742	70409	rs80356924	NC_000017.11:43094640:A:T	single nucleotide variant	intron variant|missense variant|initiator_codon_variant	Conflicting classifications of pathogenicity	Oct 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	297	BRCA1
NM_007294.4(BRCA1):c.889A>G (p.Met297Val)	BRCA1	M297V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000142628	17	41246659	17	43094642	142628	152342	rs80357196	NC_000017.11:43094641:T:C	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	297	BRCA1
NM_007294.4(BRCA1):c.889A>C (p.Met297Leu)	BRCA1	M297L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000055741	17	41246659	17	43094642	55741	70408	rs80357196	NC_000017.11:43094641:T:G	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	297	BRCA1
NM_007294.4(BRCA1):c.888A>C (p.Arg296Ser)	BRCA1	R296S	Hereditary cancer-predisposing syndrome	VCV001764975	17	41246660	17	43094643	1764975	1824469	NA	NC_000017.11:43094642:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	296	BRCA1
NM_007294.4(BRCA1):c.887G>C (p.Arg296Thr)	BRCA1	R296T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002017000	17	41246661	17	43094644	2017000	2068510	NA	NC_000017.11:43094643:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	296	BRCA1
NM_007294.4(BRCA1):c.886A>G (p.Arg296Gly)	BRCA1	R296G	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000431183	17	41246662	17	43094645	431183	424715	rs748675395	NC_000017.11:43094644:T:C	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	296	BRCA1
NM_007294.4(BRCA1):c.885C>G (p.Asp295Glu)	BRCA1	D295E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000845638	17	41246663	17	43094646	845638	845456	rs1060504557	NC_000017.11:43094645:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	295	BRCA1
NM_007294.4(BRCA1):c.884A>G (p.Asp295Gly)	BRCA1	D295G	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000233188	17	41246664	17	43094647	233188	236154	rs772684048	NC_000017.11:43094646:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	295	BRCA1
NM_007294.4(BRCA1):c.883G>T (p.Asp295Tyr)	BRCA1	D295Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001058491	17	41246665	17	43094648	1058491	1050319	rs2154487384	NC_000017.11:43094647:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	295	BRCA1
NM_007294.4(BRCA1):c.881A>G (p.Lys294Arg)	BRCA1	K294R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531293	17	41246667	17	43094650	531293	531327	rs1555592934	NC_000017.11:43094649:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	294	BRCA1
NM_007294.4(BRCA1):c.880A>G (p.Lys294Glu)	BRCA1	K294E	Hereditary cancer-predisposing syndrome	VCV000629376	17	41246668	17	43094651	629376	618688	rs1567801705	NC_000017.11:43094650:T:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	294	BRCA1
NM_007294.4(BRCA1):c.878C>G (p.Thr293Ser)	BRCA1	T293S	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000570469	17	41246670	17	43094653	570469	571209	rs747172803	NC_000017.11:43094652:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	293	BRCA1
NM_007294.4(BRCA1):c.878C>T (p.Thr293Ile)	BRCA1	T293I	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491193	17	41246670	17	43094653	491193	484952	rs747172803	NC_000017.11:43094652:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Apr 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	293	BRCA1
NM_007294.4(BRCA1):c.877A>C (p.Thr293Pro)	BRCA1	T293P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489738	17	41246671	17	43094654	489738	482984	rs1555592945	NC_000017.11:43094653:T:G	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	293	BRCA1
NM_007294.4(BRCA1):c.874C>A (p.Leu292Ile)	BRCA1	L292I	Hereditary cancer-predisposing syndrome	VCV003261457	17	41246674	17	43094657	3261457	3424226	NA	NC_000017.11:43094656:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	292	BRCA1
NM_007294.4(BRCA1):c.871T>A (p.Leu291Ile)	BRCA1	L291I	Hereditary cancer-predisposing syndrome	VCV003226179	17	41246677	17	43094660	3226179	3387242	NA	NC_000017.11:43094659:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	291	BRCA1
NM_007294.4(BRCA1):c.871T>G (p.Leu291Val)	BRCA1	L291V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001764447	17	41246677	17	43094660	1764447	1817574	NA	NC_000017.11:43094659:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Oct 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	291	BRCA1
NM_007294.4(BRCA1):c.869T>C (p.Leu290Ser)	BRCA1	L290S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000572126	17	41246679	17	43094662	572126	574490	rs730881468	NC_000017.11:43094661:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	290	BRCA1
NM_007294.4(BRCA1):c.866G>C (p.Ser289Thr)	BRCA1	S289T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000849528	17	41246682	17	43094665	849528	845457	rs776999497	NC_000017.11:43094664:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	289	BRCA1
NM_007294.4(BRCA1):c.866G>A (p.Ser289Asn)	BRCA1	S289N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441442	17	41246682	17	43094665	441442	435167	rs776999497	NC_000017.11:43094664:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	289	BRCA1
NM_007294.4(BRCA1):c.863G>A (p.Ser288Asn)	BRCA1	S288N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002118389	17	41246685	17	43094668	2118389	2176171	NA	NC_000017.11:43094667:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	288	BRCA1
NM_007294.4(BRCA1):c.862A>G (p.Ser288Gly)	BRCA1	S288G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803419	17	41246686	17	43094669	803419	791773	rs1597879544	NC_000017.11:43094668:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	288	BRCA1
NM_007294.4(BRCA1):c.861C>A (p.Asn287Lys)	BRCA1	N287K	Hereditary cancer-predisposing syndrome	VCV001764054	17	41246687	17	43094670	1764054	1820917	NA	NC_000017.11:43094669:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	287	BRCA1
NM_007294.4(BRCA1):c.861C>G (p.Asn287Lys)	BRCA1	N287K	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000420773	17	41246687	17	43094670	420773	410022	rs1064794692	NC_000017.11:43094669:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	287	BRCA1
NM_007294.4(BRCA1):c.859A>G (p.Asn287Asp)	BRCA1	N287D	Hereditary cancer-predisposing syndrome|not provided	VCV001330028	17	41246689	17	43094672	1330028	1320711	rs2154488853	NC_000017.11:43094671:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	287	BRCA1
NM_007294.4(BRCA1):c.855T>A (p.His285Gln)	BRCA1	H285Q	Hereditary breast ovarian cancer syndrome	VCV002799318	17	41246693	17	43094676	2799318	2959142	NA	NC_000017.11:43094675:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	285	BRCA1
NM_007294.4(BRCA1):c.854A>G (p.His285Arg)	BRCA1	H285R	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV001479741	17	41246694	17	43094677	1479741	1439464	rs2154489161	NC_000017.11:43094676:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	285	BRCA1
NM_007294.4(BRCA1):c.854A>C (p.His285Pro)	BRCA1	H285P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001055953	17	41246694	17	43094677	1055953	1050320	rs2154489161	NC_000017.11:43094676:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	285	BRCA1
NM_007294.4(BRCA1):c.852G>T (p.Gln284His)	BRCA1	Q284H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069237	17	41246696	17	43094679	3069237	3229864	NA	NC_000017.11:43094678:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	284	BRCA1
NM_007294.4(BRCA1):c.852G>C (p.Gln284His)	BRCA1	Q284H	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000822538	17	41246696	17	43094679	822538	813878	rs1597879571	NC_000017.11:43094678:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	284	BRCA1
NM_007294.4(BRCA1):c.851A>G (p.Gln284Arg)	BRCA1	Q284R	Hereditary cancer-predisposing syndrome|not provided|not specified|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome	VCV000055739	17	41246697	17	43094680	55739	70406	rs80357039	NC_000017.11:43094679:T:C	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	284	BRCA1
NM_007294.4(BRCA1):c.848T>C (p.Leu283Ser)	BRCA1	L283S	Hereditary cancer-predisposing syndrome	VCV001332672	17	41246700	17	43094683	1332672	1323390	rs273902792	NC_000017.11:43094682:A:G	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	283	BRCA1
NM_007294.4(BRCA1):c.845C>T (p.Ser282Leu)	BRCA1	S282L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000186539	17	41246703	17	43094686	186539	185091	rs786203027	NC_000017.11:43094685:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	282	BRCA1
NM_007294.4(BRCA1):c.844T>C (p.Ser282Pro)	BRCA1	S282P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000964205	17	41246704	17	43094687	964205	949960	rs2054037292	NC_000017.11:43094686:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	282	BRCA1
NM_007294.4(BRCA1):c.842G>A (p.Ser281Asn)	BRCA1	S281N	Hereditary cancer-predisposing syndrome	VCV001763350	17	41246706	17	43094689	1763350	1824074	NA	NC_000017.11:43094688:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	281	BRCA1
NM_007294.4(BRCA1):c.842G>C (p.Ser281Thr)	BRCA1	S281T	Hereditary cancer-predisposing syndrome	VCV000822416	17	41246706	17	43094689	822416	813879	rs1567801816	NC_000017.11:43094688:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	281	BRCA1
NM_007294.4(BRCA1):c.841A>T (p.Ser281Cys)	BRCA1	S281C	Hereditary cancer-predisposing syndrome|not provided	VCV002450671	17	41246707	17	43094690	2450671	2423157	NA	NC_000017.11:43094689:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	281	BRCA1
NM_007294.4(BRCA1):c.841A>G (p.Ser281Gly)	BRCA1	S281G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482900	17	41246707	17	43094690	482900	478845	rs1300771163	NC_000017.11:43094689:T:C	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	281	BRCA1
NM_007294.4(BRCA1):c.839C>A (p.Ala280Asp)	BRCA1	A280D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000842866	17	41246709	17	43094692	842866	845458	rs80357199	NC_000017.11:43094691:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Aug 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	280	BRCA1
NM_007294.4(BRCA1):c.839C>G (p.Ala280Gly)	BRCA1	A280G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055731	17	41246709	17	43094692	55731	70398	rs80357199	NC_000017.11:43094691:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	280	BRCA1
NM_007294.4(BRCA1):c.836A>T (p.His279Leu)	BRCA1	H279L	Hereditary cancer-predisposing syndrome	VCV000479199	17	41246712	17	43094695	479199	478782	rs80357482	NC_000017.11:43094694:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	279	BRCA1
NM_007294.4(BRCA1):c.836A>G (p.His279Arg)	BRCA1	H279R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055730	17	41246712	17	43094695	55730	70397	rs80357482	NC_000017.11:43094694:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	May 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	279	BRCA1
NM_007294.4(BRCA1):c.835C>T (p.His279Tyr)	BRCA1	H279Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000659023	17	41246713	17	43094696	659023	646044	rs1380919500	NC_000017.11:43094695:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	279	BRCA1
NM_007294.4(BRCA1):c.833C>T (p.Thr278Ile)	BRCA1	T278I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001442869	17	41246715	17	43094698	1442869	1371756	rs2154490731	NC_000017.11:43094697:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	278	BRCA1
NM_007294.4(BRCA1):c.829A>C (p.Asn277His)	BRCA1	N277H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001021564	17	41246719	17	43094702	1021564	1012786	rs2054040121	NC_000017.11:43094701:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Apr 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	277	BRCA1
NM_007294.4(BRCA1):c.829A>G (p.Asn277Asp)	BRCA1	N277D	not specified|Hereditary cancer-predisposing syndrome	VCV000926725	17	41246719	17	43094702	926725	913969	rs2054040121	NC_000017.11:43094701:T:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	277	BRCA1
NM_007294.4(BRCA1):c.827C>T (p.Thr276Ile)	BRCA1	T276I	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	VCV001709638	17	41246721	17	43094704	1709638	1707992	NA	NC_000017.11:43094703:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	276	BRCA1
NM_007294.4(BRCA1):c.827C>A (p.Thr276Lys)	BRCA1	T276K	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000252891	17	41246721	17	43094704	252891	247292	rs80357436	NC_000017.11:43094703:G:T	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	276	BRCA1
NM_007294.4(BRCA1):c.827C>G (p.Thr276Arg)	BRCA1	T276R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037706	17	41246721	17	43094704	37706	46262	rs80357436	NC_000017.11:43094703:G:C	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	276	BRCA1
NM_007294.4(BRCA1):c.824G>A (p.Gly275Asp)	BRCA1	G275D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055726	17	41246724	17	43094707	55726	70393	rs397509327	NC_000017.11:43094706:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	275	BRCA1
NM_007294.4(BRCA1):c.823G>A (p.Gly275Ser)	BRCA1	G275S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055725	17	41246725	17	43094708	55725	70392	rs8176153	NC_000017.11:43094707:C:T	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	275	BRCA1
NM_007294.4(BRCA1):c.821G>A (p.Cys274Tyr)	BRCA1	C274Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000664275	17	41246727	17	43094710	664275	646045	rs1597879808	NC_000017.11:43094709:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	274	BRCA1
NM_007294.4(BRCA1):c.820T>C (p.Cys274Arg)	BRCA1	C274R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000841619	17	41246728	17	43094711	841619	845459	rs755285181	NC_000017.11:43094710:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	274	BRCA1
NM_007294.4(BRCA1):c.817C>T (p.Pro273Ser)	BRCA1	P273S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000801088	17	41246731	17	43094714	801088	789631	rs1597879824	NC_000017.11:43094713:G:A	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	273	BRCA1
NM_007294.4(BRCA1):c.814G>A (p.Glu272Lys)	BRCA1	E272K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002128795	17	41246734	17	43094717	2128795	2178818	NA	NC_000017.11:43094716:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	272	BRCA1
NM_007294.4(BRCA1):c.812T>C (p.Val271Ala)	BRCA1	V271A	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000409371	17	41246736	17	43094719	409371	402120	rs753099787	NC_000017.11:43094718:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jun 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	271	BRCA1
NM_007294.4(BRCA1):c.812T>G (p.Val271Gly)	BRCA1	V271G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252383	17	41246736	17	43094719	252383	246824	rs753099787	NC_000017.11:43094718:A:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	271	BRCA1
NM_007294.4(BRCA1):c.811G>T (p.Val271Leu)	BRCA1	V271L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187421	17	41246737	17	43094720	187421	185094	rs80357244	NC_000017.11:43094719:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	271	BRCA1
NM_007294.4(BRCA1):c.811G>C (p.Val271Leu)	BRCA1	V271L	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|not provided	VCV000055721	17	41246737	17	43094720	55721	70388	rs80357244	NC_000017.11:43094719:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	271	BRCA1
NM_007294.4(BRCA1):c.811G>A (p.Val271Met)	BRCA1	V271M	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055720	17	41246737	17	43094720	55720	70387	rs80357244	NC_000017.11:43094719:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign/Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	271	BRCA1
NM_007294.4(BRCA1):c.809A>T (p.His270Leu)	BRCA1	H270L	not provided|Hereditary cancer-predisposing syndrome	VCV001319800	17	41246739	17	43094722	1319800	1310049	rs1597879864	NC_000017.11:43094721:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	BRCA1
NM_007294.4(BRCA1):c.809A>G (p.His270Arg)	BRCA1	H270R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000655017	17	41246739	17	43094722	655017	646046	rs1597879864	NC_000017.11:43094721:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Oct 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	BRCA1
NM_007294.4(BRCA1):c.808C>G (p.His270Asp)	BRCA1	H270D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001497072	17	41246740	17	43094723	1497072	1382474	rs2054044790	NC_000017.11:43094722:G:C	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	BRCA1
NM_007294.4(BRCA1):c.808C>T (p.His270Tyr)	BRCA1	H270Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000843295	17	41246740	17	43094723	843295	845460	rs2054044790	NC_000017.11:43094722:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	BRCA1
NM_007294.4(BRCA1):c.807G>C (p.Leu269Phe)	BRCA1	L269F	Hereditary breast ovarian cancer syndrome	VCV002764869	17	41246741	17	43094724	2764869	2928635	NA	NC_000017.11:43094723:C:G	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	269	BRCA1
NM_007294.4(BRCA1):c.804C>G (p.Asn268Lys)	BRCA1	N268K	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441285	17	41246744	17	43094727	441285	435169	rs771076131	NC_000017.11:43094726:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	268	BRCA1
NM_007294.4(BRCA1):c.803A>G (p.Asn268Ser)	BRCA1	N268S	Hereditary cancer-predisposing syndrome	VCV000827411	17	41246745	17	43094728	827411	813881	rs1597879900	NC_000017.11:43094727:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	268	BRCA1
NM_007294.4(BRCA1):c.802A>C (p.Asn268His)	BRCA1	N268H	Hereditary cancer-predisposing syndrome	VCV002774865	17	41246746	17	43094729	2774865	2935591	NA	NC_000017.11:43094728:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	268	BRCA1
NM_007294.4(BRCA1):c.802A>G (p.Asn268Asp)	BRCA1	N268D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482933	17	41246746	17	43094729	482933	478710	rs1555593066	NC_000017.11:43094728:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	268	BRCA1
NM_007294.4(BRCA1):c.799T>C (p.Ser267Pro)	BRCA1	S267P	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000141103	17	41246749	17	43094732	141103	150817	rs587781496	NC_000017.11:43094731:A:G	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	267	BRCA1
NM_007294.4(BRCA1):c.796G>T (p.Val266Phe)	BRCA1	V266F	not provided	VCV002647811	17	41246752	17	43094735	2647811	2811388	NA	NC_000017.11:43094734:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	266	BRCA1
NM_007294.4(BRCA1):c.796G>A (p.Val266Ile)	BRCA1	V266I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001473025	17	41246752	17	43094735	1473025	1501270	rs2154492345	NC_000017.11:43094734:C:T	single nucleotide variant	intron variant|missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	266	BRCA1
NM_007294.4(BRCA1):c.792T>G (p.Ser264Arg)	BRCA1	S264R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055706	17	41246756	17	43094739	55706	70373	rs80357214	NC_000017.11:43094738:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant|splice donor variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	264	BRCA1
NM_007294.4(BRCA1):c.791G>A (p.Ser264Asn)	BRCA1	S264N	not provided|Hereditary cancer-predisposing syndrome	VCV000055704	17	41246757	17	43094740	55704	70371	rs397509322	NC_000017.11:43094739:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant|splice donor variant	Conflicting classifications of pathogenicity	Oct 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	264	BRCA1
NM_007294.4(BRCA1):c.790A>G (p.Ser264Gly)	BRCA1	S264G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001359110	17	41246758	17	43094741	1359110	1357387	rs397509321	NC_000017.11:43094740:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Dec 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	264	BRCA1
NM_007294.4(BRCA1):c.790A>T (p.Ser264Cys)	BRCA1	S264C	Hereditary cancer-predisposing syndrome	VCV000055703	17	41246758	17	43094741	55703	70370	rs397509321	NC_000017.11:43094740:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	264	BRCA1
NM_007294.4(BRCA1):c.788G>A (p.Gly263Asp)	BRCA1	G263D	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000182127	17	41246760	17	43094743	182127	180884	rs397509319	NC_000017.11:43094742:C:T	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant|intron variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	263	BRCA1
NM_007294.4(BRCA1):c.788G>T (p.Gly263Val)	BRCA1	G263V	Hereditary cancer-predisposing syndrome	VCV000055701	17	41246760	17	43094743	55701	70368	rs397509319	NC_000017.11:43094742:C:A	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	263	BRCA1
NM_007294.4(BRCA1):c.788G>C (p.Gly263Ala)	BRCA1	G263A	Hereditary cancer-predisposing syndrome	VCV000055700	17	41246760	17	43094743	55700	70367	rs397509319	NC_000017.11:43094742:C:G	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	263	BRCA1
NM_007294.4(BRCA1):c.787G>A (p.Gly263Ser)	BRCA1	G263S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000133725	17	41246761	17	43094744	133725	137464	rs397509318	NC_000017.11:43094743:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	263	BRCA1
NM_007294.4(BRCA1):c.787G>T (p.Gly263Cys)	BRCA1	G263C	Hereditary cancer-predisposing syndrome	VCV000055699	17	41246761	17	43094744	55699	70366	rs397509318	NC_000017.11:43094743:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	263	BRCA1
NM_007294.4(BRCA1):c.785A>G (p.Gln262Arg)	BRCA1	Q262R	not provided|Hereditary cancer-predisposing syndrome	VCV000479195	17	41246763	17	43094746	479195	478847	rs1555593115	NC_000017.11:43094745:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	262	BRCA1
NM_007294.4(BRCA1):c.781T>A (p.Tyr261Asn)	BRCA1	Y261N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001511200	17	41246767	17	43094750	1511200	1378015	rs2054049254	NC_000017.11:43094749:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	261	BRCA1
NM_007294.4(BRCA1):c.779A>G (p.Lys260Arg)	BRCA1	K260R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000848860	17	41246769	17	43094752	848860	845461	rs2054049431	NC_000017.11:43094751:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	260	BRCA1
NM_007294.4(BRCA1):c.778A>G (p.Lys260Glu)	BRCA1	K260E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001009121	17	41246770	17	43094753	1009121	997589	rs786202263	NC_000017.11:43094752:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	260	BRCA1
NM_007294.4(BRCA1):c.778A>C (p.Lys260Gln)	BRCA1	K260Q	Hereditary cancer-predisposing syndrome	VCV000185545	17	41246770	17	43094753	185545	185095	rs786202263	NC_000017.11:43094752:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	260	BRCA1
NM_007294.4(BRCA1):c.777A>T (p.Glu259Asp)	BRCA1	E259D	Hereditary cancer-predisposing syndrome	VCV001760581	17	41246771	17	43094754	1760581	1820009	NA	NC_000017.11:43094753:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	259	BRCA1
NM_007294.4(BRCA1):c.776A>C (p.Glu259Ala)	BRCA1	E259A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000998562	17	41246772	17	43094755	998562	997590	rs2054050036	NC_000017.11:43094754:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	259	BRCA1
NM_007294.4(BRCA1):c.773C>G (p.Pro258Arg)	BRCA1	P258R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000055696	17	41246775	17	43094758	55696	70363	rs80357225	NC_000017.11:43094757:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	258	BRCA1
NM_007294.4(BRCA1):c.772C>T (p.Pro258Ser)	BRCA1	P258S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002110682	17	41246776	17	43094759	2110682	2171146	NA	NC_000017.11:43094758:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	258	BRCA1
NM_007294.4(BRCA1):c.770A>G (p.His257Arg)	BRCA1	H257R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001351073	17	41246778	17	43094761	1351073	1407423	rs2154493359	NC_000017.11:43094760:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	257	BRCA1
NM_007294.4(BRCA1):c.769C>T (p.His257Tyr)	BRCA1	H257Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000827202	17	41246779	17	43094762	827202	813882	rs1597880077	NC_000017.11:43094761:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	257	BRCA1
NM_007294.4(BRCA1):c.768G>T (p.Arg256Ser)	BRCA1	R256S	Hereditary cancer-predisposing syndrome	VCV001760148	17	41246780	17	43094763	1760148	1823384	NA	NC_000017.11:43094762:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	256	BRCA1
NM_007294.4(BRCA1):c.768G>C (p.Arg256Ser)	BRCA1	R256S	Hereditary cancer-predisposing syndrome	VCV000827196	17	41246780	17	43094763	827196	813883	rs746067447	NC_000017.11:43094762:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	256	BRCA1
NM_007294.4(BRCA1):c.767G>A (p.Arg256Lys)	BRCA1	R256K	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462688	17	41246781	17	43094764	462688	468019	rs11658785	NC_000017.11:43094763:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	256	BRCA1
NM_007294.4(BRCA1):c.766A>T (p.Arg256Trp)	BRCA1	R256W	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141549	17	41246782	17	43094765	141549	151263	rs587781833	NC_000017.11:43094764:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	256	BRCA1
NM_007294.4(BRCA1):c.765G>C (p.Glu255Asp)	BRCA1	E255D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000662612	17	41246783	17	43094766	662612	646047	rs62625299	NC_000017.11:43094765:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	255	BRCA1
NM_007294.4(BRCA1):c.764A>G (p.Glu255Gly)	BRCA1	E255G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069238	17	41246784	17	43094767	3069238	3229865	NA	NC_000017.11:43094766:T:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	May 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	255	BRCA1
NM_007294.4(BRCA1):c.760G>A (p.Ala254Thr)	BRCA1	A254T	Hereditary breast ovarian cancer syndrome	VCV002756473	17	41246788	17	43094771	2756473	2909874	NA	NC_000017.11:43094770:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	254	BRCA1
NM_007294.4(BRCA1):c.758C>A (p.Ala253Glu)	BRCA1	A253E	Hereditary cancer-predisposing syndrome	VCV001759651	17	41246790	17	43094773	1759651	1813252	NA	NC_000017.11:43094772:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	253	BRCA1
NM_007294.4(BRCA1):c.758C>T (p.Ala253Val)	BRCA1	A253V	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000489737	17	41246790	17	43094773	489737	483000	rs1555593177	NC_000017.11:43094772:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	253	BRCA1
NM_007294.4(BRCA1):c.757G>A (p.Ala253Thr)	BRCA1	A253T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000055690	17	41246791	17	43094774	55690	70357	rs80357293	NC_000017.11:43094773:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	253	BRCA1
NM_007294.4(BRCA1):c.755G>T (p.Arg252Leu)	BRCA1	R252L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003070606	17	41246793	17	43094776	3070606	3230363	NA	NC_000017.11:43094775:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	252	BRCA1
NM_007294.4(BRCA1):c.755G>A (p.Arg252His)	BRCA1	R252H	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055689	17	41246793	17	43094776	55689	70356	rs80357138	NC_000017.11:43094775:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	252	BRCA1
NM_007294.4(BRCA1):c.754C>A (p.Arg252Ser)	BRCA1	R252S	Hereditary breast ovarian cancer syndrome	VCV002858139	17	41246794	17	43094777	2858139	3018185	NA	NC_000017.11:43094776:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	252	BRCA1
NM_007294.4(BRCA1):c.754C>T (p.Arg252Cys)	BRCA1	R252C	not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055688	17	41246794	17	43094777	55688	70355	rs273902786	NC_000017.11:43094776:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	252	BRCA1
NM_007294.4(BRCA1):c.750G>C (p.Glu250Asp)	BRCA1	E250D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001345271	17	41246798	17	43094781	1345271	1443237	rs762867923	NC_000017.11:43094780:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	250	BRCA1
NM_007294.4(BRCA1):c.749A>G (p.Glu250Gly)	BRCA1	E250G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003070942	17	41246799	17	43094782	3070942	3230698	NA	NC_000017.11:43094781:T:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	May 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	250	BRCA1
NM_007294.4(BRCA1):c.748G>A (p.Glu250Lys)	BRCA1	E250K	Hereditary cancer-predisposing syndrome	VCV000630445	17	41246800	17	43094783	630445	618689	rs1567802220	NC_000017.11:43094782:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	250	BRCA1
NM_007294.4(BRCA1):c.746C>T (p.Thr249Ile)	BRCA1	T249I	Hereditary breast ovarian cancer syndrome	VCV002751325	17	41246802	17	43094785	2751325	2908621	NA	NC_000017.11:43094784:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	249	BRCA1
NM_007294.4(BRCA1):c.746C>A (p.Thr249Asn)	BRCA1	T249N	Hereditary cancer-predisposing syndrome	VCV000920439	17	41246802	17	43094785	920439	913970	rs2054054165	NC_000017.11:43094784:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	BRCA1
NM_007294.4(BRCA1):c.745A>G (p.Thr249Ala)	BRCA1	T249A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002130960	17	41246803	17	43094786	2130960	2186255	NA	NC_000017.11:43094785:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	BRCA1
NM_007294.4(BRCA1):c.745A>T (p.Thr249Ser)	BRCA1	T249S	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000037696	17	41246803	17	43094786	37696	46252	rs397507256	NC_000017.11:43094785:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	BRCA1
NM_007294.4(BRCA1):c.743C>T (p.Thr248Ile)	BRCA1	T248I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002585354	17	41246805	17	43094788	2585354	2752916	NA	NC_000017.11:43094787:G:A	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	NA	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	248	BRCA1
NM_007294.4(BRCA1):c.743C>A (p.Thr248Asn)	BRCA1	T248N	Hereditary cancer-predisposing syndrome	VCV000055687	17	41246805	17	43094788	55687	70354	rs80357062	NC_000017.11:43094787:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	248	BRCA1
NM_007294.4(BRCA1):c.742A>G (p.Thr248Ala)	BRCA1	T248A	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000531383	17	41246806	17	43094789	531383	531614	rs879255288	NC_000017.11:43094788:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	248	BRCA1
NM_007294.4(BRCA1):c.742A>C (p.Thr248Pro)	BRCA1	T248P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252390	17	41246806	17	43094789	252390	246825	rs879255288	NC_000017.11:43094788:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	248	BRCA1
NM_007294.4(BRCA1):c.741C>A (p.Asn247Lys)	BRCA1	N247K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001721749	17	41246807	17	43094790	1721749	1779467	NA	NC_000017.11:43094789:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	247	BRCA1
NM_007294.4(BRCA1):c.739A>G (p.Asn247Asp)	BRCA1	N247D	not provided|Hereditary cancer-predisposing syndrome	VCV000232600	17	41246809	17	43094792	232600	236155	rs767720128	NC_000017.11:43094791:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	247	BRCA1
NM_007294.4(BRCA1):c.738G>C (p.Leu246Phe)	BRCA1	L246F	Hereditary cancer-predisposing syndrome	VCV001758654	17	41246810	17	43094793	1758654	1819365	NA	NC_000017.11:43094792:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	246	BRCA1
NM_007294.4(BRCA1):c.736T>A (p.Leu246Met)	BRCA1	L246M	Hereditary breast ovarian cancer syndrome	VCV002823695	17	41246812	17	43094795	2823695	2982209	NA	NC_000017.11:43094794:A:T	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	Dec 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	246	BRCA1
NM_007294.4(BRCA1):c.736T>G (p.Leu246Val)	BRCA1	L246V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041835	17	41246812	17	43094795	41835	50274	rs28897675	NC_000017.11:43094794:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	246	BRCA1
NM_007294.4(BRCA1):c.735T>A (p.Asp245Glu)	BRCA1	D245E	Hereditary cancer-predisposing syndrome	VCV000631240	17	41246813	17	43094796	631240	618690	rs1567802284	NC_000017.11:43094795:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	245	BRCA1
NM_007294.4(BRCA1):c.734A>T (p.Asp245Val)	BRCA1	D245V	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000055682	17	41246814	17	43094797	55682	70349	rs80356865	NC_000017.11:43094796:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	245	BRCA1
NM_007294.4(BRCA1):c.733G>C (p.Asp245His)	BRCA1	D245H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000656411	17	41246815	17	43094798	656411	646048	rs147519994	NC_000017.11:43094797:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	245	BRCA1
NM_007294.4(BRCA1):c.733G>T (p.Asp245Tyr)	BRCA1	D245Y	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000142867	17	41246815	17	43094798	142867	152581	rs147519994	NC_000017.11:43094797:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	245	BRCA1
NM_007294.4(BRCA1):c.731_732delinsCA (p.Asn244Thr)	BRCA1	N244T	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000420254	17	41246816 - 41246817	17	43094799 - 43094800	420254	410023	rs1064794375	NC_000017.11:43094798:AT:TG	Indel	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	244	BRCA1
NM_007294.4(BRCA1):c.729T>G (p.Asn243Lys)	BRCA1	N243K	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000182126	17	41246819	17	43094802	182126	180885	rs730881467	NC_000017.11:43094801:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	243	BRCA1
NM_007294.4(BRCA1):c.727A>T (p.Asn243Tyr)	BRCA1	N243Y	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000890442	17	41246821	17	43094804	890442	877643	rs587782123	NC_000017.11:43094803:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	243	BRCA1
NM_007294.4(BRCA1):c.727A>G (p.Asn243Asp)	BRCA1	N243D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141938	17	41246821	17	43094804	141938	151652	rs587782123	NC_000017.11:43094803:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	243	BRCA1
NM_007294.4(BRCA1):c.725G>C (p.Ser242Thr)	BRCA1	S242T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001381948	17	41246823	17	43094806	1381948	1341907	rs2054059120	NC_000017.11:43094805:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	242	BRCA1
NM_007294.4(BRCA1):c.725G>A (p.Ser242Asn)	BRCA1	S242N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000848165	17	41246823	17	43094806	848165	845463	rs2054059120	NC_000017.11:43094805:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	242	BRCA1
NM_007294.4(BRCA1):c.724A>G (p.Ser242Gly)	BRCA1	S242G	Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000479205	17	41246824	17	43094807	479205	479484	rs1555593258	NC_000017.11:43094806:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	242	BRCA1
NM_007294.4(BRCA1):c.722C>T (p.Pro241Leu)	BRCA1	P241L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000055679	17	41246826	17	43094809	55679	70346	rs80357351	NC_000017.11:43094808:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	241	BRCA1
NM_007294.4(BRCA1):c.721C>A (p.Pro241Thr)	BRCA1	P241T	not specified|Hereditary cancer-predisposing syndrome	VCV000438945	17	41246827	17	43094810	438945	432921	rs1555593260	NC_000017.11:43094809:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	241	BRCA1
NM_007294.4(BRCA1):c.720A>T (p.Gln240His)	BRCA1	Q240H	Hereditary breast ovarian cancer syndrome	VCV002745946	17	41246828	17	43094811	2745946	2904139	NA	NC_000017.11:43094810:T:A	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	240	BRCA1
NM_007294.4(BRCA1):c.719A>C (p.Gln240Pro)	BRCA1	Q240P	Hereditary cancer-predisposing syndrome	VCV001757611	17	41246829	17	43094812	1757611	1815809	NA	NC_000017.11:43094811:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	240	BRCA1
NM_007294.4(BRCA1):c.718C>G (p.Gln240Glu)	BRCA1	Q240E	Hereditary breast ovarian cancer syndrome	VCV002767859	17	41246830	17	43094813	2767859	2932471	NA	NC_000017.11:43094812:G:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	240	BRCA1
NM_007294.4(BRCA1):c.717T>G (p.His239Gln)	BRCA1	H239Q	Hereditary cancer-predisposing syndrome	VCV003261466	17	41246831	17	43094814	3261466	3424235	NA	NC_000017.11:43094813:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	239	BRCA1
NM_007294.4(BRCA1):c.716A>T (p.His239Leu)	BRCA1	H239L	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231422	17	41246832	17	43094815	231422	236156	rs80357396	NC_000017.11:43094814:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	239	BRCA1
NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	BRCA1	H239R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055677	17	41246832	17	43094815	55677	70344	rs80357396	NC_000017.11:43094814:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	239	BRCA1
NM_007294.4(BRCA1):c.715C>T (p.His239Tyr)	BRCA1	H239Y	Hereditary cancer-predisposing syndrome	VCV000826868	17	41246833	17	43094816	826868	813886	rs1270749718	NC_000017.11:43094815:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	239	BRCA1
NM_007294.4(BRCA1):c.713A>G (p.His238Arg)	BRCA1	H238R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141900	17	41246835	17	43094818	141900	151614	rs587782094	NC_000017.11:43094817:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	238	BRCA1
NM_007294.4(BRCA1):c.710A>C (p.Glu237Ala)	BRCA1	E237A	Hereditary cancer-predisposing syndrome	VCV000826844	17	41246838	17	43094821	826844	813887	rs1597880432	NC_000017.11:43094820:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	237	BRCA1
NM_007294.4(BRCA1):c.707C>T (p.Thr236Ile)	BRCA1	T236I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000665165	17	41246841	17	43094824	665165	646049	rs80356990	NC_000017.11:43094823:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	236	BRCA1
NM_007294.4(BRCA1):c.707C>G (p.Thr236Ser)	BRCA1	T236S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055673	17	41246841	17	43094824	55673	70340	rs80356990	NC_000017.11:43094823:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	236	BRCA1
NM_007294.4(BRCA1):c.706A>G (p.Thr236Ala)	BRCA1	T236A	Hereditary cancer-predisposing syndrome	VCV003261494	17	41246842	17	43094825	3261494	3424262	NA	NC_000017.11:43094824:T:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	236	BRCA1
NM_007294.4(BRCA1):c.704A>G (p.Asn235Ser)	BRCA1	N235S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531207	17	41246844	17	43094827	531207	531119	rs1555593283	NC_000017.11:43094826:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	235	BRCA1
NM_007294.4(BRCA1):c.703A>C (p.Asn235His)	BRCA1	N235H	Hereditary cancer-predisposing syndrome	VCV003261465	17	41246845	17	43094828	3261465	3424234	NA	NC_000017.11:43094827:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	235	BRCA1
NM_007294.4(BRCA1):c.701C>A (p.Thr234Lys)	BRCA1	T234K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000628440	17	41246847	17	43094830	628440	618691	rs1555593290	NC_000017.11:43094829:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	234	BRCA1
NM_007294.4(BRCA1):c.701C>T (p.Thr234Ile)	BRCA1	T234I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489736	17	41246847	17	43094830	489736	482993	rs1555593290	NC_000017.11:43094829:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	234	BRCA1
NM_007294.4(BRCA1):c.700A>G (p.Thr234Ala)	BRCA1	T234A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000846722	17	41246848	17	43094831	846722	845464	rs2054062966	NC_000017.11:43094830:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	234	BRCA1
NM_007294.4(BRCA1):c.697G>A (p.Val233Ile)	BRCA1	V233I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000630093	17	41246851	17	43094834	630093	618692	rs959797914	NC_000017.11:43094833:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	233	BRCA1
NM_007294.4(BRCA1):c.695A>G (p.Asp232Gly)	BRCA1	D232G	Hereditary cancer-predisposing syndrome	VCV001756309	17	41246853	17	43094836	1756309	1812487	NA	NC_000017.11:43094835:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	232	BRCA1
NM_007294.4(BRCA1):c.695A>T (p.Asp232Val)	BRCA1	D232V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000091664	17	41246853	17	43094836	91664	97141	rs398122708	NC_000017.11:43094835:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	232	BRCA1
NM_007294.4(BRCA1):c.694G>T (p.Asp232Tyr)	BRCA1	D232Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489735	17	41246854	17	43094837	489735	482995	rs55975699	NC_000017.11:43094836:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	232	BRCA1
NM_007294.4(BRCA1):c.694G>A (p.Asp232Asn)	BRCA1	D232N	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|not specified	VCV000055672	17	41246854	17	43094837	55672	70339	rs55975699	NC_000017.11:43094836:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	232	BRCA1
NM_007294.4(BRCA1):c.692C>G (p.Thr231Arg)	BRCA1	T231R	Hereditary cancer-predisposing syndrome	VCV002450685	17	41246856	17	43094839	2450685	2423171	NA	NC_000017.11:43094838:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	231	BRCA1
NM_007294.4(BRCA1):c.692C>T (p.Thr231Met)	BRCA1	T231M	not specified|Hereditary cancer-predisposing syndrome|Hereditary cancer|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055669	17	41246856	17	43094839	55669	70336	rs80357001	NC_000017.11:43094838:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	231	BRCA1
NM_007294.4(BRCA1):c.686C>G (p.Ser229Cys)	BRCA1	S229C	Hereditary breast ovarian cancer syndrome	VCV002837242	17	41246862	17	43094845	2837242	2999621	NA	NC_000017.11:43094844:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	229	BRCA1
NM_007294.4(BRCA1):c.686C>T (p.Ser229Phe)	BRCA1	S229F	Hereditary cancer-predisposing syndrome	VCV000826675	17	41246862	17	43094845	826675	813888	rs1597880556	NC_000017.11:43094844:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	229	BRCA1
NM_007294.4(BRCA1):c.683T>A (p.Phe228Tyr)	BRCA1	F228Y	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000186506	17	41246865	17	43094848	186506	185100	rs191872612	NC_000017.11:43094847:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	228	BRCA1
NM_007294.4(BRCA1):c.679G>A (p.Glu227Lys)	BRCA1	E227K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001375429	17	41246869	17	43094852	1375429	1392202	rs879255319	NC_000017.11:43094851:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	227	BRCA1
NM_007294.4(BRCA1):c.677G>T (p.Cys226Phe)	BRCA1	C226F	Hereditary cancer-predisposing syndrome	VCV001755392	17	41246871	17	43094854	1755392	1818682	NA	NC_000017.11:43094853:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	226	BRCA1
NM_007294.4(BRCA1):c.677G>C (p.Cys226Ser)	BRCA1	C226S	Hereditary cancer-predisposing syndrome	VCV000826617	17	41246871	17	43094854	826617	813889	rs1376262238	NC_000017.11:43094853:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	226	BRCA1
NM_007294.4(BRCA1):c.677G>A (p.Cys226Tyr)	BRCA1	C226Y	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441363	17	41246871	17	43094854	441363	435170	rs1376262238	NC_000017.11:43094853:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	226	BRCA1
NM_007294.4(BRCA1):c.671C>T (p.Ala224Val)	BRCA1	A224V	Hereditary breast ovarian cancer syndrome	VCV000409319	17	41246877	17	43094860	409319	402130	rs1060502335	NC_000017.11:43094859:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 2, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	224	BRCA1
NM_007294.4(BRCA1):c.670G>C (p.Ala224Pro)	BRCA1	A224P	Hereditary cancer-predisposing syndrome	VCV001175044	17	41247863	17	43095846	1175044	1164507	rs431825419	NC_000017.11:43095845:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 23, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	224	BRCA1
NM_007294.4(BRCA1):c.670G>A (p.Ala224Thr)	BRCA1	A224T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Breast and/or ovarian cancer|not specified|Hereditary breast ovarian cancer syndrome	VCV000096954	17	41247863	17	43095846	96954	102857	rs431825419	NC_000017.11:43095845:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	224	BRCA1
NM_007294.4(BRCA1):c.668A>G (p.Lys223Arg)	BRCA1	K223R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055658	17	41247865	17	43095848	55658	70325	rs397509306	NC_000017.11:43095847:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	223	BRCA1
NM_007294.4(BRCA1):c.667A>G (p.Lys223Glu)	BRCA1	K223E	Hereditary cancer-predisposing syndrome	VCV001754832	17	41247866	17	43095849	1754832	1821922	NA	NC_000017.11:43095848:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 8, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	223	BRCA1
NM_007294.4(BRCA1):c.667A>C (p.Lys223Gln)	BRCA1	K223Q	Hereditary cancer-predisposing syndrome	VCV001754829	17	41247866	17	43095849	1754829	1821919	NA	NC_000017.11:43095848:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 10, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	223	BRCA1
NM_007294.4(BRCA1):c.665A>C (p.Lys222Thr)	BRCA1	K222T	Hereditary breast ovarian cancer syndrome	VCV000655049	17	41247868	17	43095851	655049	646050	rs398122705	NC_000017.11:43095850:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 30, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	222	BRCA1
NM_007294.4(BRCA1):c.665A>G (p.Lys222Arg)	BRCA1	K222R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091660	17	41247868	17	43095851	91660	97137	rs398122705	NC_000017.11:43095850:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	222	BRCA1
NM_007294.4(BRCA1):c.664A>G (p.Lys222Glu)	BRCA1	K222E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001754673	17	41247869	17	43095852	1754673	1812129	NA	NC_000017.11:43095851:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	222	BRCA1
NM_007294.4(BRCA1):c.662C>G (p.Ala221Gly)	BRCA1	A221G	Hereditary cancer-predisposing syndrome	VCV003226176	17	41247871	17	43095854	3226176	3387239	NA	NC_000017.11:43095853:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 12, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	221	BRCA1
NM_007294.4(BRCA1):c.662C>A (p.Ala221Glu)	BRCA1	A221E	Hereditary breast ovarian cancer syndrome	VCV001040071	17	41247871	17	43095854	1040071	1033329	rs1597881888	NC_000017.11:43095853:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	221	BRCA1
NM_007294.4(BRCA1):c.662C>T (p.Ala221Val)	BRCA1	A221V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000826519	17	41247871	17	43095854	826519	813890	rs1597881888	NC_000017.11:43095853:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	221	BRCA1
NM_007294.4(BRCA1):c.661G>T (p.Ala221Ser)	BRCA1	A221S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000037690	17	41247872	17	43095855	37690	46246	rs80357088	NC_000017.11:43095854:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	221	BRCA1
NM_007294.4(BRCA1):c.659C>G (p.Ser220Cys)	BRCA1	S220C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096953	17	41247874	17	43095857	96953	102856	rs431825418	NC_000017.11:43095856:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	220	BRCA1
NM_007294.4(BRCA1):c.657T>A (p.Asp219Glu)	BRCA1	D219E	Hereditary breast ovarian cancer syndrome	VCV002077787	17	41247876	17	43095859	2077787	2142171	NA	NC_000017.11:43095858:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	219	BRCA1
NM_007294.4(BRCA1):c.656A>T (p.Asp219Val)	BRCA1	D219V	Hereditary breast ovarian cancer syndrome|not specified	VCV000917777	17	41247877	17	43095860	917777	906105	rs2054110068	NC_000017.11:43095859:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 2, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	219	BRCA1
NM_007294.4(BRCA1):c.655G>T (p.Asp219Tyr)	BRCA1	D219Y	Hereditary cancer-predisposing syndrome	VCV001754198	17	41247878	17	43095861	1754198	1804753	NA	NC_000017.11:43095860:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	219	BRCA1
NM_007294.4(BRCA1):c.655G>C (p.Asp219His)	BRCA1	D219H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000234087	17	41247878	17	43095861	234087	236157	rs273902779	NC_000017.11:43095860:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	219	BRCA1
NM_007294.4(BRCA1):c.655G>A (p.Asp219Asn)	BRCA1	D219N	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055655	17	41247878	17	43095861	55655	70322	rs273902779	NC_000017.11:43095860:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	219	BRCA1
NM_007294.4(BRCA1):c.652T>G (p.Leu218Val)	BRCA1	L218V	not specified	VCV001684697	17	41247881	17	43095864	1684697	1676725	rs765950064	NC_000017.11:43095863:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	May 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	218	BRCA1
NM_007294.4(BRCA1):c.650G>A (p.Ser217Asn)	BRCA1	S217N	not specified	VCV001705061	17	41247883	17	43095866	1705061	1699593	NA	NC_000017.11:43095865:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	217	BRCA1
NM_007294.4(BRCA1):c.650G>C (p.Ser217Thr)	BRCA1	S217T	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531351	17	41247883	17	43095866	531351	531332	rs774284145	NC_000017.11:43095865:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	217	BRCA1
NM_007294.4(BRCA1):c.648C>G (p.Ile216Met)	BRCA1	I216M	Hereditary breast ovarian cancer syndrome	VCV000960534	17	41247885	17	43095868	960534	949961	rs2054111045	NC_000017.11:43095867:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	216	BRCA1
NM_007294.4(BRCA1):c.646A>G (p.Ile216Val)	BRCA1	I216V	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000091659	17	41247887	17	43095870	91659	97136	rs398122704	NC_000017.11:43095869:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	216	BRCA1
NM_007294.4(BRCA1):c.644A>C (p.Glu215Ala)	BRCA1	E215A	Hereditary breast ovarian cancer syndrome	VCV002066186	17	41247889	17	43095872	2066186	2128871	NA	NC_000017.11:43095871:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 30, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	215	BRCA1
NM_007294.4(BRCA1):c.643G>A (p.Glu215Lys)	BRCA1	E215K	Hereditary breast ovarian cancer syndrome	VCV001037513	17	41247890	17	43095873	1037513	1033330	rs2054111326	NC_000017.11:43095872:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 2, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	215	BRCA1
NM_007294.4(BRCA1):c.642T>G (p.Asp214Glu)	BRCA1	D214E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003240940	17	41247891	17	43095874	3240940	3399923	NA	NC_000017.11:43095873:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	214	BRCA1
NM_007294.4(BRCA1):c.641A>T (p.Asp214Val)	BRCA1	D214V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001010063	17	41247892	17	43095875	1010063	997591	rs55680408	NC_000017.11:43095874:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	214	BRCA1
NM_007294.4(BRCA1):c.641A>G (p.Asp214Gly)	BRCA1	D214G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037689	17	41247892	17	43095875	37689	46245	rs55680408	NC_000017.11:43095874:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 29, 2017	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	214	BRCA1
NM_007294.4(BRCA1):c.640G>T (p.Asp214Tyr)	BRCA1	D214Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462682	17	41247893	17	43095876	462682	466909	rs786203797	NC_000017.11:43095875:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	214	BRCA1
NM_007294.4(BRCA1):c.640G>A (p.Asp214Asn)	BRCA1	D214N	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000187522	17	41247893	17	43095876	187522	185102	rs786203797	NC_000017.11:43095875:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	214	BRCA1
NM_007294.4(BRCA1):c.639G>T (p.Arg213Ser)	BRCA1	R213S	Hereditary cancer-predisposing syndrome	VCV000480992	17	41247894	17	43095877	480992	479487	rs1131692078	NC_000017.11:43095876:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 8, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	213	BRCA1
NM_007294.4(BRCA1):c.638G>T (p.Arg213Met)	BRCA1	R213M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002692287	17	41247895	17	43095878	2692287	2853289	NA	NC_000017.11:43095877:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 2, 2020	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	213	BRCA1
NM_007294.4(BRCA1):c.638G>A (p.Arg213Lys)	BRCA1	R213K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000578841	17	41247895	17	43095878	578841	569175	rs1567803140	NC_000017.11:43095877:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 15, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	213	BRCA1
NM_007294.4(BRCA1):c.637A>G (p.Arg213Gly)	BRCA1	R213G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055652	17	41247896	17	43095879	55652	70319	rs80357081	NC_000017.11:43095878:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	213	BRCA1
NM_007294.4(BRCA1):c.635C>T (p.Thr212Ile)	BRCA1	T212I	Hereditary cancer-predisposing syndrome	VCV000919790	17	41247898	17	43095881	919790	913972	rs2054112546	NC_000017.11:43095880:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	212	BRCA1
NM_007294.4(BRCA1):c.634A>G (p.Thr212Ala)	BRCA1	T212A	Hereditary breast ovarian cancer syndrome	VCV002814785	17	41247899	17	43095882	2814785	2973315	NA	NC_000017.11:43095881:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	212	BRCA1
NM_007294.4(BRCA1):c.632G>A (p.Gly211Glu)	BRCA1	G211E	Hereditary breast ovarian cancer syndrome	VCV002851737	17	41247901	17	43095884	2851737	3006414	NA	NC_000017.11:43095883:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	211	BRCA1
NM_007294.4(BRCA1):c.632G>C (p.Gly211Ala)	BRCA1	G211A	Hereditary breast ovarian cancer syndrome	VCV001034679	17	41247901	17	43095884	1034679	1033331	rs2054112741	NC_000017.11:43095883:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	211	BRCA1
NM_007294.4(BRCA1):c.631G>A (p.Gly211Arg)	BRCA1	G211R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000631030	17	41247902	17	43095885	631030	618693	rs1192717688	NC_000017.11:43095884:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	211	BRCA1
NM_007294.4(BRCA1):c.629A>G (p.Gln210Arg)	BRCA1	Q210R	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000968031	17	41247904	17	43095887	968031	958140	rs2054113483	NC_000017.11:43095886:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	210	BRCA1
NM_007294.4(BRCA1):c.628C>G (p.Gln210Glu)	BRCA1	Q210E	Hereditary cancer-predisposing syndrome	VCV000826298	17	41247905	17	43095888	826298	813891	rs879255495	NC_000017.11:43095887:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 11, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	210	BRCA1
NM_007294.4(BRCA1):c.626C>G (p.Pro209Arg)	BRCA1	P209R	Hereditary breast ovarian cancer syndrome	VCV000845213	17	41247907	17	43095890	845213	845465	rs201596327	NC_000017.11:43095889:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	209	BRCA1
NM_007294.4(BRCA1):c.626C>T (p.Pro209Leu)	BRCA1	P209L	BRCA1-related disorder|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000409315	17	41247907	17	43095890	409315	402729	rs201596327	NC_000017.11:43095889:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	209	BRCA1
NM_007294.4(BRCA1):c.625C>G (p.Pro209Ala)	BRCA1	P209A	Hereditary cancer-predisposing syndrome	VCV001752484	17	41247908	17	43095891	1752484	1804339	NA	NC_000017.11:43095890:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	209	BRCA1
NM_007294.4(BRCA1):c.625C>T (p.Pro209Ser)	BRCA1	P209S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182125	17	41247908	17	43095891	182125	180886	rs730881466	NC_000017.11:43095890:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	209	BRCA1
NM_007294.4(BRCA1):c.622A>G (p.Thr208Ala)	BRCA1	T208A	Hereditary cancer-predisposing syndrome	VCV000920338	17	41247911	17	43095894	920338	913975	rs2054115270	NC_000017.11:43095893:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 31, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	208	BRCA1
NM_007294.4(BRCA1):c.620T>C (p.Ile207Thr)	BRCA1	I207T	Hereditary breast ovarian cancer syndrome	VCV002129908	17	41247913	17	43095896	2129908	2189185	NA	NC_000017.11:43095895:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	207	BRCA1
NM_007294.4(BRCA1):c.619A>G (p.Ile207Val)	BRCA1	I207V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000856578	17	41247914	17	43095897	856578	845466	rs2054115706	NC_000017.11:43095896:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	207	BRCA1
NM_007294.4(BRCA1):c.618A>C (p.Gln206His)	BRCA1	Q206H	not specified	VCV001330046	17	41247915	17	43095898	1330046	1320729	rs1597882068	NC_000017.11:43095897:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 23, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	BRCA1
NM_007294.4(BRCA1):c.617A>C (p.Gln206Pro)	BRCA1	Q206P	Hereditary cancer-predisposing syndrome	VCV000252888	17	41247916	17	43095899	252888	247289	rs879255494	NC_000017.11:43095898:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	BRCA1
NM_007294.4(BRCA1):c.616C>A (p.Gln206Lys)	BRCA1	Q206K	Hereditary cancer-predisposing syndrome	VCV001172402	17	41247917	17	43095900	1172402	1161367	rs397509301	NC_000017.11:43095899:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	BRCA1
NM_007294.4(BRCA1):c.616C>G (p.Gln206Glu)	BRCA1	Q206E	Hereditary cancer-predisposing syndrome	VCV000482902	17	41247917	17	43095900	482902	479519	rs397509301	NC_000017.11:43095899:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	BRCA1
NM_007294.4(BRCA1):c.612G>C (p.Leu204Phe)	BRCA1	L204F	Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000055646	17	41247921	17	43095904	55646	70313	rs80357394	NC_000017.11:43095903:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	204	BRCA1
NM_007294.4(BRCA1):c.611T>G (p.Leu204Trp)	BRCA1	L204W	Hereditary breast ovarian cancer syndrome	VCV000639275	17	41247922	17	43095905	639275	646051	rs1403004357	NC_000017.11:43095904:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	204	BRCA1
NM_007294.4(BRCA1):c.608A>T (p.Glu203Val)	BRCA1	E203V	Hereditary cancer-predisposing syndrome	VCV001751493	17	41247925	17	43095908	1751493	1811114	NA	NC_000017.11:43095907:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	203	BRCA1
NM_007294.4(BRCA1):c.608A>G (p.Glu203Gly)	BRCA1	E203G	Hereditary breast ovarian cancer syndrome	VCV001385134	17	41247925	17	43095908	1385134	1367880	rs2154515011	NC_000017.11:43095907:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	203	BRCA1
NM_007294.4(BRCA1):c.607G>A (p.Glu203Lys)	BRCA1	E203K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091658	17	41247926	17	43095909	91658	97135	rs398122703	NC_000017.11:43095908:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 14, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	203	BRCA1
NM_007294.4(BRCA1):c.605A>C (p.Gln202Pro)	BRCA1	Q202P	Hereditary breast ovarian cancer syndrome	VCV000409373	17	41247928	17	43095911	409373	402078	rs1060502366	NC_000017.11:43095910:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 15, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	202	BRCA1
NM_007294.4(BRCA1):c.604C>A (p.Gln202Lys)	BRCA1	Q202K	Hereditary breast ovarian cancer syndrome	VCV000838225	17	41247929	17	43095912	838225	845468	rs2054117377	NC_000017.11:43095911:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	202	BRCA1
NM_007294.4(BRCA1):c.601G>A (p.Asp201Asn)	BRCA1	D201N	Hereditary cancer-predisposing syndrome	VCV000055645	17	41247932	17	43095915	55645	70312	rs80357109	NC_000017.11:43095914:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	201	BRCA1
NM_007294.4(BRCA1):c.599G>A (p.Gly200Glu)	BRCA1	G200E	Hereditary cancer-predisposing syndrome	VCV000826105	17	41247934	17	43095917	826105	813892	rs1597882144	NC_000017.11:43095916:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	200	BRCA1
NM_007294.4(BRCA1):c.595G>A (p.Val199Met)	BRCA1	V199M	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000481435	17	41247938	17	43095921	481435	478797	rs1555593622	NC_000017.11:43095920:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	199	BRCA1
NM_007294.4(BRCA1):c.594T>A (p.Ser198Arg)	BRCA1	S198R	Hereditary cancer-predisposing syndrome	VCV001750681	17	41247939	17	43095922	1750681	1803831	NA	NC_000017.11:43095921:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	198	BRCA1
NM_007294.4(BRCA1):c.593G>A (p.Ser198Asn)	BRCA1	S198N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000826067	17	41249261	17	43097244	826067	813893	rs1597883925	NC_000017.11:43097243:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	198	BRCA1
NM_007294.4(BRCA1):c.592A>G (p.Ser198Gly)	BRCA1	S198G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000961241	17	41249262	17	43097245	961241	949962	rs2054176940	NC_000017.11:43097244:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	198	BRCA1
NM_007294.4(BRCA1):c.591C>G (p.Cys197Trp)	BRCA1	C197W	Hereditary breast ovarian cancer syndrome	VCV000978545	17	41249263	17	43097246	978545	949963	rs1799965	NC_000017.11:43097245:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	197	BRCA1
NM_007294.4(BRCA1):c.587A>T (p.Tyr196Phe)	BRCA1	Y196F	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462680	17	41249267	17	43097250	462680	468240	rs1555594039	NC_000017.11:43097249:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	196	BRCA1
NM_007294.4(BRCA1):c.586T>G (p.Tyr196Asp)	BRCA1	Y196D	not provided	VCV001319801	17	41249268	17	43097251	1319801	1310050	rs1597883964	NC_000017.11:43097250:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	196	BRCA1
NM_007294.4(BRCA1):c.586T>C (p.Tyr196His)	BRCA1	Y196H	Hereditary breast ovarian cancer syndrome	VCV000651908	17	41249268	17	43097251	651908	646052	rs1597883964	NC_000017.11:43097250:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	196	BRCA1
NM_007294.4(BRCA1):c.584C>G (p.Thr195Ser)	BRCA1	T195S	Hereditary breast ovarian cancer syndrome	VCV002828564	17	41249270	17	43097253	2828564	2987083	NA	NC_000017.11:43097252:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	195	BRCA1
NM_007294.4(BRCA1):c.581C>G (p.Ala194Gly)	BRCA1	A194G	Hereditary breast ovarian cancer syndrome	VCV002128550	17	41249273	17	43097256	2128550	2178573	NA	NC_000017.11:43097255:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	194	BRCA1
NM_007294.4(BRCA1):c.581C>T (p.Ala194Val)	BRCA1	A194V	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000858239	17	41249273	17	43097256	858239	845469	rs2054177836	NC_000017.11:43097255:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	194	BRCA1
NM_007294.4(BRCA1):c.580G>A (p.Ala194Thr)	BRCA1	A194T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001285455	17	41249274	17	43097257	1285455	1275298	rs2154521204	NC_000017.11:43097256:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	194	BRCA1
NM_007294.4(BRCA1):c.578A>C (p.Lys193Thr)	BRCA1	K193T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001510971	17	41249276	17	43097259	1510971	1377786	rs1420901970	NC_000017.11:43097258:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	193	BRCA1
NM_007294.4(BRCA1):c.577A>G (p.Lys193Glu)	BRCA1	K193E	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240826	17	41249277	17	43097260	240826	242809	rs878854962	NC_000017.11:43097259:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 4, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	193	BRCA1
NM_007294.4(BRCA1):c.576T>A (p.Asn192Lys)	BRCA1	N192K	Hereditary cancer-predisposing syndrome	VCV001749543	17	41249278	17	43097261	1749543	1810463	NA	NC_000017.11:43097260:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	192	BRCA1
NM_007294.4(BRCA1):c.575A>G (p.Asn192Ser)	BRCA1	N192S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000946696	17	41249279	17	43097262	946696	928324	rs2054178411	NC_000017.11:43097261:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	192	BRCA1
NM_007294.4(BRCA1):c.572T>C (p.Val191Ala)	BRCA1	V191A	Hereditary cancer-predisposing syndrome	VCV001749326	17	41249282	17	43097265	1749326	1800354	NA	NC_000017.11:43097264:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	191	BRCA1
NM_007294.4(BRCA1):c.572T>A (p.Val191Asp)	BRCA1	V191D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000055641	17	41249282	17	43097265	55641	70308	rs80357142	NC_000017.11:43097264:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	191	BRCA1
NM_007294.4(BRCA1):c.571G>T (p.Val191Phe)	BRCA1	V191F	Hereditary breast ovarian cancer syndrome	VCV001429417	17	41249283	17	43097266	1429417	1454533	rs80357090	NC_000017.11:43097265:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	191	BRCA1
NM_007294.4(BRCA1):c.571G>A (p.Val191Ile)	BRCA1	V191I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037684	17	41249283	17	43097266	37684	46240	rs80357090	NC_000017.11:43097265:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	191	BRCA1
NM_007294.4(BRCA1):c.569C>T (p.Thr190Ile)	BRCA1	T190I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002683809	17	41249285	17	43097268	2683809	2844847	NA	NC_000017.11:43097267:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	190	BRCA1
NM_007294.4(BRCA1):c.568A>G (p.Thr190Ala)	BRCA1	T190A	Hereditary breast ovarian cancer syndrome	VCV001489611	17	41249286	17	43097269	1489611	1495217	rs967624732	NC_000017.11:43097268:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	190	BRCA1
NM_007294.4(BRCA1):c.566A>G (p.Asp189Gly)	BRCA1	D189G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491179	17	41249288	17	43097271	491179	485120	rs1555594067	NC_000017.11:43097270:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	189	BRCA1
NM_007294.4(BRCA1):c.565G>T (p.Asp189Tyr)	BRCA1	D189Y	Hereditary cancer-predisposing syndrome	VCV002585846	17	41249289	17	43097272	2585846	2753406	NA	NC_000017.11:43097271:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	BRCA1
NM_007294.4(BRCA1):c.564A>C (p.Glu188Asp)	BRCA1	E188D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825873	17	41249290	17	43097273	825873	813894	rs768065826	NC_000017.11:43097272:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	188	BRCA1
NM_007294.4(BRCA1):c.563A>T (p.Glu188Val)	BRCA1	E188V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003340072	17	41249291	17	43097274	3340072	3499333	NA	NC_000017.11:43097273:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	188	BRCA1
NM_007294.4(BRCA1):c.562G>A (p.Glu188Lys)	BRCA1	E188K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491178	17	41249292	17	43097275	491178	484960	rs1555594069	NC_000017.11:43097274:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	188	BRCA1
NM_007294.4(BRCA1):c.557C>T (p.Ser186Phe)	BRCA1	S186F	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055636	17	41249297	17	43097280	55636	70303	rs55688530	NC_000017.11:43097279:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	186	BRCA1
NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	BRCA1	S186Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055635	17	41249297	17	43097280	55635	70302	rs55688530	NC_000017.11:43097279:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	186	BRCA1
NM_007294.4(BRCA1):c.556T>G (p.Ser186Ala)	BRCA1	S186A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055633	17	41249298	17	43097281	55633	70300	rs397509298	NC_000017.11:43097280:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	186	BRCA1
NM_007294.4(BRCA1):c.555T>A (p.Asp185Glu)	BRCA1	D185E	Hereditary breast ovarian cancer syndrome	VCV002814468	17	41249299	17	43097282	2814468	2976421	NA	NC_000017.11:43097281:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	185	BRCA1
NM_007294.4(BRCA1):c.554A>T (p.Asp185Val)	BRCA1	D185V	Hereditary breast ovarian cancer syndrome	VCV002750011	17	41249300	17	43097283	2750011	2918969	NA	NC_000017.11:43097282:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	185	BRCA1
NM_007294.4(BRCA1):c.553G>A (p.Asp185Asn)	BRCA1	D185N	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001721597	17	41249301	17	43097284	1721597	1772931	NA	NC_000017.11:43097283:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	185	BRCA1
NM_007294.4(BRCA1):c.551C>T (p.Ser184Phe)	BRCA1	S184F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000240825	17	41249303	17	43097286	240825	242810	rs878854961	NC_000017.11:43097285:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 15, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	184	BRCA1
NM_007294.4(BRCA1):c.550T>A (p.Ser184Thr)	BRCA1	S184T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|not specified	VCV000421643	17	41249304	17	43097287	421643	410025	rs1064795269	NC_000017.11:43097286:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	184	BRCA1
NM_007294.4(BRCA1):c.548G>A (p.Gly183Glu)	BRCA1	G183E	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002024596	17	41249306	17	43097289	2024596	2087637	NA	NC_000017.11:43097288:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	183	BRCA1
NM_007294.4(BRCA1):c.548G>C (p.Gly183Ala)	BRCA1	G183A	Hereditary breast ovarian cancer syndrome	VCV001992535	17	41249306	17	43097289	1992535	2059057	NA	NC_000017.11:43097288:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	183	BRCA1
NM_007294.4(BRCA1):c.548G>T (p.Gly183Val)	BRCA1	G183V	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441376	17	41249306	17	43097289	441376	435172	rs1555594081	NC_000017.11:43097288:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	183	BRCA1
NM_007294.4(BRCA1):c.547G>A (p.Gly183Arg)	BRCA1	G183R	Hereditary cancer-predisposing syndrome	VCV001747791	17	41251792	17	43099775	1747791	1800089	NA	NC_000017.11:43099774:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 7, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	183	BRCA1
NM_007294.4(BRCA1):c.547G>C (p.Gly183Arg)	BRCA1	G183R	not specified	VCV000431353	17	41251792	17	43099775	431353	424886	rs1135401931	NC_000017.11:43099774:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 20, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	183	BRCA1
NM_007294.4(BRCA1):c.546G>T (p.Leu182Phe)	BRCA1	L182F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000491176	17	41251793	17	43099776	491176	485398	rs1464752950	NC_000017.11:43099775:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	182	BRCA1
NM_007294.4(BRCA1):c.544T>A (p.Leu182Met)	BRCA1	L182M	Hereditary breast ovarian cancer syndrome	VCV000409323	17	41251795	17	43099778	409323	402549	rs1060502339	NC_000017.11:43099777:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	182	BRCA1
NM_007294.4(BRCA1):c.543A>C (p.Glu181Asp)	BRCA1	E181D	Hereditary cancer-predisposing syndrome	VCV003261479	17	41251796	17	43099779	3261479	3424248	NA	NC_000017.11:43099778:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	181	BRCA1
NM_007294.4(BRCA1):c.542A>C (p.Glu181Ala)	BRCA1	E181A	not provided	VCV003340216	17	41251797	17	43099780	3340216	3499474	NA	NC_000017.11:43099779:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	181	BRCA1
NM_007294.4(BRCA1):c.539T>C (p.Ile180Thr)	BRCA1	I180T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000627936	17	41251800	17	43099783	627936	618695	rs1567805965	NC_000017.11:43099782:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	180	BRCA1
NM_007294.4(BRCA1):c.538A>G (p.Ile180Val)	BRCA1	I180V	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000839084	17	41251801	17	43099784	839084	845470	rs1555594803	NC_000017.11:43099783:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	180	BRCA1
NM_007294.4(BRCA1):c.538A>C (p.Ile180Leu)	BRCA1	I180L	Hereditary cancer-predisposing syndrome	VCV000482943	17	41251801	17	43099784	482943	479523	rs1555594803	NC_000017.11:43099783:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	180	BRCA1
NM_007294.4(BRCA1):c.536A>T (p.Tyr179Phe)	BRCA1	Y179F	Familial cancer of breast	VCV001687140	17	41251803	17	43099786	1687140	1679433	rs56187033	NC_000017.11:43099785:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	179	BRCA1
NM_007294.4(BRCA1):c.536A>G (p.Tyr179Cys)	BRCA1	Y179C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037661	17	41251803	17	43099786	37661	46217	rs56187033	NC_000017.11:43099785:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	179	BRCA1
NM_007294.4(BRCA1):c.535T>C (p.Tyr179His)	BRCA1	Y179H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000141458	17	41251804	17	43099787	141458	151172	rs587781761	NC_000017.11:43099786:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	179	BRCA1
NM_007294.4(BRCA1):c.533T>A (p.Val178Asp)	BRCA1	V178D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232937	17	41251806	17	43099789	232937	236158	rs876660085	NC_000017.11:43099788:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	178	BRCA1
NM_007294.4(BRCA1):c.532G>C (p.Val178Leu)	BRCA1	V178L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479255	17	41251807	17	43099790	479255	478716	rs1259369962	NC_000017.11:43099789:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	178	BRCA1
NM_007294.4(BRCA1):c.530C>T (p.Ser177Phe)	BRCA1	S177F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825633	17	41251809	17	43099792	825633	813896	rs753940026	NC_000017.11:43099791:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	177	BRCA1
NM_007294.4(BRCA1):c.530C>G (p.Ser177Cys)	BRCA1	S177C	Hereditary cancer-predisposing syndrome	VCV000187240	17	41251809	17	43099792	187240	185108	rs753940026	NC_000017.11:43099791:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	177	BRCA1
NM_007294.4(BRCA1):c.529T>A (p.Ser177Thr)	BRCA1	S177T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000481474	17	41251810	17	43099793	481474	478798	rs1555594827	NC_000017.11:43099792:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	177	BRCA1
NM_007294.4(BRCA1):c.527C>T (p.Thr176Met)	BRCA1	T176M	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409326	17	41251812	17	43099795	409326	402741	rs587782747	NC_000017.11:43099794:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	176	BRCA1
NM_007294.4(BRCA1):c.527C>G (p.Thr176Arg)	BRCA1	T176R	Hereditary cancer-predisposing syndrome	VCV000142823	17	41251812	17	43099795	142823	152537	rs587782747	NC_000017.11:43099794:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	176	BRCA1
NM_007294.4(BRCA1):c.526A>T (p.Thr176Ser)	BRCA1	T176S	Hereditary cancer-predisposing syndrome	VCV001746486	17	41251813	17	43099796	1746486	1809974	NA	NC_000017.11:43099795:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	176	BRCA1
NM_007294.4(BRCA1):c.523A>G (p.Lys175Glu)	BRCA1	K175E	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|not specified	VCV000575630	17	41251816	17	43099799	575630	574491	rs1567806027	NC_000017.11:43099798:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	175	BRCA1
NM_007294.4(BRCA1):c.521A>G (p.Gln174Arg)	BRCA1	Q174R	Hereditary cancer-predisposing syndrome	VCV000627733	17	41251818	17	43099801	627733	618696	rs1567806035	NC_000017.11:43099800:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 21, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	174	BRCA1
NM_007294.4(BRCA1):c.521A>C (p.Gln174Pro)	BRCA1	Q174P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000584955	17	41251818	17	43099801	584955	576004	rs1567806035	NC_000017.11:43099800:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	174	BRCA1
NM_007294.4(BRCA1):c.520C>G (p.Gln174Glu)	BRCA1	Q174E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003240944	17	41251819	17	43099802	3240944	3399927	NA	NC_000017.11:43099801:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	174	BRCA1
NM_007294.4(BRCA1):c.518C>T (p.Pro173Leu)	BRCA1	P173L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000952817	17	41251821	17	43099804	952817	928325	rs2054293926	NC_000017.11:43099803:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 10, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	173	BRCA1
NM_007294.4(BRCA1):c.517C>A (p.Pro173Thr)	BRCA1	P173T	Hereditary breast ovarian cancer syndrome	VCV001419169	17	41251822	17	43099805	1419169	1386848	rs2154528497	NC_000017.11:43099804:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	173	BRCA1
NM_007294.4(BRCA1):c.515A>G (p.Gln172Arg)	BRCA1	Q172R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000482899	17	41251824	17	43099807	482899	478872	rs1555594863	NC_000017.11:43099806:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	172	BRCA1
NM_007294.4(BRCA1):c.514C>A (p.Gln172Lys)	BRCA1	Q172K	Hereditary cancer-predisposing syndrome	VCV003226171	17	41251825	17	43099808	3226171	3387234	NA	NC_000017.11:43099807:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	172	BRCA1
NM_007294.4(BRCA1):c.512T>C (p.Ile171Thr)	BRCA1	I171T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825470	17	41251827	17	43099810	825470	813897	rs1597887805	NC_000017.11:43099809:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 29, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	171	BRCA1
NM_007294.4(BRCA1):c.511A>C (p.Ile171Leu)	BRCA1	I171L	Hereditary breast ovarian cancer syndrome	VCV002094438	17	41251828	17	43099811	2094438	2145886	NA	NC_000017.11:43099810:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	171	BRCA1
NM_007294.4(BRCA1):c.511A>G (p.Ile171Val)	BRCA1	I171V	not specified	VCV000431182	17	41251828	17	43099811	431182	424716	rs777515082	NC_000017.11:43099810:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 18, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	171	BRCA1
NM_007294.4(BRCA1):c.509G>A (p.Arg170Gln)	BRCA1	R170Q	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000055400	17	41251830	17	43099813	55400	70067	rs80357264	NC_000017.11:43099812:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	170	BRCA1
NM_007294.4(BRCA1):c.508C>T (p.Arg170Trp)	BRCA1	R170W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055393	17	41251831	17	43099814	55393	70060	rs80357325	NC_000017.11:43099813:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	170	BRCA1
NM_007294.4(BRCA1):c.506A>C (p.Gln169Pro)	BRCA1	Q169P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136087	17	41251833	17	43099816	136087	139799	rs587780803	NC_000017.11:43099815:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	169	BRCA1
NM_007294.4(BRCA1):c.503A>C (p.Lys168Thr)	BRCA1	K168T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055359	17	41251836	17	43099819	55359	70026	rs273901743	NC_000017.11:43099818:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	168	BRCA1
NM_007294.4(BRCA1):c.502A>G (p.Lys168Glu)	BRCA1	K168E	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000628391	17	41251837	17	43099820	628391	618697	rs886040263	NC_000017.11:43099819:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	168	BRCA1
NM_007294.4(BRCA1):c.500C>T (p.Thr167Ile)	BRCA1	T167I	Hereditary breast ovarian cancer syndrome	VCV001009204	17	41251839	17	43099822	1009204	997593	rs2054297541	NC_000017.11:43099821:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	167	BRCA1
NM_007294.4(BRCA1):c.499A>G (p.Thr167Ala)	BRCA1	T167A	Hereditary cancer-predisposing syndrome	VCV000825351	17	41251840	17	43099823	825351	813899	rs1597887891	NC_000017.11:43099822:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 17, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	167	BRCA1
NM_007294.4(BRCA1):c.498G>C (p.Arg166Ser)	BRCA1	R166S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001020068	17	41251841	17	43099824	1020068	1012788	rs1474499188	NC_000017.11:43099823:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	166	BRCA1
NM_007294.4(BRCA1):c.497G>A (p.Arg166Lys)	BRCA1	R166K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000925718	17	41251842	17	43099825	925718	913977	rs2054298062	NC_000017.11:43099824:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	166	BRCA1
NM_007294.4(BRCA1):c.494T>C (p.Leu165Pro)	BRCA1	L165P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001175105	17	41251845	17	43099828	1175105	1164508	rs2154528996	NC_000017.11:43099827:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 1, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	165	BRCA1
NM_007294.4(BRCA1):c.493C>G (p.Leu165Val)	BRCA1	L165V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000825313	17	41251846	17	43099829	825313	813900	rs1597887932	NC_000017.11:43099828:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 27, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	165	BRCA1
NM_007294.4(BRCA1):c.491C>T (p.Thr164Ile)	BRCA1	T164I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482962	17	41251848	17	43099831	482962	479525	rs1555594889	NC_000017.11:43099830:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	164	BRCA1
NM_007294.4(BRCA1):c.490A>T (p.Thr164Ser)	BRCA1	T164S	Hereditary cancer-predisposing syndrome	VCV000919922	17	41251849	17	43099832	919922	913978	rs80357384	NC_000017.11:43099831:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 10, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	164	BRCA1
NM_007294.4(BRCA1):c.490A>C (p.Thr164Pro)	BRCA1	T164P	Hereditary breast ovarian cancer syndrome	VCV000055313	17	41251849	17	43099832	55313	69980	rs80357384	NC_000017.11:43099831:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 9, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	164	BRCA1
NM_007294.4(BRCA1):c.489A>C (p.Arg163Ser)	BRCA1	R163S	Hereditary breast ovarian cancer syndrome	VCV002813694	17	41251850	17	43099833	2813694	2969644	NA	NC_000017.11:43099832:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	163	BRCA1
NM_007294.4(BRCA1):c.489A>T (p.Arg163Ser)	BRCA1	R163S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002680209	17	41251850	17	43099833	2680209	2833936	NA	NC_000017.11:43099832:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	163	BRCA1
NM_007294.4(BRCA1):c.488G>C (p.Arg163Thr)	BRCA1	R163T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531359	17	41251851	17	43099834	531359	531384	rs1369043501	NC_000017.11:43099833:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	163	BRCA1
NM_007294.4(BRCA1):c.485T>G (p.Val162Gly)	BRCA1	V162G	Hereditary breast ovarian cancer syndrome	VCV000648393	17	41251854	17	43099837	648393	646055	rs1597888003	NC_000017.11:43099836:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	162	BRCA1
NM_007294.4(BRCA1):c.484G>A (p.Val162Met)	BRCA1	V162M	Hereditary cancer-predisposing syndrome	VCV000479271	17	41251855	17	43099838	479271	478879	rs55816927	NC_000017.11:43099837:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	162	BRCA1
NM_007294.4(BRCA1):c.484G>C (p.Val162Leu)	BRCA1	V162L	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055303	17	41251855	17	43099838	55303	69970	rs55816927	NC_000017.11:43099837:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	162	BRCA1
NM_007294.4(BRCA1):c.482C>G (p.Thr161Ser)	BRCA1	T161S	Hereditary breast ovarian cancer syndrome	VCV001493878	17	41251857	17	43099840	1493878	1449380	rs876660138	NC_000017.11:43099839:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 2, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	161	BRCA1
NM_007294.4(BRCA1):c.482C>T (p.Thr161Ile)	BRCA1	T161I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000233021	17	41251857	17	43099840	233021	236160	rs876660138	NC_000017.11:43099839:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 9, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	161	BRCA1
NM_007294.4(BRCA1):c.479G>T (p.Gly160Val)	BRCA1	G160V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000919142	17	41251860	17	43099843	919142	913979	rs1016051167	NC_000017.11:43099842:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 13, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	160	BRCA1
NM_007294.4(BRCA1):c.478G>C (p.Gly160Arg)	BRCA1	G160R	Hereditary breast ovarian cancer syndrome	VCV001390011	17	41251861	17	43099844	1390011	1245711	rs62625285	NC_000017.11:43099843:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	160	BRCA1
NM_007294.4(BRCA1):c.478G>A (p.Gly160Arg)	BRCA1	G160R	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233928	17	41251861	17	43099844	233928	236161	rs62625285	NC_000017.11:43099843:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	160	BRCA1
NM_007294.4(BRCA1):c.476T>G (p.Leu159Arg)	BRCA1	L159R	Hereditary breast ovarian cancer syndrome|not provided	VCV002983224	17	41251863	17	43099846	2983224	3142300	NA	NC_000017.11:43099845:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	159	BRCA1
NM_007294.4(BRCA1):c.475C>T (p.Leu159Phe)	BRCA1	L159F	Hereditary cancer-predisposing syndrome	VCV003261452	17	41251864	17	43099847	3261452	3424221	NA	NC_000017.11:43099846:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	159	BRCA1
NM_007294.4(BRCA1):c.472A>G (p.Asn158Asp)	BRCA1	N158D	Hereditary cancer-predisposing syndrome	VCV003226163	17	41251867	17	43099850	3226163	3387227	NA	NC_000017.11:43099849:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	158	BRCA1
NM_007294.4(BRCA1):c.472A>C (p.Asn158His)	BRCA1	N158H	Hereditary cancer-predisposing syndrome	VCV001742698	17	41251867	17	43099850	1742698	1808781	NA	NC_000017.11:43099849:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	158	BRCA1
NM_007294.4(BRCA1):c.472A>T (p.Asn158Tyr)	BRCA1	N158Y	Familial cancer of breast	VCV000055273	17	41251867	17	43099850	55273	69940	rs397509192	NC_000017.11:43099849:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	158	BRCA1
NM_007294.4(BRCA1):c.470C>G (p.Ser157Cys)	BRCA1	S157C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055266	17	41251869	17	43099852	55266	69933	rs80357045	NC_000017.11:43099851:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	157	BRCA1
NM_007294.4(BRCA1):c.469T>C (p.Ser157Pro)	BRCA1	S157P	Hereditary breast ovarian cancer syndrome	VCV000055264	17	41251870	17	43099853	55264	69931	rs80356897	NC_000017.11:43099852:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	157	BRCA1
NM_007294.4(BRCA1):c.466C>T (p.Leu156Phe)	BRCA1	L156F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000409330	17	41251873	17	43099856	409330	402140	rs587778115	NC_000017.11:43099855:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	156	BRCA1
NM_007294.4(BRCA1):c.466C>A (p.Leu156Ile)	BRCA1	L156I	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000233464	17	41251873	17	43099856	233464	236162	rs587778115	NC_000017.11:43099855:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	156	BRCA1
NM_007294.4(BRCA1):c.466C>G (p.Leu156Val)	BRCA1	L156V	Hereditary cancer-predisposing syndrome	VCV000133722	17	41251873	17	43099856	133722	137461	rs587778115	NC_000017.11:43099855:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	156	BRCA1
NM_007294.4(BRCA1):c.465A>T (p.Gln155His)	BRCA1	Q155H	not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000232297	17	41251874	17	43099857	232297	236163	rs864622260	NC_000017.11:43099856:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	155	BRCA1
NM_007294.4(BRCA1):c.465A>C (p.Gln155His)	BRCA1	Q155H	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000219804	17	41251874	17	43099857	219804	222677	rs864622260	NC_000017.11:43099856:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	155	BRCA1
NM_007294.4(BRCA1):c.463C>G (p.Gln155Glu)	BRCA1	Q155E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055247	17	41251876	17	43099859	55247	69914	rs80357180	NC_000017.11:43099858:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	155	BRCA1
NM_007294.4(BRCA1):c.461T>C (p.Val154Ala)	BRCA1	V154A	Hereditary cancer-predisposing syndrome	VCV000921239	17	41251878	17	43099861	921239	913980	rs2054304701	NC_000017.11:43099860:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	154	BRCA1
NM_007294.4(BRCA1):c.460G>A (p.Val154Ile)	BRCA1	V154I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000418595	17	41251879	17	43099862	418595	410028	rs1064793318	NC_000017.11:43099861:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	154	BRCA1
NM_007294.4(BRCA1):c.459T>A (p.Ser153Arg)	BRCA1	S153R	not provided|Hereditary cancer-predisposing syndrome	VCV001330109	17	41251880	17	43099863	1330109	1320791	rs1555594962	NC_000017.11:43099862:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	153	BRCA1
NM_007294.4(BRCA1):c.458G>A (p.Ser153Asn)	BRCA1	S153N	not provided|Hereditary breast ovarian cancer syndrome	VCV000801078	17	41251881	17	43099864	801078	789632	rs1597888197	NC_000017.11:43099863:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	153	BRCA1
NM_007294.4(BRCA1):c.457A>G (p.Ser153Gly)	BRCA1	S153G	Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000096934	17	41251882	17	43099865	96934	102837	rs28897674	NC_000017.11:43099864:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	153	BRCA1
NM_007294.4(BRCA1):c.457A>C (p.Ser153Arg)	BRCA1	S153R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|not specified	VCV000037600	17	41251882	17	43099865	37600	46156	rs28897674	NC_000017.11:43099864:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	153	BRCA1
NM_007294.4(BRCA1):c.455T>C (p.Leu152Pro)	BRCA1	L152P	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000055227	17	41251884	17	43099867	55227	69894	rs80357275	NC_000017.11:43099866:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	152	BRCA1
NM_007294.4(BRCA1):c.453T>G (p.Ser151Arg)	BRCA1	S151R	Hereditary breast ovarian cancer syndrome	VCV000937709	17	41251886	17	43099869	937709	937977	rs1555594986	NC_000017.11:43099868:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	151	BRCA1
NM_007294.4(BRCA1):c.452G>A (p.Ser151Asn)	BRCA1	S151N	Hereditary breast ovarian cancer syndrome	VCV001988377	17	41251887	17	43099870	1988377	2047525	NA	NC_000017.11:43099869:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	151	BRCA1
NM_007294.4(BRCA1):c.449C>G (p.Thr150Ser)	BRCA1	T150S	Hereditary breast ovarian cancer syndrome	VCV001045169	17	41251890	17	43099873	1045169	1033332	rs2054306888	NC_000017.11:43099872:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	150	BRCA1
NM_007294.4(BRCA1):c.448A>G (p.Thr150Ala)	BRCA1	T150A	Hereditary breast ovarian cancer syndrome	VCV002826401	17	41251891	17	43099874	2826401	2989622	NA	NC_000017.11:43099873:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	150	BRCA1
NM_007294.4(BRCA1):c.446A>G (p.Glu149Gly)	BRCA1	E149G	Hereditary cancer-predisposing syndrome	VCV001740809	17	41251893	17	43099876	1740809	1798309	NA	NC_000017.11:43099875:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	149	BRCA1
NM_007294.4(BRCA1):c.446A>C (p.Glu149Ala)	BRCA1	E149A	not provided|Breast neoplasm|not specified|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000037594	17	41251893	17	43099876	37594	46150	rs397507233	NC_000017.11:43099875:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	149	BRCA1
NM_007294.4(BRCA1):c.445G>A (p.Glu149Lys)	BRCA1	E149K	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230088	17	41251894	17	43099877	230088	236165	rs876658381	NC_000017.11:43099876:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	149	BRCA1
NM_007294.4(BRCA1):c.443A>G (p.Gln148Arg)	BRCA1	Q148R	Hereditary breast ovarian cancer syndrome	VCV001380053	17	41251896	17	43099879	1380053	1506102	rs2154530020	NC_000017.11:43099878:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	148	BRCA1
NM_007294.4(BRCA1):c.442C>A (p.Gln148Lys)	BRCA1	Q148K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233408	17	41251897	17	43099880	233408	236167	rs876659614	NC_000017.11:43099879:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	148	BRCA1
NM_007294.4(BRCA1):c.441G>T (p.Leu147Phe)	BRCA1	L147F	Hereditary breast ovarian cancer syndrome	VCV000431199	17	41256139	17	43104122	431199	424863	rs748876625	NC_000017.11:43104121:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	147	BRCA1
NM_007294.4(BRCA1):c.441G>C (p.Leu147Phe)	BRCA1	L147F	not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000220023	17	41256139	17	43104122	220023	222678	rs748876625	NC_000017.11:43104121:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	147	BRCA1
NM_007294.4(BRCA1):c.439T>G (p.Leu147Val)	BRCA1	L147V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230275	17	41256141	17	43104124	230275	236168	rs794727800	NC_000017.11:43104123:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	147	BRCA1
NM_007294.4(BRCA1):c.437C>G (p.Ser146Cys)	BRCA1	S146C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001483910	17	41256143	17	43104126	1483910	1458693	rs1060502358	NC_000017.11:43104125:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	146	BRCA1
NM_007294.4(BRCA1):c.437C>T (p.Ser146Phe)	BRCA1	S146F	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409358	17	41256143	17	43104126	409358	402146	rs1060502358	NC_000017.11:43104125:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	146	BRCA1
NM_007294.4(BRCA1):c.436T>C (p.Ser146Pro)	BRCA1	S146P	Malignant tumor of breast	VCV000433691	17	41256144	17	43104127	433691	427567	rs1555596290	NC_000017.11:43104126:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	146	BRCA1
NM_007294.4(BRCA1):c.434C>T (p.Pro145Leu)	BRCA1	P145L	not specified|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000279704	17	41256146	17	43104129	279704	265016	rs886041143	NC_000017.11:43104128:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	145	BRCA1
NM_007294.4(BRCA1):c.433C>A (p.Pro145Thr)	BRCA1	P145T	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000846046	17	41256147	17	43104130	846046	845471	rs2054618097	NC_000017.11:43104129:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	145	BRCA1
NM_007294.4(BRCA1):c.429A>C (p.Glu143Asp)	BRCA1	E143D	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000037582	17	41256151	17	43104134	37582	46138	rs397507228	NC_000017.11:43104133:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	143	BRCA1
NM_007294.4(BRCA1):c.428A>G (p.Glu143Gly)	BRCA1	E143G	Hereditary breast ovarian cancer syndrome	VCV001044896	17	41256152	17	43104135	1044896	1033333	rs2054618893	NC_000017.11:43104134:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 30, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	143	BRCA1
NM_007294.4(BRCA1):c.427G>C (p.Glu143Gln)	BRCA1	E143Q	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232628	17	41256153	17	43104136	232628	236169	rs80356991	NC_000017.11:43104135:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	143	BRCA1
NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	BRCA1	E143K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037580	17	41256153	17	43104136	37580	46136	rs80356991	NC_000017.11:43104135:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	143	BRCA1
NM_007294.4(BRCA1):c.425C>T (p.Pro142Leu)	BRCA1	P142L	Hereditary cancer-predisposing syndrome	VCV001739155	17	41256155	17	43104138	1739155	1788152	NA	NC_000017.11:43104137:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 5, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	142	BRCA1
NM_007294.4(BRCA1):c.425C>A (p.Pro142His)	BRCA1	P142H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041823	17	41256155	17	43104138	41823	50262	rs55971303	NC_000017.11:43104137:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	142	BRCA1
NM_007294.4(BRCA1):c.424C>A (p.Pro142Thr)	BRCA1	P142T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000928212	17	41256156	17	43104139	928212	913981	rs397509156	NC_000017.11:43104138:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	142	BRCA1
NM_007294.4(BRCA1):c.424C>G (p.Pro142Ala)	BRCA1	P142A	Hereditary cancer-predisposing syndrome	VCV000055152	17	41256156	17	43104139	55152	69819	rs397509156	NC_000017.11:43104138:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 23, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	142	BRCA1
NM_007294.4(BRCA1):c.422A>T (p.Glu141Val)	BRCA1	E141V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001692970	17	41256158	17	43104141	1692970	1685410	rs2154548771	NC_000017.11:43104140:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	141	BRCA1
NM_007294.4(BRCA1):c.420T>G (p.Ser140Arg)	BRCA1	S140R	Hereditary cancer-predisposing syndrome	VCV000186399	17	41256160	17	43104143	186399	185112	rs730881448	NC_000017.11:43104142:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 15, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	140	BRCA1
NM_007294.4(BRCA1):c.419G>C (p.Ser140Thr)	BRCA1	S140T	Hereditary cancer-predisposing syndrome	VCV001738622	17	41256161	17	43104144	1738622	1790955	NA	NC_000017.11:43104143:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	140	BRCA1
NM_007294.4(BRCA1):c.419G>A (p.Ser140Asn)	BRCA1	S140N	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000418067	17	41256161	17	43104144	418067	410029	rs1064793055	NC_000017.11:43104143:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	140	BRCA1
NM_007294.4(BRCA1):c.418A>G (p.Ser140Gly)	BRCA1	S140G	not provided	VCV003366033	17	41256162	17	43104145	3366033	3525240	NA	NC_000017.11:43104144:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	140	BRCA1
NM_007294.4(BRCA1):c.416A>G (p.Gln139Arg)	BRCA1	Q139R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000185488	17	41256164	17	43104147	185488	185113	rs786202213	NC_000017.11:43104146:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	139	BRCA1
NM_007294.4(BRCA1):c.413T>G (p.Leu138Arg)	BRCA1	L138R	Hereditary cancer-predisposing syndrome	VCV001738154	17	41256167	17	43104150	1738154	1797390	NA	NC_000017.11:43104149:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	138	BRCA1
NM_007294.4(BRCA1):c.413T>C (p.Leu138Pro)	BRCA1	L138P	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000433690	17	41256167	17	43104150	433690	427568	rs200449040	NC_000017.11:43104149:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	138	BRCA1
NM_007294.4(BRCA1):c.412C>G (p.Leu138Val)	BRCA1	L138V	Hereditary cancer-predisposing syndrome	VCV000142796	17	41256168	17	43104151	142796	152510	rs587782724	NC_000017.11:43104150:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 1, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	138	BRCA1
NM_007294.4(BRCA1):c.410T>A (p.Leu137His)	BRCA1	L137H	not provided	VCV000440471	17	41256170	17	43104153	440471	432925	rs751078452	NC_000017.11:43104152:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 2, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	137	BRCA1
NM_007294.4(BRCA1):c.410T>C (p.Leu137Pro)	BRCA1	L137P	Hereditary breast ovarian cancer syndrome	VCV000216666	17	41256170	17	43104153	216666	213333	rs751078452	NC_000017.11:43104152:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	137	BRCA1
NM_007294.4(BRCA1):c.409C>T (p.Leu137Phe)	BRCA1	L137F	Hereditary breast ovarian cancer syndrome|not provided	VCV001054022	17	41256171	17	43104154	1054022	1050322	rs1350236972	NC_000017.11:43104153:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	137	BRCA1
NM_007294.4(BRCA1):c.409C>A (p.Leu137Ile)	BRCA1	L137I	Hereditary breast ovarian cancer syndrome	VCV000948029	17	41256171	17	43104154	948029	928326	rs1350236972	NC_000017.11:43104153:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 14, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	137	BRCA1
NM_007294.4(BRCA1):c.407G>C (p.Arg136Thr)	BRCA1	R136T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003069240	17	41256173	17	43104156	3069240	3229867	NA	NC_000017.11:43104155:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	136	BRCA1
NM_007294.4(BRCA1):c.407G>A (p.Arg136Lys)	BRCA1	R136K	Hereditary breast ovarian cancer syndrome	VCV001051488	17	41256173	17	43104156	1051488	1050323	rs1437476481	NC_000017.11:43104155:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	136	BRCA1
NM_007294.4(BRCA1):c.406A>G (p.Arg136Gly)	BRCA1	R136G	Hereditary breast ovarian cancer syndrome	VCV001409763	17	41256174	17	43104157	1409763	1435019	rs2154548980	NC_000017.11:43104156:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	136	BRCA1
NM_007294.4(BRCA1):c.404A>C (p.Lys135Thr)	BRCA1	K135T	Hereditary breast ovarian cancer syndrome	VCV001047505	17	41256176	17	43104159	1047505	1033334	rs2054623660	NC_000017.11:43104158:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	135	BRCA1
NM_007294.4(BRCA1):c.401C>A (p.Ala134Asp)	BRCA1	A134D	Hereditary breast ovarian cancer syndrome|not provided	VCV000643188	17	41256179	17	43104162	643188	646056	rs1597896583	NC_000017.11:43104161:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	134	BRCA1
NM_007294.4(BRCA1):c.400G>A (p.Ala134Thr)	BRCA1	A134T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000658182	17	41256180	17	43104163	658182	646057	rs1597896591	NC_000017.11:43104162:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	134	BRCA1
NM_007294.4(BRCA1):c.398G>T (p.Arg133Leu)	BRCA1	R133L	Hereditary breast ovarian cancer syndrome	VCV000658804	17	41256182	17	43104165	658804	646058	rs80357357	NC_000017.11:43104164:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	133	BRCA1
NM_007294.4(BRCA1):c.398G>A (p.Arg133His)	BRCA1	R133H	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000037557	17	41256182	17	43104165	37557	46113	rs80357357	NC_000017.11:43104164:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	133	BRCA1
NM_007294.4(BRCA1):c.397C>A (p.Arg133Ser)	BRCA1	R133S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091619	17	41256183	17	43104166	91619	97096	rs80357457	NC_000017.11:43104165:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Nov 13, 2008	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	133	BRCA1
NM_007294.4(BRCA1):c.397C>T (p.Arg133Cys)	BRCA1	R133C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055067	17	41256183	17	43104166	55067	69734	rs80357457	NC_000017.11:43104165:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	133	BRCA1
NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	BRCA1	N132K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055064	17	41256184	17	43104167	55064	69731	rs80357413	NC_000017.11:43104166:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	132	BRCA1
NM_007294.4(BRCA1):c.395A>G (p.Asn132Ser)	BRCA1	N132S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000824426	17	41256185	17	43104168	824426	813902	rs1597896639	NC_000017.11:43104167:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	132	BRCA1
NM_007294.4(BRCA1):c.392G>A (p.Arg131Lys)	BRCA1	R131K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001976881	17	41256188	17	43104171	1976881	2030867	NA	NC_000017.11:43104170:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	131	BRCA1
NM_007294.4(BRCA1):c.391A>G (p.Arg131Gly)	BRCA1	R131G	Hereditary breast ovarian cancer syndrome	VCV000584956	17	41256189	17	43104172	584956	576005	rs80357207	NC_000017.11:43104171:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	131	BRCA1
NM_007294.4(BRCA1):c.389A>G (p.Tyr130Cys)	BRCA1	Y130C	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000096919	17	41256191	17	43104174	96919	102822	rs56055578	NC_000017.11:43104173:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	130	BRCA1
NM_007294.4(BRCA1):c.389A>T (p.Tyr130Phe)	BRCA1	Y130F	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000055041	17	41256191	17	43104174	55041	69708	rs56055578	NC_000017.11:43104173:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	130	BRCA1
NM_007294.4(BRCA1):c.388T>C (p.Tyr130His)	BRCA1	Y130H	Hereditary breast ovarian cancer syndrome	VCV001051035	17	41256192	17	43104175	1051035	1050324	rs1204011551	NC_000017.11:43104174:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	130	BRCA1
NM_007294.4(BRCA1):c.386G>A (p.Gly129Asp)	BRCA1	G129D	Hereditary cancer-predisposing syndrome	VCV001735682	17	41256194	17	43104177	1735682	1790176	NA	NC_000017.11:43104176:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 27, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	129	BRCA1
NM_007294.4(BRCA1):c.386G>T (p.Gly129Val)	BRCA1	G129V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481476	17	41256194	17	43104177	481476	479543	rs764231119	NC_000017.11:43104176:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	129	BRCA1
NM_007294.4(BRCA1):c.385G>T (p.Gly129Cys)	BRCA1	G129C	Hereditary breast ovarian cancer syndrome	VCV000462625	17	41256195	17	43104178	462625	467776	rs1555596362	NC_000017.11:43104177:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	129	BRCA1
NM_007294.4(BRCA1):c.385G>A (p.Gly129Ser)	BRCA1	G129S	Hereditary breast ovarian cancer syndrome	VCV000462624	17	41256195	17	43104178	462624	467777	rs1555596362	NC_000017.11:43104177:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	129	BRCA1
NM_007294.4(BRCA1):c.383T>A (p.Met128Lys)	BRCA1	M128K	Hereditary cancer-predisposing syndrome	VCV003226146	17	41256197	17	43104180	3226146	3387210	NA	NC_000017.11:43104179:A:T	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Uncertain significance	Oct 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	128	BRCA1
NM_007294.4(BRCA1):c.383T>C (p.Met128Thr)	BRCA1	M128T	Hereditary cancer-predisposing syndrome|not provided	VCV000418065	17	41256197	17	43104180	418065	410031	rs1064793053	NC_000017.11:43104179:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	128	BRCA1
NM_007294.4(BRCA1):c.382A>G (p.Met128Val)	BRCA1	M128V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000219502	17	41256198	17	43104181	219502	222679	rs864622124	NC_000017.11:43104180:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	128	BRCA1
NM_007294.4(BRCA1):c.381T>G (p.Ser127Arg)	BRCA1	S127R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer	VCV000626904	17	41256199	17	43104182	626904	615145	rs945168715	NC_000017.11:43104181:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	127	BRCA1
NM_007294.4(BRCA1):c.380G>C (p.Ser127Thr)	BRCA1	S127T	Hereditary breast ovarian cancer syndrome	VCV002827380	17	41256200	17	43104183	2827380	2983332	NA	NC_000017.11:43104182:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	127	BRCA1
NM_007294.4(BRCA1):c.380G>T (p.Ser127Ile)	BRCA1	S127I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142655	17	41256200	17	43104183	142655	152369	rs80357189	NC_000017.11:43104182:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Sep 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	127	BRCA1
NM_007294.4(BRCA1):c.380G>A (p.Ser127Asn)	BRCA1	S127N	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055012	17	41256200	17	43104183	55012	69679	rs80357189	NC_000017.11:43104182:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	127	BRCA1
NM_007294.4(BRCA1):c.378A>T (p.Gln126His)	BRCA1	Q126H	Hereditary cancer-predisposing syndrome	VCV001734914	17	41256202	17	43104185	1734914	1793253	NA	NC_000017.11:43104184:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	126	BRCA1
NM_007294.4(BRCA1):c.377A>G (p.Gln126Arg)	BRCA1	Q126R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001734826	17	41256203	17	43104186	1734826	1796618	NA	NC_000017.11:43104185:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 26, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	126	BRCA1
NM_007294.4(BRCA1):c.373A>G (p.Ile125Val)	BRCA1	I125V	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000156193	17	41256207	17	43104190	156193	165992	rs587776489	NC_000017.11:43104189:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 12, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	125	BRCA1
NM_007294.4(BRCA1):c.372C>G (p.Ile124Met)	BRCA1	I124M	Hereditary breast ovarian cancer syndrome	VCV000584957	17	41256208	17	43104191	584957	576006	rs273900715	NC_000017.11:43104190:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	124	BRCA1
NM_007294.4(BRCA1):c.370A>C (p.Ile124Leu)	BRCA1	I124L	Hereditary breast ovarian cancer syndrome	VCV000240796	17	41256210	17	43104193	240796	242812	rs80357448	NC_000017.11:43104192:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	124	BRCA1
NM_007294.4(BRCA1):c.370A>G (p.Ile124Val)	BRCA1	I124V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054971	17	41256210	17	43104193	54971	69638	rs80357448	NC_000017.11:43104192:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	124	BRCA1
NM_007294.4(BRCA1):c.368C>T (p.Ser123Phe)	BRCA1	S123F	Hereditary cancer-predisposing syndrome	VCV003261473	17	41256212	17	43104195	3261473	3424242	NA	NC_000017.11:43104194:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	123	BRCA1
NM_007294.4(BRCA1):c.364G>T (p.Val122Phe)	BRCA1	V122F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002692289	17	41256216	17	43104199	2692289	2853291	NA	NC_000017.11:43104198:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 2, 2020	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	122	BRCA1
NM_007294.4(BRCA1):c.364G>A (p.Val122Ile)	BRCA1	V122I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001199035	17	41256216	17	43104199	1199035	1188543	rs1555596409	NC_000017.11:43104198:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	122	BRCA1
NM_007294.4(BRCA1):c.364G>C (p.Val122Leu)	BRCA1	V122L	not provided	VCV000496370	17	41256216	17	43104199	496370	487996	rs1555596409	NC_000017.11:43104198:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	122	BRCA1
NM_007294.4(BRCA1):c.362A>G (p.Glu121Gly)	BRCA1	E121G	Hereditary breast ovarian cancer syndrome	VCV000462617	17	41256218	17	43104201	462617	466916	rs1555596419	NC_000017.11:43104200:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	121	BRCA1
NM_007294.4(BRCA1):c.359A>G (p.Asp120Gly)	BRCA1	D120G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000141096	17	41256221	17	43104204	141096	150810	rs587781491	NC_000017.11:43104203:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	120	BRCA1
NM_007294.4(BRCA1):c.358G>A (p.Asp120Asn)	BRCA1	D120N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000143000	17	41256222	17	43104205	143000	152714	rs587782882	NC_000017.11:43104204:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	120	BRCA1
NM_007294.4(BRCA1):c.353T>C (p.Leu118Pro)	BRCA1	L118P	Hereditary breast ovarian cancer syndrome	VCV001001081	17	41256227	17	43104210	1001081	997594	rs2054632458	NC_000017.11:43104209:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 17, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	118	BRCA1
NM_007294.4(BRCA1):c.353T>G (p.Leu118Arg)	BRCA1	L118R	not specified	VCV000928779	17	41256227	17	43104210	928779	917263	rs2054632458	NC_000017.11:43104209:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	118	BRCA1
NM_007294.4(BRCA1):c.352C>G (p.Leu118Val)	BRCA1	L118V	Hereditary cancer-predisposing syndrome	VCV000231713	17	41256228	17	43104211	231713	236170	rs876659315	NC_000017.11:43104210:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 18, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	118	BRCA1
NM_007294.4(BRCA1):c.351T>A (p.His117Gln)	BRCA1	H117Q	Hereditary breast ovarian cancer syndrome|not specified	VCV001697608	17	41256229	17	43104212	1697608	1689992	rs2154549630	NC_000017.11:43104211:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	117	BRCA1
NM_007294.4(BRCA1):c.350A>T (p.His117Leu)	BRCA1	H117L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000859031	17	41256230	17	43104213	859031	845472	rs2054632888	NC_000017.11:43104212:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	117	BRCA1
NM_007294.4(BRCA1):c.349C>T (p.His117Tyr)	BRCA1	H117Y	Hereditary cancer-predisposing syndrome	VCV000481456	17	41256231	17	43104214	481456	479545	rs1042173379	NC_000017.11:43104213:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 17, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	117	BRCA1
NM_007294.4(BRCA1):c.347A>G (p.Glu116Gly)	BRCA1	E116G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000823821	17	41256233	17	43104216	823821	813903	rs1597896908	NC_000017.11:43104215:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	116	BRCA1
NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	BRCA1	E116K	Hereditary cancer-predisposing syndrome	VCV000054893	17	41256234	17	43104217	54893	69560	rs397509071	NC_000017.11:43104216:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	116	BRCA1
NM_007294.4(BRCA1):c.344C>T (p.Pro115Leu)	BRCA1	P115L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000232058	17	41256236	17	43104219	232058	236171	rs876659528	NC_000017.11:43104218:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	115	BRCA1
NM_007294.4(BRCA1):c.343C>T (p.Pro115Ser)	BRCA1	P115S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000482958	17	41256237	17	43104220	482958	479546	rs1468589409	NC_000017.11:43104219:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	115	BRCA1
NM_007294.4(BRCA1):c.343C>A (p.Pro115Thr)	BRCA1	P115T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462611	17	41256237	17	43104220	462611	466917	rs1468589409	NC_000017.11:43104219:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	115	BRCA1
NM_007294.4(BRCA1):c.341C>T (p.Ser114Phe)	BRCA1	S114F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000958403	17	41256239	17	43104222	958403	949964	rs786202620	NC_000017.11:43104221:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	114	BRCA1
NM_007294.4(BRCA1):c.341C>G (p.Ser114Cys)	BRCA1	S114C	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000185998	17	41256239	17	43104222	185998	185117	rs786202620	NC_000017.11:43104221:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	114	BRCA1
NM_007294.4(BRCA1):c.340T>C (p.Ser114Pro)	BRCA1	S114P	Familial cancer of breast	VCV000054870	17	41256240	17	43104223	54870	69537	rs397509062	NC_000017.11:43104222:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	114	BRCA1
NM_007294.4(BRCA1):c.339C>G (p.Asn113Lys)	BRCA1	N113K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000089058	17	41256241	17	43104224	89058	94601	rs587779367	NC_000017.11:43104223:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	113	BRCA1
NM_007294.4(BRCA1):c.338A>G (p.Asn113Ser)	BRCA1	N113S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000136084	17	41256242	17	43104225	136084	139796	rs587780800	NC_000017.11:43104224:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	113	BRCA1
NM_007294.4(BRCA1):c.337A>T (p.Asn113Tyr)	BRCA1	N113Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001730800	17	41256243	17	43104226	1730800	1785788	NA	NC_000017.11:43104225:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	113	BRCA1
NM_007294.4(BRCA1):c.335A>C (p.Asn112Thr)	BRCA1	N112T	Hereditary cancer-predisposing syndrome	VCV002560824	17	41256245	17	43104228	2560824	2716984	NA	NC_000017.11:43104227:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	112	BRCA1
NM_007294.4(BRCA1):c.335A>G (p.Asn112Ser)	BRCA1	N112S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001484628	17	41256245	17	43104228	1484628	1478166	rs2154549791	NC_000017.11:43104227:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 5, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	112	BRCA1
NM_007294.4(BRCA1):c.334A>T (p.Asn112Tyr)	BRCA1	N112Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001330050	17	41256246	17	43104229	1330050	1320733	rs587782017	NC_000017.11:43104228:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 15, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	112	BRCA1
NM_007294.4(BRCA1):c.334A>G (p.Asn112Asp)	BRCA1	N112D	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000141794	17	41256246	17	43104229	141794	151508	rs587782017	NC_000017.11:43104228:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	112	BRCA1
NM_007294.4(BRCA1):c.333A>C (p.Glu111Asp)	BRCA1	E111D	Hereditary breast ovarian cancer syndrome	VCV000569377	17	41256247	17	43104230	569377	569177	rs1567810451	NC_000017.11:43104229:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	111	BRCA1
NM_007294.4(BRCA1):c.332A>T (p.Glu111Val)	BRCA1	E111V	not provided|Hereditary cancer-predisposing syndrome	VCV000496365	17	41256248	17	43104231	496365	487997	rs80357312	NC_000017.11:43104230:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 22, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	111	BRCA1
NM_007294.4(BRCA1):c.332A>C (p.Glu111Ala)	BRCA1	E111A	not provided|Hereditary breast ovarian cancer syndrome|Endometrial carcinoma|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054844	17	41256248	17	43104231	54844	69511	rs80357312	NC_000017.11:43104230:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	111	BRCA1
NM_007294.4(BRCA1):c.331G>A (p.Glu111Lys)	BRCA1	E111K	Hereditary breast ovarian cancer syndrome	VCV000852070	17	41256249	17	43104232	852070	845473	rs1414264431	NC_000017.11:43104231:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	111	BRCA1
NM_007294.4(BRCA1):c.330G>T (p.Lys110Asn)	BRCA1	K110N	Hereditary breast ovarian cancer syndrome	VCV002039757	17	41256250	17	43104233	2039757	2091219	NA	NC_000017.11:43104232:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	110	BRCA1
NM_007294.4(BRCA1):c.330G>C (p.Lys110Asn)	BRCA1	K110N	Hereditary cancer-predisposing syndrome	VCV001730068	17	41256250	17	43104233	1730068	1792274	NA	NC_000017.11:43104232:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 2, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	110	BRCA1
NM_007294.4(BRCA1):c.329A>G (p.Lys110Arg)	BRCA1	K110R	not specified|Hereditary breast ovarian cancer syndrome	VCV001804789	17	41256251	17	43104234	1804789	1861804	NA	NC_000017.11:43104233:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	110	BRCA1
NM_007294.4(BRCA1):c.329A>C (p.Lys110Thr)	BRCA1	K110T	Familial cancer of breast	VCV000054825	17	41256251	17	43104234	54825	69492	rs397509053	NC_000017.11:43104233:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	110	BRCA1
NM_007294.4(BRCA1):c.328A>G (p.Lys110Glu)	BRCA1	K110E	Hereditary breast ovarian cancer syndrome	VCV000240790	17	41256252	17	43104235	240790	242814	rs878854946	NC_000017.11:43104234:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	110	BRCA1
NM_007294.4(BRCA1):c.325A>G (p.Lys109Glu)	BRCA1	K109E	Hereditary cancer-predisposing syndrome	VCV000479247	17	41256255	17	43104238	479247	478721	rs1555596474	NC_000017.11:43104237:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	109	BRCA1
NM_007294.4(BRCA1):c.322G>T (p.Ala108Ser)	BRCA1	A108S	Hereditary cancer-predisposing syndrome	VCV001729180	17	41256258	17	43104241	1729180	1785469	NA	NC_000017.11:43104240:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	108	BRCA1
NM_007294.4(BRCA1):c.322G>A (p.Ala108Thr)	BRCA1	A108T	Hereditary cancer-predisposing syndrome	VCV001729175	17	41256258	17	43104241	1729175	1785464	NA	NC_000017.11:43104240:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	108	BRCA1
NM_007294.4(BRCA1):c.319T>C (p.Phe107Leu)	BRCA1	F107L	Hereditary cancer-predisposing syndrome	VCV000823161	17	41256261	17	43104244	823161	813905	rs878854944	NC_000017.11:43104243:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 6, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	107	BRCA1
NM_007294.4(BRCA1):c.319T>A (p.Phe107Ile)	BRCA1	F107I	Hereditary breast ovarian cancer syndrome	VCV000240788	17	41256261	17	43104244	240788	242815	rs878854944	NC_000017.11:43104243:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	107	BRCA1
NM_007294.4(BRCA1):c.317A>C (p.Asn106Thr)	BRCA1	N106T	Hereditary cancer-predisposing syndrome	VCV001728507	17	41256263	17	43104246	1728507	1791907	NA	NC_000017.11:43104245:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	106	BRCA1
NM_007294.4(BRCA1):c.316A>C (p.Asn106His)	BRCA1	N106H	Hereditary cancer-predisposing syndrome	VCV000186420	17	41256264	17	43104247	186420	185118	rs786202937	NC_000017.11:43104246:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	106	BRCA1
NM_007294.4(BRCA1):c.314A>G (p.Tyr105Cys)	BRCA1	Y105C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054780	17	41256266	17	43104249	54780	69447	rs28897673	NC_000017.11:43104248:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	105	BRCA1
NM_007294.4(BRCA1):c.312C>A (p.Ser104Arg)	BRCA1	S104R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000433689	17	41256268	17	43104251	433689	427569	rs766484283	NC_000017.11:43104250:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	104	BRCA1
NM_007294.4(BRCA1):c.310A>C (p.Ser104Arg)	BRCA1	S104R	Hereditary breast ovarian cancer syndrome	VCV000849557	17	41256270	17	43104253	849557	845474	rs753342801	NC_000017.11:43104252:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	104	BRCA1
NM_007294.4(BRCA1):c.308A>G (p.Asn103Ser)	BRCA1	N103S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV002680208	17	41256272	17	43104255	2680208	2833935	NA	NC_000017.11:43104254:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	103	BRCA1
NM_007294.4(BRCA1):c.307A>G (p.Asn103Asp)	BRCA1	N103D	Hereditary cancer-predisposing syndrome	VCV003226131	17	41256273	17	43104256	3226131	3387195	NA	NC_000017.11:43104255:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	103	BRCA1
NM_007294.4(BRCA1):c.305C>T (p.Ala102Val)	BRCA1	A102V	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001799342	17	41256275	17	43104258	1799342	1854951	NA	NC_000017.11:43104257:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	102	BRCA1
NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	BRCA1	A102G	BRCA1-related cancer predisposition	VCV000037505	17	41256275	17	43104258	37505	46061	rs80357190	NC_000017.11:43104257:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	102	BRCA1
NM_007294.4(BRCA1):c.304G>A (p.Ala102Thr)	BRCA1	A102T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000441426	17	41256276	17	43104259	441426	435174	rs1555596491	NC_000017.11:43104258:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	102	BRCA1
NM_007294.4(BRCA1):c.302_303delinsGA (p.Tyr101Ter)	BRCA1	Y101*	Hereditary breast ovarian cancer syndrome	VCV001679002	17	41256277 - 41256278	17	43104260 - 43104261	1679002	1670796	rs2154550229	NC_000017.11:43104259:AT:TC	Indel	nonsense|non-coding transcript variant|missense variant	Pathogenic	Apr 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.303T>A (p.Tyr101Ter)	BRCA1	Y101*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266331	17	41256277	17	43104260	266331	262010	rs80356936	NC_000017.11:43104259:A:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.303T>G (p.Tyr101Ter)	BRCA1	Y101*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054758	17	41256277	17	43104260	54758	69425	rs80356936	NC_000017.11:43104259:A:C	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.302A>T (p.Tyr101Phe)	BRCA1	Y101F	Hereditary breast ovarian cancer syndrome	VCV000945287	17	41256278	17	43104261	945287	928327	rs587781798	NC_000017.11:43104260:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 30, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.302A>G (p.Tyr101Cys)	BRCA1	Y101C	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000141504	17	41256278	17	43104261	141504	151218	rs587781798	NC_000017.11:43104260:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.301T>G (p.Tyr101Asp)	BRCA1	Y101D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868832	17	41256885	17	43104868	868832	854417	rs1555596637	NC_000017.11:43104867:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.301T>A (p.Tyr101Asn)	BRCA1	Y101N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868831	17	41256885	17	43104868	868831	854418	rs1555596637	NC_000017.11:43104867:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.301T>C (p.Tyr101His)	BRCA1	Y101H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000489713	17	41256885	17	43104868	489713	482998	rs1555596637	NC_000017.11:43104867:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	101	BRCA1
NM_007294.4(BRCA1):c.300G>T (p.Glu100Asp)	BRCA1	E100D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868830	17	41256886	17	43104869	868830	854419	rs1555596638	NC_000017.11:43104868:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	100	BRCA1
NM_007294.4(BRCA1):c.300G>C (p.Glu100Asp)	BRCA1	E100D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868829	17	41256886	17	43104869	868829	854420	rs1555596638	NC_000017.11:43104868:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	100	BRCA1
NM_007294.4(BRCA1):c.299A>C (p.Glu100Ala)	BRCA1	E100A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000920309	17	41256887	17	43104870	920309	913984	rs2054670624	NC_000017.11:43104869:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	100	BRCA1
NM_007294.4(BRCA1):c.297G>C (p.Leu99Phe)	BRCA1	L99F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003240941	17	41256889	17	43104872	3240941	3399924	NA	NC_000017.11:43104871:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	99	BRCA1
NM_007294.4(BRCA1):c.296T>C (p.Leu99Ser)	BRCA1	L99S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000584958	17	41256890	17	43104873	584958	576007	rs1567811021	NC_000017.11:43104872:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 16, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	99	BRCA1
NM_007294.4(BRCA1):c.295T>G (p.Leu99Val)	BRCA1	L99V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868365	17	41256891	17	43104874	868365	854422	rs2054671155	NC_000017.11:43104873:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	99	BRCA1
NM_007294.4(BRCA1):c.293G>T (p.Gly98Val)	BRCA1	G98V	Hereditary breast ovarian cancer syndrome	VCV000868360	17	41256893	17	43104876	868360	854427	rs2054671671	NC_000017.11:43104875:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	98	BRCA1
NM_007294.4(BRCA1):c.293G>C (p.Gly98Ala)	BRCA1	G98A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865642	17	41256893	17	43104876	865642	854428	rs2054671671	NC_000017.11:43104875:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	98	BRCA1
NM_007294.4(BRCA1):c.293G>A (p.Gly98Asp)	BRCA1	G98D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865641	17	41256893	17	43104876	865641	854429	rs2054671671	NC_000017.11:43104875:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	98	BRCA1
NM_007294.4(BRCA1):c.292G>T (p.Gly98Cys)	BRCA1	G98C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865640	17	41256894	17	43104877	865640	854430	rs80357409	NC_000017.11:43104876:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	98	BRCA1
NM_007294.4(BRCA1):c.292G>A (p.Gly98Ser)	BRCA1	G98S	Hereditary cancer-predisposing syndrome	VCV000865639	17	41256894	17	43104877	865639	854431	rs80357409	NC_000017.11:43104876:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	98	BRCA1
NM_007294.4(BRCA1):c.292G>C (p.Gly98Arg)	BRCA1	G98R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054724	17	41256894	17	43104877	54724	69391	rs80357409	NC_000017.11:43104876:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 1999	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	98	BRCA1
NM_007294.4(BRCA1):c.290C>A (p.Thr97Lys)	BRCA1	T97K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865374	17	41256896	17	43104879	865374	854433	rs431825393	NC_000017.11:43104878:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	97	BRCA1
NM_007294.4(BRCA1):c.290C>T (p.Thr97Ile)	BRCA1	T97I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000133721	17	41256896	17	43104879	133721	137460	rs431825393	NC_000017.11:43104878:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	97	BRCA1
NM_007294.4(BRCA1):c.290C>G (p.Thr97Arg)	BRCA1	T97R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000096909	17	41256896	17	43104879	96909	102812	rs431825393	NC_000017.11:43104878:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	97	BRCA1
NM_007294.4(BRCA1):c.289A>T (p.Thr97Ser)	BRCA1	T97S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865373	17	41256897	17	43104880	865373	854434	rs1404795980	NC_000017.11:43104879:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	97	BRCA1
NM_007294.4(BRCA1):c.289A>C (p.Thr97Pro)	BRCA1	T97P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865372	17	41256897	17	43104880	865372	854435	rs1404795980	NC_000017.11:43104879:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	97	BRCA1
NM_007294.4(BRCA1):c.289A>G (p.Thr97Ala)	BRCA1	T97A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000441379	17	41256897	17	43104880	441379	435175	rs1404795980	NC_000017.11:43104879:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	97	BRCA1
NM_007294.4(BRCA1):c.288C>A (p.Asp96Glu)	BRCA1	D96E	Hereditary cancer-predisposing syndrome	VCV000868828	17	41256898	17	43104881	868828	854437	rs146085503	NC_000017.11:43104880:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.288C>G (p.Asp96Glu)	BRCA1	D96E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865371	17	41256898	17	43104881	865371	854436	rs146085503	NC_000017.11:43104880:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.287A>T (p.Asp96Val)	BRCA1	D96V	Hereditary cancer-predisposing syndrome	VCV000868827	17	41256899	17	43104882	868827	854438	rs864622444	NC_000017.11:43104881:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Nov 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.287A>C (p.Asp96Ala)	BRCA1	D96A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868826	17	41256899	17	43104882	868826	854439	rs864622444	NC_000017.11:43104881:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.287A>G (p.Asp96Gly)	BRCA1	D96G	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000220258	17	41256899	17	43104882	220258	222681	rs864622444	NC_000017.11:43104881:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.286G>T (p.Asp96Tyr)	BRCA1	D96Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868825	17	41256900	17	43104883	868825	854440	rs80357110	NC_000017.11:43104882:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.286G>C (p.Asp96His)	BRCA1	D96H	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462596	17	41256900	17	43104883	462596	468071	rs80357110	NC_000017.11:43104882:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 26, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.286G>A (p.Asp96Asn)	BRCA1	D96N	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000054704	17	41256900	17	43104883	54704	69371	rs80357110	NC_000017.11:43104882:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 18, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	96	BRCA1
NM_007294.4(BRCA1):c.284T>G (p.Leu95Arg)	BRCA1	L95R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868351	17	41256902	17	43104885	868351	854444	rs2054675041	NC_000017.11:43104884:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	95	BRCA1
NM_007294.4(BRCA1):c.284T>C (p.Leu95Pro)	BRCA1	L95P	Hereditary cancer-predisposing syndrome	VCV000868350	17	41256902	17	43104885	868350	854445	rs2054675041	NC_000017.11:43104884:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 14, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	95	BRCA1
NM_007294.4(BRCA1):c.284T>A (p.Leu95His)	BRCA1	L95H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868349	17	41256902	17	43104885	868349	854446	rs2054675041	NC_000017.11:43104884:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	95	BRCA1
NM_007294.4(BRCA1):c.283C>T (p.Leu95Phe)	BRCA1	L95F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868348	17	41256903	17	43104886	868348	854447	rs2054675297	NC_000017.11:43104885:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	95	BRCA1
NM_007294.4(BRCA1):c.283C>G (p.Leu95Val)	BRCA1	L95V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868347	17	41256903	17	43104886	868347	854448	rs2054675297	NC_000017.11:43104885:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	95	BRCA1
NM_007294.4(BRCA1):c.283C>A (p.Leu95Ile)	BRCA1	L95I	Hereditary cancer-predisposing syndrome	VCV000868346	17	41256903	17	43104886	868346	854449	rs2054675297	NC_000017.11:43104885:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Aug 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	95	BRCA1
NM_007294.4(BRCA1):c.282G>C (p.Gln94His)	BRCA1	Q94H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865632	17	41256904	17	43104887	865632	854450	rs1597898117	NC_000017.11:43104886:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	94	BRCA1
NM_007294.4(BRCA1):c.282G>T (p.Gln94His)	BRCA1	Q94H	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000821868	17	41256904	17	43104887	821868	813906	rs1597898117	NC_000017.11:43104886:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	94	BRCA1
NM_007294.4(BRCA1):c.281A>T (p.Gln94Leu)	BRCA1	Q94L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865630	17	41256905	17	43104888	865630	854452	rs2054675893	NC_000017.11:43104887:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	94	BRCA1
NM_007294.4(BRCA1):c.281A>G (p.Gln94Arg)	BRCA1	Q94R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000865629	17	41256905	17	43104888	865629	854453	rs2054675893	NC_000017.11:43104887:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	94	BRCA1
NM_007294.4(BRCA1):c.281A>C (p.Gln94Pro)	BRCA1	Q94P	Hereditary breast ovarian cancer syndrome	VCV000865628	17	41256905	17	43104888	865628	854454	rs2054675893	NC_000017.11:43104887:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	94	BRCA1
NM_007294.4(BRCA1):c.280C>G (p.Gln94Glu)	BRCA1	Q94E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865627	17	41256906	17	43104889	865627	854455	rs886037972	NC_000017.11:43104888:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	94	BRCA1
NM_007294.4(BRCA1):c.280C>A (p.Gln94Lys)	BRCA1	Q94K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865365	17	41256906	17	43104889	865365	854456	rs886037972	NC_000017.11:43104888:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	94	BRCA1
NM_007294.4(BRCA1):c.279T>G (p.Phe93Leu)	BRCA1	F93L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865364	17	41256907	17	43104890	865364	854457	rs2054676882	NC_000017.11:43104889:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.279T>A (p.Phe93Leu)	BRCA1	F93L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865362	17	41256907	17	43104890	865362	854459	rs2054676882	NC_000017.11:43104889:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.278T>G (p.Phe93Cys)	BRCA1	F93C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865361	17	41256908	17	43104891	865361	854460	rs2054677399	NC_000017.11:43104890:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.278T>C (p.Phe93Ser)	BRCA1	F93S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865360	17	41256908	17	43104891	865360	854461	rs2054677399	NC_000017.11:43104890:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.278T>A (p.Phe93Tyr)	BRCA1	F93Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865359	17	41256908	17	43104891	865359	854462	rs2054677399	NC_000017.11:43104890:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.277T>C (p.Phe93Leu)	BRCA1	F93L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868823	17	41256909	17	43104892	868823	854464	rs2054677674	NC_000017.11:43104891:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.277T>A (p.Phe93Ile)	BRCA1	F93I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868822	17	41256909	17	43104892	868822	854465	rs2054677674	NC_000017.11:43104891:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.277T>G (p.Phe93Val)	BRCA1	F93V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865358	17	41256909	17	43104892	865358	854463	rs2054677674	NC_000017.11:43104891:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	93	BRCA1
NM_007294.4(BRCA1):c.275C>T (p.Ala92Val)	BRCA1	A92V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868818	17	41256911	17	43104894	868818	854469	rs1597898146	NC_000017.11:43104893:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	92	BRCA1
NM_007294.4(BRCA1):c.275C>A (p.Ala92Asp)	BRCA1	A92D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868817	17	41256911	17	43104894	868817	854470	rs1597898146	NC_000017.11:43104893:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	92	BRCA1
NM_007294.4(BRCA1):c.275C>G (p.Ala92Gly)	BRCA1	A92G	Hereditary cancer-predisposing syndrome	VCV000821773	17	41256911	17	43104894	821773	813907	rs1597898146	NC_000017.11:43104893:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 6, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	92	BRCA1
NM_007294.4(BRCA1):c.274G>T (p.Ala92Ser)	BRCA1	A92S	Hereditary breast ovarian cancer syndrome	VCV000868342	17	41256912	17	43104895	868342	854471	rs863224755	NC_000017.11:43104894:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	92	BRCA1
NM_007294.4(BRCA1):c.274G>A (p.Ala92Thr)	BRCA1	A92T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868341	17	41256912	17	43104895	868341	854472	rs863224755	NC_000017.11:43104894:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	92	BRCA1
NM_007294.4(BRCA1):c.274G>C (p.Ala92Pro)	BRCA1	A92P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000216657	17	41256912	17	43104895	216657	213335	rs863224755	NC_000017.11:43104894:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 16, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	92	BRCA1
NM_007294.4(BRCA1):c.273T>G (p.Cys91Trp)	BRCA1	C91W	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054666	17	41256913	17	43104896	54666	69333	rs397509006	NC_000017.11:43104895:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	91	BRCA1
NM_007294.4(BRCA1):c.272G>T (p.Cys91Phe)	BRCA1	C91F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868338	17	41256914	17	43104897	868338	854475	rs1333635543	NC_000017.11:43104896:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	91	BRCA1
NM_007294.4(BRCA1):c.272G>C (p.Cys91Ser)	BRCA1	C91S	Hereditary cancer-predisposing syndrome	VCV000821724	17	41256914	17	43104897	821724	813908	rs1333635543	NC_000017.11:43104896:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	91	BRCA1
NM_007294.4(BRCA1):c.272G>A (p.Cys91Tyr)	BRCA1	C91Y	Breast cancer, susceptibility to|Hereditary breast ovarian cancer syndrome	VCV000545480	17	41256914	17	43104897	545480	535750	rs1333635543	NC_000017.11:43104896:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 30, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	91	BRCA1
NM_007294.4(BRCA1):c.271T>G (p.Cys91Gly)	BRCA1	C91G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865620	17	41256915	17	43104898	865620	854476	rs786203939	NC_000017.11:43104897:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	91	BRCA1
NM_007294.4(BRCA1):c.271T>A (p.Cys91Ser)	BRCA1	C91S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865619	17	41256915	17	43104898	865619	854477	rs786203939	NC_000017.11:43104897:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	91	BRCA1
NM_007294.4(BRCA1):c.271T>C (p.Cys91Arg)	BRCA1	C91R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000187707	17	41256915	17	43104898	187707	185119	rs786203939	NC_000017.11:43104897:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 26, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	91	BRCA1
NM_007294.4(BRCA1):c.270T>G (p.Ile90Met)	BRCA1	I90M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865618	17	41256916	17	43104899	865618	854478	rs1555596670	NC_000017.11:43104898:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	90	BRCA1
NM_007294.4(BRCA1):c.269T>G (p.Ile90Ser)	BRCA1	I90S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865616	17	41256917	17	43104900	865616	854480	rs80357174	NC_000017.11:43104899:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	90	BRCA1
NM_007294.4(BRCA1):c.269T>A (p.Ile90Asn)	BRCA1	I90N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865353	17	41256917	17	43104900	865353	854481	rs80357174	NC_000017.11:43104899:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	90	BRCA1
NM_007294.4(BRCA1):c.269T>C (p.Ile90Thr)	BRCA1	I90T	not provided	VCV000054651	17	41256917	17	43104900	54651	69318	rs80357174	NC_000017.11:43104899:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	90	BRCA1
NM_007294.4(BRCA1):c.268A>T (p.Ile90Phe)	BRCA1	I90F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865352	17	41256918	17	43104901	865352	854482	rs1555596673	NC_000017.11:43104900:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	90	BRCA1
NM_007294.4(BRCA1):c.268A>C (p.Ile90Leu)	BRCA1	I90L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865351	17	41256918	17	43104901	865351	854483	rs1555596673	NC_000017.11:43104900:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	90	BRCA1
NM_007294.4(BRCA1):c.268A>G (p.Ile90Val)	BRCA1	I90V	Hereditary cancer-predisposing syndrome	VCV000441388	17	41256918	17	43104901	441388	435176	rs1555596673	NC_000017.11:43104900:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	90	BRCA1
NM_007294.4(BRCA1):c.267C>G (p.Ile89Met)	BRCA1	I89M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000054642	17	41256919	17	43104902	54642	69309	rs80356963	NC_000017.11:43104901:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	89	BRCA1
NM_007294.4(BRCA1):c.266T>G (p.Ile89Ser)	BRCA1	I89S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868816	17	41256920	17	43104903	868816	854486	rs80357097	NC_000017.11:43104902:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	89	BRCA1
NM_007294.4(BRCA1):c.266T>A (p.Ile89Asn)	BRCA1	I89N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868815	17	41256920	17	43104903	868815	854487	rs80357097	NC_000017.11:43104902:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	89	BRCA1
NM_007294.4(BRCA1):c.266T>C (p.Ile89Thr)	BRCA1	I89T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054635	17	41256920	17	43104903	54635	69302	rs80357097	NC_000017.11:43104902:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	89	BRCA1
NM_007294.4(BRCA1):c.265A>T (p.Ile89Phe)	BRCA1	I89F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868814	17	41256921	17	43104904	868814	854488	rs2054681350	NC_000017.11:43104903:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	89	BRCA1
NM_007294.4(BRCA1):c.265A>G (p.Ile89Val)	BRCA1	I89V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868813	17	41256921	17	43104904	868813	854489	rs2054681350	NC_000017.11:43104903:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	89	BRCA1
NM_007294.4(BRCA1):c.265A>C (p.Ile89Leu)	BRCA1	I89L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868812	17	41256921	17	43104904	868812	854490	rs2054681350	NC_000017.11:43104903:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	89	BRCA1
NM_007294.4(BRCA1):c.264A>T (p.Lys88Asn)	BRCA1	K88N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868811	17	41256922	17	43104905	868811	854491	rs2054681664	NC_000017.11:43104904:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	88	BRCA1
NM_007294.4(BRCA1):c.264A>C (p.Lys88Asn)	BRCA1	K88N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868330	17	41256922	17	43104905	868330	854493	rs2054681664	NC_000017.11:43104904:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	88	BRCA1
NM_007294.4(BRCA1):c.263A>G (p.Lys88Arg)	BRCA1	K88R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868329	17	41256923	17	43104906	868329	854494	rs2054681969	NC_000017.11:43104905:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	88	BRCA1
NM_007294.4(BRCA1):c.263A>C (p.Lys88Thr)	BRCA1	K88T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868328	17	41256923	17	43104906	868328	854495	rs2054681969	NC_000017.11:43104905:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	88	BRCA1
NM_007294.4(BRCA1):c.262A>G (p.Lys88Glu)	BRCA1	K88E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868326	17	41256924	17	43104907	868326	854497	rs2054682199	NC_000017.11:43104906:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	88	BRCA1
NM_007294.4(BRCA1):c.262A>C (p.Lys88Gln)	BRCA1	K88Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868325	17	41256924	17	43104907	868325	854498	rs2054682199	NC_000017.11:43104906:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	88	BRCA1
NM_007294.4(BRCA1):c.261G>T (p.Leu87Phe)	BRCA1	L87F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868324	17	41256925	17	43104908	868324	854499	rs757971617	NC_000017.11:43104907:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	87	BRCA1
NM_007294.4(BRCA1):c.261G>C (p.Leu87Phe)	BRCA1	L87F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868323	17	41256925	17	43104908	868323	854500	rs757971617	NC_000017.11:43104907:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	87	BRCA1
NM_007294.4(BRCA1):c.260T>C (p.Leu87Ser)	BRCA1	L87S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865611	17	41256926	17	43104909	865611	854501	rs886040054	NC_000017.11:43104908:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	87	BRCA1
NM_007294.4(BRCA1):c.260T>G (p.Leu87Trp)	BRCA1	L87W	Hereditary cancer-predisposing syndrome|not provided	VCV000801065	17	41256926	17	43104909	801065	789633	rs886040054	NC_000017.11:43104908:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 7, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	87	BRCA1
NM_007294.4(BRCA1):c.259T>A (p.Leu87Met)	BRCA1	L87M	Hereditary breast ovarian cancer syndrome	VCV000865610	17	41256927	17	43104910	865610	854502	rs80357091	NC_000017.11:43104909:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	87	BRCA1
NM_007294.4(BRCA1):c.259T>G (p.Leu87Val)	BRCA1	L87V	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054614	17	41256927	17	43104910	54614	69281	rs80357091	NC_000017.11:43104909:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	87	BRCA1
NM_007294.4(BRCA1):c.257T>G (p.Leu86Arg)	BRCA1	L86R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865340	17	41256929	17	43104912	865340	854504	rs2054683731	NC_000017.11:43104911:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	86	BRCA1
NM_007294.4(BRCA1):c.257T>C (p.Leu86Pro)	BRCA1	L86P	Hereditary breast ovarian cancer syndrome	VCV000865339	17	41256929	17	43104912	865339	854505	rs2054683731	NC_000017.11:43104911:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	86	BRCA1
NM_007294.4(BRCA1):c.257T>A (p.Leu86Gln)	BRCA1	L86Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865338	17	41256929	17	43104912	865338	854506	rs2054683731	NC_000017.11:43104911:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	86	BRCA1
NM_007294.4(BRCA1):c.256C>G (p.Leu86Val)	BRCA1	L86V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000865336	17	41256930	17	43104913	865336	854508	rs2054684036	NC_000017.11:43104912:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	86	BRCA1
NM_007294.4(BRCA1):c.256C>A (p.Leu86Ile)	BRCA1	L86I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865335	17	41256930	17	43104913	865335	854509	rs2054684036	NC_000017.11:43104912:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	86	BRCA1
NM_007294.4(BRCA1):c.255G>C (p.Glu85Asp)	BRCA1	E85D	not specified|not provided	VCV000868809	17	41256931	17	43104914	868809	854510	rs756499058	NC_000017.11:43104913:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	85	BRCA1
NM_007294.4(BRCA1):c.255G>T (p.Glu85Asp)	BRCA1	E85D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000230500	17	41256931	17	43104914	230500	236174	rs756499058	NC_000017.11:43104913:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 5, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	85	BRCA1
NM_007294.4(BRCA1):c.254A>T (p.Glu85Val)	BRCA1	E85V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868808	17	41256932	17	43104915	868808	854511	rs2054684634	NC_000017.11:43104914:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	85	BRCA1
NM_007294.4(BRCA1):c.254A>G (p.Glu85Gly)	BRCA1	E85G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868807	17	41256932	17	43104915	868807	854512	rs2054684634	NC_000017.11:43104914:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	85	BRCA1
NM_007294.4(BRCA1):c.254A>C (p.Glu85Ala)	BRCA1	E85A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868806	17	41256932	17	43104915	868806	854513	rs2054684634	NC_000017.11:43104914:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	85	BRCA1
NM_007294.4(BRCA1):c.253G>C (p.Glu85Gln)	BRCA1	E85Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868804	17	41256933	17	43104916	868804	854515	rs2054685109	NC_000017.11:43104915:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	85	BRCA1
NM_007294.4(BRCA1):c.253G>A (p.Glu85Lys)	BRCA1	E85K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868315	17	41256933	17	43104916	868315	854516	rs2054685109	NC_000017.11:43104915:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 10, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	85	BRCA1
NM_007294.4(BRCA1):c.252A>T (p.Glu84Asp)	BRCA1	E84D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868314	17	41256934	17	43104917	868314	854517	rs2054685385	NC_000017.11:43104916:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	84	BRCA1
NM_007294.4(BRCA1):c.252A>C (p.Glu84Asp)	BRCA1	E84D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868312	17	41256934	17	43104917	868312	854519	rs2054685385	NC_000017.11:43104916:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	84	BRCA1
NM_007294.4(BRCA1):c.251A>T (p.Glu84Val)	BRCA1	E84V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868311	17	41256935	17	43104918	868311	854520	rs2054685676	NC_000017.11:43104917:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	84	BRCA1
NM_007294.4(BRCA1):c.251A>G (p.Glu84Gly)	BRCA1	E84G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868310	17	41256935	17	43104918	868310	854521	rs2054685676	NC_000017.11:43104917:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	84	BRCA1
NM_007294.4(BRCA1):c.251A>C (p.Glu84Ala)	BRCA1	E84A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868309	17	41256935	17	43104918	868309	854522	rs2054685676	NC_000017.11:43104917:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	84	BRCA1
NM_007294.4(BRCA1):c.250G>C (p.Glu84Gln)	BRCA1	E84Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865328	17	41256936	17	43104919	865328	854523	rs398122661	NC_000017.11:43104918:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	84	BRCA1
NM_007294.4(BRCA1):c.250G>A (p.Glu84Lys)	BRCA1	E84K	Hereditary breast ovarian cancer syndrome	VCV000865327	17	41256936	17	43104919	865327	854524	rs398122661	NC_000017.11:43104918:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	84	BRCA1
NM_007294.4(BRCA1):c.248T>G (p.Val83Gly)	BRCA1	V83G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865324	17	41256938	17	43104921	865324	854527	rs2054686948	NC_000017.11:43104920:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	83	BRCA1
NM_007294.4(BRCA1):c.248T>A (p.Val83Asp)	BRCA1	V83D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865323	17	41256938	17	43104921	865323	854528	rs2054686948	NC_000017.11:43104920:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	83	BRCA1
NM_007294.4(BRCA1):c.247G>C (p.Val83Leu)	BRCA1	V83L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867375	17	41256939	17	43104922	867375	854529	rs1060502343	NC_000017.11:43104921:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	83	BRCA1
NM_007294.4(BRCA1):c.247G>A (p.Val83Ile)	BRCA1	V83I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629283	17	41256939	17	43104922	629283	618700	rs1060502343	NC_000017.11:43104921:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	83	BRCA1
NM_007294.4(BRCA1):c.247G>T (p.Val83Phe)	BRCA1	V83F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000409332	17	41256939	17	43104922	409332	402561	rs1060502343	NC_000017.11:43104921:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 4, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	83	BRCA1
NM_007294.4(BRCA1):c.245T>G (p.Leu82Arg)	BRCA1	L82R	Hereditary breast ovarian cancer syndrome	VCV000867371	17	41256941	17	43104924	867371	854533	rs2054687973	NC_000017.11:43104923:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 25, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	82	BRCA1
NM_007294.4(BRCA1):c.245T>C (p.Leu82Pro)	BRCA1	L82P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867370	17	41256941	17	43104924	867370	854534	rs2054687973	NC_000017.11:43104923:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	82	BRCA1
NM_007294.4(BRCA1):c.245T>A (p.Leu82His)	BRCA1	L82H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867369	17	41256941	17	43104924	867369	854535	rs2054687973	NC_000017.11:43104923:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	82	BRCA1
NM_007294.4(BRCA1):c.244C>T (p.Leu82Phe)	BRCA1	L82F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868803	17	41256942	17	43104925	868803	854536	rs2054688287	NC_000017.11:43104924:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	82	BRCA1
NM_007294.4(BRCA1):c.244C>G (p.Leu82Val)	BRCA1	L82V	Hereditary breast ovarian cancer syndrome	VCV000868802	17	41256942	17	43104925	868802	854537	rs2054688287	NC_000017.11:43104924:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	82	BRCA1
NM_007294.4(BRCA1):c.244C>A (p.Leu82Ile)	BRCA1	L82I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868801	17	41256942	17	43104925	868801	854538	rs2054688287	NC_000017.11:43104924:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	82	BRCA1
NM_007294.4(BRCA1):c.243A>T (p.Gln81His)	BRCA1	Q81H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868800	17	41256943	17	43104926	868800	854539	rs863224418	NC_000017.11:43104925:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	81	BRCA1
NM_007294.4(BRCA1):c.243A>C (p.Gln81His)	BRCA1	Q81H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868799	17	41256943	17	43104926	868799	854540	rs863224418	NC_000017.11:43104925:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	81	BRCA1
NM_007294.4(BRCA1):c.242A>G (p.Gln81Arg)	BRCA1	Q81R	Hereditary breast ovarian cancer syndrome	VCV000868798	17	41256944	17	43104927	868798	854541	rs886040862	NC_000017.11:43104926:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	81	BRCA1
NM_007294.4(BRCA1):c.242A>C (p.Gln81Pro)	BRCA1	Q81P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865599	17	41256944	17	43104927	865599	854542	rs886040862	NC_000017.11:43104926:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	81	BRCA1
NM_007294.4(BRCA1):c.242A>T (p.Gln81Leu)	BRCA1	Q81L	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided	VCV000267217	17	41256944	17	43104927	267217	262105	rs886040862	NC_000017.11:43104926:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	81	BRCA1
NM_007294.4(BRCA1):c.241C>A (p.Gln81Lys)	BRCA1	Q81K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865598	17	41256945	17	43104928	865598	854543	rs80357350	NC_000017.11:43104927:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	81	BRCA1
NM_007294.4(BRCA1):c.241C>G (p.Gln81Glu)	BRCA1	Q81E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462586	17	41256945	17	43104928	462586	468250	rs80357350	NC_000017.11:43104927:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 5, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	81	BRCA1
NM_007294.4(BRCA1):c.240T>G (p.Ser80Arg)	BRCA1	S80R	Hereditary breast ovarian cancer syndrome	VCV000865597	17	41256946	17	43104929	865597	854544	rs2054689945	NC_000017.11:43104928:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.240T>A (p.Ser80Arg)	BRCA1	S80R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865595	17	41256946	17	43104929	865595	854546	rs2054689945	NC_000017.11:43104928:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.239G>T (p.Ser80Ile)	BRCA1	S80I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865594	17	41256947	17	43104930	865594	854547	rs2054690270	NC_000017.11:43104929:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.239G>C (p.Ser80Thr)	BRCA1	S80T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865316	17	41256947	17	43104930	865316	854548	rs2054690270	NC_000017.11:43104929:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.239G>A (p.Ser80Asn)	BRCA1	S80N	Hereditary cancer-predisposing syndrome	VCV000865315	17	41256947	17	43104930	865315	854549	rs2054690270	NC_000017.11:43104929:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.238A>T (p.Ser80Cys)	BRCA1	S80C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865314	17	41256948	17	43104931	865314	854550	rs2054690791	NC_000017.11:43104930:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.238A>G (p.Ser80Gly)	BRCA1	S80G	Hereditary breast ovarian cancer syndrome|not specified	VCV000865313	17	41256948	17	43104931	865313	854551	rs2054690791	NC_000017.11:43104930:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 6, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.238A>C (p.Ser80Arg)	BRCA1	S80R	Hereditary cancer-predisposing syndrome	VCV000865312	17	41256948	17	43104931	865312	854552	rs2054690791	NC_000017.11:43104930:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	80	BRCA1
NM_007294.4(BRCA1):c.237T>G (p.Phe79Leu)	BRCA1	F79L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865311	17	41256949	17	43104932	865311	854553	rs2054691161	NC_000017.11:43104931:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	79	BRCA1
NM_007294.4(BRCA1):c.237T>A (p.Phe79Leu)	BRCA1	F79L	not specified	VCV000865309	17	41256949	17	43104932	865309	854555	rs2054691161	NC_000017.11:43104931:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	79	BRCA1
NM_007294.4(BRCA1):c.236T>G (p.Phe79Cys)	BRCA1	F79C	Hereditary cancer-predisposing syndrome	VCV000867368	17	41256950	17	43104933	867368	854556	rs2054691717	NC_000017.11:43104932:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	79	BRCA1
NM_007294.4(BRCA1):c.236T>C (p.Phe79Ser)	BRCA1	F79S	Hereditary cancer-predisposing syndrome	VCV000867367	17	41256950	17	43104933	867367	854557	rs2054691717	NC_000017.11:43104932:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	79	BRCA1
NM_007294.4(BRCA1):c.236T>A (p.Phe79Tyr)	BRCA1	F79Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867366	17	41256950	17	43104933	867366	854558	rs2054691717	NC_000017.11:43104932:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	79	BRCA1
NM_007294.4(BRCA1):c.235T>C (p.Phe79Leu)	BRCA1	F79L	Hereditary breast ovarian cancer syndrome	VCV000867365	17	41256951	17	43104934	867365	854559	rs1597898362	NC_000017.11:43104933:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	79	BRCA1
NM_007294.4(BRCA1):c.235T>G (p.Phe79Val)	BRCA1	F79V	not specified|Hereditary breast ovarian cancer syndrome	VCV000662065	17	41256951	17	43104934	662065	646059	rs1597898362	NC_000017.11:43104933:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	79	BRCA1
NM_007294.4(BRCA1):c.234A>T (p.Arg78Ser)	BRCA1	R78S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867364	17	41256952	17	43104935	867364	854560	rs2054692277	NC_000017.11:43104934:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	78	BRCA1
NM_007294.4(BRCA1):c.234A>C (p.Arg78Ser)	BRCA1	R78S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867362	17	41256952	17	43104935	867362	854562	rs2054692277	NC_000017.11:43104934:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	78	BRCA1
NM_007294.4(BRCA1):c.233G>T (p.Arg78Ile)	BRCA1	R78I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000865587	17	41256953	17	43104936	865587	854563	rs2054692582	NC_000017.11:43104935:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	78	BRCA1
NM_007294.4(BRCA1):c.233G>C (p.Arg78Thr)	BRCA1	R78T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865586	17	41256953	17	43104936	865586	854564	rs2054692582	NC_000017.11:43104935:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	78	BRCA1
NM_007294.4(BRCA1):c.233G>A (p.Arg78Lys)	BRCA1	R78K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000865585	17	41256953	17	43104936	865585	854565	rs2054692582	NC_000017.11:43104935:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	78	BRCA1
NM_007294.4(BRCA1):c.232A>G (p.Arg78Gly)	BRCA1	R78G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865583	17	41256954	17	43104937	865583	854567	rs2054692881	NC_000017.11:43104936:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	78	BRCA1
NM_007294.4(BRCA1):c.230C>A (p.Thr77Lys)	BRCA1	T77K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865304	17	41256956	17	43104939	865304	854569	rs80357209	NC_000017.11:43104938:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	77	BRCA1
NM_007294.4(BRCA1):c.230C>T (p.Thr77Met)	BRCA1	T77M	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified	VCV000054529	17	41256956	17	43104939	54529	69196	rs80357209	NC_000017.11:43104938:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	77	BRCA1
NM_007294.4(BRCA1):c.230C>G (p.Thr77Arg)	BRCA1	T77R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054528	17	41256956	17	43104939	54528	69195	rs80357209	NC_000017.11:43104938:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	77	BRCA1
NM_007294.4(BRCA1):c.229A>T (p.Thr77Ser)	BRCA1	T77S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865303	17	41256957	17	43104940	865303	854570	rs2054694217	NC_000017.11:43104939:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	77	BRCA1
NM_007294.4(BRCA1):c.229A>G (p.Thr77Ala)	BRCA1	T77A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865302	17	41256957	17	43104940	865302	854571	rs2054694217	NC_000017.11:43104939:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	77	BRCA1
NM_007294.4(BRCA1):c.229A>C (p.Thr77Pro)	BRCA1	T77P	Hereditary breast ovarian cancer syndrome	VCV000865301	17	41256957	17	43104940	865301	854572	rs2054694217	NC_000017.11:43104939:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 14, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	77	BRCA1
NM_007294.4(BRCA1):c.228T>A (p.Ser76Arg)	BRCA1	S76R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865299	17	41256958	17	43104941	865299	854574	rs1597898400	NC_000017.11:43104940:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.228T>G (p.Ser76Arg)	BRCA1	S76R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000821040	17	41256958	17	43104941	821040	813909	rs1597898400	NC_000017.11:43104940:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.227G>T (p.Ser76Ile)	BRCA1	S76I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867989	17	41256959	17	43104942	867989	854575	rs2054694832	NC_000017.11:43104941:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.227G>C (p.Ser76Thr)	BRCA1	S76T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867988	17	41256959	17	43104942	867988	854576	rs2054694832	NC_000017.11:43104941:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.227G>A (p.Ser76Asn)	BRCA1	S76N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867987	17	41256959	17	43104942	867987	854577	rs2054694832	NC_000017.11:43104941:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.226A>T (p.Ser76Cys)	BRCA1	S76C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867986	17	41256960	17	43104943	867986	854578	rs2054695336	NC_000017.11:43104942:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.226A>G (p.Ser76Gly)	BRCA1	S76G	Hereditary cancer-predisposing syndrome	VCV000867985	17	41256960	17	43104943	867985	854579	rs2054695336	NC_000017.11:43104942:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.226A>C (p.Ser76Arg)	BRCA1	S76R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867984	17	41256960	17	43104943	867984	854580	rs2054695336	NC_000017.11:43104942:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	76	BRCA1
NM_007294.4(BRCA1):c.225A>T (p.Glu75Asp)	BRCA1	E75D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867983	17	41256961	17	43104944	867983	854581	rs2054695634	NC_000017.11:43104943:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	75	BRCA1
NM_007294.4(BRCA1):c.225A>C (p.Glu75Asp)	BRCA1	E75D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867361	17	41256961	17	43104944	867361	854583	rs2054695634	NC_000017.11:43104943:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	75	BRCA1
NM_007294.4(BRCA1):c.224A>G (p.Glu75Gly)	BRCA1	E75G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867360	17	41256962	17	43104945	867360	854584	rs2054695923	NC_000017.11:43104944:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	75	BRCA1
NM_007294.4(BRCA1):c.224A>C (p.Glu75Ala)	BRCA1	E75A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867359	17	41256962	17	43104945	867359	854585	rs2054695923	NC_000017.11:43104944:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	75	BRCA1
NM_007294.4(BRCA1):c.224A>T (p.Glu75Val)	BRCA1	E75V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000842334	17	41256962	17	43104945	842334	845476	rs2054695923	NC_000017.11:43104944:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	75	BRCA1
NM_007294.4(BRCA1):c.223G>C (p.Glu75Gln)	BRCA1	E75Q	Hereditary breast ovarian cancer syndrome	VCV000867357	17	41256963	17	43104946	867357	854587	rs1567811244	NC_000017.11:43104945:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	75	BRCA1
NM_007294.4(BRCA1):c.223G>A (p.Glu75Lys)	BRCA1	E75K	Hereditary cancer-predisposing syndrome	VCV000867356	17	41256963	17	43104946	867356	854588	rs1567811244	NC_000017.11:43104945:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	75	BRCA1
NM_007294.4(BRCA1):c.222A>T (p.Gln74His)	BRCA1	Q74H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867355	17	41256964	17	43104947	867355	854589	rs730881465	NC_000017.11:43104946:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	74	BRCA1
NM_007294.4(BRCA1):c.222A>C (p.Gln74His)	BRCA1	Q74H	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000182124	17	41256964	17	43104947	182124	180892	rs730881465	NC_000017.11:43104946:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	74	BRCA1
NM_007294.4(BRCA1):c.221A>T (p.Gln74Leu)	BRCA1	Q74L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865576	17	41256965	17	43104948	865576	854590	rs2054696806	NC_000017.11:43104947:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	74	BRCA1
NM_007294.4(BRCA1):c.221A>G (p.Gln74Arg)	BRCA1	Q74R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865575	17	41256965	17	43104948	865575	854591	rs2054696806	NC_000017.11:43104947:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	74	BRCA1
NM_007294.4(BRCA1):c.221A>C (p.Gln74Pro)	BRCA1	Q74P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865574	17	41256965	17	43104948	865574	854592	rs2054696806	NC_000017.11:43104947:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	74	BRCA1
NM_007294.4(BRCA1):c.220C>G (p.Gln74Glu)	BRCA1	Q74E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865573	17	41256966	17	43104949	865573	854593	rs80357234	NC_000017.11:43104948:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	74	BRCA1
NM_007294.4(BRCA1):c.220C>A (p.Gln74Lys)	BRCA1	Q74K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000629710	17	41256966	17	43104949	629710	618701	rs80357234	NC_000017.11:43104948:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 21, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	74	BRCA1
NM_007294.4(BRCA1):c.218T>G (p.Leu73Arg)	BRCA1	L73R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865291	17	41256968	17	43104951	865291	854596	rs2054697650	NC_000017.11:43104950:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	73	BRCA1
NM_007294.4(BRCA1):c.218T>C (p.Leu73Pro)	BRCA1	L73P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865290	17	41256968	17	43104951	865290	854597	rs2054697650	NC_000017.11:43104950:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	73	BRCA1
NM_007294.4(BRCA1):c.218T>A (p.Leu73Gln)	BRCA1	L73Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865289	17	41256968	17	43104951	865289	854598	rs2054697650	NC_000017.11:43104950:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	73	BRCA1
NM_007294.4(BRCA1):c.217C>G (p.Leu73Val)	BRCA1	L73V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865288	17	41256969	17	43104952	865288	854599	rs786201203	NC_000017.11:43104951:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	73	BRCA1
NM_007294.4(BRCA1):c.216C>G (p.Ser72Arg)	BRCA1	S72R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182123	17	41256970	17	43104953	182123	180893	rs80356967	NC_000017.11:43104952:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.216C>A (p.Ser72Arg)	BRCA1	S72R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054481	17	41256970	17	43104953	54481	69148	rs80356967	NC_000017.11:43104952:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.215G>T (p.Ser72Ile)	BRCA1	S72I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867977	17	41256971	17	43104954	867977	854600	rs2054698467	NC_000017.11:43104953:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.215G>C (p.Ser72Thr)	BRCA1	S72T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867976	17	41256971	17	43104954	867976	854601	rs2054698467	NC_000017.11:43104953:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.215G>A (p.Ser72Asn)	BRCA1	S72N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867975	17	41256971	17	43104954	867975	854602	rs2054698467	NC_000017.11:43104953:C:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.214A>T (p.Ser72Cys)	BRCA1	S72C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867974	17	41256972	17	43104955	867974	854603	rs2054698736	NC_000017.11:43104954:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.214A>G (p.Ser72Gly)	BRCA1	S72G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867973	17	41256972	17	43104955	867973	854604	rs2054698736	NC_000017.11:43104954:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.214A>C (p.Ser72Arg)	BRCA1	S72R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867972	17	41256972	17	43104955	867972	854605	rs2054698736	NC_000017.11:43104954:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	72	BRCA1
NM_007294.4(BRCA1):c.213G>T (p.Arg71Ser)	BRCA1	R71S	not specified	VCV000867971	17	41256973	17	43104956	867971	854606	rs1441240938	NC_000017.11:43104955:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	71	BRCA1
NM_007294.4(BRCA1):c.213G>C (p.Arg71Ser)	BRCA1	R71S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867354	17	41256973	17	43104956	867354	854607	rs1441240938	NC_000017.11:43104955:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	71	BRCA1
NM_007294.4(BRCA1):c.212G>C (p.Arg71Thr)	BRCA1	R71T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267512	17	41258473	17	43106456	267512	262989	rs80356913	NC_000017.11:43106455:C:G	single nucleotide variant	missense variant	Pathogenic	May 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	71	BRCA1
NM_007294.4(BRCA1):c.212G>T (p.Arg71Met)	BRCA1	R71M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185705	17	41258473	17	43106456	185705	185125	rs80356913	NC_000017.11:43106455:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	71	BRCA1
NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	BRCA1	R71K	Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000054471	17	41258473	17	43106456	54471	69138	rs80356913	NC_000017.11:43106455:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	71	BRCA1
NM_007294.4(BRCA1):c.211A>T (p.Arg71Trp)	BRCA1	R71W	Hereditary cancer-predisposing syndrome	VCV000867340	17	41258474	17	43106457	867340	854609	rs80357382	NC_000017.11:43106456:T:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 27, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	71	BRCA1
NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	BRCA1	R71G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017693	17	41258474	17	43106457	17693	32732	rs80357382	NC_000017.11:43106456:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	71	BRCA1
NM_007294.4(BRCA1):c.210A>T (p.Lys70Asn)	BRCA1	K70N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867338	17	41258475	17	43106458	867338	854611	rs2054769885	NC_000017.11:43106457:T:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	70	BRCA1
NM_007294.4(BRCA1):c.210A>C (p.Lys70Asn)	BRCA1	K70N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867336	17	41258475	17	43106458	867336	854613	rs2054769885	NC_000017.11:43106457:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	70	BRCA1
NM_007294.4(BRCA1):c.209A>G (p.Lys70Arg)	BRCA1	K70R	Hereditary breast ovarian cancer syndrome	VCV000868789	17	41258476	17	43106459	868789	854615	rs2054770216	NC_000017.11:43106458:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	70	BRCA1
NM_007294.4(BRCA1):c.209A>C (p.Lys70Thr)	BRCA1	K70T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868788	17	41258476	17	43106459	868788	854616	rs2054770216	NC_000017.11:43106458:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	70	BRCA1
NM_007294.4(BRCA1):c.209A>T (p.Lys70Ile)	BRCA1	K70I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867335	17	41258476	17	43106459	867335	854614	rs2054770216	NC_000017.11:43106458:T:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	70	BRCA1
NM_007294.4(BRCA1):c.208A>G (p.Lys70Glu)	BRCA1	K70E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868786	17	41258477	17	43106460	868786	854618	rs2054770550	NC_000017.11:43106459:T:C	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	70	BRCA1
NM_007294.4(BRCA1):c.208A>C (p.Lys70Gln)	BRCA1	K70Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868785	17	41258477	17	43106460	868785	854619	rs2054770550	NC_000017.11:43106459:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	70	BRCA1
NM_007294.4(BRCA1):c.206_207delinsTG (p.Thr69Met)	BRCA1	T69M	not specified	VCV003336480	17	41258478 - 41258479	17	43106461 - 43106462	3336480	3495157	NA	NC_000017.11:43106460:GG:CA	Indel	missense variant|intron variant	Uncertain significance	May 21, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	69	BRCA1
NM_007294.4(BRCA1):c.206C>G (p.Thr69Ser)	BRCA1	T69S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868282	17	41258479	17	43106462	868282	854621	rs273898675	NC_000017.11:43106461:G:C	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	69	BRCA1
NM_007294.4(BRCA1):c.206C>T (p.Thr69Ile)	BRCA1	T69I	not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000441428	17	41258479	17	43106462	441428	435177	rs273898675	NC_000017.11:43106461:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	69	BRCA1
NM_007294.4(BRCA1):c.206C>A (p.Thr69Asn)	BRCA1	T69N	Hereditary breast ovarian cancer syndrome	VCV000054450	17	41258479	17	43106462	54450	69117	rs273898675	NC_000017.11:43106461:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	69	BRCA1
NM_007294.4(BRCA1):c.205A>T (p.Thr69Ser)	BRCA1	T69S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868281	17	41258480	17	43106463	868281	854622	rs2054771433	NC_000017.11:43106462:T:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	69	BRCA1
NM_007294.4(BRCA1):c.205A>G (p.Thr69Ala)	BRCA1	T69A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868280	17	41258480	17	43106463	868280	854623	rs2054771433	NC_000017.11:43106462:T:C	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	69	BRCA1
NM_007294.4(BRCA1):c.205A>C (p.Thr69Pro)	BRCA1	T69P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868279	17	41258480	17	43106463	868279	854624	rs2054771433	NC_000017.11:43106462:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	69	BRCA1
NM_007294.4(BRCA1):c.204A>G (p.Ile68Met)	BRCA1	I68M	Hereditary breast ovarian cancer syndrome	VCV000868278	17	41258481	17	43106464	868278	854625	rs1555597192	NC_000017.11:43106463:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	68	BRCA1
NM_007294.4(BRCA1):c.203T>C (p.Ile68Thr)	BRCA1	I68T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867942	17	41258482	17	43106465	867942	854627	rs80357116	NC_000017.11:43106464:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	68	BRCA1
NM_007294.4(BRCA1):c.203T>G (p.Ile68Arg)	BRCA1	I68R	Hereditary breast ovarian cancer syndrome|not provided	VCV000054445	17	41258482	17	43106465	54445	69112	rs80357116	NC_000017.11:43106464:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	68	BRCA1
NM_007294.4(BRCA1):c.203T>A (p.Ile68Lys)	BRCA1	I68K	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054444	17	41258482	17	43106465	54444	69111	rs80357116	NC_000017.11:43106464:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	68	BRCA1
NM_007294.4(BRCA1):c.202A>T (p.Ile68Leu)	BRCA1	I68L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867941	17	41258483	17	43106466	867941	854628	rs1555597195	NC_000017.11:43106465:T:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	68	BRCA1
NM_007294.4(BRCA1):c.202A>C (p.Ile68Leu)	BRCA1	I68L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867940	17	41258483	17	43106466	867940	854629	rs1555597195	NC_000017.11:43106465:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	68	BRCA1
NM_007294.4(BRCA1):c.202A>G (p.Ile68Val)	BRCA1	I68V	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479193	17	41258483	17	43106466	479193	478888	rs1555597195	NC_000017.11:43106465:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	68	BRCA1
NM_007294.4(BRCA1):c.201T>A (p.Asp67Glu)	BRCA1	D67E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867327	17	41258484	17	43106467	867327	854630	rs80357033	NC_000017.11:43106466:A:T	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.201T>G (p.Asp67Glu)	BRCA1	D67E	not provided	VCV000054439	17	41258484	17	43106467	54439	69106	rs80357033	NC_000017.11:43106466:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.200A>G (p.Asp67Gly)	BRCA1	D67G	Hereditary cancer-predisposing syndrome	VCV000867326	17	41258485	17	43106468	867326	854631	rs1060502331	NC_000017.11:43106467:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.200A>C (p.Asp67Ala)	BRCA1	D67A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000867325	17	41258485	17	43106468	867325	854632	rs1060502331	NC_000017.11:43106467:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.200A>T (p.Asp67Val)	BRCA1	D67V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000409307	17	41258485	17	43106468	409307	402154	rs1060502331	NC_000017.11:43106467:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.199G>C (p.Asp67His)	BRCA1	D67H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867324	17	41258486	17	43106469	867324	854633	rs80357102	NC_000017.11:43106468:C:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.199G>A (p.Asp67Asn)	BRCA1	D67N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091572	17	41258486	17	43106469	91572	97049	rs80357102	NC_000017.11:43106468:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2006	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	BRCA1	D67Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054431	17	41258486	17	43106469	54431	69098	rs80357102	NC_000017.11:43106468:C:A	single nucleotide variant	missense variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	67	BRCA1
NM_007294.4(BRCA1):c.198T>G (p.Asn66Lys)	BRCA1	N66K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865251	17	41258487	17	43106470	865251	854634	rs878854936	NC_000017.11:43106469:A:C	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.198T>A (p.Asn66Lys)	BRCA1	N66K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000820472	17	41258487	17	43106470	820472	813910	rs878854936	NC_000017.11:43106469:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.197A>T (p.Asn66Ile)	BRCA1	N66I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865250	17	41258488	17	43106471	865250	854635	rs2054774560	NC_000017.11:43106470:T:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.197A>G (p.Asn66Ser)	BRCA1	N66S	Hereditary cancer-predisposing syndrome	VCV000865249	17	41258488	17	43106471	865249	854636	rs2054774560	NC_000017.11:43106470:T:C	single nucleotide variant	missense variant	Likely benign	May 31, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.197A>C (p.Asn66Thr)	BRCA1	N66T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865248	17	41258488	17	43106471	865248	854637	rs2054774560	NC_000017.11:43106470:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.196A>C (p.Asn66His)	BRCA1	N66H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868271	17	41258489	17	43106472	868271	854640	rs2054774871	NC_000017.11:43106471:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.196A>T (p.Asn66Tyr)	BRCA1	N66Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865247	17	41258489	17	43106472	865247	854638	rs2054774871	NC_000017.11:43106471:T:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.196A>G (p.Asn66Asp)	BRCA1	N66D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865246	17	41258489	17	43106472	865246	854639	rs2054774871	NC_000017.11:43106471:T:C	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	66	BRCA1
NM_007294.4(BRCA1):c.195G>T (p.Lys65Asn)	BRCA1	K65N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868270	17	41258490	17	43106473	868270	854641	rs2054775153	NC_000017.11:43106472:C:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	65	BRCA1
NM_007294.4(BRCA1):c.195G>C (p.Lys65Asn)	BRCA1	K65N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868269	17	41258490	17	43106473	868269	854642	rs2054775153	NC_000017.11:43106472:C:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	65	BRCA1
NM_007294.4(BRCA1):c.194A>T (p.Lys65Met)	BRCA1	K65M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868267	17	41258491	17	43106474	868267	854644	rs2054775618	NC_000017.11:43106473:T:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	65	BRCA1
NM_007294.4(BRCA1):c.194A>G (p.Lys65Arg)	BRCA1	K65R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868266	17	41258491	17	43106474	868266	854645	rs2054775618	NC_000017.11:43106473:T:C	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	65	BRCA1
NM_007294.4(BRCA1):c.194A>C (p.Lys65Thr)	BRCA1	K65T	Hereditary breast ovarian cancer syndrome	VCV000868265	17	41258491	17	43106474	868265	854646	rs2054775618	NC_000017.11:43106473:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	65	BRCA1
NM_007294.4(BRCA1):c.193A>C (p.Lys65Gln)	BRCA1	K65Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867932	17	41258492	17	43106475	867932	854648	rs756948486	NC_000017.11:43106474:T:G	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	65	BRCA1
NM_007294.4(BRCA1):c.193A>G (p.Lys65Glu)	BRCA1	K65E	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531303	17	41258492	17	43106475	531303	531351	rs756948486	NC_000017.11:43106474:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	65	BRCA1
NM_007294.4(BRCA1):c.192T>G (p.Cys64Trp)	BRCA1	C64W	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Breast neoplasm	VCV000224427	17	41258493	17	43106476	224427	226211	rs587781632	NC_000017.11:43106475:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 18, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	64	BRCA1
NM_007294.4(BRCA1):c.191G>T (p.Cys64Phe)	BRCA1	C64F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867930	17	41258494	17	43106477	867930	854650	rs55851803	NC_000017.11:43106476:C:A	single nucleotide variant	missense variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	64	BRCA1
NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	BRCA1	C64S	Hereditary breast ovarian cancer syndrome	VCV000462571	17	41258494	17	43106477	462571	468251	rs55851803	NC_000017.11:43106476:C:G	single nucleotide variant	missense variant	Pathogenic	Nov 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	64	BRCA1
NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	BRCA1	C64Y	BRCA1-related cancer predisposition	VCV000054400	17	41258494	17	43106477	54400	69067	rs55851803	NC_000017.11:43106476:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 11, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	64	BRCA1
NM_007294.4(BRCA1):c.190T>A (p.Cys64Ser)	BRCA1	C64S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867317	17	41258495	17	43106478	867317	854651	rs80357064	NC_000017.11:43106477:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Aug 26, 2022	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	64	BRCA1
NM_007294.4(BRCA1):c.190T>C (p.Cys64Arg)	BRCA1	C64R	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054394	17	41258495	17	43106478	54394	69061	rs80357064	NC_000017.11:43106477:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jul 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	64	BRCA1
NM_007294.4(BRCA1):c.190T>G (p.Cys64Gly)	BRCA1	C64G	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000017660	17	41258495	17	43106478	17660	32699	rs80357064	NC_000017.11:43106477:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	64	BRCA1
NM_007294.4(BRCA1):c.189A>C (p.Leu63Phe)	BRCA1	L63F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867315	17	41258496	17	43106479	867315	854653	rs80356956	NC_000017.11:43106478:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	63	BRCA1
NM_007294.4(BRCA1):c.189A>T (p.Leu63Phe)	BRCA1	L63F	not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054389	17	41258496	17	43106479	54389	69056	rs80356956	NC_000017.11:43106478:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	63	BRCA1
NM_007294.4(BRCA1):c.188T>C (p.Leu63Ser)	BRCA1	L63S	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000054382	17	41258497	17	43106480	54382	69049	rs80357086	NC_000017.11:43106479:A:G	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	63	BRCA1
NM_007294.4(BRCA1):c.187T>G (p.Leu63Val)	BRCA1	L63V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865239	17	41258498	17	43106481	865239	854655	rs2054778672	NC_000017.11:43106480:A:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	63	BRCA1
NM_007294.4(BRCA1):c.187T>A (p.Leu63Ile)	BRCA1	L63I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865237	17	41258498	17	43106481	865237	854657	rs2054778672	NC_000017.11:43106480:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	63	BRCA1
NM_007294.4(BRCA1):c.185C>A (p.Pro62His)	BRCA1	P62H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868257	17	41258500	17	43106483	868257	854662	rs786202286	NC_000017.11:43106482:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	62	BRCA1
NM_007294.4(BRCA1):c.185C>T (p.Pro62Leu)	BRCA1	P62L	not provided|Hereditary breast ovarian cancer syndrome	VCV000865233	17	41258500	17	43106483	865233	854661	rs786202286	NC_000017.11:43106482:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	62	BRCA1
NM_007294.4(BRCA1):c.185C>G (p.Pro62Arg)	BRCA1	P62R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185578	17	41258500	17	43106483	185578	185126	rs786202286	NC_000017.11:43106482:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	62	BRCA1
NM_007294.4(BRCA1):c.184C>T (p.Pro62Ser)	BRCA1	P62S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868256	17	41258501	17	43106484	868256	854663	rs2054779515	NC_000017.11:43106483:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	62	BRCA1
NM_007294.4(BRCA1):c.184C>G (p.Pro62Ala)	BRCA1	P62A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868255	17	41258501	17	43106484	868255	854664	rs2054779515	NC_000017.11:43106483:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	62	BRCA1
NM_007294.4(BRCA1):c.184C>A (p.Pro62Thr)	BRCA1	P62T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868254	17	41258501	17	43106484	868254	854665	rs2054779515	NC_000017.11:43106483:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	62	BRCA1
NM_007294.4(BRCA1):c.183T>G (p.Cys61Trp)	BRCA1	C61W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868253	17	41258502	17	43106485	868253	854666	rs895070717	NC_000017.11:43106484:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	61	BRCA1
NM_007294.4(BRCA1):c.182G>T (p.Cys61Phe)	BRCA1	C61F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867923	17	41258503	17	43106486	867923	854668	rs80357093	NC_000017.11:43106485:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	61	BRCA1
NM_007294.4(BRCA1):c.182G>C (p.Cys61Ser)	BRCA1	C61S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867922	17	41258503	17	43106486	867922	854669	rs80357093	NC_000017.11:43106485:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	61	BRCA1
NM_007294.4(BRCA1):c.182G>A (p.Cys61Tyr)	BRCA1	C61Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054364	17	41258503	17	43106486	54364	69031	rs80357093	NC_000017.11:43106485:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	61	BRCA1
NM_007294.4(BRCA1):c.181T>C (p.Cys61Arg)	BRCA1	C61R	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054360	17	41258504	17	43106487	54360	69027	rs28897672	NC_000017.11:43106486:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 28, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	61	BRCA1
NM_007294.4(BRCA1):c.181T>A (p.Cys61Ser)	BRCA1	C61S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054359	17	41258504	17	43106487	54359	69026	rs28897672	NC_000017.11:43106486:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 2, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	61	BRCA1
NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	BRCA1	C61G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017661	17	41258504	17	43106487	17661	32700	rs28897672	NC_000017.11:43106486:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	61	BRCA1
NM_007294.4(BRCA1):c.180G>T (p.Gln60His)	BRCA1	Q60H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867921	17	41258505	17	43106488	867921	854670	rs2054781252	NC_000017.11:43106487:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	60	BRCA1
NM_007294.4(BRCA1):c.180G>C (p.Gln60His)	BRCA1	Q60H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867920	17	41258505	17	43106488	867920	854671	rs2054781252	NC_000017.11:43106487:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	60	BRCA1
NM_007294.4(BRCA1):c.179A>T (p.Gln60Leu)	BRCA1	Q60L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867307	17	41258506	17	43106489	867307	854673	rs373655067	NC_000017.11:43106488:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	60	BRCA1
NM_007294.4(BRCA1):c.179A>C (p.Gln60Pro)	BRCA1	Q60P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867306	17	41258506	17	43106489	867306	854674	rs373655067	NC_000017.11:43106488:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	60	BRCA1
NM_007294.4(BRCA1):c.179A>G (p.Gln60Arg)	BRCA1	Q60R	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000141093	17	41258506	17	43106489	141093	150807	rs373655067	NC_000017.11:43106488:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	60	BRCA1
NM_007294.4(BRCA1):c.178C>G (p.Gln60Glu)	BRCA1	Q60E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867305	17	41258507	17	43106490	867305	854675	rs80357471	NC_000017.11:43106489:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	60	BRCA1
NM_007294.4(BRCA1):c.178C>A (p.Gln60Lys)	BRCA1	Q60K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867304	17	41258507	17	43106490	867304	854676	rs80357471	NC_000017.11:43106489:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	60	BRCA1
NM_007294.4(BRCA1):c.176C>T (p.Ser59Leu)	BRCA1	S59L	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000820046	17	41258509	17	43106492	820046	813911	rs199522616	NC_000017.11:43106491:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	59	BRCA1
NM_007294.4(BRCA1):c.175T>G (p.Ser59Ala)	BRCA1	S59A	Hereditary cancer-predisposing syndrome	VCV000865225	17	41258510	17	43106493	865225	854681	rs2054783250	NC_000017.11:43106492:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 27, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	59	BRCA1
NM_007294.4(BRCA1):c.175T>C (p.Ser59Pro)	BRCA1	S59P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865224	17	41258510	17	43106493	865224	854682	rs2054783250	NC_000017.11:43106492:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	59	BRCA1
NM_007294.4(BRCA1):c.175T>A (p.Ser59Thr)	BRCA1	S59T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865223	17	41258510	17	43106493	865223	854683	rs2054783250	NC_000017.11:43106492:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	59	BRCA1
NM_007294.4(BRCA1):c.173C>T (p.Pro58Leu)	BRCA1	P58L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868244	17	41258512	17	43106495	868244	854687	rs2054783819	NC_000017.11:43106494:G:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	58	BRCA1
NM_007294.4(BRCA1):c.173C>G (p.Pro58Arg)	BRCA1	P58R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868243	17	41258512	17	43106495	868243	854688	rs2054783819	NC_000017.11:43106494:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	58	BRCA1
NM_007294.4(BRCA1):c.173C>A (p.Pro58His)	BRCA1	P58H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868242	17	41258512	17	43106495	868242	854689	rs2054783819	NC_000017.11:43106494:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	58	BRCA1
NM_007294.4(BRCA1):c.171_172delinsTT (p.Pro58Ser)	BRCA1	P58S	Hereditary cancer-predisposing syndrome	VCV003226108	17	41258513 - 41258514	17	43106496 - 43106497	3226108	3390613	NA	NC_000017.11:43106495:GC:AA	Indel	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	58	BRCA1
NM_007294.4(BRCA1):c.172C>T (p.Pro58Ser)	BRCA1	P58S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252393	17	41258513	17	43106496	252393	246829	rs397508904	NC_000017.11:43106495:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 14, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	58	BRCA1
NM_007294.4(BRCA1):c.172C>A (p.Pro58Thr)	BRCA1	P58T	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000182122	17	41258513	17	43106496	182122	180894	rs397508904	NC_000017.11:43106495:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	58	BRCA1
NM_007294.4(BRCA1):c.172C>G (p.Pro58Ala)	BRCA1	P58A	not provided|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000054337	17	41258513	17	43106496	54337	69004	rs397508904	NC_000017.11:43106495:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	58	BRCA1
NM_007294.4(BRCA1):c.170G>A (p.Gly57Glu)	BRCA1	G57E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001778531	17	41258515	17	43106498	1778531	1834503	NA	NC_000017.11:43106497:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	57	BRCA1
NM_007294.4(BRCA1):c.170G>T (p.Gly57Val)	BRCA1	G57V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867912	17	41258515	17	43106498	867912	854690	rs1597900455	NC_000017.11:43106497:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	57	BRCA1
NM_007294.4(BRCA1):c.170G>C (p.Gly57Ala)	BRCA1	G57A	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000801060	17	41258515	17	43106498	801060	789635	rs1597900455	NC_000017.11:43106497:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 2, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	57	BRCA1
NM_007294.4(BRCA1):c.169G>A (p.Gly57Arg)	BRCA1	G57R	Hereditary cancer-predisposing syndrome	VCV000482934	17	41258516	17	43106499	482934	478819	rs879255289	NC_000017.11:43106498:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 2, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	57	BRCA1
NM_007294.4(BRCA1):c.169G>C (p.Gly57Arg)	BRCA1	G57R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000252391	17	41258516	17	43106499	252391	246830	rs879255289	NC_000017.11:43106498:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	57	BRCA1
NM_007294.4(BRCA1):c.168A>C (p.Lys56Asn)	BRCA1	K56N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867910	17	41258517	17	43106500	867910	854692	rs397508898	NC_000017.11:43106499:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	56	BRCA1
NM_007294.4(BRCA1):c.168A>T (p.Lys56Asn)	BRCA1	K56N	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000054325	17	41258517	17	43106500	54325	68992	rs397508898	NC_000017.11:43106499:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	56	BRCA1
NM_007294.4(BRCA1):c.167A>T (p.Lys56Ile)	BRCA1	K56I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867909	17	41258518	17	43106501	867909	854693	rs397508897	NC_000017.11:43106500:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	56	BRCA1
NM_007294.4(BRCA1):c.167A>C (p.Lys56Thr)	BRCA1	K56T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867296	17	41258518	17	43106501	867296	854694	rs397508897	NC_000017.11:43106500:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	56	BRCA1
NM_007294.4(BRCA1):c.167A>G (p.Lys56Arg)	BRCA1	K56R	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054324	17	41258518	17	43106501	54324	68991	rs397508897	NC_000017.11:43106500:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	56	BRCA1
NM_007294.4(BRCA1):c.166A>G (p.Lys56Glu)	BRCA1	K56E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867294	17	41258519	17	43106502	867294	854696	rs2054785999	NC_000017.11:43106501:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	56	BRCA1
NM_007294.4(BRCA1):c.166A>C (p.Lys56Gln)	BRCA1	K56Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867293	17	41258519	17	43106502	867293	854697	rs2054785999	NC_000017.11:43106501:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	56	BRCA1
NM_007294.4(BRCA1):c.165G>T (p.Lys55Asn)	BRCA1	K55N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867292	17	41258520	17	43106503	867292	854698	rs1597900495	NC_000017.11:43106502:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	55	BRCA1
NM_007294.4(BRCA1):c.165G>C (p.Lys55Asn)	BRCA1	K55N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867291	17	41258520	17	43106503	867291	854699	rs1597900495	NC_000017.11:43106502:C:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	55	BRCA1
NM_007294.4(BRCA1):c.164A>T (p.Lys55Met)	BRCA1	K55M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867290	17	41258521	17	43106504	867290	854700	rs2054786724	NC_000017.11:43106503:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	55	BRCA1
NM_007294.4(BRCA1):c.164A>C (p.Lys55Thr)	BRCA1	K55T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865218	17	41258521	17	43106504	865218	854701	rs2054786724	NC_000017.11:43106503:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	55	BRCA1
NM_007294.4(BRCA1):c.164A>G (p.Lys55Arg)	BRCA1	K55R	Hereditary breast ovarian cancer syndrome	VCV000433686	17	41258521	17	43106504	433686	427572	rs2054786724	NC_000017.11:43106503:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	55	BRCA1
NM_007294.4(BRCA1):c.163A>G (p.Lys55Glu)	BRCA1	K55E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865216	17	41258522	17	43106505	865216	854703	rs2054787010	NC_000017.11:43106504:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	55	BRCA1
NM_007294.4(BRCA1):c.163A>C (p.Lys55Gln)	BRCA1	K55Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865215	17	41258522	17	43106505	865215	854704	rs2054787010	NC_000017.11:43106504:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	55	BRCA1
NM_007294.4(BRCA1):c.162G>T (p.Gln54His)	BRCA1	Q54H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865214	17	41258523	17	43106506	865214	854705	rs772226744	NC_000017.11:43106505:C:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	54	BRCA1
NM_007294.4(BRCA1):c.162G>C (p.Gln54His)	BRCA1	Q54H	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000865213	17	41258523	17	43106506	865213	854706	rs772226744	NC_000017.11:43106505:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	54	BRCA1
NM_007294.4(BRCA1):c.161A>T (p.Gln54Leu)	BRCA1	Q54L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868236	17	41258524	17	43106507	868236	854708	rs397507189	NC_000017.11:43106506:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	54	BRCA1
NM_007294.4(BRCA1):c.161A>C (p.Gln54Pro)	BRCA1	Q54P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868235	17	41258524	17	43106507	868235	854709	rs397507189	NC_000017.11:43106506:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	54	BRCA1
NM_007294.4(BRCA1):c.161A>G (p.Gln54Arg)	BRCA1	Q54R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037422	17	41258524	17	43106507	37422	45978	rs397507189	NC_000017.11:43106506:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	54	BRCA1
NM_007294.4(BRCA1):c.160C>G (p.Gln54Glu)	BRCA1	Q54E	Hereditary breast ovarian cancer syndrome	VCV000868234	17	41258525	17	43106508	868234	854710	rs80356864	NC_000017.11:43106507:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	54	BRCA1
NM_007294.4(BRCA1):c.160C>A (p.Gln54Lys)	BRCA1	Q54K	Hereditary breast ovarian cancer syndrome	VCV000091559	17	41258525	17	43106508	91559	97036	rs80356864	NC_000017.11:43106507:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	54	BRCA1
NM_007294.4(BRCA1):c.159C>G (p.Asn53Lys)	BRCA1	N53K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868233	17	41258526	17	43106509	868233	854711	rs1060504588	NC_000017.11:43106508:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.159C>A (p.Asn53Lys)	BRCA1	N53K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867901	17	41258526	17	43106509	867901	854712	rs1060504588	NC_000017.11:43106508:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.158A>T (p.Asn53Ile)	BRCA1	N53I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867900	17	41258527	17	43106510	867900	854713	rs1438140067	NC_000017.11:43106509:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.158A>G (p.Asn53Ser)	BRCA1	N53S	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000867899	17	41258527	17	43106510	867899	854714	rs1438140067	NC_000017.11:43106509:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.158A>C (p.Asn53Thr)	BRCA1	N53T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867898	17	41258527	17	43106510	867898	854715	rs1438140067	NC_000017.11:43106509:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.157A>T (p.Asn53Tyr)	BRCA1	N53Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867897	17	41258528	17	43106511	867897	854716	rs2054788992	NC_000017.11:43106510:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.157A>G (p.Asn53Asp)	BRCA1	N53D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867896	17	41258528	17	43106511	867896	854717	rs2054788992	NC_000017.11:43106510:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.157A>C (p.Asn53His)	BRCA1	N53H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867895	17	41258528	17	43106511	867895	854718	rs2054788992	NC_000017.11:43106510:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	53	BRCA1
NM_007294.4(BRCA1):c.155T>G (p.Leu52Arg)	BRCA1	L52R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867283	17	41258530	17	43106513	867283	854722	rs1060502346	NC_000017.11:43106512:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	52	BRCA1
NM_007294.4(BRCA1):c.155T>A (p.Leu52His)	BRCA1	L52H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867282	17	41258530	17	43106513	867282	854723	rs1060502346	NC_000017.11:43106512:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	52	BRCA1
NM_007294.4(BRCA1):c.155T>C (p.Leu52Pro)	BRCA1	L52P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000409340	17	41258530	17	43106513	409340	402567	rs1060502346	NC_000017.11:43106512:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	52	BRCA1
NM_007294.4(BRCA1):c.154C>G (p.Leu52Val)	BRCA1	L52V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867281	17	41258531	17	43106514	867281	854724	rs80357084	NC_000017.11:43106513:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	52	BRCA1
NM_007294.4(BRCA1):c.154C>A (p.Leu52Ile)	BRCA1	L52I	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091556	17	41258531	17	43106514	91556	97033	rs80357084	NC_000017.11:43106513:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	52	BRCA1
NM_007294.4(BRCA1):c.154C>T (p.Leu52Phe)	BRCA1	L52F	Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000037421	17	41258531	17	43106514	37421	45977	rs80357084	NC_000017.11:43106513:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	52	BRCA1
NM_007294.4(BRCA1):c.152T>G (p.Leu51Arg)	BRCA1	L51R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865205	17	41258533	17	43106516	865205	854727	rs1555597285	NC_000017.11:43106515:A:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	51	BRCA1
NM_007294.4(BRCA1):c.152T>A (p.Leu51His)	BRCA1	L51H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865204	17	41258533	17	43106516	865204	854728	rs1555597285	NC_000017.11:43106515:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	51	BRCA1
NM_007294.4(BRCA1):c.152T>C (p.Leu51Pro)	BRCA1	L51P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000433685	17	41258533	17	43106516	433685	427573	rs1555597285	NC_000017.11:43106515:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	51	BRCA1
NM_007294.4(BRCA1):c.151C>A (p.Leu51Ile)	BRCA1	L51I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868228	17	41258534	17	43106517	868228	854731	rs2054790774	NC_000017.11:43106516:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	51	BRCA1
NM_007294.4(BRCA1):c.151C>T (p.Leu51Phe)	BRCA1	L51F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865203	17	41258534	17	43106517	865203	854729	rs2054790774	NC_000017.11:43106516:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	51	BRCA1
NM_007294.4(BRCA1):c.151C>G (p.Leu51Val)	BRCA1	L51V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865202	17	41258534	17	43106517	865202	854730	rs2054790774	NC_000017.11:43106516:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	51	BRCA1
NM_007294.4(BRCA1):c.150A>C (p.Lys50Asn)	BRCA1	K50N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868227	17	41258535	17	43106518	868227	854732	rs1555597289	NC_000017.11:43106517:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	50	BRCA1
NM_007294.4(BRCA1):c.150A>T (p.Lys50Asn)	BRCA1	K50N	Hereditary cancer-predisposing syndrome	VCV000479269	17	41258535	17	43106518	479269	478822	rs1555597289	NC_000017.11:43106517:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	50	BRCA1
NM_007294.4(BRCA1):c.149A>T (p.Lys50Ile)	BRCA1	K50I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868226	17	41258536	17	43106519	868226	854733	rs2054791529	NC_000017.11:43106518:T:A	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	50	BRCA1
NM_007294.4(BRCA1):c.149A>G (p.Lys50Arg)	BRCA1	K50R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868225	17	41258536	17	43106519	868225	854734	rs2054791529	NC_000017.11:43106518:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	50	BRCA1
NM_007294.4(BRCA1):c.149A>C (p.Lys50Thr)	BRCA1	K50T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868224	17	41258536	17	43106519	868224	854735	rs2054791529	NC_000017.11:43106518:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	50	BRCA1
NM_007294.4(BRCA1):c.148A>G (p.Lys50Glu)	BRCA1	K50E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867890	17	41258537	17	43106520	867890	854737	rs747212786	NC_000017.11:43106519:T:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	50	BRCA1
NM_007294.4(BRCA1):c.148A>C (p.Lys50Gln)	BRCA1	K50Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867889	17	41258537	17	43106520	867889	854738	rs747212786	NC_000017.11:43106519:T:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	50	BRCA1
NM_007294.4(BRCA1):c.146T>C (p.Leu49Pro)	BRCA1	L49P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867886	17	41258539	17	43106522	867886	854741	rs273897660	NC_000017.11:43106521:A:G	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	49	BRCA1
NM_007294.4(BRCA1):c.146T>A (p.Leu49Gln)	BRCA1	L49Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867885	17	41258539	17	43106522	867885	854742	rs273897660	NC_000017.11:43106521:A:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	49	BRCA1
NM_007294.4(BRCA1):c.146T>G (p.Leu49Arg)	BRCA1	L49R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054263	17	41258539	17	43106522	54263	68930	rs273897660	NC_000017.11:43106521:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	49	BRCA1
NM_007294.4(BRCA1):c.145C>G (p.Leu49Val)	BRCA1	L49V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867274	17	41258540	17	43106523	867274	854744	rs2054792700	NC_000017.11:43106522:G:C	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	49	BRCA1
NM_007294.4(BRCA1):c.145C>A (p.Leu49Met)	BRCA1	L49M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867273	17	41258540	17	43106523	867273	854745	rs2054792700	NC_000017.11:43106522:G:T	single nucleotide variant	missense variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	49	BRCA1
NM_007294.4(BRCA1):c.144G>T (p.Met48Ile)	BRCA1	M48I	Hereditary cancer-predisposing syndrome	VCV000867272	17	41258541	17	43106524	867272	854746	rs587783040	NC_000017.11:43106523:C:A	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Likely benign	Mar 4, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.144G>C (p.Met48Ile)	BRCA1	M48I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867271	17	41258541	17	43106524	867271	854747	rs587783040	NC_000017.11:43106523:C:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.144G>A (p.Met48Ile)	BRCA1	M48I	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000156487	17	41258541	17	43106524	156487	166252	rs587783040	NC_000017.11:43106523:C:T	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.143T>G (p.Met48Arg)	BRCA1	M48R	Hereditary breast ovarian cancer syndrome	VCV000867270	17	41258542	17	43106525	867270	854748	rs1230532866	NC_000017.11:43106524:A:C	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.143T>C (p.Met48Thr)	BRCA1	M48T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867269	17	41258542	17	43106525	867269	854749	rs1230532866	NC_000017.11:43106524:A:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Uncertain significance	Mar 2, 2020	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.143T>A (p.Met48Lys)	BRCA1	M48K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865195	17	41258542	17	43106525	865195	854750	rs1230532866	NC_000017.11:43106524:A:T	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.142A>T (p.Met48Leu)	BRCA1	M48L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865194	17	41258543	17	43106526	865194	854751	rs879255477	NC_000017.11:43106525:T:A	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.142A>C (p.Met48Leu)	BRCA1	M48L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865193	17	41258543	17	43106526	865193	854752	rs879255477	NC_000017.11:43106525:T:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.142A>G (p.Met48Val)	BRCA1	M48V	Hereditary breast ovarian cancer syndrome|not specified	VCV000252864	17	41258543	17	43106526	252864	247265	rs879255477	NC_000017.11:43106525:T:C	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	48	BRCA1
NM_007294.4(BRCA1):c.141C>G (p.Cys47Trp)	BRCA1	C47W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865192	17	41258544	17	43106527	865192	854753	rs398122635	NC_000017.11:43106526:G:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	47	BRCA1
NM_007294.4(BRCA1):c.140G>C (p.Cys47Ser)	BRCA1	C47S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868217	17	41258545	17	43106528	868217	854754	rs80357150	NC_000017.11:43106527:C:G	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	47	BRCA1
NM_007294.4(BRCA1):c.140G>T (p.Cys47Phe)	BRCA1	C47F	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054247	17	41258545	17	43106528	54247	68914	rs80357150	NC_000017.11:43106527:C:A	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Pathogenic/Likely pathogenic	Feb 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	47	BRCA1
NM_007294.4(BRCA1):c.140G>A (p.Cys47Tyr)	BRCA1	C47Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054246	17	41258545	17	43106528	54246	68913	rs80357150	NC_000017.11:43106527:C:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	47	BRCA1
NM_007294.4(BRCA1):c.139T>C (p.Cys47Arg)	BRCA1	C47R	Hereditary breast ovarian cancer syndrome	VCV000651975	17	41258546	17	43106529	651975	646060	rs80357370	NC_000017.11:43106528:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	47	BRCA1
NM_007294.4(BRCA1):c.139T>A (p.Cys47Ser)	BRCA1	C47S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267508	17	41258546	17	43106529	267508	262990	rs80357370	NC_000017.11:43106528:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	47	BRCA1
NM_007294.4(BRCA1):c.139T>G (p.Cys47Gly)	BRCA1	C47G	Hereditary breast ovarian cancer syndrome	VCV000054242	17	41258546	17	43106529	54242	68909	rs80357370	NC_000017.11:43106528:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	May 13, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	47	BRCA1
NM_007294.4(BRCA1):c.138T>G (p.Phe46Leu)	BRCA1	F46L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868216	17	41258547	17	43106530	868216	854755	rs2054795825	NC_000017.11:43106529:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.138T>A (p.Phe46Leu)	BRCA1	F46L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868214	17	41258547	17	43106530	868214	854757	rs2054795825	NC_000017.11:43106529:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.137T>G (p.Phe46Cys)	BRCA1	F46C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867881	17	41258548	17	43106531	867881	854758	rs2054796108	NC_000017.11:43106530:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.137T>C (p.Phe46Ser)	BRCA1	F46S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867880	17	41258548	17	43106531	867880	854759	rs2054796108	NC_000017.11:43106530:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.137T>A (p.Phe46Tyr)	BRCA1	F46Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867879	17	41258548	17	43106531	867879	854760	rs2054796108	NC_000017.11:43106530:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.136T>G (p.Phe46Val)	BRCA1	F46V	Hereditary breast ovarian cancer syndrome	VCV000867878	17	41258549	17	43106532	867878	854761	rs2054796556	NC_000017.11:43106531:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.136T>C (p.Phe46Leu)	BRCA1	F46L	Hereditary cancer-predisposing syndrome	VCV000867877	17	41258549	17	43106532	867877	854762	rs2054796556	NC_000017.11:43106531:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 15, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.136T>A (p.Phe46Ile)	BRCA1	F46I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867876	17	41258549	17	43106532	867876	854763	rs2054796556	NC_000017.11:43106531:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	46	BRCA1
NM_007294.4(BRCA1):c.135A>C (p.Lys45Asn)	BRCA1	K45N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867262	17	41258550	17	43106533	867262	854765	rs80356883	NC_000017.11:43106532:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	45	BRCA1
NM_007294.4(BRCA1):c.135A>T (p.Lys45Asn)	BRCA1	K45N	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054219	17	41258550	17	43106533	54219	68886	rs80356883	NC_000017.11:43106532:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	45	BRCA1
NM_007294.4(BRCA1):c.134A>T (p.Lys45Ile)	BRCA1	K45I	Hereditary cancer-predisposing syndrome	VCV000865153	17	41267743	17	43115726	865153	854766	rs80356863	NC_000017.11:43115725:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 18, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	45	BRCA1
NM_007294.4(BRCA1):c.134A>G (p.Lys45Arg)	BRCA1	K45R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000865152	17	41267743	17	43115726	865152	854767	rs80356863	NC_000017.11:43115725:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Oct 9, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	45	BRCA1
NM_007294.4(BRCA1):c.134A>C (p.Lys45Thr)	BRCA1	K45T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified|Hereditary breast ovarian cancer syndrome	VCV000037402	17	41267743	17	43115726	37402	45958	rs80356863	NC_000017.11:43115725:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	45	BRCA1
NM_007294.4(BRCA1):c.133A>G (p.Lys45Glu)	BRCA1	K45E	Hereditary breast ovarian cancer syndrome	VCV000865150	17	41267744	17	43115727	865150	854769	rs769650474	NC_000017.11:43115726:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	45	BRCA1
NM_007294.4(BRCA1):c.133A>C (p.Lys45Gln)	BRCA1	K45Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183950	17	41267744	17	43115727	183950	185127	rs769650474	NC_000017.11:43115726:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	45	BRCA1
NM_007294.4(BRCA1):c.132C>G (p.Cys44Trp)	BRCA1	C44W	Hereditary breast ovarian cancer syndrome	VCV000647970	17	41267745	17	43115728	647970	646061	rs876658362	NC_000017.11:43115727:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Mar 6, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	44	BRCA1
NM_007294.4(BRCA1):c.131G>C (p.Cys44Ser)	BRCA1	C44S	Hereditary breast ovarian cancer syndrome	VCV000868170	17	41267746	17	43115729	868170	854771	rs80357446	NC_000017.11:43115728:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	44	BRCA1
NM_007294.4(BRCA1):c.131G>T (p.Cys44Phe)	BRCA1	C44F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054200	17	41267746	17	43115729	54200	68867	rs80357446	NC_000017.11:43115728:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	44	BRCA1
NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	BRCA1	C44Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054199	17	41267746	17	43115729	54199	68866	rs80357446	NC_000017.11:43115728:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	44	BRCA1
NM_007294.4(BRCA1):c.130T>G (p.Cys44Gly)	BRCA1	C44G	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000054193	17	41267747	17	43115730	54193	68860	rs80357327	NC_000017.11:43115729:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	44	BRCA1
NM_007294.4(BRCA1):c.130T>C (p.Cys44Arg)	BRCA1	C44R	Hereditary breast ovarian cancer syndrome	VCV000054192	17	41267747	17	43115730	54192	68859	rs80357327	NC_000017.11:43115729:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 6, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	44	BRCA1
NM_007294.4(BRCA1):c.130T>A (p.Cys44Ser)	BRCA1	C44S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054191	17	41267747	17	43115730	54191	68858	rs80357327	NC_000017.11:43115729:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	44	BRCA1
NM_007294.4(BRCA1):c.129T>G (p.Phe43Leu)	BRCA1	F43L	Hereditary cancer-predisposing syndrome	VCV000867833	17	41267748	17	43115731	867833	854772	rs2055245756	NC_000017.11:43115730:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.129T>A (p.Phe43Leu)	BRCA1	F43L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867831	17	41267748	17	43115731	867831	854774	rs2055245756	NC_000017.11:43115730:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.128T>G (p.Phe43Cys)	BRCA1	F43C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867830	17	41267749	17	43115732	867830	854775	rs1298544053	NC_000017.11:43115731:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.128T>A (p.Phe43Tyr)	BRCA1	F43Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867829	17	41267749	17	43115732	867829	854776	rs1298544053	NC_000017.11:43115731:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.128T>C (p.Phe43Ser)	BRCA1	F43S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000441341	17	41267749	17	43115732	441341	435179	rs1298544053	NC_000017.11:43115731:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.127T>G (p.Phe43Val)	BRCA1	F43V	Hereditary breast ovarian cancer syndrome	VCV000867828	17	41267750	17	43115733	867828	854777	rs1555599214	NC_000017.11:43115732:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.127T>A (p.Phe43Ile)	BRCA1	F43I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867511	17	41267750	17	43115733	867511	854778	rs1555599214	NC_000017.11:43115732:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.127T>C (p.Phe43Leu)	BRCA1	F43L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000441319	17	41267750	17	43115733	441319	435180	rs1555599214	NC_000017.11:43115732:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	43	BRCA1
NM_007294.4(BRCA1):c.126A>G (p.Ile42Met)	BRCA1	I42M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867509	17	41267751	17	43115734	867509	854780	rs2055246676	NC_000017.11:43115733:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	42	BRCA1
NM_007294.4(BRCA1):c.125T>G (p.Ile42Arg)	BRCA1	I42R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867507	17	41267752	17	43115735	867507	854782	rs2055246954	NC_000017.11:43115734:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	42	BRCA1
NM_007294.4(BRCA1):c.125T>C (p.Ile42Thr)	BRCA1	I42T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867506	17	41267752	17	43115735	867506	854783	rs2055246954	NC_000017.11:43115734:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	42	BRCA1
NM_007294.4(BRCA1):c.125T>A (p.Ile42Lys)	BRCA1	I42K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867505	17	41267752	17	43115735	867505	854784	rs2055246954	NC_000017.11:43115734:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	42	BRCA1
NM_007294.4(BRCA1):c.124A>T (p.Ile42Leu)	BRCA1	I42L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867504	17	41267753	17	43115736	867504	854785	rs80357163	NC_000017.11:43115735:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	42	BRCA1
NM_007294.4(BRCA1):c.124A>C (p.Ile42Leu)	BRCA1	I42L	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000422425	17	41267753	17	43115736	422425	410033	rs80357163	NC_000017.11:43115735:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	42	BRCA1
NM_007294.4(BRCA1):c.124A>G (p.Ile42Val)	BRCA1	I42V	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000054172	17	41267753	17	43115736	54172	68839	rs80357163	NC_000017.11:43115735:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jun 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	42	BRCA1
NM_007294.4(BRCA1):c.123C>G (p.His41Gln)	BRCA1	H41Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865144	17	41267754	17	43115737	865144	854786	rs786202211	NC_000017.11:43115736:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.123C>A (p.His41Gln)	BRCA1	H41Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865143	17	41267754	17	43115737	865143	854787	rs786202211	NC_000017.11:43115736:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.122A>C (p.His41Pro)	BRCA1	H41P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865142	17	41267755	17	43115738	865142	854788	rs80357276	NC_000017.11:43115737:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.122A>T (p.His41Leu)	BRCA1	H41L	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome	VCV000230862	17	41267755	17	43115738	230862	236179	rs80357276	NC_000017.11:43115737:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Aug 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	BRCA1	H41R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054166	17	41267755	17	43115738	54166	68833	rs80357276	NC_000017.11:43115737:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.121C>G (p.His41Asp)	BRCA1	H41D	Hereditary breast ovarian cancer syndrome	VCV000868161	17	41267756	17	43115739	868161	854789	rs1060502353	NC_000017.11:43115738:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Dec 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.121C>T (p.His41Tyr)	BRCA1	H41Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000580736	17	41267756	17	43115739	580736	569193	rs1060502353	NC_000017.11:43115738:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.121C>A (p.His41Asn)	BRCA1	H41N	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000409353	17	41267756	17	43115739	409353	402573	rs1060502353	NC_000017.11:43115738:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Oct 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	41	BRCA1
NM_007294.4(BRCA1):c.120C>G (p.Asp40Glu)	BRCA1	D40E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868160	17	41267757	17	43115740	868160	854790	rs1060504580	NC_000017.11:43115739:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.120C>A (p.Asp40Glu)	BRCA1	D40E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868159	17	41267757	17	43115740	868159	854791	rs1060504580	NC_000017.11:43115739:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.119A>T (p.Asp40Val)	BRCA1	D40V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868158	17	41267758	17	43115741	868158	854792	rs2055249737	NC_000017.11:43115740:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.119A>G (p.Asp40Gly)	BRCA1	D40G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868157	17	41267758	17	43115741	868157	854793	rs2055249737	NC_000017.11:43115740:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.119A>C (p.Asp40Ala)	BRCA1	D40A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867819	17	41267758	17	43115741	867819	854794	rs2055249737	NC_000017.11:43115740:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.118G>T (p.Asp40Tyr)	BRCA1	D40Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867818	17	41267759	17	43115742	867818	854795	rs879255290	NC_000017.11:43115741:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.118G>C (p.Asp40His)	BRCA1	D40H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867817	17	41267759	17	43115742	867817	854796	rs879255290	NC_000017.11:43115741:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.118G>A (p.Asp40Asn)	BRCA1	D40N	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000252392	17	41267759	17	43115742	252392	246831	rs879255290	NC_000017.11:43115741:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	40	BRCA1
NM_007294.4(BRCA1):c.117T>G (p.Cys39Trp)	BRCA1	C39W	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267497	17	41267760	17	43115743	267497	262993	rs886040898	NC_000017.11:43115742:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 30, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	39	BRCA1
NM_007294.4(BRCA1):c.116G>C (p.Cys39Ser)	BRCA1	C39S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867499	17	41267761	17	43115744	867499	854798	rs80357498	NC_000017.11:43115743:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	39	BRCA1
NM_007294.4(BRCA1):c.116G>T (p.Cys39Phe)	BRCA1	C39F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer	VCV000037393	17	41267761	17	43115744	37393	45949	rs80357498	NC_000017.11:43115743:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Nov 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	39	BRCA1
NM_007294.4(BRCA1):c.116G>A (p.Cys39Tyr)	BRCA1	C39Y	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast neoplasm	VCV000037392	17	41267761	17	43115744	37392	45948	rs80357498	NC_000017.11:43115743:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Dec 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	39	BRCA1
NM_007294.4(BRCA1):c.115T>G (p.Cys39Gly)	BRCA1	C39G	Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000054153	17	41267762	17	43115745	54153	68820	rs80357164	NC_000017.11:43115744:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jul 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	39	BRCA1
NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	BRCA1	C39R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054152	17	41267762	17	43115745	54152	68819	rs80357164	NC_000017.11:43115744:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	39	BRCA1
NM_007294.4(BRCA1):c.115T>A (p.Cys39Ser)	BRCA1	C39S	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000054151	17	41267762	17	43115745	54151	68818	rs80357164	NC_000017.11:43115744:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	May 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	39	BRCA1
NM_007294.4(BRCA1):c.114G>C (p.Lys38Asn)	BRCA1	K38N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867498	17	41267763	17	43115746	867498	854799	rs1800062	NC_000017.11:43115745:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	38	BRCA1
NM_007294.4(BRCA1):c.114G>T (p.Lys38Asn)	BRCA1	K38N	not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054147	17	41267763	17	43115746	54147	68814	rs1800062	NC_000017.11:43115745:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	38	BRCA1
NM_007294.4(BRCA1):c.113A>T (p.Lys38Met)	BRCA1	K38M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865133	17	41267764	17	43115747	865133	854800	rs2055251821	NC_000017.11:43115746:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	38	BRCA1
NM_007294.4(BRCA1):c.113A>G (p.Lys38Arg)	BRCA1	K38R	Hereditary breast ovarian cancer syndrome|not provided	VCV000865132	17	41267764	17	43115747	865132	854801	rs2055251821	NC_000017.11:43115746:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	38	BRCA1
NM_007294.4(BRCA1):c.113A>C (p.Lys38Thr)	BRCA1	K38T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865131	17	41267764	17	43115747	865131	854802	rs2055251821	NC_000017.11:43115746:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	38	BRCA1
NM_007294.4(BRCA1):c.112A>G (p.Lys38Glu)	BRCA1	K38E	Hereditary breast ovarian cancer syndrome	VCV000865129	17	41267765	17	43115748	865129	854804	rs2055252323	NC_000017.11:43115747:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	38	BRCA1
NM_007294.4(BRCA1):c.112A>C (p.Lys38Gln)	BRCA1	K38Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865128	17	41267765	17	43115748	865128	854805	rs2055252323	NC_000017.11:43115747:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	38	BRCA1
NM_007294.4(BRCA1):c.110C>T (p.Thr37Ile)	BRCA1	T37I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868148	17	41267767	17	43115750	868148	854807	rs80356880	NC_000017.11:43115749:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	37	BRCA1
NM_007294.4(BRCA1):c.110C>G (p.Thr37Arg)	BRCA1	T37R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054132	17	41267767	17	43115750	54132	68799	rs80356880	NC_000017.11:43115749:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	37	BRCA1
NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	BRCA1	T37K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054131	17	41267767	17	43115750	54131	68798	rs80356880	NC_000017.11:43115749:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	37	BRCA1
NM_007294.4(BRCA1):c.109A>T (p.Thr37Ser)	BRCA1	T37S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868147	17	41267768	17	43115751	868147	854808	rs2055253295	NC_000017.11:43115750:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	37	BRCA1
NM_007294.4(BRCA1):c.109A>G (p.Thr37Ala)	BRCA1	T37A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868146	17	41267768	17	43115751	868146	854809	rs2055253295	NC_000017.11:43115750:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jul 31, 2021	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	37	BRCA1
NM_007294.4(BRCA1):c.109A>C (p.Thr37Pro)	BRCA1	T37P	not provided|Hereditary breast ovarian cancer syndrome	VCV000868145	17	41267768	17	43115751	868145	854810	rs2055253295	NC_000017.11:43115750:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	37	BRCA1
NM_007294.4(BRCA1):c.107C>G (p.Ser36Cys)	BRCA1	S36C	Hereditary breast ovarian cancer syndrome	VCV002838674	17	41267770	17	43115753	2838674	2999776	NA	NC_000017.11:43115752:G:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Feb 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	36	BRCA1
NM_007294.4(BRCA1):c.107C>A (p.Ser36Tyr)	BRCA1	S36Y	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000219742	17	41267770	17	43115753	219742	222683	rs183557525	NC_000017.11:43115752:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	36	BRCA1
NM_007294.4(BRCA1):c.106T>G (p.Ser36Ala)	BRCA1	S36A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868144	17	41267771	17	43115754	868144	854811	rs905812561	NC_000017.11:43115753:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	36	BRCA1
NM_007294.4(BRCA1):c.106T>A (p.Ser36Thr)	BRCA1	S36T	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000489704	17	41267771	17	43115754	489704	483001	rs905812561	NC_000017.11:43115753:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Sep 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	36	BRCA1
NM_007294.4(BRCA1):c.104T>G (p.Val35Gly)	BRCA1	V35G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867805	17	41267773	17	43115756	867805	854815	rs1235706456	NC_000017.11:43115755:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	35	BRCA1
NM_007294.4(BRCA1):c.104T>C (p.Val35Ala)	BRCA1	V35A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867804	17	41267773	17	43115756	867804	854816	rs1235706456	NC_000017.11:43115755:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Feb 2, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	35	BRCA1
NM_007294.4(BRCA1):c.104T>A (p.Val35Asp)	BRCA1	V35D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867803	17	41267773	17	43115756	867803	854817	rs1235706456	NC_000017.11:43115755:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	35	BRCA1
NM_007294.4(BRCA1):c.103G>C (p.Val35Leu)	BRCA1	V35L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867490	17	41267774	17	43115757	867490	854818	rs879255284	NC_000017.11:43115756:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	35	BRCA1
NM_007294.4(BRCA1):c.103G>A (p.Val35Ile)	BRCA1	V35I	Hereditary breast ovarian cancer syndrome	VCV000867489	17	41267774	17	43115757	867489	854819	rs879255284	NC_000017.11:43115756:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	35	BRCA1
NM_007294.4(BRCA1):c.103G>T (p.Val35Phe)	BRCA1	V35F	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000252386	17	41267774	17	43115757	252386	246832	rs879255284	NC_000017.11:43115756:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 3, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	35	BRCA1
NM_007294.4(BRCA1):c.101C>G (p.Pro34Arg)	BRCA1	P34R	Hereditary cancer-predisposing syndrome	VCV000867486	17	41267776	17	43115759	867486	854822	rs786203319	NC_000017.11:43115758:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jul 27, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	34	BRCA1
NM_007294.4(BRCA1):c.101C>A (p.Pro34His)	BRCA1	P34H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867485	17	41267776	17	43115759	867485	854823	rs786203319	NC_000017.11:43115758:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	34	BRCA1
NM_007294.4(BRCA1):c.101C>T (p.Pro34Leu)	BRCA1	P34L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000186913	17	41267776	17	43115759	186913	185129	rs786203319	NC_000017.11:43115758:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 7, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	34	BRCA1
NM_007294.4(BRCA1):c.100C>G (p.Pro34Ala)	BRCA1	P34A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865118	17	41267777	17	43115760	865118	854824	rs1064793357	NC_000017.11:43115759:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	34	BRCA1
NM_007294.4(BRCA1):c.100C>A (p.Pro34Thr)	BRCA1	P34T	Hereditary cancer-predisposing syndrome	VCV000865117	17	41267777	17	43115760	865117	854825	rs1064793357	NC_000017.11:43115759:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 24, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	34	BRCA1
NM_007294.4(BRCA1):c.100C>T (p.Pro34Ser)	BRCA1	P34S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000418671	17	41267777	17	43115760	418671	410034	rs1064793357	NC_000017.11:43115759:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Sep 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	34	BRCA1
NM_007294.4(BRCA1):c.99A>T (p.Glu33Asp)	BRCA1	E33D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865116	17	41267778	17	43115761	865116	854826	rs2055257088	NC_000017.11:43115760:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	33	BRCA1
NM_007294.4(BRCA1):c.99A>C (p.Glu33Asp)	BRCA1	E33D	Hereditary cancer-predisposing syndrome	VCV000865114	17	41267778	17	43115761	865114	854828	rs2055257088	NC_000017.11:43115760:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	Oct 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	33	BRCA1
NM_007294.4(BRCA1):c.98A>T (p.Glu33Val)	BRCA1	E33V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865113	17	41267779	17	43115762	865113	854829	rs876660844	NC_000017.11:43115761:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	33	BRCA1
NM_007294.4(BRCA1):c.98A>G (p.Glu33Gly)	BRCA1	E33G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865112	17	41267779	17	43115762	865112	854830	rs876660844	NC_000017.11:43115761:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	33	BRCA1
NM_007294.4(BRCA1):c.98A>C (p.Glu33Ala)	BRCA1	E33A	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000234092	17	41267779	17	43115762	234092	236180	rs876660844	NC_000017.11:43115761:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	33	BRCA1
NM_007294.4(BRCA1):c.97G>A (p.Glu33Lys)	BRCA1	E33K	Hereditary cancer-predisposing syndrome	VCV000868136	17	41267780	17	43115763	868136	854831	rs80357066	NC_000017.11:43115762:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	Sep 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	33	BRCA1
NM_007294.4(BRCA1):c.97G>C (p.Glu33Gln)	BRCA1	E33Q	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000055769	17	41267780	17	43115763	55769	70436	rs80357066	NC_000017.11:43115762:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	33	BRCA1
NM_007294.4(BRCA1):c.96G>T (p.Lys32Asn)	BRCA1	K32N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868135	17	41267781	17	43115764	868135	854832	rs1597912013	NC_000017.11:43115763:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	32	BRCA1
NM_007294.4(BRCA1):c.96G>C (p.Lys32Asn)	BRCA1	K32N	Hereditary cancer-predisposing syndrome	VCV000823423	17	41267781	17	43115764	823423	813914	rs1597912013	NC_000017.11:43115763:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 23, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	32	BRCA1
NM_007294.4(BRCA1):c.95A>T (p.Lys32Met)	BRCA1	K32M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868133	17	41267782	17	43115765	868133	854834	rs2055258563	NC_000017.11:43115764:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	32	BRCA1
NM_007294.4(BRCA1):c.95A>G (p.Lys32Arg)	BRCA1	K32R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867796	17	41267782	17	43115765	867796	854835	rs2055258563	NC_000017.11:43115764:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	32	BRCA1
NM_007294.4(BRCA1):c.95A>C (p.Lys32Thr)	BRCA1	K32T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867795	17	41267782	17	43115765	867795	854836	rs2055258563	NC_000017.11:43115764:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	32	BRCA1
NM_007294.4(BRCA1):c.94A>G (p.Lys32Glu)	BRCA1	K32E	Hereditary breast ovarian cancer syndrome	VCV000867793	17	41267783	17	43115766	867793	854838	rs2055258887	NC_000017.11:43115765:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	32	BRCA1
NM_007294.4(BRCA1):c.94A>C (p.Lys32Gln)	BRCA1	K32Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867792	17	41267783	17	43115766	867792	854839	rs2055258887	NC_000017.11:43115765:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	32	BRCA1
NM_007294.4(BRCA1):c.93C>G (p.Ile31Met)	BRCA1	I31M	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000055760	17	41267784	17	43115767	55760	70427	rs80357000	NC_000017.11:43115766:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Aug 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	31	BRCA1
NM_007294.4(BRCA1):c.92T>G (p.Ile31Ser)	BRCA1	I31S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867478	17	41267785	17	43115768	867478	854842	rs2055259689	NC_000017.11:43115767:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	31	BRCA1
NM_007294.4(BRCA1):c.92T>C (p.Ile31Thr)	BRCA1	I31T	Hereditary breast ovarian cancer syndrome	VCV000867477	17	41267785	17	43115768	867477	854843	rs2055259689	NC_000017.11:43115767:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 15, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	31	BRCA1
NM_007294.4(BRCA1):c.92T>A (p.Ile31Asn)	BRCA1	I31N	Hereditary breast ovarian cancer syndrome	VCV000867476	17	41267785	17	43115768	867476	854844	rs2055259689	NC_000017.11:43115767:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	31	BRCA1
NM_007294.4(BRCA1):c.91A>T (p.Ile31Phe)	BRCA1	I31F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867475	17	41267786	17	43115769	867475	854845	rs1597912041	NC_000017.11:43115768:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	31	BRCA1
NM_007294.4(BRCA1):c.91A>C (p.Ile31Leu)	BRCA1	I31L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867474	17	41267786	17	43115769	867474	854846	rs1597912041	NC_000017.11:43115768:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	31	BRCA1
NM_007294.4(BRCA1):c.91A>G (p.Ile31Val)	BRCA1	I31V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000823090	17	41267786	17	43115769	823090	813915	rs1597912041	NC_000017.11:43115768:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	31	BRCA1
NM_007294.4(BRCA1):c.90G>T (p.Leu30Phe)	BRCA1	L30F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867473	17	41267787	17	43115770	867473	854847	rs2055260326	NC_000017.11:43115769:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	30	BRCA1
NM_007294.4(BRCA1):c.90G>C (p.Leu30Phe)	BRCA1	L30F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867472	17	41267787	17	43115770	867472	854848	rs2055260326	NC_000017.11:43115769:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	30	BRCA1
NM_007294.4(BRCA1):c.89T>G (p.Leu30Trp)	BRCA1	L30W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865103	17	41267788	17	43115771	865103	854850	rs397509331	NC_000017.11:43115770:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	30	BRCA1
NM_007294.4(BRCA1):c.89T>C (p.Leu30Ser)	BRCA1	L30S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865102	17	41267788	17	43115771	865102	854851	rs397509331	NC_000017.11:43115770:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	30	BRCA1
NM_007294.4(BRCA1):c.88T>G (p.Leu30Val)	BRCA1	L30V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865101	17	41267789	17	43115772	865101	854852	rs2055260993	NC_000017.11:43115771:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	30	BRCA1
NM_007294.4(BRCA1):c.88T>A (p.Leu30Met)	BRCA1	L30M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865099	17	41267789	17	43115772	865099	854854	rs2055260993	NC_000017.11:43115771:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	30	BRCA1
NM_007294.4(BRCA1):c.87G>C (p.Glu29Asp)	BRCA1	E29D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868126	17	41267790	17	43115773	868126	854856	rs1343667553	NC_000017.11:43115772:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	29	BRCA1
NM_007294.4(BRCA1):c.87G>T (p.Glu29Asp)	BRCA1	E29D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865098	17	41267790	17	43115773	865098	854855	rs1343667553	NC_000017.11:43115772:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	29	BRCA1
NM_007294.4(BRCA1):c.86A>T (p.Glu29Val)	BRCA1	E29V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868125	17	41267791	17	43115774	868125	854857	rs773841328	NC_000017.11:43115773:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	29	BRCA1
NM_007294.4(BRCA1):c.86A>C (p.Glu29Ala)	BRCA1	E29A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868124	17	41267791	17	43115774	868124	854858	rs773841328	NC_000017.11:43115773:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	29	BRCA1
NM_007294.4(BRCA1):c.86A>G (p.Glu29Gly)	BRCA1	E29G	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000231722	17	41267791	17	43115774	231722	236181	rs773841328	NC_000017.11:43115773:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	29	BRCA1
NM_007294.4(BRCA1):c.85G>C (p.Glu29Gln)	BRCA1	E29Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868123	17	41267792	17	43115775	868123	854859	rs80357443	NC_000017.11:43115774:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	29	BRCA1
NM_007294.4(BRCA1):c.85G>A (p.Glu29Lys)	BRCA1	E29K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868122	17	41267792	17	43115775	868122	854860	rs80357443	NC_000017.11:43115774:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	29	BRCA1
NM_007294.4(BRCA1):c.83T>G (p.Leu28Arg)	BRCA1	L28R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867783	17	41267794	17	43115777	867783	854863	rs80357266	NC_000017.11:43115776:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	28	BRCA1
NM_007294.4(BRCA1):c.83T>A (p.Leu28Gln)	BRCA1	L28Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867782	17	41267794	17	43115777	867782	854864	rs80357266	NC_000017.11:43115776:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	28	BRCA1
NM_007294.4(BRCA1):c.83T>C (p.Leu28Pro)	BRCA1	L28P	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000055732	17	41267794	17	43115777	55732	70399	rs80357266	NC_000017.11:43115776:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Sep 15, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	28	BRCA1
NM_007294.4(BRCA1):c.82C>A (p.Leu28Met)	BRCA1	L28M	Hereditary breast ovarian cancer syndrome	VCV000867464	17	41267795	17	43115778	867464	854865	rs1219301058	NC_000017.11:43115777:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	BRCA1
NM_007294.4(BRCA1):c.82C>G (p.Leu28Val)	BRCA1	L28V	Hereditary cancer-predisposing syndrome	VCV000827565	17	41267795	17	43115778	827565	813917	rs1219301058	NC_000017.11:43115777:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	BRCA1
NM_007294.4(BRCA1):c.81T>G (p.Cys27Trp)	BRCA1	C27W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867463	17	41267796	17	43115779	867463	854866	rs587780805	NC_000017.11:43115778:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	27	BRCA1
NM_007294.4(BRCA1):c.80G>A (p.Cys27Tyr)	BRCA1	C27Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000827453	17	41276034	17	43124017	827453	813918	rs1064793052	NC_000017.11:43124016:C:T	single nucleotide variant	missense variant|nonsense|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Jun 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	27	BRCA1
NM_007294.4(BRCA1):c.80G>T (p.Cys27Phe)	BRCA1	C27F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481469	17	41276034	17	43124017	481469	478848	rs1064793052	NC_000017.11:43124016:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Nov 24, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	27	BRCA1
NM_007294.4(BRCA1):c.80G>C (p.Cys27Ser)	BRCA1	C27S	Hereditary breast ovarian cancer syndrome|not provided	VCV000418064	17	41276034	17	43124017	418064	410036	rs1064793052	NC_000017.11:43124016:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	27	BRCA1
NM_007294.4(BRCA1):c.79T>G (p.Cys27Gly)	BRCA1	C27G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867751	17	41276035	17	43124018	867751	854868	rs2055713838	NC_000017.11:43124017:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	27	BRCA1
NM_007294.4(BRCA1):c.79T>C (p.Cys27Arg)	BRCA1	C27R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867750	17	41276035	17	43124018	867750	854869	rs2055713838	NC_000017.11:43124017:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	27	BRCA1
NM_007294.4(BRCA1):c.79T>A (p.Cys27Ser)	BRCA1	C27S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867749	17	41276035	17	43124018	867749	854870	rs2055713838	NC_000017.11:43124017:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	27	BRCA1
NM_007294.4(BRCA1):c.78C>G (p.Ile26Met)	BRCA1	I26M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867748	17	41276036	17	43124019	867748	854871	rs1555600862	NC_000017.11:43124018:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	26	BRCA1
NM_007294.4(BRCA1):c.77T>G (p.Ile26Ser)	BRCA1	I26S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867746	17	41276037	17	43124020	867746	854873	rs879255496	NC_000017.11:43124019:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	26	BRCA1
NM_007294.4(BRCA1):c.77T>C (p.Ile26Thr)	BRCA1	I26T	Hereditary breast ovarian cancer syndrome	VCV000856169	17	41276037	17	43124020	856169	845477	rs879255496	NC_000017.11:43124019:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	26	BRCA1
NM_007294.4(BRCA1):c.77T>A (p.Ile26Asn)	BRCA1	I26N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252890	17	41276037	17	43124020	252890	247291	rs879255496	NC_000017.11:43124019:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jul 15, 2010	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	26	BRCA1
NM_007294.4(BRCA1):c.76A>G (p.Ile26Val)	BRCA1	I26V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865067	17	41276038	17	43124021	865067	854874	rs1597923170	NC_000017.11:43124020:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	26	BRCA1
NM_007294.4(BRCA1):c.76A>C (p.Ile26Leu)	BRCA1	I26L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865066	17	41276038	17	43124021	865066	854875	rs1597923170	NC_000017.11:43124020:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	26	BRCA1
NM_007294.4(BRCA1):c.76A>T (p.Ile26Phe)	BRCA1	I26F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000827206	17	41276038	17	43124021	827206	813919	rs1597923170	NC_000017.11:43124020:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 25, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	26	BRCA1
NM_007294.4(BRCA1):c.74C>G (p.Pro25Arg)	BRCA1	P25R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865065	17	41276040	17	43124023	865065	854876	rs876660096	NC_000017.11:43124022:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	25	BRCA1
NM_007294.4(BRCA1):c.74C>T (p.Pro25Leu)	BRCA1	P25L	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000232955	17	41276040	17	43124023	232955	236182	rs876660096	NC_000017.11:43124022:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	25	BRCA1
NM_007294.4(BRCA1):c.73C>T (p.Pro25Ser)	BRCA1	P25S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865064	17	41276041	17	43124024	865064	854877	rs397509313	NC_000017.11:43124023:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	25	BRCA1
NM_007294.4(BRCA1):c.73C>G (p.Pro25Ala)	BRCA1	P25A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865063	17	41276041	17	43124024	865063	854878	rs397509313	NC_000017.11:43124023:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	25	BRCA1
NM_007294.4(BRCA1):c.73C>A (p.Pro25Thr)	BRCA1	P25T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055684	17	41276041	17	43124024	55684	70351	rs397509313	NC_000017.11:43124023:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	25	BRCA1
NM_007294.4(BRCA1):c.72T>G (p.Cys24Trp)	BRCA1	C24W	Hereditary breast ovarian cancer syndrome	VCV000652430	17	41276042	17	43124025	652430	646062	rs1597923232	NC_000017.11:43124024:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	24	BRCA1
NM_007294.4(BRCA1):c.71G>T (p.Cys24Phe)	BRCA1	C24F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868781	17	41276043	17	43124026	868781	854881	rs80357198	NC_000017.11:43124025:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	24	BRCA1
NM_007294.4(BRCA1):c.71G>C (p.Cys24Ser)	BRCA1	C24S	Hereditary breast ovarian cancer syndrome	VCV000868780	17	41276043	17	43124026	868780	854882	rs80357198	NC_000017.11:43124025:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Nov 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	24	BRCA1
NM_007294.4(BRCA1):c.71G>A (p.Cys24Tyr)	BRCA1	C24Y	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055678	17	41276043	17	43124026	55678	70345	rs80357198	NC_000017.11:43124025:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	BRCA1
NM_007294.4(BRCA1):c.70T>G (p.Cys24Gly)	BRCA1	C24G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000649351	17	41276044	17	43124027	649351	646063	rs80357410	NC_000017.11:43124026:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 25, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	BRCA1
NM_007294.4(BRCA1):c.70T>A (p.Cys24Ser)	BRCA1	C24S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000638952	17	41276044	17	43124027	638952	646064	rs80357410	NC_000017.11:43124026:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	BRCA1
NM_007294.4(BRCA1):c.70T>C (p.Cys24Arg)	BRCA1	C24R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055674	17	41276044	17	43124027	55674	70341	rs80357410	NC_000017.11:43124026:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	BRCA1
NM_007294.4(BRCA1):c.69G>T (p.Glu23Asp)	BRCA1	E23D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868756	17	41276045	17	43124028	868756	854883	rs766004110	NC_000017.11:43124027:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	23	BRCA1
NM_007294.4(BRCA1):c.69G>C (p.Glu23Asp)	BRCA1	E23D	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000232427	17	41276045	17	43124028	232427	236183	rs766004110	NC_000017.11:43124027:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	23	BRCA1
NM_007294.4(BRCA1):c.68A>T (p.Glu23Val)	BRCA1	E23V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868755	17	41276046	17	43124029	868755	854884	rs1597923307	NC_000017.11:43124028:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	23	BRCA1
NM_007294.4(BRCA1):c.68A>G (p.Glu23Gly)	BRCA1	E23G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868754	17	41276046	17	43124029	868754	854885	rs1597923307	NC_000017.11:43124028:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	23	BRCA1
NM_007294.4(BRCA1):c.68A>C (p.Glu23Ala)	BRCA1	E23A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000826690	17	41276046	17	43124029	826690	813921	rs1597923307	NC_000017.11:43124028:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	23	BRCA1
NM_007294.4(BRCA1):c.67G>A (p.Glu23Lys)	BRCA1	E23K	Hereditary cancer-predisposing syndrome	VCV000867739	17	41276047	17	43124030	867739	854887	rs372047427	NC_000017.11:43124029:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	23	BRCA1
NM_007294.4(BRCA1):c.67G>C (p.Glu23Gln)	BRCA1	E23Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441390	17	41276047	17	43124030	441390	435181	rs372047427	NC_000017.11:43124029:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	23	BRCA1
NM_007294.4(BRCA1):c.66A>T (p.Leu22Phe)	BRCA1	L22F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867738	17	41276048	17	43124031	867738	854888	rs786202533	NC_000017.11:43124030:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	22	BRCA1
NM_007294.4(BRCA1):c.66A>C (p.Leu22Phe)	BRCA1	L22F	Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Hereditary breast ovarian cancer syndrome	VCV000185882	17	41276048	17	43124031	185882	185130	rs786202533	NC_000017.11:43124030:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	22	BRCA1
NM_007294.4(BRCA1):c.65T>C (p.Leu22Ser)	BRCA1	L22S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055656	17	41276049	17	43124032	55656	70323	rs80357438	NC_000017.11:43124031:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	22	BRCA1
NM_007294.4(BRCA1):c.64T>G (p.Leu22Val)	BRCA1	L22V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865056	17	41276050	17	43124033	865056	854890	rs1597923402	NC_000017.11:43124032:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	22	BRCA1
NM_007294.4(BRCA1):c.64T>A (p.Leu22Ile)	BRCA1	L22I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865055	17	41276050	17	43124033	865055	854891	rs1597923402	NC_000017.11:43124032:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	22	BRCA1
NM_007294.4(BRCA1):c.63C>G (p.Ile21Met)	BRCA1	I21M	Hereditary breast ovarian cancer syndrome	VCV000865054	17	41276051	17	43124034	865054	854892	rs1555600921	NC_000017.11:43124033:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	21	BRCA1
NM_007294.4(BRCA1):c.62T>A (p.Ile21Asn)	BRCA1	I21N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868779	17	41276052	17	43124035	868779	854895	rs1135401834	NC_000017.11:43124034:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	21	BRCA1
NM_007294.4(BRCA1):c.62T>C (p.Ile21Thr)	BRCA1	I21T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865052	17	41276052	17	43124035	865052	854894	rs1135401834	NC_000017.11:43124034:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	21	BRCA1
NM_007294.4(BRCA1):c.62T>G (p.Ile21Ser)	BRCA1	I21S	not specified	VCV000431195	17	41276052	17	43124035	431195	424867	rs1135401834	NC_000017.11:43124034:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 31, 2014	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	21	BRCA1
NM_007294.4(BRCA1):c.61A>T (p.Ile21Phe)	BRCA1	I21F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868778	17	41276053	17	43124036	868778	854896	rs80357406	NC_000017.11:43124035:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	21	BRCA1
NM_007294.4(BRCA1):c.61A>C (p.Ile21Leu)	BRCA1	I21L	Hereditary cancer-predisposing syndrome	VCV000868777	17	41276053	17	43124036	868777	854897	rs80357406	NC_000017.11:43124035:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	21	BRCA1
NM_007294.4(BRCA1):c.61A>G (p.Ile21Val)	BRCA1	I21V	not specified|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000055648	17	41276053	17	43124036	55648	70315	rs80357406	NC_000017.11:43124035:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	21	BRCA1
NM_007294.4(BRCA1):c.60A>T (p.Lys20Asn)	BRCA1	K20N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868776	17	41276054	17	43124037	868776	854898	rs202168814	NC_000017.11:43124036:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	20	BRCA1
NM_007294.4(BRCA1):c.60A>C (p.Lys20Asn)	BRCA1	K20N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182121	17	41276054	17	43124037	182121	180895	rs202168814	NC_000017.11:43124036:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	20	BRCA1
NM_007294.4(BRCA1):c.59A>T (p.Lys20Ile)	BRCA1	K20I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868775	17	41276055	17	43124038	868775	854899	rs2055724752	NC_000017.11:43124037:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	20	BRCA1
NM_007294.4(BRCA1):c.59A>G (p.Lys20Arg)	BRCA1	K20R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868746	17	41276055	17	43124038	868746	854900	rs2055724752	NC_000017.11:43124037:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	20	BRCA1
NM_007294.4(BRCA1):c.59A>C (p.Lys20Thr)	BRCA1	K20T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868745	17	41276055	17	43124038	868745	854901	rs2055724752	NC_000017.11:43124037:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	20	BRCA1
NM_007294.4(BRCA1):c.58A>G (p.Lys20Glu)	BRCA1	K20E	Hereditary breast ovarian cancer syndrome	VCV000868743	17	41276056	17	43124039	868743	854903	rs2055725050	NC_000017.11:43124038:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 21, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	20	BRCA1
NM_007294.4(BRCA1):c.58A>C (p.Lys20Gln)	BRCA1	K20Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868742	17	41276056	17	43124039	868742	854904	rs2055725050	NC_000017.11:43124038:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	20	BRCA1
NM_007294.4(BRCA1):c.57G>T (p.Gln19His)	BRCA1	Q19H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868741	17	41276057	17	43124040	868741	854905	rs2055725365	NC_000017.11:43124039:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	19	BRCA1
NM_007294.4(BRCA1):c.57G>C (p.Gln19His)	BRCA1	Q19H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868740	17	41276057	17	43124040	868740	854906	rs2055725365	NC_000017.11:43124039:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	19	BRCA1
NM_007294.4(BRCA1):c.56A>T (p.Gln19Leu)	BRCA1	Q19L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867728	17	41276058	17	43124041	867728	854908	rs2055725680	NC_000017.11:43124040:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	19	BRCA1
NM_007294.4(BRCA1):c.56A>C (p.Gln19Pro)	BRCA1	Q19P	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867727	17	41276058	17	43124041	867727	854909	rs2055725680	NC_000017.11:43124040:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	19	BRCA1
NM_007294.4(BRCA1):c.56A>G (p.Gln19Arg)	BRCA1	Q19R	Hereditary breast ovarian cancer syndrome	VCV000864052	17	41276058	17	43124041	864052	845478	rs2055725680	NC_000017.11:43124040:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 10, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	19	BRCA1
NM_007294.4(BRCA1):c.55C>G (p.Gln19Glu)	BRCA1	Q19E	Hereditary breast ovarian cancer syndrome	VCV000867726	17	41276059	17	43124042	867726	854910	rs397509299	NC_000017.11:43124041:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 11, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	19	BRCA1
NM_007294.4(BRCA1):c.55C>A (p.Gln19Lys)	BRCA1	Q19K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867725	17	41276059	17	43124042	867725	854911	rs397509299	NC_000017.11:43124041:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	19	BRCA1
NM_007294.4(BRCA1):c.54G>T (p.Met18Ile)	BRCA1	M18I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867724	17	41276060	17	43124043	867724	854912	rs1597923450	NC_000017.11:43124042:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.54G>C (p.Met18Ile)	BRCA1	M18I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867723	17	41276060	17	43124043	867723	854913	rs1597923450	NC_000017.11:43124042:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.54G>A (p.Met18Ile)	BRCA1	M18I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000825781	17	41276060	17	43124043	825781	813922	rs1597923450	NC_000017.11:43124042:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.53T>G (p.Met18Arg)	BRCA1	M18R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531241	17	41276061	17	43124044	531241	531135	rs80356929	NC_000017.11:43124043:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Oct 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.53T>A (p.Met18Lys)	BRCA1	M18K	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome	VCV000055559	17	41276061	17	43124044	55559	70226	rs80356929	NC_000017.11:43124043:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.53T>C (p.Met18Thr)	BRCA1	M18T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037664	17	41276061	17	43124044	37664	46220	rs80356929	NC_000017.11:43124043:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.52A>T (p.Met18Leu)	BRCA1	M18L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865043	17	41276062	17	43124045	865043	854914	rs2055727017	NC_000017.11:43124044:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.52A>G (p.Met18Val)	BRCA1	M18V	not specified	VCV000865042	17	41276062	17	43124045	865042	854915	rs2055727017	NC_000017.11:43124044:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.52A>C (p.Met18Leu)	BRCA1	M18L	Hereditary cancer-predisposing syndrome	VCV000865041	17	41276062	17	43124045	865041	854916	rs2055727017	NC_000017.11:43124044:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	18	BRCA1
NM_007294.4(BRCA1):c.49_50delinsTG (p.Ala17Cys)	BRCA1	A17C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002680212	17	41276064 - 41276065	17	43124047 - 43124048	2680212	2833940	NA	NC_000017.11:43124046:GC:CA	Indel	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	17	BRCA1
NM_007294.4(BRCA1):c.50C>T (p.Ala17Val)	BRCA1	A17V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869098	17	41276064	17	43124047	869098	854920	rs1412871417	NC_000017.11:43124046:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	17	BRCA1
NM_007294.4(BRCA1):c.50C>G (p.Ala17Gly)	BRCA1	A17G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869097	17	41276064	17	43124047	869097	854921	rs1412871417	NC_000017.11:43124046:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	17	BRCA1
NM_007294.4(BRCA1):c.50C>A (p.Ala17Asp)	BRCA1	A17D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869096	17	41276064	17	43124047	869096	854922	rs1412871417	NC_000017.11:43124046:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	17	BRCA1
NM_007294.4(BRCA1):c.49G>C (p.Ala17Pro)	BRCA1	A17P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869095	17	41276065	17	43124048	869095	854923	rs1402064476	NC_000017.11:43124047:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 2, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	17	BRCA1
NM_007294.4(BRCA1):c.49G>A (p.Ala17Thr)	BRCA1	A17T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869094	17	41276065	17	43124048	869094	854924	rs1402064476	NC_000017.11:43124047:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	17	BRCA1
NM_007294.4(BRCA1):c.49G>T (p.Ala17Ser)	BRCA1	A17S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000489728	17	41276065	17	43124048	489728	483006	rs1402064476	NC_000017.11:43124047:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 1, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	17	BRCA1
NM_007294.4(BRCA1):c.48T>G (p.Asn16Lys)	BRCA1	N16K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868730	17	41276066	17	43124049	868730	854925	rs1555600963	NC_000017.11:43124048:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.48T>A (p.Asn16Lys)	BRCA1	N16K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479225	17	41276066	17	43124049	479225	478851	rs1555600963	NC_000017.11:43124048:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.47A>T (p.Asn16Ile)	BRCA1	N16I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868729	17	41276067	17	43124050	868729	854926	rs2055729319	NC_000017.11:43124049:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.47A>G (p.Asn16Ser)	BRCA1	N16S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868728	17	41276067	17	43124050	868728	854927	rs2055729319	NC_000017.11:43124049:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.47A>C (p.Asn16Thr)	BRCA1	N16T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868727	17	41276067	17	43124050	868727	854928	rs2055729319	NC_000017.11:43124049:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.46A>T (p.Asn16Tyr)	BRCA1	N16Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868726	17	41276068	17	43124051	868726	854929	rs2055729884	NC_000017.11:43124050:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.46A>G (p.Asn16Asp)	BRCA1	N16D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868725	17	41276068	17	43124051	868725	854930	rs2055729884	NC_000017.11:43124050:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.46A>C (p.Asn16His)	BRCA1	N16H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867715	17	41276068	17	43124051	867715	854931	rs2055729884	NC_000017.11:43124050:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	16	BRCA1
NM_007294.4(BRCA1):c.45T>G (p.Ile15Met)	BRCA1	I15M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867714	17	41276069	17	43124052	867714	854932	rs2055730198	NC_000017.11:43124051:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	15	BRCA1
NM_007294.4(BRCA1):c.44T>G (p.Ile15Ser)	BRCA1	I15S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867711	17	41276070	17	43124053	867711	854935	rs80357316	NC_000017.11:43124052:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	15	BRCA1
NM_007294.4(BRCA1):c.44T>A (p.Ile15Asn)	BRCA1	I15N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867710	17	41276070	17	43124053	867710	854936	rs80357316	NC_000017.11:43124052:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	15	BRCA1
NM_007294.4(BRCA1):c.44T>C (p.Ile15Thr)	BRCA1	I15T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055217	17	41276070	17	43124053	55217	69884	rs80357316	NC_000017.11:43124052:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	15	BRCA1
NM_007294.4(BRCA1):c.43A>T (p.Ile15Phe)	BRCA1	I15F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867709	17	41276071	17	43124054	867709	854937	rs80357031	NC_000017.11:43124053:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	15	BRCA1
NM_007294.4(BRCA1):c.43A>G (p.Ile15Val)	BRCA1	I15V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000865035	17	41276071	17	43124054	865035	854938	rs80357031	NC_000017.11:43124053:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 31, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	15	BRCA1
NM_007294.4(BRCA1):c.43A>C (p.Ile15Leu)	BRCA1	I15L	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055192	17	41276071	17	43124054	55192	69859	rs80357031	NC_000017.11:43124053:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	15	BRCA1
NM_007294.4(BRCA1):c.41T>G (p.Val14Gly)	BRCA1	V14G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865033	17	41276073	17	43124056	865033	854940	rs2055732014	NC_000017.11:43124055:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	14	BRCA1
NM_007294.4(BRCA1):c.41T>C (p.Val14Ala)	BRCA1	V14A	not provided	VCV000865032	17	41276073	17	43124056	865032	854941	rs2055732014	NC_000017.11:43124055:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	14	BRCA1
NM_007294.4(BRCA1):c.41T>A (p.Val14Asp)	BRCA1	V14D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865031	17	41276073	17	43124056	865031	854942	rs2055732014	NC_000017.11:43124055:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	14	BRCA1
NM_007294.4(BRCA1):c.40G>C (p.Val14Leu)	BRCA1	V14L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869093	17	41276074	17	43124057	869093	854943	rs2055732548	NC_000017.11:43124056:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	14	BRCA1
NM_007294.4(BRCA1):c.40G>A (p.Val14Ile)	BRCA1	V14I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869092	17	41276074	17	43124057	869092	854944	rs2055732548	NC_000017.11:43124056:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	14	BRCA1
NM_007294.4(BRCA1):c.40G>T (p.Val14Phe)	BRCA1	V14F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000848933	17	41276074	17	43124057	848933	845480	rs2055732548	NC_000017.11:43124056:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	14	BRCA1
NM_007294.4(BRCA1):c.39T>G (p.Asn13Lys)	BRCA1	N13K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869091	17	41276075	17	43124058	869091	854945	rs2055733269	NC_000017.11:43124057:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.39T>A (p.Asn13Lys)	BRCA1	N13K	Hereditary cancer-predisposing syndrome	VCV000869089	17	41276075	17	43124058	869089	854947	rs2055733269	NC_000017.11:43124057:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Mar 29, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.38A>T (p.Asn13Ile)	BRCA1	N13I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869088	17	41276076	17	43124059	869088	854948	rs2055733986	NC_000017.11:43124058:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.38A>G (p.Asn13Ser)	BRCA1	N13S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869087	17	41276076	17	43124059	869087	854949	rs2055733986	NC_000017.11:43124058:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.38A>C (p.Asn13Thr)	BRCA1	N13T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868721	17	41276076	17	43124059	868721	854950	rs2055733986	NC_000017.11:43124058:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.37A>T (p.Asn13Tyr)	BRCA1	N13Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868720	17	41276077	17	43124060	868720	854951	rs1597923586	NC_000017.11:43124059:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.37A>C (p.Asn13His)	BRCA1	N13H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868719	17	41276077	17	43124060	868719	854952	rs1597923586	NC_000017.11:43124059:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.37A>G (p.Asn13Asp)	BRCA1	N13D	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000666101	17	41276077	17	43124060	666101	646065	rs1597923586	NC_000017.11:43124059:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	13	BRCA1
NM_007294.4(BRCA1):c.36A>T (p.Gln12His)	BRCA1	Q12H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868718	17	41276078	17	43124061	868718	854953	rs763230080	NC_000017.11:43124060:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	12	BRCA1
NM_007294.4(BRCA1):c.36A>C (p.Gln12His)	BRCA1	Q12H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868717	17	41276078	17	43124061	868717	854954	rs763230080	NC_000017.11:43124060:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	12	BRCA1
NM_007294.4(BRCA1):c.35A>T (p.Gln12Leu)	BRCA1	Q12L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868716	17	41276079	17	43124062	868716	854955	rs1555601006	NC_000017.11:43124061:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	12	BRCA1
NM_007294.4(BRCA1):c.35A>C (p.Gln12Pro)	BRCA1	Q12P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867703	17	41276079	17	43124062	867703	854956	rs1555601006	NC_000017.11:43124061:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	12	BRCA1
NM_007294.4(BRCA1):c.35A>G (p.Gln12Arg)	BRCA1	Q12R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441517	17	41276079	17	43124062	441517	435182	rs1555601006	NC_000017.11:43124061:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	12	BRCA1
NM_007294.4(BRCA1):c.34C>A (p.Gln12Lys)	BRCA1	Q12K	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000867702	17	41276080	17	43124063	867702	854957	rs80357134	NC_000017.11:43124062:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	12	BRCA1
NM_007294.4(BRCA1):c.34C>G (p.Gln12Glu)	BRCA1	Q12E	Hereditary breast ovarian cancer syndrome	VCV000647021	17	41276080	17	43124063	647021	646066	rs80357134	NC_000017.11:43124062:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 6, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	12	BRCA1
NM_007294.4(BRCA1):c.32T>A (p.Val11Glu)	BRCA1	V11E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865022	17	41276082	17	43124065	865022	854960	rs80357017	NC_000017.11:43124064:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	11	BRCA1
NM_007294.4(BRCA1):c.32T>G (p.Val11Gly)	BRCA1	V11G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000245973	17	41276082	17	43124065	245973	245057	rs80357017	NC_000017.11:43124064:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	11	BRCA1
NM_007294.4(BRCA1):c.32T>C (p.Val11Ala)	BRCA1	V11A	Hereditary cancer-predisposing syndrome	VCV000054828	17	41276082	17	43124065	54828	69495	rs80357017	NC_000017.11:43124064:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 9, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	11	BRCA1
NM_007294.4(BRCA1):c.30_31delinsGC (p.Val11Leu)	BRCA1	V11L	Hereditary breast ovarian cancer syndrome	VCV001993518	17	41276083 - 41276084	17	43124066 - 43124067	1993518	2049305	NA	NC_000017.11:43124065:CT:GC	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	11	BRCA1
NM_007294.4(BRCA1):c.31G>T (p.Val11Leu)	BRCA1	V11L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865021	17	41276083	17	43124066	865021	854961	rs1555601019	NC_000017.11:43124065:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	11	BRCA1
NM_007294.4(BRCA1):c.31G>A (p.Val11Ile)	BRCA1	V11I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865020	17	41276083	17	43124066	865020	854962	rs1555601019	NC_000017.11:43124065:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	11	BRCA1
NM_007294.4(BRCA1):c.31G>C (p.Val11Leu)	BRCA1	V11L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000438922	17	41276083	17	43124066	438922	432927	rs1555601019	NC_000017.11:43124065:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	11	BRCA1
NM_007294.4(BRCA1):c.30A>C (p.Glu10Asp)	BRCA1	E10D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869086	17	41276084	17	43124067	869086	854965	rs2055737161	NC_000017.11:43124066:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	10	BRCA1
NM_007294.4(BRCA1):c.30A>T (p.Glu10Asp)	BRCA1	E10D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865019	17	41276084	17	43124067	865019	854963	rs2055737161	NC_000017.11:43124066:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	10	BRCA1
NM_007294.4(BRCA1):c.29A>T (p.Glu10Val)	BRCA1	E10V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869085	17	41276085	17	43124068	869085	854966	rs2055737507	NC_000017.11:43124067:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	10	BRCA1
NM_007294.4(BRCA1):c.29A>G (p.Glu10Gly)	BRCA1	E10G	Hereditary breast ovarian cancer syndrome	VCV000869084	17	41276085	17	43124068	869084	854967	rs2055737507	NC_000017.11:43124067:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	10	BRCA1
NM_007294.4(BRCA1):c.29A>C (p.Glu10Ala)	BRCA1	E10A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869083	17	41276085	17	43124068	869083	854968	rs2055737507	NC_000017.11:43124067:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	10	BRCA1
NM_007294.4(BRCA1):c.28G>C (p.Glu10Gln)	BRCA1	E10Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869081	17	41276086	17	43124069	869081	854970	rs2055737833	NC_000017.11:43124068:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	10	BRCA1
NM_007294.4(BRCA1):c.28G>A (p.Glu10Lys)	BRCA1	E10K	not specified|Hereditary breast ovarian cancer syndrome	VCV000869080	17	41276086	17	43124069	869080	854971	rs2055737833	NC_000017.11:43124068:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 24, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	10	BRCA1
NM_007294.4(BRCA1):c.27A>T (p.Glu9Asp)	BRCA1	E9D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869079	17	41276087	17	43124070	869079	854972	rs2055738370	NC_000017.11:43124069:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	9	BRCA1
NM_007294.4(BRCA1):c.27A>C (p.Glu9Asp)	BRCA1	E9D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868709	17	41276087	17	43124070	868709	854974	rs2055738370	NC_000017.11:43124069:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	9	BRCA1
NM_007294.4(BRCA1):c.26A>T (p.Glu9Val)	BRCA1	E9V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868708	17	41276088	17	43124071	868708	854975	rs2055738683	NC_000017.11:43124070:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	9	BRCA1
NM_007294.4(BRCA1):c.26A>G (p.Glu9Gly)	BRCA1	E9G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868707	17	41276088	17	43124071	868707	854976	rs2055738683	NC_000017.11:43124070:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	9	BRCA1
NM_007294.4(BRCA1):c.26A>C (p.Glu9Ala)	BRCA1	E9A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868706	17	41276088	17	43124071	868706	854977	rs2055738683	NC_000017.11:43124070:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	9	BRCA1
NM_007294.4(BRCA1):c.25G>A (p.Glu9Lys)	BRCA1	E9K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868704	17	41276089	17	43124072	868704	854979	rs1567823437	NC_000017.11:43124071:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	9	BRCA1
NM_007294.4(BRCA1):c.25G>C (p.Glu9Gln)	BRCA1	E9Q	Hereditary cancer-predisposing syndrome	VCV000630444	17	41276089	17	43124072	630444	618705	rs1567823437	NC_000017.11:43124071:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	9	BRCA1
NM_007294.4(BRCA1):c.23T>G (p.Val8Gly)	BRCA1	V8G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867694	17	41276091	17	43124074	867694	854983	rs2055739664	NC_000017.11:43124073:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	8	BRCA1
NM_007294.4(BRCA1):c.23T>C (p.Val8Ala)	BRCA1	V8A	Hereditary cancer-predisposing syndrome	VCV000867693	17	41276091	17	43124074	867693	854984	rs2055739664	NC_000017.11:43124073:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	8	BRCA1
NM_007294.4(BRCA1):c.23T>A (p.Val8Asp)	BRCA1	V8D	not provided	VCV000867692	17	41276091	17	43124074	867692	854985	rs2055739664	NC_000017.11:43124073:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	8	BRCA1
NM_007294.4(BRCA1):c.22G>T (p.Val8Phe)	BRCA1	V8F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000867691	17	41276092	17	43124075	867691	854986	rs528902306	NC_000017.11:43124074:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	8	BRCA1
NM_007294.4(BRCA1):c.22G>C (p.Val8Leu)	BRCA1	V8L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867690	17	41276092	17	43124075	867690	854987	rs528902306	NC_000017.11:43124074:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	8	BRCA1
NM_007294.4(BRCA1):c.22G>A (p.Val8Ile)	BRCA1	V8I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV000243118	17	41276092	17	43124075	243118	245058	rs528902306	NC_000017.11:43124074:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	8	BRCA1
NM_007294.4(BRCA1):c.20G>C (p.Arg7Pro)	BRCA1	R7P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865006	17	41276094	17	43124077	865006	854990	rs144792613	NC_000017.11:43124076:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	7	BRCA1
NM_007294.4(BRCA1):c.20G>T (p.Arg7Leu)	BRCA1	R7L	Hereditary cancer-predisposing syndrome	VCV000820717	17	41276094	17	43124077	820717	813924	rs144792613	NC_000017.11:43124076:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	7	BRCA1
NM_007294.4(BRCA1):c.20G>A (p.Arg7His)	BRCA1	R7H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S	VCV000184875	17	41276094	17	43124077	184875	185131	rs144792613	NC_000017.11:43124076:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	7	BRCA1
NM_007294.4(BRCA1):c.19C>G (p.Arg7Gly)	BRCA1	R7G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869078	17	41276095	17	43124078	869078	854991	rs80356994	NC_000017.11:43124077:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	7	BRCA1
NM_007294.4(BRCA1):c.19C>A (p.Arg7Ser)	BRCA1	R7S	Hereditary breast ovarian cancer syndrome	VCV000531388	17	41276095	17	43124078	531388	531401	rs80356994	NC_000017.11:43124077:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 24, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	7	BRCA1
NM_007294.4(BRCA1):c.19C>T (p.Arg7Cys)	BRCA1	R7C	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000037440	17	41276095	17	43124078	37440	45996	rs80356994	NC_000017.11:43124077:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	7	BRCA1
NM_007294.4(BRCA1):c.17T>G (p.Leu6Arg)	BRCA1	L6R	Hereditary breast ovarian cancer syndrome|not provided	VCV000869074	17	41276097	17	43124080	869074	854995	rs2055741739	NC_000017.11:43124079:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 29, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	6	BRCA1
NM_007294.4(BRCA1):c.17T>C (p.Leu6Pro)	BRCA1	L6P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869073	17	41276097	17	43124080	869073	854996	rs2055741739	NC_000017.11:43124079:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	6	BRCA1
NM_007294.4(BRCA1):c.17T>A (p.Leu6His)	BRCA1	L6H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869072	17	41276097	17	43124080	869072	854997	rs2055741739	NC_000017.11:43124079:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	6	BRCA1
NM_007294.4(BRCA1):c.16C>G (p.Leu6Val)	BRCA1	L6V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868697	17	41276098	17	43124081	868697	854998	rs1315262605	NC_000017.11:43124080:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	6	BRCA1
NM_007294.4(BRCA1):c.16C>A (p.Leu6Ile)	BRCA1	L6I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868696	17	41276098	17	43124081	868696	854999	rs1315262605	NC_000017.11:43124080:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	6	BRCA1
NM_007294.4(BRCA1):c.16C>T (p.Leu6Phe)	BRCA1	L6F	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000658584	17	41276098	17	43124081	658584	646067	rs1315262605	NC_000017.11:43124080:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	6	BRCA1
NM_007294.4(BRCA1):c.14C>G (p.Ala5Gly)	BRCA1	A5G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868693	17	41276100	17	43124083	868693	855002	rs1335137805	NC_000017.11:43124082:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	5	BRCA1
NM_007294.4(BRCA1):c.14C>A (p.Ala5Asp)	BRCA1	A5D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867683	17	41276100	17	43124083	867683	855003	rs1335137805	NC_000017.11:43124082:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	5	BRCA1
NM_007294.4(BRCA1):c.14C>T (p.Ala5Val)	BRCA1	A5V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000576432	17	41276100	17	43124083	576432	569198	rs1335137805	NC_000017.11:43124082:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 16, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	5	BRCA1
NM_007294.4(BRCA1):c.13G>T (p.Ala5Ser)	BRCA1	A5S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867682	17	41276101	17	43124084	867682	855004	rs1597923713	NC_000017.11:43124083:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	5	BRCA1
NM_007294.4(BRCA1):c.13G>A (p.Ala5Thr)	BRCA1	A5T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867681	17	41276101	17	43124084	867681	855005	rs1597923713	NC_000017.11:43124083:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	5	BRCA1
NM_007294.4(BRCA1):c.13G>C (p.Ala5Pro)	BRCA1	A5P	Hereditary cancer-predisposing syndrome	VCV000819110	17	41276101	17	43124084	819110	813925	rs1597923713	NC_000017.11:43124083:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 14, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	5	BRCA1
NM_007294.4(BRCA1):c.11C>G (p.Ser4Cys)	BRCA1	S4C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864992	17	41276103	17	43124086	864992	855009	rs786203152	NC_000017.11:43124085:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	4	BRCA1
NM_007294.4(BRCA1):c.11C>A (p.Ser4Tyr)	BRCA1	S4Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864991	17	41276103	17	43124086	864991	855010	rs786203152	NC_000017.11:43124085:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	4	BRCA1
NM_007294.4(BRCA1):c.11C>T (p.Ser4Phe)	BRCA1	S4F	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000186697	17	41276103	17	43124086	186697	185132	rs786203152	NC_000017.11:43124085:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	4	BRCA1
NM_007294.4(BRCA1):c.10T>G (p.Ser4Ala)	BRCA1	S4A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864990	17	41276104	17	43124087	864990	855011	rs876658707	NC_000017.11:43124086:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	4	BRCA1
NM_007294.4(BRCA1):c.10T>A (p.Ser4Thr)	BRCA1	S4T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000864989	17	41276104	17	43124087	864989	855012	rs876658707	NC_000017.11:43124086:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	4	BRCA1
NM_007294.4(BRCA1):c.10T>C (p.Ser4Pro)	BRCA1	S4P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV000230684	17	41276104	17	43124087	230684	236185	rs876658707	NC_000017.11:43124086:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	4	BRCA1
NM_007294.4(BRCA1):c.9A>C (p.Leu3Phe)	BRCA1	L3F	Hereditary cancer-predisposing syndrome	VCV000864988	17	41276105	17	43124088	864988	855013	rs780157871	NC_000017.11:43124087:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	3	BRCA1
NM_007294.4(BRCA1):c.9A>T (p.Leu3Phe)	BRCA1	L3F	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000441496	17	41276105	17	43124088	441496	435183	rs780157871	NC_000017.11:43124087:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	3	BRCA1
NM_007294.4(BRCA1):c.8T>C (p.Leu3Ser)	BRCA1	L3S	Hereditary breast ovarian cancer syndrome	VCV000869066	17	41276106	17	43124089	869066	855014	rs397509332	NC_000017.11:43124088:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	3	BRCA1
NM_007294.4(BRCA1):c.7T>G (p.Leu3Val)	BRCA1	L3V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869064	17	41276107	17	43124090	869064	855016	rs2055745032	NC_000017.11:43124089:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	3	BRCA1
NM_007294.4(BRCA1):c.7T>A (p.Leu3Ile)	BRCA1	L3I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869062	17	41276107	17	43124090	869062	855018	rs2055745032	NC_000017.11:43124089:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	3	BRCA1
NM_007294.4(BRCA1):c.6T>G (p.Asp2Glu)	BRCA1	D2E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000869061	17	41276108	17	43124091	869061	855019	rs754763517	NC_000017.11:43124090:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.6T>A (p.Asp2Glu)	BRCA1	D2E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868686	17	41276108	17	43124091	868686	855020	rs754763517	NC_000017.11:43124090:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.5A>T (p.Asp2Val)	BRCA1	D2V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868685	17	41276109	17	43124092	868685	855021	rs2055745664	NC_000017.11:43124091:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.5A>G (p.Asp2Gly)	BRCA1	D2G	Hereditary breast ovarian cancer syndrome	VCV000868684	17	41276109	17	43124092	868684	855022	rs2055745664	NC_000017.11:43124091:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 23, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.5A>C (p.Asp2Ala)	BRCA1	D2A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868683	17	41276109	17	43124092	868683	855023	rs2055745664	NC_000017.11:43124091:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.4G>T (p.Asp2Tyr)	BRCA1	D2Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868682	17	41276110	17	43124093	868682	855024	rs778775133	NC_000017.11:43124092:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.4G>C (p.Asp2His)	BRCA1	D2H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868681	17	41276110	17	43124093	868681	855025	rs778775133	NC_000017.11:43124092:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.4G>A (p.Asp2Asn)	BRCA1	D2N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868680	17	41276110	17	43124093	868680	855026	rs778775133	NC_000017.11:43124092:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	2	BRCA1
NM_007294.4(BRCA1):c.3G>A (p.Met1Ile)	BRCA1	M1I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431194	17	41276111	17	43124094	431194	424868	rs80357475	NC_000017.11:43124093:C:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.3G>C (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267523	17	41276111	17	43124094	267523	262996	rs80357475	NC_000017.11:43124093:C:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055072	17	41276111	17	43124094	55072	69739	rs80357475	NC_000017.11:43124093:C:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.2T>A (p.Met1Lys)	BRCA1	M1K	not provided	VCV000801069	17	41276112	17	43124095	801069	789636	rs80357111	NC_000017.11:43124094:A:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Feb 27, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.2T>G (p.Met1Arg)	BRCA1	M1R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054746	17	41276112	17	43124095	54746	69413	rs80357111	NC_000017.11:43124094:A:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 29, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	BRCA1	M1T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054745	17	41276112	17	43124095	54745	69412	rs80357111	NC_000017.11:43124094:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.1A>T (p.Met1Leu)	BRCA1	M1L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867672	17	41276113	17	43124096	867672	855027	rs80357287	NC_000017.11:43124095:T:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.1A>C (p.Met1Leu)	BRCA1	M1L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867671	17	41276113	17	43124096	867671	855028	rs80357287	NC_000017.11:43124095:T:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.1A>G (p.Met1Val)	BRCA1	M1V	Hereditary cancer-predisposing syndrome|Breast neoplasm|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054432	17	41276113	17	43124096	54432	69099	rs80357287	NC_000017.11:43124095:T:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1	BRCA1
NM_007294.4(BRCA1):c.1914A>T (p.Glu638Asp)	BRCA1	E638D	not provided	VCV003362166	NA	NA	NA	NA	3362166	3521376	NA	NA	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 2, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	638	BRCA1
NM_007294.4(BRCA1):c.2305A>C (p.Ile769Leu)	BRCA1	I769L	not provided	VCV003361703	NA	NA	NA	NA	3361703	3520913	NA	NA	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	769	BRCA1
NM_000314.8(PTEN):c.1A>C (p.Met1Leu)	PTEN	M174L	not provided	VCV003340277	10	89624227	10	87864470	3340277	3499534	NA	NC_000010.11:87864469:A:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Pathogenic	Jun 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	PTEN
NM_000314.8(PTEN):c.1A>T (p.Met1Leu)	PTEN	M174L	Cowden syndrome 1	VCV003148533	10	89624227	10	87864470	3148533	3307781	NA	NC_000010.11:87864469:A:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Likely pathogenic	Dec 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	PTEN
NM_000314.8(PTEN):c.1A>G (p.Met1Val)	PTEN	M1V	PTEN hamartoma tumor syndrome	VCV000484600	10	89624227	10	87864470	484600	475363	rs1554890324	NC_000010.11:87864469:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Pathogenic	Nov 22, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	1	PTEN
NM_000314.8(PTEN):c.2T>G (p.Met1Arg)	PTEN	M174R	Cowden syndrome 1	VCV002674279	10	89624228	10	87864471	2674279	2841767	NA	NC_000010.11:87864470:T:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Likely pathogenic	Sep 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	PTEN
NM_000314.8(PTEN):c.2T>C (p.Met1Thr)	PTEN	M174T	Cowden syndrome 1	VCV001686106	10	89624228	10	87864471	1686106	1678117	rs1858394001	NC_000010.11:87864470:T:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Pathogenic	May 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	PTEN
NM_000314.8(PTEN):c.3G>A (p.Met1Ile)	PTEN	M1I	PTEN hamartoma tumor syndrome	VCV001457954	10	89624229	10	87864472	1457954	1471521	rs2132145343	NC_000010.11:87864471:G:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Pathogenic	Jun 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	PTEN
NM_000314.8(PTEN):c.7G>A (p.Ala3Thr)	PTEN	A3T	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000827381	10	89624233	10	87864476	827381	810076	rs1589596120	NC_000010.11:87864475:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	3	PTEN
NM_000314.8(PTEN):c.8C>T (p.Ala3Val)	PTEN	A3V	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000629265	10	89624234	10	87864477	629265	617587	rs1564801650	NC_000010.11:87864476:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	3	PTEN
NM_000314.8(PTEN):c.10A>G (p.Ile4Val)	PTEN	I4V	PTEN hamartoma tumor syndrome	VCV001704153	10	89624236	10	87864479	1704153	1696630	NA	NC_000010.11:87864478:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	4	PTEN
NM_000314.8(PTEN):c.11T>C (p.Ile4Thr)	PTEN	I4T	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001420594	10	89624237	10	87864480	1420594	1403202	rs1858394571	NC_000010.11:87864479:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	4	PTEN
NM_000314.8(PTEN):c.11T>G (p.Ile4Ser)	PTEN	I4S	Hereditary cancer-predisposing syndrome	VCV000922734	10	89624237	10	87864480	922734	911207	rs1858394571	NC_000010.11:87864479:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 16, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	4	PTEN
NM_000314.8(PTEN):c.13A>T (p.Ile5Phe)	PTEN	I5F	PTEN hamartoma tumor syndrome	VCV001518129	10	89624239	10	87864482	1518129	1512400	rs1060500109	NC_000010.11:87864481:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	5	PTEN
NM_000314.8(PTEN):c.13A>G (p.Ile5Val)	PTEN	I5V	PTEN hamartoma tumor syndrome	VCV000404139	10	89624239	10	87864482	404139	397677	rs1060500109	NC_000010.11:87864481:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 29, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	5	PTEN
NM_000314.8(PTEN):c.14T>C (p.Ile5Thr)	PTEN	I5T	Macrocephaly-autism syndrome	VCV003254879	10	89624240	10	87864483	3254879	3413653	NA	NC_000010.11:87864482:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jul 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	5	PTEN
NM_000314.8(PTEN):c.14T>A (p.Ile5Asn)	PTEN	I5N	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001447678	10	89624240	10	87864483	1447678	1403565	rs2132145451	NC_000010.11:87864482:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	5	PTEN
NM_000314.8(PTEN):c.16A>G (p.Lys6Glu)	PTEN	K6E	PTEN hamartoma tumor syndrome	VCV000644390	10	89624242	10	87864485	644390	639262	rs1589596143	NC_000010.11:87864484:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	6	PTEN
NM_000314.8(PTEN):c.17A>G (p.Lys6Arg)	PTEN	K6R	Hereditary cancer-predisposing syndrome	VCV001780350	10	89624243	10	87864486	1780350	1835051	NA	NC_000010.11:87864485:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 19, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	6	PTEN
NM_000314.8(PTEN):c.18A>C (p.Lys6Asn)	PTEN	K6N	Hereditary cancer-predisposing syndrome|Neoplasm	VCV002561217	10	89624244	10	87864487	2561217	2727983	NA	NC_000010.11:87864486:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 8, 2023	criteria provided, single submitter	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	6	PTEN
NM_000314.8(PTEN):c.21G>C (p.Glu7Asp)	PTEN	E7D	PTEN hamartoma tumor syndrome	VCV000536560	10	89624247	10	87864490	536560	525493	rs1554890337	NC_000010.11:87864489:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 9, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	7	PTEN
NM_000314.8(PTEN):c.22A>G (p.Ile8Val)	PTEN	I181V	not provided	VCV003340638	10	89624248	10	87864491	3340638	3499878	NA	NC_000010.11:87864490:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 20, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	8	PTEN
NM_000314.8(PTEN):c.22A>T (p.Ile8Phe)	PTEN	I181F	Hereditary cancer-predisposing syndrome	VCV003231148	10	89624248	10	87864491	3231148	3391770	NA	NC_000010.11:87864490:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	8	PTEN
NM_000314.8(PTEN):c.25G>A (p.Val9Ile)	PTEN	V9I	Hereditary cancer-predisposing syndrome	VCV000631333	10	89624251	10	87864494	631333	617588	rs1564801672	NC_000010.11:87864493:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	9	PTEN
NM_000314.8(PTEN):c.28A>G (p.Ser10Gly)	PTEN	S10G	Hereditary cancer-predisposing syndrome	VCV000428272	10	89624254	10	87864497	428272	419689	rs572685299	NC_000010.11:87864496:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 28, 2012	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	10	PTEN
NM_000314.8(PTEN):c.29G>C (p.Ser10Thr)	PTEN	S10T	PTEN hamartoma tumor syndrome	VCV003236456	10	89624255	10	87864498	3236456	3395576	NA	NC_000010.11:87864497:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	10	PTEN
NM_000314.8(PTEN):c.30C>G (p.Ser10Arg)	PTEN	S10R	developmental delay with seizures	VCV000560657	10	89624256	10	87864499	560657	551711	rs1564801689	NC_000010.11:87864498:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 11, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	10	PTEN
NM_000314.8(PTEN):c.31A>G (p.Arg11Gly)	PTEN	R11G	PTEN hamartoma tumor syndrome	VCV001003310	10	89624257	10	87864500	1003310	994088	rs1858395868	NC_000010.11:87864499:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	11	PTEN
NM_000314.8(PTEN):c.32G>C (p.Arg11Thr)	PTEN	R11T	not provided	VCV003372634	10	89624258	10	87864501	3372634	3531824	NA	NC_000010.11:87864500:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	11	PTEN
NM_000314.8(PTEN):c.32G>A (p.Arg11Lys)	PTEN	R11K	PTEN hamartoma tumor syndrome	VCV002088470	10	89624258	10	87864501	2088470	2151544	NA	NC_000010.11:87864500:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	11	PTEN
NM_000314.8(PTEN):c.34A>C (p.Asn12His)	PTEN	N12H	PTEN hamartoma tumor syndrome	VCV001473634	10	89624260	10	87864503	1473634	1391511	rs1554890340	NC_000010.11:87864502:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	12	PTEN
NM_000314.8(PTEN):c.34A>G (p.Asn12Asp)	PTEN	N12D	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000484601	10	89624260	10	87864503	484601	475369	rs1554890340	NC_000010.11:87864502:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 26, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	12	PTEN
NM_000314.8(PTEN):c.35A>G (p.Asn12Ser)	PTEN	N12S	PTEN hamartoma tumor syndrome	VCV001320976	10	89624261	10	87864504	1320976	1311220	rs1085308044	NC_000010.11:87864503:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	12	PTEN
NM_000314.8(PTEN):c.35A>T (p.Asn12Ile)	PTEN	N12I	PTEN hamartoma tumor syndrome	VCV000944445	10	89624261	10	87864504	944445	925960	rs1085308044	NC_000010.11:87864503:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Aug 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	12	PTEN
NM_000314.8(PTEN):c.35A>C (p.Asn12Thr)	PTEN	N12T	PTEN hamartoma tumor syndrome	VCV000427586	10	89624261	10	87864504	427586	416933	rs1085308044	NC_000010.11:87864503:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Mar 1, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	12	PTEN
NM_000314.8(PTEN):c.36C>G (p.Asn12Lys)	PTEN	N12K	Hereditary cancer-predisposing syndrome	VCV000141715	10	89624262	10	87864505	141715	151429	rs587781957	NC_000010.11:87864504:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 17, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	12	PTEN
NM_000314.8(PTEN):c.37A>G (p.Lys13Glu)	PTEN	K13E	PTEN hamartoma tumor syndrome|Cowden syndrome	VCV000988004	10	89624263	10	87864506	988004	975937	rs1554890348	NC_000010.11:87864505:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Nov 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	13	PTEN
NM_000314.8(PTEN):c.37A>C (p.Lys13Gln)	PTEN	K13Q	PTEN hamartoma tumor syndrome	VCV000846550	10	89624263	10	87864506	846550	837410	rs1554890348	NC_000010.11:87864505:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jan 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	13	PTEN
NM_000314.8(PTEN):c.38A>G (p.Lys13Arg)	PTEN	K13R	Hereditary cancer-predisposing syndrome	VCV002774177	10	89624264	10	87864507	2774177	2934907	NA	NC_000010.11:87864506:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	13	PTEN
NM_000314.8(PTEN):c.39A>C (p.Lys13Asn)	PTEN	K13N	Hereditary cancer-predisposing syndrome	VCV001736845	10	89624265	10	87864508	1736845	1793887	NA	NC_000010.11:87864507:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	13	PTEN
NM_000314.8(PTEN):c.40A>T (p.Arg14Trp)	PTEN	R14W	PTEN hamartoma tumor syndrome	VCV002819090	10	89624266	10	87864509	2819090	2977616	NA	NC_000010.11:87864508:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	14	PTEN
NM_000314.8(PTEN):c.40A>G (p.Arg14Gly)	PTEN	R14G	PTEN hamartoma tumor syndrome	VCV000427589	10	89624266	10	87864509	427589	416934	rs1085308047	NC_000010.11:87864508:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	14	PTEN
NM_000314.8(PTEN):c.41G>C (p.Arg14Thr)	PTEN	R14T	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000852741	10	89624267	10	87864510	852741	837411	rs1589596246	NC_000010.11:87864509:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 7, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	14	PTEN
NM_000314.8(PTEN):c.41G>A (p.Arg14Lys)	PTEN	R14K	Hereditary cancer-predisposing syndrome	VCV000824671	10	89624267	10	87864510	824671	810078	rs1589596246	NC_000010.11:87864509:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 6, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	14	PTEN
NM_000314.8(PTEN):c.43A>G (p.Arg15Gly)	PTEN	R15G	Hereditary cancer-predisposing syndrome	VCV002561216	10	89624269	10	87864512	2561216	2727982	NA	NC_000010.11:87864511:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	15	PTEN
NM_000314.8(PTEN):c.44G>C (p.Arg15Thr)	PTEN	R15T	PTEN hamartoma tumor syndrome	VCV000428243	10	89624270	10	87864513	428243	419692	rs398123324	NC_000010.11:87864512:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	15	PTEN
NM_000314.8(PTEN):c.44G>A (p.Arg15Lys)	PTEN	R15K	PTEN hamartoma tumor syndrome	VCV000404147	10	89624270	10	87864513	404147	397912	rs398123324	NC_000010.11:87864512:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	15	PTEN
NM_000314.8(PTEN):c.45A>C (p.Arg15Ser)	PTEN	R15S	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000428194	10	89624271	10	87864514	428194	419693	rs1064794096	NC_000010.11:87864513:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	15	PTEN
NM_000314.8(PTEN):c.45A>T (p.Arg15Ser)	PTEN	R15S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000419769	10	89624271	10	87864514	419769	407979	rs1064794096	NC_000010.11:87864513:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	15	PTEN
NM_000314.8(PTEN):c.46T>A (p.Tyr16Asn)	PTEN	Y16N	PTEN hamartoma tumor syndrome	VCV000857591	10	89624272	10	87864515	857591	837412	rs1064796078	NC_000010.11:87864514:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 28, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	16	PTEN
NM_000314.8(PTEN):c.46T>C (p.Tyr16His)	PTEN	Y16H	PTEN hamartoma tumor syndrome	VCV000428195	10	89624272	10	87864515	428195	419695	rs1064796078	NC_000010.11:87864514:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	16	PTEN
NM_000314.8(PTEN):c.46T>G (p.Tyr16Asp)	PTEN	Y16D	not provided	VCV000422899	10	89624272	10	87864515	422899	407980	rs1064796078	NC_000010.11:87864514:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Dec 23, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	16	PTEN
NM_000314.8(PTEN):c.47A>C (p.Tyr16Ser)	PTEN	Y16S	PTEN hamartoma tumor syndrome	VCV002811915	10	89624273	10	87864516	2811915	2969153	NA	NC_000010.11:87864515:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	16	PTEN
NM_000314.8(PTEN):c.47A>G (p.Tyr16Cys)	PTEN	Y16C	PTEN hamartoma tumor syndrome	VCV002798148	10	89624273	10	87864516	2798148	2955385	NA	NC_000010.11:87864515:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	16	PTEN
NM_000314.8(PTEN):c.49C>G (p.Gln17Glu)	KLLN|PTEN	Q17E	PTEN hamartoma tumor syndrome	VCV000480386	10	89624275	10	87864518	480386	475447	rs786204910	NC_000010.11:87864517:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	17	PTEN
NM_000314.8(PTEN):c.50A>G (p.Gln17Arg)	PTEN	Q17R	PTEN hamartoma tumor syndrome	VCV000948026	10	89624276	10	87864519	948026	925961	rs1858398407	NC_000010.11:87864518:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 22, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	17	PTEN
NM_000314.8(PTEN):c.54G>T (p.Glu18Asp)	PTEN	E18D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000850232	10	89624280	10	87864523	850232	837413	rs1554890388	NC_000010.11:87864522:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	18	PTEN
NM_000314.8(PTEN):c.55_56delinsTT (p.Asp19Phe)	PTEN	D192F	Hereditary cancer-predisposing syndrome	VCV000825786	10	89624281 - 89624282	10	87864524 - 87864525	825786	810079	rs1589596354	NC_000010.11:87864523:GA:TT	Indel	missense variant|5 prime UTR variant	Uncertain significance	Aug 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	19	PTEN
NM_000314.8(PTEN):c.55G>A (p.Asp19Asn)	PTEN	D19N	PTEN hamartoma tumor syndrome	VCV000007837	10	89624281	10	87864524	7837	22876	rs121909233	NC_000010.11:87864523:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	19	PTEN
NM_000314.8(PTEN):c.56A>T (p.Asp19Val)	PTEN	D19V	PTEN hamartoma tumor syndrome	VCV002001733	10	89624282	10	87864525	2001733	2054934	NA	NC_000010.11:87864524:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	19	PTEN
NM_000314.8(PTEN):c.56A>G (p.Asp19Gly)	PTEN	D19G	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000492333	10	89624282	10	87864525	492333	484191	rs1554890392	NC_000010.11:87864524:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	19	PTEN
NM_000314.8(PTEN):c.59G>C (p.Gly20Ala)	PTEN	G20A	PTEN hamartoma tumor syndrome	VCV001392070	10	89624285	10	87864528	1392070	1409411	rs1064795967	NC_000010.11:87864527:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	20	PTEN
NM_000314.8(PTEN):c.59G>T (p.Gly20Val)	PTEN	G20V	PTEN hamartoma tumor syndrome	VCV000428266	10	89624285	10	87864528	428266	419696	rs1064795967	NC_000010.11:87864527:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	20	PTEN
NM_000314.8(PTEN):c.59G>A (p.Gly20Glu)	PTEN	G20E	not provided	VCV000422740	10	89624285	10	87864528	422740	407981	rs1064795967	NC_000010.11:87864527:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	20	PTEN
NM_000314.8(PTEN):c.62T>C (p.Phe21Ser)	PTEN	F21S	not provided	VCV003338761	10	89624288	10	87864531	3338761	3498031	NA	NC_000010.11:87864530:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	21	PTEN
NM_000314.8(PTEN):c.63C>A (p.Phe21Leu)	PTEN	F21L	PTEN hamartoma tumor syndrome	VCV001411463	10	89624289	10	87864532	1411463	1447912	rs1858399493	NC_000010.11:87864531:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	21	PTEN
NM_000314.8(PTEN):c.64G>T (p.Asp22Tyr)	PTEN	D22Y	PTEN hamartoma tumor syndrome|not provided	VCV000468706	10	89624290	10	87864533	468706	460357	rs876660420	NC_000010.11:87864532:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	22	PTEN
NM_000314.8(PTEN):c.64G>C (p.Asp22His)	PTEN	D22H	PTEN hamartoma tumor syndrome	VCV000233456	10	89624290	10	87864533	233456	233840	rs876660420	NC_000010.11:87864532:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	22	PTEN
NM_000314.8(PTEN):c.65A>T (p.Asp22Val)	PTEN	D22V	Hereditary cancer-predisposing syndrome	VCV003231166	10	89624291	10	87864534	3231166	3391788	NA	NC_000010.11:87864533:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	22	PTEN
NM_000314.8(PTEN):c.65A>G (p.Asp22Gly)	PTEN	D22G	Hereditary cancer-predisposing syndrome|not provided	VCV000486221	10	89624291	10	87864534	486221	475371	rs1554890398	NC_000010.11:87864533:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	22	PTEN
NM_000314.8(PTEN):c.66C>G (p.Asp22Glu)	PTEN	D22E	not provided|Macrocephaly-autism syndrome|Cowden syndrome 1	VCV001333229	10	89624292	10	87864535	1333229	1324005	rs786201335	NC_000010.11:87864534:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	22	PTEN
NM_000314.8(PTEN):c.67T>G (p.Leu23Val)	PTEN	L23V	PTEN hamartoma tumor syndrome|Neoplasm	VCV000234830	10	89624293	10	87864536	234830	231781	rs876661244	NC_000010.11:87864535:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	23	PTEN
NM_000314.8(PTEN):c.68T>C (p.Leu23Ser)	PTEN	L23S	PTEN hamartoma tumor syndrome	VCV002827098	10	89624294	10	87864537	2827098	2983050	NA	NC_000010.11:87864536:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	23	PTEN
NM_000314.8(PTEN):c.70G>T (p.Asp24Tyr)	PTEN	D24Y	Cowden syndrome 1|not provided	VCV000189398	10	89624296	10	87864539	189398	187324	rs786201995	NC_000010.11:87864538:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.70G>C (p.Asp24His)	PTEN	D24H	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1	VCV000186005	10	89624296	10	87864539	186005	183007	rs786201995	NC_000010.11:87864538:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.70G>A (p.Asp24Asn)	PTEN	D24N	not provided|Hereditary cancer-predisposing syndrome	VCV000185200	10	89624296	10	87864539	185200	183006	rs786201995	NC_000010.11:87864538:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Aug 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.71A>C (p.Asp24Ala)	PTEN	D24A	PTEN hamartoma tumor syndrome	VCV002032096	10	89624297	10	87864540	2032096	2086156	NA	NC_000010.11:87864539:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.71A>T (p.Asp24Val)	PTEN	D24V	Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV001511392	10	89624297	10	87864540	1511392	1458873	rs797044910	NC_000010.11:87864539:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.71A>G (p.Asp24Gly)	PTEN	D24G	Hereditary cancer-predisposing syndrome|Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome	VCV000208723	10	89624297	10	87864540	208723	205265	rs797044910	NC_000010.11:87864539:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.72C>A (p.Asp24Glu)	PTEN	D24E	PTEN hamartoma tumor syndrome	VCV002896983	10	89624298	10	87864541	2896983	3059911	NA	NC_000010.11:87864540:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.72C>G (p.Asp24Glu)	PTEN	D24E	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000482071	10	89624298	10	87864541	482071	475236	rs1320222638	NC_000010.11:87864540:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	PTEN
NM_000314.8(PTEN):c.73T>G (p.Leu25Val)	PTEN	L25V	not provided|PTEN hamartoma tumor syndrome	VCV000092826	10	89624299	10	87864542	92826	98733	rs398123326	NC_000010.11:87864541:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 1, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	25	PTEN
NM_000314.8(PTEN):c.74T>C (p.Leu25Ser)	PTEN	L25S	not provided	VCV000189460	10	89624300	10	87864543	189460	187325	rs786204912	NC_000010.11:87864542:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 1, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	25	PTEN
NM_000314.8(PTEN):c.75G>C (p.Leu25Phe)	PTEN	L25F	PTEN hamartoma tumor syndrome|not provided	VCV001068214	10	89624301	10	87864544	1068214	1055936	rs786201506	NC_000010.11:87864543:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Feb 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	25	PTEN
NM_000314.8(PTEN):c.75G>T (p.Leu25Phe)	PTEN	L25F	Hereditary cancer-predisposing syndrome	VCV000490117	10	89624301	10	87864544	490117	482764	rs786201506	NC_000010.11:87864543:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	25	PTEN
NM_000314.8(PTEN):c.76A>C (p.Thr26Pro)	PTEN	T26P	PTEN hamartoma tumor syndrome|not provided	VCV000234410	10	89624302	10	87864545	234410	231782	rs876661010	NC_000010.11:87864544:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Dec 19, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	26	PTEN
NM_000314.8(PTEN):c.77C>A (p.Thr26Asn)	PTEN	T26N	PTEN hamartoma tumor syndrome	VCV000949068	10	89624303	10	87864546	949068	925962	rs786204853	NC_000010.11:87864545:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Mar 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	26	PTEN
NM_000314.8(PTEN):c.77C>T (p.Thr26Ile)	PTEN	T26I	Hereditary cancer-predisposing syndrome|See cases|PTEN hamartoma tumor syndrome	VCV000189399	10	89624303	10	87864546	189399	187326	rs786204853	NC_000010.11:87864545:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	26	PTEN
NM_000314.8(PTEN):c.79T>A (p.Tyr27Asn)	PTEN	Y27N	PTEN hamartoma tumor syndrome	VCV002735432	10	89624305	10	87864548	2735432	187327	rs746128825	NC_000010.11:87864547:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	27	PTEN
NM_000314.8(PTEN):c.80A>T (p.Tyr27Phe)	PTEN	Y27F	not provided	VCV002663192	10	89653782	10	87894025	2663192	2830642	NA	NC_000010.11:87894024:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	27	PTEN
NM_000314.8(PTEN):c.80A>G (p.Tyr27Cys)	PTEN	Y27C	PTEN hamartoma tumor syndrome	VCV000404160	10	89653782	10	87894025	404160	398044	rs886041877	NC_000010.11:87894024:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	27	PTEN
NM_000314.8(PTEN):c.80A>C (p.Tyr27Ser)	PTEN	Y27S	PTEN hamartoma tumor syndrome	VCV000280724	10	89653782	10	87894025	280724	264484	rs886041877	NC_000010.11:87894024:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	27	PTEN
NM_000314.8(PTEN):c.82A>G (p.Ile28Val)	PTEN	I28V	PTEN hamartoma tumor syndrome	VCV000864251	10	89653784	10	87894027	864251	837414	rs1859092645	NC_000010.11:87894026:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	PTEN
NM_000314.8(PTEN):c.83T>C (p.Ile28Thr)	PTEN	I28T	Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided	VCV001192170	10	89653785	10	87894028	1192170	1180724	rs1355570425	NC_000010.11:87894027:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	28	PTEN
NM_000314.8(PTEN):c.83T>G (p.Ile28Ser)	PTEN	I28S	PTEN hamartoma tumor syndrome	VCV001003503	10	89653785	10	87894028	1003503	994089	rs1355570425	NC_000010.11:87894027:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	PTEN
NM_000314.8(PTEN):c.84T>G (p.Ile28Met)	PTEN	I28M	PTEN hamartoma tumor syndrome	VCV001489216	10	89653786	10	87894029	1489216	1498708	rs2132187113	NC_000010.11:87894028:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	PTEN
NM_000314.8(PTEN):c.85_86delinsAT (p.Tyr29Ile)	PTEN	Y29I	Hereditary cancer-predisposing syndrome	VCV002587204	10	89653787 - 89653788	10	87894030 - 87894031	2587204	2753880	NA	NC_000010.11:87894029:TA:AT	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jul 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	29	PTEN
NM_000314.8(PTEN):c.88C>G (p.Pro30Ala)	PTEN	P30A	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV002567270	10	89653790	10	87894033	2567270	2730912	NA	NC_000010.11:87894032:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	30	PTEN
NM_000314.8(PTEN):c.88C>A (p.Pro30Thr)	PTEN	P30T	not provided	VCV000195060	10	89653790	10	87894033	195060	192222	rs794727243	NC_000010.11:87894032:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 20, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	30	PTEN
NM_000314.8(PTEN):c.89C>T (p.Pro30Leu)	PTEN	P30L	Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV001052223	10	89653791	10	87894034	1052223	1046821	rs1589617164	NC_000010.11:87894033:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	30	PTEN
NM_000314.8(PTEN):c.89C>G (p.Pro30Arg)	PTEN	P30R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000822881	10	89653791	10	87894034	822881	810082	rs1589617164	NC_000010.11:87894033:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	30	PTEN
NM_000314.8(PTEN):c.91A>G (p.Asn31Asp)	PTEN	N31D	PTEN hamartoma tumor syndrome	VCV000943637	10	89653793	10	87894036	943637	935218	rs1859093459	NC_000010.11:87894035:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	31	PTEN
NM_000314.8(PTEN):c.93C>A (p.Asn31Lys)	PTEN	N31K	PTEN hamartoma tumor syndrome	VCV000468722	10	89653795	10	87894038	468722	461093	rs1170214930	NC_000010.11:87894037:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 29, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	31	PTEN
NM_000314.8(PTEN):c.94A>G (p.Ile32Val)	PTEN	I32V	PTEN hamartoma tumor syndrome	VCV001958206	10	89653796	10	87894039	1958206	2015756	NA	NC_000010.11:87894038:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	32	PTEN
NM_000314.8(PTEN):c.95T>A (p.Ile32Asn)	PTEN	I32N	PTEN hamartoma tumor syndrome	VCV001462894	10	89653797	10	87894040	1462894	1511331	rs1057518329	NC_000010.11:87894039:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	32	PTEN
NM_000314.8(PTEN):c.95T>C (p.Ile32Thr)	PTEN	I32T	not specified|PTEN hamartoma tumor syndrome	VCV000373288	10	89653797	10	87894040	373288	359848	rs1057518329	NC_000010.11:87894039:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	32	PTEN
NM_000314.8(PTEN):c.96T>G (p.Ile32Met)	PTEN	I32M	PTEN hamartoma tumor syndrome	VCV003071692	10	89653798	10	87894041	3071692	3233958	NA	NC_000010.11:87894040:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	32	PTEN
NM_000314.8(PTEN):c.98T>C (p.Ile33Thr)	PTEN	I33T	PTEN hamartoma tumor syndrome	VCV000536543	10	89653800	10	87894043	536543	525582	rs1554893771	NC_000010.11:87894042:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	33	PTEN
NM_000314.8(PTEN):c.100G>A (p.Ala34Thr)	PTEN	A34T	PTEN hamartoma tumor syndrome	VCV001719163	10	89653802	10	87894045	1719163	1774467	NA	NC_000010.11:87894044:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	34	PTEN
NM_000314.8(PTEN):c.100G>C (p.Ala34Pro)	PTEN	A34P	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1	VCV000822002	10	89653802	10	87894045	822002	810083	rs1589617199	NC_000010.11:87894044:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	34	PTEN
NM_000314.8(PTEN):c.101C>T (p.Ala34Val)	PTEN	A34V	not specified	VCV000492726	10	89653803	10	87894046	492726	485644	rs1554893773	NC_000010.11:87894045:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	34	PTEN
NM_000314.8(PTEN):c.103A>C (p.Met35Leu)	PTEN	M35L	Cowden syndrome 1	VCV000976722	10	89653805	10	87894048	976722	964844	rs876659443	NC_000010.11:87894047:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 19, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	35	PTEN
NM_000314.8(PTEN):c.103A>G (p.Met35Val)	PTEN	M35V	PTEN hamartoma tumor syndrome	VCV000231916	10	89653805	10	87894048	231916	233842	rs876659443	NC_000010.11:87894047:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	35	PTEN
NM_000314.8(PTEN):c.104T>C (p.Met35Thr)	PTEN	M35T	Hereditary cancer-predisposing syndrome|Cowden syndrome 1	VCV000428244	10	89653806	10	87894049	428244	419698	rs121909225	NC_000010.11:87894048:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	35	PTEN
NM_000314.8(PTEN):c.104T>G (p.Met35Arg)	PTEN	M35R	PTEN hamartoma tumor syndrome	VCV000007825	10	89653806	10	87894049	7825	22864	rs121909225	NC_000010.11:87894048:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 25, 2018	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	35	PTEN
NM_000314.8(PTEN):c.105G>A (p.Met35Ile)	PTEN	M35I	PTEN hamartoma tumor syndrome	VCV000536558	10	89653807	10	87894050	536558	525897	rs1554893782	NC_000010.11:87894049:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	35	PTEN
NM_000314.8(PTEN):c.106G>A (p.Gly36Arg)	PTEN	G36R	PTEN hamartoma tumor syndrome	VCV001334551	10	89653808	10	87894051	1334551	1325446	rs786204854	NC_000010.11:87894050:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	36	PTEN
NM_000314.8(PTEN):c.106G>C (p.Gly36Arg)	PTEN	G36R	PTEN hamartoma tumor syndrome	VCV000189400	10	89653808	10	87894051	189400	187330	rs786204854	NC_000010.11:87894050:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	36	PTEN
NM_000314.8(PTEN):c.107G>A (p.Gly36Glu)	PTEN	G36E	PTEN hamartoma tumor syndrome	VCV000486972	10	89653809	10	87894052	486972	475456	rs1554893792	NC_000010.11:87894051:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	36	PTEN
NM_000314.8(PTEN):c.112C>A (p.Pro38Thr)	PTEN	P38T	Hereditary cancer-predisposing syndrome	VCV000229912	10	89653814	10	87894057	229912	233843	rs587780004	NC_000010.11:87894056:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 6, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	38	PTEN
NM_000314.8(PTEN):c.112C>T (p.Pro38Ser)	PTEN	P38S	PTEN hamartoma tumor syndrome	VCV000127688	10	89653814	10	87894057	127688	133145	rs587780004	NC_000010.11:87894056:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	38	PTEN
NM_000314.8(PTEN):c.113C>A (p.Pro38His)	PTEN	P38H	not provided|PTEN hamartoma tumor syndrome	VCV001012092	10	89653815	10	87894058	1012092	994090	rs1064796886	NC_000010.11:87894057:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	38	PTEN
NM_000314.8(PTEN):c.113C>T (p.Pro38Leu)	PTEN	P38L	PTEN hamartoma tumor syndrome	VCV000818421	10	89653815	10	87894058	818421	810084	rs1064796886	NC_000010.11:87894057:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	38	PTEN
NM_000314.8(PTEN):c.113C>G (p.Pro38Arg)	PTEN	P38R	not provided	VCV000424262	10	89653815	10	87894058	424262	407983	rs1064796886	NC_000010.11:87894057:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	May 3, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	38	PTEN
NM_000314.8(PTEN):c.115G>A (p.Ala39Thr)	PTEN	A39T	PTEN hamartoma tumor syndrome	VCV001506231	10	89653817	10	87894060	1506231	1430156	rs2132187379	NC_000010.11:87894059:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	39	PTEN
NM_000314.8(PTEN):c.116C>T (p.Ala39Val)	PTEN	A39V	PTEN hamartoma tumor syndrome|not provided|Neoplasm	VCV002022313	10	89653818	10	87894061	2022313	2080221	NA	NC_000010.11:87894060:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	39	PTEN
NM_000314.8(PTEN):c.116C>A (p.Ala39Glu)	PTEN	A39E	PTEN hamartoma tumor syndrome	VCV001427165	10	89653818	10	87894061	1427165	1444567	rs2132187390	NC_000010.11:87894060:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 2, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	39	PTEN
NM_000314.8(PTEN):c.122G>A (p.Arg41Lys)	PTEN	R41K	PTEN hamartoma tumor syndrome	VCV002123059	10	89653824	10	87894067	2123059	2180953	NA	NC_000010.11:87894066:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	41	PTEN
NM_000314.8(PTEN):c.122G>T (p.Arg41Ile)	PTEN	R41I	Hereditary cancer-predisposing syndrome|not provided	VCV000195061	10	89653824	10	87894067	195061	192223	rs794727244	NC_000010.11:87894066:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 20, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	41	PTEN
NM_000314.8(PTEN):c.123A>T (p.Arg41Ser)	PTEN	R41S	Hereditary cancer-predisposing syndrome	VCV000484616	10	89653825	10	87894068	484616	475378	rs1554893806	NC_000010.11:87894067:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 29, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	41	PTEN
NM_000314.8(PTEN):c.125T>C (p.Leu42Pro)	PTEN	L42P	PTEN hamartoma tumor syndrome	VCV000853190	10	89653827	10	87894070	853190	837415	rs1859096966	NC_000010.11:87894069:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 22, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	42	PTEN
NM_000314.8(PTEN):c.127G>A (p.Glu43Lys)	PTEN	E43K	Hereditary cancer-predisposing syndrome	VCV000486222	10	89653829	10	87894072	486222	475237	rs1554893808	NC_000010.11:87894071:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 17, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	PTEN
NM_000314.8(PTEN):c.128A>C (p.Glu43Ala)	PTEN	E43A	PTEN hamartoma tumor syndrome	VCV002855793	10	89653830	10	87894073	2855793	3010874	NA	NC_000010.11:87894072:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	PTEN
NM_000314.8(PTEN):c.128A>G (p.Glu43Gly)	PTEN	E43G	Malignant tumor of breast	VCV002505479	10	89653830	10	87894073	2505479	2670443	NA	NC_000010.11:87894072:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	PTEN
NM_000314.8(PTEN):c.130G>A (p.Gly44Ser)	PTEN	G44S	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000484604	10	89653832	10	87894075	484604	475476	rs1554893812	NC_000010.11:87894074:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	44	PTEN
NM_000314.8(PTEN):c.131G>A (p.Gly44Asp)	PTEN	G44D	PTEN hamartoma tumor syndrome|not provided|Cowden syndrome	VCV000427582	10	89653833	10	87894076	427582	416935	rs1085308042	NC_000010.11:87894075:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	44	PTEN
NM_000314.8(PTEN):c.133G>A (p.Val45Ile)	PTEN	V45I	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001053430	10	89653835	10	87894078	1053430	1046822	rs1382752324	NC_000010.11:87894077:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	45	PTEN
NM_000314.8(PTEN):c.136T>C (p.Tyr46His)	PTEN	Y46H	not provided	VCV001701143	10	89653838	10	87894081	1701143	1693535	rs1064793325	NC_000010.11:87894080:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Oct 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	46	PTEN
NM_000314.8(PTEN):c.136T>G (p.Tyr46Asp)	PTEN	Y46D	not provided	VCV000418614	10	89653838	10	87894081	418614	407984	rs1064793325	NC_000010.11:87894080:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 5, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	46	PTEN
NM_000314.8(PTEN):c.137A>G (p.Tyr46Cys)	PTEN	Y46C	PTEN hamartoma tumor syndrome	VCV001368242	10	89653839	10	87894082	1368242	187333	rs786204915	NC_000010.11:87894081:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 31, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	46	PTEN
NM_000314.8(PTEN):c.139A>G (p.Arg47Gly)	PTEN	R47G	PTEN hamartoma tumor syndrome	VCV000189401	10	89653841	10	87894084	189401	187334	rs786204855	NC_000010.11:87894083:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	47	PTEN
NM_000314.8(PTEN):c.140G>A (p.Arg47Lys)	PTEN	R47K	PTEN hamartoma tumor syndrome	VCV000373446	10	89653842	10	87894085	373446	359849	rs1057518425	NC_000010.11:87894084:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Dec 1, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	47	PTEN
NM_000314.8(PTEN):c.142A>G (p.Asn48Asp)	PTEN	N48D	Hereditary cancer-predisposing syndrome	VCV000918670	10	89653844	10	87894087	918670	911211	rs1859098707	NC_000010.11:87894086:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 6, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	48	PTEN
NM_000314.8(PTEN):c.143A>G (p.Asn48Ser)	PTEN	N48S	Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV001379224	10	89653845	10	87894088	1379224	1486453	rs1859098783	NC_000010.11:87894087:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	48	PTEN
NM_000314.8(PTEN):c.144C>A (p.Asn48Lys)	PTEN	N48K	Hereditary cancer-predisposing syndrome|Cowden syndrome 1|Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV000580731	10	89653846	10	87894089	580731	569829	rs762518389	NC_000010.11:87894088:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	48	PTEN
NM_000314.8(PTEN):c.144C>G (p.Asn48Lys)	PTEN	N48K	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	VCV000231771	10	89653846	10	87894089	231771	233844	rs762518389	NC_000010.11:87894088:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	48	PTEN
NM_000314.8(PTEN):c.146A>G (p.Asn49Ser)	PTEN	N49S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000480377	10	89653848	10	87894091	480377	475494	rs992385562	NC_000010.11:87894090:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	49	PTEN
NM_000314.8(PTEN):c.149T>C (p.Ile50Thr)	PTEN	I50T	PTEN hamartoma tumor syndrome	VCV000492727	10	89653851	10	87894094	492727	485645	rs1554893824	NC_000010.11:87894093:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	50	PTEN
NM_000314.8(PTEN):c.150T>G (p.Ile50Met)	PTEN	I50M	PTEN hamartoma tumor syndrome	VCV000576858	10	89653852	10	87894095	576858	564002	rs1564814601	NC_000010.11:87894094:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	50	PTEN
NM_000314.8(PTEN):c.152A>G (p.Asp51Gly)	PTEN	D51G	PTEN hamartoma tumor syndrome	VCV001002716	10	89653854	10	87894097	1002716	994091	rs1859099585	NC_000010.11:87894096:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	51	PTEN
NM_000314.8(PTEN):c.154G>A (p.Asp52Asn)	PTEN	D52N	PTEN hamartoma tumor syndrome	VCV000566934	10	89653856	10	87894099	566934	564004	rs1564814606	NC_000010.11:87894098:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 26, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	52	PTEN
NM_000314.8(PTEN):c.156T>G (p.Asp52Glu)	PTEN	D52E	PTEN hamartoma tumor syndrome|not provided	VCV002502625	10	89653858	10	87894101	2502625	2667731	NA	NC_000010.11:87894100:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	52	PTEN
NM_000314.8(PTEN):c.157G>A (p.Val53Ile)	PTEN	V53I	PTEN hamartoma tumor syndrome|not provided	VCV002136907	10	89653859	10	87894102	2136907	1877911	NA	NC_000010.11:87894101:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	53	PTEN
NM_000314.8(PTEN):c.158_159delinsAT (p.Val53Asp)	PTEN	V53D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001052224	10	89653860 - 89653861	10	87894103 - 87894104	1052224	1046823	rs2132187834	NC_000010.11:87894102:TA:AT	Indel	missense variant|5 prime UTR variant	Uncertain significance	Apr 26, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	53	PTEN
NM_000314.8(PTEN):c.158T>C (p.Val53Ala)	PTEN	V53A	not provided	VCV000916219	10	89653860	10	87894103	916219	904542	rs786203375	NC_000010.11:87894102:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Mar 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	53	PTEN
NM_000314.8(PTEN):c.158T>A (p.Val53Glu)	PTEN	V53E	Hereditary cancer-predisposing syndrome	VCV000186980	10	89653860	10	87894103	186980	183015	rs786203375	NC_000010.11:87894102:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	53	PTEN
NM_000314.8(PTEN):c.160G>A (p.Val54Ile)	PTEN	V54I	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000189464	10	89653862	10	87894105	189464	187335	rs786204916	NC_000010.11:87894104:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	54	PTEN
NM_000314.8(PTEN):c.161T>G (p.Val54Gly)	PTEN	V54G	Hereditary cancer-predisposing syndrome	VCV001776587	10	89653863	10	87894106	1776587	1833863	NA	NC_000010.11:87894105:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 30, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	54	PTEN
NM_000314.8(PTEN):c.163A>G (p.Arg55Gly)	PTEN	R55G	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV002567281	10	89653865	10	87894108	2567281	2730923	NA	NC_000010.11:87894107:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	55	PTEN
NM_000314.8(PTEN):c.164G>A (p.Arg55Lys)	PTEN	R55K	PTEN hamartoma tumor syndrome	VCV002028680	10	89653866	10	87894109	2028680	2085315	NA	NC_000010.11:87894108:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 2, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	55	PTEN
NM_000314.8(PTEN):c.166T>G (p.Phe56Val)	PTEN	F56V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000924880	10	89685271	10	87925514	924880	911212	rs1589640376	NC_000010.11:87925513:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	56	PTEN
NM_000314.8(PTEN):c.166T>A (p.Phe56Ile)	PTEN	F56I	not specified|Familial meningioma	VCV000811083	10	89685271	10	87925514	811083	799619	rs1589640376	NC_000010.11:87925513:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 2, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	56	PTEN
NM_000314.8(PTEN):c.167T>A (p.Phe56Tyr)	PTEN	F56Y	PTEN hamartoma tumor syndrome	VCV002815563	10	89685272	10	87925515	2815563	2966399	NA	NC_000010.11:87925514:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	56	PTEN
NM_000314.8(PTEN):c.167T>C (p.Phe56Ser)	PTEN	F56S	Hereditary cancer-predisposing syndrome	VCV001777889	10	89685272	10	87925515	1777889	1837823	NA	NC_000010.11:87925514:T:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Nov 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	56	PTEN
NM_000314.8(PTEN):c.167T>G (p.Phe56Cys)	PTEN	F56C	PTEN hamartoma tumor syndrome|not provided	VCV001056826	10	89685272	10	87925515	1056826	1046824	rs748031178	NC_000010.11:87925514:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	56	PTEN
NM_000314.8(PTEN):c.169T>G (p.Leu57Val)	PTEN	L57V	Hereditary cancer-predisposing syndrome|not provided	VCV001318778	10	89685274	10	87925517	1318778	1307290	rs2132232119	NC_000010.11:87925516:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 6, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	57	PTEN
NM_000314.8(PTEN):c.170T>C (p.Leu57Ser)	PTEN	L57S	Hereditary cancer-predisposing syndrome	VCV001778538	10	89685275	10	87925518	1778538	1834510	NA	NC_000010.11:87925517:T:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Aug 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	57	PTEN
NM_000314.8(PTEN):c.170T>G (p.Leu57Trp)	PTEN	L57W	PTEN hamartoma tumor syndrome	VCV000185713	10	89685275	10	87925518	185713	183018	rs786202398	NC_000010.11:87925517:T:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	57	PTEN
NM_000314.8(PTEN):c.172G>T (p.Asp58Tyr)	PTEN	D58Y	PTEN hamartoma tumor syndrome	VCV000578122	10	89685277	10	87925520	578122	564006	rs1554897255	NC_000010.11:87925519:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	58	PTEN
NM_000314.8(PTEN):c.172G>A (p.Asp58Asn)	PTEN	D58N	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000468672	10	89685277	10	87925520	468672	460621	rs1554897255	NC_000010.11:87925519:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	58	PTEN
NM_000314.8(PTEN):c.173A>G (p.Asp58Gly)	PTEN	D58G	not provided	VCV000430284	10	89685278	10	87925521	430284	421808	rs1131691885	NC_000010.11:87925520:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	58	PTEN
NM_000314.8(PTEN):c.174T>G (p.Asp58Glu)	PTEN	D58E	PTEN hamartoma tumor syndrome	VCV002730744	10	89685279	10	87925522	2730744	2883479	NA	NC_000010.11:87925521:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	58	PTEN
NM_000314.8(PTEN):c.175T>C (p.Ser59Pro)	PTEN	S59P	PTEN hamartoma tumor syndrome	VCV000404153	10	89685280	10	87925523	404153	397927	rs1060500118	NC_000010.11:87925522:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 22, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	59	PTEN
NM_000314.8(PTEN):c.178A>C (p.Lys60Gln)	PTEN	K60Q	Cowden syndrome 1|Macrocephaly-autism syndrome	VCV002664745	10	89685283	10	87925526	2664745	2832195	NA	NC_000010.11:87925525:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	60	PTEN
NM_000314.8(PTEN):c.181C>A (p.His61Asn)	PTEN	H61N	Hereditary cancer-predisposing syndrome	VCV001780734	10	89685286	10	87925529	1780734	1832029	NA	NC_000010.11:87925528:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	61	PTEN
NM_000314.8(PTEN):c.181C>G (p.His61Asp)	PTEN	H61D	PTEN hamartoma tumor syndrome	VCV000007841	10	89685286	10	87925529	7841	22880	rs121909236	NC_000010.11:87925528:C:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	61	PTEN
NM_000314.8(PTEN):c.182A>C (p.His61Pro)	PTEN	H61P	Hereditary cancer-predisposing syndrome	VCV003231146	10	89685287	10	87925530	3231146	3391768	NA	NC_000010.11:87925529:A:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Oct 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	61	PTEN
NM_000314.8(PTEN):c.182A>G (p.His61Arg)	PTEN	H61R	PTEN hamartoma tumor syndrome	VCV000189402	10	89685287	10	87925530	189402	187337	rs398123316	NC_000010.11:87925529:A:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Dec 1, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	61	PTEN
NM_000314.8(PTEN):c.183T>G (p.His61Gln)	PTEN	H61Q	PTEN hamartoma tumor syndrome	VCV001719591	10	89685288	10	87925531	1719591	1772247	NA	NC_000010.11:87925530:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	61	PTEN
NM_000314.8(PTEN):c.184A>G (p.Lys62Glu)	PTEN	K62E	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000630185	10	89685289	10	87925532	630185	617590	rs1564826779	NC_000010.11:87925531:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 10, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	62	PTEN
NM_000314.8(PTEN):c.185A>G (p.Lys62Arg)	PTEN	K62R	Hereditary cancer-predisposing syndrome	VCV003231147	10	89685290	10	87925533	3231147	3391769	NA	NC_000010.11:87925532:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	62	PTEN
NM_000314.8(PTEN):c.186A>C (p.Lys62Asn)	PTEN	K62N	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000570232	10	89685291	10	87925534	570232	564007	rs1564826791	NC_000010.11:87925533:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	62	PTEN
NM_000314.8(PTEN):c.188A>C (p.Asn63Thr)	PTEN	N63T	not provided	VCV002430990	10	89685293	10	87925536	2430990	2404497	NA	NC_000010.11:87925535:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	63	PTEN
NM_000314.8(PTEN):c.188A>G (p.Asn63Ser)	PTEN	N63S	PTEN hamartoma tumor syndrome	VCV001395465	10	89685293	10	87925536	1395465	1424864	rs2132232249	NC_000010.11:87925535:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	63	PTEN
NM_000314.8(PTEN):c.190C>A (p.His64Asn)	PTEN	H64N	PTEN hamartoma tumor syndrome	VCV001393335	10	89685295	10	87925538	1393335	1399187	rs587781535	NC_000010.11:87925537:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 26, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	64	PTEN
NM_000314.8(PTEN):c.190C>T (p.His64Tyr)	PTEN	H64Y	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000141154	10	89685295	10	87925538	141154	150868	rs587781535	NC_000010.11:87925537:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 19, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	64	PTEN
NM_000314.8(PTEN):c.191A>C (p.His64Pro)	PTEN	H64P	not provided	VCV002574362	10	89685296	10	87925539	2574362	2739296	NA	NC_000010.11:87925538:A:C	single nucleotide variant	missense variant|intron variant	Pathogenic	Aug 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	64	PTEN
NM_000314.8(PTEN):c.191A>G (p.His64Arg)	PTEN	H64R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000820340	10	89685296	10	87925539	820340	810086	rs1589640471	NC_000010.11:87925538:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 11, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	64	PTEN
NM_000314.8(PTEN):c.192T>G (p.His64Gln)	PTEN	H64Q	Glioma susceptibility 2	VCV003240232	10	89685297	10	87925540	3240232	3399219	NA	NC_000010.11:87925539:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	64	PTEN
NM_000314.8(PTEN):c.193T>G (p.Tyr65Asp)	PTEN	Y65D	not provided	VCV003337498	10	89685298	10	87925541	3337498	133146	rs587780005	NC_000010.11:87925540:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	65	PTEN
NM_000314.8(PTEN):c.193T>A (p.Tyr65Asn)	PTEN	Y65N	not specified	VCV000560623	10	89685298	10	87925541	560623	551713	rs587780005	NC_000010.11:87925540:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 18, 2014	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	65	PTEN
NM_000314.8(PTEN):c.194A>G (p.Tyr65Cys)	PTEN	Y65C	PTEN hamartoma tumor syndrome	VCV000962600	10	89685299	10	87925542	962600	947117	rs1859804047	NC_000010.11:87925541:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	65	PTEN
NM_000314.8(PTEN):c.196A>C (p.Lys66Gln)	PTEN	K66Q	PTEN hamartoma tumor syndrome	VCV003069948	10	89685301	10	87925544	3069948	3233523	NA	NC_000010.11:87925543:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	66	PTEN
NM_000314.8(PTEN):c.196A>G (p.Lys66Glu)	PTEN	K66E	not provided	VCV002499958	10	89685301	10	87925544	2499958	2477937	NA	NC_000010.11:87925543:A:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Apr 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	66	PTEN
NM_000314.8(PTEN):c.197A>T (p.Lys66Met)	PTEN	K66M	not specified	VCV000560624	10	89685302	10	87925545	560624	551714	rs1564826805	NC_000010.11:87925544:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 18, 2014	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	66	PTEN
NM_000314.8(PTEN):c.198G>T (p.Lys66Asn)	PTEN	K66N	PTEN hamartoma tumor syndrome	VCV001691744	10	89685303	10	87925546	1691744	1684200	rs2132232321	NC_000010.11:87925545:G:T	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	66	PTEN
NM_000314.8(PTEN):c.199A>T (p.Ile67Leu)	PTEN	I67L	PTEN hamartoma tumor syndrome	VCV002891032	10	89685304	10	87925547	2891032	3045133	NA	NC_000010.11:87925546:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	PTEN
NM_000314.8(PTEN):c.199A>G (p.Ile67Val)	PTEN	I67V	PTEN hamartoma tumor syndrome	VCV002863055	10	89685304	10	87925547	2863055	3019243	NA	NC_000010.11:87925546:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	PTEN
NM_000314.8(PTEN):c.200T>G (p.Ile67Arg)	PTEN	I67R	PTEN hamartoma tumor syndrome	VCV002429351	10	89685305	10	87925548	2429351	2402850	NA	NC_000010.11:87925547:T:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Oct 14, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	PTEN
NM_000314.8(PTEN):c.200T>C (p.Ile67Thr)	PTEN	I67T	PTEN hamartoma tumor syndrome	VCV001380044	10	89685305	10	87925548	1380044	1506093	rs1859804665	NC_000010.11:87925547:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	PTEN
NM_000314.8(PTEN):c.200T>A (p.Ile67Lys)	PTEN	I67K	PTEN hamartoma tumor syndrome	VCV000839209	10	89685305	10	87925548	839209	837420	rs1859804665	NC_000010.11:87925547:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 2, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	PTEN
NM_000314.8(PTEN):c.201A>G (p.Ile67Met)	PTEN	I67M	PTEN hamartoma tumor syndrome	VCV002754588	10	89685306	10	87925549	2754588	2914029	NA	NC_000010.11:87925548:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	PTEN
NM_000314.8(PTEN):c.202T>G (p.Tyr68Asp)	PTEN	Y68D	PTEN hamartoma tumor syndrome	VCV000536540	10	89685307	10	87925550	536540	525502	rs398123317	NC_000010.11:87925549:T:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Jun 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	68	PTEN
NM_000314.8(PTEN):c.202T>C (p.Tyr68His)	PTEN	Y68H	Glioma susceptibility 2|Malignant tumor of prostate|Macrocephaly-autism syndrome|Familial meningioma|Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Macrocephaly-autism syndrome|Glioma susceptibility 2|Hereditary cancer-predisposing syndrome	VCV000189474	10	89685307	10	87925550	189474	187338	rs398123317	NC_000010.11:87925549:T:C	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	May 28, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	68	PTEN
NM_000314.8(PTEN):c.202T>A (p.Tyr68Asn)	PTEN	Y68N	Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided	VCV000092815	10	89685307	10	87925550	92815	98722	rs398123317	NC_000010.11:87925549:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	68	PTEN
NM_000314.8(PTEN):c.203A>C (p.Tyr68Ser)	PTEN	Y68S	Hereditary cancer-predisposing syndrome	VCV000481032	10	89685308	10	87925551	481032	475185	rs876660634	NC_000010.11:87925550:A:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Dec 22, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	68	PTEN
NM_000314.8(PTEN):c.203A>G (p.Tyr68Cys)	PTEN	Y68C	See cases|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Autism|Cognitive impairment|Microcephaly|Infantile spasms|Global developmental delay|Developmental regression|Cerebral visual impairment|Seizure|not provided	VCV000233777	10	89685308	10	87925551	233777	233846	rs876660634	NC_000010.11:87925550:A:G	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	68	PTEN
NM_000314.8(PTEN):c.205A>C (p.Asn69His)	PTEN	N69H	Hereditary cancer-predisposing syndrome	VCV000928126	10	89685310	10	87925553	928126	911213	rs1859805185	NC_000010.11:87925552:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	69	PTEN
NM_000314.8(PTEN):c.206A>T (p.Asn69Ile)	PTEN	N69I	PTEN hamartoma tumor syndrome	VCV002126293	10	89685311	10	87925554	2126293	2185461	NA	NC_000010.11:87925553:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	69	PTEN
NM_000314.8(PTEN):c.206A>G (p.Asn69Ser)	PTEN	N69S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000189476	10	89685311	10	87925554	189476	187339	rs786204922	NC_000010.11:87925553:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	69	PTEN
NM_000314.8(PTEN):c.207T>G (p.Asn69Lys)	PTEN	N69K	Hereditary cancer-predisposing syndrome	VCV000820673	10	89685312	10	87925555	820673	810088	rs1589640559	NC_000010.11:87925554:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	69	PTEN
NM_000314.8(PTEN):c.208C>T (p.Leu70Phe)	PTEN	L70F	not provided|Glioma susceptibility 2	VCV000196250	10	89685313	10	87925556	196250	193411	rs794727480	NC_000010.11:87925555:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	70	PTEN
NM_000314.8(PTEN):c.209T>G (p.Leu70Arg)	PTEN	L70R	Hereditary cancer-predisposing syndrome	VCV001785871	10	89685314	10	87925557	1785871	1850129	NA	NC_000010.11:87925556:T:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Apr 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	70	PTEN
NM_000314.8(PTEN):c.209T>C (p.Leu70Pro)	PTEN	L70P	PTEN hamartoma tumor syndrome	VCV000007826	10	89685314	10	87925557	7826	22865	rs121909226	NC_000010.11:87925556:T:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	70	PTEN
NM_000314.8(PTEN):c.212G>A (p.Cys71Tyr)	PTEN	C71Y	PTEN hamartoma tumor syndrome	VCV000936561	10	89690805	10	87931048	936561	935219	rs1554897856	NC_000010.11:87931047:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	71	PTEN
NM_000314.8(PTEN):c.212G>T (p.Cys71Phe)	PTEN	C71F	PTEN hamartoma tumor syndrome|PTEN-related disorder|not provided|Hereditary cancer-predisposing syndrome	VCV000468675	10	89690805	10	87931048	468675	461101	rs1554897856	NC_000010.11:87931047:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	71	PTEN
NM_000314.8(PTEN):c.213T>G (p.Cys71Trp)	PTEN	C71W	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000820795	10	89690806	10	87931049	820795	810089	rs1554897858	NC_000010.11:87931048:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	71	PTEN
NM_000314.8(PTEN):c.214G>A (p.Ala72Thr)	PTEN	A72T	PTEN hamartoma tumor syndrome	VCV002043159	10	89690807	10	87931050	2043159	2092021	NA	NC_000010.11:87931049:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	72	PTEN
NM_000314.8(PTEN):c.215C>G (p.Ala72Gly)	PTEN	A72G	PTEN hamartoma tumor syndrome	VCV001978595	10	89690808	10	87931051	1978595	2041671	NA	NC_000010.11:87931050:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	72	PTEN
NM_000314.8(PTEN):c.218A>G (p.Glu73Gly)	PTEN	E73G	Familial ovarian cancer	VCV001050413	10	89690811	10	87931054	1050413	1037990	rs2132238743	NC_000010.11:87931053:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	73	PTEN
NM_000314.8(PTEN):c.220A>G (p.Arg74Gly)	PTEN	R74G	PTEN hamartoma tumor syndrome	VCV002118663	10	89690813	10	87931056	2118663	2172672	NA	NC_000010.11:87931055:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	74	PTEN
NM_000314.8(PTEN):c.224A>T (p.His75Leu)	PTEN	H75L	Hereditary cancer-predisposing syndrome	VCV001788390	10	89690817	10	87931060	1788390	1844452	NA	NC_000010.11:87931059:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	75	PTEN
NM_000314.8(PTEN):c.224A>G (p.His75Arg)	PTEN	H75R	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001788388	10	89690817	10	87931060	1788388	1844450	NA	NC_000010.11:87931059:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	75	PTEN
NM_000314.8(PTEN):c.226T>C (p.Tyr76His)	PTEN	Y76H	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001355461	10	89690819	10	87931062	1355461	1509212	rs2132238814	NC_000010.11:87931061:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	76	PTEN
NM_000314.8(PTEN):c.227A>T (p.Tyr76Phe)	PTEN	Y76F	not provided	VCV001321127	10	89690820	10	87931063	1321127	1311371	rs2132238825	NC_000010.11:87931062:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	76	PTEN
NM_000314.8(PTEN):c.227A>G (p.Tyr76Cys)	PTEN	Y76C	not provided|PTEN hamartoma tumor syndrome	VCV001210590	10	89690820	10	87931063	1210590	1200589	rs2132238825	NC_000010.11:87931062:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	76	PTEN
NM_000314.8(PTEN):c.229_231delinsTAT (p.Asp77Tyr)	PTEN	D77Y	Hereditary cancer-predisposing syndrome	VCV001789093	10	89690822 - 89690824	10	87931065 - 87931067	1789093	1850764	NA	NC_000010.11:87931064:GAC:TAT	Indel	missense variant|5 prime UTR variant	Uncertain significance	Sep 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	77	PTEN
NM_000314.8(PTEN):c.229G>C (p.Asp77His)	PTEN	D77H	Hereditary cancer-predisposing syndrome	VCV000481095	10	89690822	10	87931065	481095	475507	rs1554897867	NC_000010.11:87931064:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 4, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	77	PTEN
NM_000314.8(PTEN):c.230A>G (p.Asp77Gly)	PTEN	D77G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV003075547	10	89690823	10	87931066	3075547	3233112	NA	NC_000010.11:87931065:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	77	PTEN
NM_000314.8(PTEN):c.231C>A (p.Asp77Glu)	PTEN	D77E	Hereditary cancer-predisposing syndrome	VCV000484623	10	89690824	10	87931067	484623	475190	rs755953294	NC_000010.11:87931066:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 18, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	77	PTEN
NM_000314.8(PTEN):c.233C>T (p.Thr78Ile)	PTEN	T78I	Hereditary cancer-predisposing syndrome	VCV000919215	10	89690826	10	87931069	919215	911214	rs777640028	NC_000010.11:87931068:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 13, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	78	PTEN
NM_000314.8(PTEN):c.235G>T (p.Ala79Ser)	PTEN	A79S	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1	VCV000404155	10	89690828	10	87931071	404155	397685	rs202004587	NC_000010.11:87931070:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	79	PTEN
NM_000314.8(PTEN):c.235G>A (p.Ala79Thr)	PTEN	A79T	PTEN hamartoma tumor syndrome	VCV000041682	10	89690828	10	87931071	41682	50121	rs202004587	NC_000010.11:87931070:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Apr 6, 2018	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	79	PTEN
NM_000314.8(PTEN):c.236C>A (p.Ala79Asp)	PTEN	A79D	Hereditary cancer-predisposing syndrome	VCV003311254	10	89690829	10	87931072	3311254	3468239	NA	NC_000010.11:87931071:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	79	PTEN
NM_000314.8(PTEN):c.239A>C (p.Lys80Thr)	PTEN	K80T	PTEN hamartoma tumor syndrome	VCV000955524	10	89690832	10	87931075	955524	947118	rs1859921641	NC_000010.11:87931074:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 30, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	80	PTEN
NM_000314.8(PTEN):c.242T>A (p.Phe81Tyr)	PTEN	F81Y	Hereditary cancer-predisposing syndrome	VCV000628968	10	89690835	10	87931078	628968	617592	rs876661177	NC_000010.11:87931077:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	81	PTEN
NM_000314.8(PTEN):c.242T>G (p.Phe81Cys)	PTEN	F81C	not provided	VCV000234710	10	89690835	10	87931078	234710	231784	rs876661177	NC_000010.11:87931077:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Nov 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	81	PTEN
NM_000314.8(PTEN):c.243T>G (p.Phe81Leu)	PTEN	F81L	Macrocephaly-autism syndrome	VCV001802604	10	89690836	10	87931079	1802604	1859651	NA	NC_000010.11:87931078:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	81	PTEN
NM_000314.8(PTEN):c.244A>G (p.Asn82Asp)	PTEN	N82D	not provided	VCV000418435	10	89690837	10	87931080	418435	407988	rs1064793242	NC_000010.11:87931079:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 16, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	82	PTEN
NM_000314.8(PTEN):c.250A>G (p.Arg84Gly)	PTEN	R84G	Hereditary cancer-predisposing syndrome	VCV000923833	10	89690843	10	87931086	923833	911216	rs1554897880	NC_000010.11:87931085:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	84	PTEN
NM_000314.8(PTEN):c.252A>C (p.Arg84Ser)	PTEN	R84S	Hereditary cancer-predisposing syndrome	VCV002567272	10	89690845	10	87931088	2567272	2730914	NA	NC_000010.11:87931087:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	84	PTEN
NM_000314.8(PTEN):c.253G>A (p.Val85Ile)	PTEN	V85I	not provided	VCV002499932	10	89690846	10	87931089	2499932	2477911	NA	NC_000010.11:87931088:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	85	PTEN
NM_000314.8(PTEN):c.254T>G (p.Val85Gly)	PTEN	V85G	Hereditary cancer-predisposing syndrome|not provided	VCV000428239	10	89692770	10	87933013	428239	419709	rs1114167658	NC_000010.11:87933012:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	85	PTEN
NM_000314.8(PTEN):c.256G>A (p.Ala86Thr)	PTEN	A86T	PTEN hamartoma tumor syndrome	VCV000584752	10	89692772	10	87933015	584752	575808	rs1564829780	NC_000010.11:87933014:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	86	PTEN
NM_000314.8(PTEN):c.257C>T (p.Ala86Val)	PTEN	A86V	not provided	VCV000591438	10	89692773	10	87933016	591438	582429	rs1564829783	NC_000010.11:87933015:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 16, 2018	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	86	PTEN
NM_000314.8(PTEN):c.260A>T (p.Gln87Leu)	PTEN	Q87L	Prostate cancer, hereditary, 1	VCV002687620	10	89692776	10	87933019	2687620	2848656	NA	NC_000010.11:87933018:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	87	PTEN
NM_000314.8(PTEN):c.263A>T (p.Tyr88Phe)	PTEN	Y88F	Hereditary cancer-predisposing syndrome	VCV002587207	10	89692779	10	87933022	2587207	2753883	NA	NC_000010.11:87933021:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	88	PTEN
NM_000314.8(PTEN):c.265C>T (p.Pro89Ser)	PTEN	P89S	not provided	VCV000156512	10	89692781	10	87933024	156512	166277	rs587783059	NC_000010.11:87933023:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 16, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	89	PTEN
NM_000314.8(PTEN):c.266C>G (p.Pro89Arg)	PTEN	P89R	not provided	VCV001330063	10	89692782	10	87933025	1330063	1320746	rs1554898059	NC_000010.11:87933024:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	89	PTEN
NM_000314.8(PTEN):c.266C>T (p.Pro89Leu)	PTEN	P89L	Hereditary cancer-predisposing syndrome	VCV000482078	10	89692782	10	87933025	482078	475390	rs1554898059	NC_000010.11:87933024:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	89	PTEN
NM_000314.8(PTEN):c.269T>C (p.Phe90Ser)	PTEN	F90S	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Intellectual disability|Neoplasm	VCV000976246	10	89692785	10	87933028	976246	964349	rs1859965098	NC_000010.11:87933027:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	90	PTEN
NM_000314.8(PTEN):c.271G>C (p.Glu91Gln)	PTEN	E91Q	PTEN hamartoma tumor syndrome	VCV002703168	10	89692787	10	87933030	2703168	2862864	NA	NC_000010.11:87933029:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	91	PTEN
NM_000314.8(PTEN):c.271G>A (p.Glu91Lys)	PTEN	E91K	Hereditary cancer-predisposing syndrome	VCV000492324	10	89692787	10	87933030	492324	484329	rs1554898062	NC_000010.11:87933029:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	91	PTEN
NM_000314.8(PTEN):c.272A>G (p.Glu91Gly)	PTEN	E91G	PTEN hamartoma tumor syndrome	VCV002836880	10	89692788	10	87933031	2836880	2999259	NA	NC_000010.11:87933030:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	91	PTEN
NM_000314.8(PTEN):c.273A>C (p.Glu91Asp)	PTEN	E91D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000821745	10	89692789	10	87933032	821745	810091	rs1589646019	NC_000010.11:87933031:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 1, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	91	PTEN
NM_000314.8(PTEN):c.274G>T (p.Asp92Tyr)	PTEN	D92Y	PTEN hamartoma tumor syndrome|not provided|Neoplasm	VCV000468679	10	89692790	10	87933033	468679	460365	rs1554898067	NC_000010.11:87933032:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	92	PTEN
NM_000314.8(PTEN):c.275A>T (p.Asp92Val)	PTEN	D92V	Hereditary cancer-predisposing syndrome	VCV001795656	10	89692791	10	87933034	1795656	1853015	NA	NC_000010.11:87933033:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	92	PTEN
NM_000314.8(PTEN):c.275A>G (p.Asp92Gly)	PTEN	D92G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000565960	10	89692791	10	87933034	565960	566560	rs1114167623	NC_000010.11:87933033:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	92	PTEN
NM_000314.8(PTEN):c.275A>C (p.Asp92Ala)	PTEN	D92A	Hereditary cancer-predisposing syndrome	VCV000428196	10	89692791	10	87933034	428196	419713	rs1114167623	NC_000010.11:87933033:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 15, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	92	PTEN
NM_000314.8(PTEN):c.276C>G (p.Asp92Glu)	PTEN	D92E	Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV001043062	10	89692792	10	87933035	1043062	1029840	rs779530981	NC_000010.11:87933034:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	92	PTEN
NM_000314.8(PTEN):c.277C>T (p.His93Tyr)	PTEN	H93Y	Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV000646993	10	89692793	10	87933036	646993	639268	rs786204927	NC_000010.11:87933035:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	93	PTEN
NM_000314.8(PTEN):c.277C>A (p.His93Asn)	PTEN	H93N	Loss of consciousness|Macrocephaly|Large for gestational age	VCV000523356	10	89692793	10	87933036	523356	514002	rs786204927	NC_000010.11:87933035:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jan 1, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	93	PTEN
NM_000314.8(PTEN):c.277C>G (p.His93Asp)	PTEN	H93D	PTEN hamartoma tumor syndrome	VCV000189482	10	89692793	10	87933036	189482	187344	rs786204927	NC_000010.11:87933035:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Mar 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	93	PTEN
NM_000314.8(PTEN):c.278A>T (p.His93Leu)	PTEN	H93L	PTEN hamartoma tumor syndrome	VCV001442462	10	89692794	10	87933037	1442462	1375226	rs121909238	NC_000010.11:87933036:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	93	PTEN
NM_000314.8(PTEN):c.278A>C (p.His93Pro)	PTEN	H93P	PTEN hamartoma tumor syndrome	VCV000468680	10	89692794	10	87933037	468680	460281	rs121909238	NC_000010.11:87933036:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	93	PTEN
NM_000314.8(PTEN):c.278A>G (p.His93Arg)	PTEN	H93R	PTEN hamartoma tumor syndrome	VCV000007848	10	89692794	10	87933037	7848	22887	rs121909238	NC_000010.11:87933036:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 28, 2018	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	93	PTEN
NM_000314.8(PTEN):c.280A>T (p.Asn94Tyr)	PTEN	N94Y	PTEN hamartoma tumor syndrome	VCV002824871	10	89692796	10	87933039	2824871	2989373	NA	NC_000010.11:87933038:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	94	PTEN
NM_000314.8(PTEN):c.283C>G (p.Pro95Ala)	PTEN	P95A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001796695	10	89692799	10	87933042	1796695	1855270	NA	NC_000010.11:87933041:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	95	PTEN
NM_000314.8(PTEN):c.283C>T (p.Pro95Ser)	PTEN	P95S	not provided|PTEN hamartoma tumor syndrome	VCV001381124	10	89692799	10	87933042	1381124	1499966	rs1114167630	NC_000010.11:87933041:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	95	PTEN
NM_000314.8(PTEN):c.283C>A (p.Pro95Thr)	PTEN	P95T	PTEN hamartoma tumor syndrome	VCV000428204	10	89692799	10	87933042	428204	419714	rs1114167630	NC_000010.11:87933041:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	95	PTEN
NM_000314.8(PTEN):c.284C>T (p.Pro95Leu)	PTEN	P95L	PTEN hamartoma tumor syndrome	VCV000189403	10	89692800	10	87933043	189403	187345	rs786204856	NC_000010.11:87933042:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 25, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	95	PTEN
NM_000314.8(PTEN):c.286C>A (p.Pro96Thr)	PTEN	P96T	PTEN hamartoma tumor syndrome	VCV002132256	10	89692802	10	87933045	2132256	2188097	NA	NC_000010.11:87933044:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 30, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	96	PTEN
NM_000314.8(PTEN):c.286C>G (p.Pro96Ala)	PTEN	P96A	PTEN hamartoma tumor syndrome|not provided	VCV000280630	10	89692802	10	87933045	280630	264376	rs398123320	NC_000010.11:87933044:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	96	PTEN
NM_000314.8(PTEN):c.286C>T (p.Pro96Ser)	PTEN	P96S	not provided	VCV000092819	10	89692802	10	87933045	92819	98726	rs398123320	NC_000010.11:87933044:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	May 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	96	PTEN
NM_000314.8(PTEN):c.287C>A (p.Pro96Gln)	PTEN	P96Q	PTEN hamartoma tumor syndrome|Cowden syndrome 1	VCV001457597	10	89692803	10	87933046	1457597	1393538	rs1554898074	NC_000010.11:87933045:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	96	PTEN
NM_000314.8(PTEN):c.287C>G (p.Pro96Arg)	PTEN	P96R	Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV000492730	10	89692803	10	87933046	492730	485648	rs1554898074	NC_000010.11:87933045:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	96	PTEN
NM_000314.8(PTEN):c.287C>T (p.Pro96Leu)	PTEN	P96L	PTEN hamartoma tumor syndrome|Neoplasm	VCV000449089	10	89692803	10	87933046	449089	444673	rs1554898074	NC_000010.11:87933045:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 5, 2024	reviewed by expert panel	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	96	PTEN
NM_000314.8(PTEN):c.289_290delinsTT (p.Gln97Leu)	PTEN	Q97L	Hereditary cancer-predisposing syndrome	VCV001797295	10	89692805 - 89692806	10	87933048 - 87933049	1797295	1855869	NA	NC_000010.11:87933047:CA:TT	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 8, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	97	PTEN
NM_000314.8(PTEN):c.289C>G (p.Gln97Glu)	PTEN	Q97E	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000536539	10	89692805	10	87933048	536539	525504	rs786204928	NC_000010.11:87933047:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	97	PTEN
NM_000314.8(PTEN):c.290A>G (p.Gln97Arg)	PTEN	Q97R	Hereditary cancer-predisposing syndrome	VCV001797556	10	89692806	10	87933049	1797556	1854474	NA	NC_000010.11:87933048:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 28, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	97	PTEN
NM_000314.8(PTEN):c.291G>T (p.Gln97His)	PTEN	Q97H	Hereditary cancer-predisposing syndrome	VCV002567275	10	89692807	10	87933050	2567275	2730917	NA	NC_000010.11:87933049:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	97	PTEN
NM_000314.8(PTEN):c.292C>G (p.Leu98Val)	PTEN	L98V	Hereditary cancer-predisposing syndrome	VCV000822278	10	89692808	10	87933051	822278	810092	rs1589646090	NC_000010.11:87933050:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 25, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	98	PTEN
NM_000314.8(PTEN):c.293T>G (p.Leu98Arg)	PTEN	L98R	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Glioma susceptibility 2	VCV000404143	10	89692809	10	87933052	404143	397689	rs781647403	NC_000010.11:87933051:T:G	single nucleotide variant	5 prime UTR variant|missense variant	Likely pathogenic	Dec 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	98	PTEN
NM_000314.8(PTEN):c.295G>A (p.Glu99Lys)	PTEN	E99K	Hereditary cancer-predisposing syndrome	VCV002774179	10	89692811	10	87933054	2774179	2934909	NA	NC_000010.11:87933053:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	99	PTEN
NM_000314.8(PTEN):c.295G>C (p.Glu99Gln)	PTEN	E99Q	PTEN hamartoma tumor syndrome	VCV001389580	10	89692811	10	87933054	1389580	1377060	rs2132242309	NC_000010.11:87933053:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	99	PTEN
NM_000314.8(PTEN):c.298C>A (p.Leu100Ile)	PTEN	L100I	Prostate cancer, hereditary, 1	VCV002687621	10	89692814	10	87933057	2687621	2848657	NA	NC_000010.11:87933056:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	100	PTEN
NM_000314.8(PTEN):c.298C>T (p.Leu100Phe)	PTEN	L100F	not provided	VCV001207213	10	89692814	10	87933057	1207213	1198091	rs1589646100	NC_000010.11:87933056:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 17, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	100	PTEN
NM_000314.8(PTEN):c.298C>G (p.Leu100Val)	PTEN	L100V	Hereditary cancer-predisposing syndrome|Glioma susceptibility 2	VCV000822443	10	89692814	10	87933057	822443	810093	rs1589646100	NC_000010.11:87933056:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	100	PTEN
NM_000314.8(PTEN):c.299T>C (p.Leu100Pro)	PTEN	L100P	PTEN hamartoma tumor syndrome	VCV000641295	10	89692815	10	87933058	641295	639269	rs1589646108	NC_000010.11:87933057:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 13, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	100	PTEN
NM_000314.8(PTEN):c.301A>C (p.Ile101Leu)	PTEN	I101L	PTEN hamartoma tumor syndrome	VCV002813304	10	89692817	10	87933060	2813304	2973105	NA	NC_000010.11:87933059:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	PTEN
NM_000314.8(PTEN):c.301A>G (p.Ile101Val)	PTEN	I101V	Hereditary cancer-predisposing syndrome	VCV002774180	10	89692817	10	87933060	2774180	2934910	NA	NC_000010.11:87933059:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	PTEN
NM_000314.8(PTEN):c.302T>C (p.Ile101Thr)	PTEN	I101T	not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV000822660	10	89692818	10	87933061	822660	810095	rs1339631701	NC_000010.11:87933060:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	101	PTEN
NM_000314.8(PTEN):c.302T>A (p.Ile101Asn)	PTEN	I101N	not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000648578	10	89692818	10	87933061	648578	639270	rs1339631701	NC_000010.11:87933060:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	101	PTEN
NM_000314.8(PTEN):c.304A>G (p.Lys102Glu)	PTEN	K102E	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001513427	10	89692820	10	87933063	1513427	1472482	rs786202944	NC_000010.11:87933062:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 5, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	102	PTEN
NM_000314.8(PTEN):c.304A>C (p.Lys102Gln)	PTEN	K102Q	PTEN hamartoma tumor syndrome	VCV000186427	10	89692820	10	87933063	186427	183022	rs786202944	NC_000010.11:87933062:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	102	PTEN
NM_000314.8(PTEN):c.307C>T (p.Pro103Ser)	PTEN	P103S	PTEN hamartoma tumor syndrome	VCV002095828	10	89692823	10	87933066	2095828	2149745	NA	NC_000010.11:87933065:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	103	PTEN
NM_000314.8(PTEN):c.308C>G (p.Pro103Arg)	PTEN	P103R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000404141	10	89692824	10	87933067	404141	398048	rs1060500111	NC_000010.11:87933066:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	103	PTEN
NM_000314.8(PTEN):c.311T>C (p.Phe104Ser)	PTEN	F104S	PTEN hamartoma tumor syndrome	VCV002091925	10	89692827	10	87933070	2091925	2152423	NA	NC_000010.11:87933069:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 2, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	104	PTEN
NM_000314.8(PTEN):c.311T>A (p.Phe104Tyr)	PTEN	F104Y	Hereditary cancer-predisposing syndrome	VCV000588868	10	89692827	10	87933070	588868	579694	rs1564829958	NC_000010.11:87933069:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 14, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	104	PTEN
NM_000314.8(PTEN):c.313T>C (p.Cys105Arg)	PTEN	C105R	Macrocephaly-autism syndrome	VCV002628372	10	89692829	10	87933072	2628372	2795880	NA	NC_000010.11:87933071:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Oct 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	105	PTEN
NM_000314.8(PTEN):c.313T>G (p.Cys105Gly)	PTEN	C105G	Hereditary cancer-predisposing syndrome	VCV001728081	10	89692829	10	87933072	1728081	1794949	NA	NC_000010.11:87933071:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	105	PTEN
NM_000314.8(PTEN):c.314G>A (p.Cys105Tyr)	PTEN	C105Y	PTEN hamartoma tumor syndrome	VCV000142261	10	89692830	10	87933073	142261	151975	rs587782343	NC_000010.11:87933072:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	105	PTEN
NM_000314.8(PTEN):c.315T>G (p.Cys105Trp)	PTEN	C105W	Prostate cancer, hereditary, 1	VCV002687622	10	89692831	10	87933074	2687622	2848658	NA	NC_000010.11:87933073:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	105	PTEN
NM_000314.8(PTEN):c.318A>T (p.Glu106Asp)	PTEN	E106D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001047003	10	89692834	10	87933077	1047003	1029841	rs1859969915	NC_000010.11:87933076:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	106	PTEN
NM_000314.8(PTEN):c.319G>C (p.Asp107His)	PTEN	D107H	Prostate cancer, hereditary, 1	VCV002687623	10	89692835	10	87933078	2687623	2848659	NA	NC_000010.11:87933077:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	107	PTEN
NM_000314.8(PTEN):c.319G>T (p.Asp107Tyr)	PTEN	D107Y	PTEN hamartoma tumor syndrome	VCV000484614	10	89692835	10	87933078	484614	475204	rs57374291	NC_000010.11:87933077:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	107	PTEN
NM_000314.8(PTEN):c.320A>G (p.Asp107Gly)	PTEN	D107G	Hereditary cancer-predisposing syndrome	VCV001728902	10	89692836	10	87933079	1728902	187348	rs786204858	NC_000010.11:87933078:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Mar 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	107	PTEN
NM_000314.8(PTEN):c.320A>T (p.Asp107Val)	PTEN	D107V	PTEN hamartoma tumor syndrome	VCV000372481	10	89692836	10	87933079	372481	359885	rs786204858	NC_000010.11:87933078:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 25, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	107	PTEN
NM_000314.8(PTEN):c.321T>G (p.Asp107Glu)	PTEN	D107E	Hereditary cancer-predisposing syndrome	VCV003231151	10	89692837	10	87933080	3231151	3391773	NA	NC_000010.11:87933079:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	107	PTEN
NM_000314.8(PTEN):c.321T>A (p.Asp107Glu)	PTEN	D107E	Hereditary cancer-predisposing syndrome	VCV001729064	10	89692837	10	87933080	1729064	1785353	NA	NC_000010.11:87933079:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	107	PTEN
NM_000314.8(PTEN):c.322C>T (p.Leu108Phe)	PTEN	L108F	Hereditary cancer-predisposing syndrome	VCV002562403	10	89692838	10	87933081	2562403	2721256	NA	NC_000010.11:87933080:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	108	PTEN
NM_000314.8(PTEN):c.323T>G (p.Leu108Arg)	PTEN	L108R	PTEN hamartoma tumor syndrome	VCV002764628	10	89692839	10	87933082	2764628	2928394	NA	NC_000010.11:87933081:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	108	PTEN
NM_000314.8(PTEN):c.323T>C (p.Leu108Pro)	PTEN	L108P	not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV000418436	10	89692839	10	87933082	418436	407990	rs1064793243	NC_000010.11:87933081:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Nov 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	108	PTEN
NM_000314.8(PTEN):c.326A>C (p.Asp109Ala)	PTEN	D109A	Prostate cancer, hereditary, 1	VCV002687624	10	89692842	10	87933085	2687624	2848660	NA	NC_000010.11:87933084:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	109	PTEN
NM_000314.8(PTEN):c.327C>A (p.Asp109Glu)	PTEN	D109E	Hereditary cancer-predisposing syndrome	VCV001729705	10	89692843	10	87933086	1729705	1795380	NA	NC_000010.11:87933085:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	109	PTEN
NM_000314.8(PTEN):c.328C>A (p.Gln110Lys)	PTEN	Q110K	not provided	VCV001186260	10	89692844	10	87933087	1186260	1177356	rs1114167629	NC_000010.11:87933086:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 3, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	110	PTEN
NM_000314.8(PTEN):c.328C>G (p.Gln110Glu)	PTEN	Q110E	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000428229	10	89692844	10	87933087	428229	419716	rs1114167629	NC_000010.11:87933086:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	110	PTEN
NM_000314.8(PTEN):c.329A>G (p.Gln110Arg)	PTEN	Q110R	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000567265	10	89692845	10	87933088	567265	566564	rs1564830013	NC_000010.11:87933087:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	110	PTEN
NM_000314.8(PTEN):c.331T>G (p.Trp111Gly)	PTEN	W111G	PTEN hamartoma tumor syndrome	VCV000936720	10	89692847	10	87933090	936720	935222	rs398123321	NC_000010.11:87933089:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 13, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	111	PTEN
NM_000314.8(PTEN):c.331T>C (p.Trp111Arg)	PTEN	W111R	PTEN hamartoma tumor syndrome	VCV000092820	10	89692847	10	87933090	92820	98727	rs398123321	NC_000010.11:87933089:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	111	PTEN
NM_000314.8(PTEN):c.333G>C (p.Trp111Cys)	PTEN	W111C	PTEN hamartoma tumor syndrome	VCV000581617	10	89692849	10	87933092	581617	564010	rs1554898097	NC_000010.11:87933091:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	111	PTEN
NM_000314.8(PTEN):c.334C>A (p.Leu112Ile)	PTEN	L112I	Prostate cancer, hereditary, 1	VCV002687625	10	89692850	10	87933093	2687625	2848661	NA	NC_000010.11:87933092:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	112	PTEN
NM_000314.8(PTEN):c.334C>G (p.Leu112Val)	PTEN	L112V	PTEN hamartoma tumor syndrome	VCV001406308	10	89692850	10	87933093	1406308	1408329	rs2132242699	NC_000010.11:87933092:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	112	PTEN
NM_000314.8(PTEN):c.335T>G (p.Leu112Arg)	PTEN	L112R	Cowden syndrome 1	VCV002674303	10	89692851	10	87933094	2674303	2841791	NA	NC_000010.11:87933093:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	112	PTEN
NM_000314.8(PTEN):c.335T>A (p.Leu112Gln)	PTEN	L112Q	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV002567268	10	89692851	10	87933094	2567268	2730910	NA	NC_000010.11:87933093:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	112	PTEN
NM_000314.8(PTEN):c.335T>C (p.Leu112Pro)	PTEN	L112P	not provided	VCV000007832	10	89692851	10	87933094	7832	22871	rs121909230	NC_000010.11:87933093:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 28, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	112	PTEN
NM_000314.8(PTEN):c.337A>C (p.Ser113Arg)	PTEN	S113R	Hereditary cancer-predisposing syndrome	VCV000492326	10	89692853	10	87933096	492326	484113	rs1554898100	NC_000010.11:87933095:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	113	PTEN
NM_000314.8(PTEN):c.338G>T (p.Ser113Ile)	PTEN	S113I	PTEN hamartoma tumor syndrome	VCV000139567	10	89692854	10	87933097	139567	143197	rs587781254	NC_000010.11:87933096:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	113	PTEN
NM_000314.8(PTEN):c.339T>G (p.Ser113Arg)	PTEN	S113R	Prostate cancer, hereditary, 1	VCV002687628	10	89692855	10	87933098	2687628	2848664	NA	NC_000010.11:87933097:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	113	PTEN
NM_000314.8(PTEN):c.339T>A (p.Ser113Arg)	PTEN	S113R	Prostate cancer, hereditary, 1	VCV002687627	10	89692855	10	87933098	2687627	2848663	NA	NC_000010.11:87933097:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	113	PTEN
NM_000314.8(PTEN):c.342A>C (p.Glu114Asp)	PTEN	E114D	Prostate cancer, hereditary, 1	VCV002687629	10	89692858	10	87933101	2687629	2848665	NA	NC_000010.11:87933100:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	114	PTEN
NM_000314.8(PTEN):c.343G>A (p.Asp115Asn)	PTEN	D115N	PTEN hamartoma tumor syndrome	VCV002735435	10	89692859	10	87933102	2735435	2901459	NA	NC_000010.11:87933101:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	115	PTEN
NM_000314.8(PTEN):c.343G>T (p.Asp115Tyr)	PTEN	D115Y	not provided	VCV002502137	10	89692859	10	87933102	2502137	2534347	NA	NC_000010.11:87933101:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	115	PTEN
NM_000314.8(PTEN):c.344A>G (p.Asp115Gly)	PTEN	D115G	PTEN hamartoma tumor syndrome	VCV000224542	10	89692860	10	87933103	224542	226337	rs869312775	NC_000010.11:87933102:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	115	PTEN
NM_000314.8(PTEN):c.345T>A (p.Asp115Glu)	PTEN	D115E	PTEN hamartoma tumor syndrome	VCV001377430	10	89692861	10	87933104	1377430	1473100	rs2132242798	NC_000010.11:87933103:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	115	PTEN
NM_000314.8(PTEN):c.346G>C (p.Asp116His)	PTEN	D116H	Hereditary cancer-predisposing syndrome	VCV003231153	10	89692862	10	87933105	3231153	3391775	NA	NC_000010.11:87933104:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	116	PTEN
NM_000314.8(PTEN):c.347A>C (p.Asp116Ala)	PTEN	D116A	Hereditary cancer-predisposing syndrome	VCV003311260	10	89692863	10	87933106	3311260	3468245	NA	NC_000010.11:87933105:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 7, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	116	PTEN
NM_000314.8(PTEN):c.347A>G (p.Asp116Gly)	PTEN	D116G	Hereditary cancer-predisposing syndrome	VCV000630187	10	89692863	10	87933106	630187	617594	rs1564830054	NC_000010.11:87933105:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 20, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	116	PTEN
NM_000314.8(PTEN):c.348C>A (p.Asp116Glu)	PTEN	D116E	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000849802	10	89692864	10	87933107	849802	837423	rs1114167651	NC_000010.11:87933106:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	116	PTEN
NM_000314.8(PTEN):c.349A>C (p.Asn117His)	PTEN	N117H	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|not provided	VCV000185588	10	89692865	10	87933108	185588	183025	rs771310592	NC_000010.11:87933107:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	117	PTEN
NM_000314.8(PTEN):c.350A>G (p.Asn117Ser)	PTEN	N117S	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000216421	10	89692866	10	87933109	216421	212816	rs551221430	NC_000010.11:87933108:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	117	PTEN
NM_000314.8(PTEN):c.351T>A (p.Asn117Lys)	PTEN	N117K	PTEN hamartoma tumor syndrome	VCV002753005	10	89692867	10	87933110	2753005	2909003	NA	NC_000010.11:87933109:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	117	PTEN
NM_000314.8(PTEN):c.352C>T (p.His118Tyr)	PTEN	H118Y	not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000565348	10	89692868	10	87933111	565348	566567	rs1564830084	NC_000010.11:87933110:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	118	PTEN
NM_000314.8(PTEN):c.353A>T (p.His118Leu)	PTEN	H118L	Prostate cancer, hereditary, 1|Neoplasm	VCV002687615	10	89692869	10	87933112	2687615	2848651	NA	NC_000010.11:87933111:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	118	PTEN
NM_000314.8(PTEN):c.353A>C (p.His118Pro)	PTEN	H118P	Hereditary cancer-predisposing syndrome	VCV002624869	10	89692869	10	87933112	2624869	2790364	NA	NC_000010.11:87933111:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jul 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	118	PTEN
NM_000314.8(PTEN):c.353A>G (p.His118Arg)	PTEN	H118R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000484622	10	89692869	10	87933112	484622	475397	rs1554898107	NC_000010.11:87933111:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	118	PTEN
NM_000314.8(PTEN):c.355G>C (p.Val119Leu)	PTEN	V119L	not provided|Hereditary cancer-predisposing syndrome	VCV000428226	10	89692871	10	87933114	428226	419719	rs139767111	NC_000010.11:87933113:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	119	PTEN
NM_000314.8(PTEN):c.355G>T (p.Val119Phe)	PTEN	V119F	PTEN hamartoma tumor syndrome	VCV000428193	10	89692871	10	87933114	428193	419720	rs139767111	NC_000010.11:87933113:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	119	PTEN
NM_000314.8(PTEN):c.356T>C (p.Val119Ala)	PTEN	V119A	Familial meningioma	VCV003256748	10	89692872	10	87933115	3256748	3415504	NA	NC_000010.11:87933114:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 1, 2022	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	119	PTEN
NM_000314.8(PTEN):c.356T>G (p.Val119Gly)	PTEN	V119G	Hereditary cancer-predisposing syndrome	VCV000484619	10	89692872	10	87933115	484619	475516	rs1554898113	NC_000010.11:87933114:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 23, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	119	PTEN
NM_000314.8(PTEN):c.358G>A (p.Ala120Thr)	PTEN	A120T	not provided	VCV000189485	10	89692874	10	87933117	189485	187350	rs786204930	NC_000010.11:87933116:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 22, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	120	PTEN
NM_000314.8(PTEN):c.359C>G (p.Ala120Gly)	PTEN	A120G	PTEN hamartoma tumor syndrome	VCV001498241	10	89692875	10	87933118	1498241	1372881	rs1114167647	NC_000010.11:87933117:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	120	PTEN
NM_000314.8(PTEN):c.359C>T (p.Ala120Val)	PTEN	A120V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000658145	10	89692875	10	87933118	658145	639273	rs1114167647	NC_000010.11:87933117:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 5, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	120	PTEN
NM_000314.8(PTEN):c.359C>A (p.Ala120Glu)	PTEN	A120E	PTEN hamartoma tumor syndrome	VCV000428222	10	89692875	10	87933118	428222	419721	rs1114167647	NC_000010.11:87933117:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	120	PTEN
NM_000314.8(PTEN):c.361G>C (p.Ala121Pro)	PTEN	A121P	not provided	VCV002687614	10	89692877	10	87933120	2687614	2848650	NA	NC_000010.11:87933119:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	121	PTEN
NM_000314.8(PTEN):c.361G>A (p.Ala121Thr)	PTEN	A121T	not provided	VCV002502558	10	89692877	10	87933120	2502558	2667664	NA	NC_000010.11:87933119:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	121	PTEN
NM_000314.8(PTEN):c.362C>A (p.Ala121Glu)	PTEN	A121E	Cowden syndrome 1	VCV002674284	10	89692878	10	87933121	2674284	2841772	NA	NC_000010.11:87933120:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	121	PTEN
NM_000314.8(PTEN):c.362C>T (p.Ala121Val)	PTEN	A121V	PTEN hamartoma tumor syndrome	VCV001371888	10	89692878	10	87933121	1371888	1365397	rs121909237	NC_000010.11:87933120:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	121	PTEN
NM_000314.8(PTEN):c.362C>G (p.Ala121Gly)	PTEN	A121G	Squamous cell carcinoma of the head and neck	VCV000007842	10	89692878	10	87933121	7842	22881	rs121909237	NC_000010.11:87933120:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jan 1, 2002	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	121	PTEN
NM_000314.8(PTEN):c.364A>C (p.Ile122Leu)	PTEN	I122L	Prostate cancer, hereditary, 1	VCV002687630	10	89692880	10	87933123	2687630	2848666	NA	NC_000010.11:87933122:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	122	PTEN
NM_000314.8(PTEN):c.364A>G (p.Ile122Val)	PTEN	I122V	PTEN hamartoma tumor syndrome	VCV000186161	10	89692880	10	87933123	186161	183026	rs786202740	NC_000010.11:87933122:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	122	PTEN
NM_000314.8(PTEN):c.365T>A (p.Ile122Asn)	PTEN	I122N	Prostate cancer, hereditary, 1	VCV002687631	10	89692881	10	87933124	2687631	2848667	NA	NC_000010.11:87933123:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	122	PTEN
NM_000314.8(PTEN):c.365T>G (p.Ile122Ser)	PTEN	I122S	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	VCV000824039	10	89692881	10	87933124	824039	810096	rs1589646321	NC_000010.11:87933123:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	122	PTEN
NM_000314.8(PTEN):c.367C>G (p.His123Asp)	PTEN	H123D	PTEN hamartoma tumor syndrome	VCV000428277	10	89692883	10	87933126	428277	419722	rs786204931	NC_000010.11:87933125:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 22, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	123	PTEN
NM_000314.8(PTEN):c.367C>T (p.His123Tyr)	PTEN	H123Y	Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome	VCV000189486	10	89692883	10	87933126	189486	187352	rs786204931	NC_000010.11:87933125:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	123	PTEN
NM_000314.8(PTEN):c.368A>C (p.His123Pro)	PTEN	H123P	Prostate cancer, hereditary, 1	VCV002687632	10	89692884	10	87933127	2687632	2848668	NA	NC_000010.11:87933126:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	123	PTEN
NM_000314.8(PTEN):c.368A>G (p.His123Arg)	PTEN	H123R	PTEN hamartoma tumor syndrome	VCV000007816	10	89692884	10	87933127	7816	22855	rs121909222	NC_000010.11:87933126:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	123	PTEN
NM_000314.8(PTEN):c.369C>G (p.His123Gln)	PTEN	H123Q	not provided|PTEN hamartoma tumor syndrome	VCV000427587	10	89692885	10	87933128	427587	416940	rs1085308045	NC_000010.11:87933127:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	123	PTEN
NM_000314.8(PTEN):c.370T>A (p.Cys124Ser)	PTEN	C124S	Cowden syndrome 1|Hereditary cancer-predisposing syndrome	VCV000824108	10	89692886	10	87933129	824108	810097	rs121909223	NC_000010.11:87933128:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 10, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	124	PTEN
NM_000314.8(PTEN):c.370T>G (p.Cys124Gly)	PTEN	C124G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000185817	10	89692886	10	87933129	185817	183027	rs121909223	NC_000010.11:87933128:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	124	PTEN
NM_000314.8(PTEN):c.370T>C (p.Cys124Arg)	PTEN	C124R	PTEN hamartoma tumor syndrome	VCV000007817	10	89692886	10	87933129	7817	22856	rs121909223	NC_000010.11:87933128:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 25, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	124	PTEN
NM_000314.8(PTEN):c.371G>C (p.Cys124Ser)	PTEN	C124S	Cowden syndrome 1|Glioma susceptibility 2|Hereditary cancer-predisposing syndrome	VCV002447220	10	89692887	10	87933130	2447220	2422343	NA	NC_000010.11:87933129:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	124	PTEN
NM_000314.8(PTEN):c.371G>A (p.Cys124Tyr)	PTEN	C124Y	not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000233631	10	89692887	10	87933130	233631	233851	rs876660535	NC_000010.11:87933129:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	124	PTEN
NM_000314.8(PTEN):c.372T>G (p.Cys124Trp)	PTEN	C124W	Cowden syndrome 1|Hereditary cancer-predisposing syndrome	VCV001734391	10	89692888	10	87933131	1734391	1786810	NA	NC_000010.11:87933130:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	124	PTEN
NM_000314.8(PTEN):c.373A>G (p.Lys125Glu)	PTEN	K125E	Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV001338262	10	89692889	10	87933132	1338262	1329270	rs1554898127	NC_000010.11:87933131:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	125	PTEN
NM_000314.8(PTEN):c.374A>G (p.Lys125Arg)	PTEN	K125R	Macrocephaly-autism syndrome	VCV001803052	10	89692890	10	87933133	1803052	1860081	NA	NC_000010.11:87933132:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	125	PTEN
NM_000314.8(PTEN):c.375A>C (p.Lys125Asn)	PTEN	K125N	PTEN hamartoma tumor syndrome	VCV001360588	10	89692891	10	87933134	1360588	1360154	rs2132243099	NC_000010.11:87933133:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	125	PTEN
NM_000314.8(PTEN):c.376G>C (p.Ala126Pro)	PTEN	A126P	Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV001067089	10	89692892	10	87933135	1067089	1055938	rs1554898129	NC_000010.11:87933134:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	126	PTEN
NM_000314.8(PTEN):c.376G>T (p.Ala126Ser)	PTEN	A126S	Hereditary cancer-predisposing syndrome	VCV000484625	10	89692892	10	87933135	484625	475206	rs1554898129	NC_000010.11:87933134:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 21, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	126	PTEN
NM_000314.8(PTEN):c.376G>A (p.Ala126Thr)	PTEN	A126T	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000468683	10	89692892	10	87933135	468683	460287	rs1554898129	NC_000010.11:87933134:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	126	PTEN
NM_000314.8(PTEN):c.377C>A (p.Ala126Asp)	PTEN	A126D	Cowden syndrome 1	VCV002674280	10	89692893	10	87933136	2674280	2841768	NA	NC_000010.11:87933135:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	126	PTEN
NM_000314.8(PTEN):c.377C>G (p.Ala126Gly)	PTEN	A126G	PTEN hamartoma tumor syndrome	VCV001508589	10	89692893	10	87933136	1508589	1439800	rs1114167656	NC_000010.11:87933135:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 16, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	126	PTEN
NM_000314.8(PTEN):c.377C>T (p.Ala126Val)	PTEN	A126V	Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV000428234	10	89692893	10	87933136	428234	419724	rs1114167656	NC_000010.11:87933135:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Mar 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	126	PTEN
NM_000314.8(PTEN):c.379G>C (p.Gly127Arg)	PTEN	G127R	Cowden syndrome 1	VCV002674283	10	89692895	10	87933138	2674283	2841771	NA	NC_000010.11:87933137:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	127	PTEN
NM_000314.8(PTEN):c.379G>A (p.Gly127Arg)	PTEN	G127R	not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	VCV000139568	10	89692895	10	87933138	139568	143198	rs587781255	NC_000010.11:87933137:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	127	PTEN
NM_000314.8(PTEN):c.380G>C (p.Gly127Ala)	PTEN	G127A	PTEN hamartoma tumor syndrome	VCV001967574	10	89692896	10	87933139	1967574	2021673	NA	NC_000010.11:87933138:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	127	PTEN
NM_000314.8(PTEN):c.380G>A (p.Gly127Glu)	PTEN	G127E	Hereditary cancer-predisposing syndrome	VCV000428225	10	89692896	10	87933139	428225	419725	rs398123322	NC_000010.11:87933138:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Oct 22, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	127	PTEN
NM_000314.8(PTEN):c.380G>T (p.Gly127Val)	PTEN	G127V	PTEN hamartoma tumor syndrome	VCV000092821	10	89692896	10	87933139	92821	98728	rs398123322	NC_000010.11:87933138:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	127	PTEN
NM_000314.8(PTEN):c.382A>G (p.Lys128Glu)	PTEN	K128E	Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000958105	10	89692898	10	87933141	958105	947120	rs1554898138	NC_000010.11:87933140:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Nov 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	128	PTEN
NM_000314.8(PTEN):c.383A>G (p.Lys128Arg)	PTEN	K128R	not provided|PTEN hamartoma tumor syndrome	VCV000864223	10	89692899	10	87933142	864223	837424	rs1859975512	NC_000010.11:87933141:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jan 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	128	PTEN
NM_000314.8(PTEN):c.384G>C (p.Lys128Asn)	PTEN	K128N	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000428220	10	89692900	10	87933143	428220	419726	rs1114167645	NC_000010.11:87933142:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jul 23, 2017	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	128	PTEN
NM_000314.8(PTEN):c.385G>C (p.Gly129Arg)	PTEN	G129R	Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV000804339	10	89692901	10	87933144	804339	569855	rs786204929	NC_000010.11:87933143:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Feb 14, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	129	PTEN
NM_000314.8(PTEN):c.385G>A (p.Gly129Arg)	PTEN	G129R	Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided	VCV000189484	10	89692901	10	87933144	189484	187353	rs786204929	NC_000010.11:87933143:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	129	PTEN
NM_000314.8(PTEN):c.386G>T (p.Gly129Val)	PTEN	G129V	Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000856036	10	89692902	10	87933145	856036	837425	rs121909218	NC_000010.11:87933144:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	129	PTEN
NM_000314.8(PTEN):c.386_387delinsTT (p.Gly129Val)	PTEN	G129V	not provided	VCV000439290	10	89692902 - 89692903	10	87933145 - 87933146	439290	432666	rs1554898141	NC_000010.11:87933144:GA:TT	Indel	missense variant|5 prime UTR variant	Pathogenic	Dec 15, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	129	PTEN
NM_000314.8(PTEN):c.386G>A (p.Gly129Glu)	PTEN	G129E	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000007812	10	89692902	10	87933145	7812	22851	rs121909218	NC_000010.11:87933144:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	129	PTEN
NM_000314.8(PTEN):c.388C>G (p.Arg130Gly)	PTEN	R130G	PTEN hamartoma tumor syndrome	VCV000375958	10	89692904	10	87933147	375958	362837	rs121909224	NC_000010.11:87933146:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 25, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	130	PTEN
NM_000314.8(PTEN):c.389G>T (p.Arg130Leu)	PTEN	R130L	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome	VCV000376509	10	89692905	10	87933148	376509	363388	rs121909229	NC_000010.11:87933147:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jan 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	130	PTEN
NM_000314.8(PTEN):c.389G>C (p.Arg130Pro)	PTEN	R130P	PTEN hamartoma tumor syndrome	VCV000142018	10	89692905	10	87933148	142018	151732	rs121909229	NC_000010.11:87933147:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 22, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	130	PTEN
NM_000314.8(PTEN):c.389G>A (p.Arg130Gln)	PTEN	R130Q	PTEN hamartoma tumor syndrome	VCV000007829	10	89692905	10	87933148	7829	22868	rs121909229	NC_000010.11:87933147:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Oct 18, 2017	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	130	PTEN
NM_000314.8(PTEN):c.390_391delinsGG (p.Thr131Ala)	PTEN	T131A	Prostate cancer, hereditary, 1	VCV002687547	10	89692906 - 89692907	10	87933149 - 87933150	2687547	2848583	NA	NC_000010.11:87933148:AA:GG	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	131	PTEN
NM_000314.8(PTEN):c.391A>G (p.Thr131Ala)	PTEN	T131A	PTEN hamartoma tumor syndrome	VCV001954944	10	89692907	10	87933150	1954944	2015086	NA	NC_000010.11:87933149:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	131	PTEN
NM_000314.8(PTEN):c.392C>A (p.Thr131Asn)	PTEN	T131N	PTEN hamartoma tumor syndrome	VCV002443991	10	89692908	10	87933151	2443991	2417726	NA	NC_000010.11:87933150:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	131	PTEN
NM_000314.8(PTEN):c.392C>G (p.Thr131Ser)	PTEN	T131S	Hereditary cancer-predisposing syndrome	VCV000482073	10	89692908	10	87933151	482073	475523	rs397514560	NC_000010.11:87933150:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 5, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	131	PTEN
NM_000314.8(PTEN):c.392C>T (p.Thr131Ile)	PTEN	T131I	PTEN hamartoma tumor syndrome	VCV000039669	10	89692908	10	87933151	39669	48268	rs397514560	NC_000010.11:87933150:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 28, 2018	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	131	PTEN
NM_000314.8(PTEN):c.393_394delinsAA (p.Gly132Ser)	PTEN	G132S	Prostate cancer, hereditary, 1	VCV002687548	10	89692909 - 89692910	10	87933152 - 87933153	2687548	2848584	NA	NC_000010.11:87933151:TG:AA	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	132	PTEN
NM_000314.8(PTEN):c.394G>A (p.Gly132Ser)	PTEN	G132S	not provided|Cowden syndrome 1|Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome	VCV000856796	10	89692910	10	87933153	856796	837426	rs1859977029	NC_000010.11:87933152:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jun 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	132	PTEN
NM_000314.8(PTEN):c.395G>C (p.Gly132Ala)	PTEN	G132A	Prostate cancer, hereditary, 1	VCV002687617	10	89692911	10	87933154	2687617	2848653	NA	NC_000010.11:87933153:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	132	PTEN
NM_000314.8(PTEN):c.395G>A (p.Gly132Asp)	PTEN	G132D	PTEN hamartoma tumor syndrome	VCV000092822	10	89692911	10	87933154	92822	98729	rs121909241	NC_000010.11:87933153:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	132	PTEN
NM_000314.8(PTEN):c.395G>T (p.Gly132Val)	PTEN	G132V	not provided|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	VCV000007852	10	89692911	10	87933154	7852	22891	rs121909241	NC_000010.11:87933153:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Nov 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	132	PTEN
NM_000314.8(PTEN):c.397G>T (p.Val133Leu)	PTEN	V133L	PTEN hamartoma tumor syndrome	VCV002015349	10	89692913	10	87933156	2015349	2068147	NA	NC_000010.11:87933155:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	133	PTEN
NM_000314.8(PTEN):c.397G>C (p.Val133Leu)	PTEN	V133L	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001736693	10	89692913	10	87933156	1736693	1793735	NA	NC_000010.11:87933155:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	133	PTEN
NM_000314.8(PTEN):c.397G>A (p.Val133Ile)	PTEN	V133I	PTEN hamartoma tumor syndrome|not provided	VCV000971265	10	89692913	10	87933156	971265	956264	rs1859977307	NC_000010.11:87933155:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 13, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	133	PTEN
NM_000314.8(PTEN):c.400A>G (p.Met134Val)	PTEN	M134V	PTEN hamartoma tumor syndrome|not provided	VCV002033861	10	89692916	10	87933159	2033861	2096921	NA	NC_000010.11:87933158:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	134	PTEN
NM_000314.8(PTEN):c.401T>A (p.Met134Lys)	PTEN	M134K	PTEN hamartoma tumor syndrome	VCV001036651	10	89692917	10	87933160	1036651	1029842	rs1085308046	NC_000010.11:87933159:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	PTEN
NM_000314.8(PTEN):c.401T>G (p.Met134Arg)	PTEN	M134R	not provided	VCV000431829	10	89692917	10	87933160	431829	425893	rs1085308046	NC_000010.11:87933159:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 14, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	PTEN
NM_000314.8(PTEN):c.401T>C (p.Met134Thr)	PTEN	M134T	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1	VCV000427588	10	89692917	10	87933160	427588	416941	rs1085308046	NC_000010.11:87933159:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Nov 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	134	PTEN
NM_000314.8(PTEN):c.402G>A (p.Met134Ile)	PTEN	M134I	PTEN hamartoma tumor syndrome	VCV002028290	10	89692918	10	87933161	2028290	2088765	NA	NC_000010.11:87933160:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	PTEN
NM_000314.8(PTEN):c.402G>C (p.Met134Ile)	PTEN	M134I	PTEN hamartoma tumor syndrome	VCV000619908	10	89692918	10	87933161	619908	611089	rs1114167676	NC_000010.11:87933160:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	134	PTEN
NM_000314.8(PTEN):c.402G>T (p.Met134Ile)	PTEN	M134I	not provided|Hereditary cancer-predisposing syndrome	VCV000428267	10	89692918	10	87933161	428267	419727	rs1114167676	NC_000010.11:87933160:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 18, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	134	PTEN
NM_000314.8(PTEN):c.403A>G (p.Ile135Val)	PTEN	I135V	not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV000142287	10	89692919	10	87933162	142287	152001	rs587782360	NC_000010.11:87933161:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Nov 21, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	135	PTEN
NM_000314.8(PTEN):c.404T>C (p.Ile135Thr)	PTEN	I135T	PTEN hamartoma tumor syndrome|not provided	VCV001010008	10	89692920	10	87933163	1010008	994093	rs370795352	NC_000010.11:87933162:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	135	PTEN
NM_000314.8(PTEN):c.404T>A (p.Ile135Lys)	PTEN	I135K	Glioma susceptibility 2|Malignant tumor of prostate|Macrocephaly-autism syndrome|Familial meningioma|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	VCV000428235	10	89692920	10	87933163	428235	419728	rs370795352	NC_000010.11:87933162:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Apr 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	135	PTEN
NM_000314.8(PTEN):c.405A>G (p.Ile135Met)	PTEN	I135M	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV001737440	10	89692921	10	87933164	1737440	1790639	NA	NC_000010.11:87933163:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	135	PTEN
NM_000314.8(PTEN):c.406T>C (p.Cys136Arg)	PTEN	C136R	PTEN hamartoma tumor syndrome|Cowden syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|not provided	VCV000183726	10	89692922	10	87933165	183726	183028	rs786201044	NC_000010.11:87933164:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	136	PTEN
NM_000314.8(PTEN):c.407G>T (p.Cys136Phe)	PTEN	C136F	Hereditary cancer-predisposing syndrome	VCV001737618	10	89692923	10	87933166	1737618	1787482	NA	NC_000010.11:87933165:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	136	PTEN
NM_000314.8(PTEN):c.407G>A (p.Cys136Tyr)	PTEN	C136Y	PTEN hamartoma tumor syndrome	VCV000189406	10	89692923	10	87933166	189406	187355	rs786204859	NC_000010.11:87933165:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Oct 18, 2017	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	136	PTEN
NM_000314.8(PTEN):c.408T>G (p.Cys136Trp)	PTEN	C136W	PTEN hamartoma tumor syndrome|Cowden syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000224543	10	89692924	10	87933167	224543	226338	rs869312776	NC_000010.11:87933166:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	136	PTEN
NM_000314.8(PTEN):c.409G>C (p.Ala137Pro)	PTEN	A137P	PTEN hamartoma tumor syndrome|Neoplasm	VCV000841362	10	89692925	10	87933168	841362	837427	rs1859978482	NC_000010.11:87933167:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 11, 2019	criteria provided, single submitter	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	137	PTEN
NM_000314.8(PTEN):c.409_411delinsTTT (p.Ala137Phe)	PTEN	A137F	PTEN hamartoma tumor syndrome	VCV000237645	10	89692925 - 89692927	10	87933168 - 87933170	237645	240875	rs878853938	NC_000010.11:87933167:GCA:TTT	Indel	missense variant|5 prime UTR variant	Uncertain significance	Oct 20, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	137	PTEN
NM_000314.8(PTEN):c.410C>A (p.Ala137Glu)	PTEN	A137E	not provided	VCV003340217	10	89692926	10	87933169	3340217	3499475	NA	NC_000010.11:87933168:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jul 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	137	PTEN
NM_000314.8(PTEN):c.410C>G (p.Ala137Gly)	PTEN	A137G	not specified	VCV002443228	10	89692926	10	87933169	2443228	2416948	NA	NC_000010.11:87933168:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 22, 2022	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	137	PTEN
NM_000314.8(PTEN):c.412T>C (p.Tyr138His)	PTEN	Y138H	PTEN hamartoma tumor syndrome	VCV000864397	10	89692928	10	87933171	864397	837428	rs1859978750	NC_000010.11:87933170:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	138	PTEN
NM_000314.8(PTEN):c.413A>G (p.Tyr138Cys)	PTEN	Y138C	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000486230	10	89692929	10	87933172	486230	475207	rs1554898159	NC_000010.11:87933171:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	138	PTEN
NM_000314.8(PTEN):c.415T>A (p.Leu139Ile)	PTEN	L139I	PTEN hamartoma tumor syndrome	VCV002145849	10	89692931	10	87933174	2145849	1880334	NA	NC_000010.11:87933173:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	139	PTEN
NM_000314.8(PTEN):c.417A>T (p.Leu139Phe)	PTEN	L139F	PTEN hamartoma tumor syndrome	VCV001929420	10	89692933	10	87933176	1929420	1984430	NA	NC_000010.11:87933175:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	139	PTEN
NM_000314.8(PTEN):c.417A>C (p.Leu139Phe)	PTEN	L139F	Hereditary cancer-predisposing syndrome	VCV001738466	10	89692933	10	87933176	1738466	1790799	NA	NC_000010.11:87933175:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	139	PTEN
NM_000314.8(PTEN):c.418T>A (p.Leu140Ile)	PTEN	L140I	PTEN hamartoma tumor syndrome	VCV002091506	10	89692934	10	87933177	2091506	2155889	NA	NC_000010.11:87933176:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	140	PTEN
NM_000314.8(PTEN):c.419T>C (p.Leu140Ser)	PTEN	L140S	Prostate cancer, hereditary, 1	VCV002687513	10	89692935	10	87933178	2687513	2848549	NA	NC_000010.11:87933177:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	140	PTEN
NM_000314.8(PTEN):c.421C>T (p.His141Tyr)	PTEN	H141Y	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000486231	10	89692937	10	87933180	486231	475399	rs1060500129	NC_000010.11:87933179:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 21, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	141	PTEN
NM_000314.8(PTEN):c.421C>G (p.His141Asp)	PTEN	H141D	PTEN hamartoma tumor syndrome	VCV000404171	10	89692937	10	87933180	404171	398050	rs1060500129	NC_000010.11:87933179:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 4, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	141	PTEN
NM_000314.8(PTEN):c.422A>T (p.His141Leu)	PTEN	H141L	Macrocephaly-autism syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV001708039	10	89692938	10	87933181	1708039	1706336	NA	NC_000010.11:87933180:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	141	PTEN
NM_000314.8(PTEN):c.422A>G (p.His141Arg)	PTEN	H141R	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000418438	10	89692938	10	87933181	418438	407991	rs863224666	NC_000010.11:87933180:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	141	PTEN
NM_000314.8(PTEN):c.422A>C (p.His141Pro)	PTEN	H141P	PTEN hamartoma tumor syndrome	VCV000216422	10	89692938	10	87933181	216422	212817	rs863224666	NC_000010.11:87933180:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	141	PTEN
NM_000314.8(PTEN):c.424C>G (p.Arg142Gly)	PTEN	R142G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001739065	10	89692940	10	87933183	1739065	1788062	NA	NC_000010.11:87933182:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 3, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	142	PTEN
NM_000314.8(PTEN):c.424C>T (p.Arg142Trp)	PTEN	R142W	PTEN hamartoma tumor syndrome	VCV000197662	10	89692940	10	87933183	197662	194823	rs746152219	NC_000010.11:87933182:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 17, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	142	PTEN
NM_000314.8(PTEN):c.425G>C (p.Arg142Pro)	PTEN	R142P	Hereditary cancer-predisposing syndrome	VCV000486225	10	89692941	10	87933184	486225	475402	rs753630034	NC_000010.11:87933183:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Nov 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	142	PTEN
NM_000314.8(PTEN):c.425G>A (p.Arg142Gln)	PTEN	R142Q	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000237646	10	89692941	10	87933184	237646	240876	rs753630034	NC_000010.11:87933183:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	142	PTEN
NM_000314.8(PTEN):c.427G>C (p.Gly143Arg)	PTEN	G143R	Hereditary cancer-predisposing syndrome	VCV002452967	10	89692943	10	87933186	2452967	2433948	NA	NC_000010.11:87933185:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	143	PTEN
NM_000314.8(PTEN):c.427G>A (p.Gly143Ser)	PTEN	G143S	Hereditary cancer-predisposing syndrome	VCV001171869	10	89692943	10	87933186	1171869	1160794	rs2132243629	NC_000010.11:87933185:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	143	PTEN
NM_000314.8(PTEN):c.428_429delinsAA (p.Gly143Glu)	PTEN	G143E	Prostate cancer, hereditary, 1	VCV002687514	10	89692944 - 89692945	10	87933187 - 87933188	2687514	2848550	NA	NC_000010.11:87933186:GC:AA	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	143	PTEN
NM_000314.8(PTEN):c.428G>A (p.Gly143Asp)	PTEN	G143D	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000185276	10	89692944	10	87933187	185276	183030	rs786202047	NC_000010.11:87933186:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	143	PTEN
NM_000314.8(PTEN):c.431A>G (p.Lys144Arg)	PTEN	K144R	Prostate cancer, hereditary, 1	VCV002687618	10	89692947	10	87933190	2687618	2848654	NA	NC_000010.11:87933189:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	144	PTEN
NM_000314.8(PTEN):c.431A>C (p.Lys144Thr)	PTEN	K144T	Prostate cancer, hereditary, 1	VCV002687516	10	89692947	10	87933190	2687516	2848552	NA	NC_000010.11:87933189:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	144	PTEN
NM_000314.8(PTEN):c.432_435delinsGAGG (p.Phe145Arg)	PTEN	F145R	Prostate cancer, hereditary, 1	VCV002687610	10	89692948 - 89692951	10	87933191 - 87933194	2687610	2848646	NA	NC_000010.11:87933190:ATTT:GAGG	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	145	PTEN
NM_000314.8(PTEN):c.432A>T (p.Lys144Asn)	PTEN	K144N	Prostate cancer, hereditary, 1	VCV002687518	10	89692948	10	87933191	2687518	2848554	NA	NC_000010.11:87933190:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	144	PTEN
NM_000314.8(PTEN):c.432A>C (p.Lys144Asn)	PTEN	K144N	Prostate cancer, hereditary, 1	VCV002687517	10	89692948	10	87933191	2687517	2848553	NA	NC_000010.11:87933190:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	144	PTEN
NM_000314.8(PTEN):c.433T>A (p.Phe145Ile)	PTEN	F145I	Prostate cancer, hereditary, 1	VCV002687619	10	89692949	10	87933192	2687619	2848655	NA	NC_000010.11:87933191:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	145	PTEN
NM_000314.8(PTEN):c.433T>G (p.Phe145Val)	PTEN	F145V	Prostate cancer, hereditary, 1	VCV002687519	10	89692949	10	87933192	2687519	2848555	NA	NC_000010.11:87933191:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	145	PTEN
NM_000314.8(PTEN):c.433T>C (p.Phe145Leu)	PTEN	F145L	PTEN hamartoma tumor syndrome	VCV001419656	10	89692949	10	87933192	1419656	1409876	rs2132243676	NC_000010.11:87933191:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	145	PTEN
NM_000314.8(PTEN):c.434T>C (p.Phe145Ser)	PTEN	F145S	not provided	VCV000806543	10	89692950	10	87933193	806543	796489	rs1589646560	NC_000010.11:87933192:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 1, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	145	PTEN
NM_000314.8(PTEN):c.435T>A (p.Phe145Leu)	PTEN	F145L	Hereditary cancer-predisposing syndrome	VCV001171836	10	89692951	10	87933194	1171836	1160795	rs2132243695	NC_000010.11:87933193:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	145	PTEN
NM_000314.8(PTEN):c.436T>G (p.Leu146Val)	PTEN	L146V	PTEN hamartoma tumor syndrome	VCV002099299	10	89692952	10	87933195	2099299	2150620	NA	NC_000010.11:87933194:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	146	PTEN
NM_000314.8(PTEN):c.438_439delinsGG (p.Lys147Glu)	PTEN	K147E	Prostate cancer, hereditary, 1	VCV002687550	10	89692954 - 89692955	10	87933197 - 87933198	2687550	2848586	NA	NC_000010.11:87933196:AA:GG	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	147	PTEN
NM_000314.8(PTEN):c.440A>G (p.Lys147Arg)	PTEN	K147R	not specified|not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000490113	10	89692956	10	87933199	490113	482754	rs757087471	NC_000010.11:87933198:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	147	PTEN
NM_000314.8(PTEN):c.442G>A (p.Ala148Thr)	PTEN	A148T	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000233304	10	89692958	10	87933201	233304	233852	rs876660321	NC_000010.11:87933200:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	148	PTEN
NM_000314.8(PTEN):c.448G>A (p.Glu150Lys)	PTEN	E150K	Prostate cancer, hereditary, 1	VCV002687521	10	89692964	10	87933207	2687521	2848557	NA	NC_000010.11:87933206:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	150	PTEN
NM_000314.8(PTEN):c.449A>G (p.Glu150Gly)	PTEN	E150G	PTEN hamartoma tumor syndrome|Macrocephaly-autism syndrome	VCV000468687	10	89692965	10	87933208	468687	460367	rs1554898193	NC_000010.11:87933207:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 29, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	150	PTEN
NM_000314.8(PTEN):c.451G>A (p.Ala151Thr)	PTEN	A151T	Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001476274	10	89692967	10	87933210	1476274	1423993	rs1859982098	NC_000010.11:87933209:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	151	PTEN
NM_000314.8(PTEN):c.452C>T (p.Ala151Val)	PTEN	A151V	PTEN hamartoma tumor syndrome	VCV002861996	10	89692968	10	87933211	2861996	3029358	NA	NC_000010.11:87933210:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	151	PTEN
NM_000314.8(PTEN):c.452C>A (p.Ala151Asp)	PTEN	A151D	PTEN hamartoma tumor syndrome	VCV002735436	10	89692968	10	87933211	2735436	2901460	NA	NC_000010.11:87933210:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	151	PTEN
NM_000314.8(PTEN):c.454C>G (p.Leu152Val)	PTEN	L152V	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV002687522	10	89692970	10	87933213	2687522	2848558	NA	NC_000010.11:87933212:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	152	PTEN
NM_000314.8(PTEN):c.455T>G (p.Leu152Arg)	PTEN	L152R	PTEN hamartoma tumor syndrome	VCV001721463	10	89692971	10	87933214	1721463	1772797	NA	NC_000010.11:87933213:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	152	PTEN
NM_000314.8(PTEN):c.455T>C (p.Leu152Pro)	PTEN	L152P	PTEN hamartoma tumor syndrome	VCV000536551	10	89692971	10	87933214	536551	525912	rs1554898197	NC_000010.11:87933213:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	152	PTEN
NM_000314.8(PTEN):c.457G>T (p.Asp153Tyr)	PTEN	D153Y	Hereditary cancer-predisposing syndrome	VCV001741636	10	89692973	10	87933216	1741636	1805079	NA	NC_000010.11:87933215:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	153	PTEN
NM_000314.8(PTEN):c.457G>C (p.Asp153His)	PTEN	D153H	Cowden syndrome 1	VCV000973270	10	89692973	10	87933216	973270	961521	rs9651492	NC_000010.11:87933215:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	153	PTEN
NM_000314.8(PTEN):c.457G>A (p.Asp153Asn)	PTEN	D153N	PTEN hamartoma tumor syndrome	VCV000404159	10	89692973	10	87933216	404159	398053	rs9651492	NC_000010.11:87933215:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 17, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	153	PTEN
NM_000314.8(PTEN):c.459T>A (p.Asp153Glu)	PTEN	D153E	Prostate cancer, hereditary, 1	VCV002687524	10	89692975	10	87933218	2687524	2848560	NA	NC_000010.11:87933217:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	153	PTEN
NM_000314.8(PTEN):c.460T>A (p.Phe154Ile)	PTEN	F154I	PTEN hamartoma tumor syndrome	VCV002757141	10	89692976	10	87933219	2757141	2920912	NA	NC_000010.11:87933218:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	154	PTEN
NM_000314.8(PTEN):c.461T>G (p.Phe154Cys)	PTEN	F154C	not provided	VCV001175130	10	89692977	10	87933220	1175130	1164373	rs1313989099	NC_000010.11:87933219:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	154	PTEN
NM_000314.8(PTEN):c.462C>A (p.Phe154Leu)	PTEN	F154L	PTEN hamartoma tumor syndrome	VCV002015340	10	89692978	10	87933221	2015340	2068138	NA	NC_000010.11:87933220:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	154	PTEN
NM_000314.8(PTEN):c.462C>G (p.Phe154Leu)	PTEN	F154L	PTEN hamartoma tumor syndrome	VCV000933783	10	89692978	10	87933221	933783	935223	rs1859982800	NC_000010.11:87933220:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	154	PTEN
NM_000314.8(PTEN):c.463T>A (p.Tyr155Asn)	PTEN	Y155N	Hereditary cancer-predisposing syndrome	VCV001742096	10	89692979	10	87933222	1742096	98732	rs398123325	NC_000010.11:87933221:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	155	PTEN
NM_000314.8(PTEN):c.463T>C (p.Tyr155His)	PTEN	Y155H	Hereditary cancer-predisposing syndrome|Macrocephaly-autism syndrome|Cowden syndrome 1	VCV000428237	10	89692979	10	87933222	428237	419732	rs398123325	NC_000010.11:87933221:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	155	PTEN
NM_000314.8(PTEN):c.464A>C (p.Tyr155Ser)	PTEN	Y155S	Cowden syndrome 1	VCV000547759	10	89692980	10	87933223	547759	537873	rs1060500126	NC_000010.11:87933222:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Nov 1, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	155	PTEN
NM_000314.8(PTEN):c.464A>G (p.Tyr155Cys)	PTEN	Y155C	PTEN hamartoma tumor syndrome	VCV000404168	10	89692980	10	87933223	404168	398057	rs1060500126	NC_000010.11:87933222:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 22, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	155	PTEN
NM_000314.8(PTEN):c.466_467delinsAA (p.Gly156Lys)	PTEN	G156K	PTEN hamartoma tumor syndrome	VCV002865110	10	89692982 - 89692983	10	87933225 - 87933226	2865110	3029891	NA	NC_000010.11:87933224:GG:AA	Indel	missense variant|5 prime UTR variant	Uncertain significance	May 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	156	PTEN
NM_000314.8(PTEN):c.466G>C (p.Gly156Arg)	PTEN	G156R	PTEN hamartoma tumor syndrome	VCV002007139	10	89692982	10	87933225	2007139	2062499	NA	NC_000010.11:87933224:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	156	PTEN
NM_000314.8(PTEN):c.466G>A (p.Gly156Arg)	PTEN	G156R	PTEN hamartoma tumor syndrome	VCV000468688	10	89692982	10	87933225	468688	460370	rs1554898209	NC_000010.11:87933224:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	156	PTEN
NM_000314.8(PTEN):c.467G>T (p.Gly156Val)	PTEN	G156V	Glioma susceptibility 2|Neoplasm	VCV003240230	10	89692983	10	87933226	3240230	3399217	NA	NC_000010.11:87933225:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	156	PTEN
NM_000314.8(PTEN):c.469G>A (p.Glu157Lys)	PTEN	E157K	not provided|Hereditary cancer-predisposing syndrome	VCV002435279	10	89692985	10	87933228	2435279	2413596	NA	NC_000010.11:87933227:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	157	PTEN
NM_000314.8(PTEN):c.470A>C (p.Glu157Ala)	PTEN	E157A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001370842	10	89692986	10	87933229	1370842	1430909	rs1085308051	NC_000010.11:87933228:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 14, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	157	PTEN
NM_000314.8(PTEN):c.470A>G (p.Glu157Gly)	PTEN	E157G	Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome	VCV000427593	10	89692986	10	87933229	427593	416944	rs1085308051	NC_000010.11:87933228:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 13, 2017	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	157	PTEN
NM_000314.8(PTEN):c.472_474delinsAGG (p.Val158Arg)	PTEN	V158R	Prostate cancer, hereditary, 1	VCV002687545	10	89692988 - 89692990	10	87933231 - 87933233	2687545	2848581	NA	NC_000010.11:87933230:GTA:AGG	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	158	PTEN
NM_000314.8(PTEN):c.472G>T (p.Val158Leu)	PTEN	V158L	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001037500	10	89692988	10	87933231	1037500	1029843	rs1554898217	NC_000010.11:87933230:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	158	PTEN
NM_000314.8(PTEN):c.472G>A (p.Val158Ile)	PTEN	V158I	Hereditary cancer-predisposing syndrome	VCV000492329	10	89692988	10	87933231	492329	484339	rs1554898217	NC_000010.11:87933230:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	158	PTEN
NM_000314.8(PTEN):c.473T>C (p.Val158Ala)	PTEN	V158A	Prostate cancer, hereditary, 1	VCV002687613	10	89692989	10	87933232	2687613	2848649	NA	NC_000010.11:87933231:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	158	PTEN
NM_000314.8(PTEN):c.475A>G (p.Arg159Gly)	PTEN	R159G	PTEN hamartoma tumor syndrome|Cowden syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000186094	10	89692991	10	87933234	186094	183032	rs786202688	NC_000010.11:87933233:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	159	PTEN
NM_000314.8(PTEN):c.476G>C (p.Arg159Thr)	PTEN	R159T	PTEN hamartoma tumor syndrome	VCV002735437	10	89692992	10	87933235	2735437	2901461	NA	NC_000010.11:87933234:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	159	PTEN
NM_000314.8(PTEN):c.476G>A (p.Arg159Lys)	PTEN	R159K	not provided|PTEN hamartoma tumor syndrome	VCV000646006	10	89692992	10	87933235	646006	639275	rs1114167673	NC_000010.11:87933234:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Aug 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	159	PTEN
NM_000314.8(PTEN):c.476G>T (p.Arg159Met)	PTEN	R159M	Hereditary cancer-predisposing syndrome	VCV000428262	10	89692992	10	87933235	428262	419733	rs1114167673	NC_000010.11:87933234:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jul 2, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	159	PTEN
NM_000314.8(PTEN):c.477G>C (p.Arg159Ser)	PTEN	R159S	PTEN hamartoma tumor syndrome	VCV001347476	10	89692993	10	87933236	1347476	1465906	rs1057519724	NC_000010.11:87933235:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	159	PTEN
NM_000314.8(PTEN):c.477G>T (p.Arg159Ser)	PTEN	R159S	PTEN hamartoma tumor syndrome|Neoplasm	VCV000375959	10	89692993	10	87933236	375959	362838	rs1057519724	NC_000010.11:87933235:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 25, 2019	reviewed by expert panel	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	159	PTEN
NM_000314.8(PTEN):c.478_479delinsGA (p.Thr160Asp)	PTEN	T160D	Prostate cancer, hereditary, 1	VCV002687525	10	89692994 - 89692995	10	87933237 - 87933238	2687525	2848561	NA	NC_000010.11:87933236:AC:GA	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	160	PTEN
NM_000314.8(PTEN):c.478A>C (p.Thr160Pro)	PTEN	T160P	PTEN hamartoma tumor syndrome|not specified	VCV000404170	10	89692994	10	87933237	404170	397937	rs1060500128	NC_000010.11:87933236:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 16, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	160	PTEN
NM_000314.8(PTEN):c.479C>T (p.Thr160Ile)	PTEN	T160I	not provided	VCV000431851	10	89692995	10	87933238	431851	425894	rs1554898225	NC_000010.11:87933237:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 27, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	160	PTEN
NM_000314.8(PTEN):c.481A>G (p.Arg161Gly)	PTEN	R161G	Prostate cancer, hereditary, 1	VCV002687526	10	89692997	10	87933240	2687526	2848562	NA	NC_000010.11:87933239:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	161	PTEN
NM_000314.8(PTEN):c.482G>C (p.Arg161Thr)	PTEN	R161T	Hereditary cancer-predisposing syndrome	VCV001743421	10	89692998	10	87933241	1743421	1805567	NA	NC_000010.11:87933240:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	161	PTEN
NM_000314.8(PTEN):c.484G>C (p.Asp162His)	PTEN	D162H	Hereditary cancer-predisposing syndrome	VCV003231159	10	89693000	10	87933243	3231159	3391781	NA	NC_000010.11:87933242:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	162	PTEN
NM_000314.8(PTEN):c.485A>T (p.Asp162Val)	PTEN	D162V	PTEN hamartoma tumor syndrome	VCV002707439	10	89693001	10	87933244	2707439	2867129	NA	NC_000010.11:87933243:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 15, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	162	PTEN
NM_000314.8(PTEN):c.486C>G (p.Asp162Glu)	PTEN	D162E	Cowden syndrome|not provided	VCV000224544	10	89693002	10	87933245	224544	226340	rs869312777	NC_000010.11:87933244:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 31, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	162	PTEN
NM_000314.8(PTEN):c.487A>C (p.Lys163Gln)	PTEN	K163Q	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001061726	10	89693003	10	87933246	1061726	1046825	rs1554898235	NC_000010.11:87933245:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	163	PTEN
NM_000314.8(PTEN):c.488A>G (p.Lys163Arg)	PTEN	K163R	Macrocephaly-autism syndrome|Malignant tumor of prostate|Familial meningioma|Cowden syndrome 1|Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000186180	10	89693004	10	87933247	186180	183033	rs786202753	NC_000010.11:87933246:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	163	PTEN
NM_000314.8(PTEN):c.490A>G (p.Lys164Glu)	PTEN	K164E	PTEN hamartoma tumor syndrome|not provided	VCV002579603	10	89693006	10	87933249	2579603	2744639	NA	NC_000010.11:87933248:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	164	PTEN
NM_000314.8(PTEN):c.491A>T (p.Lys164Met)	PTEN	K164M	PTEN hamartoma tumor syndrome	VCV003071050	10	89693007	10	87933250	3071050	3228633	NA	NC_000010.11:87933249:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	164	PTEN
NM_000314.8(PTEN):c.491A>G (p.Lys164Arg)	PTEN	K164R	Prostate cancer, hereditary, 1	VCV002687527	10	89693007	10	87933250	2687527	2848563	NA	NC_000010.11:87933249:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	164	PTEN
NM_000314.8(PTEN):c.492G>C (p.Lys164Asn)	PTEN	K164N	not provided	VCV002501532	10	89693008	10	87933251	2501532	2524435	NA	NC_000010.11:87933250:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 22, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	164	PTEN
NM_000314.8(PTEN):c.493G>C (p.Gly165Arg)	PTEN	G165R	Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided	VCV001067498	10	89711875	10	87952118	1067498	1055939	rs587782603	NC_000010.11:87952117:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Apr 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	165	PTEN
NM_000314.8(PTEN):c.493G>A (p.Gly165Arg)	PTEN	G165R	PTEN hamartoma tumor syndrome	VCV000428256	10	89711875	10	87952118	428256	419734	rs587782603	NC_000010.11:87952117:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 22, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	165	PTEN
NM_000314.8(PTEN):c.494G>T (p.Gly165Val)	PTEN	G165V	Macrocephaly-autism syndrome|not provided	VCV001341516	10	89711876	10	87952119	1341516	187360	rs786204863	NC_000010.11:87952118:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jan 1, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	165	PTEN
NM_000314.8(PTEN):c.494G>A (p.Gly165Glu)	PTEN	G165E	PTEN hamartoma tumor syndrome|Cowden syndrome 1	VCV000844343	10	89711876	10	87952119	844343	837429	rs786204863	NC_000010.11:87952118:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 31, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	165	PTEN
NM_000314.8(PTEN):c.496G>T (p.Val166Leu)	PTEN	V166L	PTEN hamartoma tumor syndrome	VCV001046897	10	89711878	10	87952121	1046897	1029844	rs780943695	NC_000010.11:87952120:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 10, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	166	PTEN
NM_000314.8(PTEN):c.496G>C (p.Val166Leu)	PTEN	V166L	PTEN hamartoma tumor syndrome	VCV000639793	10	89711878	10	87952121	639793	639276	rs780943695	NC_000010.11:87952120:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	166	PTEN
NM_000314.8(PTEN):c.496G>A (p.Val166Ile)	PTEN	V166I	Hereditary cancer-predisposing syndrome|Glioma susceptibility 2	VCV000187015	10	89711878	10	87952121	187015	183034	rs780943695	NC_000010.11:87952120:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	166	PTEN
NM_000314.8(PTEN):c.497T>A (p.Val166Glu)	PTEN	V166E	Hereditary cancer-predisposing syndrome	VCV000486974	10	89711879	10	87952122	486974	475212	rs1554900515	NC_000010.11:87952121:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 28, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	166	PTEN
NM_000314.8(PTEN):c.499A>G (p.Thr167Ala)	PTEN	T167A	Cowden syndrome 1	VCV001686107	10	89711881	10	87952124	1686107	1678118	rs1210737543	NC_000010.11:87952123:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	May 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	167	PTEN
NM_000314.8(PTEN):c.500C>A (p.Thr167Asn)	PTEN	T167N	PTEN hamartoma tumor syndrome	VCV000039668	10	89711882	10	87952125	39668	48267	rs397514559	NC_000010.11:87952124:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	167	PTEN
NM_000314.8(PTEN):c.502A>T (p.Ile168Phe)	PTEN	I168F	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001878988	10	89711884	10	87952127	1878988	1935738	NA	NC_000010.11:87952126:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	168	PTEN
NM_000314.8(PTEN):c.502A>G (p.Ile168Val)	PTEN	I168V	PTEN hamartoma tumor syndrome	VCV000953955	10	89711884	10	87952127	953955	947122	rs1860415565	NC_000010.11:87952126:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	168	PTEN
NM_000314.8(PTEN):c.503T>C (p.Ile168Thr)	PTEN	I168T	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000468694	10	89711885	10	87952128	468694	460635	rs1554900530	NC_000010.11:87952127:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	168	PTEN
NM_000314.8(PTEN):c.504T>G (p.Ile168Met)	PTEN	I168M	not specified	VCV002581178	10	89711886	10	87952129	2581178	2748761	NA	NC_000010.11:87952128:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	168	PTEN
NM_000314.8(PTEN):c.505C>G (p.Pro169Ala)	PTEN	P169A	PTEN hamartoma tumor syndrome	VCV000591816	10	89711887	10	87952130	591816	582805	rs1564837747	NC_000010.11:87952129:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	169	PTEN
NM_000314.8(PTEN):c.508A>T (p.Ser170Cys)	PTEN	S170C	PTEN hamartoma tumor syndrome	VCV001485373	10	89711890	10	87952133	1485373	1394098	rs1554900534	NC_000010.11:87952132:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.508A>C (p.Ser170Arg)	PTEN	S170R	Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV000569301	10	89711890	10	87952133	569301	564858	rs1554900534	NC_000010.11:87952132:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.508A>G (p.Ser170Gly)	PTEN	S170G	PTEN hamartoma tumor syndrome	VCV000536559	10	89711890	10	87952133	536559	525507	rs1554900534	NC_000010.11:87952132:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 19, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.509G>C (p.Ser170Thr)	PTEN	S170T	Hereditary cancer-predisposing syndrome	VCV001745325	10	89711891	10	87952134	1745325	1802378	NA	NC_000010.11:87952133:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 12, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.509G>A (p.Ser170Asn)	PTEN	S170N	Cowden syndrome 1|PTEN hamartoma tumor syndrome	VCV000951765	10	89711891	10	87952134	951765	925965	rs876660507	NC_000010.11:87952133:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.509G>T (p.Ser170Ile)	PTEN	S170I	PTEN-related disorder|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000233590	10	89711891	10	87952134	233590	233855	rs876660507	NC_000010.11:87952133:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Nov 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.510T>G (p.Ser170Arg)	PTEN	S170R	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000825458	10	89711892	10	87952135	825458	810100	rs121909221	NC_000010.11:87952134:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.510T>A (p.Ser170Arg)	PTEN	S170R	PTEN hamartoma tumor syndrome	VCV000007815	10	89711892	10	87952135	7815	22854	rs121909221	NC_000010.11:87952134:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	170	PTEN
NM_000314.8(PTEN):c.511C>A (p.Gln171Lys)	PTEN	Q171K	not provided	VCV001198486	10	89711893	10	87952136	1198486	1187636	rs786204864	NC_000010.11:87952135:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 15, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	171	PTEN
NM_000314.8(PTEN):c.511C>G (p.Gln171Glu)	PTEN	Q171E	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000844941	10	89711893	10	87952136	844941	837430	rs786204864	NC_000010.11:87952135:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	171	PTEN
NM_000314.8(PTEN):c.512A>C (p.Gln171Pro)	PTEN	Q171P	PTEN hamartoma tumor syndrome	VCV000573168	10	89711894	10	87952137	573168	569857	rs786204865	NC_000010.11:87952136:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 18, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	171	PTEN
NM_000314.8(PTEN):c.512A>G (p.Gln171Arg)	PTEN	Q171R	Hereditary cancer-predisposing syndrome|Macrocephaly-autism syndrome|Familial meningioma|Malignant tumor of prostate|Cowden syndrome 1|Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV000189412	10	89711894	10	87952137	189412	187362	rs786204865	NC_000010.11:87952136:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	171	PTEN
NM_000314.8(PTEN):c.515G>T (p.Arg172Met)	PTEN	R172M	PTEN hamartoma tumor syndrome	VCV001003046	10	89711897	10	87952140	1003046	994096	rs1589659399	NC_000010.11:87952139:G:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	May 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	172	PTEN
NM_000314.8(PTEN):c.515G>C (p.Arg172Thr)	PTEN	R172T	Hereditary cancer-predisposing syndrome	VCV000825490	10	89711897	10	87952140	825490	810101	rs1589659399	NC_000010.11:87952139:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 31, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	172	PTEN
NM_000314.8(PTEN):c.517C>G (p.Arg173Gly)	PTEN	R173G	not provided	VCV001176553	10	89711899	10	87952142	1176553	1165963	rs121913293	NC_000010.11:87952141:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	173	PTEN
NM_000314.8(PTEN):c.517C>A (p.Arg173Ser)	PTEN	R173S	PTEN hamartoma tumor syndrome	VCV000404142	10	89711899	10	87952142	404142	398061	rs121913293	NC_000010.11:87952141:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 14, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	173	PTEN
NM_000314.8(PTEN):c.517C>T (p.Arg173Cys)	PTEN	R173C	PTEN hamartoma tumor syndrome	VCV000189500	10	89711899	10	87952142	189500	187363	rs121913293	NC_000010.11:87952141:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Oct 18, 2017	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	173	PTEN
NM_000314.8(PTEN):c.518G>T (p.Arg173Leu)	PTEN	R173L	Hereditary cancer-predisposing syndrome	VCV000428258	10	89711900	10	87952143	428258	419738	rs121913294	NC_000010.11:87952142:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Mar 2, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	173	PTEN
NM_000314.8(PTEN):c.518G>A (p.Arg173His)	PTEN	R173H	not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome|Neoplasm	VCV000376032	10	89711900	10	87952143	376032	362911	rs121913294	NC_000010.11:87952142:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	173	PTEN
NM_000314.8(PTEN):c.518G>C (p.Arg173Pro)	PTEN	R173P	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000185195	10	89711900	10	87952143	185195	183035	rs121913294	NC_000010.11:87952142:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Apr 26, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	173	PTEN
NM_000314.8(PTEN):c.520T>C (p.Tyr174His)	PTEN	Y174H	Macrocephaly-autism syndrome	VCV003220859	10	89711902	10	87952145	3220859	3380077	NA	NC_000010.11:87952144:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 4, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	174	PTEN
NM_000314.8(PTEN):c.520T>A (p.Tyr174Asn)	PTEN	Y174N	PTEN hamartoma tumor syndrome	VCV000142220	10	89711902	10	87952145	142220	151934	rs587782316	NC_000010.11:87952144:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	174	PTEN
NM_000314.8(PTEN):c.521A>G (p.Tyr174Cys)	PTEN	Y174C	PTEN hamartoma tumor syndrome	VCV000220007	10	89711903	10	87952146	220007	222000	rs864622341	NC_000010.11:87952145:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	174	PTEN
NM_000314.8(PTEN):c.523G>A (p.Val175Met)	PTEN	V175M	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001067224	10	89711905	10	87952148	1067224	1055940	rs1860417734	NC_000010.11:87952147:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	175	PTEN
NM_000314.8(PTEN):c.523G>T (p.Val175Leu)	PTEN	V175L	PTEN hamartoma tumor syndrome	VCV000960928	10	89711905	10	87952148	960928	947123	rs1860417734	NC_000010.11:87952147:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 25, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	175	PTEN
NM_000314.8(PTEN):c.526T>C (p.Tyr176His)	PTEN	Y176H	Neoplasm	VCV003257937	10	89711908	10	87952151	3257937	3416696	NA	NC_000010.11:87952150:T:C	single nucleotide variant	missense variant|5 prime UTR variant	NA	NA	NA	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	176	PTEN
NM_000314.8(PTEN):c.527A>G (p.Tyr176Cys)	PTEN	Y176C	not specified|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|not provided	VCV000185585	10	89711909	10	87952152	185585	183037	rs757498880	NC_000010.11:87952151:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	176	PTEN
NM_000314.8(PTEN):c.529T>G (p.Tyr177Asp)	PTEN	Y177D	Hereditary cancer-predisposing syndrome|Cowden syndrome	VCV000988005	10	89711911	10	87952154	988005	975938	rs1860418425	NC_000010.11:87952153:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	177	PTEN
NM_000314.8(PTEN):c.529T>C (p.Tyr177His)	PTEN	Y177H	Macrocephaly-autism syndrome	VCV000974864	10	89711911	10	87952154	974864	963155	rs1860418425	NC_000010.11:87952153:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	NA	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	177	PTEN
NM_000314.8(PTEN):c.529T>A (p.Tyr177Asn)	PTEN	Y177N	Cowden syndrome 1	VCV000873327	10	89711911	10	87952154	873327	861457	rs1860418425	NC_000010.11:87952153:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	177	PTEN
NM_000314.8(PTEN):c.530A>G (p.Tyr177Cys)	PTEN	Y177C	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000580948	10	89711912	10	87952155	580948	566576	rs1564837839	NC_000010.11:87952154:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 12, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	177	PTEN
NM_000314.8(PTEN):c.532T>C (p.Tyr178His)	PTEN	Y178H	PTEN hamartoma tumor syndrome	VCV002081510	10	89711914	10	87952157	2081510	2139445	NA	NC_000010.11:87952156:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	178	PTEN
NM_000314.8(PTEN):c.532T>G (p.Tyr178Asp)	PTEN	Y178D	PTEN hamartoma tumor syndrome	VCV000945254	10	89711914	10	87952157	945254	925966	rs1860418734	NC_000010.11:87952156:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 24, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	178	PTEN
NM_000314.8(PTEN):c.533A>T (p.Tyr178Phe)	PTEN	Y178F	Hereditary cancer-predisposing syndrome	VCV001746919	10	89711915	10	87952158	1746919	1806464	NA	NC_000010.11:87952157:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	178	PTEN
NM_000314.8(PTEN):c.533A>G (p.Tyr178Cys)	PTEN	Y178C	PTEN hamartoma tumor syndrome|not provided	VCV000189413	10	89711915	10	87952158	189413	187364	rs786204866	NC_000010.11:87952157:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	178	PTEN
NM_000314.8(PTEN):c.536G>A (p.Ser179Asn)	PTEN	S179N	PTEN hamartoma tumor syndrome	VCV001408807	10	89711918	10	87952161	1408807	1500473	rs2132269260	NC_000010.11:87952160:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	179	PTEN
NM_000314.8(PTEN):c.538T>C (p.Tyr180His)	PTEN	Y180H	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000481129	10	89711920	10	87952163	481129	475535	rs746280047	NC_000010.11:87952162:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	180	PTEN
NM_000314.8(PTEN):c.539A>C (p.Tyr180Ser)	PTEN	Y180S	Hereditary cancer-predisposing syndrome	VCV000484608	10	89711921	10	87952164	484608	475543	rs1554900585	NC_000010.11:87952163:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 18, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	180	PTEN
NM_000314.8(PTEN):c.542T>C (p.Leu181Pro)	PTEN	L181P	PTEN hamartoma tumor syndrome	VCV000825730	10	89711924	10	87952167	825730	810103	rs1589659492	NC_000010.11:87952166:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	181	PTEN
NM_000314.8(PTEN):c.545T>C (p.Leu182Ser)	PTEN	L182S	PTEN hamartoma tumor syndrome	VCV000187827	10	89711927	10	87952170	187827	185731	rs794729664	NC_000010.11:87952169:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 1, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	182	PTEN
NM_000314.8(PTEN):c.549G>T (p.Lys183Asn)	PTEN	K183N	Hereditary cancer-predisposing syndrome	VCV000231562	10	89711931	10	87952174	231562	233857	rs876659227	NC_000010.11:87952173:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 6, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	183	PTEN
NM_000314.8(PTEN):c.551A>G (p.Asn184Ser)	PTEN	N184S	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001347066	10	89711933	10	87952176	1347066	1453179	rs587781895	NC_000010.11:87952175:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	184	PTEN
NM_000314.8(PTEN):c.551A>T (p.Asn184Ile)	PTEN	N184I	Hereditary cancer-predisposing syndrome	VCV000141636	10	89711933	10	87952176	141636	151350	rs587781895	NC_000010.11:87952175:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 11, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	184	PTEN
NM_000314.8(PTEN):c.554A>G (p.His185Arg)	PTEN	H185R	PTEN hamartoma tumor syndrome	VCV002118280	10	89711936	10	87952179	2118280	2176062	NA	NC_000010.11:87952178:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	185	PTEN
NM_000314.8(PTEN):c.556C>G (p.Leu186Val)	PTEN	L186V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000825836	10	89711938	10	87952181	825836	810104	rs1589659546	NC_000010.11:87952180:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	186	PTEN
NM_000314.8(PTEN):c.560A>G (p.Asp187Gly)	PTEN	D187G	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000189501	10	89711942	10	87952185	189501	187366	rs786204943	NC_000010.11:87952184:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 3, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	187	PTEN
NM_000314.8(PTEN):c.562T>G (p.Tyr188Asp)	PTEN	Y188D	PTEN hamartoma tumor syndrome	VCV001401407	10	89711944	10	87952187	1401407	1379394	rs1860421158	NC_000010.11:87952186:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	188	PTEN
NM_000314.8(PTEN):c.563A>T (p.Tyr188Phe)	PTEN	Y188F	Hereditary cancer-predisposing syndrome	VCV001748789	10	89711945	10	87952188	1748789	1803242	NA	NC_000010.11:87952187:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	188	PTEN
NM_000314.8(PTEN):c.563A>G (p.Tyr188Cys)	PTEN	Y188C	PTEN hamartoma tumor syndrome|not provided	VCV001319460	10	89711945	10	87952188	1319460	1309713	rs2132269501	NC_000010.11:87952187:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	188	PTEN
NM_000314.8(PTEN):c.566G>A (p.Arg189Lys)	PTEN	R189K	Hereditary cancer-predisposing syndrome	VCV001748955	10	89711948	10	87952191	1748955	1803408	NA	NC_000010.11:87952190:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 30, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	PTEN
NM_000314.8(PTEN):c.566G>C (p.Arg189Thr)	PTEN	R189T	Hereditary cancer-predisposing syndrome	VCV000825885	10	89711948	10	87952191	825885	810106	rs1589659565	NC_000010.11:87952190:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 17, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	PTEN
NM_000314.8(PTEN):c.568C>A (p.Pro190Thr)	PTEN	P190T	PTEN hamartoma tumor syndrome	VCV001489316	10	89711950	10	87952193	1489316	1494922	rs1860421606	NC_000010.11:87952192:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	190	PTEN
NM_000314.8(PTEN):c.569C>G (p.Pro190Arg)	PTEN	P190R	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000536538	10	89711951	10	87952194	536538	525589	rs1554900617	NC_000010.11:87952193:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	190	PTEN
NM_000314.8(PTEN):c.569C>T (p.Pro190Leu)	PTEN	P190L	PTEN hamartoma tumor syndrome	VCV000468698	10	89711951	10	87952194	468698	460296	rs1554900617	NC_000010.11:87952193:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	190	PTEN
NM_000314.8(PTEN):c.571G>C (p.Val191Leu)	PTEN	V191L	not provided	VCV000423079	10	89711953	10	87952196	423079	407995	rs1060500130	NC_000010.11:87952195:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 13, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	191	PTEN
NM_000314.8(PTEN):c.571G>T (p.Val191Leu)	PTEN	V191L	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000404173	10	89711953	10	87952196	404173	397492	rs1060500130	NC_000010.11:87952195:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	191	PTEN
NM_000314.8(PTEN):c.574G>T (p.Ala192Ser)	PTEN	A192S	PTEN hamartoma tumor syndrome	VCV002833276	10	89711956	10	87952199	2833276	3001603	NA	NC_000010.11:87952198:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	192	PTEN
NM_000314.8(PTEN):c.575C>G (p.Ala192Gly)	PTEN	A192G	PTEN hamartoma tumor syndrome	VCV003074642	10	89711957	10	87952200	3074642	3229609	NA	NC_000010.11:87952199:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	192	PTEN
NM_000314.8(PTEN):c.578T>C (p.Leu193Pro)	PTEN	L193P	PTEN hamartoma tumor syndrome|not provided	VCV000431875	10	89711960	10	87952203	431875	425896	rs1554900620	NC_000010.11:87952202:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 18, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	193	PTEN
NM_000314.8(PTEN):c.580T>A (p.Leu194Met)	PTEN	L194M	not provided	VCV002442682	10	89711962	10	87952205	2442682	2416393	NA	NC_000010.11:87952204:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	194	PTEN
NM_000314.8(PTEN):c.583T>C (p.Phe195Leu)	PTEN	F195L	PTEN hamartoma tumor syndrome	VCV001014592	10	89711965	10	87952208	1014592	1009273	rs1860422659	NC_000010.11:87952207:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 15, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	195	PTEN
NM_000314.8(PTEN):c.584T>C (p.Phe195Ser)	PTEN	F195S	Hereditary cancer-predisposing syndrome	VCV001750073	10	89711966	10	87952209	1750073	1807051	NA	NC_000010.11:87952208:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	195	PTEN
NM_000314.8(PTEN):c.586C>G (p.His196Asp)	PTEN	H196D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000826023	10	89711968	10	87952211	826023	810107	rs1589659615	NC_000010.11:87952210:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	196	PTEN
NM_000314.8(PTEN):c.587A>C (p.His196Pro)	PTEN	H196P	PTEN hamartoma tumor syndrome|not provided	VCV001694039	10	89711969	10	87952212	1694039	1686474	rs1564837944	NC_000010.11:87952211:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	196	PTEN
NM_000314.8(PTEN):c.587A>G (p.His196Arg)	PTEN	H196R	not provided	VCV000618852	10	89711969	10	87952212	618852	609771	rs1564837944	NC_000010.11:87952211:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 5, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	196	PTEN
NM_000314.8(PTEN):c.589A>G (p.Lys197Glu)	PTEN	K197E	PTEN hamartoma tumor syndrome	VCV002749648	10	89711971	10	87952214	2749648	2908245	NA	NC_000010.11:87952213:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	197	PTEN
NM_000314.8(PTEN):c.589A>C (p.Lys197Gln)	PTEN	K197Q	Hereditary cancer-predisposing syndrome	VCV000629237	10	89711971	10	87952214	629237	617598	rs1554900629	NC_000010.11:87952213:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	197	PTEN
NM_000314.8(PTEN):c.590_591delinsTA (p.Lys197Ile)	PTEN	K197I	Hereditary cancer-predisposing syndrome	VCV003231163	10	89711972 - 89711973	10	87952215 - 87952216	3231163	3391785	NA	NC_000010.11:87952214:AG:TA	Indel	missense variant|5 prime UTR variant	Uncertain significance	Feb 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	197	PTEN
NM_000314.8(PTEN):c.590A>G (p.Lys197Arg)	PTEN	K197R	Hereditary cancer-predisposing syndrome	VCV001750436	10	89711972	10	87952215	1750436	1803587	NA	NC_000010.11:87952214:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	197	PTEN
NM_000314.8(PTEN):c.592A>G (p.Met198Val)	PTEN	M198V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000468701	10	89711974	10	87952217	468701	461122	rs1554900633	NC_000010.11:87952216:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	198	PTEN
NM_000314.8(PTEN):c.593T>G (p.Met198Arg)	PTEN	M198R	Hereditary cancer-predisposing syndrome	VCV002774181	10	89711975	10	87952218	2774181	2934911	NA	NC_000010.11:87952217:T:G	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Mar 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	198	PTEN
NM_000314.8(PTEN):c.593T>C (p.Met198Thr)	PTEN	M198T	PTEN hamartoma tumor syndrome|Glioma susceptibility 2|Macrocephaly-autism syndrome|Familial meningioma|Cowden syndrome 1|Malignant tumor of prostate|not provided	VCV001481095	10	89711975	10	87952218	1481095	1451533	rs1554900635	NC_000010.11:87952217:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	198	PTEN
NM_000314.8(PTEN):c.593T>A (p.Met198Lys)	PTEN	M198K	PTEN hamartoma tumor syndrome	VCV000468702	10	89711975	10	87952218	468702	461124	rs1554900635	NC_000010.11:87952217:T:A	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Feb 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	198	PTEN
NM_000314.8(PTEN):c.594G>A (p.Met198Ile)	PTEN	M198I	Hereditary cancer-predisposing syndrome	VCV001750675	10	89711976	10	87952219	1750675	1803825	NA	NC_000010.11:87952218:G:A	single nucleotide variant	missense variant|initiator_codon_variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	198	PTEN
NM_000314.8(PTEN):c.595A>T (p.Met199Leu)	PTEN	M199L	Hereditary cancer-predisposing syndrome	VCV000919891	10	89711977	10	87952220	919891	911222	rs1434191423	NC_000010.11:87952219:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	199	PTEN
NM_000314.8(PTEN):c.595A>G (p.Met199Val)	PTEN	M199V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000629479	10	89711977	10	87952220	629479	617599	rs1434191423	NC_000010.11:87952219:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	199	PTEN
NM_000314.8(PTEN):c.596T>A (p.Met199Lys)	PTEN	M199K	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000237651	10	89711978	10	87952221	237651	240879	rs587781538	NC_000010.11:87952220:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	199	PTEN
NM_000314.8(PTEN):c.596T>C (p.Met199Thr)	PTEN	M199T	not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000141157	10	89711978	10	87952221	141157	150871	rs587781538	NC_000010.11:87952220:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	199	PTEN
NM_000314.8(PTEN):c.597G>C (p.Met199Ile)	PTEN	M199I	PTEN hamartoma tumor syndrome	VCV002814792	10	89711979	10	87952222	2814792	2973322	NA	NC_000010.11:87952221:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	199	PTEN
NM_000314.8(PTEN):c.597G>A (p.Met199Ile)	PTEN	M199I	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001014247	10	89711979	10	87952222	1014247	1009274	rs1589659663	NC_000010.11:87952221:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	199	PTEN
NM_000314.8(PTEN):c.598T>G (p.Phe200Val)	PTEN	F200V	Hereditary cancer-predisposing syndrome	VCV000142452	10	89711980	10	87952223	142452	152166	rs587782473	NC_000010.11:87952222:T:G	single nucleotide variant	missense variant	Likely pathogenic	May 9, 2013	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	200	PTEN
NM_000314.8(PTEN):c.599T>C (p.Phe200Ser)	PTEN	F200S	PTEN hamartoma tumor syndrome	VCV000189414	10	89711981	10	87952224	189414	187368	rs786204867	NC_000010.11:87952223:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	200	PTEN
NM_000314.8(PTEN):c.604A>G (p.Thr202Ala)	PTEN	T202A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000654178	10	89711986	10	87952229	654178	639277	rs786204944	NC_000010.11:87952228:A:G	single nucleotide variant	missense variant	Uncertain significance	May 19, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	202	PTEN
NM_000314.8(PTEN):c.604A>T (p.Thr202Ser)	PTEN	T202S	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000189502	10	89711986	10	87952229	189502	187369	rs786204944	NC_000010.11:87952228:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	202	PTEN
NM_000314.8(PTEN):c.605C>G (p.Thr202Ser)	PTEN	T202S	PTEN hamartoma tumor syndrome	VCV001716764	10	89711987	10	87952230	1716764	1778445	NA	NC_000010.11:87952229:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	202	PTEN
NM_000314.8(PTEN):c.605C>T (p.Thr202Ile)	PTEN	T202I	PTEN hamartoma tumor syndrome	VCV000427595	10	89711987	10	87952230	427595	416946	rs1085308053	NC_000010.11:87952229:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	202	PTEN
NM_000314.8(PTEN):c.607A>C (p.Ile203Leu)	PTEN	I203L	not provided|PTEN hamartoma tumor syndrome	VCV002001581	10	89711989	10	87952232	2001581	2054782	NA	NC_000010.11:87952231:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	203	PTEN
NM_000314.8(PTEN):c.607A>T (p.Ile203Phe)	PTEN	I203F	Hereditary cancer-predisposing syndrome	VCV001331912	10	89711989	10	87952232	1331912	1322632	rs1564837997	NC_000010.11:87952231:A:T	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	203	PTEN
NM_000314.8(PTEN):c.607A>G (p.Ile203Val)	PTEN	I203V	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000578650	10	89711989	10	87952232	578650	569858	rs1564837997	NC_000010.11:87952231:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	203	PTEN
NM_000314.8(PTEN):c.608T>G (p.Ile203Ser)	PTEN	I203S	PTEN hamartoma tumor syndrome	VCV002713606	10	89711990	10	87952233	2713606	2872030	NA	NC_000010.11:87952232:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	203	PTEN
NM_000314.8(PTEN):c.610C>T (p.Pro204Ser)	PTEN	P204S	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000468704	10	89711992	10	87952235	468704	460300	rs786204868	NC_000010.11:87952234:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 13, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	204	PTEN
NM_000314.8(PTEN):c.610C>G (p.Pro204Ala)	PTEN	P204A	PTEN hamartoma tumor syndrome	VCV000189415	10	89711992	10	87952235	189415	187370	rs786204868	NC_000010.11:87952234:C:G	single nucleotide variant	missense variant	Pathogenic	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	204	PTEN
NM_000314.8(PTEN):c.611C>T (p.Pro204Leu)	PTEN	P204L	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001481117	10	89711993	10	87952236	1481117	1451555	rs2132269834	NC_000010.11:87952235:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	204	PTEN
NM_000314.8(PTEN):c.613A>T (p.Met205Leu)	PTEN	M205L	PTEN hamartoma tumor syndrome	VCV001462187	10	89711995	10	87952238	1462187	1507514	rs776763121	NC_000010.11:87952237:A:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	205	PTEN
NM_000314.8(PTEN):c.613A>G (p.Met205Val)	PTEN	M205V	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|not provided|Hereditary cancer-predisposing syndrome	VCV000404146	10	89711995	10	87952238	404146	398063	rs776763121	NC_000010.11:87952237:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	205	PTEN
NM_000314.8(PTEN):c.614T>C (p.Met205Thr)	PTEN	M205T	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000480381	10	89711996	10	87952239	480381	475282	rs1185592373	NC_000010.11:87952238:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	205	PTEN
NM_000314.8(PTEN):c.615G>A (p.Met205Ile)	PTEN	M205I	PTEN hamartoma tumor syndrome	VCV000492734	10	89711997	10	87952240	492734	485652	rs1554900653	NC_000010.11:87952239:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	205	PTEN
NM_000314.8(PTEN):c.616T>G (p.Phe206Val)	PTEN	F206V	PTEN hamartoma tumor syndrome	VCV002758375	10	89711998	10	87952241	2758375	2910474	NA	NC_000010.11:87952240:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	PTEN
NM_000314.8(PTEN):c.617T>A (p.Phe206Tyr)	PTEN	F206Y	Hereditary cancer-predisposing syndrome	VCV001752060	10	89711999	10	87952242	1752060	1807741	NA	NC_000010.11:87952241:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	PTEN
NM_000314.8(PTEN):c.618C>G (p.Phe206Leu)	PTEN	F206L	Hereditary cancer-predisposing syndrome	VCV003311257	10	89712000	10	87952243	3311257	3468242	NA	NC_000010.11:87952242:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	PTEN
NM_000314.8(PTEN):c.619A>T (p.Ser207Cys)	PTEN	S207C	Hereditary cancer-predisposing syndrome	VCV000826234	10	89712001	10	87952244	826234	810108	rs1589659733	NC_000010.11:87952243:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	207	PTEN
NM_000314.8(PTEN):c.620G>T (p.Ser207Ile)	PTEN	S207I	PTEN hamartoma tumor syndrome	VCV002818811	10	89712002	10	87952245	2818811	2981183	NA	NC_000010.11:87952244:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	207	PTEN
NM_000314.8(PTEN):c.622G>A (p.Gly208Ser)	PTEN	G208S	Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000838223	10	89712004	10	87952247	838223	837431	rs1860425648	NC_000010.11:87952246:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	208	PTEN
NM_000314.8(PTEN):c.623G>A (p.Gly208Asp)	PTEN	G208D	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001035121	10	89712005	10	87952248	1035121	1029845	rs1860425741	NC_000010.11:87952247:G:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	208	PTEN
NM_000314.8(PTEN):c.625G>A (p.Gly209Arg)	PTEN	G209R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000490114	10	89712007	10	87952250	490114	482771	rs765433422	NC_000010.11:87952249:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	209	PTEN
NM_000314.8(PTEN):c.628A>G (p.Thr210Ala)	PTEN	T210A	Hereditary cancer-predisposing syndrome	VCV000480943	10	89712010	10	87952253	480943	475406	rs1554900663	NC_000010.11:87952252:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	210	PTEN
NM_000314.8(PTEN):c.629C>T (p.Thr210Ile)	PTEN	T210I	PTEN hamartoma tumor syndrome	VCV001999180	10	89712011	10	87952254	1999180	2060973	NA	NC_000010.11:87952253:C:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	210	PTEN
NM_000314.8(PTEN):c.631T>C (p.Cys211Arg)	PTEN	C211R	PTEN hamartoma tumor syndrome	VCV001042754	10	89712013	10	87952256	1042754	1029846	rs1860426392	NC_000010.11:87952255:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	211	PTEN
NM_000314.8(PTEN):c.633C>G (p.Cys211Trp)	PTEN	C211W	PTEN hamartoma tumor syndrome	VCV000279878	10	89712015	10	87952258	279878	264437	rs121909232	NC_000010.11:87952257:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 18, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	211	PTEN
NM_000314.8(PTEN):c.634A>G (p.Asn212Asp)	PTEN	N212D	not provided	VCV001320458	10	89712016	10	87952259	1320458	1310703	rs1860426730	NC_000010.11:87952258:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	212	PTEN
NM_000314.8(PTEN):c.634A>C (p.Asn212His)	PTEN	N212H	PTEN hamartoma tumor syndrome	VCV000948056	10	89712016	10	87952259	948056	925967	rs1860426730	NC_000010.11:87952258:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	212	PTEN
NM_000314.8(PTEN):c.635A>G (p.Asn212Ser)	PTEN	N212S	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000495808	10	89717610	10	87957853	495808	487380	rs1554825156	NC_000010.11:87957852:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	212	PTEN
NM_000314.8(PTEN):c.637C>T (p.Pro213Ser)	PTEN	P213S	Hereditary cancer-predisposing syndrome	VCV000826369	10	89717612	10	87957855	826369	810109	rs1589663135	NC_000010.11:87957854:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	213	PTEN
NM_000314.8(PTEN):c.638C>T (p.Pro213Leu)	PTEN	P213L	PTEN hamartoma tumor syndrome	VCV001485363	10	89717613	10	87957856	1485363	1394089	rs1156887945	NC_000010.11:87957855:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	213	PTEN
NM_000314.8(PTEN):c.638C>A (p.Pro213His)	PTEN	P213H	Inborn genetic diseases	VCV000522165	10	89717613	10	87957856	522165	511877	rs1156887945	NC_000010.11:87957855:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	213	PTEN
NM_000314.8(PTEN):c.641A>T (p.Gln214Leu)	PTEN	Q214L	PTEN hamartoma tumor syndrome	VCV001470275	10	89717616	10	87957859	1470275	1372237	rs1564566726	NC_000010.11:87957858:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	214	PTEN
NM_000314.8(PTEN):c.641A>C (p.Gln214Pro)	PTEN	Q214P	Hereditary cancer-predisposing syndrome	VCV000587985	10	89717616	10	87957859	587985	579913	rs1564566726	NC_000010.11:87957858:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	214	PTEN
NM_000314.8(PTEN):c.643T>G (p.Phe215Val)	PTEN	F215V	PTEN hamartoma tumor syndrome	VCV001012022	10	89717618	10	87957861	1012022	994097	rs1860539219	NC_000010.11:87957860:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	215	PTEN
NM_000314.8(PTEN):c.645T>G (p.Phe215Leu)	PTEN	F215L	PTEN hamartoma tumor syndrome	VCV002848369	10	89717620	10	87957863	2848369	3005611	NA	NC_000010.11:87957862:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	215	PTEN
NM_000314.8(PTEN):c.646G>A (p.Val216Met)	PTEN	V216M	PTEN hamartoma tumor syndrome	VCV000655477	10	89717621	10	87957864	655477	639279	rs1589663150	NC_000010.11:87957863:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	216	PTEN
NM_000314.8(PTEN):c.647T>C (p.Val216Ala)	PTEN	V216A	Hereditary cancer-predisposing syndrome	VCV000826431	10	89717622	10	87957865	826431	810111	rs1589663156	NC_000010.11:87957864:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	216	PTEN
NM_000314.8(PTEN):c.648_650delinsTGG (p.Val217Gly)	PTEN	V217G	Hereditary cancer-predisposing syndrome	VCV001753762	10	89717623 - 89717625	10	87957866 - 87957868	1753762	1808143	NA	NC_000010.11:87957865:GGT:TGG	Indel	missense variant	Uncertain significance	Feb 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	217	PTEN
NM_000314.8(PTEN):c.649G>C (p.Val217Leu)	PTEN	V217L	PTEN hamartoma tumor syndrome	VCV003072410	10	89717624	10	87957867	3072410	3230851	NA	NC_000010.11:87957866:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	217	PTEN
NM_000314.8(PTEN):c.649G>A (p.Val217Ile)	PTEN	V217I	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000007838	10	89717624	10	87957867	7838	22877	rs121909234	NC_000010.11:87957866:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	217	PTEN
NM_000314.8(PTEN):c.650T>G (p.Val217Gly)	PTEN	V217G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000404152	10	89717625	10	87957868	404152	397693	rs1060500117	NC_000010.11:87957867:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	217	PTEN
NM_000314.8(PTEN):c.652T>C (p.Cys218Arg)	PTEN	C218R	PTEN hamartoma tumor syndrome	VCV002866544	10	89717627	10	87957870	2866544	3020152	NA	NC_000010.11:87957869:T:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	218	PTEN
NM_000314.8(PTEN):c.653G>T (p.Cys218Phe)	PTEN	C218F	not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001754111	10	89717628	10	87957871	1754111	1804666	NA	NC_000010.11:87957870:G:T	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	218	PTEN
NM_000314.8(PTEN):c.653G>A (p.Cys218Tyr)	PTEN	C218Y	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000945328	10	89717628	10	87957871	945328	925968	rs1860540059	NC_000010.11:87957870:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	218	PTEN
NM_000314.8(PTEN):c.653G>C (p.Cys218Ser)	PTEN	C218S	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000923643	10	89717628	10	87957871	923643	911225	rs1860540059	NC_000010.11:87957870:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	218	PTEN
NM_000314.8(PTEN):c.656A>C (p.Gln219Pro)	PTEN	Q219P	Hereditary cancer-predisposing syndrome|not specified|PTEN hamartoma tumor syndrome	VCV000449090	10	89717631	10	87957874	449090	444676	rs1554825172	NC_000010.11:87957873:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	219	PTEN
NM_000314.8(PTEN):c.658C>G (p.Leu220Val)	PTEN	L220V	Hereditary cancer-predisposing syndrome	VCV003311265	10	89717633	10	87957876	3311265	3468250	NA	NC_000010.11:87957875:C:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	220	PTEN
NM_000314.8(PTEN):c.659T>C (p.Leu220Pro)	PTEN	L220P	Hereditary cancer-predisposing syndrome	VCV000928466	10	89717634	10	87957877	928466	911226	rs141373793	NC_000010.11:87957876:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	220	PTEN
NM_000314.8(PTEN):c.661A>G (p.Lys221Glu)	PTEN	K221E	not provided	VCV003026433	10	89717636	10	87957879	3026433	3186745	NA	NC_000010.11:87957878:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	221	PTEN
NM_000314.8(PTEN):c.664G>A (p.Val222Met)	PTEN	V222M	not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000385323	10	89717639	10	87957882	385323	371877	rs878853943	NC_000010.11:87957881:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	222	PTEN
NM_000314.8(PTEN):c.664G>T (p.Val222Leu)	PTEN	V222L	PTEN hamartoma tumor syndrome	VCV000237652	10	89717639	10	87957882	237652	240880	rs878853943	NC_000010.11:87957881:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	222	PTEN
NM_000314.8(PTEN):c.665T>C (p.Val222Ala)	PTEN	V222A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001401574	10	89717640	10	87957883	1401574	1457234	rs2132276621	NC_000010.11:87957882:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	222	PTEN
NM_000314.8(PTEN):c.668A>G (p.Lys223Arg)	PTEN	K223R	PTEN hamartoma tumor syndrome	VCV000574870	10	89717643	10	87957886	574870	564860	rs778528056	NC_000010.11:87957885:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	223	PTEN
NM_000314.8(PTEN):c.670A>T (p.Ile224Leu)	PTEN	I224L	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000490116	10	89717645	10	87957888	490116	482778	rs1554825177	NC_000010.11:87957887:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	224	PTEN
NM_000314.8(PTEN):c.671T>A (p.Ile224Lys)	PTEN	I224K	PTEN hamartoma tumor syndrome	VCV000999105	10	89717646	10	87957889	999105	994098	rs1589663235	NC_000010.11:87957888:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	224	PTEN
NM_000314.8(PTEN):c.671T>C (p.Ile224Thr)	PTEN	I224T	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000653399	10	89717646	10	87957889	653399	639280	rs1589663235	NC_000010.11:87957888:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2018	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	224	PTEN
NM_000314.8(PTEN):c.672A>G (p.Ile224Met)	PTEN	I224M	PTEN hamartoma tumor syndrome	VCV000189505	10	89717647	10	87957890	189505	187371	rs786204946	NC_000010.11:87957889:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	224	PTEN
NM_000314.8(PTEN):c.673T>C (p.Tyr225His)	PTEN	Y225H	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000231899	10	89717648	10	87957891	231899	233859	rs876659433	NC_000010.11:87957890:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	225	PTEN
NM_000314.8(PTEN):c.677C>T (p.Ser226Phe)	PTEN	S226F	not provided|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV001330017	10	89717652	10	87957895	1330017	1320701	rs2132276728	NC_000010.11:87957894:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	226	PTEN
NM_000314.8(PTEN):c.679T>A (p.Ser227Thr)	PTEN	S227T	Hereditary cancer-predisposing syndrome	VCV003311261	10	89717654	10	87957897	3311261	3468246	NA	NC_000010.11:87957896:T:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	227	PTEN
NM_000314.8(PTEN):c.680C>T (p.Ser227Phe)	PTEN	S227F	Hereditary cancer-predisposing syndrome	VCV002452972	10	89717655	10	87957898	2452972	2433953	NA	NC_000010.11:87957897:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	227	PTEN
NM_000314.8(PTEN):c.683A>C (p.Asn228Thr)	PTEN	N228T	PTEN hamartoma tumor syndrome	VCV002832413	10	89717658	10	87957901	2832413	2994797	NA	NC_000010.11:87957900:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	228	PTEN
NM_000314.8(PTEN):c.683A>T (p.Asn228Ile)	PTEN	N228I	Hereditary cancer-predisposing syndrome	VCV000924852	10	89717658	10	87957901	924852	911227	rs748240670	NC_000010.11:87957900:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	228	PTEN
NM_000314.8(PTEN):c.683A>G (p.Asn228Ser)	PTEN	N228S	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000404154	10	89717658	10	87957901	404154	398076	rs748240670	NC_000010.11:87957900:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	228	PTEN
NM_000314.8(PTEN):c.685T>A (p.Ser229Thr)	PTEN	S229T	PTEN hamartoma tumor syndrome	VCV000141771	10	89717660	10	87957903	141771	151485	rs587781998	NC_000010.11:87957902:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	229	PTEN
NM_000314.8(PTEN):c.688G>A (p.Gly230Arg)	PTEN	G230R	Hereditary cancer-predisposing syndrome	VCV001755993	10	89717663	10	87957906	1755993	1815488	NA	NC_000010.11:87957905:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	230	PTEN
NM_000314.8(PTEN):c.689G>A (p.Gly230Glu)	PTEN	G230E	Hereditary cancer-predisposing syndrome	VCV001756040	10	89717664	10	87957907	1756040	1812218	NA	NC_000010.11:87957906:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	230	PTEN
NM_000314.8(PTEN):c.691C>A (p.Pro231Thr)	PTEN	P231T	PTEN hamartoma tumor syndrome	VCV001720896	10	89717666	10	87957909	1720896	1774878	NA	NC_000010.11:87957908:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	231	PTEN
NM_000314.8(PTEN):c.692C>T (p.Pro231Leu)	PTEN	P231L	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000536552	10	89717667	10	87957910	536552	525756	rs1554825190	NC_000010.11:87957909:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	231	PTEN
NM_000314.8(PTEN):c.694A>G (p.Thr232Ala)	PTEN	T232A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV002567273	10	89717669	10	87957912	2567273	2730915	NA	NC_000010.11:87957911:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	232	PTEN
NM_000314.8(PTEN):c.695C>A (p.Thr232Lys)	PTEN	T232K	PTEN hamartoma tumor syndrome	VCV002828231	10	89717670	10	87957913	2828231	2990169	NA	NC_000010.11:87957912:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	232	PTEN
NM_000314.8(PTEN):c.695C>T (p.Thr232Ile)	PTEN	T232I	not provided	VCV001315922	10	89717670	10	87957913	1315922	1306180	rs2132276908	NC_000010.11:87957912:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	232	PTEN
NM_000314.8(PTEN):c.697C>G (p.Arg233Gly)	PTEN	R233G	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000843242	10	89717672	10	87957915	843242	837434	rs121909219	NC_000010.11:87957914:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	233	PTEN
NM_000314.8(PTEN):c.698G>A (p.Arg233Gln)	PTEN	R233Q	PTEN hamartoma tumor syndrome	VCV000376510	10	89717673	10	87957916	376510	363389	rs770025422	NC_000010.11:87957915:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	233	PTEN
NM_000314.8(PTEN):c.700C>G (p.Arg234Gly)	PTEN	R234G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000492337	10	89717675	10	87957918	492337	484353	rs786201730	NC_000010.11:87957917:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	234	PTEN
NM_000314.8(PTEN):c.700C>T (p.Arg234Trp)	PTEN	R234W	PTEN hamartoma tumor syndrome	VCV000184844	10	89717675	10	87957918	184844	183040	rs786201730	NC_000010.11:87957917:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	234	PTEN
NM_000314.8(PTEN):c.701G>T (p.Arg234Leu)	PTEN	R234L	PTEN hamartoma tumor syndrome	VCV003075548	10	89717676	10	87957919	3075548	3233113	NA	NC_000010.11:87957918:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	234	PTEN
NM_000314.8(PTEN):c.701G>A (p.Arg234Gln)	PTEN	R234Q	PTEN hamartoma tumor syndrome	VCV000007840	10	89717676	10	87957919	7840	22879	rs121909235	NC_000010.11:87957918:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	234	PTEN
NM_000314.8(PTEN):c.703G>A (p.Glu235Lys)	PTEN	E235K	Glioma susceptibility 2	VCV002678096	10	89717678	10	87957921	2678096	2833118	NA	NC_000010.11:87957920:G:A	single nucleotide variant	missense variant	Uncertain significance	May 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	235	PTEN
NM_000314.8(PTEN):c.704A>C (p.Glu235Ala)	PTEN	E235A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001718817	10	89717679	10	87957922	1718817	1776321	NA	NC_000010.11:87957921:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	235	PTEN
NM_000314.8(PTEN):c.706G>T (p.Asp236Tyr)	PTEN	D236Y	PTEN hamartoma tumor syndrome	VCV002080106	10	89717681	10	87957924	2080106	2139326	NA	NC_000010.11:87957923:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	236	PTEN
NM_000314.8(PTEN):c.706G>C (p.Asp236His)	PTEN	D236H	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001016535	10	89717681	10	87957924	1016535	1009275	rs1860544115	NC_000010.11:87957923:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	236	PTEN
NM_000314.8(PTEN):c.706G>A (p.Asp236Asn)	PTEN	D236N	PTEN hamartoma tumor syndrome	VCV000940273	10	89717681	10	87957924	940273	935224	rs1860544115	NC_000010.11:87957923:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	236	PTEN
NM_000314.8(PTEN):c.707A>C (p.Asp236Ala)	PTEN	D236A	PTEN hamartoma tumor syndrome	VCV002805466	10	89717682	10	87957925	2805466	2963992	NA	NC_000010.11:87957924:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	236	PTEN
NM_000314.8(PTEN):c.712T>G (p.Phe238Val)	PTEN	F238V	Hereditary cancer-predisposing syndrome	VCV002452981	10	89717687	10	87957930	2452981	2430042	NA	NC_000010.11:87957929:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	238	PTEN
NM_000314.8(PTEN):c.713T>C (p.Phe238Ser)	PTEN	F238S	PTEN hamartoma tumor syndrome	VCV003070715	10	89717688	10	87957931	3070715	3230472	NA	NC_000010.11:87957930:T:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	238	PTEN
NM_000314.8(PTEN):c.715A>G (p.Met239Val)	PTEN	M239V	PTEN hamartoma tumor syndrome	VCV000184878	10	89717690	10	87957933	184878	183042	rs786201758	NC_000010.11:87957932:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	239	PTEN
NM_000314.8(PTEN):c.716T>C (p.Met239Thr)	PTEN	M239T	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000826884	10	89717691	10	87957934	826884	810112	rs786204871	NC_000010.11:87957933:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	239	PTEN
NM_000314.8(PTEN):c.716T>G (p.Met239Arg)	PTEN	M239R	Inborn genetic diseases|PTEN hamartoma tumor syndrome	VCV000189418	10	89717691	10	87957934	189418	187372	rs786204871	NC_000010.11:87957933:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	239	PTEN
NM_000314.8(PTEN):c.719A>G (p.Tyr240Cys)	PTEN	Y240C	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001757614	10	89717694	10	87957937	1757614	1815812	NA	NC_000010.11:87957936:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	240	PTEN
NM_000314.8(PTEN):c.721T>A (p.Phe241Ile)	PTEN	F241I	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000856828	10	89717696	10	87957939	856828	837436	rs1554825207	NC_000010.11:87957938:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	241	PTEN
NM_000314.8(PTEN):c.721T>G (p.Phe241Val)	PTEN	F241V	not provided	VCV000450079	10	89717696	10	87957939	450079	444677	rs1554825207	NC_000010.11:87957938:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	241	PTEN
NM_000314.8(PTEN):c.721T>C (p.Phe241Leu)	PTEN	F241L	not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000440220	10	89717696	10	87957939	440220	433076	rs1554825207	NC_000010.11:87957938:T:C	single nucleotide variant	missense variant	Likely pathogenic	Oct 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	241	PTEN
NM_000314.8(PTEN):c.722T>C (p.Phe241Ser)	PTEN	F241S	PTEN hamartoma tumor syndrome	VCV000007850	10	89717697	10	87957940	7850	22889	rs121909240	NC_000010.11:87957939:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	241	PTEN
NM_000314.8(PTEN):c.723T>G (p.Phe241Leu)	PTEN	F241L	PTEN-related disorder|Hereditary cancer-predisposing syndrome	VCV000428247	10	89717698	10	87957941	428247	419744	rs17849090	NC_000010.11:87957940:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	241	PTEN
NM_000314.8(PTEN):c.724G>A (p.Glu242Lys)	PTEN	E242K	Hereditary cancer-predisposing syndrome	VCV001332611	10	89717699	10	87957942	1332611	1323329	rs1554825210	NC_000010.11:87957941:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	242	PTEN
NM_000314.8(PTEN):c.725A>T (p.Glu242Val)	PTEN	E242V	PTEN hamartoma tumor syndrome|not specified|not provided	VCV000917595	10	89717700	10	87957943	917595	905923	rs1860545768	NC_000010.11:87957942:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	242	PTEN
NM_000314.8(PTEN):c.730C>T (p.Pro244Ser)	PTEN	P244S	not provided	VCV000420743	10	89717705	10	87957948	420743	407998	rs1064794675	NC_000010.11:87957947:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	244	PTEN
NM_000314.8(PTEN):c.731C>T (p.Pro244Leu)	PTEN	P244L	PTEN hamartoma tumor syndrome	VCV003070126	10	89717706	10	87957949	3070126	3231615	NA	NC_000010.11:87957948:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	244	PTEN
NM_000314.8(PTEN):c.734_735delinsCC (p.Gln245Pro)	PTEN	Q245P	PTEN-related disorder	VCV002631220	10	89717709 - 89717710	10	87957952 - 87957953	2631220	2803371	NA	NC_000010.11:87957951:AG:CC	Indel	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	245	PTEN
NM_000314.8(PTEN):c.734A>C (p.Gln245Pro)	PTEN	Q245P	not specified|Familial meningioma	VCV000373667	10	89717709	10	87957952	373667	359974	rs1057518538	NC_000010.11:87957951:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	245	PTEN
NM_000314.8(PTEN):c.735G>C (p.Gln245His)	PTEN	Q245H	Hereditary cancer-predisposing syndrome	VCV000826986	10	89717710	10	87957953	826986	810114	rs1589663424	NC_000010.11:87957952:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	245	PTEN
NM_000314.8(PTEN):c.736C>A (p.Pro246Thr)	PTEN	P246T	PTEN hamartoma tumor syndrome	VCV000965633	10	89717711	10	87957954	965633	956267	rs1860546467	NC_000010.11:87957953:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	246	PTEN
NM_000314.8(PTEN):c.737C>G (p.Pro246Arg)	PTEN	P246R	Hereditary cancer-predisposing syndrome|Neoplasm	VCV002587208	10	89717712	10	87957955	2587208	2753884	NA	NC_000010.11:87957954:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	246	PTEN
NM_000314.8(PTEN):c.737C>A (p.Pro246Gln)	PTEN	P246Q	Hereditary cancer-predisposing syndrome	VCV002231857	10	89717712	10	87957955	2231857	2223895	NA	NC_000010.11:87957954:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	246	PTEN
NM_000314.8(PTEN):c.737C>T (p.Pro246Leu)	PTEN	P246L	PTEN hamartoma tumor syndrome	VCV000142269	10	89717712	10	87957955	142269	151983	rs587782350	NC_000010.11:87957954:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 18, 2017	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	246	PTEN
NM_000314.8(PTEN):c.740T>C (p.Leu247Ser)	PTEN	L247S	PTEN hamartoma tumor syndrome	VCV000223142	10	89717715	10	87957958	223142	224868	rs1057519368	NC_000010.11:87957957:T:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	247	PTEN
NM_000314.8(PTEN):c.742C>T (p.Pro248Ser)	PTEN	P248S	Ovarian neoplasm	VCV000627646	10	89717717	10	87957960	627646	616001	rs1564566931	NC_000010.11:87957959:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	248	PTEN
NM_000314.8(PTEN):c.743C>T (p.Pro248Leu)	PTEN	P248L	PTEN hamartoma tumor syndrome	VCV002823685	10	89717718	10	87957961	2823685	2982199	NA	NC_000010.11:87957960:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	248	PTEN
NM_000314.8(PTEN):c.743C>G (p.Pro248Arg)	PTEN	P248R	Hereditary cancer-predisposing syndrome	VCV001332212	10	89717718	10	87957961	1332212	1322931	rs759560822	NC_000010.11:87957960:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	248	PTEN
NM_000314.8(PTEN):c.745G>A (p.Val249Met)	PTEN	V249M	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001378842	10	89717720	10	87957963	1378842	1408033	rs2132277398	NC_000010.11:87957962:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	249	PTEN
NM_000314.8(PTEN):c.746T>A (p.Val249Glu)	PTEN	V249E	PTEN hamartoma tumor syndrome	VCV001525684	10	89717721	10	87957964	1525684	1395740	rs2132277407	NC_000010.11:87957963:T:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	249	PTEN
NM_000314.8(PTEN):c.746T>G (p.Val249Gly)	PTEN	V249G	PTEN hamartoma tumor syndrome	VCV001066565	10	89717721	10	87957964	1066565	1055941	rs2132277407	NC_000010.11:87957963:T:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	249	PTEN
NM_000314.8(PTEN):c.749G>A (p.Cys250Tyr)	PTEN	C250Y	Hereditary cancer-predisposing syndrome	VCV001759194	10	89717724	10	87957967	1759194	1816101	NA	NC_000010.11:87957966:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	250	PTEN
NM_000314.8(PTEN):c.752G>A (p.Gly251Asp)	PTEN	G251D	not provided|Cowden syndrome 1	VCV001064566	10	89717727	10	87957970	1064566	1052806	rs1554825226	NC_000010.11:87957969:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	251	PTEN
NM_000314.8(PTEN):c.752G>T (p.Gly251Val)	PTEN	G251V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000536548	10	89717727	10	87957970	536548	525772	rs1554825226	NC_000010.11:87957969:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	251	PTEN
NM_000314.8(PTEN):c.752G>C (p.Gly251Ala)	PTEN	G251A	PTEN hamartoma tumor syndrome	VCV000468711	10	89717727	10	87957970	468711	460302	rs1554825226	NC_000010.11:87957969:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	251	PTEN
NM_000314.8(PTEN):c.752_753delinsTG (p.Gly251Val)	PTEN	G251V	Hereditary cancer-predisposing syndrome	VCV000428249	10	89717727 - 89717728	10	87957970 - 87957971	428249	419748	rs1114167664	NC_000010.11:87957969:GT:TG	Indel	missense variant	Likely pathogenic	Oct 2, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	251	PTEN
NM_000314.8(PTEN):c.754G>A (p.Asp252Asn)	PTEN	D252N	Hereditary cancer-predisposing syndrome|not provided	VCV000827117	10	89717729	10	87957972	827117	810115	rs1589663499	NC_000010.11:87957971:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	252	PTEN
NM_000314.8(PTEN):c.755A>T (p.Asp252Val)	PTEN	D252V	Cowden syndrome|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000575811	10	89717730	10	87957973	575811	566586	rs121909239	NC_000010.11:87957972:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	252	PTEN
NM_000314.8(PTEN):c.755A>G (p.Asp252Gly)	PTEN	D252G	PTEN hamartoma tumor syndrome	VCV000007849	10	89717730	10	87957973	7849	22888	rs121909239	NC_000010.11:87957972:A:G	single nucleotide variant	missense variant	Pathogenic	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	252	PTEN
NM_000314.8(PTEN):c.757A>G (p.Ile253Val)	PTEN	I253V	Hereditary cancer-predisposing syndrome	VCV003311267	10	89717732	10	87957975	3311267	3468252	NA	NC_000010.11:87957974:A:G	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	253	PTEN
NM_000314.8(PTEN):c.758T>G (p.Ile253Ser)	PTEN	I253S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001478930	10	89717733	10	87957976	1478930	1426301	rs1554825235	NC_000010.11:87957975:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	253	PTEN
NM_000314.8(PTEN):c.758T>C (p.Ile253Thr)	PTEN	I253T	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001001963	10	89717733	10	87957976	1001963	994099	rs1554825235	NC_000010.11:87957975:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	253	PTEN
NM_000314.8(PTEN):c.758T>A (p.Ile253Asn)	PTEN	I253N	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000480942	10	89717733	10	87957976	480942	475554	rs1554825235	NC_000010.11:87957975:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	253	PTEN
NM_000314.8(PTEN):c.761A>T (p.Lys254Ile)	PTEN	K254I	not provided	VCV001687639	10	89717736	10	87957979	1687639	1679934	rs1114167633	NC_000010.11:87957978:A:T	single nucleotide variant	missense variant	Uncertain significance	May 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	254	PTEN
NM_000314.8(PTEN):c.761A>G (p.Lys254Arg)	PTEN	K254R	PTEN hamartoma tumor syndrome	VCV001382720	10	89717736	10	87957979	1382720	1513194	rs1114167633	NC_000010.11:87957978:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	254	PTEN
NM_000314.8(PTEN):c.761A>C (p.Lys254Thr)	PTEN	K254T	Hereditary cancer-predisposing syndrome|not provided	VCV000428207	10	89717736	10	87957979	428207	419750	rs1114167633	NC_000010.11:87957978:A:C	single nucleotide variant	missense variant	Likely pathogenic	May 7, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	254	PTEN
NM_000314.8(PTEN):c.763G>A (p.Val255Ile)	PTEN	V255I	Hereditary cancer-predisposing syndrome	VCV001759934	10	89717738	10	87957981	1759934	1823170	NA	NC_000010.11:87957980:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	255	PTEN
NM_000314.8(PTEN):c.764T>G (p.Val255Gly)	PTEN	V255G	Macrocephaly-autism syndrome|Familial meningioma|Glioma susceptibility 2|Familial prostate cancer|Cowden syndrome 1	VCV003381971	10	89717739	10	87957982	3381971	3541151	NA	NC_000010.11:87957981:T:G	single nucleotide variant	missense variant	Likely pathogenic	NA	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	255	PTEN
NM_000314.8(PTEN):c.764T>A (p.Val255Glu)	PTEN	V255E	Hereditary cancer-predisposing syndrome|PTEN-related disorder|not provided	VCV000623214	10	89717739	10	87957982	623214	612151	rs1564566998	NC_000010.11:87957981:T:A	single nucleotide variant	missense variant	Likely pathogenic	Dec 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	255	PTEN
NM_000314.8(PTEN):c.767A>G (p.Glu256Gly)	PTEN	E256G	PTEN hamartoma tumor syndrome	VCV002764864	10	89717742	10	87957985	2764864	2928630	NA	NC_000010.11:87957984:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	256	PTEN
NM_000314.8(PTEN):c.771C>A (p.Phe257Leu)	PTEN	F257L	Hereditary cancer-predisposing syndrome	VCV000492340	10	89717746	10	87957989	492340	484225	rs1554825245	NC_000010.11:87957988:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	257	PTEN
NM_000314.8(PTEN):c.779A>G (p.Lys260Arg)	PTEN	K260R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000404167	10	89717754	10	87957997	404167	397714	rs1060500125	NC_000010.11:87957996:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	260	PTEN
NM_000314.8(PTEN):c.781C>G (p.Gln261Glu)	PTEN	Q261E	Cowden syndrome 1	VCV000873325	10	89717756	10	87957999	873325	861455	rs730882131	NC_000010.11:87957998:C:G	single nucleotide variant	missense variant	Uncertain significance	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	261	PTEN
NM_000314.8(PTEN):c.783G>C (p.Gln261His)	PTEN	Q261H	PTEN hamartoma tumor syndrome	VCV002764865	10	89717758	10	87958001	2764865	2928631	NA	NC_000010.11:87958000:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	261	PTEN
NM_000314.8(PTEN):c.783G>T (p.Gln261His)	PTEN	Q261H	PTEN hamartoma tumor syndrome	VCV000468713	10	89717758	10	87958001	468713	461141	rs760146269	NC_000010.11:87958000:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	261	PTEN
NM_000314.8(PTEN):c.785A>C (p.Asn262Thr)	PTEN	N262T	Hereditary cancer-predisposing syndrome	VCV000492341	10	89717760	10	87958003	492341	484226	rs763784377	NC_000010.11:87958002:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	262	PTEN
NM_000314.8(PTEN):c.786C>A (p.Asn262Lys)	PTEN	N262K	PTEN hamartoma tumor syndrome	VCV001387816	10	89717761	10	87958004	1387816	1374437	rs2132277734	NC_000010.11:87958003:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	262	PTEN
NM_000314.8(PTEN):c.793C>G (p.Leu265Val)	PTEN	L265V	PTEN hamartoma tumor syndrome	VCV001483449	10	89717768	10	87958011	1483449	187376	rs786204872	NC_000010.11:87958010:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	265	PTEN
NM_000314.8(PTEN):c.794T>C (p.Leu265Pro)	PTEN	L265P	PTEN hamartoma tumor syndrome	VCV000468715	10	89717769	10	87958012	468715	461146	rs1335033900	NC_000010.11:87958011:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	265	PTEN
NM_000314.8(PTEN):c.796A>G (p.Lys266Glu)	PTEN	K266E	PTEN hamartoma tumor syndrome|not provided	VCV002010415	10	89717771	10	87958014	2010415	2067079	NA	NC_000010.11:87958013:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	266	PTEN
NM_000314.8(PTEN):c.797A>G (p.Lys266Arg)	PTEN	K266R	Neoplasm	VCV003257939	10	89717772	10	87958015	3257939	3416698	NA	NC_000010.11:87958014:A:G	single nucleotide variant	missense variant	NA	NA	NA	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	266	PTEN
NM_000314.8(PTEN):c.800A>C (p.Lys267Thr)	PTEN	K267T	PTEN hamartoma tumor syndrome	VCV001518655	10	89717775	10	87958018	1518655	1509048	rs1554825264	NC_000010.11:87958017:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	267	PTEN
NM_000314.8(PTEN):c.800A>G (p.Lys267Arg)	PTEN	K267R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000468716	10	89717775	10	87958018	468716	460303	rs1554825264	NC_000010.11:87958017:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	267	PTEN
NM_000314.8(PTEN):c.801G>C (p.Lys267Asn)	PTEN	K267N	PTEN hamartoma tumor syndrome	VCV001014805	10	89717776	10	87958019	1014805	1009276	rs1554825266	NC_000010.11:87958018:G:C	single nucleotide variant	missense variant	Pathogenic	Mar 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	267	PTEN
NM_000314.8(PTEN):c.801G>T (p.Lys267Asn)	PTEN	K267N	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000536549	10	89717776	10	87958019	536549	525509	rs1554825266	NC_000010.11:87958018:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	267	PTEN
NM_000314.8(PTEN):c.804C>G (p.Asp268Glu)	PTEN	D268E	Hereditary cancer-predisposing syndrome	VCV001761790	10	89720653	10	87960896	1761790	1823732	NA	NC_000010.11:87960895:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	268	PTEN
NM_000314.8(PTEN):c.804C>A (p.Asp268Glu)	PTEN	D268E	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome|not specified	VCV000092834	10	89720653	10	87960896	92834	98741	rs398123328	NC_000010.11:87960895:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	268	PTEN
NM_000314.8(PTEN):c.805A>G (p.Lys269Glu)	PTEN	K269E	PTEN hamartoma tumor syndrome	VCV000838212	10	89720654	10	87960897	838212	837438	rs1860616265	NC_000010.11:87960896:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	269	PTEN
NM_000314.8(PTEN):c.808A>T (p.Met270Leu)	PTEN	M270L	NA	VCV002575197	10	89720657	10	87960900	2575197	2740098	NA	NC_000010.11:87960899:A:T	single nucleotide variant	missense variant	no classification for the single variant	NA	no classification for the single variant	NA	NA	NA	no classification for the single variant	NA	no classification for the single variant	NA	270	PTEN
NM_000314.8(PTEN):c.808A>C (p.Met270Leu)	PTEN	M270L	PTEN hamartoma tumor syndrome	VCV001508866	10	89720657	10	87960900	1508866	1451983	rs1554825502	NC_000010.11:87960899:A:C	single nucleotide variant	missense variant	Uncertain significance	May 28, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	270	PTEN
NM_000314.8(PTEN):c.808A>G (p.Met270Val)	PTEN	M270V	not specified|PTEN hamartoma tumor syndrome|not provided	VCV000449644	10	89720657	10	87960900	449644	444678	rs1554825502	NC_000010.11:87960899:A:G	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	270	PTEN
NM_000314.8(PTEN):c.809T>G (p.Met270Arg)	PTEN	M270R	Macrocephaly-autism syndrome	VCV003376309	10	89720658	10	87960901	3376309	3535490	NA	NC_000010.11:87960900:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	270	PTEN
NM_000314.8(PTEN):c.809T>A (p.Met270Lys)	PTEN	M270K	PTEN hamartoma tumor syndrome	VCV001431374	10	89720658	10	87960901	1431374	1490673	rs2132281749	NC_000010.11:87960900:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	270	PTEN
NM_000314.8(PTEN):c.810G>C (p.Met270Ile)	PTEN	M270I	not provided	VCV002579956	10	89720659	10	87960902	2579956	2747466	NA	NC_000010.11:87960901:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	270	PTEN
NM_000314.8(PTEN):c.810G>A (p.Met270Ile)	PTEN	M270I	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001762038	10	89720659	10	87960902	1762038	1820174	NA	NC_000010.11:87960901:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	270	PTEN
NM_000314.8(PTEN):c.810G>T (p.Met270Ile)	PTEN	M270I	PTEN hamartoma tumor syndrome	VCV000584754	10	89720659	10	87960902	584754	575810	rs1195369834	NC_000010.11:87960901:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	270	PTEN
NM_000314.8(PTEN):c.815A>C (p.His272Pro)	PTEN	H272P	Hereditary cancer-predisposing syndrome	VCV000428223	10	89720664	10	87960907	428223	419754	rs1114167648	NC_000010.11:87960906:A:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 2, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	272	PTEN
NM_000314.8(PTEN):c.816C>G (p.His272Gln)	PTEN	H272Q	PTEN hamartoma tumor syndrome	VCV002832004	10	89720665	10	87960908	2832004	2998218	NA	NC_000010.11:87960907:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	272	PTEN
NM_000314.8(PTEN):c.817_818delinsCC (p.Phe273Pro)	PTEN	F273P	not provided	VCV003379978	10	89720666 - 89720667	10	87960909 - 87960910	3379978	3539154	NA	NC_000010.11:87960908:TT:CC	Indel	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	273	PTEN
NM_000314.8(PTEN):c.817T>A (p.Phe273Ile)	PTEN	F273I	not provided	VCV003370722	10	89720666	10	87960909	3370722	3529912	NA	NC_000010.11:87960908:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	273	PTEN
NM_000314.8(PTEN):c.820T>G (p.Trp274Gly)	PTEN	W274G	PTEN hamartoma tumor syndrome	VCV002747932	10	89720669	10	87960912	2747932	2912143	NA	NC_000010.11:87960911:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	274	PTEN
NM_000314.8(PTEN):c.820T>C (p.Trp274Arg)	PTEN	W274R	PTEN hamartoma tumor syndrome	VCV000655461	10	89720669	10	87960912	655461	639283	rs1589665591	NC_000010.11:87960911:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	274	PTEN
NM_000314.8(PTEN):c.821G>T (p.Trp274Leu)	PTEN	W274L	PTEN hamartoma tumor syndrome|not provided	VCV000427600	10	89720670	10	87960913	427600	416952	rs786204875	NC_000010.11:87960912:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	274	PTEN
NM_000314.8(PTEN):c.822G>C (p.Trp274Cys)	PTEN	W274C	Hereditary cancer-predisposing syndrome	VCV001762552	10	89720671	10	87960914	1762552	1816950	NA	NC_000010.11:87960913:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	274	PTEN
NM_000314.8(PTEN):c.823G>A (p.Val275Ile)	PTEN	V275I	Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV000627703	10	89720672	10	87960915	627703	617600	rs1410198544	NC_000010.11:87960914:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	275	PTEN
NM_000314.8(PTEN):c.824T>C (p.Val275Ala)	PTEN	V275A	not specified	VCV002682204	10	89720673	10	87960916	2682204	2843235	NA	NC_000010.11:87960915:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	275	PTEN
NM_000314.8(PTEN):c.826A>G (p.Asn276Asp)	PTEN	N276D	not provided|PTEN hamartoma tumor syndrome	VCV000653985	10	89720675	10	87960918	653985	639285	rs1589665622	NC_000010.11:87960917:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	276	PTEN
NM_000314.8(PTEN):c.827A>G (p.Asn276Ser)	PTEN	N276S	Macrocephaly-autism syndrome	VCV002502345	10	89720676	10	87960919	2502345	2543828	NA	NC_000010.11:87960918:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	276	PTEN
NM_000314.8(PTEN):c.827A>T (p.Asn276Ile)	PTEN	N276I	PTEN hamartoma tumor syndrome|Cowden syndrome	VCV000988006	10	89720676	10	87960919	988006	975939	rs1860618095	NC_000010.11:87960918:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	276	PTEN
NM_000314.8(PTEN):c.828T>A (p.Asn276Lys)	PTEN	N276K	PTEN hamartoma tumor syndrome	VCV002090171	10	89720677	10	87960920	2090171	2151955	NA	NC_000010.11:87960919:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	276	PTEN
NM_000314.8(PTEN):c.829A>G (p.Thr277Ala)	PTEN	T277A	PTEN hamartoma tumor syndrome	VCV000571869	10	89720678	10	87960921	571869	566589	rs1564568216	NC_000010.11:87960920:A:G	single nucleotide variant	missense variant	Pathogenic	Jun 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	277	PTEN
NM_000314.8(PTEN):c.830C>G (p.Thr277Arg)	PTEN	T277R	PTEN hamartoma tumor syndrome	VCV000428268	10	89720679	10	87960922	428268	419755	rs398123329	NC_000010.11:87960921:C:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 23, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	277	PTEN
NM_000314.8(PTEN):c.830C>T (p.Thr277Ile)	PTEN	T277I	PTEN hamartoma tumor syndrome|Neoplasm	VCV000184277	10	89720679	10	87960922	184277	183046	rs398123329	NC_000010.11:87960921:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	277	PTEN
NM_000314.8(PTEN):c.830C>A (p.Thr277Lys)	PTEN	T277K	PTEN hamartoma tumor syndrome|not provided	VCV000092835	10	89720679	10	87960922	92835	98742	rs398123329	NC_000010.11:87960921:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	277	PTEN
NM_000314.8(PTEN):c.832T>C (p.Phe278Leu)	PTEN	F278L	not provided	VCV003371163	10	89720681	10	87960924	3371163	3530353	NA	NC_000010.11:87960923:T:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	278	PTEN
NM_000314.8(PTEN):c.833T>G (p.Phe278Cys)	PTEN	F278C	PTEN hamartoma tumor syndrome	VCV001375150	10	89720682	10	87960925	1375150	1466436	rs2132281915	NC_000010.11:87960924:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	278	PTEN
NM_000314.8(PTEN):c.834C>A (p.Phe278Leu)	PTEN	F278L	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000822319	10	89720683	10	87960926	822319	810116	rs867171992	NC_000010.11:87960925:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	278	PTEN
NM_000314.8(PTEN):c.835T>C (p.Phe279Leu)	PTEN	F279L	not specified	VCV002576379	10	89720684	10	87960927	2576379	2741275	NA	NC_000010.11:87960926:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	279	PTEN
NM_000314.8(PTEN):c.838A>C (p.Ile280Leu)	PTEN	I280L	Hereditary cancer-predisposing syndrome	VCV000822361	10	89720687	10	87960930	822361	810117	rs1474354667	NC_000010.11:87960929:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	280	PTEN
NM_000314.8(PTEN):c.838A>G (p.Ile280Val)	PTEN	I280V	PTEN hamartoma tumor syndrome	VCV000468719	10	89720687	10	87960930	468719	460380	rs1474354667	NC_000010.11:87960929:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	280	PTEN
NM_000314.8(PTEN):c.839T>A (p.Ile280Lys)	PTEN	I280K	Hereditary cancer-predisposing syndrome	VCV002774185	10	89720688	10	87960931	2774185	2934915	NA	NC_000010.11:87960930:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	280	PTEN
NM_000314.8(PTEN):c.840A>G (p.Ile280Met)	PTEN	I280M	not provided	VCV003370850	10	89720689	10	87960932	3370850	3530040	NA	NC_000010.11:87960931:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	280	PTEN
NM_000314.8(PTEN):c.841C>T (p.Pro281Ser)	PTEN	P281S	PTEN hamartoma tumor syndrome	VCV000468720	10	89720690	10	87960933	468720	460305	rs750705904	NC_000010.11:87960932:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	281	PTEN
NM_000314.8(PTEN):c.841C>G (p.Pro281Ala)	PTEN	P281A	PTEN hamartoma tumor syndrome	VCV000184466	10	89720690	10	87960933	184466	183047	rs750705904	NC_000010.11:87960932:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	281	PTEN
NM_000314.8(PTEN):c.844G>C (p.Gly282Arg)	PTEN	G282R	Hereditary cancer-predisposing syndrome	VCV002567282	10	89720693	10	87960936	2567282	2730924	NA	NC_000010.11:87960935:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	282	PTEN
NM_000314.8(PTEN):c.845G>A (p.Gly282Glu)	PTEN	G282E	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000954195	10	89720694	10	87960937	954195	947124	rs1860619555	NC_000010.11:87960936:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	282	PTEN
NM_000314.8(PTEN):c.847C>G (p.Pro283Ala)	PTEN	P283A	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000629197	10	89720696	10	87960939	629197	617601	rs876658988	NC_000010.11:87960938:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	283	PTEN
NM_000314.8(PTEN):c.847C>T (p.Pro283Ser)	PTEN	P283S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000231154	10	89720696	10	87960939	231154	233867	rs876658988	NC_000010.11:87960938:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	283	PTEN
NM_000314.8(PTEN):c.848C>G (p.Pro283Arg)	PTEN	P283R	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV001474758	10	89720697	10	87960940	1474758	1503845	rs1860619820	NC_000010.11:87960939:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	283	PTEN
NM_000314.8(PTEN):c.848C>T (p.Pro283Leu)	PTEN	P283L	Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000923099	10	89720697	10	87960940	923099	911229	rs1860619820	NC_000010.11:87960939:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	283	PTEN
NM_000314.8(PTEN):c.852G>T (p.Glu284Asp)	PTEN	E284D	PTEN hamartoma tumor syndrome	VCV000947876	10	89720701	10	87960944	947876	925969	rs1860620187	NC_000010.11:87960943:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	284	PTEN
NM_000314.8(PTEN):c.853G>A (p.Glu285Lys)	PTEN	E285K	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000589540	10	89720702	10	87960945	589540	579697	rs1564568265	NC_000010.11:87960944:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	285	PTEN
NM_000314.8(PTEN):c.855A>T (p.Glu285Asp)	PTEN	E285D	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001440481	10	89720704	10	87960947	1440481	1461766	rs751888926	NC_000010.11:87960946:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	285	PTEN
NM_000314.8(PTEN):c.856A>G (p.Thr286Ala)	PTEN	T286A	PTEN hamartoma tumor syndrome	VCV002777407	10	89720705	10	87960948	2777407	2939857	NA	NC_000010.11:87960947:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	286	PTEN
NM_000314.8(PTEN):c.857C>A (p.Thr286Asn)	PTEN	T286N	PTEN hamartoma tumor syndrome	VCV002814779	10	89720706	10	87960949	2814779	2973309	NA	NC_000010.11:87960948:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	286	PTEN
NM_000314.8(PTEN):c.859T>A (p.Ser287Thr)	PTEN	S287T	Hereditary cancer-predisposing syndrome	VCV001763987	10	89720708	10	87960951	1763987	1820851	NA	NC_000010.11:87960950:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	287	PTEN
NM_000314.8(PTEN):c.859T>C (p.Ser287Pro)	PTEN	S287P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000536547	10	89720708	10	87960951	536547	525933	rs1554825526	NC_000010.11:87960950:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	287	PTEN
NM_000314.8(PTEN):c.862G>A (p.Glu288Lys)	PTEN	E288K	Familial meningioma|VACTERL with hydrocephalus|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|Cowden syndrome 1|Malignant tumor of prostate|Macrocephaly-autism syndrome|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000484603	10	89720711	10	87960954	484603	475556	rs1554825528	NC_000010.11:87960953:G:A	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	288	PTEN
NM_000314.8(PTEN):c.865A>G (p.Lys289Glu)	PTEN	K289E	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000142912	10	89720714	10	87960957	142912	152626	rs562015640	NC_000010.11:87960956:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	289	PTEN
NM_000314.8(PTEN):c.866A>G (p.Lys289Arg)	PTEN	K289R	Epileptic encephalopathy	VCV002687759	10	89720715	10	87960958	2687759	2848795	NA	NC_000010.11:87960957:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	289	PTEN
NM_000314.8(PTEN):c.868G>A (p.Val290Ile)	PTEN	V290I	PTEN hamartoma tumor syndrome	VCV000840900	10	89720717	10	87960960	840900	837441	rs35600253	NC_000010.11:87960959:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	290	PTEN
NM_000314.8(PTEN):c.868G>C (p.Val290Leu)	PTEN	V290L	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000822663	10	89720717	10	87960960	822663	810119	rs35600253	NC_000010.11:87960959:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	290	PTEN
NM_000314.8(PTEN):c.869T>C (p.Val290Ala)	PTEN	V290A	PTEN hamartoma tumor syndrome|not provided	VCV000234815	10	89720718	10	87960961	234815	231787	rs876661234	NC_000010.11:87960960:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	290	PTEN
NM_000314.8(PTEN):c.872A>G (p.Glu291Gly)	PTEN	E291G	PTEN hamartoma tumor syndrome	VCV000578559	10	89720721	10	87960964	578559	564885	rs1564568318	NC_000010.11:87960963:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	291	PTEN
NM_000314.8(PTEN):c.874A>G (p.Asn292Asp)	PTEN	N292D	Glioma susceptibility 2	VCV003240231	10	89720723	10	87960966	3240231	3399218	NA	NC_000010.11:87960965:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	292	PTEN
NM_000314.8(PTEN):c.875A>T (p.Asn292Ile)	PTEN	N292I	PTEN hamartoma tumor syndrome	VCV002877017	10	89720724	10	87960967	2877017	3033122	NA	NC_000010.11:87960966:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	292	PTEN
NM_000314.8(PTEN):c.875A>G (p.Asn292Ser)	PTEN	N292S	PTEN hamartoma tumor syndrome	VCV001425524	10	89720724	10	87960967	1425524	1431763	rs2132282266	NC_000010.11:87960966:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	292	PTEN
NM_000314.8(PTEN):c.878G>C (p.Gly293Ala)	PTEN	G293A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV002587206	10	89720727	10	87960970	2587206	2753882	NA	NC_000010.11:87960969:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	293	PTEN
NM_000314.8(PTEN):c.878G>T (p.Gly293Val)	PTEN	G293V	PTEN hamartoma tumor syndrome	VCV000958992	10	89720727	10	87960970	958992	947125	rs1860622339	NC_000010.11:87960969:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	293	PTEN
NM_000314.8(PTEN):c.881G>A (p.Ser294Asn)	PTEN	S294N	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000484617	10	89720730	10	87960973	484617	475246	rs1175543698	NC_000010.11:87960972:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	294	PTEN
NM_000314.8(PTEN):c.882T>G (p.Ser294Arg)	PTEN	S294R	PTEN hamartoma tumor syndrome	VCV000127693	10	89720731	10	87960974	127693	133150	rs143335584	NC_000010.11:87960973:T:G	single nucleotide variant	missense variant	Likely benign	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	294	PTEN
NM_000314.8(PTEN):c.886T>C (p.Cys296Arg)	PTEN	C296R	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Glioma susceptibility 2	VCV000185480	10	89720735	10	87960978	185480	183050	rs786202207	NC_000010.11:87960977:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	296	PTEN
NM_000314.8(PTEN):c.887G>A (p.Cys296Tyr)	PTEN	C296Y	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Glioma susceptibility 2	VCV000404163	10	89720736	10	87960979	404163	397954	rs1060500121	NC_000010.11:87960978:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	296	PTEN
NM_000314.8(PTEN):c.888T>G (p.Cys296Trp)	PTEN	C296W	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000822798	10	89720737	10	87960980	822798	810120	rs1589665853	NC_000010.11:87960979:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	296	PTEN
NM_000314.8(PTEN):c.889G>T (p.Asp297Tyr)	PTEN	D297Y	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000418439	10	89720738	10	87960981	418439	408003	rs370064195	NC_000010.11:87960980:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	297	PTEN
NM_000314.8(PTEN):c.889G>C (p.Asp297His)	PTEN	D297H	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000404172	10	89720738	10	87960981	404172	397520	rs370064195	NC_000010.11:87960980:G:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	297	PTEN
NM_000314.8(PTEN):c.890A>G (p.Asp297Gly)	PTEN	D297G	PTEN hamartoma tumor syndrome	VCV001052858	10	89720739	10	87960982	1052858	1046826	rs2132282426	NC_000010.11:87960981:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	297	PTEN
NM_000314.8(PTEN):c.892C>A (p.Gln298Lys)	PTEN	Q298K	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000570880	10	89720741	10	87960984	570880	564027	rs371387815	NC_000010.11:87960983:C:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	298	PTEN
NM_000314.8(PTEN):c.892C>G (p.Gln298Glu)	PTEN	Q298E	PTEN hamartoma tumor syndrome	VCV000127695	10	89720741	10	87960984	127695	133152	rs371387815	NC_000010.11:87960983:C:G	single nucleotide variant	missense variant	Likely benign	Aug 4, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	298	PTEN
NM_000314.8(PTEN):c.893A>C (p.Gln298Pro)	PTEN	Q298P	PTEN hamartoma tumor syndrome	VCV002105292	10	89720742	10	87960985	2105292	2169644	NA	NC_000010.11:87960984:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	298	PTEN
NM_000314.8(PTEN):c.895G>A (p.Glu299Lys)	PTEN	E299K	PTEN hamartoma tumor syndrome	VCV002788987	10	89720744	10	87960987	2788987	2956595	NA	NC_000010.11:87960986:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	299	PTEN
NM_000314.8(PTEN):c.896A>G (p.Glu299Gly)	PTEN	E299G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000484624	10	89720745	10	87960988	484624	475557	rs1554825550	NC_000010.11:87960987:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	299	PTEN
NM_000314.8(PTEN):c.898A>G (p.Ile300Val)	PTEN	I300V	Hereditary cancer-predisposing syndrome	VCV001692373	10	89720747	10	87960990	1692373	1684813	rs2132282509	NC_000010.11:87960989:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	300	PTEN
NM_000314.8(PTEN):c.901G>T (p.Asp301Tyr)	PTEN	D301Y	not provided	VCV000872239	10	89720750	10	87960993	872239	859819	rs758644748	NC_000010.11:87960992:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	301	PTEN
NM_000314.8(PTEN):c.901G>A (p.Asp301Asn)	PTEN	D301N	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000233963	10	89720750	10	87960993	233963	233870	rs758644748	NC_000010.11:87960992:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	301	PTEN
NM_000314.8(PTEN):c.904A>G (p.Ser302Gly)	PTEN	S302G	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001501773	10	89720753	10	87960996	1501773	1398641	rs1334444415	NC_000010.11:87960995:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	PTEN
NM_000314.8(PTEN):c.905G>A (p.Ser302Asn)	PTEN	S302N	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000486226	10	89720754	10	87960997	486226	475559	rs745638189	NC_000010.11:87960996:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	PTEN
NM_000314.8(PTEN):c.906C>G (p.Ser302Arg)	PTEN	S302R	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome|Glioma susceptibility 2	VCV000234182	10	89720755	10	87960998	234182	233871	rs876660906	NC_000010.11:87960997:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	302	PTEN
NM_000314.8(PTEN):c.907A>G (p.Ile303Val)	PTEN	I303V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000428242	10	89720756	10	87960999	428242	419763	rs1114167660	NC_000010.11:87960998:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	303	PTEN
NM_000314.8(PTEN):c.908T>G (p.Ile303Ser)	PTEN	I303S	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000230633	10	89720757	10	87961000	230633	233872	rs772018727	NC_000010.11:87960999:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	303	PTEN
NM_000314.8(PTEN):c.911G>T (p.Cys304Phe)	PTEN	C304F	Hereditary cancer-predisposing syndrome	VCV001765878	10	89720760	10	87961003	1765878	1817828	NA	NC_000010.11:87961002:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	304	PTEN
NM_000314.8(PTEN):c.913A>G (p.Ser305Gly)	PTEN	S305G	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000230819	10	89720762	10	87961005	230819	233873	rs775461980	NC_000010.11:87961004:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	305	PTEN
NM_000314.8(PTEN):c.914G>T (p.Ser305Ile)	PTEN	S305I	PTEN hamartoma tumor syndrome|not provided	VCV000619910	10	89720763	10	87961006	619910	611090	rs587780007	NC_000010.11:87961005:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	305	PTEN
NM_000314.8(PTEN):c.914G>A (p.Ser305Asn)	PTEN	S305N	PTEN hamartoma tumor syndrome	VCV000127696	10	89720763	10	87961006	127696	133153	rs587780007	NC_000010.11:87961005:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2019	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	305	PTEN
NM_000314.8(PTEN):c.915T>G (p.Ser305Arg)	PTEN	S305R	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000230040	10	89720764	10	87961007	230040	233874	rs876658345	NC_000010.11:87961006:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	305	PTEN
NM_000314.8(PTEN):c.916A>G (p.Ile306Val)	PTEN	I306V	Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	VCV000187604	10	89720765	10	87961008	187604	183053	rs786203858	NC_000010.11:87961007:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	306	PTEN
NM_000314.8(PTEN):c.917T>C (p.Ile306Thr)	PTEN	I306T	PTEN hamartoma tumor syndrome	VCV001356075	10	89720766	10	87961009	1356075	1354371	rs2132282700	NC_000010.11:87961008:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	306	PTEN
NM_000314.8(PTEN):c.918A>G (p.Ile306Met)	PTEN	I306M	PTEN hamartoma tumor syndrome	VCV002912092	10	89720767	10	87961010	2912092	3073250	NA	NC_000010.11:87961009:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	306	PTEN
NM_000314.8(PTEN):c.919G>C (p.Glu307Gln)	PTEN	E307Q	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000185517	10	89720768	10	87961011	185517	183054	rs746930141	NC_000010.11:87961010:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	307	PTEN
NM_000314.8(PTEN):c.920A>G (p.Glu307Gly)	PTEN	E307G	PTEN hamartoma tumor syndrome|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000484626	10	89720769	10	87961012	484626	475427	rs1197734477	NC_000010.11:87961011:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	307	PTEN
NM_000314.8(PTEN):c.921G>C (p.Glu307Asp)	PTEN	E307D	PTEN hamartoma tumor syndrome	VCV002754132	10	89720770	10	87961013	2754132	2916600	NA	NC_000010.11:87961012:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	307	PTEN
NM_000314.8(PTEN):c.922C>T (p.Arg308Cys)	PTEN	R308C	Hereditary cancer-predisposing syndrome|not specified|not provided|Macrocephaly-autism syndrome|Familial meningioma|Malignant tumor of prostate|Cowden syndrome 1|Glioma susceptibility 2|PTEN hamartoma tumor syndrome	VCV000420367	10	89720771	10	87961014	420367	408005	rs1064794436	NC_000010.11:87961013:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	308	PTEN
NM_000314.8(PTEN):c.923G>T (p.Arg308Leu)	PTEN	R308L	PTEN hamartoma tumor syndrome	VCV002104965	10	89720772	10	87961015	2104965	2158971	NA	NC_000010.11:87961014:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	308	PTEN
NM_000314.8(PTEN):c.923G>A (p.Arg308His)	PTEN	R308H	Ovarian cancer|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000184506	10	89720772	10	87961015	184506	183055	rs786201507	NC_000010.11:87961014:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	308	PTEN
NM_000314.8(PTEN):c.928G>A (p.Asp310Asn)	PTEN	D310N	Hereditary cancer-predisposing syndrome	VCV001766444	10	89720777	10	87961020	1766444	1815022	NA	NC_000010.11:87961019:G:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	310	PTEN
NM_000314.8(PTEN):c.929A>G (p.Asp310Gly)	PTEN	D310G	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000566673	10	89720778	10	87961021	566673	566591	rs1564568473	NC_000010.11:87961020:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	310	PTEN
NM_000314.8(PTEN):c.932A>T (p.Asn311Ile)	PTEN	N311I	PTEN hamartoma tumor syndrome	VCV002896208	10	89720781	10	87961024	2896208	3066889	NA	NC_000010.11:87961023:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	311	PTEN
NM_000314.8(PTEN):c.934G>A (p.Asp312Asn)	PTEN	D312N	PTEN hamartoma tumor syndrome	VCV000237656	10	89720783	10	87961026	237656	240885	rs878853946	NC_000010.11:87961025:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	PTEN
NM_000314.8(PTEN):c.935A>C (p.Asp312Ala)	PTEN	D312A	Hereditary cancer-predisposing syndrome	VCV003231173	10	89720784	10	87961027	3231173	3391795	NA	NC_000010.11:87961026:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	PTEN
NM_000314.8(PTEN):c.935A>T (p.Asp312Val)	PTEN	D312V	Hereditary cancer-predisposing syndrome	VCV002452979	10	89720784	10	87961027	2452979	2430040	NA	NC_000010.11:87961026:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	PTEN
NM_000314.8(PTEN):c.935A>G (p.Asp312Gly)	PTEN	D312G	PTEN hamartoma tumor syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000216423	10	89720784	10	87961027	216423	212825	rs863224667	NC_000010.11:87961026:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	312	PTEN
NM_000314.8(PTEN):c.937A>C (p.Lys313Gln)	PTEN	K313Q	PTEN hamartoma tumor syndrome	VCV000639572	10	89720786	10	87961029	639572	639289	rs1589666011	NC_000010.11:87961028:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	313	PTEN
NM_000314.8(PTEN):c.941A>T (p.Glu314Val)	PTEN	E314V	PTEN hamartoma tumor syndrome	VCV000936326	10	89720790	10	87961033	936326	935225	rs1171478249	NC_000010.11:87961032:A:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	314	PTEN
NM_000314.8(PTEN):c.941A>C (p.Glu314Ala)	PTEN	E314A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Glioma susceptibility 2	VCV000452024	10	89720790	10	87961033	452024	444679	rs1171478249	NC_000010.11:87961032:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	314	PTEN
NM_000314.8(PTEN):c.943T>G (p.Tyr315Asp)	PTEN	Y315D	Hereditary cancer-predisposing syndrome	VCV001766972	10	89720792	10	87961035	1766972	1825214	NA	NC_000010.11:87961034:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	315	PTEN
NM_000314.8(PTEN):c.944A>T (p.Tyr315Phe)	PTEN	Y315F	Hereditary cancer-predisposing syndrome	VCV001766981	10	89720793	10	87961036	1766981	1825223	NA	NC_000010.11:87961035:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	315	PTEN
NM_000314.8(PTEN):c.946C>G (p.Leu316Val)	PTEN	L316V	Hereditary cancer-predisposing syndrome	VCV001767056	10	89720795	10	87961038	1767056	1821398	NA	NC_000010.11:87961037:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	316	PTEN
NM_000314.8(PTEN):c.946C>A (p.Leu316Ile)	PTEN	L316I	PTEN hamartoma tumor syndrome	VCV000468723	10	89720795	10	87961038	468723	460646	rs1554825577	NC_000010.11:87961037:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	316	PTEN
NM_000314.8(PTEN):c.947T>C (p.Leu316Pro)	PTEN	L316P	PTEN hamartoma tumor syndrome	VCV000418653	10	89720796	10	87961039	418653	408007	rs1064793345	NC_000010.11:87961038:T:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 9, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	316	PTEN
NM_000314.8(PTEN):c.949G>T (p.Val317Leu)	PTEN	V317L	Hereditary cancer-predisposing syndrome	VCV002587212	10	89720798	10	87961041	2587212	2753888	NA	NC_000010.11:87961040:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	317	PTEN
NM_000314.8(PTEN):c.949G>C (p.Val317Leu)	PTEN	V317L	PTEN hamartoma tumor syndrome	VCV002103446	10	89720798	10	87961041	2103446	2169096	NA	NC_000010.11:87961040:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	317	PTEN
NM_000314.8(PTEN):c.949G>A (p.Val317Ile)	PTEN	V317I	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	VCV000230554	10	89720798	10	87961041	230554	233875	rs876658630	NC_000010.11:87961040:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	317	PTEN
NM_000314.8(PTEN):c.953T>G (p.Leu318Arg)	PTEN	L318R	PTEN hamartoma tumor syndrome	VCV003075549	10	89720802	10	87961045	3075549	3233114	NA	NC_000010.11:87961044:T:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	318	PTEN
NM_000314.8(PTEN):c.953T>C (p.Leu318Pro)	PTEN	L318P	PTEN hamartoma tumor syndrome	VCV002746803	10	89720802	10	87961045	2746803	2897678	NA	NC_000010.11:87961044:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	318	PTEN
NM_000314.8(PTEN):c.956C>T (p.Thr319Ile)	PTEN	T319I	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001317087	10	89720805	10	87961048	1317087	1306905	rs761350690	NC_000010.11:87961047:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	319	PTEN
NM_000314.8(PTEN):c.956C>A (p.Thr319Asn)	PTEN	T319N	PTEN hamartoma tumor syndrome	VCV001010093	10	89720805	10	87961048	1010093	994102	rs761350690	NC_000010.11:87961047:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	319	PTEN
NM_000314.8(PTEN):c.959T>C (p.Leu320Ser)	PTEN	L320S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 1	VCV001043063	10	89720808	10	87961051	1043063	1029848	rs1114167667	NC_000010.11:87961050:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	320	PTEN
NM_000314.8(PTEN):c.962C>T (p.Thr321Ile)	PTEN	T321I	Hereditary cancer-predisposing syndrome	VCV001767610	10	89720811	10	87961054	1767610	1818261	NA	NC_000010.11:87961053:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	321	PTEN
NM_000314.8(PTEN):c.964A>G (p.Lys322Glu)	PTEN	K322E	not provided	VCV002504932	10	89720813	10	87961056	2504932	2669899	NA	NC_000010.11:87961055:A:G	single nucleotide variant	missense variant	Uncertain significance	May 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	322	PTEN
NM_000314.8(PTEN):c.965A>G (p.Lys322Arg)	PTEN	K322R	Hereditary cancer-predisposing syndrome	VCV001767686	10	89720814	10	87961057	1767686	1818337	NA	NC_000010.11:87961056:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	322	PTEN
NM_000314.8(PTEN):c.967A>C (p.Asn323His)	PTEN	N323H	Hereditary cancer-predisposing syndrome	VCV000823396	10	89720816	10	87961059	823396	810123	rs1589666149	NC_000010.11:87961058:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	323	PTEN
NM_000314.8(PTEN):c.968A>C (p.Asn323Thr)	PTEN	N323T	PTEN hamartoma tumor syndrome	VCV000644448	10	89720817	10	87961060	644448	639292	rs1589666155	NC_000010.11:87961059:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	323	PTEN
NM_000314.8(PTEN):c.969T>A (p.Asn323Lys)	PTEN	N323K	Hereditary cancer-predisposing syndrome	VCV001767858	10	89720818	10	87961061	1767858	1818509	NA	NC_000010.11:87961060:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	323	PTEN
NM_000314.8(PTEN):c.971A>G (p.Asp324Gly)	PTEN	D324G	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000823437	10	89720820	10	87961063	823437	810124	rs1589666167	NC_000010.11:87961062:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	324	PTEN
NM_000314.8(PTEN):c.972T>A (p.Asp324Glu)	PTEN	D324E	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000834923	10	89720821	10	87961064	834923	837445	rs1860630615	NC_000010.11:87961063:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	324	PTEN
NM_000314.8(PTEN):c.973C>A (p.Leu325Ile)	PTEN	L325I	Hereditary cancer-predisposing syndrome	VCV001768042	10	89720822	10	87961065	1768042	1825475	NA	NC_000010.11:87961064:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	325	PTEN
NM_000314.8(PTEN):c.974T>G (p.Leu325Arg)	PTEN	L325R	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000428251	10	89720823	10	87961066	428251	419769	rs1114167654	NC_000010.11:87961065:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	325	PTEN
NM_000314.8(PTEN):c.974T>C (p.Leu325Pro)	PTEN	L325P	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000428231	10	89720823	10	87961066	428231	419768	rs1114167654	NC_000010.11:87961065:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	325	PTEN
NM_000314.8(PTEN):c.976G>A (p.Asp326Asn)	PTEN	D326N	PTEN hamartoma tumor syndrome|not provided|Neoplasm	VCV002498032	10	89720825	10	87961068	2498032	2473114	NA	NC_000010.11:87961067:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	326	PTEN
NM_000314.8(PTEN):c.977A>G (p.Asp326Gly)	PTEN	D326G	PTEN hamartoma tumor syndrome	VCV000857109	10	89720826	10	87961069	857109	837446	rs1860631246	NC_000010.11:87961068:A:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	326	PTEN
NM_000314.8(PTEN):c.978C>G (p.Asp326Glu)	PTEN	D326E	PTEN hamartoma tumor syndrome	VCV001056002	10	89720827	10	87961070	1056002	1046827	rs1860631336	NC_000010.11:87961069:C:G	single nucleotide variant	missense variant	Uncertain significance	May 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	326	PTEN
NM_000314.8(PTEN):c.978C>A (p.Asp326Glu)	PTEN	D326E	PTEN hamartoma tumor syndrome	VCV001000404	10	89720827	10	87961070	1000404	994103	rs1860631336	NC_000010.11:87961069:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	326	PTEN
NM_000314.8(PTEN):c.986A>G (p.Asn329Ser)	PTEN	N329S	PTEN hamartoma tumor syndrome	VCV000944439	10	89720835	10	87961078	944439	925970	rs1860631722	NC_000010.11:87961077:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	329	PTEN
NM_000314.8(PTEN):c.988A>G (p.Lys330Glu)	PTEN	K330E	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000630780	10	89720837	10	87961080	630780	617604	rs1554825607	NC_000010.11:87961079:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	330	PTEN
NM_000314.8(PTEN):c.989A>G (p.Lys330Arg)	PTEN	K330R	Hereditary cancer-predisposing syndrome	VCV001768513	10	89720838	10	87961081	1768513	1828922	NA	NC_000010.11:87961080:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	330	PTEN
NM_000314.8(PTEN):c.998C>A (p.Ala333Asp)	PTEN	A333D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000823591	10	89720847	10	87961090	823591	810126	rs1554825616	NC_000010.11:87961089:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	333	PTEN
NM_000314.8(PTEN):c.998C>T (p.Ala333Val)	PTEN	A333V	Hereditary cancer-predisposing syndrome	VCV000484606	10	89720847	10	87961090	484606	475430	rs1554825616	NC_000010.11:87961089:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	333	PTEN
NM_000314.8(PTEN):c.1001A>T (p.Asn334Ile)	PTEN	N334I	PTEN hamartoma tumor syndrome	VCV002001625	10	89720850	10	87961093	2001625	2054826	NA	NC_000010.11:87961092:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	334	PTEN
NM_000314.8(PTEN):c.1001A>G (p.Asn334Ser)	PTEN	N334S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000490110	10	89720850	10	87961093	490110	482708	rs1206321984	NC_000010.11:87961092:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	334	PTEN
NM_000314.8(PTEN):c.1002C>G (p.Asn334Lys)	PTEN	N334K	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000492310	10	89720851	10	87961094	492310	484122	rs1554825620	NC_000010.11:87961093:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	334	PTEN
NM_000314.8(PTEN):c.1004G>T (p.Arg335Leu)	PTEN	R335L	Cowden syndrome 1	VCV000548724	10	89720853	10	87961096	548724	539299	rs1085308040	NC_000010.11:87961095:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	335	PTEN
NM_000314.8(PTEN):c.1004G>A (p.Arg335Gln)	PTEN	R335Q	Hereditary cancer-predisposing syndrome|Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome	VCV000427580	10	89720853	10	87961096	427580	416953	rs1085308040	NC_000010.11:87961095:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	335	PTEN
NM_000314.8(PTEN):c.1006T>C (p.Tyr336His)	PTEN	Y336H	PTEN hamartoma tumor syndrome	VCV000836781	10	89720855	10	87961098	836781	837447	rs1860633558	NC_000010.11:87961097:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	336	PTEN
NM_000314.8(PTEN):c.1007A>G (p.Tyr336Cys)	PTEN	Y336C	PTEN hamartoma tumor syndrome	VCV002109916	10	89720856	10	87961099	2109916	2163791	NA	NC_000010.11:87961098:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	336	PTEN
NM_000314.8(PTEN):c.1010T>C (p.Phe337Ser)	PTEN	F337S	not provided|Hereditary cancer-predisposing syndrome	VCV001728487	10	89720859	10	87961102	1728487	1791887	NA	NC_000010.11:87961101:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	337	PTEN
NM_000314.8(PTEN):c.1010T>A (p.Phe337Tyr)	PTEN	F337Y	Hereditary cancer-predisposing syndrome	VCV000484613	10	89720859	10	87961102	484613	475295	rs1554825641	NC_000010.11:87961101:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	337	PTEN
NM_000314.8(PTEN):c.1012T>A (p.Ser338Thr)	PTEN	S338T	PTEN hamartoma tumor syndrome	VCV001439337	10	89720861	10	87961104	1439337	1349737	rs2132283644	NC_000010.11:87961103:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	338	PTEN
NM_000314.8(PTEN):c.1013C>A (p.Ser338Tyr)	PTEN	S338Y	PTEN hamartoma tumor syndrome	VCV002834356	10	89720862	10	87961105	2834356	2991623	NA	NC_000010.11:87961104:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	338	PTEN
NM_000314.8(PTEN):c.1013C>G (p.Ser338Cys)	PTEN	S338C	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001736322	10	89720862	10	87961105	1736322	1796855	NA	NC_000010.11:87961104:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	338	PTEN
NM_000314.8(PTEN):c.1015C>G (p.Pro339Ala)	PTEN	P339A	PTEN hamartoma tumor syndrome	VCV003073991	10	89720864	10	87961107	3073991	3232861	NA	NC_000010.11:87961106:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	339	PTEN
NM_000314.8(PTEN):c.1015C>T (p.Pro339Ser)	PTEN	P339S	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000961193	10	89720864	10	87961107	961193	947126	rs1860634292	NC_000010.11:87961106:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	339	PTEN
NM_000314.8(PTEN):c.1016C>A (p.Pro339Gln)	PTEN	P339Q	PTEN hamartoma tumor syndrome	VCV000584755	10	89720865	10	87961108	584755	575811	rs1564568679	NC_000010.11:87961107:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	339	PTEN
NM_000314.8(PTEN):c.1018A>C (p.Asn340His)	PTEN	N340H	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not specified|not provided	VCV000189510	10	89720867	10	87961110	189510	187387	rs759852661	NC_000010.11:87961109:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	340	PTEN
NM_000314.8(PTEN):c.1018A>G (p.Asn340Asp)	PTEN	N340D	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000185586	10	89720867	10	87961110	185586	183059	rs759852661	NC_000010.11:87961109:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	340	PTEN
NM_000314.8(PTEN):c.1019A>G (p.Asn340Ser)	PTEN	N340S	Hereditary cancer-predisposing syndrome	VCV001752598	10	89720868	10	87961111	1752598	1801032	NA	NC_000010.11:87961110:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	340	PTEN
NM_000314.8(PTEN):c.1020T>A (p.Asn340Lys)	PTEN	N340K	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000536555	10	89720869	10	87961112	536555	525800	rs1554825649	NC_000010.11:87961111:T:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	340	PTEN
NM_000314.8(PTEN):c.1021T>A (p.Phe341Ile)	PTEN	F341I	PTEN hamartoma tumor syndrome	VCV001013941	10	89720870	10	87961113	1013941	1009279	rs1554825652	NC_000010.11:87961112:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	341	PTEN
NM_000314.8(PTEN):c.1021T>G (p.Phe341Val)	PTEN	F341V	not provided|Cowden syndrome 1	VCV000495806	10	89720870	10	87961113	495806	487475	rs1554825652	NC_000010.11:87961112:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	341	PTEN
NM_000314.8(PTEN):c.1022T>G (p.Phe341Cys)	PTEN	F341C	PTEN hamartoma tumor syndrome	VCV000847564	10	89720871	10	87961114	847564	837448	rs1860635056	NC_000010.11:87961113:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	341	PTEN
NM_000314.8(PTEN):c.1025A>C (p.Lys342Thr)	PTEN	K342T	not provided|Hereditary cancer-predisposing syndrome	VCV000419745	10	89720874	10	87961117	419745	408008	rs1064794080	NC_000010.11:87961116:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	342	PTEN
NM_000314.8(PTEN):c.1026G>T (p.Lys342Asn)	PTEN	K342N	PTEN hamartoma tumor syndrome	VCV001067478	10	89720875	10	87961118	1067478	1055944	rs398123314	NC_000010.11:87961117:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	342	PTEN
NM_000314.8(PTEN):c.1026G>C (p.Lys342Asn)	PTEN	K342N	not provided|Hereditary cancer-predisposing syndrome	VCV000092811	10	89720875	10	87961118	92811	98718	rs398123314	NC_000010.11:87961117:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	342	PTEN
NM_000314.8(PTEN):c.1027G>T (p.Val343Leu)	PTEN	V343L	PTEN hamartoma tumor syndrome|not provided	VCV002576380	10	89725044	10	87965287	2576380	2741276	NA	NC_000010.11:87965286:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	343	PTEN
NM_000314.8(PTEN):c.1027G>A (p.Val343Met)	PTEN	V343M	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000404161	10	89725044	10	87965287	404161	398084	rs1060500120	NC_000010.11:87965286:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	343	PTEN
NM_000314.8(PTEN):c.1028T>G (p.Val343Gly)	PTEN	V343G	Hereditary cancer-predisposing syndrome	VCV000630756	10	89725045	10	87965288	630756	617605	rs1564570264	NC_000010.11:87965287:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	343	PTEN
NM_000314.8(PTEN):c.1031A>G (p.Lys344Arg)	PTEN	K344R	Hereditary cancer-predisposing syndrome	VCV000923007	10	89725048	10	87965291	923007	911232	rs1860732053	NC_000010.11:87965290:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	344	PTEN
NM_000314.8(PTEN):c.1033C>G (p.Leu345Val)	PTEN	L345V	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000428214	10	89725050	10	87965293	428214	419773	rs1114167639	NC_000010.11:87965292:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	345	PTEN
NM_000314.8(PTEN):c.1034T>A (p.Leu345Gln)	PTEN	L345Q	PTEN hamartoma tumor syndrome	VCV002745184	10	89725051	10	87965294	2745184	2897346	NA	NC_000010.11:87965293:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	345	PTEN
NM_000314.8(PTEN):c.1034T>G (p.Leu345Arg)	PTEN	L345R	PTEN hamartoma tumor syndrome	VCV000802613	10	89725051	10	87965294	802613	791007	rs1554826024	NC_000010.11:87965293:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 2, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	345	PTEN
NM_000314.8(PTEN):c.1034T>C (p.Leu345Pro)	PTEN	L345P	PTEN hamartoma tumor syndrome	VCV000484605	10	89725051	10	87965294	484605	475440	rs1554826024	NC_000010.11:87965293:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	345	PTEN
NM_000314.8(PTEN):c.1036T>G (p.Tyr346Asp)	PTEN	Y346D	Hereditary cancer-predisposing syndrome	VCV000822057	10	89725053	10	87965296	822057	810127	rs1589669128	NC_000010.11:87965295:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	346	PTEN
NM_000314.8(PTEN):c.1037A>G (p.Tyr346Cys)	PTEN	Y346C	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000480380	10	89725054	10	87965297	480380	475441	rs1554826026	NC_000010.11:87965296:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	346	PTEN
NM_000314.8(PTEN):c.1041C>G (p.Phe347Leu)	PTEN	F347L	PTEN hamartoma tumor syndrome	VCV001045279	10	89725058	10	87965301	1045279	1029849	rs1554826029	NC_000010.11:87965300:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	347	PTEN
NM_000314.8(PTEN):c.1042A>C (p.Thr348Pro)	PTEN	T348P	PTEN hamartoma tumor syndrome|not provided	VCV002860672	10	89725059	10	87965302	2860672	3025600	NA	NC_000010.11:87965301:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	348	PTEN
NM_000314.8(PTEN):c.1043C>G (p.Thr348Arg)	PTEN	T348R	Hereditary cancer-predisposing syndrome	VCV001774712	10	89725060	10	87965303	1774712	1837248	NA	NC_000010.11:87965302:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	348	PTEN
NM_000314.8(PTEN):c.1048A>G (p.Thr350Ala)	PTEN	T350A	Hereditary cancer-predisposing syndrome	VCV002452977	10	89725065	10	87965308	2452977	2433958	NA	NC_000010.11:87965307:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	350	PTEN
NM_000314.8(PTEN):c.1048A>C (p.Thr350Pro)	PTEN	T350P	Hereditary cancer-predisposing syndrome	VCV001775972	10	89725065	10	87965308	1775972	1827772	NA	NC_000010.11:87965307:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	350	PTEN
NM_000314.8(PTEN):c.1051G>A (p.Val351Ile)	PTEN	V351I	Hereditary cancer-predisposing syndrome	VCV000628248	10	89725068	10	87965311	628248	617607	rs1564570314	NC_000010.11:87965310:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	351	PTEN
NM_000314.8(PTEN):c.1054G>C (p.Glu352Gln)	PTEN	E352Q	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000627921	10	89725071	10	87965314	627921	617608	rs1554826034	NC_000010.11:87965313:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	352	PTEN
NM_000314.8(PTEN):c.1055A>G (p.Glu352Gly)	PTEN	E352G	PTEN hamartoma tumor syndrome	VCV001351177	10	89725072	10	87965315	1351177	1407527	rs2132289351	NC_000010.11:87965314:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	352	PTEN
NM_000314.8(PTEN):c.1056G>T (p.Glu352Asp)	PTEN	E352D	Glioma susceptibility 2	VCV003240233	10	89725073	10	87965316	3240233	3399220	NA	NC_000010.11:87965315:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	352	PTEN
NM_000314.8(PTEN):c.1057G>A (p.Glu353Lys)	PTEN	E353K	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV002567264	10	89725074	10	87965317	2567264	2730907	NA	NC_000010.11:87965316:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	353	PTEN
NM_000314.8(PTEN):c.1058A>G (p.Glu353Gly)	PTEN	E353G	PTEN hamartoma tumor syndrome	VCV000237638	10	89725075	10	87965318	237638	240888	rs878853932	NC_000010.11:87965317:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	353	PTEN
NM_000314.8(PTEN):c.1061C>G (p.Pro354Arg)	PTEN	P354R	Hereditary cancer-predisposing syndrome	VCV001780374	10	89725078	10	87965321	1780374	1835075	NA	NC_000010.11:87965320:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	354	PTEN
NM_000314.8(PTEN):c.1061C>A (p.Pro354Gln)	PTEN	P354Q	PTEN hamartoma tumor syndrome	VCV000143020	10	89725078	10	87965321	143020	152734	rs375709098	NC_000010.11:87965320:C:A	single nucleotide variant	missense variant	Likely benign	Jun 14, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	354	PTEN
NM_000314.8(PTEN):c.1061C>T (p.Pro354Leu)	PTEN	P354L	PTEN hamartoma tumor syndrome	VCV000142212	10	89725078	10	87965321	142212	151926	rs375709098	NC_000010.11:87965320:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	354	PTEN
NM_000314.8(PTEN):c.1064C>T (p.Ser355Leu)	PTEN	S355L	not specified|Hereditary cancer-predisposing syndrome	VCV001685048	10	89725081	10	87965324	1685048	1677071	rs2132289421	NC_000010.11:87965323:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	355	PTEN
NM_000314.8(PTEN):c.1066A>C (p.Asn356His)	PTEN	N356H	Hereditary cancer-predisposing syndrome	VCV003311266	10	89725083	10	87965326	3311266	3468251	NA	NC_000010.11:87965325:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	356	PTEN
NM_000314.8(PTEN):c.1066A>T (p.Asn356Tyr)	PTEN	N356Y	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|not provided|not specified	VCV000189397	10	89725083	10	87965326	189397	187389	rs587782345	NC_000010.11:87965325:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	356	PTEN
NM_000314.8(PTEN):c.1066A>G (p.Asn356Asp)	PTEN	N356D	Glioma susceptibility 2|Hereditary cancer-predisposing syndrome|not specified|PTEN hamartoma tumor syndrome|not provided	VCV000142263	10	89725083	10	87965326	142263	151977	rs587782345	NC_000010.11:87965325:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	356	PTEN
NM_000314.8(PTEN):c.1067A>T (p.Asn356Ile)	PTEN	N356I	Hereditary cancer-predisposing syndrome	VCV000628653	10	89725084	10	87965327	628653	617609	rs1564570353	NC_000010.11:87965326:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	356	PTEN
NM_000314.8(PTEN):c.1068T>A (p.Asn356Lys)	PTEN	N356K	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000569595	10	89725085	10	87965328	569595	564030	rs1564570356	NC_000010.11:87965327:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	356	PTEN
NM_000314.8(PTEN):c.1069C>G (p.Pro357Ala)	PTEN	P357A	PTEN hamartoma tumor syndrome	VCV000854810	10	89725086	10	87965329	854810	837450	rs876661264	NC_000010.11:87965328:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	357	PTEN
NM_000314.8(PTEN):c.1069C>A (p.Pro357Thr)	PTEN	P357T	Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	VCV000234861	10	89725086	10	87965329	234861	231792	rs876661264	NC_000010.11:87965328:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	357	PTEN
NM_000314.8(PTEN):c.1070C>T (p.Pro357Leu)	PTEN	P357L	Glioma susceptibility 2|Hereditary cancer-predisposing syndrome	VCV002567280	10	89725087	10	87965330	2567280	2730922	NA	NC_000010.11:87965329:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	357	PTEN
NM_000314.8(PTEN):c.1072G>C (p.Glu358Gln)	PTEN	E358Q	PTEN hamartoma tumor syndrome	VCV001063157	10	89725089	10	87965332	1063157	1046828	rs1554826040	NC_000010.11:87965331:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	358	PTEN
NM_000314.8(PTEN):c.1072G>A (p.Glu358Lys)	PTEN	E358K	PTEN hamartoma tumor syndrome	VCV000961773	10	89725089	10	87965332	961773	947127	rs1554826040	NC_000010.11:87965331:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	358	PTEN
NM_000314.8(PTEN):c.1074G>C (p.Glu358Asp)	PTEN	E358D	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000231962	10	89725091	10	87965334	231962	233879	rs876659464	NC_000010.11:87965333:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	358	PTEN
NM_000314.8(PTEN):c.1075G>T (p.Ala359Ser)	PTEN	A359S	not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000220596	10	89725092	10	87965335	220596	222005	rs864622594	NC_000010.11:87965334:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	359	PTEN
NM_000314.8(PTEN):c.1076C>T (p.Ala359Val)	PTEN	A359V	not provided	VCV001695819	10	89725093	10	87965336	1695819	1688228	rs2132289511	NC_000010.11:87965335:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	359	PTEN
NM_000314.8(PTEN):c.1078A>G (p.Ser360Gly)	PTEN	S360G	PTEN hamartoma tumor syndrome	VCV000140777	10	89725095	10	87965338	140777	150491	rs587781273	NC_000010.11:87965337:A:G	single nucleotide variant	missense variant	Likely benign	Oct 11, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	360	PTEN
NM_000314.8(PTEN):c.1079G>C (p.Ser360Thr)	PTEN	S360T	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000404169	10	89725096	10	87965339	404169	397524	rs1060500127	NC_000010.11:87965338:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	360	PTEN
NM_000314.8(PTEN):c.1081A>G (p.Ser361Gly)	PTEN	S361G	Hereditary cancer-predisposing syndrome	VCV002774186	10	89725098	10	87965341	2774186	2934916	NA	NC_000010.11:87965340:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	361	PTEN
NM_000314.8(PTEN):c.1081A>C (p.Ser361Arg)	PTEN	S361R	Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000492314	10	89725098	10	87965341	492314	484362	rs1472028496	NC_000010.11:87965340:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	361	PTEN
NM_000314.8(PTEN):c.1082G>C (p.Ser361Thr)	PTEN	S361T	Hereditary cancer-predisposing syndrome	VCV003231144	10	89725099	10	87965342	3231144	3391766	NA	NC_000010.11:87965341:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	361	PTEN
NM_000314.8(PTEN):c.1082G>T (p.Ser361Ile)	PTEN	S361I	Hereditary cancer-predisposing syndrome	VCV001786821	10	89725099	10	87965342	1786821	1844190	NA	NC_000010.11:87965341:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	361	PTEN
NM_000314.8(PTEN):c.1087A>G (p.Thr363Ala)	PTEN	T363A	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000484607	10	89725104	10	87965347	484607	475251	rs765416558	NC_000010.11:87965346:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	363	PTEN
NM_000314.8(PTEN):c.1088C>T (p.Thr363Ile)	PTEN	T363I	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000818353	10	89725105	10	87965348	818353	810129	rs750585255	NC_000010.11:87965347:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	363	PTEN
NM_000314.8(PTEN):c.1090T>C (p.Ser364Pro)	PTEN	S364P	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001022675	10	89725107	10	87965350	1022675	1009281	rs1860735904	NC_000010.11:87965349:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	364	PTEN
NM_000314.8(PTEN):c.1091C>G (p.Ser364Cys)	PTEN	S364C	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000857491	10	89725108	10	87965351	857491	837451	rs1164665914	NC_000010.11:87965350:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	364	PTEN
NM_000314.8(PTEN):c.1093G>C (p.Val365Leu)	PTEN	V365L	Hereditary cancer-predisposing syndrome	VCV002452976	10	89725110	10	87965353	2452976	2433957	NA	NC_000010.11:87965352:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	365	PTEN
NM_000314.8(PTEN):c.1093G>A (p.Val365Ile)	PTEN	V365I	PTEN hamartoma tumor syndrome	VCV000237639	10	89725110	10	87965353	237639	240889	rs758542021	NC_000010.11:87965352:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	365	PTEN
NM_000314.8(PTEN):c.1096A>C (p.Thr366Pro)	PTEN	T366P	Neoplasm	VCV003257940	10	89725113	10	87965356	3257940	3416699	NA	NC_000010.11:87965355:A:C	single nucleotide variant	missense variant	NA	NA	NA	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	366	PTEN
NM_000314.8(PTEN):c.1096A>G (p.Thr366Ala)	PTEN	T366A	PTEN hamartoma tumor syndrome	VCV000576100	10	89725113	10	87965356	576100	569864	rs1564570409	NC_000010.11:87965355:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	366	PTEN
NM_000314.8(PTEN):c.1097C>T (p.Thr366Ile)	PTEN	T366I	Hereditary cancer-predisposing syndrome	VCV003311256	10	89725114	10	87965357	3311256	3468241	NA	NC_000010.11:87965356:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	366	PTEN
NM_000314.8(PTEN):c.1103A>T (p.Asp368Val)	PTEN	D368V	PTEN hamartoma tumor syndrome	VCV000949056	10	89725120	10	87965363	949056	925972	rs1860736589	NC_000010.11:87965362:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	368	PTEN
NM_000314.8(PTEN):c.1104T>A (p.Asp368Glu)	PTEN	D368E	Hereditary cancer-predisposing syndrome|not provided	VCV000185298	10	89725121	10	87965364	185298	183062	rs35979531	NC_000010.11:87965363:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2015	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	368	PTEN
NM_000314.8(PTEN):c.1105G>A (p.Val369Ile)	PTEN	V369I	PTEN hamartoma tumor syndrome	VCV000142088	10	89725122	10	87965365	142088	151802	rs587782224	NC_000010.11:87965364:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	369	PTEN
NM_000314.8(PTEN):c.1114A>G (p.Asn372Asp)	PTEN	N372D	PTEN hamartoma tumor syndrome	VCV001503862	10	89725131	10	87965374	1503862	1424266	rs2132289789	NC_000010.11:87965373:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	372	PTEN
NM_000314.8(PTEN):c.1115A>G (p.Asn372Ser)	PTEN	N372S	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000468670	10	89725132	10	87965375	468670	460670	rs1370349057	NC_000010.11:87965374:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	372	PTEN
NM_000314.8(PTEN):c.1116T>A (p.Asn372Lys)	PTEN	N372K	Hereditary cancer-predisposing syndrome	VCV001796384	10	89725133	10	87965376	1796384	1852819	NA	NC_000010.11:87965375:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	372	PTEN
NM_000314.8(PTEN):c.1120C>T (p.Pro374Ser)	PTEN	P374S	Hereditary cancer-predisposing syndrome	VCV002488773	10	89725137	10	87965380	2488773	2470439	NA	NC_000010.11:87965379:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	374	PTEN
NM_000314.8(PTEN):c.1123G>A (p.Asp375Asn)	PTEN	D375N	PTEN hamartoma tumor syndrome	VCV000568323	10	89725140	10	87965383	568323	564032	rs1564570429	NC_000010.11:87965382:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	375	PTEN
NM_000314.8(PTEN):c.1124A>G (p.Asp375Gly)	PTEN	D375G	PTEN hamartoma tumor syndrome	VCV000651164	10	89725141	10	87965384	651164	639294	rs1589669344	NC_000010.11:87965383:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	375	PTEN
NM_000314.8(PTEN):c.1126C>G (p.His376Asp)	PTEN	H376D	not provided	VCV002682052	10	89725143	10	87965386	2682052	2843084	NA	NC_000010.11:87965385:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	376	PTEN
NM_000314.8(PTEN):c.1126C>T (p.His376Tyr)	PTEN	H376Y	not provided	VCV002502682	10	89725143	10	87965386	2502682	2667788	NA	NC_000010.11:87965385:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	376	PTEN
NM_000314.8(PTEN):c.1130A>T (p.Tyr377Phe)	PTEN	Y377F	Hereditary cancer-predisposing syndrome|not specified|PTEN hamartoma tumor syndrome|Glioma susceptibility 2	VCV000186450	10	89725147	10	87965390	186450	183063	rs751286806	NC_000010.11:87965389:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	377	PTEN
NM_000314.8(PTEN):c.1132A>G (p.Arg378Gly)	PTEN	R378G	PTEN hamartoma tumor syndrome	VCV000536550	10	89725149	10	87965392	536550	525520	rs1554826055	NC_000010.11:87965391:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	378	PTEN
NM_000314.8(PTEN):c.1133G>C (p.Arg378Thr)	PTEN	R378T	not provided	VCV002431002	10	89725150	10	87965393	2431002	2404508	NA	NC_000010.11:87965392:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	378	PTEN
NM_000314.8(PTEN):c.1159C>T (p.Pro387Ser)	PTEN	P387S	PTEN hamartoma tumor syndrome	VCV001062913	10	89725176	10	87965419	1062913	1046829	rs2132290116	NC_000010.11:87965418:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	387	PTEN
NM_000314.8(PTEN):c.1160C>T (p.Pro387Leu)	PTEN	P387L	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000576918	10	89725177	10	87965420	576918	566600	rs1564570452	NC_000010.11:87965419:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	387	PTEN
NM_000314.8(PTEN):c.1163A>T (p.Glu388Val)	PTEN	E388V	Hereditary cancer-predisposing syndrome	VCV002587203	10	89725180	10	87965423	2587203	2753879	NA	NC_000010.11:87965422:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	388	PTEN
NM_000314.8(PTEN):c.1164G>T (p.Glu388Asp)	PTEN	E388D	PTEN hamartoma tumor syndrome	VCV001379559	10	89725181	10	87965424	1379559	1482938	rs1860738430	NC_000010.11:87965423:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	388	PTEN
NM_000314.8(PTEN):c.1164G>C (p.Glu388Asp)	PTEN	E388D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000924240	10	89725181	10	87965424	924240	911235	rs1860738430	NC_000010.11:87965423:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	388	PTEN
NM_000314.8(PTEN):c.1166A>G (p.Asn389Ser)	PTEN	N389S	PTEN hamartoma tumor syndrome	VCV001373194	10	89725183	10	87965426	1373194	1463194	rs1860738514	NC_000010.11:87965425:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	389	PTEN
NM_000314.8(PTEN):c.1169A>G (p.Glu390Gly)	PTEN	E390G	Hereditary cancer-predisposing syndrome|not provided	VCV001806618	10	89725186	10	87965429	1806618	1863624	NA	NC_000010.11:87965428:A:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	390	PTEN
NM_000314.8(PTEN):c.1171C>T (p.Pro391Ser)	PTEN	P391S	PTEN hamartoma tumor syndrome	VCV000187673	10	89725188	10	87965431	187673	183064	rs786203911	NC_000010.11:87965430:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	391	PTEN
NM_000314.8(PTEN):c.1172C>T (p.Pro391Leu)	PTEN	P391L	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000490112	10	89725189	10	87965432	490112	482790	rs1554826059	NC_000010.11:87965431:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	391	PTEN
NM_000314.8(PTEN):c.1172C>A (p.Pro391His)	PTEN	P391H	Hereditary cancer-predisposing syndrome	VCV000490111	10	89725189	10	87965432	490111	482766	rs1554826059	NC_000010.11:87965431:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	391	PTEN
NM_000314.8(PTEN):c.1177G>T (p.Asp393Tyr)	PTEN	D393Y	PTEN hamartoma tumor syndrome	VCV000841411	10	89725194	10	87965437	841411	837452	rs1860739011	NC_000010.11:87965436:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	393	PTEN
NM_000314.8(PTEN):c.1178A>G (p.Asp393Gly)	PTEN	D393G	Hereditary cancer-predisposing syndrome	VCV000560733	10	89725195	10	87965438	560733	551805	rs1564570482	NC_000010.11:87965437:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2018	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	393	PTEN
NM_000314.8(PTEN):c.1182A>T (p.Glu394Asp)	PTEN	E394D	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV001912822	10	89725199	10	87965442	1912822	1976923	NA	NC_000010.11:87965441:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	394	PTEN
NM_000314.8(PTEN):c.1183G>T (p.Asp395Tyr)	PTEN	D395Y	PTEN hamartoma tumor syndrome	VCV002126147	10	89725200	10	87965443	2126147	2185315	NA	NC_000010.11:87965442:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	395	PTEN
NM_000314.8(PTEN):c.1184A>G (p.Asp395Gly)	PTEN	D395G	Hereditary cancer-predisposing syndrome	VCV001742938	10	89725201	10	87965444	1742938	1809019	NA	NC_000010.11:87965443:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	395	PTEN
NM_000314.8(PTEN):c.1186C>G (p.Gln396Glu)	PTEN	Q396E	Hereditary cancer-predisposing syndrome	VCV002452973	10	89725203	10	87965446	2452973	2433954	NA	NC_000010.11:87965445:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	396	PTEN
NM_000314.8(PTEN):c.1189C>T (p.His397Tyr)	PTEN	H397Y	Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Familial meningioma|Macrocephaly-autism syndrome|Glioma susceptibility 2|Malignant tumor of prostate|Hereditary cancer-predisposing syndrome	VCV000818542	10	89725206	10	87965449	818542	810132	rs1589669413	NC_000010.11:87965448:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	397	PTEN
NM_000314.8(PTEN):c.1190A>T (p.His397Leu)	PTEN	H397L	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000818548	10	89725207	10	87965450	818548	810133	rs876661021	NC_000010.11:87965449:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	397	PTEN
NM_000314.8(PTEN):c.1190A>G (p.His397Arg)	PTEN	H397R	not provided|PTEN hamartoma tumor syndrome	VCV000234434	10	89725207	10	87965450	234434	231789	rs876661021	NC_000010.11:87965449:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	397	PTEN
NM_000314.8(PTEN):c.1191T>G (p.His397Gln)	PTEN	H397Q	PTEN hamartoma tumor syndrome	VCV001037031	10	89725208	10	87965451	1037031	1029850	rs1860739604	NC_000010.11:87965450:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	397	PTEN
NM_000314.8(PTEN):c.1193C>T (p.Thr398Ile)	PTEN	T398I	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV001039305	10	89725210	10	87965453	1039305	1029851	rs1860739729	NC_000010.11:87965452:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	398	PTEN
NM_000314.8(PTEN):c.1197A>T (p.Gln399His)	PTEN	Q399H	not provided	VCV001318532	10	89725214	10	87965457	1318532	1308316	rs374684043	NC_000010.11:87965456:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	399	PTEN
NM_000314.8(PTEN):c.1197A>C (p.Gln399His)	PTEN	Q399H	Hereditary cancer-predisposing syndrome	VCV000921678	10	89725214	10	87965457	921678	911236	rs374684043	NC_000010.11:87965456:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	399	PTEN
NM_000314.8(PTEN):c.1198A>G (p.Ile400Val)	PTEN	I400V	Glioma susceptibility 2|not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	VCV000216420	10	89725215	10	87965458	216420	212826	rs863224665	NC_000010.11:87965457:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	400	PTEN
NM_000314.8(PTEN):c.1202C>A (p.Thr401Lys)	PTEN	T401K	Hereditary cancer-predisposing syndrome	VCV001747840	10	89725219	10	87965462	1747840	1800138	NA	NC_000010.11:87965461:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	401	PTEN
NM_000314.8(PTEN):c.1202C>T (p.Thr401Ile)	PTEN	T401I	PTEN hamartoma tumor syndrome	VCV000847238	10	89725219	10	87965462	847238	837453	rs1860740005	NC_000010.11:87965461:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	401	PTEN
NM_000314.8(PTEN):c.1204A>G (p.Lys402Glu)	PTEN	K402E	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000536557	10	89725221	10	87965464	536557	525590	rs1554826064	NC_000010.11:87965463:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	402	PTEN
NM_000314.8(PTEN):c.1206A>C (p.Lys402Asn)	PTEN	K402N	not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	VCV000422815	10	89725223	10	87965466	422815	408011	rs1064796017	NC_000010.11:87965465:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	402	PTEN
NM_000314.8(PTEN):c.1207G>T (p.Val403Phe)	PTEN	V403F	PTEN hamartoma tumor syndrome	VCV002101671	10	89725224	10	87965467	2101671	2147929	NA	NC_000010.11:87965466:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	403	PTEN
NM_000314.8(PTEN):c.1207G>A (p.Val403Ile)	PTEN	V403I	PTEN hamartoma tumor syndrome	VCV001401113	10	89725224	10	87965467	1401113	1379101	rs2132290414	NC_000010.11:87965466:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	403	PTEN
NM_000546.6(TP53):c.1179C>G (p.Asp393Glu)	TP53	D393E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001026463	17	7572930	17	7669612	1026463	1013140	rs2072829931	NC_000017.11:7669611:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Oct 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	393	TP53
NM_000546.6(TP53):c.1177G>T (p.Asp393Tyr)	TP53	D393Y	Hereditary cancer-predisposing syndrome	VCV001741120	17	7572932	17	7669614	1741120	1808497	NA	NC_000017.11:7669613:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jul 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	393	TP53
NM_000546.6(TP53):c.1177G>C (p.Asp393His)	TP53	D393H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000818502	17	7572932	17	7669614	818502	814442	rs1192921623	NC_000017.11:7669613:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	393	TP53
NM_000546.6(TP53):c.1177G>A (p.Asp393Asn)	TP53	D393N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000492574	17	7572932	17	7669614	492574	485503	rs1192921623	NC_000017.11:7669613:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Mar 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	393	TP53
NM_000546.6(TP53):c.1174T>C (p.Ser392Pro)	TP53	S392P	Li-Fraumeni syndrome	VCV002095568	17	7572935	17	7669617	2095568	2153474	NA	NC_000017.11:7669616:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	392	TP53
NM_000546.6(TP53):c.1173C>G (p.Asp391Glu)	TP53	D391E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000629063	17	7572936	17	7669618	629063	618824	rs1567540133	NC_000017.11:7669617:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	391	TP53
NM_000546.6(TP53):c.1171G>A (p.Asp391Asn)	TP53	D391N	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV003232049	17	7572938	17	7669620	3232049	3385589	NA	NC_000017.11:7669619:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	391	TP53
NM_000546.6(TP53):c.1168C>A (p.Pro390Thr)	TP53	P390T	Hereditary cancer-predisposing syndrome	VCV000818485	17	7572941	17	7669623	818485	814443	rs1597345232	NC_000017.11:7669622:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 17, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	390	TP53
NM_000546.6(TP53):c.1165G>A (p.Gly389Arg)	TP53	G389R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000458522	17	7572944	17	7669626	458522	467483	rs587783064	NC_000017.11:7669625:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	389	TP53
NM_000546.6(TP53):c.1165G>T (p.Gly389Trp)	TP53	G389W	Li-Fraumeni syndrome 1	VCV000156517	17	7572944	17	7669626	156517	166282	rs587783064	NC_000017.11:7669625:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 24, 2014	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	389	TP53
NM_000546.6(TP53):c.1164A>T (p.Glu388Asp)	TP53	E388D	Hereditary cancer-predisposing syndrome	VCV001737684	17	7572945	17	7669627	1737684	1787548	NA	NC_000017.11:7669626:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	388	TP53
NM_000546.6(TP53):c.1163A>C (p.Glu388Ala)	TP53	E388A	Li-Fraumeni syndrome	VCV000141425	17	7572946	17	7669628	141425	151139	rs587781736	NC_000017.11:7669627:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 10, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	388	TP53
NM_000546.6(TP53):c.1162G>C (p.Glu388Gln)	TP53	E388Q	Hereditary cancer-predisposing syndrome	VCV001737291	17	7572947	17	7669629	1737291	1790490	NA	NC_000017.11:7669628:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jul 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	388	TP53
NM_000546.6(TP53):c.1160C>G (p.Thr387Arg)	TP53	T387R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000485050	17	7572949	17	7669631	485050	479232	rs927888647	NC_000017.11:7669630:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	387	TP53
NM_000546.6(TP53):c.1159A>C (p.Thr387Pro)	TP53	T387P	Hereditary cancer-predisposing syndrome	VCV002585882	17	7572950	17	7669632	2585882	2753442	NA	NC_000017.11:7669631:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Aug 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	387	TP53
NM_000546.6(TP53):c.1157A>G (p.Lys386Arg)	TP53	K386R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000818446	17	7572952	17	7669634	818446	814444	rs1597345314	NC_000017.11:7669633:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	May 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	386	TP53
NM_000546.6(TP53):c.1155C>A (p.Phe385Leu)	TP53	F385L	Hereditary cancer-predisposing syndrome	VCV001735082	17	7572954	17	7669636	1735082	1793421	NA	NC_000017.11:7669635:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Dec 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	385	TP53
NM_000546.6(TP53):c.1153T>C (p.Phe385Leu)	TP53	F385L	Hereditary cancer-predisposing syndrome	VCV000485029	17	7572956	17	7669638	485029	479204	rs1555524094	NC_000017.11:7669637:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	385	TP53
NM_000546.6(TP53):c.1152G>A (p.Met384Ile)	TP53	M384I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000639734	17	7572957	17	7669639	639734	646725	rs1597345344	NC_000017.11:7669638:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Aug 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	384	TP53
NM_000546.6(TP53):c.1151T>G (p.Met384Arg)	TP53	M384R	Li-Fraumeni syndrome	VCV000458521	17	7572958	17	7669640	458521	469099	rs1060501196	NC_000017.11:7669639:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 20, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	384	TP53
NM_000546.6(TP53):c.1151T>C (p.Met384Thr)	TP53	M384T	Li-Fraumeni syndrome 1	VCV000406575	17	7572958	17	7669640	406575	402994	rs1060501196	NC_000017.11:7669639:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	384	TP53
NM_000546.6(TP53):c.1150A>T (p.Met384Leu)	TP53	M384L	Li-Fraumeni syndrome	VCV001493091	17	7572959	17	7669641	1493091	1515927	rs730882009	NC_000017.11:7669640:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	384	TP53
NM_000546.6(TP53):c.1150A>G (p.Met384Val)	TP53	M384V	Li-Fraumeni syndrome 1	VCV000182939	17	7572959	17	7669641	182939	180986	rs730882009	NC_000017.11:7669640:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	384	TP53
NM_000546.6(TP53):c.1148T>C (p.Leu383Pro)	TP53	L383P	Hereditary cancer-predisposing syndrome	VCV003232048	17	7572961	17	7669643	3232048	3385588	NA	NC_000017.11:7669642:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	383	TP53
NM_000546.6(TP53):c.1147C>T (p.Leu383Phe)	TP53	L383F	Hereditary cancer-predisposing syndrome|not provided	VCV000619733	17	7572962	17	7669644	619733	611257	rs150842067	NC_000017.11:7669643:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 2, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	383	TP53
NM_000546.6(TP53):c.1145A>T (p.Lys382Ile)	TP53	K382I	Hereditary cancer-predisposing syndrome	VCV001732327	17	7572964	17	7669646	1732327	1789358	NA	NC_000017.11:7669645:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	382	TP53
NM_000546.6(TP53):c.1145A>C (p.Lys382Thr)	TP53	K382T	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome	VCV000860528	17	7572964	17	7669646	860528	846248	rs2072835191	NC_000017.11:7669645:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	382	TP53
NM_000546.6(TP53):c.1141A>G (p.Lys381Glu)	TP53	K381E	Li-Fraumeni syndrome	VCV000976475	17	7572968	17	7669650	976475	964740	rs2072835371	NC_000017.11:7669649:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	381	TP53
NM_000546.6(TP53):c.1139A>G (p.His380Arg)	TP53	H380R	Li-Fraumeni syndrome	VCV002123066	17	7572970	17	7669652	2123066	2180960	NA	NC_000017.11:7669651:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	380	TP53
NM_000546.6(TP53):c.1136G>A (p.Arg379His)	TP53	R379H	Li-Fraumeni syndrome 1	VCV000246221	17	7572973	17	7669655	246221	245067	rs863224682	NC_000017.11:7669654:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	379	TP53
NM_000546.6(TP53):c.1136G>T (p.Arg379Leu)	TP53	R379L	Li-Fraumeni syndrome 1	VCV000216463	17	7572973	17	7669655	216463	213384	rs863224682	NC_000017.11:7669654:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Apr 2, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	379	TP53
NM_000546.6(TP53):c.1135C>A (p.Arg379Ser)	TP53	R379S	Li-Fraumeni syndrome 1	VCV000186762	17	7572974	17	7669656	186762	185334	rs749061599	NC_000017.11:7669655:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	379	TP53
NM_000546.6(TP53):c.1135C>T (p.Arg379Cys)	TP53	R379C	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000186611	17	7572974	17	7669656	186611	185333	rs749061599	NC_000017.11:7669655:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	379	TP53
NM_000546.6(TP53):c.1133C>A (p.Ser378Tyr)	TP53	S378Y	Adrenocortical carcinoma, hereditary	VCV003068296	17	7572976	17	7669658	3068296	3227630	NA	NC_000017.11:7669657:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	378	TP53
NM_000546.6(TP53):c.1133C>G (p.Ser378Cys)	TP53	S378C	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480749	17	7572976	17	7669658	480749	479278	rs1555524130	NC_000017.11:7669657:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	378	TP53
NM_000546.6(TP53):c.1130C>T (p.Thr377Ile)	TP53	T377I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000822222	17	7572979	17	7669661	822222	814445	rs1597345549	NC_000017.11:7669660:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	377	TP53
NM_000546.6(TP53):c.1129A>C (p.Thr377Pro)	TP53	T377P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000975959	17	7572980	17	7669662	975959	964494	rs774269719	NC_000017.11:7669661:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	377	TP53
NM_000546.6(TP53):c.1129A>G (p.Thr377Ala)	TP53	T377A	Li-Fraumeni syndrome|not provided	VCV000569094	17	7572980	17	7669662	569094	574620	rs774269719	NC_000017.11:7669661:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	377	TP53
NM_000546.6(TP53):c.1127C>T (p.Ser376Phe)	TP53	S376F	Hereditary cancer-predisposing syndrome	VCV000492573	17	7572982	17	7669664	492573	485286	rs1555524151	NC_000017.11:7669663:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 30, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	376	TP53
NM_000546.6(TP53):c.1125G>T (p.Gln375His)	TP53	Q375H	Hereditary cancer-predisposing syndrome	VCV001799016	17	7572984	17	7669666	1799016	1856285	NA	NC_000017.11:7669665:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	375	TP53
NM_000546.6(TP53):c.1123C>A (p.Gln375Lys)	TP53	Q375K	Hereditary cancer-predisposing syndrome	VCV001798385	17	7572986	17	7669668	1798385	1856525	NA	NC_000017.11:7669667:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	375	TP53
NM_000546.6(TP53):c.1121G>A (p.Gly374Asp)	TP53	G374D	Li-Fraumeni syndrome	VCV002719153	17	7572988	17	7669670	2719153	2873674	NA	NC_000017.11:7669669:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	374	TP53
NM_000546.6(TP53):c.1121G>T (p.Gly374Val)	TP53	G374V	Hereditary cancer-predisposing syndrome	VCV001797938	17	7572988	17	7669670	1797938	1853557	NA	NC_000017.11:7669669:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 7, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	374	TP53
NM_000546.6(TP53):c.1120G>T (p.Gly374Cys)	TP53	G374C	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000665996	17	7572989	17	7669671	665996	646726	rs587781858	NC_000017.11:7669670:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	374	TP53
NM_000546.6(TP53):c.1120G>C (p.Gly374Arg)	TP53	G374R	Li-Fraumeni syndrome	VCV000230269	17	7572989	17	7669671	230269	236436	rs587781858	NC_000017.11:7669670:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	374	TP53
NM_000546.6(TP53):c.1120G>A (p.Gly374Ser)	TP53	G374S	Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000141583	17	7572989	17	7669671	141583	151297	rs587781858	NC_000017.11:7669670:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	374	TP53
NM_000546.6(TP53):c.1119G>C (p.Lys373Asn)	TP53	K373N	Hereditary cancer-predisposing syndrome	VCV003328167	17	7572990	17	7669672	3328167	3486880	NA	NC_000017.11:7669671:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	373	TP53
NM_000546.6(TP53):c.1119G>T (p.Lys373Asn)	TP53	K373N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000839498	17	7572990	17	7669672	839498	846249	rs1342613419	NC_000017.11:7669671:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	373	TP53
NM_000546.6(TP53):c.1118A>T (p.Lys373Met)	TP53	K373M	Li-Fraumeni syndrome	VCV001059527	17	7572991	17	7669673	1059527	1050658	rs1567540504	NC_000017.11:7669672:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	373	TP53
NM_000546.6(TP53):c.1118A>G (p.Lys373Arg)	TP53	K373R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000577458	17	7572991	17	7669673	577458	574621	rs1567540504	NC_000017.11:7669672:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	373	TP53
NM_000546.6(TP53):c.1115A>C (p.Lys372Thr)	TP53	K372T	not specified	VCV000439315	17	7572994	17	7669676	439315	432939	rs876658876	NC_000017.11:7669675:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 26, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	372	TP53
NM_000546.6(TP53):c.1115A>G (p.Lys372Arg)	TP53	K372R	TP53-related disorder|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000230970	17	7572994	17	7669676	230970	236437	rs876658876	NC_000017.11:7669675:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Aug 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	372	TP53
NM_000546.6(TP53):c.1112C>A (p.Ser371Tyr)	TP53	S371Y	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001482750	17	7572997	17	7669679	1482750	1442115	rs2150988837	NC_000017.11:7669678:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Aug 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	371	TP53
NM_000546.6(TP53):c.1109A>T (p.Lys370Met)	TP53	K370M	Hereditary cancer-predisposing syndrome	VCV001794493	17	7573000	17	7669682	1794493	1852239	NA	NC_000017.11:7669681:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	370	TP53
NM_000546.6(TP53):c.1109A>C (p.Lys370Thr)	TP53	K370T	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001510904	17	7573000	17	7669682	1510904	1465581	rs2150988865	NC_000017.11:7669681:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	May 17, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	370	TP53
NM_000546.6(TP53):c.1104C>A (p.His368Gln)	TP53	H368Q	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000657014	17	7573005	17	7669687	657014	646727	rs1289241865	NC_000017.11:7669686:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 6, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	368	TP53
NM_000546.6(TP53):c.1104C>G (p.His368Gln)	TP53	H368Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1	VCV000485038	17	7573005	17	7669687	485038	479248	rs1289241865	NC_000017.11:7669686:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	368	TP53
NM_000546.6(TP53):c.1103A>G (p.His368Arg)	TP53	H368R	Li-Fraumeni syndrome	VCV001386302	17	7573006	17	7669688	1386302	1361310	rs2150988929	NC_000017.11:7669687:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	368	TP53
NM_000546.6(TP53):c.1102C>A (p.His368Asn)	TP53	H368N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000919211	17	7573007	17	7669689	919211	914175	rs786204227	NC_000017.11:7669688:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	368	TP53
NM_000546.6(TP53):c.1102C>T (p.His368Tyr)	TP53	H368Y	Li-Fraumeni syndrome 1	VCV000188342	17	7573007	17	7669689	188342	186272	rs786204227	NC_000017.11:7669688:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Apr 19, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	368	TP53
NM_000546.6(TP53):c.1100G>C (p.Ser367Thr)	TP53	S367T	Li-Fraumeni syndrome	VCV000858737	17	7573927	17	7670609	858737	846250	rs749150541	NC_000017.11:7670608:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 18, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	367	TP53
NM_000546.6(TP53):c.1099A>G (p.Ser367Gly)	TP53	S367G	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000231953	17	7573928	17	7670610	231953	236439	rs876659459	NC_000017.11:7670609:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	367	TP53
NM_000546.6(TP53):c.1097C>A (p.Ser366Tyr)	TP53	S366Y	Li-Fraumeni syndrome	VCV002762393	17	7573930	17	7670612	2762393	2930889	NA	NC_000017.11:7670611:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	366	TP53
NM_000546.6(TP53):c.1097C>T (p.Ser366Phe)	TP53	S366F	Hereditary cancer-predisposing syndrome	VCV002565396	17	7573930	17	7670612	2565396	2732369	NA	NC_000017.11:7670611:G:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	May 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	366	TP53
NM_000546.6(TP53):c.1097C>G (p.Ser366Cys)	TP53	S366C	Hereditary cancer-predisposing syndrome	VCV000927316	17	7573930	17	7670612	927316	914176	rs2072905459	NC_000017.11:7670611:G:C	single nucleotide variant	3 prime UTR variant|missense variant	Uncertain significance	Jun 23, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	366	TP53
NM_000546.6(TP53):c.1096T>A (p.Ser366Thr)	TP53	S366T	Li-Fraumeni syndrome	VCV002005578	17	7573931	17	7670613	2005578	2052342	NA	NC_000017.11:7670612:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	366	TP53
NM_000546.6(TP53):c.1096T>C (p.Ser366Pro)	TP53	S366P	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000528252	17	7573931	17	7670613	528252	532181	rs17881470	NC_000017.11:7670612:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 19, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	366	TP53
NM_000546.6(TP53):c.1096T>G (p.Ser366Ala)	TP53	S366A	Li-Fraumeni syndrome	VCV000135360	17	7573931	17	7670613	135360	139099	rs17881470	NC_000017.11:7670612:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	366	TP53
NM_000546.6(TP53):c.1094A>C (p.His365Pro)	TP53	H365P	Hereditary cancer-predisposing syndrome	VCV001790091	17	7573933	17	7670615	1790091	1844838	NA	NC_000017.11:7670614:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	365	TP53
NM_000546.6(TP53):c.1093C>T (p.His365Tyr)	TP53	H365Y	Li-Fraumeni syndrome	VCV000080708	17	7573934	17	7670616	80708	91599	rs267605075	NC_000017.11:7670615:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	365	TP53
NM_000546.6(TP53):c.1091C>T (p.Ala364Val)	TP53	A364V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000568955	17	7573936	17	7670618	568955	574622	rs1567541711	NC_000017.11:7670617:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	364	TP53
NM_000546.6(TP53):c.1090G>A (p.Ala364Thr)	TP53	A364T	Li-Fraumeni syndrome	VCV001414768	17	7573937	17	7670619	1414768	1369970	rs2072906212	NC_000017.11:7670618:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 6, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	364	TP53
NM_000546.6(TP53):c.1090G>T (p.Ala364Ser)	TP53	A364S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000848951	17	7573937	17	7670619	848951	846251	rs2072906212	NC_000017.11:7670618:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	364	TP53
NM_000546.6(TP53):c.1089G>T (p.Arg363Ser)	TP53	R363S	Li-Fraumeni syndrome	VCV000945439	17	7573938	17	7670620	945439	928547	rs1597348743	NC_000017.11:7670619:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 14, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	363	TP53
NM_000546.6(TP53):c.1087_1088inv (p.Arg363Leu)	TP53	R363L	Adrenocortical carcinoma, hereditary	VCV003240618	17	7573939 - 7573940	17	7670621 - 7670622	3240618	3399604	NA	NC_000017.11:7670620:CT:AG	Inversion	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 29, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	363	TP53
NM_000546.6(TP53):c.1088G>A (p.Arg363Lys)	TP53	R363K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000233244	17	7573939	17	7670621	233244	236440	rs876660285	NC_000017.11:7670620:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	363	TP53
NM_000546.6(TP53):c.1087A>G (p.Arg363Gly)	TP53	R363G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	VCV000188151	17	7573940	17	7670622	188151	186273	rs745751553	NC_000017.11:7670621:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	363	TP53
NM_000546.6(TP53):c.1086C>A (p.Ser362Arg)	TP53	S362R	Li-Fraumeni syndrome	VCV002078374	17	7573941	17	7670623	2078374	2138889	NA	NC_000017.11:7670622:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	362	TP53
NM_000546.6(TP53):c.1085G>T (p.Ser362Ile)	TP53	S362I	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000485048	17	7573942	17	7670624	485048	479286	rs768803947	NC_000017.11:7670623:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	362	TP53
NM_000546.6(TP53):c.1085G>A (p.Ser362Asn)	TP53	S362N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000458516	17	7573942	17	7670624	458516	468368	rs768803947	NC_000017.11:7670623:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	362	TP53
NM_000546.6(TP53):c.1084A>G (p.Ser362Gly)	TP53	S362G	not provided	VCV001205464	17	7573943	17	7670625	1205464	1195255	rs1287887419	NC_000017.11:7670624:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 14, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	362	TP53
NM_000546.6(TP53):c.1084A>T (p.Ser362Cys)	TP53	S362C	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000458515	17	7573943	17	7670625	458515	469106	rs1287887419	NC_000017.11:7670624:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	362	TP53
NM_000546.6(TP53):c.1082G>A (p.Gly361Glu)	TP53	G361E	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000141331	17	7573945	17	7670627	141331	151045	rs587781663	NC_000017.11:7670626:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	361	TP53
NM_000546.6(TP53):c.1081G>A (p.Gly361Arg)	TP53	G361R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001961562	17	7573946	17	7670628	1961562	2016531	NA	NC_000017.11:7670627:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	361	TP53
NM_000546.6(TP53):c.1081G>C (p.Gly361Arg)	TP53	G361R	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480761	17	7573946	17	7670628	480761	479257	rs1555524361	NC_000017.11:7670627:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	361	TP53
NM_000546.6(TP53):c.1079G>A (p.Gly360Glu)	TP53	G360E	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000230306	17	7573948	17	7670630	230306	236441	rs35993958	NC_000017.11:7670629:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	360	TP53
NM_000546.6(TP53):c.1079G>T (p.Gly360Val)	TP53	G360V	Li-Fraumeni syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000142552	17	7573948	17	7670630	142552	152266	rs35993958	NC_000017.11:7670629:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Dec 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	360	TP53
NM_000546.6(TP53):c.1079G>C (p.Gly360Ala)	TP53	G360A	Li-Fraumeni syndrome	VCV000142003	17	7573948	17	7670630	142003	151717	rs35993958	NC_000017.11:7670629:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	360	TP53
NM_000546.6(TP53):c.1078G>C (p.Gly360Arg)	TP53	G360R	Hereditary cancer-predisposing syndrome	VCV001785528	17	7573949	17	7670631	1785528	1840325	NA	NC_000017.11:7670630:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	360	TP53
NM_000546.6(TP53):c.1078G>T (p.Gly360Trp)	TP53	G360W	Hereditary cancer-predisposing syndrome	VCV000480753	17	7573949	17	7670631	480753	479206	rs786203298	NC_000017.11:7670630:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 28, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	360	TP53
NM_000546.6(TP53):c.1078G>A (p.Gly360Arg)	TP53	G360R	Hereditary cancer-predisposing syndrome|not provided|TP53-related disorder|Li-Fraumeni syndrome|not specified	VCV000186887	17	7573949	17	7670631	186887	185335	rs786203298	NC_000017.11:7670630:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Feb 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	360	TP53
NM_000546.6(TP53):c.1076C>G (p.Pro359Arg)	TP53	P359R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001171953	17	7573951	17	7670633	1171953	1161406	rs1483922249	NC_000017.11:7670632:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	359	TP53
NM_000546.6(TP53):c.1073A>T (p.Glu358Val)	TP53	E358V	not specified|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000230534	17	7573954	17	7670636	230534	236442	rs773553186	NC_000017.11:7670635:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	358	TP53
NM_000546.6(TP53):c.1072G>A (p.Glu358Lys)	TP53	E358K	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000142105	17	7573955	17	7670637	142105	151819	rs587782237	NC_000017.11:7670636:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	358	TP53
NM_000546.6(TP53):c.1070A>C (p.Lys357Thr)	TP53	K357T	Li-Fraumeni syndrome	VCV002820330	17	7573957	17	7670639	2820330	2981416	NA	NC_000017.11:7670638:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	357	TP53
NM_000546.6(TP53):c.1069A>G (p.Lys357Glu)	TP53	K357E	Squamous cell carcinoma of the head and neck	VCV000584919	17	7573958	17	7670640	584919	576029	rs1567541856	NC_000017.11:7670639:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 28, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	357	TP53
NM_000546.6(TP53):c.1067G>C (p.Gly356Ala)	TP53	G356A	Li-Fraumeni syndrome	VCV001716142	17	7573960	17	7670642	1716142	1771439	NA	NC_000017.11:7670641:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	356	TP53
NM_000546.6(TP53):c.1066G>A (p.Gly356Arg)	TP53	G356R	Hereditary cancer-predisposing syndrome	VCV002774646	17	7573961	17	7670643	2774646	2935373	NA	NC_000017.11:7670642:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	356	TP53
NM_000546.6(TP53):c.1066G>T (p.Gly356Trp)	TP53	G356W	Li-Fraumeni syndrome	VCV001998185	17	7573961	17	7670643	1998185	2053966	NA	NC_000017.11:7670642:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	356	TP53
NM_000546.6(TP53):c.1066G>C (p.Gly356Arg)	TP53	G356R	Li-Fraumeni syndrome	VCV000234059	17	7573961	17	7670643	234059	236443	rs766786605	NC_000017.11:7670642:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	356	TP53
NM_000546.6(TP53):c.1064C>A (p.Ala355Asp)	TP53	A355D	Hereditary cancer-predisposing syndrome	VCV002774647	17	7573963	17	7670645	2774647	2935374	NA	NC_000017.11:7670644:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	355	TP53
NM_000546.6(TP53):c.1064C>G (p.Ala355Gly)	TP53	A355G	Li-Fraumeni syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV001046623	17	7573963	17	7670645	1046623	1033670	rs1555524382	NC_000017.11:7670644:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	355	TP53
NM_000546.6(TP53):c.1064C>T (p.Ala355Val)	TP53	A355V	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000528241	17	7573963	17	7670645	528241	531793	rs1555524382	NC_000017.11:7670644:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	355	TP53
NM_000546.6(TP53):c.1063G>A (p.Ala355Thr)	TP53	A355T	Hereditary cancer-predisposing syndrome	VCV001781085	17	7573964	17	7670646	1781085	1839353	NA	NC_000017.11:7670645:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	355	TP53
NM_000546.6(TP53):c.1063G>T (p.Ala355Ser)	TP53	A355S	Li-Fraumeni syndrome	VCV001468494	17	7573964	17	7670646	1468494	1358854	rs1157427821	NC_000017.11:7670645:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	355	TP53
NM_000546.6(TP53):c.1061A>C (p.Gln354Pro)	TP53	Q354P	Hereditary cancer-predisposing syndrome	VCV003328171	17	7573966	17	7670648	3328171	3486884	NA	NC_000017.11:7670647:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	May 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	354	TP53
NM_000546.6(TP53):c.1061A>T (p.Gln354Leu)	TP53	Q354L	Hereditary cancer-predisposing syndrome	VCV003232047	17	7573966	17	7670648	3232047	3385587	NA	NC_000017.11:7670647:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Dec 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	354	TP53
NM_000546.6(TP53):c.1061A>G (p.Gln354Arg)	TP53	Q354R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000629928	17	7573966	17	7670648	629928	618828	rs752142489	NC_000017.11:7670647:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	354	TP53
NM_000546.6(TP53):c.1060C>G (p.Gln354Glu)	TP53	Q354E	Li-Fraumeni syndrome	VCV001061283	17	7573967	17	7670649	1061283	1050661	rs755394212	NC_000017.11:7670648:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	354	TP53
NM_000546.6(TP53):c.1060C>A (p.Gln354Lys)	TP53	Q354K	Li-Fraumeni syndrome	VCV000231485	17	7573967	17	7670649	231485	236444	rs755394212	NC_000017.11:7670648:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	354	TP53
NM_000546.6(TP53):c.1057G>T (p.Ala353Ser)	TP53	A353S	Li-Fraumeni syndrome	VCV002126647	17	7573970	17	7670652	2126647	2181947	NA	NC_000017.11:7670651:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	353	TP53
NM_000546.6(TP53):c.1056T>G (p.Asp352Glu)	TP53	D352E	Hereditary cancer-predisposing syndrome	VCV001778759	17	7573971	17	7670653	1778759	1831343	NA	NC_000017.11:7670652:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Sep 24, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	352	TP53
NM_000546.6(TP53):c.1054G>A (p.Asp352Asn)	TP53	D352N	Adrenocortical carcinoma, hereditary	VCV003240620	17	7573973	17	7670655	3240620	3399606	NA	NC_000017.11:7670654:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	352	TP53
NM_000546.6(TP53):c.1054G>C (p.Asp352His)	TP53	D352H	Li-Fraumeni syndrome	VCV002847409	17	7573973	17	7670655	2847409	3012329	NA	NC_000017.11:7670654:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	352	TP53
NM_000546.6(TP53):c.1054G>T (p.Asp352Tyr)	TP53	D352Y	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000481148	17	7573973	17	7670655	481148	479208	rs1555524394	NC_000017.11:7670654:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	352	TP53
NM_000546.6(TP53):c.1053G>T (p.Lys351Asn)	TP53	K351N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000822085	17	7573974	17	7670656	822085	814447	rs1597349035	NC_000017.11:7670655:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	351	TP53
NM_000546.6(TP53):c.1052A>G (p.Lys351Arg)	TP53	K351R	Li-Fraumeni syndrome	VCV000458513	17	7573975	17	7670657	458513	468370	rs1555524396	NC_000017.11:7670656:T:C	single nucleotide variant	3 prime UTR variant|missense variant	Uncertain significance	Jun 10, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	351	TP53
NM_000546.6(TP53):c.1051A>G (p.Lys351Glu)	TP53	K351E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000072340	17	7573976	17	7670658	72340	83231	rs141402957	NC_000017.11:7670657:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	351	TP53
NM_000546.6(TP53):c.1049T>C (p.Leu350Pro)	TP53	L350P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV002450751	17	7573978	17	7670660	2450751	2423237	NA	NC_000017.11:7670659:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	350	TP53
NM_000546.6(TP53):c.1048C>G (p.Leu350Val)	TP53	L350V	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000854234	17	7573979	17	7670661	854234	846252	rs768046010	NC_000017.11:7670660:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Sep 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	350	TP53
NM_000546.6(TP53):c.1048C>T (p.Leu350Phe)	TP53	L350F	Hereditary cancer-predisposing syndrome	VCV000481022	17	7573979	17	7670661	481022	479295	rs768046010	NC_000017.11:7670660:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 26, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	350	TP53
NM_000546.6(TP53):c.1046A>G (p.Glu349Gly)	TP53	E349G	Hereditary cancer-predisposing syndrome	VCV001775423	17	7573981	17	7670663	1775423	1830620	NA	NC_000017.11:7670662:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Dec 21, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	349	TP53
NM_000546.6(TP53):c.1045G>A (p.Glu349Lys)	TP53	E349K	Li-Fraumeni syndrome	VCV000839717	17	7573982	17	7670664	839717	846253	rs1567541975	NC_000017.11:7670663:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 22, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	349	TP53
NM_000546.6(TP53):c.1045G>C (p.Glu349Gln)	TP53	E349Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000657729	17	7573982	17	7670664	657729	646728	rs1567541975	NC_000017.11:7670663:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	349	TP53
NM_000546.6(TP53):c.1043T>C (p.Leu348Ser)	TP53	L348S	Li-Fraumeni syndrome	VCV002746088	17	7573984	17	7670666	2746088	2911598	NA	NC_000017.11:7670665:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	348	TP53
NM_000546.6(TP53):c.1042T>G (p.Leu348Val)	TP53	L348V	Li-Fraumeni syndrome	VCV000406571	17	7573985	17	7670667	406571	403000	rs1060501193	NC_000017.11:7670666:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	348	TP53
NM_000546.6(TP53):c.1040C>G (p.Ala347Gly)	TP53	A347G	Hereditary breast ovarian cancer syndrome	VCV002683739	17	7573987	17	7670669	2683739	2844772	NA	NC_000017.11:7670668:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Nov 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	347	TP53
NM_000546.6(TP53):c.1039_1040delinsTT (p.Ala347Phe)	TP53	A347F	Li-Fraumeni syndrome	VCV002039935	17	7573987 - 7573988	17	7670669 - 7670670	2039935	2091397	NA	NC_000017.11:7670668:GC:AA	Indel	missense variant|3 prime UTR variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	347	TP53
NM_000546.6(TP53):c.1040C>T (p.Ala347Val)	TP53	A347V	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000422725	17	7573987	17	7670669	422725	410249	rs397516434	NC_000017.11:7670668:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	347	TP53
NM_000546.6(TP53):c.1040C>A (p.Ala347Asp)	TP53	A347D	Li-Fraumeni syndrome	VCV000043587	17	7573987	17	7670669	43587	52756	rs397516434	NC_000017.11:7670668:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	347	TP53
NM_000546.6(TP53):c.1039G>T (p.Ala347Ser)	TP53	A347S	Hereditary cancer-predisposing syndrome	VCV001773570	17	7573988	17	7670670	1773570	1830076	NA	NC_000017.11:7670669:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	347	TP53
NM_000546.6(TP53):c.1039G>A (p.Ala347Thr)	TP53	A347T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Familial cancer of breast	VCV000662690	17	7573988	17	7670670	662690	646729	rs1597349147	NC_000017.11:7670669:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Feb 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	347	TP53
NM_000546.6(TP53):c.1038G>C (p.Glu346Asp)	TP53	E346D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000480755	17	7573989	17	7670671	480755	479962	rs1555524406	NC_000017.11:7670670:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	May 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	346	TP53
NM_000546.6(TP53):c.1037A>G (p.Glu346Gly)	TP53	E346G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV003011115	17	7573990	17	7670672	3011115	3180502	NA	NC_000017.11:7670671:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	346	TP53
NM_000546.6(TP53):c.1036G>A (p.Glu346Lys)	TP53	E346K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000646925	17	7573991	17	7670673	646925	646730	rs1567542019	NC_000017.11:7670672:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	346	TP53
NM_000546.6(TP53):c.1031T>G (p.Leu344Arg)	TP53	L344R	Li-Fraumeni syndrome	VCV002758378	17	7573996	17	7670678	2758378	2910477	NA	NC_000017.11:7670677:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	344	TP53
NM_000546.6(TP53):c.1031T>C (p.Leu344Pro)	TP53	L344P	Li-Fraumeni syndrome	VCV000012375	17	7573996	17	7670678	12375	27414	rs121912662	NC_000017.11:7670677:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	344	TP53
NM_000546.6(TP53):c.1030C>A (p.Leu344Met)	TP53	L344M	Hereditary cancer-predisposing syndrome	VCV001771001	17	7573997	17	7670679	1771001	1836139	NA	NC_000017.11:7670678:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 21, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	344	TP53
NM_000546.6(TP53):c.1030C>G (p.Leu344Val)	TP53	L344V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000956897	17	7573997	17	7670679	956897	950302	rs1597349242	NC_000017.11:7670678:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 25, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	344	TP53
NM_000546.6(TP53):c.1029G>C (p.Glu343Asp)	TP53	E343D	Adrenocortical carcinoma, hereditary	VCV002679227	17	7573998	17	7670680	2679227	2836804	NA	NC_000017.11:7670679:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	343	TP53
NM_000546.6(TP53):c.1027G>C (p.Glu343Gln)	TP53	E343Q	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV001015453	17	7574000	17	7670682	1015453	1013142	rs375573770	NC_000017.11:7670681:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	343	TP53
NM_000546.6(TP53):c.1025G>T (p.Arg342Leu)	TP53	R342L	Li-Fraumeni syndrome	VCV001055894	17	7574002	17	7670684	1055894	1050662	rs375338359	NC_000017.11:7670683:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	342	TP53
NM_000546.6(TP53):c.1024_1025delinsTT (p.Arg342Leu)	TP53	R342L	Hereditary cancer-predisposing syndrome	VCV000822031	17	7574002 - 7574003	17	7670684 - 7670685	822031	814450	rs1597349305	NC_000017.11:7670683:CG:AA	Indel	missense variant|3 prime UTR variant	Uncertain significance	Oct 3, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	342	TP53
NM_000546.6(TP53):c.1025G>A (p.Arg342Gln)	TP53	R342Q	Li-Fraumeni syndrome	VCV000233136	17	7574002	17	7670684	233136	236445	rs375338359	NC_000017.11:7670683:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	342	TP53
NM_000546.6(TP53):c.1025G>C (p.Arg342Pro)	TP53	R342P	Li-Fraumeni syndrome	VCV000215996	17	7574002	17	7670684	215996	213385	rs375338359	NC_000017.11:7670683:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	342	TP53
NM_000546.6(TP53):c.1024C>G (p.Arg342Gly)	TP53	R342G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001769035	17	7574003	17	7670685	1769035	1826034	NA	NC_000017.11:7670684:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	342	TP53
NM_000546.6(TP53):c.1023C>A (p.Phe341Leu)	TP53	F341L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV003071734	17	7574004	17	7670686	3071734	3233999	NA	NC_000017.11:7670685:G:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	341	TP53
NM_000546.6(TP53):c.1023C>G (p.Phe341Leu)	TP53	F341L	Hereditary cancer-predisposing syndrome	VCV002585878	17	7574004	17	7670686	2585878	2753438	NA	NC_000017.11:7670685:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	341	TP53
NM_000546.6(TP53):c.1021_1022delinsAG (p.Phe341Ser)	TP53	F341S	Hereditary cancer-predisposing syndrome	VCV002450748	17	7574005 - 7574006	17	7670687 - 7670688	2450748	2423234	NA	NC_000017.11:7670686:AA:CT	Indel	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Dec 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	341	TP53
NM_000546.6(TP53):c.1021T>A (p.Phe341Ile)	TP53	F341I	Li-Fraumeni syndrome	VCV001395664	17	7574006	17	7670688	1395664	1425063	rs2150995025	NC_000017.11:7670687:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	341	TP53
NM_000546.6(TP53):c.1020G>C (p.Met340Ile)	TP53	M340I	not specified	VCV003256325	17	7574007	17	7670689	3256325	3415087	NA	NC_000017.11:7670688:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jul 31, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	340	TP53
NM_000546.6(TP53):c.1020G>T (p.Met340Ile)	TP53	M340I	Hereditary cancer-predisposing syndrome	VCV001759327	17	7574007	17	7670689	1759327	1816234	NA	NC_000017.11:7670688:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Oct 30, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	340	TP53
NM_000546.6(TP53):c.1020G>A (p.Met340Ile)	TP53	M340I	Li-Fraumeni syndrome	VCV001020154	17	7574007	17	7670689	1020154	1013143	rs1463722976	NC_000017.11:7670688:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	340	TP53
NM_000546.6(TP53):c.1019T>A (p.Met340Lys)	TP53	M340K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000818264	17	7574008	17	7670690	818264	814451	rs1597349348	NC_000017.11:7670689:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	340	TP53
NM_000546.6(TP53):c.1016A>T (p.Glu339Val)	TP53	E339V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000959616	17	7574011	17	7670693	959616	950303	rs1237829645	NC_000017.11:7670692:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Feb 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	339	TP53
NM_000546.6(TP53):c.1016A>G (p.Glu339Gly)	TP53	E339G	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000822016	17	7574011	17	7670693	822016	814452	rs1237829645	NC_000017.11:7670692:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	May 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	339	TP53
NM_000546.6(TP53):c.1015G>A (p.Glu339Lys)	TP53	E339K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not specified	VCV000142846	17	7574012	17	7670694	142846	152560	rs17882252	NC_000017.11:7670693:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	339	TP53
NM_000546.6(TP53):c.1015G>C (p.Glu339Gln)	TP53	E339Q	Li-Fraumeni syndrome	VCV000141893	17	7574012	17	7670694	141893	151607	rs17882252	NC_000017.11:7670693:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	339	TP53
NM_000546.6(TP53):c.1014C>G (p.Phe338Leu)	TP53	F338L	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000482226	17	7574013	17	7670695	482226	479272	rs150293825	NC_000017.11:7670694:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Aug 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	338	TP53
NM_000546.6(TP53):c.1013T>G (p.Phe338Cys)	TP53	F338C	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000628432	17	7574014	17	7670696	628432	618829	rs1064796401	NC_000017.11:7670695:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	338	TP53
NM_000546.6(TP53):c.1013T>C (p.Phe338Ser)	TP53	F338S	Breast-ovarian cancer, familial, susceptibility to, 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000423398	17	7574014	17	7670696	423398	410250	rs1064796401	NC_000017.11:7670695:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	338	TP53
NM_000546.6(TP53):c.1010G>C (p.Arg337Pro)	TP53	R337P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000177879	17	7574017	17	7670699	177879	176640	rs121912664	NC_000017.11:7670698:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	337	TP53
NM_000546.6(TP53):c.1010G>T (p.Arg337Leu)	TP53	R337L	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000142828	17	7574017	17	7670699	142828	152542	rs121912664	NC_000017.11:7670698:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	337	TP53
NM_000546.6(TP53):c.1010G>A (p.Arg337His)	TP53	R337H	Breast neoplasm|Hereditary breast ovarian cancer syndrome|not provided|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Squamous cell carcinoma of the head and neck|Bone marrow failure syndrome 5|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Nasopharyngeal carcinoma|Li-Fraumeni syndrome 1|Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Choroid plexus papilloma|Bone osteosarcoma|Colorectal cancer|Carcinoma of pancreas|Familial cancer of breast|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000012379	17	7574017	17	7670699	12379	27418	rs121912664	NC_000017.11:7670698:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic/Likely pathogenic	Jan 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	337	TP53
NM_000546.6(TP53):c.1009C>A (p.Arg337Ser)	TP53	R337S	Li-Fraumeni syndrome 1	VCV001019612	17	7574018	17	7670700	1019612	1013144	rs587782529	NC_000017.11:7670699:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 3, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	337	TP53
NM_000546.6(TP53):c.1009C>G (p.Arg337Gly)	TP53	R337G	Li-Fraumeni syndrome	VCV000237938	17	7574018	17	7670700	237938	242977	rs587782529	NC_000017.11:7670699:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 19, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	337	TP53
NM_000546.6(TP53):c.1009C>T (p.Arg337Cys)	TP53	R337C	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000142536	17	7574018	17	7670700	142536	152250	rs587782529	NC_000017.11:7670699:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic/Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	337	TP53
NM_000546.6(TP53):c.1006G>C (p.Glu336Gln)	TP53	E336Q	Hereditary cancer-predisposing syndrome	VCV002450754	17	7574021	17	7670703	2450754	2423240	NA	NC_000017.11:7670702:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Feb 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	336	TP53
NM_000546.6(TP53):c.1004G>T (p.Arg335Leu)	TP53	R335L	Hereditary cancer-predisposing syndrome	VCV003328160	17	7574023	17	7670705	3328160	3486873	NA	NC_000017.11:7670704:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	335	TP53
NM_000546.6(TP53):c.1004G>C (p.Arg335Pro)	TP53	R335P	Li-Fraumeni syndrome	VCV000840626	17	7574023	17	7670705	840626	846254	rs771939956	NC_000017.11:7670704:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 1, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	335	TP53
NM_000546.6(TP53):c.1004G>A (p.Arg335His)	TP53	R335H	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480738	17	7574023	17	7670705	480738	479964	rs771939956	NC_000017.11:7670704:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	335	TP53
NM_000546.6(TP53):c.1003C>T (p.Arg335Cys)	TP53	R335C	Li-Fraumeni syndrome	VCV000141159	17	7574024	17	7670706	141159	150873	rs375444154	NC_000017.11:7670705:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 4, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	335	TP53
NM_000546.6(TP53):c.1001G>A (p.Gly334Glu)	TP53	G334E	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome	VCV000951578	17	7574026	17	7670708	951578	928548	rs1286563734	NC_000017.11:7670707:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	334	TP53
NM_000546.6(TP53):c.1000G>T (p.Gly334Trp)	TP53	G334W	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000428876	17	7574027	17	7670709	428876	420637	rs730882028	NC_000017.11:7670708:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	334	TP53
NM_000546.6(TP53):c.1000G>A (p.Gly334Arg)	TP53	G334R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000186086	17	7574027	17	7670709	186086	185337	rs730882028	NC_000017.11:7670708:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Nov 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	334	TP53
NM_000546.6(TP53):c.1000G>C (p.Gly334Arg)	TP53	G334R	Li-Fraumeni syndrome	VCV000182969	17	7574027	17	7670709	182969	180990	rs730882028	NC_000017.11:7670708:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	334	TP53
NM_000546.6(TP53):c.998G>A (p.Arg333His)	TP53	R333H	Li-Fraumeni syndrome 1	VCV000142273	17	7574029	17	7670711	142273	151987	rs573154688	NC_000017.11:7670710:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	May 6, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	333	TP53
NM_000546.6(TP53):c.997C>T (p.Arg333Cys)	TP53	R333C	Li-Fraumeni syndrome 1	VCV000184745	17	7574030	17	7670712	184745	185338	rs769934890	NC_000017.11:7670711:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Apr 19, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	333	TP53
NM_000546.6(TP53):c.996C>G (p.Ile332Met)	TP53	I332M	Li-Fraumeni syndrome	VCV000458583	17	7574031	17	7670713	458583	467489	rs1555524470	NC_000017.11:7670712:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 30, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	332	TP53
NM_000546.6(TP53):c.995T>C (p.Ile332Thr)	TP53	I332T	Hereditary cancer-predisposing syndrome	VCV001768734	17	7574032	17	7670714	1768734	1825734	NA	NC_000017.11:7670713:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	332	TP53
NM_000546.6(TP53):c.995T>A (p.Ile332Asn)	TP53	I332N	Hereditary cancer-predisposing syndrome	VCV001768732	17	7574032	17	7670714	1768732	1825732	NA	NC_000017.11:7670713:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Feb 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	332	TP53
NM_000546.6(TP53):c.993G>T (p.Gln331His)	TP53	Q331H	Li-Fraumeni syndrome	VCV002832740	17	7576853	17	7673535	2832740	2991284	NA	NC_000017.11:7673534:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	331	TP53
NM_000546.6(TP53):c.993G>C (p.Gln331His)	TP53	Q331H	Li-Fraumeni syndrome	VCV001497451	17	7576853	17	7673535	1497451	1476072	rs11575996	NC_000017.11:7673534:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	331	TP53
NM_000546.6(TP53):c.992A>G (p.Gln331Arg)	TP53	Q331R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000421319	17	7576854	17	7673536	421319	410252	rs1064795056	NC_000017.11:7673535:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	331	TP53
NM_000546.6(TP53):c.991C>G (p.Gln331Glu)	TP53	Q331E	Li-Fraumeni syndrome	VCV001950710	17	7576855	17	7673537	1950710	2007415	NA	NC_000017.11:7673536:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	331	TP53
NM_000546.6(TP53):c.991C>A (p.Gln331Lys)	TP53	Q331K	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000823553	17	7576855	17	7673537	823553	814453	rs1597359130	NC_000017.11:7673536:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	331	TP53
NM_000546.6(TP53):c.989T>G (p.Leu330Arg)	TP53	L330R	Li-Fraumeni syndrome	VCV001510133	17	7576857	17	7673539	1510133	1442188	rs1597359140	NC_000017.11:7673538:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	330	TP53
NM_000546.6(TP53):c.989T>A (p.Leu330His)	TP53	L330H	Li-Fraumeni syndrome	VCV001409387	17	7576857	17	7673539	1409387	1340458	rs1597359140	NC_000017.11:7673538:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	330	TP53
NM_000546.6(TP53):c.989T>C (p.Leu330Pro)	TP53	L330P	Li-Fraumeni syndrome	VCV000651580	17	7576857	17	7673539	651580	646731	rs1597359140	NC_000017.11:7673538:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	330	TP53
NM_000546.6(TP53):c.988C>T (p.Leu330Phe)	TP53	L330F	Li-Fraumeni syndrome	VCV001024800	17	7576858	17	7673540	1024800	1013145	rs2073148779	NC_000017.11:7673539:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	330	TP53
NM_000546.6(TP53):c.986C>T (p.Thr329Ile)	TP53	T329I	Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000652718	17	7576860	17	7673542	652718	646732	rs969930693	NC_000017.11:7673541:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	329	TP53
NM_000546.6(TP53):c.985A>G (p.Thr329Ala)	TP53	T329A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000939133	17	7576861	17	7673543	939133	938233	rs2073149675	NC_000017.11:7673542:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	329	TP53
NM_000546.6(TP53):c.983T>C (p.Phe328Ser)	TP53	F328S	Li-Fraumeni syndrome	VCV000648339	17	7576863	17	7673545	648339	646733	rs1597359175	NC_000017.11:7673544:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	328	TP53
NM_000546.6(TP53):c.980A>G (p.Tyr327Cys)	TP53	Y327C	Li-Fraumeni syndrome	VCV002783073	17	7576866	17	7673548	2783073	2938174	NA	NC_000017.11:7673547:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	327	TP53
NM_000546.6(TP53):c.978A>T (p.Glu326Asp)	TP53	E326D	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV001021810	17	7576868	17	7673550	1021810	1013146	rs1000256867	NC_000017.11:7673549:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	326	TP53
NM_000546.6(TP53):c.977A>T (p.Glu326Val)	TP53	E326V	Acute myeloid leukemia	VCV002578514	17	7576869	17	7673551	2578514	2743448	NA	NC_000017.11:7673550:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	326	TP53
NM_000546.6(TP53):c.974G>A (p.Gly325Glu)	TP53	G325E	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome	VCV000480952	17	7576872	17	7673554	480952	479273	rs121912659	NC_000017.11:7673553:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	325	TP53
NM_000546.6(TP53):c.974G>T (p.Gly325Val)	TP53	G325V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000012367	17	7576872	17	7673554	12367	27406	rs121912659	NC_000017.11:7673553:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	325	TP53
NM_000546.6(TP53):c.973G>A (p.Gly325Arg)	TP53	G325R	not specified|Hereditary cancer-predisposing syndrome	VCV000480740	17	7576873	17	7673555	480740	479977	rs863224500	NC_000017.11:7673554:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	325	TP53
NM_000546.6(TP53):c.972T>A (p.Asp324Glu)	TP53	D324E	Hereditary cancer-predisposing syndrome	VCV002450758	17	7576874	17	7673556	2450758	2423244	NA	NC_000017.11:7673555:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	324	TP53
NM_000546.6(TP53):c.970G>A (p.Asp324Asn)	TP53	D324N	Acute myeloid leukemia	VCV002578516	17	7576876	17	7673558	2578516	2743450	NA	NC_000017.11:7673557:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	324	TP53
NM_000546.6(TP53):c.970G>T (p.Asp324Tyr)	TP53	D324Y	Hereditary cancer-predisposing syndrome	VCV000630832	17	7576876	17	7673558	630832	618831	rs1064794810	NC_000017.11:7673557:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	324	TP53
NM_000546.6(TP53):c.970G>C (p.Asp324His)	TP53	D324H	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000420950	17	7576876	17	7673558	420950	410253	rs1064794810	NC_000017.11:7673557:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	324	TP53
NM_000546.6(TP53):c.968T>C (p.Leu323Pro)	TP53	L323P	Hereditary cancer-predisposing syndrome	VCV000823403	17	7576878	17	7673560	823403	814455	rs1597359353	NC_000017.11:7673559:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	323	TP53
NM_000546.6(TP53):c.967C>G (p.Leu323Val)	TP53	L323V	Adrenocortical carcinoma, hereditary	VCV002679234	17	7576879	17	7673561	2679234	2836811	NA	NC_000017.11:7673560:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	323	TP53
NM_000546.6(TP53):c.965C>G (p.Pro322Arg)	TP53	P322R	Adrenocortical carcinoma, hereditary	VCV002679228	17	7576881	17	7673563	2679228	2836805	NA	NC_000017.11:7673562:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	322	TP53
NM_000546.6(TP53):c.964C>G (p.Pro322Ala)	TP53	P322A	Li-Fraumeni syndrome	VCV001720306	17	7576882	17	7673564	1720306	1779345	NA	NC_000017.11:7673563:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	322	TP53
NM_000546.6(TP53):c.964C>A (p.Pro322Thr)	TP53	P322T	Hereditary cancer-predisposing syndrome	VCV000231553	17	7576882	17	7673564	231553	236449	rs863224687	NC_000017.11:7673563:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	322	TP53
NM_000546.6(TP53):c.964C>T (p.Pro322Ser)	TP53	P322S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000216475	17	7576882	17	7673564	216475	213387	rs863224687	NC_000017.11:7673563:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	322	TP53
NM_000546.6(TP53):c.959A>C (p.Lys320Thr)	TP53	K320T	Li-Fraumeni syndrome	VCV003071811	17	7576887	17	7673569	3071811	3234076	NA	NC_000017.11:7673568:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	320	TP53
NM_000546.6(TP53):c.956A>C (p.Lys319Thr)	TP53	K319T	Hereditary cancer-predisposing syndrome	VCV003328169	17	7576890	17	7673572	3328169	3486882	NA	NC_000017.11:7673571:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	319	TP53
NM_000546.6(TP53):c.953C>G (p.Pro318Arg)	TP53	P318R	Li-Fraumeni syndrome	VCV002081538	17	7576893	17	7673575	2081538	2139473	NA	NC_000017.11:7673574:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	318	TP53
NM_000546.6(TP53):c.953C>T (p.Pro318Leu)	TP53	P318L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000492627	17	7576893	17	7673575	492627	485311	rs1555524975	NC_000017.11:7673574:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	318	TP53
NM_000546.6(TP53):c.952C>T (p.Pro318Ser)	TP53	P318S	Acute myeloid leukemia	VCV002575170	17	7576894	17	7673576	2575170	2740100	NA	NC_000017.11:7673575:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	318	TP53
NM_000546.6(TP53):c.951G>T (p.Gln317His)	TP53	Q317H	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000406585	17	7576895	17	7673577	406585	402537	rs1060501199	NC_000017.11:7673576:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	317	TP53
NM_000546.6(TP53):c.950A>T (p.Gln317Leu)	TP53	Q317L	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000855943	17	7576896	17	7673578	855943	846256	rs1159579789	NC_000017.11:7673577:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	317	TP53
NM_000546.6(TP53):c.950A>G (p.Gln317Arg)	TP53	Q317R	TP53-related disorder|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000581024	17	7576896	17	7673578	581024	572277	rs1159579789	NC_000017.11:7673577:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	317	TP53
NM_000546.6(TP53):c.949C>A (p.Gln317Lys)	TP53	Q317K	Li-Fraumeni syndrome 1	VCV000231008	17	7576897	17	7673579	231008	236450	rs764735889	NC_000017.11:7673578:G:T	single nucleotide variant	missense variant	Likely benign	Aug 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	317	TP53
NM_000546.6(TP53):c.947C>T (p.Pro316Leu)	TP53	P316L	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000528273	17	7576899	17	7673581	528273	531796	rs1555524979	NC_000017.11:7673580:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	316	TP53
NM_000546.6(TP53):c.946C>T (p.Pro316Ser)	TP53	P316S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000823268	17	7576900	17	7673582	823268	814457	rs772773208	NC_000017.11:7673581:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	316	TP53
NM_000546.6(TP53):c.946C>A (p.Pro316Thr)	TP53	P316T	Li-Fraumeni syndrome 1	VCV000230382	17	7576900	17	7673582	230382	236451	rs772773208	NC_000017.11:7673581:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	316	TP53
NM_000546.6(TP53):c.944C>T (p.Ser315Phe)	TP53	S315F	Li-Fraumeni syndrome	VCV001009427	17	7576902	17	7673584	1009427	997950	rs2073157445	NC_000017.11:7673583:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	315	TP53
NM_000546.6(TP53):c.944C>G (p.Ser315Cys)	TP53	S315C	Hereditary cancer-predisposing syndrome	VCV000927085	17	7576902	17	7673584	927085	914178	rs2073157445	NC_000017.11:7673583:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	315	TP53
NM_000546.6(TP53):c.943T>C (p.Ser315Pro)	TP53	S315P	Li-Fraumeni syndrome	VCV002891760	17	7576903	17	7673585	2891760	3051902	NA	NC_000017.11:7673584:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	315	TP53
NM_000546.6(TP53):c.943T>A (p.Ser315Thr)	TP53	S315T	Li-Fraumeni syndrome	VCV000185212	17	7576903	17	7673585	185212	185339	rs762620193	NC_000017.11:7673584:A:T	single nucleotide variant	missense variant	Likely benign	Sep 4, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	315	TP53
NM_000546.6(TP53):c.941C>G (p.Ser314Cys)	TP53	S314C	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000848532	17	7576905	17	7673587	848532	846257	rs751440465	NC_000017.11:7673586:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	314	TP53
NM_000546.6(TP53):c.941C>T (p.Ser314Phe)	TP53	S314F	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000406587	17	7576905	17	7673587	406587	403141	rs751440465	NC_000017.11:7673586:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	314	TP53
NM_000546.6(TP53):c.938G>A (p.Ser313Asn)	TP53	S313N	Hereditary cancer-predisposing syndrome	VCV002450750	17	7576908	17	7673590	2450750	2423236	NA	NC_000017.11:7673589:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jan 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	313	TP53
NM_000546.6(TP53):c.935C>A (p.Thr312Asn)	TP53	T312N	Hereditary cancer-predisposing syndrome	VCV001766672	17	7576911	17	7673593	1766672	1824915	NA	NC_000017.11:7673592:G:T	single nucleotide variant	missense variant	Likely benign	Jun 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	TP53
NM_000546.6(TP53):c.935C>T (p.Thr312Ile)	TP53	T312I	not specified	VCV001697592	17	7576911	17	7673593	1697592	1689976	rs145151284	NC_000017.11:7673592:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	TP53
NM_000546.6(TP53):c.935C>G (p.Thr312Ser)	TP53	T312S	Li-Fraumeni syndrome	VCV000141102	17	7576911	17	7673593	141102	150816	rs145151284	NC_000017.11:7673592:G:C	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	312	TP53
NM_000546.6(TP53):c.934A>G (p.Thr312Ala)	TP53	T312A	Adrenocortical carcinoma, hereditary	VCV002679231	17	7576912	17	7673594	2679231	2836808	NA	NC_000017.11:7673593:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	TP53
NM_000546.6(TP53):c.932A>G (p.Asn311Ser)	TP53	N311S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000406589	17	7576914	17	7673596	406589	402538	rs56184981	NC_000017.11:7673595:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	311	TP53
NM_000546.6(TP53):c.932A>C (p.Asn311Thr)	TP53	N311T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000219969	17	7576914	17	7673596	219969	222735	rs56184981	NC_000017.11:7673595:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	311	TP53
NM_000546.6(TP53):c.931A>C (p.Asn311His)	TP53	N311H	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000528240	17	7576915	17	7673597	528240	531922	rs1555525007	NC_000017.11:7673596:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	311	TP53
NM_000546.6(TP53):c.930C>G (p.Asn310Lys)	TP53	N310K	Hereditary cancer-predisposing syndrome	VCV000428879	17	7576916	17	7673598	428879	420640	rs876660829	NC_000017.11:7673597:G:C	single nucleotide variant	missense variant	Likely benign	Oct 30, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	310	TP53
NM_000546.6(TP53):c.930C>A (p.Asn310Lys)	TP53	N310K	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000234067	17	7576916	17	7673598	234067	236452	rs876660829	NC_000017.11:7673597:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	310	TP53
NM_000546.6(TP53):c.929A>G (p.Asn310Ser)	TP53	N310S	Hereditary cancer-predisposing syndrome	VCV001766454	17	7576917	17	7673599	1766454	1815032	NA	NC_000017.11:7673598:T:C	single nucleotide variant	missense variant	Likely benign	Oct 28, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	310	TP53
NM_000546.6(TP53):c.929A>T (p.Asn310Ile)	TP53	N310I	Li-Fraumeni syndrome	VCV001720175	17	7576917	17	7673599	1720175	1779214	NA	NC_000017.11:7673598:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	310	TP53
NM_000546.6(TP53):c.928A>C (p.Asn310His)	TP53	N310H	Li-Fraumeni syndrome	VCV002841682	17	7576918	17	7673600	2841682	3003619	NA	NC_000017.11:7673599:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	310	TP53
NM_000546.6(TP53):c.928A>G (p.Asn310Asp)	TP53	N310D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000651517	17	7576918	17	7673600	651517	646735	rs1597359691	NC_000017.11:7673599:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	310	TP53
NM_000546.6(TP53):c.926C>T (p.Pro309Leu)	TP53	P309L	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV001471105	17	7576920	17	7673602	1471105	1488176	rs2151012345	NC_000017.11:7673601:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	309	TP53
NM_000546.6(TP53):c.925C>T (p.Pro309Ser)	TP53	P309S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000458575	17	7576921	17	7673603	458575	467495	rs1555525012	NC_000017.11:7673602:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	309	TP53
NM_000546.6(TP53):c.920C>T (p.Ala307Val)	TP53	A307V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000666137	17	7576926	17	7673608	666137	646736	rs1457582183	NC_000017.11:7673607:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	307	TP53
NM_000546.6(TP53):c.920C>G (p.Ala307Gly)	TP53	A307G	Hereditary cancer-predisposing syndrome	VCV000485027	17	7576926	17	7673608	485027	479225	rs1457582183	NC_000017.11:7673607:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	307	TP53
NM_000546.6(TP53):c.919G>A (p.Ala307Thr)	TP53	A307T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV002809879	17	7577019	17	7673701	2809879	2972248	NA	NC_000017.11:7673700:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	307	TP53
NM_000546.6(TP53):c.919G>C (p.Ala307Pro)	TP53	A307P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001766148	17	7577019	17	7673701	1766148	1814726	NA	NC_000017.11:7673700:C:G	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	307	TP53
NM_000546.6(TP53):c.917G>A (p.Arg306Gln)	TP53	R306Q	Hereditary cancer-predisposing syndrome|not specified|not provided|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Familial cancer of breast|Adrenocortical carcinoma, hereditary	VCV000458574	17	7577021	17	7673703	458574	469117	rs1048095040	NC_000017.11:7673702:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	306	TP53
NM_000546.6(TP53):c.916C>G (p.Arg306Gly)	TP53	R306G	Hereditary cancer-predisposing syndrome	VCV003328176	17	7577022	17	7673704	3328176	3486889	NA	NC_000017.11:7673703:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 20, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	306	TP53
NM_000546.6(TP53):c.911C>T (p.Thr304Ile)	TP53	T304I	Li-Fraumeni syndrome|not provided	VCV001020758	17	7577027	17	7673709	1020758	1013148	rs2073173236	NC_000017.11:7673708:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	304	TP53
NM_000546.6(TP53):c.910A>G (p.Thr304Ala)	TP53	T304A	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000142702	17	7577028	17	7673710	142702	152416	rs587782654	NC_000017.11:7673709:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	304	TP53
NM_000546.6(TP53):c.909C>G (p.Ser303Arg)	TP53	S303R	Li-Fraumeni syndrome	VCV001024359	17	7577029	17	7673711	1024359	1013149	rs1412434159	NC_000017.11:7673710:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	303	TP53
NM_000546.6(TP53):c.908G>A (p.Ser303Asn)	TP53	S303N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000230695	17	7577030	17	7673712	230695	236454	rs876658714	NC_000017.11:7673711:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	303	TP53
NM_000546.6(TP53):c.907A>G (p.Ser303Gly)	TP53	S303G	Li-Fraumeni syndrome 1	VCV000142332	17	7577031	17	7673713	142332	152046	rs587782391	NC_000017.11:7673712:T:C	single nucleotide variant	missense variant	Likely benign	May 7, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	303	TP53
NM_000546.6(TP53):c.905G>C (p.Gly302Ala)	TP53	G302A	Hereditary cancer-predisposing syndrome	VCV003328162	17	7577033	17	7673715	3328162	3486875	NA	NC_000017.11:7673714:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	302	TP53
NM_000546.6(TP53):c.905G>A (p.Gly302Glu)	TP53	G302E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000406591	17	7577033	17	7673715	406591	402545	rs1060501202	NC_000017.11:7673714:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	TP53
NM_000546.6(TP53):c.904G>A (p.Gly302Arg)	TP53	G302R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001047514	17	7577034	17	7673716	1047514	1033671	rs863224686	NC_000017.11:7673715:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	302	TP53
NM_000546.6(TP53):c.904G>C (p.Gly302Arg)	TP53	G302R	Li-Fraumeni syndrome	VCV000216473	17	7577034	17	7673716	216473	213389	rs863224686	NC_000017.11:7673715:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	302	TP53
NM_000546.6(TP53):c.902C>T (p.Pro301Leu)	TP53	P301L	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000481049	17	7577036	17	7673718	481049	480005	rs1555525067	NC_000017.11:7673717:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	301	TP53
NM_000546.6(TP53):c.901C>T (p.Pro301Ser)	TP53	P301S	Li-Fraumeni syndrome	VCV001469089	17	7577037	17	7673719	1469089	1370198	rs2151014122	NC_000017.11:7673718:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	301	TP53
NM_000546.6(TP53):c.901C>G (p.Pro301Ala)	TP53	P301A	Hereditary cancer-predisposing syndrome	VCV001332597	17	7577037	17	7673719	1332597	1323315	rs2151014122	NC_000017.11:7673718:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	301	TP53
NM_000546.6(TP53):c.899C>T (p.Pro300Leu)	TP53	P300L	Hereditary cancer-predisposing syndrome	VCV001765377	17	7577039	17	7673721	1765377	1821018	NA	NC_000017.11:7673720:G:A	single nucleotide variant	missense variant	Likely benign	Dec 5, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	300	TP53
NM_000546.6(TP53):c.896T>C (p.Leu299Pro)	TP53	L299P	Li-Fraumeni syndrome	VCV002036477	17	7577042	17	7673724	2036477	2090533	NA	NC_000017.11:7673723:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	299	TP53
NM_000546.6(TP53):c.894G>C (p.Glu298Asp)	TP53	E298D	Li-Fraumeni syndrome	VCV002863364	17	7577044	17	7673726	2863364	3029440	NA	NC_000017.11:7673725:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	298	TP53
NM_000546.6(TP53):c.893A>C (p.Glu298Ala)	TP53	E298A	Adrenocortical carcinoma, hereditary	VCV002679238	17	7577045	17	7673727	2679238	2836815	NA	NC_000017.11:7673726:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	298	TP53
NM_000546.6(TP53):c.893A>G (p.Glu298Gly)	TP53	E298G	Hereditary cancer-predisposing syndrome	VCV000927512	17	7577045	17	7673727	927512	914179	rs2073176960	NC_000017.11:7673726:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	298	TP53
NM_000546.6(TP53):c.892G>C (p.Glu298Gln)	TP53	E298Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001495821	17	7577046	17	7673728	1495821	1362736	rs201744589	NC_000017.11:7673727:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	298	TP53
NM_000546.6(TP53):c.892G>A (p.Glu298Lys)	TP53	E298K	Li-Fraumeni syndrome	VCV000141483	17	7577046	17	7673728	141483	151197	rs201744589	NC_000017.11:7673727:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	298	TP53
NM_000546.6(TP53):c.891C>G (p.His297Gln)	TP53	H297Q	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000926470	17	7577047	17	7673729	926470	914180	rs750578863	NC_000017.11:7673728:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	297	TP53
NM_000546.6(TP53):c.891C>A (p.His297Gln)	TP53	H297Q	Li-Fraumeni syndrome	VCV000660046	17	7577047	17	7673729	660046	646738	rs750578863	NC_000017.11:7673728:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	297	TP53
NM_000546.6(TP53):c.890A>G (p.His297Arg)	TP53	H297R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000231990	17	7577048	17	7673730	231990	236456	rs876659477	NC_000017.11:7673729:T:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	297	TP53
NM_000546.6(TP53):c.889C>T (p.His297Tyr)	TP53	H297Y	Li-Fraumeni syndrome	VCV001933263	17	7577049	17	7673731	1933263	1982233	NA	NC_000017.11:7673730:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	297	TP53
NM_000546.6(TP53):c.887A>G (p.His296Arg)	TP53	H296R	not provided	VCV000100816	17	7577051	17	7673733	100816	106676	rs483352696	NC_000017.11:7673732:T:C	single nucleotide variant	missense variant	Likely pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	296	TP53
NM_000546.6(TP53):c.886C>T (p.His296Tyr)	TP53	H296Y	Li-Fraumeni syndrome	VCV000132973	17	7577052	17	7673734	132973	136722	rs672601296	NC_000017.11:7673733:G:A	single nucleotide variant	missense variant	Likely benign	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	296	TP53
NM_000546.6(TP53):c.884C>A (p.Pro295His)	TP53	P295H	not specified	VCV003340041	17	7577054	17	7673736	3340041	3499303	NA	NC_000017.11:7673735:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 17, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	295	TP53
NM_000546.6(TP53):c.884C>T (p.Pro295Leu)	TP53	P295L	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000420974	17	7577054	17	7673736	420974	410256	rs751713111	NC_000017.11:7673735:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	295	TP53
NM_000546.6(TP53):c.883C>T (p.Pro295Ser)	TP53	P295S	Li-Fraumeni syndrome	VCV000428862	17	7577055	17	7673737	428862	420643	rs1131691006	NC_000017.11:7673736:G:A	single nucleotide variant	missense variant	Likely benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	295	TP53
NM_000546.6(TP53):c.881A>C (p.Glu294Ala)	TP53	E294A	Li-Fraumeni syndrome	VCV001494469	17	7577057	17	7673739	1494469	1350211	rs2151014555	NC_000017.11:7673738:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	294	TP53
NM_000546.6(TP53):c.880G>A (p.Glu294Lys)	TP53	E294K	Li-Fraumeni syndrome	VCV001001614	17	7577058	17	7673740	1001614	997951	rs1057520607	NC_000017.11:7673739:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	294	TP53
NM_000546.6(TP53):c.877G>C (p.Gly293Arg)	TP53	G293R	Li-Fraumeni syndrome	VCV001365220	17	7577061	17	7673743	1365220	1502264	rs587780076	NC_000017.11:7673742:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	293	TP53
NM_000546.6(TP53):c.877G>A (p.Gly293Arg)	TP53	G293R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000230208	17	7577061	17	7673743	230208	236457	rs587780076	NC_000017.11:7673742:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	293	TP53
NM_000546.6(TP53):c.877G>T (p.Gly293Trp)	TP53	G293W	Li-Fraumeni syndrome	VCV000127826	17	7577061	17	7673743	127826	133283	rs587780076	NC_000017.11:7673742:C:A	single nucleotide variant	missense variant	Likely benign	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	293	TP53
NM_000546.6(TP53):c.876A>T (p.Lys292Asn)	TP53	K292N	Adrenocortical carcinoma, hereditary	VCV002679235	17	7577062	17	7673744	2679235	2836812	NA	NC_000017.11:7673743:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	292	TP53
NM_000546.6(TP53):c.876A>C (p.Lys292Asn)	TP53	K292N	Li-Fraumeni syndrome	VCV001718571	17	7577062	17	7673744	1718571	1778931	NA	NC_000017.11:7673743:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	292	TP53
NM_000546.6(TP53):c.875A>C (p.Lys292Thr)	TP53	K292T	Li-Fraumeni syndrome	VCV001021706	17	7577063	17	7673745	1021706	1013150	rs121912663	NC_000017.11:7673744:T:G	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	292	TP53
NM_000546.6(TP53):c.875A>G (p.Lys292Arg)	TP53	K292R	Li-Fraumeni syndrome 1	VCV000406577	17	7577063	17	7673745	406577	403145	rs121912663	NC_000017.11:7673744:T:C	single nucleotide variant	missense variant	Likely benign	Apr 2, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	292	TP53
NM_000546.6(TP53):c.875A>T (p.Lys292Ile)	TP53	K292I	Hereditary cancer-predisposing syndrome	VCV000012378	17	7577063	17	7673745	12378	27417	rs121912663	NC_000017.11:7673744:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	292	TP53
NM_000546.6(TP53):c.874A>G (p.Lys292Glu)	TP53	K292E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001006477	17	7577064	17	7673746	1006477	997952	rs2073181505	NC_000017.11:7673745:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	292	TP53
NM_000546.6(TP53):c.873G>C (p.Lys291Asn)	TP53	K291N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000629930	17	7577065	17	7673747	629930	618834	rs372613518	NC_000017.11:7673746:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	291	TP53
NM_000546.6(TP53):c.871A>C (p.Lys291Gln)	TP53	K291Q	Li-Fraumeni syndrome	VCV001061526	17	7577067	17	7673749	1061526	1050663	rs1555525126	NC_000017.11:7673748:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	291	TP53
NM_000546.6(TP53):c.871A>G (p.Lys291Glu)	TP53	K291E	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000480951	17	7577067	17	7673749	480951	480010	rs1555525126	NC_000017.11:7673748:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	291	TP53
NM_000546.6(TP53):c.870_871delinsAC (p.Lys291Gln)	TP53	K291Q	Li-Fraumeni syndrome	VCV000406594	17	7577067 - 7577068	17	7673749 - 7673750	406594	402550	rs1060501205	NC_000017.11:7673748:TG:GT	Indel	missense variant	Uncertain significance	Jun 5, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	291	TP53
NM_000546.6(TP53):c.869G>T (p.Arg290Leu)	TP53	R290L	Li-Fraumeni syndrome|not specified|Bone marrow failure syndrome 5|Hereditary cancer-predisposing syndrome	VCV000633445	17	7577069	17	7673751	633445	621605	rs55819519	NC_000017.11:7673750:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	290	TP53
NM_000546.6(TP53):c.869G>C (p.Arg290Pro)	TP53	R290P	Li-Fraumeni syndrome	VCV000458572	17	7577069	17	7673751	458572	468375	rs55819519	NC_000017.11:7673750:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	290	TP53
NM_000546.6(TP53):c.869G>A (p.Arg290His)	TP53	R290H	Li-Fraumeni syndrome	VCV000127825	17	7577069	17	7673751	127825	133282	rs55819519	NC_000017.11:7673750:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	290	TP53
NM_000546.6(TP53):c.867_868delinsAA (p.Arg290Ser)	TP53	R290S	not specified	VCV001338368	17	7577070 - 7577071	17	7673752 - 7673753	1338368	1329376	rs2151014889	NC_000017.11:7673751:GG:TT	Indel	missense variant	Uncertain significance	Jan 22, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	290	TP53
NM_000546.6(TP53):c.868C>G (p.Arg290Gly)	TP53	R290G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000628970	17	7577070	17	7673752	628970	618835	rs770374782	NC_000017.11:7673751:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	290	TP53
NM_000546.6(TP53):c.868C>T (p.Arg290Cys)	TP53	R290C	Li-Fraumeni syndrome 1	VCV000216472	17	7577070	17	7673752	216472	213390	rs770374782	NC_000017.11:7673751:G:A	single nucleotide variant	missense variant	Likely benign	May 13, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	290	TP53
NM_000546.6(TP53):c.866T>C (p.Leu289Pro)	TP53	L289P	Li-Fraumeni syndrome 1	VCV001172923	17	7577072	17	7673754	1172923	1162106	rs2151014987	NC_000017.11:7673753:A:G	single nucleotide variant	missense variant	Likely benign	Jun 16, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	289	TP53
NM_000546.6(TP53):c.865C>A (p.Leu289Ile)	TP53	L289I	Li-Fraumeni syndrome	VCV001439164	17	7577073	17	7673755	1439164	1349565	rs1555525154	NC_000017.11:7673754:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	289	TP53
NM_000546.6(TP53):c.865C>T (p.Leu289Phe)	TP53	L289F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000822635	17	7577073	17	7673755	822635	814461	rs1555525154	NC_000017.11:7673754:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	289	TP53
NM_000546.6(TP53):c.865C>G (p.Leu289Val)	TP53	L289V	not provided	VCV000496049	17	7577073	17	7673755	496049	488010	rs1555525154	NC_000017.11:7673754:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	289	TP53
NM_000546.6(TP53):c.863A>C (p.Asn288Thr)	TP53	N288T	Li-Fraumeni syndrome	VCV002119726	17	7577075	17	7673757	2119726	2180206	NA	NC_000017.11:7673756:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	288	TP53
NM_000546.6(TP53):c.862A>G (p.Asn288Asp)	TP53	N288D	Li-Fraumeni syndrome	VCV001024822	17	7577076	17	7673758	1024822	1013151	rs2073184850	NC_000017.11:7673757:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	288	TP53
NM_000546.6(TP53):c.861G>T (p.Glu287Asp)	TP53	E287D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000925213	17	7577077	17	7673759	925213	914182	rs748891343	NC_000017.11:7673758:C:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	287	TP53
NM_000546.6(TP53):c.861G>C (p.Glu287Asp)	TP53	E287D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000422130	17	7577077	17	7673759	422130	410257	rs748891343	NC_000017.11:7673758:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	287	TP53
NM_000546.6(TP53):c.859G>A (p.Glu287Lys)	TP53	E287K	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000141781	17	7577079	17	7673761	141781	151495	rs587782006	NC_000017.11:7673760:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 12, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	287	TP53
NM_000546.6(TP53):c.857A>C (p.Glu286Ala)	TP53	E286A	Li-Fraumeni syndrome 1	VCV000376593	17	7577081	17	7673763	376593	363472	rs1057519985	NC_000017.11:7673762:T:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 21, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	286	TP53
NM_000546.6(TP53):c.857A>T (p.Glu286Val)	TP53	E286V	Li-Fraumeni syndrome	VCV000376592	17	7577081	17	7673763	376592	363471	rs1057519985	NC_000017.11:7673762:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	286	TP53
NM_000546.6(TP53):c.857A>G (p.Glu286Gly)	TP53	E286G	Li-Fraumeni syndrome	VCV000376590	17	7577081	17	7673763	376590	363469	rs1057519985	NC_000017.11:7673762:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	286	TP53
NM_000546.6(TP53):c.856G>C (p.Glu286Gln)	TP53	E286Q	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376591	17	7577082	17	7673764	376591	363470	rs786201059	NC_000017.11:7673763:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	286	TP53
NM_000546.6(TP53):c.856G>A (p.Glu286Lys)	TP53	E286K	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000183752	17	7577082	17	7673764	183752	185345	rs786201059	NC_000017.11:7673763:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	286	TP53
NM_000546.6(TP53):c.854A>G (p.Glu285Gly)	TP53	E285G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000919894	17	7577084	17	7673766	919894	914183	rs121912667	NC_000017.11:7673765:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	285	TP53
NM_000546.6(TP53):c.854A>T (p.Glu285Val)	TP53	E285V	Li-Fraumeni syndrome	VCV000012384	17	7577084	17	7673766	12384	27423	rs121912667	NC_000017.11:7673765:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 21, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	285	TP53
NM_000546.6(TP53):c.853G>C (p.Glu285Gln)	TP53	E285Q	Li-Fraumeni syndrome	VCV000954095	17	7577085	17	7673767	954095	950304	rs112431538	NC_000017.11:7673766:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	285	TP53
NM_000546.6(TP53):c.853G>A (p.Glu285Lys)	TP53	E285K	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000420133	17	7577085	17	7673767	420133	410258	rs112431538	NC_000017.11:7673766:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	285	TP53
NM_000546.6(TP53):c.851C>G (p.Thr284Arg)	TP53	T284R	Adrenocortical carcinoma, hereditary	VCV002679230	17	7577087	17	7673769	2679230	2836807	NA	NC_000017.11:7673768:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	284	TP53
NM_000546.6(TP53):c.851C>T (p.Thr284Ile)	TP53	T284I	Li-Fraumeni syndrome 1	VCV000216471	17	7577087	17	7673769	216471	213391	rs863224685	NC_000017.11:7673768:G:A	single nucleotide variant	missense variant	Likely benign	May 13, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	284	TP53
NM_000546.6(TP53):c.850A>C (p.Thr284Pro)	TP53	T284P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV001763670	17	7577088	17	7673770	1763670	1820537	NA	NC_000017.11:7673769:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	284	TP53
NM_000546.6(TP53):c.850A>G (p.Thr284Ala)	TP53	T284A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000964952	17	7577088	17	7673770	964952	958328	rs1204379654	NC_000017.11:7673769:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	284	TP53
NM_000546.6(TP53):c.850A>T (p.Thr284Ser)	TP53	T284S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000458571	17	7577088	17	7673770	458571	467508	rs1204379654	NC_000017.11:7673769:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 26, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	284	TP53
NM_000546.6(TP53):c.848G>C (p.Arg283Pro)	TP53	R283P	Li-Fraumeni syndrome|not specified|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000486555	17	7577090	17	7673772	486555	479238	rs371409680	NC_000017.11:7673771:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	283	TP53
NM_000546.6(TP53):c.848G>A (p.Arg283His)	TP53	R283H	Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|TP53-related disorder|not specified|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Astrocytoma	VCV000142324	17	7577090	17	7673772	142324	152038	rs371409680	NC_000017.11:7673771:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	283	TP53
NM_000546.6(TP53):c.847C>G (p.Arg283Gly)	TP53	R283G	Li-Fraumeni syndrome	VCV000580186	17	7577091	17	7673773	580186	569763	rs149633775	NC_000017.11:7673772:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	283	TP53
NM_000546.6(TP53):c.847C>T (p.Arg283Cys)	TP53	R283C	Li-Fraumeni syndrome	VCV000127824	17	7577091	17	7673773	127824	133281	rs149633775	NC_000017.11:7673772:G:A	single nucleotide variant	missense variant	Likely benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	283	TP53
NM_000546.6(TP53):c.845G>C (p.Arg282Pro)	TP53	R282P	Squamous cell carcinoma of the head and neck|Carcinoma of pancreas|Choroid plexus papilloma|Familial cancer of breast|Bone marrow failure syndrome 5|Li-Fraumeni syndrome 1|Glioma susceptibility 1|Bone osteosarcoma|Nasopharyngeal carcinoma|Hepatocellular carcinoma|Colorectal cancer|Adrenocortical carcinoma, hereditary|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376659	17	7577093	17	7673775	376659	363538	rs730882008	NC_000017.11:7673774:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	282	TP53
NM_000546.6(TP53):c.845G>A (p.Arg282Gln)	TP53	R282Q	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided|Li-Fraumeni syndrome 1	VCV000237956	17	7577093	17	7673775	237956	242978	rs730882008	NC_000017.11:7673774:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	282	TP53
NM_000546.6(TP53):c.845G>T (p.Arg282Leu)	TP53	R282L	Li-Fraumeni syndrome 1	VCV000182938	17	7577093	17	7673775	182938	180994	rs730882008	NC_000017.11:7673774:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	282	TP53
NM_000546.6(TP53):c.844C>G (p.Arg282Gly)	TP53	R282G	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000140821	17	7577094	17	7673776	140821	150535	rs28934574	NC_000017.11:7673775:G:C	single nucleotide variant	missense variant	Pathogenic	Jun 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	282	TP53
NM_000546.6(TP53):c.844C>T (p.Arg282Trp)	TP53	R282W	Li-Fraumeni syndrome 1|Colorectal cancer|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|Astrocytoma, anaplastic|Pleomorphic xanthoastrocytoma|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000012364	17	7577094	17	7673776	12364	27403	rs28934574	NC_000017.11:7673775:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	282	TP53
NM_000546.6(TP53):c.843C>A (p.Asp281Glu)	TP53	D281E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000406568	17	7577095	17	7673777	406568	403007	rs1057519984	NC_000017.11:7673776:G:T	single nucleotide variant	missense variant	Likely pathogenic	May 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	281	TP53
NM_000546.6(TP53):c.843C>G (p.Asp281Glu)	TP53	D281E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376587	17	7577095	17	7673777	376587	363466	rs1057519984	NC_000017.11:7673776:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	281	TP53
NM_000546.6(TP53):c.842A>C (p.Asp281Ala)	TP53	D281A	Adrenocortical carcinoma, hereditary	VCV000376589	17	7577096	17	7673778	376589	363468	rs587781525	NC_000017.11:7673777:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	281	TP53
NM_000546.6(TP53):c.842A>T (p.Asp281Val)	TP53	D281V	not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000182968	17	7577096	17	7673778	182968	180995	rs587781525	NC_000017.11:7673777:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 15, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	281	TP53
NM_000546.6(TP53):c.842A>G (p.Asp281Gly)	TP53	D281G	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000141141	17	7577096	17	7673778	141141	150855	rs587781525	NC_000017.11:7673777:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	281	TP53
NM_000546.6(TP53):c.841G>C (p.Asp281His)	TP53	D281H	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376588	17	7577097	17	7673779	376588	363467	rs764146326	NC_000017.11:7673778:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	281	TP53
NM_000546.6(TP53):c.841G>A (p.Asp281Asn)	TP53	D281N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376586	17	7577097	17	7673779	376586	363465	rs764146326	NC_000017.11:7673778:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	281	TP53
NM_000546.6(TP53):c.841G>T (p.Asp281Tyr)	TP53	D281Y	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376585	17	7577097	17	7673779	376585	363464	rs764146326	NC_000017.11:7673778:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	281	TP53
NM_000546.6(TP53):c.838_840delinsCTC (p.Arg280Leu)	TP53	R280L	Li-Fraumeni syndrome	VCV001042468	17	7577098 - 7577100	17	7673780 - 7673782	1042468	1033672	rs2073193451	NC_000017.11:7673779:TCT:GAG	Indel	missense variant	Uncertain significance	Aug 31, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	280	TP53
NM_000546.6(TP53):c.840A>T (p.Arg280Ser)	TP53	R280S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast	VCV000988616	17	7577098	17	7673780	988616	976547	rs1567547687	NC_000017.11:7673779:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	280	TP53
NM_000546.6(TP53):c.840A>C (p.Arg280Ser)	TP53	R280S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000634747	17	7577098	17	7673780	634747	622585	rs1567547687	NC_000017.11:7673779:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	280	TP53
NM_000546.6(TP53):c.839G>A (p.Arg280Lys)	TP53	R280K	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck	VCV000376657	17	7577099	17	7673781	376657	363536	rs121912660	NC_000017.11:7673780:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	280	TP53
NM_000546.6(TP53):c.839G>T (p.Arg280Ile)	TP53	R280I	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000161517	17	7577099	17	7673781	161517	171613	rs121912660	NC_000017.11:7673780:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	280	TP53
NM_000546.6(TP53):c.839G>C (p.Arg280Thr)	TP53	R280T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000012368	17	7577099	17	7673781	12368	27407	rs121912660	NC_000017.11:7673780:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	280	TP53
NM_000546.6(TP53):c.838A>G (p.Arg280Gly)	TP53	R280G	Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376658	17	7577100	17	7673782	376658	363537	rs753660142	NC_000017.11:7673781:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	280	TP53
NM_000546.6(TP53):c.836G>T (p.Gly279Val)	TP53	G279V	Li-Fraumeni syndrome	VCV001434495	17	7577102	17	7673784	1434495	1494311	rs1064793881	NC_000017.11:7673783:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	279	TP53
NM_000546.6(TP53):c.836G>A (p.Gly279Glu)	TP53	G279E	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	VCV000419454	17	7577102	17	7673784	419454	410259	rs1064793881	NC_000017.11:7673783:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	279	TP53
NM_000546.6(TP53):c.835G>A (p.Gly279Arg)	TP53	G279R	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000458568	17	7577103	17	7673785	458568	468863	rs1555525248	NC_000017.11:7673784:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	279	TP53
NM_000546.6(TP53):c.833C>A (p.Pro278His)	TP53	P278H	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000376646	17	7577105	17	7673787	376646	363525	rs876659802	NC_000017.11:7673786:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	278	TP53
NM_000546.6(TP53):c.833C>G (p.Pro278Arg)	TP53	P278R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376644	17	7577105	17	7673787	376644	363523	rs876659802	NC_000017.11:7673786:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	278	TP53
NM_000546.6(TP53):c.833C>T (p.Pro278Leu)	TP53	P278L	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000232497	17	7577105	17	7673787	232497	236459	rs876659802	NC_000017.11:7673786:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	278	TP53
NM_000546.6(TP53):c.832C>G (p.Pro278Ala)	TP53	P278A	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376645	17	7577106	17	7673788	376645	363524	rs17849781	NC_000017.11:7673787:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	278	TP53
NM_000546.6(TP53):c.832C>A (p.Pro278Thr)	TP53	P278T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376643	17	7577106	17	7673788	376643	363522	rs17849781	NC_000017.11:7673787:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	278	TP53
NM_000546.6(TP53):c.832C>T (p.Pro278Ser)	TP53	P278S	not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376642	17	7577106	17	7673788	376642	363521	rs17849781	NC_000017.11:7673787:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	278	TP53
NM_000546.6(TP53):c.831T>G (p.Cys277Trp)	TP53	C277W	Hereditary cancer-predisposing syndrome	VCV001762926	17	7577107	17	7673789	1762926	1814019	NA	NC_000017.11:7673788:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	277	TP53
NM_000546.6(TP53):c.830G>C (p.Cys277Ser)	TP53	C277S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000655556	17	7577108	17	7673790	655556	646740	rs763098116	NC_000017.11:7673789:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	277	TP53
NM_000546.6(TP53):c.830G>T (p.Cys277Phe)	TP53	C277F	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|TP53-related disorder	VCV000458567	17	7577108	17	7673790	458567	469122	rs763098116	NC_000017.11:7673789:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	277	TP53
NM_000546.6(TP53):c.830G>A (p.Cys277Tyr)	TP53	C277Y	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|not provided	VCV000185722	17	7577108	17	7673790	185722	185348	rs763098116	NC_000017.11:7673789:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	277	TP53
NM_000546.6(TP53):c.829T>G (p.Cys277Gly)	TP53	C277G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV002757236	17	7577109	17	7673791	2757236	2921007	NA	NC_000017.11:7673790:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	277	TP53
NM_000546.6(TP53):c.829T>C (p.Cys277Arg)	TP53	C277R	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast	VCV000421804	17	7577109	17	7673791	421804	410260	rs1064795369	NC_000017.11:7673790:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 14, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	277	TP53
NM_000546.6(TP53):c.827C>A (p.Ala276Asp)	TP53	A276D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Neoplasm	VCV000232683	17	7577111	17	7673793	232683	236460	rs786202082	NC_000017.11:7673792:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	276	TP53
NM_000546.6(TP53):c.827C>G (p.Ala276Gly)	TP53	A276G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000185319	17	7577111	17	7673793	185319	185349	rs786202082	NC_000017.11:7673792:G:C	single nucleotide variant	missense variant	Pathogenic	Jul 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	276	TP53
NM_000546.6(TP53):c.826G>A (p.Ala276Thr)	TP53	A276T	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000827547	17	7577112	17	7673794	827547	814462	rs1131691029	NC_000017.11:7673793:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	276	TP53
NM_000546.6(TP53):c.826G>C (p.Ala276Pro)	TP53	A276P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000428893	17	7577112	17	7673794	428893	420645	rs1131691029	NC_000017.11:7673793:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	276	TP53
NM_000546.6(TP53):c.825T>G (p.Cys275Trp)	TP53	C275W	Hereditary cancer-predisposing syndrome	VCV000485044	17	7577113	17	7673795	485044	479287	rs1555525279	NC_000017.11:7673794:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 9, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	275	TP53
NM_000546.6(TP53):c.824G>C (p.Cys275Ser)	TP53	C275S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376583	17	7577114	17	7673796	376583	363462	rs863224451	NC_000017.11:7673795:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	275	TP53
NM_000546.6(TP53):c.824G>T (p.Cys275Phe)	TP53	C275F	Li-Fraumeni syndrome	VCV000376582	17	7577114	17	7673796	376582	363461	rs863224451	NC_000017.11:7673795:C:A	single nucleotide variant	missense variant	Pathogenic	Sep 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	275	TP53
NM_000546.6(TP53):c.824G>A (p.Cys275Tyr)	TP53	C275Y	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000215997	17	7577114	17	7673796	215997	213392	rs863224451	NC_000017.11:7673795:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	275	TP53
NM_000546.6(TP53):c.823T>G (p.Cys275Gly)	TP53	C275G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV001414106	17	7577115	17	7673797	1414106	1358129	rs1057519983	NC_000017.11:7673796:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	275	TP53
NM_000546.6(TP53):c.823T>A (p.Cys275Ser)	TP53	C275S	Li-Fraumeni syndrome	VCV000960924	17	7577115	17	7673797	960924	950305	rs1057519983	NC_000017.11:7673796:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	275	TP53
NM_000546.6(TP53):c.823T>C (p.Cys275Arg)	TP53	C275R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376584	17	7577115	17	7673797	376584	363463	rs1057519983	NC_000017.11:7673796:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	275	TP53
NM_000546.6(TP53):c.821_822inv (p.Val274Glu)	TP53	V274E	Li-Fraumeni syndrome	VCV001417760	17	7577116 - 7577117	17	7673798 - 7673799	1417760	1374247	NA	NC_000017.11:7673797:AA:TT	Inversion	missense variant	Uncertain significance	Oct 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	274	TP53
NM_000546.6(TP53):c.821T>C (p.Val274Ala)	TP53	V274A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376677	17	7577117	17	7673799	376677	363556	rs1057520006	NC_000017.11:7673798:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 27, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	274	TP53
NM_000546.6(TP53):c.821T>G (p.Val274Gly)	TP53	V274G	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376676	17	7577117	17	7673799	376676	363555	rs1057520006	NC_000017.11:7673798:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	274	TP53
NM_000546.6(TP53):c.821T>A (p.Val274Asp)	TP53	V274D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376675	17	7577117	17	7673799	376675	363554	rs1057520006	NC_000017.11:7673798:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	274	TP53
NM_000546.6(TP53):c.820G>C (p.Val274Leu)	TP53	V274L	Li-Fraumeni syndrome	VCV000376678	17	7577118	17	7673800	376678	363557	rs1057520005	NC_000017.11:7673799:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	274	TP53
NM_000546.6(TP53):c.820G>T (p.Val274Phe)	TP53	V274F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376674	17	7577118	17	7673800	376674	363553	rs1057520005	NC_000017.11:7673799:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	274	TP53
NM_000546.6(TP53):c.818G>T (p.Arg273Leu)	TP53	R273L	Li-Fraumeni syndrome 1|Carcinoma of pancreas|Choroid plexus papilloma|Familial cancer of breast|Bone marrow failure syndrome 5|Li-Fraumeni syndrome 1|Glioma susceptibility 1|Bone osteosarcoma|Nasopharyngeal carcinoma|Hepatocellular carcinoma|Colorectal cancer|Adrenocortical carcinoma, hereditary|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000376655	17	7577120	17	7673802	376655	363534	rs28934576	NC_000017.11:7673801:C:A	single nucleotide variant	missense variant	Pathogenic	Sep 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	273	TP53
NM_000546.6(TP53):c.818G>C (p.Arg273Pro)	TP53	R273P	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000231060	17	7577120	17	7673802	231060	236461	rs28934576	NC_000017.11:7673801:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	273	TP53
NM_000546.6(TP53):c.818G>A (p.Arg273His)	TP53	R273H	Li-Fraumeni syndrome|Neoplasm	VCV000012366	17	7577120	17	7673802	12366	27405	rs28934576	NC_000017.11:7673801:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	273	TP53
NM_000546.6(TP53):c.817C>G (p.Arg273Gly)	TP53	R273G	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Bone osteosarcoma|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Hepatocellular carcinoma|Adrenocortical carcinoma, hereditary|Carcinoma of pancreas|Choroid plexus papilloma|Familial cancer of breast|Glioma susceptibility 1|Basal cell carcinoma, susceptibility to, 7|Bone marrow failure syndrome 5|Colorectal cancer|Hereditary cancer-predisposing syndrome	VCV000634682	17	7577121	17	7673803	634682	622586	rs121913343	NC_000017.11:7673802:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	273	TP53
NM_000546.6(TP53):c.817C>A (p.Arg273Ser)	TP53	R273S	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376656	17	7577121	17	7673803	376656	363535	rs121913343	NC_000017.11:7673802:G:T	single nucleotide variant	missense variant	Pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	273	TP53
NM_000546.6(TP53):c.817C>T (p.Arg273Cys)	TP53	R273C	not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000043594	17	7577121	17	7673803	43594	52763	rs121913343	NC_000017.11:7673802:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	273	TP53
NM_000546.6(TP53):c.815T>C (p.Val272Ala)	TP53	V272A	Li-Fraumeni syndrome	VCV000565884	17	7577123	17	7673805	565884	574629	rs876660333	NC_000017.11:7673804:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	272	TP53
NM_000546.6(TP53):c.815T>A (p.Val272Glu)	TP53	V272E	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376673	17	7577123	17	7673805	376673	363552	rs876660333	NC_000017.11:7673804:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	272	TP53
NM_000546.6(TP53):c.815T>G (p.Val272Gly)	TP53	V272G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000233323	17	7577123	17	7673805	233323	236462	rs876660333	NC_000017.11:7673804:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	272	TP53
NM_000546.6(TP53):c.814G>C (p.Val272Leu)	TP53	V272L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000574679	17	7577124	17	7673806	574679	574631	rs121912657	NC_000017.11:7673805:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 8, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	272	TP53
NM_000546.6(TP53):c.814G>A (p.Val272Met)	TP53	V272M	Li-Fraumeni syndrome 1|Neoplasm	VCV000185814	17	7577124	17	7673806	185814	185350	rs121912657	NC_000017.11:7673805:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 18, 2022	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	272	TP53
NM_000546.6(TP53):c.814G>T (p.Val272Leu)	TP53	V272L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000012358	17	7577124	17	7673806	12358	27397	rs121912657	NC_000017.11:7673805:C:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	272	TP53
NM_000546.6(TP53):c.813G>T (p.Glu271Asp)	TP53	E271D	Li-Fraumeni syndrome	VCV000859912	17	7577125	17	7673807	859912	846260	rs1567548081	NC_000017.11:7673806:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	271	TP53
NM_000546.6(TP53):c.812A>T (p.Glu271Val)	TP53	E271V	Li-Fraumeni syndrome 1	VCV003147994	17	7577126	17	7673808	3147994	3307242	NA	NC_000017.11:7673807:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Feb 20, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	271	TP53
NM_000546.6(TP53):c.812A>G (p.Glu271Gly)	TP53	E271G	Li-Fraumeni syndrome	VCV002858983	17	7577126	17	7673808	2858983	3025198	NA	NC_000017.11:7673807:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	271	TP53
NM_000546.6(TP53):c.811_812delinsTT (p.Glu271Leu)	TP53	E271L	Li-Fraumeni syndrome	VCV000568838	17	7577126 - 7577127	17	7673808 - 7673809	568838	572293	rs1567548090	NC_000017.11:7673807:TC:AA	Indel	missense variant	Uncertain significance	Jun 3, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	271	TP53
NM_000546.6(TP53):c.811G>A (p.Glu271Lys)	TP53	E271K	not provided|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000406566	17	7577127	17	7673809	406566	403011	rs1060501191	NC_000017.11:7673808:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	271	TP53
NM_000546.6(TP53):c.810T>A (p.Phe270Leu)	TP53	F270L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001431729	17	7577128	17	7673810	1431729	1405800	rs1057519987	NC_000017.11:7673809:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	TP53
NM_000546.6(TP53):c.810T>G (p.Phe270Leu)	TP53	F270L	Breast neoplasm|Gastric adenocarcinoma|Squamous cell carcinoma of the skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Lung adenocarcinoma|Neoplasm of brain|Carcinoma of esophagus|Ovarian serous cystadenocarcinoma	VCV000376595	17	7577128	17	7673810	376595	363474	rs1057519987	NC_000017.11:7673809:A:C	single nucleotide variant	missense variant	Likely pathogenic	May 31, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	270	TP53
NM_000546.6(TP53):c.809T>G (p.Phe270Cys)	TP53	F270C	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary	VCV000376597	17	7577129	17	7673811	376597	363476	rs1057519986	NC_000017.11:7673810:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	TP53
NM_000546.6(TP53):c.809T>C (p.Phe270Ser)	TP53	F270S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	VCV000376594	17	7577129	17	7673811	376594	363473	rs1057519986	NC_000017.11:7673810:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	270	TP53
NM_000546.6(TP53):c.808T>C (p.Phe270Leu)	TP53	F270L	Adrenocortical carcinoma, hereditary|Breast and/or ovarian cancer|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000634778	17	7577130	17	7673812	634778	622588	rs1057519988	NC_000017.11:7673811:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	TP53
NM_000546.6(TP53):c.808T>G (p.Phe270Val)	TP53	F270V	Hereditary cancer-predisposing syndrome	VCV000376598	17	7577130	17	7673812	376598	363477	rs1057519988	NC_000017.11:7673811:A:C	single nucleotide variant	missense variant	Pathogenic	Jun 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	270	TP53
NM_000546.6(TP53):c.808T>A (p.Phe270Ile)	TP53	F270I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376596	17	7577130	17	7673812	376596	363475	rs1057519988	NC_000017.11:7673811:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 9, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	270	TP53
NM_000546.6(TP53):c.807C>G (p.Ser269Arg)	TP53	S269R	not provided|Li-Fraumeni syndrome	VCV002113149	17	7577131	17	7673813	2113149	2164437	NA	NC_000017.11:7673812:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	269	TP53
NM_000546.6(TP53):c.806G>A (p.Ser269Asn)	TP53	S269N	Hereditary cancer-predisposing syndrome	VCV003076193	17	7577132	17	7673814	3076193	3235479	NA	NC_000017.11:7673813:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	269	TP53
NM_000546.6(TP53):c.806G>T (p.Ser269Ile)	TP53	S269I	Acute myeloid leukemia	VCV002575169	17	7577132	17	7673814	2575169	2740099	NA	NC_000017.11:7673813:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	269	TP53
NM_000546.6(TP53):c.805A>T (p.Ser269Cys)	TP53	S269C	Acute myeloid leukemia	VCV002575177	17	7577133	17	7673815	2575177	2740107	NA	NC_000017.11:7673814:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	269	TP53
NM_000546.6(TP53):c.805A>C (p.Ser269Arg)	TP53	S269R	Li-Fraumeni syndrome	VCV000647256	17	7577133	17	7673815	647256	646742	rs1597362155	NC_000017.11:7673814:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	269	TP53
NM_000546.6(TP53):c.804C>G (p.Asn268Lys)	TP53	N268K	Li-Fraumeni syndrome	VCV001349719	17	7577134	17	7673816	1349719	1394482	rs1597362168	NC_000017.11:7673815:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	268	TP53
NM_000546.6(TP53):c.803A>G (p.Asn268Ser)	TP53	N268S	Li-Fraumeni syndrome	VCV002831391	17	7577135	17	7673817	2831391	3000991	NA	NC_000017.11:7673816:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	268	TP53
NM_000546.6(TP53):c.802A>T (p.Asn268Tyr)	TP53	N268Y	Hereditary cancer-predisposing syndrome	VCV000827405	17	7577136	17	7673818	827405	814464	rs1597362182	NC_000017.11:7673817:T:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	268	TP53
NM_000546.6(TP53):c.800G>T (p.Arg267Leu)	TP53	R267L	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000852206	17	7577138	17	7673820	852206	846262	rs587780075	NC_000017.11:7673819:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	267	TP53
NM_000546.6(TP53):c.800G>C (p.Arg267Pro)	TP53	R267P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000428867	17	7577138	17	7673820	428867	420646	rs587780075	NC_000017.11:7673819:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 12, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	267	TP53
NM_000546.6(TP53):c.800G>A (p.Arg267Gln)	TP53	R267Q	Li-Fraumeni syndrome	VCV000127823	17	7577138	17	7673820	127823	133280	rs587780075	NC_000017.11:7673819:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	267	TP53
NM_000546.6(TP53):c.799C>G (p.Arg267Gly)	TP53	R267G	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV001761541	17	7577139	17	7673821	1761541	1813848	NA	NC_000017.11:7673820:G:C	single nucleotide variant	missense variant	Pathogenic	Jul 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	267	TP53
NM_000546.6(TP53):c.799C>T (p.Arg267Trp)	TP53	R267W	Adrenocortical carcinoma, hereditary|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Li-Fraumeni syndrome 1|Familial cancer of breast|Glioma susceptibility 1|Carcinoma of pancreas|Choroid plexus papilloma|Carcinoma of colon|Basal cell carcinoma, susceptibility to, 7|Adrenocortical carcinoma, hereditary|Bone osteosarcoma|Familial cancer of breast|Nasopharyngeal carcinoma|Li-Fraumeni syndrome 1|Hepatocellular carcinoma|Li-Fraumeni syndrome	VCV000141764	17	7577139	17	7673821	141764	151478	rs55832599	NC_000017.11:7673820:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	267	TP53
NM_000546.6(TP53):c.797G>T (p.Gly266Val)	TP53	G266V	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000233303	17	7577141	17	7673823	233303	236463	rs193920774	NC_000017.11:7673822:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 22, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	266	TP53
NM_000546.6(TP53):c.797G>A (p.Gly266Glu)	TP53	G266E	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000161516	17	7577141	17	7673823	161516	171614	rs193920774	NC_000017.11:7673822:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	266	TP53
NM_000546.6(TP53):c.796G>A (p.Gly266Arg)	TP53	G266R	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000458566	17	7577142	17	7673824	458566	469137	rs1057519990	NC_000017.11:7673823:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	266	TP53
NM_000546.6(TP53):c.796G>C (p.Gly266Arg)	TP53	G266R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000376605	17	7577142	17	7673824	376605	363484	rs1057519990	NC_000017.11:7673823:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	266	TP53
NM_000546.6(TP53):c.794T>G (p.Leu265Arg)	TP53	L265R	Li-Fraumeni syndrome	VCV002764543	17	7577144	17	7673826	2764543	2931746	NA	NC_000017.11:7673825:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	265	TP53
NM_000546.6(TP53):c.794T>A (p.Leu265Gln)	TP53	L265Q	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000953467	17	7577144	17	7673826	953467	950307	rs879253942	NC_000017.11:7673825:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	265	TP53
NM_000546.6(TP53):c.794T>C (p.Leu265Pro)	TP53	L265P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	VCV000245777	17	7577144	17	7673826	245777	245069	rs879253942	NC_000017.11:7673825:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	265	TP53
NM_000546.6(TP53):c.791T>C (p.Leu264Pro)	TP53	L264P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000480759	17	7577147	17	7673829	480759	479319	rs1555525353	NC_000017.11:7673828:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	264	TP53
NM_000546.6(TP53):c.790C>A (p.Leu264Ile)	TP53	L264I	Li-Fraumeni syndrome	VCV000640121	17	7577148	17	7673830	640121	646744	rs1597362366	NC_000017.11:7673829:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	264	TP53
NM_000546.6(TP53):c.789T>A (p.Asn263Lys)	TP53	N263K	Hereditary cancer-predisposing syndrome	VCV000485047	17	7577149	17	7673831	485047	480021	rs770598448	NC_000017.11:7673830:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	263	TP53
NM_000546.6(TP53):c.788A>G (p.Asn263Ser)	TP53	N263S	Hereditary cancer-predisposing syndrome	VCV000827313	17	7577150	17	7673832	827313	814467	rs1597362411	NC_000017.11:7673831:T:C	single nucleotide variant	missense variant	Likely benign	Aug 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	263	TP53
NM_000546.6(TP53):c.787A>T (p.Asn263Tyr)	TP53	N263Y	Li-Fraumeni syndrome	VCV001364128	17	7577151	17	7673833	1364128	1386067	rs72661119	NC_000017.11:7673832:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	263	TP53
NM_000546.6(TP53):c.787A>C (p.Asn263His)	TP53	N263H	Li-Fraumeni syndrome	VCV000528251	17	7577151	17	7673833	528251	531865	rs72661119	NC_000017.11:7673832:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	263	TP53
NM_000546.6(TP53):c.787A>G (p.Asn263Asp)	TP53	N263D	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000142916	17	7577151	17	7673833	142916	152630	rs72661119	NC_000017.11:7673832:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	263	TP53
NM_000546.6(TP53):c.785G>A (p.Gly262Asp)	TP53	G262D	Li-Fraumeni syndrome	VCV002993845	17	7577153	17	7673835	2993845	3145163	NA	NC_000017.11:7673834:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 10, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	262	TP53
NM_000546.6(TP53):c.785G>T (p.Gly262Val)	TP53	G262V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000428889	17	7577153	17	7673835	428889	420647	rs1131691025	NC_000017.11:7673834:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	262	TP53
NM_000546.6(TP53):c.784G>C (p.Gly262Arg)	TP53	G262R	Hereditary cancer-predisposing syndrome	VCV001760888	17	7577154	17	7673836	1760888	1816503	NA	NC_000017.11:7673835:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	262	TP53
NM_000546.6(TP53):c.784G>A (p.Gly262Ser)	TP53	G262S	Li-Fraumeni syndrome	VCV000141228	17	7577154	17	7673836	141228	150942	rs200579969	NC_000017.11:7673835:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	262	TP53
NM_000546.6(TP53):c.782G>C (p.Ser261Thr)	TP53	S261T	Hereditary cancer-predisposing syndrome	VCV000187005	17	7577499	17	7674181	187005	185351	rs786203396	NC_000017.11:7674180:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	261	TP53
NM_000546.6(TP53):c.781A>G (p.Ser261Gly)	TP53	S261G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001383522	17	7577500	17	7674182	1383522	1354662	rs2151019863	NC_000017.11:7674181:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	261	TP53
NM_000546.6(TP53):c.779C>T (p.Ser260Phe)	TP53	S260F	Li-Fraumeni syndrome	VCV002765819	17	7577502	17	7674184	2765819	2922693	NA	NC_000017.11:7674183:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	260	TP53
NM_000546.6(TP53):c.779C>A (p.Ser260Tyr)	TP53	S260Y	Li-Fraumeni syndrome 1	VCV000231033	17	7577502	17	7674184	231033	236465	rs876658916	NC_000017.11:7674183:G:T	single nucleotide variant	missense variant	Likely benign	Aug 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	260	TP53
NM_000546.6(TP53):c.776A>C (p.Asp259Ala)	TP53	D259A	Malignant lymphoma, large B-cell, diffuse	VCV002671888	17	7577505	17	7674187	2671888	2839415	NA	NC_000017.11:7674186:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 4, 2023	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	259	TP53
NM_000546.6(TP53):c.776A>T (p.Asp259Val)	TP53	D259V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000485034	17	7577505	17	7674187	485034	479321	rs745425759	NC_000017.11:7674186:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	259	TP53
NM_000546.6(TP53):c.776A>G (p.Asp259Gly)	TP53	D259G	Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000188349	17	7577505	17	7674187	188349	186275	rs745425759	NC_000017.11:7674186:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	259	TP53
NM_000546.6(TP53):c.775G>C (p.Asp259His)	TP53	D259H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001349622	17	7577506	17	7674188	1349622	1394385	rs1567548929	NC_000017.11:7674187:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	259	TP53
NM_000546.6(TP53):c.775G>T (p.Asp259Tyr)	TP53	D259Y	Li-Fraumeni syndrome	VCV000634680	17	7577506	17	7674188	634680	622590	rs1567548929	NC_000017.11:7674187:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	259	TP53
NM_000546.6(TP53):c.774A>C (p.Glu258Asp)	TP53	E258D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV001360091	17	7577507	17	7674189	1360091	1473964	rs2073239956	NC_000017.11:7674188:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	258	TP53
NM_000546.6(TP53):c.773A>T (p.Glu258Val)	TP53	E258V	Li-Fraumeni syndrome	VCV002808296	17	7577508	17	7674190	2808296	2968098	NA	NC_000017.11:7674189:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	258	TP53
NM_000546.6(TP53):c.773A>C (p.Glu258Ala)	TP53	E258A	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000458563	17	7577508	17	7674190	458563	469144	rs1060501201	NC_000017.11:7674189:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	258	TP53
NM_000546.6(TP53):c.773A>G (p.Glu258Gly)	TP53	E258G	Bone osteosarcoma|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000406590	17	7577508	17	7674190	406590	402555	rs1060501201	NC_000017.11:7674189:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	258	TP53
NM_000546.6(TP53):c.772G>A (p.Glu258Lys)	TP53	E258K	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000012348	17	7577509	17	7674191	12348	27387	rs121912652	NC_000017.11:7674190:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	258	TP53
NM_000546.6(TP53):c.770T>C (p.Leu257Pro)	TP53	L257P	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000458562	17	7577511	17	7674193	458562	467516	rs28934577	NC_000017.11:7674192:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	257	TP53
NM_000546.6(TP53):c.770T>G (p.Leu257Arg)	TP53	L257R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000142134	17	7577511	17	7674193	142134	151848	rs28934577	NC_000017.11:7674192:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 5, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	257	TP53
NM_000546.6(TP53):c.770T>A (p.Leu257Gln)	TP53	L257Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000012372	17	7577511	17	7674193	12372	27411	rs28934577	NC_000017.11:7674192:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	257	TP53
NM_000546.6(TP53):c.769C>G (p.Leu257Val)	TP53	L257V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000827201	17	7577512	17	7674194	827201	814468	rs779761818	NC_000017.11:7674193:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	257	TP53
NM_000546.6(TP53):c.767C>A (p.Thr256Lys)	TP53	T256K	Li-Fraumeni syndrome	VCV002826159	17	7577514	17	7674196	2826159	2979552	NA	NC_000017.11:7674195:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	256	TP53
NM_000546.6(TP53):c.767C>T (p.Thr256Ile)	TP53	T256I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000858889	17	7577514	17	7674196	858889	846263	rs2073241840	NC_000017.11:7674195:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	256	TP53
NM_000546.6(TP53):c.766A>C (p.Thr256Pro)	TP53	T256P	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000528269	17	7577515	17	7674197	528269	532201	rs587781433	NC_000017.11:7674196:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	256	TP53
NM_000546.6(TP53):c.766A>G (p.Thr256Ala)	TP53	T256A	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000141011	17	7577515	17	7674197	141011	150725	rs587781433	NC_000017.11:7674196:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	256	TP53
NM_000546.6(TP53):c.764T>C (p.Ile255Thr)	TP53	I255T	Li-Fraumeni syndrome	VCV000376623	17	7577517	17	7674199	376623	363502	rs876659675	NC_000017.11:7674198:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	255	TP53
NM_000546.6(TP53):c.764T>G (p.Ile255Ser)	TP53	I255S	Li-Fraumeni syndrome	VCV000376622	17	7577517	17	7674199	376622	363501	rs876659675	NC_000017.11:7674198:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	255	TP53
NM_000546.6(TP53):c.764T>A (p.Ile255Asn)	TP53	I255N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	VCV000232289	17	7577517	17	7674199	232289	236468	rs876659675	NC_000017.11:7674198:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	255	TP53
NM_000546.6(TP53):c.763A>G (p.Ile255Val)	TP53	I255V	Chronic myelogenous leukemia, BCR-ABL1 positive	VCV003242231	17	7577518	17	7674200	3242231	3401206	NA	NC_000017.11:7674199:T:C	single nucleotide variant	missense variant|non-coding transcript variant	NA	NA	NA	Tier IV - Benign/Likely benign	NA	no assertion criteria provided	NA	NA	NA	NA	255	TP53
NM_000546.6(TP53):c.763A>T (p.Ile255Phe)	TP53	I255F	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000376621	17	7577518	17	7674200	376621	363500	rs1057519995	NC_000017.11:7674199:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	255	TP53
NM_000546.6(TP53):c.761_762delinsAT (p.Ile254Asn)	TP53	I254N	Li-Fraumeni syndrome	VCV002817584	17	7577519 - 7577520	17	7674201 - 7674202	2817584	2977395	NA	NC_000017.11:7674200:GA:AT	Indel	missense variant|non-coding transcript variant	Pathogenic	Nov 30, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	254	TP53
NM_000546.6(TP53):c.762C>G (p.Ile254Met)	TP53	I254M	Li-Fraumeni syndrome	VCV002135554	17	7577519	17	7674201	2135554	2188809	NA	NC_000017.11:7674200:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	254	TP53
NM_000546.6(TP53):c.761T>C (p.Ile254Thr)	TP53	I254T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001759844	17	7577520	17	7674202	1759844	1813445	NA	NC_000017.11:7674201:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	254	TP53
NM_000546.6(TP53):c.761T>A (p.Ile254Asn)	TP53	I254N	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000856299	17	7577520	17	7674202	856299	846265	rs1330865474	NC_000017.11:7674201:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	254	TP53
NM_000546.6(TP53):c.761T>G (p.Ile254Ser)	TP53	I254S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000659457	17	7577520	17	7674202	659457	646747	rs1330865474	NC_000017.11:7674201:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	254	TP53
NM_000546.6(TP53):c.760A>G (p.Ile254Val)	TP53	I254V	Li-Fraumeni syndrome 1	VCV000406605	17	7577521	17	7674203	406605	402557	rs746601313	NC_000017.11:7674202:T:C	single nucleotide variant	missense variant	Likely benign	Aug 3, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	254	TP53
NM_000546.6(TP53):c.758C>T (p.Thr253Ile)	TP53	T253I	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000837688	17	7577523	17	7674205	837688	846266	rs1555525465	NC_000017.11:7674204:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 10, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	253	TP53
NM_000546.6(TP53):c.758C>A (p.Thr253Asn)	TP53	T253N	not specified|Li-Fraumeni syndrome	VCV000505571	17	7577523	17	7674205	505571	497493	rs1555525465	NC_000017.11:7674204:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	253	TP53
NM_000546.6(TP53):c.757A>C (p.Thr253Pro)	TP53	T253P	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV003148769	17	7577524	17	7674206	3148769	3308017	NA	NC_000017.11:7674205:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	253	TP53
NM_000546.6(TP53):c.757A>G (p.Thr253Ala)	TP53	T253A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000827132	17	7577524	17	7674206	827132	814470	rs1597364185	NC_000017.11:7674205:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 26, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	253	TP53
NM_000546.6(TP53):c.755T>C (p.Leu252Pro)	TP53	L252P	Li-Fraumeni syndrome|not provided	VCV000012350	17	7577526	17	7674208	12350	27389	rs121912653	NC_000017.11:7674207:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 3, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	252	TP53
NM_000546.6(TP53):c.754C>G (p.Leu252Val)	TP53	L252V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001759470	17	7577527	17	7674209	1759470	1813071	NA	NC_000017.11:7674208:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	252	TP53
NM_000546.6(TP53):c.754C>T (p.Leu252Phe)	TP53	L252F	Li-Fraumeni syndrome	VCV001053765	17	7577527	17	7674209	1053765	1050665	rs2151020426	NC_000017.11:7674208:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	252	TP53
NM_000546.6(TP53):c.753C>G (p.Ile251Met)	TP53	I251M	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000485046	17	7577528	17	7674210	485046	480024	rs878854074	NC_000017.11:7674209:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	251	TP53
NM_000546.6(TP53):c.752T>A (p.Ile251Asn)	TP53	I251N	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000528254	17	7577529	17	7674211	528254	532202	rs730882027	NC_000017.11:7674210:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	251	TP53
NM_000546.6(TP53):c.752T>C (p.Ile251Thr)	TP53	I251T	not specified|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000439320	17	7577529	17	7674211	439320	432940	rs730882027	NC_000017.11:7674210:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	251	TP53
NM_000546.6(TP53):c.752T>G (p.Ile251Ser)	TP53	I251S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000182967	17	7577529	17	7674211	182967	180997	rs730882027	NC_000017.11:7674210:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	251	TP53
NM_000546.6(TP53):c.751A>G (p.Ile251Val)	TP53	I251V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001759315	17	7577530	17	7674212	1759315	1816222	NA	NC_000017.11:7674211:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	251	TP53
NM_000546.6(TP53):c.751A>T (p.Ile251Phe)	TP53	I251F	Li-Fraumeni syndrome	VCV001518844	17	7577530	17	7674212	1518844	1343038	rs730882007	NC_000017.11:7674211:T:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	251	TP53
NM_000546.6(TP53):c.751A>C (p.Ile251Leu)	TP53	I251L	Hereditary cancer-predisposing syndrome|Gastric cancer|Li-Fraumeni syndrome 1|not provided	VCV000182937	17	7577530	17	7674212	182937	180998	rs730882007	NC_000017.11:7674211:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	251	TP53
NM_000546.6(TP53):c.749C>T (p.Pro250Leu)	TP53	P250L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000420136	17	7577532	17	7674214	420136	410263	rs1064794311	NC_000017.11:7674213:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	250	TP53
NM_000546.6(TP53):c.748C>G (p.Pro250Ala)	TP53	P250A	Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001759142	17	7577533	17	7674215	1759142	1816049	NA	NC_000017.11:7674214:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	250	TP53
NM_000546.6(TP53):c.748C>A (p.Pro250Thr)	TP53	P250T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001759140	17	7577533	17	7674215	1759140	1816047	NA	NC_000017.11:7674214:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	250	TP53
NM_000546.6(TP53):c.748C>T (p.Pro250Ser)	TP53	P250S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV001316970	17	7577533	17	7674215	1316970	1306788	rs2151020578	NC_000017.11:7674214:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	250	TP53
NM_000546.6(TP53):c.747G>C (p.Arg249Ser)	TP53	R249S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000406598	17	7577534	17	7674216	406598	403018	rs28934571	NC_000017.11:7674215:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	TP53
NM_000546.6(TP53):c.747G>T (p.Arg249Ser)	TP53	R249S	not provided|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000012352	17	7577534	17	7674216	12352	27391	rs28934571	NC_000017.11:7674215:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	249	TP53
NM_000546.6(TP53):c.746G>T (p.Arg249Met)	TP53	R249M	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376653	17	7577535	17	7674217	376653	363532	rs587782329	NC_000017.11:7674216:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	TP53
NM_000546.6(TP53):c.746G>C (p.Arg249Thr)	TP53	R249T	not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376015	17	7577535	17	7674217	376015	362894	rs587782329	NC_000017.11:7674216:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	249	TP53
NM_000546.6(TP53):c.746G>A (p.Arg249Lys)	TP53	R249K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000142241	17	7577535	17	7674217	142241	151955	rs587782329	NC_000017.11:7674216:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	TP53
NM_000546.6(TP53):c.745A>G (p.Arg249Gly)	TP53	R249G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376654	17	7577536	17	7674218	376654	363533	rs587782082	NC_000017.11:7674217:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	TP53
NM_000546.6(TP53):c.745A>T (p.Arg249Trp)	TP53	R249W	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000141881	17	7577536	17	7674218	141881	151595	rs587782082	NC_000017.11:7674217:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	249	TP53
NM_000546.6(TP53):c.743G>C (p.Arg248Pro)	TP53	R248P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000237954	17	7577538	17	7674220	237954	242980	rs11540652	NC_000017.11:7674219:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	248	TP53
NM_000546.6(TP53):c.743G>T (p.Arg248Leu)	TP53	R248L	Li-Fraumeni syndrome	VCV000230253	17	7577538	17	7674220	230253	236469	rs11540652	NC_000017.11:7674219:C:A	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	248	TP53
NM_000546.6(TP53):c.743G>A (p.Arg248Gln)	TP53	R248Q	Li-Fraumeni syndrome|Neoplasm	VCV000012356	17	7577538	17	7674220	12356	27395	rs11540652	NC_000017.11:7674219:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	248	TP53
NM_000546.6(TP53):c.741_742delinsTT (p.Arg248Trp)	TP53	R248W	Li-Fraumeni syndrome	VCV000437017	17	7577539 - 7577540	17	7674221 - 7674222	437017	430018	rs1555525498	NC_000017.11:7674220:GG:AA	Indel	missense variant	Likely pathogenic	Mar 31, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	248	TP53
NM_000546.6(TP53):c.742C>G (p.Arg248Gly)	TP53	R248G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Carcinoma of colon	VCV000376652	17	7577539	17	7674221	376652	363531	rs121912651	NC_000017.11:7674220:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	248	TP53
NM_000546.6(TP53):c.742C>T (p.Arg248Trp)	TP53	R248W	Li-Fraumeni syndrome|Neoplasm	VCV000012347	17	7577539	17	7674221	12347	27386	rs121912651	NC_000017.11:7674220:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	248	TP53
NM_000546.6(TP53):c.740A>G (p.Asn247Ser)	TP53	N247S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000406595	17	7577541	17	7674223	406595	403151	rs786201762	NC_000017.11:7674222:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	247	TP53
NM_000546.6(TP53):c.740A>T (p.Asn247Ile)	TP53	N247I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000184882	17	7577541	17	7674223	184882	185354	rs786201762	NC_000017.11:7674222:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 9, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	247	TP53
NM_000546.6(TP53):c.738G>C (p.Met246Ile)	TP53	M246I	Hereditary cancer-predisposing syndrome	VCV001758655	17	7577543	17	7674225	1758655	1819366	NA	NC_000017.11:7674224:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 12, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.738G>T (p.Met246Ile)	TP53	M246I	Li-Fraumeni syndrome	VCV000968639	17	7577543	17	7674225	968639	958329	rs1019340046	NC_000017.11:7674224:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.738G>A (p.Met246Ile)	TP53	M246I	Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000480961	17	7577543	17	7674225	480961	479328	rs1019340046	NC_000017.11:7674224:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.737T>A (p.Met246Lys)	TP53	M246K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000480764	17	7577544	17	7674226	480764	479245	rs587780074	NC_000017.11:7674225:A:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.737T>C (p.Met246Thr)	TP53	M246T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000428886	17	7577544	17	7674226	428886	420650	rs587780074	NC_000017.11:7674225:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.737T>G (p.Met246Arg)	TP53	M246R	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000127822	17	7577544	17	7674226	127822	133279	rs587780074	NC_000017.11:7674225:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 31, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.736A>T (p.Met246Leu)	TP53	M246L	Li-Fraumeni syndrome	VCV000406586	17	7577545	17	7674227	406586	402539	rs483352695	NC_000017.11:7674226:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.736A>C (p.Met246Leu)	TP53	M246L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000186737	17	7577545	17	7674227	186737	185355	rs483352695	NC_000017.11:7674226:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 31, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.736A>G (p.Met246Val)	TP53	M246V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV000100815	17	7577545	17	7674227	100815	106675	rs483352695	NC_000017.11:7674226:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	246	TP53
NM_000546.6(TP53):c.734_735delinsAT (p.Gly245Asp)	TP53	G245D	Li-Fraumeni syndrome	VCV000861760	17	7577546 - 7577547	17	7674228 - 7674229	861760	846267	rs2073251813	NC_000017.11:7674227:GC:AT	Indel	missense variant	Pathogenic	Apr 1, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	245	TP53
NM_000546.6(TP53):c.734G>T (p.Gly245Val)	TP53	G245V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000376603	17	7577547	17	7674229	376603	363482	rs121912656	NC_000017.11:7674228:C:A	single nucleotide variant	missense variant	Pathogenic	Mar 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	245	TP53
NM_000546.6(TP53):c.734G>C (p.Gly245Ala)	TP53	G245A	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000265357	17	7577547	17	7674229	265357	260191	rs121912656	NC_000017.11:7674228:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	245	TP53
NM_000546.6(TP53):c.734G>A (p.Gly245Asp)	TP53	G245D	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000012355	17	7577547	17	7674229	12355	27394	rs121912656	NC_000017.11:7674228:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	245	TP53
NM_000546.6(TP53):c.733G>C (p.Gly245Arg)	TP53	G245R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376604	17	7577548	17	7674230	376604	363483	rs28934575	NC_000017.11:7674229:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	245	TP53
NM_000546.6(TP53):c.733G>A (p.Gly245Ser)	TP53	G245S	Li-Fraumeni syndrome	VCV000012365	17	7577548	17	7674230	12365	27404	rs28934575	NC_000017.11:7674229:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	245	TP53
NM_000546.6(TP53):c.733G>T (p.Gly245Cys)	TP53	G245C	not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000012349	17	7577548	17	7674230	12349	27388	rs28934575	NC_000017.11:7674229:C:A	single nucleotide variant	missense variant	Pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	245	TP53
NM_000546.6(TP53):c.731G>C (p.Gly244Ala)	TP53	G244A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000458560	17	7577550	17	7674232	458560	467518	rs985033810	NC_000017.11:7674231:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	244	TP53
NM_000546.6(TP53):c.731G>T (p.Gly244Val)	TP53	G244V	Li-Fraumeni syndrome 1	VCV000376601	17	7577550	17	7674232	376601	363480	rs985033810	NC_000017.11:7674231:C:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 16, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	244	TP53
NM_000546.6(TP53):c.731G>A (p.Gly244Asp)	TP53	G244D	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000372785	17	7577550	17	7674232	372785	360335	rs985033810	NC_000017.11:7674231:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	244	TP53
NM_000546.6(TP53):c.730G>C (p.Gly244Arg)	TP53	G244R	Squamous cell carcinoma of the head and neck|Uterine carcinosarcoma|Gastric adenocarcinoma|Small cell lung carcinoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Lung adenocarcinoma|Neoplasm of brain|Malignant neoplasm of body of uterus|Ovarian serous cystadenocarcinoma|Neoplasm of the large intestine|Hepatocellular carcinoma|Glioblastoma	VCV000376602	17	7577551	17	7674233	376602	363481	rs1057519989	NC_000017.11:7674232:C:G	single nucleotide variant	missense variant	Likely pathogenic	May 31, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	244	TP53
NM_000546.6(TP53):c.730G>A (p.Gly244Ser)	TP53	G244S	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000376600	17	7577551	17	7674233	376600	363479	rs1057519989	NC_000017.11:7674232:C:T	single nucleotide variant	missense variant	Pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	244	TP53
NM_000546.6(TP53):c.730G>T (p.Gly244Cys)	TP53	G244C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Li-Fraumeni syndrome	VCV000376599	17	7577551	17	7674233	376599	363478	rs1057519989	NC_000017.11:7674232:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 29, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	244	TP53
NM_000546.6(TP53):c.729G>A (p.Met243Ile)	TP53	M243I	Li-Fraumeni syndrome	VCV000840505	17	7577552	17	7674234	840505	846268	rs2073253636	NC_000017.11:7674233:C:T	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	243	TP53
NM_000546.6(TP53):c.728T>C (p.Met243Thr)	TP53	M243T	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000182936	17	7577553	17	7674235	182936	180999	rs730882006	NC_000017.11:7674234:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	243	TP53
NM_000546.6(TP53):c.727A>T (p.Met243Leu)	TP53	M243L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001758050	17	7577554	17	7674236	1758050	1812931	NA	NC_000017.11:7674235:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	243	TP53
NM_000546.6(TP53):c.727A>G (p.Met243Val)	TP53	M243V	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000406567	17	7577554	17	7674236	406567	402568	rs786203117	NC_000017.11:7674235:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	243	TP53
NM_000546.6(TP53):c.727A>C (p.Met243Leu)	TP53	M243L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000186653	17	7577554	17	7674236	186653	185356	rs786203117	NC_000017.11:7674235:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	243	TP53
NM_000546.6(TP53):c.725_726delinsCA (p.Cys242Ser)	TP53	C242S	Li-Fraumeni syndrome	VCV002124706	17	7577555 - 7577556	17	7674237 - 7674238	2124706	2181300	NA	NC_000017.11:7674236:GC:TG	Indel	missense variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	242	TP53
NM_000546.6(TP53):c.726C>G (p.Cys242Trp)	TP53	C242W	Li-Fraumeni syndrome	VCV000376580	17	7577555	17	7674237	376580	363459	rs375874539	NC_000017.11:7674236:G:C	single nucleotide variant	missense variant	Pathogenic	Mar 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	242	TP53
NM_000546.6(TP53):c.725G>C (p.Cys242Ser)	TP53	C242S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000647334	17	7577556	17	7674238	647334	646750	rs121912655	NC_000017.11:7674237:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	242	TP53
NM_000546.6(TP53):c.725G>T (p.Cys242Phe)	TP53	C242F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000376578	17	7577556	17	7674238	376578	363457	rs121912655	NC_000017.11:7674237:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	242	TP53
NM_000546.6(TP53):c.725G>A (p.Cys242Tyr)	TP53	C242Y	Li-Fraumeni syndrome 1|not provided|Familial cancer of breast|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000012354	17	7577556	17	7674238	12354	27393	rs121912655	NC_000017.11:7674237:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	242	TP53
NM_000546.6(TP53):c.724T>C (p.Cys242Arg)	TP53	C242R	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome	VCV000449512	17	7577557	17	7674239	449512	445902	rs1057519982	NC_000017.11:7674238:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	242	TP53
NM_000546.6(TP53):c.724T>G (p.Cys242Gly)	TP53	C242G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376581	17	7577557	17	7674239	376581	363460	rs1057519982	NC_000017.11:7674238:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	242	TP53
NM_000546.6(TP53):c.724T>A (p.Cys242Ser)	TP53	C242S	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376579	17	7577557	17	7674239	376579	363458	rs1057519982	NC_000017.11:7674238:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	242	TP53
NM_000546.6(TP53):c.722C>A (p.Ser241Tyr)	TP53	S241Y	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376663	17	7577559	17	7674241	376663	363542	rs28934573	NC_000017.11:7674240:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	241	TP53
NM_000546.6(TP53):c.722C>G (p.Ser241Cys)	TP53	S241C	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000177791	17	7577559	17	7674241	177791	176503	rs28934573	NC_000017.11:7674240:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	241	TP53
NM_000546.6(TP53):c.722C>T (p.Ser241Phe)	TP53	S241F	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Bone marrow failure syndrome 5|Adrenocortical carcinoma, hereditary|Basal cell carcinoma, susceptibility to, 7|Choroid plexus papilloma|Carcinoma of pancreas|Glioma susceptibility 1|Colorectal cancer|Nasopharyngeal carcinoma|Li-Fraumeni syndrome 1|Hepatocellular carcinoma|Bone osteosarcoma|Familial cancer of breast|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000012359	17	7577559	17	7674241	12359	27398	rs28934573	NC_000017.11:7674240:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	241	TP53
NM_000546.6(TP53):c.721T>A (p.Ser241Thr)	TP53	S241T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000959232	17	7577560	17	7674242	959232	950308	rs1057520002	NC_000017.11:7674241:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	241	TP53
NM_000546.6(TP53):c.721T>G (p.Ser241Ala)	TP53	S241A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376665	17	7577560	17	7674242	376665	363544	rs1057520002	NC_000017.11:7674241:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	241	TP53
NM_000546.6(TP53):c.721T>C (p.Ser241Pro)	TP53	S241P	Li-Fraumeni syndrome	VCV000376664	17	7577560	17	7674242	376664	363543	rs1057520002	NC_000017.11:7674241:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	241	TP53
NM_000546.6(TP53):c.720T>A (p.Ser240Arg)	TP53	S240R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001504304	17	7577561	17	7674243	1504304	1337179	rs764342812	NC_000017.11:7674242:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	240	TP53
NM_000546.6(TP53):c.720T>G (p.Ser240Arg)	TP53	S240R	Li-Fraumeni syndrome|not provided	VCV000458559	17	7577561	17	7674243	458559	467533	rs764342812	NC_000017.11:7674242:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	240	TP53
NM_000546.6(TP53):c.719G>A (p.Ser240Asn)	TP53	S240N	Acute myeloid leukemia	VCV002502882	17	7577562	17	7674244	2502882	2667997	NA	NC_000017.11:7674243:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	240	TP53
NM_000546.6(TP53):c.719G>T (p.Ser240Ile)	TP53	S240I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001036853	17	7577562	17	7674244	1036853	1033673	rs2073256828	NC_000017.11:7674243:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	240	TP53
NM_000546.6(TP53):c.718A>C (p.Ser240Arg)	TP53	S240R	not specified|Hereditary cancer-predisposing syndrome	VCV000826894	17	7577563	17	7674245	826894	814472	rs1567549584	NC_000017.11:7674244:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	240	TP53
NM_000546.6(TP53):c.718A>G (p.Ser240Gly)	TP53	S240G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1	VCV000584921	17	7577563	17	7674245	584921	576031	rs1567549584	NC_000017.11:7674244:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	240	TP53
NM_000546.6(TP53):c.717C>G (p.Asn239Lys)	TP53	N239K	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000385614	17	7577564	17	7674246	385614	376607	rs1057522275	NC_000017.11:7674245:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	239	TP53
NM_000546.6(TP53):c.716A>T (p.Asn239Ile)	TP53	N239I	Li-Fraumeni syndrome	VCV002748594	17	7577565	17	7674247	2748594	2918846	NA	NC_000017.11:7674246:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	239	TP53
NM_000546.6(TP53):c.716A>C (p.Asn239Thr)	TP53	N239T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376638	17	7577565	17	7674247	376638	363517	rs1057519999	NC_000017.11:7674246:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	239	TP53
NM_000546.6(TP53):c.716A>G (p.Asn239Ser)	TP53	N239S	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000376637	17	7577565	17	7674247	376637	363516	rs1057519999	NC_000017.11:7674246:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	239	TP53
NM_000546.6(TP53):c.715A>G (p.Asn239Asp)	TP53	N239D	Adrenocortical carcinoma, hereditary|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000234036	17	7577566	17	7674248	234036	236471	rs876660807	NC_000017.11:7674247:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	239	TP53
NM_000546.6(TP53):c.714T>G (p.Cys238Trp)	TP53	C238W	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000161515	17	7577567	17	7674249	161515	171615	rs193920789	NC_000017.11:7674248:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 28, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	238	TP53
NM_000546.6(TP53):c.713G>C (p.Cys238Ser)	TP53	C238S	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376575	17	7577568	17	7674250	376575	363454	rs730882005	NC_000017.11:7674249:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	238	TP53
NM_000546.6(TP53):c.713G>T (p.Cys238Phe)	TP53	C238F	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376574	17	7577568	17	7674250	376574	363453	rs730882005	NC_000017.11:7674249:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	238	TP53
NM_000546.6(TP53):c.713G>A (p.Cys238Tyr)	TP53	C238Y	Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Li-Fraumeni syndrome|Neoplasm	VCV000182935	17	7577568	17	7674250	182935	181000	rs730882005	NC_000017.11:7674249:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	238	TP53
NM_000546.6(TP53):c.712T>A (p.Cys238Ser)	TP53	C238S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000485039	17	7577569	17	7674251	485039	479331	rs1057519981	NC_000017.11:7674250:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	238	TP53
NM_000546.6(TP53):c.712T>G (p.Cys238Gly)	TP53	C238G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376577	17	7577569	17	7674251	376577	363456	rs1057519981	NC_000017.11:7674250:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	238	TP53
NM_000546.6(TP53):c.712T>C (p.Cys238Arg)	TP53	C238R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376576	17	7577569	17	7674251	376576	363455	rs1057519981	NC_000017.11:7674250:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	238	TP53
NM_000546.6(TP53):c.711G>C (p.Met237Ile)	TP53	M237I	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV001757269	17	7577570	17	7674252	1757269	1819274	NA	NC_000017.11:7674251:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.711G>T (p.Met237Ile)	TP53	M237I	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000634770	17	7577570	17	7674252	634770	622595	rs587782664	NC_000017.11:7674251:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.711G>A (p.Met237Ile)	TP53	M237I	Li-Fraumeni syndrome 1|Neoplasm	VCV000142714	17	7577570	17	7674252	142714	152428	rs587782664	NC_000017.11:7674251:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 20, 2021	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	237	TP53
NM_000546.6(TP53):c.710T>C (p.Met237Thr)	TP53	M237T	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000481069	17	7577571	17	7674253	481069	479333	rs765848205	NC_000017.11:7674252:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.710T>G (p.Met237Arg)	TP53	M237R	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000419524	17	7577571	17	7674253	419524	410264	rs765848205	NC_000017.11:7674252:A:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.710T>A (p.Met237Lys)	TP53	M237K	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376636	17	7577571	17	7674253	376636	363515	rs765848205	NC_000017.11:7674252:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.709A>T (p.Met237Leu)	TP53	M237L	Hereditary cancer-predisposing syndrome	VCV002774649	17	7577572	17	7674254	2774649	2935376	NA	NC_000017.11:7674253:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.709A>C (p.Met237Leu)	TP53	M237L	Hereditary cancer-predisposing syndrome	VCV001757126	17	7577572	17	7674254	1757126	1819131	NA	NC_000017.11:7674253:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.709A>G (p.Met237Val)	TP53	M237V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1	VCV000182934	17	7577572	17	7674254	182934	181001	rs730882004	NC_000017.11:7674253:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 28, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	237	TP53
NM_000546.6(TP53):c.707A>G (p.Tyr236Cys)	TP53	Y236C	not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000376693	17	7577574	17	7674256	376693	363572	rs730882026	NC_000017.11:7674255:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	236	TP53
NM_000546.6(TP53):c.707A>C (p.Tyr236Ser)	TP53	Y236S	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000182966	17	7577574	17	7674256	182966	181002	rs730882026	NC_000017.11:7674255:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 19, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	236	TP53
NM_000546.6(TP53):c.706T>A (p.Tyr236Asn)	TP53	Y236N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376694	17	7577575	17	7674257	376694	363573	rs587782289	NC_000017.11:7674256:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	236	TP53
NM_000546.6(TP53):c.706T>C (p.Tyr236His)	TP53	Y236H	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000216469	17	7577575	17	7674257	216469	213394	rs587782289	NC_000017.11:7674256:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	236	TP53
NM_000546.6(TP53):c.706T>G (p.Tyr236Asp)	TP53	Y236D	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000142183	17	7577575	17	7674257	142183	151897	rs587782289	NC_000017.11:7674256:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	236	TP53
NM_000546.6(TP53):c.704A>G (p.Asn235Ser)	TP53	N235S	Li-Fraumeni syndrome	VCV000127821	17	7577577	17	7674259	127821	133278	rs144340710	NC_000017.11:7674258:T:C	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	235	TP53
NM_000546.6(TP53):c.703A>G (p.Asn235Asp)	TP53	N235D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000919580	17	7577578	17	7674260	919580	914187	rs786204145	NC_000017.11:7674259:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	235	TP53
NM_000546.6(TP53):c.703A>T (p.Asn235Tyr)	TP53	N235Y	Li-Fraumeni syndrome	VCV000188206	17	7577578	17	7674260	188206	186276	rs786204145	NC_000017.11:7674259:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	235	TP53
NM_000546.6(TP53):c.700_702delinsCAG (p.Tyr234Gln)	TP53	Y234Q	Li-Fraumeni syndrome	VCV002751786	17	7577579 - 7577581	17	7674261 - 7674263	2751786	2919448	NA	NC_000017.11:7674260:GTA:CTG	Indel	missense variant|non-coding transcript variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	234	TP53
NM_000546.6(TP53):c.701A>C (p.Tyr234Ser)	TP53	Y234S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376690	17	7577580	17	7674262	376690	363569	rs587780073	NC_000017.11:7674261:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 24, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	234	TP53
NM_000546.6(TP53):c.701A>G (p.Tyr234Cys)	TP53	Y234C	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000127820	17	7577580	17	7674262	127820	133277	rs587780073	NC_000017.11:7674261:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	234	TP53
NM_000546.6(TP53):c.700T>A (p.Tyr234Asn)	TP53	Y234N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376692	17	7577581	17	7674263	376692	363571	rs864622237	NC_000017.11:7674262:A:T	single nucleotide variant	missense variant	Pathogenic	Dec 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	234	TP53
NM_000546.6(TP53):c.700T>C (p.Tyr234His)	TP53	Y234H	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000376691	17	7577581	17	7674263	376691	363570	rs864622237	NC_000017.11:7674262:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	234	TP53
NM_000546.6(TP53):c.700T>G (p.Tyr234Asp)	TP53	Y234D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000219759	17	7577581	17	7674263	219759	222738	rs864622237	NC_000017.11:7674262:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	234	TP53
NM_000546.6(TP53):c.698A>G (p.His233Arg)	TP53	H233R	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000246388	17	7577583	17	7674265	246388	245071	rs879254233	NC_000017.11:7674264:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 6, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	233	TP53
NM_000546.6(TP53):c.695T>A (p.Ile232Asn)	TP53	I232N	Li-Fraumeni syndrome	VCV000850008	17	7577586	17	7674268	850008	846269	rs587781589	NC_000017.11:7674267:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 23, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	232	TP53
NM_000546.6(TP53):c.695T>G (p.Ile232Ser)	TP53	I232S	Hereditary cancer-predisposing syndrome	VCV000634756	17	7577586	17	7674268	634756	622596	rs587781589	NC_000017.11:7674267:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	232	TP53
NM_000546.6(TP53):c.695T>C (p.Ile232Thr)	TP53	I232T	Hereditary cancer-predisposing syndrome|not provided	VCV000141224	17	7577586	17	7674268	141224	150938	rs587781589	NC_000017.11:7674267:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	232	TP53
NM_000546.6(TP53):c.694A>T (p.Ile232Phe)	TP53	I232F	Li-Fraumeni syndrome	VCV002827498	17	7577587	17	7674269	2827498	2983450	NA	NC_000017.11:7674268:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	232	TP53
NM_000546.6(TP53):c.694A>C (p.Ile232Leu)	TP53	I232L	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000482214	17	7577587	17	7674269	482214	479339	rs1555525562	NC_000017.11:7674268:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	232	TP53
NM_000546.6(TP53):c.692C>G (p.Thr231Ser)	TP53	T231S	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000921142	17	7577589	17	7674271	921142	914189	rs1555525564	NC_000017.11:7674270:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	231	TP53
NM_000546.6(TP53):c.692C>T (p.Thr231Ile)	TP53	T231I	Li-Fraumeni syndrome	VCV000458557	17	7577589	17	7674271	458557	469145	rs1555525564	NC_000017.11:7674270:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	231	TP53
NM_000546.6(TP53):c.691A>G (p.Thr231Ala)	TP53	T231A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000863153	17	7577590	17	7674272	863153	846270	rs1597365411	NC_000017.11:7674271:T:C	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	231	TP53
NM_000546.6(TP53):c.689C>T (p.Thr230Ile)	TP53	T230I	Li-Fraumeni syndrome	VCV001366616	17	7577592	17	7674274	1366616	1337781	rs2151022203	NC_000017.11:7674273:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	230	TP53
NM_000546.6(TP53):c.688A>G (p.Thr230Ala)	TP53	T230A	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000953956	17	7577593	17	7674275	953956	950310	rs1597365431	NC_000017.11:7674274:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	230	TP53
NM_000546.6(TP53):c.686G>C (p.Cys229Ser)	TP53	C229S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000582302	17	7577595	17	7674277	582302	574633	rs1064793603	NC_000017.11:7674276:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	229	TP53
NM_000546.6(TP53):c.686G>A (p.Cys229Tyr)	TP53	C229Y	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000419040	17	7577595	17	7674277	419040	410265	rs1064793603	NC_000017.11:7674276:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	229	TP53
NM_000546.6(TP53):c.685T>G (p.Cys229Gly)	TP53	C229G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001026715	17	7577596	17	7674278	1026715	1013153	rs1064794312	NC_000017.11:7674277:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	229	TP53
NM_000546.6(TP53):c.685T>C (p.Cys229Arg)	TP53	C229R	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000420137	17	7577596	17	7674278	420137	410266	rs1064794312	NC_000017.11:7674277:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	229	TP53
NM_000546.6(TP53):c.684C>A (p.Asp228Glu)	TP53	D228E	Li-Fraumeni syndrome	VCV000954848	17	7577597	17	7674279	954848	950311	rs2073267220	NC_000017.11:7674278:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	228	TP53
NM_000546.6(TP53):c.684C>G (p.Asp228Glu)	TP53	D228E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000926556	17	7577597	17	7674279	926556	914190	rs2073267220	NC_000017.11:7674278:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	228	TP53
NM_000546.6(TP53):c.682G>T (p.Asp228Tyr)	TP53	D228Y	Hereditary cancer-predisposing syndrome	VCV002450759	17	7577599	17	7674281	2450759	2423245	NA	NC_000017.11:7674280:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	228	TP53
NM_000546.6(TP53):c.682G>A (p.Asp228Asn)	TP53	D228N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001395667	17	7577599	17	7674281	1395667	1425066	rs2151022353	NC_000017.11:7674280:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	228	TP53
NM_000546.6(TP53):c.677G>C (p.Gly226Ala)	TP53	G226A	Li-Fraumeni syndrome|Nasopharyngeal carcinoma|Li-Fraumeni syndrome 1|Colorectal cancer|Adrenocortical carcinoma, hereditary|Carcinoma of pancreas|Choroid plexus papilloma|Familial cancer of breast|Bone osteosarcoma|Bone marrow failure syndrome 5|Glioma susceptibility 1|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7	VCV000951459	17	7577604	17	7674286	951459	928550	rs970212462	NC_000017.11:7674285:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	226	TP53
NM_000546.6(TP53):c.677G>T (p.Gly226Val)	TP53	G226V	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000458556	17	7577604	17	7674286	458556	468379	rs970212462	NC_000017.11:7674285:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	226	TP53
NM_000546.6(TP53):c.676G>A (p.Gly226Ser)	TP53	G226S	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000648028	17	7577605	17	7674287	648028	646753	rs1597365543	NC_000017.11:7674286:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	226	TP53
NM_000546.6(TP53):c.674T>A (p.Val225Asp)	TP53	V225D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000850916	17	7577607	17	7674289	850916	846272	rs2073269361	NC_000017.11:7674288:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	225	TP53
NM_000546.6(TP53):c.673G>T (p.Val225Phe)	TP53	V225F	Li-Fraumeni syndrome	VCV002122381	17	7577608	17	7674290	2122381	2173806	NA	NC_000017.11:7674289:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	225	TP53
NM_000546.6(TP53):c.673G>A (p.Val225Ile)	TP53	V225I	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480736	17	7577608	17	7674290	480736	479298	rs746504075	NC_000017.11:7674289:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	225	TP53
NM_000546.6(TP53):c.672G>C (p.Glu224Asp)	TP53	E224D	Li-Fraumeni syndrome	VCV001493447	17	7578177	17	7674859	1493447	1355645	rs267605076	NC_000017.11:7674858:C:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	224	TP53
NM_000546.6(TP53):c.672G>T (p.Glu224Asp)	TP53	E224D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000635390	17	7578177	17	7674859	635390	623214	rs267605076	NC_000017.11:7674858:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	224	TP53
NM_000546.6(TP53):c.671A>G (p.Glu224Gly)	TP53	E224G	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000826574	17	7578178	17	7674860	826574	814474	rs1131691028	NC_000017.11:7674859:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	224	TP53
NM_000546.6(TP53):c.671A>C (p.Glu224Ala)	TP53	E224A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000428892	17	7578178	17	7674860	428892	420651	rs1131691028	NC_000017.11:7674859:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	224	TP53
NM_000546.6(TP53):c.670G>A (p.Glu224Lys)	TP53	E224K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary	VCV000480767	17	7578179	17	7674861	480767	479251	rs1555525707	NC_000017.11:7674860:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	224	TP53
NM_000546.6(TP53):c.668C>T (p.Pro223Leu)	TP53	P223L	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000234214	17	7578181	17	7674863	234214	236473	rs138983188	NC_000017.11:7674862:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	223	TP53
NM_000546.6(TP53):c.665C>A (p.Pro222Gln)	TP53	P222Q	Li-Fraumeni syndrome	VCV001461784	17	7578184	17	7674866	1461784	1494727	rs146340390	NC_000017.11:7674865:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	222	TP53
NM_000546.6(TP53):c.665C>T (p.Pro222Leu)	TP53	P222L	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not specified|Breast and/or ovarian cancer|Squamous cell carcinoma of the head and neck	VCV000161397	17	7578184	17	7674866	161397	171191	rs146340390	NC_000017.11:7674865:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	222	TP53
NM_000546.6(TP53):c.664C>T (p.Pro222Ser)	TP53	P222S	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000406592	17	7578185	17	7674867	406592	402581	rs1060501203	NC_000017.11:7674866:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	222	TP53
NM_000546.6(TP53):c.661_662delinsAT (p.Glu221Met)	TP53	E221M	Li-Fraumeni syndrome	VCV002824912	17	7578187 - 7578188	17	7674869 - 7674870	2824912	2989414	NA	NC_000017.11:7674868:TC:AT	Indel	missense variant	Uncertain significance	Jan 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	221	TP53
NM_000546.6(TP53):c.662A>C (p.Glu221Ala)	TP53	E221A	Li-Fraumeni syndrome	VCV000573679	17	7578187	17	7674869	573679	572297	rs1567551121	NC_000017.11:7674868:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	221	TP53
NM_000546.6(TP53):c.661G>A (p.Glu221Lys)	TP53	E221K	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000184647	17	7578188	17	7674870	184647	185360	rs786201592	NC_000017.11:7674869:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	221	TP53
NM_000546.6(TP53):c.659A>G (p.Tyr220Cys)	TP53	Y220C	Li-Fraumeni syndrome|Neoplasm	VCV000127819	17	7578190	17	7674872	127819	133276	rs121912666	NC_000017.11:7674871:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	220	TP53
NM_000546.6(TP53):c.659A>C (p.Tyr220Ser)	TP53	Y220S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000012383	17	7578190	17	7674872	12383	27422	rs121912666	NC_000017.11:7674871:T:G	single nucleotide variant	missense variant	Pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	220	TP53
NM_000546.6(TP53):c.658T>G (p.Tyr220Asp)	TP53	Y220D	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376689	17	7578191	17	7674873	376689	363568	rs530941076	NC_000017.11:7674872:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	220	TP53
NM_000546.6(TP53):c.658T>A (p.Tyr220Asn)	TP53	Y220N	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000376688	17	7578191	17	7674873	376688	363567	rs530941076	NC_000017.11:7674872:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 23, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	220	TP53
NM_000546.6(TP53):c.658T>C (p.Tyr220His)	TP53	Y220H	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000376687	17	7578191	17	7674873	376687	363566	rs530941076	NC_000017.11:7674872:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	220	TP53
NM_000546.6(TP53):c.656C>G (p.Pro219Arg)	TP53	P219R	Li-Fraumeni syndrome	VCV000953426	17	7578193	17	7674875	953426	950312	rs1420675064	NC_000017.11:7674874:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	219	TP53
NM_000546.6(TP53):c.656C>T (p.Pro219Leu)	TP53	P219L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000826488	17	7578193	17	7674875	826488	814475	rs1420675064	NC_000017.11:7674874:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	219	TP53
NM_000546.6(TP53):c.655C>G (p.Pro219Ala)	TP53	P219A	Li-Fraumeni syndrome	VCV002850523	17	7578194	17	7674876	2850523	3016130	NA	NC_000017.11:7674875:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	219	TP53
NM_000546.6(TP53):c.655C>A (p.Pro219Thr)	TP53	P219T	Li-Fraumeni syndrome	VCV002758381	17	7578194	17	7674876	2758381	2910480	NA	NC_000017.11:7674875:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	219	TP53
NM_000546.6(TP53):c.655C>T (p.Pro219Ser)	TP53	P219S	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000245673	17	7578194	17	7674876	245673	245072	rs879253894	NC_000017.11:7674875:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	219	TP53
NM_000546.6(TP53):c.653T>A (p.Val218Glu)	TP53	V218E	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV001754112	17	7578196	17	7674878	1754112	1804667	NA	NC_000017.11:7674877:A:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	218	TP53
NM_000546.6(TP53):c.653T>G (p.Val218Gly)	TP53	V218G	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000528249	17	7578196	17	7674878	528249	532211	rs1555525743	NC_000017.11:7674877:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	218	TP53
NM_000546.6(TP53):c.652G>A (p.Val218Met)	TP53	V218M	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000237952	17	7578197	17	7674879	237952	242983	rs878854072	NC_000017.11:7674878:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	218	TP53
NM_000546.6(TP53):c.649G>T (p.Val217Leu)	TP53	V217L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001386154	17	7578200	17	7674882	1386154	1361162	rs35163653	NC_000017.11:7674881:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	217	TP53
NM_000546.6(TP53):c.649G>A (p.Val217Met)	TP53	V217M	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000183071	17	7578200	17	7674882	183071	181220	rs35163653	NC_000017.11:7674881:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	217	TP53
NM_000546.6(TP53):c.647T>A (p.Val216Glu)	TP53	V216E	Hereditary cancer-predisposing syndrome	VCV000376672	17	7578202	17	7674884	376672	363551	rs1057520004	NC_000017.11:7674883:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	216	TP53
NM_000546.6(TP53):c.647T>G (p.Val216Gly)	TP53	V216G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376671	17	7578202	17	7674884	376671	363550	rs1057520004	NC_000017.11:7674883:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	216	TP53
NM_000546.6(TP53):c.646G>C (p.Val216Leu)	TP53	V216L	Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome	VCV000406596	17	7578203	17	7674885	406596	403028	rs730882025	NC_000017.11:7674884:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 4, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	216	TP53
NM_000546.6(TP53):c.646G>T (p.Val216Leu)	TP53	V216L	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000376670	17	7578203	17	7674885	376670	363549	rs730882025	NC_000017.11:7674884:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	216	TP53
NM_000546.6(TP53):c.646G>A (p.Val216Met)	TP53	V216M	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided|Neoplasm	VCV000182965	17	7578203	17	7674885	182965	181005	rs730882025	NC_000017.11:7674884:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	216	TP53
NM_000546.6(TP53):c.645T>A (p.Ser215Arg)	TP53	S215R	Li-Fraumeni syndrome	VCV002020649	17	7578204	17	7674886	2020649	2079833	NA	NC_000017.11:7674885:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.645T>G (p.Ser215Arg)	TP53	S215R	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376661	17	7578204	17	7674886	376661	363540	rs1057520001	NC_000017.11:7674885:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.644G>A (p.Ser215Asn)	TP53	S215N	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000376662	17	7578205	17	7674887	376662	363541	rs587782177	NC_000017.11:7674886:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.644G>T (p.Ser215Ile)	TP53	S215I	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376660	17	7578205	17	7674887	376660	363539	rs587782177	NC_000017.11:7674886:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.644G>C (p.Ser215Thr)	TP53	S215T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000142012	17	7578205	17	7674887	142012	151726	rs587782177	NC_000017.11:7674886:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.643A>T (p.Ser215Cys)	TP53	S215C	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001753522	17	7578206	17	7674888	1753522	1807905	NA	NC_000017.11:7674887:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.643A>C (p.Ser215Arg)	TP53	S215R	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000428895	17	7578206	17	7674888	428895	420652	rs886039484	NC_000017.11:7674887:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.643A>G (p.Ser215Gly)	TP53	S215G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|not provided|Li-Fraumeni syndrome 1	VCV000265337	17	7578206	17	7674888	265337	260192	rs886039484	NC_000017.11:7674887:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	215	TP53
NM_000546.6(TP53):c.642T>G (p.His214Gln)	TP53	H214Q	Li-Fraumeni syndrome|not specified|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000140943	17	7578207	17	7674889	140943	150657	rs587781386	NC_000017.11:7674888:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	214	TP53
NM_000546.6(TP53):c.641A>C (p.His214Pro)	TP53	H214P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000643078	17	7578208	17	7674890	643078	646754	rs1057519992	NC_000017.11:7674889:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	214	TP53
NM_000546.6(TP53):c.641A>T (p.His214Leu)	TP53	H214L	Li-Fraumeni syndrome	VCV000376616	17	7578208	17	7674890	376616	363495	rs1057519992	NC_000017.11:7674889:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	214	TP53
NM_000546.6(TP53):c.641A>G (p.His214Arg)	TP53	H214R	Li-Fraumeni syndrome	VCV000376615	17	7578208	17	7674890	376615	363494	rs1057519992	NC_000017.11:7674889:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	214	TP53
NM_000546.6(TP53):c.640C>T (p.His214Tyr)	TP53	H214Y	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001053808	17	7578209	17	7674891	1053808	1050668	rs876658466	NC_000017.11:7674890:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	214	TP53
NM_000546.6(TP53):c.640C>A (p.His214Asn)	TP53	H214N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000230254	17	7578209	17	7674891	230254	236476	rs876658466	NC_000017.11:7674890:G:T	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	214	TP53
NM_000546.6(TP53):c.638G>T (p.Arg213Leu)	TP53	R213L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376650	17	7578211	17	7674893	376650	363529	rs587778720	NC_000017.11:7674892:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	213	TP53
NM_000546.6(TP53):c.638G>C (p.Arg213Pro)	TP53	R213P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|Li-Fraumeni syndrome 1|Neoplasm	VCV000231214	17	7578211	17	7674893	231214	236477	rs587778720	NC_000017.11:7674892:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	213	TP53
NM_000546.6(TP53):c.638G>A (p.Arg213Gln)	TP53	R213Q	Adrenocortical carcinoma, hereditary|not provided|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000135359	17	7578211	17	7674893	135359	139098	rs587778720	NC_000017.11:7674892:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	213	TP53
NM_000546.6(TP53):c.637C>G (p.Arg213Gly)	TP53	R213G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376651	17	7578212	17	7674894	376651	363530	rs397516436	NC_000017.11:7674893:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	213	TP53
NM_000546.6(TP53):c.634T>A (p.Phe212Ile)	TP53	F212I	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000422414	17	7578215	17	7674897	422414	410267	rs1064795766	NC_000017.11:7674896:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	212	TP53
NM_000546.6(TP53):c.632C>T (p.Thr211Ile)	TP53	T211I	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001503185	17	7578217	17	7674899	1503185	1400903	rs2073331490	NC_000017.11:7674898:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	211	TP53
NM_000546.6(TP53):c.632C>G (p.Thr211Ser)	TP53	T211S	Li-Fraumeni syndrome	VCV001019369	17	7578217	17	7674899	1019369	1013154	rs2073331490	NC_000017.11:7674898:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	211	TP53
NM_000546.6(TP53):c.631A>C (p.Thr211Pro)	TP53	T211P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000528235	17	7578218	17	7674900	528235	531804	rs1060501198	NC_000017.11:7674899:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	211	TP53
NM_000546.6(TP53):c.631A>G (p.Thr211Ala)	TP53	T211A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000406581	17	7578218	17	7674900	406581	402583	rs1060501198	NC_000017.11:7674899:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	211	TP53
NM_000546.6(TP53):c.629A>G (p.Asn210Ser)	TP53	N210S	Hereditary cancer-predisposing syndrome	VCV003232058	17	7578220	17	7674902	3232058	3385598	NA	NC_000017.11:7674901:T:C	single nucleotide variant	missense variant	Likely benign	Dec 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	210	TP53
NM_000546.6(TP53):c.628A>T (p.Asn210Tyr)	TP53	N210Y	Li-Fraumeni syndrome	VCV000406588	17	7578221	17	7674903	406588	402592	rs1060501200	NC_000017.11:7674902:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	210	TP53
NM_000546.6(TP53):c.627A>C (p.Arg209Ser)	TP53	R209S	Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome	VCV002450746	17	7578222	17	7674904	2450746	2423232	NA	NC_000017.11:7674903:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	209	TP53
NM_000546.6(TP53):c.626G>A (p.Arg209Lys)	TP53	R209K	Li-Fraumeni syndrome|Familial cancer of breast	VCV000962629	17	7578223	17	7674905	962629	950313	rs2073332791	NC_000017.11:7674904:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 23, 2019	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	209	TP53
NM_000546.6(TP53):c.625A>G (p.Arg209Gly)	TP53	R209G	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000627819	17	7578224	17	7674906	627819	618838	rs1429743956	NC_000017.11:7674905:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	209	TP53
NM_000546.6(TP53):c.623A>C (p.Asp208Ala)	TP53	D208A	Li-Fraumeni syndrome	VCV002759300	17	7578226	17	7674908	2759300	2917882	NA	NC_000017.11:7674907:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	208	TP53
NM_000546.6(TP53):c.623A>T (p.Asp208Val)	TP53	D208V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001036023	17	7578226	17	7674908	1036023	1033675	rs1464727668	NC_000017.11:7674907:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	208	TP53
NM_000546.6(TP53):c.623A>G (p.Asp208Gly)	TP53	D208G	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000584922	17	7578226	17	7674908	584922	576032	rs1464727668	NC_000017.11:7674907:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	208	TP53
NM_000546.6(TP53):c.622G>A (p.Asp208Asn)	TP53	D208N	Hereditary cancer-predisposing syndrome	VCV001752332	17	7578227	17	7674909	1752332	1804187	NA	NC_000017.11:7674908:C:T	single nucleotide variant	missense variant	Likely benign	Apr 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	208	TP53
NM_000546.6(TP53):c.622G>T (p.Asp208Tyr)	TP53	D208Y	Lung adenocarcinoma|Li-Fraumeni syndrome	VCV001350980	17	7578227	17	7674909	1350980	1492568	rs1597368376	NC_000017.11:7674908:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	208	TP53
NM_000546.6(TP53):c.622G>C (p.Asp208His)	TP53	D208H	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000826261	17	7578227	17	7674909	826261	814480	rs1597368376	NC_000017.11:7674908:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	208	TP53
NM_000546.6(TP53):c.619G>A (p.Asp207Asn)	TP53	D207N	Li-Fraumeni syndrome	VCV002969522	17	7578230	17	7674912	2969522	3132063	NA	NC_000017.11:7674911:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	207	TP53
NM_000546.6(TP53):c.619G>C (p.Asp207His)	TP53	D207H	Hereditary cancer-predisposing syndrome	VCV000919639	17	7578230	17	7674912	919639	914191	rs923100890	NC_000017.11:7674911:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	207	TP53
NM_000546.6(TP53):c.617T>G (p.Leu206Trp)	TP53	L206W	Adrenocortical carcinoma, hereditary	VCV002679229	17	7578232	17	7674914	2679229	2836806	NA	NC_000017.11:7674913:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	TP53
NM_000546.6(TP53):c.617T>C (p.Leu206Ser)	TP53	L206S	not specified|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000439319	17	7578232	17	7674914	439319	432941	rs1555525804	NC_000017.11:7674913:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	206	TP53
NM_000546.6(TP53):c.614A>C (p.Tyr205Ser)	TP53	Y205S	Multiple myeloma|Breast neoplasm|Pancreatic adenocarcinoma|Neoplasm of brain|Uterine carcinosarcoma|Papillary renal cell carcinoma type 1|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Lung adenocarcinoma|Hepatocellular carcinoma|Malignant neoplasm of body of uterus|Ovarian serous cystadenocarcinoma|Carcinoma of esophagus|Non-Hodgkin lymphoma|Neoplasm of the large intestine	VCV000376683	17	7578235	17	7674917	376683	363562	rs1057520007	NC_000017.11:7674916:T:G	single nucleotide variant	missense variant	Likely pathogenic	May 31, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	205	TP53
NM_000546.6(TP53):c.614A>T (p.Tyr205Phe)	TP53	Y205F	Multiple myeloma|Breast neoplasm|Pancreatic adenocarcinoma|Uterine carcinosarcoma|Ovarian serous cystadenocarcinoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Squamous cell carcinoma of the head and neck|Neoplasm of brain|Carcinoma of esophagus|Squamous cell lung carcinoma|Papillary renal cell carcinoma type 1|Malignant neoplasm of body of uterus|Lung adenocarcinoma|Non-Hodgkin lymphoma|Glioblastoma	VCV000376682	17	7578235	17	7674917	376682	363561	rs1057520007	NC_000017.11:7674916:T:A	single nucleotide variant	missense variant	Likely pathogenic	May 31, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	205	TP53
NM_000546.6(TP53):c.614A>G (p.Tyr205Cys)	TP53	Y205C	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376681	17	7578235	17	7674917	376681	363560	rs1057520007	NC_000017.11:7674916:T:C	single nucleotide variant	missense variant	Pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	205	TP53
NM_000546.6(TP53):c.613T>G (p.Tyr205Asp)	TP53	Y205D	Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome	VCV000376686	17	7578236	17	7674918	376686	363565	rs1057520008	NC_000017.11:7674917:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	205	TP53
NM_000546.6(TP53):c.613T>C (p.Tyr205His)	TP53	Y205H	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376685	17	7578236	17	7674918	376685	363564	rs1057520008	NC_000017.11:7674917:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	205	TP53
NM_000546.6(TP53):c.613T>A (p.Tyr205Asn)	TP53	Y205N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376684	17	7578236	17	7674918	376684	363563	rs1057520008	NC_000017.11:7674917:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	205	TP53
NM_000546.6(TP53):c.611A>T (p.Glu204Val)	TP53	E204V	Hereditary cancer-predisposing syndrome	VCV001751713	17	7578238	17	7674920	1751713	1807394	NA	NC_000017.11:7674919:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	204	TP53
NM_000546.6(TP53):c.611A>G (p.Glu204Gly)	TP53	E204G	Li-Fraumeni syndrome	VCV000949463	17	7578238	17	7674920	949463	928552	rs1260903787	NC_000017.11:7674919:T:C	single nucleotide variant	missense variant	Uncertain significance	May 10, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	204	TP53
NM_000546.6(TP53):c.608T>A (p.Val203Glu)	TP53	V203E	Li-Fraumeni syndrome	VCV000644883	17	7578241	17	7674923	644883	646755	rs1597368504	NC_000017.11:7674922:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	203	TP53
NM_000546.6(TP53):c.607G>C (p.Val203Leu)	TP53	V203L	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000482235	17	7578242	17	7674924	482235	479316	rs730882003	NC_000017.11:7674923:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	203	TP53
NM_000546.6(TP53):c.607G>T (p.Val203Leu)	TP53	V203L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000482218	17	7578242	17	7674924	482218	480041	rs730882003	NC_000017.11:7674923:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	203	TP53
NM_000546.6(TP53):c.607G>A (p.Val203Met)	TP53	V203M	Li-Fraumeni syndrome 1	VCV000182933	17	7578242	17	7674924	182933	181006	rs730882003	NC_000017.11:7674923:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	203	TP53
NM_000546.6(TP53):c.605G>C (p.Arg202Pro)	TP53	R202P	Hereditary cancer-predisposing syndrome	VCV000826165	17	7578244	17	7674926	826165	814481	rs587778719	NC_000017.11:7674925:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	202	TP53
NM_000546.6(TP53):c.605G>T (p.Arg202Leu)	TP53	R202L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000182932	17	7578244	17	7674926	182932	181007	rs587778719	NC_000017.11:7674925:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	202	TP53
NM_000546.6(TP53):c.605G>A (p.Arg202His)	TP53	R202H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000135358	17	7578244	17	7674926	135358	139097	rs587778719	NC_000017.11:7674925:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	202	TP53
NM_000546.6(TP53):c.604C>G (p.Arg202Gly)	TP53	R202G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000231661	17	7578245	17	7674927	231661	236478	rs587780072	NC_000017.11:7674926:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	202	TP53
NM_000546.6(TP53):c.604C>T (p.Arg202Cys)	TP53	R202C	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000127818	17	7578245	17	7674927	127818	133275	rs587780072	NC_000017.11:7674926:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	202	TP53
NM_000546.6(TP53):c.601T>A (p.Leu201Met)	TP53	L201M	Hereditary cancer-predisposing syndrome	VCV001751128	17	7578248	17	7674930	1751128	1800857	NA	NC_000017.11:7674929:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	201	TP53
NM_000546.6(TP53):c.599A>G (p.Asn200Ser)	TP53	N200S	Hereditary cancer-predisposing syndrome	VCV000924379	17	7578250	17	7674932	924379	914193	rs2073338940	NC_000017.11:7674931:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	200	TP53
NM_000546.6(TP53):c.598A>T (p.Asn200Tyr)	TP53	N200Y	Hereditary cancer-predisposing syndrome	VCV002450739	17	7578251	17	7674933	2450739	2423225	NA	NC_000017.11:7674932:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	200	TP53
NM_000546.6(TP53):c.598A>C (p.Asn200His)	TP53	N200H	Li-Fraumeni syndrome	VCV002006345	17	7578251	17	7674933	2006345	2069440	NA	NC_000017.11:7674932:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	200	TP53
NM_000546.6(TP53):c.598A>G (p.Asn200Asp)	TP53	N200D	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001061739	17	7578251	17	7674933	1061739	1050669	rs2151027554	NC_000017.11:7674932:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	200	TP53
NM_000546.6(TP53):c.596G>A (p.Gly199Glu)	TP53	G199E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000582257	17	7578253	17	7674935	582257	571620	rs1555525857	NC_000017.11:7674934:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	199	TP53
NM_000546.6(TP53):c.596G>T (p.Gly199Val)	TP53	G199V	not provided	VCV000451799	17	7578253	17	7674935	451799	445903	rs1555525857	NC_000017.11:7674934:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 20, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	199	TP53
NM_000546.6(TP53):c.595G>A (p.Gly199Arg)	TP53	G199R	Li-Fraumeni syndrome	VCV001015039	17	7578254	17	7674936	1015039	1013155	rs1567551821	NC_000017.11:7674935:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	199	TP53
NM_000546.6(TP53):c.593A>G (p.Glu198Gly)	TP53	E198G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001750606	17	7578256	17	7674938	1750606	1803756	NA	NC_000017.11:7674937:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	198	TP53
NM_000546.6(TP53):c.590T>G (p.Val197Gly)	TP53	V197G	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000826051	17	7578259	17	7674941	826051	814482	rs1567551903	NC_000017.11:7674940:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	197	TP53
NM_000546.6(TP53):c.590T>A (p.Val197Glu)	TP53	V197E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000634757	17	7578259	17	7674941	634757	622609	rs1567551903	NC_000017.11:7674940:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	197	TP53
NM_000546.6(TP53):c.589G>C (p.Val197Leu)	TP53	V197L	Hereditary cancer-predisposing syndrome	VCV000480766	17	7578260	17	7674942	480766	480042	rs786204041	NC_000017.11:7674941:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	197	TP53
NM_000546.6(TP53):c.589G>T (p.Val197Leu)	TP53	V197L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000216468	17	7578260	17	7674942	216468	213396	rs786204041	NC_000017.11:7674941:C:A	single nucleotide variant	missense variant	Uncertain significance	May 12, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	197	TP53
NM_000546.6(TP53):c.589G>A (p.Val197Met)	TP53	V197M	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000188060	17	7578260	17	7674942	188060	186277	rs786204041	NC_000017.11:7674941:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	197	TP53
NM_000546.6(TP53):c.587G>C (p.Arg196Pro)	TP53	R196P	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000231165	17	7578262	17	7674944	231165	236479	rs483352697	NC_000017.11:7674943:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	196	TP53
NM_000546.6(TP53):c.587G>A (p.Arg196Gln)	TP53	R196Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1	VCV000216467	17	7578262	17	7674944	216467	213397	rs483352697	NC_000017.11:7674943:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	196	TP53
NM_000546.6(TP53):c.587G>T (p.Arg196Leu)	TP53	R196L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000100814	17	7578262	17	7674944	100814	106674	rs483352697	NC_000017.11:7674943:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 4, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	196	TP53
NM_000546.6(TP53):c.586C>G (p.Arg196Gly)	TP53	R196G	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000232344	17	7578263	17	7674945	232344	236480	rs397516435	NC_000017.11:7674944:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	196	TP53
NM_000546.6(TP53):c.585C>G (p.Ile195Met)	TP53	I195M	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376620	17	7578264	17	7674946	376620	363499	rs1057519994	NC_000017.11:7674945:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	195	TP53
NM_000546.6(TP53):c.584T>G (p.Ile195Ser)	TP53	I195S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000376619	17	7578265	17	7674947	376619	363498	rs760043106	NC_000017.11:7674946:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	195	TP53
NM_000546.6(TP53):c.584T>A (p.Ile195Asn)	TP53	I195N	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376618	17	7578265	17	7674947	376618	363497	rs760043106	NC_000017.11:7674946:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	195	TP53
NM_000546.6(TP53):c.584T>C (p.Ile195Thr)	TP53	I195T	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000216077	17	7578265	17	7674947	216077	213398	rs760043106	NC_000017.11:7674946:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	195	TP53
NM_000546.6(TP53):c.583A>T (p.Ile195Phe)	TP53	I195F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Malignant tumor of esophagus	VCV000376617	17	7578266	17	7674948	376617	363496	rs942158624	NC_000017.11:7674947:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	195	TP53
NM_000546.6(TP53):c.581T>C (p.Leu194Pro)	TP53	L194P	Li-Fraumeni syndrome	VCV000376635	17	7578268	17	7674950	376635	363514	rs1057519998	NC_000017.11:7674949:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	194	TP53
NM_000546.6(TP53):c.581T>A (p.Leu194His)	TP53	L194H	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000376634	17	7578268	17	7674950	376634	363513	rs1057519998	NC_000017.11:7674949:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	194	TP53
NM_000546.6(TP53):c.581T>G (p.Leu194Arg)	TP53	L194R	Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|Colorectal cancer|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000376633	17	7578268	17	7674950	376633	363512	rs1057519998	NC_000017.11:7674949:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	194	TP53
NM_000546.6(TP53):c.580C>T (p.Leu194Phe)	TP53	L194F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000127817	17	7578269	17	7674951	127817	133274	rs587780071	NC_000017.11:7674950:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	194	TP53
NM_000546.6(TP53):c.579T>A (p.His193Gln)	TP53	H193Q	Hereditary cancer-predisposing syndrome	VCV000825975	17	7578270	17	7674952	825975	814484	rs1597368777	NC_000017.11:7674951:A:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	193	TP53
NM_000546.6(TP53):c.578A>C (p.His193Pro)	TP53	H193P	Li-Fraumeni syndrome	VCV000376612	17	7578271	17	7674953	376612	363491	rs786201838	NC_000017.11:7674952:T:G	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	193	TP53
NM_000546.6(TP53):c.578A>T (p.His193Leu)	TP53	H193L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000185822	17	7578271	17	7674953	185822	185366	rs786201838	NC_000017.11:7674952:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	193	TP53
NM_000546.6(TP53):c.578A>G (p.His193Arg)	TP53	H193R	Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided	VCV000184979	17	7578271	17	7674953	184979	185367	rs786201838	NC_000017.11:7674952:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	193	TP53
NM_000546.6(TP53):c.577C>A (p.His193Asn)	TP53	H193N	Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of brain|Papillary renal cell carcinoma, sporadic|Brainstem glioma|Uterine carcinosarcoma|Gastric adenocarcinoma|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Hepatocellular carcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|B-cell chronic lymphocytic leukemia|Small cell lung carcinoma|Prostate adenocarcinoma|Malignant neoplasm of body of uterus|Ovarian serous cystadenocarcinoma|Lung adenocarcinoma	VCV000376614	17	7578272	17	7674954	376614	363493	rs876658468	NC_000017.11:7674953:G:T	single nucleotide variant	missense variant	Likely pathogenic	May 31, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	193	TP53
NM_000546.6(TP53):c.577C>G (p.His193Asp)	TP53	H193D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376613	17	7578272	17	7674954	376613	363492	rs876658468	NC_000017.11:7674953:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	193	TP53
NM_000546.6(TP53):c.577C>T (p.His193Tyr)	TP53	H193Y	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV000230256	17	7578272	17	7674954	230256	236481	rs876658468	NC_000017.11:7674953:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	193	TP53
NM_000546.6(TP53):c.576G>C (p.Gln192His)	TP53	Q192H	Malignant tumor of esophagus	VCV000988617	17	7578273	17	7674955	988617	976548	rs2073344721	NC_000017.11:7674954:C:G	single nucleotide variant	missense variant	Likely benign	NA	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	192	TP53
NM_000546.6(TP53):c.576G>T (p.Gln192His)	TP53	Q192H	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000922531	17	7578273	17	7674955	922531	914194	rs2073344721	NC_000017.11:7674954:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	192	TP53
NM_000546.6(TP53):c.575A>C (p.Gln192Pro)	TP53	Q192P	Li-Fraumeni syndrome	VCV001036209	17	7578274	17	7674956	1036209	1033676	rs730882002	NC_000017.11:7674955:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	192	TP53
NM_000546.6(TP53):c.575A>G (p.Gln192Arg)	TP53	Q192R	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000182931	17	7578274	17	7674956	182931	181009	rs730882002	NC_000017.11:7674955:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	192	TP53
NM_000546.6(TP53):c.574C>G (p.Gln192Glu)	TP53	Q192E	Adrenocortical carcinoma, hereditary	VCV002679236	17	7578275	17	7674957	2679236	2836813	NA	NC_000017.11:7674956:G:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	192	TP53
NM_000546.6(TP53):c.572C>T (p.Pro191Leu)	TP53	P191L	Li-Fraumeni syndrome	VCV002703874	17	7578277	17	7674959	2703874	2856300	NA	NC_000017.11:7674958:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	191	TP53
NM_000546.6(TP53):c.572C>A (p.Pro191His)	TP53	P191H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000853530	17	7578277	17	7674959	853530	846275	rs587778718	NC_000017.11:7674958:G:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	191	TP53
NM_000546.6(TP53):c.572C>G (p.Pro191Arg)	TP53	P191R	Li-Fraumeni syndrome	VCV000127816	17	7578277	17	7674959	127816	133273	rs587778718	NC_000017.11:7674958:G:C	single nucleotide variant	missense variant	Likely benign	Jun 21, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	191	TP53
NM_000546.6(TP53):c.571C>T (p.Pro191Ser)	TP53	P191S	Li-Fraumeni syndrome	VCV001024017	17	7578278	17	7674960	1024017	1013156	rs868590738	NC_000017.11:7674959:G:A	single nucleotide variant	missense variant	Uncertain significance	May 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	191	TP53
NM_000546.6(TP53):c.569C>T (p.Pro190Leu)	TP53	P190L	Li-Fraumeni syndrome 1	VCV000418517	17	7578280	17	7674962	418517	410268	rs876660825	NC_000017.11:7674961:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 27, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	190	TP53
NM_000546.6(TP53):c.569C>G (p.Pro190Arg)	TP53	P190R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000234061	17	7578280	17	7674962	234061	236482	rs876660825	NC_000017.11:7674961:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	190	TP53
NM_000546.6(TP53):c.568C>G (p.Pro190Ala)	TP53	P190A	Li-Fraumeni syndrome	VCV001021934	17	7578281	17	7674963	1021934	1013157	rs876660254	NC_000017.11:7674962:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	190	TP53
NM_000546.6(TP53):c.568C>T (p.Pro190Ser)	TP53	P190S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000646725	17	7578281	17	7674963	646725	646756	rs876660254	NC_000017.11:7674962:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	190	TP53
NM_000546.6(TP53):c.568C>A (p.Pro190Thr)	TP53	P190T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000233197	17	7578281	17	7674963	233197	236483	rs876660254	NC_000017.11:7674962:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	190	TP53
NM_000546.6(TP53):c.566C>A (p.Ala189Asp)	TP53	A189D	Li-Fraumeni syndrome	VCV002137906	17	7578283	17	7674965	2137906	1871515	NA	NC_000017.11:7674964:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	TP53
NM_000546.6(TP53):c.566C>G (p.Ala189Gly)	TP53	A189G	Li-Fraumeni syndrome	VCV001378428	17	7578283	17	7674965	1378428	1492858	rs121912665	NC_000017.11:7674964:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	TP53
NM_000546.6(TP53):c.566C>T (p.Ala189Val)	TP53	A189V	not provided|Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome	VCV000012382	17	7578283	17	7674965	12382	27421	rs121912665	NC_000017.11:7674964:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	189	TP53
NM_000546.6(TP53):c.565G>T (p.Ala189Ser)	TP53	A189S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000528262	17	7578284	17	7674966	528262	531932	rs1555525921	NC_000017.11:7674965:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	189	TP53
NM_000546.6(TP53):c.562C>G (p.Leu188Val)	TP53	L188V	Li-Fraumeni syndrome	VCV000933702	17	7578287	17	7674969	933702	938236	rs2073348975	NC_000017.11:7674968:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	188	TP53
NM_000546.6(TP53):c.560G>T (p.Gly187Val)	TP53	G187V	Li-Fraumeni syndrome	VCV002032550	17	7578289	17	7674971	2032550	2082768	NA	NC_000017.11:7674970:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	187	TP53
NM_000546.6(TP53):c.560G>C (p.Gly187Ala)	TP53	G187A	Li-Fraumeni syndrome	VCV001479275	17	7578289	17	7674971	1479275	1426645	rs1064795841	NC_000017.11:7674970:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	187	TP53
NM_000546.6(TP53):c.560G>A (p.Gly187Asp)	TP53	G187D	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000422532	17	7578289	17	7674971	422532	410269	rs1064795841	NC_000017.11:7674970:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	187	TP53
NM_000546.6(TP53):c.559G>A (p.Gly187Ser)	TP53	G187S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000840399	17	7578371	17	7675053	840399	846277	rs776167460	NC_000017.11:7675052:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	187	TP53
NM_000546.6(TP53):c.559G>C (p.Gly187Arg)	TP53	G187R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000635392	17	7578371	17	7675053	635392	623216	rs776167460	NC_000017.11:7675052:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	187	TP53
NM_000546.6(TP53):c.558T>A (p.Asp186Glu)	TP53	D186E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000230006	17	7578372	17	7675054	230006	236484	rs375275361	NC_000017.11:7675053:A:T	single nucleotide variant	missense variant	Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	186	TP53
NM_000546.6(TP53):c.556G>A (p.Asp186Asn)	TP53	D186N	Li-Fraumeni syndrome 1	VCV000406601	17	7578374	17	7675056	406601	402562	rs1060501206	NC_000017.11:7675055:C:T	single nucleotide variant	missense variant	Likely benign	Mar 25, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	186	TP53
NM_000546.6(TP53):c.555C>G (p.Ser185Arg)	TP53	S185R	Hereditary cancer-predisposing syndrome	VCV001748280	17	7578375	17	7675057	1748280	1806528	NA	NC_000017.11:7675056:G:C	single nucleotide variant	missense variant	Likely benign	Nov 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	185	TP53
NM_000546.6(TP53):c.554G>A (p.Ser185Asn)	TP53	S185N	Li-Fraumeni syndrome	VCV000141359	17	7578376	17	7675058	141359	151073	rs150607408	NC_000017.11:7675057:C:T	single nucleotide variant	missense variant	Likely benign	Sep 4, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	185	TP53
NM_000546.6(TP53):c.551A>G (p.Asp184Gly)	TP53	D184G	Li-Fraumeni syndrome	VCV000406606	17	7578379	17	7675061	406606	403154	rs1060501209	NC_000017.11:7675060:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	184	TP53
NM_000546.6(TP53):c.550G>C (p.Asp184His)	TP53	D184H	Prostate cancer, hereditary, 1	VCV002687701	17	7578380	17	7675062	2687701	2848737	NA	NC_000017.11:7675061:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	184	TP53
NM_000546.6(TP53):c.548C>T (p.Ser183Leu)	TP53	S183L	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480735	17	7578382	17	7675064	480735	480053	rs1555525970	NC_000017.11:7675063:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 29, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	183	TP53
NM_000546.6(TP53):c.547T>C (p.Ser183Pro)	TP53	S183P	Hereditary cancer-predisposing syndrome	VCV003328150	17	7578383	17	7675065	3328150	3486863	NA	NC_000017.11:7675064:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	183	TP53
NM_000546.6(TP53):c.546C>G (p.Cys182Trp)	TP53	C182W	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV000423137	17	7578384	17	7675066	423137	410270	rs1064796257	NC_000017.11:7675065:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	182	TP53
NM_000546.6(TP53):c.544T>C (p.Cys182Arg)	TP53	C182R	Hereditary cancer-predisposing syndrome	VCV002774651	17	7578386	17	7675068	2774651	2935378	NA	NC_000017.11:7675067:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	182	TP53
NM_000546.6(TP53):c.544T>G (p.Cys182Gly)	TP53	C182G	Li-Fraumeni syndrome	VCV001489700	17	7578386	17	7675068	1489700	1495306	rs2151030158	NC_000017.11:7675067:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	182	TP53
NM_000546.6(TP53):c.542G>C (p.Arg181Pro)	TP53	R181P	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000825729	17	7578388	17	7675070	825729	814487	rs397514495	NC_000017.11:7675069:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	181	TP53
NM_000546.6(TP53):c.542G>A (p.Arg181His)	TP53	R181H	Adrenocortical carcinoma, hereditary|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1	VCV000142320	17	7578388	17	7675070	142320	152034	rs397514495	NC_000017.11:7675069:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	181	TP53
NM_000546.6(TP53):c.542G>T (p.Arg181Leu)	TP53	R181L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000039420	17	7578388	17	7675070	39420	48019	rs397514495	NC_000017.11:7675069:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	181	TP53
NM_000546.6(TP53):c.541C>A (p.Arg181Ser)	TP53	R181S	Li-Fraumeni syndrome	VCV000230764	17	7578389	17	7675071	230764	236486	rs587782596	NC_000017.11:7675070:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	181	TP53
NM_000546.6(TP53):c.541C>T (p.Arg181Cys)	TP53	R181C	not provided|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Li-Fraumeni syndrome	VCV000142624	17	7578389	17	7675071	142624	152338	rs587782596	NC_000017.11:7675070:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 30, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	181	TP53
NM_000546.6(TP53):c.540G>T (p.Glu180Asp)	TP53	E180D	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV001521256	17	7578390	17	7675072	1521256	1446909	rs2073362479	NC_000017.11:7675071:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	180	TP53
NM_000546.6(TP53):c.540G>C (p.Glu180Asp)	TP53	E180D	Li-Fraumeni syndrome	VCV001509915	17	7578390	17	7675072	1509915	1445834	rs2073362479	NC_000017.11:7675071:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	180	TP53
NM_000546.6(TP53):c.538G>A (p.Glu180Lys)	TP53	E180K	Li-Fraumeni syndrome	VCV000245711	17	7578392	17	7675074	245711	245073	rs879253911	NC_000017.11:7675073:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	180	TP53
NM_000546.6(TP53):c.537T>A (p.His179Gln)	TP53	H179Q	Li-Fraumeni syndrome	VCV000406578	17	7578393	17	7675075	406578	402563	rs876660821	NC_000017.11:7675074:A:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	179	TP53
NM_000546.6(TP53):c.537T>G (p.His179Gln)	TP53	H179Q	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376607	17	7578393	17	7675075	376607	363486	rs876660821	NC_000017.11:7675074:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	179	TP53
NM_000546.6(TP53):c.536A>C (p.His179Pro)	TP53	H179P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376611	17	7578394	17	7675076	376611	363490	rs1057519991	NC_000017.11:7675075:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 4, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	179	TP53
NM_000546.6(TP53):c.536A>T (p.His179Leu)	TP53	H179L	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome	VCV000376608	17	7578394	17	7675076	376608	363487	rs1057519991	NC_000017.11:7675075:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	179	TP53
NM_000546.6(TP53):c.536A>G (p.His179Arg)	TP53	H179R	not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376606	17	7578394	17	7675076	376606	363485	rs1057519991	NC_000017.11:7675075:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	179	TP53
NM_000546.6(TP53):c.535C>G (p.His179Asp)	TP53	H179D	Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not specified|Li-Fraumeni syndrome	VCV000376610	17	7578395	17	7675077	376610	363489	rs587780070	NC_000017.11:7675076:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 1, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	179	TP53
NM_000546.6(TP53):c.535C>A (p.His179Asn)	TP53	H179N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000376609	17	7578395	17	7675077	376609	363488	rs587780070	NC_000017.11:7675076:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	179	TP53
NM_000546.6(TP53):c.535C>T (p.His179Tyr)	TP53	H179Y	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000127815	17	7578395	17	7675077	127815	133272	rs587780070	NC_000017.11:7675076:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 24, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	179	TP53
NM_000546.6(TP53):c.534C>G (p.His178Gln)	TP53	H178Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000947223	17	7578396	17	7675078	947223	928554	rs1555526001	NC_000017.11:7675077:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	178	TP53
NM_000546.6(TP53):c.534C>A (p.His178Gln)	TP53	H178Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome	VCV000575702	17	7578396	17	7675078	575702	569777	rs1555526001	NC_000017.11:7675077:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	178	TP53
NM_000546.6(TP53):c.533A>G (p.His178Arg)	TP53	H178R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV002780373	17	7578397	17	7675079	2780373	2944113	NA	NC_000017.11:7675078:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	178	TP53
NM_000546.6(TP53):c.533A>C (p.His178Pro)	TP53	H178P	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000485030	17	7578397	17	7675079	485030	479269	rs1555526004	NC_000017.11:7675078:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	178	TP53
NM_000546.6(TP53):c.532C>G (p.His178Asp)	TP53	H178D	Li-Fraumeni syndrome	VCV000482223	17	7578398	17	7675080	482223	480057	rs1064795203	NC_000017.11:7675079:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	178	TP53
NM_000546.6(TP53):c.532C>A (p.His178Asn)	TP53	H178N	not provided|Li-Fraumeni syndrome	VCV000421546	17	7578398	17	7675080	421546	410271	rs1064795203	NC_000017.11:7675079:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	178	TP53
NM_000546.6(TP53):c.530C>A (p.Pro177His)	TP53	P177H	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000956854	17	7578400	17	7675082	956854	950315	rs751477326	NC_000017.11:7675081:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	177	TP53
NM_000546.6(TP53):c.530C>G (p.Pro177Arg)	TP53	P177R	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000458547	17	7578400	17	7675082	458547	468390	rs751477326	NC_000017.11:7675081:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	177	TP53
NM_000546.6(TP53):c.530C>T (p.Pro177Leu)	TP53	P177L	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000406583	17	7578400	17	7675082	406583	402594	rs751477326	NC_000017.11:7675081:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	177	TP53
NM_000546.6(TP53):c.529C>G (p.Pro177Ala)	TP53	P177A	Hereditary cancer-predisposing syndrome	VCV002585883	17	7578401	17	7675083	2585883	2753443	NA	NC_000017.11:7675082:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	177	TP53
NM_000546.6(TP53):c.529C>T (p.Pro177Ser)	TP53	P177S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000646495	17	7578401	17	7675083	646495	646758	rs147002414	NC_000017.11:7675082:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	177	TP53
NM_000546.6(TP53):c.529C>A (p.Pro177Thr)	TP53	P177T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000482220	17	7578401	17	7675083	482220	479318	rs147002414	NC_000017.11:7675082:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	177	TP53
NM_000546.6(TP53):c.526_528delinsCGG (p.Cys176Arg)	TP53	C176R	Ovarian neoplasm	VCV000634759	17	7578402 - 7578404	17	7675084 - 7675086	634759	622616	rs1567552847	NC_000017.11:7675083:GCA:CCG	Indel	missense variant	Likely pathogenic	Dec 1, 2018	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	176	TP53
NM_000546.6(TP53):c.528C>G (p.Cys176Trp)	TP53	C176W	Hereditary cancer-predisposing syndrome|TP53-related disorder|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376572	17	7578402	17	7675084	376572	363451	rs1057519980	NC_000017.11:7675083:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	176	TP53
NM_000546.6(TP53):c.527G>T (p.Cys176Phe)	TP53	C176F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000376569	17	7578403	17	7675085	376569	363448	rs786202962	NC_000017.11:7675084:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	176	TP53
NM_000546.6(TP53):c.527G>A (p.Cys176Tyr)	TP53	C176Y	Squamous cell carcinoma|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|TP53-related disorder|not provided	VCV000186451	17	7578403	17	7675085	186451	185371	rs786202962	NC_000017.11:7675084:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	176	TP53
NM_000546.6(TP53):c.526T>C (p.Cys176Arg)	TP53	C176R	Breast neoplasm|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376573	17	7578404	17	7675086	376573	363452	rs967461896	NC_000017.11:7675085:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	176	TP53
NM_000546.6(TP53):c.526T>G (p.Cys176Gly)	TP53	C176G	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376571	17	7578404	17	7675086	376571	363450	rs967461896	NC_000017.11:7675085:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	176	TP53
NM_000546.6(TP53):c.526T>A (p.Cys176Ser)	TP53	C176S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000376570	17	7578404	17	7675086	376570	363449	rs967461896	NC_000017.11:7675085:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	176	TP53
NM_000546.6(TP53):c.524G>T (p.Arg175Leu)	TP53	R175L	Li-Fraumeni syndrome	VCV000182963	17	7578406	17	7675088	182963	181010	rs28934578	NC_000017.11:7675087:C:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	175	TP53
NM_000546.6(TP53):c.524G>A (p.Arg175His)	TP53	R175H	Li-Fraumeni syndrome|Neoplasm	VCV000012374	17	7578406	17	7675088	12374	27413	rs28934578	NC_000017.11:7675087:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	175	TP53
NM_000546.6(TP53):c.523C>G (p.Arg175Gly)	TP53	R175G	Li-Fraumeni syndrome|Neoplasm	VCV000376649	17	7578407	17	7675089	376649	363528	rs138729528	NC_000017.11:7675088:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	175	TP53
NM_000546.6(TP53):c.523C>T (p.Arg175Cys)	TP53	R175C	Li-Fraumeni syndrome	VCV000245851	17	7578407	17	7675089	245851	245074	rs138729528	NC_000017.11:7675088:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	175	TP53
NM_000546.6(TP53):c.522G>C (p.Arg174Ser)	TP53	R174S	Li-Fraumeni syndrome	VCV001058186	17	7578408	17	7675090	1058186	1050671	rs2151030685	NC_000017.11:7675089:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	174	TP53
NM_000546.6(TP53):c.521G>A (p.Arg174Lys)	TP53	R174K	not provided	VCV000423887	17	7578409	17	7675091	423887	410272	rs1064796681	NC_000017.11:7675090:C:T	single nucleotide variant	missense variant	Likely benign	Sep 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	174	TP53
NM_000546.6(TP53):c.520A>T (p.Arg174Trp)	TP53	R174W	Li-Fraumeni syndrome	VCV000964680	17	7578410	17	7675092	964680	958331	rs864622115	NC_000017.11:7675091:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	174	TP53
NM_000546.6(TP53):c.520A>G (p.Arg174Gly)	TP53	R174G	Li-Fraumeni syndrome	VCV000219487	17	7578410	17	7675092	219487	222740	rs864622115	NC_000017.11:7675091:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	174	TP53
NM_000546.6(TP53):c.518T>A (p.Val173Glu)	TP53	V173E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000376669	17	7578412	17	7675094	376669	363548	rs1057519747	NC_000017.11:7675093:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	173	TP53
NM_000546.6(TP53):c.518T>C (p.Val173Ala)	TP53	V173A	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376017	17	7578412	17	7675094	376017	362896	rs1057519747	NC_000017.11:7675093:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 30, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	173	TP53
NM_000546.6(TP53):c.518T>G (p.Val173Gly)	TP53	V173G	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000376016	17	7578412	17	7675094	376016	362895	rs1057519747	NC_000017.11:7675093:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	173	TP53
NM_000546.6(TP53):c.517G>C (p.Val173Leu)	TP53	V173L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Primary intracranial sarcoma, DICER1-mutant	VCV002185665	17	7578413	17	7675095	2185665	1910599	NA	NC_000017.11:7675094:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications	Tier III - Unknown	NA	criteria provided, single submitter	NA	NA	NA	NA	173	TP53
NM_000546.6(TP53):c.517G>T (p.Val173Leu)	TP53	V173L	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000376668	17	7578413	17	7675095	376668	363547	rs876660754	NC_000017.11:7675094:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	173	TP53
NM_000546.6(TP53):c.517G>A (p.Val173Met)	TP53	V173M	Li-Fraumeni syndrome	VCV000233951	17	7578413	17	7675095	233951	232035	rs876660754	NC_000017.11:7675094:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	173	TP53
NM_000546.6(TP53):c.515T>A (p.Val172Asp)	TP53	V172D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|TP53-related disorder|Hereditary cancer-predisposing syndrome	VCV000836761	17	7578415	17	7675097	836761	846279	rs1131691021	NC_000017.11:7675096:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	172	TP53
NM_000546.6(TP53):c.515T>C (p.Val172Ala)	TP53	V172A	Li-Fraumeni syndrome	VCV000528245	17	7578415	17	7675097	528245	531935	rs1131691021	NC_000017.11:7675096:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	172	TP53
NM_000546.6(TP53):c.515T>G (p.Val172Gly)	TP53	V172G	Hereditary cancer-predisposing syndrome	VCV000428883	17	7578415	17	7675097	428883	420657	rs1131691021	NC_000017.11:7675096:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	172	TP53
NM_000546.6(TP53):c.514G>A (p.Val172Ile)	TP53	V172I	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000825481	17	7578416	17	7675098	825481	814489	rs1131691043	NC_000017.11:7675097:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	172	TP53
NM_000546.6(TP53):c.514G>T (p.Val172Phe)	TP53	V172F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000428909	17	7578416	17	7675098	428909	420658	rs1131691043	NC_000017.11:7675097:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	172	TP53
NM_000546.6(TP53):c.513G>T (p.Glu171Asp)	TP53	E171D	Acute myeloid leukemia	VCV002446885	17	7578417	17	7675099	2446885	2422010	NA	NC_000017.11:7675098:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	171	TP53
NM_000546.6(TP53):c.512A>G (p.Glu171Gly)	TP53	E171G	Hereditary cancer-predisposing syndrome	VCV001745525	17	7578418	17	7675100	1745525	1802577	NA	NC_000017.11:7675099:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	171	TP53
NM_000546.6(TP53):c.511G>A (p.Glu171Lys)	TP53	E171K	Li-Fraumeni syndrome 1	VCV000141566	17	7578419	17	7675101	141566	151280	rs587781845	NC_000017.11:7675100:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	171	TP53
NM_000546.6(TP53):c.509C>G (p.Thr170Arg)	TP53	T170R	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not specified|Li-Fraumeni syndrome	VCV000490174	17	7578421	17	7675103	490174	483072	rs779000871	NC_000017.11:7675102:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	170	TP53
NM_000546.6(TP53):c.509C>T (p.Thr170Met)	TP53	T170M	Li-Fraumeni syndrome 1	VCV000184014	17	7578421	17	7675103	184014	185374	rs779000871	NC_000017.11:7675102:G:A	single nucleotide variant	missense variant	Likely benign	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	170	TP53
NM_000546.6(TP53):c.508A>G (p.Thr170Ala)	TP53	T170A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000135949	17	7578422	17	7675104	135949	139661	rs587780729	NC_000017.11:7675103:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	170	TP53
NM_000546.6(TP53):c.507G>T (p.Met169Ile)	TP53	M169I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000919322	17	7578423	17	7675105	919322	914195	rs2073372247	NC_000017.11:7675104:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	169	TP53
NM_000546.6(TP53):c.506T>G (p.Met169Arg)	TP53	M169R	Li-Fraumeni syndrome	VCV000568736	17	7578424	17	7675106	568736	572308	rs1567553114	NC_000017.11:7675105:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	169	TP53
NM_000546.6(TP53):c.505A>T (p.Met169Leu)	TP53	M169L	Li-Fraumeni syndrome	VCV002886753	17	7578425	17	7675107	2886753	3050798	NA	NC_000017.11:7675106:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	169	TP53
NM_000546.6(TP53):c.505A>G (p.Met169Val)	TP53	M169V	Li-Fraumeni syndrome	VCV000844926	17	7578425	17	7675107	844926	846280	rs2073372575	NC_000017.11:7675106:T:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	169	TP53
NM_000546.6(TP53):c.504C>G (p.His168Gln)	TP53	H168Q	Hereditary cancer-predisposing syndrome	VCV001745001	17	7578426	17	7675108	1745001	1805847	NA	NC_000017.11:7675107:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	168	TP53
NM_000546.6(TP53):c.503A>C (p.His168Pro)	TP53	H168P	Hereditary cancer-predisposing syndrome	VCV003328154	17	7578427	17	7675109	3328154	3486867	NA	NC_000017.11:7675108:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 14, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	168	TP53
NM_000546.6(TP53):c.503A>T (p.His168Leu)	TP53	H168L	Hereditary cancer-predisposing syndrome	VCV001744933	17	7578427	17	7675109	1744933	1805779	NA	NC_000017.11:7675108:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 3, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	168	TP53
NM_000546.6(TP53):c.503A>G (p.His168Arg)	TP53	H168R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000428866	17	7578427	17	7675109	428866	420659	rs867114783	NC_000017.11:7675108:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	168	TP53
NM_000546.6(TP53):c.502C>A (p.His168Asn)	TP53	H168N	Prostate cancer, hereditary, 1	VCV002687697	17	7578428	17	7675110	2687697	2848733	NA	NC_000017.11:7675109:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	168	TP53
NM_000546.6(TP53):c.500A>G (p.Gln167Arg)	TP53	Q167R	Li-Fraumeni syndrome	VCV000653104	17	7578430	17	7675112	653104	646760	rs1319163924	NC_000017.11:7675111:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	167	TP53
NM_000546.6(TP53):c.500A>C (p.Gln167Pro)	TP53	Q167P	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000490173	17	7578430	17	7675112	490173	483047	rs1319163924	NC_000017.11:7675111:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	167	TP53
NM_000546.6(TP53):c.499C>A (p.Gln167Lys)	TP53	Q167K	Li-Fraumeni syndrome	VCV002736423	17	7578431	17	7675113	2736423	2895114	NA	NC_000017.11:7675112:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	167	TP53
NM_000546.6(TP53):c.497C>T (p.Ser166Leu)	TP53	S166L	Li-Fraumeni syndrome	VCV000528239	17	7578433	17	7675115	528239	531813	rs1555526101	NC_000017.11:7675114:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	166	TP53
NM_000546.6(TP53):c.496T>G (p.Ser166Ala)	TP53	S166A	Prostate cancer, hereditary, 1	VCV002687713	17	7578434	17	7675116	2687713	2848749	NA	NC_000017.11:7675115:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	166	TP53
NM_000546.6(TP53):c.494A>T (p.Gln165Leu)	TP53	Q165L	Acute myeloid leukemia	VCV002505496	17	7578436	17	7675118	2505496	2670460	NA	NC_000017.11:7675117:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	NA	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	165	TP53
NM_000546.6(TP53):c.493C>A (p.Gln165Lys)	TP53	Q165K	not specified|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000482232	17	7578437	17	7675119	482232	480067	rs730882001	NC_000017.11:7675118:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	165	TP53
NM_000546.6(TP53):c.492G>T (p.Lys164Asn)	TP53	K164N	Li-Fraumeni syndrome	VCV002848594	17	7578438	17	7675120	2848594	3015491	NA	NC_000017.11:7675119:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	164	TP53
NM_000546.6(TP53):c.492G>C (p.Lys164Asn)	TP53	K164N	Hereditary cancer-predisposing syndrome	VCV000428899	17	7578438	17	7675120	428899	420660	rs1131691034	NC_000017.11:7675119:C:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2014	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	164	TP53
NM_000546.6(TP53):c.490A>C (p.Lys164Gln)	TP53	K164Q	Prostate cancer, hereditary, 1	VCV002687712	17	7578440	17	7675122	2687712	2848748	NA	NC_000017.11:7675121:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	164	TP53
NM_000546.6(TP53):c.490A>G (p.Lys164Glu)	TP53	K164E	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000246416	17	7578440	17	7675122	246416	245075	rs879254249	NC_000017.11:7675121:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	164	TP53
NM_000546.6(TP53):c.488A>C (p.Tyr163Ser)	TP53	Y163S	Li-Fraumeni syndrome	VCV002757988	17	7578442	17	7675124	2757988	2914831	NA	NC_000017.11:7675123:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	163	TP53
NM_000546.6(TP53):c.488A>G (p.Tyr163Cys)	TP53	Y163C	Li-Fraumeni syndrome	VCV000127814	17	7578442	17	7675124	127814	133271	rs148924904	NC_000017.11:7675123:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	163	TP53
NM_000546.6(TP53):c.487T>C (p.Tyr163His)	TP53	Y163H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000376680	17	7578443	17	7675125	376680	363559	rs786203436	NC_000017.11:7675124:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	163	TP53
NM_000546.6(TP53):c.487T>A (p.Tyr163Asn)	TP53	Y163N	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376679	17	7578443	17	7675125	376679	363558	rs786203436	NC_000017.11:7675124:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	163	TP53
NM_000546.6(TP53):c.487T>G (p.Tyr163Asp)	TP53	Y163D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000187052	17	7578443	17	7675125	187052	185375	rs786203436	NC_000017.11:7675124:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 18, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	163	TP53
NM_000546.6(TP53):c.485T>C (p.Ile162Thr)	TP53	I162T	Li-Fraumeni syndrome	VCV001992967	17	7578445	17	7675127	1992967	2052620	NA	NC_000017.11:7675126:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	162	TP53
NM_000546.6(TP53):c.485T>A (p.Ile162Asn)	TP53	I162N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001408611	17	7578445	17	7675127	1408611	1500277	rs587780069	NC_000017.11:7675126:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	162	TP53
NM_000546.6(TP53):c.485T>G (p.Ile162Ser)	TP53	I162S	Li-Fraumeni syndrome|not provided	VCV000127813	17	7578445	17	7675127	127813	133270	rs587780069	NC_000017.11:7675126:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	162	TP53
NM_000546.6(TP53):c.484A>G (p.Ile162Val)	TP53	I162V	Hereditary cancer-predisposing syndrome	VCV001743548	17	7578446	17	7675128	1743548	1801895	NA	NC_000017.11:7675127:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	162	TP53
NM_000546.6(TP53):c.484A>T (p.Ile162Phe)	TP53	I162F	Li-Fraumeni syndrome	VCV000948225	17	7578446	17	7675128	948225	928555	rs2073377305	NC_000017.11:7675127:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	162	TP53
NM_000546.6(TP53):c.482C>T (p.Ala161Val)	TP53	A161V	Li-Fraumeni syndrome	VCV002019530	17	7578448	17	7675130	2019530	2086417	NA	NC_000017.11:7675129:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	161	TP53
NM_000546.6(TP53):c.482C>A (p.Ala161Asp)	TP53	A161D	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000422295	17	7578448	17	7675130	422295	410273	rs1064795691	NC_000017.11:7675129:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	161	TP53
NM_000546.6(TP53):c.481G>C (p.Ala161Pro)	TP53	A161P	Neoplasm	VCV003258033	17	7578449	17	7675131	3258033	3416792	NA	NC_000017.11:7675130:C:G	single nucleotide variant	missense variant|non-coding transcript variant	NA	NA	NA	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	161	TP53
NM_000546.6(TP53):c.481G>A (p.Ala161Thr)	TP53	A161T	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000161518	17	7578449	17	7675131	161518	171616	rs193920817	NC_000017.11:7675130:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	161	TP53
NM_000546.6(TP53):c.480G>A (p.Met160Ile)	TP53	M160I	Li-Fraumeni syndrome 1	VCV000230758	17	7578450	17	7675132	230758	236488	rs772354334	NC_000017.11:7675131:C:T	single nucleotide variant	missense variant|initiator_codon_variant	Likely benign	Oct 27, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	160	TP53
NM_000546.6(TP53):c.479T>C (p.Met160Thr)	TP53	M160T	Li-Fraumeni syndrome	VCV002915501	17	7578451	17	7675133	2915501	3074051	NA	NC_000017.11:7675132:A:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Uncertain significance	Aug 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	160	TP53
NM_000546.6(TP53):c.478A>G (p.Met160Val)	TP53	M160V	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000444396	17	7578452	17	7675134	444396	438036	rs377274728	NC_000017.11:7675133:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	160	TP53
NM_000546.6(TP53):c.476C>A (p.Ala159Asp)	TP53	A159D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV001026335	17	7578454	17	7675136	1026335	1013159	rs1555526131	NC_000017.11:7675135:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	159	TP53
NM_000546.6(TP53):c.476C>T (p.Ala159Val)	TP53	A159V	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000458545	17	7578454	17	7675136	458545	467544	rs1555526131	NC_000017.11:7675135:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	159	TP53
NM_000546.6(TP53):c.475_476delinsTT (p.Ala159Phe)	TP53	A159F	not specified	VCV000182961	17	7578454 - 7578455	17	7675136 - 7675137	182961	181012	rs730882022	NC_000017.11:7675135:GC:AA	Indel	missense variant|5 prime UTR variant	Uncertain significance	Sep 21, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	159	TP53
NM_000546.6(TP53):c.475G>A (p.Ala159Thr)	TP53	A159T	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001909172	17	7578455	17	7675137	1909172	1965945	NA	NC_000017.11:7675136:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	159	TP53
NM_000546.6(TP53):c.475G>C (p.Ala159Pro)	TP53	A159P	not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000182929	17	7578455	17	7675137	182929	181013	rs730882000	NC_000017.11:7675136:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	159	TP53
NM_000546.6(TP53):c.472_474delinsATT (p.Arg158Ile)	TP53	R158I	Li-Fraumeni syndrome	VCV000958850	17	7578456 - 7578458	17	7675138 - 7675140	958850	950316	rs2073381096	NC_000017.11:7675137:GCG:AAT	Indel	missense variant|5 prime UTR variant	Uncertain significance	Oct 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.473_474delinsTT (p.Arg158Leu)	TP53	R158L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000568285	17	7578456 - 7578457	17	7675138 - 7675139	568285	574635	rs1567553501	NC_000017.11:7675137:GC:AA	Indel	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.473G>T (p.Arg158Leu)	TP53	R158L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000528248	17	7578457	17	7675139	528248	531819	rs587782144	NC_000017.11:7675138:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.473G>C (p.Arg158Pro)	TP53	R158P	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	VCV000246118	17	7578457	17	7675139	246118	245076	rs587782144	NC_000017.11:7675138:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.473G>A (p.Arg158His)	TP53	R158H	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Basal cell carcinoma, susceptibility to, 7|Familial cancer of breast|Glioma susceptibility 1|Bone osteosarcoma|Nasopharyngeal carcinoma|Familial pancreatic carcinoma|Hepatocellular carcinoma|Bone marrow failure syndrome 5|Choroid plexus papilloma|Colorectal cancer|not provided|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Breast and/or ovarian cancer	VCV000141963	17	7578457	17	7675139	141963	151677	rs587782144	NC_000017.11:7675138:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jun 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.472C>A (p.Arg158Ser)	TP53	R158S	Li-Fraumeni syndrome	VCV001067910	17	7578458	17	7675140	1067910	1056473	rs587780068	NC_000017.11:7675139:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.472C>G (p.Arg158Gly)	TP53	R158G	Li-Fraumeni syndrome	VCV000856171	17	7578458	17	7675140	856171	846283	rs587780068	NC_000017.11:7675139:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Dec 9, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.472C>T (p.Arg158Cys)	TP53	R158C	Li-Fraumeni syndrome 1|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000127812	17	7578458	17	7675140	127812	133269	rs587780068	NC_000017.11:7675139:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	158	TP53
NM_000546.6(TP53):c.470_471delinsGT (p.Val157Gly)	TP53	V157G	Li-Fraumeni syndrome 1	VCV003148383	17	7578459 - 7578460	17	7675141 - 7675142	3148383	3307631	NA	NC_000017.11:7675140:GA:AC	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Feb 14, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	157	TP53
NM_000546.6(TP53):c.470T>G (p.Val157Gly)	TP53	V157G	Li-Fraumeni syndrome 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000915695	17	7578460	17	7675142	915695	904019	rs1131691023	NC_000017.11:7675141:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	157	TP53
NM_000546.6(TP53):c.470T>A (p.Val157Asp)	TP53	V157D	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000482231	17	7578460	17	7675142	482231	480072	rs1131691023	NC_000017.11:7675141:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	157	TP53
NM_000546.6(TP53):c.470T>C (p.Val157Ala)	TP53	V157A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome	VCV000428887	17	7578460	17	7675142	428887	420661	rs1131691023	NC_000017.11:7675141:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	157	TP53
NM_000546.6(TP53):c.469G>C (p.Val157Leu)	TP53	V157L	Li-Fraumeni syndrome	VCV001515529	17	7578461	17	7675143	1515529	1505394	rs121912654	NC_000017.11:7675142:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	157	TP53
NM_000546.6(TP53):c.469G>A (p.Val157Ile)	TP53	V157I	Li-Fraumeni syndrome 1	VCV000185404	17	7578461	17	7675143	185404	185377	rs121912654	NC_000017.11:7675142:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 26, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	157	TP53
NM_000546.6(TP53):c.469G>T (p.Val157Phe)	TP53	V157F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma|Neoplasm	VCV000012353	17	7578461	17	7675143	12353	27392	rs121912654	NC_000017.11:7675142:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	157	TP53
NM_000546.6(TP53):c.467G>C (p.Arg156Pro)	TP53	R156P	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000634768	17	7578463	17	7675145	634768	622620	rs371524413	NC_000017.11:7675144:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 3, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	156	TP53
NM_000546.6(TP53):c.467G>A (p.Arg156His)	TP53	R156H	Li-Fraumeni syndrome 1	VCV000127811	17	7578463	17	7675145	127811	133268	rs371524413	NC_000017.11:7675144:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 22, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	156	TP53
NM_000546.6(TP53):c.466C>A (p.Arg156Ser)	TP53	R156S	Hereditary cancer-predisposing syndrome	VCV001742298	17	7578464	17	7675146	1742298	1798499	NA	NC_000017.11:7675145:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 5, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	156	TP53
NM_000546.6(TP53):c.466C>G (p.Arg156Gly)	TP53	R156G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001517870	17	7578464	17	7675146	1517870	1512142	rs563378859	NC_000017.11:7675145:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	156	TP53
NM_000546.6(TP53):c.466C>T (p.Arg156Cys)	TP53	R156C	Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Nasopharyngeal carcinoma|Familial cancer of breast|Carcinoma of pancreas|Choroid plexus papilloma|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome 1|Bone osteosarcoma|Carcinoma of colon|Hepatocellular carcinoma|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|not specified|not provided|Li-Fraumeni syndrome	VCV000127810	17	7578464	17	7675146	127810	133267	rs563378859	NC_000017.11:7675145:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	156	TP53
NM_000546.6(TP53):c.464C>T (p.Thr155Ile)	TP53	T155I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001005876	17	7578466	17	7675148	1005876	997957	rs786202752	NC_000017.11:7675147:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	155	TP53
NM_000546.6(TP53):c.464C>A (p.Thr155Asn)	TP53	T155N	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified	VCV000406564	17	7578466	17	7675148	406564	402565	rs786202752	NC_000017.11:7675147:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	155	TP53
NM_000546.6(TP53):c.464C>G (p.Thr155Ser)	TP53	T155S	not provided|Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome	VCV000186179	17	7578466	17	7675148	186179	185380	rs786202752	NC_000017.11:7675147:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	155	TP53
NM_000546.6(TP53):c.463A>C (p.Thr155Pro)	TP53	T155P	Li-Fraumeni syndrome	VCV002768025	17	7578467	17	7675149	2768025	2932637	NA	NC_000017.11:7675148:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 21, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	155	TP53
NM_000546.6(TP53):c.463A>G (p.Thr155Ala)	TP53	T155A	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000458544	17	7578467	17	7675149	458544	468396	rs772683278	NC_000017.11:7675148:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	155	TP53
NM_000546.6(TP53):c.461_462delinsAT (p.Gly154Asp)	TP53	G154D	Prostate cancer, hereditary, 1	VCV002687710	17	7578468 - 7578469	17	7675150 - 7675151	2687710	2848746	NA	NC_000017.11:7675149:GC:AT	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	154	TP53
NM_000546.6(TP53):c.461G>C (p.Gly154Ala)	TP53	G154A	Li-Fraumeni syndrome	VCV002840669	17	7578469	17	7675151	2840669	3000492	NA	NC_000017.11:7675150:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	154	TP53
NM_000546.6(TP53):c.461G>T (p.Gly154Val)	TP53	G154V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000651769	17	7578469	17	7675151	651769	646762	rs762846821	NC_000017.11:7675150:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 14, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	154	TP53
NM_000546.6(TP53):c.461G>A (p.Gly154Asp)	TP53	G154D	Li-Fraumeni syndrome 1	VCV000237950	17	7578469	17	7675151	237950	242984	rs762846821	NC_000017.11:7675150:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 26, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	154	TP53
NM_000546.6(TP53):c.460G>T (p.Gly154Cys)	TP53	G154C	Hereditary cancer-predisposing syndrome	VCV001741887	17	7578470	17	7675152	1741887	1801530	NA	NC_000017.11:7675151:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	154	TP53
NM_000546.6(TP53):c.460G>C (p.Gly154Arg)	TP53	G154R	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000482229	17	7578470	17	7675152	482229	479327	rs137852789	NC_000017.11:7675151:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	154	TP53
NM_000546.6(TP53):c.460G>A (p.Gly154Ser)	TP53	G154S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|not provided|Hereditary cancer-predisposing syndrome|not specified|Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Nasopharyngeal carcinoma|Familial cancer of breast|Bone marrow failure syndrome 5|Carcinoma of pancreas|Choroid plexus papilloma|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome 1|Colorectal cancer|Bone osteosarcoma|Hepatocellular carcinoma	VCV000133284	17	7578470	17	7675152	133284	137023	rs137852789	NC_000017.11:7675151:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	154	TP53
NM_000546.6(TP53):c.458C>T (p.Pro153Leu)	TP53	P153L	Li-Fraumeni syndrome	VCV000645432	17	7578472	17	7675154	645432	646763	rs1597370799	NC_000017.11:7675153:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	153	TP53
NM_000546.6(TP53):c.457C>G (p.Pro153Ala)	TP53	P153A	Prostate cancer, hereditary, 1	VCV002687700	17	7578473	17	7675155	2687700	2848736	NA	NC_000017.11:7675154:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	153	TP53
NM_000546.6(TP53):c.457C>T (p.Pro153Ser)	TP53	P153S	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000422563	17	7578473	17	7675155	422563	410274	rs1064795860	NC_000017.11:7675154:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	153	TP53
NM_000546.6(TP53):c.455C>A (p.Pro152Gln)	TP53	P152Q	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001058730	17	7578475	17	7675157	1058730	1050672	rs587782705	NC_000017.11:7675156:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	152	TP53
NM_000546.6(TP53):c.455C>G (p.Pro152Arg)	TP53	P152R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000824998	17	7578475	17	7675157	824998	814494	rs587782705	NC_000017.11:7675156:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 15, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	152	TP53
NM_000546.6(TP53):c.455C>T (p.Pro152Leu)	TP53	P152L	Li-Fraumeni syndrome|Neoplasm	VCV000142766	17	7578475	17	7675157	142766	152480	rs587782705	NC_000017.11:7675156:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	152	TP53
NM_000546.6(TP53):c.454C>A (p.Pro152Thr)	TP53	P152T	Prostate cancer, hereditary, 1	VCV002687709	17	7578476	17	7675158	2687709	2848745	NA	NC_000017.11:7675157:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	152	TP53
NM_000546.6(TP53):c.454C>T (p.Pro152Ser)	TP53	P152S	Li-Fraumeni syndrome|Glioma susceptibility 1|not provided|Hereditary cancer-predisposing syndrome	VCV000482230	17	7578476	17	7675158	482230	479353	rs767328513	NC_000017.11:7675157:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	152	TP53
NM_000546.6(TP53):c.451_452delinsAG (p.Pro151Ser)	TP53	P151S	Li-Fraumeni syndrome	VCV002700111	17	7578478 - 7578479	17	7675160 - 7675161	2700111	2858963	NA	NC_000017.11:7675159:GG:CT	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	151	TP53
NM_000546.6(TP53):c.451_452delinsTT (p.Pro151Phe)	TP53	P151F	Hereditary cancer-predisposing syndrome	VCV000824960	17	7578478 - 7578479	17	7675160 - 7675161	824960	814495	rs1597370899	NC_000017.11:7675159:GG:AA	Indel	missense variant|5 prime UTR variant	Likely pathogenic	Oct 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	151	TP53
NM_000546.6(TP53):c.452C>G (p.Pro151Arg)	TP53	P151R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376640	17	7578478	17	7675160	376640	363519	rs1057520000	NC_000017.11:7675159:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	151	TP53
NM_000546.6(TP53):c.452C>A (p.Pro151His)	TP53	P151H	Li-Fraumeni syndrome	VCV000376639	17	7578478	17	7675160	376639	363518	rs1057520000	NC_000017.11:7675159:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	151	TP53
NM_000546.6(TP53):c.451C>G (p.Pro151Ala)	TP53	P151A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376641	17	7578479	17	7675161	376641	363520	rs28934874	NC_000017.11:7675160:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	151	TP53
NM_000546.6(TP53):c.451C>T (p.Pro151Ser)	TP53	P151S	Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000012370	17	7578479	17	7675161	12370	27409	rs28934874	NC_000017.11:7675160:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	151	TP53
NM_000546.6(TP53):c.451C>A (p.Pro151Thr)	TP53	P151T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided	VCV000012369	17	7578479	17	7675161	12369	27408	rs28934874	NC_000017.11:7675160:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	151	TP53
NM_000546.6(TP53):c.449C>T (p.Thr150Ile)	TP53	T150I	Li-Fraumeni syndrome	VCV001350373	17	7578481	17	7675163	1350373	1469333	rs2151032692	NC_000017.11:7675162:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	150	TP53
NM_000546.6(TP53):c.446C>G (p.Ser149Cys)	TP53	S149C	Hereditary cancer-predisposing syndrome	VCV003328163	17	7578484	17	7675166	3328163	3486876	NA	NC_000017.11:7675165:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	149	TP53
NM_000546.6(TP53):c.446C>A (p.Ser149Tyr)	TP53	S149Y	Li-Fraumeni syndrome	VCV002754115	17	7578484	17	7675166	2754115	2916583	NA	NC_000017.11:7675165:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	149	TP53
NM_000546.6(TP53):c.446C>T (p.Ser149Phe)	TP53	S149F	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000486559	17	7578484	17	7675166	486559	479329	rs1555526214	NC_000017.11:7675165:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	149	TP53
NM_000546.6(TP53):c.445T>C (p.Ser149Pro)	TP53	S149P	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV002679232	17	7578485	17	7675167	2679232	2836809	NA	NC_000017.11:7675166:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	149	TP53
NM_000546.6(TP53):c.444T>G (p.Asp148Glu)	TP53	D148E	Li-Fraumeni syndrome	VCV001478891	17	7578486	17	7675168	1478891	1426262	rs2151032767	NC_000017.11:7675167:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	148	TP53
NM_000546.6(TP53):c.443A>T (p.Asp148Val)	TP53	D148V	Prostate cancer, hereditary, 1	VCV002687708	17	7578487	17	7675169	2687708	2848744	NA	NC_000017.11:7675168:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	148	TP53
NM_000546.6(TP53):c.443A>C (p.Asp148Ala)	TP53	D148A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000485032	17	7578487	17	7675169	485032	479274	rs1046611742	NC_000017.11:7675168:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 18, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	148	TP53
NM_000546.6(TP53):c.442G>A (p.Asp148Asn)	TP53	D148N	Li-Fraumeni syndrome	VCV000568069	17	7578488	17	7675170	568069	569780	rs1131691007	NC_000017.11:7675169:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 24, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	148	TP53
NM_000546.6(TP53):c.442G>T (p.Asp148Tyr)	TP53	D148Y	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000428863	17	7578488	17	7675170	428863	420662	rs1131691007	NC_000017.11:7675169:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	148	TP53
NM_000546.6(TP53):c.440T>A (p.Val147Asp)	TP53	V147D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV001351017	17	7578490	17	7675172	1351017	1492605	rs1453167097	NC_000017.11:7675171:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	147	TP53
NM_000546.6(TP53):c.440T>C (p.Val147Ala)	TP53	V147A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000842812	17	7578490	17	7675172	842812	846284	rs1453167097	NC_000017.11:7675171:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	147	TP53
NM_000546.6(TP53):c.439G>A (p.Val147Ile)	TP53	V147I	Li-Fraumeni syndrome	VCV000528255	17	7578491	17	7675173	528255	531826	rs1555526226	NC_000017.11:7675172:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 28, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	147	TP53
NM_000546.6(TP53):c.438G>C (p.Trp146Cys)	TP53	W146C	Hereditary cancer-predisposing syndrome	VCV001740219	17	7578492	17	7675174	1740219	1791252	NA	NC_000017.11:7675173:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	146	TP53
NM_000546.6(TP53):c.438G>T (p.Trp146Cys)	TP53	W146C	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000824855	17	7578492	17	7675174	824855	814496	rs1131691026	NC_000017.11:7675173:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	146	TP53
NM_000546.6(TP53):c.436T>G (p.Trp146Gly)	TP53	W146G	Li-Fraumeni syndrome 1	VCV000186587	17	7578494	17	7675176	186587	185381	rs786203064	NC_000017.11:7675175:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 4, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	146	TP53
NM_000546.6(TP53):c.434T>G (p.Leu145Arg)	TP53	L145R	Li-Fraumeni syndrome	VCV001027110	17	7578496	17	7675178	1027110	1013160	rs587782197	NC_000017.11:7675177:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	145	TP53
NM_000546.6(TP53):c.434T>A (p.Leu145Gln)	TP53	L145Q	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000480760	17	7578496	17	7675178	480760	479277	rs587782197	NC_000017.11:7675177:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	145	TP53
NM_000546.6(TP53):c.434T>C (p.Leu145Pro)	TP53	L145P	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000142050	17	7578496	17	7675178	142050	151764	rs587782197	NC_000017.11:7675177:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	145	TP53
NM_000546.6(TP53):c.433C>G (p.Leu145Val)	TP53	L145V	Hereditary cancer-predisposing syndrome	VCV002774652	17	7578497	17	7675179	2774652	2935379	NA	NC_000017.11:7675178:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	145	TP53
NM_000546.6(TP53):c.432G>T (p.Gln144His)	TP53	Q144H	not provided	VCV000376648	17	7578498	17	7675180	376648	363527	rs786201419	NC_000017.11:7675179:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 5, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	144	TP53
NM_000546.6(TP53):c.431A>G (p.Gln144Arg)	TP53	Q144R	Li-Fraumeni syndrome	VCV002080519	17	7578499	17	7675181	2080519	2135752	NA	NC_000017.11:7675180:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	144	TP53
NM_000546.6(TP53):c.431A>T (p.Gln144Leu)	TP53	Q144L	Li-Fraumeni syndrome	VCV000376647	17	7578499	17	7675181	376647	363526	rs786203071	NC_000017.11:7675180:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	144	TP53
NM_000546.6(TP53):c.431A>C (p.Gln144Pro)	TP53	Q144P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000186594	17	7578499	17	7675181	186594	185384	rs786203071	NC_000017.11:7675180:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	144	TP53
NM_000546.6(TP53):c.428T>A (p.Val143Glu)	TP53	V143E	Prostate cancer, hereditary, 1	VCV002687706	17	7578502	17	7675184	2687706	2848742	NA	NC_000017.11:7675183:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	143	TP53
NM_000546.6(TP53):c.428T>C (p.Val143Ala)	TP53	V143A	Li-Fraumeni syndrome	VCV000804214	17	7578502	17	7675184	804214	792574	rs1555526241	NC_000017.11:7675183:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	143	TP53
NM_000546.6(TP53):c.428T>G (p.Val143Gly)	TP53	V143G	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000486556	17	7578502	17	7675184	486556	479330	rs1555526241	NC_000017.11:7675183:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	143	TP53
NM_000546.6(TP53):c.427G>C (p.Val143Leu)	TP53	V143L	Prostate cancer, hereditary, 1	VCV002687704	17	7578503	17	7675185	2687704	2848740	NA	NC_000017.11:7675184:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	143	TP53
NM_000546.6(TP53):c.427G>T (p.Val143Leu)	TP53	V143L	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not specified	VCV000185729	17	7578503	17	7675185	185729	185385	rs587782620	NC_000017.11:7675184:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	143	TP53
NM_000546.6(TP53):c.427G>A (p.Val143Met)	TP53	V143M	not provided|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Breast neoplasm|Li-Fraumeni syndrome 1	VCV000142657	17	7578503	17	7675185	142657	152371	rs587782620	NC_000017.11:7675184:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	143	TP53
NM_000546.6(TP53):c.425C>T (p.Pro142Leu)	TP53	P142L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000864520	17	7578505	17	7675187	864520	846285	rs779196500	NC_000017.11:7675186:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	142	TP53
NM_000546.6(TP53):c.424C>T (p.Pro142Ser)	TP53	P142S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000824720	17	7578506	17	7675188	824720	814498	rs1597371187	NC_000017.11:7675187:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	142	TP53
NM_000546.6(TP53):c.423C>G (p.Cys141Trp)	TP53	C141W	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376564	17	7578507	17	7675189	376564	363443	rs1057519977	NC_000017.11:7675188:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jun 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	141	TP53
NM_000546.6(TP53):c.422G>T (p.Cys141Phe)	TP53	C141F	Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	VCV000376568	17	7578508	17	7675190	376568	363447	rs587781288	NC_000017.11:7675189:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 12, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	141	TP53
NM_000546.6(TP53):c.422G>A (p.Cys141Tyr)	TP53	C141Y	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000140801	17	7578508	17	7675190	140801	150515	rs587781288	NC_000017.11:7675189:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	141	TP53
NM_000546.6(TP53):c.421T>A (p.Cys141Ser)	TP53	C141S	Prostate adenocarcinoma|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of brain|Multiple myeloma|Acute myeloid leukemia|Papillary renal cell carcinoma type 1|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma	VCV000376567	17	7578509	17	7675191	376567	363446	rs1057519978	NC_000017.11:7675190:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 31, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	141	TP53
NM_000546.6(TP53):c.421T>G (p.Cys141Gly)	TP53	C141G	Malignant neoplasm of body of uterus|Pancreatic adenocarcinoma|Multiple myeloma|Breast neoplasm|Neoplasm of the large intestine|Prostate adenocarcinoma|Neoplasm of brain|Lung adenocarcinoma|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Papillary renal cell carcinoma type 1|Squamous cell lung carcinoma	VCV000376566	17	7578509	17	7675191	376566	363445	rs1057519978	NC_000017.11:7675190:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 31, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	141	TP53
NM_000546.6(TP53):c.421T>C (p.Cys141Arg)	TP53	C141R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376565	17	7578509	17	7675191	376565	363444	rs1057519978	NC_000017.11:7675190:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 17, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	141	TP53
NM_000546.6(TP53):c.419C>A (p.Thr140Asn)	TP53	T140N	Hereditary cancer-predisposing syndrome	VCV000185918	17	7578511	17	7675193	185918	185386	rs786202561	NC_000017.11:7675192:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	140	TP53
NM_000546.6(TP53):c.418A>T (p.Thr140Ser)	TP53	T140S	not provided|Li-Fraumeni syndrome	VCV001525853	17	7578512	17	7675194	1525853	1395909	rs1597371253	NC_000017.11:7675193:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	140	TP53
NM_000546.6(TP53):c.418A>G (p.Thr140Ala)	TP53	T140A	Li-Fraumeni syndrome	VCV000644101	17	7578512	17	7675194	644101	646764	rs1597371253	NC_000017.11:7675193:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 31, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	140	TP53
NM_000546.6(TP53):c.417G>T (p.Lys139Asn)	TP53	K139N	Li-Fraumeni syndrome	VCV000584923	17	7578513	17	7675195	584923	576033	rs1567554121	NC_000017.11:7675194:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	139	TP53
NM_000546.6(TP53):c.416A>G (p.Lys139Arg)	TP53	K139R	Li-Fraumeni syndrome	VCV001500748	17	7578514	17	7675196	1500748	1501671	rs2151033390	NC_000017.11:7675195:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	139	TP53
NM_000546.6(TP53):c.416A>C (p.Lys139Thr)	TP53	K139T	Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV001338658	17	7578514	17	7675196	1338658	1329664	rs2151033390	NC_000017.11:7675195:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	139	TP53
NM_000546.6(TP53):c.415A>C (p.Lys139Gln)	TP53	K139Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001692473	17	7578515	17	7675197	1692473	1684913	rs1212996409	NC_000017.11:7675196:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	139	TP53
NM_000546.6(TP53):c.415A>G (p.Lys139Glu)	TP53	K139E	Li-Fraumeni syndrome	VCV000658923	17	7578515	17	7675197	658923	646765	rs1212996409	NC_000017.11:7675196:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	139	TP53
NM_000546.6(TP53):c.413C>G (p.Ala138Gly)	TP53	A138G	Li-Fraumeni syndrome	VCV001375764	17	7578517	17	7675199	1375764	1470152	rs750600586	NC_000017.11:7675198:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 17, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	138	TP53
NM_000546.6(TP53):c.413C>A (p.Ala138Asp)	TP53	A138D	Li-Fraumeni syndrome	VCV000528270	17	7578517	17	7675199	528270	531829	rs750600586	NC_000017.11:7675198:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	138	TP53
NM_000546.6(TP53):c.413C>T (p.Ala138Val)	TP53	A138V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1	VCV000184863	17	7578517	17	7675199	184863	185387	rs750600586	NC_000017.11:7675198:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	138	TP53
NM_000546.6(TP53):c.412G>A (p.Ala138Thr)	TP53	A138T	Li-Fraumeni syndrome	VCV001053218	17	7578518	17	7675200	1053218	1050673	rs28934875	NC_000017.11:7675199:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	138	TP53
NM_000546.6(TP53):c.412G>C (p.Ala138Pro)	TP53	A138P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000012376	17	7578518	17	7675200	12376	27415	rs28934875	NC_000017.11:7675199:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jun 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	138	TP53
NM_000546.6(TP53):c.409_410delinsGA (p.Leu137Glu)	TP53	L137E	Li-Fraumeni syndrome	VCV001713937	17	7578520 - 7578521	17	7675202 - 7675203	1713937	1773208	NA	NC_000017.11:7675201:AG:TC	Indel	missense variant|5 prime UTR variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	137	TP53
NM_000546.6(TP53):c.409C>G (p.Leu137Val)	TP53	L137V	Li-Fraumeni syndrome	VCV001005829	17	7578521	17	7675203	1005829	997958	rs2073396963	NC_000017.11:7675202:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	137	TP53
NM_000546.6(TP53):c.408A>T (p.Gln136His)	TP53	Q136H	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000482213	17	7578522	17	7675204	482213	479281	rs758781593	NC_000017.11:7675203:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	136	TP53
NM_000546.6(TP53):c.408A>C (p.Gln136His)	TP53	Q136H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000186301	17	7578522	17	7675204	186301	185390	rs758781593	NC_000017.11:7675203:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	136	TP53
NM_000546.6(TP53):c.407A>C (p.Gln136Pro)	TP53	Q136P	Li-Fraumeni syndrome	VCV000580807	17	7578523	17	7675205	580807	572315	rs1567554216	NC_000017.11:7675204:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	136	TP53
NM_000546.6(TP53):c.406C>G (p.Gln136Glu)	TP53	Q136E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000480751	17	7578524	17	7675206	480751	479283	rs1555526268	NC_000017.11:7675205:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	136	TP53
NM_000546.6(TP53):c.405C>G (p.Cys135Trp)	TP53	C135W	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376561	17	7578525	17	7675207	376561	363440	rs1057519976	NC_000017.11:7675206:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	135	TP53
NM_000546.6(TP53):c.404G>T (p.Cys135Phe)	TP53	C135F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376559	17	7578526	17	7675208	376559	363438	rs587781991	NC_000017.11:7675207:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	135	TP53
NM_000546.6(TP53):c.404G>A (p.Cys135Tyr)	TP53	C135Y	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000141762	17	7578526	17	7675208	141762	151476	rs587781991	NC_000017.11:7675207:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	135	TP53
NM_000546.6(TP53):c.403T>G (p.Cys135Gly)	TP53	C135G	Li-Fraumeni syndrome	VCV000376563	17	7578527	17	7675209	376563	363442	rs1057519975	NC_000017.11:7675208:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	135	TP53
NM_000546.6(TP53):c.403T>A (p.Cys135Ser)	TP53	C135S	Li-Fraumeni syndrome	VCV000376562	17	7578527	17	7675209	376562	363441	rs1057519975	NC_000017.11:7675208:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	135	TP53
NM_000546.6(TP53):c.403T>C (p.Cys135Arg)	TP53	C135R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376560	17	7578527	17	7675209	376560	363439	rs1057519975	NC_000017.11:7675208:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	135	TP53
NM_000546.6(TP53):c.402T>G (p.Phe134Leu)	TP53	F134L	Li-Fraumeni syndrome	VCV001018290	17	7578528	17	7675210	1018290	1013161	rs1555526278	NC_000017.11:7675209:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.402T>A (p.Phe134Leu)	TP53	F134L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000871293	17	7578528	17	7675210	871293	860439	rs1555526278	NC_000017.11:7675209:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.401T>C (p.Phe134Ser)	TP53	F134S	Li-Fraumeni syndrome	VCV001519634	17	7578529	17	7675211	1519634	1516923	rs780442292	NC_000017.11:7675210:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.401T>A (p.Phe134Tyr)	TP53	F134Y	Li-Fraumeni syndrome	VCV001509393	17	7578529	17	7675211	1509393	1365014	rs780442292	NC_000017.11:7675210:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.401T>G (p.Phe134Cys)	TP53	F134C	Hereditary cancer-predisposing syndrome	VCV000230477	17	7578529	17	7675211	230477	236493	rs780442292	NC_000017.11:7675210:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 10, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.400T>G (p.Phe134Val)	TP53	F134V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast	VCV000988615	17	7578530	17	7675212	988615	976549	rs267605077	NC_000017.11:7675211:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.400T>A (p.Phe134Ile)	TP53	F134I	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480953	17	7578530	17	7675212	480953	479343	rs267605077	NC_000017.11:7675211:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.400T>C (p.Phe134Leu)	TP53	F134L	Li-Fraumeni syndrome	VCV000080710	17	7578530	17	7675212	80710	91601	rs267605077	NC_000017.11:7675211:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 13, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	TP53
NM_000546.6(TP53):c.399G>A (p.Met133Ile)	TP53	M133I	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000421437	17	7578531	17	7675213	421437	410276	rs1064795139	NC_000017.11:7675212:C:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	133	TP53
NM_000546.6(TP53):c.398T>G (p.Met133Arg)	TP53	M133R	Prostate cancer, hereditary, 1	VCV002687699	17	7578532	17	7675214	2687699	2848735	NA	NC_000017.11:7675213:A:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	133	TP53
NM_000546.6(TP53):c.398T>A (p.Met133Lys)	TP53	M133K	Breast carcinoma|Neoplasm	VCV002430159	17	7578532	17	7675214	2430159	2403662	NA	NC_000017.11:7675213:A:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Likely pathogenic	NA	no assertion criteria provided	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	133	TP53
NM_000546.6(TP53):c.398T>C (p.Met133Thr)	TP53	M133T	not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000012357	17	7578532	17	7675214	12357	27396	rs28934873	NC_000017.11:7675213:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Pathogenic	Oct 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	133	TP53
NM_000546.6(TP53):c.397A>G (p.Met133Val)	TP53	M133V	Li-Fraumeni syndrome	VCV000528246	17	7578533	17	7675215	528246	531943	rs1057280220	NC_000017.11:7675214:T:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Uncertain significance	Nov 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	133	TP53
NM_000546.6(TP53):c.396G>T (p.Lys132Asn)	TP53	K132N	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000634773	17	7578534	17	7675216	634773	622631	rs866775781	NC_000017.11:7675215:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	132	TP53
NM_000546.6(TP53):c.396G>C (p.Lys132Asn)	TP53	K132N	Li-Fraumeni syndrome	VCV000376624	17	7578534	17	7675216	376624	363503	rs866775781	NC_000017.11:7675215:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 18, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	132	TP53
NM_000546.6(TP53):c.395A>T (p.Lys132Met)	TP53	K132M	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376629	17	7578535	17	7675217	376629	363508	rs1057519996	NC_000017.11:7675216:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	132	TP53
NM_000546.6(TP53):c.395A>C (p.Lys132Thr)	TP53	K132T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376627	17	7578535	17	7675217	376627	363506	rs1057519996	NC_000017.11:7675216:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	132	TP53
NM_000546.6(TP53):c.395A>G (p.Lys132Arg)	TP53	K132R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000376625	17	7578535	17	7675217	376625	363504	rs1057519996	NC_000017.11:7675216:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	132	TP53
NM_000546.6(TP53):c.394A>C (p.Lys132Gln)	TP53	K132Q	Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376628	17	7578536	17	7675218	376628	363507	rs747342068	NC_000017.11:7675217:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	132	TP53
NM_000546.6(TP53):c.394A>G (p.Lys132Glu)	TP53	K132E	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376626	17	7578536	17	7675218	376626	363505	rs747342068	NC_000017.11:7675217:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	132	TP53
NM_000546.6(TP53):c.393C>A (p.Asn131Lys)	TP53	N131K	Li-Fraumeni syndrome	VCV000246429	17	7578537	17	7675219	246429	245078	rs769270327	NC_000017.11:7675218:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	131	TP53
NM_000546.6(TP53):c.392A>G (p.Asn131Ser)	TP53	N131S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV001057941	17	7578538	17	7675220	1057941	1050674	rs1131691037	NC_000017.11:7675219:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 14, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Uncertain significance	Jul 31, 2024	criteria provided, single submitter	NA	131	TP53
NM_000546.6(TP53):c.392A>T (p.Asn131Ile)	TP53	N131I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000428902	17	7578538	17	7675220	428902	420665	rs1131691037	NC_000017.11:7675219:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	131	TP53
NM_000546.6(TP53):c.391A>T (p.Asn131Tyr)	TP53	N131Y	Hereditary cancer-predisposing syndrome	VCV000141988	17	7578539	17	7675221	141988	151702	rs587782160	NC_000017.11:7675220:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Mar 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	131	TP53
NM_000546.6(TP53):c.388_390delinsGAT (p.Leu130Asp)	TP53	L130D	Prostate cancer, hereditary, 1	VCV002687693	17	7578540 - 7578542	17	7675222 - 7675224	2687693	2848729	NA	NC_000017.11:7675221:GAG:ATC	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	130	TP53
NM_000546.6(TP53):c.389T>A (p.Leu130His)	TP53	L130H	Hereditary cancer-predisposing syndrome	VCV000824351	17	7578541	17	7675223	824351	814500	rs1131691013	NC_000017.11:7675222:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Mar 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	130	TP53
NM_000546.6(TP53):c.389T>C (p.Leu130Pro)	TP53	L130P	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Bone osteosarcoma|Li-Fraumeni syndrome 1|Familial cancer of breast|Glioma susceptibility 1|Nasopharyngeal carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Basal cell carcinoma, susceptibility to, 7|Colorectal cancer|Hepatocellular carcinoma|Bone marrow failure syndrome 5	VCV000428873	17	7578541	17	7675223	428873	420666	rs1131691013	NC_000017.11:7675222:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	May 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	130	TP53
NM_000546.6(TP53):c.388C>G (p.Leu130Val)	TP53	L130V	Adrenocortical carcinoma, hereditary|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000458543	17	7578542	17	7675224	458543	469158	rs863224683	NC_000017.11:7675223:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 23, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	130	TP53
NM_000546.6(TP53):c.388C>T (p.Leu130Phe)	TP53	L130F	not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000216466	17	7578542	17	7675224	216466	213401	rs863224683	NC_000017.11:7675223:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	130	TP53
NM_000546.6(TP53):c.386C>A (p.Ala129Asp)	TP53	A129D	Hereditary cancer-predisposing syndrome	VCV001735669	17	7578544	17	7675226	1735669	1790163	NA	NC_000017.11:7675225:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Nov 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	129	TP53
NM_000546.6(TP53):c.386C>G (p.Ala129Gly)	TP53	A129G	Li-Fraumeni syndrome	VCV000458542	17	7578544	17	7675226	458542	469161	rs137852792	NC_000017.11:7675225:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 13, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	129	TP53
NM_000546.6(TP53):c.386C>T (p.Ala129Val)	TP53	A129V	Familial cancer of breast	VCV000133280	17	7578544	17	7675226	133280	137019	rs137852792	NC_000017.11:7675225:G:A	single nucleotide variant	missense variant|5 prime UTR variant	not provided	NA	no classification provided	NA	NA	NA	NA	NA	NA	NA	129	TP53
NM_000546.6(TP53):c.385G>T (p.Ala129Ser)	TP53	A129S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000824314	17	7578545	17	7675227	824314	814501	rs1438095083	NC_000017.11:7675226:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 6, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	129	TP53
NM_000546.6(TP53):c.385G>A (p.Ala129Thr)	TP53	A129T	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000482217	17	7578545	17	7675227	482217	480076	rs1438095083	NC_000017.11:7675226:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	129	TP53
NM_000546.6(TP53):c.383C>G (p.Pro128Arg)	TP53	P128R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001718564	17	7578547	17	7675229	1718564	1778924	NA	NC_000017.11:7675228:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	128	TP53
NM_000546.6(TP53):c.383C>T (p.Pro128Leu)	TP53	P128L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000824286	17	7578547	17	7675229	824286	814502	rs1597371657	NC_000017.11:7675228:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	128	TP53
NM_000546.6(TP53):c.382C>T (p.Pro128Ser)	TP53	P128S	Prostate cancer, hereditary, 1	VCV002687698	17	7578548	17	7675230	2687698	2848734	NA	NC_000017.11:7675229:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	128	TP53
NM_000546.6(TP53):c.382C>A (p.Pro128Thr)	TP53	P128T	Li-Fraumeni syndrome|not provided|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000480743	17	7578548	17	7675230	480743	479344	rs1555526327	NC_000017.11:7675229:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	128	TP53
NM_000546.6(TP53):c.380C>A (p.Ser127Tyr)	TP53	S127Y	Li-Fraumeni syndrome 1	VCV000656751	17	7578550	17	7675232	656751	646767	rs730881999	NC_000017.11:7675231:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 20, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	127	TP53
NM_000546.6(TP53):c.380C>G (p.Ser127Cys)	TP53	S127C	Li-Fraumeni syndrome	VCV000219532	17	7578550	17	7675232	219532	222742	rs730881999	NC_000017.11:7675231:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	127	TP53
NM_000546.6(TP53):c.380C>T (p.Ser127Phe)	TP53	S127F	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|not specified|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000182928	17	7578550	17	7675232	182928	181015	rs730881999	NC_000017.11:7675231:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	127	TP53
NM_000546.6(TP53):c.379T>C (p.Ser127Pro)	TP53	S127P	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000934410	17	7578551	17	7675233	934410	938240	rs1597371694	NC_000017.11:7675232:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	127	TP53
NM_000546.6(TP53):c.379T>A (p.Ser127Thr)	TP53	S127T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000824232	17	7578551	17	7675233	824232	814503	rs1597371694	NC_000017.11:7675232:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	127	TP53
NM_000546.6(TP53):c.376_377delinsCT (p.Tyr126Leu)	TP53	Y126L	Prostate cancer, hereditary, 1	VCV002687703	17	7578553 - 7578554	17	7675235 - 7675236	2687703	2848739	NA	NC_000017.11:7675234:TA:AG	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 1, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	126	TP53
NM_000546.6(TP53):c.377A>C (p.Tyr126Ser)	TP53	Y126S	Li-Fraumeni syndrome	VCV001054765	17	7578553	17	7675235	1054765	1050675	rs1555526335	NC_000017.11:7675234:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 10, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	126	TP53
NM_000546.6(TP53):c.377A>G (p.Tyr126Cys)	TP53	Y126C	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000458541	17	7578553	17	7675235	458541	467547	rs1555526335	NC_000017.11:7675234:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	126	TP53
NM_000546.6(TP53):c.376T>C (p.Tyr126His)	TP53	Y126H	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001734755	17	7578554	17	7675236	1734755	1796547	NA	NC_000017.11:7675235:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 13, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	126	TP53
NM_000546.6(TP53):c.376T>A (p.Tyr126Asn)	TP53	Y126N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000428871	17	7578554	17	7675236	428871	420667	rs886039483	NC_000017.11:7675235:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	126	TP53
NM_000546.6(TP53):c.376T>G (p.Tyr126Asp)	TP53	Y126D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	VCV000265333	17	7578554	17	7675236	265333	260193	rs886039483	NC_000017.11:7675235:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	126	TP53
NM_000546.6(TP53):c.374C>G (p.Thr125Arg)	TP53	T125R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Neoplasm	VCV000376667	17	7579313	17	7675995	376667	363546	rs786201057	NC_000017.11:7675994:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	125	TP53
NM_000546.6(TP53):c.374C>A (p.Thr125Lys)	TP53	T125K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000216465	17	7579313	17	7675995	216465	213402	rs786201057	NC_000017.11:7675994:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 15, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	125	TP53
NM_000546.6(TP53):c.374C>T (p.Thr125Met)	TP53	T125M	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000183748	17	7579313	17	7675995	183748	185394	rs786201057	NC_000017.11:7675994:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	125	TP53
NM_000546.6(TP53):c.373A>G (p.Thr125Ala)	TP53	T125A	Hereditary cancer-predisposing syndrome	VCV001734453	17	7579314	17	7675996	1734453	1786872	NA	NC_000017.11:7675995:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	125	TP53
NM_000546.6(TP53):c.373A>C (p.Thr125Pro)	TP53	T125P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376666	17	7579314	17	7675996	376666	363545	rs1057520003	NC_000017.11:7675995:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	125	TP53
NM_000546.6(TP53):c.371G>C (p.Cys124Ser)	TP53	C124S	Li-Fraumeni syndrome	VCV001021578	17	7579316	17	7675998	1021578	1013163	rs2073449166	NC_000017.11:7675997:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	124	TP53
NM_000546.6(TP53):c.370T>G (p.Cys124Gly)	TP53	C124G	Hereditary cancer-predisposing syndrome	VCV000230661	17	7579317	17	7675999	230661	236494	rs730881997	NC_000017.11:7675998:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	124	TP53
NM_000546.6(TP53):c.370T>A (p.Cys124Ser)	TP53	C124S	Li-Fraumeni syndrome 1	VCV000182926	17	7579317	17	7675999	182926	181018	rs730881997	NC_000017.11:7675998:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	124	TP53
NM_000546.6(TP53):c.368C>G (p.Thr123Ser)	TP53	T123S	Li-Fraumeni syndrome	VCV001460570	17	7579319	17	7676001	1460570	1504619	rs1555526486	NC_000017.11:7676000:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	123	TP53
NM_000546.6(TP53):c.368C>T (p.Thr123Ile)	TP53	T123I	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000480737	17	7579319	17	7676001	480737	480090	rs1555526486	NC_000017.11:7676000:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	123	TP53
NM_000546.6(TP53):c.365T>C (p.Val122Ala)	TP53	V122A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001465964	17	7579322	17	7676004	1465964	1448789	rs2151038394	NC_000017.11:7676003:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	122	TP53
NM_000546.6(TP53):c.364G>T (p.Val122Leu)	TP53	V122L	Li-Fraumeni syndrome	VCV002121740	17	7579323	17	7676005	2121740	2176934	NA	NC_000017.11:7676004:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	122	TP53
NM_000546.6(TP53):c.364G>A (p.Val122Met)	TP53	V122M	Li-Fraumeni syndrome 1	VCV000141101	17	7579323	17	7676005	141101	150815	rs587781495	NC_000017.11:7676004:C:T	single nucleotide variant	missense variant	Likely benign	Jun 2, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	122	TP53
NM_000546.6(TP53):c.361T>C (p.Ser121Pro)	TP53	S121P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000854451	17	7579326	17	7676008	854451	846288	rs2073450567	NC_000017.11:7676007:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	121	TP53
NM_000546.6(TP53):c.359A>G (p.Lys120Arg)	TP53	K120R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001360099	17	7579328	17	7676010	1360099	1473972	rs2073450819	NC_000017.11:7676009:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	120	TP53
NM_000546.6(TP53):c.359A>T (p.Lys120Met)	TP53	K120M	not specified	VCV000917693	17	7579328	17	7676010	917693	906036	rs2073450819	NC_000017.11:7676009:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	120	TP53
NM_000546.6(TP53):c.358A>C (p.Lys120Gln)	TP53	K120Q	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|TP53-related disorder	VCV000423255	17	7579329	17	7676011	423255	410277	rs121912658	NC_000017.11:7676010:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	120	TP53
NM_000546.6(TP53):c.358A>G (p.Lys120Glu)	TP53	K120E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000141098	17	7579329	17	7676011	141098	150812	rs121912658	NC_000017.11:7676010:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	120	TP53
NM_000546.6(TP53):c.356C>A (p.Ala119Asp)	TP53	A119D	Hereditary cancer-predisposing syndrome	VCV001732774	17	7579331	17	7676013	1732774	1786461	NA	NC_000017.11:7676012:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	119	TP53
NM_000546.6(TP53):c.356C>G (p.Ala119Gly)	TP53	A119G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000949408	17	7579331	17	7676013	949408	928556	rs2073451331	NC_000017.11:7676012:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	119	TP53
NM_000546.6(TP53):c.355G>C (p.Ala119Pro)	TP53	A119P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000481073	17	7579332	17	7676014	481073	479346	rs1555526506	NC_000017.11:7676013:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	119	TP53
NM_000546.6(TP53):c.353C>T (p.Thr118Ile)	TP53	T118I	Li-Fraumeni syndrome 1	VCV000419837	17	7579334	17	7676016	419837	410278	rs1064794141	NC_000017.11:7676015:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	118	TP53
NM_000546.6(TP53):c.350G>A (p.Gly117Glu)	TP53	G117E	Hereditary cancer-predisposing syndrome	VCV002450745	17	7579337	17	7676019	2450745	2423231	NA	NC_000017.11:7676018:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	117	TP53
NM_000546.6(TP53):c.350G>C (p.Gly117Ala)	TP53	G117A	Li-Fraumeni syndrome	VCV001055289	17	7579337	17	7676019	1055289	1050676	rs755238756	NC_000017.11:7676018:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	117	TP53
NM_000546.6(TP53):c.350G>T (p.Gly117Val)	TP53	G117V	Li-Fraumeni syndrome	VCV000837018	17	7579337	17	7676019	837018	846289	rs755238756	NC_000017.11:7676018:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	117	TP53
NM_000546.6(TP53):c.349G>C (p.Gly117Arg)	TP53	G117R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001462102	17	7579338	17	7676020	1462102	1507429	rs1555526518	NC_000017.11:7676019:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	117	TP53
NM_000546.6(TP53):c.349G>A (p.Gly117Arg)	TP53	G117R	Hereditary cancer-predisposing syndrome	VCV000480758	17	7579338	17	7676020	480758	479363	rs1555526518	NC_000017.11:7676019:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	117	TP53
NM_000546.6(TP53):c.346T>G (p.Ser116Ala)	TP53	S116A	not provided|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000649358	17	7579341	17	7676023	649358	646768	rs989692988	NC_000017.11:7676022:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	116	TP53
NM_000546.6(TP53):c.344A>G (p.His115Arg)	TP53	H115R	Li-Fraumeni syndrome 1	VCV000182925	17	7579343	17	7676025	182925	181019	rs730881996	NC_000017.11:7676024:T:C	single nucleotide variant	missense variant	Likely benign	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	115	TP53
NM_000546.6(TP53):c.343C>A (p.His115Asn)	TP53	H115N	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000480741	17	7579344	17	7676026	480741	480091	rs1555526532	NC_000017.11:7676025:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 23, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	115	TP53
NM_000546.6(TP53):c.341T>C (p.Leu114Ser)	TP53	L114S	Li-Fraumeni syndrome|not specified|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000458536	17	7579346	17	7676028	458536	467548	rs781724995	NC_000017.11:7676027:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	114	TP53
NM_000546.6(TP53):c.340T>G (p.Leu114Val)	TP53	L114V	Li-Fraumeni syndrome	VCV001011474	17	7579347	17	7676029	1011474	997961	rs2073453661	NC_000017.11:7676028:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	114	TP53
NM_000546.6(TP53):c.339C>G (p.Phe113Leu)	TP53	F113L	Li-Fraumeni syndrome	VCV002702402	17	7579348	17	7676030	2702402	2856119	NA	NC_000017.11:7676029:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	113	TP53
NM_000546.6(TP53):c.339C>A (p.Phe113Leu)	TP53	F113L	Li-Fraumeni syndrome	VCV002125367	17	7579348	17	7676030	2125367	2177968	NA	NC_000017.11:7676029:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	113	TP53
NM_000546.6(TP53):c.338T>C (p.Phe113Ser)	TP53	F113S	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000823709	17	7579349	17	7676031	823709	814505	rs1567555667	NC_000017.11:7676030:A:G	single nucleotide variant	missense variant	Uncertain significance	May 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	113	TP53
NM_000546.6(TP53):c.338T>G (p.Phe113Cys)	TP53	F113C	Li-Fraumeni syndrome	VCV000634690	17	7579349	17	7676031	634690	622637	rs1567555667	NC_000017.11:7676030:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	113	TP53
NM_000546.6(TP53):c.337T>A (p.Phe113Ile)	TP53	F113I	Li-Fraumeni syndrome	VCV001469551	17	7579350	17	7676032	1469551	1475500	rs587781642	NC_000017.11:7676031:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	113	TP53
NM_000546.6(TP53):c.337T>G (p.Phe113Val)	TP53	F113V	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000141302	17	7579350	17	7676032	141302	151016	rs587781642	NC_000017.11:7676031:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	113	TP53
NM_000546.6(TP53):c.335G>A (p.Gly112Asp)	TP53	G112D	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV001319402	17	7579352	17	7676034	1319402	1309655	rs1390502714	NC_000017.11:7676033:C:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	112	TP53
NM_000546.6(TP53):c.334G>A (p.Gly112Ser)	TP53	G112S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000492575	17	7579353	17	7676035	492575	485522	rs1423803759	NC_000017.11:7676034:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	112	TP53
NM_000546.6(TP53):c.332T>A (p.Leu111Gln)	TP53	L111Q	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376632	17	7579355	17	7676037	376632	363511	rs1057519997	NC_000017.11:7676036:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	111	TP53
NM_000546.6(TP53):c.332T>G (p.Leu111Arg)	TP53	L111R	Li-Fraumeni syndrome	VCV000376631	17	7579355	17	7676037	376631	363510	rs1057519997	NC_000017.11:7676036:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	111	TP53
NM_000546.6(TP53):c.332T>C (p.Leu111Pro)	TP53	L111P	Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376630	17	7579355	17	7676037	376630	363509	rs1057519997	NC_000017.11:7676036:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	111	TP53
NM_000546.6(TP53):c.331C>G (p.Leu111Val)	TP53	L111V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV001730178	17	7579356	17	7676038	1730178	1792384	NA	NC_000017.11:7676037:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	111	TP53
NM_000546.6(TP53):c.331C>A (p.Leu111Met)	TP53	L111M	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000836750	17	7579356	17	7676038	836750	846290	rs1403707528	NC_000017.11:7676037:G:T	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	111	TP53
NM_000546.6(TP53):c.329_330delinsCC (p.Arg110Pro)	TP53	R110P	Li-Fraumeni syndrome	VCV000641505	17	7579357 - 7579358	17	7676039 - 7676040	641505	646770	rs1597373700	NC_000017.11:7676038:AC:GG	Indel	missense variant	Pathogenic	Aug 28, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	110	TP53
NM_000546.6(TP53):c.329G>T (p.Arg110Leu)	TP53	R110L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000406597	17	7579358	17	7676040	406597	402569	rs11540654	NC_000017.11:7676039:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	110	TP53
NM_000546.6(TP53):c.329G>C (p.Arg110Pro)	TP53	R110P	Adrenocortical carcinoma, hereditary|Familial cancer of breast|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000233627	17	7579358	17	7676040	233627	236497	rs11540654	NC_000017.11:7676039:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	110	TP53
NM_000546.6(TP53):c.329G>A (p.Arg110His)	TP53	R110H	Li-Fraumeni syndrome	VCV000127808	17	7579358	17	7676040	127808	133265	rs11540654	NC_000017.11:7676039:C:T	single nucleotide variant	missense variant	Likely benign	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	110	TP53
NM_000546.6(TP53):c.328C>G (p.Arg110Gly)	TP53	R110G	Hereditary cancer-predisposing syndrome	VCV000823452	17	7579359	17	7676041	823452	814506	rs587781371	NC_000017.11:7676040:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	110	TP53
NM_000546.6(TP53):c.328C>T (p.Arg110Cys)	TP53	R110C	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|not specified|Li-Fraumeni syndrome|Breast and/or ovarian cancer|Neoplasm	VCV000142206	17	7579359	17	7676041	142206	151920	rs587781371	NC_000017.11:7676040:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	NA	110	TP53
NM_000546.6(TP53):c.328C>A (p.Arg110Ser)	TP53	R110S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000140921	17	7579359	17	7676041	140921	150635	rs587781371	NC_000017.11:7676040:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	110	TP53
NM_000546.6(TP53):c.324_326inv (p.Phe109Asn)	TP53	F109N	Li-Fraumeni syndrome	VCV002417541	17	7579361 - 7579363	17	7676043 - 7676045	2417541	1937612	NA	NC_000017.11:7676042:AAA:TTT	Inversion	missense variant	Uncertain significance	Aug 25, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	109	TP53
NM_000546.6(TP53):c.326T>A (p.Phe109Tyr)	TP53	F109Y	Li-Fraumeni syndrome	VCV001054035	17	7579361	17	7676043	1054035	1050677	rs1064796722	NC_000017.11:7676042:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	109	TP53
NM_000546.6(TP53):c.326T>G (p.Phe109Cys)	TP53	F109C	Li-Fraumeni syndrome 1	VCV000634784	17	7579361	17	7676043	634784	622638	rs1064796722	NC_000017.11:7676042:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 12, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	109	TP53
NM_000546.6(TP53):c.326T>C (p.Phe109Ser)	TP53	F109S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not specified|not provided|Li-Fraumeni syndrome	VCV000423970	17	7579361	17	7676043	423970	410280	rs1064796722	NC_000017.11:7676042:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	109	TP53
NM_000546.6(TP53):c.325T>A (p.Phe109Ile)	TP53	F109I	Li-Fraumeni syndrome|not provided	VCV002627017	17	7579362	17	7676044	2627017	2794537	NA	NC_000017.11:7676043:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	109	TP53
NM_000546.6(TP53):c.325T>G (p.Phe109Val)	TP53	F109V	Hereditary cancer-predisposing syndrome|not provided	VCV000389644	17	7579362	17	7676044	389644	378807	rs1057523496	NC_000017.11:7676043:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	109	TP53
NM_000546.6(TP53):c.323G>T (p.Gly108Val)	TP53	G108V	Hereditary cancer-predisposing syndrome	VCV001729287	17	7579364	17	7676046	1729287	1785575	NA	NC_000017.11:7676045:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	108	TP53
NM_000546.6(TP53):c.323G>A (p.Gly108Asp)	TP53	G108D	Li-Fraumeni syndrome	VCV001371608	17	7579364	17	7676046	1371608	1450045	rs2151039440	NC_000017.11:7676045:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	108	TP53
NM_000546.6(TP53):c.322G>T (p.Gly108Cys)	TP53	G108C	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001487358	17	7579365	17	7676047	1487358	1485251	rs587782461	NC_000017.11:7676046:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	108	TP53
NM_000546.6(TP53):c.322G>C (p.Gly108Arg)	TP53	G108R	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Li-Fraumeni syndrome 1	VCV000458535	17	7579365	17	7676047	458535	469170	rs587782461	NC_000017.11:7676046:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	108	TP53
NM_000546.6(TP53):c.322G>A (p.Gly108Ser)	TP53	G108S	Li-Fraumeni syndrome 1	VCV000142431	17	7579365	17	7676047	142431	152145	rs587782461	NC_000017.11:7676046:C:T	single nucleotide variant	missense variant	Likely benign	Sep 1, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	108	TP53
NM_000546.6(TP53):c.320A>G (p.Tyr107Cys)	TP53	Y107C	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000142691	17	7579367	17	7676049	142691	152405	rs587782447	NC_000017.11:7676048:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	107	TP53
NM_000546.6(TP53):c.320A>C (p.Tyr107Ser)	TP53	Y107S	Hereditary cancer-predisposing syndrome	VCV000142414	17	7579367	17	7676049	142414	152128	rs587782447	NC_000017.11:7676048:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2013	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	107	TP53
NM_000546.6(TP53):c.319T>G (p.Tyr107Asp)	TP53	Y107D	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000641482	17	7579368	17	7676050	641482	646771	rs368771578	NC_000017.11:7676049:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	107	TP53
NM_000546.6(TP53):c.319T>A (p.Tyr107Asn)	TP53	Y107N	Li-Fraumeni syndrome	VCV000406572	17	7579368	17	7676050	406572	402599	rs368771578	NC_000017.11:7676049:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	107	TP53
NM_000546.6(TP53):c.318C>G (p.Ser106Arg)	TP53	S106R	not provided|Li-Fraumeni syndrome	VCV000492752	17	7579369	17	7676051	492752	485679	rs1555526581	NC_000017.11:7676050:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	106	TP53
NM_000546.6(TP53):c.317G>T (p.Ser106Ile)	TP53	S106I	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000629791	17	7579370	17	7676052	629791	618840	rs1567555883	NC_000017.11:7676051:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	106	TP53
NM_000546.6(TP53):c.314_315delinsCA (p.Gly105Ala)	TP53	G105A	Hereditary cancer-predisposing syndrome	VCV000822977	17	7579372 - 7579373	17	7676054 - 7676055	822977	814508	rs1597373856	NC_000017.11:7676053:GC:TG	Indel	missense variant	Uncertain significance	Nov 14, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	105	TP53
NM_000546.6(TP53):c.314G>C (p.Gly105Ala)	TP53	G105A	Li-Fraumeni syndrome	VCV002035647	17	7579373	17	7676055	2035647	2097431	NA	NC_000017.11:7676054:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	105	TP53
NM_000546.6(TP53):c.314G>T (p.Gly105Val)	TP53	G105V	Lung adenocarcinoma	VCV000634708	17	7579373	17	7676055	634708	622639	rs587781504	NC_000017.11:7676054:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	105	TP53
NM_000546.6(TP53):c.314G>A (p.Gly105Asp)	TP53	G105D	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000141114	17	7579373	17	7676055	141114	150828	rs587781504	NC_000017.11:7676054:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	105	TP53
NM_000546.6(TP53):c.313G>A (p.Gly105Ser)	TP53	G105S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000428884	17	7579374	17	7676056	428884	420671	rs1060501195	NC_000017.11:7676055:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	105	TP53
NM_000546.6(TP53):c.313G>C (p.Gly105Arg)	TP53	G105R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000406574	17	7579374	17	7676056	406574	402601	rs1060501195	NC_000017.11:7676055:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	105	TP53
NM_000546.6(TP53):c.311A>T (p.Gln104Leu)	TP53	Q104L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000945802	17	7579376	17	7676058	945802	928558	rs2073460244	NC_000017.11:7676057:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 6, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	104	TP53
NM_000546.6(TP53):c.307_309delinsCAG (p.Tyr103Gln)	TP53	Y103Q	Li-Fraumeni syndrome	VCV003010803	17	7579378 - 7579380	17	7676060 - 7676062	3010803	532220	NA	NC_000017.11:7676059:GTA:CTG	Indel	missense variant	Uncertain significance	Sep 11, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	103	TP53
NM_000546.6(TP53):c.308A>C (p.Tyr103Ser)	TP53	Y103S	Li-Fraumeni syndrome	VCV002729592	17	7579379	17	7676061	2729592	2893504	NA	NC_000017.11:7676060:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	103	TP53
NM_000546.6(TP53):c.305C>T (p.Thr102Ile)	TP53	T102I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	VCV000186132	17	7579382	17	7676064	186132	185396	rs786202717	NC_000017.11:7676063:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	102	TP53
NM_000546.6(TP53):c.304A>G (p.Thr102Ala)	TP53	T102A	Hereditary cancer-predisposing syndrome	VCV001799231	17	7579383	17	7676065	1799231	1854840	NA	NC_000017.11:7676064:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	102	TP53
NM_000546.6(TP53):c.304A>T (p.Thr102Ser)	TP53	T102S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000582041	17	7579383	17	7676065	582041	572328	rs1567555968	NC_000017.11:7676064:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	102	TP53
NM_000546.6(TP53):c.303A>T (p.Lys101Asn)	TP53	K101N	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000237947	17	7579384	17	7676066	237947	242986	rs878854069	NC_000017.11:7676065:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	101	TP53
NM_000546.6(TP53):c.301A>G (p.Lys101Glu)	TP53	K101E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001059163	17	7579386	17	7676068	1059163	1050678	rs1373046761	NC_000017.11:7676067:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	101	TP53
NM_000546.6(TP53):c.301A>C (p.Lys101Gln)	TP53	K101Q	Li-Fraumeni syndrome	VCV000649735	17	7579386	17	7676068	649735	646772	rs1373046761	NC_000017.11:7676067:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	TP53
NM_000546.6(TP53):c.296C>T (p.Ser99Phe)	TP53	S99F	Li-Fraumeni syndrome	VCV000579376	17	7579391	17	7676073	579376	572332	rs1567556019	NC_000017.11:7676072:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	99	TP53
NM_000546.6(TP53):c.296C>G (p.Ser99Cys)	TP53	S99C	Li-Fraumeni syndrome	VCV000566954	17	7579391	17	7676073	566954	569785	rs1567556019	NC_000017.11:7676072:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	99	TP53
NM_000546.6(TP53):c.293C>G (p.Pro98Arg)	TP53	P98R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001444043	17	7579394	17	7676076	1444043	1488041	rs1245723119	NC_000017.11:7676075:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	98	TP53
NM_000546.6(TP53):c.293C>T (p.Pro98Leu)	TP53	P98L	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000528236	17	7579394	17	7676076	528236	531949	rs1245723119	NC_000017.11:7676075:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	98	TP53
NM_000546.6(TP53):c.292C>A (p.Pro98Thr)	TP53	P98T	Li-Fraumeni syndrome	VCV001465351	17	7579395	17	7676077	1465351	1511175	rs1597374015	NC_000017.11:7676076:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	98	TP53
NM_000546.6(TP53):c.292C>G (p.Pro98Ala)	TP53	P98A	not provided|Li-Fraumeni syndrome	VCV001039474	17	7579395	17	7676077	1039474	1033677	rs1597374015	NC_000017.11:7676076:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	98	TP53
NM_000546.6(TP53):c.292C>T (p.Pro98Ser)	TP53	P98S	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	VCV000822279	17	7579395	17	7676077	822279	814511	rs1597374015	NC_000017.11:7676076:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	98	TP53
NM_000546.6(TP53):c.290T>C (p.Val97Ala)	TP53	V97A	Hereditary cancer-predisposing syndrome	VCV001797574	17	7579397	17	7676079	1797574	1854492	NA	NC_000017.11:7676078:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	97	TP53
NM_000546.6(TP53):c.290T>A (p.Val97Asp)	TP53	V97D	not provided|Hereditary cancer-predisposing syndrome	VCV000182924	17	7579397	17	7676079	182924	181021	rs730881995	NC_000017.11:7676078:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	97	TP53
NM_000546.6(TP53):c.289G>A (p.Val97Ile)	TP53	V97I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001026336	17	7579398	17	7676080	1026336	1013164	rs730882023	NC_000017.11:7676079:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	97	TP53
NM_000546.6(TP53):c.289G>T (p.Val97Phe)	TP53	V97F	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000458532	17	7579398	17	7676080	458532	468879	rs730882023	NC_000017.11:7676079:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 14, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	97	TP53
NM_000546.6(TP53):c.289G>C (p.Val97Leu)	TP53	V97L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000182962	17	7579398	17	7676080	182962	181022	rs730882023	NC_000017.11:7676079:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	97	TP53
NM_000546.6(TP53):c.284C>T (p.Ser95Phe)	TP53	S95F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001796813	17	7579403	17	7676085	1796813	1855388	NA	NC_000017.11:7676084:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	95	TP53
NM_000546.6(TP53):c.281C>T (p.Ser94Leu)	TP53	S94L	Hereditary cancer-predisposing syndrome	VCV001796426	17	7579406	17	7676088	1796426	1852861	NA	NC_000017.11:7676087:G:A	single nucleotide variant	missense variant	Likely benign	Sep 25, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	94	TP53
NM_000546.6(TP53):c.278T>G (p.Leu93Arg)	TP53	L93R	Li-Fraumeni syndrome	VCV002825997	17	7579409	17	7676091	2825997	2979390	NA	NC_000017.11:7676090:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	93	TP53
NM_000546.6(TP53):c.275C>T (p.Pro92Leu)	TP53	P92L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000480733	17	7579412	17	7676094	480733	479349	rs1210700121	NC_000017.11:7676093:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	92	TP53
NM_000546.6(TP53):c.272G>C (p.Trp91Ser)	TP53	W91S	Hereditary cancer-predisposing syndrome	VCV003232053	17	7579415	17	7676097	3232053	3385593	NA	NC_000017.11:7676096:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	91	TP53
NM_000546.6(TP53):c.271T>C (p.Trp91Arg)	TP53	W91R	Li-Fraumeni syndrome	VCV000845798	17	7579416	17	7676098	845798	846292	rs2073465780	NC_000017.11:7676097:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	91	TP53
NM_000546.6(TP53):c.269C>T (p.Ser90Phe)	TP53	S90F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000528268	17	7579418	17	7676100	528268	532223	rs1555526625	NC_000017.11:7676099:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2017	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	90	TP53
NM_000546.6(TP53):c.266C>T (p.Pro89Leu)	TP53	P89L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000182923	17	7579421	17	7676103	182923	181023	rs730881994	NC_000017.11:7676102:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	89	TP53
NM_000546.6(TP53):c.265C>A (p.Pro89Thr)	TP53	P89T	Hereditary cancer-predisposing syndrome	VCV000821636	17	7579422	17	7676104	821636	814513	rs1597374210	NC_000017.11:7676103:G:T	single nucleotide variant	missense variant	Likely benign	Jan 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	89	TP53
NM_000546.6(TP53):c.263C>G (p.Ala88Gly)	TP53	A88G	not specified	VCV001343497	17	7579424	17	7676106	1343497	1335196	rs1555526631	NC_000017.11:7676105:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	88	TP53
NM_000546.6(TP53):c.263C>T (p.Ala88Val)	TP53	A88V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000480734	17	7579424	17	7676106	480734	479350	rs1555526631	NC_000017.11:7676105:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	88	TP53
NM_000546.6(TP53):c.262G>C (p.Ala88Pro)	TP53	A88P	Hereditary cancer-predisposing syndrome	VCV000629276	17	7579425	17	7676107	629276	618841	rs1567556231	NC_000017.11:7676106:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	88	TP53
NM_000546.6(TP53):c.260C>G (p.Pro87Arg)	TP53	P87R	Hereditary cancer-predisposing syndrome	VCV001793771	17	7579427	17	7676109	1793771	1845896	NA	NC_000017.11:7676108:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	87	TP53
NM_000546.6(TP53):c.260C>T (p.Pro87Leu)	TP53	P87L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000942021	17	7579427	17	7676109	942021	938241	rs2073467677	NC_000017.11:7676108:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	87	TP53
NM_000546.6(TP53):c.259C>G (p.Pro87Ala)	TP53	P87A	Li-Fraumeni syndrome	VCV002861491	17	7579428	17	7676110	2861491	3018966	NA	NC_000017.11:7676109:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	87	TP53
NM_000546.6(TP53):c.259C>T (p.Pro87Ser)	TP53	P87S	Li-Fraumeni syndrome	VCV002831109	17	7579428	17	7676110	2831109	2990910	NA	NC_000017.11:7676109:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	87	TP53
NM_000546.6(TP53):c.257C>T (p.Ala86Val)	TP53	A86V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000654187	17	7579430	17	7676112	654187	646773	rs1597374264	NC_000017.11:7676111:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 25, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	86	TP53
NM_000546.6(TP53):c.256G>C (p.Ala86Pro)	TP53	A86P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001793227	17	7579431	17	7676113	1793227	1848740	NA	NC_000017.11:7676112:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 8, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	86	TP53
NM_000546.6(TP53):c.256G>A (p.Ala86Thr)	TP53	A86T	not provided|not specified|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000141967	17	7579431	17	7676113	141967	151681	rs587782148	NC_000017.11:7676112:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	86	TP53
NM_000546.6(TP53):c.254C>T (p.Pro85Leu)	TP53	P85L	Li-Fraumeni syndrome	VCV002811095	17	7579433	17	7676115	2811095	2975608	NA	NC_000017.11:7676114:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	85	TP53
NM_000546.6(TP53):c.253C>G (p.Pro85Ala)	TP53	P85A	Li-Fraumeni syndrome	VCV002831218	17	7579434	17	7676116	2831218	2991019	NA	NC_000017.11:7676115:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	85	TP53
NM_000546.6(TP53):c.253C>T (p.Pro85Ser)	TP53	P85S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000923486	17	7579434	17	7676116	923486	914200	rs2073468813	NC_000017.11:7676115:G:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	85	TP53
NM_000546.6(TP53):c.250_251delinsAA (p.Ala84Asn)	TP53	A84N	Li-Fraumeni syndrome	VCV002708097	17	7579436 - 7579437	17	7676118 - 7676119	2708097	2874262	NA	NC_000017.11:7676117:GC:TT	Indel	missense variant|non-coding transcript variant	Uncertain significance	Jan 7, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	84	TP53
NM_000546.6(TP53):c.251C>T (p.Ala84Val)	TP53	A84V	not provided|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV001792511	17	7579436	17	7676118	1792511	1842099	NA	NC_000017.11:7676117:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	84	TP53
NM_000546.6(TP53):c.250G>A (p.Ala84Thr)	TP53	A84T	Li-Fraumeni syndrome	VCV000140833	17	7579437	17	7676119	140833	150547	rs587781307	NC_000017.11:7676118:C:T	single nucleotide variant	missense variant	Likely benign	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	84	TP53
NM_000546.6(TP53):c.248C>A (p.Ala83Glu)	TP53	A83E	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000141956	17	7579439	17	7676121	141956	151670	rs201717599	NC_000017.11:7676120:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	83	TP53
NM_000546.6(TP53):c.248C>T (p.Ala83Val)	TP53	A83V	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1	VCV000127805	17	7579439	17	7676121	127805	133262	rs201717599	NC_000017.11:7676120:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	83	TP53
NM_000546.6(TP53):c.247G>A (p.Ala83Thr)	TP53	A83T	Li-Fraumeni syndrome	VCV002029805	17	7579440	17	7676122	2029805	2088997	NA	NC_000017.11:7676121:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	83	TP53
NM_000546.6(TP53):c.245C>G (p.Pro82Arg)	TP53	P82R	Li-Fraumeni syndrome	VCV000458530	17	7579442	17	7676124	458530	467552	rs534447939	NC_000017.11:7676123:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	82	TP53
NM_000546.6(TP53):c.245C>T (p.Pro82Leu)	TP53	P82L	Li-Fraumeni syndrome	VCV000182946	17	7579442	17	7676124	182946	181024	rs534447939	NC_000017.11:7676123:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	82	TP53
NM_000546.6(TP53):c.244C>T (p.Pro82Ser)	TP53	P82S	Li-Fraumeni syndrome	VCV001021579	17	7579443	17	7676125	1021579	1013165	rs1555526664	NC_000017.11:7676124:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	82	TP53
NM_000546.6(TP53):c.244C>G (p.Pro82Ala)	TP53	P82A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000482216	17	7579443	17	7676125	482216	480094	rs1555526664	NC_000017.11:7676124:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	82	TP53
NM_000546.6(TP53):c.242C>T (p.Thr81Ile)	TP53	T81I	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000583101	17	7579445	17	7676127	583101	571630	rs1567556386	NC_000017.11:7676126:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	81	TP53
NM_000546.6(TP53):c.239C>T (p.Pro80Leu)	TP53	P80L	Hereditary cancer-predisposing syndrome	VCV001790682	17	7579448	17	7676130	1790682	1841583	NA	NC_000017.11:7676129:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	80	TP53
NM_000546.6(TP53):c.238C>T (p.Pro80Ser)	TP53	P80S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000406593	17	7579449	17	7676131	406593	403155	rs1060501204	NC_000017.11:7676130:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	80	TP53
NM_000546.6(TP53):c.236C>G (p.Ala79Gly)	TP53	A79G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000655254	17	7579451	17	7676133	655254	646775	rs1597374438	NC_000017.11:7676132:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	79	TP53
NM_000546.6(TP53):c.233C>T (p.Ala78Val)	TP53	A78V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001401526	17	7579454	17	7676136	1401526	1457186	rs876658527	NC_000017.11:7676135:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 30, 2021	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	78	TP53
NM_000546.6(TP53):c.233C>G (p.Ala78Gly)	TP53	A78G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000230368	17	7579454	17	7676136	230368	236506	rs876658527	NC_000017.11:7676135:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	78	TP53
NM_000546.6(TP53):c.232G>T (p.Ala78Ser)	TP53	A78S	Li-Fraumeni syndrome	VCV000848797	17	7579455	17	7676137	848797	846293	rs1555526673	NC_000017.11:7676136:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	78	TP53
NM_000546.6(TP53):c.232G>A (p.Ala78Thr)	TP53	A78T	Hereditary cancer-predisposing syndrome	VCV000485045	17	7579455	17	7676137	485045	480096	rs1555526673	NC_000017.11:7676136:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	78	TP53
NM_000546.6(TP53):c.229C>G (p.Pro77Ala)	TP53	P77A	Li-Fraumeni syndrome	VCV001718262	17	7579458	17	7676140	1718262	1778622	NA	NC_000017.11:7676139:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	77	TP53
NM_000546.6(TP53):c.229C>T (p.Pro77Ser)	TP53	P77S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000528266	17	7579458	17	7676140	528266	531842	rs753085009	NC_000017.11:7676139:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	77	TP53
NM_000546.6(TP53):c.229C>A (p.Pro77Thr)	TP53	P77T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000458528	17	7579458	17	7676140	458528	467553	rs753085009	NC_000017.11:7676139:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	77	TP53
NM_000546.6(TP53):c.227C>T (p.Ala76Val)	TP53	A76V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001941172	17	7579460	17	7676142	1941172	2001333	NA	NC_000017.11:7676141:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	76	TP53
NM_000546.6(TP53):c.226G>A (p.Ala76Thr)	TP53	A76T	Hereditary cancer-predisposing syndrome	VCV001171287	17	7579461	17	7676143	1171287	1161410	rs2151041434	NC_000017.11:7676142:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	76	TP53
NM_000546.6(TP53):c.224C>T (p.Pro75Leu)	TP53	P75L	Li-Fraumeni syndrome	VCV000836766	17	7579463	17	7676145	836766	846294	rs2073472370	NC_000017.11:7676144:G:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	75	TP53
NM_000546.6(TP53):c.223C>A (p.Pro75Thr)	TP53	P75T	Li-Fraumeni syndrome	VCV002003705	17	7579464	17	7676146	2003705	2051762	NA	NC_000017.11:7676145:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	75	TP53
NM_000546.6(TP53):c.221C>G (p.Ala74Gly)	TP53	A74G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001787901	17	7579466	17	7676148	1787901	1847344	NA	NC_000017.11:7676147:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	74	TP53
NM_000546.6(TP53):c.221C>T (p.Ala74Val)	TP53	A74V	Li-Fraumeni syndrome	VCV000141547	17	7579466	17	7676148	141547	151261	rs587781832	NC_000017.11:7676147:G:A	single nucleotide variant	missense variant	Likely benign	Aug 11, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	74	TP53
NM_000546.6(TP53):c.220G>T (p.Ala74Ser)	TP53	A74S	Li-Fraumeni syndrome	VCV001361776	17	7579467	17	7676149	1361776	1476500	rs2151041540	NC_000017.11:7676148:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	74	TP53
NM_000546.6(TP53):c.218T>C (p.Val73Ala)	TP53	V73A	Li-Fraumeni syndrome	VCV002168377	17	7579469	17	7676151	2168377	1895925	NA	NC_000017.11:7676150:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	73	TP53
NM_000546.6(TP53):c.217G>A (p.Val73Met)	TP53	V73M	Li-Fraumeni syndrome	VCV000142386	17	7579470	17	7676152	142386	152100	rs587782423	NC_000017.11:7676151:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	73	TP53
NM_000546.6(TP53):c.215_216delinsGT (p.Pro72Arg)	TP53	P72R	not specified|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000237944	17	7579471 - 7579472	17	7676153 - 7676154	237944	242989	rs878854066	NC_000017.11:7676152:GG:AC	Indel	missense variant	Likely benign	Jan 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.214_215delinsAG (p.Pro72Ser)	TP53	P72S	Hereditary cancer-predisposing syndrome	VCV003328172	17	7579472 - 7579473	17	7676154 - 7676155	3328172	3486885	NA	NC_000017.11:7676153:GG:CT	Indel	missense variant|non-coding transcript variant	Uncertain significance	May 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.214_215inv (p.Pro72Gly)	TP53	P72G	Hereditary cancer-predisposing syndrome	VCV001786573	17	7579472 - 7579473	17	7676154 - 7676155	1786573	1843943	NA	NC_000017.11:7676153:GG:CC	Inversion	missense variant	Uncertain significance	Dec 2, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.215C>T (p.Pro72Leu)	TP53	P72L	Li-Fraumeni syndrome	VCV000864652	17	7579472	17	7676154	864652	846295	rs1042522	NC_000017.11:7676153:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.215C>A (p.Pro72His)	TP53	P72H	Li-Fraumeni syndrome 1	VCV000185120	17	7579472	17	7676154	185120	185405	rs1042522	NC_000017.11:7676153:G:T	single nucleotide variant	missense variant	Likely benign	Apr 19, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.214_215delinsTG (p.Pro72Cys)	TP53	P72C	Li-Fraumeni syndrome 1	VCV000182953	17	7579472 - 7579473	17	7676154 - 7676155	182953	181026	rs730882014	NC_000017.11:7676153:GG:CA	Indel	missense variant	Uncertain significance	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.215C>G (p.Pro72Arg)	TP53	P72R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome 1|Bone osteosarcoma|Bone marrow failure syndrome 5|Carcinoma of pancreas|Choroid plexus papilloma|Nasopharyngeal carcinoma|Familial cancer of breast|Colorectal cancer|Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided|Neoplasm	VCV000012351	17	7579472	17	7676154	12351	27390	rs1042522	NC_000017.11:7676153:G:C	single nucleotide variant	missense variant	Benign	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	Benign	Jul 31, 2024	criteria provided, single submitter	NA	72	TP53
NM_000546.6(TP53):c.214C>T (p.Pro72Ser)	TP53	P72S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000485023	17	7579473	17	7676155	485023	479355	rs587782769	NC_000017.11:7676154:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 3, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.214C>A (p.Pro72Thr)	TP53	P72T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000232750	17	7579473	17	7676155	232750	236507	rs587782769	NC_000017.11:7676154:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 21, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.214C>G (p.Pro72Ala)	TP53	P72A	Li-Fraumeni syndrome	VCV000142854	17	7579473	17	7676155	142854	152568	rs587782769	NC_000017.11:7676154:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	72	TP53
NM_000546.6(TP53):c.212C>G (p.Pro71Arg)	TP53	P71R	Li-Fraumeni syndrome	VCV000237943	17	7579475	17	7676157	237943	242990	rs878854065	NC_000017.11:7676156:G:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	71	TP53
NM_000546.6(TP53):c.211C>G (p.Pro71Ala)	TP53	P71A	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000577431	17	7579476	17	7676158	577431	572340	rs1567556576	NC_000017.11:7676157:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	71	TP53
NM_000546.6(TP53):c.211C>T (p.Pro71Ser)	TP53	P71S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000572378	17	7579476	17	7676158	572378	572337	rs1567556576	NC_000017.11:7676157:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	71	TP53
NM_000546.6(TP53):c.209C>T (p.Ala70Val)	TP53	A70V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000630031	17	7579478	17	7676160	630031	618842	rs1567556594	NC_000017.11:7676159:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	70	TP53
NM_000546.6(TP53):c.206C>T (p.Ala69Val)	TP53	A69V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000528260	17	7579481	17	7676163	528260	531847	rs756233241	NC_000017.11:7676162:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	69	TP53
NM_000546.6(TP53):c.206C>G (p.Ala69Gly)	TP53	A69G	Li-Fraumeni syndrome	VCV000230112	17	7579481	17	7676163	230112	236508	rs756233241	NC_000017.11:7676162:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	69	TP53
NM_000546.6(TP53):c.205G>C (p.Ala69Pro)	TP53	A69P	Hereditary cancer-predisposing syndrome	VCV000919370	17	7579482	17	7676164	919370	914202	rs1567556618	NC_000017.11:7676163:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	69	TP53
NM_000546.6(TP53):c.205G>A (p.Ala69Thr)	TP53	A69T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000575773	17	7579482	17	7676164	575773	571633	rs1567556618	NC_000017.11:7676163:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	69	TP53
NM_000546.6(TP53):c.202G>C (p.Glu68Gln)	TP53	E68Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000490170	17	7579485	17	7676167	490170	483061	rs869312782	NC_000017.11:7676166:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	68	TP53
NM_000546.6(TP53):c.200C>A (p.Pro67Gln)	TP53	P67Q	Li-Fraumeni syndrome	VCV000528264	17	7579487	17	7676169	528264	531953	rs1555526709	NC_000017.11:7676168:G:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	TP53
NM_000546.6(TP53):c.199C>G (p.Pro67Ala)	TP53	P67A	Li-Fraumeni syndrome	VCV003074199	17	7579488	17	7676170	3074199	3231335	NA	NC_000017.11:7676169:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	TP53
NM_000546.6(TP53):c.199C>T (p.Pro67Ser)	TP53	P67S	Li-Fraumeni syndrome	VCV000835228	17	7579488	17	7676170	835228	846296	rs2073476832	NC_000017.11:7676169:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	67	TP53
NM_000546.6(TP53):c.198G>A (p.Met66Ile)	TP53	M66I	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480745	17	7579489	17	7676171	480745	480111	rs1555526711	NC_000017.11:7676170:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 30, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	66	TP53
NM_000546.6(TP53):c.197T>G (p.Met66Arg)	TP53	M66R	Li-Fraumeni syndrome	VCV001714129	17	7579490	17	7676172	1714129	1773400	NA	NC_000017.11:7676171:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	66	TP53
NM_000546.6(TP53):c.197T>C (p.Met66Thr)	TP53	M66T	not provided	VCV001316731	17	7579490	17	7676172	1316731	1307825	rs2151042010	NC_000017.11:7676171:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	66	TP53
NM_000546.6(TP53):c.196A>G (p.Met66Val)	TP53	M66V	Hereditary cancer-predisposing syndrome	VCV001783578	17	7579491	17	7676173	1783578	1839674	NA	NC_000017.11:7676172:T:C	single nucleotide variant	missense variant	Likely benign	Oct 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	66	TP53
NM_000546.6(TP53):c.194G>C (p.Arg65Thr)	TP53	R65T	Li-Fraumeni syndrome	VCV000406607	17	7579493	17	7676175	406607	403043	rs1060501210	NC_000017.11:7676174:C:G	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	65	TP53
NM_000546.6(TP53):c.193A>G (p.Arg65Gly)	TP53	R65G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000820372	17	7579494	17	7676176	820372	814514	rs1555526721	NC_000017.11:7676175:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 11, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	65	TP53
NM_000546.6(TP53):c.190C>T (p.Pro64Ser)	TP53	P64S	Hereditary cancer-predisposing syndrome	VCV002774654	17	7579497	17	7676179	2774654	2935381	NA	NC_000017.11:7676178:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	64	TP53
NM_000546.6(TP53):c.188C>G (p.Ala63Gly)	TP53	A63G	Li-Fraumeni syndrome 1	VCV000229693	17	7579499	17	7676181	229693	236509	rs372201428	NC_000017.11:7676180:G:C	single nucleotide variant	missense variant	Likely benign	Aug 5, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	63	TP53
NM_000546.6(TP53):c.188C>T (p.Ala63Val)	TP53	A63V	Li-Fraumeni syndrome 1	VCV000182922	17	7579499	17	7676181	182922	181027	rs372201428	NC_000017.11:7676180:G:A	single nucleotide variant	missense variant	Likely benign	Apr 12, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	63	TP53
NM_000546.6(TP53):c.187G>A (p.Ala63Thr)	TP53	A63T	Hereditary cancer-predisposing syndrome	VCV000231015	17	7579500	17	7676182	231015	236510	rs876658902	NC_000017.11:7676181:C:T	single nucleotide variant	missense variant	Likely benign	Mar 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	63	TP53
NM_000546.6(TP53):c.185A>C (p.Glu62Ala)	TP53	E62A	Li-Fraumeni syndrome	VCV001388326	17	7579502	17	7676184	1388326	1371067	rs2151042192	NC_000017.11:7676183:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	62	TP53
NM_000546.6(TP53):c.184G>A (p.Glu62Lys)	TP53	E62K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000859320	17	7579503	17	7676185	859320	846297	rs1567556752	NC_000017.11:7676184:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 28, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	62	TP53
NM_000546.6(TP53):c.183T>A (p.Asp61Glu)	TP53	D61E	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000820144	17	7579504	17	7676186	820144	814515	rs1597374797	NC_000017.11:7676185:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 8, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	61	TP53
NM_000546.6(TP53):c.182A>T (p.Asp61Val)	TP53	D61V	Li-Fraumeni syndrome	VCV001347666	17	7579505	17	7676187	1347666	1391583	rs1460793472	NC_000017.11:7676186:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	61	TP53
NM_000546.6(TP53):c.182A>G (p.Asp61Gly)	TP53	D61G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000950660	17	7579505	17	7676187	950660	928560	rs1460793472	NC_000017.11:7676186:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	61	TP53
NM_000546.6(TP53):c.181G>T (p.Asp61Tyr)	TP53	D61Y	Li-Fraumeni syndrome	VCV001366182	17	7579506	17	7676188	1366182	1411524	rs2151042257	NC_000017.11:7676187:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	61	TP53
NM_000546.6(TP53):c.179C>T (p.Pro60Leu)	TP53	P60L	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000820098	17	7579508	17	7676190	820098	814516	rs1597374820	NC_000017.11:7676189:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 8, 2019	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	60	TP53
NM_000546.6(TP53):c.176G>C (p.Gly59Ala)	TP53	G59A	Li-Fraumeni syndrome	VCV002747093	17	7579511	17	7676193	2747093	2907853	NA	NC_000017.11:7676192:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	59	TP53
NM_000546.6(TP53):c.176G>A (p.Gly59Asp)	TP53	G59D	Hereditary cancer-predisposing syndrome	VCV000820048	17	7579511	17	7676193	820048	814517	rs1597374828	NC_000017.11:7676192:C:T	single nucleotide variant	missense variant	Likely benign	Jan 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	59	TP53
NM_000546.6(TP53):c.175G>T (p.Gly59Cys)	TP53	G59C	Li-Fraumeni syndrome	VCV002812726	17	7579512	17	7676194	2812726	2975958	NA	NC_000017.11:7676193:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	59	TP53
NM_000546.6(TP53):c.175G>A (p.Gly59Ser)	TP53	G59S	Hereditary cancer-predisposing syndrome	VCV001779558	17	7579512	17	7676194	1779558	1838211	NA	NC_000017.11:7676193:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	59	TP53
NM_000546.6(TP53):c.175G>C (p.Gly59Arg)	TP53	G59R	Li-Fraumeni syndrome	VCV001491657	17	7579512	17	7676194	1491657	1342694	rs1237722021	NC_000017.11:7676193:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	59	TP53
NM_000546.6(TP53):c.173C>G (p.Pro58Arg)	TP53	P58R	Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000127804	17	7579514	17	7676196	127804	133261	rs144386518	NC_000017.11:7676195:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	58	TP53
NM_000546.6(TP53):c.172C>G (p.Pro58Ala)	TP53	P58A	Hereditary cancer-predisposing syndrome	VCV001778944	17	7579515	17	7676197	1778944	1831528	NA	NC_000017.11:7676196:G:C	single nucleotide variant	missense variant	Likely benign	Feb 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	58	TP53
NM_000546.6(TP53):c.172C>A (p.Pro58Thr)	TP53	P58T	Li-Fraumeni syndrome	VCV000947099	17	7579515	17	7676197	947099	928561	rs2073479616	NC_000017.11:7676196:G:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	58	TP53
NM_000546.6(TP53):c.171C>A (p.Asp57Glu)	TP53	D57E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000142863	17	7579516	17	7676198	142863	152577	rs587782776	NC_000017.11:7676197:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	57	TP53
NM_000546.6(TP53):c.170A>G (p.Asp57Gly)	TP53	D57G	Li-Fraumeni syndrome	VCV002695282	17	7579517	17	7676199	2695282	2854142	NA	NC_000017.11:7676198:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	57	TP53
NM_000546.6(TP53):c.170A>T (p.Asp57Val)	TP53	D57V	Hereditary cancer-predisposing syndrome	VCV001778520	17	7579517	17	7676199	1778520	1834492	NA	NC_000017.11:7676198:T:A	single nucleotide variant	missense variant	Likely benign	Nov 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	57	TP53
NM_000546.6(TP53):c.170A>C (p.Asp57Ala)	TP53	D57A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001425412	17	7579517	17	7676199	1425412	1431651	rs1442824382	NC_000017.11:7676198:T:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	57	TP53
NM_000546.6(TP53):c.166G>A (p.Glu56Lys)	TP53	E56K	Hereditary cancer-predisposing syndrome	VCV003232051	17	7579521	17	7676203	3232051	3385591	NA	NC_000017.11:7676202:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	56	TP53
NM_000546.6(TP53):c.164C>G (p.Thr55Ser)	TP53	T55S	Li-Fraumeni syndrome	VCV002130489	17	7579523	17	7676205	2130489	2187617	NA	NC_000017.11:7676204:G:C	single nucleotide variant	missense variant	Uncertain significance	May 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	55	TP53
NM_000546.6(TP53):c.163A>C (p.Thr55Pro)	TP53	T55P	Li-Fraumeni syndrome	VCV002705758	17	7579524	17	7676206	2705758	2856895	NA	NC_000017.11:7676205:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	55	TP53
NM_000546.6(TP53):c.160T>C (p.Phe54Leu)	TP53	F54L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000481098	17	7579527	17	7676209	481098	479290	rs1555526742	NC_000017.11:7676208:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 16, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	54	TP53
NM_000546.6(TP53):c.158G>T (p.Trp53Leu)	TP53	W53L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001775891	17	7579529	17	7676211	1775891	1827691	NA	NC_000017.11:7676210:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	53	TP53
NM_000546.6(TP53):c.157T>C (p.Trp53Arg)	TP53	W53R	Hereditary cancer-predisposing syndrome	VCV001775671	17	7579530	17	7676212	1775671	1827471	NA	NC_000017.11:7676211:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	53	TP53
NM_000546.6(TP53):c.157T>A (p.Trp53Arg)	TP53	W53R	Li-Fraumeni syndrome	VCV001473030	17	7579530	17	7676212	1473030	1501275	rs2151042721	NC_000017.11:7676211:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	53	TP53
NM_000546.6(TP53):c.155A>G (p.Gln52Arg)	TP53	Q52R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000237942	17	7579532	17	7676214	237942	242991	rs774656101	NC_000017.11:7676213:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	52	TP53
NM_000546.6(TP53):c.152A>G (p.Glu51Gly)	TP53	E51G	Li-Fraumeni syndrome	VCV000577888	17	7579535	17	7676217	577888	572341	rs1567556923	NC_000017.11:7676216:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	51	TP53
NM_000546.6(TP53):c.151G>A (p.Glu51Lys)	TP53	E51K	Li-Fraumeni syndrome	VCV000850781	17	7579536	17	7676218	850781	846299	rs1567556930	NC_000017.11:7676217:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	51	TP53
NM_000546.6(TP53):c.149T>C (p.Ile50Thr)	TP53	I50T	Li-Fraumeni syndrome 1	VCV000216464	17	7579538	17	7676220	216464	213405	rs370502517	NC_000017.11:7676219:A:G	single nucleotide variant	missense variant	Likely benign	Apr 2, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	50	TP53
NM_000546.6(TP53):c.149T>A (p.Ile50Asn)	TP53	I50N	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000187302	17	7579538	17	7676220	187302	185410	rs370502517	NC_000017.11:7676219:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	50	TP53
NM_000546.6(TP53):c.148A>C (p.Ile50Leu)	TP53	I50L	Li-Fraumeni syndrome	VCV002877402	17	7579539	17	7676221	2877402	3041611	NA	NC_000017.11:7676220:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	50	TP53
NM_000546.6(TP53):c.147T>G (p.Asp49Glu)	TP53	D49E	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001506044	17	7579540	17	7676222	1506044	1339774	rs786201148	NC_000017.11:7676221:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	49	TP53
NM_000546.6(TP53):c.147T>A (p.Asp49Glu)	TP53	D49E	Li-Fraumeni syndrome	VCV001361888	17	7579540	17	7676222	1361888	1376514	rs786201148	NC_000017.11:7676221:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	49	TP53
NM_000546.6(TP53):c.146A>G (p.Asp49Gly)	TP53	D49G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000231133	17	7579541	17	7676223	231133	236512	rs759728549	NC_000017.11:7676222:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	49	TP53
NM_000546.6(TP53):c.145G>A (p.Asp49Asn)	TP53	D49N	Li-Fraumeni syndrome	VCV000186363	17	7579542	17	7676224	186363	185412	rs587780728	NC_000017.11:7676223:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	49	TP53
NM_000546.6(TP53):c.145G>C (p.Asp49His)	TP53	D49H	Li-Fraumeni syndrome 1	VCV000135948	17	7579542	17	7676224	135948	139660	rs587780728	NC_000017.11:7676223:C:G	single nucleotide variant	missense variant	Likely benign	Jan 10, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	49	TP53
NM_000546.6(TP53):c.144C>A (p.Asp48Glu)	TP53	D48E	Li-Fraumeni syndrome	VCV000141056	17	7579543	17	7676225	141056	150770	rs587781460	NC_000017.11:7676224:G:T	single nucleotide variant	missense variant	Likely benign	Sep 4, 2020	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	48	TP53
NM_000546.6(TP53):c.143A>G (p.Asp48Gly)	TP53	D48G	Li-Fraumeni syndrome	VCV002795844	17	7579544	17	7676226	2795844	2958263	NA	NC_000017.11:7676225:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 3, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	48	TP53
NM_000546.6(TP53):c.140C>G (p.Pro47Arg)	TP53	P47R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000819145	17	7579547	17	7676229	819145	814518	rs1597375038	NC_000017.11:7676228:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 28, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	47	TP53
NM_000546.6(TP53):c.139C>G (p.Pro47Ala)	TP53	P47A	Li-Fraumeni syndrome	VCV001721838	17	7579548	17	7676230	1721838	1779556	NA	NC_000017.11:7676229:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	47	TP53
NM_000546.6(TP53):c.139C>A (p.Pro47Thr)	TP53	P47T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000406608	17	7579548	17	7676230	406608	403046	rs1800371	NC_000017.11:7676229:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	47	TP53
NM_000546.6(TP53):c.139C>T (p.Pro47Ser)	TP53	P47S	Li-Fraumeni syndrome	VCV000043588	17	7579548	17	7676230	43588	52757	rs1800371	NC_000017.11:7676229:G:A	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	47	TP53
NM_000546.6(TP53):c.137C>A (p.Ser46Tyr)	TP53	S46Y	Li-Fraumeni syndrome	VCV000659626	17	7579550	17	7676232	659626	646777	rs1597375058	NC_000017.11:7676231:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	46	TP53
NM_000546.6(TP53):c.136T>C (p.Ser46Pro)	TP53	S46P	Hereditary cancer-predisposing syndrome	VCV000232223	17	7579551	17	7676233	232223	236514	rs876659630	NC_000017.11:7676232:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	46	TP53
NM_000546.6(TP53):c.134T>C (p.Leu45Pro)	TP53	L45P	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000246049	17	7579553	17	7676235	246049	245079	rs879254066	NC_000017.11:7676234:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	45	TP53
NM_000546.6(TP53):c.133C>G (p.Leu45Val)	TP53	L45V	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000659842	17	7579554	17	7676236	659842	646778	rs1597375092	NC_000017.11:7676235:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 31, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	45	TP53
NM_000546.6(TP53):c.132G>A (p.Met44Ile)	TP53	M44I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000406565	17	7579555	17	7676237	406565	402571	rs1060501190	NC_000017.11:7676236:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	44	TP53
NM_000546.6(TP53):c.131T>C (p.Met44Thr)	TP53	M44T	Hereditary cancer-predisposing syndrome	VCV001769879	17	7579556	17	7676238	1769879	1832364	NA	NC_000017.11:7676237:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	44	TP53
NM_000546.6(TP53):c.131T>A (p.Met44Lys)	TP53	M44K	Hereditary cancer-predisposing syndrome	VCV001769875	17	7579556	17	7676238	1769875	1832360	NA	NC_000017.11:7676237:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	44	TP53
NM_000546.6(TP53):c.131T>G (p.Met44Arg)	TP53	M44R	Hereditary cancer-predisposing syndrome	VCV000928344	17	7579556	17	7676238	928344	914204	rs2073484962	NC_000017.11:7676237:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	44	TP53
NM_000546.6(TP53):c.130A>C (p.Met44Leu)	TP53	M44L	Li-Fraumeni syndrome	VCV002087249	17	7579557	17	7676239	2087249	2137310	NA	NC_000017.11:7676238:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	44	TP53
NM_000546.6(TP53):c.129G>C (p.Leu43Phe)	TP53	L43F	Hereditary cancer-predisposing syndrome	VCV001692471	17	7579558	17	7676240	1692471	1684911	rs754332870	NC_000017.11:7676239:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	43	TP53
NM_000546.6(TP53):c.129G>T (p.Leu43Phe)	TP53	L43F	Li-Fraumeni syndrome	VCV000864154	17	7579558	17	7676240	864154	846300	rs754332870	NC_000017.11:7676239:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	TP53
NM_000546.6(TP53):c.127T>G (p.Leu43Val)	TP53	L43V	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV002774655	17	7579560	17	7676242	2774655	2935382	NA	NC_000017.11:7676241:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	43	TP53
NM_000546.6(TP53):c.127T>A (p.Leu43Met)	TP53	L43M	Li-Fraumeni syndrome	VCV000663719	17	7579560	17	7676242	663719	646779	rs1597375116	NC_000017.11:7676241:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	TP53
NM_000546.6(TP53):c.125A>G (p.Asp42Gly)	TP53	D42G	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000141464	17	7579562	17	7676244	141464	151178	rs587781767	NC_000017.11:7676243:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	42	TP53
NM_000546.6(TP53):c.124G>A (p.Asp42Asn)	TP53	D42N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001471049	17	7579563	17	7676245	1471049	1395276	rs756847009	NC_000017.11:7676244:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	42	TP53
NM_000546.6(TP53):c.122A>G (p.Asp41Gly)	TP53	D41G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000863522	17	7579565	17	7676247	863522	846301	rs2073486528	NC_000017.11:7676246:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	41	TP53
NM_000546.6(TP53):c.121G>A (p.Asp41Asn)	TP53	D41N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000485040	17	7579566	17	7676248	485040	479378	rs1555526789	NC_000017.11:7676247:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	41	TP53
NM_000546.6(TP53):c.119T>C (p.Met40Thr)	TP53	M40T	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000142995	17	7579568	17	7676250	142995	152709	rs587782877	NC_000017.11:7676249:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	40	TP53
NM_000546.6(TP53):c.118A>G (p.Met40Val)	TP53	M40V	not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000643576	17	7579569	17	7676251	643576	646780	rs1597375159	NC_000017.11:7676250:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Conflicting classifications of pathogenicity	May 4, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	40	TP53
NM_000546.6(TP53):c.116C>T (p.Ala39Val)	TP53	A39V	Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000569629	17	7579571	17	7676253	569629	571669	rs1353016807	NC_000017.11:7676252:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	39	TP53
NM_000546.6(TP53):c.115G>T (p.Ala39Ser)	TP53	A39S	Li-Fraumeni syndrome	VCV002024235	17	7579572	17	7676254	2024235	2077012	NA	NC_000017.11:7676253:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	39	TP53
NM_000546.6(TP53):c.115G>A (p.Ala39Thr)	TP53	A39T	Li-Fraumeni syndrome	VCV001035024	17	7579572	17	7676254	1035024	1033678	rs2073487457	NC_000017.11:7676253:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 28, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	39	TP53
NM_000546.6(TP53):c.113A>G (p.Gln38Arg)	TP53	Q38R	Li-Fraumeni syndrome	VCV001717844	17	7579574	17	7676256	1717844	1771820	NA	NC_000017.11:7676255:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	38	TP53
NM_000546.6(TP53):c.113A>C (p.Gln38Pro)	TP53	Q38P	Li-Fraumeni syndrome	VCV000940878	17	7579574	17	7676256	940878	938243	rs2073487567	NC_000017.11:7676255:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 6, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	38	TP53
NM_000546.6(TP53):c.110C>G (p.Ser37Cys)	TP53	S37C	Hereditary cancer-predisposing syndrome	VCV001794698	17	7579577	17	7676259	1794698	1852443	NA	NC_000017.11:7676258:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 11, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	37	TP53
NM_000546.6(TP53):c.110C>T (p.Ser37Phe)	TP53	S37F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000567972	17	7579577	17	7676259	567972	569791	rs1567557177	NC_000017.11:7676258:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	37	TP53
NM_000546.6(TP53):c.107C>T (p.Pro36Leu)	TP53	P36L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000818331	17	7579580	17	7676262	818331	814519	rs587781866	NC_000017.11:7676261:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	36	TP53
NM_000546.6(TP53):c.107C>A (p.Pro36Gln)	TP53	P36Q	Li-Fraumeni syndrome	VCV000141597	17	7579580	17	7676262	141597	151311	rs587781866	NC_000017.11:7676261:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	36	TP53
NM_000546.6(TP53):c.106C>T (p.Pro36Ser)	TP53	P36S	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000182921	17	7579581	17	7676263	182921	181028	rs730881993	NC_000017.11:7676262:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	36	TP53
NM_000546.6(TP53):c.105G>C (p.Leu35Phe)	TP53	L35F	Li-Fraumeni syndrome	VCV000142562	17	7579582	17	7676264	142562	152276	rs121912661	NC_000017.11:7676263:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	35	TP53
NM_000546.6(TP53):c.105G>T (p.Leu35Phe)	TP53	L35F	Li-Fraumeni syndrome	VCV000012371	17	7579582	17	7676264	12371	27410	rs121912661	NC_000017.11:7676263:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 6, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	35	TP53
NM_000546.6(TP53):c.103T>A (p.Leu35Met)	TP53	L35M	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000406609	17	7579584	17	7676266	406609	402574	rs1060501211	NC_000017.11:7676265:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 14, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	35	TP53
NM_000546.6(TP53):c.101C>T (p.Pro34Leu)	TP53	P34L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000818276	17	7579586	17	7676268	818276	814521	rs1322947350	NC_000017.11:7676267:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 15, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	34	TP53
NM_000546.6(TP53):c.101C>G (p.Pro34Arg)	TP53	P34R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000628478	17	7579586	17	7676268	628478	618843	rs1322947350	NC_000017.11:7676267:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	34	TP53
NM_000546.6(TP53):c.100C>T (p.Pro34Ser)	TP53	P34S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000935999	17	7579587	17	7676269	935999	938244	rs786201968	NC_000017.11:7676268:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	34	TP53
NM_000546.6(TP53):c.100C>G (p.Pro34Ala)	TP53	P34A	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000186313	17	7579587	17	7676269	186313	185416	rs786201968	NC_000017.11:7676268:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	34	TP53
NM_000546.6(TP53):c.100C>A (p.Pro34Thr)	TP53	P34T	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000185157	17	7579587	17	7676269	185157	185417	rs786201968	NC_000017.11:7676268:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	34	TP53
NM_000546.6(TP53):c.98C>T (p.Ser33Phe)	TP53	S33F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000649861	17	7579589	17	7676271	649861	646781	rs1555526832	NC_000017.11:7676270:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	33	TP53
NM_000546.6(TP53):c.98C>A (p.Ser33Tyr)	TP53	S33Y	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000482211	17	7579589	17	7676271	482211	479368	rs1555526832	NC_000017.11:7676270:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	33	TP53
NM_000546.6(TP53):c.97T>A (p.Ser33Thr)	TP53	S33T	Li-Fraumeni syndrome	VCV001043464	17	7579590	17	7676272	1043464	1033679	rs2073489444	NC_000017.11:7676271:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 14, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	33	TP53
NM_000546.6(TP53):c.94C>G (p.Leu32Val)	TP53	L32V	Hereditary cancer-predisposing syndrome	VCV001767161	17	7579702	17	7676384	1767161	1821503	NA	NC_000017.11:7676383:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Oct 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	32	TP53
NM_000546.6(TP53):c.91G>T (p.Val31Phe)	TP53	V31F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000233852	17	7579705	17	7676387	233852	236515	rs201753350	NC_000017.11:7676386:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	31	TP53
NM_000546.6(TP53):c.91G>A (p.Val31Ile)	TP53	V31I	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000127827	17	7579705	17	7676387	127827	133284	rs201753350	NC_000017.11:7676386:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 1, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	31	TP53
NM_000546.6(TP53):c.89A>T (p.Asn30Ile)	TP53	N30I	Li-Fraumeni syndrome	VCV001515391	17	7579707	17	7676389	1515391	1505256	rs2151045549	NC_000017.11:7676388:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	30	TP53
NM_000546.6(TP53):c.87C>G (p.Asn29Lys)	TP53	N29K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000638927	17	7579709	17	7676391	638927	646783	rs1011445550	NC_000017.11:7676390:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	29	TP53
NM_000546.6(TP53):c.86A>C (p.Asn29Thr)	TP53	N29T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000842527	17	7579710	17	7676392	842527	846302	rs2073506642	NC_000017.11:7676391:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	29	TP53
NM_000546.6(TP53):c.85A>G (p.Asn29Asp)	TP53	N29D	Hereditary cancer-predisposing syndrome	VCV000822586	17	7579711	17	7676393	822586	814522	rs1597375899	NC_000017.11:7676392:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Nov 25, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	29	TP53
NM_000546.6(TP53):c.83A>T (p.Glu28Val)	TP53	E28V	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome	VCV000185581	17	7579713	17	7676395	185581	185419	rs786202289	NC_000017.11:7676394:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 29, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	28	TP53
NM_000546.6(TP53):c.80C>G (p.Pro27Arg)	TP53	P27R	Li-Fraumeni syndrome	VCV000664352	17	7579716	17	7676398	664352	646784	rs1555526933	NC_000017.11:7676397:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	27	TP53
NM_000546.6(TP53):c.80C>T (p.Pro27Leu)	TP53	P27L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000481176	17	7579716	17	7676398	481176	480117	rs1555526933	NC_000017.11:7676397:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	27	TP53
NM_000546.6(TP53):c.79C>G (p.Pro27Ala)	TP53	P27A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001505620	17	7579717	17	7676399	1505620	1437187	rs922736614	NC_000017.11:7676398:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	27	TP53
NM_000546.6(TP53):c.79C>T (p.Pro27Ser)	TP53	P27S	not specified|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000528271	17	7579717	17	7676399	528271	532225	rs922736614	NC_000017.11:7676398:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 10, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	27	TP53
NM_000546.6(TP53):c.79C>A (p.Pro27Thr)	TP53	P27T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome	VCV000406600	17	7579717	17	7676399	406600	402604	rs922736614	NC_000017.11:7676398:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 2, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	27	TP53
NM_000546.6(TP53):c.76C>A (p.Leu26Ile)	TP53	L26I	Hereditary cancer-predisposing syndrome	VCV000923838	17	7579720	17	7676402	923838	914205	rs2073507946	NC_000017.11:7676401:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 5, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	26	TP53
NM_000546.6(TP53):c.74T>G (p.Leu25Arg)	TP53	L25R	Hereditary cancer-predisposing syndrome	VCV001759212	17	7579839	17	7676521	1759212	1816119	NA	NC_000017.11:7676520:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	25	TP53
NM_000546.6(TP53):c.63C>G (p.Asp21Glu)	TP53	D21E	Li-Fraumeni syndrome	VCV002694309	17	7579850	17	7676532	2694309	2860448	NA	NC_000017.11:7676531:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	21	TP53
NM_000546.6(TP53):c.59C>T (p.Ser20Leu)	TP53	S20L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000826109	17	7579854	17	7676536	826109	814523	rs1597376439	NC_000017.11:7676535:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	20	TP53
NM_000546.6(TP53):c.58T>C (p.Ser20Pro)	TP53	S20P	Hereditary cancer-predisposing syndrome	VCV000232673	17	7579855	17	7676537	232673	236516	rs876659913	NC_000017.11:7676536:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	20	TP53
NM_000546.6(TP53):c.52A>T (p.Thr18Ser)	TP53	T18S	Li-Fraumeni syndrome	VCV001415322	17	7579861	17	7676543	1415322	1374830	rs2151047486	NC_000017.11:7676542:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	18	TP53
NM_000546.6(TP53):c.48G>C (p.Gln16His)	TP53	Q16H	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1	VCV000642623	17	7579865	17	7676547	642623	646785	rs1597376489	NC_000017.11:7676546:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	16	TP53
NM_000546.6(TP53):c.47A>G (p.Gln16Arg)	TP53	Q16R	Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000835067	17	7579866	17	7676548	835067	846303	rs2073520057	NC_000017.11:7676547:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	16	TP53
NM_000546.6(TP53):c.46C>A (p.Gln16Lys)	TP53	Q16K	Li-Fraumeni syndrome 1	VCV001172924	17	7579867	17	7676549	1172924	1162107	rs2151047550	NC_000017.11:7676548:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 16, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	16	TP53
NM_000546.6(TP53):c.43A>C (p.Ser15Arg)	TP53	S15R	Li-Fraumeni syndrome	VCV001016947	17	7579870	17	7676552	1016947	1013167	rs2073520545	NC_000017.11:7676551:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 19, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	15	TP53
NM_000546.6(TP53):c.41T>A (p.Leu14Gln)	TP53	L14Q	Li-Fraumeni syndrome	VCV002026528	17	7579872	17	7676554	2026528	2088284	NA	NC_000017.11:7676553:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 24, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	14	TP53
NM_000546.6(TP53):c.40C>G (p.Leu14Val)	TP53	L14V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000577290	17	7579873	17	7676555	577290	574641	rs1567558112	NC_000017.11:7676554:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	14	TP53
NM_000546.6(TP53):c.38C>G (p.Pro13Arg)	TP53	P13R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000485028	17	7579875	17	7676557	485028	480121	rs878854070	NC_000017.11:7676556:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	13	TP53
NM_000546.6(TP53):c.38C>T (p.Pro13Leu)	TP53	P13L	Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000237949	17	7579875	17	7676557	237949	242993	rs878854070	NC_000017.11:7676556:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	13	TP53
NM_000546.6(TP53):c.37C>G (p.Pro13Ala)	TP53	P13A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV001735038	17	7579876	17	7676558	1735038	1793377	NA	NC_000017.11:7676557:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 3, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	13	TP53
NM_000546.6(TP53):c.37C>T (p.Pro13Ser)	TP53	P13S	Li-Fraumeni syndrome 1	VCV000406604	17	7579876	17	7676558	406604	403166	rs1060501208	NC_000017.11:7676557:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 27, 2022	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	13	TP53
NM_000546.6(TP53):c.35C>G (p.Pro12Arg)	TP53	P12R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000663876	17	7579878	17	7676560	663876	646786	rs1482497533	NC_000017.11:7676559:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	12	TP53
NM_000546.6(TP53):c.35C>A (p.Pro12His)	TP53	P12H	Li-Fraumeni syndrome	VCV000578235	17	7579878	17	7676560	578235	569792	rs1482497533	NC_000017.11:7676559:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 13, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	12	TP53
NM_000546.6(TP53):c.35C>T (p.Pro12Leu)	TP53	P12L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000528258	17	7579878	17	7676560	528258	532229	rs1482497533	NC_000017.11:7676559:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 11, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	12	TP53
NM_000546.6(TP53):c.31G>A (p.Glu11Lys)	TP53	E11K	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome	VCV000418693	17	7579882	17	7676564	418693	410285	rs201382018	NC_000017.11:7676563:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	11	TP53
NM_000546.6(TP53):c.31G>C (p.Glu11Gln)	TP53	E11Q	Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000041723	17	7579882	17	7676564	41723	50162	rs201382018	NC_000017.11:7676563:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	11	TP53
NM_000546.6(TP53):c.29T>A (p.Val10Asp)	TP53	V10D	Li-Fraumeni syndrome	VCV002813114	17	7579884	17	7676566	2813114	2972916	NA	NC_000017.11:7676565:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	10	TP53
NM_000546.6(TP53):c.29T>G (p.Val10Gly)	TP53	V10G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000822501	17	7579884	17	7676566	822501	814525	rs1418778734	NC_000017.11:7676565:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	10	TP53
NM_000546.6(TP53):c.28G>T (p.Val10Phe)	TP53	V10F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000968647	17	7579885	17	7676567	968647	958333	rs535274413	NC_000017.11:7676566:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 12, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	10	TP53
NM_000546.6(TP53):c.28G>C (p.Val10Leu)	TP53	V10L	Li-Fraumeni syndrome 1	VCV000231387	17	7579885	17	7676567	231387	236519	rs535274413	NC_000017.11:7676566:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 2, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	10	TP53
NM_000546.6(TP53):c.28G>A (p.Val10Ile)	TP53	V10I	Li-Fraumeni syndrome	VCV000127806	17	7579885	17	7676567	127806	133263	rs535274413	NC_000017.11:7676566:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	10	TP53
NM_000546.6(TP53):c.27C>A (p.Ser9Arg)	TP53	S9R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000821828	17	7579886	17	7676568	821828	814526	rs757282628	NC_000017.11:7676567:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	9	TP53
NM_000546.6(TP53):c.27C>G (p.Ser9Arg)	TP53	S9R	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000496047	17	7579886	17	7676568	496047	487911	rs757282628	NC_000017.11:7676567:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 18, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	9	TP53
NM_000546.6(TP53):c.26G>A (p.Ser9Asn)	TP53	S9N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000458531	17	7579887	17	7676569	458531	468887	rs1555527015	NC_000017.11:7676568:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	9	TP53
NM_000546.6(TP53):c.25A>G (p.Ser9Gly)	TP53	S9G	Li-Fraumeni syndrome	VCV002108374	17	7579888	17	7676570	2108374	2159788	NA	NC_000017.11:7676569:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	9	TP53
NM_000546.6(TP53):c.25A>C (p.Ser9Arg)	TP53	S9R	Li-Fraumeni syndrome	VCV000528238	17	7579888	17	7676570	528238	532231	rs1555527017	NC_000017.11:7676569:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 30, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	9	TP53
NM_000546.6(TP53):c.23C>G (p.Pro8Arg)	TP53	P8R	Hereditary cancer-predisposing syndrome	VCV001790705	17	7579890	17	7676572	1790705	1841606	NA	NC_000017.11:7676571:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Feb 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	8	TP53
NM_000546.6(TP53):c.23C>T (p.Pro8Leu)	TP53	P8L	Hereditary cancer-predisposing syndrome	VCV000231868	17	7579890	17	7676572	231868	236520	rs876659415	NC_000017.11:7676571:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Likely benign	May 15, 2015	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	8	TP53
NM_000546.6(TP53):c.22C>A (p.Pro8Thr)	TP53	P8T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000664710	17	7579891	17	7676573	664710	646787	rs1597376589	NC_000017.11:7676572:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 1, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	8	TP53
NM_000546.6(TP53):c.21T>G (p.Asp7Glu)	TP53	D7E	Hereditary cancer-predisposing syndrome	VCV000485049	17	7579892	17	7676574	485049	479373	rs587781277	NC_000017.11:7676573:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 14, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	7	TP53
NM_000546.6(TP53):c.21T>A (p.Asp7Glu)	TP53	D7E	Li-Fraumeni syndrome	VCV000140782	17	7579892	17	7676574	140782	150496	rs587781277	NC_000017.11:7676573:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 5, 2024	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	7	TP53
NM_000546.6(TP53):c.19G>A (p.Asp7Asn)	TP53	D7N	Hereditary cancer-predisposing syndrome	VCV001784158	17	7579894	17	7676576	1784158	1849717	NA	NC_000017.11:7676575:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	7	TP53
NM_000546.6(TP53):c.19G>C (p.Asp7His)	TP53	D7H	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000142689	17	7579894	17	7676576	142689	152403	rs587782646	NC_000017.11:7676575:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	7	TP53
NM_000546.6(TP53):c.14A>G (p.Gln5Arg)	TP53	Q5R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV000233248	17	7579899	17	7676581	233248	236521	rs781595324	NC_000017.11:7676580:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	5	TP53
NM_000546.6(TP53):c.11C>A (p.Pro4Gln)	TP53	P4Q	Hereditary cancer-predisposing syndrome	VCV002450740	17	7579902	17	7676584	2450740	2423226	NA	NC_000017.11:7676583:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	4	TP53
NM_000546.6(TP53):c.11C>G (p.Pro4Arg)	TP53	P4R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000406582	17	7579902	17	7676584	406582	403057	rs878854064	NC_000017.11:7676583:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	4	TP53
NM_000546.6(TP53):c.11C>T (p.Pro4Leu)	TP53	P4L	Li-Fraumeni syndrome 1	VCV000237941	17	7579902	17	7676584	237941	242994	rs878854064	NC_000017.11:7676583:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 4, 2021	reviewed by expert panel	NA	NA	NA	NA	NA	NA	NA	4	TP53
NM_000546.6(TP53):c.10C>G (p.Pro4Ala)	TP53	P4A	Li-Fraumeni syndrome	VCV002848843	17	7579903	17	7676585	2848843	3012487	NA	NC_000017.11:7676584:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 19, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	4	TP53
NM_000546.6(TP53):c.10C>T (p.Pro4Ser)	TP53	P4S	Li-Fraumeni syndrome	VCV001485939	17	7579903	17	7676585	1485939	1468418	rs1356004172	NC_000017.11:7676584:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	4	TP53
NM_000546.6(TP53):c.8A>G (p.Glu3Gly)	TP53	E3G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000187706	17	7579905	17	7676587	187706	185425	rs786203938	NC_000017.11:7676586:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 17, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	3	TP53
NM_000546.6(TP53):c.7G>C (p.Glu3Gln)	TP53	E3Q	not specified|Li-Fraumeni syndrome|Lung adenocarcinoma	VCV000861772	17	7579906	17	7676588	861772	846304	rs2073524362	NC_000017.11:7676587:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	3	TP53
NM_000546.6(TP53):c.7G>A (p.Glu3Lys)	TP53	E3K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000858236	17	7579906	17	7676588	858236	846305	rs2073524362	NC_000017.11:7676587:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 10, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	3	TP53
NM_000546.6(TP53):c.5A>G (p.Glu2Gly)	TP53	E2G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000926778	17	7579908	17	7676590	926778	914206	rs2073524631	NC_000017.11:7676589:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	2	TP53
NM_000546.6(TP53):c.4G>A (p.Glu2Lys)	TP53	E2K	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000490172	17	7579909	17	7676591	490172	483078	rs769884991	NC_000017.11:7676590:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	2	TP53
NM_000546.6(TP53):c.278T>C (p.Leu93Pro)	TP53	L93P	not provided	VCV003359424	NA	NA	NA	NA	3359424	3518636	NA	NA	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	93	TP53
NM_003073.5(SMARCB1):c.205G>A (p.Gly69Ser)	SMARCB1	G69S	not provided	VCV001471392	22	24134054	22	23791867	1471392	1488463	rs2145960551	NC_000022.11:23791866:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	69	SMARCB1
NM_003073.5(SMARCB1):c.1A>C (p.Met1Leu)	SMARCB1	M1L	not provided	VCV002712544	22	24129357	22	23787170	2712544	2868381	NA	NC_000022.11:23787169:A:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	SMARCB1
NM_003073.5(SMARCB1):c.1A>G (p.Met1Val)	SMARCB1	M1V	Hereditary cancer-predisposing syndrome|Rhabdoid tumor predisposition syndrome 1|Schwannomatosis 1|not provided	VCV000135257	22	24129357	22	23787170	135257	138996	rs367768260	NC_000022.11:23787169:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Benign/Likely benign	Jan 25, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	1	SMARCB1
NM_003073.5(SMARCB1):c.2T>C (p.Met1Thr)	SMARCB1	M1T	Hereditary cancer-predisposing syndrome	VCV003320807	22	24129358	22	23787171	3320807	3477762	NA	NC_000022.11:23787170:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	May 8, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	1	SMARCB1
NM_003073.5(SMARCB1):c.4A>G (p.Met2Val)	SMARCB1	M2V	not provided	VCV001507035	22	24129360	22	23787173	1507035	1427095	rs2145951889	NC_000022.11:23787172:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	2	SMARCB1
NM_003073.5(SMARCB1):c.5T>G (p.Met2Arg)	SMARCB1	M2R	not provided	VCV001720691	22	24129361	22	23787174	1720691	1776873	NA	NC_000022.11:23787173:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	2	SMARCB1
NM_003073.5(SMARCB1):c.6G>A (p.Met2Ile)	SMARCB1	M2I	not provided	VCV002728217	22	24129362	22	23787175	2728217	2889555	NA	NC_000022.11:23787174:G:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	2	SMARCB1
NM_003073.5(SMARCB1):c.8T>A (p.Met3Lys)	SMARCB1	M3K	not provided	VCV002736303	22	24129364	22	23787177	2736303	2894995	NA	NC_000022.11:23787176:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	3	SMARCB1
NM_003073.5(SMARCB1):c.9G>T (p.Met3Ile)	SMARCB1	M3I	Hereditary cancer-predisposing syndrome	VCV003320795	22	24129365	22	23787178	3320795	3477750	NA	NC_000022.11:23787177:G:T	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	3	SMARCB1
NM_003073.5(SMARCB1):c.10A>T (p.Met4Leu)	SMARCB1	M4L	not provided	VCV002113167	22	24129366	22	23787179	2113167	2164455	NA	NC_000022.11:23787178:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	4	SMARCB1
NM_003073.5(SMARCB1):c.11T>C (p.Met4Thr)	SMARCB1	M4T	not provided|Hereditary cancer-predisposing syndrome	VCV001045351	22	24129367	22	23787180	1045351	1035065	rs371477865	NC_000022.11:23787179:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	4	SMARCB1
NM_003073.5(SMARCB1):c.13G>T (p.Ala5Ser)	SMARCB1	A5S	not provided	VCV002829104	22	24129369	22	23787182	2829104	2983770	NA	NC_000022.11:23787181:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	5	SMARCB1
NM_003073.5(SMARCB1):c.13G>C (p.Ala5Pro)	SMARCB1	A5P	not provided	VCV001313737	22	24129369	22	23787182	1313737	1303998	rs1928040877	NC_000022.11:23787181:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	5	SMARCB1
NM_003073.5(SMARCB1):c.14C>T (p.Ala5Val)	SMARCB1	A5V	Hereditary cancer-predisposing syndrome|not provided	VCV000577312	22	24129370	22	23787183	577312	573289	rs1568933235	NC_000022.11:23787182:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	5	SMARCB1
NM_003073.5(SMARCB1):c.16C>G (p.Leu6Val)	SMARCB1	L6V	Hereditary cancer-predisposing syndrome	VCV002482351	22	24129372	22	23787185	2482351	2458864	NA	NC_000022.11:23787184:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	6	SMARCB1
NM_003073.5(SMARCB1):c.20G>T (p.Ser7Ile)	SMARCB1	S7I	Hereditary cancer-predisposing syndrome	VCV001785888	22	24129376	22	23787189	1785888	1850146	NA	NC_000022.11:23787188:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	7	SMARCB1
NM_003073.5(SMARCB1):c.20G>A (p.Ser7Asn)	SMARCB1	S7N	not provided	VCV001037645	22	24129376	22	23787189	1037645	1035066	rs1928042033	NC_000022.11:23787188:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	7	SMARCB1
NM_003073.5(SMARCB1):c.22A>G (p.Lys8Glu)	SMARCB1	K8E	not provided	VCV001379500	22	24129378	22	23787191	1379500	1486728	rs2145951968	NC_000022.11:23787190:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	8	SMARCB1
NM_003073.5(SMARCB1):c.23A>G (p.Lys8Arg)	SMARCB1	K8R	not provided|Hereditary cancer-predisposing syndrome	VCV001790699	22	24129379	22	23787192	1790699	1841600	NA	NC_000022.11:23787191:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	8	SMARCB1
NM_003073.5(SMARCB1):c.26C>G (p.Thr9Ser)	SMARCB1	T9S	Rhabdoid tumor predisposition syndrome 1	VCV003240533	22	24129382	22	23787195	3240533	3399519	NA	NC_000022.11:23787194:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	9	SMARCB1
NM_003073.5(SMARCB1):c.31G>A (p.Gly11Arg)	SMARCB1	G11R	Intellectual disability|not provided	VCV000451032	22	24129387	22	23787200	451032	446380	rs1555875308	NC_000022.11:23787199:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 12, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	11	SMARCB1
NM_003073.5(SMARCB1):c.35A>G (p.Gln12Arg)	SMARCB1	Q12R	not provided|Hereditary cancer-predisposing syndrome	VCV001733063	22	24129391	22	23787204	1733063	1796137	NA	NC_000022.11:23787203:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	12	SMARCB1
NM_003073.5(SMARCB1):c.35A>C (p.Gln12Pro)	SMARCB1	Q12P	Hereditary cancer-predisposing syndrome	VCV001733059	22	24129391	22	23787204	1733059	1796133	NA	NC_000022.11:23787203:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	12	SMARCB1
NM_003073.5(SMARCB1):c.41C>A (p.Pro14His)	SMARCB1	P14H	Hereditary cancer-predisposing syndrome|not provided	VCV001738639	22	24129397	22	23787210	1738639	1790972	NA	NC_000022.11:23787209:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	14	SMARCB1
NM_003073.5(SMARCB1):c.43G>A (p.Val15Met)	SMARCB1	V15M	not provided	VCV002882485	22	24129399	22	23787212	2882485	3043086	NA	NC_000022.11:23787211:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	15	SMARCB1
NM_003073.5(SMARCB1):c.43G>T (p.Val15Leu)	SMARCB1	V15L	Hereditary cancer-predisposing syndrome	VCV001740321	22	24129399	22	23787212	1740321	1791354	NA	NC_000022.11:23787211:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	15	SMARCB1
NM_003073.5(SMARCB1):c.44T>C (p.Val15Ala)	SMARCB1	V15A	not provided	VCV000861317	22	24129400	22	23787213	861317	849089	rs1928044034	NC_000022.11:23787212:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	15	SMARCB1
NM_003073.5(SMARCB1):c.54G>C (p.Gln18His)	SMARCB1	Q18H	not provided	VCV001511951	22	24129410	22	23787223	1511951	1455586	rs1220062951	NC_000022.11:23787222:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	18	SMARCB1
NM_003073.5(SMARCB1):c.56T>A (p.Leu19Gln)	SMARCB1	L19Q	Hereditary cancer-predisposing syndrome	VCV003320799	22	24129412	22	23787225	3320799	3477754	NA	NC_000022.11:23787224:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	19	SMARCB1
NM_003073.5(SMARCB1):c.59A>C (p.Glu20Ala)	SMARCB1	E20A	not provided	VCV001486330	22	24129415	22	23787228	1486330	1491431	rs2145952083	NC_000022.11:23787227:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	20	SMARCB1
NM_003073.5(SMARCB1):c.61G>A (p.Asp21Asn)	SMARCB1	D21N	Hereditary cancer-predisposing syndrome|not provided	VCV000826242	22	24129417	22	23787230	826242	814988	rs1601382598	NC_000022.11:23787229:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	21	SMARCB1
NM_003073.5(SMARCB1):c.62A>G (p.Asp21Gly)	SMARCB1	D21G	not provided	VCV001218089	22	24129418	22	23787231	1218089	1208071	rs2145952092	NC_000022.11:23787230:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	21	SMARCB1
NM_003073.5(SMARCB1):c.64G>A (p.Asp22Asn)	SMARCB1	D22N	not provided|Hereditary cancer-predisposing syndrome	VCV000646013	22	24129420	22	23787233	646013	649217	rs1417899723	NC_000022.11:23787232:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	22	SMARCB1
NM_003073.5(SMARCB1):c.67G>A (p.Gly23Ser)	SMARCB1	G23S	Hereditary cancer-predisposing syndrome|SMARCB1-related disorder|not provided	VCV000840331	22	24129423	22	23787236	840331	849090	rs1287987691	NC_000022.11:23787235:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	23	SMARCB1
NM_003073.5(SMARCB1):c.68G>A (p.Gly23Asp)	SMARCB1	G23D	Hereditary cancer-predisposing syndrome|not provided	VCV000826695	22	24129424	22	23787237	826695	814989	rs1601382621	NC_000022.11:23787236:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	23	SMARCB1
NM_003073.5(SMARCB1):c.70G>A (p.Glu24Lys)	SMARCB1	E24K	Hereditary cancer-predisposing syndrome|not provided	VCV000826836	22	24129426	22	23787239	826836	814990	rs1601382640	NC_000022.11:23787238:G:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	SMARCB1
NM_003073.5(SMARCB1):c.71A>C (p.Glu24Ala)	SMARCB1	E24A	Hereditary cancer-predisposing syndrome|not provided	VCV001059096	22	24129427	22	23787240	1059096	1052029	rs2145952118	NC_000022.11:23787239:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	24	SMARCB1
NM_003073.5(SMARCB1):c.73T>G (p.Phe25Val)	SMARCB1	F25V	Hereditary cancer-predisposing syndrome	VCV001758743	22	24129429	22	23787242	1758743	1819454	NA	NC_000022.11:23787241:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	25	SMARCB1
NM_003073.5(SMARCB1):c.74T>C (p.Phe25Ser)	SMARCB1	F25S	not provided|Hereditary cancer-predisposing syndrome	VCV001514377	22	24129430	22	23787243	1514377	1492191	rs2145952130	NC_000022.11:23787242:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	25	SMARCB1
NM_003073.5(SMARCB1):c.79A>G (p.Met27Val)	SMARCB1	M27V	Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000941247	22	24129435	22	23787248	941247	939214	rs762676176	NC_000022.11:23787247:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	27	SMARCB1
NM_003073.5(SMARCB1):c.79A>C (p.Met27Leu)	SMARCB1	M27L	not provided|Intellectual disability, autosomal dominant 15|Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome	VCV000464339	22	24129435	22	23787248	464339	469939	rs762676176	NC_000022.11:23787247:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	27	SMARCB1
NM_003073.5(SMARCB1):c.80T>G (p.Met27Arg)	SMARCB1	M27R	not provided	VCV000838596	22	24129436	22	23787249	838596	849091	rs763994045	NC_000022.11:23787248:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 21, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	27	SMARCB1
NM_003073.5(SMARCB1):c.82A>T (p.Ile28Phe)	SMARCB1	I28F	Hereditary cancer-predisposing syndrome	VCV003223089	22	24129438	22	23787251	3223089	3386727	NA	NC_000022.11:23787250:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	SMARCB1
NM_003073.5(SMARCB1):c.82A>G (p.Ile28Val)	SMARCB1	I28V	not provided|SMARCB1-related disorder	VCV002630806	22	24129438	22	23787251	2630806	2796561	NA	NC_000022.11:23787250:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	28	SMARCB1
NM_003073.5(SMARCB1):c.83_84delinsAA (p.Ile28Lys)	SMARCB1	I28K	not provided	VCV001061593	22	24129439 - 24129440	22	23787252 - 23787253	1061593	1052030	rs2145952163	NC_000022.11:23787251:TC:AA	Indel	missense variant	Uncertain significance	Oct 2, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	SMARCB1
NM_003073.5(SMARCB1):c.84C>G (p.Ile28Met)	SMARCB1	I28M	Intellectual disability, autosomal dominant 15	VCV001709002	22	24129440	22	23787253	1709002	1707356	NA	NC_000022.11:23787252:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	28	SMARCB1
NM_003073.5(SMARCB1):c.85G>A (p.Gly29Ser)	SMARCB1	G29S	not provided	VCV001507853	22	24129441	22	23787254	1507853	1352312	rs774011967	NC_000022.11:23787253:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	29	SMARCB1
NM_003073.5(SMARCB1):c.85G>C (p.Gly29Arg)	SMARCB1	G29R	not provided	VCV000948259	22	24129441	22	23787254	948259	929411	rs774011967	NC_000022.11:23787253:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	29	SMARCB1
NM_003073.5(SMARCB1):c.92A>G (p.Glu31Gly)	SMARCB1	E31G	not provided	VCV002764125	22	24129448	22	23787261	2764125	2922294	NA	NC_000022.11:23787260:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	31	SMARCB1
NM_003073.5(SMARCB1):c.92A>T (p.Glu31Val)	SMARCB1	E31V	not provided	VCV000008031	22	24129448	22	23787261	8031	23070	rs267607072	NC_000022.11:23787260:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	31	SMARCB1
NM_003073.5(SMARCB1):c.101A>G (p.Asn34Ser)	SMARCB1	N34S	not provided|Hereditary cancer-predisposing syndrome	VCV001357192	22	24133950	22	23791763	1357192	1345169	rs2145959891	NC_000022.11:23791762:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	34	SMARCB1
NM_003073.5(SMARCB1):c.106C>T (p.Leu36Phe)	SMARCB1	L36F	not provided	VCV001434297	22	24133955	22	23791768	1434297	1494113	rs2145959920	NC_000022.11:23791767:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	36	SMARCB1
NM_003073.5(SMARCB1):c.109C>T (p.Arg37Cys)	SMARCB1	R37C	not provided	VCV003363753	22	24133958	22	23791771	3363753	3522962	NA	NC_000022.11:23791770:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 6, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	37	SMARCB1
NM_003073.5(SMARCB1):c.110G>T (p.Arg37Leu)	SMARCB1	R37L	Developmental disorder	VCV002920689	22	24133959	22	23791772	2920689	3081157	NA	NC_000022.11:23791771:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	37	SMARCB1
NM_003073.5(SMARCB1):c.110G>C (p.Arg37Pro)	SMARCB1	R37P	Adenoid cystic carcinoma	VCV000495134	22	24133959	22	23791772	495134	486686	rs398122368	NC_000022.11:23791771:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2018	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	37	SMARCB1
NM_003073.5(SMARCB1):c.110G>A (p.Arg37His)	SMARCB1	R37H	not provided|SMARCB1-related BAFopathy|Intellectual disability, autosomal dominant 15|Coffin-Siris syndrome	VCV000088893	22	24133959	22	23791772	88893	94452	rs398122368	NC_000022.11:23791771:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 9, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	37	SMARCB1
NM_003073.5(SMARCB1):c.119G>A (p.Arg40Gln)	SMARCB1	R40Q	not provided	VCV000934572	22	24133968	22	23791781	934572	939215	rs1928397102	NC_000022.11:23791780:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	40	SMARCB1
NM_003073.5(SMARCB1):c.128T>G (p.Leu43Arg)	SMARCB1	L43R	not provided	VCV001021181	22	24133977	22	23791790	1021181	1014499	rs1928397303	NC_000022.11:23791789:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	43	SMARCB1
NM_003073.5(SMARCB1):c.142C>T (p.Pro48Ser)	SMARCB1	P48S	Hereditary cancer-predisposing syndrome	VCV001772465	22	24133991	22	23791804	1772465	1826877	NA	NC_000022.11:23791803:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	48	SMARCB1
NM_003073.5(SMARCB1):c.143C>T (p.Pro48Leu)	SMARCB1	P48L	not provided	VCV000030202	22	24133992	22	23791805	30202	39158	rs387906811	NC_000022.11:23791804:C:T	single nucleotide variant	missense variant	Uncertain significance	May 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	48	SMARCB1
NM_003073.5(SMARCB1):c.146C>T (p.Ser49Leu)	SMARCB1	S49L	not provided	VCV002011738	22	24133995	22	23791808	2011738	2070967	NA	NC_000022.11:23791807:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	49	SMARCB1
NM_003073.5(SMARCB1):c.148C>G (p.Leu50Val)	SMARCB1	L50V	not provided	VCV002131004	22	24133997	22	23791810	2131004	2186299	NA	NC_000022.11:23791809:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	50	SMARCB1
NM_003073.5(SMARCB1):c.153G>C (p.Trp51Cys)	SMARCB1	W51C	not provided	VCV001405975	22	24134002	22	23791815	1405975	1493237	rs2145960213	NC_000022.11:23791814:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	51	SMARCB1
NM_003073.5(SMARCB1):c.158G>A (p.Arg53Gln)	SMARCB1	R53Q	not provided|Hereditary cancer-predisposing syndrome	VCV002184420	22	24134007	22	23791820	2184420	1920928	NA	NC_000022.11:23791819:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	53	SMARCB1
NM_003073.5(SMARCB1):c.158G>T (p.Arg53Leu)	SMARCB1	R53L	Hereditary cancer-predisposing syndrome|not provided	VCV000410706	22	24134007	22	23791820	410706	403764	rs779769475	NC_000022.11:23791819:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	53	SMARCB1
NM_003073.5(SMARCB1):c.166A>T (p.Thr56Ser)	SMARCB1	T56S	not provided|Hereditary cancer-predisposing syndrome	VCV000573208	22	24134015	22	23791828	573208	571721	rs1568936098	NC_000022.11:23791827:A:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	56	SMARCB1
NM_003073.5(SMARCB1):c.169G>A (p.Val57Met)	SMARCB1	V57M	Hereditary cancer-predisposing syndrome|Rhabdoid tumor predisposition syndrome 1|not provided	VCV000532973	22	24134018	22	23791831	532973	534082	rs922052006	NC_000022.11:23791830:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	57	SMARCB1
NM_003073.5(SMARCB1):c.170T>C (p.Val57Ala)	SMARCB1	V57A	not provided	VCV002880616	22	24134019	22	23791832	2880616	3034109	NA	NC_000022.11:23791831:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	57	SMARCB1
NM_003073.5(SMARCB1):c.185A>C (p.Lys62Thr)	SMARCB1	K62T	Hereditary cancer-predisposing syndrome	VCV001692744	22	24134034	22	23791847	1692744	1685184	rs1928402357	NC_000022.11:23791846:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	62	SMARCB1
NM_003073.5(SMARCB1):c.185A>T (p.Lys62Ile)	SMARCB1	K62I	not provided	VCV000950406	22	24134034	22	23791847	950406	929413	rs1928402357	NC_000022.11:23791846:A:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	62	SMARCB1
NM_003073.5(SMARCB1):c.193G>T (p.Ala65Ser)	SMARCB1	A65S	not provided	VCV000532965	22	24134042	22	23791855	532965	534169	rs1555875920	NC_000022.11:23791854:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	65	SMARCB1
NM_003073.5(SMARCB1):c.196T>G (p.Ser66Ala)	SMARCB1	S66A	Hereditary cancer-predisposing syndrome|not provided	VCV000656232	22	24134045	22	23791858	656232	649218	rs1601388691	NC_000022.11:23791857:T:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	66	SMARCB1
NM_003073.5(SMARCB1):c.197C>T (p.Ser66Leu)	SMARCB1	S66L	not provided|Hereditary cancer-predisposing syndrome	VCV002730811	22	24134046	22	23791859	2730811	2883545	NA	NC_000022.11:23791858:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	66	SMARCB1
NM_003073.5(SMARCB1):c.202C>T (p.His68Tyr)	SMARCB1	H68Y	not provided	VCV002013202	22	24134051	22	23791864	2013202	2071139	NA	NC_000022.11:23791863:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	68	SMARCB1
NM_003073.5(SMARCB1):c.203A>T (p.His68Leu)	SMARCB1	H68L	not provided	VCV000934285	22	24134052	22	23791865	934285	939216	rs1928403840	NC_000022.11:23791864:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	68	SMARCB1
NM_003073.5(SMARCB1):c.233A>G (p.Asp78Gly)	SMARCB1	D78G	not provided	VCV002196238	22	24135746	22	23793559	2196238	1923712	NA	NC_000022.11:23793558:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	78	SMARCB1
NM_003073.5(SMARCB1):c.235C>A (p.His79Asn)	SMARCB1	H79N	Hereditary cancer-predisposing syndrome	VCV003320818	22	24135748	22	23793561	3320818	3474265	NA	NC_000022.11:23793560:C:A	single nucleotide variant	missense variant	Uncertain significance	May 25, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	79	SMARCB1
NM_003073.5(SMARCB1):c.238G>A (p.Gly80Arg)	SMARCB1	G80R	not provided|Hereditary cancer-predisposing syndrome	VCV001790550	22	24135751	22	23793564	1790550	1841451	NA	NC_000022.11:23793563:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	80	SMARCB1
NM_003073.5(SMARCB1):c.242A>G (p.Tyr81Cys)	SMARCB1	Y81C	not provided|Hereditary cancer-predisposing syndrome	VCV001435705	22	24135755	22	23793568	1435705	1500701	rs2145963676	NC_000022.11:23793567:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	81	SMARCB1
NM_003073.5(SMARCB1):c.244A>C (p.Thr82Pro)	SMARCB1	T82P	not provided	VCV001475407	22	24135757	22	23793570	1475407	1404316	rs1053189632	NC_000022.11:23793569:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	82	SMARCB1
NM_003073.5(SMARCB1):c.244A>G (p.Thr82Ala)	SMARCB1	T82A	not provided	VCV000839331	22	24135757	22	23793570	839331	849092	rs1053189632	NC_000022.11:23793569:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	82	SMARCB1
NM_003073.5(SMARCB1):c.245C>T (p.Thr82Met)	SMARCB1	T82M	Hereditary cancer-predisposing syndrome|not provided	VCV001002790	22	24135758	22	23793571	1002790	999351	rs1928538526	NC_000022.11:23793570:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	82	SMARCB1
NM_003073.5(SMARCB1):c.257C>A (p.Thr86Asn)	SMARCB1	T86N	not provided	VCV001392274	22	24135770	22	23793583	1392274	1409615	rs747794500	NC_000022.11:23793582:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	86	SMARCB1
NM_003073.5(SMARCB1):c.260G>A (p.Ser87Asn)	SMARCB1	S87N	not provided|Hereditary cancer-predisposing syndrome	VCV001793783	22	24135773	22	23793586	1793783	1845908	NA	NC_000022.11:23793585:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	87	SMARCB1
NM_003073.5(SMARCB1):c.262G>T (p.Val88Leu)	SMARCB1	V88L	not provided	VCV000653102	22	24135775	22	23793588	653102	649219	rs1601391025	NC_000022.11:23793587:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	88	SMARCB1
NM_003073.5(SMARCB1):c.277G>T (p.Ala93Ser)	SMARCB1	A93S	Hereditary cancer-predisposing syndrome	VCV002452592	22	24135790	22	23793603	2452592	2433574	NA	NC_000022.11:23793602:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	93	SMARCB1
NM_003073.5(SMARCB1):c.277G>A (p.Ala93Thr)	SMARCB1	A93T	not provided	VCV001435720	22	24135790	22	23793603	1435720	1500716	rs2145963919	NC_000022.11:23793602:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	93	SMARCB1
NM_003073.5(SMARCB1):c.278C>T (p.Ala93Val)	SMARCB1	A93V	not provided	VCV001313749	22	24135791	22	23793604	1313749	1304010	rs2145963921	NC_000022.11:23793603:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	93	SMARCB1
NM_003073.5(SMARCB1):c.281C>T (p.Ser94Leu)	SMARCB1	S94L	Hereditary cancer-predisposing syndrome|not provided	VCV000852841	22	24135794	22	23793607	852841	849093	rs1223772419	NC_000022.11:23793606:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	94	SMARCB1
NM_003073.5(SMARCB1):c.283G>A (p.Glu95Lys)	SMARCB1	E95K	not provided	VCV001368371	22	24135796	22	23793609	1368371	1339964	rs2145963960	NC_000022.11:23793608:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	95	SMARCB1
NM_003073.5(SMARCB1):c.284A>G (p.Glu95Gly)	SMARCB1	E95G	not provided	VCV000582740	22	24135797	22	23793610	582740	573290	rs1568937129	NC_000022.11:23793609:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	95	SMARCB1
NM_003073.5(SMARCB1):c.286G>A (p.Val96Met)	SMARCB1	V96M	not provided	VCV001719248	22	24135799	22	23793612	1719248	1774552	NA	NC_000022.11:23793611:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	96	SMARCB1
NM_003073.5(SMARCB1):c.301G>C (p.Asp101His)	SMARCB1	D101H	not provided	VCV001042238	22	24135814	22	23793627	1042238	1035068	rs774488493	NC_000022.11:23793626:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	SMARCB1
NM_003073.5(SMARCB1):c.301G>T (p.Asp101Tyr)	SMARCB1	D101Y	not provided	VCV001037169	22	24135814	22	23793627	1037169	1035069	rs774488493	NC_000022.11:23793626:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	SMARCB1
NM_003073.5(SMARCB1):c.301G>A (p.Asp101Asn)	SMARCB1	D101N	Hereditary cancer-predisposing syndrome|not provided	VCV000653538	22	24135814	22	23793627	653538	649220	rs774488493	NC_000022.11:23793626:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	101	SMARCB1
NM_003073.5(SMARCB1):c.302A>G (p.Asp101Gly)	SMARCB1	D101G	not provided	VCV000582394	22	24135815	22	23793628	582394	571724	rs762188226	NC_000022.11:23793627:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	101	SMARCB1
NM_003073.5(SMARCB1):c.307A>C (p.Asn103His)	SMARCB1	N103H	not provided	VCV001468458	22	24135820	22	23793633	1468458	1362702	rs2145964114	NC_000022.11:23793632:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	103	SMARCB1
NM_003073.5(SMARCB1):c.308A>G (p.Asn103Ser)	SMARCB1	N103S	not provided	VCV001010556	22	24135821	22	23793634	1010556	999352	rs1928543301	NC_000022.11:23793633:A:G	single nucleotide variant	missense variant	Uncertain significance	May 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	103	SMARCB1
NM_003073.5(SMARCB1):c.310G>A (p.Asp104Asn)	SMARCB1	D104N	Hereditary cancer-predisposing syndrome	VCV002624835	22	24135823	22	23793636	2624835	2790330	NA	NC_000022.11:23793635:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	104	SMARCB1
NM_003073.5(SMARCB1):c.311A>C (p.Asp104Ala)	SMARCB1	D104A	not provided	VCV001358577	22	24135824	22	23793637	1358577	1360738	rs2145964151	NC_000022.11:23793636:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	104	SMARCB1
NM_003073.5(SMARCB1):c.314A>G (p.Glu105Gly)	SMARCB1	E105G	Hereditary cancer-predisposing syndrome|not provided	VCV001474800	22	24135827	22	23793640	1474800	1503886	rs2145964182	NC_000022.11:23793639:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	105	SMARCB1
NM_003073.5(SMARCB1):c.323A>G (p.Lys108Arg)	SMARCB1	K108R	not provided	VCV001714604	22	24135836	22	23793649	1714604	1771221	NA	NC_000022.11:23793648:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	108	SMARCB1
NM_003073.5(SMARCB1):c.329T>C (p.Val110Ala)	SMARCB1	V110A	Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000650818	22	24135842	22	23793655	650818	649221	rs1601391157	NC_000022.11:23793654:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	110	SMARCB1
NM_003073.5(SMARCB1):c.332C>G (p.Ser111Cys)	SMARCB1	S111C	Hereditary cancer-predisposing syndrome|not provided	VCV001919200	22	24135845	22	23793658	1919200	1971640	NA	NC_000022.11:23793657:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	111	SMARCB1
NM_003073.5(SMARCB1):c.334A>G (p.Ile112Val)	SMARCB1	I112V	Hereditary cancer-predisposing syndrome|not provided	VCV000872342	22	24135847	22	23793660	872342	860706	rs1928546194	NC_000022.11:23793659:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	112	SMARCB1
NM_003073.5(SMARCB1):c.340A>G (p.Thr114Ala)	SMARCB1	T114A	not provided	VCV001003802	22	24135853	22	23793666	1003802	999353	rs750822703	NC_000022.11:23793665:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	114	SMARCB1
NM_003073.5(SMARCB1):c.340A>C (p.Thr114Pro)	SMARCB1	T114P	Hereditary cancer-predisposing syndrome|not provided	VCV000655687	22	24135853	22	23793666	655687	649222	rs750822703	NC_000022.11:23793665:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 22, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	114	SMARCB1
NM_003073.5(SMARCB1):c.346C>A (p.Pro116Thr)	SMARCB1	P116T	not provided	VCV001000107	22	24135859	22	23793672	1000107	999354	rs1928547553	NC_000022.11:23793671:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	116	SMARCB1
NM_003073.5(SMARCB1):c.347C>T (p.Pro116Leu)	SMARCB1	P116L	not provided	VCV002769304	22	24135860	22	23793673	2769304	2923579	NA	NC_000022.11:23793672:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	116	SMARCB1
NM_003073.5(SMARCB1):c.347C>A (p.Pro116His)	SMARCB1	P116H	not provided|Hereditary cancer-predisposing syndrome	VCV001731824	22	24135860	22	23793673	1731824	1792727	NA	NC_000022.11:23793672:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	116	SMARCB1
NM_003073.5(SMARCB1):c.349C>T (p.Pro117Ser)	SMARCB1	P117S	Hereditary cancer-predisposing syndrome	VCV002566863	22	24135862	22	23793675	2566863	2732524	NA	NC_000022.11:23793674:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	117	SMARCB1
NM_003073.5(SMARCB1):c.352A>C (p.Thr118Pro)	SMARCB1	T118P	Hereditary cancer-predisposing syndrome|not provided	VCV001443874	22	24135865	22	23793678	1443874	1487873	rs761082514	NC_000022.11:23793677:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	118	SMARCB1
NM_003073.5(SMARCB1):c.358C>T (p.Leu120Phe)	SMARCB1	L120F	Hereditary cancer-predisposing syndrome|not provided	VCV000410712	22	24135871	22	23793684	410712	403774	rs754350320	NC_000022.11:23793683:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	120	SMARCB1
NM_003073.5(SMARCB1):c.366A>T (p.Glu122Asp)	SMARCB1	E122D	Hereditary cancer-predisposing syndrome|not provided	VCV000410705	22	24143134	22	23800947	410705	404327	rs1060503018	NC_000022.11:23800946:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	122	SMARCB1
NM_003073.5(SMARCB1):c.374C>T (p.Ala125Val)	SMARCB1	A125V	not provided	VCV002781398	22	24143142	22	23800955	2781398	2937796	NA	NC_000022.11:23800954:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	125	SMARCB1
NM_003073.5(SMARCB1):c.374C>G (p.Ala125Gly)	SMARCB1	A125G	Hereditary cancer-predisposing syndrome|not provided	VCV000658087	22	24143142	22	23800955	658087	649223	rs1029942798	NC_000022.11:23800954:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	125	SMARCB1
NM_003073.5(SMARCB1):c.377A>G (p.Lys126Arg)	SMARCB1	K126R	not provided|Hereditary cancer-predisposing syndrome	VCV002156962	22	24143145	22	23800958	2156962	1883238	NA	NC_000022.11:23800957:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	126	SMARCB1
NM_003073.5(SMARCB1):c.380G>A (p.Arg127Lys)	SMARCB1	R127K	Hereditary cancer-predisposing syndrome	VCV003320791	22	24143148	22	23800961	3320791	3477746	NA	NC_000022.11:23800960:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	127	SMARCB1
NM_003073.5(SMARCB1):c.386G>C (p.Ser129Thr)	SMARCB1	S129T	not provided	VCV002118276	22	24143154	22	23800967	2118276	2176058	NA	NC_000022.11:23800966:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	129	SMARCB1
NM_003073.5(SMARCB1):c.400A>C (p.Thr134Pro)	SMARCB1	T134P	not provided	VCV001723694	22	24143168	22	23800981	1723694	1781179	NA	NC_000022.11:23800980:A:C	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	134	SMARCB1
NM_003073.5(SMARCB1):c.403C>G (p.Leu135Val)	SMARCB1	L135V	not provided|not specified	VCV002005109	22	24143171	22	23800984	2005109	2055737	NA	NC_000022.11:23800983:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	135	SMARCB1
NM_003073.5(SMARCB1):c.413G>C (p.Ser138Thr)	SMARCB1	S138T	not provided|Hereditary cancer-predisposing syndrome	VCV001334614	22	24143181	22	23800994	1334614	1325509	rs1929110548	NC_000022.11:23800993:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	138	SMARCB1
NM_003073.5(SMARCB1):c.415T>C (p.Ser139Pro)	SMARCB1	S139P	not provided	VCV002500414	22	24143183	22	23800996	2500414	2523312	NA	NC_000022.11:23800995:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	139	SMARCB1
NM_003073.5(SMARCB1):c.430G>A (p.Ala144Thr)	SMARCB1	A144T	Hereditary cancer-predisposing syndrome	VCV001739623	22	24143198	22	23801011	1739623	1797991	NA	NC_000022.11:23801010:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	144	SMARCB1
NM_003073.5(SMARCB1):c.433G>A (p.Val145Met)	SMARCB1	V145M	not specified|Hereditary cancer-predisposing syndrome	VCV000824808	22	24143201	22	23801014	824808	814996	rs1601401880	NC_000022.11:23801013:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	145	SMARCB1
NM_003073.5(SMARCB1):c.434T>G (p.Val145Gly)	SMARCB1	V145G	not provided	VCV000646868	22	24143202	22	23801015	646868	649224	rs1601401889	NC_000022.11:23801014:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	145	SMARCB1
NM_003073.5(SMARCB1):c.437C>G (p.Pro146Arg)	SMARCB1	P146R	See cases	VCV001691051	22	24143205	22	23801018	1691051	1683459	rs2145978507	NC_000022.11:23801017:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	146	SMARCB1
NM_003073.5(SMARCB1):c.440G>A (p.Cys147Tyr)	SMARCB1	C147Y	not provided	VCV002430774	22	24143208	22	23801021	2430774	2404281	NA	NC_000022.11:23801020:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	147	SMARCB1
NM_003073.5(SMARCB1):c.448A>G (p.Thr150Ala)	SMARCB1	T150A	not provided	VCV000852718	22	24143216	22	23801029	852718	849094	rs745619005	NC_000022.11:23801028:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	150	SMARCB1
NM_003073.5(SMARCB1):c.460A>T (p.Asn154Tyr)	SMARCB1	N154Y	Hereditary cancer-predisposing syndrome	VCV000486506	22	24143228	22	23801041	486506	480031	rs1555877022	NC_000022.11:23801040:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	154	SMARCB1
NM_003073.5(SMARCB1):c.461A>G (p.Asn154Ser)	SMARCB1	N154S	not provided|Hereditary cancer-predisposing syndrome	VCV000389577	22	24143229	22	23801042	389577	378719	rs1057523475	NC_000022.11:23801041:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	154	SMARCB1
NM_003073.5(SMARCB1):c.463C>T (p.Arg155Cys)	SMARCB1	R155C	not provided	VCV000835144	22	24143231	22	23801044	835144	849095	rs1458920579	NC_000022.11:23801043:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	155	SMARCB1
NM_003073.5(SMARCB1):c.464G>A (p.Arg155His)	SMARCB1	R155H	Hereditary cancer-predisposing syndrome	VCV001742175	22	24143232	22	23801045	1742175	1801817	NA	NC_000022.11:23801044:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	155	SMARCB1
NM_003073.5(SMARCB1):c.466A>G (p.Met156Val)	SMARCB1	M156V	Hereditary cancer-predisposing syndrome|not provided	VCV000410711	22	24143234	22	23801047	410711	404285	rs540120954	NC_000022.11:23801046:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	156	SMARCB1
NM_003073.5(SMARCB1):c.467T>C (p.Met156Thr)	SMARCB1	M156T	not provided|Hereditary cancer-predisposing syndrome	VCV002179538	22	24143235	22	23801048	2179538	1916058	NA	NC_000022.11:23801047:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	156	SMARCB1
NM_003073.5(SMARCB1):c.468G>A (p.Met156Ile)	SMARCB1	M156I	Hereditary cancer-predisposing syndrome	VCV001742468	22	24143236	22	23801049	1742468	1798669	NA	NC_000022.11:23801048:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	156	SMARCB1
NM_003073.5(SMARCB1):c.469G>T (p.Gly157Cys)	SMARCB1	G157C	not provided	VCV000570203	22	24143237	22	23801050	570203	575218	rs1568941668	NC_000022.11:23801049:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	157	SMARCB1
NM_003073.5(SMARCB1):c.473G>A (p.Arg158Gln)	SMARCB1	R158Q	not provided|Hereditary cancer-predisposing syndrome	VCV002196498	22	24143241	22	23801054	2196498	1933034	NA	NC_000022.11:23801053:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	158	SMARCB1
NM_003073.5(SMARCB1):c.473G>T (p.Arg158Leu)	SMARCB1	R158L	not provided	VCV000945406	22	24143241	22	23801054	945406	929414	rs1232172026	NC_000022.11:23801053:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	158	SMARCB1
NM_003073.5(SMARCB1):c.487A>G (p.Thr163Ala)	SMARCB1	T163A	SMARCB1-related disorder|Intellectual disability, autosomal dominant 15	VCV001029504	22	24143255	22	23801068	1029504	1018796	rs1929117173	NC_000022.11:23801067:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	163	SMARCB1
NM_003073.5(SMARCB1):c.488C>G (p.Thr163Ser)	SMARCB1	T163S	not provided	VCV001421474	22	24143256	22	23801069	1421474	1422890	rs2145978836	NC_000022.11:23801068:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	163	SMARCB1
NM_003073.5(SMARCB1):c.492C>A (p.Phe164Leu)	SMARCB1	F164L	not provided	VCV001056670	22	24143260	22	23801073	1056670	1052031	rs780005225	NC_000022.11:23801072:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	164	SMARCB1
NM_003073.5(SMARCB1):c.501C>G (p.Cys167Trp)	SMARCB1	C167W	not provided|Hereditary cancer-predisposing syndrome	VCV000575245	22	24145482	22	23803295	575245	575219	rs779221331	NC_000022.11:23803294:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	167	SMARCB1
NM_003073.5(SMARCB1):c.502T>C (p.Phe168Leu)	SMARCB1	F168L	not provided	VCV002825396	22	24145483	22	23803296	2825396	2982629	NA	NC_000022.11:23803295:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	168	SMARCB1
NM_003073.5(SMARCB1):c.505G>C (p.Asp169His)	SMARCB1	D169H	not provided|Hereditary cancer-predisposing syndrome	VCV001745098	22	24145486	22	23803299	1745098	1805944	NA	NC_000022.11:23803298:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	169	SMARCB1
NM_003073.5(SMARCB1):c.508G>A (p.Asp170Asn)	SMARCB1	D170N	not provided	VCV000565841	22	24145489	22	23803302	565841	571725	rs1568943134	NC_000022.11:23803301:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	170	SMARCB1
NM_003073.5(SMARCB1):c.509A>G (p.Asp170Gly)	SMARCB1	D170G	not provided	VCV001984276	22	24145490	22	23803303	1984276	2039529	NA	NC_000022.11:23803302:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	170	SMARCB1
NM_003073.5(SMARCB1):c.512A>G (p.His171Arg)	SMARCB1	H171R	not provided|Hereditary cancer-predisposing syndrome	VCV000197748	22	24145493	22	23803306	197748	194909	rs794727718	NC_000022.11:23803305:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	171	SMARCB1
NM_003073.5(SMARCB1):c.515A>T (p.Asp172Val)	SMARCB1	D172V	not provided	VCV001355719	22	24145496	22	23803309	1355719	1509470	rs2145982695	NC_000022.11:23803308:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	172	SMARCB1
NM_003073.5(SMARCB1):c.517C>T (p.Pro173Ser)	SMARCB1	P173S	not provided	VCV002891649	22	24145498	22	23803311	2891649	3055458	NA	NC_000022.11:23803310:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	173	SMARCB1
NM_003073.5(SMARCB1):c.517C>G (p.Pro173Ala)	SMARCB1	P173A	not provided|Hereditary cancer-predisposing syndrome	VCV001381594	22	24145498	22	23803311	1381594	1496556	rs772788649	NC_000022.11:23803310:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	173	SMARCB1
NM_003073.5(SMARCB1):c.520G>T (p.Ala174Ser)	SMARCB1	A174S	Hereditary cancer-predisposing syndrome|not provided	VCV000486502	22	24145501	22	23803314	486502	479998	rs746433763	NC_000022.11:23803313:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 11, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	174	SMARCB1
NM_003073.5(SMARCB1):c.526A>G (p.Ile176Val)	SMARCB1	I176V	not provided	VCV002001816	22	24145507	22	23803320	2001816	2055017	NA	NC_000022.11:23803319:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	176	SMARCB1
NM_003073.5(SMARCB1):c.526A>C (p.Ile176Leu)	SMARCB1	I176L	not provided	VCV001046894	22	24145507	22	23803320	1046894	1035070	rs1929285188	NC_000022.11:23803319:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	176	SMARCB1
NM_003073.5(SMARCB1):c.529C>T (p.His177Tyr)	SMARCB1	H177Y	Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome	VCV002679021	22	24145510	22	23803323	2679021	2836599	NA	NC_000022.11:23803322:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	177	SMARCB1
NM_003073.5(SMARCB1):c.537C>A (p.Asn179Lys)	SMARCB1	N179K	not provided	VCV002997269	22	24145518	22	23803331	2997269	3156330	NA	NC_000022.11:23803330:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	179	SMARCB1
NM_003073.5(SMARCB1):c.538G>C (p.Ala180Pro)	SMARCB1	A180P	Autism spectrum disorder	VCV002430013	22	24145519	22	23803332	2430013	2403516	NA	NC_000022.11:23803331:G:C	single nucleotide variant	missense variant	Likely benign	Mar 26, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	180	SMARCB1
NM_003073.5(SMARCB1):c.538G>T (p.Ala180Ser)	SMARCB1	A180S	not provided|not specified	VCV001705235	22	24145519	22	23803332	1705235	1699763	NA	NC_000022.11:23803331:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	180	SMARCB1
NM_003073.5(SMARCB1):c.538G>A (p.Ala180Thr)	SMARCB1	A180T	not provided	VCV000566524	22	24145519	22	23803332	566524	573967	rs1568943183	NC_000022.11:23803331:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	180	SMARCB1
NM_003073.5(SMARCB1):c.539C>T (p.Ala180Val)	SMARCB1	A180V	not provided	VCV000464329	22	24145520	22	23803333	464329	470916	rs1555877280	NC_000022.11:23803332:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	180	SMARCB1
NM_003073.5(SMARCB1):c.546G>T (p.Gln182His)	SMARCB1	Q182H	not provided|Hereditary cancer-predisposing syndrome	VCV000862381	22	24145527	22	23803340	862381	849097	rs1929287151	NC_000022.11:23803339:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	182	SMARCB1
NM_003073.5(SMARCB1):c.547C>T (p.Pro183Ser)	SMARCB1	P183S	not provided	VCV002101411	22	24145528	22	23803341	2101411	2147669	NA	NC_000022.11:23803340:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	183	SMARCB1
NM_003073.5(SMARCB1):c.548C>T (p.Pro183Leu)	SMARCB1	P183L	Hereditary cancer-predisposing syndrome	VCV003320814	22	24145529	22	23803342	3320814	83795	rs138515783	NC_000022.11:23803341:C:T	single nucleotide variant	missense variant	Uncertain significance	May 26, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	183	SMARCB1
NM_003073.5(SMARCB1):c.550G>C (p.Glu184Gln)	SMARCB1	E184Q	Hereditary cancer-predisposing syndrome	VCV003320800	22	24145531	22	23803344	3320800	3477755	NA	NC_000022.11:23803343:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	184	SMARCB1
NM_003073.5(SMARCB1):c.550G>A (p.Glu184Lys)	SMARCB1	E184K	not provided|Hereditary cancer-predisposing syndrome	VCV000825794	22	24145531	22	23803344	825794	814997	rs776374083	NC_000022.11:23803343:G:A	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	184	SMARCB1
NM_003073.5(SMARCB1):c.552G>T (p.Glu184Asp)	SMARCB1	E184D	not provided	VCV001354356	22	24145533	22	23803346	1354356	1341474	rs2145982835	NC_000022.11:23803345:G:T	single nucleotide variant	missense variant	Uncertain significance	May 19, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	184	SMARCB1
NM_003073.5(SMARCB1):c.553G>A (p.Val185Met)	SMARCB1	V185M	Hereditary cancer-predisposing syndrome|not provided	VCV001060761	22	24145534	22	23803347	1060761	1052032	rs1251083217	NC_000022.11:23803346:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	185	SMARCB1
NM_003073.5(SMARCB1):c.557T>C (p.Leu186Pro)	SMARCB1	L186P	Hereditary cancer-predisposing syndrome|not provided	VCV000825840	22	24145538	22	23803351	825840	814998	rs1601405018	NC_000022.11:23803350:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	186	SMARCB1
NM_003073.5(SMARCB1):c.559G>T (p.Val187Phe)	SMARCB1	V187F	not provided|Hereditary cancer-predisposing syndrome	VCV000580638	22	24145540	22	23803353	580638	571735	rs1568943235	NC_000022.11:23803352:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2020	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	187	SMARCB1
NM_003073.5(SMARCB1):c.562C>T (p.Pro188Ser)	SMARCB1	P188S	not provided	VCV002971148	22	24145543	22	23803356	2971148	83797	rs146210466	NC_000022.11:23803355:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	188	SMARCB1
NM_003073.5(SMARCB1):c.565A>G (p.Ile189Val)	SMARCB1	I189V	not provided	VCV000665220	22	24145546	22	23803359	665220	649225	rs1601405054	NC_000022.11:23803358:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	SMARCB1
NM_003073.5(SMARCB1):c.566T>C (p.Ile189Thr)	SMARCB1	I189T	Hereditary cancer-predisposing syndrome	VCV003320811	22	24145547	22	23803360	3320811	3474259	NA	NC_000022.11:23803359:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	SMARCB1
NM_003073.5(SMARCB1):c.567C>G (p.Ile189Met)	SMARCB1	I189M	Hereditary cancer-predisposing syndrome	VCV002624836	22	24145548	22	23803361	2624836	2790331	NA	NC_000022.11:23803360:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	189	SMARCB1
NM_003073.5(SMARCB1):c.568C>T (p.Arg190Trp)	SMARCB1	R190W	Hereditary cancer-predisposing syndrome|Autism spectrum disorder|Schwannomatosis 1|not provided	VCV000825898	22	24145549	22	23803362	825898	814999	rs1601405064	NC_000022.11:23803361:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 13, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	190	SMARCB1
NM_003073.5(SMARCB1):c.577A>G (p.Met193Val)	SMARCB1	M193V	Hereditary cancer-predisposing syndrome	VCV003223084	22	24145558	22	23803371	3223084	3386722	NA	NC_000022.11:23803370:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	193	SMARCB1
NM_003073.5(SMARCB1):c.578T>C (p.Met193Thr)	SMARCB1	M193T	not provided	VCV003018050	22	24145559	22	23803372	3018050	3171865	NA	NC_000022.11:23803371:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	193	SMARCB1
NM_003073.5(SMARCB1):c.579G>A (p.Met193Ile)	SMARCB1	M193I	not provided	VCV000965912	22	24145560	22	23803373	965912	959039	rs1929290030	NC_000022.11:23803372:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	193	SMARCB1
NM_003073.5(SMARCB1):c.582G>C (p.Glu194Asp)	SMARCB1	E194D	not provided	VCV000571583	22	24145563	22	23803376	571583	573292	rs759241720	NC_000022.11:23803375:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	194	SMARCB1
NM_003073.5(SMARCB1):c.583A>T (p.Ile195Phe)	SMARCB1	I195F	Hereditary cancer-predisposing syndrome|not provided	VCV001034790	22	24145564	22	23803377	1034790	1035071	rs1929290525	NC_000022.11:23803376:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	195	SMARCB1
NM_003073.5(SMARCB1):c.585C>G (p.Ile195Met)	SMARCB1	I195M	not provided	VCV001429463	22	24145566	22	23803379	1429463	1454578	rs757546528	NC_000022.11:23803378:C:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	195	SMARCB1
NM_003073.5(SMARCB1):c.586_587delinsAT (p.Asp196Ile)	SMARCB1	D196I	not provided	VCV002126576	22	24145567 - 24145568	22	23803380 - 23803381	2126576	2181876	NA	NC_000022.11:23803379:GA:AT	Indel	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	196	SMARCB1
NM_003073.5(SMARCB1):c.593A>G (p.Gln198Arg)	SMARCB1	Q198R	Hereditary cancer-predisposing syndrome	VCV003320817	22	24145574	22	23803387	3320817	3474264	NA	NC_000022.11:23803386:A:G	single nucleotide variant	missense variant	Uncertain significance	May 17, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	198	SMARCB1
NM_003073.5(SMARCB1):c.595A>G (p.Lys199Glu)	SMARCB1	K199E	Inborn genetic diseases	VCV000985112	22	24145576	22	23803389	985112	974224	rs1929291829	NC_000022.11:23803388:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	199	SMARCB1
NM_003073.5(SMARCB1):c.599T>G (p.Leu200Arg)	SMARCB1	L200R	not provided	VCV002695445	22	24145580	22	23803393	2695445	2854304	NA	NC_000022.11:23803392:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	200	SMARCB1
NM_003073.5(SMARCB1):c.602G>A (p.Arg201Gln)	SMARCB1	R201Q	Intellectual disability, autosomal dominant 15	VCV000438304	22	24145583	22	23803396	438304	431926	rs1555877287	NC_000022.11:23803395:G:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 1, 2016	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	201	SMARCB1
NM_003073.5(SMARCB1):c.607G>A (p.Ala203Thr)	SMARCB1	A203T	Rhabdoid tumor predisposition syndrome 2|Hereditary cancer-predisposing syndrome|not provided|Schwannomatosis 1|Rhabdoid tumor predisposition syndrome 1	VCV000340912	22	24145588	22	23803401	340912	351197	rs762962010	NC_000022.11:23803400:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	203	SMARCB1
NM_003073.5(SMARCB1):c.613A>T (p.Thr205Ser)	SMARCB1	T205S	not provided	VCV000464331	22	24145594	22	23803407	464331	471397	rs1555877290	NC_000022.11:23803406:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	205	SMARCB1
NM_003073.5(SMARCB1):c.614C>T (p.Thr205Ile)	SMARCB1	T205I	not provided	VCV001395589	22	24145595	22	23803408	1395589	1424988	rs2145983068	NC_000022.11:23803407:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	205	SMARCB1
NM_003073.5(SMARCB1):c.616T>C (p.Trp206Arg)	SMARCB1	W206R	not provided	VCV002578187	22	24145597	22	23803410	2578187	2743078	NA	NC_000022.11:23803409:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	206	SMARCB1
NM_003073.5(SMARCB1):c.620A>G (p.Asn207Ser)	SMARCB1	N207S	Intellectual disability, autosomal dominant 15|Hereditary cancer-predisposing syndrome|not provided	VCV001478236	22	24145601	22	23803414	1478236	1351743	rs763872301	NC_000022.11:23803413:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	207	SMARCB1
NM_003073.5(SMARCB1):c.622A>G (p.Met208Val)	SMARCB1	M208V	not provided|Hereditary cancer-predisposing syndrome	VCV001383821	22	24145603	22	23803416	1383821	1447417	rs1457130071	NC_000022.11:23803415:A:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	208	SMARCB1
NM_003073.5(SMARCB1):c.627T>A (p.Asn209Lys)	SMARCB1	N209K	not provided	VCV002102868	22	24145608	22	23803421	2102868	2161928	NA	NC_000022.11:23803420:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	209	SMARCB1
NM_003073.5(SMARCB1):c.630G>T (p.Glu210Asp)	SMARCB1	E210D	not provided|Hereditary cancer-predisposing syndrome	VCV001752795	22	24158958	22	23816771	1752795	1801228	NA	NC_000022.11:23816770:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	210	SMARCB1
NM_003073.5(SMARCB1):c.632A>G (p.Lys211Arg)	SMARCB1	K211R	Rhabdoid tumor predisposition syndrome 1	VCV003240532	22	24158960	22	23816773	3240532	3399518	NA	NC_000022.11:23816772:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	211	SMARCB1
NM_003073.5(SMARCB1):c.634T>G (p.Leu212Val)	SMARCB1	L212V	not provided	VCV001716717	22	24158962	22	23816775	1716717	1778398	NA	NC_000022.11:23816774:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	212	SMARCB1
NM_003073.5(SMARCB1):c.637A>T (p.Met213Leu)	SMARCB1	M213L	not provided	VCV000969237	22	24158965	22	23816778	969237	959040	rs1930218815	NC_000022.11:23816777:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	213	SMARCB1
NM_003073.5(SMARCB1):c.641C>G (p.Thr214Arg)	SMARCB1	T214R	Hereditary cancer-predisposing syndrome|not provided|Rhabdoid tumor predisposition syndrome 1	VCV001327094	22	24158969	22	23816782	1327094	1317594	rs780906523	NC_000022.11:23816781:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	214	SMARCB1
NM_003073.5(SMARCB1):c.641C>T (p.Thr214Met)	SMARCB1	T214M	Ovarian cancer|not provided|Hereditary cancer-predisposing syndrome	VCV000859261	22	24158969	22	23816782	859261	849098	rs780906523	NC_000022.11:23816781:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 14, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	214	SMARCB1
NM_003073.5(SMARCB1):c.643C>T (p.Pro215Ser)	SMARCB1	P215S	Hereditary cancer-predisposing syndrome	VCV003320819	22	24158971	22	23816784	3320819	3474266	NA	NC_000022.11:23816783:C:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	215	SMARCB1
NM_003073.5(SMARCB1):c.652T>G (p.Phe218Val)	SMARCB1	F218V	not provided	VCV002002566	22	24158980	22	23816793	2002566	2061790	NA	NC_000022.11:23816792:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	218	SMARCB1
NM_003073.5(SMARCB1):c.652T>C (p.Phe218Leu)	SMARCB1	F218L	not provided|Hereditary cancer-predisposing syndrome	VCV001707957	22	24158980	22	23816793	1707957	1706255	NA	NC_000022.11:23816792:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	218	SMARCB1
NM_003073.5(SMARCB1):c.662T>C (p.Ile221Thr)	SMARCB1	I221T	Hereditary cancer-predisposing syndrome	VCV001754572	22	24158990	22	23816803	1754572	1812029	NA	NC_000022.11:23816802:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	221	SMARCB1
NM_003073.5(SMARCB1):c.664C>G (p.Leu222Val)	SMARCB1	L222V	not provided	VCV002991054	22	24158992	22	23816805	2991054	3151308	NA	NC_000022.11:23816804:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	222	SMARCB1
NM_003073.5(SMARCB1):c.665T>C (p.Leu222Pro)	SMARCB1	L222P	not provided	VCV002829790	22	24158993	22	23816806	2829790	2990452	NA	NC_000022.11:23816805:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	222	SMARCB1
NM_003073.5(SMARCB1):c.668G>A (p.Cys223Tyr)	SMARCB1	C223Y	not provided|Hereditary cancer-predisposing syndrome	VCV000659792	22	24158996	22	23816809	659792	649226	rs1470474620	NC_000022.11:23816808:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	223	SMARCB1
NM_003073.5(SMARCB1):c.673G>A (p.Asp225Asn)	SMARCB1	D225N	Hereditary cancer-predisposing syndrome|not provided	VCV001041054	22	24159001	22	23816814	1041054	1035072	rs768379745	NC_000022.11:23816813:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	225	SMARCB1
NM_003073.5(SMARCB1):c.673G>T (p.Asp225Tyr)	SMARCB1	D225Y	not provided|Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome	VCV000581167	22	24159001	22	23816814	581167	573969	rs768379745	NC_000022.11:23816813:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	225	SMARCB1
NM_003073.5(SMARCB1):c.682T>A (p.Leu228Met)	SMARCB1	L228M	not provided	VCV001716146	22	24159010	22	23816823	1716146	1771443	NA	NC_000022.11:23816822:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	228	SMARCB1
NM_003073.5(SMARCB1):c.688C>A (p.Pro230Thr)	SMARCB1	P230T	Hereditary cancer-predisposing syndrome	VCV003320801	22	24159016	22	23816829	3320801	3477756	NA	NC_000022.11:23816828:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	230	SMARCB1
NM_003073.5(SMARCB1):c.689C>A (p.Pro230Gln)	SMARCB1	P230Q	not provided	VCV002157332	22	24159017	22	23816830	2157332	1893520	NA	NC_000022.11:23816829:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	230	SMARCB1
NM_003073.5(SMARCB1):c.689C>T (p.Pro230Leu)	SMARCB1	P230L	not provided|Hereditary cancer-predisposing syndrome	VCV001449813	22	24159017	22	23816830	1449813	1412996	rs2146009762	NC_000022.11:23816829:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	230	SMARCB1
NM_003073.5(SMARCB1):c.695C>T (p.Thr232Met)	SMARCB1	T232M	not provided|Hereditary cancer-predisposing syndrome|Rhabdoid tumor predisposition syndrome 1	VCV000464334	22	24159023	22	23816836	464334	469971	rs776693680	NC_000022.11:23816835:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 9, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	232	SMARCB1
NM_003073.5(SMARCB1):c.698T>A (p.Phe233Tyr)	SMARCB1	F233Y	not provided	VCV002172231	22	24159026	22	23816839	2172231	1907470	NA	NC_000022.11:23816838:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	233	SMARCB1
NM_003073.5(SMARCB1):c.700G>T (p.Val234Leu)	SMARCB1	V234L	Rhabdoid tumor predisposition syndrome 1|not provided	VCV002116736	22	24159028	22	23816841	2116736	2175819	NA	NC_000022.11:23816840:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	234	SMARCB1
NM_003073.5(SMARCB1):c.700G>C (p.Val234Leu)	SMARCB1	V234L	Hereditary cancer-predisposing syndrome|not provided	VCV001698160	22	24159028	22	23816841	1698160	1690539	rs1272912695	NC_000022.11:23816840:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	234	SMARCB1
NM_003073.5(SMARCB1):c.706G>C (p.Ala236Pro)	SMARCB1	A236P	not provided	VCV001350535	22	24159034	22	23816847	1350535	1469495	rs1930223455	NC_000022.11:23816846:G:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	236	SMARCB1
NM_003073.5(SMARCB1):c.710T>G (p.Ile237Ser)	SMARCB1	I237S	not provided|Intellectual disability, autosomal dominant 15	VCV001407743	22	24159038	22	23816851	1407743	1506623	rs2146009925	NC_000022.11:23816850:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	237	SMARCB1
NM_003073.5(SMARCB1):c.712G>T (p.Ala238Ser)	SMARCB1	A238S	Rhabdoid tumor predisposition syndrome 2	VCV001710933	22	24159040	22	23816853	1710933	1709344	NA	NC_000022.11:23816852:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	238	SMARCB1
NM_003073.5(SMARCB1):c.712G>A (p.Ala238Thr)	SMARCB1	A238T	Hereditary cancer-predisposing syndrome|not provided	VCV000410709	22	24159040	22	23816853	410709	403780	rs765514964	NC_000022.11:23816852:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	238	SMARCB1
NM_003073.5(SMARCB1):c.713C>T (p.Ala238Val)	SMARCB1	A238V	not provided	VCV000410708	22	24159041	22	23816854	410708	404331	rs1060503019	NC_000022.11:23816853:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	238	SMARCB1
NM_003073.5(SMARCB1):c.719C>G (p.Ala240Gly)	SMARCB1	A240G	Rhabdoid tumor predisposition syndrome 1	VCV002679019	22	24159047	22	23816860	2679019	2836597	NA	NC_000022.11:23816859:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	240	SMARCB1
NM_003073.5(SMARCB1):c.721A>G (p.Ile241Val)	SMARCB1	I241V	not provided	VCV002888808	22	24159049	22	23816862	2888808	3047666	NA	NC_000022.11:23816861:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	241	SMARCB1
NM_003073.5(SMARCB1):c.731A>T (p.Gln244Leu)	SMARCB1	Q244L	not provided	VCV000532972	22	24159059	22	23816872	532972	534182	rs763202805	NC_000022.11:23816871:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	244	SMARCB1
NM_003073.5(SMARCB1):c.733A>G (p.Ile245Val)	SMARCB1	I245V	Hereditary cancer-predisposing syndrome	VCV001758399	22	24159061	22	23816874	1758399	1822916	NA	NC_000022.11:23816873:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	245	SMARCB1
NM_003073.5(SMARCB1):c.734T>C (p.Ile245Thr)	SMARCB1	I245T	Hereditary cancer-predisposing syndrome	VCV000486503	22	24159062	22	23816875	486503	479953	rs1555879350	NC_000022.11:23816874:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	245	SMARCB1
NM_003073.5(SMARCB1):c.736G>A (p.Glu246Lys)	SMARCB1	E246K	not provided|Hereditary cancer-predisposing syndrome	VCV000839989	22	24159064	22	23816877	839989	849099	rs1930225458	NC_000022.11:23816876:G:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	246	SMARCB1
NM_003073.5(SMARCB1):c.742T>C (p.Tyr248His)	SMARCB1	Y248H	Hereditary cancer-predisposing syndrome	VCV003320805	22	24159070	22	23816883	3320805	3477760	NA	NC_000022.11:23816882:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	248	SMARCB1
NM_003073.5(SMARCB1):c.743A>G (p.Tyr248Cys)	SMARCB1	Y248C	not provided|Hereditary cancer-predisposing syndrome	VCV001008863	22	24159071	22	23816884	1008863	999355	rs1444281296	NC_000022.11:23816883:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	248	SMARCB1
NM_003073.5(SMARCB1):c.745C>T (p.Pro249Ser)	SMARCB1	P249S	not provided	VCV000964441	22	24159073	22	23816886	964441	951362	rs1930226221	NC_000022.11:23816885:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	249	SMARCB1
NM_003073.5(SMARCB1):c.748A>G (p.Thr250Ala)	SMARCB1	T250A	not provided|Hereditary cancer-predisposing syndrome	VCV002127105	22	24159076	22	23816889	2127105	2178418	NA	NC_000022.11:23816888:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	250	SMARCB1
NM_003073.5(SMARCB1):c.749C>T (p.Thr250Met)	SMARCB1	T250M	Hereditary cancer-predisposing syndrome|not provided|Rhabdoid tumor predisposition syndrome 1	VCV000464337	22	24159077	22	23816890	464337	470917	rs751957685	NC_000022.11:23816889:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 7, 2024	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	250	SMARCB1
NM_003073.5(SMARCB1):c.754A>G (p.Ser252Gly)	SMARCB1	S252G	Hereditary cancer-predisposing syndrome|not provided	VCV001759465	22	24159082	22	23816895	1759465	1813066	NA	NC_000022.11:23816894:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	252	SMARCB1
NM_003073.5(SMARCB1):c.755G>A (p.Ser252Asn)	SMARCB1	S252N	Hereditary cancer-predisposing syndrome|not provided	VCV000577001	22	24159083	22	23816896	577001	575220	rs372924301	NC_000022.11:23816895:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	252	SMARCB1
NM_003073.5(SMARCB1):c.758T>C (p.Ile253Thr)	SMARCB1	I253T	Hereditary cancer-predisposing syndrome|not provided	VCV001400604	22	24159086	22	23816899	1400604	1440831	rs2146010326	NC_000022.11:23816898:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	253	SMARCB1
NM_003073.5(SMARCB1):c.759C>G (p.Ile253Met)	SMARCB1	I253M	not provided	VCV001370810	22	24159087	22	23816900	1370810	1430877	rs889171672	NC_000022.11:23816899:C:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	253	SMARCB1
NM_003073.5(SMARCB1):c.765G>C (p.Glu255Asp)	SMARCB1	E255D	not provided	VCV002740746	22	24159093	22	23816906	2740746	2902813	NA	NC_000022.11:23816905:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	255	SMARCB1
NM_003073.5(SMARCB1):c.767A>G (p.Asp256Gly)	SMARCB1	D256G	not provided	VCV000858679	22	24159095	22	23816908	858679	849100	rs749976156	NC_000022.11:23816907:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	256	SMARCB1
NM_003073.5(SMARCB1):c.769C>A (p.Gln257Lys)	SMARCB1	Q257K	not provided	VCV001706970	22	24159097	22	23816910	1706970	1705281	NA	NC_000022.11:23816909:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	257	SMARCB1
NM_003073.5(SMARCB1):c.771G>C (p.Gln257His)	SMARCB1	Q257H	not provided	VCV001716147	22	24159099	22	23816912	1716147	1771444	NA	NC_000022.11:23816911:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	257	SMARCB1
NM_003073.5(SMARCB1):c.772T>C (p.Ser258Pro)	SMARCB1	S258P	Hereditary cancer-predisposing syndrome	VCV003320813	22	24159100	22	23816913	3320813	3474261	NA	NC_000022.11:23816912:T:C	single nucleotide variant	missense variant	Uncertain significance	May 3, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	258	SMARCB1
NM_003073.5(SMARCB1):c.781C>A (p.Arg261Ser)	SMARCB1	R261S	Hereditary cancer-predisposing syndrome	VCV001760761	22	24159109	22	23816922	1760761	1816377	NA	NC_000022.11:23816921:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	261	SMARCB1
NM_003073.5(SMARCB1):c.781C>T (p.Arg261Cys)	SMARCB1	R261C	Hereditary cancer-predisposing syndrome|Rhabdoid tumor predisposition syndrome 1|not provided	VCV001692746	22	24159109	22	23816922	1692746	1685186	rs1368176286	NC_000022.11:23816921:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	261	SMARCB1
NM_003073.5(SMARCB1):c.782G>A (p.Arg261His)	SMARCB1	R261H	not provided|Hereditary cancer-predisposing syndrome	VCV001061155	22	24159110	22	23816923	1061155	1052033	rs779587990	NC_000022.11:23816922:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	261	SMARCB1
NM_003073.5(SMARCB1):c.784G>A (p.Val262Ile)	SMARCB1	V262I	not provided|Hereditary cancer-predisposing syndrome	VCV002240619	22	24159112	22	23816925	2240619	2222273	NA	NC_000022.11:23816924:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	262	SMARCB1
NM_003073.5(SMARCB1):c.787A>G (p.Ile263Val)	SMARCB1	I263V	not provided|Hereditary cancer-predisposing syndrome	VCV001760986	22	24159115	22	23816928	1760986	1816601	NA	NC_000022.11:23816927:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	263	SMARCB1
NM_003073.5(SMARCB1):c.788T>C (p.Ile263Thr)	SMARCB1	I263T	Hereditary cancer-predisposing syndrome	VCV003223087	22	24159116	22	23816929	3223087	3386725	NA	NC_000022.11:23816928:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	263	SMARCB1
NM_003073.5(SMARCB1):c.790A>T (p.Ile264Phe)	SMARCB1	I264F	not provided	VCV001021461	22	24159118	22	23816931	1021461	1014502	rs887245809	NC_000022.11:23816930:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	264	SMARCB1
NM_003073.5(SMARCB1):c.790A>G (p.Ile264Val)	SMARCB1	I264V	not provided|Hereditary cancer-predisposing syndrome	VCV000580688	22	24159118	22	23816931	580688	575221	rs887245809	NC_000022.11:23816930:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	264	SMARCB1
NM_003073.5(SMARCB1):c.790A>C (p.Ile264Leu)	SMARCB1	I264L	not provided	VCV000410701	22	24159118	22	23816931	410701	404300	rs887245809	NC_000022.11:23816930:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2016	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	264	SMARCB1
NM_003073.5(SMARCB1):c.805C>T (p.His269Tyr)	SMARCB1	H269Y	SMARCB1-related disorder	VCV003350066	22	24167421	22	23825234	3350066	3509293	NA	NC_000022.11:23825233:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 17, 2024	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	269	SMARCB1
NM_003073.5(SMARCB1):c.812G>A (p.Gly271Glu)	SMARCB1	G271E	SMARCB1-related BAFopathy|Intellectual disability, autosomal dominant 15	VCV001029505	22	24167428	22	23825241	1029505	1018797	rs2030318562	NC_000022.11:23825240:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 10, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	271	SMARCB1
NM_003073.5(SMARCB1):c.815A>G (p.Asn272Ser)	SMARCB1	N272S	Hereditary cancer-predisposing syndrome	VCV002452595	22	24167431	22	23825244	2452595	2433577	NA	NC_000022.11:23825243:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	272	SMARCB1
NM_003073.5(SMARCB1):c.820T>G (p.Ser274Ala)	SMARCB1	S274A	not provided	VCV002850592	22	24167436	22	23825249	2850592	3012948	NA	NC_000022.11:23825248:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	274	SMARCB1
NM_003073.5(SMARCB1):c.823C>G (p.Leu275Val)	SMARCB1	L275V	Hereditary cancer-predisposing syndrome	VCV003320823	22	24167439	22	23825252	3320823	3474270	NA	NC_000022.11:23825251:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	275	SMARCB1
NM_003073.5(SMARCB1):c.826G>A (p.Val276Met)	SMARCB1	V276M	not provided	VCV000939855	22	24167442	22	23825255	939855	939220	rs2030319219	NC_000022.11:23825254:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	276	SMARCB1
NM_003073.5(SMARCB1):c.827T>C (p.Val276Ala)	SMARCB1	V276A	not provided	VCV000944473	22	24167443	22	23825256	944473	929415	rs2030319413	NC_000022.11:23825255:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	276	SMARCB1
NM_003073.5(SMARCB1):c.829G>A (p.Asp277Asn)	SMARCB1	D277N	not provided	VCV000942219	22	24167445	22	23825258	942219	939221	rs2030319772	NC_000022.11:23825257:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	277	SMARCB1
NM_003073.5(SMARCB1):c.831C>G (p.Asp277Glu)	SMARCB1	D277E	not provided	VCV001043491	22	24167447	22	23825260	1043491	1035073	rs1601433351	NC_000022.11:23825259:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	277	SMARCB1
NM_003073.5(SMARCB1):c.836T>G (p.Phe279Cys)	SMARCB1	F279C	not provided	VCV001018508	22	24167452	22	23825265	1018508	1014503	rs2030320193	NC_000022.11:23825264:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	279	SMARCB1
NM_003073.5(SMARCB1):c.845A>G (p.Asp282Gly)	SMARCB1	D282G	not provided	VCV000852251	22	24167461	22	23825274	852251	849101	rs2030320561	NC_000022.11:23825273:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	282	SMARCB1
NM_003073.5(SMARCB1):c.847A>T (p.Met283Leu)	SMARCB1	M283L	not provided	VCV001920981	22	24167463	22	23825276	1920981	1968670	NA	NC_000022.11:23825275:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	283	SMARCB1
NM_003073.5(SMARCB1):c.849G>C (p.Met283Ile)	SMARCB1	M283I	Hereditary cancer-predisposing syndrome	VCV003223090	22	24167465	22	23825278	3223090	3386728	NA	NC_000022.11:23825277:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	283	SMARCB1
NM_003073.5(SMARCB1):c.849G>A (p.Met283Ile)	SMARCB1	M283I	Hereditary cancer-predisposing syndrome	VCV000822513	22	24167465	22	23825278	822513	815002	rs1601433375	NC_000022.11:23825277:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	283	SMARCB1
NM_003073.5(SMARCB1):c.850T>G (p.Ser284Ala)	SMARCB1	S284A	not provided	VCV001054902	22	24167466	22	23825279	1054902	1052034	rs2146026778	NC_000022.11:23825278:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	284	SMARCB1
NM_003073.5(SMARCB1):c.853G>A (p.Glu285Lys)	SMARCB1	E285K	Hereditary cancer-predisposing syndrome	VCV002452587	22	24167469	22	23825282	2452587	2433569	NA	NC_000022.11:23825281:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	285	SMARCB1
NM_003073.5(SMARCB1):c.857A>G (p.Lys286Arg)	SMARCB1	K286R	not provided	VCV001470226	22	24167473	22	23825286	1470226	1372188	rs2146026825	NC_000022.11:23825285:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	286	SMARCB1
NM_003073.5(SMARCB1):c.862A>G (p.Asn288Asp)	SMARCB1	N288D	Hereditary cancer-predisposing syndrome	VCV003320802	22	24167478	22	23825291	3320802	3477757	NA	NC_000022.11:23825290:A:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	288	SMARCB1
NM_003073.5(SMARCB1):c.866C>T (p.Ser289Leu)	SMARCB1	S289L	not provided	VCV000962107	22	24167482	22	23825295	962107	951363	rs2030322042	NC_000022.11:23825294:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	289	SMARCB1
NM_003073.5(SMARCB1):c.868C>T (p.Pro290Ser)	SMARCB1	P290S	Intellectual disability, autosomal dominant 15	VCV001805132	22	24167484	22	23825297	1805132	1862147	NA	NC_000022.11:23825296:C:T	single nucleotide variant	missense variant	Likely benign	Dec 21, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	290	SMARCB1
NM_003073.5(SMARCB1):c.868C>G (p.Pro290Ala)	SMARCB1	P290A	not provided|Hereditary cancer-predisposing syndrome	VCV000949337	22	24167484	22	23825297	949337	929416	rs2030322683	NC_000022.11:23825296:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	290	SMARCB1
NM_003073.5(SMARCB1):c.880G>A (p.Ala294Thr)	SMARCB1	A294T	Hereditary cancer-predisposing syndrome|not provided	VCV000532967	22	24167496	22	23825309	532967	534083	rs1555880578	NC_000022.11:23825308:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	294	SMARCB1
NM_003073.5(SMARCB1):c.881C>T (p.Ala294Val)	SMARCB1	A294V	Hereditary cancer-predisposing syndrome|not provided	VCV000486505	22	24167497	22	23825310	486505	480036	rs1555880581	NC_000022.11:23825309:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	294	SMARCB1
NM_003073.5(SMARCB1):c.883C>G (p.Leu295Val)	SMARCB1	L295V	not provided	VCV002101410	22	24167499	22	23825312	2101410	2147668	NA	NC_000022.11:23825311:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	295	SMARCB1
NM_003073.5(SMARCB1):c.888G>T (p.Lys296Asn)	SMARCB1	K296N	Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000198489	22	24167504	22	23825317	198489	195650	rs769322487	NC_000022.11:23825316:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 13, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	296	SMARCB1
NM_003073.5(SMARCB1):c.892T>C (p.Cys298Arg)	SMARCB1	C298R	Hereditary cancer-predisposing syndrome	VCV001765159	22	24167508	22	23825321	1765159	1824653	NA	NC_000022.11:23825320:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	298	SMARCB1
NM_003073.5(SMARCB1):c.894C>G (p.Cys298Trp)	SMARCB1	C298W	not provided	VCV001020099	22	24167510	22	23825323	1020099	1014504	rs2030323849	NC_000022.11:23825322:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	298	SMARCB1
NM_003073.5(SMARCB1):c.896C>T (p.Ser299Leu)	SMARCB1	S299L	Hereditary cancer-predisposing syndrome|not provided	VCV000937299	22	24167512	22	23825325	937299	939222	rs1362758319	NC_000022.11:23825324:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	299	SMARCB1
NM_003073.5(SMARCB1):c.914G>A (p.Gly305Glu)	SMARCB1	G305E	not provided	VCV002862744	22	24167530	22	23825343	2862744	3022793	NA	NC_000022.11:23825342:G:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	305	SMARCB1
NM_003073.5(SMARCB1):c.923T>A (p.Val308Asp)	SMARCB1	V308D	Hereditary cancer-predisposing syndrome	VCV003320809	22	24167539	22	23825352	3320809	3474257	NA	NC_000022.11:23825351:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	308	SMARCB1
NM_003073.5(SMARCB1):c.933C>G (p.Ile311Met)	SMARCB1	I311M	not provided	VCV001718558	22	24167549	22	23825362	1718558	1778918	NA	NC_000022.11:23825361:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	311	SMARCB1
NM_003073.5(SMARCB1):c.934G>A (p.Ala312Thr)	SMARCB1	A312T	Hereditary cancer-predisposing syndrome|not provided	VCV000961239	22	24167550	22	23825363	961239	951364	rs749348930	NC_000022.11:23825362:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	312	SMARCB1
NM_003073.5(SMARCB1):c.935C>T (p.Ala312Val)	SMARCB1	A312V	not provided	VCV000938994	22	24167551	22	23825364	938994	939223	rs2030327085	NC_000022.11:23825363:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	312	SMARCB1
NM_003073.5(SMARCB1):c.941G>A (p.Ser314Asn)	SMARCB1	S314N	Hereditary cancer-predisposing syndrome	VCV002447182	22	24167557	22	23825370	2447182	2422305	NA	NC_000022.11:23825369:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	314	SMARCB1
NM_003073.5(SMARCB1):c.943A>T (p.Ile315Phe)	SMARCB1	I315F	not provided	VCV001390691	22	24167559	22	23825372	1390691	1396864	rs2146027104	NC_000022.11:23825371:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	315	SMARCB1
NM_003073.5(SMARCB1):c.946C>G (p.Arg316Gly)	SMARCB1	R316G	not provided	VCV002728487	22	24167562	22	23825375	2728487	2886384	NA	NC_000022.11:23825374:C:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	316	SMARCB1
NM_003073.5(SMARCB1):c.946C>T (p.Arg316Trp)	SMARCB1	R316W	Hereditary cancer-predisposing syndrome|not provided	VCV000464341	22	24167562	22	23825375	464341	471804	rs769023941	NC_000022.11:23825374:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	316	SMARCB1
NM_003073.5(SMARCB1):c.947G>A (p.Arg316Gln)	SMARCB1	R316Q	not provided|Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome	VCV000951906	22	24167563	22	23825376	951906	929417	rs2030327999	NC_000022.11:23825375:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	316	SMARCB1
NM_003073.5(SMARCB1):c.953A>G (p.Gln318Arg)	SMARCB1	Q318R	not provided	VCV002831386	22	24167569	22	23825382	2831386	3000986	NA	NC_000022.11:23825381:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	318	SMARCB1
NM_003073.5(SMARCB1):c.958A>G (p.Ser320Gly)	SMARCB1	S320G	Hereditary cancer-predisposing syndrome	VCV003320796	22	24167574	22	23825387	3320796	3477751	NA	NC_000022.11:23825386:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	320	SMARCB1
NM_003073.5(SMARCB1):c.961T>A (p.Trp321Arg)	SMARCB1	W321R	not provided	VCV001372690	22	24167577	22	23825390	1372690	1440068	rs2146027158	NC_000022.11:23825389:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	321	SMARCB1
NM_003073.5(SMARCB1):c.964C>T (p.His322Tyr)	SMARCB1	H322Y	Hereditary cancer-predisposing syndrome	VCV002566864	22	24167580	22	23825393	2566864	2732525	NA	NC_000022.11:23825392:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	322	SMARCB1
NM_003073.5(SMARCB1):c.967C>A (p.Gln323Lys)	SMARCB1	Q323K	Hereditary cancer-predisposing syndrome|not provided|Rhabdoid tumor predisposition syndrome 1	VCV000486504	22	24167583	22	23825396	486504	479955	rs1265308124	NC_000022.11:23825395:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	323	SMARCB1
NM_003073.5(SMARCB1):c.969G>C (p.Gln323His)	SMARCB1	Q323H	not provided	VCV002007581	22	24167585	22	23825398	2007581	2073242	NA	NC_000022.11:23825397:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	323	SMARCB1
NM_003073.5(SMARCB1):c.977A>C (p.Tyr326Ser)	SMARCB1	Y326S	Hereditary cancer-predisposing syndrome	VCV001768155	22	24167593	22	23825406	1768155	1825588	NA	NC_000022.11:23825405:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	326	SMARCB1
NM_003073.5(SMARCB1):c.979G>A (p.Ala327Thr)	SMARCB1	A327T	Hereditary cancer-predisposing syndrome|not provided	VCV000660223	22	24167595	22	23825408	660223	649228	rs1601433577	NC_000022.11:23825407:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	327	SMARCB1
NM_003073.5(SMARCB1):c.985A>G (p.Ser329Gly)	SMARCB1	S329G	not provided	VCV000566461	22	24167601	22	23825414	566461	571744	rs1568957782	NC_000022.11:23825413:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	329	SMARCB1
NM_003073.5(SMARCB1):c.986G>A (p.Ser329Asn)	SMARCB1	S329N	not provided	VCV002131423	22	24167602	22	23825415	2131423	2191558	NA	NC_000022.11:23825414:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	329	SMARCB1
NM_003073.5(SMARCB1):c.987C>A (p.Ser329Arg)	SMARCB1	S329R	not provided	VCV000949393	22	24175759	22	23833572	949393	929419	rs137942040	NC_000022.11:23833571:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	329	SMARCB1
NM_003073.5(SMARCB1):c.988G>A (p.Glu330Lys)	SMARCB1	E330K	not provided|Hereditary cancer-predisposing syndrome	VCV002482362	22	24175760	22	23833573	2482362	2458875	NA	NC_000022.11:23833572:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2022	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	330	SMARCB1
NM_003073.5(SMARCB1):c.990G>C (p.Glu330Asp)	SMARCB1	E330D	Hereditary cancer-predisposing syndrome	VCV003320820	22	24175762	22	23833575	3320820	3474267	NA	NC_000022.11:23833574:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	330	SMARCB1
NM_003073.5(SMARCB1):c.995C>T (p.Pro332Leu)	SMARCB1	P332L	not provided	VCV001492253	22	24175767	22	23833580	1492253	1446484	rs2146041698	NC_000022.11:23833579:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	332	SMARCB1
NM_003073.5(SMARCB1):c.995C>G (p.Pro332Arg)	SMARCB1	P332R	not provided	VCV001388307	22	24175767	22	23833580	1388307	1371048	rs2146041698	NC_000022.11:23833579:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	332	SMARCB1
NM_003073.5(SMARCB1):c.1007T>C (p.Val336Ala)	SMARCB1	V336A	Hereditary cancer-predisposing syndrome	VCV001788372	22	24175779	22	23833592	1788372	1844434	NA	NC_000022.11:23833591:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	336	SMARCB1
NM_003073.5(SMARCB1):c.1011G>T (p.Glu337Asp)	SMARCB1	E337D	not provided	VCV002862170	22	24175783	22	23833596	2862170	3025821	NA	NC_000022.11:23833595:G:T	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	337	SMARCB1
NM_003073.5(SMARCB1):c.1012A>G (p.Ile338Val)	SMARCB1	I338V	not provided	VCV002828090	22	24175784	22	23833597	2828090	2990028	NA	NC_000022.11:23833596:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	338	SMARCB1
NM_003073.5(SMARCB1):c.1012A>C (p.Ile338Leu)	SMARCB1	I338L	not provided	VCV001055761	22	24175784	22	23833597	1055761	1052035	rs2146041824	NC_000022.11:23833596:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	338	SMARCB1
NM_003073.5(SMARCB1):c.1013T>C (p.Ile338Thr)	SMARCB1	I338T	Hereditary cancer-predisposing syndrome|not provided	VCV001380690	22	24175785	22	23833598	1380690	1421512	rs2146041839	NC_000022.11:23833597:T:C	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	338	SMARCB1
NM_003073.5(SMARCB1):c.1018A>G (p.Ile340Val)	SMARCB1	I340V	not provided	VCV002083891	22	24175790	22	23833603	2083891	2136550	NA	NC_000022.11:23833602:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	340	SMARCB1
NM_003073.5(SMARCB1):c.1020C>G (p.Ile340Met)	SMARCB1	I340M	not provided	VCV002185255	22	24175792	22	23833605	2185255	1913958	NA	NC_000022.11:23833604:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	340	SMARCB1
NM_003073.5(SMARCB1):c.1021C>T (p.Arg341Trp)	SMARCB1	R341W	Hereditary cancer-predisposing syndrome|not provided	VCV001760991	22	24175793	22	23833606	1760991	1816606	NA	NC_000022.11:23833605:C:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	341	SMARCB1
NM_003073.5(SMARCB1):c.1022G>T (p.Arg341Leu)	SMARCB1	R341L	Hereditary cancer-predisposing syndrome	VCV002452593	22	24175794	22	23833607	2452593	2433575	NA	NC_000022.11:23833606:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	341	SMARCB1
NM_003073.5(SMARCB1):c.1022G>A (p.Arg341Gln)	SMARCB1	R341Q	Hereditary cancer-predisposing syndrome|not provided	VCV000532966	22	24175794	22	23833607	532966	534627	rs748441485	NC_000022.11:23833606:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 19, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	341	SMARCB1
NM_003073.5(SMARCB1):c.1025A>G (p.Asn342Ser)	SMARCB1	N342S	not provided	VCV001505644	22	24175797	22	23833610	1505644	1437211	rs2146041993	NC_000022.11:23833609:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	342	SMARCB1
NM_003073.5(SMARCB1):c.1028C>T (p.Thr343Met)	SMARCB1	T343M	Hereditary cancer-predisposing syndrome|not provided	VCV000464320	22	24175800	22	23833613	464320	470918	rs773457718	NC_000022.11:23833612:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	343	SMARCB1
NM_003073.5(SMARCB1):c.1033G>A (p.Asp345Asn)	SMARCB1	D345N	not provided	VCV000546230	22	24175805	22	23833618	546230	537017	rs794727911	NC_000022.11:23833617:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	345	SMARCB1
NM_003073.5(SMARCB1):c.1033G>T (p.Asp345Tyr)	SMARCB1	D345Y	not provided|Hereditary cancer-predisposing syndrome	VCV000198781	22	24175805	22	23833618	198781	195941	rs794727911	NC_000022.11:23833617:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	345	SMARCB1
NM_003073.5(SMARCB1):c.1037C>T (p.Ala346Val)	SMARCB1	A346V	Rhabdoid tumor predisposition syndrome 1|not provided	VCV001063816	22	24175809	22	23833622	1063816	1052036	rs1231539032	NC_000022.11:23833621:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	346	SMARCB1
NM_003073.5(SMARCB1):c.1042C>G (p.Gln348Glu)	SMARCB1	Q348E	not provided	VCV002110680	22	24175814	22	23833627	2110680	2171144	NA	NC_000022.11:23833626:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	348	SMARCB1
NM_003073.5(SMARCB1):c.1052C>T (p.Pro351Leu)	SMARCB1	P351L	Hereditary cancer-predisposing syndrome|not provided	VCV000850717	22	24175824	22	23833637	850717	849103	rs2030790017	NC_000022.11:23833636:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2019	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	351	SMARCB1
NM_003073.5(SMARCB1):c.1061A>G (p.Glu354Gly)	SMARCB1	E354G	Hereditary cancer-predisposing syndrome	VCV001780323	22	24175833	22	23833646	1780323	1835024	NA	NC_000022.11:23833645:A:G	single nucleotide variant	missense variant	Uncertain significance	May 30, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	354	SMARCB1
NM_003073.5(SMARCB1):c.1069A>G (p.Thr357Ala)	SMARCB1	T357A	Hereditary cancer-predisposing syndrome	VCV001782663	22	24175841	22	23833654	1782663	1846028	NA	NC_000022.11:23833653:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	357	SMARCB1
NM_003073.5(SMARCB1):c.1070C>T (p.Thr357Ile)	SMARCB1	T357I	not provided	VCV000580796	22	24175842	22	23833655	580796	573971	rs1555881567	NC_000022.11:23833654:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 12, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	357	SMARCB1
NM_003073.5(SMARCB1):c.1070C>G (p.Thr357Arg)	SMARCB1	T357R	Intellectual disability, autosomal dominant 15|Hereditary cancer-predisposing syndrome	VCV000559897	22	24175842	22	23833655	559897	550644	rs1555881567	NC_000022.11:23833654:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 22, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	357	SMARCB1
NM_003073.5(SMARCB1):c.1075G>A (p.Ala359Thr)	SMARCB1	A359T	not provided|Hereditary cancer-predisposing syndrome	VCV001784737	22	24175847	22	23833660	1784737	1846795	NA	NC_000022.11:23833659:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	359	SMARCB1
NM_003073.5(SMARCB1):c.1084G>A (p.Glu362Lys)	SMARCB1	E362K	SMARCB1-related disorder	VCV002631196	22	24175856	22	23833669	2631196	2803347	NA	NC_000022.11:23833668:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	362	SMARCB1
NM_003073.5(SMARCB1):c.1087A>G (p.Lys363Glu)	SMARCB1	K363E	Intellectual disability, autosomal dominant 15|not provided	VCV000212263	22	24175859	22	23833672	212263	208780	rs797045989	NC_000022.11:23833671:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 2, 2021	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	363	SMARCB1
NM_003073.5(SMARCB1):c.1089G>T (p.Lys363Asn)	SMARCB1	K363N	not provided|Intellectual disability, autosomal dominant 15|SMARCB1-related BAFopathy	VCV000561114	22	24175861	22	23833674	561114	552228	rs1568963037	NC_000022.11:23833673:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 7, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	363	SMARCB1
NM_003073.5(SMARCB1):c.1091A>T (p.Lys364Met)	SMARCB1	K364M	not provided	VCV001039859	22	24175863	22	23833676	1039859	1035074	rs2030793132	NC_000022.11:23833675:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	364	SMARCB1
NM_003073.5(SMARCB1):c.1092G>T (p.Lys364Asn)	SMARCB1	K364N	not provided	VCV002701457	22	24175864	22	23833677	2701457	2862451	NA	NC_000022.11:23833676:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	364	SMARCB1
NM_003073.5(SMARCB1):c.1096C>G (p.Arg366Gly)	SMARCB1	R366G	Intellectual disability, autosomal dominant 15	VCV001343154	22	24175868	22	23833681	1343154	1334799	rs886039520	NC_000022.11:23833680:C:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 20, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	366	SMARCB1
NM_003073.5(SMARCB1):c.1096C>T (p.Arg366Cys)	SMARCB1	R366C	not provided|Intellectual disability, autosomal dominant 15	VCV000265393	22	24175868	22	23833681	265393	260251	rs886039520	NC_000022.11:23833680:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 20, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	366	SMARCB1
NM_003073.5(SMARCB1):c.1097G>A (p.Arg366His)	SMARCB1	R366H	not provided	VCV000532968	22	24175869	22	23833682	532968	534195	rs1555881572	NC_000022.11:23833681:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	366	SMARCB1
NM_003073.5(SMARCB1):c.1099G>C (p.Asp367His)	SMARCB1	D367H	not provided	VCV001521059	22	24175871	22	23833684	1521059	1446712	rs2030794083	NC_000022.11:23833683:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	367	SMARCB1
NM_003073.5(SMARCB1):c.1106A>T (p.Asp369Val)	SMARCB1	D369V	Inborn genetic diseases	VCV000985428	22	24175878	22	23833691	985428	974225	rs2030794445	NC_000022.11:23833690:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2018	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	369	SMARCB1
NM_003073.5(SMARCB1):c.1115C>T (p.Thr372Met)	SMARCB1	T372M	Hereditary cancer-predisposing syndrome|not provided	VCV000464321	22	24175887	22	23833700	464321	471405	rs992198711	NC_000022.11:23833699:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	372	SMARCB1
NM_003073.5(SMARCB1):c.1120C>T (p.Arg374Trp)	SMARCB1	R374W	not provided|Intellectual disability, autosomal dominant 15	VCV000633561	22	24176329	22	23834142	633561	621989	rs1568963596	NC_000022.11:23834141:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 22, 2022	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	374	SMARCB1
NM_003073.5(SMARCB1):c.1121G>A (p.Arg374Gln)	SMARCB1	R374Q	Intellectual disability, autosomal dominant 15|SMARCB1-related BAFopathy|Hereditary cancer-predisposing syndrome|not provided	VCV000372511	22	24176330	22	23834143	372511	360483	rs1057517825	NC_000022.11:23834142:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	374	SMARCB1
NM_003073.5(SMARCB1):c.1127G>C (p.Arg376Thr)	SMARCB1	R376T	not specified	VCV001723239	22	24176336	22	23834149	1723239	1780731	NA	NC_000022.11:23834148:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	376	SMARCB1
NM_003073.5(SMARCB1):c.1129C>G (p.Arg377Gly)	SMARCB1	R377G	NK-cell enteropathy	VCV000638627	22	24176338	22	23834151	638627	626407	rs1601446826	NC_000022.11:23834150:C:G	single nucleotide variant	missense variant	Likely pathogenic	Jul 31, 2019	no assertion criteria provided	NA	NA	NA	NA	NA	NA	NA	377	SMARCB1
NM_003073.5(SMARCB1):c.1130G>A (p.Arg377His)	SMARCB1	R377H	not provided|Hereditary cancer-predisposing syndrome	VCV000030203	22	24176339	22	23834152	30203	39159	rs387906812	NC_000022.11:23834151:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 29, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	377	SMARCB1
NM_003073.5(SMARCB1):c.1132C>T (p.Leu378Phe)	SMARCB1	L378F	not provided	VCV001000534	22	24176341	22	23834154	1000534	999356	rs2030838981	NC_000022.11:23834153:C:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	378	SMARCB1
NM_003073.5(SMARCB1):c.1133T>C (p.Leu378Pro)	SMARCB1	L378P	not provided	VCV000916053	22	24176342	22	23834155	916053	904326	rs1410970733	NC_000022.11:23834154:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 16, 2020	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	378	SMARCB1
NM_003073.5(SMARCB1):c.1142C>T (p.Thr381Met)	SMARCB1	T381M	not provided|Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome	VCV000651993	22	24176351	22	23834164	651993	649229	rs1387467529	NC_000022.11:23834163:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	381	SMARCB1
NM_003073.5(SMARCB1):c.1142C>G (p.Thr381Arg)	SMARCB1	T381R	Hereditary cancer-predisposing syndrome|not provided	VCV000623977	22	24176351	22	23834164	623977	613186	rs1387467529	NC_000022.11:23834163:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 21, 2020	criteria provided, conflicting classifications	NA	NA	NA	NA	NA	NA	NA	381	SMARCB1
NM_003073.5(SMARCB1):c.1145C>T (p.Ala382Val)	SMARCB1	A382V	not provided|Hereditary cancer-predisposing syndrome	VCV000822249	22	24176354	22	23834167	822249	815007	rs756129754	NC_000022.11:23834166:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	382	SMARCB1
NM_003073.5(SMARCB1):c.1148C>T (p.Pro383Leu)	SMARCB1	P383L	not provided	VCV001710405	22	24176357	22	23834170	1710405	1708815	NA	NC_000022.11:23834169:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	383	SMARCB1
NM_003073.5(SMARCB1):c.1150G>C (p.Ala384Pro)	SMARCB1	A384P	not specified	VCV001338295	22	24176359	22	23834172	1338295	1329303	rs2146045278	NC_000022.11:23834171:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2017	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	384	SMARCB1
NM_003073.5(SMARCB1):c.1155G>C (p.Trp385Cys)	SMARCB1	W385C	not provided	VCV001306948	22	24176364	22	23834177	1306948	1295897	rs2030841425	NC_000022.11:23834176:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts	NA	NA	NA	NA	NA	NA	NA	385	SMARCB1
NM_003073.5(SMARCB1):c.1155G>T (p.Trp385Cys)	SMARCB1	W385C	not provided	VCV000859091	22	24176364	22	23834177	859091	849104	rs2030841425	NC_000022.11:23834176:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2019	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	385	SMARCB1
NM_003073.5(SMARCB1):c.973A>C (p.Thr325Pro)	SMARCB1	T325P	not provided	VCV003360710	NA	NA	NA	NA	3360710	3519921	NA	NA	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, single submitter	NA	NA	NA	NA	NA	NA	NA	325	SMARCB1
